Citrus Sinensis ID: 010116
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | 2.2.26 [Sep-21-2011] | |||||||
| Q5AP53 | 732 | Serine/threonine-protein | N/A | no | 0.866 | 0.613 | 0.465 | 1e-118 | |
| Q6TGC6 | 507 | Serine/threonine-protein | N/A | no | 0.862 | 0.881 | 0.465 | 1e-118 | |
| Q9Y2H1 | 464 | Serine/threonine-protein | yes | no | 0.841 | 0.939 | 0.480 | 1e-115 | |
| Q7TSE6 | 464 | Serine/threonine-protein | yes | no | 0.841 | 0.939 | 0.475 | 1e-115 | |
| Q6BLJ9 | 716 | Serine/threonine-protein | yes | no | 0.868 | 0.628 | 0.455 | 1e-115 | |
| O13310 | 469 | Serine/threonine-protein | yes | no | 0.862 | 0.953 | 0.452 | 1e-115 | |
| Q5R8M1 | 465 | Serine/threonine-protein | yes | no | 0.841 | 0.937 | 0.477 | 1e-115 | |
| Q15208 | 465 | Serine/threonine-protein | no | no | 0.841 | 0.937 | 0.477 | 1e-115 | |
| Q54Y26 | 530 | Probable serine/threonine | yes | no | 0.851 | 0.832 | 0.454 | 1e-115 | |
| A2VDV2 | 465 | Serine/threonine-protein | no | no | 0.841 | 0.937 | 0.477 | 1e-114 |
| >sp|Q5AP53|CBK1_CANAL Serine/threonine-protein kinase CBK1 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) GN=CBK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 425 bits (1093), Expect = e-118, Method: Compositional matrix adjust.
Identities = 226/485 (46%), Positives = 320/485 (65%), Gaps = 36/485 (7%)
Query: 5 EEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDV-PMEEQIN 63
E + L SK T +K A+ K +EN+Y + + + ER +RR LE K+A+ D+ EE+ N
Sbjct: 250 ERKPNLLSKTTQDKAASIKLTLENYYTSSVSHAIERNQRRLELENKIANEDIGSSEERKN 309
Query: 64 -LIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
+++L +KE++F+RLKR K+ ++DF + +IG+GAFGEVRL ++K +G IYAMK L KS
Sbjct: 310 RQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS 369
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT 182
EM + Q+ HV+AER++LA S IV LYYSFQD++YLYLIME+LPGGD+MT+L+R +
Sbjct: 370 EMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQDSQYLYLIMEFLPGGDLMTMLIRWEV 429
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
TE++ RFYIA+ VLAIE+IHK +IHRDIKPDN+L+D GH+KLSDFGL + +
Sbjct: 430 FTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNILIDNRGHVKLSDFGL-----STGFH 484
Query: 243 AIHEHKTIDDENMAEPMDIDGCFPD--TDNKSS--------WKSPHEQLQHWQMNRRKLA 292
H+ + EP + P+ T ++S S + +Q W+ +RR +A
Sbjct: 485 KTHDSNYYNKLLEKEPSNTH-LQPNQLTSGRNSVMVDAIHLTMSNRQTMQTWRKSRRLMA 543
Query: 293 FSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN 352
+STVGTPDYIAPE+ + +GYG ECDWWSLGAIM+E L+G+PPF +++P T RKI++W+
Sbjct: 544 YSTVGTPDYIAPEIFIHQGYGQECDWWSLGAIMFECLIGWPPFCSENPHDTYRKILNWQE 603
Query: 353 HLKFPDDSKLSPEAKDLICRLLCDVEHRLGT-GGAHQIKAHPWFKDVVWDKLYEMEAAFK 411
+ P+D LSPEA+DLI R L E+R+G GGA +IK HP+F+ V WD + ++A F
Sbjct: 604 SFQIPEDVHLSPEAEDLIKRFLTSAENRIGRYGGAEEIKQHPFFRGVDWDSIRGVQAPFV 663
Query: 412 PEINGELDTQNFMKFDEL----DPPASGR--------TSSGPSRKMLLTPK-DLSFVGYT 458
P ++ DT++F D+L D PA + +G RK PK DL F+GYT
Sbjct: 664 PRLSSMTDTRHFPT-DDLASVPDNPAMSKAMEQRELDAKNGGGRK---NPKEDLPFIGYT 719
Query: 459 YKNFD 463
Y FD
Sbjct: 720 YSRFD 724
|
Serine/threonine-protein kinase required for wild-type hyphal growth and transcriptional regulation of cell-wall-associated genes. Involved in the biofilm formation through phosphorylation of the master regulator of biofilm formation BCR1. Candida albicans (strain SC5314 / ATCC MYA-2876) (taxid: 237561) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6TGC6|CBK1_PNECA Serine/threonine-protein kinase CBK1 OS=Pneumocystis carinii GN=CBK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1090), Expect = e-118, Method: Compositional matrix adjust.
Identities = 212/455 (46%), Positives = 304/455 (66%), Gaps = 8/455 (1%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
+K T E+ A+ K +E+ Y+ ++ ER +RR E KLA E + + L +K
Sbjct: 50 TKTTHERAASVKLKLEHLYKVTVEQTVERNQRRMDFEAKLAQDRGSEERKKRQLNSLGQK 109
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
E++F+RL+R K+ ++DF + +IG+GAFGEVRL ++ +G IYAMK L KSEM K+ Q+
Sbjct: 110 ESQFLRLRRTKLSLNDFHTVKVIGKGAFGEVRLVQKIDTGKIYAMKTLLKSEMFKKDQLA 169
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
HV+AER++LAE S +V LYYSFQD++YLYLIME+LPGGD+MT+L++ DT +E+V RFY
Sbjct: 170 HVKAERDVLAESDSPWVVSLYYSFQDSQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY 229
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA+ +LAIE++HK +IHRDIKPDN+L+DK GH+KLSDFGL + A ++
Sbjct: 230 IAECILAIEAVHKLGFIHRDIKPDNILIDKTGHIKLSDFGLSMGFHKTHDNAYYQRLFES 289
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N + + DT + + S +++ W+ NRR +A+STVGTPDYIAPE+ + G
Sbjct: 290 KINTSTSSTQNSLMVDTISLT--MSSKDKIATWKKNRRIMAYSTVGTPDYIAPEIFTQHG 347
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
YG ECDWWSLGAIM+E L+G+PPF +++ T RKI++WR +L FP+D LS EA+DLI
Sbjct: 348 YGQECDWWSLGAIMFECLIGWPPFCSENAHETYRKIINWRENLYFPEDLHLSAEAEDLIR 407
Query: 372 RLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDP 431
+LL + RLG GA+ IK HP+F+ V WD + E+ A F P++ DT F+E+D
Sbjct: 408 KLLTSADQRLGRYGANDIKLHPFFRGVNWDTIREINAPFIPQLKSITDTS---YFEEIDT 464
Query: 432 PASGRTSSGPSRKMLL---TPKDLSFVGYTYKNFD 463
+ +S P + + ++L+FVGYTYK FD
Sbjct: 465 IPNITMNSPPVLQNKIPSDVDQNLAFVGYTYKRFD 499
|
Protein kinase that seems to play a role in signaling pathways necessary for cell growth and mating. Pneumocystis carinii (taxid: 4754) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens GN=STK38L PE=1 SV=3 | Back alignment and function description |
|---|
Score = 417 bits (1072), Expect = e-115, Method: Compositional matrix adjust.
Identities = 218/454 (48%), Positives = 294/454 (64%), Gaps = 18/454 (3%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T E+V AK +EN Y + +ER+ R+ LE + + EE+ RK
Sbjct: 14 SNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHARK 73
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETEF+RLKR ++ +DDFE L +IGRGAFGEVRL ++K +G+IYAMK L+KS+M+++ QV
Sbjct: 74 ETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKSDMLEKEQVA 133
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
H+RAER++L E +VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FY
Sbjct: 134 HIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 193
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
I+++VLAI++IH+ +IHRDIKPDNLLLD GH+KLSDFGLC L + H+T
Sbjct: 194 ISETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA-------HRTEF 246
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N+ D F + ++K + + W+ NRR+LA+STVGTPDYIAPEV ++ G
Sbjct: 247 YRNLTHNPPSDFSFQNMNSK-------RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG 299
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
Y CDWWSLG IMYEML+GYPPF ++ P T RK+++W+ L FP + +S +AKDLI
Sbjct: 300 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLIL 359
Query: 372 RLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDP 431
R D E+R+G G +IK HP+F+ V W+ + E AA EI DT NF F E D
Sbjct: 360 RFCIDSENRIGNSGVEEIKGHPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDDFPESDI 419
Query: 432 PASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAV 465
++ P K KD F+ YTYK F+ +
Sbjct: 420 LQPVPNTTEPDYK----SKDWVFLNYTYKRFEGL 449
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TSE6|ST38L_MOUSE Serine/threonine-protein kinase 38-like OS=Mus musculus GN=Stk38l PE=1 SV=2 | Back alignment and function description |
|---|
Score = 416 bits (1070), Expect = e-115, Method: Compositional matrix adjust.
Identities = 216/454 (47%), Positives = 293/454 (64%), Gaps = 18/454 (3%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T E+V AK +EN Y + +ER+ R+ LE + + EE+ RK
Sbjct: 14 SNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHARK 73
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETEF+RLKR ++ +DDFE L +IGRGAFGEVRL ++K +G+IYAMK L+K++M+++ QV
Sbjct: 74 ETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVA 133
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
H+RAER++L E +VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FY
Sbjct: 134 HIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 193
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
I+++VLAI++IH+ +IHRD+KPDNLLLD GH+KLSDFGLC L + H+T
Sbjct: 194 ISETVLAIDAIHQLGFIHRDVKPDNLLLDAKGHVKLSDFGLCTGLKKA-------HRTEF 246
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N+ D F + ++K + + W+ NRR+LA+STVGTPDYIAPEV ++ G
Sbjct: 247 YRNLTHNPPSDFSFQNMNSK-------RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG 299
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
Y CDWWSLG IMYEML+G+PPF ++ P T RK++ W+ L FP + +S +AKDLI
Sbjct: 300 YNKLCDWWSLGVIMYEMLIGFPPFCSETPQETYRKVMSWKETLAFPPEVPVSEKAKDLIL 359
Query: 372 RLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDP 431
R D E+R+G GG +IK HP+F+ V W + E AA EI DT NF F E D
Sbjct: 360 RFCTDSENRIGNGGVEEIKGHPFFEGVDWGHIRERPAAIPIEIRSIDDTSNFDDFPESDI 419
Query: 432 PASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAV 465
++ P K KD F+ YTYK F+ +
Sbjct: 420 LQPVPNTTEPDYK----SKDWVFLNYTYKRFEGL 449
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6BLJ9|CBK1_DEBHA Serine/threonine-protein kinase CBK1 OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) GN=CBK1 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 415 bits (1067), Expect = e-115, Method: Compositional matrix adjust.
Identities = 216/474 (45%), Positives = 318/474 (67%), Gaps = 24/474 (5%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLAS--SDVPMEEQINLIKDLE 69
+K+ +K ++ K +EN+Y+ + + ER +RR LE KL + S E + +++L
Sbjct: 237 NKIAQDKASSIKLKLENYYQMSVAHAIERNQRRLDLEHKLLNEESGSSEERKNRQLQNLG 296
Query: 70 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ 129
+KE++F+RL+R K+ ++DF + +IG+GAFGEVRL +++ +G IYAMK L KSEM K+ Q
Sbjct: 297 KKESQFLRLRRTKLSLEDFNTVKVIGKGAFGEVRLVQKRDTGKIYAMKTLLKSEMYKKDQ 356
Query: 130 VEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVAR 189
+ HV+AER++LA S +V LYYSFQD +YLYLIME+LPGGD+MT+L+R TE++ R
Sbjct: 357 LAHVKAERDVLAGSDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIRWQIFTEDITR 416
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
FY+A+ VLAIE+IHK +IHRDIKPDN+L+D GH+KLSDFGL T + + K
Sbjct: 417 FYMAECVLAIEAIHKLGFIHRDIKPDNILIDIRGHIKLSDFGLSTGFH-KTHDSNYYKKL 475
Query: 250 IDDEN--MAEPMDIDGCFPD--TDNKSSW--------KSPHEQLQHWQMNRRKLAFSTVG 297
++ EN P + + P T+N++S S +Q+Q W+ +RR +A+STVG
Sbjct: 476 LEKENPHHTNPQNGNLQAPSMATNNRNSMMVDAIHLTMSNRQQMQTWRKSRRLMAYSTVG 535
Query: 298 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFP 357
TPDYIAPE+ + +GYG ECDWWSLGAIM+E L+G+PPF ++ P T RKI++W+ L+ P
Sbjct: 536 TPDYIAPEIFVHQGYGQECDWWSLGAIMFECLIGWPPFCSETPHETYRKILNWQETLQIP 595
Query: 358 DDSKLSPEAKDLICRLLCDVEHRLGT-GGAHQIKAHPWFKDVVWDKLYEMEAAFKPEING 416
DD LSPE++DLI +LL + E+RLG GA ++K+HP+F+ V WD + +++A F P++
Sbjct: 596 DDIHLSPESEDLIRKLLTNAENRLGRYNGADELKSHPFFRGVDWDTIRKVDAPFIPKLRS 655
Query: 417 ELDTQNFMKFDELD--PPASGRTSSGPSRKMLL-----TPKDLSFVGYTYKNFD 463
DT+ F DEL+ P + + + R +L +DL F+GYTY FD
Sbjct: 656 ITDTR-FFPTDELENVPDSPALSKAMEQRDQVLQNGGNVKEDLPFIGYTYSRFD 708
|
Protein kinase that seems to play a role in the regulation of cell morphogenesis and proliferation. Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) (taxid: 284592) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O13310|ORB6_SCHPO Serine/threonine-protein kinase orb6 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=orb6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1067), Expect = e-115, Method: Compositional matrix adjust.
Identities = 210/464 (45%), Positives = 300/464 (64%), Gaps = 17/464 (3%)
Query: 5 EEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINL 64
E L K T++KV K++IE++Y+ + + ER +RR LE++LA+ E +
Sbjct: 10 ERNPSLFPKSTLDKVQKTKKYIEHYYKVAVDHAVERNQRRINLEQRLATERGSEERKNRQ 69
Query: 65 IKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM 124
++ KE++F+R +R ++ ++DF + +IG+GAFGEVRL ++ +G IYAMK L K+EM
Sbjct: 70 LRASGEKESQFLRFRRTRLSLEDFSTIKVIGKGAFGEVRLVQKLDTGKIYAMKSLLKTEM 129
Query: 125 VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLT 184
KR Q+ HV+AER+LL E S +V LYY+FQD+ YLYLIME+LPGGD+MT+L+ DT +
Sbjct: 130 FKRDQLAHVKAERDLLVESDSPWVVSLYYAFQDSLYLYLIMEFLPGGDLMTMLINYDTFS 189
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL---DCSTL 241
E+V RFY+A+ VLAI +H+ YIHRDIKPDN+L+D++GH+KLSDFGL D S
Sbjct: 190 EDVTRFYMAECVLAIADVHRMGYIHRDIKPDNILIDRDGHIKLSDFGLSTGFYKQDQSAS 249
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
Y K + +D + +K +++ W+ NRR +A+STVGTPDY
Sbjct: 250 YM----KPRTGNTVKRGQMVDAIWLTMSSK-------DKMATWKKNRRVMAYSTVGTPDY 298
Query: 302 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSK 361
IAPE+ L++GYG +CDWWSLGAIM+E L+G+PPF +++ T RKI++WR L FP+D
Sbjct: 299 IAPEIFLQQGYGQDCDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLTFPNDIH 358
Query: 362 LSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQ 421
LS EA+DL+ RL+ D EHRLG GGA +I HP+F + WD + E A F P + DT
Sbjct: 359 LSIEARDLMDRLMTDSEHRLGRGGAIEIMQHPFFTGIDWDHIRETAAPFIPNLKSITDTH 418
Query: 422 NFMKFDELDPPASGRTSSGPSR--KMLLTPKDLSFVGYTYKNFD 463
F DEL+ + P+ L +L+F+GYTYK F+
Sbjct: 419 YF-PVDELEQVPEQPVTQQPASVDPQTLEQTNLAFLGYTYKKFN 461
|
Interacts with pak1/shk1 and coordinates cell morphogenesis with the cell cycle. It is essential for maintenance of cell polarity and is involved in mitotic control. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8M1|STK38_PONAB Serine/threonine-protein kinase 38 OS=Pongo abelii GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1066), Expect = e-115, Method: Compositional matrix adjust.
Identities = 218/457 (47%), Positives = 300/457 (65%), Gaps = 21/457 (4%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T E+V K +EN Y + +ER+ R+ LE+ + + EE+ RK
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETEF+RLKR ++ ++DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
H+RAER++L E S +VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA++VLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L + H+T
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA-------HRTEF 245
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N+ + D F + ++K + + W+ NRR+LAFSTVGTPDYIAPEV ++ G
Sbjct: 246 YRNLNHSLPSDFTFQNMNSK-------RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
Y CDWWSLG IMYEML+GYPPF ++ P T +K+++W+ L FP + +S +AKDLI
Sbjct: 299 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLIL 358
Query: 372 RLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELD- 430
R C+ EHR+G G +IK++ +F+ V W+ + E AA EI DT NF +F E D
Sbjct: 359 RFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDI 418
Query: 431 --PPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAV 465
P + TS+ P KD F+ YTYK F+ +
Sbjct: 419 LKPTVA--TSNHPETD--YKNKDWVFINYTYKRFEGL 451
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q15208|STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1066), Expect = e-115, Method: Compositional matrix adjust.
Identities = 218/457 (47%), Positives = 300/457 (65%), Gaps = 21/457 (4%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T E+V K +EN Y + +ER+ R+ LE+ + + EE+ RK
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETEF+RLKR ++ ++DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
H+RAER++L E S +VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA++VLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L + H+T
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA-------HRTEF 245
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N+ + D F + ++K + + W+ NRR+LAFSTVGTPDYIAPEV ++ G
Sbjct: 246 YRNLNHSLPSDFTFQNMNSK-------RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
Y CDWWSLG IMYEML+GYPPF ++ P T +K+++W+ L FP + +S +AKDLI
Sbjct: 299 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLIL 358
Query: 372 RLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELD- 430
R C+ EHR+G G +IK++ +F+ V W+ + E AA EI DT NF +F E D
Sbjct: 359 RFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDI 418
Query: 431 --PPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAV 465
P + TS+ P KD F+ YTYK F+ +
Sbjct: 419 LKPTVA--TSNHPETD--YKNKDWVFINYTYKRFEGL 451
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y26|NDRA_DICDI Probable serine/threonine-protein kinase ndrA OS=Dictyostelium discoideum GN=ndrA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1064), Expect = e-115, Method: Compositional matrix adjust.
Identities = 219/482 (45%), Positives = 302/482 (62%), Gaps = 41/482 (8%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S+ TM++ AAK +IE +Y ++++ER +RR LE KL + + +E +L K+L++K
Sbjct: 36 SRPTMDRSLAAKMYIEQYYINAQQSVKERGQRRKDLELKLENMKLSSKESNDLRKELDKK 95
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
E+++MR+KR K+ DFE++ IIGRGAFGEV L R ++S ++YAMK+LKKSEM+K+ Q
Sbjct: 96 ESDYMRIKRLKLKRSDFEVIRIIGRGAFGEVSLVRHRESNDLYAMKRLKKSEMLKKEQAA 155
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
HVRAER++LA ++ +VKLYYSFQD YLYLIMEYLPGGDMM+LL++ D TEN ARFY
Sbjct: 156 HVRAERDVLASANTNWVVKLYYSFQDDNYLYLIMEYLPGGDMMSLLIKYDIFTENQARFY 215
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA+++LAIES+H YIHRDIKPDNLLLD GH+KL D GLC L++ ++ +
Sbjct: 216 IAETILAIESVHTLGYIHRDIKPDNLLLDSKGHVKLCDLGLCTGF--HRLHSSEFYQMLV 273
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+ M M + P T E++ W+ RR LA+S VGTPDY APEV L+ G
Sbjct: 274 GDAMTIKMKLIEATPLTQT--------ERIASWKKARRALAYSAVGTPDYTAPEVFLQIG 325
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
Y E DWWSLG I+YEM+VG+PPF +D+ TC KI++ + L+ P D LS E DLI
Sbjct: 326 YNKEVDWWSLGVILYEMVVGHPPFLSDNTTETCLKILNCKETLQIPTDMGLSKEVIDLIK 385
Query: 372 RLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDP 431
RL+C+ + A +IK HP+FK V WD + A F PE+ DT NF ++E+
Sbjct: 386 RLVCEKDR---YKSADEIKLHPFFKGVNWDNIRNQSAPFVPELKSPTDTSNFDIYEEIPN 442
Query: 432 PASGR----------------------TSSGPSRKMLLT------PKDLSFVGYTYKNFD 463
T + P++K + KDL+F+G+T+K FD
Sbjct: 443 DIDDDDNNNNNNSNNNINLNDNINSNCTYTTPTKKSNIMGKGNIKDKDLAFIGFTFKGFD 502
Query: 464 AV 465
AV
Sbjct: 503 AV 504
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2VDV2|STK38_BOVIN Serine/threonine-protein kinase 38 OS=Bos taurus GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1064), Expect = e-114, Method: Compositional matrix adjust.
Identities = 218/457 (47%), Positives = 299/457 (65%), Gaps = 21/457 (4%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T E+V K +EN Y + +ER+ R+ LE+ + + EE+ RK
Sbjct: 13 SSHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETEF+RLKR ++ ++DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
H+RAER++L E S +VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA++VLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L + H+T
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA-------HRTEF 245
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N+ + D F + ++K + + W+ NRR+LAFSTVGTPDYIAPEV ++ G
Sbjct: 246 YRNLNHSLPSDFTFQNMNSK-------RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
Y CDWWSLG IMYEML+GYPPF ++ P T +K+++W+ L FP + +S +AKDLI
Sbjct: 299 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLIL 358
Query: 372 RLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELD- 430
R C+ EHR+G G +IK + +F+ V W+ + E AA EI DT NF +F E D
Sbjct: 359 RFCCEWEHRIGAPGVEEIKNNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDI 418
Query: 431 --PPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAV 465
P + TS+ P KD F+ YTYK F+ +
Sbjct: 419 LKPTVA--TSNHPDTD--YKNKDWVFINYTYKRFEGL 451
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | ||||||
| 343887276 | 538 | serine/threonine-protein kinase [Citrus | 0.984 | 0.947 | 0.862 | 0.0 | |
| 359476253 | 503 | PREDICTED: serine/threonine-protein kina | 0.969 | 0.998 | 0.849 | 0.0 | |
| 449486685 | 514 | PREDICTED: serine/threonine-protein kina | 0.967 | 0.974 | 0.856 | 0.0 | |
| 255550097 | 623 | serine/threonine-protein kinase, putativ | 0.889 | 0.739 | 0.913 | 0.0 | |
| 224092142 | 474 | predicted protein [Populus trichocarpa] | 0.882 | 0.964 | 0.921 | 0.0 | |
| 296081672 | 487 | unnamed protein product [Vitis vinifera] | 0.940 | 1.0 | 0.852 | 0.0 | |
| 357465779 | 509 | Serine/threonine protein kinase 38-like | 0.953 | 0.970 | 0.827 | 0.0 | |
| 356514683 | 503 | PREDICTED: serine/threonine-protein kina | 0.944 | 0.972 | 0.833 | 0.0 | |
| 356507026 | 503 | PREDICTED: serine/threonine-protein kina | 0.944 | 0.972 | 0.837 | 0.0 | |
| 297802680 | 519 | hypothetical protein ARALYDRAFT_913113 [ | 0.982 | 0.980 | 0.816 | 0.0 |
| >gi|343887276|dbj|BAK61822.1| serine/threonine-protein kinase [Citrus unshiu] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2392), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/530 (86%), Positives = 467/530 (88%), Gaps = 20/530 (3%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL
Sbjct: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG
Sbjct: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA
Sbjct: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK
Sbjct: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD 368
KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD
Sbjct: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD 368
Query: 369 LICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDE 428
LICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDE
Sbjct: 369 LICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDE 428
Query: 429 LDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKGLRSLDLKRSLSAKQPSIGSIF 488
+ + +S ++ P S Y L+ L+ ++ G I
Sbjct: 429 WPYKEAPKVASFTVLVFVMVPLQSSLFLNWYSVLSYSWILQHLEELVQDPHERYRCGEIT 488
Query: 489 S--------------------ESAIDNTNKRTAEETEVQMLASSGDPMLP 518
+ ESAIDNTNKRTAEETEVQMLASSGDPMLP
Sbjct: 489 THNGIVHLGDWKWGLGWNCEGESAIDNTNKRTAEETEVQMLASSGDPMLP 538
|
Source: Citrus unshiu Species: Citrus unshiu Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476253|ref|XP_002280119.2| PREDICTED: serine/threonine-protein kinase CBK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/519 (84%), Positives = 465/519 (89%), Gaps = 17/519 (3%)
Query: 1 MEEAE-EEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPME 59
MEE EEEVLGS LTMEKVAAAKQFIENHYR QMK IQERKERRWVLER+LASSDVP E
Sbjct: 1 MEEGSGEEEVLGSSLTMEKVAAAKQFIENHYRTQMKTIQERKERRWVLERRLASSDVPKE 60
Query: 60 EQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL 119
EQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKS NIYAMKKL
Sbjct: 61 EQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSENIYAMKKL 120
Query: 120 KKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR 179
KKSEM+ RGQVEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGDMMTLLMR
Sbjct: 121 KKSEMLIRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMR 180
Query: 180 EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
EDTL+E+VA+FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC
Sbjct: 181 EDTLSESVAKFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCR 240
Query: 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
TL A+ E + +DDEN E MDIDG FPD DN+SSWKSP EQLQHWQMNRRKLAFSTVGTP
Sbjct: 241 TLSALKEDEVMDDENSRESMDIDGGFPDADNRSSWKSPREQLQHWQMNRRKLAFSTVGTP 300
Query: 300 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD 359
DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY+DDP+TTCRKIVHW+NHLKFP+D
Sbjct: 301 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMTTCRKIVHWKNHLKFPED 360
Query: 360 SKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELD 419
KL+ EAKDLI RLLCDVEHRLGTGG QIKAHPWFKDVVWDKLYEMEAAFKPE+NGELD
Sbjct: 361 PKLTAEAKDLIYRLLCDVEHRLGTGGVGQIKAHPWFKDVVWDKLYEMEAAFKPEVNGELD 420
Query: 420 TQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKGLRSLDLKRSLSA 479
T+NFMKFDELDPP R+ SGPSRKMLLTPKDLSFVGYTYKNFDA+KGLR
Sbjct: 421 TRNFMKFDELDPPTQARSGSGPSRKMLLTPKDLSFVGYTYKNFDALKGLR---------- 470
Query: 480 KQPSIGSIFSESAIDNTNKRTAEETEVQMLASSGDPMLP 518
PS G ++ D T + TA++T+VQMLA SGDPM P
Sbjct: 471 --PSSG----DARADYTARETADDTDVQMLAPSGDPMSP 503
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449486685|ref|XP_004157368.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2345), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/510 (85%), Positives = 465/510 (91%), Gaps = 9/510 (1%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
V GS LTMEKVAAAK+FIENHYRAQMKNIQERKERRW+LERKLASSDVP EEQINLIKDL
Sbjct: 14 VQGSSLTMEKVAAAKKFIENHYRAQMKNIQERKERRWMLERKLASSDVPKEEQINLIKDL 73
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSG+IYAMKKLKKSEM+ RG
Sbjct: 74 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGDIYAMKKLKKSEMLMRG 133
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGDMMTLLMREDTLTENVA
Sbjct: 134 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMREDTLTENVA 193
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
+FYIAQSVLAIESIH+HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD TL A+HE+K
Sbjct: 194 KFYIAQSVLAIESIHRHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDSLTLSALHENK 253
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
+DDEN+AEPMDID DN+SSWKSP EQL HWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 254 AMDDENLAEPMDID------DNRSSWKSPSEQLHHWQMNRRKLAFSTVGTPDYIAPEVLL 307
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD 368
KKGYGMECDWWSLGAIMYEMLVGYPPFY+DDPITTCRKIVHW+NHLKFP+D+KL+ EAKD
Sbjct: 308 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPITTCRKIVHWKNHLKFPEDAKLTIEAKD 367
Query: 369 LICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDE 428
LICRLLCDVEHRLGTGGA+QIKAHPWFKDVVWD+LYEMEAAFKPE+NGELDTQNFMKFDE
Sbjct: 368 LICRLLCDVEHRLGTGGAYQIKAHPWFKDVVWDRLYEMEAAFKPEVNGELDTQNFMKFDE 427
Query: 429 LDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKGLRSLDLKRSLSAKQPSIGSIF 488
LDPP G+ SGPSRKMLLTPKDLSFVGYTYKNFDAVKG L + LS KQP I +
Sbjct: 428 LDPPIPGKRGSGPSRKMLLTPKDLSFVGYTYKNFDAVKG--GLHDAQRLSMKQPPI-DVL 484
Query: 489 SESAIDNTNKRTAEETEVQMLASSGDPMLP 518
+ + D T + + E+QM+A SGDPMLP
Sbjct: 485 NGTGGDYTTELIGNDAEMQMVAVSGDPMLP 514
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550097|ref|XP_002516099.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223544585|gb|EEF46101.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 901 bits (2328), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/465 (91%), Positives = 443/465 (95%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
VLGS LTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVP EEQI+LIKDL
Sbjct: 13 VLGSSLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPKEEQISLIKDL 72
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM+ RG
Sbjct: 73 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLMRG 132
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGDMMTLLMREDTLTENVA
Sbjct: 133 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMREDTLTENVA 192
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC+TL I E+K
Sbjct: 193 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCTTLSVIPENK 252
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
TIDD+N EPMDIDG PD DNKS+W+SPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 253 TIDDKNSNEPMDIDGGIPDADNKSNWRSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 312
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD 368
KKGYGMECDWWSLGAIMYEMLVGYPPFY+DDPITTCRKIVHWRNHLKFP+D++L+ EAKD
Sbjct: 313 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPITTCRKIVHWRNHLKFPEDARLTFEAKD 372
Query: 369 LICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDE 428
LI RLLCDVEHRLGTGGA+QIKAHPWF+DVVWDKLYEMEAAFKPE+NGELDTQNFMKFDE
Sbjct: 373 LIYRLLCDVEHRLGTGGANQIKAHPWFRDVVWDKLYEMEAAFKPEVNGELDTQNFMKFDE 432
Query: 429 LDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKGLRSLDL 473
L+ P+ RT SGPSRKMLLTPKDLSFVGYTYKNFDAVKG S +
Sbjct: 433 LNAPSPSRTGSGPSRKMLLTPKDLSFVGYTYKNFDAVKGQHSFGM 477
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224092142|ref|XP_002309485.1| predicted protein [Populus trichocarpa] gi|222855461|gb|EEE93008.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2312), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/458 (92%), Positives = 441/458 (96%), Gaps = 1/458 (0%)
Query: 10 LGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLE 69
LGS LTMEKVAAAKQFIENHYRAQMK I+ERKERRWVLERKLASSDVP EEQ+NLIKDLE
Sbjct: 12 LGSSLTMEKVAAAKQFIENHYRAQMKTIKERKERRWVLERKLASSDVPKEEQMNLIKDLE 71
Query: 70 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ 129
RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM+KRGQ
Sbjct: 72 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLKRGQ 131
Query: 130 VEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVAR 189
VEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGDMMTLL+REDTLTENVA+
Sbjct: 132 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLIREDTLTENVAK 191
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
FYIAQS+LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC+TL IHE+KT
Sbjct: 192 FYIAQSILAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCATLSVIHENKT 251
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309
IDDENM EPMDIDG D DNKSSW+SPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK
Sbjct: 252 IDDENMTEPMDIDGGIADADNKSSWRSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 311
Query: 310 KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDL 369
KGYGMECDWWSLGAI+YEMLVGYPPFY+DDPITTCRKIVHWRNHLKFP+D++LS EAKDL
Sbjct: 312 KGYGMECDWWSLGAILYEMLVGYPPFYSDDPITTCRKIVHWRNHLKFPEDARLSLEAKDL 371
Query: 370 ICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDEL 429
ICRLLCDVEHRLGTGGA+QIKAHPWF DV W+KLYEMEAAFKPE+NGELDT+NFMKFDE
Sbjct: 372 ICRLLCDVEHRLGTGGANQIKAHPWFNDVAWEKLYEMEAAFKPEVNGELDTRNFMKFDES 431
Query: 430 DPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKG 467
DPPA+ RTSSG SRKMLLTPKDLSFVGYTYKNFDAVKG
Sbjct: 432 DPPAAARTSSG-SRKMLLTPKDLSFVGYTYKNFDAVKG 468
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081672|emb|CBI20677.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 894 bits (2309), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/503 (85%), Positives = 453/503 (90%), Gaps = 16/503 (3%)
Query: 16 MEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERKETEF 75
MEKVAAAKQFIENHYR QMK IQERKERRWVLER+LASSDVP EEQINLIKDLERKETEF
Sbjct: 1 MEKVAAAKQFIENHYRTQMKTIQERKERRWVLERRLASSDVPKEEQINLIKDLERKETEF 60
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRA 135
MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKS NIYAMKKLKKSEM+ RGQVEHVRA
Sbjct: 61 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSENIYAMKKLKKSEMLIRGQVEHVRA 120
Query: 136 ERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQS 195
ERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGDMMTLLMREDTL+E+VA+FYIAQS
Sbjct: 121 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMREDTLSESVAKFYIAQS 180
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC TL A+ E + +DDEN
Sbjct: 181 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCRTLSALKEDEVMDDENS 240
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315
E MDIDG FPD DN+SSWKSP EQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME
Sbjct: 241 RESMDIDGGFPDADNRSSWKSPREQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 300
Query: 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC 375
CDWWSLGAIMYEMLVGYPPFY+DDP+TTCRKIVHW+NHLKFP+D KL+ EAKDLI RLLC
Sbjct: 301 CDWWSLGAIMYEMLVGYPPFYSDDPMTTCRKIVHWKNHLKFPEDPKLTAEAKDLIYRLLC 360
Query: 376 DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASG 435
DVEHRLGTGG QIKAHPWFKDVVWDKLYEMEAAFKPE+NGELDT+NFMKFDELDPP
Sbjct: 361 DVEHRLGTGGVGQIKAHPWFKDVVWDKLYEMEAAFKPEVNGELDTRNFMKFDELDPPTQA 420
Query: 436 RTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKGLRSLDLKRSLSAKQPSIGSIFSESAIDN 495
R+ SGPSRKMLLTPKDLSFVGYTYKNFDA+KGLR PS G ++ D
Sbjct: 421 RSGSGPSRKMLLTPKDLSFVGYTYKNFDALKGLR------------PSSG----DARADY 464
Query: 496 TNKRTAEETEVQMLASSGDPMLP 518
T + TA++T+VQMLA SGDPM P
Sbjct: 465 TARETADDTDVQMLAPSGDPMSP 487
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357465779|ref|XP_003603174.1| Serine/threonine protein kinase 38-like protein [Medicago truncatula] gi|355492222|gb|AES73425.1| Serine/threonine protein kinase 38-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2301), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/511 (82%), Positives = 460/511 (90%), Gaps = 17/511 (3%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
VLGS LTMEKVAAAK+FIENHYRAQMKNIQ+RKERRWVLERKLA+SDVP EE++NLIKDL
Sbjct: 15 VLGSSLTMEKVAAAKKFIENHYRAQMKNIQDRKERRWVLERKLATSDVPTEERLNLIKDL 74
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETE+MRLKRHKICV+DF+LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM++RG
Sbjct: 75 ERKETEYMRLKRHKICVNDFDLLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLRRG 134
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD+MTLLMREDTL+ENVA
Sbjct: 135 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDIMTLLMREDTLSENVA 194
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
RFY+AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP+DC TL +HE++
Sbjct: 195 RFYMAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPIDCITLPTLHENQ 254
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
T+DDE +AEPMDID C PD DN+ SW+SP EQLQHWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 255 TMDDETLAEPMDIDSCVPDADNRKSWRSPREQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 314
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD 368
KKGYGMECDWWSLGAIMYEMLVGYPPFY+DDPITTCRKIVHWRNHL+FP+D ++ EAKD
Sbjct: 315 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPITTCRKIVHWRNHLRFPEDPHVTHEAKD 374
Query: 369 LICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDE 428
LI RLLCDV+HRLGT GA +IKAHPWFK V WDKLYEMEAAFKP++NGELDTQNFMKFDE
Sbjct: 375 LIYRLLCDVDHRLGTRGAQEIKAHPWFKGVEWDKLYEMEAAFKPQVNGELDTQNFMKFDE 434
Query: 429 LDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVK-GLRSLDLKRSLSAKQPSIGSI 487
++ P + R SG SRKMLLTPKDL+FVGYTYKNFDAVK GLR
Sbjct: 435 VESPDAARAGSGSSRKMLLTPKDLNFVGYTYKNFDAVKEGLR----------------QS 478
Query: 488 FSESAIDNTNKRTAEETEVQMLASSGDPMLP 518
SES D +KRT +ET +QMLASSGDPMLP
Sbjct: 479 LSESMQDYASKRTTDETGLQMLASSGDPMLP 509
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514683|ref|XP_003526033.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2293), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/511 (83%), Positives = 461/511 (90%), Gaps = 22/511 (4%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
VLGS LTMEKVAAAK+FIENHYRAQMKNIQERKERRWVLERKLASSDVP EE+INLIKDL
Sbjct: 14 VLGSSLTMEKVAAAKKFIENHYRAQMKNIQERKERRWVLERKLASSDVPNEERINLIKDL 73
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETE+MRLKRHKICV+DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM++RG
Sbjct: 74 ERKETEYMRLKRHKICVNDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLRRG 133
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGD+MTLLMREDTL+ENVA
Sbjct: 134 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDIMTLLMREDTLSENVA 193
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC+ L +HE++
Sbjct: 194 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCNALSTLHENQ 253
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
TIDDE +AEPMD+D D DN+SSW+SP EQLQHWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 254 TIDDETLAEPMDVD----DADNRSSWRSPREQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 309
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD 368
KKGYGMECDWWSLGAIMYEMLVGYPPF++DDPITTCRKIVHWRNHL+FPD+++L+ EAKD
Sbjct: 310 KKGYGMECDWWSLGAIMYEMLVGYPPFFSDDPITTCRKIVHWRNHLRFPDEAQLTLEAKD 369
Query: 369 LICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDE 428
LI RLLCDV+HRLGT GA++IKAHPWFK V WDKLYEMEAAFKP++NGELDTQNFMKFDE
Sbjct: 370 LIYRLLCDVDHRLGTRGANEIKAHPWFKGVEWDKLYEMEAAFKPQVNGELDTQNFMKFDE 429
Query: 429 LDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVK-GLRSLDLKRSLSAKQPSIGSI 487
+DPP + RT SG SRKM LT KDLSFVGYTYKNFDAVK GLR
Sbjct: 430 VDPPTAARTGSGSSRKM-LTTKDLSFVGYTYKNFDAVKEGLR----------------QS 472
Query: 488 FSESAIDNTNKRTAEETEVQMLASSGDPMLP 518
F +S + +KR AEET +QMLASSGDPM+P
Sbjct: 473 FGDSMQEYASKRAAEETSLQMLASSGDPMVP 503
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507026|ref|XP_003522272.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2291), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/511 (83%), Positives = 459/511 (89%), Gaps = 22/511 (4%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
VLGS LTMEKVAAAK+FIENHYRAQMKNIQERKERRWVLERKLASSDVP EE+INLIKDL
Sbjct: 14 VLGSSLTMEKVAAAKKFIENHYRAQMKNIQERKERRWVLERKLASSDVPNEERINLIKDL 73
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETE+MRLKRHKICV+DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM++RG
Sbjct: 74 ERKETEYMRLKRHKICVNDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLRRG 133
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGD+MTLLMREDTL+ENVA
Sbjct: 134 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREDTLSENVA 193
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC L +HE++
Sbjct: 194 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCIALSTLHENQ 253
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
TIDDE +AEPMD+D D DN+SSW+SP EQLQHWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 254 TIDDETLAEPMDVD----DADNRSSWRSPREQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 309
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD 368
KKGYGMECDWWSLGAIMYEMLVGYPPFY+DDPITTCRKIVHWRNHL+FPDD++L+ EAKD
Sbjct: 310 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPITTCRKIVHWRNHLRFPDDAQLTLEAKD 369
Query: 369 LICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDE 428
LI RLLCDV+HRLGT GA +IKAHPWFK V WDKLYEMEAAFKP++NGELDTQNFMKFDE
Sbjct: 370 LIYRLLCDVDHRLGTRGAIEIKAHPWFKGVDWDKLYEMEAAFKPQVNGELDTQNFMKFDE 429
Query: 429 LDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVK-GLRSLDLKRSLSAKQPSIGSI 487
+DPP + RT SG SRKM LT KDLSFVGYTYKNFDAVK GLR
Sbjct: 430 VDPPTAARTGSGSSRKM-LTTKDLSFVGYTYKNFDAVKEGLR----------------QS 472
Query: 488 FSESAIDNTNKRTAEETEVQMLASSGDPMLP 518
F +S + +KR AEET +QMLASSGDPM+P
Sbjct: 473 FGDSMQEYASKRAAEETSLQMLASSGDPMVP 503
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297802680|ref|XP_002869224.1| hypothetical protein ARALYDRAFT_913113 [Arabidopsis lyrata subsp. lyrata] gi|297315060|gb|EFH45483.1| hypothetical protein ARALYDRAFT_913113 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 881 bits (2276), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/518 (81%), Positives = 461/518 (88%), Gaps = 9/518 (1%)
Query: 2 EEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQ 61
E +EEVLGS LTMEKVAAAKQ+IENHYRAQ KNIQERKERRW+LERKLASS VP EEQ
Sbjct: 8 ESGTDEEVLGSSLTMEKVAAAKQYIENHYRAQNKNIQERKERRWILERKLASSGVPKEEQ 67
Query: 62 INLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK 121
I++IKDLERKETEFMRLKR+KI VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK
Sbjct: 68 ISMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK 127
Query: 122 SEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED 181
SEMV RGQVEHVRAERNLLAEVASH IVKLYYSFQD EYLYLIMEYLPGGDMMTLLMRED
Sbjct: 128 SEMVMRGQVEHVRAERNLLAEVASHYIVKLYYSFQDPEYLYLIMEYLPGGDMMTLLMRED 187
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
TL E+VARFYIAQSVLAIESIH++NYIHRDIKPDNLLLDK+GHMKLSDFGLCKPLDC L
Sbjct: 188 TLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCRNL 247
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
+I E++ DDE M+EPMD+D CFPDTDNK SW+SP EQLQHWQMNRRKLAFSTVGTPDY
Sbjct: 248 PSIQENRATDDETMSEPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLAFSTVGTPDY 307
Query: 302 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSK 361
IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPI+TCRKIVHWRNHLKFP+D+K
Sbjct: 308 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPISTCRKIVHWRNHLKFPEDAK 367
Query: 362 LSPEAKDLICRLLCDVEHRLGT-GGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDT 420
LS EAKDLICRLLC+V+HRLGT GGA QIK HPWFKDVVW+KLYEMEAA+KPE+NGELDT
Sbjct: 368 LSSEAKDLICRLLCNVDHRLGTGGGAQQIKDHPWFKDVVWEKLYEMEAAYKPEVNGELDT 427
Query: 421 QNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKGLR-SLDLKRSLSA 479
QNFMKFDE++ P RT SGPSRKMLL PKDLSFVGYTYKNFDAVKGLR SL++ R++S
Sbjct: 428 QNFMKFDEVNSPVPERTRSGPSRKMLLAPKDLSFVGYTYKNFDAVKGLRHSLEMARTMSL 487
Query: 480 KQPSIGSIFSESAIDNTNKRTAEETEVQMLASSGDPML 517
+ ++ E + E E Q+++S DPM+
Sbjct: 488 DRSPAEAMPVELI-------SGEAAEAQIVSSMDDPMI 518
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | ||||||
| TAIR|locus:2125894 | 519 | AT4G33080 [Arabidopsis thalian | 0.982 | 0.980 | 0.810 | 3.4e-228 | |
| TAIR|locus:2047590 | 527 | AT2G19400 [Arabidopsis thalian | 0.976 | 0.960 | 0.718 | 1.7e-202 | |
| TAIR|locus:2090925 | 568 | AT3G23310 [Arabidopsis thalian | 0.928 | 0.846 | 0.668 | 1.2e-177 | |
| TAIR|locus:2129650 | 551 | AT4G14350 [Arabidopsis thalian | 0.924 | 0.869 | 0.678 | 2.5e-177 | |
| TAIR|locus:2024167 | 569 | AT1G03920 [Arabidopsis thalian | 0.928 | 0.845 | 0.658 | 6.9e-173 | |
| TAIR|locus:2054784 | 569 | AT2G20470 [Arabidopsis thalian | 0.936 | 0.852 | 0.630 | 8.2e-170 | |
| TAIR|locus:2178208 | 516 | AT5G09890 [Arabidopsis thalian | 0.924 | 0.928 | 0.612 | 3.5e-162 | |
| TAIR|locus:2204574 | 562 | AT1G30640 [Arabidopsis thalian | 0.907 | 0.836 | 0.614 | 1.1e-158 | |
| CGD|CAL0006211 | 732 | CBK1 [Candida albicans (taxid: | 0.876 | 0.620 | 0.470 | 4.3e-109 | |
| UNIPROTKB|Q5AP53 | 732 | CBK1 "Serine/threonine-protein | 0.876 | 0.620 | 0.470 | 4.3e-109 |
| TAIR|locus:2125894 AT4G33080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2202 (780.2 bits), Expect = 3.4e-228, P = 3.4e-228
Identities = 420/518 (81%), Positives = 458/518 (88%)
Query: 2 EEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQ 61
E +EEVLGS LTMEKVAAAKQ+IENHY+AQ KNIQERKERRW+LERKLASS VP EEQ
Sbjct: 8 ENGTDEEVLGSSLTMEKVAAAKQYIENHYKAQNKNIQERKERRWILERKLASSGVPKEEQ 67
Query: 62 INLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK 121
IN+IKDLERKETEFMRLKR+KI VDDFELLTIIGRGAFGEVRLCRE+KSGNIYAMKKLKK
Sbjct: 68 INMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCRERKSGNIYAMKKLKK 127
Query: 122 SEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED 181
SEMV RGQVEHVRAERNLLAEV SH IVKLYYSFQD EYLYLIMEYLPGGDMMTLLMRED
Sbjct: 128 SEMVMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYLIMEYLPGGDMMTLLMRED 187
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
TL E+VARFYIAQSVLAIESIH++NYIHRDIKPDNLLLDK+GHMKLSDFGLCKPLDC L
Sbjct: 188 TLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCRNL 247
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
+I E++ DDE M+EPMD+D CFPDTDNK SW+SP EQLQHWQMNRRKLAFSTVGTPDY
Sbjct: 248 PSIQENRATDDETMSEPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLAFSTVGTPDY 307
Query: 302 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSK 361
IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPI+TCRKIVHWRNHLKFP+D+K
Sbjct: 308 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPISTCRKIVHWRNHLKFPEDAK 367
Query: 362 LSPEAKDLICRLLCDVEHRLGTGG-AHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDT 420
S EAKDLICRLLC+V+HRLGTGG A QIK HPWFKDVVW+KLYEMEAA+KPE+N ELDT
Sbjct: 368 FSSEAKDLICRLLCNVDHRLGTGGGAQQIKDHPWFKDVVWEKLYEMEAAYKPEVNDELDT 427
Query: 421 QNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKGLR-SLDLKRSLSA 479
QNFMKFDE++ PA RT SG SRKMLL PKDLSFVGYTYKNFDAVKGLR SL++ R++S
Sbjct: 428 QNFMKFDEVNSPAPERTRSGLSRKMLLAPKDLSFVGYTYKNFDAVKGLRHSLEMARTMSL 487
Query: 480 KQPSIGSIFSESAIDNTNKRTAEETEVQMLASSGDPML 517
+ ++ E + E E QM++S DPM+
Sbjct: 488 DRSPAEAMPVELI-------SGEAAEAQMVSSMDDPMI 518
|
|
| TAIR|locus:2047590 AT2G19400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1939 (687.6 bits), Expect = 1.7e-202, Sum P(2) = 1.7e-202
Identities = 367/511 (71%), Positives = 434/511 (84%)
Query: 1 MEEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEE 60
+E+ E+E L S T+EKVAAAK++IENHY +M++IQ+RKERRWVLE+K+AS DV +E
Sbjct: 18 VEDNFEDEGLVSNSTLEKVAAAKKYIENHYNRRMRHIQQRKERRWVLEQKIASLDVSEKE 77
Query: 61 QINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK 120
Q+ L++DL+RKETE+ RL R+++CVDDF+LL+IIGRGAFGEVRLCREKK+GNIYAMKKLK
Sbjct: 78 QLELLEDLQRKETEYTRLMRNRLCVDDFDLLSIIGRGAFGEVRLCREKKTGNIYAMKKLK 137
Query: 121 KSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE 180
KSEM+ RGQVEHVRAERNLLAEVAS CIVKLYYSFQD EYLYLIMEYL GGD+MTLLMRE
Sbjct: 138 KSEMLSRGQVEHVRAERNLLAEVASDCIVKLYYSFQDPEYLYLIMEYLSGGDVMTLLMRE 197
Query: 181 DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
+TLTE VARFYIAQSVLAIESIHKHNY+HRDIKPDNLLLDK GHMKLSDFGLCKPLDC
Sbjct: 198 ETLTETVARFYIAQSVLAIESIHKHNYVHRDIKPDNLLLDKYGHMKLSDFGLCKPLDCRN 257
Query: 241 LYAIHEHKTIDDENMAEPMDID-GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
+ A++ ++ ++DEN+ E +D D C + WKSP EQLQHWQ+NRRKLA+STVGTP
Sbjct: 258 ISAMNVNEPLNDENINESIDGDENCSIGRRGRR-WKSPLEQLQHWQINRRKLAYSTVGTP 316
Query: 300 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD 359
DYIAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFY+DDP+TTCRKIV WR HL FP+
Sbjct: 317 DYIAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVSWRTHLVFPEG 376
Query: 360 SKLSPEAKDLICRLLCDVEHRLGT--GGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGE 417
++L+PEA+DLICRLLCD EHRLG+ GA QIKAH WFKDV W+KLYEM+AAFKP +NGE
Sbjct: 377 ARLTPEARDLICRLLCDSEHRLGSHGAGAEQIKAHTWFKDVEWEKLYEMDAAFKPVVNGE 436
Query: 418 LDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKGLR-SLDLKRS 476
LDTQNFMKFDE++ P RT SGPS K+ +TP++++FVGYTY+NFDAV+G R SLD+K S
Sbjct: 437 LDTQNFMKFDEVECPKPARTGSGPSWKVSITPQNINFVGYTYRNFDAVRGSRHSLDIKGS 496
Query: 477 LSAKQPSIGSIFSESAIDNTNKRTAEETEVQ 507
+S + S S S+SAID T T + Q
Sbjct: 497 VSPPRSSTDSTRSDSAIDYTKLSTGGDGSQQ 527
|
|
| TAIR|locus:2090925 AT3G23310 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1725 (612.3 bits), Expect = 1.2e-177, P = 1.2e-177
Identities = 331/495 (66%), Positives = 404/495 (81%)
Query: 7 EEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIK 66
EE + S +T +K AAAKQ+IENHY+ Q+++ Q+RKERR +LE KLA+++V EEQ NL+K
Sbjct: 40 EEAV-SNVTKQKAAAAKQYIENHYKKQVQSQQQRKERRDMLENKLAAAEVSEEEQKNLLK 98
Query: 67 DLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK 126
DLE+KETE+MR +RHK+ DDFE LT+IG+GAFGEVR+CREK +GN+YAMKKLKKSEM++
Sbjct: 99 DLEKKETEYMRRQRHKMGTDDFEPLTMIGKGAFGEVRICREKTTGNVYAMKKLKKSEMLR 158
Query: 127 RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN 186
RGQVEHV+AERNLLAEV S+CIVKLY SFQD EYLYLIMEYLPGGDMMTLLMR+DTLTE+
Sbjct: 159 RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTED 218
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246
ARFY+ ++VLAIESIHKHNYIHRDIKPDNLLLD++GHMKLSDFGLCKPLDCS L E
Sbjct: 219 EARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRSGHMKLSDFGLCKPLDCSIL---QE 275
Query: 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306
+ N++ + DG P ++ +S EQLQ+WQ NRR LA+STVGTPDYIAPEV
Sbjct: 276 KDFVVAHNLSGALQSDGR-PVAPRRT--RSQMEQLQNWQRNRRMLAYSTVGTPDYIAPEV 332
Query: 307 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEA 366
LLKKGYGMECDWWSLGAIMYEMLVG+PPFY+D+P+TTCRKIV+W+N+LKFPD+ +LSPEA
Sbjct: 333 LLKKGYGMECDWWSLGAIMYEMLVGFPPFYSDEPMTTCRKIVNWKNYLKFPDEVRLSPEA 392
Query: 367 KDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKF 426
KDLICRLLC+VE R+GT GA++IK HPWF V W+KLY+M+AAF P++N ELDTQNF KF
Sbjct: 393 KDLICRLLCNVEQRIGTKGANEIKEHPWFSGVEWEKLYQMKAAFIPQVNDELDTQNFEKF 452
Query: 427 DELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVK-----GLRSLDLKRSLSAKQ 481
+E D SGP RKML + KD++FVGYTYKN + V G+ L K+S K+
Sbjct: 453 EETDKQVPKTPKSGPWRKML-SSKDINFVGYTYKNVEIVNHDQLPGIAELK-KKSTKPKR 510
Query: 482 PSIGSIFSESAIDNT 496
PSI S+F + + +T
Sbjct: 511 PSIKSLFEDESASST 525
|
|
| TAIR|locus:2129650 AT4G14350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1722 (611.2 bits), Expect = 2.5e-177, P = 2.5e-177
Identities = 336/495 (67%), Positives = 398/495 (80%)
Query: 7 EEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIK 66
EE L S +T EK AAAK +IENHY+ QM+++QERKERR +LE+KLA+++V EEQ NL+K
Sbjct: 39 EEAL-SNITKEKAAAAKLYIENHYKMQMQSLQERKERRKMLEKKLAAAEVSEEEQNNLLK 97
Query: 67 DLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK 126
DLE KETE+MR +RHK+ DDFE LT+IG+GAFGEVR+CREK +GN+YAMKKLKKSEM++
Sbjct: 98 DLEMKETEYMRRQRHKMGADDFEPLTMIGKGAFGEVRICREKGTGNVYAMKKLKKSEMLR 157
Query: 127 RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN 186
RGQVEHV+AERNLLAEV S+CIVKLY SFQD EYLYLIMEYLPGGDMMTLLMR+DTLTE+
Sbjct: 158 RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTED 217
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246
ARFYI ++VLAIESIHKHNYIHRDIKPDNLLLDK+GHMKLSDFGLCKPLDCS L +
Sbjct: 218 EARFYIGETVLAIESIHKHNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCSNLQ--EK 275
Query: 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306
T+ N++ + DG P ++ EQL +WQ NRR LA+STVGTPDYIAPEV
Sbjct: 276 DFTVA-RNVSGALQSDGR-PVATRRTQ----QEQLLNWQRNRRMLAYSTVGTPDYIAPEV 329
Query: 307 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEA 366
LLKKGYGMECDWWSLGAIMYEMLVG+PPFY+DDP+TTCRKIV+WRN+LKFPD+ +LSPEA
Sbjct: 330 LLKKGYGMECDWWSLGAIMYEMLVGFPPFYSDDPMTTCRKIVNWRNYLKFPDEVRLSPEA 389
Query: 367 KDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKF 426
KDLICRLLC+VE RLGT GA +IK HPWF+ W KLY+M+AAF P++N ELDTQNF KF
Sbjct: 390 KDLICRLLCNVEQRLGTKGADEIKGHPWFRGTEWGKLYQMKAAFIPQVNDELDTQNFEKF 449
Query: 427 DELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNF-----DAVKGLRSLDLKRSLSAKQ 481
+E D SGP RKML + KD++FVGYTYKN D + G+ L K+S K+
Sbjct: 450 EETDKQVPKSAKSGPWRKML-SSKDINFVGYTYKNVEIVNDDQIPGIAELK-KKSNKPKR 507
Query: 482 PSIGSIFSESAIDNT 496
PSI S+F + T
Sbjct: 508 PSIKSLFEDETSGGT 522
|
|
| TAIR|locus:2024167 AT1G03920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1680 (596.4 bits), Expect = 6.9e-173, P = 6.9e-173
Identities = 328/498 (65%), Positives = 398/498 (79%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T +KVAAAKQ+IENHY+ QMKN+ ERKERR LE+KLA +DV E+Q NL+K LE+K
Sbjct: 61 SNSTKQKVAAAKQYIENHYKEQMKNLNERKERRTTLEKKLADADVCEEDQTNLMKFLEKK 120
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETE+MRL+RHK+ DDFELLT+IG+GAFGEVR+ RE +G+++AMKKLKKSEM++RGQVE
Sbjct: 121 ETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVVREINTGHVFAMKKLKKSEMLRRGQVE 180
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
HVRAERNLLAEV S+CIVKLY SFQD EYLYLIMEYLPGGDMMTLLMR+DTL+E+ A+FY
Sbjct: 181 HVRAERNLLAEVDSNCIVKLYCSFQDNEYLYLIMEYLPGGDMMTLLMRKDTLSEDEAKFY 240
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA+SVLAIESIH NYIHRDIKPDNLLLD+ GH++LSDFGLCKPLDCS ID
Sbjct: 241 IAESVLAIESIHNRNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSV---------ID 291
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
E+ G ++ + + +S EQL+HWQ NRR LA+STVGTPDYIAPEVLLKKG
Sbjct: 292 GEDFTVGNAGSGGGSESVSTTPKRSQQEQLEHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 351
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
YGMECDWWSLGAIMYEMLVGYPPFYADDP++TCRKIV+W+ HLKFP++S+LS A+DLI
Sbjct: 352 YGMECDWWSLGAIMYEMLVGYPPFYADDPMSTCRKIVNWKTHLKFPEESRLSRGARDLIG 411
Query: 372 RLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDP 431
+LLC V RLG+ GA QIKAHPWF+ V W+K+Y+MEAAF PE+N +LDTQNF KFDE D
Sbjct: 412 KLLCSVNQRLGSTGASQIKAHPWFEGVQWEKIYQMEAAFIPEVNDDLDTQNFEKFDEEDN 471
Query: 432 PASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVK-----GLRSLDLKRSLSAKQPSIGS 486
+ +GP RKML + KD++FVGYTYKNF+ V G+ L K S S K+PS+ S
Sbjct: 472 QTQAPSRTGPWRKML-SSKDINFVGYTYKNFEIVNDYQVPGIAELKKKESKS-KRPSVKS 529
Query: 487 IFSESAIDNTNKRTAEET 504
+F ES D+++ + ++T
Sbjct: 530 LF-ESESDSSSSGSEQQT 546
|
|
| TAIR|locus:2054784 AT2G20470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1651 (586.2 bits), Expect = 8.2e-170, P = 8.2e-170
Identities = 319/506 (63%), Positives = 400/506 (79%)
Query: 3 EAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQI 62
E +EE V S T +KVAAAKQ+IENHY+ QMK +QERKERR +LE+KLA +DV E+Q
Sbjct: 41 ETDEEAV--SNTTKQKVAAAKQYIENHYKEQMKILQERKERRSMLEQKLADADVSEEDQN 98
Query: 63 NLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
NL+K LE+KETE+MRL+RHK+ V DF+LLT+IG+GAFGEVR+CREK +G +YAMKKLKK+
Sbjct: 99 NLLKFLEKKETEYMRLQRHKLGVADFDLLTMIGKGAFGEVRVCREKTTGQVYAMKKLKKA 158
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT 182
EM++RGQVEHVRAERNLLAEV S+ IVKLY SFQD ++LYL+MEYLPGGDMMTLLMR+DT
Sbjct: 159 EMLRRGQVEHVRAERNLLAEVDSNYIVKLYCSFQDDDHLYLVMEYLPGGDMMTLLMRKDT 218
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
LTE A+FY+A++VLAIESIH+HNYIHRDIKPDNLLLD+ GH++LSDFGLCKPLDCS
Sbjct: 219 LTEEEAKFYVAETVLAIESIHRHNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCS--- 275
Query: 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302
AI E+ ++ N + + P ++ EQL+HWQ NRR LA+STVGTPDYI
Sbjct: 276 AIGENDFSNNSNGSTEQEAGSTAPK-------RTQQEQLEHWQRNRRTLAYSTVGTPDYI 328
Query: 303 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKL 362
APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY+DDP++TCRKIV+W++HLKFP+++ L
Sbjct: 329 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWKSHLKFPEEAIL 388
Query: 363 SPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQN 422
S EAKDLI LLC V RLG+ GA ++KAH WF+ V WD +++M+AAF PE+N +LDTQN
Sbjct: 389 SREAKDLINSLLCSVRRRLGSKGADELKAHTWFETVDWDTIFDMDAAFVPEVNDDLDTQN 448
Query: 423 FMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKGLR---SLDLKRSLSA 479
F KFDE + + SGP RKML + KD++FVGYTYKNF+ V + +LK+ +
Sbjct: 449 FEKFDESESETQTSSKSGPWRKML-SSKDINFVGYTYKNFEIVNDYQVPGMAELKKKKKS 507
Query: 480 KQPSIGSIFSESAIDNTNKRTAEETE 505
+P + S+F DN + T++ +E
Sbjct: 508 TRPMVKSLF-----DNGSSETSDSSE 528
|
|
| TAIR|locus:2178208 AT5G09890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1579 (560.9 bits), Expect = 3.5e-162, P = 3.5e-162
Identities = 299/488 (61%), Positives = 379/488 (77%)
Query: 3 EAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQI 62
E E + + S +T +K AAAKQFIENHY+ ++ + ER ERR +RK+ + +P+EEQ
Sbjct: 17 ETETDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHERMERRREFQRKVQEAQLPVEEQD 76
Query: 63 NLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
++++L R+ETE+MRL+R KI +DDFELLT+IG+GAFGEVRLCR + + +YAMKKLKK+
Sbjct: 77 EMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLCRLRSTSEVYAMKKLKKT 136
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT 182
EM+ RGQVEHVR+ERNLLAEV S IVKL+YSFQD+E LYLIMEYLPGGD+MTLLMRED
Sbjct: 137 EMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIMEYLPGGDIMTLLMREDI 196
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
L+E+VARFYIA+S+LAI SIH+HNY+HRDIKPDNL+LDK+GH+KLSDFGLCKPLD
Sbjct: 197 LSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKSGHLKLSDFGLCKPLDDKYSS 256
Query: 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302
+ E DDE +++ + D D K+ W+ P EQL W+ NRR LA+STVGT DY+
Sbjct: 257 LLLE----DDEMLSQDSENQSGKSDAD-KAPWQMPKEQLLQWKRNRRALAYSTVGTLDYM 311
Query: 303 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKL 362
APEVLLKKGYGMECDWWSLGAI+YEMLVGYPPF +DDP TCRKI++WR LKFP++ K+
Sbjct: 312 APEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCRKIINWRVCLKFPEEPKI 371
Query: 363 SPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQN 422
S EA+DLICRLLCDV+ RLGT G +IK+HPWFK WDKLY+MEAA++P ++GELDTQN
Sbjct: 372 SDEARDLICRLLCDVDSRLGTRGVEEIKSHPWFKGTPWDKLYDMEAAYRPIVDGELDTQN 431
Query: 423 FMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKGLRS---LDLKRSLSA 479
F KF E++ S GP RKML T KD +F+G+T+K D + + S D+K + S
Sbjct: 432 FEKFPEVEGSPSEAPQVGPWRKML-TSKDTNFIGFTFKKSDITRSMESSGSADMKSNGSG 490
Query: 480 KQPSIGSI 487
+ PS+ S+
Sbjct: 491 EAPSLISL 498
|
|
| TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1546 (549.3 bits), Expect = 1.1e-158, P = 1.1e-158
Identities = 297/483 (61%), Positives = 378/483 (78%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T +KVAAAKQ+IENHY+ Q K++QERKERR +LE+ LA +DV +E++++++K+ E+K
Sbjct: 44 SNATKQKVAAAKQYIENHYKIQKKSLQERKERRSILEQNLADADVTVEDKMDILKNFEKK 103
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
E E+MRL+R K+ VDDFELL+IIGRGAFGEVR+C+EK +G++YAMKKLKKSEM++RGQVE
Sbjct: 104 EMEYMRLQRQKMGVDDFELLSIIGRGAFGEVRICKEKSTGSVYAMKKLKKSEMLRRGQVE 163
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
HV+AERN+LAEV S IVKL YSFQD E+LYLIMEYLPGGDMMTLLMR+DTL E+ RFY
Sbjct: 164 HVKAERNVLAEVDSPFIVKLCYSFQDDEHLYLIMEYLPGGDMMTLLMRKDTLREDETRFY 223
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
+AQ++LAIESIHKHNY+HRDIKPDNLL+ +NGH+KLSDFGL K L+ S + + + +D
Sbjct: 224 VAQTILAIESIHKHNYVHRDIKPDNLLITRNGHIKLSDFGLSKSLE-SKNFPDFKAELVD 282
Query: 252 DENM-AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310
A D P ++ EQL HWQ NRR LAFSTVGTPDYIAPEVLLKK
Sbjct: 283 RSTKPAAEHDRLSKPPSAPRRTQ----QEQLLHWQQNRRTLAFSTVGTPDYIAPEVLLKK 338
Query: 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLI 370
GYGMECDWWSLGAIM+EMLVG+PPFY+++P+ TCRKIV+W+ LKFPD++KLS E KDLI
Sbjct: 339 GYGMECDWWSLGAIMFEMLVGFPPFYSEEPLATCRKIVNWKTCLKFPDEAKLSIEVKDLI 398
Query: 371 CRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELD 430
RLLC+VE RLGT G H+IKAHPWF+ V W++LYE A + P++ ELDTQNF KFDE+
Sbjct: 399 RRLLCNVEQRLGTKGVHEIKAHPWFRGVEWERLYESNAPYIPQVKHELDTQNFEKFDEVP 458
Query: 431 PPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVK-----GLRSLDLKRSLSAKQPSIG 485
+ S P RKM+ + KD +F+GYT+KN + V G+ L ++S +A +PS+
Sbjct: 459 STCQTSSKSSPWRKMI-SSKDANFLGYTFKNLEIVDEHHIPGMAELK-RKSKTANKPSLK 516
Query: 486 SIF 488
++F
Sbjct: 517 TLF 519
|
|
| CGD|CAL0006211 CBK1 [Candida albicans (taxid:5476)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
Identities = 226/480 (47%), Positives = 319/480 (66%)
Query: 5 EEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDV-PMEEQIN 63
E + L SK T +K A+ K +EN+Y + + + ER +RR LE K+A+ D+ EE+ N
Sbjct: 250 ERKPNLLSKTTQDKAASIKLTLENYYTSSVSHAIERNQRRLELENKIANEDIGSSEERKN 309
Query: 64 L-IKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
+++L +KE++F+RLKR K+ ++DF + +IG+GAFGEVRL ++K +G IYAMK L KS
Sbjct: 310 RQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS 369
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT 182
EM + Q+ HV+AER++LA S IV LYYSFQD++YLYLIME+LPGGD+MT+L+R +
Sbjct: 370 EMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQDSQYLYLIMEFLPGGDLMTMLIRWEV 429
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
TE++ RFYIA+ VLAIE+IHK +IHRDIKPDN+L+D GH+KLSDFGL T
Sbjct: 430 FTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNILIDNRGHVKLSDFGLSTGFH-KTHD 488
Query: 243 AIHEHKTIDDE--NM-AEPMDIDGCFPDT--DNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297
+ + +K ++ E N +P + D S + +Q W+ +RR +A+STVG
Sbjct: 489 SNYYNKLLEKEPSNTHLQPNQLTSGRNSVMVDAIHLTMSNRQTMQTWRKSRRLMAYSTVG 548
Query: 298 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFP 357
TPDYIAPE+ + +GYG ECDWWSLGAIM+E L+G+PPF +++P T RKI++W+ + P
Sbjct: 549 TPDYIAPEIFIHQGYGQECDWWSLGAIMFECLIGWPPFCSENPHDTYRKILNWQESFQIP 608
Query: 358 DDSKLSPEAKDLICRLLCDVEHRLGT-GGAHQIKAHPWFKDVVWDKLYEMEAAFKPEING 416
+D LSPEA+DLI R L E+R+G GGA +IK HP+F+ V WD + ++A F P ++
Sbjct: 609 EDVHLSPEAEDLIKRFLTSAENRIGRYGGAEEIKQHPFFRGVDWDSIRGVQAPFVPRLSS 668
Query: 417 ELDTQNFMKFDEL----DPPASGRT--------SSGPSRKMLLTPK-DLSFVGYTYKNFD 463
DT++F D+L D PA + +G RK PK DL F+GYTY FD
Sbjct: 669 MTDTRHFPT-DDLASVPDNPAMSKAMEQRELDAKNGGGRK---NPKEDLPFIGYTYSRFD 724
|
|
| UNIPROTKB|Q5AP53 CBK1 "Serine/threonine-protein kinase CBK1" [Candida albicans SC5314 (taxid:237561)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
Identities = 226/480 (47%), Positives = 319/480 (66%)
Query: 5 EEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDV-PMEEQIN 63
E + L SK T +K A+ K +EN+Y + + + ER +RR LE K+A+ D+ EE+ N
Sbjct: 250 ERKPNLLSKTTQDKAASIKLTLENYYTSSVSHAIERNQRRLELENKIANEDIGSSEERKN 309
Query: 64 L-IKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
+++L +KE++F+RLKR K+ ++DF + +IG+GAFGEVRL ++K +G IYAMK L KS
Sbjct: 310 RQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS 369
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT 182
EM + Q+ HV+AER++LA S IV LYYSFQD++YLYLIME+LPGGD+MT+L+R +
Sbjct: 370 EMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQDSQYLYLIMEFLPGGDLMTMLIRWEV 429
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
TE++ RFYIA+ VLAIE+IHK +IHRDIKPDN+L+D GH+KLSDFGL T
Sbjct: 430 FTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNILIDNRGHVKLSDFGLSTGFH-KTHD 488
Query: 243 AIHEHKTIDDE--NM-AEPMDIDGCFPDT--DNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297
+ + +K ++ E N +P + D S + +Q W+ +RR +A+STVG
Sbjct: 489 SNYYNKLLEKEPSNTHLQPNQLTSGRNSVMVDAIHLTMSNRQTMQTWRKSRRLMAYSTVG 548
Query: 298 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFP 357
TPDYIAPE+ + +GYG ECDWWSLGAIM+E L+G+PPF +++P T RKI++W+ + P
Sbjct: 549 TPDYIAPEIFIHQGYGQECDWWSLGAIMFECLIGWPPFCSENPHDTYRKILNWQESFQIP 608
Query: 358 DDSKLSPEAKDLICRLLCDVEHRLGT-GGAHQIKAHPWFKDVVWDKLYEMEAAFKPEING 416
+D LSPEA+DLI R L E+R+G GGA +IK HP+F+ V WD + ++A F P ++
Sbjct: 609 EDVHLSPEAEDLIKRFLTSAENRIGRYGGAEEIKQHPFFRGVDWDSIRGVQAPFVPRLSS 668
Query: 417 ELDTQNFMKFDEL----DPPASGRT--------SSGPSRKMLLTPK-DLSFVGYTYKNFD 463
DT++F D+L D PA + +G RK PK DL F+GYTY FD
Sbjct: 669 MTDTRHFPT-DDLASVPDNPAMSKAMEQRELDAKNGGGRK---NPKEDLPFIGYTYSRFD 724
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9Y2H1 | ST38L_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.4801 | 0.8416 | 0.9396 | yes | no |
| Q7TSE6 | ST38L_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.4757 | 0.8416 | 0.9396 | yes | no |
| Q5R8M1 | STK38_PONAB | 2, ., 7, ., 1, 1, ., 1 | 0.4770 | 0.8416 | 0.9376 | yes | no |
| Q54Y26 | NDRA_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.4543 | 0.8513 | 0.8320 | yes | no |
| Q2L6W9 | SAX1_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.4460 | 0.8918 | 0.9705 | yes | no |
| O13310 | ORB6_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.4525 | 0.8629 | 0.9530 | yes | no |
| Q2LZZ7 | TRC_DROPS | 2, ., 7, ., 1, 1, ., 1 | 0.4823 | 0.8378 | 0.9475 | yes | no |
| Q9NBK5 | TRC_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.4766 | 0.8571 | 0.9589 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_VI001527 | hypothetical protein (474 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 518 | |||
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.0 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-170 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-157 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-132 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-130 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-127 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-116 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-116 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-114 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-113 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-111 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-106 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-106 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-100 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-100 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-96 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-95 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-91 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-89 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-89 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-84 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-82 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-81 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-81 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-80 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-78 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-77 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-75 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-75 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-71 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-70 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-69 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-68 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-68 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-67 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-66 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-64 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-63 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-63 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-61 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-61 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-60 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-59 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-57 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-55 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-55 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-53 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-52 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-51 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-50 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-50 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-50 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-50 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-49 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-49 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-49 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-47 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-45 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-45 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-44 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-43 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-42 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-42 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-42 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-42 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-40 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-40 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-39 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-39 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-35 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-34 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-34 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-33 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-32 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-32 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-30 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-29 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-28 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-28 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-28 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-28 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-26 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-26 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-25 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-24 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-24 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-21 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-20 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-20 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-07 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-05 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.001 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.001 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.002 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.003 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.004 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 594 bits (1534), Expect = 0.0
Identities = 219/378 (57%), Positives = 271/378 (71%), Gaps = 14/378 (3%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE + +IGRGAFGEVRL ++K +G+IYAMKKL+KSEM+++ QV HVRAER++LAE +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+VKLYYSFQD YLYLIMEYLPGGDMMTLLM++DT TE RFYIA+++LAI+SIHK
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
YIHRDIKPDNLLLD GH+KLSDFGLC L S H+T ++ + F
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS-------HRTEFYRILSH--ALPSNF 171
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
D +K S + + W+ NRR LA+STVGTPDYIAPEV L+ GY ECDWWSLG IM
Sbjct: 172 LDFISKP--MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGG 385
YEMLVGYPPF +D+P T RKI++W+ L+FPD+ LSPEAKDLI RL C+ E RLG G
Sbjct: 230 YEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNG 289
Query: 386 AHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKM 445
++IK+HP+FK V W+ + E A PE+ DT NF F+E+D TS GP R
Sbjct: 290 VNEIKSHPFFKGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVP--TSPGPPRGK 347
Query: 446 LLTPKDLSFVGYTYKNFD 463
+ KDL+F+GYTYK F+
Sbjct: 348 -IKSKDLAFIGYTYKRFE 364
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 483 bits (1246), Expect = e-170
Identities = 196/375 (52%), Positives = 253/375 (67%), Gaps = 25/375 (6%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE++ +IGRGAFGEV L R+K +G +YAMK L+KS+M+KR Q+ HVRAER++LA+ S
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IVKLYYSFQD E+LYL+MEY+PGGD+M LL+R+D E ARFYIA+ VLA++S+HK
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+IHRDIKPDN+L+D +GH+KL+DFGLCK +++ K +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK--------KMNKAKDREYYLNDSHNL----- 167
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
DN + H+Q RR A STVGTPDYIAPEVL YG+ECDWWSLG I+
Sbjct: 168 LFRDNVLVRRRDHKQ-------RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGG 385
YEML G+PPFY+D T KI++W+ L+FP D +SPEA DLICRLLCD E RLG+
Sbjct: 221 YEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGS-- 278
Query: 386 AHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKM 445
+IK+HP+FK + W+ L E + F PE++ LDT NF F++ D S S K
Sbjct: 279 FEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSNFDDFED-DKDLSDYLSQN--SKK 335
Query: 446 LLTPKDLSFVGYTYK 460
L K L+FVG+TYK
Sbjct: 336 LNKGKQLAFVGFTYK 350
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 451 bits (1162), Expect = e-157
Identities = 199/388 (51%), Positives = 270/388 (69%), Gaps = 21/388 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+DF + +IG+GAFGEVRL ++K +G IYAMK L KSEM K+ Q+ HV+AER++LAE S
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+V LYYSFQD +YLYLIME+LPGGD+MT+L++ DT +E+V RFY+A+ VLAIE++HK
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+IHRDIKPDN+L+D+ GH+KLSDFGL ST + HK D + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGL------STGF----HKQHDSAYYQKLLQGKSNK 170
Query: 266 PDTDNKSSWK--------SPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
DN++S S +Q+ W+ NRR +A+STVGTPDYIAPE+ L++GYG ECD
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDV 377
WWSLGAIM+E L+G+PPF +++ T RKI++WR L FPDD LS EA+DLI RL+ +
Sbjct: 231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNA 290
Query: 378 EHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELD--PPASG 435
E+RLG GGAH+IK+HP+F+ V WD + ++ A F P++ DT F DEL+ P A
Sbjct: 291 ENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYF-PTDELEQVPEAPA 349
Query: 436 RTSSGPSRKMLLTPKDLSFVGYTYKNFD 463
+ P+++ DL+F+GYTYK FD
Sbjct: 350 LKQAAPAQQEESVELDLAFIGYTYKRFD 377
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 387 bits (995), Expect = e-132
Identities = 191/378 (50%), Positives = 254/378 (67%), Gaps = 18/378 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE L +IGRGAFGEVRL ++K +G+IYAMK L+K++M+++ QV H+RAER++L E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+VK++YSFQD LYLIME+LPGGDMMTLLM++DTL+E +FYIA++VLAI++IH+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+IHRDIKPDNLLLD GH+KLSDFGLC L H+T N+ D F
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK-------KAHRTEFYRNLTHNPPSDFSF 173
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
+ ++K + + W+ NRR+LA+STVGTPDYIAPEV ++ GY CDWWSLG IM
Sbjct: 174 QNMNSK-------RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGG 385
YEML+GYPPF ++ P T RK+++W+ L FP + +S +AKDLI R D E+R+G+ G
Sbjct: 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNG 286
Query: 386 AHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKM 445
+IK+HP+F+ V W + E AA EI DT NF +F E D + P K
Sbjct: 287 VEEIKSHPFFEGVDWGHIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEPDYK- 345
Query: 446 LLTPKDLSFVGYTYKNFD 463
KD F+ YTYK F+
Sbjct: 346 ---SKDWVFLNYTYKRFE 360
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 382 bits (982), Expect = e-130
Identities = 194/381 (50%), Positives = 259/381 (67%), Gaps = 21/381 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV H+RAER++L E S
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FYIA++VLAI+SIH+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+IHRDIKPDNLLLD GH+KLSDFGLC L H+T N+ + D F
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK-------KAHRTEFYRNLNHSLPSDFTF 173
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
+ ++K + + W+ NRR+LAFSTVGTPDYIAPEV ++ GY CDWWSLG IM
Sbjct: 174 QNMNSK-------RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGG 385
YEML+GYPPF ++ P T +K+++W+ L FP + +S +AKDLI R C+ EHR+G G
Sbjct: 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPG 286
Query: 386 AHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKF---DELDPPASGRTSSGPS 442
+IK +P+F+ V W+ + E AA EI DT NF +F D L P + TS+ P
Sbjct: 287 VEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVA--TSNHPE 344
Query: 443 RKMLLTPKDLSFVGYTYKNFD 463
KD F+ YTYK F+
Sbjct: 345 TD--YKNKDWVFINYTYKRFE 363
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 375 bits (964), Expect = e-127
Identities = 174/383 (45%), Positives = 233/383 (60%), Gaps = 18/383 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F + IG GAFGEV L R+ + +YAMK L+K++++ R Q HV+AER++LAE +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+VKLYYSFQD + LY +M+Y+PGGDMM+LL+R E++ARFYIA+ AIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC---STLYAIHEHKTIDD-ENMAEPMDIDG 263
IHRDIKPDN+L+D++GH+KL+DFGLC S Y +H D E E +ID
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
C P E+ + ++R LA S VGTP+YIAPEVLL+ GY CDWWS+G
Sbjct: 183 CRL---------KPLERR-RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGT 383
I+YEMLVG PPF AD P T K+++W L P +KLS EA DLI RL C E RLG
Sbjct: 233 ILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGK 292
Query: 384 GGAHQIKAHPWFKDVVWDKLY-EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPS 442
GA +IKAHP+FK + + L +A + P+I DT NF D + S P
Sbjct: 293 NGADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPD 352
Query: 443 RKMLLTPKDL---SFVGYTYKNF 462
R + + +F +T++ F
Sbjct: 353 RNVKPNNRKRTEHAFYEFTFRRF 375
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 343 bits (882), Expect = e-116
Identities = 132/303 (43%), Positives = 179/303 (59%), Gaps = 54/303 (17%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G+FG+V L R+K +G +YAMK LKK +++KR +VEH ERN+L+ + IVKL+Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
+FQ E LYL++EY PGG++ + L +E +E ARFY A+ VLA+E +H I+RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
P+N+LLD +GH+KL+DFGL K L
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL------------------------------------- 143
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333
+ + GTP+Y+APEVLL KGYG DWWSLG ++YEML G P
Sbjct: 144 ------------SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
Query: 334 PFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392
PFYA+D KI+ L+FP+ LSPEA+DLI LL D RLG+GGA +IKAH
Sbjct: 192 PFYAEDRKEIYEKILKDP--LRFPEF--LSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247
Query: 393 PWF 395
P+F
Sbjct: 248 PFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 343 bits (883), Expect = e-116
Identities = 139/346 (40%), Positives = 192/346 (55%), Gaps = 61/346 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE + +G G+FG V L R K SG YA+K L K+++VK QVEHV E+ +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+V LY SFQD LYL+MEY+PGG++ + L + E VARFY AQ VLA+E +H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+ ++RD+KP+NLLLD +G++K++DFG K + T
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT------------------------- 155
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
++ GTP+Y+APE++L KGYG DWW+LG ++
Sbjct: 156 ---------------------------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGT- 383
YEML GYPPF+ D+PI KI+ + ++FP S SP+AKDLI LL D+ RLG
Sbjct: 189 YEMLAGYPPFFDDNPIQIYEKILEGK--VRFP--SFFSPDAKDLIRNLLQVDLTKRLGNL 244
Query: 384 -GGAHQIKAHPWFKDVVWDKLYEM--EAAFKPEINGELDTQNFMKF 426
G + IK HPWF + W L + EA F P++ G DT NF +
Sbjct: 245 KNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDDY 290
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 339 bits (871), Expect = e-114
Identities = 162/381 (42%), Positives = 213/381 (55%), Gaps = 58/381 (15%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE+L +IGRGAFGEV + + K +G +YAMK L K EM+KR + R ER++L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK 204
I L+Y+FQD LYL+M+Y GGD++TLL + ED L E++ARFY+A+ VLAI+S+H+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
Y+HRDIKPDN+LLDKNGH++L+DFG C L
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL--------------------------- 153
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDWW 319
D +S+ VGTPDYI+PE+L K YG ECDWW
Sbjct: 154 -ADGTVQSN--------------------VAVGTPDYISPEILQAMEDGKGRYGPECDWW 192
Query: 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPE-AKDLICRLLCDVE 378
SLG MYEML G PFYA+ + T KI++ + H +FP D E AKDLI RL+C E
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPE 252
Query: 379 HRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTS 438
RLG G K HP+F+ + WD + A + PE++ DT NF D+ D + S
Sbjct: 253 TRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNF-DVDDDDLRNTE--S 309
Query: 439 SGPSRKMLLTPKDLSFVGYTY 459
PS + L FVG+TY
Sbjct: 310 LPPSSHGAFSGNHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 339 bits (870), Expect = e-113
Identities = 166/400 (41%), Positives = 228/400 (57%), Gaps = 60/400 (15%)
Query: 68 LERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR 127
L R E ++ + ++ +DF+++ +IGRGAFGEV+L R K S +YAMK L K EM+KR
Sbjct: 25 LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR 84
Query: 128 GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV 187
ER+++A S IV+L+Y+FQD +YLY++MEY+PGGD++ L+ D + E
Sbjct: 85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKW 143
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
ARFY A+ VLA+++IH +IHRD+KPDN+LLDK+GH+KL+DFG C
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM------------- 190
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
MD +G M R A VGTPDYI+PEVL
Sbjct: 191 ----------KMDANG----------------------MVRCDTA---VGTPDYISPEVL 215
Query: 308 LKKG----YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLS 363
+G YG ECDWWS+G +YEMLVG PFYAD + T KI+ +N L FPDD ++S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS 275
Query: 364 PEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFK--DVVWDKLYEMEAAFKPEINGELDTQ 421
+AKDLIC L D E RLG G +IK+HP+FK +D + E A PE++ ++DT
Sbjct: 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTS 335
Query: 422 NFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461
NF ++ D + P K L F+G+TY
Sbjct: 336 NFDDIEDDDKN----EETFPLPKA-FAGNQLPFIGFTYSK 370
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 335 bits (860), Expect = e-111
Identities = 168/381 (44%), Positives = 238/381 (62%), Gaps = 9/381 (2%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F + +G GAFGEV L + + +YAMK L+K +++ R QV HV+AER++LAE +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+VKLYYSFQD + LY +M+Y+PGGDMM+LL+R + E +ARFYIA+ LAIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRDIKPDN+L+D +GH+KL+DFGLC + ++ + ++ EP D+ + D
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL---WDD 179
Query: 268 TDN-KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326
N + + + + + ++R LA S VGTP+YIAPEVLL+KGY CDWWS+G I++
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGA 386
EMLVG PPF A P T K+++W N L P KLSPEA DLI +L C E RLG GA
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299
Query: 387 HQIKAHPWFKDVVWDK-LYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKM 445
IKAHP+F +V + + A + P+I+ +DT NF +E P S +
Sbjct: 300 DDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDT 359
Query: 446 LLTPK----DLSFVGYTYKNF 462
L +P + +F +T++ F
Sbjct: 360 LCSPNGKHPEHAFYEFTFRRF 380
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 318 bits (816), Expect = e-106
Identities = 130/308 (42%), Positives = 190/308 (61%), Gaps = 44/308 (14%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
I +GA+G V L ++K +G+IYA+K +KK++M+++ QV+ V ER++L++ S +VKLYY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
SFQ + LYL+MEYLPGGD+ +LL +L E+VAR YIA+ VLA+E +H + IHRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
PDN+L+D NGH+KL+DFGL S + + ++D+ D +
Sbjct: 121 PDNILIDSNGHLKLTDFGL------SKVGLVRRQINLNDDE------------KEDKR-- 160
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333
VGTPDYIAPEV+L +G+ DWWSLG I+YE LVG P
Sbjct: 161 ---------------------IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199
Query: 334 PFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392
PF+ + P + I++ + +++P+D ++S EA DLI +LL D E RLG +IK H
Sbjct: 200 PFHGETPEEIFQNILNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257
Query: 393 PWFKDVVW 400
P+FK + W
Sbjct: 258 PFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 321 bits (824), Expect = e-106
Identities = 165/349 (47%), Positives = 224/349 (64%), Gaps = 14/349 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F + +G GAFGEV L R+ + +YAMK L+K +++ R QV HV+AER++LAE +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+V+LYYSFQD + LY +M+Y+PGGDMM+LL+R E++ARFYIA+ A+ES+HK +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID--DENMAEPMDIDGCF 265
IHRDIKPDN+L+D++GH+KL+DFGL C+ H+ K D + MD +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL-----CTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 266 PDTDNKSSWK--SPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
D N P E+ Q ++R LA S VGTP+YIAPEVLL+ GY CDWWS+G
Sbjct: 178 GDPANCRCGDRLKPLERRAARQ-HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGT 383
I+YEMLVG PPF A P+ T K+++W+ L P +KLSPEA DLI +L E RLG
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGK 296
Query: 384 GGAHQIKAHPWFKDVVWDK-LYEMEAAFKPEINGELDTQNFMKFDELDP 431
GA +IKAHP+FK + + L + A + P+I DT N FD +DP
Sbjct: 297 NGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSN---FDPVDP 342
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 302 bits (775), Expect = e-100
Identities = 115/309 (37%), Positives = 167/309 (54%), Gaps = 56/309 (18%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E+L +G G+FG+V L R+KK+G + A+K +KK ++ K E + E +L ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
IV+LY F+D + LYL+MEY GGD+ LL + L+E+ ARFY+ Q + A+E +H
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
+HRD+KP+N+LLD++GH+KL+DFGL +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR--------------------------------- 145
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
Q++ + + VGTP+Y+APEVLL KGYG D WSLG I+YE
Sbjct: 146 -----------------QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYE 188
Query: 328 MLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA 386
+L G PPF DD + K + P + +SPEAKDLI +LL D E RL A
Sbjct: 189 LLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL---TA 245
Query: 387 HQIKAHPWF 395
+ HP+F
Sbjct: 246 EEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 304 bits (779), Expect = e-100
Identities = 145/384 (37%), Positives = 211/384 (54%), Gaps = 65/384 (16%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DF++ +++GRG FGEV++ REK +G+IYAMK +KKS ++ + V ER++L+ S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK 204
I +L Y+FQD + LYL+MEY PGGD+++LL R ED E++A+FY+A+ VLAI S+H+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
Y+HRDIKP+N+L+D+ GH+KL+DFG L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--------------------------- 153
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------KKGYGMECDW 318
N+ + VGTPDYIAPEVL K YG+ECDW
Sbjct: 154 ---------------------ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192
Query: 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVE 378
WSLG I YEM+ G PF+ T I++++ LKFP+D K+S + DLI LLC +
Sbjct: 193 WSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQK 252
Query: 379 HRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTS 438
RLG G + HP+F + W+ + F P + + DT NF + + S R S
Sbjct: 253 ERLGYEG---LCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPE----KNSTRRS 305
Query: 439 SGPSRKML---LTPKDLSFVGYTY 459
+ ++ + KDL FVG+++
Sbjct: 306 QSSTTQLKPNGFSGKDLPFVGFSF 329
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 295 bits (756), Expect = 6e-96
Identities = 166/407 (40%), Positives = 229/407 (56%), Gaps = 73/407 (17%)
Query: 59 EEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKK 118
++ IN I+DL K +D+E++ +IGRGAFGEV+L R K + +YAMK
Sbjct: 29 KDTINKIRDLRMK-------------AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 75
Query: 119 LKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM 178
L K EM+KR ER+++A S +V+L+Y+FQD YLY++MEY+PGGD++ L+
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 135
Query: 179 REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238
D + E ARFY A+ VLA+++IH +IHRD+KPDN+LLDK+GH+KL+DFG C
Sbjct: 136 NYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---- 190
Query: 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGT 298
M+ +G M R A VGT
Sbjct: 191 -------------------KMNKEG----------------------MVRCDTA---VGT 206
Query: 299 PDYIAPEVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL 354
PDYI+PEVL +G YG ECDWWS+G +YEMLVG PFYAD + T KI++ +N L
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 266
Query: 355 KFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKD--VVWDKLYEMEAAFKP 412
FPDD+ +S EAK+LIC L D E RLG G +IK H +FK+ W+ L + A P
Sbjct: 267 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP 326
Query: 413 EINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTY 459
+++ ++DT NF +E G + P K + L FVG+TY
Sbjct: 327 DLSSDIDTSNFDDIEE----DKGEEETFPIPKAFVG-NQLPFVGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 291 bits (745), Expect = 7e-95
Identities = 162/387 (41%), Positives = 217/387 (56%), Gaps = 70/387 (18%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE++ +IGRGAFGEV + + K + IYAMK L K EM+KR + R ERN+L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK 204
I L+Y+FQD YLYL+M+Y GGD++TLL + ED L E++ARFYIA+ VLAI SIH+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+Y+HRDIKPDN+LLD NGH++L+DFG C M+ DG
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCL-----------------------KMNQDGT 157
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL--LKKG---YGMECDWW 319
+ VGTPDYI+PE+L ++ G YG ECDWW
Sbjct: 158 VQSS-------------------------VAVGTPDYISPEILQAMEDGMGKYGPECDWW 192
Query: 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-SKLSPEAKDLICRLLCDVE 378
SLG MYEML G PFYA+ + T KI++ +FP + +S EAKDLI RL+C E
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE 252
Query: 379 HRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNF------MKFDELDPP 432
RLG G K H +F+ + W+ + +EA + P+++ DT NF ++ E+ PP
Sbjct: 253 RRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNPEIAPP 312
Query: 433 ASGRTSSGPSRKMLLTPKDLSFVGYTY 459
+S SG L FVG+TY
Sbjct: 313 SSHTGFSG---------LHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 282 bits (722), Expect = 8e-91
Identities = 161/412 (39%), Positives = 233/412 (56%), Gaps = 61/412 (14%)
Query: 55 DVP-MEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNI 113
D P + + N+ L R E ++++ ++ +D++++ +IGRGAFGEV+L R K S +
Sbjct: 11 DFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV 70
Query: 114 YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173
YAMK L K EM+KR ER+++A S +V+L+ +FQD +YLY++MEY+PGGD+
Sbjct: 71 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL 130
Query: 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
+ L+ D + E A+FY A+ VLA+++IH IHRD+KPDN+LLDK+GH+KL+DFG C
Sbjct: 131 VNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC 189
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
+ D+ M C DT
Sbjct: 190 MKM--------------DETGMVR------C--DT------------------------- 202
Query: 294 STVGTPDYIAPEVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH 349
VGTPDYI+PEVL +G YG ECDWWS+G ++EMLVG PFYAD + T KI+
Sbjct: 203 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261
Query: 350 WRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVV--WDKLYEME 407
+N L FP+D ++S AK+LIC L D E RLG G +IK HP+FK+ WD + E
Sbjct: 262 HKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETA 321
Query: 408 AAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTY 459
A PE++ ++D+ NF ++ G + P K + L F+G+TY
Sbjct: 322 APVVPELSSDIDSSNFDDIED----DKGDVETFPIPKAFVG-NQLPFIGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 278 bits (711), Expect = 1e-89
Identities = 159/387 (41%), Positives = 215/387 (55%), Gaps = 70/387 (18%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+DFE+L +IGRGAFGEV + + K + ++AMK L K EM+KR + R ER++L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK 204
I L+Y+FQD LYL+M+Y GGD++TLL + ED L E++ARFY+A+ V+AI+S+H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+Y+HRDIKPDN+L+D NGH++L+DFG C L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL---------------------------- 152
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDWW 319
D +SS VGTPDYI+PE+L K YG ECDWW
Sbjct: 153 MEDGTVQSS--------------------VAVGTPDYISPEILQAMEDGKGKYGPECDWW 192
Query: 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-SKLSPEAKDLICRLLCDVE 378
SLG MYEML G PFYA+ + T KI++ + +FP + +S +AKDLI RL+C E
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSRE 252
Query: 379 HRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNF------MKFDELDPP 432
HRLG G K HP+F + WD + EA + PE++ DT NF +K E PP
Sbjct: 253 HRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPP 312
Query: 433 ASGRTSSGPSRKMLLTPKDLSFVGYTY 459
S SG L FVG+TY
Sbjct: 313 PSHTAFSG---------HHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 3e-89
Identities = 114/314 (36%), Positives = 160/314 (50%), Gaps = 57/314 (18%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G FG V L + K +A+K +KK +V+ GQ EH+ +E+ +L E IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
+F+D +Y+Y++MEY GG++ T+L E ARFYIA VLA E +H I+RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
P+NLLLD NG++KL DFG K
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK--------------------------------------- 141
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333
++ + ++ GTP+Y+APE++L KGY D+WSLG ++YE+L G P
Sbjct: 142 -----------KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP 190
Query: 334 PFYAD--DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCD-VEHRLG--TGGAHQ 388
PF D DP+ I+ L+FP + + AKDLI +LL E RLG GG
Sbjct: 191 PFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKD 248
Query: 389 IKAHPWFKDVVWDK 402
IK H WF W+
Sbjct: 249 IKKHKWFNGFDWEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 262 bits (671), Expect = 1e-84
Identities = 124/312 (39%), Positives = 172/312 (55%), Gaps = 59/312 (18%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER-NLLAEVASHCIVKLY 152
I +GAFG V L +++ +G+ +A+K LKKS+M+ + QV +V+AER ++ + S + KLY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
YSFQ +YLYL+MEYL GGD +L+ L E+ A+ YIA+ VL +E +H+ IHRDI
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
KP+NLL+D+ GH+KL+DFGL N E G
Sbjct: 124 KPENLLIDQTGHLKLTDFGL-------------------SRNGLENKKFVG--------- 155
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 332
TPDY+APE +L G DWWSLG +++E L GY
Sbjct: 156 -------------------------TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGY 190
Query: 333 PPFYADDPITTCRKIVHWRNHLKFPDDSK--LSPEAKDLICRLLC-DVEHRLGTGGAHQI 389
PPF+A+ P I+ + +P++ K SPEA DLI RLLC D RLG G +I
Sbjct: 191 PPFHAETPDAVFDNILS--RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248
Query: 390 KAHPWFKDVVWD 401
K+HP+FK + WD
Sbjct: 249 KSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 1e-82
Identities = 117/313 (37%), Positives = 176/313 (56%), Gaps = 36/313 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDF+ IIG G+F V L +EK++ YA+K L K +++K +V++V+ E+ +L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
H I+KLYY+FQD E LY ++EY P G+++ + + +L E RFY A+ +LA+E +H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
IHRD+KP+N+LLDK+ H+K++DFG K L D + E D
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVL--------------DPNSSPESNKGDAT 166
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
D+ + RR +F VGT +Y++PE+L +K G D W+LG I
Sbjct: 167 NIDSQIEK-------------NRRRFASF--VGTAEYVSPELLNEKPAGKSSDLWALGCI 211
Query: 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383
+Y+ML G PPF + T +KI+ FP + P+AKDLI +LL D + RLG
Sbjct: 212 IYQMLTGKPPFRGSNEYLTFQKILK--LEYSFPPN--FPPDAKDLIEKLLVLDPQDRLGV 267
Query: 384 G-GAHQIKAHPWF 395
G ++KAHP+F
Sbjct: 268 NEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 255 bits (654), Expect = 2e-81
Identities = 124/340 (36%), Positives = 192/340 (56%), Gaps = 38/340 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+DFE + +I GA+G V L R K++ +AMKK+ K ++ R Q++ V ER++L +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+V ++ SF+ +L ++MEY+ GGD TLL L ++AR Y A++VLA+E +H +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+HRD+KPDNLL+ GH+KL+DFGL K S ++E +++ E +D C
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH--IEKDTREFLDKQVC- 177
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
GTP+YIAPEV+L++GYG DWW++G I+
Sbjct: 178 -------------------------------GTPEYIAPEVILRQGYGKPVDWWAMGIIL 206
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLL-CDVEHRLGT 383
YE LVG PF+ D P +++ + +++P+ D L +A+DLI RLL + RLGT
Sbjct: 207 YEFLVGCVPFFGDTPEELFGQVIS--DDIEWPEGDEALPADAQDLISRLLRQNPLERLGT 264
Query: 384 GGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNF 423
GGA ++K H +F + W+ L +A F P++ E DT F
Sbjct: 265 GGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 9e-81
Identities = 117/342 (34%), Positives = 172/342 (50%), Gaps = 40/342 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
F+ + ++G+G G V L R K +G ++A+K L K EM+KR +V+ V E+ +LA +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIH 203
+ LY SFQ YL L+M+Y PGG++ LL R+ L+E VARFY A+ +LA+E +H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
++RD+KP+N+LL ++GH+ LSDF L K D P+
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP----------------PPV---- 160
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST-------VGTPDYIAPEVLLKKGYGMEC 316
S S + + VGT +YIAPEV+ G+G
Sbjct: 161 -SKALRKGSRRSSVNSIP------SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV 213
Query: 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC- 375
DWW+LG ++YEML G PF + T I+ + FP +S A+DLI +LL
Sbjct: 214 DWWTLGILLYEMLYGTTPFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVK 271
Query: 376 DVEHRLGT-GGAHQIKAHPWFKDVVWDKLYEMEAAFKPEING 416
D RLG+ GA +IK HP+F+ V W + P +
Sbjct: 272 DPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 4e-80
Identities = 138/379 (36%), Positives = 200/379 (52%), Gaps = 69/379 (18%)
Query: 91 LTIIGRGAFGEVRLCR---EKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEVASH 146
L ++G+G +G+V R +G I+AMK LKK+ +V+ + H +AERN+L V
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
IV L Y+FQ LYLI+EYL GG++ L RE E+ A FY+++ LA+E +H+
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
I+RD+KP+N+LLD GH+KL+DFGLCK +IHE
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKE-------SIHE-------------------- 153
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326
+ H + GT +Y+APE+L++ G+G DWWSLGA+MY
Sbjct: 154 ------------GTVTH----------TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMY 191
Query: 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG- 384
+ML G PPF A++ T KI+ + L P L+PEA+DL+ +LL + RLG G
Sbjct: 192 DMLTGAPPFTAENRKKTIDKIL--KGKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGP 247
Query: 385 -GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF-MKFDELDPPASGRTSSG 440
A ++++HP+F+ V WD L ++E FKP + E D F KF P S
Sbjct: 248 GDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDS------ 301
Query: 441 PSRKMLLTPKDLSFVGYTY 459
P L + F+G+TY
Sbjct: 302 PDDSTLSESANQIFLGFTY 320
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 1e-78
Identities = 119/343 (34%), Positives = 181/343 (52%), Gaps = 61/343 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DD E + +G G FG V L R++ S + YA+K + E+++ Q +HV E+ +L EV+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I++L+++ D +LY++MEY+PGG++ + L + + FY ++ V A+E +H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
++RD+KP+N+LLDK GH+KL+DFG K K D
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-------------KLRD-------------- 153
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
+ W + GTP+Y+APEV+ KG+ DWW+LG ++
Sbjct: 154 ----------------RTWTL---------CGTPEYLAPEVIQSKGHNKAVDWWALGILI 188
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGT- 383
YEMLVGYPPF+ D+P KI+ + L+FP L AKDLI +LL D RLG
Sbjct: 189 YEMLVGYPPFFDDNPFGIYEKILAGK--LEFP--RHLDLYAKDLIKKLLVVDRTRRLGNM 244
Query: 384 -GGAHQIKAHPWFKDVVWDKLYEM--EAAFKPEINGELDTQNF 423
GA +K H WFK V WD + + + P+++ + DT NF
Sbjct: 245 KNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 1e-77
Identities = 110/313 (35%), Positives = 151/313 (48%), Gaps = 58/313 (18%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ELL +G G+FG V + K +G I A+K LKK + R E +L ++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
IV+L +F+D ++LYL+MEY GGD+ L R L+E+ A+ Q + +E +H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRD+KP+N+LLD+NG +K++DFGL K L S T
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS----SSSLTTF----------------- 158
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 326
VGTP Y+APEVLL GYG + D WSLG I+Y
Sbjct: 159 ----------------------------VGTPWYMAPEVLLGGNGYGPKVDVWSLGVILY 190
Query: 327 EMLVGYPPFYAD---DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382
E+L G PPF + D + R+I+ P S S EAKDLI + L D R
Sbjct: 191 ELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP- 249
Query: 383 TGGAHQIKAHPWF 395
A +I HPWF
Sbjct: 250 --TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 1e-75
Identities = 128/333 (38%), Positives = 184/333 (55%), Gaps = 56/333 (16%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+G+FG+V R++ + IYA+K ++K+ +V R +V H AER +LA+V IV L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
SFQ E LYL++ ++ GG++ L RE + ARFY A+ + A+E++HK N I+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
P+N+LLD GH+ L DFGLCK NM D D ++
Sbjct: 121 PENILLDYQGHIALCDFGLCK------------------LNMK----------DDDKTNT 152
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333
+ GTP+Y+APE+LL GY DWW+LG ++YEML G P
Sbjct: 153 F---------------------CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP 191
Query: 334 PFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392
PFY ++ RKI+ + L+FPD +AKDL+ LL D RLG GA +IK H
Sbjct: 192 PFYDENVNEMYRKIL--QEPLRFPDG--FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247
Query: 393 PWFKDVVWDKLY--EMEAAFKPEINGELDTQNF 423
P+F + W KL ++ FKP ++ +DT NF
Sbjct: 248 PFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNF 280
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 240 bits (613), Expect = 4e-75
Identities = 123/375 (32%), Positives = 189/375 (50%), Gaps = 60/375 (16%)
Query: 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVK 150
+IG+G+FG+V L + K G YA+K L+K ++K+ + +H+ AERN+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L+YSFQ + LY +++Y+ GG++ L RE + E ARFY A+ A+ +H N I+R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
D+KP+N+LLD GH+ L+DFGLCK E +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK------------------EGIE-------------- 148
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330
K + GTP+Y+APEVL K+ Y DWW LGA++YEML
Sbjct: 149 -----------------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
Query: 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA-HQ 388
G PPFY+ D I++ LK +S A+ L+ LL D RLG +
Sbjct: 192 GLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247
Query: 389 IKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNFMK--FDELDPPASGRTSSGPSRK 444
IK H +F + WD L ++ F P ++G +D ++F +E P + G++
Sbjct: 248 IKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVS 307
Query: 445 MLLTPKDLSFVGYTY 459
+ D +F+G++Y
Sbjct: 308 ASVKEADDAFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 2e-71
Identities = 116/337 (34%), Positives = 174/337 (51%), Gaps = 59/337 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L K + +YA+K LKK +++ VE E+ +LA H + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ FQ + L+ +MEY+ GGD+M + R E ARFY A+ VL ++ +H+ I+RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD GH+K++DFG+CK E +
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCK------------------EGILG-----------GVT 152
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
+S + GTPDYIAPE+L + YG DWW+LG ++YEML G
Sbjct: 153 TS--------------------TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG 192
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG--TGGAHQ 388
PF DD + I+ + +++P LS EAK ++ L + E RLG G
Sbjct: 193 QSPFEGDDEDELFQSILE--DEVRYP--RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQD 248
Query: 389 IKAHPWFKDVVWDKL--YEMEAAFKPEINGELDTQNF 423
IK HP+F+++ WDKL E++ FKP+I G D NF
Sbjct: 249 IKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNF 285
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 5e-70
Identities = 120/338 (35%), Positives = 177/338 (52%), Gaps = 60/338 (17%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVK 150
IG+G FG+V R+K + IYAMK L K E+V + +V H ERN+L S IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L +SFQ LYL+ +Y+ GG++ L +E +E+ A+FYIA+ VLA+E +HK++ ++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
D+KP+N+LLD GH+ L DFGL K
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA----------------------------------- 145
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 329
+ K + GT +Y+APEVLL +KGY D+WSLG +++EM
Sbjct: 146 --------------NLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC 191
Query: 330 VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG-TGGAH 387
G+ PFYA+D R I + ++FP + LS E + + LL + +HRLG A
Sbjct: 192 CGWSPFYAEDTQQMYRNIAFGK--VRFPKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDAV 248
Query: 388 QIKAHPWFKDVVWDKLYE--MEAAFKPEINGELDTQNF 423
++K HP+F D+ WD L + + FKP ++ + D NF
Sbjct: 249 ELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNF 286
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 5e-69
Identities = 118/336 (35%), Positives = 170/336 (50%), Gaps = 58/336 (17%)
Query: 87 DFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMV-KRGQVEHVRAERNLLAE 142
+FELL ++G GA+G+V L R+ +G +YAMK LKK+ +V K EH R ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 143 V-ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
V +V L+Y+FQ L+LI++Y+ GG++ T L + + TE+ R YIA+ VLA++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H+ I+RDIK +N+LLD GH+ L+DFGL K
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER------------------ 162
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--GYGMECDWW 319
A+S GT +Y+APEV+ G+ DWW
Sbjct: 163 ------------------------------AYSFCGTIEYMAPEVIRGGSGGHDKAVDWW 192
Query: 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVE 378
SLG + +E+L G PF D + +I K P +S EA+D I +LL D +
Sbjct: 193 SLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPK 252
Query: 379 HRLGTGGAHQIKAHPWFKDVVWDKLYE--MEAAFKP 412
RLG GA +IK HP+F+ + WD L + A FKP
Sbjct: 253 KRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 1e-68
Identities = 129/383 (33%), Positives = 191/383 (49%), Gaps = 71/383 (18%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL--AEVAS 145
F L ++GRG FG+V L KK+G +YA+K LKK +++ R +VE + E+ + A
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
H +V L+ FQ +++ +MEY GGD+M + + D +E A FY A VL ++ +H+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+ ++RD+K DNLLLD G +K++DFGLCK E M
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK------------------EGM--------- 152
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFST-VGTPDYIAPEVLLKKGYGMECDWWSLGA 323
+R ST GTP+++APEVL + Y DWW LG
Sbjct: 153 -------------------GFGDRT----STFCGTPEFLAPEVLTETSYTRAVDWWGLGV 189
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382
++YEMLVG PF DD IV+ + +++P LS EA ++ RLL + E RLG
Sbjct: 190 LIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYP--RFLSREAISIMRRLLRRNPERRLG 245
Query: 383 TG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF-MKFDELDPPASGRT 437
+G A +K P+F+D+ WD L +++ F P I G D NF +F P
Sbjct: 246 SGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAP-----V 300
Query: 438 SSGPSRKMLLTPKD-LSFVGYTY 459
+ P LLT ++ F G+ Y
Sbjct: 301 LTPPREPRLLTEEEQELFRGFDY 323
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 5e-68
Identities = 106/313 (33%), Positives = 154/313 (49%), Gaps = 61/313 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
FELL +IG+GAFG+V + +++ + ++AMK + K + V++G V +V ER +L E+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+V L+YSFQD E +YL+++ L GGD+ L ++ +E +F+I + VLA+E +H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRDIKPDN+LLD+ GH+ ++DF + A
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNI----------ATKVTP------------------- 152
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
L ST GTP Y+APEVL ++GY + DWWSLG YE
Sbjct: 153 ---------------------DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYE 191
Query: 328 MLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKL----SPEAKDLICRLL-CDVEHRLG 382
L G P+ R I + D S EA D I +LL D + RLG
Sbjct: 192 CLRGKRPYRGHS-----RTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLG 246
Query: 383 TGGAHQIKAHPWF 395
+K HP+F
Sbjct: 247 -DNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 220 bits (561), Expect = 2e-67
Identities = 132/385 (34%), Positives = 203/385 (52%), Gaps = 68/385 (17%)
Query: 87 DFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAE 142
+FELL ++G GA+G+V L R+ +G +YAMK L+K+ +V++ + VEH R ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 143 V-ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
V S +V L+Y+FQ L+LI++Y+ GG+M T L + D +E+ RFY + +LA+E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+HK ++RDIK +N+LLD GH+ L+DFGL K E ++E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK------------------EFLSE---- 158
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWS 320
++ +S GT +Y+APE++ K G+G DWWS
Sbjct: 159 --------------------------EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS 192
Query: 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379
LG +++E+L G PF + T ++ P S + PEA+DL+ +LL D +
Sbjct: 193 LGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKK 252
Query: 380 RLGTG--GAHQIKAHPWFKDVVWDKLYE--MEAAFKPEINGELDTQNFM-KFDELDPPAS 434
RLG G GA +IK HP+FK + W+ L + F+P I ELD NF +F L+P S
Sbjct: 253 RLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYS 312
Query: 435 GRTSSGPSRKMLLTPKDLSFVGYTY 459
+ ++ F GY++
Sbjct: 313 PAGTPPSGARV--------FQGYSF 329
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 5e-66
Identities = 126/371 (33%), Positives = 180/371 (48%), Gaps = 75/371 (20%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
DFE+ +G G+FG VR+ + K +G YA+K LKK E++K QV+HV E+++L E++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
IV + SFQD +Y ++E++ GG++ T L + +VA+FY A+ VLA E +H +
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
I+RD+KP EN+ +D G
Sbjct: 139 IIYRDLKP--------------------------------------ENLL--LDNKGHVK 158
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326
TD + K P F+ GTP+Y+APEV+ KG+G DWW++G ++Y
Sbjct: 159 VTDFGFAKKVPDR------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLY 206
Query: 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLL-CDVEHRLGT 383
E + GYPPF+ D P KI+ R LKFP+ D + A+DL+ LL D RLGT
Sbjct: 207 EFIAGYPPFFDDTPFRIYEKILAGR--LKFPNWFDGR----ARDLVKGLLQTDHTKRLGT 260
Query: 384 --GGAHQIKAHPWFKDVVWDKLYE--MEAAFKPEINGELDTQNFMKFDELDPPASGRTSS 439
GG +K HP+F WDKLY A + DT NF K+ P S
Sbjct: 261 LKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKY-----PDSPVDRL 315
Query: 440 GPSRKMLLTPK 450
P LT
Sbjct: 316 PP-----LTAA 321
|
Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 1e-64
Identities = 131/355 (36%), Positives = 190/355 (53%), Gaps = 68/355 (19%)
Query: 91 LTIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
L ++G+G+FG+V L R+ +G +YAMK LKK+ + R +V + ER++LAEV
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
IVKL+Y+FQ LYLI+++L GGD+ T L +E TE +FY+A+ LA++ +H
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
I+RD+KP+N+LLD+ GH+KL+DFGL K ++ID E
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK-------------ESIDHE-------------- 152
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
K A+S GT +Y+APEV+ ++G+ DWWS G +M+E
Sbjct: 153 ----------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 190
Query: 328 MLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG-- 384
ML G PF D T I+ + L P LSPEA+ L+ L + +RLG G
Sbjct: 191 MLTGSLPFQGKDRKETMTMIL--KAKLGMPQF--LSPEAQSLLRALFKRNPANRLGAGPD 246
Query: 385 GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRT 437
G +IK HP+F + W+KLY E++ FKP + DT F DP + RT
Sbjct: 247 GVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYF------DPEFTSRT 295
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 3e-63
Identities = 121/357 (33%), Positives = 184/357 (51%), Gaps = 64/357 (17%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNI--YAMKKLKKSEMVKRGQVEHVRAE 136
+++K+ +DF + +G G+FG V L K+ + A+K+ +KS+++K+ QV+HV +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 137 RNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
R +L + V LY SF+D YLYL++E++ GG+ T L R +V FY AQ V
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
L E + N ++RD+KP+NLLLDK+G +K++DFG K +D T
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT---------------- 185
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316
++ GTP+YIAPE+LL G+G
Sbjct: 186 ------------------------------------YTLCGTPEYIAPEILLNVGHGKAA 209
Query: 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC- 375
DWW+LG +YE+LVG PPFYA++P+ +KI+ + FP L K L+ +LL
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFP--KFLDNNCKHLMKKLLSH 265
Query: 376 DVEHRLGT--GGAHQIKAHPWFKDVVWDKLYE--MEAAFKPEINGELDTQNFMKFDE 428
D+ R G GA +K HPWF ++ W L +E +KP+ D+ NF + E
Sbjct: 266 DLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQE 322
|
Length = 340 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 6e-63
Identities = 122/374 (32%), Positives = 182/374 (48%), Gaps = 65/374 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L K + +A+K LKK +++ VE ER +LA H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ +FQ E+L+ +MEYL GGD+M + E ARFY A+ + ++ +HK I+RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLDK+GH+K++DFG+CK
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKE------------------------------------ 145
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
MN A + GTPDYIAPE+L + Y DWWS G ++YEML+G
Sbjct: 146 -------------NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390
PF+ +D I++ R H FP +S EAKD + +L D RLG G I+
Sbjct: 193 QSPFHGEDEDELFDSILNDRPH--FP--RWISKEAKDCLSKLFERDPTKRLGVDG--DIR 246
Query: 391 AHPWFKDVVWDKL--YEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLT 448
HP+F+ + W++L E+ FKP++ D NF + + P K LL
Sbjct: 247 QHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVR-----LSPVDKKLLA 301
Query: 449 PKDLS-FVGYTYKN 461
D F G+++ N
Sbjct: 302 SMDQEQFRGFSFTN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 4e-61
Identities = 119/340 (35%), Positives = 167/340 (49%), Gaps = 66/340 (19%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
+IG+G+FG+V L + K G+ YA+K L+K ++K+ + H+ AERN+L + H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+YSFQ E LY +++Y+ GG++ L RE E ARFY A+ AI +H N I+RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+KP+N+LLD GH+ L+DFGLCK E + EP + F
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK------------------EGV-EPEETTSTF------ 156
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
GTP+Y+APEVL K+ Y DWW LGA++YEML G
Sbjct: 157 ------------------------CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEH-----RLGTGGA 386
PPFY+ D I+H L+ P C LL + H RLG
Sbjct: 193 LPPFYSRDVSQMYDNILH--KPLQLP------GGKTVAACDLLVGLLHKDQRRRLGAKAD 244
Query: 387 HQ-IKAHPWFKDVVWDKLYEMEAA--FKPEINGELDTQNF 423
IK H +F + WD LY + P + G D ++F
Sbjct: 245 FLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHF 284
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 6e-61
Identities = 117/383 (30%), Positives = 185/383 (48%), Gaps = 67/383 (17%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA-EVAS 145
DF L ++G+G+FG+V L K + +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
I+RD+K DN++LD GH+K++DFG+CK EN+ F
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK------------------ENI---------F 153
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
+ + GTPDYIAPE++ + YG DWW+ G ++
Sbjct: 154 GGKTTR----------------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEH---RLG 382
YEML G PPF +D + I+ +++ +P LS EA + LL +H RLG
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIME--HNVSYP--KSLSKEAVSICKGLL--TKHPAKRLG 245
Query: 383 TG--GAHQIKAHPWFKDVVWDKLYEME--AAFKPEINGELDTQNFMKFDELDPPASGRTS 438
G G I+ H +F+ + W+KL E FKP++ G +NF KF +PP
Sbjct: 246 CGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTREPPV----L 301
Query: 439 SGPSRKMLLTPKDLSFVGYTYKN 461
+ P + ++ F G+++ N
Sbjct: 302 TPPDKLVIANIDQSEFQGFSFVN 324
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 3e-60
Identities = 115/348 (33%), Positives = 173/348 (49%), Gaps = 62/348 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L K + +YA+K LKK +++ V+ E+ +LA A H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ FQ + L+ +MEY+ GGD+M + R E +RFY A+ LA+ +H+H I+RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD GH KL+DFG+CK E +
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCK------------------EGILN-------------- 149
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
+ GTPDYIAPE+L + YG DWW+LG +MYEM+ G
Sbjct: 150 -----------------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG----TGGA 386
PPF AD+ I+H + + +P LS EA ++ + + RLG GG
Sbjct: 193 QPPFEADNEDDLFESILH--DDVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGE 248
Query: 387 HQIKAHPWFKDVVWDKL--YEMEAAFKPEINGELDTQNF-MKFDELDP 431
IK HP+FK++ W L +++ FKP+I + D NF F + +P
Sbjct: 249 DAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEP 296
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 8e-59
Identities = 111/338 (32%), Positives = 172/338 (50%), Gaps = 60/338 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L R K+SG +YA+K LKK +++ VE E+ +L+ +H + +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
Y FQ + L+ +ME++ GGD+M + + E ARFY A+ A+ +H I+RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD GH KL+DFG+CK I KT
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKE-------GIFNGKTTS-------------------- 154
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
+ GTPDYIAPE+L + YG DWW++G ++YEML G
Sbjct: 155 ----------------------TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT---GGAH 387
+ PF A++ I+ + + +P + LS +A D++ + + RLG+ GG
Sbjct: 193 HAPFEAENEDDLFEAIL--NDEVVYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEE 248
Query: 388 QIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF 423
I HP+FK++ W+KL ++E F+P I D NF
Sbjct: 249 AILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNF 286
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 2e-57
Identities = 125/374 (33%), Positives = 184/374 (49%), Gaps = 60/374 (16%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
+IG+G+FG+V L + K G YA+K L+K ++ R + +H+ AERN+L + H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+YSFQ TE LY +++++ GG++ L RE + E ARFY A+ A+ +H N ++RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+KP+N+LLD GH+ L+DFGL C A + T
Sbjct: 122 LKPENILLDSQGHVVLTDFGL-----CKEGIAQSDTTT---------------------- 154
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
+ GTP+Y+APEV+ K+ Y DWW LGA++YEML G
Sbjct: 155 ----------------------TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGT-GGAHQI 389
PPFY D I+H L+ S A ++ LL D + RLG +I
Sbjct: 193 LPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248
Query: 390 KAHPWFKDVVWDKLYE--MEAAFKPEINGELDTQNF-MKFDELDPPASGRTSSGPS-RKM 445
+ HP+F+ + W L + + F P + G D NF F E P S SS S
Sbjct: 249 QEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNA 308
Query: 446 LLTPKDLSFVGYTY 459
+ D +FVG++Y
Sbjct: 309 SVLEADDAFVGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-55
Identities = 118/338 (34%), Positives = 177/338 (52%), Gaps = 60/338 (17%)
Query: 87 DFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRGQV-EHVRAERNLLAE 142
+FELL ++G GA+G+V L R+ SG +YAMK LKK+ +V++ + EH R ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 143 V-ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ S +V L+Y+FQ L+LI++Y+ GG++ T L + + E + Y + VLA+E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+HK I+RDIK +N+LLD NGH+ L+DFGL K +DE
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-------------HEDEV------- 160
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL--KKGYGMECDWW 319
+ A+S GT +Y+AP+++ G+ DWW
Sbjct: 161 ----------------------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWW 192
Query: 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVE 378
S+G +MYE+L G PF D + +I + P ++S AKD+I RLL D +
Sbjct: 193 SMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPK 252
Query: 379 HRLGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKP 412
RLG G A +IK HP+F+ + WD L ++ A FKP
Sbjct: 253 KRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-55
Identities = 120/374 (32%), Positives = 188/374 (50%), Gaps = 60/374 (16%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
+IG+G+FG+V L R K YA+K L+K ++K+ + +H+ +ERN+L + H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
++SFQ + LY +++Y+ GG++ L RE E ARFY A+ A+ +H N ++RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+KP+N+LLD GH+ L+DFGLCK EN+ E F
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCK------------------ENI-EHNGTTSTF------ 156
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
GTP+Y+APEVL K+ Y DWW LGA++YEML G
Sbjct: 157 ------------------------CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG-TGGAHQI 389
PPFY+ + I++ LK ++ A+ L+ LL D RLG +I
Sbjct: 193 LPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248
Query: 390 KAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF-MKF-DELDPPASGRTSSGPSRKM 445
K H +F + WD L ++ F P ++G D ++F +F +E P + G++
Sbjct: 249 KNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVTA 308
Query: 446 LLTPKDLSFVGYTY 459
+ +F+G++Y
Sbjct: 309 SVKEAAEAFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 2e-55
Identities = 75/148 (50%), Positives = 109/148 (73%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
DF++LT +G+G +G+V L ++K +G I A+K++KKS + K +V HV ER++L S
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
+VKL Y+FQD EYLYL MEY+PGGD TLL L+E+ ARFY+A+ A++++H+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
YIHRD+KP+N L+D +GH+KL+DFGL K
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 5e-53
Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 57/307 (18%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
++GRG+FG V L +K +G + A+K ++ S + ++E + E +L+ + IV+ Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYY 65
Query: 153 YSFQDTE--YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
S +D E L + +EY+ GG + +LL + L E V R Y Q + + +H + +HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
DIK N+L+D +G +KL+DFG K I+ +
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAK-----------RLGDIETGEGTGSV----------- 163
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330
GTP ++APEV+ + YG D WSLG + EM
Sbjct: 164 -------------------------RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT 198
Query: 331 GYPPFYA-DDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ 388
G PP+ +P+ KI + P+ LS EAKD + + L D + R A +
Sbjct: 199 GKPPWSELGNPMAALYKIGSSGEPPEIPEH--LSEEAKDFLRKCLRRDPKKR---PTADE 253
Query: 389 IKAHPWF 395
+ HP+
Sbjct: 254 LLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 8e-52
Identities = 110/337 (32%), Positives = 168/337 (49%), Gaps = 59/337 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L K + +A+K LKK ++ VE E+ +L+ H + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
Y +FQ E L+ +MEYL GGD+M + A FY A+ + ++ +H ++RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD +GH+K++DFG+CK ENM D K
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK------------------ENML-----------GDAK 152
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
+ + GTPDYIAPE+LL + Y DWWS G ++YEML+G
Sbjct: 153 TC--------------------TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390
PF+ D + I ++ +P L+ EAKD++ +L + E RLG G I+
Sbjct: 193 QSPFHGHDEEELFQSIR--MDNPCYP--RWLTREAKDILVKLFVREPERRLGVKG--DIR 246
Query: 391 AHPWFKDVVWDKL--YEMEAAFKPEINGELDTQNFMK 425
HP+F+++ W L E+E FKP++ D NF K
Sbjct: 247 QHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDK 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 9e-52
Identities = 105/329 (31%), Positives = 157/329 (47%), Gaps = 61/329 (18%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G FGEV C+ K +G +YA KKL K + KR + E+ +L +V+S IV L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+F+ + L L+M + GGD+ + + E E A FY AQ + +E +H+ ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+KP+N+LLD +G++++SD GL A+
Sbjct: 121 LKPENVLLDDHGNVRISDLGL----------AVE-------------------LKGG--- 148
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
K GTP Y+APEVL + Y DW++LG +YEM+ G
Sbjct: 149 ---KKIK---------------GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190
Query: 332 YPPFYADDPITTCRKIVH--WRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT--GGA 386
PF ++ +++PD K SPEAKDL LL D E RLG G A
Sbjct: 191 RSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQKDPEKRLGCRGGSA 248
Query: 387 HQIKAHPWFKDVVWDKLY--EMEAAFKPE 413
+++ HP FKD+ W +L +E F P+
Sbjct: 249 DEVREHPLFKDLNWRRLEAGMLEPPFIPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 2e-51
Identities = 82/238 (34%), Positives = 116/238 (48%), Gaps = 54/238 (22%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G FG V L R+KK+G A+K +KK + +E + E +L ++ IVKLY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
F+D +LYL+MEY GG + LL E L+E+ + Q + +E +H + IHRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 213 KPDNLLLDK-NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
KP+N+LLD NG +KL+DFGL K L
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLT---------------------------------- 144
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 328
+ + L + VGTP Y+APEVLL K Y + D WSLG I+YE+
Sbjct: 145 ---------------SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 6e-51
Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 57/292 (19%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+E++ IG+G+FG+V L R K G +Y +K++ S M + E E +L ++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL----MREDTLTENVARFYIAQSVLAIESI 202
I+K Y SF++ L ++MEY GGD+ + E + Q LA++ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H +HRDIKP N+ L NG +KL DFG+ K L + A KT+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA----KTV------------ 163
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
VGTP Y++PE+ K Y + D WSLG
Sbjct: 164 ---------------------------------VGTPYYLSPELCQNKPYNYKSDIWSLG 190
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
++YE+ PF ++ + KI+ + P S+ S E ++L+ LL
Sbjct: 191 CVLYELCTLKHPFEGENLLELALKIL--KGQYP-PIPSQYSSELRNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 7e-51
Identities = 92/314 (29%), Positives = 137/314 (43%), Gaps = 67/314 (21%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
FE+L IG+G FGEV R K++G A+K +K K+ E + E +L +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTE-NVARFYIAQSVL-AIES 201
IVK Y S+ + L+++ME+ GG D++ + TLTE +A Y+ + +L +E
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIA--YVCKELLKGLEY 113
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H + IHRDIK N+LL +G +KL DFGL
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA--------------------------- 146
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
Q++ K + VGTP ++APEV+ K Y + D WSL
Sbjct: 147 -----------------------QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSL 183
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
G E+ G PP+ P+ KI + K S E KD + + L + E R
Sbjct: 184 GITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKR 242
Query: 381 LGTGGAHQIKAHPW 394
A Q+ HP+
Sbjct: 243 ---PTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-50
Identities = 112/336 (33%), Positives = 163/336 (48%), Gaps = 58/336 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
++G+G FG+V L REK +G YAMK L+K ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
Y+FQ + L +MEY GG++ L RE TE ARFY A+ V A+E +H + ++RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
K +NL+LDK+G H I D + C + +
Sbjct: 122 KLENLMLDKDG-----------------------HIKITDFGL--------CKEGISDGA 150
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 332
+ K+ GTP+Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 151 TMKT------------------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 333 PPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGTG--GAHQI 389
PFY D I+ ++FP LSPEAK L+ LL D + RLG G A ++
Sbjct: 193 LPFYNQDHERLFELIL--MEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 248
Query: 390 KAHPWFKDVVWDKLYE--MEAAFKPEINGELDTQNF 423
H +F + W + + + FKP++ E+DT+ F
Sbjct: 249 MEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYF 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 2e-50
Identities = 121/383 (31%), Positives = 188/383 (49%), Gaps = 68/383 (17%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
DF L ++G+G+FG+V L K + +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 147 -CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
I+RD+K DN++LD GH+K++DFG+CK ENM DG
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK------------------ENM-----WDGVT 157
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
T GTPDYIAPE++ + YG DWW+ G ++
Sbjct: 158 TKT--------------------------FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEH---RLG 382
YEML G PF +D + I+ +++ +P +S EA IC+ L +H RLG
Sbjct: 192 YEMLAGQAPFEGEDEDELFQSIM--EHNVAYP--KSMSKEAV-AICKGLM-TKHPGKRLG 245
Query: 383 TG--GAHQIKAHPWFKDVVWDKL--YEMEAAFKPEINGELDTQNFMKFDELDPPASGRTS 438
G G IK H +F+ + W+KL E++ +KP+ G D +NF KF PP
Sbjct: 246 CGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGR-DAENFDKFFTRHPP----VL 300
Query: 439 SGPSRKMLLTPKDLSFVGYTYKN 461
+ P +++++ F G++Y N
Sbjct: 301 TPPDQEVIMNLDQSEFEGFSYVN 323
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 117/382 (30%), Positives = 186/382 (48%), Gaps = 66/382 (17%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-AS 145
DF L ++G+G+FG+V L K + +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ + + +H+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
I+RD+K DN++LD GH+K++DFG+CK E+M + +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK------------------EHMVDGVTTR--- 159
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
+ GTPDYIAPE++ + YG DWW+ G ++
Sbjct: 160 ----------------------------TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVE--HRLGT 383
YEML G PPF +D + I+ +++ +P LS EA IC+ L RLG
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIM--EHNVSYP--KSLSKEAVS-ICKGLMTKHPSKRLGC 246
Query: 384 G--GAHQIKAHPWFKDVVWDKL--YEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSS 439
G G I+ H +F+ + WDKL E++ FKP++ G+ +NF KF P +
Sbjct: 247 GPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKFFTRGQP----VLT 301
Query: 440 GPSRKMLLTPKDLSFVGYTYKN 461
P + ++ F G++Y N
Sbjct: 302 PPDQLVIANIDQADFEGFSYVN 323
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 8e-50
Identities = 109/346 (31%), Positives = 170/346 (49%), Gaps = 65/346 (18%)
Query: 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVK 150
+IGRG++ +V L KK+ IYAMK +KK + ++ V+ E+++ ++H +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L+ FQ L+ ++E++ GGD+M + R+ L E ARFY A+ LA+ +H+ I+R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
D+K DN+LLD GH+KL+D+G+CK E + P D F
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK------------------EGI-RPGDTTSTF----- 156
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330
GTP+YIAPE+L + YG DWW+LG +M+EM+
Sbjct: 157 -------------------------CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 331 GYPPF----YADDPITTCRKI---VHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382
G PF +D+P V ++ P LS +A ++ L D + RLG
Sbjct: 192 GRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKASSVLKGFLNKDPKERLG 249
Query: 383 ---TGGAHQIKAHPWFKDVVWDKLYEMEAA--FKPEINGELDTQNF 423
G IK+HP+F+++ WD L + + +KP I + D NF
Sbjct: 250 CHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNF 295
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-49
Identities = 112/345 (32%), Positives = 172/345 (49%), Gaps = 65/345 (18%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
+IGRG++ +V L R KK+ IYAMK +KK + ++ V+ E+++ + ++H +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ FQ L+ ++EY+ GGD+M + R+ L E ARFY A+ LA+ +H+ I+RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD GH+KL+D+G+CK E + P D F
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK------------------EGL-RPGDTTSTF------ 156
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
GTP+YIAPE+L + YG DWW+LG +M+EM+ G
Sbjct: 157 ------------------------CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
Query: 332 YPPF----YADDPITTCRKI---VHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG- 382
PF +D+P V ++ P LS +A ++ L D + RLG
Sbjct: 193 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGC 250
Query: 383 --TGGAHQIKAHPWFKDVVWDKLYEMEAA--FKPEINGELDTQNF 423
G I+ HP+F++V WD + + + FKP I+GE NF
Sbjct: 251 HPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNF 295
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 6e-49
Identities = 122/378 (32%), Positives = 176/378 (46%), Gaps = 69/378 (18%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
++G+G FG+V L +EK +G YAMK LKK +V + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH-KHNYIHRD 211
YSFQ + L +MEY GG++ L RE +E+ ARFY A+ V A++ +H + N ++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K +NL+LDK+G H I D + + DG T
Sbjct: 122 LKLENLMLDKDG-----------------------HIKITDFGLCKEGIKDGATMKT--- 155
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
GTP+Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 156 -----------------------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGTGG--AHQ 388
PFY D I+ ++FP LSPEAK L+ LL D + RLG G A +
Sbjct: 193 RLPFYNQDHEKLFELIL--MEEIRFP--RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKE 248
Query: 389 IKAHPWFKDVVWDKLYE--MEAAFKPEINGELDTQNF-----MKFDELDPPASGRTSSGP 441
I H +F +VW +YE + FKP++ E DT+ F + + PP
Sbjct: 249 IMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPP-----DQDD 303
Query: 442 SRKMLLTPKDLSFVGYTY 459
S + + + F ++Y
Sbjct: 304 SMETVDNERRPHFPQFSY 321
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 9e-49
Identities = 109/335 (32%), Positives = 167/335 (49%), Gaps = 59/335 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L K G +A+K LKK ++ VE E+ +LA + + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
Y +FQ E+L+ +ME+L GGD+M + + A FY A+ V ++ +H I+RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN++LD++GH+K++DFG+CK EN+ DN+
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK------------------ENVF-----------GDNR 152
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
+S + GTPDYIAPE+L Y DWWS G ++YEML+G
Sbjct: 153 AS--------------------TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIK 390
PF+ DD I H +P ++ E+KD++ +L D RLG G I+
Sbjct: 193 QSPFHGDDEDELFESIRVDTPH--YP--RWITKESKDILEKLFERDPTRRLGVVG--NIR 246
Query: 391 AHPWFKDVVWDKL--YEMEAAFKPEINGELDTQNF 423
HP+FK + W L E++ FKP++ D NF
Sbjct: 247 GHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNF 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 4e-47
Identities = 111/343 (32%), Positives = 175/343 (51%), Gaps = 63/343 (18%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
+IGRG++ +V L R KK+ IYAMK +KK + ++ V+ E+++ + +S+ +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ FQ T L+L++EY+ GGD+M + R+ L E ARFY A+ +A+ +H+ I+RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD +GH+KL+D+G+CK +G P D
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK---------------------------EGLGPG-DTT 153
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
S++ GTP+YIAPE+L + YG DWW+LG +M+EM+ G
Sbjct: 154 STF---------------------CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192
Query: 332 YPPF--YADDPITTCRKI---VHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG--- 382
PF D+P V ++ P LS +A ++ L D + RLG
Sbjct: 193 RSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVKASHVLKGFLNKDPKERLGCQP 250
Query: 383 TGGAHQIKAHPWFKDVVWDKLYEMEAA--FKPEINGELDTQNF 423
G IK+H +F+ + WD L + + FKP+I + +NF
Sbjct: 251 QTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENF 293
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 2e-45
Identities = 69/150 (46%), Positives = 102/150 (68%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+++F ++ I RGAFG+V L R+K + +YA+K +KK++M+ + V V+AER+ LA
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
S IV LYYS Q +YL+MEYL GGD+ +LL E +A YI++ LA++ +H+
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
H IHRD+KPDN+L+ GH+KL+DFGL K
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 162 bits (409), Expect = 6e-45
Identities = 107/337 (31%), Positives = 151/337 (44%), Gaps = 66/337 (19%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +L +G G+FGEV L R++K + A+K L K K +VE E +LA +
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 147 -CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSVLAIESI 202
IVKLY FQD LYL+MEY+ GG + LL R+ L+E+ A F +AQ + A+E +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 203 HKHNYIHRDIKPDNLLLDKNGHM-KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
H IHRDIKP+N+LLD++G + KL DFGL K L +
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS----------- 166
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG---YGMECDW 318
++VGTP Y+APEVLL D
Sbjct: 167 --------------------------------TSVGTPGYMAPEVLLGLSLAYASSSSDI 194
Query: 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD---------DSKLSPEAKDL 369
WSLG +YE+L G PPF + + + + L P +S A DL
Sbjct: 195 WSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDL 254
Query: 370 ICRLL-CDVEHRLGTGGA--HQIKAHPWFKDVVWDKL 403
+ +LL D ++RL + H + AH K+ L
Sbjct: 255 LKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291
|
Length = 384 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 5e-44
Identities = 109/336 (32%), Positives = 157/336 (46%), Gaps = 58/336 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
++G+G FG+V L REK SG YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
YSFQ + L +MEY+ GG++ L RE +E+ RFY A+ V A++ +H ++RD+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
K +NL+L D + + D C + +
Sbjct: 122 KLENLML-------------------------------DKDGHIKITDFGLCKEGITDAA 150
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 332
+ K+ GTP+Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 151 TMKT------------------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 333 PPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQI 389
PFY D I+ +KFP LS +AK L+ LL D RLG G A +I
Sbjct: 193 LPFYNQDHEKLFELIL--MEDIKFP--RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEI 248
Query: 390 KAHPWFKDVVWDKLYE--MEAAFKPEINGELDTQNF 423
H +F V W +Y+ + FKP++ E DT+ F
Sbjct: 249 MRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYF 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 6e-43
Identities = 87/310 (28%), Positives = 140/310 (45%), Gaps = 57/310 (18%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+++L +IGRGAFG V ++G+ A+K++ ++ K ++ + E +LL +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHP 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
IVK S + ++ LY+I+EY G + ++ + E++ Y+ Q + + +H+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
IHRDIK N+L K+G +KL+DFG+ L+ D
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLN-------------DVS------------- 153
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326
K S VGTP ++APEV+ G D WSLG +
Sbjct: 154 -----------------------KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVI 190
Query: 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD-LICRLLCDVEHRLGTGG 385
E+L G PP+Y +P+ +IV +H P+ +SPE KD L+ D R
Sbjct: 191 ELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEG--ISPELKDFLMQCFQKDPNLRP---T 244
Query: 386 AHQIKAHPWF 395
A Q+ HPW
Sbjct: 245 AKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 1e-42
Identities = 100/321 (31%), Positives = 155/321 (48%), Gaps = 63/321 (19%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HC--IV 149
IIGRG FGEV CR+ +G +YAMK L K + + ER +L+ V++ C IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIH 209
+ Y+F + L I++ + GGD+ L + +E RFY A+ +L +E +H ++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTD 269
RD+KP N+LLD++GH+++SD GL C
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA----CDF----------------------------- 147
Query: 270 NKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 328
S K PH ++VGT Y+APEVL K Y DW+SLG +++++
Sbjct: 148 ---SKKKPH---------------ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 189
Query: 329 LVGYPPF--YADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG--T 383
L G+ PF + ++ ++ PD SPE + L+ LL DV RLG
Sbjct: 190 LRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDS--FSPELRSLLEGLLQRDVNRRLGCLG 246
Query: 384 GGAHQIKAHPWFKDVVWDKLY 404
GA ++K HP+F+ + W ++
Sbjct: 247 RGAQEVKEHPFFRSLDWQMVF 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 68/183 (37%), Positives = 94/183 (51%), Gaps = 17/183 (9%)
Query: 291 LAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW 350
A S VG+PDY+APEVL KGY D+WSLG ++YE L G+PPF P T + +W
Sbjct: 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
Query: 351 RNHLKFPD----DSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEM 406
+ L+ P LS EA DLI +L+ D R G IK HP+FK+V W++L E+
Sbjct: 214 KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRF--GSLEDIKNHPFFKEVDWNELREL 271
Query: 407 EAAFKPEINGELDTQNFMKFDELDPPA---------SGRTSSGPSRKMLLTPKDLSFVGY 457
+ F PE+ E+DT F F+ D A G + + FVG+
Sbjct: 272 KPPFVPELESEIDTGYFDDFENEDDMAKYKDVHEKKKAAGKGGANGRD--PGNRRKFVGF 329
Query: 458 TYK 460
T++
Sbjct: 330 TFR 332
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 102/333 (30%), Positives = 160/333 (48%), Gaps = 57/333 (17%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F ++G+G FGEV C+ + +G +YA KKL+K + KR E+ +L +V S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKH 205
+V L Y+++ + L L++ + GGD+ + M E E A FY A+ +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
++RD+KP+N+LLD +GH+++SD GL A+H + E I G
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGL----------AVH---------VPEGQTIKG-- 160
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
VGT Y+APEV+ + Y DWW+LG ++
Sbjct: 161 -----------------------------RVGTVGYMAPEVVKNERYTFSPDWWALGCLL 191
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT- 383
YEM+ G PF ++ ++ K SP+A+ L LLC D + RLG
Sbjct: 192 YEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQ 251
Query: 384 -GGAHQIKAHPWFKDVVWDKLYE--MEAAFKPE 413
GGA ++K HP FK + + +L +E FKP+
Sbjct: 252 GGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 9e-42
Identities = 97/339 (28%), Positives = 155/339 (45%), Gaps = 69/339 (20%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F ++G+G FGEV C+ + +G +YA KKL+K + KR E+ +L +V S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKH 205
+V L Y+++ + L L++ + GGD+ + M E A FY A+ +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
++RD+KP+N+LLD GH+++SD GL I E +TI
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA--------VEIPEGETI--------------- 158
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
+ TVG Y+APEV+ + Y DWW LG ++
Sbjct: 159 ------------------------RGRVGTVG---YMAPEVVKNERYTFSPDWWGLGCLI 191
Query: 326 YEMLVGYPPFYADDPITTCRKIVHW----RNHLKFPDD--SKLSPEAKDLICRLLC-DVE 378
YEM+ G PF ++ V R + ++ K S A+ + +LL D
Sbjct: 192 YEMIEGKSPFRQR------KEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPG 245
Query: 379 HRLG--TGGAHQIKAHPWFKDVVWDKLYE--MEAAFKPE 413
RLG GA ++KAHP+F+ + +L +E F P+
Sbjct: 246 FRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 84/318 (26%), Positives = 134/318 (42%), Gaps = 65/318 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVA 144
D E + ++G+G+ G V R K +G IYA+KK+ + R Q+ E L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL---LRELKTLRSCE 57
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIH 203
S +VK Y +F + +++EY+ GG + LL + + E V YIA+ +L ++ +H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-YIARQILKGLDYLH 116
Query: 204 -KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
K + IHRDIKP NLL++ G +K++DFG+ K L+ +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT----------------------- 153
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
D +++ VGT Y++PE + + Y D WSLG
Sbjct: 154 -----LDQCNTF---------------------VGTVTYMSPERIQGESYSYAADIWSLG 187
Query: 323 AIMYEMLVGYPPFYAD---DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVE 378
+ E +G PF + I + SPE +D I L D +
Sbjct: 188 LTLLECALGKFPFLPPGQPSFFELMQAIC--DGPPPSLPAEEFSPEFRDFISACLQKDPK 245
Query: 379 HRLGTGGAHQIKAHPWFK 396
R A ++ HP+ K
Sbjct: 246 KRP---SAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 94/331 (28%), Positives = 142/331 (42%), Gaps = 91/331 (27%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
++ L IG GA GEV ++ +G A+KK++ + K + + ++ +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEIL----IMKDCKHPN 76
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF----------YIAQSVL 197
IV Y S+ + L+++MEY+ GG +LT+ + + Y+ + VL
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGG----------SLTDIITQNFVRMNEPQIAYVCREVL 126
Query: 198 -AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+E +H N IHRDIK DN+LL K+G +KL+DFG L
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL-------------------- 166
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316
T KS +R S VGTP ++APEV+ +K YG +
Sbjct: 167 -----------TKEKS---------------KRN---SVVGTPYWMAPEVIKRKDYGPKV 197
Query: 317 DWWSLGAIMYEMLVGYPPFYADDP------ITTCRKIVHWRNHLKFPDDSKLSPEAKDLI 370
D WSLG + EM G PP+ + P ITT K + + K SPE KD +
Sbjct: 198 DIWSLGIMCIEMAEGEPPYLREPPLRALFLITT--KGIP-----PLKNPEKWSPEFKDFL 250
Query: 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400
+ L D E R A ++ HP+ K
Sbjct: 251 NKCLVKDPEKR---PSAEELLQHPFLKKACP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 3e-40
Identities = 96/319 (30%), Positives = 148/319 (46%), Gaps = 60/319 (18%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G FGEV C+ + +G +YA KKL K + KR E E+ +LA+V S IV L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDT----LTENVARFYIAQSVLAIESIHKHNYIH 209
+FQ L L+M + GGD+ + D E A FY AQ + +E +H+ I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTD 269
RD+KP+N+LLD +G+++ I D +A
Sbjct: 121 RDLKPENVLLDNDGNVR-----------------------ISDLGLAV------------ 145
Query: 270 NKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329
+L+ Q + A GTP ++APE+L + Y D+++LG +YEM+
Sbjct: 146 ----------ELKDGQSKTKGYA----GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191
Query: 330 VGYPPFYADDPITTCRKIVH--WRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG--TG 384
PF A +++ + + +PD K SP +K LL D E RLG G
Sbjct: 192 AARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDG 249
Query: 385 GAHQIKAHPWFKDVVWDKL 403
++ HP F+D+ W +L
Sbjct: 250 NCDGLRTHPLFRDLNWRQL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-39
Identities = 90/291 (30%), Positives = 132/291 (45%), Gaps = 57/291 (19%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
DFE+L IG+G+FG V K +YAMK++ S+M +R + E + E +LA++ S
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTEN-VARFYIAQSVLAIESIH 203
I++ Y SF D L ++MEY GD+ LL R L E+ V RF+I Q +L + +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+HRDIK NL LD ++K+ D G+ K L +T +A TI
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA----NTI------------- 161
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
VGTP Y++PE+ K Y + D W+LG
Sbjct: 162 --------------------------------VGTPYYLSPELCEDKPYNEKSDVWALGV 189
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
++YE G PF A++ KI+ P S + LI + L
Sbjct: 190 VLYECCTGKHPFDANNQGALILKIIRGVFP---PVSQMYSQQLAQLIDQCL 237
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 90/307 (29%), Positives = 139/307 (45%), Gaps = 65/307 (21%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVR---AERNLLAEVASHCIVK 150
+G G+FG V G+ +A+K++ ++ + GQ E V+ E LL+++ IV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQ-EAVKQLEQEIALLSKLQHPNIVQ 66
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
+ ++ + LY+ +E +PGG + LL + + E V R Y Q +L +E +H N +HR
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
DIK N+L+D NG +KL+DFG+ K
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAK------------------------------------ 150
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEML 329
Q+ A S G+P ++APEV+ ++G YG+ D WSLG + EM
Sbjct: 151 --------------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA 196
Query: 330 VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC---DVEHRLGTGGA 386
G PP+ + + KI + PD LS EAKD I L C D R A
Sbjct: 197 TGKPPWSQLEGVAAVFKIGRSKELPPIPDH--LSDEAKDFI--LKCLQRDPSLRP---TA 249
Query: 387 HQIKAHP 393
++ HP
Sbjct: 250 AELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 61/142 (42%), Positives = 91/142 (64%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
++G+G FG+V L REK +G YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
YSFQ + L +MEY GG++ L RE +E+ ARFY A+ V A+ +H + ++RD+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 213 KPDNLLLDKNGHMKLSDFGLCK 234
K +NL+LDK+GH+K++DFGLCK
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-38
Identities = 105/328 (32%), Positives = 160/328 (48%), Gaps = 77/328 (23%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-VKRGQVEHVRAERNLLAEVAS-HC--I 148
IIGRG FGEV CR+ +G +YAMK L K + +K+G+ + ER +L+ V++ C I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-ERIMLSLVSTGDCPFI 59
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYI 208
V + Y+F + L I++ + GGD+ L + +E RFY + +L +E +H +
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDT 268
+RD+KP N+LLD++GH+++SD GL C
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA----CDF---------------------------- 147
Query: 269 DNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 327
S K PH ++VGT Y+APEVL K Y DW+SLG ++++
Sbjct: 148 ----SKKKPH---------------ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFK 188
Query: 328 MLVGYPPF--------YADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVE 378
+L G+ PF + D +T + + PD SPE K L+ LL DV
Sbjct: 189 LLRGHSPFRQHKTKDKHEIDRMTLTVNV-------ELPD--SFSPELKSLLEGLLQRDVS 239
Query: 379 HRLGT--GGAHQIKAHPWFKDVVWDKLY 404
RLG GA ++K H +FK + W ++Y
Sbjct: 240 KRLGCLGRGAQEVKEHVFFKGIDWQQVY 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 78/262 (29%), Positives = 114/262 (43%), Gaps = 61/262 (23%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D+E+L IG+G+FG VR R K G I K++ M + + + +E N+L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHP 59
Query: 147 CIVKLYYSFQDTE--YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIE 200
IV+ Y D LY++MEY GGD+ L+ + + E + Q +LA+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 201 SIH-----KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
H + +HRD+KP N+ LD N ++KL DFGL K L + +A KT
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA----KTY----- 170
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315
VGTP Y++PE L Y +
Sbjct: 171 ----------------------------------------VGTPYYMSPEQLNHMSYDEK 190
Query: 316 CDWWSLGAIMYEMLVGYPPFYA 337
D WSLG ++YE+ PPF A
Sbjct: 191 SDIWSLGCLIYELCALSPPFTA 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 6e-36
Identities = 81/284 (28%), Positives = 124/284 (43%), Gaps = 50/284 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLK--KSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
++G+GAFG V LC + +G A+K++ + +V + E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
Y +D E L + MEY+PGG + L LTE V R Y Q + +E +H + +HR
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
DIK N+L D G++KL DFG K L I T
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQ-----TICSSGTGMK------------------ 165
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330
S GTP +++PEV+ +GYG + D WS+G + EML
Sbjct: 166 -----------------------SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
Query: 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
PP+ + + KI + + P +SP+A++ + R
Sbjct: 203 EKPPWAEFEAMAAIFKIATQPTNPQLPSH--VSPDARNFLRRTF 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 89/306 (29%), Positives = 132/306 (43%), Gaps = 55/306 (17%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG G FG+V +G + A+K+++ + ++ + E +L E+ H + YY
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVL-ELLKHPNLVKYY 65
Query: 154 SFQ-DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
+ E +Y+ MEY GG + LL L E+V R Y Q + + +H H +HRDI
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
KP N+ LD NG +KL DFG L K+
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKL----------------------------------KN 151
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEML 329
+ + E++Q GTP Y+APEV+ KG+G D WSLG ++ EM
Sbjct: 152 NTTTMGEEVQSL-----------AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200
Query: 330 VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR-LLCDVEHRLGTGGAHQ 388
G P+ D V + PD +LSPE KD + R L D + R A +
Sbjct: 201 TGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASE 257
Query: 389 IKAHPW 394
+ HP+
Sbjct: 258 LLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 96/334 (28%), Positives = 154/334 (46%), Gaps = 59/334 (17%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F ++G+G FGEV C+ + +G +YA KKL+K + KR E+ +L +V S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKH 205
+V L Y+++ + L L++ + GGD+ + M E A FY A+ +E + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
++RD+KP+N+LLD GH+++SD GL I E +T+
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA--------VQIPEGETV--------------- 158
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
R ++ TVG Y+APEV+ + Y DWW LG ++
Sbjct: 159 ----------------------RGRVG--TVG---YMAPEVINNEKYTFSPDWWGLGCLI 191
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC--DVEHRLGT 383
YEM+ G PF ++ + K S +AK ICR+L + + RLG
Sbjct: 192 YEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS-ICRMLLTKNPKERLGC 250
Query: 384 --GGAHQIKAHPWFKDVVWDKLYE--MEAAFKPE 413
GA +K HP FK++ + +L +E F P+
Sbjct: 251 RGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 60/292 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ F++L +G G++G V K++G + A+K + + ++ + E ++L + S
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PV--EEDLQEIIKEISILKQCDS 57
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTENVARFYIAQSVLAIESI 202
IVK Y S+ L+++MEY G D+M + TLTE + Q++ +E +
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H + IHRDIK N+LL++ G KL+DFG+
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVS----------------------------- 146
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
QL M +R + +GTP ++APEV+ + GY + D WSLG
Sbjct: 147 ----------------GQLTD-TMAKRN---TVIGTPFWMAPEVIQEIGYNNKADIWSLG 186
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
EM G PP+ P+ I + D K SPE D + + L
Sbjct: 187 ITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDFVKKCL 237
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 5e-35
Identities = 92/315 (29%), Positives = 144/315 (45%), Gaps = 64/315 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKK--LKKSEMVKRGQVEHVRAERNLLAEV 143
+ F LL IG+G+FGEV +K++ + A+K L+++E ++E ++ E L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
S I K Y SF L++IMEY GG + LL + L E F + + +L +E +H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+ IHRDIK N+LL + G +KL+DFG+ S
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGV------SG----------------------- 146
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
QL M++R + VGTP ++APEV+ + GY + D WSLG
Sbjct: 147 ----------------QLTS-TMSKRN---TFVGTPFWMAPEVIKQSGYDEKADIWSLGI 186
Query: 324 IMYEMLVGYPPFYAD-DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381
E+ G PP +D P+ I +N+ + +K S KD + L D + R
Sbjct: 187 TAIELAKGEPP-LSDLHPMRVLFLIP--KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERP 243
Query: 382 GTGGAHQIKAHPWFK 396
A ++ H + K
Sbjct: 244 ---SAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 94/341 (27%), Positives = 135/341 (39%), Gaps = 91/341 (26%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--LLAEVAS 145
++ L IG G +G V R+K +G I A+KK+K + A R LL E+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNH 57
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I+KL F+ LYL+ E++ + R+ L E++ + Y+ Q + + H H
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+HRD+KP+NLL++ G +KL+DFGL +
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFG---------------------------- 149
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 324
SP H+ V T Y APE+LL KGY D WS+G I
Sbjct: 150 ----------SPVRPYTHY-----------VVTRWYRAPELLLGDKGYSTPVDIWSVGCI 188
Query: 325 MYEMLVGYPPFYADDPITTCRKI---------VHW-------RN-------------HLK 355
E+L P F I KI W RN
Sbjct: 189 FAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKL 248
Query: 356 FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395
FP+ SP+A DL+ ++L D R+ A Q AHP+F
Sbjct: 249 FPN---ASPQALDLLSQMLHYDPHKRI---TAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 9e-34
Identities = 92/334 (27%), Positives = 154/334 (46%), Gaps = 59/334 (17%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F ++G+G FGEV C+ + +G +YA K+L+K + KR E+ +L +V S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKH 205
+V L Y+++ + L L++ + GGD+ + M E A FY A+ + +E +H+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
N ++RD+KP+N+LLD G H I D +A +
Sbjct: 122 NTVYRDLKPENILLDDYG-----------------------HIRISDLGLAVKI------ 152
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
P+ + VGT Y+APEVL + Y + D+W LG ++
Sbjct: 153 PEGE---------------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLI 191
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC--DVEHRLGT 383
YEM+ G PF ++ + +K S EAK IC++L D + RLG
Sbjct: 192 YEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS-ICKMLLTKDPKQRLGC 250
Query: 384 G--GAHQIKAHPWFKDVVWDKLYE--MEAAFKPE 413
GA ++K HP+F+++ + +L ++ F P+
Sbjct: 251 QEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 87/314 (27%), Positives = 147/314 (46%), Gaps = 64/314 (20%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ IG G+ G V + +K +G A+KK+ ++ K+ + E + E ++ +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQHP 76
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKH 205
IV++Y S+ + L+++ME+L GG + ++ E +A + +VL A+ +H
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALSFLHAQ 134
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
IHRDIK D++LL +G +KLSDFG C + E
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFC--------------AQVSKE------------ 168
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
+ RRK S VGTP ++APEV+ + YG E D WSLG ++
Sbjct: 169 --------------------VPRRK---SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHL--KFPDDSKLSPEAKDLICRLLC-DVEHRLG 382
EM+ G PP++ + P+ ++I R++L K + K+SP + + R+L D R
Sbjct: 206 IEMVDGEPPYFNEPPLQAMKRI---RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR-- 260
Query: 383 TGGAHQIKAHPWFK 396
A ++ HP+
Sbjct: 261 -ATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 96/342 (28%), Positives = 138/342 (40%), Gaps = 94/342 (27%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-QVEHVRAERNLLAEVASH 146
+E L +G G +G V R+KK+G I A+KK++ + + G +R E +LL E+ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTALR-EISLLKEL-KH 57
Query: 147 -CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESIHK 204
IVKL LYL+ EY D+ L R L+ N+ + + Q + + H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCK----PLDCSTLYAIHEHKTIDDENMAEPMD 260
H +HRD+KP N+L++++G +KL+DFGL + PL T HE T+
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT----HEVVTL---------- 162
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWW 319
W Y APE+LL K Y D W
Sbjct: 163 -------------W--------------------------YRAPEILLGSKHYSTAVDIW 183
Query: 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPDDSK--------- 361
S+G I EM+ G P F D I KI W K PD
Sbjct: 184 SVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKD 243
Query: 362 -------LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395
L PE DL+ ++L + R+ A + HP+F
Sbjct: 244 LEKVLPRLDPEGIDLLSKMLQYNPAKRI---SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 74/260 (28%), Positives = 114/260 (43%), Gaps = 73/260 (28%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK-----SEMVKRGQVEHVRAERNLLAE 142
++++ +G G FG V L R K++G + A+KK+KK E + + V++ L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM---NLREVKS----LRK 53
Query: 143 VASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQSV 196
+ H IVKL F++ + LY + EY+ G L LM++ +E+V R I Q +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ IHKH + HRD+KP+NLL+ +K++DFGL + + Y
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-------------- 155
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGME 315
TD V T Y APE+LL+ Y
Sbjct: 156 -----------TD-------------------------YVSTRWYRAPEILLRSTSYSSP 179
Query: 316 CDWWSLGAIMYEMLVGYPPF 335
D W+LG IM E+ P F
Sbjct: 180 VDIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 82/345 (23%), Positives = 127/345 (36%), Gaps = 96/345 (27%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL---KKSEMVKRGQVEHVRAERNLLAEV 143
+++L IG GA G V +++++G A+KK+ + + + ++A L
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA----LQAC 56
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
+VKL F L+MEY+P L E L E + Y+ + + +H
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+ +HRD+KP NLL+ +G +K++DFGL +
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFS-------------------------- 150
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLG 322
+ S H+ V T Y APE+L + Y D W++G
Sbjct: 151 --EEEPRLYS----HQ----------------VATRWYRAPELLYGARKYDPGVDLWAVG 188
Query: 323 AIMYEMLVGYPPFYADDPI---------------TTC----------------RKIVHWR 351
I E+L G P F ++ I T K +
Sbjct: 189 CIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLE 248
Query: 352 NHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAHPWF 395
FPD SPEA DL+ LL D RL A + HP+F
Sbjct: 249 EI--FPD---ASPEALDLLKGLLVYDPSKRL---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 65/258 (25%), Positives = 112/258 (43%), Gaps = 58/258 (22%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
DF++L +G+G++G V + YA+K++ M ++ + + V R +LA V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR-ILASVNHP 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTL-----TENVARFYIAQSVLAIES 201
I+ +F D L ++MEY P GD+ + + + + R +I Q + +++
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQA 118
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H+ +HRD+K N+LL N +K+ D G+ K L
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVL------------------------- 153
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
++ +A + +GTP Y+APEV + Y + D WSL
Sbjct: 154 --------------------------KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187
Query: 322 GAIMYEMLVGYPPFYADD 339
G ++YEM PPF A
Sbjct: 188 GCLLYEMATFAPPFEARS 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 99/341 (29%), Positives = 140/341 (41%), Gaps = 88/341 (25%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS---EMVKRGQVEHVRAERNLLAEVA 144
+E+L ++G GA+G V CR K +G I A+KK K+S E VK+ + V+ R L E
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE-- 60
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
IV L +F+ LYL+ EY+ + L L + R YI Q + AI H
Sbjct: 61 --NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
HN IHRDIKP+N+L+ ++G +KL DFG + L
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR-----------------------PA 155
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWWSLGA 323
P TD V T Y APE+L+ YG D W++G
Sbjct: 156 SPLTD-------------------------YVATRWYRAPELLVGDTNYGKPVDVWAIGC 190
Query: 324 IMYEMLVGYPPFYADD-------------PITTCRKIVHWRNH----LKFPDDS------ 360
IM E+L G P F D P+ + + N + FP+ S
Sbjct: 191 IMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLE 250
Query: 361 -----KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395
K+S A D + L D + RL ++ HP+F
Sbjct: 251 RRYPGKVSSPALDFLKACLRMDPKERL---TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 51/255 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DD+EL+ +IG GA V + A+K++ + + V+ +R E +++
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+VK Y SF + L+L+M YL GG D+M L E + + + + +E +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H + IHRDIK N+LL ++G +K++DFG+ ++A+ D
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGV-------------------SASLADGGD-- 157
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-LKKGYGMECDWWSL 321
RK+ + VGTP ++APEV+ GY + D WS
Sbjct: 158 ------------------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF 193
Query: 322 GAIMYEMLVGYPPFY 336
G E+ G P+
Sbjct: 194 GITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 91/332 (27%), Positives = 139/332 (41%), Gaps = 84/332 (25%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
FEL+ +IG G +G+V R KK+G + A+K + + + E ++ E N+L + +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 145 SH-CIVKLYYSF-------QDTEYLYLIMEYLPGG---DMM-TLLMREDTLTENVARFYI 192
+H I Y +F D + L+L+ME GG D++ L + L E + +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
+++ + +H++ IHRDIK N+LL KN +KL DFG+ LD STL
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD-STLG---------- 168
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL----- 307
RR + +GTP ++APEV+
Sbjct: 169 -----------------------------------RRN---TFIGTPYWMAPEVIACDEQ 190
Query: 308 LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN---HLKFPDDSKLSP 364
Y D WSLG E+ G PP P+ KI RN LK P S
Sbjct: 191 PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP--RNPPPTLKSP--ENWSK 246
Query: 365 EAKDLI--CRLLCDVEHRLGTGGAHQIKAHPW 394
+ D I C L+ + E R ++ HP+
Sbjct: 247 KFNDFISEC-LIKNYEQRPFME---ELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 81/311 (26%), Positives = 127/311 (40%), Gaps = 82/311 (26%)
Query: 97 GAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI-------V 149
G FG+V + + K + ++ K +K ++ A E H + +
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKA---------KNFNA-----IEPMVHQLMKDNPNFI 72
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIH 209
KLYYS + LIM+Y+ GD+ LL +E L+E + I Q V A+ +HKHN IH
Sbjct: 73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIH 132
Query: 210 RDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDT 268
DIK +N+L D + L D+GLCK + + Y DG
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-------------------DG----- 168
Query: 269 DNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 328
T DY +PE + Y + DWW++G + YE+
Sbjct: 169 -----------------------------TLDYFSPEKIKGHNYDVSFDWWAVGVLTYEL 199
Query: 329 LVGYPPF--YADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGG 385
L G PF D+ + + + R K P +S A D + +L ++ +RL
Sbjct: 200 LTGKHPFKEDEDEELDL--ESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNY- 256
Query: 386 AHQIKAHPWFK 396
++I HP+ K
Sbjct: 257 -NEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 86/305 (28%), Positives = 144/305 (47%), Gaps = 62/305 (20%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG G+ G V + REK SG A+K + ++ K+ + E + E ++ + +V++Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKHNYIHRDI 212
S+ E L+++ME+L GG + ++ + E +A + +SVL A+ +H IHRDI
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT--VCESVLQALCYLHSQGVIHRDI 143
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
K D++LL +G +KLSDFG C
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCA-------------------------------------- 165
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 332
Q+ R+ L VGTP ++APEV+ + YG E D WSLG ++ EM+ G
Sbjct: 166 -------QISKDVPKRKSL----VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
Query: 333 PPFYADDPITTCRKIVHWRNH--LKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIK 390
PP+++D P+ +++ R+ K + K+SP +D + R+L A ++
Sbjct: 215 PPYFSDSPVQAMKRL---RDSPPPKLKNAHKISPVLRDFLERML--TREPQERATAQELL 269
Query: 391 AHPWF 395
HP+
Sbjct: 270 DHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 88/304 (28%), Positives = 138/304 (45%), Gaps = 58/304 (19%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+GA G V + +G A+K++ + K+ E + E ++ E IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
S+ + L+++MEYL GG + T ++ E + E + + A+E +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
DN+LL +G +KL+DFG C +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQI------------------------------------- 165
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333
+P EQ + M VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 166 --TP-EQSKRSTM---------VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 334 PFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAH 392
P+ ++P+ I + + KLS +D + R L DVE R G A ++ H
Sbjct: 214 PYLNENPLRALYLIAT-NGTPELQNPEKLSAIFRDFLNRCLEMDVEKR---GSAKELLQH 269
Query: 393 PWFK 396
P+ K
Sbjct: 270 PFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 87/341 (25%), Positives = 134/341 (39%), Gaps = 87/341 (25%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E + IG G +G+V R KK+G + A+KK++ + + +R E LL ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 148 IVKLY---YSFQDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIH 203
IV+L S Y++ EY+ D+ LL + TE+ + Y+ Q + ++ +H
Sbjct: 60 IVRLKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+ +HRDIK N+L++ +G +KL+DFGL A P
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGL-----------------------ARPYTKRN 154
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLG 322
T NR V T Y PE+LL YG E D WS+G
Sbjct: 155 SADYT------------------NR-------VITLWYRPPELLLGATRYGPEVDMWSVG 189
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPD--------------- 358
I+ E+ +G P F + KI W K P
Sbjct: 190 CILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLR 249
Query: 359 ---DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395
+ P A DL+ +LL D + R+ A Q H +F
Sbjct: 250 EFFKHLIDPSALDLLDKLLTLDPKKRI---SADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 89/308 (28%), Positives = 137/308 (44%), Gaps = 59/308 (19%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLK----KSEMVKRGQVEHVRAERNLLAEVASHCI 148
++G+GAFG V LC + +G A K+++ E K +V + E LL + I
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSK--EVSALECEIQLLKNLQHERI 66
Query: 149 VKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
V+ Y +D + L + MEY+PGG + L LTE+V R Y Q + + +H +
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
+HRDIK N+L D G++KL DFG K L +TI C
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRL-----------QTI-------------CMS 162
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326
T + S GTP +++PEV+ +GYG + D WSLG +
Sbjct: 163 GTGIR----------------------SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVV 200
Query: 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGA 386
EML PP+ + + KI + + P S +S A+D + + + HR A
Sbjct: 201 EMLTEKPPWAEYEAMAAIFKIATQPTNPQLP--SHISEHARDFLGCIFVEARHR---PSA 255
Query: 387 HQIKAHPW 394
++ HP+
Sbjct: 256 EELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 86/317 (27%), Positives = 139/317 (43%), Gaps = 59/317 (18%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G FGEV + K +G +YA KKL K + K+ + E+ +L +V S IV L Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVAR--FYIAQSVLAIESIHKHNYIHRD 211
+F+ +L L+M + GGD+ + + R Y AQ I +H + ++RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+KP+N+LLD G+ +LS D + + KTI
Sbjct: 121 MKPENVLLDDQGNCRLS--------DLGLAVELKDGKTITQR------------------ 154
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
GT Y+APE+L ++ Y DW+++G +YEM+ G
Sbjct: 155 ------------------------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190
Query: 332 YPPF--YADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC--DVEHRLGTGGAH 387
PF + + K + +KF + + E+KD ICRL E RLG+ +
Sbjct: 191 RTPFKDHKEKVAKEELKRRTLEDEVKFEHQN-FTEESKD-ICRLFLAKKPEDRLGSREKN 248
Query: 388 -QIKAHPWFKDVVWDKL 403
+ H +FK + + +L
Sbjct: 249 DDPRKHEFFKTINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 74/254 (29%), Positives = 107/254 (42%), Gaps = 53/254 (20%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +L ++G G+FG L + S YAMK+++ VE R E LLA++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP--KSSSAVEDSRKEAVLLAKMKHP 58
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDTLTENVARFYIAQSVLAIESIHK 204
IV SF+ +LY++MEY GGD+M L R E+ + Q L ++ IH+
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+HRDIK N+ L +NG +KL DFG + L P
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-------------------TSPG----- 154
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
A + VGTP Y+ PE+ Y + D WSLG I
Sbjct: 155 -------------------------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCI 189
Query: 325 MYEMLVGYPPFYAD 338
+YE+ PF A+
Sbjct: 190 LYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 57/290 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E + ++GRGAFG V LCR K + +K++ +M K + + E +L ++
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPN 60
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIESIHKH 205
I++ Y +F + + L ++MEY PGG + + L E+ + Q +LA+ +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 206 NYIHRDIKPDNLLLDKNGH-MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+HRD+K N+LLDK+ +K+ DFG+ K L
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL---------------------------- 152
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
S KS A++ VGTP YI+PE+ K Y + D W+LG +
Sbjct: 153 --------SSKSK--------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCV 190
Query: 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
+YE+ F A + KI+ P + SP+ + LI +L
Sbjct: 191 LYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQLILSML 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 79/312 (25%), Positives = 128/312 (41%), Gaps = 58/312 (18%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+ +F++ IG+G F V G + A+KK++ EM+ + E +LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARF-YIAQSVLAIE 200
++K SF + L +++E GD+ ++ ++ L + Y Q A+E
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H +HRDIKP N+ + G +KL D GL + T A
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA----------------- 163
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
S VGTP Y++PE + + GY + D WS
Sbjct: 164 --------------------------------HSLVGTPYYMSPERIHENGYNFKSDIWS 191
Query: 321 LGAIMYEMLVGYPPFYAD--DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377
LG ++YEM PFY D + + C+KI ++ P D S E +DL+ R + D
Sbjct: 192 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPPLPAD-HYSEELRDLVSRCINPDP 249
Query: 378 EHRLGTGGAHQI 389
E R Q+
Sbjct: 250 EKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 56/290 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E++ IG G+FG++ L + K +K++ ++M + + E + E LLA++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKH 205
IV + SFQ+ L+++MEY GGD+M + R+ +E+ + Q L ++ IH
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 206 NYIHRDIKPDNLLLDKNGHM-KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+HRDIK N+ L KNG + KL DFG+ + L+ S
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM------------------------ 156
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
+LA++ VGTP Y++PE+ + Y + D WSLG +
Sbjct: 157 -------------------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCV 191
Query: 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
+YE+ PF ++ KI P S + + LI +L
Sbjct: 192 LYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSLISQLF 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 67/259 (25%), Positives = 114/259 (44%), Gaps = 56/259 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+D+EL+ IG G +G+V R+ +G + A+K +K + E ++ E ++L E
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDM-MTLLMREDTLTENVARFYIAQSVLAIESIHK 204
IV + S+ + L+++MEY GG + + L+E + +++ + +H+
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
IHRDIK N+LL ++G +KL+DFG+ L +
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT------------------------- 154
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---LKKGYGMECDWWSL 321
+ +RK S +GTP ++APEV K GY +CD W+L
Sbjct: 155 ---------------------IAKRK---SFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190
Query: 322 GAIMYEMLVGYPPFYADDP 340
G E+ PP + P
Sbjct: 191 GITAIELAELQPPMFDLHP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 84/336 (25%), Positives = 133/336 (39%), Gaps = 78/336 (23%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEVAS 145
+E +G G + V R+K++G I A+KK+K E + + A R LL E+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I+ L F + L+ E++ + + LT + Y+ ++ +E +H +
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+HRD+KP+NLL+ +G +KL+DFGL +
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLAR------------------------------- 150
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 324
S+ SP+ ++ H V T Y APE+L + YG+ D WS+G I
Sbjct: 151 -------SFGSPNRKMTH-----------QVVTRWYRAPELLFGARHYGVGVDMWSVGCI 192
Query: 325 MYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPDDSKLSP----------- 364
E+L+ P D I KI W PD + P
Sbjct: 193 FAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFP 252
Query: 365 ----EAKDLICRLLCDVEHRLGTGGAHQIKAHPWFK 396
+A DL+ RLL ++ T A Q HP+F
Sbjct: 253 AASDDALDLLQRLLTLNPNKRIT--ARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 78/289 (26%), Positives = 125/289 (43%), Gaps = 55/289 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ + ++G+GAFGE L R + ++ K++ + + ++ + E +L+ +
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPN 60
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIHKH 205
I+ Y F D L + MEY GG + ++R+ E + +Y+ Q V A+ IHK
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+HRDIK N+ L K G +KL DFG+ K L + +MAE
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILG-------------SEYSMAE-------- 159
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
+ VGTP Y++PE+ Y + D W+LG ++
Sbjct: 160 ----------------------------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVL 191
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
YE+L F A +P+ KIV N+ P S S E L+ LL
Sbjct: 192 YELLTLKRTFDATNPLNLVVKIVQ-GNYT--PVVSVYSSELISLVHSLL 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 85/300 (28%), Positives = 132/300 (44%), Gaps = 56/300 (18%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK----KSEMVKRGQVEHVRAERNLLAE 142
++ L ++G+GAFG V LC + +G A+K+++ E K +V + E LL
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSK--EVNALECEIQLLKN 60
Query: 143 VASHCIVKLYYSFQDT--EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
+ IV+ Y +D L + ME++PGG + L LTENV R Y Q + +
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H + +HRDIK N+L D G++KL DFG K L +TI
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-----------QTI---------- 159
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
C T K S GTP +++PEV+ +GYG + D WS
Sbjct: 160 ---CLSGTGMK----------------------SVTGTPYWMSPEVISGEGYGRKADIWS 194
Query: 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHR 380
+G + EML PP+ + + KI + P +S +D + R+ + + R
Sbjct: 195 VGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-27
Identities = 70/249 (28%), Positives = 111/249 (44%), Gaps = 49/249 (19%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLK------KSEMVKRGQVEHVRAERNLLAEVASH 146
+IG G+FG V L SG + A+K+++ S+ KR ++ + E LL E+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
IV+ S D ++L + +EY+PGG + LL E + R ++ Q + + +H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
IHRDIK N+L+D G +K+SDFG+ K L+ ++L
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSL------------------------- 161
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326
S G+ ++APEV+ + Y + D WSLG ++
Sbjct: 162 ------------------STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVV 203
Query: 327 EMLVGYPPF 335
EML G PF
Sbjct: 204 EMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 90/305 (29%), Positives = 144/305 (47%), Gaps = 60/305 (19%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+GA G V + +G A+K++ + K+ + E + E ++ E+ + IV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
SF + L+++MEYL GG + T ++ E + E + + A+E +H + IHRDIK
Sbjct: 84 SFLVGDELFVVMEYLAGGSL-TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
DN+LL +G +KL+DFG C + P+ +S
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQIT----------------------------PEQSKRS- 173
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 174 --------------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 334 PFYADDPITTCRKI-VHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKA 391
P+ ++P+ I + L+ P+ KLSP +D + R L DVE R G A ++
Sbjct: 214 PYLNENPLRALYLIATNGTPELQNPE--KLSPIFRDFLNRCLEMDVEKR---GSAKELLQ 268
Query: 392 HPWFK 396
HP+ K
Sbjct: 269 HPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 79/265 (29%), Positives = 122/265 (46%), Gaps = 57/265 (21%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE---MVKRGQVEHVRAERNLLAEVA 144
+E L ++G G++G V C+ K++G I A+KK +SE MVK+ + +R +L ++
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLR 58
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+V L F+ + LYL+ E++ + L + L E+ R Y+ Q + IE H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
HN IHRDIKP+N+L+ ++G +KL DFG + L A P ++
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTL-------------------AAPGEV--- 156
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 323
TD V T Y APE+L+ YG D W++G
Sbjct: 157 --YTD-------------------------YVATRWYRAPELLVGDTKYGRAVDIWAVGC 189
Query: 324 IMYEMLVGYPPFYADDPITTCRKIV 348
++ EML G P F D I I+
Sbjct: 190 LVTEMLTGEPLFPGDSDIDQLYHII 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 88/306 (28%), Positives = 147/306 (48%), Gaps = 64/306 (20%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG G+ G V + K SG + A+KK+ ++ K+ + E + E ++ + +V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKHNYIHRDI 212
S+ + L+++ME+L GG + ++ E +A + +VL A+ +H IHRDI
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLAVLKALSVLHAQGVIHRDI 142
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
K D++LL +G +KLSDFG C + +K
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQV---------------------------------SK- 168
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 332
++ RRK S VGTP ++APE++ + YG E D WSLG ++ EM+ G
Sbjct: 169 ------------EVPRRK---SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
Query: 333 PPFYADDPITTCRKIVHWRNHL--KFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI 389
PP++ + P+ + I R++L K + K+SP K + RLL D R A ++
Sbjct: 214 PPYFNEPPLKAMKMI---RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR---ATAAEL 267
Query: 390 KAHPWF 395
HP+
Sbjct: 268 LKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 80/290 (27%), Positives = 133/290 (45%), Gaps = 60/290 (20%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLK-------KSEMVKRGQVEHVRAERNLLAEVAS 145
+IG+G +G V L +G + A+K+++ + + ++ V+ +R+E L ++
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 146 HCIVKLYYSFQDTE-YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
IV+ Y F+ TE YL + +EY+PGG + + L E + RF+ Q + + +H
Sbjct: 68 LNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+HRD+K DNLL+D +G K+SDFG+ K D +Y +D+NM
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSD--DIYD-------NDQNM--------- 168
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV--LLKKGYGMECDWWSLG 322
S G+ ++APEV +GY + D WSLG
Sbjct: 169 -----------------------------SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLG 199
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLI 370
++ EM G P+ ++ I K+ + R+ P D LSP A D +
Sbjct: 200 CVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 91/313 (29%), Positives = 137/313 (43%), Gaps = 59/313 (18%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL----KKSEMVKRGQVEHVRAERNLLAE 142
++ L ++GRGAFGEV LC + +G A+K++ E K +V + E LL
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSK--EVNALECEIQLLKN 60
Query: 143 VASHCIVKLYYSFQDTEY--LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
+ IV+ Y +D E L + +EY+PGG + L LTENV R Y Q + +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H + +HRDIK N+L D G++KL DFG K + +TI
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-----------QTI---------- 159
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
C T K S GTP +++PEV+ +GYG + D WS
Sbjct: 160 ---CMSGTGIK----------------------SVTGTPYWMSPEVISGEGYGRKADVWS 194
Query: 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHR 380
+ + EML PP+ + + KI PD +S +D + ++ + E R
Sbjct: 195 VACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG--VSDACRDFLKQIFVE-EKR 251
Query: 381 LGTGGAHQIKAHP 393
T A + HP
Sbjct: 252 RPT--AEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 58/287 (20%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---A 144
++ L +IGRGA+G V + +G + A+K + V ++ E LL+++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQ 60
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
I K Y S+ L++IMEY GG + TL M+ + E I + ++A++ IHK
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
IHRDIK N+L+ G++KL DFG+ L+ ++
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS------------------------ 155
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 323
++ F VGTP ++APEV+ + K Y + D WSLG
Sbjct: 156 -----------------------SKRSTF--VGTPYWMAPEVITEGKYYDTKADIWSLGI 190
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLI 370
+YEM G PP+ D I + + D+ S ++ +
Sbjct: 191 TIYEMATGNPPYSDVDAFRAMMLIPKSKPP-RLEDNG-YSKLLREFV 235
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 55/132 (41%), Positives = 73/132 (55%), Gaps = 9/132 (6%)
Query: 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKF 356
GTP+Y+APEVL YG DWW LG +MYEM+ G PFY D I+ ++F
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRF 214
Query: 357 PDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFK 411
P LSPEAK L+ LL D + RLG G A +I H +F + W + ++E FK
Sbjct: 215 P--RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFK 272
Query: 412 PEINGELDTQNF 423
P++ E DT+ F
Sbjct: 273 PQVTSETDTRYF 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 55/283 (19%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG G+FG+ L + K+ G Y +K++ S+M + + E R E +L+ + IV+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQE 66
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
SF++ LY++M+Y GGD+ + R E+ + Q LA++ +H +HRD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
IK N+ L K+G +KL DFG+ + L + T++
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVL----------NSTVE-------------------- 156
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331
LA + +GTP Y++PE+ + Y + D W+LG ++YEM
Sbjct: 157 -------------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL 197
Query: 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
F A + KI+ R P S S + ++L+ +L
Sbjct: 198 KHAFEAGNMKNLVLKII--RGSYP-PVSSHYSYDLRNLVSQLF 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 75/318 (23%), Positives = 121/318 (38%), Gaps = 70/318 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEHVRAERNLLAEVASHCIV 149
+G GAF R+ K+G + A+K++ Q VE +R E L+A + I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIH 209
++ + + + L +E++ GG + LL + E V Y Q + + +H++ IH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTD 269
RD+K NLL+D G I D A + G
Sbjct: 127 RDVKGANLLIDSTGQ----------------------RLRIADFGAAARLAAKGTGAG-- 162
Query: 270 NKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329
+ Q Q+ +GT ++APEVL + YG CD WS+G ++ EM
Sbjct: 163 ----------EFQG-QL---------LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA 202
Query: 330 VGYPPFYADDPITTCRKIVHWRNHLKF-----------PDDSKLSPEAKDLICRLLCDVE 378
PP+ A+ NHL LSP +D+ R C
Sbjct: 203 TAKPPWNAEK----------HSNHLALIFKIASATTAPSIPEHLSPGLRDVTLR--CLEL 250
Query: 379 HRLGTGGAHQIKAHPWFK 396
+ ++ HP F+
Sbjct: 251 QPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 87/306 (28%), Positives = 145/306 (47%), Gaps = 62/306 (20%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG G+ G V + EK +G A+KK+ ++ K+ + E + E ++ + +V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKHNYIHRDI 212
S+ + L+++ME+L GG + ++ E +A + SVL A+ +H IHRDI
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--VCLSVLRALSYLHNQGVIHRDI 144
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
K D++LL +G +KLSDFG C +
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCA------------------------------------QV 168
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 332
S + P +RK S VGTP ++APEV+ + YG E D WSLG ++ EM+ G
Sbjct: 169 SKEVP----------KRK---SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
Query: 333 PPFYADDPITTCRKIVHWRNHL--KFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIK 390
PP++ + P+ R+I R++L + D K+S + + +L + T A ++
Sbjct: 216 PPYFNEPPLQAMRRI---RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT--AQELL 270
Query: 391 AHPWFK 396
HP+ K
Sbjct: 271 QHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 81/305 (26%), Positives = 134/305 (43%), Gaps = 50/305 (16%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRAERNLLAEVASHCIV 149
++G+GA+G V C G + A+K+++ + + + E ++ E +LL + IV
Sbjct: 7 VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIH 209
+ + D + + ME++PGG + ++L R L E V Y Q + + +H + +H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTD 269
RDIK +N++L NG +KL DFG + L L+ H NM + M
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH-------SNMLKSMH--------- 169
Query: 270 NKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329
GTP ++APEV+ + GYG + D WS+G ++EM
Sbjct: 170 ---------------------------GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA 202
Query: 330 VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQI 389
G PP + D + I R + DS S A D + L +H + A Q+
Sbjct: 203 TGKPPLASMDRLAAMFYIGAHRGLMPRLPDS-FSAAAIDFVTSCLTRDQHERPS--ALQL 259
Query: 390 KAHPW 394
H +
Sbjct: 260 LRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 85/305 (27%), Positives = 141/305 (46%), Gaps = 60/305 (19%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+GA G V + +G A+K++ + K+ E + E ++ E + IV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 83
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
S+ + L+++MEYL GG + T ++ E + E + + A++ +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
DN+LL +G +KL+DFG C + P+ +S
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQIT----------------------------PEQSKRS- 173
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 174 --------------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 334 PFYADDPITTCRKI-VHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKA 391
P+ ++P+ I + L+ P+ +LS +D + R L DV+ R G A ++
Sbjct: 214 PYLNENPLRALYLIATNGTPELQNPE--RLSAVFRDFLNRCLEMDVDRR---GSAKELLQ 268
Query: 392 HPWFK 396
HP+ K
Sbjct: 269 HPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 85/341 (24%), Positives = 140/341 (41%), Gaps = 92/341 (26%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+++L IG G F EV + +K+G YA+K +KK QV ++R E L ++ H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH-FKSLEQVNNLR-EIQALRRLSPHP 58
Query: 148 -IVKLYYSFQD--TEYLYLIMEYLPGGDM-MTLLM--REDTLTENVARFYIAQSVLAIES 201
I++L D T L L+ E + DM + L+ R+ L E + Y+ Q + +++
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H++ HRDIKP+N+L+ + +KL+DFG C+ + Y +
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEY---------------- 158
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWWS 320
+ T Y APE LL G YG + D W+
Sbjct: 159 ----------------------------------ISTRWYRAPECLLTDGYYGPKMDIWA 184
Query: 321 LGAIMYEMLVGYPPFYADDPI---------------TTCRKIVHWRN-HLKFPDDS---- 360
+G + +E+L +P F + + +K R+ + FP
Sbjct: 185 VGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGL 244
Query: 361 -----KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395
S E DL+ +LL D + R+ A Q HP+F
Sbjct: 245 RKLLPNASAEGLDLLKKLLAYDPDERI---TAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 81/327 (24%), Positives = 128/327 (39%), Gaps = 82/327 (25%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA---E 142
DD E L +G G G V + +G I A+K + ++E A + + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---------RLEINEAIQKQILRELD 51
Query: 143 VASHC----IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVL 197
+ C IV Y +F + + + MEY+ GG + +L + + E + IA +VL
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-IAVAVL 110
Query: 198 A--IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
KH IHRD+KP N+L++ G +KL DFG+ L ++
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-------------VNS--- 154
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315
LA + VGT Y+APE + Y ++
Sbjct: 155 -----------------------------------LAKTFVGTSSYMAPERIQGNDYSVK 179
Query: 316 CDWWSLGAIMYEMLVG-YP-PFYADDPITT---CRKIVHWRNHLKFPDDSKLSPEAKDLI 370
D WSLG + E+ G +P P D P + IV+ + P K SP+ +D +
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSG-KFSPDFQDFV 237
Query: 371 CRLLC-DVEHRLGTGGAHQIKAHPWFK 396
L D R ++ HP+ K
Sbjct: 238 NLCLIKDPRER---PSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 87/305 (28%), Positives = 139/305 (45%), Gaps = 60/305 (19%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+GA G V + +G A++++ + K+ E + E ++ E + IV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
S+ + L+++MEYL GG + T ++ E + E + + A+E +H + IHRDIK
Sbjct: 85 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
DN+LL +G +KL+DFG C
Sbjct: 144 SDNILLGMDGSVKLTDFGFCA--------------------------------------- 164
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333
Q+ Q R + VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 165 ------QITPEQSKRSTM----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 334 PFYADDPITTCRKI-VHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKA 391
P+ ++P+ I + L+ P+ KLS +D + R L DVE R G A ++
Sbjct: 215 PYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKR---GSAKELLQ 269
Query: 392 HPWFK 396
H + K
Sbjct: 270 HQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 90/353 (25%), Positives = 141/353 (39%), Gaps = 101/353 (28%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--LLAEVAS 145
+ELL IG GA+G V +K++G A+KK+ V ++ R R LL +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI---SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 146 HCIVKL--------YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
I+ L F D +Y++ E + D+ ++ LT++ ++++ Q +
Sbjct: 59 ENIIGLLDILRPPSPEDFND---VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
++ +H N IHRD+KP N+L++ N +K+ DFGL + +D DE+
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP-------------DEDEKG 161
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316
+ T+ V T Y APE+LL Y
Sbjct: 162 FL--------TE-------------------------YVVTRWYRAPELLLSSSRYTKAI 188
Query: 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH-----------------WRNHLK---- 355
D WS+G I E+L P F D I IV RN+LK
Sbjct: 189 DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPK 248
Query: 356 ---------FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398
FP SPEA DL+ ++L D + R+ A + AHP+ +
Sbjct: 249 KPKKPLSKLFPG---ASPEAIDLLEKMLVFDPKKRI---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 81/258 (31%), Positives = 117/258 (45%), Gaps = 53/258 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ FE+L ++G GA+G V CR K++ I A+KK K SE + + +R E +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIH 203
IV+L +F+ LYL+ EY+ +M+ LL M E V R YI Q + AI H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKV-RSYIYQLIKAIHWCH 117
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
K++ +HRDIKP+NLL+ N +KL DFG + L + + N E
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-----------NANYTE------ 160
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
V T Y +PE+LL YG D WS+G
Sbjct: 161 -------------------------------YVATRWYRSPELLLGAPYGKAVDMWSVGC 189
Query: 324 IMYEMLVGYPPFYADDPI 341
I+ E+ G P F + I
Sbjct: 190 ILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 61/266 (22%), Positives = 107/266 (40%), Gaps = 58/266 (21%)
Query: 89 ELLTIIGRGAFGEVRLCR-EKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
L +G GAFGEV + + K G A+K LK+ + Q+E E ++ ++
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKL- 58
Query: 145 SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLAIESI 202
H +VKL + E LY++MEY+ GGD+++ L L+ + + Q +E +
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
N+IHRD+ N L+ +N +K+SDFGL + +++ P+
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSR--------DLYDDDYYRKRGGKLPI--- 167
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
W +APE L + + + D WS G
Sbjct: 168 --------------------RW-----------------MAPESLKEGKFTSKSDVWSFG 190
Query: 323 AIMYEML-VGYPPFYADDPITTCRKI 347
+++E+ +G P+ +
Sbjct: 191 VLLWEIFTLGEQPYPGMSNEEVLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-23
Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 74/305 (24%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSG-NIYAMKK-------LKKSEMVKRGQVEHVRAERNL 139
+ +L +G GAFG V R+K +G N+ A+K+ K + + + + +E +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 140 LAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDM----MTLLMREDTLTENVARFYIAQ 194
+ E H IV+ Y +F + + LY++M+ + G + +L ++ TE Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 195 SVLAIESIHKHNYI-HRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
VLA+ +HK I HRD+ P+N++L ++ + ++DFGL K
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ------------------ 163
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313
K P +L S VGT Y PE++ + YG
Sbjct: 164 ---------------------KQPESKLT-----------SVVGTILYSCPEIVKNEPYG 191
Query: 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH----------WRNHLKFPDDSKLS 363
+ D W+ G I+Y+M PPFY+ + ++ KIV + + S L+
Sbjct: 192 EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLT 251
Query: 364 PEAKD 368
P+A+
Sbjct: 252 PDAEA 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 8e-23
Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 89 ELLTIIGRGAFGEVRLCR-EKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
L +G GAFGEV + K A+K LK+ + Q+E E ++ ++
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKL- 58
Query: 145 SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIES 201
H IVKL + E L ++MEY+PGGD++ L R L+ + + Q +E
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
+ N+IHRD+ N L+ +N +K+SDFGL + L Y + K
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK 165
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 3e-22
Identities = 69/302 (22%), Positives = 114/302 (37%), Gaps = 63/302 (20%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
EL +G GAFGEV K G A+K LK+ + + E E +++ ++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV-LAIESI 202
+ IV+L E LY++ EY+PGGD++ L + +A + +E +
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
N++HRD+ N L+ +N +K+SDFGL + + Y
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGG-------------- 164
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
K P W +APE L + + D WS G
Sbjct: 165 ------------KLP----IKW-----------------MAPESLKDGKFTSKSDVWSFG 191
Query: 323 AIMYEML-VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC---DVE 378
+++E+ +G P+ + L P++ E +L+ L C D E
Sbjct: 192 VLLWEIFTLGEQPYPGMSNEEVLELLED-GYRLPRPENC--PDELYELM--LQCWAYDPE 246
Query: 379 HR 380
R
Sbjct: 247 DR 248
|
Length = 258 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 89/346 (25%), Positives = 131/346 (37%), Gaps = 101/346 (29%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRAERNLLAEVA 144
++ + IG G +G V R+K +G I A+KK++ + E V + E +LL E+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELN 56
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDM-MTLLMR---EDTLTENVARFYIAQSVLAIE 200
IV+L LYL+ E+L D+ + M L + + Y+ Q + I
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK----PLDCSTLYAIHEHKTIDDENMA 256
H H +HRD+KP NLL+D+ G +KL+DFGL + P+ T
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT---------------- 157
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGME 315
HE + W Y APE+LL + Y
Sbjct: 158 ---------------------HEVVTLW----------------YRAPEILLGSRQYSTP 180
Query: 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPD-------- 358
D WS+G I EM+ P F D I +I W PD
Sbjct: 181 VDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW 240
Query: 359 ----DSK----LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395
SK L + DL+ ++L D R+ A HP+F
Sbjct: 241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI---SAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 8e-22
Identities = 82/295 (27%), Positives = 126/295 (42%), Gaps = 74/295 (25%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +E++ IG+G +G+V KK G++ A+K L V E + AE N+L + +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEAEYNILQSLPN 77
Query: 146 H-CIVKLYYSFQDTEY-----LYLIMEYLPGGDMMTL----LMREDTLTENVARFYIAQS 195
H +VK Y F + L+L++E GG + L L+ L E + + + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+L ++ +H + IHRD+K +N+LL G +KL DFG+ L + L
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-------------- 183
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-----LKK 310
RR ++VGTP ++APEV+
Sbjct: 184 --------------------------------RRN---TSVGTPFWMAPEVIACEQQYDY 208
Query: 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPE 365
Y CD WSLG E+ G PP + P+ T KI RN P + L PE
Sbjct: 209 SYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP--RN----PPPTLLHPE 257
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 79/342 (23%), Positives = 128/342 (37%), Gaps = 89/342 (26%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E L IG GA+G V R+ +G A+KK++ + + +R E LL ++ S
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFE 59
Query: 148 ---IVKLYYSFQDTEY-----LYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVL 197
IV+L L L+ E++ D+ T L + + L + + Q +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
++ +H H +HRD+KP N+L+ +G +K++DFGL +
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS-------------------- 158
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
++M S V T Y APEVLL+ Y D
Sbjct: 159 --------------------------FEMALT----SVVVTLWYRAPEVLLQSSYATPVD 188
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIV---------HWRNHLKFPDDS-------- 360
WS+G I E+ P F KI W ++ P S
Sbjct: 189 MWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRS 248
Query: 361 ------KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395
++ E DL+ ++L + R+ A Q HP+F
Sbjct: 249 FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ---HPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 78/312 (25%), Positives = 125/312 (40%), Gaps = 62/312 (19%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+F++ IGRG F EV A+KK++ EM+ + E +LL ++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAIESI 202
++K SF + L +++E GD+ ++ ++ + E Y Q A+E +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H +HRDIKP N+ + G +KL D GL + T
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---------------------- 160
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
A S VGTP Y++PE + + GY + D WSLG
Sbjct: 161 ---------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLG 193
Query: 323 AIMYEMLVGYPPFYAD--DPITTCRKIVHWRNHLKFP--DDSKLSPEAKDLICRLLC-DV 377
++YEM PFY D + + C+KI +P S + ++L+ + D
Sbjct: 194 CLLYEMAALQSPFYGDKMNLFSLCQKI----EQCDYPPLPTEHYSEKLRELVSMCIYPDP 249
Query: 378 EHRLGTGGAHQI 389
+ R G HQI
Sbjct: 250 DQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 90/350 (25%), Positives = 134/350 (38%), Gaps = 86/350 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKK-LKKSEMVKRGQVEHVRAER--NLLAE 142
D+E+L +G G FGEV R+ K+G + A+KK L +E K G + A R +L +
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGF--PITALREIKILKK 63
Query: 143 VASHCIVKL---YYSFQDTEY-----LYLIMEYLPGGDMMTLLMRED-TLTENVARFYIA 193
+ +V L D +Y++ Y+ D+ LL LTE+ + Y+
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYML 122
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
Q + I +H+++ +HRDIK N+L+D G +K++DFGL +P D
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD---------------- 166
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGY 312
+ K RK + V T Y PE+LL ++ Y
Sbjct: 167 ---------------GPPPNPKGGG------GGGTRKYT-NLVVTRWYRPPELLLGERRY 204
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH------------WR------NHL 354
D W +G + EM P I I WR
Sbjct: 205 TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVH 264
Query: 355 KFPDDS--------KLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAHPWF 395
F + KL PE DL+ +LL D RL A HP+F
Sbjct: 265 SFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL---TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 80/324 (24%), Positives = 132/324 (40%), Gaps = 71/324 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D+ E+L +G+G +G V + +G AMK+++ + + + E ++L + S
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSVLAIESI 202
IV Y +F +Y+ MEY+ G + L + + + E+V R V ++ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 203 -HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+HN IHRD+KP N+L++ NG +KL DFG+ L S
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---------------------- 156
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG------YGME 315
LA + +G Y+APE + G Y ++
Sbjct: 157 -----------------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ 187
Query: 316 CDWWSLGAIMYEMLVG---YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372
D WSLG + EM +G YPP + IV + P S +A+D + +
Sbjct: 188 SDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-GDPPTLPSG--YSDDAQDFVAK 244
Query: 373 LLCDVEHRLGTGGAHQIKAHPWFK 396
L + +R T Q+ HPW
Sbjct: 245 CLNKIPNRRPT--YAQLLEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 72/288 (25%), Positives = 123/288 (42%), Gaps = 52/288 (18%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR--------GQVE-HVRAERNL--LAE 142
+G G +G+V + +G I A+KK+K E+ G H R L + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+ I+ L + + +++ L+M+ + D+ ++ R+ LTE+ + + Q + + +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
HK ++HRD+ P N+ ++ G K++DFGL + Y + DE M
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLAR----RYGYPPYSDTLSKDETMQ------ 185
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSL 321
RR+ S V T Y APE+L+ + Y D WS+
Sbjct: 186 -------------------------RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDL 369
G I E+L G P F ++ I +I L P++ P+AK L
Sbjct: 221 GCIFAELLTGKPLFPGENEIDQLGRIF---ELLGTPNEDNW-PQAKKL 264
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 8e-21
Identities = 70/289 (24%), Positives = 124/289 (42%), Gaps = 56/289 (19%)
Query: 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+ ++G+G++GEV L R + G Y +KKL +R + + E LL+++ IV
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIV 62
Query: 150 KLYYSFQDTE-YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHN 206
S++ + LY++M + GGD+ L + L EN + Q +A++ +H+ +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
+HRD+K N+ L + +K+ D G+ + L+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE----------------------------- 153
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326
N+ +A + +GTP Y++PE+ K Y + D W+LG +Y
Sbjct: 154 --------------------NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVY 193
Query: 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC 375
EM F A D + +I+ + P SPE +LI +L
Sbjct: 194 EMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPELGELIATMLS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 70/254 (27%), Positives = 110/254 (43%), Gaps = 52/254 (20%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F L IG+G+FGEV + ++ + A+K + E ++E ++ E +L++ S
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
I + Y S+ L++IMEYL GG + LL + L E + + + ++ +H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRDIK N+LL + G +KL+DFG+
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG--------------------------------- 149
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
QL Q+ R VGTP ++APEV+ + Y + D WSLG E
Sbjct: 150 ------------QLTDTQIKRNTF----VGTPFWMAPEVIKQSAYDFKADIWSLGITAIE 193
Query: 328 MLVGYPPFYADDPI 341
+ G PP P+
Sbjct: 194 LAKGEPPNSDLHPM 207
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 79/296 (26%), Positives = 127/296 (42%), Gaps = 79/296 (26%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC----- 147
++G+G +G V R+ + A+K++ + + R + L E+A H
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---------RYVQPLHEEIALHSYLKHR 65
Query: 148 -IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL------MREDTLTENVARFYIAQSVLAIE 200
IV+ S + + + ME +PGG + LL ++++ E FY Q + ++
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIIFYTKQILEGLK 122
Query: 201 SIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
+H + +HRDIK DN+L++ +G +K+SDFG K L
Sbjct: 123 YLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----------------------- 159
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECD 317
G P T+ + GT Y+APEV+ K +GYG D
Sbjct: 160 --AGINPCTE------------------------TFTGTLQYMAPEVIDKGPRGYGAPAD 193
Query: 318 WWSLGAIMYEMLVGYPPFYA-DDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372
WSLG + EM G PPF +P K+ ++ H + P+ LS EAK+ I R
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES--LSAEAKNFILR 247
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 69/306 (22%), Positives = 125/306 (40%), Gaps = 79/306 (25%)
Query: 97 GAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI---VKLYY 153
G +V L + ++ + +K L+KS R ++ + HC+ V L+
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLT-----------IIPHCVPNMVCLHK 52
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
+ ++L++++ GG + + + + + E + + A+ V+A++++H+ + RD+
Sbjct: 53 YIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN 112
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
P+N+LLD GH++L+ F S
Sbjct: 113 PNNILLDDRGHIQLTYF-----------------------------------------SR 131
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333
W + + Y APEV CDWWSLGAI++E+L G
Sbjct: 132 WSEVEDSCDGEAVENM-----------YCAPEVGGISEETEACDWWSLGAILFELLTG-- 178
Query: 334 PFYADDPITTCRKI-VHWRNHLKFPDDSKLSPEAKDLICRLL-CDVEHRLGTGGA--HQI 389
+ C ++ L P+ +S EA+ L+ +LL + RLG G A I
Sbjct: 179 -----KTLVECHPSGINTHTTLNIPE--WVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231
Query: 390 KAHPWF 395
K+HP+F
Sbjct: 232 KSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 69/247 (27%), Positives = 107/247 (43%), Gaps = 52/247 (21%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F L IG+G+FGEV + ++ + A+K + E ++E ++ E +L++ S
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+ K Y S+ L++IMEYL GG + LL R E + + + ++ +H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRDIK N+LL + G +KL+DFG+
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG--------------------------------- 149
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
QL Q+ R VGTP ++APEV+ + Y + D WSLG E
Sbjct: 150 ------------QLTDTQIKRNTF----VGTPFWMAPEVIQQSAYDSKADIWSLGITAIE 193
Query: 328 MLVGYPP 334
+ G PP
Sbjct: 194 LAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 69/267 (25%), Positives = 109/267 (40%), Gaps = 55/267 (20%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+F + IGRG F EV G A+KK++ +++ E +LL ++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAIESI 202
++K Y SF + L +++E GD+ ++ ++ + E Y Q A+E +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H +HRDIKP N+ + G +KL D GL + T
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---------------------- 160
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
A S VGTP Y++PE + + GY + D WSLG
Sbjct: 161 ---------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLG 193
Query: 323 AIMYEMLVGYPPFYAD--DPITTCRKI 347
++YEM PFY D + + C+KI
Sbjct: 194 CLLYEMAALQSPFYGDKMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 78/263 (29%), Positives = 104/263 (39%), Gaps = 63/263 (23%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVAS 145
D+ + IG G +G V R KK+G I AMKK++ +SE + G E +LL E+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQH 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN------VARFYIAQSVLAI 199
IV L LYLI E+L M L D+L + + + Y+ Q + I
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
H +HRD+KP NLL+D G +KL+DFGL + HE T+
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL--------- 165
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDW 318
W Y APEVLL Y D
Sbjct: 166 --------------W--------------------------YRAPEVLLGSPRYSTPVDI 185
Query: 319 WSLGAIMYEMLVGYPPFYADDPI 341
WS+G I EM P F+ D I
Sbjct: 186 WSIGTIFAEMATKKPLFHGDSEI 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-20
Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 68/277 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +E++ IG+G +G+V KK+G+ A+K L + E + AE N+L ++
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73
Query: 146 H-CIVKLYYSF-----QDTEYLYLIMEYLPGGDMMTL----LMREDTLTENVARFYIAQS 195
H +VK Y + ++ + L+L++E GG + L L R + + E + + + ++
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
++ ++ +H + IHRD+K +N+LL G +KL DFG+ L + L
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-------------- 179
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-----LKK 310
RR ++VGTP ++APEV+ L
Sbjct: 180 --------------------------------RRN---TSVGTPFWMAPEVIACEQQLDS 204
Query: 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKI 347
Y CD WSLG E+ G PP P+ KI
Sbjct: 205 TYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 8e-20
Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 56/261 (21%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASHCIVKL 151
+G+G+FG V L ++KK+ +K LK+ + + + E LL+++ IVK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 152 YYSFQDTEYLYLIMEYLPGGDM----MTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+ SF + + +I EY G D+ L TL+EN + Q +L + +H+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
+HRD+K N+ L KN +K+ DFG+ + L
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSRLL------------------------------- 155
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
M LA + GTP Y++PE L +GY + D WSLG I+YE
Sbjct: 156 ------------------MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197
Query: 328 MLVGYPPFYADDPITTCRKIV 348
M F + ++ +IV
Sbjct: 198 MCCLAHAFEGQNFLSVVLRIV 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-19
Identities = 50/130 (38%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 296 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK 355
+GTPDY+APE+LL K +G DWW+LG ++E L G PPF + P + I++ R+ +
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN-RD-IP 598
Query: 356 FPD-DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPE 413
+P+ + KLS A++ I LL D R G ++K HP F V W+ L F P+
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKR---AGLKELKQHPLFHGVDWENLQNQTMPFIPQ 655
Query: 414 INGELDTQNF 423
+ E DT F
Sbjct: 656 PDDETDTSYF 665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 69/247 (27%), Positives = 108/247 (43%), Gaps = 52/247 (21%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F L IG+G+FGEV + ++ + A+K + E ++E ++ E +L++ S
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+ K Y S+ L++IMEYL GG + LL L E + + + ++ +H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRDIK N+LL ++G +KL+DFG+
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--------------------------------- 149
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
QL Q+ R VGTP ++APEV+ + Y + D WSLG E
Sbjct: 150 ------------QLTDTQIKRNTF----VGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 193
Query: 328 MLVGYPP 334
+ G PP
Sbjct: 194 LAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 80/322 (24%), Positives = 138/322 (42%), Gaps = 67/322 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEV 143
D +E++ +G GAFG+V + K++G A K +++ E ++E E ++L+E
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-----ELEDFMVEIDILSEC 59
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESI 202
IV LY ++ L++++E+ GG + ++++ E LTE R+ Q + A+ +
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H H IHRD+K N+LL +G +KL+DFG+
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGV------------------------------ 149
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECD 317
S K+ + +R + +GTP ++APEV+ Y + D
Sbjct: 150 ----------SAKNKST------LQKRD---TFIGTPYWMAPEVVACETFKDNPYDYKAD 190
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-D 376
WSLG + E+ PP + +P+ KI+ SK S D + L D
Sbjct: 191 IWSLGITLIELAQMEPPHHELNPMRVLLKILK-SEPPTLDQPSKWSSSFNDFLKSCLVKD 249
Query: 377 VEHRLGTGGAHQIKAHPWFKDV 398
+ R ++ HP+ D
Sbjct: 250 PDDRPTAA---ELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 71/264 (26%), Positives = 112/264 (42%), Gaps = 71/264 (26%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
FEL+ ++G G +G+V R K+G + A+K + +E + E ++ E N+L + + H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 148 IVKLYYSF--------QDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVL 197
+ YY D + L+L+ME+ G + L+ + + L E+ YI + +L
Sbjct: 74 NIATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-YICREIL 131
Query: 198 -AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ +H H IHRDIK N+LL +N +KL DFG+ LD +T+ N
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----------RTVGRRN-- 179
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKG 311
+ +GTP ++APEV+
Sbjct: 180 -------------------------------------TFIGTPYWMAPEVIACDENPDAT 202
Query: 312 YGMECDWWSLGAIMYEMLVGYPPF 335
Y D WSLG EM G PP
Sbjct: 203 YDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 75/269 (27%), Positives = 114/269 (42%), Gaps = 85/269 (31%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--------- 138
+E+L +G+GA+G V ++++ + A+KK+ A RN
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------------FDAFRNATDAQRTFR 55
Query: 139 ---LLAEVASH-CIVKL---YYSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVA 188
L E+ H IVKL + D + +YL+ EY M T L +R + L +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKD-IYLVFEY-----METDLHAVIRANILEDVHK 109
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
R+ + Q + A++ IH N IHRD+KP N+LL+ + +KL+DFGL + L
Sbjct: 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE---------- 159
Query: 249 TIDDENMAEPMDIDGCFPD-TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
++ + P TD V T Y APE+L
Sbjct: 160 ----------LEENPENPVLTD-------------------------YVATRWYRAPEIL 184
Query: 308 LK-KGYGMECDWWSLGAIMYEMLVGYPPF 335
L Y D WS+G I+ EML+G P F
Sbjct: 185 LGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 51/154 (33%), Positives = 87/154 (56%), Gaps = 7/154 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE---MVKRGQVEHVRAERNLLAE 142
+ +E L+ IG G++G V CR +++G I A+KK +SE ++K+ + +R +L +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQ 56
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+ +V L F+ L+L+ EY + L + E++ + I Q++ A+
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
HKHN IHRD+KP+N+L+ K G +KL DFG + L
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 87/349 (24%), Positives = 126/349 (36%), Gaps = 107/349 (30%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRAERNLLAEVA 144
F+ + IG G +G V R K +G + A+KK++ ++E V + E +LL E+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYL-----------PGGDMMTLLMREDTLTENVARFYIA 193
IVKL LYL+ E+L P + L++ Y+
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS----------YLF 107
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
Q + + H H +HRD+KP NLL++ G +KL+DFGL + HE T+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL--- 164
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGY 312
W Y APE+LL K Y
Sbjct: 165 --------------------W--------------------------YRAPEILLGCKYY 178
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKI---------VHWRNHLKFPDDSK-- 361
D WSLG I EM+ F D I +I V W PD
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238
Query: 362 --------------LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395
L + +DL+ ++L D R+ A AHP+F
Sbjct: 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA---LAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 72/256 (28%), Positives = 103/256 (40%), Gaps = 54/256 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE L +G G G V + SG I A +KL E +K + E +L E S
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLE-IKPAIRNQIIRELKVLHECNS 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV-ARFYIAQSVLAIESIHK 204
IV Y +F + + ME++ GG + +L + + EN+ + IA K
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
H +HRD+KP N+L++ G +KL DFG+ L ID
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------------ID------------- 152
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
+A S VGT Y++PE L Y ++ D WSLG
Sbjct: 153 -------------------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 325 MYEMLVGYPPFYADDP 340
+ EM +G P D
Sbjct: 188 LVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 58/281 (20%), Positives = 104/281 (37%), Gaps = 65/281 (23%)
Query: 93 IIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+G GAFGEV + K A+K LK+ + + E ++ ++ +V
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVV 59
Query: 150 KLY-YSFQDTEYLYLIMEYLPGGDMMTLL---------MREDTLTENVARFYIAQSVLAI 199
+L ++ E LYL++EY+ GGD++ L + TL+ + Q +
Sbjct: 60 RLLGVCTEE-EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
E + ++HRD+ N L+ ++ +K+SDFGL + + D++
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--------------RDVYDDDYYR-K 163
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319
G P + W M APE L + + D W
Sbjct: 164 KTGGKLP-------IR--------W-M----------------APESLKDGIFTSKSDVW 191
Query: 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDD 359
S G +++E+ G P+ + L P+
Sbjct: 192 SFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEY 231
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 70/268 (26%), Positives = 114/268 (42%), Gaps = 67/268 (25%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
FEL+ ++G G +G+V R K+G + A+K + V + E ++ E N+L + + H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 148 IVKLYY-SFQDT------EYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLA 198
+ YY +F + L+L+ME+ G + L+ + +TL E + + +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
+ +H+H IHRDIK N+LL +N +KL DFG+ LD +T+ N
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----------RTVGRRN---- 169
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYG 313
+ +GTP ++APEV+ Y
Sbjct: 170 -----------------------------------TFIGTPYWMAPEVIACDENPDATYD 194
Query: 314 MECDWWSLGAIMYEMLVGYPPFYADDPI 341
+ D WSLG EM G PP P+
Sbjct: 195 FKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 90/335 (26%), Positives = 149/335 (44%), Gaps = 64/335 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVASH 146
+E++ +G GAFG+V + K++G + A K ++ KSE ++E E +LA
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDYMVEIEILATCNHP 69
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHKH 205
IVKL +F L++++E+ PGG + +++ D LTE + Q + A++ +H
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
IHRD+K N+LL +G +KL+DFG+ + KT+
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGV----------SAKNVKTL--------------- 164
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDWWS 320
+R+ +F +GTP ++APEV++ Y + D WS
Sbjct: 165 ----------------------QRRDSF--IGTPYWMAPEVVMCETMKDTPYDYKADIWS 200
Query: 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHR 380
LG + EM PP + +P+ KI SK S E +D + L +H
Sbjct: 201 LGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLSQPSKWSMEFRDFLKTAL--DKHP 257
Query: 381 LGTGGAHQIKAHPWFKDVVWDK-LYEMEAAFKPEI 414
A Q+ HP+ V ++ L E+ A K E+
Sbjct: 258 ETRPSAAQLLEHPFVSSVTSNRPLRELVAEAKAEV 292
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 92/350 (26%), Positives = 130/350 (37%), Gaps = 96/350 (27%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +E L IG G +G+V R+K +G + A+KK + EM + G E +LL + S
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQML-S 58
Query: 146 HC--IVKLYYSFQDTE------YLYLIMEYLPGGDMMTLLMRE-----DTLTENVARFYI 192
IV+L + E LYL+ EYL D+ + L + ++
Sbjct: 59 ESIYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
Q + + HKH +HRD+KP NLL+DK G +K++D GL +
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR----------------- 159
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KK 310
+ P+ HE + W Y APEVLL
Sbjct: 160 --AFSIPVK--------------SYTHEIVTLW----------------YRAPEVLLGST 187
Query: 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKF----- 356
Y D WS+G I EM P F D + I W K
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHE 247
Query: 357 -----PDDSK-----LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395
P D LSPE DL+ ++L D R+ A HP+F
Sbjct: 248 FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT---HPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 66/261 (25%), Positives = 111/261 (42%), Gaps = 59/261 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEV 143
+DFEL+ IG G +G+V R +G + A+K KL+ E V+ E ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-----DFAVVQQEIIMMKDC 63
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
IV + S+ + L++ ME+ GG + + L+E+ + +++ + +H
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+HRDIK N+LL NGH+KL+DFG+ + +
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT------------------------ 159
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWS 320
+ +RK S +GTP ++APEV K GY CD W+
Sbjct: 160 ----------------------IAKRK---SFIGTPYWMAPEVAAVERKGGYNQLCDIWA 194
Query: 321 LGAIMYEMLVGYPPFYADDPI 341
+G E+ PP + P+
Sbjct: 195 VGITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 87/347 (25%), Positives = 128/347 (36%), Gaps = 90/347 (25%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+D +E + IG G +G V R++ + A+KK++ E G E +LL E+
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQ 59
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTE-----NVARFYIAQSVLAI 199
IV+L + LYL+ EYL + L D+ + + + Y+ Q + I
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 200 ESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
H H +HRD+KP NLL+D+ +KL+DFGL + HE T+
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL-------- 167
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECD 317
W Y APE+LL + Y D
Sbjct: 168 ---------------W--------------------------YRAPEILLGSRHYSTPVD 186
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPDDSK------- 361
WS+G I EM+ P F D I KI W PD
Sbjct: 187 IWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPP 246
Query: 362 ---------LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398
L P DL+ ++L D R+ A + H +FKD+
Sbjct: 247 KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE---HEYFKDL 290
|
Length = 294 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 88/350 (25%), Positives = 138/350 (39%), Gaps = 119/350 (34%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-- 143
+D + L IGRGAFG V K SG I A+K+++ S + ++ Q + LL ++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQ-------KRLLMDLDV 55
Query: 144 ---ASHC--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM----------REDTLTENVA 188
+S C IVK Y + ++ ME +M + + + + E +
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEEIL 109
Query: 189 RFYIAQSVL-AIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246
IA + + A+ + + IHRD+KP N+LLD+NG++KL DFG+ L S
Sbjct: 110 G-KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS------- 161
Query: 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306
+A+ D GC P Y+APE
Sbjct: 162 --------IAKTRDA-GCRP----------------------------------YMAPER 178
Query: 307 LL---KKGYGMECDWWSLGAIMYEMLVG---YPPF-----------YADDPITTCRKIVH 349
+ + GY + D WSLG +YE+ G YP + D PI
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPI-------- 230
Query: 350 WRNHLKFPDDSKLSPEAKDLI--CRLLCDVEHRLGTGGAHQIKAHPWFKD 397
L ++ + SP + I C L+ D R ++ HP+ KD
Sbjct: 231 ----LSNSEEREFSPSFVNFINLC-LIKDESKRPKYK---ELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 85/317 (26%), Positives = 142/317 (44%), Gaps = 65/317 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL-KKSEMVKRGQVEHVRAERNLLAEVA 144
+ +E++ +G GAFG+V + K++G + A K + KSE ++E E ++LA
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCD 60
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIH 203
IVKL +F L++++E+ GG + +++ E LTE R Q++ A+ +H
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
++ IHRD+K N+L +G +KL+DFG+ + +TI
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGV----------SAKNTRTI------------- 157
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDW 318
RR S +GTP ++APEV++ + Y + D
Sbjct: 158 -----------------------QRRD---SFIGTPYWMAPEVVMCETSKDRPYDYKADV 191
Query: 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL-CDV 377
WSLG + EM PP + +P+ KI S+ S E KD + + L +V
Sbjct: 192 WSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLAQPSRWSSEFKDFLKKCLEKNV 250
Query: 378 EHRLGTGGAHQIKAHPW 394
+ R T Q+ HP+
Sbjct: 251 DARWTTT---QLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 18/157 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE--MVKRGQVEHVRAERNLLAEV 143
+ L+ +G GA G V CR K +G I+A+K + +++ Q+ +R E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK-QI--LR-ELEINKSC 56
Query: 144 ASHCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMREDTLTENVARF------YIAQS 195
S IVK Y +F D + + + MEY GG + ++ + + + R IA+S
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK---VKKRGGRIGEKVLGKIAES 113
Query: 196 VL-AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
VL + +H IHRDIKP N+LL + G +KL DFG
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-17
Identities = 72/255 (28%), Positives = 103/255 (40%), Gaps = 63/255 (24%)
Query: 90 LLTIIGR----GAFGEVRLCREKKSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVA 144
L T++GR AF R G+ K + K M+ Q + R+E + LA
Sbjct: 71 LTTLVGRNPTTAAFVATR-------GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD 123
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDM----MTLLMREDTLTENVARFYIAQSVLAIE 200
IVK + F+ + L LIMEY GGD+ L E Q VLA++
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H +HRD+K N+ L G +KL DFG K ++ +
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-------------------QYSDSVS 224
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
+D +A S GTP Y+APE+ +K Y + D WS
Sbjct: 225 LD----------------------------VASSFCGTPYYLAPELWERKRYSKKADMWS 256
Query: 321 LGAIMYEMLVGYPPF 335
LG I+YE+L + PF
Sbjct: 257 LGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 79/271 (29%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
K CVD F+++ IG G +G+V R+K +G + A+KK++ + + +R E +L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILR 61
Query: 142 EVASHCIVKLY---------YSF-QDTEYLYLIMEYLPGGDMMTLLMREDTL---TENVA 188
++ IV L F +D YL+ EY+ D+M LL E L +E+
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLL--ESGLVHFSEDHI 118
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
+ ++ Q + + HK N++HRDIK N+LL+ G +KL+DFGL + LY E +
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR------LYNSEESR 172
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
P T NK V T Y PE+LL
Sbjct: 173 -----------------PYT-NK------------------------VITLWYRPPELLL 190
Query: 309 -KKGYGMECDWWSLGAIMYEMLVGYPPFYAD 338
++ YG D WS G I+ E+ P F A+
Sbjct: 191 GEERYGPAIDVWSCGCILGELFTKKPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 83/336 (24%), Positives = 129/336 (38%), Gaps = 81/336 (24%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E L IG G +G V + +++ I A+K+++ + + +R E LL E+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKN 60
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
IV+LY + L L+ EY + + + ++ Q + + H HN
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
+HRD+KP NLL++KNG +KL+DFGL + + I P+ C+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARA------FGI-------------PVR---CY-- 156
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 326
E + W Y P+VL K Y D WS G I
Sbjct: 157 ---------SAEVVTLW----------------YRPPDVLFGAKLYSTSIDMWSAGCIFA 191
Query: 327 EML-VGYPPFYADDPITTCRKIVH---------WRNHLKFPDD----------------S 360
E+ G P F +D ++I W K PD
Sbjct: 192 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVP 251
Query: 361 KLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAHPWF 395
KL+ +DL+ LL C+ R+ A Q HP+F
Sbjct: 252 KLNSTGRDLLQNLLVCNPVQRISAEEALQ---HPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 62/258 (24%), Positives = 107/258 (41%), Gaps = 55/258 (21%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D+EL+ +G G +G+V R +G + A+K +K + ++ E ++ E
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHC 66
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
IV + S+ E L++ MEY GG + + L+E + +++ + +H
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
+HRDIK N+LL NG +KL+DFG+ + +
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITAT--------------------------- 159
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK---GYGMECDWWSLGA 323
+ +RK S +GTP ++APEV + GY CD W++G
Sbjct: 160 -------------------IAKRK---SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI 197
Query: 324 IMYEMLVGYPPFYADDPI 341
E+ PP + P+
Sbjct: 198 TAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 69/260 (26%), Positives = 108/260 (41%), Gaps = 64/260 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--LLAEV 143
++ L+ IG GA+G V K +G A+KK+ E Q R R +L
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH----QTFCQRTLREIKILRRF 60
Query: 144 ASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
I+ + SF+ +Y++ E + D+ L+ + L+ + ++++ Q +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRG 118
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
++ IH N +HRD+KP NLLL+ N +K+ DFGL + D
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD--------------------- 157
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST--VGTPDYIAPEVLLK-KGYGME 315
P+ D+ F T V T Y APE++L KGY
Sbjct: 158 -------PEHDHTG--------------------FLTEYVATRWYRAPEIMLNSKGYTKA 190
Query: 316 CDWWSLGAIMYEMLVGYPPF 335
D WS+G I+ EML P F
Sbjct: 191 IDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 80/304 (26%)
Query: 88 FELLTIIGRGAFGEVRLCR--EKKSGNIYAMKKL----KKSEMVKRGQVE-----HVRAE 136
+EL+ +G+GA+G V R E A+KK+ K + KR E H R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 137 RNLLAEVASHCIVKL----YYSFQDTEYLYL-IMEYLPGGDMMTLLMREDTLTENVARFY 191
+N+ C+ + +F + YLY +ME D+ ++ LT+ + +
Sbjct: 62 KNIT------CLYDMDIVFPGNFNEL-YLYEELMEA----DLHQIIRSGQPLTDAHFQSF 110
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
I Q + ++ IH N +HRD+KP NLL++ + +K+ DFGL + E+ +
Sbjct: 111 IYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR--------GFSENPGEN 162
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-K 310
M E V T Y APE++L +
Sbjct: 163 AGFMTE-------------------------------------YVATRWYRAPEIMLSFQ 185
Query: 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKL----SPEA 366
Y D WS+G I+ E+L P F D + +I+ L PD+ L SP+A
Sbjct: 186 SYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ---VLGTPDEETLSRIGSPKA 242
Query: 367 KDLI 370
++ I
Sbjct: 243 QNYI 246
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 85/349 (24%), Positives = 136/349 (38%), Gaps = 93/349 (26%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL-----L 140
++ + IG GA+G V + +SG A+KK+ + V A+R L L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV------PTLAKRTLRELKIL 58
Query: 141 AEVASHCIVKLYYSFQ----DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
I+ + + D + +Y++M+ L D+ ++ + LTE R+++ Q +
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLL 117
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
++ IH N IHRD+KP NLL++++ +++ DFG+ + L S EHK M
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT----EHKYF----MT 169
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGME 315
E V T Y APE+LL Y
Sbjct: 170 E-------------------------------------YVATRWYRAPELLLSLPEYTTA 192
Query: 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV-----------------HWRNHL-KFP 357
D WS+G I EML F + + + I+ R ++ P
Sbjct: 193 IDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLP 252
Query: 358 DDS---------KLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAHPWFK 396
K SPEA DL+ ++L D E R+ A Q HP+
Sbjct: 253 RKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ---HPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 57/256 (22%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-QVEHVRAERNLLAEV 143
V +FE L IG G +G V R+ SG I A+KK++ + + G + +R E LL +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLR-EITLLLNL 63
Query: 144 ASHCIVKLYYSF--QDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIE 200
IV+L + + ++L+MEY D+ +LL T +E+ + + Q + ++
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H++ IHRD+K NLLL G +K++DFGL + A+PM
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY----------------GLPAKPM- 165
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWW 319
+P V T Y APE+LL Y D W
Sbjct: 166 ---------------TP-----------------KVVTLWYRAPELLLGCTTYTTAIDMW 193
Query: 320 SLGAIMYEMLVGYPPF 335
++G I+ E+L P
Sbjct: 194 AVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 93/349 (26%), Positives = 139/349 (39%), Gaps = 97/349 (27%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-QVEHVRAERNLLAEV 143
VD++E L I G +G V R+KK+G I A+KKLK E K G + +R E N+L ++
Sbjct: 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLR-EINILLKL 61
Query: 144 ASHCIVKLYY----SFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVL 197
IV + S D +Y++MEY+ D+ +L+ M++ L V + + Q +
Sbjct: 62 QHPNIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEV-KCLMLQLLS 117
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
+ +H + +HRD+K NLL L++ G+ K I D +A
Sbjct: 118 GVAHLHDNWILHRDLKTSNLL--------LNNRGILK---------------ICDFGLAR 154
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMEC 316
+ + V T Y APE+LL K Y
Sbjct: 155 E-------------------------YGSPLKPYT-QLVVTLWYRAPELLLGAKEYSTAI 188
Query: 317 DWWSLGAIMYEML---------------------VGYP-----PFYADDP-ITTCRKIVH 349
D WS+G I E+L +G P P +++ P +
Sbjct: 189 DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248
Query: 350 WRNHL--KFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395
N L KFP S LS DL+ RLL D R+ A HP+F
Sbjct: 249 PYNQLRKKFPALS-LSDNGFDLLNRLLTYDPAKRI---SAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 76/302 (25%), Positives = 123/302 (40%), Gaps = 65/302 (21%)
Query: 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKL 151
++G GA G V + G +A+K + M + +AE L IVK
Sbjct: 38 RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 152 YYSF--------QDTEYLYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAI 199
+ F ++ + L+++Y GD+ + T E+ A Q +LA+
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
+H + IHRDIK N+LL NG +KL DFG K +YA T+ D
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK------MYA----ATVSD------- 199
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319
D+ F GTP Y+APE+ +K Y + D +
Sbjct: 200 DVGRTF------------------------------CGTPYYVAPEIWRRKPYSKKADMF 229
Query: 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKF-PDDSKLSPEAKDLICRLLCDVE 378
SLG ++YE+L PF ++ +++H ++ P +SPE ++++ LL
Sbjct: 230 SLGVLLYELLTLKRPFDGEN----MEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDP 285
Query: 379 HR 380
R
Sbjct: 286 KR 287
|
Length = 496 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 67/261 (25%), Positives = 105/261 (40%), Gaps = 61/261 (23%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
V +E L IG+G FGEV R KK+ I A+KK+ + + +R E +L +
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLK 69
Query: 145 SHCIVKL----------YYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIA 193
+V L Y ++ + YL+ E+ D+ LL ++ T + + +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGS--FYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMK 126
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
+ + IH++ +HRD+K N+L+ K+G +KL+DFGL + S
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS---------KNSKP 177
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGY 312
N + NR V T Y PE+LL ++ Y
Sbjct: 178 N---------RY--------------------TNR-------VVTLWYRPPELLLGERDY 201
Query: 313 GMECDWWSLGAIMYEMLVGYP 333
G D W G IM EM P
Sbjct: 202 GPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 89/340 (26%), Positives = 145/340 (42%), Gaps = 104/340 (30%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-- 143
DD E++ +GRGA+G V R +G I A+K++ R V + ++ LL ++
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVN-SQEQKRLLMDLDI 52
Query: 144 ---ASHC--IVKLYYS-FQDTEYLYLIMEYLPGGDMMTLL-------------MREDTLT 184
+ C V Y + F++ + +++ ME M T L + ED L
Sbjct: 53 SMRSVDCPYTVTFYGALFREGD-VWICMEV-----MDTSLDKFYKKVYDKGLTIPEDILG 106
Query: 185 ENVARFYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+ IA S++ A+E +H K + IHRD+KP N+L+++NG +KL DFG+ L
Sbjct: 107 K------IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL------ 154
Query: 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302
+D +A+ +D GC P Y+
Sbjct: 155 -------VDS--VAKTIDA-GCKP----------------------------------YM 170
Query: 303 APE----VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYAD--DPITTCRKIVHWRNHLKF 356
APE L +KGY ++ D WSLG M E+ G P Y P +++V +
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFP-YDSWKTPFQQLKQVVE-EPSPQL 228
Query: 357 PDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFK 396
P + K SPE +D + + L ++ HP+F+
Sbjct: 229 PAE-KFSPEFQDFVNKCLKKNYKERPN--YPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 57/250 (22%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G GAFG V R++ +G A+KK+ K + E LL + I+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 154 SF-QDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
F E +Y + E L G D+ LL L + ++++ Q + ++ +H +HRD+
Sbjct: 77 IFISPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDL 134
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
KP N+L+++N +K+ DFGL +
Sbjct: 135 KPSNILINENCDLKICDFGLARI------------------------------------- 157
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 331
Q QM V T Y APE++L + Y +E D WS G I EML G
Sbjct: 158 ---------QDPQMT------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 332 YPPFYADDPI 341
P F D +
Sbjct: 203 KPLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 61/288 (21%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK----SEMVKRGQVEHVRAERNLLAEV 143
++++ +IG+G GEV L + A+KK+++ + ++K+ +R E + A++
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLR-EAKIAADL 59
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM---REDTLTENVARFYIAQSVLA-- 198
IV +Y D + +Y M Y+ G + +LL ++++L++ +A SV A
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFL 116
Query: 199 ---------IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
IE +H +HRD+KPDN+LL G + + D+G
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI--------------- 161
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309
+ + E ++ + + M + VGTPDY+APE LL
Sbjct: 162 --FKKLEE-----------EDLLDIDVDERNICYSSMT---IPGKIVGTPDYMAPERLLG 205
Query: 310 KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFP 357
D ++LG I+Y+ML P+ RKI +R+ + P
Sbjct: 206 VPASESTDIYALGVILYQMLTLSFPYRRKKG----RKI-SYRDVILSP 248
|
Length = 932 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 69/270 (25%), Positives = 113/270 (41%), Gaps = 72/270 (26%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+++ ++D E L IG G G+V R KK+G++ A+K+++++ + E+ R +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMD 63
Query: 139 LLAEVASH-C--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA-- 193
L + SH C IVK Y F +++ ME M T L + + I
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDSDVFICMEL-----MSTCLDKLLKRIQGPIPEDILGK 118
Query: 194 QSVLAIESIH----KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
+V ++++H KH IHRD+KP N+LLD +G++KL DFG+ L
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL------------- 165
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-- 307
D+K+ +S G Y+APE +
Sbjct: 166 ------------------VDSKAKTRS-------------------AGCAAYMAPERIDP 188
Query: 308 --LKKGYGMECDWWSLGAIMYEMLVGYPPF 335
Y + D WSLG + E+ G P+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 70/258 (27%), Positives = 105/258 (40%), Gaps = 60/258 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE ++ +G G G V K SG I A +KL E +K + E +L E S
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLE-IKPAIRNQIIRELQVLHECNS 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI--- 202
IV Y +F + + ME++ GG + +L + + E + S+ I+ +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYL 119
Query: 203 -HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
KH +HRD+KP N+L++ G +KL DFG+ L ID
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------------ID---------- 156
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
+A S VGT Y++PE L Y ++ D WS+
Sbjct: 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 322 GAIMYEMLVGYPPFYADD 339
G + EM +G P D
Sbjct: 189 GLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 69/255 (27%), Positives = 103/255 (40%), Gaps = 54/255 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE ++ +G G G V + K SG I A +KL E +K + E +L E S
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMA-RKLIHLE-IKPAIRNQIIRELQVLHECNS 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV-ARFYIAQSVLAIESIHK 204
IV Y +F + + ME++ GG + +L + E + + IA K
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
H +HRD+KP N+L++ G +KL DFG+ L ID
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------------ID------------- 156
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
+A S VGT Y++PE L Y ++ D WS+G
Sbjct: 157 -------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 325 MYEMLVGYPPFYADD 339
+ E+ +G P D
Sbjct: 192 LVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 63/252 (25%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F L IG G+FG V R+ ++ + A+KK+ S + + + E L ++
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
++ + +L+MEY G L + + L E ++ + +H H
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRDIK N+LL + G +KL+DFG
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFG------------------------------------ 160
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAI 324
+S SP A S VGTP ++APEV+L + Y + D WSLG
Sbjct: 161 ---SASLVSP--------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 325 MYEMLVGYPPFY 336
E+ PP +
Sbjct: 204 CIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 82/349 (23%), Positives = 136/349 (38%), Gaps = 99/349 (28%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK---SEMVKRGQVEHVRAERNLLAE 142
D ++ L+ +G GA+G+V + K+G A+KKL + S + + +R LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR----LLKH 70
Query: 143 VASHCIVKLYYSFQDTEYL------YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+ ++ L F L YL+ L G D+ + ++ L+++ +F + Q +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVYQIL 128
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
++ IH IHRD+KP N+ +++ DC E K I D +A
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNE---------------DC-------ELK-ILDFGLA 165
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGME 315
D E + V T Y APE++L Y
Sbjct: 166 RHTD-----------------DEMTGY------------VATRWYRAPEIMLNWMHYNQT 196
Query: 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV-----------------HWRNHLK-FP 357
D WS+G IM E+L G F D I ++I+ RN+++ P
Sbjct: 197 VDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLP 256
Query: 358 DDSK---------LSPEAKDLICRLL-CDVEHRLGTGGAHQIKAHPWFK 396
K +P A DL+ ++L D + R+ A + AHP+
Sbjct: 257 QMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI---TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 64/256 (25%), Positives = 110/256 (42%), Gaps = 64/256 (25%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL--KKSEMVKRGQVEHVRAERNLLAEVA 144
+ E + IG GA G V + +G +YA+K + + V+R + E +L +V
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----QICREIEILRDVN 130
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+VK + F + +++E++ GG + + ++ +VAR Q + I +H+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHR 186
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+ +HRDIKP NLL++ ++K++DFG+ + L +T+D N
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA----------QTMDPCN---------- 226
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---LKKGY--GMECDWW 319
S+VGT Y++PE + L G G D W
Sbjct: 227 -----------------------------SSVGTIAYMSPERINTDLNHGAYDGYAGDIW 257
Query: 320 SLGAIMYEMLVGYPPF 335
SLG + E +G PF
Sbjct: 258 SLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 70/302 (23%), Positives = 112/302 (37%), Gaps = 70/302 (23%)
Query: 84 CVDD----FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
DD F L IG G+FG V R+ ++ + A+KK+ S + + + E
Sbjct: 9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
L ++ ++ + +L+MEY G L + + L E ++ +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
+H HN IHRD+K N+LL + G +KL DFG
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG---------------------------- 160
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMEC 316
+S +P A VGTP ++APEV+L + Y +
Sbjct: 161 -----------SASIMAP--------------ANXFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIV----------HWRNHLKFPDDSKLSPEA 366
D WSLG E+ PP + + ++ I HW + + DS L
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255
Query: 367 KD 368
+D
Sbjct: 256 QD 257
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 63/252 (25%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F L IG G+FG V R+ ++ + A+KK+ S + + + E L +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
++ + +L+MEY G L + + L E ++ + +H HN
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRDIK N+LL + G +KL+DFG ++A P
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG--------------------SASIASP--------- 177
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAI 324
A S VGTP ++APEV+L + Y + D WSLG
Sbjct: 178 ------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 213
Query: 325 MYEMLVGYPPFY 336
E+ PP +
Sbjct: 214 CIELAERKPPLF 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 24/166 (14%)
Query: 91 LTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +G+G FG V LCR + +G + A+KKL+ S + E +L +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHD 65
Query: 147 CIVK---LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF-------YIAQSV 196
IVK + YS L L+MEYLP G + D L ++ R Y +Q
Sbjct: 66 NIVKYKGVCYSAGRRN-LRLVMEYLPYGSL------RDYLQKHRERLDHRKLLLYASQIC 118
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+E + Y+HRD+ N+L++ +K+ DFGL K L Y
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 76/312 (24%), Positives = 125/312 (40%), Gaps = 75/312 (24%)
Query: 88 FELLTIIGRGAFGEVRLCRE-KKSGNIYAMKKLK---KSEMVKRGQVEHVRAERNLLAEV 143
+E + IG GA+G+V R+ K G A+K+++ E + + V R+L E
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL--ET 60
Query: 144 ASH-CIVKLY----YSFQDTEY-LYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQS 195
H +V+L+ S D E L L+ E++ D+ T L + E + + + Q
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+ ++ +H H +HRD+KP N+L+ +G +KL+DFGL + +Y+
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR------IYS------------ 161
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315
+QM S V T Y APEVLL+ Y
Sbjct: 162 ----------------------------FQM----ALTSVVVTLWYRAPEVLLQSSYATP 189
Query: 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV---------HWRNHLKFPDDSKLSPEA 366
D WS+G I EM P F + KI+ W + P ++
Sbjct: 190 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP-RQAFHSKS 248
Query: 367 KDLICRLLCDVE 378
I + + D++
Sbjct: 249 AQPIEKFVTDID 260
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 74/292 (25%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEVASHCIVKL 151
IGRGA+G V + ++ A+KK+ +++ R R LL + ++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 152 --------YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
+F D +Y +M+ D+ ++ TL+++ ++++ Q + ++ IH
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMD----TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
N +HRD+KP NLLL+ N +K+ DFGL + + + M E
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLART------------TSEKGDFMTE------ 167
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322
V T Y APE+LL Y D WS+G
Sbjct: 168 -------------------------------YVVTRWYRAPELLLNCSEYTTAIDVWSVG 196
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKL----SPEAKDLI 370
I E+L P F D + + I L P + L + +A+ I
Sbjct: 197 CIFAELLGRKPLFPGKDYVHQLKLIT---ELLGSPSEEDLGFIRNEKARRYI 245
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 62/266 (23%), Positives = 102/266 (38%), Gaps = 62/266 (23%)
Query: 89 ELLTIIGRGAFGE--VRLCREKKSGNIYAMKKL----KKSEMVKRGQVEHVRAERNLLAE 142
ELLT+IG+ V L + K + + A+KK+ E +K Q E + R L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQE-IITSRQL--- 56
Query: 143 VASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLA 198
H I+ SF LY++ + G L++ + L E F + + A
Sbjct: 57 --QHPNILPYVTSFIVDSELYVVSPLMAYGSC-EDLLKTHFPEGLPELAIAFILKDVLNA 113
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
++ IH +IHR +K ++LL +G + LS S + + + D
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYS----VSMIKHGKRQRVVHD------ 163
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMEC 316
FP + + W ++PEVL + +GY +
Sbjct: 164 ------FPKS---------SVKNLPW-----------------LSPEVLQQNLQGYNEKS 191
Query: 317 DWWSLGAIMYEMLVGYPPFYADDPIT 342
D +S+G E+ G+ PF D P T
Sbjct: 192 DIYSVGITACELANGHVPF-KDMPAT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 44/158 (27%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+I + +L+ +G G FGEV + S + A+K LK M V+ E NL+
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMK 56
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAI 199
+ +V+LY E +Y+I EY+ G ++ L ++ + + + AQ +
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 116
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
I + NYIHRD++ N+L+ ++ K++DFGL + ++
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL---KKSEMVKRGQVEHVRAERNLLAE 142
+D E ++ +G G G V + +G + A K + KS + K+ + E ++ E
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMHE 59
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA--IE 200
S IV Y +F + + + ME++ G + + + + + IA +V+
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-KIAVAVVEGLTY 118
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ H +HRDIKP N+L++ G +KL DFG+
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGV 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 59/244 (24%), Positives = 96/244 (39%), Gaps = 57/244 (23%)
Query: 94 IGRGAFGEVRLCREK----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+G G FG+V LCR +G A+K LK + ++ E +L + IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 150 KLYYSFQDTEY---LYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKH 205
K Y + + LIME+LP G + L R ++ + Y Q ++ +
Sbjct: 70 K-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
Y+HRD+ N+L++ +K+ DFGL K ++ E+ T+ D
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD-----KEYYTVKD------------- 170
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
D D+ W APE L++ + + D WS G +
Sbjct: 171 -DLDSPVFW---------------------------YAPECLIQSKFYIASDVWSFGVTL 202
Query: 326 YEML 329
YE+L
Sbjct: 203 YELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 6/155 (3%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
++ D + +G G +GEV KK A+K LK+ M +VE E ++
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 57
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIA-QSVLAI 199
E+ +V+L Y+I E++ G+++ L + V Y+A Q A+
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
E + K N+IHRD+ N L+ +N +K++DFGL +
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 86/348 (24%), Positives = 136/348 (39%), Gaps = 110/348 (31%)
Query: 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKK---SEM-VKRGQVE-----HVRAERNLLA 141
L +G GA+G V +K++G A+KKL + SE+ KR E H++ E N++
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE-NVIG 78
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAI 199
+ FQD YL+M Y M T L + L+E+ ++ + Q + +
Sbjct: 79 LLDVFTSAVSGDEFQD---FYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS-TLYAIHEHKTIDDENMAEP 258
+ IH IHRD+KP NL ++++ +K+ DFGL + D T Y +
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-------------- 176
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ W E + +W Y D
Sbjct: 177 -------------TRWYRAPEVILNWMH-------------------------YNQTVDI 198
Query: 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVH-----------------WRNHLK------ 355
WS+G IM EML G F D + +I+ ++++K
Sbjct: 199 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYP 258
Query: 356 -------FPDDSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAHPWF 395
FP K SP+A DL+ ++L DV+ RL A + HP+F
Sbjct: 259 RKDFSTLFP---KASPQAVDLLEKMLELDVDKRL---TATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 64/260 (24%), Positives = 99/260 (38%), Gaps = 60/260 (23%)
Query: 84 CVDDFELLTI----IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
DD E + + IG G+FG V + + A+KK+ S + + + E
Sbjct: 15 YKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKF 74
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
L ++ ++ + +L+MEY G L + + L E ++ +
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 134
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
+H HN IHRDIK N+LL + G +KL+DFG
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFG---------------------------- 166
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMEC 316
+S SP A S VGTP ++APEV+L + Y +
Sbjct: 167 -----------SASKSSP--------------ANSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 317 DWWSLGAIMYEMLVGYPPFY 336
D WSLG E+ PP +
Sbjct: 202 DVWSLGITCIELAERKPPLF 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 65/257 (25%), Positives = 104/257 (40%), Gaps = 56/257 (21%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G + V R K + N+ A+K+++ E + +R E +LL + IV L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR-LEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
L L+ EYL L + ++ + + ++ Q + + HK +HRD+K
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
P NLL+++ G +KL+DFGL + T KT +E
Sbjct: 131 PQNLLINEKGELKLADFGLARAKSVPT-------KTYSNE-------------------- 163
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGY 332
V T Y P+VLL Y D W +G I+YEM G
Sbjct: 164 ----------------------VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
Query: 333 PPFYADDPITTCRKIVH 349
P F P +T ++ +H
Sbjct: 202 PMF----PGSTVKEELH 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 70/284 (24%), Positives = 113/284 (39%), Gaps = 83/284 (29%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
++++E++ IG G FGEV L + K++ + K + + +R + + V E N++ E+
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK 70
Query: 145 SHCIVKLYYSF--QDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA----QSVLA 198
IV+ F + + LY++ME+ GD+ + + + + I Q + A
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 199 IESIHK-------HNYIHRDIKPDNLLLDK---------------NGH--MKLSDFGLCK 234
+ H +HRD+KP N+ L NG K+ DFGL
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL-- 188
Query: 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294
K I E+MA S
Sbjct: 189 ------------SKNIGIESMAH------------------------------------S 200
Query: 295 TVGTPDYIAPEVLL--KKGYGMECDWWSLGAIMYEMLVGYPPFY 336
VGTP Y +PE+LL K Y + D W+LG I+YE+ G PF+
Sbjct: 201 CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
|
Length = 1021 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 5e-11
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 2/149 (1%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +E L +G G++ V + K +G + A+K ++ E + G E +LL +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV L+ E L L+ EY+ + L + ++ Q + + IH+
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+HRD+KP NLL+ G +KL+DFGL +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVASH 146
F+ L +G G + V R + +G I A+K++ +E G E +L+ E+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHE 58
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDM---MTLLMREDTLTENVARFYIAQSVLAIESIH 203
IV+L+ L L+ EY+ D+ M L N + + Q + I H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
++ +HRD+KP NLL++K G +KL+DFGL +
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 47/152 (30%), Positives = 68/152 (44%), Gaps = 17/152 (11%)
Query: 94 IGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRA----ERNLLAEVAS 145
+G G FG+V LCR +G A+K L S E R+ E +L +
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS------GEEQHRSDFEREIEILRTLDH 65
Query: 146 HCIVKL-YYSFQDTEY-LYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESI 202
IVK + L LIMEYLP G + L R D + + +Q ++ +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
YIHRD+ N+L++ +K+SDFGL K
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ +L+ +G G FGEV + + A+K LK+ M E AE NL+ ++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIESIH 203
+V+LY + E +Y+I EY+ G ++ L + + + + AQ + I
Sbjct: 61 PRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ NYIHRD++ N+L+ + K++DFGL +
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 39/140 (27%), Positives = 71/140 (50%), Gaps = 4/140 (2%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+G FG+V K + + A+K + S + + + ++ +L + IVKL
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCR-STLPPDLKRKFLQEAE-ILKQYDHPNIVKLIG 59
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
+ +Y++ME +PGG ++T L ++ + LT + +E + N IHRD+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 213 KPDNLLLDKNGHMKLSDFGL 232
N L+ +N +K+SDFG+
Sbjct: 120 AARNCLVGENNVLKISDFGM 139
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 64/261 (24%), Positives = 107/261 (40%), Gaps = 56/261 (21%)
Query: 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
L +G G + V R K + N+ A+K+++ E + +R E +LL ++ IV
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHANIVT 68
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L+ + L L+ EYL L +++ + + ++ Q + + H+ +HR
Sbjct: 69 LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
D+KP NLL+++ G +KL+DFGL + T KT +E
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPT-------KTYSNE----------------- 164
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 329
V T Y P++LL Y + D W +G I YEM
Sbjct: 165 -------------------------VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199
Query: 330 VGYPPFYADDPITTCRKIVHW 350
G P F P +T + +H+
Sbjct: 200 TGRPLF----PGSTVEEQLHF 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 66/265 (24%), Positives = 105/265 (39%), Gaps = 75/265 (28%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA--- 144
+++ +IG+G++G V + +G A+KK+ EHV +L E+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKLLR 54
Query: 145 --SHC-IVKLYY--------SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA 193
H IV++ + F+D +Y++ E L D+ ++ D LT +F++
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKD---IYVVFE-LMESDLHQVIKANDDLTPEHHQFFLY 110
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
Q + A++ IH N HRD+KP N+L + + +K+ DFGL +
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV------------------ 152
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV---LLKK 310
F DT W V T Y APE+ K
Sbjct: 153 ----------AFNDTPTAIFWT------------------DYVATRWYRAPELCGSFFSK 184
Query: 311 GYGMECDWWSLGAIMYEMLVGYPPF 335
Y D WS+G I E+L G P F
Sbjct: 185 -YTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 95/388 (24%), Positives = 148/388 (38%), Gaps = 122/388 (31%)
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS-EMVKRGQV 130
++ F LKR ++ L IG GA G V + +G A+KKL + + V +
Sbjct: 9 DSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK- 60
Query: 131 EHVRAERNL-LAEVASH-CIVKLYYSF------QDTEYLYLIMEYLPGG--DMMTLLMRE 180
RA R L L ++ +H I+ L F ++ + +YL+ME + ++ + +
Sbjct: 61 ---RAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH 117
Query: 181 DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
+ ++ + + Q + I+ +H IHRD+KP N+++ + +K+ DFGL
Sbjct: 118 ERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------- 165
Query: 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPD 300
+T M P V T
Sbjct: 166 -------RTAGTSFMMTPY------------------------------------VVTRY 182
Query: 301 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV------------ 348
Y APEV+L GY D WS+G IM EM+ G F D I KI+
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242
Query: 349 --------HWRNHLK---------FPDD---------SKLSPE-AKDLICRLLC-DVEHR 380
+ N K FPD +KL A+DL+ ++L D E R
Sbjct: 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302
Query: 381 LGTGGAHQIKAHPWFKDVVWDKLYEMEA 408
+ A Q HP+ VW E+EA
Sbjct: 303 ISVDDALQ---HPYIN--VWYDPSEVEA 325
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 58/246 (23%), Positives = 99/246 (40%), Gaps = 52/246 (21%)
Query: 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
L +G G + V R K + N+ A+K+++ + G E +LL ++ IV
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L+ + L L+ EYL + + ++ + + ++ Q + + H+ +HR
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
D+KP NLL+++ G +KL+DFGL + T KT +E +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPT-------KTYSNEVV--------------- 166
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEML 329
+ W P P+VLL Y + D W +G I +EM
Sbjct: 167 -TLWYRP--------------------------PDVLLGSSEYSTQIDMWGVGCIFFEMA 199
Query: 330 VGYPPF 335
G P F
Sbjct: 200 SGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK---SEMVKRGQVEHVRAERNLLAE 142
D + L +G GA+G V ++++G A+KKL + SE+ + +R LL
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKH 70
Query: 143 VASHCIVKLYYSFQDTEYL------YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+ ++ L F L YL+M ++ G + LM+ + L+E+ +F + Q +
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
++ IH IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 75/334 (22%), Positives = 115/334 (34%), Gaps = 108/334 (32%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D E IG GAFG V + + G A+KK+ V + V R R L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFREL------- 50
Query: 147 CIVKLYYSFQDT-----------------EYLYLIMEYLPGGDMMTLLMREDTLTENVAR 189
K+ F+ E +Y++ E L D+ +++ L+ + +
Sbjct: 51 ---KMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQPLSSDHVK 106
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
++ Q + ++ +H +HRDIKP NLL++ N +K+ DFGL +
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV-------------- 152
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL- 308
+ + K V T Y APE+L+
Sbjct: 153 ----------------------------------EEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW----------------RN 352
+ Y D WS+G I E+L F A PI I R
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238
Query: 353 HL-----KFPDDSKL-------SPEAKDLICRLL 374
H+ K P L + EA L+CR+L
Sbjct: 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRML 272
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 94 IGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+G G FG+V L +G + A+K LK+ + + E N+L + IV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIV 69
Query: 150 KLY--YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI-AQSVL-AIESIHKH 205
K S Q + L LIMEY+P G + L + N+A+ + AQ + + +H
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL---NLAQLLLFAQQICEGMAYLHSQ 126
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+YIHRD+ N+LLD + +K+ DFGL K + Y
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 67/253 (26%), Positives = 115/253 (45%), Gaps = 53/253 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM----VKRGQVE-----HVRAE 136
+ ++ L+ +G GA+G V + K+G A+KKL + KR E H++ E
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 137 RNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
N++ + + F D +YL+ +L G D+ ++ + LT++ +F I Q +
Sbjct: 77 -NVIGLLDVFTPARSLEEFND---VYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQIL 130
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS---------------TL 241
++ IH + IHRD+KP NL ++++ +K+ DFGL + D L
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML 190
Query: 242 YAIHEHKTIDDEN----MAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297
+H ++T+D + MAE + FP TD+ +++ KL VG
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---------------IDQLKLILRLVG 235
Query: 298 TPDYIAPEVLLKK 310
TP LLKK
Sbjct: 236 TP----GAELLKK 244
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 93 IIGRGAFGEVRLCREKK-----SGNI-YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+G GAFGEV SG I A+K L+K + + E + E +L++
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFL-KEAHLMSNFNHP 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED---------TLTENVAR-FYIAQSV 196
IVKL E Y+IME + GGD+++ L TL E + +A+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGH-----MKLSDFGLCKPLDCSTLYAIHEHKTID 251
+ +E +H +IHRD+ N L+ + G+ +K+ DFGL + + S Y +
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 252 DENMAEPMDIDGCF 265
MA +DG F
Sbjct: 177 VRWMAPESLLDGKF 190
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 6/146 (4%)
Query: 94 IGRGAFGEVR--LCREKKSGNI-YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
+G G FG V + K + A+K LK+ + G+ E +R E +++A++ CIV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI-AAGKKEFLR-EASVMAQLDHPCIVR 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L + E L L+ME P G ++ L + + + + Q + + + +++HR
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPL 236
D+ N+LL K+SDFG+ + L
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 61/272 (22%), Positives = 103/272 (37%), Gaps = 68/272 (25%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D + I+G G G V + I A+K + V+ + + +E +L + S
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK--QIMSELEILYKCDSP 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDM-MTLLMREDTLTENVARFYIAQSVL-AIESIHK 204
I+ Y +F + + E++ GG + + + E L IA +V+ + +
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR------IAVAVVKGLTYLWS 113
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+HRD+KP N+L++ G +KL DFG+ L S
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------------------------- 148
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
+A + VGT Y+APE + + YG+ D WSLG
Sbjct: 149 --------------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGIS 182
Query: 325 MYEMLVG---YPPFYADD----PITTCRKIVH 349
E+ +G YP + P+ + IV
Sbjct: 183 FMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 41/146 (28%), Positives = 76/146 (52%), Gaps = 8/146 (5%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G FGEV + K + A+K +K M VE AE N++ + +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 67
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIESIHKHNYIHRD 211
+ E +Y+I E++ G ++ L ++ + + + + AQ + I + NYIHRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLD 237
++ N+L+ + K++DFGL + ++
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIE 153
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 93 IIGRGAFGEVR--LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
++G+G FGEV ++K + K+ E+ + +E +L + IVK
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYI--AQSVLAIESIHKHN 206
L + +Y++ME +PGGD ++ L + ++ T+ + +F + A + +ES N
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KN 113
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
IHRD+ N L+ +N +K+SDFG+ + D
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQED 144
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 64/271 (23%), Positives = 108/271 (39%), Gaps = 68/271 (25%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRA---ERNLLAEVA 144
++ LT +G GA+G V + + A+KKL + + H R E LL +
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ----SLIHARRTYRELRLLKHMK 72
Query: 145 SHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
++ L S ++ +YL+ L G D+ ++ + L++ +F I Q +
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRG 130
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
++ IH IHRD+KP N+ ++++ +++ DFGL + DDE
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--------------QADDEMTG-- 174
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317
V T Y APE++L Y D
Sbjct: 175 ------------------------------------YVATRWYRAPEIMLNWMHYNQTVD 198
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIV 348
WS+G IM E+L G F +D I ++I+
Sbjct: 199 IWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 53/246 (21%), Positives = 94/246 (38%), Gaps = 60/246 (24%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D L +G G FG V+ + + ++ A+K +K+ M + +E + L E
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHEK--- 60
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKH 205
+V+LY +Y++ EY+ G ++ L + + + V + +
Sbjct: 61 -LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+IHRD+ N L+D G +K+SDFGL + +DDE
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSR-------------YVLDDEYT---------- 156
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP---DYIAPEVLLKKGYGMECDWWSLG 322
S+VG+ + PEVLL + + D W+ G
Sbjct: 157 ----------------------------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFG 188
Query: 323 AIMYEM 328
+M+E+
Sbjct: 189 VLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 72/285 (25%), Positives = 107/285 (37%), Gaps = 71/285 (24%)
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
++ F LKR ++ L IG GA G V + G A+KKL + + Q
Sbjct: 14 DSTFTVLKR-------YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTH 63
Query: 132 HVRAERNL--LAEVASHCIVKLYYSF------QDTEYLYLIMEYLPGGDMMTLLMREDTL 183
RA R L L V I+ L F ++ + +YL+ME + + M D
Sbjct: 64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD-- 121
Query: 184 TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
+ + Q + I+ +H IHRD+KP N+++ + +K+ DFGL
Sbjct: 122 -HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---------- 170
Query: 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303
+T M P V T Y A
Sbjct: 171 ----RTACTNFMMTPY------------------------------------VVTRYYRA 190
Query: 304 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV 348
PEV+L GY D WS+G IM E++ G F D I K++
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 66/262 (25%), Positives = 105/262 (40%), Gaps = 64/262 (24%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRAERNLLAEVA 144
+E + IG GA+G V R+ SG+ A+K ++ + + V V + L E
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRL--EAF 59
Query: 145 SH-CIVKLY----YSFQDTEY-LYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSV 196
H IV+L S D E + L+ E++ D+ T L + L + + Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
++ +H + +HRD+KP+N+L+ G +KL+DFGL + +Y+
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQ----------- 161
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316
M + V T Y APEVLL+ Y
Sbjct: 162 --MALT-------------------------------PVVVTLWYRAPEVLLQSTYATPV 188
Query: 317 DWWSLGAIMYEMLVGYPPFYAD 338
D WS+G I EM P F +
Sbjct: 189 DMWSVGCIFAEMFRRKPLFCGN 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 23/169 (13%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSG--NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
+D + +IG G FG+V R KK G A+K++K E + E +L ++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKL 64
Query: 144 ASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES- 201
H I+ L + + YLYL +EY P G+++ L R+ + E F IA S + S
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 123
Query: 202 ----------------IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ + +IHRD+ N+L+ +N K++DFGL +
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 58/258 (22%), Positives = 99/258 (38%), Gaps = 67/258 (25%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G+ G V + A+KK+ ++ V+H E ++ + IVK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS---VKHALREIKIIRRLDHDNIVKVYE 69
Query: 154 -----SFQDTEYL---------YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
TE + Y++ EY+ + ++ + L+E AR ++ Q + +
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLRGL 127
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHM-KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
+ IH N +HRD+KP N+ ++ + K+ DFGL + +D + HK E +
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH-----YSHKGYLSEGLV-- 180
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317
+ W Y +P +LL Y D
Sbjct: 181 -------------TKW--------------------------YRSPRLLLSPNNYTKAID 201
Query: 318 WWSLGAIMYEMLVGYPPF 335
W+ G I EML G P F
Sbjct: 202 MWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-- 144
+ +L IG+G FG+V L + G A+K LK + A + LAE +
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK----------DDSTAAQAFLAEASVM 54
Query: 145 ---SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVL-A 198
H +V+L LY++ EY+ G ++ L R + + A V
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+E + + N++HRD+ N+L+ ++ K+SDFGL K
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 61/248 (24%), Positives = 92/248 (37%), Gaps = 56/248 (22%)
Query: 91 LTIIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148
L +G G++ V + +G + A+K +K E V + E +LL + I
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANI 65
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYI 208
V L+ E L + EY+ ++ L R ++ Q + + IH + +
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDT 268
HRD+KP NLL+ G +KL+DFGL + K+I + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARA------------KSIPSQTYS------------ 161
Query: 269 DNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYE 327
S V T Y P+VLL Y D W G I E
Sbjct: 162 -------------------------SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIE 196
Query: 328 MLVGYPPF 335
ML G P F
Sbjct: 197 MLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 95/406 (23%), Positives = 149/406 (36%), Gaps = 115/406 (28%)
Query: 63 NLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK- 121
N +E ++ F LKR ++ L IG GA G V + A+KKL +
Sbjct: 1 NQFYSVEVGDSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 53
Query: 122 ---SEMVKRGQVEHVRAE----RNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMM 174
KR E V + +N+++ + K FQD +YL+ME +
Sbjct: 54 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD---VYLVMELMDANLCQ 110
Query: 175 TLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ M D + + Q + I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 111 VIQMELD---HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
Query: 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294
T S +P+
Sbjct: 168 ---------------------------------TAGTSFMMTPY---------------- 178
Query: 295 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW---- 350
V T Y APEV+L GY D WS+G IM EM+ F D I K++
Sbjct: 179 -VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 351 ------------RNHLK------------------FPDDSK----LSPEAKDLICRLLC- 375
RN+++ FP DS+ + +A+DL+ ++L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 376 DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQ 421
D R+ A Q HP+ VW E+EA + +LD +
Sbjct: 298 DPAKRISVDEALQ---HPYIN--VWYDPAEVEAPPPQIYDKQLDER 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 85 VDDFELLTI--IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+D EL + +G G FG V L + + ++ A+K +++ M + +E + L
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEAKVMMKL--- 56
Query: 143 VASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIE 200
SH +V+LY ++++ EY+ G ++ L + V A+E
Sbjct: 57 --SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + +IHRD+ N L+ ++ +K+SDFGL
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFGL 146
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 12/156 (7%)
Query: 91 LTIIGRGAFGEVRLCREKKS--GNIYAMKKLKKSEMVKRGQVE-HVRAERNLLAEVASHC 147
+T +GRG FGEV L + K + +K + K ++ R E ++ +++
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM----REDTL----TENVARFYIA-QSVLA 198
+V+L ++ E Y+I+EY GD+ L +++ L + + Q L
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
++ + ++HRD+ N L+ +K+S L K
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 72/289 (24%), Positives = 110/289 (38%), Gaps = 71/289 (24%)
Query: 68 LERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR 127
+E ++ F LKR ++ L IG GA G V + A+KKL + +
Sbjct: 13 VEIGDSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQ 62
Query: 128 GQVEHVRAERNL-LAEVASH-CIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMR 179
Q RA R L L + +H I+ L S ++ + +Y++ME + + M
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 180 EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
D + + Q + I+ +H IHRD+KP N+++ + +K+ DFGL
Sbjct: 123 LD---HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------ 173
Query: 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
+T M P V T
Sbjct: 174 --------RTAGTSFMMTP------------------------------------YVVTR 189
Query: 300 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV 348
Y APEV+L GY D WS+G IM EM+ G F D I K++
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-08
Identities = 14/51 (27%), Positives = 23/51 (45%), Gaps = 4/51 (7%)
Query: 413 EINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFD 463
++ DT NF +PP S P ++L + L F G++Y N +
Sbjct: 1 KVKSPTDTSNFDPEFTSEPP----KLSPPDSEVLSSIDQLEFRGFSYVNPE 47
|
Length = 47 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIY--AMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
+D + +IG G FG+V KK G A+K LK E E +L ++
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 144 ASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTEN 186
H I+ L + ++ YLY+ +EY P G+++ L + TLT
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ + ++ + + +IHRD+ N+L+ +N K++DFGL +
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 94 IGRGAFGEVR--LCREKKSGNIYAMKKLK-------KSEMVKRGQVEHVRAERNLLAEVA 144
+G G FG V+ + + +K A+K LK + EM++ ++ H ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMH---------QLD 53
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIESI 202
+ IV++ + E L L+ME GG + L +++ NV + Q + ++ +
Sbjct: 54 NPYIVRMI-GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYL 111
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
N++HRD+ N+LL + K+SDFGL K L
Sbjct: 112 EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 64/272 (23%), Positives = 103/272 (37%), Gaps = 90/272 (33%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH--------VRA 135
++ ++ L +G G++ V R K +G + A+K+++ +EH +R
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR---------LEHEEGAPFTAIR- 52
Query: 136 ERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL-----------PGGDMMTLLMREDTLT 184
E +LL ++ IV L+ + L L+ EYL GG L+
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-----------LS 101
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244
+ R ++ Q + + H+ +HRD+KP NLL+ + G +KL+DFGL + +
Sbjct: 102 MHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161
Query: 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304
+E T+ W P PD
Sbjct: 162 NEVVTL-----------------------WYRP---------------------PD---- 173
Query: 305 EVLL-KKGYGMECDWWSLGAIMYEMLVGYPPF 335
VLL Y D W +G I YEM G P F
Sbjct: 174 -VLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 57/245 (23%), Positives = 105/245 (42%), Gaps = 57/245 (23%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G FG V L + + + A+K + + M + +E E ++ +++ +V+LY
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYG 66
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVL-AIESIHKHNYIHRD 211
+ LY++ E++ G ++ L R+ L++++ + Q V +E + ++++IHRD
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-LSMCQDVCEGMEYLERNSFIHRD 125
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+ N L+ G +K+SDFG+ T Y +DDE +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGM-------TRY------VLDDEYTSS-------------- 158
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 330
S K P + + PEV Y + D WS G +M+E+
Sbjct: 159 SGAKFPVK---------------------WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTE 197
Query: 331 GYPPF 335
G PF
Sbjct: 198 GKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 65/279 (23%), Positives = 112/279 (40%), Gaps = 76/279 (27%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEV------RLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
+KRH I L +G GAFG+V LC E+ + A+K LK + R
Sbjct: 2 IKRHNIV-----LKRELGEGAFGKVFLAECYNLCPEQDK-ILVAVKTLKDASDNARKDF- 54
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMM---------TLLMREDT 182
H AE LL + IVK Y + + L ++ EY+ GD+ +LM E
Sbjct: 55 HREAE--LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 112
Query: 183 LTENVAR---FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238
+ + +IAQ + A + + +++HRD+ N L+ +N +K+ DFG+ + +
Sbjct: 113 RPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 172
Query: 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGT 298
+ Y + H + P+
Sbjct: 173 TDYYRVGGHTML-------PI--------------------------------------- 186
Query: 299 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 336
++ PE ++ + + E D WSLG +++E+ G P+Y
Sbjct: 187 -RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 52/260 (20%), Positives = 91/260 (35%), Gaps = 57/260 (21%)
Query: 111 GNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL 168
G ++ K + + V K GQ E LL V ++++ + +++ +
Sbjct: 80 GRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139
Query: 169 PGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKHNYIHRDIKPDNLLLDKNGHMKL 227
D+ T L + I + +L + +H IHRD+K +N+ ++ + +
Sbjct: 140 -SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCI 198
Query: 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMN 287
D G + + P
Sbjct: 199 GDLGAAQ------------------FPVVAPAF--------------------------- 213
Query: 288 RRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKI 347
GT + APEVL + Y + D WS G +++EML YP +DP +T +
Sbjct: 214 -----LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEEY 267
Query: 348 V-HWRNHL-KFPDDSKLSPE 365
V +HL K K+ PE
Sbjct: 268 VKSCHSHLLKIISTLKVHPE 287
|
Length = 357 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ +L+ +G G FGEV + + + A+K LK M +E E ++ ++
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMKKLRH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIESIH 203
+V+LY + E +Y++ EY+ G ++ L + + AQ + I
Sbjct: 61 DKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ NYIHRD++ N+L+ K++DFGL +
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 40/147 (27%), Positives = 68/147 (46%), Gaps = 7/147 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+L +G G FGEV + + + A+K LK M E E ++ ++
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKH 205
+V+LY + E +Y++ EY+ G ++ L + L AQ + +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGL 232
NYIHRD+ N+L+ +N K++DFGL
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-07
Identities = 19/69 (27%), Positives = 29/69 (42%), Gaps = 8/69 (11%)
Query: 396 KDVVWDKLY--EMEAAFKPEINGELDTQNF-MKFDELDPPASGRTSSGPSRKMLLTPKDL 452
+ + WDKL E+E F P+I DT NF +F E P + + +
Sbjct: 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVL-----TPVDSPLSGGIQQE 55
Query: 453 SFVGYTYKN 461
F G++Y
Sbjct: 56 PFRGFSYVF 64
|
Length = 64 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 4/145 (2%)
Query: 94 IGRGAFGEVR--LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKL 151
+G G FG V+ + + KKS A+K LK + E +R E N++ ++ + IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIVRM 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ E L+ME G + L + +TE + Q + ++ + + N++HRD
Sbjct: 62 I-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPL 236
+ N+LL + K+SDFGL K L
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 55/252 (21%), Positives = 95/252 (37%), Gaps = 60/252 (23%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ +L+ + G+ GEV +C K G+ K + K+ + + + + SH
Sbjct: 94 YNILSSLTPGSEGEVFVC--TKHGDEQRKKVIVKAVTGGKTPGREIDILKTI-----SHR 146
Query: 148 -IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKH 205
I+ L ++++ + ++M D+ T + R L A I + +L A+ +H
Sbjct: 147 AIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGR 204
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFG-LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
IHRD+K +N+ LD+ + L DFG CK
Sbjct: 205 GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH-------------------------- 238
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
PDT W GT + +PE+L Y + D WS G +
Sbjct: 239 -PDTPQCYGW---------------------SGTLETNSPELLALDPYCAKTDIWSAGLV 276
Query: 325 MYEMLVGYPPFY 336
++EM V +
Sbjct: 277 LFEMSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 40/166 (24%), Positives = 64/166 (38%), Gaps = 21/166 (12%)
Query: 86 DDFELLTIIGRGAFGEVRL--CREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLL 140
D L +G GAFG+V L C + N + A+K LK E + E LL
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELL 62
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--------------TLTEN 186
IVK Y + + ++ EY+ GD+ L LT +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
Q + + +++HRD+ N L+ + +K+ DFG+
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G FGEV + + + A+K LK M ++ + + L E +V+LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEK----LVQLYA 68
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIESIHKHNYIHRD 211
+ E +Y++ EY+ G ++ L E + + AQ + + + NY+HRD
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLD 237
++ N+L+ +N K++DFGL + ++
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 3/142 (2%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IGRG FGEV R + A+K + E + E +L + + IV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA-IESIHKHNYIHRDI 212
+ +Y++ME + GGD +T L E + + ++ A +E + + IHRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 213 KPDNLLLDKNGHMKLSDFGLCK 234
N L+ + +K+SDFG+ +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 37/146 (25%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G FGEV + + + A+K LK M+ ++ E ++ ++ +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPLYA 68
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA--IESIHKHNYIHRD 211
+ E +Y++ E++ G ++ L D + + + +A + I + NYIHRD
Sbjct: 69 VVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLD 237
++ N+L+ N K++DFGL + ++
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 42/167 (25%), Positives = 71/167 (42%), Gaps = 19/167 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-VKRGQVEHVRAERNLLAEVA 144
+D L IG G FG+V +Y + +K + VK + + R + A
Sbjct: 6 EDITLGRCIGEGQFGDVYQ-------GVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEA 58
Query: 145 --------SHCIVKLYYSFQDTEYLYLIMEYLPGGDM-MTLLMREDTLTENVARFYIAQS 195
H IVKL + ++++ME P G++ L + + +L Y Q
Sbjct: 59 YIMRQFDHPH-IVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL 116
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
A+ + ++HRDI N+L+ +KL DFGL + L+ + Y
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 11/150 (7%)
Query: 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148
+LL +G G FGEV + + A+K LK M + AE ++ ++ +
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKKLRHPKL 63
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAIESIHK 204
++LY E +Y++ E + G ++ L L + + AQ + +
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID--MAAQVASGMAYLEA 121
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
NYIHRD+ N+L+ +N K++DFGL +
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 93 IIGRGAFGEVRLCREKKSG-NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVK 150
+IG G FG+V R KK G + A K K E + E +L ++ H I+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN--VARFYIAQSVLA---------- 198
L + + YLYL +EY P G+++ L + L + A S L+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 199 ----IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
++ + + +IHRD+ N+L+ +N K++DFGL +
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 41/151 (27%), Positives = 77/151 (50%), Gaps = 10/151 (6%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +LL IG+G FG+V L + GN A+K +K + AE +++ ++
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 59
Query: 147 CIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVL-AIESIH 203
+V+L ++ LY++ EY+ G ++ L R ++ + V A+E +
Sbjct: 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+N++HRD+ N+L+ ++ K+SDFGL K
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 18/155 (11%)
Query: 93 IIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+IG G FGEV RL K A+K LK K Q +E +++ + I+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNII 68
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI------- 202
L ++ + ++ EY+ G + L + D +F + Q V + I
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYL 122
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
Y+HRD+ N+L++ N K+SDFGL + L+
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 67/295 (22%), Positives = 111/295 (37%), Gaps = 73/295 (24%)
Query: 55 DVPMEEQI-NLIKDLERKETE----FMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKK 109
D M+ I ++ D + + + R I F +L GA G C + K
Sbjct: 56 DKHMDIDIFDIFADEDESDADASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDNK 115
Query: 110 SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169
+ + ++K GQ E ++L + I++L +F ++ LI LP
Sbjct: 116 T---------CEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LP 163
Query: 170 --GGDMMTLLM--REDTLTENVARFYIAQSVL-AIESIHKHNYIHRDIKPDNLLLDKNGH 224
D+ L R + + +A I +SVL AI+ +H++ IHRDIK +N+ ++ G
Sbjct: 164 RYKTDLYCYLAAKRNIAICDILA---IERSVLRAIQYLHENRIIHRDIKAENIFINHPGD 220
Query: 225 MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHW 284
+ L DFG CFP N + +
Sbjct: 221 VCLGDFGA------------------------------ACFPVDINANKY---------- 240
Query: 285 QMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADD 339
+ GT APE+L + YG D WS G +++EM + + D
Sbjct: 241 --------YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 93 IIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+IG G FGEV K G A+K LK K Q + +E +++ + + H I+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNII 69
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA-IESIHKHNYI 208
+L + +I EY+ G + L D + + + + A ++ + NY+
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
HRD+ N+L++ N K+SDFGL + L+
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLE 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 27/97 (27%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHM 225
E++ G + M +D NV + + Q + + +H+ +HRDIKP+NLL+ +G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
Query: 226 KLSDFG----LCKPLDCSTLYAIHEHKTIDDENMAEP 258
K+ DFG +C ++ + LY + + + E + P
Sbjct: 349 KIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385
|
Length = 507 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 18/167 (10%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNL 139
I + +IG G FGEV R K G A+K LK K Q E ++
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK--QRLDFLTEASI 58
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+ + I++L + + +I EY+ G + L D +F + Q V +
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND------GKFTVGQLVGML 112
Query: 200 ESI-------HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
I + NY+HRD+ N+L++ N K+SDFGL + L+ S
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 27/165 (16%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKL------KKSEMVKRGQVEHVRAERNLLA 141
++L IIG G+FG V + A+KK+ K E++ + H+ N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NII- 122
Query: 142 EVASHCIVKLYY---SFQDTE---YLYLIMEYLPGG--DMMTLLMRED-TLTENVARFYI 192
+K YY F+ E +L ++ME++P M R + L + + Y
Sbjct: 123 ------FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-MKLSDFGLCKPL 236
Q A+ IH HRD+KP NLL+D N H +KL DFG K L
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221
|
Length = 440 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 37/183 (20%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEM---VKRGQ-----VEHVRAERN------- 138
+G G FGEV LC + M+K + V Q V+ +R + N
Sbjct: 13 LGEGQFGEVHLCEAE------GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 139 -----LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR----EDTLTENVA- 188
+++ + I++L ++ L +I EY+ GD+ L R E +V
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 189 ------RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
F Q ++ + N++HRD+ N L+ KN +K++DFG+ + L Y
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 243 AIH 245
I
Sbjct: 187 RIQ 189
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 26/159 (16%)
Query: 93 IIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVR----AERNLLAEVAS 145
+IG G FGEV RL K A+K LK G E R +E +++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS------GYTEKQRRDFLSEASIMGQFDH 64
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI--- 202
I+ L + + +I E++ G + + L + D +F + Q V + I
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAG 118
Query: 203 ----HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ NY+HRD+ N+L++ N K+SDFGL + L+
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 43/168 (25%), Positives = 67/168 (39%), Gaps = 25/168 (14%)
Query: 86 DDFELLTIIGRGAFGEV-----RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
D LL +G GAFGEV R A+K L E E ++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIM 63
Query: 141 AEVASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVAR---------- 189
++ IV+L SF+ ++++E + GGD+ + L E +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCK 234
+A+ +E H +IHRDI N LL G K++DFG+ +
Sbjct: 123 RDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 86 DDFELLTIIGRGAFGEVR------LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
++ +G GAFG+V L + + A+K LK + + E + +E +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPT--AHSSEREALMSELKI 91
Query: 140 LAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSV 196
++ + +H IV L + + +I EY GD++ L R E LT + Q
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHM-KLSDFGLCK 234
+ + N IHRD+ N+LL +G + K+ DFGL +
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLL-THGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 68/272 (25%)
Query: 89 ELLTIIGRG--AFGEVRLCREKKSGNIYAMKKLK----KSEMVKRGQVE-HVRAERNLLA 141
ELLT+IGRG V L R K +G ++++ +EMV Q E HV +
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHV-------S 53
Query: 142 EVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVL- 197
++ +H IV +F L+++ ++ G L+ D ++E +A YI Q VL
Sbjct: 54 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSE-LAIAYILQGVLK 112
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
A++ IH Y+HR +K ++L+ +G + LS GL
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISVDGKVYLS--GL------------------------- 145
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS--TVGTPDYIAPEVLLK--KGYG 313
+S + H Q R F +V +++PEVL + +GY
Sbjct: 146 -----------------RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 188
Query: 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCR 345
+ D +S+G E+ G+ PF D P T
Sbjct: 189 AKSDIYSVGITACELANGHVPF-KDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 40/144 (27%), Positives = 53/144 (36%), Gaps = 51/144 (35%)
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246
VAR Q + AI+ IH IHRDIK +N+L++ + L DFG
Sbjct: 265 VAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGA-------------- 306
Query: 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306
CF + SW +P + GT D APEV
Sbjct: 307 ----------------ACFA----RGSWSTP-------------FHYGIAGTVDTNAPEV 333
Query: 307 LLKKGYGMECDWWSLGAIMYEMLV 330
L Y D WS G +++E V
Sbjct: 334 LAGDPYTPSVDIWSAGLVIFEAAV 357
|
Length = 461 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 49/152 (32%), Positives = 70/152 (46%), Gaps = 21/152 (13%)
Query: 94 IGRGAFGEVRLCREKKSGNIYA---MKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCI 148
IG G FG+V L E SG A +K+L+ S V + +E + R+L C
Sbjct: 3 IGNGWFGKVIL-GEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC- 60
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLL--------MREDTLTENVARFYIAQSVLAIE 200
L + T YL L+ME+ P GD+ L M D T IA +L
Sbjct: 61 --LGQCTEVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL--- 114
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+HK+N+IH D+ N LL + +K+ D+GL
Sbjct: 115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 39/178 (21%), Positives = 81/178 (45%), Gaps = 28/178 (15%)
Query: 94 IGRGAFGEVRLCREK--------------KSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
+G G FGEV LC + + A+K L+ +++ K + + ++ E +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR-ADVTKTARNDFLK-EIKI 70
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-----TLTENVAR----- 189
++ + + I++L + L +I EY+ GD+ L + + T N+
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 190 -FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
Y+A + + ++ + N++HRD+ N L+ + +K++DFG+ + L Y I
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 61/276 (22%), Positives = 96/276 (34%), Gaps = 75/276 (27%)
Query: 77 RLKRHKICVDDFELLTIIGRGAFGEVRLC--------REKKSGNIYAMKKLKKSE----- 123
+LK + F ++ + GAFG++ +C E + G + K E
Sbjct: 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK 198
Query: 124 MVKRGQVEHVRAERNLLA--EVASHCIVKLYYSFQDTEYLYLIME--------YLPGGDM 173
VK G ++ E +LA + I+K+ + Y+I + ++
Sbjct: 199 RVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA- 257
Query: 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
+D R + Q + A+E IH IHRDIK +N+ L+ +G + L DFG
Sbjct: 258 ---FDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
P E E D +
Sbjct: 315 MPF----------------EKEREAFD--------------------------------Y 326
Query: 294 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329
VGT +PE+L GY D WS G I+ +ML
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 54/249 (21%), Positives = 108/249 (43%), Gaps = 43/249 (17%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR-GQVEHVRAERNLLAEVASH 146
F++L+++G G FG+V ++K A+K ++ R ++E E+ A+ A
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADR 190
Query: 147 -CIVKLYYSFQ-DTEYLYLIM-EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
++K+ FQ +T ++ ++M +Y P ++ +M+ + I Q+ +A++ H
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKYGPC--LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH 248
Query: 204 KH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+ +H D+KP+N+L++ + D + D D+
Sbjct: 249 TELHLMHTDLKPENILMETS--------------DTVVDPVTNRA-LPPDPCRVRICDLG 293
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
GC + ++++ V T Y +PEV+L G+ D WS+G
Sbjct: 294 GCCDERHSRTA---------------------IVSTRHYRSPEVVLGLGWMYSTDMWSMG 332
Query: 323 AIMYEMLVG 331
I+YE+ G
Sbjct: 333 CIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 34/117 (29%), Positives = 47/117 (40%), Gaps = 12/117 (10%)
Query: 290 KLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADD-----PITTC 344
LA + GT Y+APE + K Y + D WSLG + E+ PF + PI
Sbjct: 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL 217
Query: 345 RKIVHWRNHLKFPDDSKL----SPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKD 397
IV+ N + D+ S E KD I + C + + HPW K
Sbjct: 218 SYIVNMPN-PELKDEPGNGIKWSEEFKDFIKQ--CLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 51/223 (22%), Positives = 78/223 (34%), Gaps = 46/223 (20%)
Query: 115 AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DTEYLYLIMEYLPGGDM 173
A+K L+ + Q R E L A + IV L S + L+ + EY+PG +
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDF 230
+L + L + Q + A+ H +HRD+KP N+++ + G H K+ DF
Sbjct: 67 REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDF 126
Query: 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRK 290
G+ TL P +
Sbjct: 127 GI------GTL-----------------------LPGV---------RDADV----ATLT 144
Query: 291 LAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333
+GTP Y APE L + D ++ G I E L G
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 57/280 (20%), Positives = 100/280 (35%), Gaps = 72/280 (25%)
Query: 94 IGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148
+G GAFG+V L K + A+K LK + R + E LL + I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQHEHI 69
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----TLTENVAR-----------FYIA 193
VK Y D + L ++ EY+ GD+ L L + R +IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 194 QSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
+ + + + +++HRD+ N L+ N +K+ DFG+ + + + Y + H +
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-- 187
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
P+ ++ PE ++ + +
Sbjct: 188 -----PI----------------------------------------RWMPPESIMYRKF 202
Query: 313 GMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWR 351
E D WS G I++E+ G P++ I R
Sbjct: 203 TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 23/167 (13%)
Query: 87 DFELLTIIGRGAFGEV-----RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
L +G GAFG+V E+ S A+K LK++ K + R E L++
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMS 63
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR----EDTLTENVAR-------- 189
++ IV L + ++ EYL GD+ L+R D E+
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 190 ---FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+IA + A +E + H+++HRD+ N L+ + +K+SDFGL
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 9/165 (5%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEVAS 145
+F L +G G FGEV K + A+K LK +++K+ + V+A + L +
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHK--- 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF-YIAQSVL-AIESIH 203
H ++ L+ E +Y+I E + G ++ L + VA +A V + +
Sbjct: 63 H-LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
+ N IHRD+ N+L+ ++ K++DFGL + + +Y + K
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKK 165
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 38/129 (29%), Positives = 49/129 (37%), Gaps = 30/129 (23%)
Query: 294 STVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH--- 349
+ V T Y AP+VLL + Y D WS+G IM EM+ G P F + KI
Sbjct: 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218
Query: 350 ------WRNHLKFPDDSKLSPEAK----------------DLICRLL-CDVEHRLGTGGA 386
W + P+ P DL+ RLL + E R+ A
Sbjct: 219 TPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI---SA 275
Query: 387 HQIKAHPWF 395
H HPWF
Sbjct: 276 HDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 67/262 (25%)
Query: 89 ELLTIIGRG--AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
EL IGRG V L R +G + ++ ++ EH++A +N V SH
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITD----LENCTEEHLKALQN--EVVLSH 54
Query: 147 C-----IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAI 199
I+ + F +L++I ++ G +LL + ++E + + ++ +
Sbjct: 55 FFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGL 114
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI----HEHKTIDDENM 255
+H++ YIHR+IK ++L+ +G + LS GL S LY++ + K + D
Sbjct: 115 NYLHQNGYIHRNIKASHILISGDGLVSLS--GL------SHLYSLVRNGQKAKVVYD--- 163
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--GYG 313
FP FST P +++PE+L + GY
Sbjct: 164 ---------FPQ-------------------------FSTSVLP-WLSPELLRQDLYGYN 188
Query: 314 MECDWWSLGAIMYEMLVGYPPF 335
++ D +S+G E+ G PF
Sbjct: 189 VKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 29/170 (17%)
Query: 94 IGRGAFGEVRLCR----------------EKKSGNIYAMKKLKKSEMVKRGQVEHVRAER 137
+G G FGEV LC + + A+K L+ E E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEV 70
Query: 138 NLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD-----------MMTLLMREDTLTEN 186
+L+ ++ I +L L +IMEY+ GD L +L+ +
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
+ Q + + N++HRD+ N L+ KN +K++DFG+ + L
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 88 FELLTIIGRGAFGEVR---LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
F L ++G+G FG VR L E S A+K LK +++ +E E + E
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59
Query: 145 SHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMR----EDTLT---ENVARFY 191
++KL + +I+ ++ GD+ T L+ E+ T + + RF
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
I +E + N+IHRD+ N +L++N + ++DFGL K
Sbjct: 120 I-DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 20/108 (18%), Positives = 41/108 (37%), Gaps = 12/108 (11%)
Query: 131 EHVRAERNLLAEVASHCIV--KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
E +L +A + K+ S + + YL+ME++ G L +
Sbjct: 36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG----ETLDEVSEEEKEDI 91
Query: 189 RFYIAQSVLAIESIHKHNY---IHRDIKPDNLLLDKNGHMKLSDFGLC 233
+A+ + +H+ H D+ P N+L+D + + D+
Sbjct: 92 AEQLAE---LLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 33/165 (20%), Positives = 69/165 (41%), Gaps = 23/165 (13%)
Query: 86 DDFELLTIIGRGAFGEVR--LCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLL 140
+ L+ +G+G+FG V L + G A+K + +E + E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV--NENASMRERIEFLNEASVM 63
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENV------ARFY- 191
E H +V+L + ++ME + GD+ + L R + +F
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 192 ----IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
IA + + + ++HRD+ N ++ ++ +K+ DFG+
Sbjct: 124 MAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGM 165
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 64/279 (22%), Positives = 107/279 (38%), Gaps = 77/279 (27%)
Query: 86 DDFELLTIIGRGAFGEVRLCRE-----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
++ E + IG+GAFG V R + + A+K LK+ E Q + R E L+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQR-EAALM 62
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFY-------- 191
AE IVKL + + L+ EY+ GD+ L R +++
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 192 ------------IAQSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238
IA+ V A + + + ++HRD+ N L+ +N +K++DFGL +
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR---- 178
Query: 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGT 298
+Y+ +K EN A P+ W
Sbjct: 179 -NIYSADYYKA--SENDAIPI-----------------------RW-------------- 198
Query: 299 PDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFY 336
+ PE + Y E D W+ G +++E+ G P+Y
Sbjct: 199 ---MPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 33/178 (18%)
Query: 87 DFELLTIIGRGAFGEV------RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
+ L +G G FG+V RL + + A+K LK++ ++ + +E NLL
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLL 57
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR--------------------- 179
+V ++KLY + L LI+EY G + + L
Sbjct: 58 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 180 ---EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
E LT + Q ++ + + +HRD+ N+L+ + MK+SDFGL +
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 41/186 (22%), Positives = 74/186 (39%), Gaps = 35/186 (18%)
Query: 94 IGRGAFGEVRLCR---------------EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+G G FGEV LC +K + K+ + + K + + ++ E
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK-EVK 71
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR---EDTLTENVARFYIAQS 195
+L+ + I++L D + L +I EY+ GD+ L +D A
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 196 VLAI----------------ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
+ AI + + N++HRD+ N L+ +N +K++DFG+ + L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191
Query: 240 TLYAIH 245
Y I
Sbjct: 192 DYYRIQ 197
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 49/241 (20%), Positives = 87/241 (36%), Gaps = 56/241 (23%)
Query: 94 IGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
+G G+FG VR SG A+K LK ++ ++ E ++ + +++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYI 208
LY L ++ E P G ++ L ++ + Y Q + + +I
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDT 268
HRD+ N+LL + +K+ DFGL + L
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALP------------------------------- 148
Query: 269 DNKSSWKSPHEQLQHWQMN-RRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
N+ H+ M K+ F+ + APE L + + D W G ++E
Sbjct: 149 QNE----------DHYVMEEHLKVPFA------WCAPESLRTRTFSHASDVWMFGVTLWE 192
Query: 328 M 328
M
Sbjct: 193 M 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 9/162 (5%)
Query: 93 IIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+IG+G FG V L A+K L + ++ +VE E ++ + + ++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNVL 59
Query: 150 KLYYSFQDTEYLYLI-MEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIESIHKHN 206
L +E L+ + Y+ GD+ + R +T V + Q +E +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
++HRD+ N +LD++ +K++DFGL + + Y++H H
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.001
Identities = 39/154 (25%), Positives = 60/154 (38%), Gaps = 30/154 (19%)
Query: 93 IIGRGA-----------FGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+IG+GA V R K Y +L E ++ E RAE LL+
Sbjct: 340 LIGKGAEADIKKGEYLGRDAVIKERVPKG---YRHPEL--DERLRT---ERTRAEARLLS 391
Query: 142 EVASHCI-VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
E + + Y D E ++MEY+ G D+ +L L V +
Sbjct: 392 EARRAGVPTPVIYDV-DPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGE--------IVA 442
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+HK +H D+ N ++ + + L DFGL K
Sbjct: 443 KLHKAGIVHGDLTTSNFIVR-DDRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 56/272 (20%), Positives = 104/272 (38%), Gaps = 83/272 (30%)
Query: 94 IGRGAFGEVRLCREKKSGNIY----------AMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
+G AFG++ G++Y A+K LK ++ Q + E +L+AE+
Sbjct: 13 LGECAFGKIY------KGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAEL 64
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMR-----------EDTLTENVAR-- 189
IV L + + ++ EYL GD+ L+MR ED ++
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 190 --FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246
+IA + A +E + H ++H+D+ N+L+ + H+K+SD GL + + + Y +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ- 183
Query: 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306
P + W + PE
Sbjct: 184 -------------------PKSLLPIRW---------------------------MPPEA 197
Query: 307 LLKKGYGMECDWWSLGAIMYEML-VGYPPFYA 337
++ + + D WS G +++E+ G P+Y
Sbjct: 198 IMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 43/181 (23%), Positives = 73/181 (40%), Gaps = 28/181 (15%)
Query: 86 DDFELLTIIGRGAFGEVRL-------CREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
D L +G GAFG+V + S A+K LK K + + +E
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETS--TVAVKMLKDDATEK--DLSDLVSEME 67
Query: 139 LLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR----------------ED 181
++ + H I+ L LY+++EY G++ L E+
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
TLT+ + Q +E + IHRD+ N+L+ ++ MK++DFGL + +
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 242 Y 242
Y
Sbjct: 188 Y 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 88 FELLTIIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+L I+G G FG V +L ++ S A+K +K ++E +E + +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS-EIEEFLSEAACMKDFD 59
Query: 145 SHCIVKLY-YSFQDTEYLYL-----IMEYLPGGDMMTLL--MREDTLTENVA-----RFY 191
++KL F+ + + I+ ++ GD+ + L R L E + +F
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF- 118
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ L +E + N+IHRD+ N +L ++ + ++DFGL K
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 34/149 (22%), Positives = 55/149 (36%), Gaps = 50/149 (33%)
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
Q + +HK IH+DI N ++D+ +K++D L + L
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL----------------- 167
Query: 254 NMAEPMDIDGCFPDTDNKS-SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
PMD C D +N+ W +A E L+ K Y
Sbjct: 168 ---FPMDYH-CLGDNENRPVKW---------------------------MALESLVNKEY 196
Query: 313 GMECDWWSLGAIMYEML-VGYPPFYADDP 340
D WS G +++E++ +G P+ DP
Sbjct: 197 SSASDVWSFGVLLWELMTLGQTPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 55/274 (20%), Positives = 103/274 (37%), Gaps = 72/274 (26%)
Query: 86 DDFELLTIIGRGAFGEVRLC------REKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
D L +G G FG+V + ++K + K+ K + ++ + V +E +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 73
Query: 140 LAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL----------------MREDT 182
+ + H I+ L + LY+I+EY G++ L + ++
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+T Q +E + IHRD+ N+L+ +N MK++DFGL + ++
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN----- 188
Query: 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302
+ID T+ + K ++
Sbjct: 189 -----------------NIDYYKKTTNGRLPVK-------------------------WM 206
Query: 303 APEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 335
APE L + Y + D WS G +M+E+ +G P+
Sbjct: 207 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 29/174 (16%)
Query: 94 IGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148
+G GAFG+V L ++ + A+K LK++ R + + E LL + I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-----------------TLTENVA-RF 190
V+ Y + L ++ EY+ GD+ L TL + +A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244
IA ++ + S+H ++HRD+ N L+ + +K+ DFG+ + + + Y +
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 31/157 (19%)
Query: 94 IGRGAFGEVRLCREKKSGNIYA---MKKLKKS-------EMVKRGQVEHVRAERNLLAEV 143
IG G FG+V L E G A +K+L+ S ++ Q N+L +
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL------MREDTLTENVARFY--IAQS 195
CI + YL L++E+ P GD+ L + + + + R +A
Sbjct: 62 G-QCI-------ESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+L + H+ ++IH D+ N L + +K+ D+GL
Sbjct: 113 LLWL---HQADFIHSDLALRNCQLTADLSVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 22/79 (27%), Positives = 42/79 (53%), Gaps = 8/79 (10%)
Query: 161 LYLIMEYLPGGDMMTLLMREDTLTENVARF-----YIAQSVLAIESIHKHNYIHRDIKPD 215
LY++ME + G+++ L +V + +A+ + +ES +HRD+
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAAR 129
Query: 216 NLLLDKNGHMKLSDFGLCK 234
N+L+ ++G K+SDFGL +
Sbjct: 130 NILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 48/188 (25%), Positives = 74/188 (39%), Gaps = 42/188 (22%)
Query: 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE--MVKR----GQV 130
L R DDF L +G GAFG V K S K+ KK ++K+ G V
Sbjct: 123 GLFRPSFKKDDFVLGKKLGEGAFGVVY----KASL---VNKQSKKEGKYVLKKATEYGAV 175
Query: 131 EHVRAERNLLAEVASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTE 185
E ER A + C +Y S + + +L+ Y G + LM+
Sbjct: 176 EIWMNERVRRA-CPNSCADFVYGFLEPVSSKKEDEYWLVWRY-EGESTLADLMQSKEFPY 233
Query: 186 NVARFY----------------IAQSVL-----AIESIHKHNYIHRDIKPDNLLLD-KNG 223
NV + I Q+++ A++ +H +HRD+KP N++ +G
Sbjct: 234 NVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG 293
Query: 224 HMKLSDFG 231
K+ D G
Sbjct: 294 SFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 19/50 (38%), Positives = 27/50 (54%), Gaps = 1/50 (2%)
Query: 301 YIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH 349
Y APE++L Y D WSLG I+ EM++GYP F + +I+
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
|
Length = 440 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.37 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.29 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.06 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.48 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.4 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.2 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.17 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.0 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.96 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.92 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.89 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.8 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.71 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 97.61 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.55 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.55 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.55 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.38 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.13 | |
| PLN02236 | 344 | choline kinase | 97.05 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.0 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.96 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.92 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.87 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.56 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.47 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.47 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.33 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.07 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.95 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.78 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 95.6 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.34 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.26 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.24 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.02 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.98 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.37 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-114 Score=884.11 Aligned_cols=466 Identities=64% Similarity=0.988 Sum_probs=425.6
Q ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHhhhhcCCcC
Q 010116 5 EEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKIC 84 (518)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~r~~r~~~le~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~ 84 (518)
++.+.+.++.|++|+++||+||++||.++++.+++|++|++.+++.+++.+++.+++.+.++.+..+|++|+|++|.++.
T Consensus 60 ~~~~~~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~ 139 (550)
T KOG0605|consen 60 SEYEFLVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLS 139 (550)
T ss_pred cccccccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhHHHHHHHhccccCC
Confidence 45667889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.+||+++++||+||||+||+|+.+.||++||||+++|+.+...++++|++.|++||...++|+||+|||+|||.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||+||||++++|++.+.|+|+.++||++++++||+.||++|||||||||+|+|||..|||||+|||||+.+.+......
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998876554332
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
+............. .+..++.......+..+..++++|+.+++.+++++||||+||||||+.+++|+..|||||||||
T Consensus 300 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 300 YRLDEQMQINLSEA--KPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hcchhhhhhhhccC--CCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 22111111111111 1112222233455666889999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccCCccccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i~w~~l~ 404 (518)
|||||+|+|||+++++.+++++|++|+..+.||....+|++|+|||.+|||||.+|+|++|++||++||||++|+|+.|+
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~ 457 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLR 457 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhh
Confidence 99999999999999999999999999999999999999999999999999999999998899999999999999999999
Q ss_pred cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccC------CCCCCcccCceeeCCcccccccccc
Q 010116 405 EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLL------TPKDLSFVGYTYKNFDAVKGLRSLD 472 (518)
Q Consensus 405 ~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~f~~~~~~~~~~~~~~~~~~ 472 (518)
+.+|||+|.++++.||+||++|++++.+......+++++++.. +.++.+|+||||++++.+.......
T Consensus 458 ~~~apfvP~v~~~~DT~yFddF~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~~~~~~~~~~ 531 (550)
T KOG0605|consen 458 EMPAPFVPQVNSELDTQYFDDFPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFDGLNKANSLL 531 (550)
T ss_pred cCCCCCCCCCCCcccccccccCcccccCcccccccccchhhhhcccccCCcccccccceeeecccccccccccc
Confidence 9999999999999999999999999888888888888888732 3677889999999999987766653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-86 Score=684.05 Aligned_cols=441 Identities=42% Similarity=0.714 Sum_probs=387.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHhhhhcCCcCCCCeeEEeeEee
Q 010116 17 EKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGR 96 (518)
Q Consensus 17 ~~~~~~k~~~~~~~~~~~~~~~~r~~r~~~le~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~f~i~~~LG~ 96 (518)
-.-.|-|-|+|+|..+.++..|+|..|+..||+.+....++...+.+..+-+.++|..|.|++|.++...-|..++.||-
T Consensus 560 ysPqafkFfMEQHVEnvlksyqqr~~Rk~QLEkEM~kagLpd~~q~qMrkmL~QKESnYiRLkRaKMdKSmFvkik~iGv 639 (1034)
T KOG0608|consen 560 YSPQAFKFFMEQHVENVLKSYQQREKRKKQLEKEMVKAGLPDIMQNQMRKMLQQKESNYIRLKRAKMDKSMFVKIKTIGV 639 (1034)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHhhhhhHHHHHHhhccccceEEEeeecc
Confidence 66788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCchHHH
Q 010116 97 GAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176 (518)
Q Consensus 97 G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~ 176 (518)
|+||+|.|++..+|...||||.+.|.+++.++++.|+++|++||++.++++||+||++|+|++++|+||+|++||||+.+
T Consensus 640 GAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSL 719 (1034)
T KOG0608|consen 640 GAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSL 719 (1034)
T ss_pred cccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccC
Q 010116 177 LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256 (518)
Q Consensus 177 l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 256 (518)
|.+.+.|+|+.||||++++.+|++++|+.|+|||||||+|||||.||||||+|||||.-+...+....+... +-...
T Consensus 720 LIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~g---dH~Rq 796 (1034)
T KOG0608|consen 720 LIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEG---DHHRQ 796 (1034)
T ss_pred HHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCC---Ccccc
Confidence 999999999999999999999999999999999999999999999999999999999988776554444321 11223
Q ss_pred CCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCC
Q 010116 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 336 (518)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 336 (518)
++++......+.+.. -..-..+..+..++.++.+.|||+.|+|||||...+|+..|||||.|||||||+.|++||.
T Consensus 797 DSmep~~e~~d~~~~----lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~ 872 (1034)
T KOG0608|consen 797 DSMEPSPEWADISKC----LKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFL 872 (1034)
T ss_pred ccCCCchhhcccccc----chHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCcc
Confidence 333322111111111 0111223445667889999999999999999999999999999999999999999999999
Q ss_pred CCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccCCccccccccCCccccCCC
Q 010116 337 ADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEING 416 (518)
Q Consensus 337 ~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i~w~~l~~~~~p~~p~~~~ 416 (518)
.+.+-++..+|++|+..+.||...++|+++.+||.+|+|+++.|+|..++++|++||||++|||..|++..+||+|.+..
T Consensus 873 ~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItH 952 (1034)
T KOG0608|consen 873 ADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITH 952 (1034)
T ss_pred CCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhccCCcCccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCcccccCC-CCCCcccCceeeCCcccc
Q 010116 417 ELDTQNFMKFDELDPPASGRTSSGPSRKMLLT-PKDLSFVGYTYKNFDAVK 466 (518)
Q Consensus 417 ~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~~~~~~~~~~~~ 466 (518)
+.||+||+.++.+..-...+.++..+.. ++ -....|..|||..|=..+
T Consensus 953 ptDTSNFdpvdpeklwnddses~~~~~~--~nkhpehaFyEFTfRrFFDdn 1001 (1034)
T KOG0608|consen 953 PTDTSNFDPVDPEKLWNDDSESPNVRDT--LNKHPEHAFYEFTFRRFFDDN 1001 (1034)
T ss_pred CCccccCCcCCccccccccccCCCcccc--cccCCccceeEeeeehhccCC
Confidence 9999999999876543333332222211 12 223589999999874443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-81 Score=617.03 Aligned_cols=329 Identities=45% Similarity=0.785 Sum_probs=286.8
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+..+||+++++||+|+||+|++|+.++|++.||||+|+|..+...+.++++.+|++||..++||+||+|+++||+.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|||+||++||+|+.+|++++.|+|+.+++|+++|++||.|||++|||||||||||||||.+|||+|+|||||+..-..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-- 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-- 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999953211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
...+.++|||+.|||||++.+.+|+.+||||||
T Consensus 179 -----------------------------------------------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL 211 (357)
T KOG0598|consen 179 -----------------------------------------------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSL 211 (357)
T ss_pred -----------------------------------------------CCccccccCCccccChHHHhcCCCCcccchHhH
Confidence 113447899999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC-CChhhhhcCcccccCC
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT-GGAHQIKAHPWFKDVV 399 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~-~~a~eil~Hpff~~i~ 399 (518)
||++||||+|.+||.+.+...++.+|+..+ +.++. ..+|.+++|||++||. ||.+|+|. .++.+|++||||++||
T Consensus 212 GillYeML~G~pPF~~~~~~~~~~~I~~~k--~~~~p-~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 212 GILLYEMLTGKPPFYAEDVKKMYDKILKGK--LPLPP-GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHHHHHhhCCCCCcCccHHHHHHHHhcCc--CCCCC-ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 999999999999999999999999999843 33333 3589999999999998 99999984 3899999999999999
Q ss_pred ccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCc--ccccC-CCCCCcccCceeeCC
Q 010116 400 WDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPS--RKMLL-TPKDLSFVGYTYKNF 462 (518)
Q Consensus 400 w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~f~~~~~~~~ 462 (518)
|+.+. ++.|||+|.+.+..|+++|+.......+......+.+. ..... ......|.||||...
T Consensus 289 W~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~gft~~~~ 356 (357)
T KOG0598|consen 289 WEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDMSAFTAFSRTYNKIFPGFTYVAS 356 (357)
T ss_pred HHHHHhcCCCCCeecCCCCccccccccHHHHhccccCCccccCcccccccccccccccccCCccccCC
Confidence 99996 68999999999999999999743332221111111111 11112 233456999999753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-78 Score=579.87 Aligned_cols=293 Identities=47% Similarity=0.910 Sum_probs=280.3
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
...+||++++.||.|+||+|.+++++.+|..||||++.+..+++..|++|+.+|+++|+.+.||++++|+++|.|..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 77899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
|||||++||.|+++|.+.++|+|..|+||++||++||+|||+++||||||||||||||++||+||+|||+|+.+.
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999763
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
..+++.||||+|+|||++..++|+.++||||||
T Consensus 196 -----------------------------------------------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalG 228 (355)
T KOG0616|consen 196 -----------------------------------------------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALG 228 (355)
T ss_pred -----------------------------------------------CcEEEecCCccccChHHhhcCCCCcchhHHHHH
Confidence 136789999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCC
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVV 399 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~ 399 (518)
|++|||+.|++||++.++..++.+|+. ..+.||. .+|++++|||++||+ |-.+|.|+. |.++|+.||||++++
T Consensus 229 VLIYEMlaG~pPF~~~~~~~iY~KI~~--~~v~fP~--~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 229 VLIYEMLAGYPPFYDDNPIQIYEKILE--GKVKFPS--YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred HHHHHHHcCCCCCcCCChHHHHHHHHh--CcccCCc--ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 999999999999999999999999998 5789995 799999999999998 999999874 899999999999999
Q ss_pred ccccc--cccCCccc-cCCCcccCCCCCCCCCCCC
Q 010116 400 WDKLY--EMEAAFKP-EINGELDTQNFMKFDELDP 431 (518)
Q Consensus 400 w~~l~--~~~~p~~p-~~~~~~d~~~f~~~~~~~~ 431 (518)
|+.+. ++++||+| .+.+..|++||+.+.+.+.
T Consensus 305 W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y~e~~~ 339 (355)
T KOG0616|consen 305 WEAILQRKIEPPFEPPNIHGPGDTSNFDDYEEEDT 339 (355)
T ss_pred HHHHhhccccCCCCCccccCCcccccccccccccc
Confidence 99996 69999998 8899999999999877663
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-79 Score=662.34 Aligned_cols=334 Identities=49% Similarity=0.861 Sum_probs=299.8
Q ss_pred hhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 77 ~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
.++..++..+||+|+++||+|+||.|.+++++.|+++||||+++|-++.++.....|+.|++||...+++|||.|+++||
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34556778899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
|+.++|||||||+||||.++|.+.++++|+.|+||+++|+.||..||+.|+|||||||+|||||.+|||||+|||.|-.+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-----CC
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KG 311 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~ 311 (518)
+.. |. ....+.||||+|++||+|.. +.
T Consensus 226 ~~d-----------------------G~-------------------------V~s~~aVGTPDYISPEvLqs~~~~~g~ 257 (1317)
T KOG0612|consen 226 DAD-----------------------GT-------------------------VRSSVAVGTPDYISPEVLQSQGDGKGE 257 (1317)
T ss_pred CCC-----------------------Cc-------------------------EEeccccCCCCccCHHHHHhhcCCccc
Confidence 522 11 12336799999999999973 45
Q ss_pred CCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhc
Q 010116 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKA 391 (518)
Q Consensus 312 y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~ 391 (518)
||..|||||+||++||||+|..|||+++-.+++.+|++.+..+.||+...+|++++|||++|||+|+.|+|++|+++|+.
T Consensus 258 yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 258 YGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKN 337 (1317)
T ss_pred cCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHh
Confidence 99999999999999999999999999999999999999889999998888999999999999999999999999999999
Q ss_pred CcccccCCccccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeC
Q 010116 392 HPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461 (518)
Q Consensus 392 Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 461 (518)
||||.|++|+.+++..|||+|+++++.||+||+-...............+ .-++..++.|+||||..
T Consensus 338 HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p~~~~---~~f~Gn~LPFIGfTy~~ 404 (1317)
T KOG0612|consen 338 HPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFPPRIP---KAFSGNHLPFIGFTYTH 404 (1317)
T ss_pred CccccCCChhhhhhcCCCCCCcCCCCCccccccccccccchhhccCCCCC---CCCcCCcCCeeeeeecc
Confidence 99999999999999999999999999999999643322211111111111 12567889999999974
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-75 Score=609.96 Aligned_cols=324 Identities=38% Similarity=0.700 Sum_probs=291.4
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~ 159 (518)
.++..++|.++++||+|+||+|+++..+.+++.||||+++|..++.++.++..+.|++|+.... ||+++.|+.+||+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4788999999999999999999999999999999999999999999999999999999999885 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
++|+||||+.||| +.+++..+.|+|..|+||+++|++||.|||++||||||||.+|||||.+||+||+||||||..-.
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC-
Confidence 9999999999999 55555678999999999999999999999999999999999999999999999999999996421
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
....+.++||||.|||||++.+..|+.++|||
T Consensus 521 ------------------------------------------------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW 552 (694)
T KOG0694|consen 521 ------------------------------------------------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWW 552 (694)
T ss_pred ------------------------------------------------CCCccccccCChhhcChhhhccCcccchhhHH
Confidence 11246689999999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFK 396 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~ 396 (518)
||||+|||||+|.+||.+++..+.+..|++ ....+|. .+|.++.+++++||. ||++|+|++ ++++|++||||+
T Consensus 553 ~lGVLlyeML~Gq~PF~gddEee~FdsI~~--d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr 628 (694)
T KOG0694|consen 553 GLGVLLYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR 628 (694)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCCCCCC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence 999999999999999999999999999998 5778886 699999999999998 999999984 799999999999
Q ss_pred cCCccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCC
Q 010116 397 DVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNF 462 (518)
Q Consensus 397 ~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 462 (518)
.|||++|. +++|||+|.++++.|.+||++.+..+.+..+..... .+-...+..|.||+|.+.
T Consensus 629 ~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~~----~l~~~~q~~F~~Fs~~~~ 692 (694)
T KOG0694|consen 629 SIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDPR----PLTEEEQEAFRDFSFVAE 692 (694)
T ss_pred cCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCCCCcc----ccchhhHHHhcCccccCC
Confidence 99999996 699999999999999999997555554444322211 112234568999999764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-71 Score=550.17 Aligned_cols=336 Identities=34% Similarity=0.570 Sum_probs=277.5
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
+...+..++|++++.||.|.-|+||||+.+.++..+|||+|.|..+..++...++..|++||+.++||+++.||..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 45667888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
++.|+|||||+||||..+++++ ..|++..||||+++++.||+|||-.||||||||||||||.++|||.|+||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999875 68999999999999999999999999999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCCC-C-CCCCCCCCCCCCCCCCCc---hh---HHH-HHhhhcccccccccCCCCccChhhh
Q 010116 237 DCSTLYAIHEHKTIDDENMAEP-M-DIDGCFPDTDNKSSWKSP---HE---QLQ-HWQMNRRKLAFSTVGTPDYIAPEVL 307 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~---~~---~~~-~~~~~~~~~~~s~~GT~~Y~APEvl 307 (518)
... +................ . -..+|+.........+.. .. .+. -..........++|||-.|+||||+
T Consensus 230 ~~~--Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 230 PVS--PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred CCC--CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 332 11111110000000000 0 001222211000000000 00 000 0011122356789999999999999
Q ss_pred cCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC-C
Q 010116 308 LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG-G 385 (518)
Q Consensus 308 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~-~ 385 (518)
.+.+++.++|||+|||++||||+|..||.+.+..+++.+|+. .++.||....+|..|+|||++||. ||.+|+|+. |
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~--~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG--QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc--CCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence 999999999999999999999999999999999999999998 789999988999999999999998 999999986 9
Q ss_pred hhhhhcCcccccCCccccccccCCccccCCCcc
Q 010116 386 AHQIKAHPWFKDVVWDKLYEMEAAFKPEINGEL 418 (518)
Q Consensus 386 a~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~ 418 (518)
|.||++||||+||+|.-++-..||++|...+..
T Consensus 386 A~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~ 418 (459)
T KOG0610|consen 386 AAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG 418 (459)
T ss_pred hHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence 999999999999999977789999999876543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-72 Score=542.77 Aligned_cols=331 Identities=39% Similarity=0.693 Sum_probs=294.0
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
..+.+++.++|+.+++||+|.||+|-+|+.+.+|+.||||+++|..++.++.+.|...|-++|+..+||++..|-++||.
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 34577899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+.+|+||||.+||+|+.+|.+...|+|+.++||-++|++||.|||+++||+||||.+|+|||+||||||+|||||+.--
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999531
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.- ...+.++||||.|+|||||....|+.++|
T Consensus 320 ~~-------------------------------------------------g~t~kTFCGTPEYLAPEVleDnDYgraVD 350 (516)
T KOG0690|consen 320 KY-------------------------------------------------GDTTKTFCGTPEYLAPEVLEDNDYGRAVD 350 (516)
T ss_pred cc-------------------------------------------------cceeccccCChhhcCchhhccccccceee
Confidence 10 11345899999999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPW 394 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpf 394 (518)
||.+||+||||++|+.||++.+....+.-|+. ..++||. .+|++|+.|+..||. ||.+|+|.+ .|.||..|+|
T Consensus 351 WWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 351 WWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--EDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred hhhhhHHHHHHHhccCcccccchhHHHHHHHh--hhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence 99999999999999999999999999999887 6899996 799999999999998 999999986 8999999999
Q ss_pred cccCCccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeC
Q 010116 395 FKDVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461 (518)
Q Consensus 395 f~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 461 (518)
|.+|+|+.++ ++.|||+|.+.++.|+++|+......+...+.+....+...........|..|+|.+
T Consensus 427 F~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~ 495 (516)
T KOG0690|consen 427 FASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYGSTVDEDEERRPHFPQFSYSA 495 (516)
T ss_pred hccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcceeEecCCCCCCcccchhhhhccCCcceeeec
Confidence 9999999986 699999999999999999987443332221111111111112334567899999965
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-67 Score=537.49 Aligned_cols=285 Identities=40% Similarity=0.718 Sum_probs=258.2
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCe
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 160 (518)
+.+..||.+++.||.|+|++|++|+++.+++.||||++.|..+++...+..+..|+++|..| .||.||+||++|||+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 66789999999999999999999999999999999999999999999999999999999999 89999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+|+||+++|+|.++|.+.+.|+|..+|+|++||+.||+|||++|||||||||||||||.|||+||+|||-|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999886542
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
...... .+ ... ......++|||..|.+||+|.....+..+|+|+
T Consensus 229 ~~~~~~------------~~--------~~~----------------a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWA 272 (604)
T KOG0592|consen 229 KSQENP------------VD--------PNQ----------------ASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWA 272 (604)
T ss_pred ccccCc------------cC--------ccc----------------ccCcccceeeeecccCHHHhcCCCCCcccchHH
Confidence 211000 00 000 000124799999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
||||+|.|+.|.|||.+.+..-++++|+. -...||. .+++.++|||.+||. ||.+|+ |+++|++||||.+|+
T Consensus 273 lGCilyQmlaG~PPFra~NeyliFqkI~~--l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rl---t~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 273 LGCILYQMLAGQPPFRAANEYLIFQKIQA--LDYEFPE--GFPEDARDLIKKLLVRDPSDRL---TSQQIKAHPFFEGVD 345 (604)
T ss_pred HHHHHHHHhcCCCCCccccHHHHHHHHHH--hcccCCC--CCCHHHHHHHHHHHccCccccc---cHHHHhhCcccccCC
Confidence 99999999999999999999999999998 3566664 799999999999998 999999 889999999999999
Q ss_pred ccccccccCC
Q 010116 400 WDKLYEMEAA 409 (518)
Q Consensus 400 w~~l~~~~~p 409 (518)
|+.|.+..||
T Consensus 346 w~nlw~~~PP 355 (604)
T KOG0592|consen 346 WENLWQQTPP 355 (604)
T ss_pred hhhhhhcCCC
Confidence 9999987765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-69 Score=529.80 Aligned_cols=330 Identities=36% Similarity=0.672 Sum_probs=298.3
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
..+...||.++.+||+|+||+|.++..+.|.+.||||+++|..++..+.++..+.|.++|+.. +-|++|+|+.+||+-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 356678999999999999999999999999999999999999999999999999999999988 4679999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||+.||||+.+++.-+.|.|..|.||+++|+.||-+||++|||+||||.+|||||.+|||||+|||+|+.--.
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999985321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.+..+.++||||.|+|||++..++|+.++|||
T Consensus 503 ------------------------------------------------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWW 534 (683)
T KOG0696|consen 503 ------------------------------------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 534 (683)
T ss_pred ------------------------------------------------CCcceeeecCCCcccccceEEecccccchhHH
Confidence 12345689999999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFK 396 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~ 396 (518)
|+||+|||||.|++||.+++..+.++.|.. ....+|. .+|.+|.+++..+|. .|.+|+|++ +-.+|..||||+
T Consensus 535 a~GVLLyEmlaGQpPFdGeDE~elF~aI~e--hnvsyPK--slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR 610 (683)
T KOG0696|consen 535 AFGVLLYEMLAGQPPFDGEDEDELFQAIME--HNVSYPK--SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFR 610 (683)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHH--ccCcCcc--cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchh
Confidence 999999999999999999999999999998 5678886 799999999999998 999999997 778999999999
Q ss_pred cCCccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCccccc
Q 010116 397 DVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKG 467 (518)
Q Consensus 397 ~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~ 467 (518)
.|||+++. +++|||+|.++..-|++||+++....++..+.+.. -.+.+..+..|.||+|.|++-+..
T Consensus 611 ~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD~----~v~~nldq~eF~gFsfvNpefv~~ 679 (683)
T KOG0696|consen 611 RIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPDK----LVMMNLDQSEFEGFSFVNPEFVKP 679 (683)
T ss_pred hccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCchH----HHHhcCchhhcCceeeeChhhcCC
Confidence 99999996 69999999999999999999988877666544332 122344567899999999876644
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-66 Score=515.45 Aligned_cols=358 Identities=32% Similarity=0.569 Sum_probs=296.7
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
+....++.+.|...++||+|+||+||-|+.+.||+.||+|++.|..+.++.......+|+.||..+++++||.|-|+|++
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 44567889999999999999999999999999999999999999999888888889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.+.+||||..|+||||..+|.+.+ .|+|..++||++||++||++||+.+||+|||||+|||||+.|||+|+|+|||..
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999999999997755 899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
+..+. ...+.|||.+||||||+.++.|+.+
T Consensus 337 i~~g~--------------------------------------------------~~~~rvGT~GYMAPEvl~ne~Y~~s 366 (591)
T KOG0986|consen 337 IPEGK--------------------------------------------------PIRGRVGTVGYMAPEVLQNEVYDFS 366 (591)
T ss_pred cCCCC--------------------------------------------------ccccccCcccccCHHHHcCCcccCC
Confidence 65331 1225699999999999999999999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCCh----hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--Chhh
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDP----ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQ 388 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~e 388 (518)
+|||||||++|||+.|+.||..... .+.-+.++. ....+| .++|+++++|++.||+ ||.+|+||. |+++
T Consensus 367 ~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~e 442 (591)
T KOG0986|consen 367 PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQE 442 (591)
T ss_pred ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcc--cccCHHHHHHHHHHHccCHHHhccCCCcCcch
Confidence 9999999999999999999976432 234444444 456667 4899999999999998 999999996 8999
Q ss_pred hhcCcccccCCccccc--cccCCccccC-----CCcccCCCCCCCCCCC---------CCCCCCCCCCCcccccCCC---
Q 010116 389 IKAHPWFKDVVWDKLY--EMEAAFKPEI-----NGELDTQNFMKFDELD---------PPASGRTSSGPSRKMLLTP--- 449 (518)
Q Consensus 389 il~Hpff~~i~w~~l~--~~~~p~~p~~-----~~~~d~~~f~~~~~~~---------~~~~~~~~~~~~~~~~~~~--- 449 (518)
+++||||+++||.+|. .++|||+|+. .+.+|+.+|+.+.... ....+...|.+|++.++..
T Consensus 443 vk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~VKGV~ld~~D~~fy~~F~tg~vsipWQnE~~ET~~f 522 (591)
T KOG0986|consen 443 VKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFSTVKGVKLDDTDTDFYKNFATGSVSIPWQNEMIETECF 522 (591)
T ss_pred hhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcccccceecccccHHHHHhccCCcccchHHHHHHHhhhH
Confidence 9999999999999997 5899999987 4678888888654432 1244567888998875532
Q ss_pred CCCcccCceeeCCcccccccccccccccCCCCCCccccccccccc
Q 010116 450 KDLSFVGYTYKNFDAVKGLRSLDLKRSLSAKQPSIGSIFSESAID 494 (518)
Q Consensus 450 ~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 494 (518)
..++..|-.- ...+++. ..-+...+++|...++|.....+
T Consensus 523 ~elnv~~~~~---~~~~d~~--~~~p~~~~~~~~~~~l~~~~~~~ 562 (591)
T KOG0986|consen 523 EELNVFGDDG---AKNPDLR--YLFPNRLEKRGEGPRLFTMKNIS 562 (591)
T ss_pred HHhhcccccc---ccCcchh--cccCCccccCCCCcccccccccc
Confidence 2233222221 1112222 22344456777777777766544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-62 Score=510.60 Aligned_cols=362 Identities=51% Similarity=0.913 Sum_probs=293.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||+||+|+++.+++.||||++.+..........++..|+.++..++||||++++++|++...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|||+||+|.+++.+.+.+++..++.++.|++.||+|||++|||||||||+|||++.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999998899999999999999999999999999999999999999999999999999999865432111000
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
... ......+..+.. .........|..+......+.+||+.|+|||++.+.+|+.++|||||||++
T Consensus 161 ~~~-------~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 161 RNL-------NHSLPSDFTFQN-------MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred ccc-------cccccccccccc-------cccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 000 000000000000 000111122333334445678999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccCCcccccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYE 405 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i~w~~l~~ 405 (518)
|||++|.+||.+.+....+.+|..+...+.+|....+|+++++||.+|+++|.+|+++.+++||++||||++++|+.+..
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~ 306 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRE 306 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHh
Confidence 99999999999999999999999887788888777789999999999998889998877999999999999999999987
Q ss_pred ccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCC
Q 010116 406 MEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNF 462 (518)
Q Consensus 406 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 462 (518)
..++..+.+....|+++|+.+...+.......++.. ........+..|.||||+.|
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 362 (363)
T cd05628 307 RPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNH-PETDYKNKDWVFINYTYKRF 362 (363)
T ss_pred CCCCCCccCCCcchhhccCCCCccccccccccccCC-cccccCcCCcccCCceeecC
Confidence 666666778888899999988665533322222211 12224456778999999855
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-64 Score=497.93 Aligned_cols=265 Identities=33% Similarity=0.565 Sum_probs=236.7
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc----hhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK----RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~----~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
..+.|.+.+.||+|+||.|.+|..+.||+.||||++++..... ......+.+|++||+.++|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567889999999999999999999999999999999876544 223445789999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC---CcEEEeeccccccc
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN---GHMKLSDFGLCKPL 236 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~---g~vKL~DFGla~~~ 236 (518)
+.||||||+.||+|++.+..++.+.|+..+.|+.|++.||.|||++||+|||||||||||..+ .++||+|||+||..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999876 89999999999975
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC---C
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY---G 313 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y---~ 313 (518)
... ..+.++||||.|.||||+.++++ .
T Consensus 330 g~~--------------------------------------------------sfm~TlCGTpsYvAPEVl~~kg~~~~~ 359 (475)
T KOG0615|consen 330 GEG--------------------------------------------------SFMKTLCGTPSYVAPEVLASKGVEYYP 359 (475)
T ss_pred ccc--------------------------------------------------eehhhhcCCccccChhheecCCeeccc
Confidence 422 13458999999999999998764 5
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhh-HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPIT-TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
.++|+|||||+||-+|+|++||.+..... ...+|..++-.+.-+.+..+|.+++|||.+||. ||++|+ ++.|+|+
T Consensus 360 ~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~---s~~eaL~ 436 (475)
T KOG0615|consen 360 SKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP---SADEALN 436 (475)
T ss_pred chheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc---CHHHHhc
Confidence 57899999999999999999998876555 778888876666666778899999999999998 999999 8999999
Q ss_pred CcccccCCcc
Q 010116 392 HPWFKDVVWD 401 (518)
Q Consensus 392 Hpff~~i~w~ 401 (518)
||||+.++-.
T Consensus 437 hpW~~~~~~~ 446 (475)
T KOG0615|consen 437 HPWFKDAPCL 446 (475)
T ss_pred Chhhhccccc
Confidence 9999977643
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-62 Score=507.31 Aligned_cols=364 Identities=59% Similarity=1.011 Sum_probs=300.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|..++||||++++++|++..++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 58999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+++.+.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876432111100
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
... ..... ...+. ..............|...++....+.+||+.|+|||++.+.+|+.++|||||||++
T Consensus 161 ~~~-------~~~~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 161 RIL-------SHALP--SNFLD--FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred ccc-------ccccc--ccccc--cccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 000 00000 00000 00001111122334444555566778999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccCCcccccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYE 405 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i~w~~l~~ 405 (518)
|||++|.+||.+.+....+..+..|...+.+|....+|+++++||.+||++|.+|++..++.+++.||||++++|+.+..
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~ 309 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEHIRE 309 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHHHhh
Confidence 99999999999999999999999888888888877889999999999999999999655699999999999999999988
Q ss_pred ccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCc
Q 010116 406 MEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFD 463 (518)
Q Consensus 406 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~ 463 (518)
..+|+.|.+....|.++|+.+++.+.....+.... . .....+++.|+||+|++|+
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 310 RPAPIIPELKSITDTSNFDDFEEIDLDVPTSPGPP--R-GKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred cCCCCCCCCCCchhhhhccccccccccccCCCccc--c-ccccccCCCCCCCeeeCCC
Confidence 89999999999999999998766654333222111 1 1145789999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-65 Score=512.56 Aligned_cols=297 Identities=37% Similarity=0.722 Sum_probs=281.1
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+...+++++..||-||||.|=+++.+.....+|+|+++|..++...+.+|+..|++||..+++|+||+||-+|.|+.++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 45678899999999999999999998777667999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
||+||-|-||+|++.|..++.|++..++||++.++.|++|||++|||+|||||+|+|||.+|.+||.|||+||.+..+
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-- 573 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-- 573 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999987533
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
..+.++||||.|.|||++++++++.++|+|||
T Consensus 574 ------------------------------------------------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaL 605 (732)
T KOG0614|consen 574 ------------------------------------------------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWAL 605 (732)
T ss_pred ------------------------------------------------CceeeecCCcccccchhhhccCcchhhHHHHH
Confidence 35679999999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC--CCChhhhhcCcccccC
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG--TGGAHQIKAHPWFKDV 398 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g--~~~a~eil~Hpff~~i 398 (518)
|+++||||+|.|||.+.+++.++..|+.+...+.||. .++..+.+||++|.. +|.+|+| .+++.+|++|.||.+.
T Consensus 606 GIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr--~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 606 GILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR--RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc--ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 9999999999999999999999999999888888995 799999999999987 9999999 5699999999999999
Q ss_pred Cccccc--cccCCccccCCCcccCCCCCCCCCCC
Q 010116 399 VWDKLY--EMEAAFKPEINGELDTQNFMKFDELD 430 (518)
Q Consensus 399 ~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~ 430 (518)
||+.|+ .+.||++|.+.++.|++||+.|+...
T Consensus 684 dweglr~~~L~pPi~~~va~ptD~s~Fd~~p~dn 717 (732)
T KOG0614|consen 684 DWEGLRSRTLPPPIIPSVANPTDVSNFDNFPPDN 717 (732)
T ss_pred ChhhhhhccCCCCccccCCCcccchhccCCCccc
Confidence 999996 59999999999999999999986654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-61 Score=501.41 Aligned_cols=376 Identities=51% Similarity=0.920 Sum_probs=294.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||+||+|+++.+|+.||||++.+..........++.+|+.+++.++|||||+++++|++..++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998876656667788999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|..++.....+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999754321110000
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
. ............+..... .................|..++.....+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 161 ~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 161 Q-KLLQGKSNKNRIDNRNSV-AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred c-cccccccccccccccccc-ccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 000000000000000000 00000001112223334444444455578999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccCCcccccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYE 405 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i~w~~l~~ 405 (518)
|||++|.+||.+.+....+.++..|...+.+|....+|+++++||.+||++|.+|+++.++.+++.||||++++|+.+..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~ 318 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQ 318 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHHHcc
Confidence 99999999999998888889999887788888877799999999999999999998878999999999999999999999
Q ss_pred ccCCccccCCCcccCCCCCCCCCCCCCCCCC-CCCCCcccccCCCCCCcccCceeeCCc
Q 010116 406 MEAAFKPEINGELDTQNFMKFDELDPPASGR-TSSGPSRKMLLTPKDLSFVGYTYKNFD 463 (518)
Q Consensus 406 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~f~~~~~~~~~ 463 (518)
+.+|+.|.+....++.+|........+.... ....+.........++.|+||||++|+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (377)
T cd05629 319 IRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRFD 377 (377)
T ss_pred CCCCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCCC
Confidence 9999999999988988886543322222111 111111111134678899999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-63 Score=476.02 Aligned_cols=328 Identities=34% Similarity=0.628 Sum_probs=282.9
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
+.+...||+++++||+|+|++|.+++.+.|.+.||||+++|.-+...+.++.+..|..+.... +||++|.|+.+|+++.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 557789999999999999999999999999999999999998887888899999999999876 7999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+++|.||++||||+.+++++..++|+.|+||.++|++||.|||++|||+||||.+|||||..||+||+|+|+|+.--..
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999853110
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
...+.++||||.|+|||++++..|+.++|||
T Consensus 405 -------------------------------------------------gd~tstfcgtpnyiapeilrgeeygfsvdww 435 (593)
T KOG0695|consen 405 -------------------------------------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWW 435 (593)
T ss_pred -------------------------------------------------CcccccccCCCcccchhhhcccccCceehHH
Confidence 1134589999999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCC-------CChhhH-HHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC---Chh
Q 010116 320 SLGAIMYEMLVGYPPFYA-------DDPITT-CRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG---GAH 387 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~-------~~~~~~-~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~---~a~ 387 (518)
+|||+||||+.|+.||.- .+.... ++-|+. ..+.+|. .+|-.+..+++..|. ||.+|+||. +..
T Consensus 436 algvlmfemmagrspfdivgm~n~d~ntedylfqvile--kqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~ 511 (593)
T KOG0695|consen 436 ALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--KQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFS 511 (593)
T ss_pred HHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--hcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchh
Confidence 999999999999999942 222333 334444 4667775 688899999999998 999999996 899
Q ss_pred hhhcCcccccCCccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCccc
Q 010116 388 QIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAV 465 (518)
Q Consensus 388 eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 465 (518)
+|+.||||+.|||+.+. ++.|||.|.+.++.+..||+.-...+.+..+.......++ ..+..|.||.|.|+-.+
T Consensus 512 dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i~r----idqsefegfeyinpl~m 587 (593)
T KOG0695|consen 512 DIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAIKR----IDQSEFEGFEYINPLLM 587 (593)
T ss_pred hhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCCCCHHHHHh----cchhhcCcceecchhhc
Confidence 99999999999999996 4889999999999999999975555544333322222222 23457999999886543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-61 Score=501.58 Aligned_cols=257 Identities=36% Similarity=0.604 Sum_probs=242.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
.+|...+.||+|||+.||.+++..+|+.||+|++.|+.+.+..+.+.+.+|+.|.+.++|||||++|.+|+|.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|+|..|+|+.++++...++|.+|++|+.||+.||.|||+++|||||||..||+|+++.+|||+|||||..+....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~----- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG----- 172 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999875220
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
..-.+.||||.|+||||+.+.+++..+||||+||||
T Consensus 173 --------------------------------------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvm 208 (592)
T KOG0575|consen 173 --------------------------------------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVM 208 (592)
T ss_pred --------------------------------------------cccceecCCCcccChhHhccCCCCCchhhhhhhhHH
Confidence 123489999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc-ccC
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF-KDV 398 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff-~~i 398 (518)
|-||+|+|||...+-.+++.+|.. .+..+|. .+|.+|+|||.+||. ||.+|| ++++|+.|+|| ++.
T Consensus 209 YtLL~G~PPFetk~vkety~~Ik~--~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rp---sl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 209 YTLLVGRPPFETKTVKETYNKIKL--NEYSMPS--HLSAEAKDLIRKLLRPNPSERP---SLDEVLDHPFFKSGF 276 (592)
T ss_pred HhhhhCCCCcccchHHHHHHHHHh--cCccccc--ccCHHHHHHHHHHhcCCcccCC---CHHHHhcCHhhhCCC
Confidence 999999999999999999999987 5677775 799999999999998 999999 99999999999 443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-60 Score=498.55 Aligned_cols=372 Identities=44% Similarity=0.757 Sum_probs=288.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
.+|+++++||+|+||+||+|+++.+++.||||++.+..........++.+|+.+++.++|||||+++++|++...+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999999877666777889999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|||+||+|.+++.+.+.+++..++++++||+.||+|||++|||||||||+|||++.+|++||+|||+|..+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754321110000
Q ss_pred ccccccccccCCCCCCCC--CCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 246 EHKTIDDENMAEPMDIDG--CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
... +........... ..+............+. ............+.+||+.|+|||++.+.+|+.++|||||||
T Consensus 161 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 161 QSG---DHVRQDSMDFSNEWGDPANCRCGDRLKPLER-RAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccc---cccccccccccccccccccccccccccchhh-hhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000 000000000000 00000000000000000 000111223345679999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccCCcccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i~w~~l 403 (518)
++|||++|++||.+.++.....++..+...+.+|....+|+++++||.+|+++|.+|++..++++|+.||||++++|...
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~ 316 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSD 316 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChHHH
Confidence 99999999999999999888889988877888887778999999999998779999997767999999999999999874
Q ss_pred -ccccCCccccCCCcccCCCCCCCCCCCCCCCCCCC------CCCcccccCCCCCCcccCceeeCC
Q 010116 404 -YEMEAAFKPEINGELDTQNFMKFDELDPPASGRTS------SGPSRKMLLTPKDLSFVGYTYKNF 462 (518)
Q Consensus 404 -~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~f~~~~~~~~ 462 (518)
.+..+|+.|.+..+.|+++|+.++..+........ ...|.+. -..++..|.||||++|
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 381 (382)
T cd05625 317 LRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNGWYKN-GKHPEHAFYEFTFRRF 381 (382)
T ss_pred HhcCCCCccCcCCCcchhhhcCCCCcccccccccccccccccccccccc-ccccCcccccceeccc
Confidence 56789999999999999999876543321111100 0011111 2356789999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-60 Score=495.48 Aligned_cols=360 Identities=52% Similarity=0.911 Sum_probs=291.4
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|+++.+++.||||++.+..........++..|+.++..++||||++++++|++.+++|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|||+||+|.+++.+.+.+++..++.|++|++.||+|||++|||||||||+|||++.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999866432111100
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
.... .....+..+. ..........|..++.....+.+||+.|+|||++.+.+|+.++|||||||++
T Consensus 161 ~~~~-------~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 161 RNLT-------HNPPSDFSFQ-------NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred cccc-------cCCccccccc-------ccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 0000 0000000000 0000011112333344456678999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccCCcccccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYE 405 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i~w~~l~~ 405 (518)
|||++|++||.+.++.....++..+...+.+|....+|+++++||.+|+.||.+|++..++.+|++||||++++|..+..
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~ 306 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRE 306 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhc
Confidence 99999999999999999999999887778888766789999999999766999999887899999999999999999987
Q ss_pred ccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCc
Q 010116 406 MEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFD 463 (518)
Q Consensus 406 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~ 463 (518)
..++..+.+....|+++|+.+.+........ .+... -...++..|.+|+|+.++
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~ 360 (360)
T cd05627 307 RPAAIPIEIKSIDDTSNFDEFPESDILQPAE-NTIEP---DYKSKDWVFLNYTYKRFE 360 (360)
T ss_pred CCCCCCccCCCcchhhhcCCCCcccccCCCc-ccccc---ccCcCCcccCCceeecCC
Confidence 6666666778888999998876554322111 11111 145678899999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-59 Score=490.36 Aligned_cols=373 Identities=44% Similarity=0.759 Sum_probs=283.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
..|++++.||+|+||+||+|+++.+++.||||++.+..........++.+|+.+|+.++|||||+++++|.+..++|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998877767777888999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|||+||+|.+++.+...+++..++.+++|++.||+|||++|||||||||+||||+.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998765322111000
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHH--HHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQL--QHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
...... ......... ................+ ..........+.+.+||+.|+|||++.+.+|+.++|||||||
T Consensus 161 ~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 161 QKGSHI---RQDSMEPSD-LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccc---cccccCccc-ccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000000 000000000 00000000000000000 000111222345789999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccCCcccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i~w~~l 403 (518)
++|||++|.+||...++.....++..+...+.+|....+|+++++||.+|||.+.+|.++.++.+|++||||.+++|...
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~~ 316 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSD 316 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhHH
Confidence 99999999999999888888888888777788887778999999999999884444444449999999999999999875
Q ss_pred -ccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCC-Cccc---ccCCCCCCcccCceeeCC
Q 010116 404 -YEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSG-PSRK---MLLTPKDLSFVGYTYKNF 462 (518)
Q Consensus 404 -~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~f~~~~~~~~ 462 (518)
....+|+.|.+..+.|+++|+.+.+..+.......+. .+.. .........|.||||+.|
T Consensus 317 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (381)
T cd05626 317 IRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRRF 380 (381)
T ss_pred hhcCCCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeecc
Confidence 4567899999999999999987765443221111111 1110 001123578999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-58 Score=477.43 Aligned_cols=371 Identities=45% Similarity=0.802 Sum_probs=285.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|+++.+++.||+|++.+..........++.+|+.+|+.++||||+++++.|++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998755322111000
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
... ................... .. ... ...............+.+||+.|||||++.+.+|+.++|||||||++
T Consensus 161 ~~~---~~~~~~~~~~~~~~~~~~~-~~-~~~-~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 161 QKG---DHHRQDSMEPSEEWSEIDR-CR-LKP-LERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccc---ccccccccccccccccccc-cc-ccc-hhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 000 0000000000000000000 00 000 00000001111233467999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccCCcccc-c
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKL-Y 404 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i~w~~l-~ 404 (518)
|||++|++||.+.++......+..|...+.+|....+++++.+||.+|+++|.+|++..++.++++||||++++|..+ .
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~~~~ 314 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASLIR 314 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHHHhh
Confidence 999999999999998888888888877777777778999999999998779999998778999999999999999988 4
Q ss_pred cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCccc---ccCCCCCCcccCceeeCC
Q 010116 405 EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRK---MLLTPKDLSFVGYTYKNF 462 (518)
Q Consensus 405 ~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~f~~~~~~~~ 462 (518)
...+|+.|.+..+.|+++|+..............+..+.. .........|.-|+|.+|
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (376)
T cd05598 315 RQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFRRF 375 (376)
T ss_pred cCCCCCCCcCCCcchhhhcCCCCcccccccccccccccccccccccccCCcccccceeccc
Confidence 6788999999999999999876554433222111111111 112234457778888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-57 Score=471.84 Aligned_cols=330 Identities=45% Similarity=0.864 Sum_probs=277.0
Q ss_pred hhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 77 ~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
.+....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.
T Consensus 34 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred HHHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34556677789999999999999999999999999999999998766655556677889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
++..+|+|||||+||+|.+++.. ..+++..+++++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999999999999854 46899999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC----C
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG----Y 312 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y 312 (518)
..... ....+.+||+.|+|||++.+.+ |
T Consensus 193 ~~~~~------------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 224 (370)
T cd05621 193 DETGM------------------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYY 224 (370)
T ss_pred ccCCc------------------------------------------------eecccCCCCcccCCHHHHhccCCCCCC
Confidence 32100 0112568999999999997643 7
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcC
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~H 392 (518)
+.++|||||||++|||++|.+||.+.+....+.+|+.....+.+|....+|+.+++||.+||+++.+|+++.++.++++|
T Consensus 225 ~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 225 GRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 89999999999999999999999999988888888876666778877778999999999999877777666699999999
Q ss_pred cccccCCcc--ccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceee
Q 010116 393 PWFKDVVWD--KLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 393 pff~~i~w~--~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
|||++..|. .+....+|+.|.+....|.++|+........... .+..+.... .+..|.||+|.
T Consensus 305 p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~ 369 (370)
T cd05621 305 PFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVET----FPIPKAFVG-NQLPFIGFTYY 369 (370)
T ss_pred cccCCCCcChHhcCCCCCCcCCCCCCcchhhhcCCcccccccccc----CCCCccccc-cccccCCCEec
Confidence 999986654 5557789999999999999999866544322211 111121122 35899999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-58 Score=472.23 Aligned_cols=349 Identities=54% Similarity=0.954 Sum_probs=286.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||+||+|++..+|+.||||++.+...........+..|+.++..++||||++++++|.+..++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999999877666677788999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||++............
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876433211000
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
....... ...... .................+||+.|+|||++.+..|+.++|||||||++
T Consensus 161 ~~~~~~~------~~~~~~--------------~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 220 (350)
T cd05573 161 LNDSHNL------LFRDNV--------------LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220 (350)
T ss_pred ccccccc------cccccc--------------cccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhh
Confidence 0000000 000000 00000000111223457899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCC-hhhhhcCcccccCCccccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGG-AHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~-a~eil~Hpff~~i~w~~l~ 404 (518)
|||++|++||...+......++..|...+.+|....+++++++||.+||+||.+|+ + +.+|++||||++++|+...
T Consensus 221 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~---~s~~~ll~hp~~~~~~~~~~~ 297 (350)
T cd05573 221 YEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRL---GSFEEIKSHPFFKGIDWENLR 297 (350)
T ss_pred hhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcC---CCHHHHhcCCCcCCCCHHHHh
Confidence 99999999999999888999999888888888877789999999999999999999 6 9999999999999999999
Q ss_pred cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceee
Q 010116 405 EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 405 ~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
...+|++|.+.+..|+.+|+............ +..+. .........|+||+|+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 350 (350)
T cd05573 298 ETKPPFVPELSSPLDTSNFDDFEDDKDLSDYL--SQNSK-KLNKGKQLAFVGFTYK 350 (350)
T ss_pred hCCCCcCCCCCCchhhhhcCCCCccccccccc--ccccc-cccccccCccCCCccC
Confidence 88999999999999999998876554332211 11111 1133567899999994
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=467.60 Aligned_cols=330 Identities=46% Similarity=0.865 Sum_probs=278.6
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
++...+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44566778999999999999999999999999999999999987666566666778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
..++|+|||||+||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999999998854 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC----CC
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG----YG 313 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y~ 313 (518)
... .....+.+||+.|+|||++.+.+ |+
T Consensus 194 ~~~------------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~ 225 (371)
T cd05622 194 KEG------------------------------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYG 225 (371)
T ss_pred cCC------------------------------------------------cccccCcccCccccCHHHHhccCCCccCC
Confidence 110 00112568999999999997643 88
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCc
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHP 393 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hp 393 (518)
.++|||||||++|||++|.+||.+.+....+.+|+.....+.+|....+|.++++||.+||.+|..|+++.++++|++||
T Consensus 226 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 99999999999999999999999999988899998766667788777899999999999999888888777999999999
Q ss_pred ccccCC--ccccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeC
Q 010116 394 WFKDVV--WDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461 (518)
Q Consensus 394 ff~~i~--w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 461 (518)
||++.+ |..+.+..+|++|.+....++++|+............ +.... ....+..|.||+|.+
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~ 370 (371)
T cd05622 306 FFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETF----PIPKA-FVGNQLPFVGFTYYS 370 (371)
T ss_pred ccCCCChhHHhcCCCCCCCCCCCCCcchhhhcCCCcccccccccC----CCCcc-ccccccccCCCeecC
Confidence 999865 4566788899999999999999988654433211111 11112 223358999999953
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-57 Score=461.52 Aligned_cols=315 Identities=38% Similarity=0.693 Sum_probs=264.7
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG 171 (518)
+.||+|+||.||+|+++.+|+.||||++++..........++.+|..+|+.++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998876656666778889999999999999999999999999999999999999
Q ss_pred chHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccccc
Q 010116 172 DMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (518)
Q Consensus 172 ~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~ 251 (518)
+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----------- 149 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----------- 149 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-----------
Confidence 999999888899999999999999999999999999999999999999999999999999987532100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhC
Q 010116 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331 (518)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 331 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 150 --------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 191 (323)
T cd05571 150 --------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (323)
T ss_pred --------------------------------------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcC
Confidence 011256899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccccc--cc
Q 010116 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EM 406 (518)
Q Consensus 332 ~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~l~--~~ 406 (518)
.+||.+.+.......+.. ....+|. .+++++++||.+||+ ||.+|++.. ++.+|++||||.+++|..+. .+
T Consensus 192 ~~Pf~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~ 267 (323)
T cd05571 192 RLPFYNQDHEKLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKL 267 (323)
T ss_pred CCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 999999888777777765 3456664 689999999999998 999999643 69999999999999999886 57
Q ss_pred cCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCCcccccCCCCCCcccCceee
Q 010116 407 EAAFKPEINGELDTQNFMK-FDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 407 ~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
.+|+.|.+....|+++|+. +........+. .+.....+........|.+|+|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~ 321 (323)
T cd05571 268 EPPFKPQVTSETDTRYFDEEFTAQSITITPP-DRYDSLGLLQLEERPHFPQFSYS 321 (323)
T ss_pred CCCcCCCCCCcchhhhcCcccccCCcccCCC-CcccccccccccccccCCCCeee
Confidence 8899999999999999874 32221111111 11111111112346789999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-57 Score=462.34 Aligned_cols=322 Identities=43% Similarity=0.807 Sum_probs=276.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||+|+||+||+|+++.+|+.||||++++...........+..|+.+++.++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998876555556777889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||++||+|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--- 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc---
Confidence 999999999999776 7899999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc------CCCCCccccc
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------KKGYGMECDW 318 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~------~~~y~~~~Di 318 (518)
......+||+.|+|||++. +..|+.++||
T Consensus 158 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di 192 (330)
T cd05601 158 ---------------------------------------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192 (330)
T ss_pred ---------------------------------------------eeeecccCCccccCHHHhccccccccCCCCCccee
Confidence 0112357999999999997 4568899999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccC
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|||||++|||++|..||...+....+.++......+.+|....+++++++||.+||+||.+|+ +++++++||||..+
T Consensus 193 wslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~---t~~~l~~h~~~~~~ 269 (330)
T cd05601 193 WSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERL---GYEGLCCHPFFSKI 269 (330)
T ss_pred ecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCC---CHHHHhCCCCcCCC
Confidence 999999999999999999998888888888776667788777899999999999999999999 89999999999999
Q ss_pred CccccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCcee
Q 010116 399 VWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTY 459 (518)
Q Consensus 399 ~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ 459 (518)
+|..+....+|+.|.+....|+++|+......+............ .-.+.++..|+||+|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 329 (330)
T cd05601 270 DWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKP-NGFSGKDLPFVGFSF 329 (330)
T ss_pred CHHHHhhCCCCccCcCCCcchhhhcCCCccccccccccccccCCC-cCCCCCCCCccCcee
Confidence 999999888999999999999999976544433222111111111 114567899999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=459.43 Aligned_cols=292 Identities=42% Similarity=0.813 Sum_probs=262.0
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
.....++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++||||++++++|.+++.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 34556899999999999999999999999999999999988766666667889999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+||||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999998754211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
..+.+||+.|+|||++.+..++.++||||
T Consensus 172 ---------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diws 200 (329)
T PTZ00263 172 ---------------------------------------------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWT 200 (329)
T ss_pred ---------------------------------------------------cceecCChhhcCHHHHcCCCCCCcceeec
Confidence 12467999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC--CChhhhhcCccccc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT--GGAHQIKAHPWFKD 397 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~--~~a~eil~Hpff~~ 397 (518)
|||++|||++|.+||.+.++...+..+.. ..+.+|. .+++.+++||.+||. ||.+|+++ .++++|+.||||++
T Consensus 201 lG~il~elltg~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 201 MGVLLYEFIAGYPPFFDDTPFRIYEKILA--GRLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred hHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCcCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999999999999988888888876 3455664 589999999999998 99999964 36899999999999
Q ss_pred CCccccc--cccCCccccCCCcccCCCCCCCCC
Q 010116 398 VVWDKLY--EMEAAFKPEINGELDTQNFMKFDE 428 (518)
Q Consensus 398 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~ 428 (518)
++|..+. ...+|+.+.+....++.+|..+.+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (329)
T PTZ00263 277 ANWDKLYARYYPAPIPVRVKSPGDTSNFEKYPD 309 (329)
T ss_pred CCHHHHHhCCCCCCcCCCCCCcccchhccCCcc
Confidence 9999886 466788888888889999987644
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-56 Score=461.92 Aligned_cols=327 Identities=47% Similarity=0.877 Sum_probs=273.0
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.+.
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 44567788999999999999999999999999999999999887666666667788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..+|+|||||+||+|..++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999998854 5689999999999999999999999999999999999999999999999999876431
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC----CCCc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK----GYGM 314 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~----~y~~ 314 (518)
... ....+.+||+.|+|||++.+. .|+.
T Consensus 195 ~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 226 (370)
T cd05596 195 NGM------------------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGR 226 (370)
T ss_pred CCc------------------------------------------------ccCCCCCCCcCeECHHHhccCCCCCCCCC
Confidence 100 011246899999999999754 3889
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCc
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHP 393 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hp 393 (518)
++|||||||++|||++|.+||.+.+....+.+|......+.+|....+|.++++||++||. +|. |+++.++.+|++||
T Consensus 227 ~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~-r~~R~s~~ell~h~ 305 (370)
T cd05596 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREV-RLGRNGVDEIKSHP 305 (370)
T ss_pred ceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhh-ccCCCCHHHHhcCc
Confidence 9999999999999999999999999888888888766677888777799999999999998 554 44334899999999
Q ss_pred ccccCCccc--cccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceee
Q 010116 394 WFKDVVWDK--LYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 394 ff~~i~w~~--l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
||++.+|.. +....+|+.|.+....|+++|+.............. + +. .......|.||+|.
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~-~~~~~~~~~~~~~~ 369 (370)
T cd05596 306 FFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDDKNEETFPL--P--KA-FAGNQLPFIGFTYS 369 (370)
T ss_pred ccCCCChhhHHhcCCCcCccCcCCCcchhhhcCCccccccccccCCC--c--cc-cccccCccCCCeec
Confidence 999988864 456778999999999999999876444321111111 1 11 22336679999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-56 Score=459.03 Aligned_cols=294 Identities=41% Similarity=0.810 Sum_probs=262.5
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCC-cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSG-NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~-~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
...+..++|++++.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+++.++|||||+++++|.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 45567889999999999999999999877665 78999999887666666778889999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..+|+||||++||+|.+++.+...+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999875421
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
. ..+.+||+.|+|||++.+..++.++||
T Consensus 184 ~----------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di 211 (340)
T PTZ00426 184 R----------------------------------------------------TYTLCGTPEYIAPEILLNVGHGKAADW 211 (340)
T ss_pred C----------------------------------------------------cceecCChhhcCHHHHhCCCCCccccc
Confidence 1 124689999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC--CChhhhhcCccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT--GGAHQIKAHPWF 395 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~--~~a~eil~Hpff 395 (518)
|||||++|||++|.+||.+.++...+..+.. ....+|. .+++++++||++||. ||.+|++. .+++++++||||
T Consensus 212 wSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 212 WTLGIFIYEILVGCPPFYANEPLLIYQKILE--GIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred cchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 9999999999999999999988888888876 3445554 689999999999998 99999864 389999999999
Q ss_pred ccCCccccc--cccCCccccCCCcccCCCCCCCCCC
Q 010116 396 KDVVWDKLY--EMEAAFKPEINGELDTQNFMKFDEL 429 (518)
Q Consensus 396 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~ 429 (518)
++++|..+. .+.+|++|......+.++|..+.+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (340)
T PTZ00426 288 GNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQED 323 (340)
T ss_pred CCCCHHHHHhCCCCCCcCCCCCCCcchhhcCCCccc
Confidence 999999875 5789999999998999888765444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-57 Score=445.80 Aligned_cols=259 Identities=31% Similarity=0.513 Sum_probs=234.1
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe-E
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY-L 161 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~-l 161 (518)
+..++.+.++.||+|+.|+||+|+++.|++.||+|++.-. .+......+.+|++|++.++||+||++|++|.++.. +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 5566899999999999999999999999999999999322 344456778999999999999999999999999995 9
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+||||.||+|..++...++++|.....++.+++.||.|||. ++||||||||+|||+++.|.|||||||.++.+..+
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999999988999999999999999999999995 99999999999999999999999999999876422
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
.+.+++||..|||||-+.+..|+.++||||
T Consensus 233 --------------------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWS 262 (364)
T KOG0581|consen 233 --------------------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIWS 262 (364)
T ss_pred --------------------------------------------------hcccccccccccChhhhcCCcCCcccceec
Confidence 456899999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCC-----ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 321 LGAIMYEMLVGYPPFYAD-----DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~-----~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
||+.++||++|+.||... +..+.+..|+.. .++.+|.. .+|+++++||..||. ||.+|+ ++.|+++|||
T Consensus 263 LGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~---s~~qLl~Hpf 337 (364)
T KOG0581|consen 263 LGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEG-EFSPEFRSFVSCCLRKDPSERP---SAKQLLQHPF 337 (364)
T ss_pred ccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcc-cCCHHHHHHHHHHhcCCcccCC---CHHHHhcCHH
Confidence 999999999999999874 667778888874 45667763 699999999999998 999999 8999999999
Q ss_pred cccCC
Q 010116 395 FKDVV 399 (518)
Q Consensus 395 f~~i~ 399 (518)
++...
T Consensus 338 i~~~~ 342 (364)
T KOG0581|consen 338 IKKFE 342 (364)
T ss_pred Hhhcc
Confidence 98643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-57 Score=447.73 Aligned_cols=259 Identities=34% Similarity=0.595 Sum_probs=235.9
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
...+|.+.+.||+|+||+||+|+++.++..||||.+.+..+ ....++.+..|+.||++++|||||.|++++++++++||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 35799999999999999999999999999999999988765 45567788999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC------CcEEEeecccccccC
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN------GHMKLSDFGLCKPLD 237 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~------g~vKL~DFGla~~~~ 237 (518)
|||||.||||..||++.+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999865 468999999999875
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.+ ..+.+.||+|-||||||+....|+.++|
T Consensus 167 ~~--------------------------------------------------~~a~tlcGSplYMAPEV~~~~~YdAKAD 196 (429)
T KOG0595|consen 167 PG--------------------------------------------------SMAETLCGSPLYMAPEVIMSQQYDAKAD 196 (429)
T ss_pred ch--------------------------------------------------hHHHHhhCCccccCHHHHHhccccchhh
Confidence 32 2345899999999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
+||+|+|+|+|++|++||...++.+.+..+.......+++. ..+++...+|+..+|+ ++.+|. +..+-..|+|..
T Consensus 197 LWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~---~~~~~~~~~~l~ 272 (429)
T KOG0595|consen 197 LWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRI---SFEDFFDHPFLA 272 (429)
T ss_pred HHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCchhhhhhHHHhcCccccC---chHHhhhhhhcc
Confidence 99999999999999999999999999998887666555554 4678888899999998 999999 788889999886
Q ss_pred c
Q 010116 397 D 397 (518)
Q Consensus 397 ~ 397 (518)
.
T Consensus 273 ~ 273 (429)
T KOG0595|consen 273 A 273 (429)
T ss_pred c
Confidence 5
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=451.26 Aligned_cols=324 Identities=47% Similarity=0.862 Sum_probs=271.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|+++++||+|+||+||+++.+.+++.||+|++.+...........+..|+.++..++|++|++++++|++...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 57999999999999999999999999999999998766656666677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||++||+|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.+....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~---- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC----
Confidence 99999999999976 4689999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----CCCCCcccccc
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDWW 319 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiW 319 (518)
.......+||+.|+|||++. ...|+.++|||
T Consensus 157 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvw 192 (332)
T cd05623 157 --------------------------------------------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW 192 (332)
T ss_pred --------------------------------------------cceecccccCccccCHHHHhccccCCCCCCCcCCEE
Confidence 00112357999999999996 35689999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCC-CCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccC
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-SKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~-~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||||++|||++|++||.+.+....+.++......+.+|.. ..+|+++++||++||+.+.+|+++.++.++++||||.++
T Consensus 193 SlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred eeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 9999999999999999999998988888875545555543 357999999999999966778777799999999999999
Q ss_pred CccccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceee
Q 010116 399 VWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 399 ~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
+|+.+....+|+.|...++.+++++...+........ ...++... .+.....|.||||.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~ 331 (332)
T cd05623 273 DWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSET--MPPPSHTA-FSGHHLPFVGFTYT 331 (332)
T ss_pred CHHHHhhCCCCccCCCCCCcccccCCCCcccccccCC--CCCCCccc-cccCCCCcCCeeec
Confidence 9999999999999999999998888654332222111 11111111 23456789999984
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=451.19 Aligned_cols=324 Identities=49% Similarity=0.870 Sum_probs=271.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+..++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999998876666667778899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||++||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|..+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--- 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC---
Confidence 99999999999976 46899999999999999999999999999999999999999999999999999876432100
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-----CCCCcccccc
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KGYGMECDWW 319 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiW 319 (518)
......+||+.|+|||++.+ ..++.++|||
T Consensus 158 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 192 (331)
T cd05597 158 ---------------------------------------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWW 192 (331)
T ss_pred ---------------------------------------------ccccceeccccccCHHHHhhccccccCCCCcceee
Confidence 00113479999999999973 4578999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCC-CCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccC
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-SKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~-~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||||++|+|++|+.||.+.+..+.+..+......+.+|.. ..+|+++++||++||+.|.+|+++.++.+++.||||.++
T Consensus 193 slG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred hhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 9999999999999999998888888888775555555542 357999999999999977777766699999999999999
Q ss_pred CccccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceee
Q 010116 399 VWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 399 ~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
+|..+....+|+.|......++++|+..+........ ..++...........+.||+|.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 331 (331)
T cd05597 273 DWDNIRNSTAPYVPEVSSPTDTSNFDVDDDDLRNTES---LPPSSHGAFSGNHLPFVGFTYT 331 (331)
T ss_pred CHHHHhhCCCCccCcCCCcchhhhcCCcccccccccc---cCCCCcCcCCcCCCCCCceeeC
Confidence 9999988889999999999999888754432211111 1111111234556788899983
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=450.76 Aligned_cols=293 Identities=50% Similarity=0.901 Sum_probs=257.4
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++..++|++|++++++|++.+++|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999998766555566677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||++||+|..++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--- 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc---
Confidence 99999999999977 47899999999999999999999999999999999999999999999999999976532100
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-----CCCCcccccc
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KGYGMECDWW 319 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiW 319 (518)
......+||+.|+|||++.+ ..++.++|||
T Consensus 158 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 192 (331)
T cd05624 158 ---------------------------------------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 192 (331)
T ss_pred ---------------------------------------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEE
Confidence 00113579999999999976 5688999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCC-CCCChhHHHHHHHHhccccccCCCCChhhhhcCcccccC
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-SKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~-~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||||++|||++|+.||.+.+....+.++......+.+|.. ..+++++++||.+||+.+.+|++..+++++++||||+++
T Consensus 193 SlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred eeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 9999999999999999999888888888775545555542 357899999999999966677776689999999999999
Q ss_pred CccccccccCCccccCCCcccCCCCCCC
Q 010116 399 VWDKLYEMEAAFKPEINGELDTQNFMKF 426 (518)
Q Consensus 399 ~w~~l~~~~~p~~p~~~~~~d~~~f~~~ 426 (518)
+|+.+....+|+.|......+.++|+.-
T Consensus 273 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 300 (331)
T cd05624 273 DWENIRNLEAPYIPDVSSPSDTSNFDVD 300 (331)
T ss_pred CHHHHhhCCCCccCCCCCcchhhhcCCc
Confidence 9999999999999999888888888643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=449.30 Aligned_cols=317 Identities=35% Similarity=0.679 Sum_probs=267.7
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVm 165 (518)
+|++++.||+|+||.||+|+++.+++.||||++.+..............|..++..+ .||+|++++++|++.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999887655555666778888888877 5789999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~----- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
......+||+.|+|||++.+..|+.++|||||||++
T Consensus 156 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 191 (323)
T cd05616 156 --------------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191 (323)
T ss_pred --------------------------------------------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHH
Confidence 012256899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~ 402 (518)
|||++|++||.+.+.......+.. ..+.+|. .+++++++||.+||. ||.+|+++. +..+|+.||||+.++|..
T Consensus 192 ~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 192 YEMLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999999999999988888888876 3455564 689999999999998 999999753 578999999999999999
Q ss_pred cc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeC
Q 010116 403 LY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461 (518)
Q Consensus 403 l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 461 (518)
+. ..++|+.|.... .|..+|+.+....++..+.. .+....+.....|.||+|.|
T Consensus 268 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05616 268 LERKEVQPPYKPKACG-RDAENFDKFFTRHPPVLTPP----DQEVIMNLDQSEFEGFSYVN 323 (323)
T ss_pred HHhCCCCCCcCCcCCC-chhhhcCchhccCCccCCCC----CccccccccccccCCCcccC
Confidence 86 578999998754 78888888766443332211 12222333346788998864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-55 Score=452.28 Aligned_cols=289 Identities=46% Similarity=0.840 Sum_probs=260.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+..|+.++..++||||++++++|++..++|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876555566778899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875421
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
...+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 154 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 188 (333)
T cd05600 154 ---------------------------------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCML 188 (333)
T ss_pred ---------------------------------------------ccCCcccCccccChhHhcCCCCCCccceecchHHH
Confidence 11256799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCC----CCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDS----KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~----~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
|||++|.+||.+.+....+..+..+...+..|... .+|+++.+||.+||. +|.+|+ ++.+|++||||++++|
T Consensus 189 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~---s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 189 YEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG---SLEDIKNHPFFKEVDW 265 (333)
T ss_pred hhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcC---CHHHHHhCcccCCCCH
Confidence 99999999999999888888888776555555432 579999999999998 777888 8999999999999999
Q ss_pred cccccccCCccccCCCcccCCCCCCCCCC
Q 010116 401 DKLYEMEAAFKPEINGELDTQNFMKFDEL 429 (518)
Q Consensus 401 ~~l~~~~~p~~p~~~~~~d~~~f~~~~~~ 429 (518)
..+....||+.|.+....+..+|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (333)
T cd05600 266 NELRELKPPFVPELESEIDTGYFDDFENE 294 (333)
T ss_pred HHHhhCCCCCCCCCCCcchhhhccCCCCc
Confidence 99999999999999988888888765444
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-55 Score=448.71 Aligned_cols=318 Identities=36% Similarity=0.693 Sum_probs=269.1
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC-ceeEEEEEeecCCeEEEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~f~~~~~lylVm 165 (518)
+|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|+.++..+.|+ +|++++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 689999999999999999999999999999999887655556677888999999999765 6889999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
......+||+.|+|||++.+..|+.++|||||||++
T Consensus 156 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 191 (324)
T cd05587 156 --------------------------------------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191 (324)
T ss_pred --------------------------------------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHH
Confidence 011256899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~ 402 (518)
|||++|++||.+.+.......+... ...+|. .+++++++||.+||. ||.+|++.. ..++++.||||++++|..
T Consensus 192 ~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~ 267 (324)
T cd05587 192 YEMLAGQPPFDGEDEDELFQSIMEH--NVSYPK--SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK 267 (324)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 9999999999999888888888763 444553 689999999999998 999999652 458999999999999998
Q ss_pred cc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeC
Q 010116 403 LY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461 (518)
Q Consensus 403 l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 461 (518)
+. .+.+|+.|.+....+.++|+.+............ +..+.+.....|.+|+|.|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05587 268 LERREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPD----KLVIANIDQSEFQGFSFVN 324 (324)
T ss_pred HHhCCCCCCccCcCCCcchhhhcCcccccCccccCCCC----ccccccccccccCCCcccC
Confidence 85 4778999999988999999887655433322111 1122234456788888864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=444.13 Aligned_cols=285 Identities=41% Similarity=0.823 Sum_probs=256.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998765555556678899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------ 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
..+.+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 188 (291)
T cd05612 155 ----------------------------------------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILI 188 (291)
T ss_pred ----------------------------------------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 1245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~ 402 (518)
|+|++|..||.+.+....+..+... .+.+|. .+++.+++||++||. ||.+|+++. ++++++.||||..++|..
T Consensus 189 ~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 264 (291)
T cd05612 189 YEMLVGYPPFFDDNPFGIYEKILAG--KLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264 (291)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence 9999999999999888888888763 455554 579999999999998 999999643 599999999999999998
Q ss_pred cc--cccCCccccCCCcccCCCCCCC
Q 010116 403 LY--EMEAAFKPEINGELDTQNFMKF 426 (518)
Q Consensus 403 l~--~~~~p~~p~~~~~~d~~~f~~~ 426 (518)
+. ...||..|.+....|+.||+..
T Consensus 265 ~~~~~~~~~~~p~~~~~~~~~~~~~~ 290 (291)
T cd05612 265 VPQRKLKPPIVPKVSHDGDTSNFDDY 290 (291)
T ss_pred HhcCCCCCCEeCCCCCccccccccCC
Confidence 75 5778899999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-55 Score=444.01 Aligned_cols=279 Identities=44% Similarity=0.840 Sum_probs=250.9
Q ss_pred EeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010116 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (518)
Q Consensus 94 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L 173 (518)
||+|+||.||+|++..+++.||+|++.+..........++.+|+.+|..++||||++++++|.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999877665666778889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccccccc
Q 010116 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253 (518)
Q Consensus 174 ~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 253 (518)
..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------------- 147 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------------- 147 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------------
Confidence 9999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCC
Q 010116 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333 (518)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 333 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 148 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~ 191 (312)
T cd05585 148 ------------------------------------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP 191 (312)
T ss_pred ------------------------------------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCC
Confidence 01124689999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccc--cccCCc
Q 010116 334 PFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLY--EMEAAF 410 (518)
Q Consensus 334 PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~--~~~~p~ 410 (518)
||.+.+....+..+.. ..+.+|. .+++++++||.+||. ||.+|++..++.+++.||||+.++|..+. .+.+++
T Consensus 192 pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~ 267 (312)
T cd05585 192 PFYDENVNEMYRKILQ--EPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPF 267 (312)
T ss_pred CcCCCCHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCc
Confidence 9999888888887776 4555664 689999999999998 99999987789999999999999998774 577899
Q ss_pred cccCCCcccCCCCCC
Q 010116 411 KPEINGELDTQNFMK 425 (518)
Q Consensus 411 ~p~~~~~~d~~~f~~ 425 (518)
.|.+....++++|+.
T Consensus 268 ~~~~~~~~~~~~~~~ 282 (312)
T cd05585 268 KPAVSSAIDTSNFDE 282 (312)
T ss_pred CCCCCCccchhhcCc
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=454.96 Aligned_cols=259 Identities=36% Similarity=0.663 Sum_probs=235.0
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch--hhHHHHHHHHHHHHHhC-CCceeEEEEEeecCC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR--GQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTE 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~--~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~ 159 (518)
...+.|.+.+.||+|+||+|++|++..+|..||+|++.+...... ...+.+.+|+.+++.+. ||||++++.++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456799999999999999999999999999999998877533312 34567789999999999 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC-CcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~-g~vKL~DFGla~~~~~ 238 (518)
.+|+|||||.||+|++++...+++.|.+++.|+.|++.||+|||++||+||||||||||+|.+ +++||+|||++.....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999 9999999999986520
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC-C-Cccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-Y-GMEC 316 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y-~~~~ 316 (518)
......+.||||.|+|||++.+.+ | +.++
T Consensus 174 -------------------------------------------------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~a 204 (370)
T KOG0583|consen 174 -------------------------------------------------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAA 204 (370)
T ss_pred -------------------------------------------------CCCcccCCCCCcccCCHHHhCCCCCcCCchh
Confidence 012344789999999999999988 9 6899
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCC-ChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKL-SPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~-s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
||||+||+||.|++|+.||...+...++.+|.. ..+.+|. .+ |+++++||++||. ||.+|+ ++.+|+.|||
T Consensus 205 DvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~--~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~---t~~~i~~h~w 277 (370)
T KOG0583|consen 205 DVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK--GEFKIPS--YLLSPEARSLIEKMLVPDPSTRI---TLLEILEHPW 277 (370)
T ss_pred hhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc--CCccCCC--CcCCHHHHHHHHHHcCCCcccCC---CHHHHhhChh
Confidence 999999999999999999999999999999876 5778886 46 9999999999998 999999 8999999999
Q ss_pred ccc
Q 010116 395 FKD 397 (518)
Q Consensus 395 f~~ 397 (518)
|+.
T Consensus 278 ~~~ 280 (370)
T KOG0583|consen 278 FQK 280 (370)
T ss_pred hcc
Confidence 996
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-55 Score=444.59 Aligned_cols=282 Identities=38% Similarity=0.706 Sum_probs=249.3
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
++||+|+||+||+|+++.+++.||||++.+.........+.+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999887655556677788898888876 699999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.+...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---------- 150 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---------- 150 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (320)
T cd05590 151 ---------------------------------------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191 (320)
T ss_pred ---------------------------------------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh
Confidence 01124679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC---ChhhhhcCcccccCCccccc--
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG---GAHQIKAHPWFKDVVWDKLY-- 404 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~---~a~eil~Hpff~~i~w~~l~-- 404 (518)
|++||.+.+....+..+.. ....+|. .+++++++||++||. ||.+|+++. +.++++.||||.+++|+.+.
T Consensus 192 g~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~ 267 (320)
T cd05590 192 GHAPFEAENEDDLFEAILN--DEVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRR 267 (320)
T ss_pred CCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence 9999999988888888876 3344453 689999999999998 999999542 34999999999999999885
Q ss_pred cccCCccccCCCcccCCCCCCC
Q 010116 405 EMEAAFKPEINGELDTQNFMKF 426 (518)
Q Consensus 405 ~~~~p~~p~~~~~~d~~~f~~~ 426 (518)
.+.|||.|.+....|.++|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~ 289 (320)
T cd05590 268 QIEPPFRPRIKSREDVSNFDPD 289 (320)
T ss_pred CCCCCcCCCCCCcchhhhcCcc
Confidence 5789999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=443.61 Aligned_cols=312 Identities=36% Similarity=0.658 Sum_probs=261.4
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
++||+|+||.||+|+++.+++.||||++.+...........+..|..++..+ +||+|++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999887665566677788899999876 799999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---------- 150 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---------- 150 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 191 (321)
T cd05591 151 ---------------------------------------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA 191 (321)
T ss_pred ---------------------------------------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc
Confidence 01224679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC----ChhhhhcCcccccCCccccc-
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG----GAHQIKAHPWFKDVVWDKLY- 404 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~----~a~eil~Hpff~~i~w~~l~- 404 (518)
|++||.+.+....+..+.. ....+|. .+++++.+||.+||. ||.+|+++. +++++++||||.+++|..+.
T Consensus 192 g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~ 267 (321)
T cd05591 192 GQPPFEADNEDDLFESILH--DDVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ 267 (321)
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence 9999999998888888876 3444553 589999999999998 999999763 68999999999999999885
Q ss_pred -cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceee
Q 010116 405 -EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 405 -~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
...+||.|.+....+..+|+.......+......+. .+....+..|.||+|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 320 (321)
T cd05591 268 RKIKPPFKPKIKTKRDVNNFDQDFTKEEPVLTPVDPA----VIKQINQEEFRGFSFF 320 (321)
T ss_pred CCCCCCCCCCCCCcchhhhcCCccccCccccCCCCcc----ccccccccccCCCccc
Confidence 467889999888888888875322222221111111 1122345679999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=443.37 Aligned_cols=281 Identities=41% Similarity=0.761 Sum_probs=249.7
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG 171 (518)
++||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|+.++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876655666778889999999999999999999999999999999999999
Q ss_pred chHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccccc
Q 010116 172 DMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (518)
Q Consensus 172 ~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~ 251 (518)
+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----------- 149 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----------- 149 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-----------
Confidence 999999888899999999999999999999999999999999999999999999999999987532100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhC
Q 010116 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331 (518)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 331 (518)
......+||+.|+|||++.+..|+.++|||||||++|+|++|
T Consensus 150 --------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 191 (328)
T cd05593 150 --------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (328)
T ss_pred --------------------------------------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC
Confidence 011246899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccccc--cc
Q 010116 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EM 406 (518)
Q Consensus 332 ~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~l~--~~ 406 (518)
.+||.+.+.......+.. ....+|. .+++++.+||++||+ ||.+|++.. ++.+|++||||.+++|..+. .+
T Consensus 192 ~~Pf~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~ 267 (328)
T cd05593 192 RLPFYNQDHEKLFELILM--EDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKL 267 (328)
T ss_pred CCCCCCCCHHHHHHHhcc--CCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCC
Confidence 999998888777776654 3455664 689999999999998 999998653 79999999999999999885 46
Q ss_pred cCCccccCCCcccCCCCCC
Q 010116 407 EAAFKPEINGELDTQNFMK 425 (518)
Q Consensus 407 ~~p~~p~~~~~~d~~~f~~ 425 (518)
.+|+.|.+..+.++.+|+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~ 286 (328)
T cd05593 268 VPPFKPQVTSETDTRYFDE 286 (328)
T ss_pred CCCcCCcCCCcchhhhcCc
Confidence 7899999999999988874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-54 Score=441.64 Aligned_cols=316 Identities=35% Similarity=0.693 Sum_probs=264.6
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVm 165 (518)
+|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+..|..++..+. |++|++++++|++.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999998876555566777888999998886 567889999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~----- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
....+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 156 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 191 (323)
T cd05615 156 --------------------------------------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191 (323)
T ss_pred --------------------------------------------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHH
Confidence 011246799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~ 402 (518)
|||++|.+||.+.+.......+.. ....+|. .+++++++||.+||. ||.+|++.. +.++++.||||++++|..
T Consensus 192 ~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~ 267 (323)
T cd05615 192 YEMLAGQPPFDGEDEDELFQSIME--HNVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDK 267 (323)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHH
Confidence 999999999999988888888876 3455554 689999999999998 999999753 578999999999999998
Q ss_pred cc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCC-CCcccCceeeC
Q 010116 403 LY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPK-DLSFVGYTYKN 461 (518)
Q Consensus 403 l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~f~~~~~~~ 461 (518)
+. .+.+||.|..... +.++|+++.....+....+.+ ..+... ..-|.||+|.|
T Consensus 268 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05615 268 LENREIQPPFKPKVCGK-GAENFDKFFTRGQPVLTPPDQ-----LVIANIDQADFEGFSYVN 323 (323)
T ss_pred HhcCCCCcCccCccCCC-chhhcCccccccCCCCCCCcc-----cccccccccccCCCcccC
Confidence 86 4779999987664 588888876544332211111 112222 34788888864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-54 Score=441.95 Aligned_cols=316 Identities=37% Similarity=0.689 Sum_probs=264.1
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHH---HhCCCceeEEEEEeecCCeEEEE
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA---EVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~---~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
|++++.||+|+||.||+|+++.+|+.||||++++.........+.+..|+.++. .++||||++++++|.+...+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999998876555566677888887764 56799999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||++||+|..++. .+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 155 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---- 155 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC----
Confidence 99999999998874 4679999999999999999999999999999999999999999999999999987432100
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
....+.+||+.|+|||++.+..|+.++|||||||+
T Consensus 156 ---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i 190 (324)
T cd05589 156 ---------------------------------------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVL 190 (324)
T ss_pred ---------------------------------------------CcccccccCccccCHhHhcCCCCCcccchhhHHHH
Confidence 01125689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCcc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~ 401 (518)
+|||++|.+||.+.+.......+... ...+|. .+++++.+||.+||. ||.+|+++. ++.++++||||++++|.
T Consensus 191 l~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 191 IYEMLVGESPFPGDDEEEVFDSIVND--EVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 99999999999998888888777763 344553 689999999999998 999999754 79999999999999999
Q ss_pred ccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceee
Q 010116 402 KLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 402 ~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
.+. .+.+|+.|.+....|.++|..-.....+..+... +...+.+..+..|.+|+|.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05589 267 DLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVLTPPR---EPRLLTEEEQELFRGFDYV 324 (324)
T ss_pred HHHhCCCCcCccCCCCCcchhhhcCccccccccccCCCc---cccccchhhhcccCCcccC
Confidence 874 5778999999999999988753333222221111 1222234567789999883
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=442.20 Aligned_cols=282 Identities=41% Similarity=0.747 Sum_probs=250.1
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG 171 (518)
++||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+++.++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998876555566777889999999999999999999999999999999999999
Q ss_pred chHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccccc
Q 010116 172 DMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (518)
Q Consensus 172 ~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~ 251 (518)
+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----------- 149 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----------- 149 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-----------
Confidence 999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhC
Q 010116 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331 (518)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 331 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 150 --------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g 191 (323)
T cd05595 150 --------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (323)
T ss_pred --------------------------------------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC
Confidence 011246799999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccccc--cc
Q 010116 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EM 406 (518)
Q Consensus 332 ~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~l~--~~ 406 (518)
+.||.+.+.......+.. ....+|. .+++++++||.+||. ||.+|++.. ++.++++||||.+++|..+. .+
T Consensus 192 ~~Pf~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~ 267 (323)
T cd05595 192 RLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 267 (323)
T ss_pred CCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 999999888777777765 3455564 689999999999998 999998643 79999999999999999886 46
Q ss_pred cCCccccCCCcccCCCCCCC
Q 010116 407 EAAFKPEINGELDTQNFMKF 426 (518)
Q Consensus 407 ~~p~~p~~~~~~d~~~f~~~ 426 (518)
.||+.|.+..+.+++.|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~ 287 (323)
T cd05595 268 LPPFKPQVTSEVDTRYFDDE 287 (323)
T ss_pred CCCcCCCCCChhhhhhcCcc
Confidence 78999999999999988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=442.59 Aligned_cols=313 Identities=34% Similarity=0.633 Sum_probs=255.0
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
++||+|+||.||+|+++.+++.||+|++++...........+..|+.++..+ +||||++++++|.+...+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999887655555677788999999988 799999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----------- 149 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----------- 149 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998742110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
.....+.+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 150 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 191 (329)
T cd05588 150 --------------------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191 (329)
T ss_pred --------------------------------------CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH
Confidence 001225689999999999999999999999999999999999
Q ss_pred CCCCCCCCC--------h-hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC---ChhhhhcCccccc
Q 010116 331 GYPPFYADD--------P-ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG---GAHQIKAHPWFKD 397 (518)
Q Consensus 331 G~~PF~~~~--------~-~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~---~a~eil~Hpff~~ 397 (518)
|+.||.... . ......+.. ..+.+|. .+++++++||++||. ||.+|+++. +++++++||||+.
T Consensus 192 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 192 GRSPFDIVGMSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCCCcccccccccccccchHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999996311 1 112333333 3455554 689999999999998 999999652 5899999999999
Q ss_pred CCccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeC
Q 010116 398 VVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461 (518)
Q Consensus 398 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 461 (518)
++|..+. ...||+.|.+....+..+|......+.......... .+....+..|.||.|.|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~~~~~~~~~~~ 329 (329)
T cd05588 268 IDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDDPD----VIARIDQSEFEGFEYIN 329 (329)
T ss_pred CCHHHHHhCCCCCCccccCCCcchhhhcCCccccCccccCCCCcc----ccccccccccCCCcccC
Confidence 9999885 467889999988888888875433332221111111 11123346888998865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-54 Score=441.34 Aligned_cols=312 Identities=35% Similarity=0.640 Sum_probs=255.7
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
+.||+|+||+||+|+.+.+++.||+|++.+...........+..|+.++..+ +||+|++++++|++...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999887665556677889999999888 699999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.....+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---------- 150 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---------- 150 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987431100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
....+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~ 191 (327)
T cd05617 151 ---------------------------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA 191 (327)
T ss_pred ---------------------------------------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHh
Confidence 01225689999999999999999999999999999999999
Q ss_pred CCCCCCCCC------h-hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC---ChhhhhcCcccccCC
Q 010116 331 GYPPFYADD------P-ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG---GAHQIKAHPWFKDVV 399 (518)
Q Consensus 331 G~~PF~~~~------~-~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~---~a~eil~Hpff~~i~ 399 (518)
|.+||.... . ......+.. ....+|. .+|..+++||.+||. ||.+|+++. ++++|+.||||++++
T Consensus 192 g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 192 GRSPFDIITDNPDMNTEDYLFQVILE--KPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred CCCCCCccCCCcccccHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 999996421 1 223333333 3445554 689999999999998 999999652 678999999999999
Q ss_pred ccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCC-CCCcccCceeeC
Q 010116 400 WDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTP-KDLSFVGYTYKN 461 (518)
Q Consensus 400 w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~~~~~~~ 461 (518)
|+.+. ...+||.|.+....+.++|+.-...++...+.... .++.. ....|.||.|+|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 327 (327)
T cd05617 268 WDLLEKKQVTPPFKPQITDDYGLENFDTQFTSEPVQLTPDDE-----DVIKRIDQSEFEGFEYIN 327 (327)
T ss_pred HHHHHhCCCCCCccCCCCCCcchhhcCCccccCcccCCCCCc-----cccccccccccCCCcCCC
Confidence 99885 57789999999888889987543333222211111 11222 334788888865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=441.05 Aligned_cols=316 Identities=39% Similarity=0.717 Sum_probs=260.0
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHH-HHHHhCCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
+.||+|+||+||+|+++.+|+.||||++.+...........+..|+. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765554455556666665 45789999999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~----------- 149 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH----------- 149 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998743110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
.......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 150 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 191 (323)
T cd05575 150 --------------------------------------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191 (323)
T ss_pred --------------------------------------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhc
Confidence 001124679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC-ChhhhhcCcccccCCccccc--cc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG-GAHQIKAHPWFKDVVWDKLY--EM 406 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~-~a~eil~Hpff~~i~w~~l~--~~ 406 (518)
|.+||.+.+....+..+... .+.++ ..+++++.+||.+||+ ||.+|++.. .+.+++.||||+.++|..+. .+
T Consensus 192 g~~pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~ 267 (323)
T cd05575 192 GLPPFYSRDTAEMYDNILNK--PLRLK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKI 267 (323)
T ss_pred CCCCCCCCCHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccC
Confidence 99999998888888888763 33444 3679999999999998 999999653 56899999999999999886 57
Q ss_pred cCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCCc-ccccCCCCCCcccCceee
Q 010116 407 EAAFKPEINGELDTQNFMK-FDELDPPASGRTSSGPS-RKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 407 ~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~f~~~~~~ 460 (518)
.+|+.|.+....+.++|+. +.+...+.+...+..+. ........+..|.||+|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05575 268 TPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFLGFSYA 323 (323)
T ss_pred CCCcCCCCCCcchhhhcCccccccccccccCCCcccccccccccccccccCCCccC
Confidence 8999999988888888875 33222222111111111 111234678899999983
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-54 Score=438.61 Aligned_cols=312 Identities=36% Similarity=0.674 Sum_probs=259.6
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
++||+|+||+||+|++..+++.||||++++.........+....|+.++..+ +||||++++++|.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999877555555566667788787754 899999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---------- 150 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 191 (316)
T cd05592 151 ---------------------------------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191 (316)
T ss_pred ---------------------------------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh
Confidence 01225689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccc--ccc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLY--EME 407 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~--~~~ 407 (518)
|..||.+.+.......+.. ....+| ..++.++.+||.+||. ||.+|++. +.+++.||||+.++|..+. ...
T Consensus 192 G~~Pf~~~~~~~~~~~i~~--~~~~~~--~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~ 265 (316)
T cd05592 192 GQSPFHGEDEDELFDSILN--DRPHFP--RWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIP 265 (316)
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCC--CCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCC
Confidence 9999999888887777765 233444 3689999999999998 99999942 4689999999999999875 578
Q ss_pred CCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCC
Q 010116 408 AAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNF 462 (518)
Q Consensus 408 ~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 462 (518)
|||.|......+..+|+..........+... ...+.+.....|.||.|.|+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05592 266 PPFKPKVKSPSDASNFDREFTNEKVRLSPVD----KKLLASMDQEQFRGFSFTNP 316 (316)
T ss_pred CCcCCCCCCcchhhhcCcccccccccCCCcc----ccccccccccccCCCcccCc
Confidence 8999999999999999864433322222111 11222334568999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-55 Score=455.97 Aligned_cols=261 Identities=31% Similarity=0.568 Sum_probs=240.8
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
-...-|++++.||.|+-|.|.+|++..||+..|||++.+.......+...+.+|+-||+.+.||||++||++|++..++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 34577999999999999999999999999999999999886566667778999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
+|+||++||.|+++|.++++++|.+|+.|+.||+.|+.|+|..+|+||||||+|+|||..+.|||+|||+|..-..+
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--- 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--- 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999753211
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-Cccccccch
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSL 321 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSl 321 (518)
++..+-||+|.|.|||++.+.+| |.++||||.
T Consensus 166 -----------------------------------------------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSC 198 (786)
T KOG0588|consen 166 -----------------------------------------------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSC 198 (786)
T ss_pred -----------------------------------------------ccccccCCCcccCCchhhcCCCCCCCccccchh
Confidence 24457899999999999999999 899999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
|||||.||+|..||.+++-...+.++.. +.+..| ..+|++|+|||++||. ||..|+ +.+||++|||+.+..-
T Consensus 199 GVILfALLtG~LPFdDdNir~LLlKV~~--G~f~MP--s~Is~eaQdLLr~ml~VDp~~Ri---T~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 199 GVILFALLTGKLPFDDDNIRVLLLKVQR--GVFEMP--SNISSEAQDLLRRMLDVDPSTRI---TTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHc--CcccCC--CcCCHHHHHHHHHHhccCccccc---cHHHHhhCchhhcCCC
Confidence 9999999999999999999888888877 566777 4799999999999998 999999 8999999999998653
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-54 Score=440.49 Aligned_cols=316 Identities=39% Similarity=0.686 Sum_probs=261.5
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHH-HHHHhCCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
+.||+|+||+||+|+++.+|+.||||++.+...........+..|+. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765544445556666665 46778999999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---------- 150 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---------- 150 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 191 (325)
T cd05604 151 ---------------------------------------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY 191 (325)
T ss_pred ---------------------------------------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc
Confidence 01125689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC-ChhhhhcCcccccCCccccc--cc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG-GAHQIKAHPWFKDVVWDKLY--EM 406 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~-~a~eil~Hpff~~i~w~~l~--~~ 406 (518)
|.+||.+.+....+.++... .+.++ ..++..+.+||++||. ||.+|++.. ++.+|+.||||++++|..+. .+
T Consensus 192 G~~pf~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~ 267 (325)
T cd05604 192 GLPPFYCRDVAEMYDNILHK--PLVLR--PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKI 267 (325)
T ss_pred CCCCCCCCCHHHHHHHHHcC--CccCC--CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCC
Confidence 99999999888888888763 33343 3589999999999998 999999754 67899999999999999886 46
Q ss_pred cCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCC-cccccCCCCCCcccCceee
Q 010116 407 EAAFKPEINGELDTQNFMK-FDELDPPASGRTSSGP-SRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 407 ~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~f~~~~~~ 460 (518)
.+|+.|.+....|.++|+. +.+...+.+...++.+ .........+..|.||+|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (325)
T cd05604 268 PPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYA 323 (325)
T ss_pred CCCcCCcCCCcchhhhcCCccccCCcccCcccccccccccccccccccccCCCEec
Confidence 7899999999999999985 3333333222211111 1111233568899999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-54 Score=438.19 Aligned_cols=314 Identities=42% Similarity=0.793 Sum_probs=254.9
Q ss_pred CeeEEeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeE
Q 010116 87 DFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~l 161 (518)
+|++++.||+|+||.||+|++. .+++.||+|++.+..... ....+++..|+.++..+ +||+|++++++|.++..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 578999999998765432 23456788999999999 589999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 320 (518)
.....+.+||+.|+|||++.+. .++.++||||
T Consensus 160 -----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 192 (332)
T cd05614 160 -----------------------------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS 192 (332)
T ss_pred -----------------------------------------------CCccccccCCccccCHHHhcCCCCCCCcccccc
Confidence 0112356899999999999875 5899999999
Q ss_pred hhHHHHHHHhCCCCCCCCCh----hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCc
Q 010116 321 LGAIMYEMLVGYPPFYADDP----ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHP 393 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hp 393 (518)
|||++|||++|..||..... ......+.. ....+| ..+++.+++||.+||. ||.+|++.. +++++++||
T Consensus 193 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 193 LGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred chhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 99999999999999975432 223333333 223333 4689999999999998 999999776 899999999
Q ss_pred ccccCCccccc--cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCCcccccCCCCCCcccCceee
Q 010116 394 WFKDVVWDKLY--EMEAAFKPEINGELDTQNFMK-FDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 394 ff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
||++++|..+. ...+||.|......|..+|.. +....+... ..+..+ .....|.||+|.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~ 330 (332)
T cd05614 269 FFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYS-PAGTPP-------SGARVFQGYSFV 330 (332)
T ss_pred CcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccC-CCCCCc-------ccccccCCceec
Confidence 99999999875 578899999998888888864 333322221 111111 224478899885
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-56 Score=412.13 Aligned_cols=259 Identities=39% Similarity=0.620 Sum_probs=240.9
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
...+.+||++.+.||+|-||.||+|+.+.++-.||+|++.|+.+...+-...+++|++|-+.++||||.++|++|.|+..
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 45678999999999999999999999999999999999999998777777779999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 161 LYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~--~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
+||++||.++|+|+..|. +...++|..+..|+.|++.||.|+|..+||||||||+|+|++..|.+||+|||.+...++
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999999998 667899999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
+ .-.+.|||.+|.+||+..+.+++..+|+
T Consensus 177 ~---------------------------------------------------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~ 205 (281)
T KOG0580|consen 177 N---------------------------------------------------KRKTLCGTLDYLPPEMVEGRGHDKFVDL 205 (281)
T ss_pred C---------------------------------------------------CceeeecccccCCHhhcCCCCccchhhH
Confidence 1 1237899999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|++|++.||+++|.+||.+.+..+++++|.. ..+.+| +.+|.+|+|||.+||. +|.+|+ ...|++.|||...
T Consensus 206 w~lgvl~yeflvg~ppFes~~~~etYkrI~k--~~~~~p--~~is~~a~dlI~~ll~~~p~~r~---~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 206 WSLGVLCYEFLVGLPPFESQSHSETYKRIRK--VDLKFP--STISGGAADLISRLLVKNPIERL---ALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--ccccCC--cccChhHHHHHHHHhccCccccc---cHHHHhhhHHHHh
Confidence 9999999999999999999999999999987 467777 5899999999999998 999999 8999999999864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-54 Score=436.37 Aligned_cols=311 Identities=34% Similarity=0.654 Sum_probs=256.1
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
++||+|+||.||+|+++.+|+.||+|++++..............|..++... +||+|++++++|.+.+++|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999876554445566677888888764 899999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.....+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987421100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~ 191 (316)
T cd05620 151 ---------------------------------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191 (316)
T ss_pred ---------------------------------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh
Confidence 01225689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccc--ccc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLY--EME 407 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~--~~~ 407 (518)
|..||.+.+.......+.. ....+|. .++.++++||.+||. ||.+|++. ++++++||||++++|..+. ...
T Consensus 192 g~~Pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~ 265 (316)
T cd05620 192 GQSPFHGDDEDELFESIRV--DTPHYPR--WITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELD 265 (316)
T ss_pred CCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCC
Confidence 9999999888777777655 3344553 589999999999998 99999932 3689999999999999875 577
Q ss_pred CCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeC
Q 010116 408 AAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461 (518)
Q Consensus 408 ~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 461 (518)
+|+.|.+....+..+|+.-.....+..+.. ......+..+..|.||.|.+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05620 266 PPFKPKVKSPSDYSNFDREFLSEKPRLSYS----DKNLIDSMDQSAFAGFSFIN 315 (316)
T ss_pred CCcCCCCCCcchhhhcCccccccCcccCCC----cccccccccccCcCCCcccC
Confidence 899999998888888875322222221111 11111223345889998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-54 Score=436.10 Aligned_cols=308 Identities=38% Similarity=0.703 Sum_probs=260.4
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
+.||+|+||+||+|+++.+++.||||++++...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999987665566677788899999888 699999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------- 150 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---------- 150 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987421110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+||+.|+|||++.+..|+.++|+|||||++|+|++
T Consensus 151 ---------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~ 191 (318)
T cd05570 151 ---------------------------------------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA 191 (318)
T ss_pred ---------------------------------------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh
Confidence 01224679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCCh-----hhhhcCcccccCCccccc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA-----HQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a-----~eil~Hpff~~i~w~~l~ 404 (518)
|..||.+.+.......+.. ....+|. .+++++++||.+||. ||.+|+ ++ .+++.||||+.++|..+.
T Consensus 192 G~~pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~dP~~R~---s~~~~~~~~ll~~~~~~~~~~~~~~ 264 (318)
T cd05570 192 GQSPFEGDDEDELFQSILE--DEVRYPR--WLSKEAKSILKSFLTKNPEKRL---GCLPTGEQDIKGHPFFREIDWDKLE 264 (318)
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHccCCHHHcC---CCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 9999998888777777765 3445553 689999999999998 999999 66 999999999999998765
Q ss_pred --cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCcee
Q 010116 405 --EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTY 459 (518)
Q Consensus 405 --~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ 459 (518)
.+.+|+.|.+....+.++|+.-...+.+..+.. ....+.+..+..|.||+|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 317 (318)
T cd05570 265 RKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPP----DEAIIRNIDQEEFRGFSY 317 (318)
T ss_pred hCCCCCCcCCCCCCcchhhhcCchhccCcccCCCC----cccccccccccccCCCCC
Confidence 578999999999999999874322222221111 111223345678999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=428.34 Aligned_cols=277 Identities=32% Similarity=0.603 Sum_probs=234.9
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|++++.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++|++|++++++|.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987665544455667889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 167 y~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|++||+|..++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence 99999999888543 469999999999999999999999999999999999999999999999999987642110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
.....+||+.|+|||++.+..|+.++|||||||+
T Consensus 157 ----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvi 190 (285)
T cd05631 157 ----------------------------------------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCL 190 (285)
T ss_pred ----------------------------------------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHH
Confidence 0124579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC--CChhhhhcCcccccCCcc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT--GGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~--~~a~eil~Hpff~~i~w~ 401 (518)
+|||++|++||.+.+.......+.........+....+|+++.+||++||. ||.+|++. .+++++++||||.+++|+
T Consensus 191 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 191 IYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred HHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 999999999998765433222222211111222224689999999999998 99999964 269999999999999999
Q ss_pred ccc--cccCCcccc
Q 010116 402 KLY--EMEAAFKPE 413 (518)
Q Consensus 402 ~l~--~~~~p~~p~ 413 (518)
.+. .++|||+|+
T Consensus 271 ~~~~~~~~~~~~~~ 284 (285)
T cd05631 271 RLEANMLEPPFCPD 284 (285)
T ss_pred HHHhCcCCcCCCCC
Confidence 997 478999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=434.43 Aligned_cols=309 Identities=36% Similarity=0.667 Sum_probs=258.5
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
+.||+|+||+||+|+++.+++.||||++++..............|..++... +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544445556677788888764 899999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
....+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 191 (316)
T cd05619 151 ---------------------------------------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191 (316)
T ss_pred ---------------------------------------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 01125679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh-hhhcCcccccCCccccc--cc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH-QIKAHPWFKDVVWDKLY--EM 406 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~-eil~Hpff~~i~w~~l~--~~ 406 (518)
|..||.+.+.......+... ...+|. .++.++++||.+||+ ||.+|+ ++. +++.||||+.++|..+. ..
T Consensus 192 G~~pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~~P~~R~---~~~~~l~~h~~~~~~~~~~~~~~~~ 264 (316)
T cd05619 192 GQSPFHGHDEEELFQSIRMD--NPCYPR--WLTREAKDILVKLFVREPERRL---GVKGDIRQHPFFREIDWSALEEREI 264 (316)
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHhccCHhhcC---CChHHHHcCcccCCCCHHHHHhCCC
Confidence 99999998887777776542 334443 589999999999998 999999 564 89999999999999875 57
Q ss_pred cCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCc-ccCceeeC
Q 010116 407 EAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLS-FVGYTYKN 461 (518)
Q Consensus 407 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-f~~~~~~~ 461 (518)
++|+.|.+....+.++|++-.....+..... .+.++++.+.+ |.||+|.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05619 265 EPPFKPKVKSANDCSNFDKEFLNEKPRLSVT-----DRMLINSMDQNMFENFSFIN 315 (316)
T ss_pred CCCcCCCCCCccchhhcChhhhcCCcccCCC-----cccccccccccccCCCcccC
Confidence 8999999999999999987544433332211 22334445544 88888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-55 Score=437.77 Aligned_cols=268 Identities=37% Similarity=0.669 Sum_probs=232.4
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch-----------hhHHHHHHHHHHHHHhCCCcee
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR-----------GQVEHVRAERNLLAEVASHCIV 149 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~-----------~~~~~~~~E~~il~~l~hp~Iv 149 (518)
....+++|++++.||+|.||.|.+|++..+++.||||++.|...... ..++.+++|+.||+++.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 34567899999999999999999999999999999999988764322 2357899999999999999999
Q ss_pred EEEEEeecC--CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEE
Q 010116 150 KLYYSFQDT--EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKL 227 (518)
Q Consensus 150 ~l~~~f~~~--~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL 227 (518)
+|+.+..|. +.+|||+|||..|.+...=-...-+++.+||.|+..++.||+|||.+|||||||||+|+||+++|+|||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 999999764 579999999999988754433333999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhh
Q 010116 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (518)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 307 (518)
+|||.|..+..+.. .+...++ ..++|||.|+|||..
T Consensus 252 sDFGVs~~~~~~~~---------------------------------~~~d~~L-----------~~tvGTPAF~APE~c 287 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSD---------------------------------EGSDDQL-----------SRTVGTPAFFAPELC 287 (576)
T ss_pred eccceeeecccCCc---------------------------------cccHHHH-----------hhcCCCccccchHhh
Confidence 99999886532200 0011111 137999999999999
Q ss_pred cCC---CC-CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 308 LKK---GY-GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 308 ~~~---~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
.++ .| +.+.||||+||+||.|+.|..||.++...+++.+|++ .++.||....+.++++|||.+||+ ||.+|+
T Consensus 288 ~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri- 364 (576)
T KOG0585|consen 288 SGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRI- 364 (576)
T ss_pred cCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc--CcccCCCcccccHHHHHHHHHHhhcChhhee-
Confidence 872 33 7899999999999999999999999999999999998 789999988899999999999999 999999
Q ss_pred CCChhhhhcCccccc
Q 010116 383 TGGAHQIKAHPWFKD 397 (518)
Q Consensus 383 ~~~a~eil~Hpff~~ 397 (518)
++.+|+.|||...
T Consensus 365 --~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 365 --TLPDIKLHPWVTR 377 (576)
T ss_pred --ehhhheecceecc
Confidence 8999999999853
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=435.75 Aligned_cols=313 Identities=35% Similarity=0.645 Sum_probs=252.2
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
+.||+|+||+||+|+++.+++.||+|++++...........+..|..++..+ +||||++++++|.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999887555555667788899998876 899999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---------- 150 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---------- 150 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (329)
T cd05618 151 ---------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191 (329)
T ss_pred ---------------------------------------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh
Confidence 01124689999999999999999999999999999999999
Q ss_pred CCCCCCCC---------ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC---ChhhhhcCccccc
Q 010116 331 GYPPFYAD---------DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG---GAHQIKAHPWFKD 397 (518)
Q Consensus 331 G~~PF~~~---------~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~---~a~eil~Hpff~~ 397 (518)
|..||... ........+.. ....+|. .++.++++||.+||. ||.+|+++. ++.+|++||||++
T Consensus 192 g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 192 GRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CCCCCccCCCcCCcccccHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999521 11122333333 3455664 689999999999998 999999642 5789999999999
Q ss_pred CCccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeC
Q 010116 398 VVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461 (518)
Q Consensus 398 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 461 (518)
++|+.+. +..+|+.|.+.+..+..+|+.....++...........+ ......|.||.|+|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 329 (329)
T cd05618 268 VDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDDIVR----KIDQSEFEGFEYIN 329 (329)
T ss_pred CCHHHHHcCCCCcCccCCCCCcccchhcCcccccCCccCCCCcccccc----cccccccCCCcccC
Confidence 9999775 578999999988888887765322221111111111111 12335688998865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-56 Score=414.72 Aligned_cols=259 Identities=32% Similarity=0.592 Sum_probs=237.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.+.|++-.+||+|+|+.||.|.+..||+.||+|++.-..+..+ ..+.+.+|++|-+.++|||||+|..++..+.+.|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4678888999999999999999999999999999987665544 667899999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CCcEEEeecccccccCCCcc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g~vKL~DFGla~~~~~~~~ 241 (518)
+|+|.||+|..-+-.+-.++|..+-.|+.||+.||.|+|.+||||||+||+|+||.+ .--+||+|||+|..+..+
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-- 166 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-- 166 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc--
Confidence 999999999988877788999999999999999999999999999999999999964 345899999999976421
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
..+..++|||.|||||++.+.+|+..+|||+.
T Consensus 167 ------------------------------------------------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~c 198 (355)
T KOG0033|consen 167 ------------------------------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 198 (355)
T ss_pred ------------------------------------------------cccccccCCCcccCHHHhhcCCCCCcchhhhh
Confidence 13457899999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|||||-||.|++||++.+....+.+|....-.+.-|.++.+|+++++||++||. ||.+|+ ++.|+|+|||+++
T Consensus 199 GViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRI---ta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 199 GVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRI---TADEALKHPWICN 272 (355)
T ss_pred hHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhc---cHHHHhCCchhcc
Confidence 999999999999999999999999999977777777889999999999999998 999999 8999999999985
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-53 Score=434.32 Aligned_cols=282 Identities=42% Similarity=0.761 Sum_probs=248.2
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG 171 (518)
+.||+|+||.||+|+++.+|+.||+|++.+...........+..|..++..++||||++++++|.+...+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876555556677888999999999999999999999999999999999999
Q ss_pred chHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 172 DMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 172 ~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
+|..++.+...+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---------- 150 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---------- 150 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----------
Confidence 999999888899999999999999999999997 799999999999999999999999999987432110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 191 (325)
T cd05594 151 ---------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 191 (325)
T ss_pred ---------------------------------------cccccccCCcccCCHHHHccCCCCCccccccccceeeeecc
Confidence 01124579999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccccc--c
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--E 405 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~l~--~ 405 (518)
|..||.+.+.......+.. ....+|. .+++++.+||.+||+ ||.+|++.. ++.++++||||.++.|..+. .
T Consensus 192 G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~ 267 (325)
T cd05594 192 GRLPFYNQDHEKLFELILM--EEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKK 267 (325)
T ss_pred CCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCC
Confidence 9999999888777776655 3455664 689999999999998 999998542 79999999999999999885 4
Q ss_pred ccCCccccCCCcccCCCCCCC
Q 010116 406 MEAAFKPEINGELDTQNFMKF 426 (518)
Q Consensus 406 ~~~p~~p~~~~~~d~~~f~~~ 426 (518)
..+|+.|....+.++.+|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~ 288 (325)
T cd05594 268 LVPPFKPQVTSETDTRYFDEE 288 (325)
T ss_pred CCCCcCCcCCCcchhhhcCch
Confidence 668999999888888888743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-53 Score=433.29 Aligned_cols=316 Identities=37% Similarity=0.685 Sum_probs=256.4
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHH-HHHHhCCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|.. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998765544444445555554 56788999999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---------- 150 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---------- 150 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (325)
T cd05602 151 ---------------------------------------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 191 (325)
T ss_pred ---------------------------------------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc
Confidence 01225689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC-ChhhhhcCcccccCCccccc--cc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG-GAHQIKAHPWFKDVVWDKLY--EM 406 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~-~a~eil~Hpff~~i~w~~l~--~~ 406 (518)
|.+||.+.+....+..+... ...++ ..+++++++||.+||. ||.+|++.. ...++++|+||..++|+.+. ..
T Consensus 192 g~~pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 267 (325)
T cd05602 192 GLPPFYSRNTAEMYDNILNK--PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKI 267 (325)
T ss_pred CCCCCCCCCHHHHHHHHHhC--CcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCC
Confidence 99999999888888887763 33433 3689999999999998 999999654 56699999999999999986 46
Q ss_pred cCCccccCCCcccCCCCCC-CCCCCCCCCC-CCCCCCcccccCCCCCCcccCceee
Q 010116 407 EAAFKPEINGELDTQNFMK-FDELDPPASG-RTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 407 ~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
.+|+.|.+....++.+|+. +.....+.+. ..................|.||+|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~ 323 (325)
T cd05602 268 TPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVTASVKEAAEAFLGFSYA 323 (325)
T ss_pred CcCcCCCCCCcchhhhcCCccccCCcccccCCCchhhhhcccccccccccCCCccC
Confidence 7889999988888888864 3322211111 1111111111233455679999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-53 Score=431.79 Aligned_cols=313 Identities=42% Similarity=0.781 Sum_probs=257.5
Q ss_pred EeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 91 LTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
++.||+|+||.||+|+.. .+++.||+|++.+..... .....++.+|+.+|+.++||||++++++|.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 578999999998765432 2345667899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------- 153 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE------- 153 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-------
Confidence 9999999999988899999999999999999999999999999999999999999999999999998743211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
.......+||+.|+|||++.+..++.++|||||||++|
T Consensus 154 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 191 (323)
T cd05584 154 ------------------------------------------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMY 191 (323)
T ss_pred ------------------------------------------CCcccccCCCccccChhhccCCCCCCcceecccHHHHH
Confidence 00122467999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCcccc
Q 010116 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 327 eml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~l 403 (518)
||++|++||.+.+.......+.. ..+.+| ..+++++.+||.+||. ||.+|++.. ++++++.||||+..+|..+
T Consensus 192 ell~G~~pf~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~ 267 (323)
T cd05584 192 DMLTGAPPFTAENRKKTIDKILK--GKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL 267 (323)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHc--CCCCCC--CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 99999999999888888877776 344455 3689999999999998 999999643 7999999999999999988
Q ss_pred c--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeC
Q 010116 404 Y--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461 (518)
Q Consensus 404 ~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 461 (518)
. ...+|+.|......|.+.|..-.....+......+. ........|.||+|..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 322 (323)
T cd05584 268 LARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST-----LSESANQIFLGFTYVA 322 (323)
T ss_pred hcCCCCCCcCCCCCCcchhhhcCchhcccccccCccccc-----cccccccCcCCCeecC
Confidence 5 467889988888888877764222211111111111 1223357899999953
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-53 Score=429.54 Aligned_cols=282 Identities=41% Similarity=0.759 Sum_probs=244.4
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHH-HHHHhCCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
++||+|+||.||+|++..+|+.||+|++.+...........+..|+. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998766544444555666654 67889999999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---------- 150 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987421100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (321)
T cd05603 151 ---------------------------------------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY 191 (321)
T ss_pred ---------------------------------------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc
Confidence 01124689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC-ChhhhhcCcccccCCccccc--cc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG-GAHQIKAHPWFKDVVWDKLY--EM 406 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~-~a~eil~Hpff~~i~w~~l~--~~ 406 (518)
|.+||.+.+.......+.. ..+.+|. ..+.++.+||.+||. ||.+|++.. ++.++++||||..++|..+. .+
T Consensus 192 g~~pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T cd05603 192 GLPPFYSRDVSQMYDNILH--KPLQLPG--GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRI 267 (321)
T ss_pred CCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCC
Confidence 9999999888787777776 3445553 578999999999998 999999753 67799999999999999886 47
Q ss_pred cCCccccCCCcccCCCCCCC
Q 010116 407 EAAFKPEINGELDTQNFMKF 426 (518)
Q Consensus 407 ~~p~~p~~~~~~d~~~f~~~ 426 (518)
.+|+.|......+...|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~ 287 (321)
T cd05603 268 TPPYNPNVAGPADLRHFDPE 287 (321)
T ss_pred CCCcCCCCCCcchhhhcCCc
Confidence 78899988888888888753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-53 Score=434.01 Aligned_cols=280 Identities=43% Similarity=0.779 Sum_probs=244.2
Q ss_pred EeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh---CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 94 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
||+|+||+||+|+++.+|+.||+|++.+..........+...|..++... +||+|++++.+|.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999877655555566677788888766 699999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---------- 150 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---------- 150 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----------
Confidence 9999999888999999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccchhHHHHHHH
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEML 329 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml 329 (518)
......+||+.|+|||++.+. .|+.++|||||||++|+|+
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell 191 (330)
T cd05586 151 ---------------------------------------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC 191 (330)
T ss_pred ---------------------------------------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEec
Confidence 012256899999999999764 5899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC-ChhhhhcCcccccCCccccc--c
Q 010116 330 VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG-GAHQIKAHPWFKDVVWDKLY--E 405 (518)
Q Consensus 330 ~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~-~a~eil~Hpff~~i~w~~l~--~ 405 (518)
+|..||.+.+....+..+.. ....+|. ..+++++++||++||+ ||.+|+++. ++.+++.||||++++|..+. .
T Consensus 192 tG~~Pf~~~~~~~~~~~i~~--~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~ 268 (330)
T cd05586 192 CGWSPFYAEDTQQMYRNIAF--GKVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQ 268 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHc--CCCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCC
Confidence 99999999888887777765 3455554 3589999999999998 999999764 79999999999999999885 4
Q ss_pred ccCCccccCCCcccCCCCCC
Q 010116 406 MEAAFKPEINGELDTQNFMK 425 (518)
Q Consensus 406 ~~~p~~p~~~~~~d~~~f~~ 425 (518)
+.+|+.|.+....+.++|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~ 288 (330)
T cd05586 269 ITPPFKPIVDSDEDVSNFDP 288 (330)
T ss_pred CCCCccCCCCCCcchhhcCc
Confidence 77899999988888888864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=417.32 Aligned_cols=251 Identities=34% Similarity=0.577 Sum_probs=223.2
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEE-EeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY-SFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~-~f~~~~ 159 (518)
...+..+|+|+++||+|+||+||+|++..+|..+|.|.+. -.+......+.+..|+++|++++|||||+.|. .|..+.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 4556678999999999999999999999999999999998 44556666778889999999999999999998 676655
Q ss_pred e-EEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--eEEcCCCCCceeeCCCCcEEEeec
Q 010116 160 Y-LYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHK--HN--YIHRDIKPDNLLLDKNGHMKLSDF 230 (518)
Q Consensus 160 ~-lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~--~g--iiHRDIKPeNILld~~g~vKL~DF 230 (518)
. ++||||||.+|||..+++. +..++|..++.|+.|++.||..+|. .. |+||||||.||+|+.+|.|||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 9999999999999999864 4689999999999999999999999 45 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 310 (518)
||++.+... ...+.|.||||.||+||++...
T Consensus 173 GL~r~l~s~-------------------------------------------------~tfA~S~VGTPyYMSPE~i~~~ 203 (375)
T KOG0591|consen 173 GLGRFLSSK-------------------------------------------------TTFAHSLVGTPYYMSPERIHES 203 (375)
T ss_pred hhHhHhcch-------------------------------------------------hHHHHhhcCCCcccCHHHHhcC
Confidence 999987532 2346689999999999999999
Q ss_pred CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~ 383 (518)
+|+.++|||||||++|||+.-.+||++++-.+.+.+|.++ ...+.|. ..+|.++..||..|++ ||..||++
T Consensus 204 ~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~-~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 204 GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPD-EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcH-HHhhhHHHHHHHHHccCCcccCCCc
Confidence 9999999999999999999999999999999999999885 2223443 4789999999999999 99999953
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=409.15 Aligned_cols=263 Identities=33% Similarity=0.595 Sum_probs=236.9
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----KRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
..|+-.++||+|..+.|..|.++.+|+.+|+|++.-.... .....+..+.|+.||+++ .||+|++|.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4566778999999999999999999999999998532211 122345678899999998 6999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
++++|+|.|+.|.|+++|...-.++|..++.+++|++.|++|||.++||||||||+|||+|++.++||+|||+|..+..+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc------CCCCC
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------KKGYG 313 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~------~~~y~ 313 (518)
......||||+|+|||.+. ..||+
T Consensus 177 --------------------------------------------------ekLrelCGTPgYLAPEtikC~m~e~~pGYs 206 (411)
T KOG0599|consen 177 --------------------------------------------------EKLRELCGTPGYLAPETIKCSMYENHPGYS 206 (411)
T ss_pred --------------------------------------------------hhHHHhcCCCcccChhheeeecccCCCCcc
Confidence 1234689999999999996 35899
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
..+|.|++|||||-||.|.+||+.....-+++.|+.++-.+.-|++..+|.+++|||++||+ ||.+|+ +++|+++|
T Consensus 207 ~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ri---take~LaH 283 (411)
T KOG0599|consen 207 KEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRI---TAKEALAH 283 (411)
T ss_pred chhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcc---cHHHHhcC
Confidence 99999999999999999999999999999999999988888889999999999999999998 999999 89999999
Q ss_pred cccccCCcc
Q 010116 393 PWFKDVVWD 401 (518)
Q Consensus 393 pff~~i~w~ 401 (518)
|||..+--.
T Consensus 284 pff~q~~~~ 292 (411)
T KOG0599|consen 284 PFFIQIAQQ 292 (411)
T ss_pred hHHHHHHHh
Confidence 999755433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-54 Score=438.98 Aligned_cols=255 Identities=33% Similarity=0.598 Sum_probs=233.4
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|-+...||+|+||.||+++.+.|.+.||||.+.|..- ....+..+++|++|++.++|||||.++++|++..++++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 678899999999999999999999999999999988643 3345778999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|||.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.||||+..|++|+||||+|+......
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence 99976 999999999999999999999999999999999999999999999999999999999999999754221
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
...+++-|||.|||||++.+.+|+..+|.||||||+
T Consensus 155 --------------------------------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcil 190 (808)
T KOG0597|consen 155 --------------------------------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCIL 190 (808)
T ss_pred --------------------------------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHH
Confidence 134477899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|||++|+|||+..+-......|+. .+.+.|. .+|..+++||..||. ||.+|+ ++.+++.|||.++-
T Consensus 191 YE~~~G~PPF~a~si~~Lv~~I~~--d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rl---tW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 191 YELYVGQPPFYARSITQLVKSILK--DPVKPPS--TASSSFVNFLQGLLIKDPAQRL---TWTDLLGHPFWKGK 257 (808)
T ss_pred HHHhcCCCCchHHHHHHHHHHHhc--CCCCCcc--cccHHHHHHHHHHhhcChhhcc---cHHHHhcChHHhhh
Confidence 999999999999998888888887 4555554 799999999999998 999999 89999999999863
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=432.73 Aligned_cols=261 Identities=37% Similarity=0.621 Sum_probs=239.3
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~ly 162 (518)
..+.|++.+.||+|.||.||+|+++.||+.||+|++.|.........+.+.+|+.||+.+. |||||.++++|++...+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467999999999999999999999999999999999987766656788999999999998 999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC----CcEEEeecccccccCC
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN----GHMKLSDFGLCKPLDC 238 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~----g~vKL~DFGla~~~~~ 238 (518)
+|||+|.||+|++.+... .++|..+..++.|++.|+.|||+.||+||||||||+|+... +.+|++|||+++....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999877 59999999999999999999999999999999999999643 5799999999987642
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
. ......||||.|+|||++...+|+..+|+
T Consensus 192 ~--------------------------------------------------~~~~~~~Gtp~y~APEvl~~~~y~~~~Di 221 (382)
T KOG0032|consen 192 G--------------------------------------------------ERLHTIVGTPEYVAPEVLGGRPYGDEVDV 221 (382)
T ss_pred C--------------------------------------------------ceEeeecCCccccCchhhcCCCCCcccch
Confidence 1 13457899999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||+||++|.|++|.+||.+.+....+.+|....-.+.-+.+..+|..|+|||++||. ||..|+ +|.++++|||+++
T Consensus 222 WS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~---ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 222 WSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRL---TAAQALQHPWIKS 298 (382)
T ss_pred hHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCC---CHHHHhcCccccC
Confidence 999999999999999999999999999999866666666778899999999999998 999999 8999999999886
Q ss_pred C
Q 010116 398 V 398 (518)
Q Consensus 398 i 398 (518)
.
T Consensus 299 ~ 299 (382)
T KOG0032|consen 299 I 299 (382)
T ss_pred C
Confidence 4
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=408.46 Aligned_cols=259 Identities=32% Similarity=0.518 Sum_probs=221.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
+.|+.+.++|+|+||.||+|+++.||+.||||++..++. .....+-.++|+.+|++++|+|+|.|+.+|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 568899999999999999999999999999999876542 1222344689999999999999999999999999999999
Q ss_pred eecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||.. ++.+.|.+ ...++++.++.|+.|++.|+.|+|++++||||||||||||+.+|.+||||||+|+.+....
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg---- 155 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG---- 155 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc----
Confidence 99965 55555655 4789999999999999999999999999999999999999999999999999999764210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 323 (518)
..-+..|.|.+|+|||.+.+ ..|+.++||||+||
T Consensus 156 ---------------------------------------------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGC 190 (396)
T KOG0593|consen 156 ---------------------------------------------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGC 190 (396)
T ss_pred ---------------------------------------------chhhhhhhhhhccChhhhcccCcCCCcccchhhhH
Confidence 01235789999999999998 78999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCc-----------------ccCCCC----------CCCChhHHHHHHHHhc-
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNH-----------------LKFPDD----------SKLSPEAKDLICRLLC- 375 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~-----------------l~~p~~----------~~~s~~~~dLI~~lL~- 375 (518)
++.||++|.+.|.+.+.......|...-+. +.+|.. +.+|.-+.||+.+||.
T Consensus 191 v~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~ 270 (396)
T KOG0593|consen 191 VFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKM 270 (396)
T ss_pred HHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcC
Confidence 999999999999999998888777652211 223331 3578889999999998
Q ss_pred cccccCCCCChhhhhcCcccccC
Q 010116 376 DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||.+|+ +.++++.||||.++
T Consensus 271 dP~~R~---sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 271 DPDDRL---SCEQLLHHPYFDGF 290 (396)
T ss_pred Cccccc---cHHHHhcChHHHHH
Confidence 999999 88999999999653
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-52 Score=423.00 Aligned_cols=281 Identities=43% Similarity=0.756 Sum_probs=242.2
Q ss_pred EeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 91 LTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
++.||+|+||.||++++. .+|+.||+|++.+.... ......+..|+.+|+.++||||++++++|.+...+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999863 57899999999876432 22345567899999999999999999999999999999999
Q ss_pred cCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccc
Q 010116 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247 (518)
Q Consensus 168 ~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 247 (518)
++||+|.+++.+...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-------- 151 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-------- 151 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--------
Confidence 999999999988889999999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHH
Q 010116 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327 (518)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilye 327 (518)
.....+.+||+.|+|||++.+..++.++|||||||++||
T Consensus 152 -----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~e 190 (318)
T cd05582 152 -----------------------------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 190 (318)
T ss_pred -----------------------------------------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeee
Confidence 011235689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCC--hhhhhcCcccccCCccccc
Q 010116 328 MLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGG--AHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 328 ml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~--a~eil~Hpff~~i~w~~l~ 404 (518)
|++|..||...+.......+.. ..+.+|. .+++++++||++||. ||.+|+++.. +.+++.||||..++|..+.
T Consensus 191 l~tg~~p~~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T cd05582 191 MLTGSLPFQGKDRKETMTMILK--AKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLY 266 (318)
T ss_pred eccCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHH
Confidence 9999999999888887777765 3445553 689999999999998 9999995542 8889999999999999886
Q ss_pred --cccCCccccCCCcccCCCCCC
Q 010116 405 --EMEAAFKPEINGELDTQNFMK 425 (518)
Q Consensus 405 --~~~~p~~p~~~~~~d~~~f~~ 425 (518)
+..+|+.|......+..+|+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~ 289 (318)
T cd05582 267 RREIKPPFKPAVGRPDDTFYFDP 289 (318)
T ss_pred hcCCCCCcCCCCCCcchhhhcCc
Confidence 467888888877777666654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=431.88 Aligned_cols=255 Identities=32% Similarity=0.558 Sum_probs=230.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
...|....+||+|+.|.||.|+...+++.||||.+....... .+-+.+|+.+|+..+|+|||+++.+|.-.+.+++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 456888899999999999999999999999999998765433 45689999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||||+||+|.+.+. ...++|.+++.++.+++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+.+...
T Consensus 349 MEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--- 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--- 424 (550)
T ss_pred EeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC---
Confidence 99999999988884 45699999999999999999999999999999999999999999999999999998753210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
.-.+.||||.|||||++..+.|+.++||||||++
T Consensus 425 ----------------------------------------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIM 458 (550)
T KOG0578|consen 425 ----------------------------------------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIM 458 (550)
T ss_pred ----------------------------------------------ccccccCCCCccchhhhhhcccCccccchhhhhH
Confidence 1126899999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
++||+-|.|||..+++......|.. .+.+.+.....+|++++||+.+||+ |+.+|. +|.|+|.||||+
T Consensus 459 aIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ra---sA~eLL~HpFl~ 527 (550)
T KOG0578|consen 459 AIEMVEGEPPYLNENPLRALYLIAT-NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRA---SAKELLEHPFLK 527 (550)
T ss_pred HHHHhcCCCCccCCChHHHHHHHhh-cCCCCcCCccccCHHHHHHHHHHhhcchhcCC---CHHHHhcChhhh
Confidence 9999999999999999888888766 3456666667999999999999999 999999 899999999995
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-52 Score=420.68 Aligned_cols=262 Identities=31% Similarity=0.484 Sum_probs=229.2
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--C
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--E 159 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~ 159 (518)
....+.|+.+.+||+|+||.||+|++..||+.||+|++.... .+.+......+|+.||+.++||||++|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 445678999999999999999999999999999999998654 3455667788999999999999999999988766 7
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|||+|||+. ||..++... -.|++.+++.|+.||+.||+|||++||+|||||..|||||.+|.+||+|||||+.+..
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 89999999965 999999764 5899999999999999999999999999999999999999999999999999997643
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 317 (518)
.. ....++.|-|++|+|||+|++ ..|+.++|
T Consensus 271 ~~------------------------------------------------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVD 302 (560)
T KOG0600|consen 271 SG------------------------------------------------SAPYTSRVVTLWYRPPELLLGATSYGTAVD 302 (560)
T ss_pred CC------------------------------------------------CcccccceEEeeccChHHhcCCccccccee
Confidence 21 112346789999999999998 67999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhh---------hcCcccCCC-----------------CCCCChhHHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPD-----------------DSKLSPEAKDLIC 371 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---------~~~~l~~p~-----------------~~~~s~~~~dLI~ 371 (518)
+||+||||.||++|+|.|.+.+..+.+.+|.+ |. ..++|. ...+++.+.+|+.
T Consensus 303 lWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~ 381 (560)
T KOG0600|consen 303 LWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLE 381 (560)
T ss_pred ehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHH
Confidence 99999999999999999999999999999976 33 223331 1246899999999
Q ss_pred HHhc-cccccCCCCChhhhhcCccccc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
.||+ ||.+|. +|.+++.|+||..
T Consensus 382 ~lL~ldP~kR~---tA~~aL~seyF~t 405 (560)
T KOG0600|consen 382 KLLSLDPDKRG---TASSALQSEYFTT 405 (560)
T ss_pred HHhccCccccc---cHHHHhcCccccc
Confidence 9999 999999 8999999999953
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-51 Score=407.97 Aligned_cols=275 Identities=33% Similarity=0.638 Sum_probs=234.7
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|++.++||+|+||+||++.+..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999987655444445567789999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 167 y~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+++++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 99999999888653 469999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
...+.+||+.|+|||++.+..++.++||||+||+
T Consensus 157 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~ 190 (285)
T cd05605 157 ----------------------------------------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCL 190 (285)
T ss_pred ----------------------------------------------ccccccCCCCccCcHHhcCCCCCccccchhHHHH
Confidence 0114579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhc--CcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCC
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWR--NHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVV 399 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~--~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~ 399 (518)
+|||++|..||.+.+.......+.... ....++ ..+++.+++||.+||. ||.+|+++. ++++++.||||...+
T Consensus 191 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 191 IYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 999999999998866544333332211 122233 3589999999999998 999999876 899999999999999
Q ss_pred ccccc--cccCCcccc
Q 010116 400 WDKLY--EMEAAFKPE 413 (518)
Q Consensus 400 w~~l~--~~~~p~~p~ 413 (518)
|.++. .+.|||.|.
T Consensus 269 ~~~~~~~~~~~~~~~~ 284 (285)
T cd05605 269 FKRLEAGMLEPPFCPD 284 (285)
T ss_pred HHHHhhCCCCCCCCCC
Confidence 99986 477889884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=412.08 Aligned_cols=256 Identities=31% Similarity=0.606 Sum_probs=236.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
..+|++.+.||+|+||+|-+|.+...|+.||||.|+|+.+......-++++|++||..++||||+.+|.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999999999999999999999998888899999999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||..||+|++|+...+.|+|.+++.+++||+.|+.|+|+++++|||||.+|||||.++++||+||||+..+..
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~------ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD------ 205 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876532
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-CccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGv 323 (518)
.+...++||+|-|.+||++.+.+| +..+|.|||||
T Consensus 206 --------------------------------------------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGv 241 (668)
T KOG0611|consen 206 --------------------------------------------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGV 241 (668)
T ss_pred --------------------------------------------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHH
Confidence 234558999999999999999999 89999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
+||-|+.|..||.+.+...+.++|..+ ...-|. -+.+|.-||+.||. ||+.|. ++++|..|-|. +|.
T Consensus 242 LLYtLVyGtMPFDG~Dhk~lvrQIs~G--aYrEP~---~PSdA~gLIRwmLmVNP~RRA---TieDiAsHWWv---Nwg 309 (668)
T KOG0611|consen 242 LLYTLVYGTMPFDGRDHKRLVRQISRG--AYREPE---TPSDASGLIRWMLMVNPERRA---TIEDIASHWWV---NWG 309 (668)
T ss_pred HHHHHhhcccccCCchHHHHHHHhhcc--cccCCC---CCchHHHHHHHHHhcCcccch---hHHHHhhhhee---ecc
Confidence 999999999999999999999999763 333332 46789999999998 999999 89999999886 464
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=405.01 Aligned_cols=268 Identities=35% Similarity=0.655 Sum_probs=226.0
Q ss_pred EeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010116 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (518)
Q Consensus 94 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L 173 (518)
||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+++.++||||++++++|.+...+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999877655555567788899999999999999999999999999999999999999
Q ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccc
Q 010116 174 MTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (518)
Q Consensus 174 ~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 249 (518)
..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 888743 3579999999999999999999999999999999999999999999999999987653210
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHH
Q 010116 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329 (518)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 329 (518)
.......||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 152 ----------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 191 (280)
T cd05608 152 ----------------------------------------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191 (280)
T ss_pred ----------------------------------------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHH
Confidence 0112457999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhh--cCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccccc
Q 010116 330 VGYPPFYADDPITTCRKIVHW--RNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 330 ~G~~PF~~~~~~~~~~~i~~~--~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~l~ 404 (518)
+|+.||...........+... .....+| ..+|+++.+||.+||. ||.+|++.. +++++++||||++++|..+.
T Consensus 192 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 269 (280)
T cd05608 192 AARGPFRARGEKVENKELKQRILNDSVTYP--DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLE 269 (280)
T ss_pred hCCCCCCCCCcchhHHHHHHhhcccCCCCc--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHh
Confidence 999999875432222222211 1223333 3689999999999998 999999653 68999999999999999885
Q ss_pred c--ccCCccc
Q 010116 405 E--MEAAFKP 412 (518)
Q Consensus 405 ~--~~~p~~p 412 (518)
. ..+||.|
T Consensus 270 ~~~~~~~~~~ 279 (280)
T cd05608 270 AGMLPPPFVP 279 (280)
T ss_pred hccCCCCCCC
Confidence 3 6677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=409.36 Aligned_cols=259 Identities=35% Similarity=0.577 Sum_probs=219.7
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC--eEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE--YLY 162 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~--~ly 162 (518)
..++...+.||+|+||.||++....+|..+|||.+.... ....+.+.+|+.+|.+++|||||+.++.....+ .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 356888899999999999999999999999999987652 122677899999999999999999999755444 699
Q ss_pred EEEeecCCCchHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-CCcEEEeecccccccCCCc
Q 010116 163 LIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~-~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-~g~vKL~DFGla~~~~~~~ 240 (518)
+.|||++||+|.+++.+.+ .|+|..++.|.+|++.||.|||++|||||||||+|||++. +|.+||+|||+++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998876 8999999999999999999999999999999999999999 7999999999998764200
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC--Cccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY--GMECDW 318 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y--~~~~Di 318 (518)
. ......+..|||.|||||++.. ++ +.++||
T Consensus 173 ~----------------------------------------------~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDi 205 (313)
T KOG0198|consen 173 T----------------------------------------------KSDSELSVQGTPNYMAPEVIRN-GEVARRESDI 205 (313)
T ss_pred c----------------------------------------------cccccccccCCccccCchhhcC-CCcCCccchh
Confidence 0 0011236789999999999997 43 349999
Q ss_pred cchhHHHHHHHhCCCCCCC-CChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 319 WSLGAIMYEMLVGYPPFYA-DDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
|||||++.||+||.+||.. .........|......+.+|. .+|++++|||.+|+. ||.+|+ +|.+++.|||.+
T Consensus 206 WSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~--~ls~~a~~Fl~~C~~~~p~~Rp---ta~eLL~hpf~~ 280 (313)
T KOG0198|consen 206 WSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPD--SLSDEAKDFLRKCFKRDPEKRP---TAEELLEHPFLK 280 (313)
T ss_pred hhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHhhcCcccCc---CHHHHhhChhhh
Confidence 9999999999999999987 555555566655333445554 699999999999998 999999 999999999997
Q ss_pred cC
Q 010116 397 DV 398 (518)
Q Consensus 397 ~i 398 (518)
..
T Consensus 281 ~~ 282 (313)
T KOG0198|consen 281 QN 282 (313)
T ss_pred cc
Confidence 53
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-52 Score=418.52 Aligned_cols=257 Identities=32% Similarity=0.523 Sum_probs=223.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCC-eEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTE-YLY 162 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~-~ly 162 (518)
.++|.++++||.|+||.||+|+.+.+|..||||.|++.-. ..++. .-.+|+.-|++++ |||||+|.+++.+.+ .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4689999999999999999999999999999999987532 22222 2357899999998 999999999999888 999
Q ss_pred EEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 163 LIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
+||||| ..+|+.+++.+ ..|+|..++.|+.||+.||+|+|++|+.||||||||||+.....|||+|||||+.+.+..
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp- 164 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP- 164 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC-
Confidence 999999 56999999654 789999999999999999999999999999999999999989999999999999875432
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 320 (518)
.-+..|-|.+|+|||+|+.. -|+.++|+|+
T Consensus 165 -------------------------------------------------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA 195 (538)
T KOG0661|consen 165 -------------------------------------------------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWA 195 (538)
T ss_pred -------------------------------------------------CcchhhhcccccchHHhhhccccCCchHHHH
Confidence 12357899999999999874 5799999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhc-----------------CcccCCCC---------CCCChhHHHHHHHHh
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWR-----------------NHLKFPDD---------SKLSPEAKDLICRLL 374 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~-----------------~~l~~p~~---------~~~s~~~~dLI~~lL 374 (518)
+|||++|+.+-+|.|.|.+..+.+.+|..-. ..+.||.. +..++++.+||.+||
T Consensus 196 ~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll 275 (538)
T KOG0661|consen 196 VGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLL 275 (538)
T ss_pred HHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHh
Confidence 9999999999999999999999988886521 23444442 246899999999999
Q ss_pred c-cccccCCCCChhhhhcCccccc
Q 010116 375 C-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
. ||.+|+ +|.++++||||..
T Consensus 276 ~WDP~kRp---TA~~al~~pffq~ 296 (538)
T KOG0661|consen 276 AWDPDKRP---TASQALQHPFFQV 296 (538)
T ss_pred cCCCccCc---cHHHHhcCccccc
Confidence 9 999999 9999999999974
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=399.97 Aligned_cols=285 Identities=48% Similarity=0.919 Sum_probs=256.5
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|.+++.+...+++..+..++.|++.||.|||+.||+||||+|+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999988899999999999999999999999999999999999999999999999999998764311
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
....+||+.|+|||.+.+..++.++|+||||+++
T Consensus 155 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 188 (290)
T cd05580 155 ----------------------------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188 (290)
T ss_pred ----------------------------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHH
Confidence 1135799999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~ 402 (518)
|+|++|..||...+......++.. ....+|. .+++.++++|.+||+ ||.+|+++. +++++++||||+.++|..
T Consensus 189 ~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 264 (290)
T cd05580 189 YEMLAGYPPFFDDNPIQIYEKILE--GKVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264 (290)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhc--CCccCCc--cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence 999999999998887777777764 3445554 579999999999998 999999765 899999999999999999
Q ss_pred cc--cccCCccccCCCcccCCCCCCC
Q 010116 403 LY--EMEAAFKPEINGELDTQNFMKF 426 (518)
Q Consensus 403 l~--~~~~p~~p~~~~~~d~~~f~~~ 426 (518)
+. .+.+|+.|......|++.|+.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (290)
T cd05580 265 LLQRKIEAPFIPKVKGPGDTSNFDDY 290 (290)
T ss_pred HhhccCCCCccCCCCCccccccccCC
Confidence 86 5889999999988898888753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=399.36 Aligned_cols=275 Identities=35% Similarity=0.678 Sum_probs=231.3
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++|++|+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999987655444445667889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 167 y~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 99999999988543 469999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
...+.+||+.|+|||++.+..++.++|+|||||+
T Consensus 157 ----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~ 190 (285)
T cd05630 157 ----------------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL 190 (285)
T ss_pred ----------------------------------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHH
Confidence 0113579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChh---hHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccC
Q 010116 325 MYEMLVGYPPFYADDPI---TTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDV 398 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~---~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i 398 (518)
+|+|++|.+||...... .....+... ....++ ..+++++++||.+||+ ||.+|++.. +++|+++||||+.+
T Consensus 191 l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 191 LYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYS--EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcC--ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999875432 122222221 111233 3588999999999999 999999532 39999999999999
Q ss_pred Ccccccc--ccCCccccC
Q 010116 399 VWDKLYE--MEAAFKPEI 414 (518)
Q Consensus 399 ~w~~l~~--~~~p~~p~~ 414 (518)
+|..+.. ..|||+|.+
T Consensus 268 ~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 268 NFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred CHHHHhcCCCCCCCCCCC
Confidence 9998864 778999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-50 Score=399.35 Aligned_cols=269 Identities=28% Similarity=0.457 Sum_probs=233.3
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
..+.+..++|++..+||.|..++||+|+...++.+||||++.-.... ..++.+++|...|+.++||||++.+.+|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 34677889999999999999999999999999999999999876543 3478899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
..+|+||.||.+|++.+++... ..+.|..++.++++++.||.|||++|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999763 67999999999999999999999999999999999999999999999999998765
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGM 314 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~ 314 (518)
..+.. ..+....+++|||.|||||++.. .||+.
T Consensus 177 ~~~G~---------------------------------------------R~~~rf~tfvgtp~wmAPEvl~q~~~GYdf 211 (516)
T KOG0582|consen 177 FDSGD---------------------------------------------RQVTRFNTFVGTPCWMAPEVLMQQLHGYDF 211 (516)
T ss_pred cccCc---------------------------------------------eeeEeeccccCcccccChHHhhhcccCccc
Confidence 32210 00111257899999999999764 78999
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCC--------CCCCCChhHHHHHHHHhc-cccccCCCCC
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFP--------DDSKLSPEAKDLICRLLC-DVEHRLGTGG 385 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p--------~~~~~s~~~~dLI~~lL~-dp~~R~g~~~ 385 (518)
++||||||++..||.+|..||....+.+++..-++. .++.+ ....++..++.+|..||. ||.+|+ +
T Consensus 212 KaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn--~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp---t 286 (516)
T KOG0582|consen 212 KADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN--DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRP---T 286 (516)
T ss_pred hhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC--CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCC---C
Confidence 999999999999999999999998888877666553 33222 233567889999999998 999999 8
Q ss_pred hhhhhcCcccccCC
Q 010116 386 AHQIKAHPWFKDVV 399 (518)
Q Consensus 386 a~eil~Hpff~~i~ 399 (518)
|+++++|+||+...
T Consensus 287 AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 287 ASKLLKHAFFKKAK 300 (516)
T ss_pred HHHHhccHHHhhcc
Confidence 99999999998764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=390.67 Aligned_cols=262 Identities=31% Similarity=0.488 Sum_probs=225.3
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee--cCCe
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DTEY 160 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~--~~~~ 160 (518)
-.++.|+.+..|++|+||.||.|+++.|++.||+|+++... .+.+.--...+|+++|.+++|||||.+-.+.. +-+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 35678999999999999999999999999999999997654 33344445678999999999999999988775 3457
Q ss_pred EEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+|||||||. -||..++..- .+|...+++.++.|++.||+|||.+.|+||||||+|+|+...|.+||+|||||+.+...
T Consensus 152 iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 152 IYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999999995 4999999765 48999999999999999999999999999999999999999999999999999987532
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 318 (518)
. +..+..|-|.+|+|||+|++ ..|+.++|+
T Consensus 231 ~-------------------------------------------------k~~T~lVVTLWYRaPELLLG~~tyst~iDM 261 (419)
T KOG0663|consen 231 L-------------------------------------------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDM 261 (419)
T ss_pred c-------------------------------------------------ccCcceEEEeeecCHHHhcCCcccCcchhh
Confidence 1 22346789999999999998 569999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhh---------hcCc--------ccCCCC-----------CCCChhHHHHH
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WRNH--------LKFPDD-----------SKLSPEAKDLI 370 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~---------~~~~--------l~~p~~-----------~~~s~~~~dLI 370 (518)
||+|||+.||++++|.|.+.+......+|.. |.+- ..|+.. ..+|..+.||+
T Consensus 262 WSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Ll 341 (419)
T KOG0663|consen 262 WSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLL 341 (419)
T ss_pred hhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHH
Confidence 9999999999999999999999999999876 2211 112210 12679999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
..||+ ||.+|+ +|.|.|+|+||++.
T Consensus 342 n~llt~dP~kR~---tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 342 NKLLTYDPGKRI---TAEDGLKHEYFRET 367 (419)
T ss_pred HHHhccCccccc---cHHHhhcccccccC
Confidence 99999 999999 89999999999964
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=395.23 Aligned_cols=267 Identities=32% Similarity=0.572 Sum_probs=222.4
Q ss_pred EeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010116 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (518)
Q Consensus 94 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L 173 (518)
||+|+||.||+++.+.+|+.||+|++.+...........+..|+++++.++||||++++++|++..++|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999876554444455567799999999999999999999999999999999999999
Q ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccccc
Q 010116 174 MTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (518)
Q Consensus 174 ~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~ 251 (518)
..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence 9888654 358899999999999999999999999999999999999999999999999987643210
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhC
Q 010116 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331 (518)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 331 (518)
......||+.|+|||++.+..++.++|+|||||++|||++|
T Consensus 150 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g 190 (277)
T cd05607 150 ---------------------------------------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190 (277)
T ss_pred ---------------------------------------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC
Confidence 01134699999999999999999999999999999999999
Q ss_pred CCCCCCCChh----hHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC-ChhhhhcCcccccCCccccc-
Q 010116 332 YPPFYADDPI----TTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG-GAHQIKAHPWFKDVVWDKLY- 404 (518)
Q Consensus 332 ~~PF~~~~~~----~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~-~a~eil~Hpff~~i~w~~l~- 404 (518)
.+||...... .....+.. ....++. ..+++++++||++||. ||.+|++.. -.++++.||||++++|..+.
T Consensus 191 ~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~ 267 (277)
T cd05607 191 RTPFKDHKEKVAKEELKRRTLE--DEVKFEH-QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA 267 (277)
T ss_pred CCCCCCCcchhhHHHHHHHhhc--ccccccc-ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhc
Confidence 9999764332 22233332 2223332 3689999999999998 999999432 12788999999999999987
Q ss_pred -cccCCcccc
Q 010116 405 -EMEAAFKPE 413 (518)
Q Consensus 405 -~~~~p~~p~ 413 (518)
...+||.|+
T Consensus 268 ~~~~~~~~~~ 277 (277)
T cd05607 268 GLIPPPFVPD 277 (277)
T ss_pred CcCCCCCCCC
Confidence 467788763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=378.36 Aligned_cols=258 Identities=31% Similarity=0.557 Sum_probs=223.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|..+++||+|+||.||+|++..||+.||||+++.... +.+......+|+.+|++++|+||+.|.++|.+.+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 468888999999999999999999999999999987643 3333445788999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||+ .||...++.+ ..++...++.|+.+++.||+|||++.|+||||||.|+|++++|.+||+|||||+.+....
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~---- 155 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN---- 155 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC----
Confidence 9996 5999988664 689999999999999999999999999999999999999999999999999999765321
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 323 (518)
+ .....|-|.+|+|||++.+ ..|+..+|+||.||
T Consensus 156 --------------------------------------------~-~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGC 190 (318)
T KOG0659|consen 156 --------------------------------------------R-IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGC 190 (318)
T ss_pred --------------------------------------------c-ccccceeeeeccChHHhccchhcCCcchhhhHHH
Confidence 0 1112378999999999987 67999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhh---------hcCccc---------CCC------CCCCChhHHHHHHHHhc-ccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLK---------FPD------DSKLSPEAKDLICRLLC-DVE 378 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~---------~~~~l~---------~p~------~~~~s~~~~dLI~~lL~-dp~ 378 (518)
|+.||+-|.|-|.+++..+....|.. |..--. +|. .+..|.++.||+.+||. ||.
T Consensus 191 I~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~ 270 (318)
T KOG0659|consen 191 IFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPK 270 (318)
T ss_pred HHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCch
Confidence 99999999999999999999888876 221111 111 12357889999999999 999
Q ss_pred ccCCCCChhhhhcCccccc
Q 010116 379 HRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 379 ~R~g~~~a~eil~Hpff~~ 397 (518)
+|+ ++.|+++|+||+.
T Consensus 271 ~Ri---ta~qaL~~~yf~~ 286 (318)
T KOG0659|consen 271 KRI---TASQALKHPYFKS 286 (318)
T ss_pred hcc---cHHHHhcchhhhc
Confidence 999 8999999999985
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=405.70 Aligned_cols=258 Identities=33% Similarity=0.563 Sum_probs=233.4
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
.=|++.+.||+|-|..|-+|++--||..||||++.|..+.. -...|+..|++.|+.++|||||+||.+..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45889999999999999999999999999999999886543 34578889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee-CCCCcEEEeecccccccCCCcccc
Q 010116 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL-DKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl-d~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|+-.||||++|+++. ..+.|+.++.|++||+.||.|+|+..+|||||||+||++ .+-|-|||+|||++-.+.++
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---- 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---- 172 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc----
Confidence 999999999999886 689999999999999999999999999999999999876 56799999999998876533
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC-ccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG-MECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiWSlG 322 (518)
+...+.||++.|-|||+|++..|+ +++||||||
T Consensus 173 ----------------------------------------------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLG 206 (864)
T KOG4717|consen 173 ----------------------------------------------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLG 206 (864)
T ss_pred ----------------------------------------------chhhcccchhhccCchhhhcCccCCcchhhhHHH
Confidence 234578999999999999999995 688999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
||||.|++|++||...+..+++..|+.++ ...| ..+|.+++|||..||. ||.+|. +.++|..|+|++++|-.
T Consensus 207 VILyMLVCGq~PFqeANDSETLTmImDCK--YtvP--shvS~eCrdLI~sMLvRdPkkRA---slEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 207 VILYMLVCGQPPFQEANDSETLTMIMDCK--YTVP--SHVSKECRDLIQSMLVRDPKKRA---SLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHHHhCCCccccccchhhhhhhhccc--ccCc--hhhhHHHHHHHHHHHhcCchhhc---cHHHHhccccccCCCCC
Confidence 99999999999999999999999998753 2334 5899999999999998 999999 89999999999998743
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-50 Score=392.35 Aligned_cols=261 Identities=31% Similarity=0.508 Sum_probs=223.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-----CCe
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-----TEY 160 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-----~~~ 160 (518)
..|..++.||+|+||.|+.|.++.||+.||||++... +...-..++..+|+.+|+.++|+||+.+++.+.. -..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4566689999999999999999999999999998643 3344456788999999999999999999999976 346
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+|+|+| +.||...+..+..++++.+++++.|++.||.|+|+.||+||||||.|+|++.++.+||||||||+..+...
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999999 78999999888889999999999999999999999999999999999999999999999999999764220
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWW 319 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 319 (518)
.....+..|-|.+|.|||++.. ..|+.++|||
T Consensus 180 -----------------------------------------------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiW 212 (359)
T KOG0660|consen 180 -----------------------------------------------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIW 212 (359)
T ss_pred -----------------------------------------------cccchhcceeeeeecCHHHHhccccccchhhhh
Confidence 0112346789999999999876 7899999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC---------------------cccCCC------CCCCChhHHHHHHH
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN---------------------HLKFPD------DSKLSPEAKDLICR 372 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------------~l~~p~------~~~~s~~~~dLI~~ 372 (518)
|+|||+.|||+|++.|.+.+....+..|+...+ ....|. .++.++.|.||+.+
T Consensus 213 SvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlek 292 (359)
T KOG0660|consen 213 SVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEK 292 (359)
T ss_pred hhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHH
Confidence 999999999999999999988888777765211 011111 13678999999999
Q ss_pred Hhc-cccccCCCCChhhhhcCcccccC
Q 010116 373 LLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 373 lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||. ||.+|+ +++|+++||||...
T Consensus 293 mL~fdP~kRi---ta~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 293 MLVFDPKKRI---TAEEALAHPYLAPY 316 (359)
T ss_pred HhccCccccC---CHHHHhcChhhhhh
Confidence 999 999999 99999999999853
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-49 Score=392.29 Aligned_cols=258 Identities=34% Similarity=0.493 Sum_probs=216.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2334567888999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 155 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN---- 155 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc----
Confidence 9999887766555557899999999999999999999999999999999999999999999999999986532100
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
......+||+.|+|||++.+..|+.++|||||||++
T Consensus 156 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil 191 (287)
T cd07848 156 --------------------------------------------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCIL 191 (287)
T ss_pred --------------------------------------------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHH
Confidence 001145799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCc-----------------ccCCCC-----------CCCChhHHHHHHHHhc-c
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNH-----------------LKFPDD-----------SKLSPEAKDLICRLLC-D 376 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~-----------------l~~p~~-----------~~~s~~~~dLI~~lL~-d 376 (518)
|||++|++||.+.+.......+...... ..+|.. ..+|++++|||.+||. |
T Consensus 192 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~ 271 (287)
T cd07848 192 GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLN 271 (287)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCC
Confidence 9999999999987765554444331111 111110 1368899999999999 9
Q ss_pred ccccCCCCChhhhhcCccc
Q 010116 377 VEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 377 p~~R~g~~~a~eil~Hpff 395 (518)
|.+|+ +++++++||||
T Consensus 272 P~~R~---s~~~~l~hp~f 287 (287)
T cd07848 272 PTDRY---LTEQCLNHPAF 287 (287)
T ss_pred cccCC---CHHHHhcCCCC
Confidence 99999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=389.60 Aligned_cols=275 Identities=33% Similarity=0.631 Sum_probs=233.4
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|+..+.||+|+||+||++++..+++.||+|++.+...........+.+|+.+|+.++|++|+.+++.|.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37889999999999999999999999999999987655444445567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 167 y~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----
Confidence 99999999888553 469999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
...+.+||+.|+|||++.+..++.++|+|||||+
T Consensus 157 ----------------------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~ 190 (285)
T cd05632 157 ----------------------------------------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCL 190 (285)
T ss_pred ----------------------------------------------cccCCCCCcCccChHHhcCCCCCcccchHHHHHH
Confidence 0124579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhc--CcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCC
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWR--NHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVV 399 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~--~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~ 399 (518)
+|+|++|.+||.+.........+.... ....++ ..+++++.+||.+||. ||.+|+++. ++.+++.||||+.++
T Consensus 191 l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 191 IYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccC--ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 999999999998876554433332211 112222 3688999999999998 999999643 489999999999999
Q ss_pred ccccc--cccCCcccc
Q 010116 400 WDKLY--EMEAAFKPE 413 (518)
Q Consensus 400 w~~l~--~~~~p~~p~ 413 (518)
|.++. ++.|||.|.
T Consensus 269 ~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 269 FKRLEAGMLDPPFVPD 284 (285)
T ss_pred HHHHhcCcCCCCCCCC
Confidence 99875 577899885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=390.94 Aligned_cols=303 Identities=40% Similarity=0.734 Sum_probs=253.4
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||++.++.+++.||+|.+.+...........+.+|+++++.++||||++++++|.+..++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998775544556677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998743211100000
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
... ... ...........|++.|+|||.+.+..++.++|+|||||++
T Consensus 161 ~~~----------------~~~------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl 206 (305)
T cd05609 161 EGH----------------IEK------------------DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206 (305)
T ss_pred ccc----------------ccc------------------chhhccccCCccCccccCchhccCCCCCchhhHHHHHHHH
Confidence 000 000 0000011235689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCC-CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~-~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l 403 (518)
|||++|..||.+.+..+....+... ....|.. ..+++++++||.+||. ||.+|+++.++.++++||||...+|..+
T Consensus 207 ~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~ 284 (305)
T cd05609 207 YEFLVGCVPFFGDTPEELFGQVISD--DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284 (305)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence 9999999999988887777776653 2333332 2578999999999998 9999998777999999999999999998
Q ss_pred ccccCCccccCCCcccCCCCC
Q 010116 404 YEMEAAFKPEINGELDTQNFM 424 (518)
Q Consensus 404 ~~~~~p~~p~~~~~~d~~~f~ 424 (518)
.+...+++|.+....|+++|+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~ 305 (305)
T cd05609 285 LRQKAEFIPQLESEDDTSYFD 305 (305)
T ss_pred hhcCCCCCCCCCCccccccCC
Confidence 877788999998888877754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=394.44 Aligned_cols=261 Identities=28% Similarity=0.435 Sum_probs=212.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||.|+||.||+|+++.+++.||||++..... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999875432 22234567899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++ |+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--- 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---
Confidence 99995 6788777554 679999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
....+.+||+.|+|||++.+ ..|+.++||||||
T Consensus 158 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 191 (303)
T cd07869 158 ----------------------------------------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVG 191 (303)
T ss_pred ----------------------------------------------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHH
Confidence 01124578999999999876 4689999999999
Q ss_pred HHHHHHHhCCCCCCCCChh-hHHHHHhhhcCcc---------cC------------CC-------CCCCChhHHHHHHHH
Q 010116 323 AIMYEMLVGYPPFYADDPI-TTCRKIVHWRNHL---------KF------------PD-------DSKLSPEAKDLICRL 373 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~-~~~~~i~~~~~~l---------~~------------p~-------~~~~s~~~~dLI~~l 373 (518)
|++|+|++|.+||.+.... .....+....... .. |. ...++++++|||.+|
T Consensus 192 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 271 (303)
T cd07869 192 CIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKL 271 (303)
T ss_pred HHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHH
Confidence 9999999999999875432 2222222100000 00 00 012467899999999
Q ss_pred hc-cccccCCCCChhhhhcCcccccCCc
Q 010116 374 LC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
|+ ||.+|+ ++.|+++||||+++.+
T Consensus 272 L~~dp~~R~---s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 272 LQCFPKNRL---SAQAALSHEYFSDLPP 296 (303)
T ss_pred hccCchhcc---CHHHHhcCcccccCCh
Confidence 98 999999 8999999999998874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=392.41 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=215.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||.|+||.||+|+++.+++.||+|+++.... ......+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5789999999999999999999999999999999875432 22345677899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++| +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--- 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--- 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC---
Confidence 999975 899888654 468999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
......+||+.|+|||++.+ ..|+.++||||||
T Consensus 158 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 191 (288)
T cd07871 158 ----------------------------------------------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG 191 (288)
T ss_pred ----------------------------------------------ccccCceecccccChHHhcCCcccCcHHHHHHHH
Confidence 00123578999999999876 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcC-----------------cccCCC---------CCCCChhHHHHHHHHhc-
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRN-----------------HLKFPD---------DSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~-----------------~l~~p~---------~~~~s~~~~dLI~~lL~- 375 (518)
|++|+|++|++||.+.+..+....+..... ...+|. ...++++++|||++||+
T Consensus 192 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 271 (288)
T cd07871 192 CILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLY 271 (288)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCc
Confidence 999999999999998887766655543111 011111 12578899999999999
Q ss_pred cccccCCCCChhhhhcCccc
Q 010116 376 DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff 395 (518)
||.+|+ +++|+++||||
T Consensus 272 dp~~R~---t~~~~l~hp~f 288 (288)
T cd07871 272 ETKSRI---SAEAALRHSYF 288 (288)
T ss_pred CcccCC---CHHHHhcCCCC
Confidence 999999 89999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=390.93 Aligned_cols=308 Identities=38% Similarity=0.669 Sum_probs=248.5
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++||+|+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776554456677899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 166 EYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||+.|++|.+++.+. ..+++..++.++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 579999999999999999999999999999999999999999999999999998654321110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHH-HHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQL-QHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
....... +......... ..............+||..|+|||++.+..++.++||||||
T Consensus 161 ~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG 219 (316)
T cd05574 161 SKALRKG---------------------SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219 (316)
T ss_pred ccccccc---------------------cccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHH
Confidence 0000000 0000000000 00000011122356899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC-ChhhhhcCcccccCCc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG-GAHQIKAHPWFKDVVW 400 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~-~a~eil~Hpff~~i~w 400 (518)
|++|+|++|..||.+.+....+.++.. ....++....+++++++||.+||+ ||.+|+... ++++++.||||++++|
T Consensus 220 ~ll~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 220 ILLYEMLYGTTPFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred HHHHHHhhCCCCCCCCchHHHHHHHhc--CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 999999999999998888777777765 345566555589999999999998 999999321 2999999999999999
Q ss_pred cccccccCCccccCCC
Q 010116 401 DKLYEMEAAFKPEING 416 (518)
Q Consensus 401 ~~l~~~~~p~~p~~~~ 416 (518)
..+....+|-.|.+.+
T Consensus 298 ~~~~~~~~~~~~~~~~ 313 (316)
T cd05574 298 ALIRHTTPPIIPRPDD 313 (316)
T ss_pred hhcccCCCCCCCCccc
Confidence 9998877777776654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=381.86 Aligned_cols=261 Identities=31% Similarity=0.537 Sum_probs=221.7
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc-eeEEEEEeecCC----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTE---- 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~---- 159 (518)
...|+.+.+||.|+||+||.|+.+.+|+.||+|++.-.... ++.-....+|+.+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34577788899999999999999999999999999765321 334455688999999999999 999999999887
Q ss_pred --eEEEEEeecCCCchHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 160 --YLYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 160 --~lylVmEy~~gG~L~~~l~~~~----~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
.+|||+||+ .-||..++.... .++...++.++.||+.||+|||++||+||||||.||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 569999997654 5888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GY 312 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y 312 (518)
+...-.. +...+-++|.+|+|||++.+. .|
T Consensus 168 ra~~ip~-------------------------------------------------~~yt~evvTlWYRaPEvLlGs~~Y 198 (323)
T KOG0594|consen 168 RAFSIPM-------------------------------------------------RTYTPEVVTLWYRAPEVLLGSTSY 198 (323)
T ss_pred HHhcCCc-------------------------------------------------ccccccEEEeeccCHHHhcCCCcC
Confidence 8543110 012356899999999999985 79
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhh---------hcCcc-------cCCCC----------CCCChhH
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WRNHL-------KFPDD----------SKLSPEA 366 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---------~~~~l-------~~p~~----------~~~s~~~ 366 (518)
+..+|+||+|||++||+++.+.|.+.+...+...|.. |.... .|+.+ +..++++
T Consensus 199 s~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~ 278 (323)
T KOG0594|consen 199 STSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDG 278 (323)
T ss_pred CCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccH
Confidence 9999999999999999999999999999888888876 32211 22222 1235699
Q ss_pred HHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 367 KDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 367 ~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
.+|+.+||+ +|.+|. +|..++.||||..+.
T Consensus 279 ~dll~~~L~y~p~~R~---Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 279 IELLSKLLQYDPAKRI---SAKGALTHPYFSELP 309 (323)
T ss_pred HHHHHHHhccCcccCc---CHHHHhcChhhcccc
Confidence 999999999 999999 899999999999763
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=379.34 Aligned_cols=252 Identities=34% Similarity=0.579 Sum_probs=217.7
Q ss_pred CCCeeEE-eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEee----cC
Q 010116 85 VDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ----DT 158 (518)
Q Consensus 85 ~~~f~i~-~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~----~~ 158 (518)
++||.+- ++||-|-.|+|..|.++.||+.||+|++.-+ ...++|+++--.. .|||||.++++|+ ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 5778775 5899999999999999999999999998543 2456777776555 6999999998875 45
Q ss_pred CeEEEEEeecCCCchHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CCcEEEeecccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLC 233 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~--l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g~vKL~DFGla 233 (518)
..+.+|||.|.||+|+..++.++. |+|.+|..++.||..||.|||+.+|.||||||||+|... |..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 789999999999999999988754 999999999999999999999999999999999999975 457999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
|..... ....+.|-||.|.||||+....|+
T Consensus 212 K~t~~~--------------------------------------------------~~L~TPc~TPyYvaPevlg~eKyd 241 (400)
T KOG0604|consen 212 KETQEP--------------------------------------------------GDLMTPCFTPYYVAPEVLGPEKYD 241 (400)
T ss_pred cccCCC--------------------------------------------------ccccCCcccccccCHHHhCchhcC
Confidence 964321 123367999999999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCC----hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhh
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADD----PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ 388 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~e 388 (518)
..||+||+|||||-||+|+|||++.. +..+.++|..+.-.++-|+|+.+|.+++|||++||. +|.+|+ ++++
T Consensus 242 kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl---TI~~ 318 (400)
T KOG0604|consen 242 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL---TIEE 318 (400)
T ss_pred CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe---eHHH
Confidence 99999999999999999999999864 335677888755555556678899999999999998 999999 8999
Q ss_pred hhcCccccc
Q 010116 389 IKAHPWFKD 397 (518)
Q Consensus 389 il~Hpff~~ 397 (518)
++.|||...
T Consensus 319 ~m~hpwi~~ 327 (400)
T KOG0604|consen 319 VMDHPWINQ 327 (400)
T ss_pred hhcCchhcc
Confidence 999999985
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=391.68 Aligned_cols=263 Identities=27% Similarity=0.417 Sum_probs=213.3
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC-----CeE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----EYL 161 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~~l 161 (518)
+|++.+.||+|+||.||+|+++.+|..||||++.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 1223345678899999999999999999987543 358
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||| +++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999999 579999998888999999999999999999999999999999999999999999999999999975421100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCcccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECDWW 319 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiW 319 (518)
........+||+.|+|||++.+ ..|+.++|||
T Consensus 159 ----------------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Dvw 192 (338)
T cd07859 159 ----------------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 192 (338)
T ss_pred ----------------------------------------------ccccccCCCCCCCcCCHHHHhccccccCchhHHH
Confidence 0001124679999999999976 6789999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhc--------------------------CcccCC-CCCCCChhHHHHHHH
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWR--------------------------NHLKFP-DDSKLSPEAKDLICR 372 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--------------------------~~l~~p-~~~~~s~~~~dLI~~ 372 (518)
||||++|||++|++||.+.+.......+.... ....+. ....+++++.+||.+
T Consensus 193 SlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 272 (338)
T cd07859 193 SIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER 272 (338)
T ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHH
Confidence 99999999999999998776544332221100 000000 012467899999999
Q ss_pred Hhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 373 LLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 373 lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
||+ ||.+|+ +++||++||||+++..
T Consensus 273 ~l~~~P~~Rp---t~~e~l~hp~f~~~~~ 298 (338)
T cd07859 273 LLAFDPKDRP---TAEEALADPYFKGLAK 298 (338)
T ss_pred HcCcCcccCC---CHHHHhcCchhhhcCc
Confidence 998 999999 8999999999987553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=390.59 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=220.4
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
+..++|++++.||+|+||.||+|++..+|..||+|++.... .......+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 34689999999999999999999999999999999987542 2334567889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
+||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+|++||+|||++..+...
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999999999998888899999999999999999999986 6999999999999999999999999998754211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.....+||+.|+|||++.+..|+.++|||||
T Consensus 158 -------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 188 (331)
T cd06649 158 -------------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (331)
T ss_pred -------------------------------------------------ccccCCCCcCcCCHhHhcCCCCCchHhHHHH
Confidence 0124579999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHH----------------------------------------------hhhcCccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKI----------------------------------------------VHWRNHLK 355 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i----------------------------------------------~~~~~~l~ 355 (518)
||++|||++|+.||...+..+....+ ... ....
T Consensus 189 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 267 (331)
T cd06649 189 GLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNE-PPPK 267 (331)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhC-CCcC
Confidence 99999999999999766543332111 100 0111
Q ss_pred CCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 356 FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 356 ~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
.+. ..+++++++||.+||. ||++|+ ++.+|++||||+....
T Consensus 268 ~~~-~~~~~~l~~li~~~L~~~P~~Rp---t~~ell~h~~~~~~~~ 309 (331)
T cd06649 268 LPN-GVFTPDFQEFVNKCLIKNPAERA---DLKMLMNHTFIKRSEV 309 (331)
T ss_pred CCC-ccccHHHHHHHHHHccCCcccCC---CHHHHhcChHHhhccc
Confidence 111 2478899999999998 999999 8999999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=407.62 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=211.8
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC---
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--- 158 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--- 158 (518)
.....+|+++++||+|+||.||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 345678999999999999999999999999999999886532 2234699999999999999998877432
Q ss_pred -----CeEEEEEeecCCCchHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-cEEEe
Q 010116 159 -----EYLYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLS 228 (518)
Q Consensus 159 -----~~lylVmEy~~gG~L~~~l~----~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-~vKL~ 228 (518)
.++|+||||+++ +|..++. ....+++..++.|+.||+.||.|||++|||||||||+|||++.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 358899999975 6666653 346799999999999999999999999999999999999999765 69999
Q ss_pred ecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc
Q 010116 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308 (518)
Q Consensus 229 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 308 (518)
|||+|+.+.... ...+.+||+.|+|||++.
T Consensus 214 DFGla~~~~~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~ 243 (440)
T PTZ00036 214 DFGSAKNLLAGQ--------------------------------------------------RSVSYICSRFYRAPELML 243 (440)
T ss_pred ccccchhccCCC--------------------------------------------------CcccCCCCcCccCHHHhc
Confidence 999998653210 112467999999999987
Q ss_pred C-CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC---------------cccCCC----------CCCC
Q 010116 309 K-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN---------------HLKFPD----------DSKL 362 (518)
Q Consensus 309 ~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------~l~~p~----------~~~~ 362 (518)
+ ..|+.++|||||||++|||++|++||.+.+......+++.... .+.+|. +...
T Consensus 244 ~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~ 323 (440)
T PTZ00036 244 GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGT 323 (440)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCC
Confidence 6 4799999999999999999999999999887777666654211 111221 1246
Q ss_pred ChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 363 SPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 363 s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
|+++++||.+||+ ||.+|+ ++.|+++||||..+.+
T Consensus 324 ~~~~~~li~~~L~~dP~~R~---ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 324 PDDAINFISQFLKYEPLKRL---NPIEALADPFFDDLRD 359 (440)
T ss_pred CHHHHHHHHHHCCCChhHCc---CHHHHhCChhHHhhhc
Confidence 7899999999998 999999 8999999999987654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=383.28 Aligned_cols=251 Identities=31% Similarity=0.554 Sum_probs=214.2
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-----CCeE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-----TEYL 161 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-----~~~l 161 (518)
.|.-.+++|.|+||.||.|....+++.||||+...+.-. -.+|..||+.++|||||+|.++|.. +-++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 588899999999999999999999999999988655321 2368999999999999999999853 2257
Q ss_pred EEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC-CcEEEeeccccccc
Q 010116 162 YLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPL 236 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~-g~vKL~DFGla~~~ 236 (518)
.+||||||. +|..++.. +..++.-.++.|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 799999964 88888864 5789999999999999999999999999999999999999987 99999999999987
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGME 315 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~ 315 (518)
..+. ...+..-|..|+|||.+.+ ..|+.+
T Consensus 177 ~~~e--------------------------------------------------pniSYicSRyYRaPELifga~~Yt~~ 206 (364)
T KOG0658|consen 177 VKGE--------------------------------------------------PNISYICSRYYRAPELIFGATEYTTS 206 (364)
T ss_pred ccCC--------------------------------------------------CceeEEEeccccCHHHHcCccccCce
Confidence 5431 1125677899999999998 679999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC---------------cccCCC----------CCCCChhHHHHH
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN---------------HLKFPD----------DSKLSPEAKDLI 370 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------~l~~p~----------~~~~s~~~~dLI 370 (518)
.||||.||+|.||+-|++.|.+++...+...|+..-+ ..++|. ...+++++.||+
T Consensus 207 IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll 286 (364)
T KOG0658|consen 207 IDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLL 286 (364)
T ss_pred eEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHH
Confidence 9999999999999999999999999888887765211 222332 134689999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
.++|. +|.+|. ++.|++.||||...
T Consensus 287 ~~~L~Y~P~~R~---~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 287 SKLLQYSPSKRL---SALEALAHPFFDEL 312 (364)
T ss_pred HHHhccChhhcC---CHHHHhcchhhHHh
Confidence 99999 999999 89999999999854
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=398.90 Aligned_cols=256 Identities=31% Similarity=0.507 Sum_probs=228.5
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
..|..+..||+|+||.||+|.+..+++.||+|++.-.. ....++.+..|+.+|.+++++||.+.|++|.....++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 46888899999999999999999999999999997654 3456888999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|||.||++.++|.....+.|..+..++++++.||.|||.++.||||||+.|||+..+|.+||+|||++..+....
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~----- 165 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV----- 165 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh-----
Confidence 999999999999888888999999999999999999999999999999999999999999999999988764210
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
....+++|||.||||||+...+|+.++||||||++.
T Consensus 166 --------------------------------------------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITa 201 (467)
T KOG0201|consen 166 --------------------------------------------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITA 201 (467)
T ss_pred --------------------------------------------hccccccccccccchhhhccccccchhhhhhhhHHH
Confidence 122589999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|||++|.||+....+......|-+. .++.+. ..+|+.+++||..||. ||+.|+ +|.++++|+|.+..
T Consensus 202 iEla~GePP~s~~hPmrvlflIpk~-~PP~L~--~~~S~~~kEFV~~CL~k~P~~Rp---sA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 202 IELAKGEPPHSKLHPMRVLFLIPKS-APPRLD--GDFSPPFKEFVEACLDKNPEFRP---SAKELLKHKFIKRA 269 (467)
T ss_pred HHHhcCCCCCcccCcceEEEeccCC-CCCccc--cccCHHHHHHHHHHhhcCcccCc---CHHHHhhhHHHHhc
Confidence 9999999999998886665555431 122222 3789999999999998 999999 89999999999863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=390.19 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=219.5
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcE-EEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNI-YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~-~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
+.+..+++.+...||+|+||+||.+.++ |.. ||+|++......... .+.+.+|+.+|..++|||||++++++.+..
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3444566677778999999999988765 556 999999876544433 778999999999999999999999999887
Q ss_pred -eEEEEEeecCCCchHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEEcCCCCCceeeCCCC-cEEEeeccccc
Q 010116 160 -YLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHN-YIHRDIKPDNLLLDKNG-HMKLSDFGLCK 234 (518)
Q Consensus 160 -~lylVmEy~~gG~L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~g-iiHRDIKPeNILld~~g-~vKL~DFGla~ 234 (518)
.++|||||+++|+|..+|.+ +..++...+..++.+|+.|++|||+++ ||||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999988 689999999999999999999999999 99999999999999998 99999999998
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc--CCCC
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL--KKGY 312 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~--~~~y 312 (518)
...... ...++..||+.|||||++. +..|
T Consensus 193 ~~~~~~-------------------------------------------------~~~~~~~GT~~wMAPEv~~~~~~~~ 223 (362)
T KOG0192|consen 193 EKVISK-------------------------------------------------TSMTSVAGTYRWMAPEVLRGEKSPY 223 (362)
T ss_pred eecccc-------------------------------------------------ccccCCCCCccccChhhhcCCCCcC
Confidence 643210 0112367999999999999 6799
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+.++||||||++||||+||..||.+..+......++.....+.+|. .+++.+..||.+|+. ||..|| +..+|..
T Consensus 224 ~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~--~~~~~l~~l~~~CW~~dp~~RP---~f~ei~~ 298 (362)
T KOG0192|consen 224 TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK--ECPPHLSSLMERCWLVDPSRRP---SFLEIVS 298 (362)
T ss_pred CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHhCCCCCCcCC---CHHHHHH
Confidence 9999999999999999999999999998777777776555566664 489999999999998 999999 7777664
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=398.45 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=211.1
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+...+|++++.||+|+||.||+|++..+++.||+|+... ..+.+|+.+|+.++|||||+++++|......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3556789999999999999999999999999999997532 3467899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+|||++ +++|..++.....+++..++.++.|++.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 9999999 57999999888889999999999999999999999999999999999999999999999999986432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.......+||+.|+|||++.+..|+.++|||||
T Consensus 237 -----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 269 (391)
T PHA03212 237 -----------------------------------------------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSA 269 (391)
T ss_pred -----------------------------------------------ccccccccCccCCCChhhhcCCCCCcHHHHHHH
Confidence 001225689999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCh-------hhHHHHHhhhcCc------------------------ccC----CC---CCCCC
Q 010116 322 GAIMYEMLVGYPPFYADDP-------ITTCRKIVHWRNH------------------------LKF----PD---DSKLS 363 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~~------------------------l~~----p~---~~~~s 363 (518)
||++|||++|..||...+. ......++..... ... |. ...++
T Consensus 270 Gvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (391)
T PHA03212 270 GIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELP 349 (391)
T ss_pred HHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhh
Confidence 9999999999988865321 1122222211000 000 00 01346
Q ss_pred hhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 364 PEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 364 ~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
.++.+||.+||+ ||.+|+ +|.|+++||||+.+
T Consensus 350 ~~l~~Li~~mL~~dP~~Rp---ta~elL~hp~f~~~ 382 (391)
T PHA03212 350 IDLEYLICKMLAFDAHHRP---SAEALLDFAAFQDI 382 (391)
T ss_pred hhHHHHHHHHhcCChhhCC---CHHHHhcChhhccC
Confidence 789999999999 999999 89999999999864
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=394.38 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=218.1
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----eE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-----YL 161 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-----~l 161 (518)
+|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.+.. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986532 22234467889999999999999999999998877 89
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||+. ++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 99999995 6898888888899999999999999999999999999999999999999999999999999987543110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 320 (518)
.......+||+.|+|||++.+. .|+.++||||
T Consensus 158 -----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 190 (372)
T cd07853 158 -----------------------------------------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWS 190 (372)
T ss_pred -----------------------------------------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHh
Confidence 0011234689999999999874 5899999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC---------------------cccC-------CCCCCCChhHHHHHHH
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRN---------------------HLKF-------PDDSKLSPEAKDLICR 372 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------------~l~~-------p~~~~~s~~~~dLI~~ 372 (518)
|||++|||++|++||.+.++......|..... .... ......++++.+||.+
T Consensus 191 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 270 (372)
T cd07853 191 VGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCR 270 (372)
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHH
Confidence 99999999999999998887766665543111 0011 1112468899999999
Q ss_pred Hhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 373 LLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 373 lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
||+ ||.+|+ ++.|++.||||++..+
T Consensus 271 mL~~dP~~R~---t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 271 MLVFDPDKRI---SAADALAHPYLDEGRL 296 (372)
T ss_pred hCCCChhhCc---CHHHHhcCHhhCCCcc
Confidence 999 999999 8999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=377.07 Aligned_cols=270 Identities=37% Similarity=0.661 Sum_probs=225.7
Q ss_pred EeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010116 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (518)
Q Consensus 94 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L 173 (518)
||+|+||+||+|.+..+|+.||+|++.+...........+..|..+|+.++||+|++++++|...+.+|+||||++||+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876554444556677899999999999999999999999999999999999999
Q ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccccc
Q 010116 174 MTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (518)
Q Consensus 174 ~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~ 251 (518)
.+++.+.. .+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----------- 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----------- 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----------
Confidence 99997755 79999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhC
Q 010116 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331 (518)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 331 (518)
......|+..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 150 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g 190 (277)
T cd05577 150 ---------------------------------------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190 (277)
T ss_pred ---------------------------------------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC
Confidence 01134688899999999988899999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccccc--cc
Q 010116 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EM 406 (518)
Q Consensus 332 ~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~l~--~~ 406 (518)
+.||...........+.........+....+++++++||.+||. ||.+|++.. ++.+++.||||+.++|..+. ..
T Consensus 191 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~ 270 (277)
T cd05577 191 RSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGML 270 (277)
T ss_pred CCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCC
Confidence 99998765432222232211111222223579999999999998 999999653 68889999999999999885 46
Q ss_pred cCCcccc
Q 010116 407 EAAFKPE 413 (518)
Q Consensus 407 ~~p~~p~ 413 (518)
.|||.|+
T Consensus 271 ~~~~~~~ 277 (277)
T cd05577 271 EPPFIPD 277 (277)
T ss_pred CCCCCCC
Confidence 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=394.68 Aligned_cols=257 Identities=33% Similarity=0.527 Sum_probs=233.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe-EEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY-LYL 163 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~-lyl 163 (518)
.++|+.+++||+|+||.+++++++..++.|++|.+.-.....+.. .....|..+++++.|||||..+++|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 478999999999999999999999999999999998776554433 367889999999999999999999998888 999
Q ss_pred EEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 164 IMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
||+||+||+|...+.+. ..|+|+.+..|+.|++.||.|||+++|+|||||+.||++++++.|||+|||+||.+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 99999999999999654 57999999999999999999999999999999999999999999999999999987532
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
...+.+.+|||.||.||++.+.+|+.++|||||
T Consensus 160 -----------------------------------------------~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsL 192 (426)
T KOG0589|consen 160 -----------------------------------------------DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSL 192 (426)
T ss_pred -----------------------------------------------hhhhheecCCCcccCHHHhCCCCCCccCcchhh
Confidence 124568999999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||++|||++-+++|.+.+......+|.... -.|.+...|.+++.||+.||. +|+.|| +|.+++.+|....
T Consensus 193 GC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RP---sa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 193 GCCLYEMCTLKPAFKASNMSELILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRP---SALELLRRPHLLR 263 (426)
T ss_pred cchHHHHHhcccccCccchHHHHHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCC---CHHHHhhChhhhh
Confidence 999999999999999999999999998743 456667899999999999998 999999 8999999998763
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=377.16 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=210.3
Q ss_pred CCeeEEeeEeecCceEEEEEEEec-CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh---CCCceeEEEEEee-----
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQ----- 156 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~-t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~----- 156 (518)
.+|++++.||+|+||+||+|++.. +|+.||+|++..... .........+|..+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 578899999875432 222334556777777766 6999999999875
Q ss_pred cCCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
....+|+||||++ |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999996 6899998653 468999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCc
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 314 (518)
..... ......+||+.|+|||++.+..|+.
T Consensus 159 ~~~~~--------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 188 (290)
T cd07862 159 IYSFQ--------------------------------------------------MALTSVVVTLWYRAPEVLLQSSYAT 188 (290)
T ss_pred eccCC--------------------------------------------------cccccccccccccChHHHhCCCCCC
Confidence 54211 0112457999999999999999999
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc---------ccCCC--------------CCCCChhHHHHHH
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH---------LKFPD--------------DSKLSPEAKDLIC 371 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---------l~~p~--------------~~~~s~~~~dLI~ 371 (518)
++|||||||++|||++|.+||.+.+......+|+..... ..++. ...+++.+++||.
T Consensus 189 ~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 268 (290)
T cd07862 189 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 268 (290)
T ss_pred ccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHH
Confidence 999999999999999999999998888877777653211 00100 0246788999999
Q ss_pred HHhc-cccccCCCCChhhhhcCccc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+||+ ||++|+ ++.++++||||
T Consensus 269 ~~l~~~P~~R~---s~~~~l~hp~f 290 (290)
T cd07862 269 KCLTFNPAKRI---SAYSALSHPYF 290 (290)
T ss_pred HHhccCchhcC---CHHHHhcCCCC
Confidence 9998 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=373.81 Aligned_cols=260 Identities=30% Similarity=0.564 Sum_probs=219.0
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
..||+|+|+.|--|....||..||||++.|.. .....++.+|++++.++ .|+||++|+++|+|+..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 57899999999999999999999999998864 33456789999999998 599999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc---EEEeecccccccCCCcccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKPLDCSTLYAIHEH 247 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~---vKL~DFGla~~~~~~~~~~~~~~ 247 (518)
|.|..+++++..|+|.+|..++.+|+.||.|||.+||.||||||+|||..+..+ ||||||.|...+......
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~----- 235 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC----- 235 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC-----
Confidence 999999999999999999999999999999999999999999999999977655 799999997654322100
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----CCCCCccccccchh
Q 010116 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDWWSLG 322 (518)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiWSlG 322 (518)
. ..+. ....+.||+..||||||+. ..-|+..||.||||
T Consensus 236 ------------s-past------------------------P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG 278 (463)
T KOG0607|consen 236 ------------S-PAST------------------------PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG 278 (463)
T ss_pred ------------C-CCCC------------------------ccccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence 0 0000 0134789999999999975 24589999999999
Q ss_pred HHHHHHHhCCCCCCCC----------C-----hhhHHHHHhhhcCcccCCC--CCCCChhHHHHHHHHhc-cccccCCCC
Q 010116 323 AIMYEMLVGYPPFYAD----------D-----PITTCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGTG 384 (518)
Q Consensus 323 vilyeml~G~~PF~~~----------~-----~~~~~~~i~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~~ 384 (518)
||+|-||.|++||.+. . ....+..|.. +...||+ |..+|.+++|||+.||. |+.+|+
T Consensus 279 vIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE--GkYeFPdkdWahIS~eakdlisnLlvrda~~rl--- 353 (463)
T KOG0607|consen 279 VILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE--GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL--- 353 (463)
T ss_pred HHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc--cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh---
Confidence 9999999999999653 1 1233445555 4566775 66799999999999998 999999
Q ss_pred ChhhhhcCcccccCCcc
Q 010116 385 GAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 385 ~a~eil~Hpff~~i~w~ 401 (518)
++.++++|||+..+--+
T Consensus 354 sa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 354 SAAQVLNHPWVQRCAPE 370 (463)
T ss_pred hhhhccCCccccccchh
Confidence 89999999999986544
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=403.95 Aligned_cols=255 Identities=24% Similarity=0.442 Sum_probs=207.5
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC------CceeEEEEEee
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS------HCIVKLYYSFQ 156 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h------p~Iv~l~~~f~ 156 (518)
+..++|+++++||+|+||+||+|++..+++.||||++++.. ........|+.++..+.| ++|++++++|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34578999999999999999999999999999999996532 122345667777777754 45899999987
Q ss_pred cC-CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCC-----------
Q 010116 157 DT-EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNG----------- 223 (518)
Q Consensus 157 ~~-~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g----------- 223 (518)
.. .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 65 5799999998 88999999888899999999999999999999998 5999999999999998776
Q ss_pred -----cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCC
Q 010116 224 -----HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGT 298 (518)
Q Consensus 224 -----~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT 298 (518)
.+||+|||++..... .....+||
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~----------------------------------------------------~~~~~~gt 308 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH----------------------------------------------------SRTAIVST 308 (467)
T ss_pred CCCCceEEECCCCccccCcc----------------------------------------------------ccccccCC
Confidence 499999998753210 11256899
Q ss_pred CCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc-----------------------
Q 010116 299 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK----------------------- 355 (518)
Q Consensus 299 ~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~----------------------- 355 (518)
+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.......+......+.
T Consensus 309 ~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 388 (467)
T PTZ00284 309 RHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLR 388 (467)
T ss_pred ccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhccccc
Confidence 999999999999999999999999999999999999998877665554433211100
Q ss_pred ---CCC------------CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 356 ---FPD------------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 356 ---~p~------------~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
.|. ...-++.+.|||.+||+ ||.+|+ ++.||++||||..
T Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~---ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 389 PCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL---NARQMTTHPYVLK 443 (467)
T ss_pred ccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC---CHHHHhcCccccc
Confidence 000 00114567899999999 999999 8999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=414.46 Aligned_cols=152 Identities=45% Similarity=0.791 Sum_probs=143.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|.+++.||+|+||.||+|++..+++.||||++++...........+..|+.+++.++||||+++++++.+..++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999887666666667889999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
|||+.||+|..++...+.+++..++.|+.||+.||.|||.+|||||||||+||||+.+|++||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=373.97 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=208.8
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh---CCCceeEEEEEeec-----C
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQD-----T 158 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~~-----~ 158 (518)
+|++++.||+|+||+||+|+++.+|+.||+|.++.... .......+.+|+.+++.+ +||||++++++|.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999876432 222233455677777665 79999999998864 3
Q ss_pred CeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
..+|+||||++ ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 46899999997 5898888654 45899999999999999999999999999999999999999999999999998754
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
.... .....+||+.|+|||++.+..++.++
T Consensus 159 ~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 188 (288)
T cd07863 159 SCQM--------------------------------------------------ALTPVVVTLWYRAPEVLLQSTYATPV 188 (288)
T ss_pred cCcc--------------------------------------------------cCCCccccccccCchHhhCCCCCCcc
Confidence 3210 01235789999999999999999999
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC---------cccCCC--------------CCCCChhHHHHHHHH
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN---------HLKFPD--------------DSKLSPEAKDLICRL 373 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------~l~~p~--------------~~~~s~~~~dLI~~l 373 (518)
|||||||++|+|++|.+||.+........++..... ....+. ...++.++++||.+|
T Consensus 189 DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (288)
T cd07863 189 DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEM 268 (288)
T ss_pred hhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHH
Confidence 999999999999999999998877766666654211 111110 124678899999999
Q ss_pred hc-cccccCCCCChhhhhcCccc
Q 010116 374 LC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~Hpff 395 (518)
|+ ||.+|+ ++.+++.||||
T Consensus 269 L~~dP~~R~---t~~~~l~hp~f 288 (288)
T cd07863 269 LTFNPHKRI---SAFRALQHPFF 288 (288)
T ss_pred hccCcccCC---CHHHHhcCCCC
Confidence 99 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=373.44 Aligned_cols=258 Identities=36% Similarity=0.669 Sum_probs=211.2
Q ss_pred eEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHH---hCCCceeEEEEEeecCCeEEEEEeecC
Q 010116 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE---VASHCIVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 93 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~---l~hp~Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
.||+|+||.||++++..+++.||+|++.+.............+|..++.. .+||+|+.++++|...+.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999987654333323334445444443 479999999999999999999999999
Q ss_pred CCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccc
Q 010116 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (518)
Q Consensus 170 gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 249 (518)
||+|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---------- 150 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---------- 150 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----------
Confidence 9999999988889999999999999999999999999999999999999999999999999998644211
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-CCCCCccccccchhHHHHHH
Q 010116 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 328 (518)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvilyem 328 (518)
.....+||+.|+|||++. +..++.++|+||+||++|+|
T Consensus 151 -----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l 189 (279)
T cd05633 151 -----------------------------------------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKL 189 (279)
T ss_pred -----------------------------------------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHH
Confidence 011346999999999987 46689999999999999999
Q ss_pred HhCCCCCCCCChhh--HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCcccc
Q 010116 329 LVGYPPFYADDPIT--TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 329 l~G~~PF~~~~~~~--~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~l 403 (518)
++|..||....... ...... ......+| ..+++++++||.+||. ||.+|+++. ++.++++||||++++|...
T Consensus 190 ~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 190 LRGHSPFRQHKTKDKHEIDRMT-LTVNVELP--DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred HhCCCCcCCCCCcCHHHHHHHh-hcCCcCCc--cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 99999997643221 111111 11223333 3689999999999998 999999643 6999999999999999987
Q ss_pred c
Q 010116 404 Y 404 (518)
Q Consensus 404 ~ 404 (518)
.
T Consensus 267 ~ 267 (279)
T cd05633 267 Y 267 (279)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=368.05 Aligned_cols=257 Identities=47% Similarity=0.843 Sum_probs=220.1
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHH-HhCCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA-EVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
+.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++. ..+||||++++++|...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999999999999999998765444444445556655544 45899999999999999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------------ 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------------ 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
.....|++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 150 -----------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~ 188 (260)
T cd05611 150 -----------------------------------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188 (260)
T ss_pred -----------------------------------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH
Confidence 013468899999999998889999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
|.+||...+.......+..............+++++.++|.+||. ||.+|+++.+++|++.||||++++|+
T Consensus 189 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 189 GYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 999999888877776665532222212223578999999999998 99999988788999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=383.13 Aligned_cols=258 Identities=29% Similarity=0.423 Sum_probs=217.6
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
+..++|++.+.||.|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34589999999999999999999999999999999987542 2334566889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
+||||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++..+...
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999999998888899999999999999999999975 7999999999999999999999999998754211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.....+||+.|+|||++.+..++.++|||||
T Consensus 158 -------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 188 (333)
T cd06650 158 -------------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (333)
T ss_pred -------------------------------------------------ccccCCCCccccCHHHhcCCCCCcHHHHHHH
Confidence 0113579999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHH--------------------------------------------HhhhcCcccCC
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRK--------------------------------------------IVHWRNHLKFP 357 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~--------------------------------------------i~~~~~~l~~p 357 (518)
||++|+|++|+.||........... +.+. ....++
T Consensus 189 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 267 (333)
T cd06650 189 GLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLP 267 (333)
T ss_pred HHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcC-CCccCC
Confidence 9999999999999976544322111 1110 011111
Q ss_pred CCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 358 DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 358 ~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
. ..+++++++||.+||. ||.+|+ ++.|++.||||+..
T Consensus 268 ~-~~~~~~~~~li~~~L~~~P~~Rp---t~~ell~h~~~~~~ 305 (333)
T cd06650 268 S-GVFGAEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRS 305 (333)
T ss_pred C-CCcCHHHHHHHHHhccCCcccCc---CHHHHhhCHHHhcC
Confidence 1 2367899999999999 999999 89999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=387.31 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=212.1
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC-----
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT----- 158 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~----- 158 (518)
..++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3578999999999999999999999999999999987543 2233456678899999999999999999988654
Q ss_pred -CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 -~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
..+|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999964 67777643 58899999999999999999999999999999999999999999999999997542
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
... .....+||+.|+|||++.+..|+.++|
T Consensus 178 ~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~D 207 (364)
T cd07875 178 TSF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVD 207 (364)
T ss_pred CCC--------------------------------------------------cccCCcccCCcCCHHHHhCCCCCchhh
Confidence 110 112457999999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc----------------------------------ccCCC----C
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH----------------------------------LKFPD----D 359 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------------------------------l~~p~----~ 359 (518)
||||||++|+|++|..||.+.+......+++..... ..++. .
T Consensus 208 iwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (364)
T cd07875 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287 (364)
T ss_pred HHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccccccccc
Confidence 999999999999999999988877766665431110 00110 0
Q ss_pred CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 360 SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 360 ~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
...+.++++||.+||+ ||.+|+ ++.++++||||.
T Consensus 288 ~~~~~~~~dll~~mL~~dP~~R~---t~~e~L~hp~~~ 322 (364)
T cd07875 288 KLKASQARDLLSKMLVIDASKRI---SVDEALQHPYIN 322 (364)
T ss_pred ccccHHHHHHHHHhcCcCcccCC---CHHHHhcCcccc
Confidence 1135688999999999 999999 899999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=388.83 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=208.5
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++|+||++++++|.+.+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 4578999999999999999999999999999999986542 22345678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||||++||+|... ....+..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.+....
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 222 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--- 222 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc---
Confidence 9999999998643 356788888999999999999999999999999999999999999999999988653110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-----CCCCccccc
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KGYGMECDW 318 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~Di 318 (518)
....+.+||+.|+|||++.. ..++.++||
T Consensus 223 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dv 256 (353)
T PLN00034 223 ----------------------------------------------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDI 256 (353)
T ss_pred ----------------------------------------------ccccccccCccccCccccccccccCcCCCcchhH
Confidence 00124579999999999853 234679999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHh--hhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIV--HWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
|||||++|||++|+.||...........+. ........ ...++.++++||.+||. ||.+|+ ++.||++||||
T Consensus 257 wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~Rp---t~~ell~hp~~ 331 (353)
T PLN00034 257 WSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEA--PATASREFRHFISCCLQREPAKRW---SAMQLLQHPFI 331 (353)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCC--CCccCHHHHHHHHHHccCChhhCc---CHHHHhcCccc
Confidence 999999999999999997543322211111 11112222 24688999999999998 999999 89999999999
Q ss_pred ccC
Q 010116 396 KDV 398 (518)
Q Consensus 396 ~~i 398 (518)
.+-
T Consensus 332 ~~~ 334 (353)
T PLN00034 332 LRA 334 (353)
T ss_pred ccC
Confidence 863
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=385.42 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=209.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 159 (518)
.++|++++.||+|+||.||+|++..+|+.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 578999999999999999999999999999999997642 22334566788999999999999999999987543
Q ss_pred -eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 -YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 -~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|+||||+.+ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 57999999965 5666653 3589999999999999999999999999999999999999999999999999875321
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
. ......+||+.|+|||++.+..|+.++||
T Consensus 176 ~--------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 205 (359)
T cd07876 176 N--------------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDI 205 (359)
T ss_pred C--------------------------------------------------ccCCCCcccCCCCCchhccCCCCCcchhh
Confidence 1 01124579999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhc--------------------Cccc--------------CCC----CC
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWR--------------------NHLK--------------FPD----DS 360 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--------------------~~l~--------------~p~----~~ 360 (518)
|||||++|+|++|.+||.+.+.......+.... .... +|. ..
T Consensus 206 wSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (359)
T cd07876 206 WSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDK 285 (359)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccccccccc
Confidence 999999999999999998876554433332210 0000 110 11
Q ss_pred CCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 361 KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 361 ~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
..++++++||.+||+ ||.+|+ ++.|++.||||..
T Consensus 286 ~~~~~~~~li~~mL~~dP~~R~---t~~e~l~hp~~~~ 320 (359)
T cd07876 286 LKTSQARDLLSKMLVIDPDKRI---SVDEALRHPYITV 320 (359)
T ss_pred ccchhHHHHHHHHhccCcccCC---CHHHHhcCchhhh
Confidence 246789999999999 999999 8999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=398.57 Aligned_cols=257 Identities=30% Similarity=0.432 Sum_probs=221.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecC-CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKS-GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t-~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
..|.+.+.||+|+||.||+|....+ +..||+|.+... .......+++|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3499999999999999999998877 788999976443 233456678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 165 MEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 165 mEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
|||++||+|.++|.. ...+++..+..++.|++.||+|||++|||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999988753 3578999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
. .....+.+||+.|+|||++.+..|+.++||||
T Consensus 224 ~-----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 256 (478)
T PTZ00267 224 S-----------------------------------------------LDVASSFCGTPYYLAPELWERKRYSKKADMWS 256 (478)
T ss_pred c-----------------------------------------------cccccccCCCccccCHhHhCCCCCCcHHhHHH
Confidence 0 00123578999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|||++|||++|+.||.+.+.......+.... ...+| ..+++++++||.+||. ||.+|+ ++.+++.|||++.+
T Consensus 257 lG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~--~~~s~~~~~li~~~L~~dP~~Rp---s~~~~l~~~~~~~~ 329 (478)
T PTZ00267 257 LGVILYELLTLHRPFKGPSQREIMQQVLYGK-YDPFP--CPVSSGMKALLDPLLSKNPALRP---TTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCC--ccCCHHHHHHHHHHhccChhhCc---CHHHHHhCHHHHHH
Confidence 9999999999999999988877777776532 22233 4689999999999998 999999 89999999999754
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=369.10 Aligned_cols=258 Identities=36% Similarity=0.672 Sum_probs=213.8
Q ss_pred eEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHH---HHHhCCCceeEEEEEeecCCeEEEEEeecC
Q 010116 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL---LAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 93 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i---l~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
+||+|+||.||+|++..+++.||+|++.+..............|..+ ++...||+|++++++|.+.+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987644333322333444443 444579999999999999999999999999
Q ss_pred CCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccc
Q 010116 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (518)
Q Consensus 170 gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 249 (518)
||+|..++.+.+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---------- 150 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---------- 150 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----------
Confidence 9999999988889999999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhHHHHHH
Q 010116 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 328 (518)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyem 328 (518)
.....+||+.|+|||++.+ ..|+.++|+||+||++|+|
T Consensus 151 -----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l 189 (278)
T cd05606 151 -----------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 189 (278)
T ss_pred -----------------------------------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHH
Confidence 0113579999999999975 4689999999999999999
Q ss_pred HhCCCCCCCCCh---hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccc
Q 010116 329 LVGYPPFYADDP---ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 329 l~G~~PF~~~~~---~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~ 402 (518)
++|..||..... ......+.. ....+|. .+|+++.+||.+||. ||.+|+.+. ++.++++||||++++|..
T Consensus 190 ~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 190 LRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred HhCCCCCCCCCccchHHHHHHhhc--cCCCCCC--cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 999999987632 222222221 2334443 579999999999998 999999876 899999999999999998
Q ss_pred ccc
Q 010116 403 LYE 405 (518)
Q Consensus 403 l~~ 405 (518)
+..
T Consensus 266 ~~~ 268 (278)
T cd05606 266 VFL 268 (278)
T ss_pred hhh
Confidence 864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=364.03 Aligned_cols=259 Identities=32% Similarity=0.541 Sum_probs=224.3
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
++|++.+.||+|+||.||.|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754322 22345678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||||++|++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.+|.++|+|||+++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~- 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS- 160 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754321000
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
........|++.|+|||++.+..++.++|+|||||
T Consensus 161 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (263)
T cd06625 161 ---------------------------------------------GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGC 195 (263)
T ss_pred ---------------------------------------------cccccCCCcCccccCcceeccCCCCchhhhHHHHH
Confidence 00001356889999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
++|||++|++||.+.+......++........+| ..++..+.+||.+||. +|.+|+ ++.++++||||
T Consensus 196 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 263 (263)
T cd06625 196 TVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP--SHVSPDARNFLRRTFVENAKKRP---SAEELLRHFFV 263 (263)
T ss_pred HHHHHHhCCCCccccchHHHHHHHhccCCCCCCC--ccCCHHHHHHHHHHhhcCcccCC---CHHHHhhCCCC
Confidence 9999999999998887776666666544444454 3689999999999998 999999 89999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=376.21 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=215.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|.+++.||+|+||.||+|+++.+++.||+|+++.... ......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999999875432 22334567899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||+++ +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--- 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc---
Confidence 999965 888887654 568999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
......+||+.|+|||++.+ ..++.++||||||
T Consensus 159 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 192 (309)
T cd07872 159 ----------------------------------------------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVG 192 (309)
T ss_pred ----------------------------------------------cccccccccccccCCHHHhCCCCCCcHHHHHHHH
Confidence 00113468999999999876 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcC-----------------cccCCC---------CCCCChhHHHHHHHHhc-
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRN-----------------HLKFPD---------DSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~-----------------~l~~p~---------~~~~s~~~~dLI~~lL~- 375 (518)
|++|+|++|++||.+.+.......+..... ...+|. ...+++++++||.+||.
T Consensus 193 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 272 (309)
T cd07872 193 CIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQY 272 (309)
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccC
Confidence 999999999999998876655554432100 011111 12478999999999999
Q ss_pred cccccCCCCChhhhhcCcccccC
Q 010116 376 DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||.+|+ ++.|++.||||+++
T Consensus 273 dp~~R~---t~~e~l~h~~~~~~ 292 (309)
T cd07872 273 ESKKRI---SAEEAMKHAYFRSL 292 (309)
T ss_pred ChhhCC---CHHHHhcChhhhhc
Confidence 999999 89999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=399.79 Aligned_cols=262 Identities=28% Similarity=0.457 Sum_probs=223.7
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC---
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE--- 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~--- 159 (518)
...++|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|..++|++|++++..|....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 445799999999999999999999999999999999976543 3344566888999999999999999998775432
Q ss_pred -----eEEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeec
Q 010116 160 -----YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (518)
Q Consensus 160 -----~lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DF 230 (518)
.+++||||++||+|.+++.. ...+++..+..++.|++.||.|||++|||||||||+|||++.+|++||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 47899999999999999864 247999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 310 (518)
|+++.+..... .....+.+||+.|+|||++.+.
T Consensus 188 Gls~~~~~~~~-----------------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~ 220 (496)
T PTZ00283 188 GFSKMYAATVS-----------------------------------------------DDVGRTFCGTPYYVAPEIWRRK 220 (496)
T ss_pred ccCeecccccc-----------------------------------------------ccccccccCCcceeCHHHhCCC
Confidence 99986532100 0012256899999999999999
Q ss_pred CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhh
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI 389 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei 389 (518)
.|+.++|||||||++|||++|..||.+.+......++.... ...+| ..+++++.+||.+||+ ||.+|+ ++.++
T Consensus 221 ~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~L~~dP~~RP---s~~el 294 (496)
T PTZ00283 221 PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-YDPLP--PSISPEMQEIVTALLSSDPKRRP---SSSKL 294 (496)
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcccChhhCc---CHHHH
Confidence 99999999999999999999999999988877777776532 12233 4689999999999998 999999 89999
Q ss_pred hcCcccccC
Q 010116 390 KAHPWFKDV 398 (518)
Q Consensus 390 l~Hpff~~i 398 (518)
++|||++..
T Consensus 295 l~~p~~~~~ 303 (496)
T PTZ00283 295 LNMPICKLF 303 (496)
T ss_pred HhCHHHHHh
Confidence 999999853
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=363.82 Aligned_cols=255 Identities=37% Similarity=0.613 Sum_probs=214.9
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
|++++.||+|+||+||+|++..+++.||+|++......... ......|..+++.++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999887543332 22334599999999999999999999999999999999
Q ss_pred cCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccc
Q 010116 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247 (518)
Q Consensus 168 ~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 247 (518)
+++++|.+++.....+++..+..++.|++.||.+||++||+||||||+||+++.+|.++|+|||++......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-------- 151 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-------- 151 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------
Confidence 999999999988889999999999999999999999999999999999999999999999999998753110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-CCCCCccccccchhHHHH
Q 010116 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvily 326 (518)
.......+||+.|+|||++. +..++.++||||||+++|
T Consensus 152 -----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 190 (260)
T PF00069_consen 152 -----------------------------------------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILY 190 (260)
T ss_dssp -----------------------------------------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccccccccccccccccccccccccccccccccccccc
Confidence 01123567999999999998 788999999999999999
Q ss_pred HHHhCCCCCCCCC---hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 327 EMLVGYPPFYADD---PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 327 eml~G~~PF~~~~---~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+|++|..||.... ......+................++++.+||.+||. ||.+|+ ++.++++||||
T Consensus 191 ~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~---~~~~l~~~~~~ 260 (260)
T PF00069_consen 191 ELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRP---SAEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGST---THHHHHTSGGG
T ss_pred cccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCc---CHHHHhcCCCC
Confidence 9999999999873 333333333311111222111234899999999998 999999 89999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=364.54 Aligned_cols=257 Identities=45% Similarity=0.840 Sum_probs=226.3
Q ss_pred EeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010116 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (518)
Q Consensus 94 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L 173 (518)
||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+...+|+||||++||+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999877655555667899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccccccc
Q 010116 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253 (518)
Q Consensus 174 ~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 253 (518)
.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.+|.++|+|||+++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------- 147 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------- 147 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------------
Confidence 9999888889999999999999999999999999999999999999999999999999988653210
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCC
Q 010116 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333 (518)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 333 (518)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.+
T Consensus 148 -------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~ 190 (262)
T cd05572 148 -------------------------------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP 190 (262)
T ss_pred -------------------------------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCC
Confidence 1124578999999999998899999999999999999999999
Q ss_pred CCCCCC--hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC--CChhhhhcCcccccCCccc
Q 010116 334 PFYADD--PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT--GGAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 334 PF~~~~--~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~--~~a~eil~Hpff~~i~w~~ 402 (518)
||.... +.....++......+.+|. .++++++++|.+||+ ||.+|++. .++.|+++||||++.+|+.
T Consensus 191 p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 262 (262)
T cd05572 191 PFGEDDEDPMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWEG 262 (262)
T ss_pred CcCCCCCCHHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCCC
Confidence 998876 6666777764344555664 458999999999998 99999942 1499999999999999973
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=396.12 Aligned_cols=262 Identities=29% Similarity=0.470 Sum_probs=231.9
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.+-|+|+..||-|+||+||+|..+.++-..|.|+|... .....+.+.-|++||+.++||+||+|+++|..++.++|+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 45678899999999999999999999988999998543 456778899999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
.|||.||-...++.. ...|++.+++.+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+......
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t---- 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST---- 183 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH----
Confidence 999999988887755 468999999999999999999999999999999999999999999999999997653210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----CCCCCccccc
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDW 318 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~Di 318 (518)
+....++.|||.||||||+. ..+|++++||
T Consensus 184 ---------------------------------------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDi 218 (1187)
T KOG0579|consen 184 ---------------------------------------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADI 218 (1187)
T ss_pred ---------------------------------------------HhhhccccCCcccccchheeeccccCCCchhhhhH
Confidence 11234899999999999986 4689999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||||+.|.||..+.||-..-++...+-+|... .++.+-.++.+|..++||+.+||. ||..|+ ++.++++||||.+
T Consensus 219 WSlGITLIEMAqiEPPHhelnpMRVllKiaKS-ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp---~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 219 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRP---PAAQLLKHPFVQN 294 (1187)
T ss_pred HhhhhHHHHHhccCCCccccchHHHHHHHhhc-CCCcccCcchhhhHHHHHHHHHHhcCCccCC---CHHHHhhCccccc
Confidence 99999999999999999999999999888764 345555567899999999999998 999999 8999999999998
Q ss_pred CCccc
Q 010116 398 VVWDK 402 (518)
Q Consensus 398 i~w~~ 402 (518)
++-.+
T Consensus 295 ~~SnK 299 (1187)
T KOG0579|consen 295 APSNK 299 (1187)
T ss_pred CCcch
Confidence 87553
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=389.86 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=216.5
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEe--cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
...+|++++.||.|+||.||+|... .++..||+|.+.+.. ...+|+.+|+.++|||||+++++|.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3457999999999999999999764 356789999886532 245799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+|||++ +++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||++..+.....
T Consensus 162 ~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9999999 478999997778999999999999999999999999999999999999999999999999999876532100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.......+||+.|+|||++.+..|+.++|||||
T Consensus 241 -----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 273 (392)
T PHA03207 241 -----------------------------------------------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSA 273 (392)
T ss_pred -----------------------------------------------cccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence 001225689999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChh---hHHHHHhhhcC--cccCCC----------------------------CCCCChhHHH
Q 010116 322 GAIMYEMLVGYPPFYADDPI---TTCRKIVHWRN--HLKFPD----------------------------DSKLSPEAKD 368 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~---~~~~~i~~~~~--~l~~p~----------------------------~~~~s~~~~d 368 (518)
||++|||++|..||.+.... ..+..++.... .+.+|. ...++.++++
T Consensus 274 Gvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (392)
T PHA03207 274 GLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEY 353 (392)
T ss_pred HHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHH
Confidence 99999999999999875432 22222222100 111111 1235678999
Q ss_pred HHHHHhc-cccccCCCCChhhhhcCcccccCCcccccc
Q 010116 369 LICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYE 405 (518)
Q Consensus 369 LI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~~ 405 (518)
||++||+ ||.+|+ ++.||+.||||...+|+.+..
T Consensus 354 li~~ml~~dp~~Rp---sa~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 354 LIAKMLTFDQEFRP---SAQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred HHHHHhccChhhCC---CHHHHhhCchhhccchhhhcC
Confidence 9999999 999999 899999999999999988753
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=388.26 Aligned_cols=253 Identities=27% Similarity=0.429 Sum_probs=216.5
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-C-----CceeEEEEEeecCCe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-S-----HCIVKLYYSFQDTEY 160 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-h-----p~Iv~l~~~f~~~~~ 160 (518)
+|+++++||+|+||.|-+|++..|++.||||++++.. ........|+.||..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 6899999999999999999999999999999998753 34455678999999997 3 389999999999999
Q ss_pred EEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC--CcEEEeeccccccc
Q 010116 161 LYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN--GHMKLSDFGLCKPL 236 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~--g~vKL~DFGla~~~ 236 (518)
+|||+|.+ +-+|+++|+.+ ..|+...++.++.||+.||.+||++||||+|||||||||..- ..|||+|||.|...
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 77999999765 579999999999999999999999999999999999999754 37999999998754
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
.. ..++.+.+..|+|||||++.+|+.+.
T Consensus 342 ~q----------------------------------------------------~vytYiQSRfYRAPEVILGlpY~~~I 369 (586)
T KOG0667|consen 342 SQ----------------------------------------------------RVYTYIQSRFYRAPEVILGLPYDTAI 369 (586)
T ss_pred CC----------------------------------------------------cceeeeeccccccchhhccCCCCCcc
Confidence 21 23477889999999999999999999
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC--------------------------------------------
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN-------------------------------------------- 352 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-------------------------------------------- 352 (518)
|+||||||++||++|.|.|.+++..+.+..|+...+
T Consensus 370 DmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~ 449 (586)
T KOG0667|consen 370 DMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKY 449 (586)
T ss_pred ceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhh
Confidence 999999999999999999999999999988876110
Q ss_pred ------cccCC-CCC--------CCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 353 ------HLKFP-DDS--------KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 353 ------~l~~p-~~~--------~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
....| ... .-...+.|||.+||. ||.+|+ ++.++++||||.+..
T Consensus 450 ~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~---tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 450 YRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI---TPAQALNHPFLTGTS 509 (586)
T ss_pred hhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC---CHHHHhcCccccccc
Confidence 00011 000 012456899999999 999999 899999999998643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=378.93 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=208.4
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEE
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS 154 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 154 (518)
+.+..++|++.++||+|+||.||+|.+. .+++.||||++.... .......+.+|..+|..+ +|||||+++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 4566789999999999999999999752 456789999987542 223456788999999999 89999999998
Q ss_pred eecC-CeEEEEEeecCCCchHHHHhhc-----------------------------------------------------
Q 010116 155 FQDT-EYLYLIMEYLPGGDMMTLLMRE----------------------------------------------------- 180 (518)
Q Consensus 155 f~~~-~~lylVmEy~~gG~L~~~l~~~----------------------------------------------------- 180 (518)
+... ..+|+||||++||+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8754 4689999999999999998642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccccc
Q 010116 181 ---------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (518)
Q Consensus 181 ---------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~ 251 (518)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--------- 230 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--------- 230 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch---------
Confidence 24778889999999999999999999999999999999999999999999999854211000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-
Q 010116 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 330 (518)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 330 (518)
....+..||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 231 --------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~ 272 (338)
T cd05102 231 --------------------------------------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 272 (338)
T ss_pred --------------------------------------hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhC
Confidence 00113456789999999999999999999999999999997
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|.+||.+..........+........| ..+++++.+||.+||. ||.+|| ++.+|++
T Consensus 273 g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---s~~el~~ 329 (338)
T cd05102 273 GASPYPGVQINEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERP---TFSALVE 329 (338)
T ss_pred CCCCCCCCCccHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999998765544444444322333333 4688999999999998 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=380.01 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=210.2
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC-----
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT----- 158 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~----- 158 (518)
..++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35789999999999999999999999999999999875422 233456677899999999999999999998654
Q ss_pred -CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 -~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
..+|+||||+++ +|...+.. .+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999965 67666643 58999999999999999999999999999999999999999999999999997543
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
... .....+||+.|+|||++.+..|+.++|
T Consensus 171 ~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~D 200 (355)
T cd07874 171 TSF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVD 200 (355)
T ss_pred Ccc--------------------------------------------------ccCCccccCCccCHHHHcCCCCCchhh
Confidence 110 112457999999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC-------------------------ccc---------CCC----C
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN-------------------------HLK---------FPD----D 359 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-------------------------~l~---------~p~----~ 359 (518)
||||||++|+|++|..||.+.+.......++.... .+. ++. .
T Consensus 201 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (355)
T cd07874 201 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280 (355)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccc
Confidence 99999999999999999998776555443332100 000 000 1
Q ss_pred CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 360 SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 360 ~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
...+.++++||.+||. ||.+|+ ++.||++||||..
T Consensus 281 ~~~~~~~~~li~~mL~~dP~~Rp---s~~ell~hp~~~~ 316 (355)
T cd07874 281 KLKASQARDLLSKMLVIDPAKRI---SVDEALQHPYINV 316 (355)
T ss_pred cccchHHHHHHHHHhcCCchhcC---CHHHHhcCcchhc
Confidence 1245788999999998 999999 8999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=381.34 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=212.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------ 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------ 158 (518)
.++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+|+.++||||++++++|.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3689999999999999999999999999999999876432 223345677899999999999999999988643
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..+|++||++ |++|..++. ...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 3579999998 889987774 56799999999999999999999999999999999999999999999999999875421
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 317 (518)
. ..+.+||+.|+|||++.+ ..|+.++|
T Consensus 171 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 198 (343)
T cd07878 171 E----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVD 198 (343)
T ss_pred C----------------------------------------------------cCCccccccccCchHhcCCccCCchhh
Confidence 1 124579999999999987 57899999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---------------------cCCC------CCCCChhHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL---------------------KFPD------DSKLSPEAKDLI 370 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---------------------~~p~------~~~~s~~~~dLI 370 (518)
||||||++|+|++|++||.+.+.......+....... ..+. ....++.+.+||
T Consensus 199 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 278 (343)
T cd07878 199 IWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLL 278 (343)
T ss_pred hHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHH
Confidence 9999999999999999998877665555543321100 0111 123567899999
Q ss_pred HHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
.+||. ||.+|+ ++.|++.||||...
T Consensus 279 ~~mL~~dp~~R~---s~~ell~hp~~~~~ 304 (343)
T cd07878 279 EKMLVLDSDKRI---SASEALAHPYFSQY 304 (343)
T ss_pred HHHcCCChhhCC---CHHHHhcCcchhcc
Confidence 99998 999999 89999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=382.84 Aligned_cols=257 Identities=35% Similarity=0.631 Sum_probs=224.5
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG 171 (518)
++||+|-||+||-++++.+|+.||||+|.|-.+... +...+++|+.||..+.||.||.|-.-|++.+.+++|||-+ .|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 689999999999999999999999999998876544 4578999999999999999999999999999999999999 56
Q ss_pred chHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC---cEEEeecccccccCCCccccccc
Q 010116 172 DMMTLLM--REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 172 ~L~~~l~--~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g---~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|+.+.+. ..++++|...+|++.||+.||.|||-+||+|.|||||||||.+.. .+||||||+|+.+....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks------ 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS------ 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh------
Confidence 7777764 358999999999999999999999999999999999999997643 69999999999875321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
...+.||||.|+|||||++++|+.+-|+||+|||+|
T Consensus 722 --------------------------------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiY 757 (888)
T KOG4236|consen 722 --------------------------------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIY 757 (888)
T ss_pred --------------------------------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEE
Confidence 123789999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHhhhcCcccCCC--CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC-ccc
Q 010116 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV-WDK 402 (518)
Q Consensus 327 eml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~-w~~ 402 (518)
--|.|..||..+. ++-.+|.+. .+-+|. |..+|++|.|||..||+ .-.+|. ++...+.|||+++.. |-+
T Consensus 758 VsLSGTFPFNEdE--dIndQIQNA--aFMyPp~PW~eis~~AidlIn~LLqVkm~kRy---svdk~lsh~Wlq~yq~w~D 830 (888)
T KOG4236|consen 758 VSLSGTFPFNEDE--DINDQIQNA--AFMYPPNPWSEISPEAIDLINNLLQVKMRKRY---SVDKSLSHPWLQDYQTWLD 830 (888)
T ss_pred EEecccccCCCcc--chhHHhhcc--ccccCCCchhhcCHHHHHHHHHHHHHHHHHhc---chHhhccchhhhcchHHHH
Confidence 9999999997654 344555552 344443 56799999999999998 999999 899999999999875 888
Q ss_pred ccccc
Q 010116 403 LYEME 407 (518)
Q Consensus 403 l~~~~ 407 (518)
|++++
T Consensus 831 LRelE 835 (888)
T KOG4236|consen 831 LRELE 835 (888)
T ss_pred HHHHH
Confidence 87544
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=386.88 Aligned_cols=258 Identities=30% Similarity=0.553 Sum_probs=233.0
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
...+..|.+++.||+|.|++|.++++..|+..||||.+.|..... ....++.+|+++|..++|||||+||.+......+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 445678999999999999999999999999999999999876433 3345588999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||+.||+++++|.+.++..+..++.++.|++.|++|||+++|||||||++||||+.+.++||+|||++..+..+.
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~- 209 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL- 209 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998775331
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-Cccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWS 320 (518)
...+.||+|.|.|||+..+..| +.++|+||
T Consensus 210 -------------------------------------------------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Ws 240 (596)
T KOG0586|consen 210 -------------------------------------------------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWS 240 (596)
T ss_pred -------------------------------------------------cccccCCCCCccChHhhcCcccCCcceehhh
Confidence 2237899999999999999888 78999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+|+++|-|+.|..||.+.+-.+....++..+ +.+|. .+|.++++||+++|. +|.+|. +.++|..|.|...
T Consensus 241 lgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk--~rIp~--~ms~dce~lLrk~lvl~Pskr~---~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 241 LGVVLYALVEGSLPFDGQNLKELRPRVLRGK--YRIPF--YMSCDCEDLLRKFLVLNPSKRG---PCDQIMKDRWRND 311 (596)
T ss_pred hhhhheeeeecccccCCcccccccchheeee--ecccc--eeechhHHHHHHhhccCccccC---CHHHhhhhcccch
Confidence 9999999999999999998888777777644 44443 489999999999998 999999 8999999999874
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=366.45 Aligned_cols=265 Identities=30% Similarity=0.461 Sum_probs=225.2
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..+.|++++.||.|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||++++++|..+..+|+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 346799999999999999999999999999999998754 23446678889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||||++||+|..++.+ ...+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999999999888754 4678999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----CCCCCcccc
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECD 317 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~D 317 (518)
.......|++.|+|||++. ...|+.++|
T Consensus 165 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 197 (292)
T cd06644 165 -----------------------------------------------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 197 (292)
T ss_pred -----------------------------------------------cccceecCCccccCceeeccccccCCCCCchhh
Confidence 0012456899999999985 345788999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
||||||++|||++|.+||...++.....++.... ....+....++.++.+||.+||. ||.+|+ ++++|++||||.
T Consensus 198 v~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~ 273 (292)
T cd06644 198 IWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTLSQPSKWSMEFRDFLKTALDKHPETRP---SAAQLLEHPFVS 273 (292)
T ss_pred hHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC-CccCCCCcccCHHHHHHHHHHhcCCcccCc---CHHHHhcCcccc
Confidence 9999999999999999998877766665554421 12223334688999999999998 999999 899999999999
Q ss_pred cCCccccc
Q 010116 397 DVVWDKLY 404 (518)
Q Consensus 397 ~i~w~~l~ 404 (518)
.++|.+..
T Consensus 274 ~~~~~~~~ 281 (292)
T cd06644 274 SVTSNRPL 281 (292)
T ss_pred ccccchhH
Confidence 99998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=364.36 Aligned_cols=276 Identities=42% Similarity=0.754 Sum_probs=225.6
Q ss_pred CeeEEeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeE
Q 010116 87 DFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~l 161 (518)
+|++.+.||.|+||.||+|++. .+|+.||+|++.+..... ....+++.+|+.++..+ +|++|++++++|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 478999999997654332 23456788899999999 589999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||++||+|.+++.....+++..+..++.|++.||.|||+.|++||||||+|||++.+|++||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCcccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECDWW 319 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiW 319 (518)
.......+|++.|+|||++.+ ..++.++|||
T Consensus 160 -----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~ 192 (290)
T cd05613 160 -----------------------------------------------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWW 192 (290)
T ss_pred -----------------------------------------------ccccccccCCcccCChhhccCCCCCCCccccHH
Confidence 001124579999999999875 4578899999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhc--CcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWR--NHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPW 394 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpf 394 (518)
||||++|+|++|..||...........+.... ....+| ..+++.+.+||.+||. ||.+|+++. ++++++.|||
T Consensus 193 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~ 270 (290)
T cd05613 193 SMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270 (290)
T ss_pred HHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence 99999999999999997543322222222111 122333 3588999999999998 999998653 8999999999
Q ss_pred cccCCccccc--cccCCccc
Q 010116 395 FKDVVWDKLY--EMEAAFKP 412 (518)
Q Consensus 395 f~~i~w~~l~--~~~~p~~p 412 (518)
|..++|+.+. ..++||.|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~ 290 (290)
T cd05613 271 FQKINWDDLAAKKVPAPFKP 290 (290)
T ss_pred cccCCHHHHhhccCCCCCCC
Confidence 9999998874 24445543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=366.99 Aligned_cols=261 Identities=27% Similarity=0.470 Sum_probs=216.2
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++++.||.|+||.||+|+++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875432 2233457789999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||||++ ++|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 999996 5888888653 578999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccch
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSL 321 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSl 321 (518)
.......+|+.|+|||++.+ ..++.++|||||
T Consensus 159 -----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 191 (301)
T cd07873 159 -----------------------------------------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGV 191 (301)
T ss_pred -----------------------------------------------CcccccceeecccCcHHHhCCCCCccHHHHHHH
Confidence 00113467899999999876 458899999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcC-----------------cccCCC---------CCCCChhHHHHHHHHhc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRN-----------------HLKFPD---------DSKLSPEAKDLICRLLC 375 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~-----------------~l~~p~---------~~~~s~~~~dLI~~lL~ 375 (518)
||++|+|++|++||.+.+.......+..... ...+|. ...+++++++||.+||+
T Consensus 192 G~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~ 271 (301)
T cd07873 192 GCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQ 271 (301)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhc
Confidence 9999999999999998876655544433110 111121 12578899999999999
Q ss_pred -cccccCCCCChhhhhcCcccccCC
Q 010116 376 -DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 376 -dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
||.+|+ ++.||++||||+.+-
T Consensus 272 ~dp~~R~---t~~eil~h~~f~~~~ 293 (301)
T cd07873 272 FEGRKRI---SAEEAMKHPYFHCLG 293 (301)
T ss_pred CCcccCc---CHHHHhcCccccccc
Confidence 999999 899999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=362.39 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=211.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|++..+++.||+|++.+.. .......+.+|+.+++.++||||++++++|.+....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 47899999999999999999999999999999987542 2334456889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|..+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------ 148 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------ 148 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc------
Confidence 99999998654 35789999999999999999999999999999999999999999999999998754311
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
.....+||+.|+|||++.+..++.++|+|||||++
T Consensus 149 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 183 (279)
T cd06619 149 ---------------------------------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183 (279)
T ss_pred ---------------------------------------------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHH
Confidence 01245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChh-------hHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 326 YEMLVGYPPFYADDPI-------TTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 326 yeml~G~~PF~~~~~~-------~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|+|++|..||...... .....+... .....+ ...+++++++||.+||+ ||.+|+ ++++++.||||..
T Consensus 184 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp---~~~eil~~~~~~~ 258 (279)
T cd06619 184 MELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-DPPVLP-VGQFSEKFVHFITQCMRKQPKERP---APENLMDHPFIVQ 258 (279)
T ss_pred HHHHhCCCCchhhcccccccchHHHHHHHhcc-CCCCCC-CCcCCHHHHHHHHHHhhCChhhCC---CHHHHhcCccccc
Confidence 9999999999653221 222222221 112222 23578999999999998 999999 8999999999986
Q ss_pred CC
Q 010116 398 VV 399 (518)
Q Consensus 398 i~ 399 (518)
.+
T Consensus 259 ~~ 260 (279)
T cd06619 259 YN 260 (279)
T ss_pred cc
Confidence 54
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=372.07 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=194.5
Q ss_pred EeeEeecCceEEEEEEEe--cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec--CCeEEEEEe
Q 010116 91 LTIIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TEYLYLIME 166 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~~lylVmE 166 (518)
.++||+|+||+||+|+++ .+++.||+|++..... ...+.+|+.+|+.++||||++++++|.+ ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999976 4678999999865432 2346789999999999999999999854 567999999
Q ss_pred ecCCCchHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee----CCCCcEEEeecccc
Q 010116 167 YLPGGDMMTLLMRE---------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLC 233 (518)
Q Consensus 167 y~~gG~L~~~l~~~---------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl----d~~g~vKL~DFGla 233 (518)
|+. ++|..++... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.+|.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 994 6888877432 258999999999999999999999999999999999999 56689999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGY 312 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y 312 (518)
+.+...... .......+||+.|+|||++.+ ..|
T Consensus 160 ~~~~~~~~~----------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~ 193 (317)
T cd07868 160 RLFNSPLKP----------------------------------------------LADLDPVVVTFWYRAPELLLGARHY 193 (317)
T ss_pred eccCCCCcc----------------------------------------------ccccCCccccccccCCHHHcCCCCc
Confidence 865321000 001124679999999999987 468
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChh---------hHHHHHhhh---------cCcccCCC----------------
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPI---------TTCRKIVHW---------RNHLKFPD---------------- 358 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~---------~~~~~i~~~---------~~~l~~p~---------------- 358 (518)
+.++|||||||++|||++|.+||.+.... .....+... .....++.
T Consensus 194 ~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (317)
T cd07868 194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC 273 (317)
T ss_pred CchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcc
Confidence 99999999999999999999999754321 112222210 00000000
Q ss_pred ---------CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 359 ---------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 359 ---------~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
....+.++.|||.+||+ ||.+|+ +++|+++||||
T Consensus 274 ~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07868 274 SLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYF 317 (317)
T ss_pred cccchHHhcCCCCChHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 01235679999999999 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=367.71 Aligned_cols=255 Identities=30% Similarity=0.436 Sum_probs=215.6
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|++++..++||||++++++|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986532 2334556888999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||++||+|.+++.+.+.+++..++.++.|++.||.|||+ ++++||||||+|||++.+|.+||+|||++......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 153 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 153 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence 999999999999888899999999999999999999997 69999999999999999999999999998643211
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
...+.+|++.|+|||++.+..++.++|+|||||+
T Consensus 154 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~ 187 (308)
T cd06615 154 ----------------------------------------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187 (308)
T ss_pred ----------------------------------------------ccccCCCCcCccChhHhcCCCCCccchHHHHHHH
Confidence 0124579999999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhc-----------------------------------CcccCCCCCCCChhHHHH
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWR-----------------------------------NHLKFPDDSKLSPEAKDL 369 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~-----------------------------------~~l~~p~~~~~s~~~~dL 369 (518)
+|+|++|..||...+.......+-... .....|. ..+++++++|
T Consensus 188 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 266 (308)
T cd06615 188 LVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDF 266 (308)
T ss_pred HHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHH
Confidence 999999999997665433322111100 0111121 1368899999
Q ss_pred HHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 370 ICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 370 I~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|.+||. ||.+|+ ++.+|+.||||.+
T Consensus 267 i~~~l~~~P~~Rp---t~~~ll~~~~~~~ 292 (308)
T cd06615 267 VDKCLKKNPKERA---DLKELTKHPFIKR 292 (308)
T ss_pred HHHHccCChhhCc---CHHHHhcChhhhh
Confidence 999998 999999 8999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=356.38 Aligned_cols=260 Identities=31% Similarity=0.526 Sum_probs=218.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhh--hchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--CeE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYL 161 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~l 161 (518)
++|++.+.||+|+||.||++++..+|..||||++..... ........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998864321 1233567788999999999999999999998764 578
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||++||+|.+++.+...+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999876431100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
. .......+||..|+|||++.+..++.++|||||
T Consensus 162 ~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 195 (265)
T cd06652 162 S----------------------------------------------GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSV 195 (265)
T ss_pred c----------------------------------------------ccccccCCCCccccChhhhcCCCCCcchhHHHH
Confidence 0 000123568999999999999899999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCcccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~ 396 (518)
||++|||++|++||...+......++.........| ..++..+.++|++||.+|.+|+ ++++|+.|||++
T Consensus 196 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~p~~Rp---~~~~il~~~~~~ 265 (265)
T cd06652 196 GCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLRP---SADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc--hhhCHHHHHHHHHHhcChhhCC---CHHHHhcCcccC
Confidence 999999999999998876665555554322222233 3578899999999999999999 899999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=357.08 Aligned_cols=264 Identities=49% Similarity=0.889 Sum_probs=227.0
Q ss_pred EeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010116 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (518)
Q Consensus 94 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L 173 (518)
||.|+||.||+|++..+|+.||+|++.+.........+.+.+|.++++.++||||+++++.+.+...+|+||||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999877655556678899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccccccc
Q 010116 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253 (518)
Q Consensus 174 ~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 253 (518)
.+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--------- 151 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--------- 151 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc---------
Confidence 99998878999999999999999999999999999999999999999999999999999875432110000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCC
Q 010116 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333 (518)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 333 (518)
+ .........+|++.|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 152 ------------~--------------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 199 (265)
T cd05579 152 ------------N--------------------DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199 (265)
T ss_pred ------------c--------------------cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 0 00001124568899999999998889999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 334 PFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 334 PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
||...........+.. ..+.+|....+++.+.+||.+||+ +|.+|+...++.+++.||||++++|
T Consensus 200 p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 200 PFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred CCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 9998888777777665 345555544468999999999998 9999996555699999999999999
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=362.55 Aligned_cols=274 Identities=42% Similarity=0.758 Sum_probs=226.3
Q ss_pred CeeEEeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeE
Q 010116 87 DFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~l 161 (518)
+|++.+.||+|+||.||+|+.. .+++.||||++++..... .....++.+|..++..+ +||+|++++++|.+...+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5889999999999999999864 467899999998654432 23456678899999999 699999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||++||+|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC--CCcccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--YGMECDWW 319 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y~~~~DiW 319 (518)
.......+|++.|+|||++.+.. ++.++|+|
T Consensus 160 -----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~ 192 (288)
T cd05583 160 -----------------------------------------------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWW 192 (288)
T ss_pred -----------------------------------------------ccccccccCCccccCHHHhcCCCCCCcchhhhH
Confidence 00112457899999999987654 78999999
Q ss_pred chhHHHHHHHhCCCCCCCCChh----hHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPI----TTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~----~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
|||+++|+|++|..||...... .....+.. ... +....+++++.+||.+||. ||.+|++..++.++++|||
T Consensus 193 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 193 SLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--SKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred HHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc--cCC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 9999999999999999654322 22223322 122 2234688999999999998 9999997777899999999
Q ss_pred cccCCccccc--cccCCccc
Q 010116 395 FKDVVWDKLY--EMEAAFKP 412 (518)
Q Consensus 395 f~~i~w~~l~--~~~~p~~p 412 (518)
|+.++|+.+. ...+||.|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~ 288 (288)
T cd05583 269 FQGIDWDDLAAKRIPAPFKP 288 (288)
T ss_pred cccCCHHHHhhhccCCCCCC
Confidence 9999998885 35566654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=351.74 Aligned_cols=253 Identities=29% Similarity=0.547 Sum_probs=216.3
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-CCeEEEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-TEYLYLIM 165 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-~~~lylVm 165 (518)
+|++++.||+|+||.||++.++.+++.||+|++..... .....+.+.+|..+++.++|+||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999876432 23345668889999999999999999998874 45789999
Q ss_pred eecCCCchHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 166 EYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 166 Ey~~gG~L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||++|++|.+++.. ...+++..+..++.+++.||.+||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 99999999999865 3468999999999999999999999999999999999999999999999999987653210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
.......|++.|+|||++.+..++.++|||||||
T Consensus 157 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08223 157 ----------------------------------------------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGC 190 (257)
T ss_pred ----------------------------------------------CccccccCCcCccChhHhcCCCCCchhhhHHHHH
Confidence 0112456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
++|+|++|..||...+.......+.... ....+ ..+++++.+||.+||+ ||.+|+ ++.++++||||
T Consensus 191 il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 257 (257)
T cd08223 191 CVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMP--KDYSPELGELIATMLSKRPEKRP---SVKSILRQPYI 257 (257)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCc--cccCHHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 9999999999998877766665555421 11222 3688999999999998 999999 89999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=358.88 Aligned_cols=255 Identities=28% Similarity=0.485 Sum_probs=214.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|..+++.++||||+++++++.+.+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 457888999999999999999999999999999987542 22345677899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..+....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~---- 160 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI---- 160 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc----
Confidence 9999999999999888899999999999999999999999999999999999999999999999999987543110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CCCCCccccccch
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWSL 321 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSl 321 (518)
......+||+.|+|||++. ...++.++|+|||
T Consensus 161 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSl 195 (267)
T cd06645 161 ---------------------------------------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAV 195 (267)
T ss_pred ---------------------------------------------cccccccCcccccChhhhccccCCCCCchhhhHHH
Confidence 0011457999999999985 4568999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcC-cccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRN-HLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
||++|+|++|.+||....+......+..... ...+.....++..+.+||.+||. ||.+|+ ++.+|+.|||
T Consensus 196 G~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~ll~~~~ 267 (267)
T cd06645 196 GITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRP---TAEKLLQHPF 267 (267)
T ss_pred HHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCc---CHHHHhcCCC
Confidence 9999999999999987665444433322111 11111223578899999999998 999999 8999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=404.16 Aligned_cols=265 Identities=29% Similarity=0.458 Sum_probs=220.2
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD- 157 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~- 157 (518)
..+....++|++++.||+|+||+||+|+++.++..||+|++..... .......+..|+.+|+.++|||||+++++|.+
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 4456677899999999999999999999999999999999876543 23345678899999999999999999999854
Q ss_pred -CCeEEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CeEEcCCCCCceeeCC----
Q 010116 158 -TEYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKH-------NYIHRDIKPDNLLLDK---- 221 (518)
Q Consensus 158 -~~~lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~-------giiHRDIKPeNILld~---- 221 (518)
...+||||||+++|+|..+|.. ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4579999999999999999865 35799999999999999999999985 4999999999999964
Q ss_pred -------------CCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhc
Q 010116 222 -------------NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNR 288 (518)
Q Consensus 222 -------------~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (518)
.+.+||+|||++..+...
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~------------------------------------------------- 195 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIE------------------------------------------------- 195 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccc-------------------------------------------------
Confidence 345899999998754311
Q ss_pred ccccccccCCCCccChhhhcC--CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhH
Q 010116 289 RKLAFSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEA 366 (518)
Q Consensus 289 ~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~ 366 (518)
......+||+.|+|||++.+ ..|+.++||||||||||||++|.+||...+.......++.. ...+|. ...++++
T Consensus 196 -s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~--~p~lpi-~~~S~eL 271 (1021)
T PTZ00266 196 -SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKR--GPDLPI-KGKSKEL 271 (1021)
T ss_pred -ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhc--CCCCCc-CCCCHHH
Confidence 01124579999999999965 45899999999999999999999999876655554444432 222332 3578999
Q ss_pred HHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 367 KDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 367 ~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
.+||.+||. +|.+|| ++.+++.||||+.+..
T Consensus 272 ~dLI~~~L~~dPeeRP---Sa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 272 NILIKNLLNLSAKERP---SALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHHHHhcCChhHCc---CHHHHhccHHHhhcCC
Confidence 999999998 999999 8999999999987653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=361.67 Aligned_cols=248 Identities=21% Similarity=0.253 Sum_probs=213.2
Q ss_pred CCCeeEE--eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec----C
Q 010116 85 VDDFELL--TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----T 158 (518)
Q Consensus 85 ~~~f~i~--~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~----~ 158 (518)
.++++.. ..||+|++|.||+|.. +|+.||||++.+.........+.+.+|+.+|..++|||||+++++|.+ .
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 3444444 6899999999999976 689999999987644333446778899999999999999999999877 4
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
..+|+||||++||+|.+++.....+++..+..++.+++.||.|||+ .+++||||||+|||++.+|.+||+|||+++...
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 5789999999999999999888889999999999999999999998 599999999999999999999999999987542
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCcc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGME 315 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~ 315 (518)
.. ....+||+.|+|||++.+ ..|+.+
T Consensus 175 ~~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k 202 (283)
T PHA02988 175 SP----------------------------------------------------PFKNVNFMVYFSYKMLNDIFSEYTIK 202 (283)
T ss_pred cc----------------------------------------------------cccccCcccccCHHHhhhccccccch
Confidence 11 113468999999999976 689999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+|||||||++|||++|..||.+.+.......++.....+.+| ..+++++++||.+||. ||.+|| ++.+|+.
T Consensus 203 ~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rp---s~~ell~ 274 (283)
T PHA02988 203 DDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIVEACTSHDSIKRP---NIKEILY 274 (283)
T ss_pred hhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHHHHHhcCCcccCc---CHHHHHH
Confidence 999999999999999999999988888888777654444544 3579999999999998 999999 8998874
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=354.67 Aligned_cols=259 Identities=32% Similarity=0.542 Sum_probs=217.3
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhh--hchhhHHHHHHHHHHHHHhCCCceeEEEEEeec--CCeE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TEYL 161 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~~l 161 (518)
.+|++.+.||+|+||.||+|.+..++..||+|++..... ........+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999999999999999865422 123355678899999999999999999999876 3678
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876531100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.. .......|+..|+|||++.+..++.++|+|||
T Consensus 162 ~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 195 (266)
T cd06651 162 SG----------------------------------------------TGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195 (266)
T ss_pred cC----------------------------------------------CccccCCccccccCHHHhCCCCCCchhhhHHH
Confidence 00 00113468899999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
||++|||++|++||...+......++........+| ..+++.+++||+ ||. +|.+|+ +++||+.||||+
T Consensus 196 G~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~-~~~~~p~~Rp---~~~eil~hp~~~ 265 (266)
T cd06651 196 GCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP--SHISEHARDFLG-CIFVEARHRP---SAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc--hhcCHHHHHHHH-HhcCChhhCc---CHHHHhcCcccc
Confidence 999999999999998877666555554433333444 357899999995 555 999999 899999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=358.18 Aligned_cols=255 Identities=33% Similarity=0.512 Sum_probs=209.9
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++++.||.|+||.||+|+++.++..||||++.... ........+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 6899999999999999999999999999999986542 222334667889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 167 YLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 167 y~~gG~L~~~l~~~---~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|++ |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--- 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence 997 6888887542 579999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
.......|++.|+|||++.+ ..++.++|+||||
T Consensus 156 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 189 (285)
T cd07861 156 ----------------------------------------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIG 189 (285)
T ss_pred ----------------------------------------------ccccCCcccccccChHHhcCCCCcCcHHHHHHHH
Confidence 00113467899999999876 4579999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCc----------------ccCC---------CCCCCChhHHHHHHHHhc-c
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNH----------------LKFP---------DDSKLSPEAKDLICRLLC-D 376 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------------l~~p---------~~~~~s~~~~dLI~~lL~-d 376 (518)
|++|+|++|++||.+.+.......+...... ..++ ....+++++++||.+||+ |
T Consensus 190 ~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 269 (285)
T cd07861 190 TIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYD 269 (285)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCC
Confidence 9999999999999887654433332211000 0000 012478999999999999 9
Q ss_pred ccccCCCCChhhhhcCccc
Q 010116 377 VEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 377 p~~R~g~~~a~eil~Hpff 395 (518)
|.+|+ ++.+|+.||||
T Consensus 270 P~~Rp---t~~~ll~~~~~ 285 (285)
T cd07861 270 PAKRI---SAKKALNHPYF 285 (285)
T ss_pred hhhCC---CHHHHhcCCCC
Confidence 99999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=359.68 Aligned_cols=259 Identities=29% Similarity=0.484 Sum_probs=221.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||.|+||.||++.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 46799999999999999999999889999999998654 234456788899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++||+|..++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--- 157 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--- 157 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc---
Confidence 9999999999998664 579999999999999999999999999999999999999999999999999876542110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----CCCCCccccc
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDW 318 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~Di 318 (518)
.......||+.|+|||++. ...++.++|+
T Consensus 158 ----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi 191 (280)
T cd06611 158 ----------------------------------------------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADI 191 (280)
T ss_pred ----------------------------------------------cccceeecchhhcCHHHHhhcccCCCCCCccccH
Confidence 0112457999999999985 3457889999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|||||++|+|++|.+||...+......++.... ...+..+..++.++.+||.+||. ||.+|+ ++.+|++||||..
T Consensus 192 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~ 267 (280)
T cd06611 192 WSLGITLIELAQMEPPHHELNPMRVLLKILKSE-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFVSD 267 (280)
T ss_pred HHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC-CCCcCCcccCCHHHHHHHHHHhccChhhCc---CHHHHhcChhhcc
Confidence 999999999999999999887776666665421 22233334688999999999998 999999 8999999999987
Q ss_pred CC
Q 010116 398 VV 399 (518)
Q Consensus 398 i~ 399 (518)
..
T Consensus 268 ~~ 269 (280)
T cd06611 268 QS 269 (280)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=354.94 Aligned_cols=253 Identities=42% Similarity=0.767 Sum_probs=219.6
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++.+.||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987765555567889999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|+.|++|..++.....+++..+..++.|++.||.|||++||+|+||+|+||+++.+|.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------ 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------
Confidence 99999999999877899999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
......|+..|+|||++.+..++.++|+|||||++|
T Consensus 155 --------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~ 190 (258)
T cd05578 155 --------------------------------------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAY 190 (258)
T ss_pred --------------------------------------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHH
Confidence 011346889999999999988999999999999999
Q ss_pred HHHhCCCCCCCCCh--hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCCh--hhhhcCccc
Q 010116 327 EMLVGYPPFYADDP--ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA--HQIKAHPWF 395 (518)
Q Consensus 327 eml~G~~PF~~~~~--~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a--~eil~Hpff 395 (518)
+|++|..||...+. ...+.+.... ....+| ..++.++.++|.+||. ||.+|+ ++ .|+++||||
T Consensus 191 ~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~~~l~~~~~~ 258 (258)
T cd05578 191 ECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYP--ATWSTEAIDAINKLLERDPQKRL---GDNLKDLKNHPYF 258 (258)
T ss_pred HHHhCCCCCCCCCccHHHHHHHHhcc-ccccCc--ccCcHHHHHHHHHHccCChhHcC---CccHHHHhcCCCC
Confidence 99999999988764 2222222221 223333 3678999999999998 999999 56 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=356.12 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=214.6
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++++.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3468999999999999999999999999999999986542 2334567889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||||+++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++..+....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--- 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--- 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc---
Confidence 99999999999999888899999999999999999999999999999999999999999999999999988653110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CCCCCccccccc
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWS 320 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWS 320 (518)
......+|++.|+|||++. ...++.++||||
T Consensus 161 ----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws 194 (267)
T cd06646 161 ----------------------------------------------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWA 194 (267)
T ss_pred ----------------------------------------------cccCccccCccccCHhHcccccCCCCcchhhHHH
Confidence 0011356899999999985 455888999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhc-CcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWR-NHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
|||++|||++|.+||...++......+.... .....+....++..+.+||++||+ ||.+|+ ++++|++|+|
T Consensus 195 ~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~l~ 267 (267)
T cd06646 195 VGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRP---TAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCc---CHHHHhcCCC
Confidence 9999999999999997665544333332211 111122223578999999999998 999999 8999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=356.82 Aligned_cols=255 Identities=30% Similarity=0.501 Sum_probs=216.8
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
|++++.||.|+||.||++++..++..+|+|.+.... ....+.+.+|+.+++.++||||++++++|......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 577889999999999999999999999999986542 23456788899999999999999999999999999999999
Q ss_pred cCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 168 LPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 168 ~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
++||+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~------ 157 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------ 157 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc------
Confidence 999999988765 4679999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----CCCCCccccccch
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDWWSL 321 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiWSl 321 (518)
......+||+.|+|||++. +..++.++|||||
T Consensus 158 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 194 (282)
T cd06643 158 -------------------------------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 194 (282)
T ss_pred -------------------------------------------cccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence 0011456899999999984 4567889999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||++|||++|.+||...++.....++.... ....+.+..++.++++||.+||. ||.+|+ ++.+|++||||+..
T Consensus 195 Gvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~ 268 (282)
T cd06643 195 GITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHccCCCCccccCHHHHHHHHhhcC-CCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCCCEecc
Confidence 999999999999999887766666665432 12223334688999999999998 999999 89999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=367.18 Aligned_cols=264 Identities=21% Similarity=0.349 Sum_probs=209.4
Q ss_pred EEeeEeec--CceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 90 LLTIIGRG--AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 90 i~~~LG~G--~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
++++||+| +||+||+++.+.+|+.||+|++..... .......+.+|+.+++.++||||++++++|.+++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999875432 234456788899999999999999999999999999999999
Q ss_pred cCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 168 LPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 168 ~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
+++|+|.+++... ..+++..++.++.|++.||.|||++|||||||||+|||++.++.++|+|||.+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~-- 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL-- 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc--
Confidence 9999999999653 568999999999999999999999999999999999999999999999998765432110000
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCccccccchhH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECDWWSLGA 323 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGv 323 (518)
. . ........+++..|+|||++.+ .+|+.++|||||||
T Consensus 159 ----------~-------~-----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (327)
T cd08227 159 ----------R-------V-----------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198 (327)
T ss_pred ----------c-------c-----------------------cccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence 0 0 0000113467888999999976 46999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCc------------------------------------------ccCCCCCC
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNH------------------------------------------LKFPDDSK 361 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~------------------------------------------l~~p~~~~ 361 (518)
++|||++|++||.................. ...+....
T Consensus 199 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (327)
T cd08227 199 TACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRT 278 (327)
T ss_pred HHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccc
Confidence 999999999999865543333222211000 00011123
Q ss_pred CChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 362 LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 362 ~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
+++++++||.+||+ ||.+|+ +++++++||||+.+.
T Consensus 279 ~~~~~~~li~~~l~~dP~~Rp---t~~ell~~p~f~~~~ 314 (327)
T cd08227 279 FSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFKQIK 314 (327)
T ss_pred cCHHHHHHHHHHHhhCchhcC---CHHHHhcChhhhhcc
Confidence 57889999999998 999999 899999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=351.22 Aligned_cols=259 Identities=29% Similarity=0.485 Sum_probs=221.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||.|+||+||+|....++..+|+|++.+..... ....+.+|+.+|+.++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 57999999999999999999998899999999987654322 5677899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 166 EYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~---~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||++|++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 46999999999999999999999999999999999999999999999999998865422100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccch
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSL 321 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSl 321 (518)
........+|++.|+|||++... .++.++|+|||
T Consensus 159 ---------------------------------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~sl 193 (267)
T cd06610 159 ---------------------------------------------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF 193 (267)
T ss_pred ---------------------------------------------cccccccccCChhhcChHHHccccCcCcccchHhH
Confidence 00011245799999999999876 78999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCC---CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD---SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~---~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
||++|+|++|..||...+....+.++... ....++.. ..+++++++||.+||+ ||.+|+ ++.+|+.||||
T Consensus 194 G~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~ll~~p~~ 267 (267)
T cd06610 194 GITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRP---TAEELLKHKFF 267 (267)
T ss_pred hHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccccccHHHHHHHHHHcCCChhhCc---CHHHHhhCCCC
Confidence 99999999999999888776666665543 12222222 2678999999999998 999999 89999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.11 Aligned_cols=253 Identities=34% Similarity=0.532 Sum_probs=220.2
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|.+.+.||+|+||.||+|..+.+++.||+|.+...... ......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999998765433 3345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 167 y~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+++++|+|||+++.+....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence 99999999999764 578999999999999999999999999999999999999999999999999988653210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
......+|++.|+|||++.+..++.++|+|||||+
T Consensus 156 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 190 (256)
T cd08529 156 ---------------------------------------------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVV 190 (256)
T ss_pred ---------------------------------------------chhhccccCccccCHHHhcCCCCCCccchHHHHHH
Confidence 00124578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+|+|++|..||...+.......+.... ...++ ..+++++.++|.+||+ +|++|+ ++.+++.|||+
T Consensus 191 l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 256 (256)
T cd08529 191 LYECCTGKHPFDANNQGALILKIIRGV-FPPVS--QMYSQQLAQLIDQCLTKDYRQRP---DTFQLLRNPSL 256 (256)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCc--cccCHHHHHHHHHHccCCcccCc---CHHHHhhCCCC
Confidence 999999999999888777666665521 12222 2678999999999998 999999 89999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=355.02 Aligned_cols=253 Identities=30% Similarity=0.512 Sum_probs=211.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeec------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD------ 157 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~------ 157 (518)
.+.|++.+.||+|+||.||+|+...+++.||+|++.... .....+..|+.++..+ +||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 356888999999999999999999999999999987542 2345678899999998 79999999999875
Q ss_pred CCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 35689999999999999999763 4689999999999999999999999999999999999999999999999999875
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----CC
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KK 310 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~ 310 (518)
..... ......+||+.|+|||++. +.
T Consensus 161 ~~~~~-------------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~ 191 (272)
T cd06637 161 LDRTV-------------------------------------------------GRRNTFIGTPYWMAPEVIACDENPDA 191 (272)
T ss_pred ccccc-------------------------------------------------ccCCcccccccccCHhHhccccCcCC
Confidence 43110 0012457999999999986 34
Q ss_pred CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhh
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI 389 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei 389 (518)
.|+.++|||||||++|||++|..||....+......+.. ..........++.++++||.+||. ||.+|+ ++.+|
T Consensus 192 ~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~i 266 (272)
T cd06637 192 TYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--NPAPRLKSKKWSKKFQSFIESCLVKNHSQRP---TTEQL 266 (272)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--CCCCCCCCCCcCHHHHHHHHHHcCCChhhCC---CHHHH
Confidence 688999999999999999999999987665554444332 222222234678999999999998 999999 89999
Q ss_pred hcCccc
Q 010116 390 KAHPWF 395 (518)
Q Consensus 390 l~Hpff 395 (518)
+.||||
T Consensus 267 l~~~~~ 272 (272)
T cd06637 267 MKHPFI 272 (272)
T ss_pred hhCCCC
Confidence 999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=352.14 Aligned_cols=260 Identities=30% Similarity=0.496 Sum_probs=217.6
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechh---hhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE---MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~---~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
+|++.+.||+|+||+||+|.. .+|+.+|+|.+.... .........+.+|+.+++.++|+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 578899999999999999975 578999999986432 1223345678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||||++||+|.+++.+...+++..+..++.|++.||+|||+.||+|+||+|+||+++++|.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999988643210000
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
. .........||+.|+|||++.+..++.++|+|||||
T Consensus 160 ~-------------------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~ 196 (265)
T cd06631 160 T-------------------------------------------HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGC 196 (265)
T ss_pred c-------------------------------------------ccccccccCCCccccChhhhcCCCCcchhhHHHHHH
Confidence 0 000112457999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCc-ccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNH-LKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~-l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
++|+|++|.+||...+.......+...... ..++ ..++.++.+||++||. +|.+|+ ++.+++.||||
T Consensus 197 ~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~ 265 (265)
T cd06631 197 TVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP--DSFSAAAIDFVTSCLTRDQHERP---SALQLLRHDFL 265 (265)
T ss_pred HHHHHHhCCCccccCChHHHHHHhhhccCCCCCCC--CCCCHHHHHHHHHHhcCCcccCC---CHHHHhcCCCC
Confidence 999999999999887665555444432111 1222 3688999999999998 999999 89999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=359.79 Aligned_cols=255 Identities=29% Similarity=0.512 Sum_probs=214.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|++..+|+.||+|.+.... .......+.+|+.+++.++||||++++++|.....+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47899999999999999999999999999999886531 2334567888999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 166 EYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~---~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
||++|++|..++... ..+++..++.++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999888653 379999999999999999999997 59999999999999999999999999998754211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC------CCCcc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK------GYGME 315 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~------~y~~~ 315 (518)
.....+|++.|+|||++.+. .++.+
T Consensus 157 -------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 187 (286)
T cd06622 157 -------------------------------------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ 187 (286)
T ss_pred -------------------------------------------------ccccCCCccCccCcchhcCCCCCccCCCCcc
Confidence 01134688999999998543 46889
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhh--cCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW--RNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+|+|||||++|+|++|..||...........+... .....+| ..+++++.+||.+||. +|.+|+ ++.+++.|
T Consensus 188 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~~ 262 (286)
T cd06622 188 SDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP--SGYSDDAQDFVAKCLNKIPNRRP---TYAQLLEH 262 (286)
T ss_pred cchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC--cccCHHHHHHHHHHcccCcccCC---CHHHHhcC
Confidence 99999999999999999999876554444332221 1223333 3589999999999998 999999 89999999
Q ss_pred cccccC
Q 010116 393 PWFKDV 398 (518)
Q Consensus 393 pff~~i 398 (518)
|||...
T Consensus 263 ~~~~~~ 268 (286)
T cd06622 263 PWLVKY 268 (286)
T ss_pred hhhhhc
Confidence 999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=357.20 Aligned_cols=265 Identities=19% Similarity=0.304 Sum_probs=218.0
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEec-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 155 (518)
|.+..++|++.+.||+|+||.||+|..+. .+..||+|.+..... ......+.+|..+++.++||||+++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34567899999999999999999997653 345899998865432 22334577899999999999999999999
Q ss_pred ecCCeEEEEEeecCCCchHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcE
Q 010116 156 QDTEYLYLIMEYLPGGDMMTLLMRE----------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHM 225 (518)
Q Consensus 156 ~~~~~lylVmEy~~gG~L~~~l~~~----------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~v 225 (518)
.+....|+||||++||+|.+++.+. ..++...+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 9999999999999999999999653 234567888999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChh
Q 010116 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (518)
Q Consensus 226 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 305 (518)
||+|||+++........ ......+++..|+|||
T Consensus 159 ~L~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~~pE 191 (288)
T cd05061 159 KIGDFGMTRDIYETDYY-----------------------------------------------RKGGKGLLPVRWMAPE 191 (288)
T ss_pred EECcCCccccccccccc-----------------------------------------------cccCCCcccccccCHH
Confidence 99999998854321100 0001234678899999
Q ss_pred hhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC
Q 010116 306 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383 (518)
Q Consensus 306 vl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~ 383 (518)
.+.+..++.++|+|||||++|||++ |.+||.+.+..+....+... ....++ ..+++.++++|.+||. ||.+|+
T Consensus 192 ~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp-- 266 (288)
T cd05061 192 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYLDQP--DNCPERVTDLMRMCWQFNPKMRP-- 266 (288)
T ss_pred HhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCChhHCc--
Confidence 9999999999999999999999998 89999888777666665542 222333 3568999999999998 999999
Q ss_pred CChhhhhc------CcccccCCc
Q 010116 384 GGAHQIKA------HPWFKDVVW 400 (518)
Q Consensus 384 ~~a~eil~------Hpff~~i~w 400 (518)
++.++++ ||||++++|
T Consensus 267 -s~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 267 -TFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred -CHHHHHHHHHhhcCCCCCCCCC
Confidence 7888876 999999999
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=354.97 Aligned_cols=249 Identities=31% Similarity=0.544 Sum_probs=202.5
Q ss_pred CCeeEEeeE--eecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEE
Q 010116 86 DDFELLTII--GRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 86 ~~f~i~~~L--G~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ly 162 (518)
++|++.+.+ |.|+||.||+|+.+.++..||+|++.+..... .|..+...+ +||||++++++|.+.+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 355666655 99999999999999999999999987653211 122222222 7999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-cEEEeecccccccCCCcc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-~vKL~DFGla~~~~~~~~ 241 (518)
+||||++||+|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 9999999999999998878999999999999999999999999999999999999999998 9999999998754211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
....||+.|+|||++.+..++.++|||||
T Consensus 164 ---------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 192 (267)
T PHA03390 164 ---------------------------------------------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192 (267)
T ss_pred ---------------------------------------------------ccCCCCCcccChhhhcCCCCCchhhHHHH
Confidence 13468999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||++|+|++|..||.....................+....+|+.+++||.+||+ ||.+|+. ++++|++||||++
T Consensus 193 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--~~~~~l~h~~~~~ 267 (267)
T PHA03390 193 GVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT--NYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCc--hHHHHhcCCcccC
Confidence 999999999999998654332211111111111122223689999999999999 9999993 2699999999973
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=351.56 Aligned_cols=260 Identities=32% Similarity=0.510 Sum_probs=219.2
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh------chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV------KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
.|.+.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999999999999999988654322 12345678899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+||||++|++|.+++...+.+++..++.++.|++.||.|||++|++||||+|+|||++.++.+||+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998654211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
... . .........|++.|+|||++.+..++.++|+||
T Consensus 161 ~~~--------------------~-----------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s 197 (267)
T cd06628 161 LST--------------------K-----------------------TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWS 197 (267)
T ss_pred ccC--------------------C-----------------------ccccccccCCCcCccChhHhccCCCCchhhhHH
Confidence 000 0 000011356899999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
|||++|+|++|+.||...+......++... ....+| ..++.++.+||.+||. ||.+|+ ++.+|+.||||
T Consensus 198 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 267 (267)
T cd06628 198 LGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIP--SNISSEAIDFLEKTFEIDHNKRP---TAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHhhCCCCCCCccHHHHHHHHhcc-CCCcCC--cccCHHHHHHHHHHccCCchhCc---CHHHHhhCCCC
Confidence 999999999999999887665555554442 122333 3578999999999998 999999 89999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=354.54 Aligned_cols=257 Identities=30% Similarity=0.473 Sum_probs=214.5
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875432 2223355788999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++++.|..++.....+++..++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---- 155 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence 9999998888877777899999999999999999999999999999999999999999999999999886532100
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 324 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvi 324 (518)
......|+..|+|||++.+ ..++.++|||||||+
T Consensus 156 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i 190 (286)
T cd07847 156 ---------------------------------------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCV 190 (286)
T ss_pred ---------------------------------------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHH
Confidence 0113458889999999876 568999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcC-----------------cccCCC----------CCCCChhHHHHHHHHhc-c
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRN-----------------HLKFPD----------DSKLSPEAKDLICRLLC-D 376 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~-----------------~l~~p~----------~~~~s~~~~dLI~~lL~-d 376 (518)
+|+|++|++||.+.+..+....+..... ....|. ...++..+.+||.+||+ |
T Consensus 191 ~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 270 (286)
T cd07847 191 FAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMD 270 (286)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCC
Confidence 9999999999988776554443322100 011111 12468899999999998 9
Q ss_pred ccccCCCCChhhhhcCccc
Q 010116 377 VEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 377 p~~R~g~~~a~eil~Hpff 395 (518)
|.+|+ ++.|++.||||
T Consensus 271 p~~Rp---~~~eil~~~~f 286 (286)
T cd07847 271 PTERL---SCEELLEHPYF 286 (286)
T ss_pred ccccC---CHHHHhcCCCC
Confidence 99999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=391.77 Aligned_cols=286 Identities=26% Similarity=0.367 Sum_probs=212.2
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCC-cEEEEE--------------EeechhhhchhhHHHHHHHHHHHHHhCCCc
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSG-NIYAMK--------------KLKKSEMVKRGQVEHVRAERNLLAEVASHC 147 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~-~~~AiK--------------~l~k~~~~~~~~~~~~~~E~~il~~l~hp~ 147 (518)
...++|++++.||+|+||+||+|..+... ..++.| ++.+...........+.+|+.+|+.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999999865432 222222 111111112223456789999999999999
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC
Q 010116 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE-----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN 222 (518)
Q Consensus 148 Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~-----~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~ 222 (518)
||++++++.+.+..|+||+++ +++|..++... .......++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999999999999999999 56787776432 234467788999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCcc
Q 010116 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (518)
Q Consensus 223 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 302 (518)
|.+||+|||+++.+.... .....+.+||+.|+
T Consensus 304 ~~vkL~DFGla~~~~~~~------------------------------------------------~~~~~~~~gt~~y~ 335 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKER------------------------------------------------EAFDYGWVGTVATN 335 (501)
T ss_pred CCEEEEeCCCceecCccc------------------------------------------------ccccccccCCcCCC
Confidence 999999999998653210 00122468999999
Q ss_pred ChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCC---ChhhHHHHHhhhcC--cccCCC-------------------
Q 010116 303 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYAD---DPITTCRKIVHWRN--HLKFPD------------------- 358 (518)
Q Consensus 303 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~--~l~~p~------------------- 358 (518)
|||++.+.+|+.++|||||||++|||++|..|+... ++.....+++.... ...+|.
T Consensus 336 aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~ 415 (501)
T PHA03210 336 SPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGH 415 (501)
T ss_pred CchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCcc
Confidence 999999999999999999999999999987654332 22233333322100 001111
Q ss_pred -------CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccccc---------cCCccccCCCcccC
Q 010116 359 -------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEM---------EAAFKPEINGELDT 420 (518)
Q Consensus 359 -------~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~~~---------~~p~~p~~~~~~d~ 420 (518)
...++.++.++|.+||+ ||.+|+ ++.|++.||||.+..++.+..+ -.|+.|.+..+.|+
T Consensus 416 ~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp---sa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (501)
T PHA03210 416 SVPPLIRNLGLPADFEYPLVKMLTFDWHLRP---GAAELLALPLFSAEEEEEILFIHGLKSGAAHFKPIKPACRIESDT 491 (501)
T ss_pred chhhHHHhcCCChHHHHHHHHHhccCcccCc---CHHHHhhChhhhcCCchHHHHHHhhhccccccccCCchheecccc
Confidence 12356788899999999 999999 8999999999999887665321 23566666555554
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=372.94 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=203.7
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
...+|++++.||+|+||.||+|++..+++.||+|+..+. ....|..+++.++|||||+++++|.+....|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 345799999999999999999999999999999985443 23468999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||||+. |+|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 999994 688888865 467999999999999999999999999999999999999999999999999998742110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
....+.+||+.|+|||++.+..|+.++||||||
T Consensus 211 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 243 (357)
T PHA03209 211 -----------------------------------------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAG 243 (357)
T ss_pred -----------------------------------------------cccccccccccccCCeecCCCCCCchhhHHHHH
Confidence 011245799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChh----------hHHHHHhhhc--CcccCC----------------------------CCCCC
Q 010116 323 AIMYEMLVGYPPFYADDPI----------TTCRKIVHWR--NHLKFP----------------------------DDSKL 362 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~----------~~~~~i~~~~--~~l~~p----------------------------~~~~~ 362 (518)
|++|||+++..|+....+. ..+..++... ....+| ....+
T Consensus 244 vvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (357)
T PHA03209 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNL 323 (357)
T ss_pred HHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCC
Confidence 9999999865554332111 1111111100 011111 01246
Q ss_pred ChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 363 SPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 363 s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
+.++.+||.+||. ||.+|+ ++.||++||||+.+
T Consensus 324 ~~~~~~li~~mL~~dP~~Rp---ta~e~l~hp~f~~~ 357 (357)
T PHA03209 324 PIDGEFLVHKMLTFDAAMRP---SAEEILNYPMFAQL 357 (357)
T ss_pred CchHHHHHHHHHcCCcccCc---CHHHHhcCchhccC
Confidence 7788999999999 999999 89999999999863
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=358.39 Aligned_cols=255 Identities=29% Similarity=0.503 Sum_probs=207.9
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++++.||+|+||.||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48999999999999999999999999999999876432 22334567789999999999999999999999999999999
Q ss_pred ecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 167 YLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 167 y~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|+. ++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----- 153 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----- 153 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-----
Confidence 996 578887755 5679999999999999999999999999999999999999999999999999987543110
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccchhHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAI 324 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvi 324 (518)
.......||+.|+|||++.+. .++.++|||||||+
T Consensus 154 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 189 (284)
T cd07839 154 --------------------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 189 (284)
T ss_pred --------------------------------------------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHH
Confidence 001134688999999998774 47999999999999
Q ss_pred HHHHHhCCCCCC-CCChhhHHHHHhhhc---------------CcccCCC----------CCCCChhHHHHHHHHhc-cc
Q 010116 325 MYEMLVGYPPFY-ADDPITTCRKIVHWR---------------NHLKFPD----------DSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 325 lyeml~G~~PF~-~~~~~~~~~~i~~~~---------------~~l~~p~----------~~~~s~~~~dLI~~lL~-dp 377 (518)
+|+|++|..||. +.+....+..+.... ....++. ...+++++++||.+||. ||
T Consensus 190 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 269 (284)
T cd07839 190 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNP 269 (284)
T ss_pred HHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCCh
Confidence 999999988854 444444433332210 0000110 12478999999999998 99
Q ss_pred cccCCCCChhhhhcCccc
Q 010116 378 EHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 378 ~~R~g~~~a~eil~Hpff 395 (518)
.+|+ ++++|+.||||
T Consensus 270 ~~R~---t~~~il~h~~f 284 (284)
T cd07839 270 VQRI---SAEEALQHPYF 284 (284)
T ss_pred hhcC---CHHHHhcCCCC
Confidence 9999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=354.07 Aligned_cols=257 Identities=33% Similarity=0.546 Sum_probs=221.6
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||.|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++||||++++++|.+...+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47889999999999999999999999999999987543 2334567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.+|.++|+|||+++.+....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM----- 152 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-----
Confidence 999999999998655 89999999999999999999999999999999999999999999999999998654210
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
......+||+.|+|||++.+..++.++|||||||++
T Consensus 153 --------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il 188 (274)
T cd06609 153 --------------------------------------------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA 188 (274)
T ss_pred --------------------------------------------cccccccCCccccChhhhccCCCCchhhHHHHHHHH
Confidence 011245789999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
|+|++|.+||...++......+... .....+. ..+++++.++|.+||+ ||.+|+ ++++++.||||.+..
T Consensus 189 ~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rp---t~~~il~~~~~~~~~ 258 (274)
T cd06609 189 IELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEG-NKFSKPFKDFVSLCLNKDPKERP---SAKELLKHKFIKKAK 258 (274)
T ss_pred HHHHhCCCCcccCchHHHHHHhhhc-CCCCCcc-cccCHHHHHHHHHHhhCChhhCc---CHHHHhhChhhcCCC
Confidence 9999999999887766665555442 1222222 2378999999999998 999999 899999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=351.52 Aligned_cols=260 Identities=28% Similarity=0.480 Sum_probs=216.4
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc---hhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK---RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
+|+..+.||+|+||.||++.+..+++.||+|++....... ......+..|+.+++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987543221 2245678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-cEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-~vKL~DFGla~~~~~~~~~ 242 (518)
||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888999999999999999999999999999999999999998887 4999999998765321000
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
........+||..|+|||++.+..++.++|+||||
T Consensus 161 ---------------------------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 195 (268)
T cd06630 161 ---------------------------------------------AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVG 195 (268)
T ss_pred ---------------------------------------------CCccccccccccceeCHhHhccCCCCcccchHHHH
Confidence 00001135689999999999989999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhh---cCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHW---RNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~---~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
|++|+|++|..||...+.......+... .....+| ..++++++++|.+||. ||.+|+ ++.++++||||+
T Consensus 196 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~ll~~~~~~ 268 (268)
T cd06630 196 CVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP--EHLSPGLRDVTLRCLELQPEDRP---PSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc--hhhCHHHHHHHHHHcCCCcccCc---CHHHHhcCcccC
Confidence 9999999999999765543333333221 1122223 3578999999999998 999999 899999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=372.25 Aligned_cols=258 Identities=23% Similarity=0.314 Sum_probs=211.3
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 153 (518)
.+.+..++|++.+.||+|+||.||+|++..+ +..||+|+++.... ......+.+|+.+++.+ +|+|||++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 3456677899999999999999999986544 35799999976432 23456788999999999 8999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhc-----------------------------------------------------
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE----------------------------------------------------- 180 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~----------------------------------------------------- 180 (518)
+|.+...+|+|||||+||+|.+++...
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 999999999999999999999998542
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 181 -----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 181 -----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
..+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+|+.+......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~- 268 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY- 268 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-
Confidence 24788889999999999999999999999999999999999999999999998764321000
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
....+..+|+.|||||++.+..|+.++|||||||
T Consensus 269 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGv 302 (374)
T cd05106 269 ----------------------------------------------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 302 (374)
T ss_pred ----------------------------------------------eeccCCCCccceeCHHHhcCCCCCccccHHHHHH
Confidence 0011234567899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 324 IMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 324 ilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
++|||++ |.+||..........++.........| ..+++++++||.+||+ ||.+|| ++.+|.+
T Consensus 303 il~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---s~~~l~~ 367 (374)
T cd05106 303 LLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERP---TFSQISQ 367 (374)
T ss_pred HHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9999997 999998876555555555432222333 3578999999999998 999999 8888865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=356.46 Aligned_cols=257 Identities=32% Similarity=0.539 Sum_probs=220.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
..+|++++.||.|+||.||++.+..+|+.||+|.+.... ....+.+.+|..+++.++||||++++++|.+...+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 357999999999999999999999999999999986543 23456788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||++||+|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~---- 169 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ---- 169 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc----
Confidence 999999999998854 478999999999999999999999999999999999999999999999999987543110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
......+|++.|+|||++.+..++.++|+|||||+
T Consensus 170 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvi 204 (296)
T cd06655 170 ---------------------------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204 (296)
T ss_pred ---------------------------------------------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHH
Confidence 00113468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
+|+|++|++||.+.++......+... ....+.....+++.+++||.+||. ||.+|+ ++.+|+.||||+..
T Consensus 205 l~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~il~~~~~~~~ 275 (296)
T cd06655 205 AIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSPIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhc-CCcccCCcccCCHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhhc
Confidence 99999999999988776555544432 122222334689999999999998 999999 89999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=350.39 Aligned_cols=259 Identities=29% Similarity=0.518 Sum_probs=216.7
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh-------chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-------KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.|.+.+.||.|+||.||+|....+|+.||+|.+...... .....+.+..|..+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999999999999988643211 1223467888999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||++||+|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.+|.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC--CCcccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--YGMECD 317 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y~~~~D 317 (518)
.. ........|+..|+|||++.... ++.++|
T Consensus 162 ~~-----------------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~D 194 (272)
T cd06629 162 YD-----------------------------------------------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVD 194 (272)
T ss_pred cc-----------------------------------------------ccccccccCCccccCHHHhccccCCCCccch
Confidence 00 00112456899999999998754 899999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCC--CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~--~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
+||||+++|+|++|..||...+.......+........++.. ..++.++++||.+||. ||.+|+ ++.+|++|||
T Consensus 195 v~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~ 271 (272)
T cd06629 195 IWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP---TARELLQHPF 271 (272)
T ss_pred hHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCC---CHHHHhhCCC
Confidence 999999999999999999776655555444332233344432 2568999999999998 999999 8999999999
Q ss_pred c
Q 010116 395 F 395 (518)
Q Consensus 395 f 395 (518)
|
T Consensus 272 ~ 272 (272)
T cd06629 272 I 272 (272)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=356.13 Aligned_cols=256 Identities=31% Similarity=0.520 Sum_probs=218.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
..+|++++.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|..+++.+.||||+++++.|.+...+|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4689999999999999999999999999999999876532 2346688899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||++||+|.+++. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~---- 170 (296)
T cd06654 96 MEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---- 170 (296)
T ss_pred ecccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc----
Confidence 99999999999885 4568999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
......+|++.|+|||.+.+..++.++|+|||||+
T Consensus 171 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvi 205 (296)
T cd06654 171 ---------------------------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205 (296)
T ss_pred ---------------------------------------------cccCcccCCccccCHHHHcCCCCCccchHHHHHHH
Confidence 00113468999999999999889999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+|+|++|++||...++......+... .....+....+++.+.+||.+||. ||.+|+ ++.+|+.||||..
T Consensus 206 l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~eil~~~~~~~ 275 (296)
T cd06654 206 AIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (296)
T ss_pred HHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCCCCccccCHHHHHHHHHHCcCCcccCc---CHHHHhhChhhhc
Confidence 99999999999887765544333321 122222234688999999999998 999999 8999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=364.50 Aligned_cols=262 Identities=29% Similarity=0.478 Sum_probs=214.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------ 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------ 158 (518)
.++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 478999999999999999999999999999999986542 2233445677899999999999999999998654
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..+|+||||+. |+|...+... +++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999995 5888887544 99999999999999999999999999999999999999999999999999876431
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
.. ......||+.|+|||++.+..++.++||
T Consensus 171 ~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 200 (353)
T cd07850 171 SF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDI 200 (353)
T ss_pred CC--------------------------------------------------CCCCCcccccccCHHHHhCCCCCCchhh
Confidence 10 0123568999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc----------------------------------cCCC-----C
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL----------------------------------KFPD-----D 359 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l----------------------------------~~p~-----~ 359 (518)
|||||++|+|++|+.||.+.+....+.+++...... .++. .
T Consensus 201 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
T cd07850 201 WSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHN 280 (353)
T ss_pred HhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCccccccc
Confidence 999999999999999999887665555543311100 0110 1
Q ss_pred CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcccccc
Q 010116 360 SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYE 405 (518)
Q Consensus 360 ~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~~ 405 (518)
...++++++||.+||+ ||.+|+ ++.||+.||||+ .|-....
T Consensus 281 ~~~~~~~~~li~~~L~~dP~~R~---t~~eiL~~~~~~--~~~~~~~ 322 (353)
T cd07850 281 KLKASQARDLLSKMLVIDPEKRI---SVDDALQHPYIN--VWYDPSE 322 (353)
T ss_pred ccchhHHHHHHHHHcCCChhhCc---CHHHHhcChhHh--hccCCcc
Confidence 1246678999999999 999999 899999999998 4544433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=346.45 Aligned_cols=253 Identities=32% Similarity=0.532 Sum_probs=217.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++.+.||.|+||.||+|....+++.||+|.+..... .+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999999999999999876532 56788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
+||++|++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.+|.+||+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--- 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--- 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---
Confidence 999999999999965 4678999999999999999999999999999999999999999999999999988653210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
.......|++.|+|||++.+..++.++|||||||
T Consensus 154 ----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~ 187 (256)
T cd06612 154 ----------------------------------------------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI 187 (256)
T ss_pred ----------------------------------------------cccccccCCccccCHHHHhcCCCCchhhHHHHHH
Confidence 0011345889999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
++|+|++|.+||...++......+... ....+.....++.++.+||.+||. ||.+|+ ++.+|+.||||
T Consensus 188 il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~~il~~~~~ 256 (256)
T cd06612 188 TAIEMAEGKPPYSDIHPMRAIFMIPNK-PPPTLSDPEKWSPEFNDFVKKCLVKDPEERP---SAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhCCCCCCCcchhhhhhhhccC-CCCCCCchhhcCHHHHHHHHHHHhcChhhCc---CHHHHhcCCCC
Confidence 999999999999877665544443331 112222234578899999999998 999999 89999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=351.28 Aligned_cols=258 Identities=29% Similarity=0.487 Sum_probs=212.3
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEe----
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSF---- 155 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f---- 155 (518)
.....++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|..+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3446789999999999999999999999999999999876532 1234577899999999 799999999987
Q ss_pred -ecCCeEEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeec
Q 010116 156 -QDTEYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (518)
Q Consensus 156 -~~~~~lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DF 230 (518)
.+...+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+||+++.+|.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 355689999999999999988742 357899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK- 309 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~- 309 (518)
|++....... ......+||+.|+|||++..
T Consensus 169 g~~~~~~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~~ 199 (286)
T cd06638 169 GVSAQLTSTR-------------------------------------------------LRRNTSVGTPFWMAPEVIACE 199 (286)
T ss_pred CceeecccCC-------------------------------------------------CccccccCCCcccChhhhchh
Confidence 9987653110 00113469999999999853
Q ss_pred ----CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC
Q 010116 310 ----KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG 384 (518)
Q Consensus 310 ----~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~ 384 (518)
..|+.++|||||||++|||++|.+||...+......++... ..........++.++.+||.+||. ||.+|+
T Consensus 200 ~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 275 (286)
T cd06638 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-PPPTLHQPELWSNEFNDFIRKCLTKDYEKRP--- 275 (286)
T ss_pred hhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc-CCCcccCCCCcCHHHHHHHHHHccCCcccCC---
Confidence 45899999999999999999999999887665544443322 112222223567899999999998 999999
Q ss_pred ChhhhhcCccc
Q 010116 385 GAHQIKAHPWF 395 (518)
Q Consensus 385 ~a~eil~Hpff 395 (518)
++.||++||||
T Consensus 276 s~~ell~~~~~ 286 (286)
T cd06638 276 TVSDLLQHVFI 286 (286)
T ss_pred CHHHHhhcccC
Confidence 89999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=350.07 Aligned_cols=257 Identities=31% Similarity=0.532 Sum_probs=214.1
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecC---
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDT--- 158 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~--- 158 (518)
...++|++.+.||+|+||.||+|....+++.||+|++.... .....+.+|..++..+ +||||++++++|...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 35688999999999999999999999999999999986542 2234567899999998 899999999998643
Q ss_pred --CeEEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccc
Q 010116 159 --EYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (518)
Q Consensus 159 --~~lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGl 232 (518)
..+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 468999999999999998853 46789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC--
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-- 310 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-- 310 (518)
+........ .....+|++.|+|||++...
T Consensus 175 ~~~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 205 (291)
T cd06639 175 SAQLTSTRL-------------------------------------------------RRNTSVGTPFWMAPEVIACEQQ 205 (291)
T ss_pred chhcccccc-------------------------------------------------cccCccCCccccChhhhcCCCC
Confidence 876532100 01134689999999998643
Q ss_pred ---CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCCh
Q 010116 311 ---GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA 386 (518)
Q Consensus 311 ---~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a 386 (518)
.++.++|||||||++|||++|++||...++......+..+. ...+.....++.++++||.+||. ||.+|+ ++
T Consensus 206 ~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~ 281 (291)
T cd06639 206 YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP-PPTLLHPEKWCRSFNHFISQCLIKDFEARP---SV 281 (291)
T ss_pred cccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC-CCCCCcccccCHHHHHHHHHHhhcChhhCc---CH
Confidence 36899999999999999999999998877766665554431 22222233577899999999998 999999 89
Q ss_pred hhhhcCcccc
Q 010116 387 HQIKAHPWFK 396 (518)
Q Consensus 387 ~eil~Hpff~ 396 (518)
.+|++||||+
T Consensus 282 ~~il~~~~~~ 291 (291)
T cd06639 282 THLLEHPFIK 291 (291)
T ss_pred HHHhcCcccC
Confidence 9999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=358.76 Aligned_cols=249 Identities=25% Similarity=0.430 Sum_probs=192.5
Q ss_pred eeEeecCceEEEEEEEec--CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee--cCCeEEEEEee
Q 010116 92 TIIGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DTEYLYLIMEY 167 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~--~~~~lylVmEy 167 (518)
.+||+|+||+||+|+.+. ++..||+|.+..... ...+.+|+.+|+.++||||++++++|. +...+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 689999999999999754 668899999865422 235678999999999999999999884 46689999999
Q ss_pred cCCCchHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee----CCCCcEEEeeccccc
Q 010116 168 LPGGDMMTLLMR---------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCK 234 (518)
Q Consensus 168 ~~gG~L~~~l~~---------~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl----d~~g~vKL~DFGla~ 234 (518)
+. ++|..++.. ...+++..++.++.|++.||.|||+.||+||||||+|||+ +.+|.+||+|||+|+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 578777642 1358899999999999999999999999999999999999 567899999999998
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCC
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYG 313 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~ 313 (518)
........ .......+||+.|+|||++.+ ..++
T Consensus 161 ~~~~~~~~----------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~ 194 (317)
T cd07867 161 LFNSPLKP----------------------------------------------LADLDPVVVTFWYRAPELLLGARHYT 194 (317)
T ss_pred ccCCCccc----------------------------------------------ccccCcceecccccCcHHhcCCCccC
Confidence 65322100 001124679999999999987 4589
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChh---------hHHHHHhh---------hcC---cccCC---------------
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPI---------TTCRKIVH---------WRN---HLKFP--------------- 357 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~---------~~~~~i~~---------~~~---~l~~p--------------- 357 (518)
.++|||||||++|||++|.+||...... ....++.. |.. ...++
T Consensus 195 ~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (317)
T cd07867 195 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSS 274 (317)
T ss_pred cHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCch
Confidence 9999999999999999999999754321 11111111 000 00000
Q ss_pred -------CCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 358 -------DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 358 -------~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
.....+..+.+||.+||+ ||.+|+ ++.|+++||||
T Consensus 275 ~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07867 275 LIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI---TSEQALQDPYF 317 (317)
T ss_pred hhhhhhcccCCCChHHHHHHHHHhccCccccc---CHHHHhcCCCC
Confidence 011235678999999999 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=356.64 Aligned_cols=256 Identities=30% Similarity=0.522 Sum_probs=217.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
..+|++++.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||++++++|.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3789999999999999999999999999999999875432 2346678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||++||+|..++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~---- 169 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---- 169 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc----
Confidence 999999999999854 568999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
.......|++.|+|||.+.+..++.++|+|||||+
T Consensus 170 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvi 204 (297)
T cd06656 170 ---------------------------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204 (297)
T ss_pred ---------------------------------------------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHH
Confidence 00113468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+|+|++|.+||.+.++......+... ..........+++.+++||.+||. ||.+|+ ++.+|+.||||+.
T Consensus 205 l~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~ 274 (297)
T cd06656 205 AIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPERLSAVFRDFLNRCLEMDVDRRG---SAKELLQHPFLKL 274 (297)
T ss_pred HHHHHhCCCCCCCCCcchheeeeccC-CCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhcc
Confidence 99999999999887654433322221 112222234678999999999998 999999 8999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=351.43 Aligned_cols=255 Identities=30% Similarity=0.493 Sum_probs=211.8
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEee-----
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ----- 156 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~----- 156 (518)
...+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.++..+ +||||++++++|.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34578999999999999999999999999999999986542 2345678899999988 7999999999985
Q ss_pred -cCCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 157 -DTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 157 -~~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
....+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 356899999999999999998653 46889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL----- 308 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~----- 308 (518)
....... ......+|++.|+|||++.
T Consensus 169 ~~~~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~l~~~~~~ 199 (282)
T cd06636 169 AQLDRTV-------------------------------------------------GRRNTFIGTPYWMAPEVIACDENP 199 (282)
T ss_pred hhhhccc-------------------------------------------------cCCCcccccccccCHhhcCcccCc
Confidence 7542110 0012457999999999986
Q ss_pred CCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 309 ~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
+..|+.++|+|||||++|||++|.+||....+......+... ..... ....++.++.+||.+||. ||.+|+ ++.
T Consensus 200 ~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp---~~~ 274 (282)
T cd06636 200 DATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKL-KSKKWSKKFIDFIEGCLVKNYLSRP---STE 274 (282)
T ss_pred CcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC-CCCCC-cccccCHHHHHHHHHHhCCChhhCc---CHH
Confidence 356889999999999999999999999877665544443331 11111 223578999999999998 999999 899
Q ss_pred hhhcCccc
Q 010116 388 QIKAHPWF 395 (518)
Q Consensus 388 eil~Hpff 395 (518)
||+.||||
T Consensus 275 ell~~~~~ 282 (282)
T cd06636 275 QLLKHPFI 282 (282)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.85 Aligned_cols=255 Identities=29% Similarity=0.503 Sum_probs=223.3
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
-|+++.+||.|+||.||+|.++.+|+++|||.+.-. ...+.+..|+.||+++++|+||+.|++|-....+++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 477889999999999999999999999999987543 346678899999999999999999999998899999999
Q ss_pred ecCCCchHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 167 YLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 167 y~~gG~L~~~l~-~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||..|++.+.+. ++.+|+|+++..++...+.||+|||...-||||||..||||+.+||.||+|||.|..+...
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT------ 182 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT------ 182 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh------
Confidence 999999999985 4579999999999999999999999999999999999999999999999999998765311
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
.....+..|||-||||||+..-+|+..+||||||+..
T Consensus 183 -------------------------------------------MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITa 219 (502)
T KOG0574|consen 183 -------------------------------------------MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITA 219 (502)
T ss_pred -------------------------------------------HHhhCccccCcccccHHHHHHhccchhhhHhhhcchh
Confidence 0112378899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
.||..|+|||..-.+...+.-|-. +.+..|..+..+|.++-|||++||. +|++|. +|-++++|||.++..
T Consensus 220 IEMAEG~PPYsDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~---TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 220 IEMAEGRPPYSDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERK---TALRLCEHTFIKNAP 290 (502)
T ss_pred hhhhcCCCCcccccccceeEeccC-CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHH---HHHHHhhhhhhcCCC
Confidence 999999999988777665544433 2344455555689999999999997 999999 899999999998654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.62 Aligned_cols=257 Identities=33% Similarity=0.531 Sum_probs=215.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|.++.+++.||+|++.+..... ...+.+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999999999999987654322 34556788999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||+++++|..+......+++..+..++.|++.||.|||+.||+||||+|+||++++++.++|+|||++..+....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~----- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----- 154 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence 999999998887666779999999999999999999999999999999999999999999999999987643210
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 324 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvi 324 (518)
.......|++.|+|||++.+ ..++.++|||||||+
T Consensus 155 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 190 (286)
T cd07846 155 --------------------------------------------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCL 190 (286)
T ss_pred --------------------------------------------cccCcccceeeccCcHHhccccccCchHhHHHHHHH
Confidence 01123568899999999876 457899999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcc-----------------cCCC----------CCCCChhHHHHHHHHhc-c
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHL-----------------KFPD----------DSKLSPEAKDLICRLLC-D 376 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l-----------------~~p~----------~~~~s~~~~dLI~~lL~-d 376 (518)
+|||++|++||.+.+.......+..+...+ ..|. ...++..+.+||.+||. |
T Consensus 191 l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 270 (286)
T cd07846 191 VTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRID 270 (286)
T ss_pred HHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCC
Confidence 999999999998777655544444321111 1111 13578899999999998 9
Q ss_pred ccccCCCCChhhhhcCccc
Q 010116 377 VEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 377 p~~R~g~~~a~eil~Hpff 395 (518)
|.+|+ ++.+|+.||||
T Consensus 271 P~~Rp---~~~~il~~~~~ 286 (286)
T cd07846 271 PDDRP---SSSQLLHHEFF 286 (286)
T ss_pred cccch---hHHHHhcCCCC
Confidence 99999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=376.75 Aligned_cols=253 Identities=24% Similarity=0.280 Sum_probs=205.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.++|+|||++++++...+..|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996422 2356799999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||++ +|+|..++... ..+++..++.++.|++.||.|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-- 315 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-- 315 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc--
Confidence 9999 57888888654 5799999999999999999999999999999999999999999999999999876431100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
.......+||+.|+|||++.+..|+.++|||||||
T Consensus 316 ---------------------------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGv 350 (461)
T PHA03211 316 ---------------------------------------------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGL 350 (461)
T ss_pred ---------------------------------------------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHH
Confidence 00112467999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCh-------hhHHHHHhhhcCc--ccCC-----------------------------CCCCCChh
Q 010116 324 IMYEMLVGYPPFYADDP-------ITTCRKIVHWRNH--LKFP-----------------------------DDSKLSPE 365 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~-------~~~~~~i~~~~~~--l~~p-----------------------------~~~~~s~~ 365 (518)
++|||++|..|+..... .....+++..... ..++ ....++.+
T Consensus 351 iL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (461)
T PHA03211 351 VIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLD 430 (461)
T ss_pred HHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccch
Confidence 99999998876654221 1122222221100 0011 01145678
Q ss_pred HHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 366 AKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 366 ~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+.+||.+||. ||.+|+ ++.||++||||+.
T Consensus 431 ~~dli~~mL~~DP~~RP---sa~elL~hp~f~~ 460 (461)
T PHA03211 431 VEYLVCRALTFDGARRP---SAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHHcccChhhCc---CHHHHhhCcccCC
Confidence 9999999999 999999 8999999999974
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=345.57 Aligned_cols=255 Identities=31% Similarity=0.529 Sum_probs=217.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++.+.||.|+||.||+|.+..+++.||+|++.... ......+.+|..+++.++||||+++++++.+...+|+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999997543 22457788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++|++|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..+....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 155 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--- 155 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence 9999999999998776 789999999999999999999999999999999999999999999999999987543110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC---CCCccccccc
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK---GYGMECDWWS 320 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~---~y~~~~DiWS 320 (518)
......+|+..|+|||++.+. .++.++|+||
T Consensus 156 ----------------------------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~s 189 (262)
T cd06613 156 ----------------------------------------------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWA 189 (262)
T ss_pred ----------------------------------------------hccccccCCccccCchhhcccccCCcCchhhhHH
Confidence 001135789999999999877 8899999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhc-CcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWR-NHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
|||++|+|++|.+||...++......+.... ..........++.++++||.+||+ ||..|+ ++.+|+.|||
T Consensus 190 lG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~ 262 (262)
T cd06613 190 LGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP---TATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCC---CHHHHhcCCC
Confidence 9999999999999998877665554443321 011111223567899999999998 999999 8999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=355.16 Aligned_cols=260 Identities=30% Similarity=0.461 Sum_probs=215.6
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--CeE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYL 161 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~l 161 (518)
..++|++++.||.|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++|+||+++++++.+. +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46889999999999999999999999999999999875432 222233466799999999999999999999765 579
Q ss_pred EEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 162 YLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.+|.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999996 588888865 3679999999999999999999999999999999999999999999999999988653210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWW 319 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 319 (518)
.......+++.|+|||++.+ ..++.++|||
T Consensus 163 -------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw 193 (309)
T cd07845 163 -------------------------------------------------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMW 193 (309)
T ss_pred -------------------------------------------------CCCCcccccccccChhhhcCCCCcCchHHHH
Confidence 00112346889999999876 5689999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC-----------------cccCCCC---------CCCChhHHHHHHHH
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN-----------------HLKFPDD---------SKLSPEAKDLICRL 373 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-----------------~l~~p~~---------~~~s~~~~dLI~~l 373 (518)
||||++|||++|++||.+.+....+..+..... .+.++.. ..+++++.+||.+|
T Consensus 194 slG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 273 (309)
T cd07845 194 AVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFL 273 (309)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHH
Confidence 999999999999999999888887777765321 0111110 13589999999999
Q ss_pred hc-cccccCCCCChhhhhcCccccc
Q 010116 374 LC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|+ ||.+|+ ++.+|+.||||++
T Consensus 274 l~~dp~~R~---t~~~il~h~~f~~ 295 (309)
T cd07845 274 LMYDPKKRA---TAEEALESSYFKE 295 (309)
T ss_pred hcCChhhCc---CHHHHhcChhhcc
Confidence 99 999999 8999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.02 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=216.8
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++++.||+|+||+||++.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3578999999999999999999999999999999986542 23345678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||||++||+|..++.+.+.+++..++.++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999999999888889999999999999999999997 69999999999999999999999999998643211
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
.....+||..|+|||++.+..++.++|+||||
T Consensus 158 ------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 189 (284)
T cd06620 158 ------------------------------------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189 (284)
T ss_pred ------------------------------------------------ccCccccCcccCCHHHHccCCCCccchHHHHH
Confidence 01135799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCChh-----------hHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 323 AIMYEMLVGYPPFYADDPI-----------TTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~-----------~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
|++|+|++|..||...... .....+... ....++. ..++.++.+||.+||. ||.+|+ ++.||+
T Consensus 190 ~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rp---t~~e~~ 264 (284)
T cd06620 190 ISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLPS-SDFPEDLRDFVDACLLKDPTERP---TPQQLC 264 (284)
T ss_pred HHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCCc-hhcCHHHHHHHHHHhcCCcccCc---CHHHHh
Confidence 9999999999999875542 222233221 1222222 2378899999999998 999999 899999
Q ss_pred cCccccc
Q 010116 391 AHPWFKD 397 (518)
Q Consensus 391 ~Hpff~~ 397 (518)
+||||..
T Consensus 265 ~~~~~~~ 271 (284)
T cd06620 265 AMPPFIQ 271 (284)
T ss_pred cCccccc
Confidence 9999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=369.29 Aligned_cols=258 Identities=23% Similarity=0.297 Sum_probs=209.4
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEE-----ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEE
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCRE-----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS 154 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 154 (518)
+.+..++|++.+.||+|+||.||+|+. ..++..||+|+++.... ....+.+.+|+.+|..+ +|||||+++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 445567899999999999999999974 34677899999875432 23346788999999999 89999999999
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhcC-----------------------------------------------------
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMRED----------------------------------------------------- 181 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~~----------------------------------------------------- 181 (518)
|.+....|+|||||+||+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999986421
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 182 ----------------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 182 ----------------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 4678888999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
... ....+..+++.|+|||++.+..|+.++|||
T Consensus 268 ~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~ 300 (375)
T cd05104 268 SNY-----------------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVW 300 (375)
T ss_pred ccc-----------------------------------------------cccCCCCCCcceeChhHhcCCCCCCCCCHH
Confidence 000 001123467789999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||++|||++ |.+||..........+++... ...+.+...+.++++||.+||. ||.+|| ++.+|++.
T Consensus 301 slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~~ 370 (375)
T cd05104 301 SYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG--YRMLSPECAPSEMYDIMKSCWDADPLKRP---TFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC--ccCCCCCCCCHHHHHHHHHHccCChhHCc---CHHHHHHH
Confidence 99999999998 899998765544444444422 2222223568899999999998 999999 89998763
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=342.65 Aligned_cols=253 Identities=29% Similarity=0.522 Sum_probs=219.5
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++++.||+|+||.||+++...+|+.||+|.+...... ......+.+|+.+++.++||||++++++|.+..++|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 589999999999999999999999999999998765432 2344678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 167 y~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch----
Confidence 99999999998654 368999999999999999999999999999999999999999999999999987643210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
.......|++.|+|||++.+..++.++|+|||||+
T Consensus 156 ---------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i 190 (256)
T cd08218 156 ---------------------------------------------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCV 190 (256)
T ss_pred ---------------------------------------------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHH
Confidence 00113468999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+|+|++|..||...+.......++... ....| ..++.++.++|.+||. +|.+|+ ++.+|+.||||
T Consensus 191 ~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~vl~~~~~ 256 (256)
T cd08218 191 LYEMCTLKHAFEAGNMKNLVLKIIRGS-YPPVS--SHYSYDLRNLVSQLFKRNPRDRP---SVNSILEKNFI 256 (256)
T ss_pred HHHHHcCCCCccCCCHHHHHHHHhcCC-CCCCc--ccCCHHHHHHHHHHhhCChhhCc---CHHHHhhCcCC
Confidence 999999999999888877777776532 22233 4688999999999998 999999 89999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=344.20 Aligned_cols=260 Identities=33% Similarity=0.498 Sum_probs=221.0
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|.+.+.||+|+||.||++....+++.||+|+++..... ......+..|+.+++.++|++|+++++.+.+.+.+|+|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 588999999999999999999989999999999766432 4567889999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|+++++|.+++.....+++..++.++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~--- 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM--- 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc---
Confidence 99999999999887789999999999999999999999999999999999999999999999999988654221000
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC---CCccccccchhH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG---YGMECDWWSLGA 323 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~---y~~~~DiWSlGv 323 (518)
........|++.|+|||++.+.. ++.++|+|||||
T Consensus 157 ------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~ 194 (264)
T cd06626 157 ------------------------------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC 194 (264)
T ss_pred ------------------------------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHH
Confidence 00011356889999999998766 899999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
++|+|++|+.||...+........+.......+|....+++.+.+||.+||. +|.+|+ ++.+|+.|||+
T Consensus 195 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~i~~~~~~ 264 (264)
T cd06626 195 VVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPFV 264 (264)
T ss_pred HHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCC---CHHHHhcCCCC
Confidence 9999999999997654333222222223455666665679999999999998 999999 89999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=374.63 Aligned_cols=249 Identities=31% Similarity=0.562 Sum_probs=219.3
Q ss_pred eEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCc
Q 010116 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD 172 (518)
Q Consensus 93 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~ 172 (518)
+||+|+||+||.|++..|....|||.+.... ...++-+..|+.+-+.++|.|||+.++++..++++-|.||-+|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 7999999999999999999999999986542 3345668899999999999999999999999999999999999999
Q ss_pred hHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-CCcEEEeecccccccCCCccccccccc
Q 010116 173 MMTLLMRE-DTL--TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCSTLYAIHEHK 248 (518)
Q Consensus 173 L~~~l~~~-~~l--~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~ 248 (518)
|.++|... +++ .|..+-||..||+.||.|||.+.|||||||-+|||++. .|.+||+|||-||.+..-
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--------- 729 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--------- 729 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC---------
Confidence 99999776 788 88999999999999999999999999999999999974 799999999999976311
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCccccccchhHHHH
Q 010116 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMY 326 (518)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvily 326 (518)
...+.++.||..|||||++.. .||+.++|||||||.+.
T Consensus 730 ----------------------------------------nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~v 769 (1226)
T KOG4279|consen 730 ----------------------------------------NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMV 769 (1226)
T ss_pred ----------------------------------------CccccccccchhhhChHhhccCCcCCCchhhhhhccceeE
Confidence 012447889999999999976 57999999999999999
Q ss_pred HHHhCCCCCCCC-ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 327 EMLVGYPPFYAD-DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 327 eml~G~~PF~~~-~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||.||+|||... ++.....++--.+.++++|. .+|.+|+.||.+|+. ||.+|+ +|.+++..||++.-
T Consensus 770 EMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe--elsaeak~FilrcFepd~~~R~---sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 770 EMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE--ELSAEAKNFILRCFEPDPCDRP---SAKDLLQDPFLQHN 838 (1226)
T ss_pred eeccCCCCeeecCChhHhhhhhcceecCCCCcH--HHHHHHHHHHHHHcCCCcccCc---cHHHhccCcccccC
Confidence 999999999763 45555556655566777775 699999999999998 999999 89999999999853
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=349.38 Aligned_cols=258 Identities=28% Similarity=0.491 Sum_probs=209.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHH-HHHhCCCceeEEEEEeecCCeEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
++|++++.||+|+||.||+|+++.+|+.||||++++... ...+ ..+..|..+ ++..+||||+++++++..+..+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 589999999999999999999999999999999876532 1222 234445554 6677999999999999999999999
Q ss_pred EeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 165 MEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 165 mEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|||++ |+|..++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 677777643 35799999999999999999999997 9999999999999999999999999998754211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC----CCCCcc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK----KGYGME 315 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~----~~y~~~ 315 (518)
. ......||..|+|||++.+ .+++.+
T Consensus 158 ~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 187 (283)
T cd06617 158 V--------------------------------------------------AKTIDAGCKPYMAPERINPELNQKGYDVK 187 (283)
T ss_pred c--------------------------------------------------ccccccCCccccChhhcCCcccccccCcc
Confidence 0 0112468899999999865 567899
Q ss_pred ccccchhHHHHHHHhCCCCCCCC-ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCc
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYAD-DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHP 393 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hp 393 (518)
+|+|||||++|+|++|..||... ........+... ....+|. ..+|.++.+||.+||. +|.+|+ ++.+|+.||
T Consensus 188 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~ 262 (283)
T cd06617 188 SDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-PSPQLPA-EKFSPEFQDFVNKCLKKNYKERP---NYPELLQHP 262 (283)
T ss_pred ccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-CCCCCCc-cccCHHHHHHHHHHccCChhhCc---CHHHHhcCc
Confidence 99999999999999999999653 233334444331 2333443 3588999999999998 999999 899999999
Q ss_pred ccccCCcc
Q 010116 394 WFKDVVWD 401 (518)
Q Consensus 394 ff~~i~w~ 401 (518)
||....+.
T Consensus 263 ~~~~~~~~ 270 (283)
T cd06617 263 FFELHLSK 270 (283)
T ss_pred hhhhcccc
Confidence 99986654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=342.03 Aligned_cols=253 Identities=32% Similarity=0.527 Sum_probs=220.7
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++++.||.|+||.||+++...+++.+++|.+...... ......+.+|+.+++.++|+||++++++|.+...+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 589999999999999999999999999999998755432 3445668899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 167 y~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999764 5689999999999999999999999999999999999999999999999999876532100
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 157 ----------------------------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i 190 (256)
T cd08221 157 ----------------------------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCV 190 (256)
T ss_pred ----------------------------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHH
Confidence 0124568999999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+|+|++|..||...+..+....+.... +. +....++.++.++|.+||+ +|.+|+ ++.++++|||+
T Consensus 191 ~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~i~~~l~~~p~~R~---s~~~ll~~~~l 256 (256)
T cd08221 191 LYELLTLKRTFDATNPLNLVVKIVQGN--YT-PVVSVYSSELISLVHSLLQQDPEKRP---TADEVLDQPLL 256 (256)
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHcCC--CC-CCccccCHHHHHHHHHHcccCcccCC---CHHHHhhCcCC
Confidence 999999999999988888777776532 22 1224678999999999998 999999 89999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=353.86 Aligned_cols=255 Identities=20% Similarity=0.329 Sum_probs=205.8
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEec----------------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKK----------------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~----------------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~ 147 (518)
..++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+|..++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45789999999999999999998542 34579999987542 2334567889999999999999
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeE
Q 010116 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE-------------------DTLTENVARFYIAQSVLAIESIHKHNYI 208 (518)
Q Consensus 148 Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~-------------------~~l~e~~~~~~~~ql~~aL~~LH~~gii 208 (518)
|+++++++.+.+.+|+||||++||+|.+++... ..++...+..++.|++.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999998543 2367778899999999999999999999
Q ss_pred EcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhc
Q 010116 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNR 288 (518)
Q Consensus 209 HRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (518)
||||||+|||++.++.+||+|||+++.+......
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---------------------------------------------- 194 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---------------------------------------------- 194 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCcee----------------------------------------------
Confidence 9999999999999999999999999865322100
Q ss_pred ccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh--CCCCCCCCChhhHHHHHhhhc----CcccCCCCCCC
Q 010116 289 RKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYADDPITTCRKIVHWR----NHLKFPDDSKL 362 (518)
Q Consensus 289 ~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~--G~~PF~~~~~~~~~~~i~~~~----~~l~~p~~~~~ 362 (518)
......++|+.|+|||++.+..++.++|||||||++|||++ |..||...+.......+.... ..........+
T Consensus 195 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (304)
T cd05096 195 -RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPC 273 (304)
T ss_pred -EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCC
Confidence 01123457889999999999999999999999999999986 668888776655554443210 11111122357
Q ss_pred ChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 363 SPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 363 s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
+..+.+||.+||. ||.+|| ++.+|.
T Consensus 274 ~~~~~~li~~cl~~~p~~RP---s~~~i~ 299 (304)
T cd05096 274 PQGLYELMLQCWSRDCRERP---SFSDIH 299 (304)
T ss_pred CHHHHHHHHHHccCCchhCc---CHHHHH
Confidence 8999999999998 999999 899884
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=347.57 Aligned_cols=253 Identities=18% Similarity=0.270 Sum_probs=212.0
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
+..++|++.+.||+|+||.||+|..+ ..+..||+|+++... .......+.+|..++..++||||+++++++....
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34568999999999999999999875 346789999987642 2334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|+||||++||+|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999999764 5799999999999999999999999999999999999999999999999998664311
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
... .......+|+.|+|||++.+..++.++||
T Consensus 160 ~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 191 (266)
T cd05064 160 EAI------------------------------------------------YTTMSGKSPVLWAAPEAIQYHHFSSASDV 191 (266)
T ss_pred cch------------------------------------------------hcccCCCCceeecCHHHHhhCCccchhHH
Confidence 100 00112346778999999999999999999
Q ss_pred cchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 319 WSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 319 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||++|||++ |.+||.+.+.......+... ...|.+..++..+.++|.+||. +|.+|| ++.+|++
T Consensus 192 ~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~RP---~~~~i~~ 260 (266)
T cd05064 192 WSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG---FRLPAPRNCPNLLHQLMLDCWQKERGERP---RFSQIHS 260 (266)
T ss_pred HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---CCCCCCCCCCHHHHHHHHHHcCCCchhCC---CHHHHHH
Confidence 999999999775 99999988877766666542 2334445788999999999998 999999 7888865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=351.52 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=215.1
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCC-----cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSG-----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~-----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
+..++|++++.||+|+||.||+|.....+ ..||+|.+.... .......+.+|+.++..++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34578999999999999999999876655 689999986542 23344568899999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK 221 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~ 221 (518)
....|++|||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 45788999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCc
Q 010116 222 NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301 (518)
Q Consensus 222 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 301 (518)
++.+||+|||+++........ .......+|+.|
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y 192 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYY-----------------------------------------------RVQSKSLLPVRW 192 (283)
T ss_pred CCcEEECCCcceeeccccccc-----------------------------------------------cccCCCcccccc
Confidence 999999999998864321100 011234678999
Q ss_pred cChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccc
Q 010116 302 IAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379 (518)
Q Consensus 302 ~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~ 379 (518)
+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ..... ...+++++.+|+.+||. ||.+
T Consensus 193 ~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~--~~~~~~~~~~l~~~c~~~~p~~ 269 (283)
T cd05048 193 MPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR-QLLPC--PEDCPARVYALMIECWNEIPAR 269 (283)
T ss_pred cCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCC--cccCCHHHHHHHHHHccCChhh
Confidence 99999999999999999999999999998 99999998887777766542 12222 34689999999999998 9999
Q ss_pred cCCCCChhhhhcC
Q 010116 380 RLGTGGAHQIKAH 392 (518)
Q Consensus 380 R~g~~~a~eil~H 392 (518)
|| ++.+|++|
T Consensus 270 Rp---~~~~i~~~ 279 (283)
T cd05048 270 RP---RFKDIHTR 279 (283)
T ss_pred Cc---CHHHHHHH
Confidence 99 89999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=349.94 Aligned_cols=257 Identities=31% Similarity=0.516 Sum_probs=216.0
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++.+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999976542 23345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 167 YLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 167 y~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|+ |++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.+|.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999999865 46799999999999999999999999999999999999999999999999999886532100
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccchhHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAI 324 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvi 324 (518)
......+||+.|+|||++.+. .++.++|||||||+
T Consensus 155 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~ 190 (286)
T cd07832 155 --------------------------------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCI 190 (286)
T ss_pred --------------------------------------------CccccccCcccccCceeeeccccCCchhHHHHHHHH
Confidence 011235789999999998764 46999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcC-----------------cccCCCC---------CCCChhHHHHHHHHhc-cc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRN-----------------HLKFPDD---------SKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~-----------------~l~~p~~---------~~~s~~~~dLI~~lL~-dp 377 (518)
+|||++|.+||.+.+.......+..... ...++.. ..++.++.+||.+||. ||
T Consensus 191 l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 270 (286)
T cd07832 191 FAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDP 270 (286)
T ss_pred HHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccCh
Confidence 9999999999988877666655543111 1111111 2457899999999998 99
Q ss_pred cccCCCCChhhhhcCcccc
Q 010116 378 EHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 378 ~~R~g~~~a~eil~Hpff~ 396 (518)
.+|+ ++++++.||||.
T Consensus 271 ~~R~---~~~~~l~h~~~~ 286 (286)
T cd07832 271 SKRL---SAAEALRHPYFT 286 (286)
T ss_pred hhCC---CHHHHhhCcCcC
Confidence 9999 899999999993
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=350.04 Aligned_cols=274 Identities=41% Similarity=0.748 Sum_probs=227.9
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylV 164 (518)
++|.+.+.||+|+||.||+|....+|+.||+|++.+...........+..|..++..+. ||||++++++|.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998866555555677889999999998 99999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.+|+++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999986643211000
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
.. ...+....... .........+|++.|+|||++....++.++|+|||||+
T Consensus 161 ~~--------------~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~ 211 (280)
T cd05581 161 NK--------------GDATNIDSQIE---------------KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCI 211 (280)
T ss_pred CC--------------CCCcccccccc---------------ccccccccccCCccccCHHHhCCCCCChhhhHHHHHHH
Confidence 00 00000000000 00012235678999999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCCh----hhhhcCccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA----HQIKAHPWF 395 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a----~eil~Hpff 395 (518)
+|+|++|+.||...+....+..+.. ....+| ..+++.+.+||.+||. ||.+|+ ++ +++++||||
T Consensus 212 l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~R~---~~~~~~~~ll~~~~~ 280 (280)
T cd05581 212 IYQMLTGKPPFRGSNEYLTFQKILK--LEYSFP--PNFPPDAKDLIEKLLVLDPQDRL---GVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHHh--cCCCCC--CccCHHHHHHHHHHhcCCHhhCC---CcccCHHHHhcCCCC
Confidence 9999999999998887676666654 333444 3679999999999998 999999 78 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=353.59 Aligned_cols=259 Identities=31% Similarity=0.496 Sum_probs=215.9
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
+|++++.||.|+||.||+|.+..+|+.||||++...... .......+..|+.+++.++|+||+++++++.+...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999876543 122345567899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~-~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||+ +|+|..++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--- 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence 9999 999999997765 89999999999999999999999999999999999999999999999999988653210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
.......+++.|+|||++.+ ..++.++|+||||
T Consensus 157 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 190 (298)
T cd07841 157 ----------------------------------------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVG 190 (298)
T ss_pred ----------------------------------------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHH
Confidence 00112357889999999865 5679999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc------------------cCCC------CCCCChhHHHHHHHHhc-cc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHL------------------KFPD------DSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l------------------~~p~------~~~~s~~~~dLI~~lL~-dp 377 (518)
|++|||++|.+||.+.+......++....... ..+. ...++.++.+||.+||. ||
T Consensus 191 ~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 270 (298)
T cd07841 191 CIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270 (298)
T ss_pred HHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCc
Confidence 99999999999998877766655554311000 0000 12457899999999998 99
Q ss_pred cccCCCCChhhhhcCcccccC
Q 010116 378 EHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 378 ~~R~g~~~a~eil~Hpff~~i 398 (518)
.+|+ ++.||+.||||++.
T Consensus 271 ~~R~---s~~e~l~~~~~~~~ 288 (298)
T cd07841 271 NKRI---TARQALEHPYFSND 288 (298)
T ss_pred ccCc---CHHHHhhCccccCC
Confidence 9999 89999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.68 Aligned_cols=259 Identities=31% Similarity=0.531 Sum_probs=218.9
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechh--hhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--CeE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE--MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYL 161 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~l 161 (518)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... .........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875432 11234456788999999999999999999998764 568
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
++||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999986532100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
. ........||+.|+|||++.+..++.++|+|||
T Consensus 162 ~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 195 (264)
T cd06653 162 S----------------------------------------------GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV 195 (264)
T ss_pred c----------------------------------------------CccccccCCcccccCHhhhcCCCCCccccHHHH
Confidence 0 000113568999999999999889999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff 395 (518)
||++|+|++|.+||..........++........+| ..+++++.++|.+||.+|..|+ ++.+++.|||.
T Consensus 196 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~~i~~~l~~~~~r~---~~~~~~~~~~~ 264 (264)
T cd06653 196 ACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP--DGVSDACRDFLKQIFVEEKRRP---TAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCC--cccCHHHHHHHHHHhcCcccCc---cHHHHhcCCCC
Confidence 999999999999998876666665555432233344 4689999999999999889999 89999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=341.87 Aligned_cols=254 Identities=33% Similarity=0.571 Sum_probs=217.4
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhh--hchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
+|+..+.||+|+||+||+|....+++.||+|++..... ........+.+|+.+++.++|+||+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 46778899999999999999988999999999876432 1233456788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||++|++|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987643210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC-CCccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGv 323 (518)
......|++.|+|||.+.... ++.++|+|||||
T Consensus 157 ----------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~ 190 (258)
T cd06632 157 ----------------------------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC 190 (258)
T ss_pred ----------------------------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHH
Confidence 011456899999999998776 999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
++|+|++|.+||..........++........+| ..+++++++||.+||. +|.+|+ ++.+++.|||+
T Consensus 191 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 258 (258)
T cd06632 191 TVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIP--DHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPFV 258 (258)
T ss_pred HHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcC--CCcCHHHHHHHHHHhhcCcccCc---CHHHHhcCCCC
Confidence 9999999999998776555554444322222333 3578999999999998 999999 89999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.58 Aligned_cols=249 Identities=33% Similarity=0.533 Sum_probs=214.1
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++.+.||.|+||.||++.+..+++.||+|.++... .....+.+..|..+++.++||||++++++|.+...+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999986543 22345678889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 167 YLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 167 y~~gG~L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|++||+|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc----
Confidence 9999999998864 3468999999999999999999999999999999999999999999999999987543110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
.......|++.|+|||++.+..++.++|+||||++
T Consensus 155 ---------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i 189 (255)
T cd08219 155 ---------------------------------------------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCI 189 (255)
T ss_pred ---------------------------------------------cccccccCCccccCHHHHccCCcCchhhhhhhchh
Confidence 01124578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+|+|++|.+||...+.......+.... ....| ..++..+++||.+||. ||.+|| ++.+|+.-
T Consensus 190 ~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~ 252 (255)
T cd08219 190 LYELCTLKHPFQANSWKNLILKVCQGS-YKPLP--SHYSYELRSLIKQMFKRNPRSRP---SATTILSR 252 (255)
T ss_pred heehhhccCCCCCCCHHHHHHHHhcCC-CCCCC--cccCHHHHHHHHHHHhCCcccCC---CHHHHhhc
Confidence 999999999999887766666665421 11223 4688999999999998 999999 89998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.84 Aligned_cols=252 Identities=31% Similarity=0.565 Sum_probs=218.3
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++++.||+|+||.||+|....+++.||+|.+..... .......+.+|+.+|+.++||||+++++.+.....+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999976543 33446778899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-cEEEeecccccccCCCcccc
Q 010116 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 167 y~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-~vKL~DFGla~~~~~~~~~~ 243 (518)
|++|++|.+++... ..+++..+..++.+++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--- 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence 99999999999763 4589999999999999999999999999999999999998655 57999999988653210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
.....+|++.|+|||++.+..++.++|+|||||
T Consensus 157 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 189 (256)
T cd08220 157 -----------------------------------------------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGC 189 (256)
T ss_pred -----------------------------------------------cccccccCCcccCchhccCCCCCcccchHHHHH
Confidence 011356899999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
++|+|++|..||.+.+.......+... ....++ ..+++++++||.+||. ||.+|+ ++.++++||||
T Consensus 190 ~l~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---t~~~ll~~p~~ 256 (256)
T cd08220 190 VLYELASLKRAFEAANLPALVLKIMSG-TFAPIS--DRYSPDLRQLILSMLNLDPSKRP---QLSQIMAQPIC 256 (256)
T ss_pred HHHHHHhCCCCcccCchHHHHHHHHhc-CCCCCC--CCcCHHHHHHHHHHccCChhhCC---CHHHHhhCCCC
Confidence 999999999999888777766666542 122333 3589999999999998 999999 89999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=349.68 Aligned_cols=257 Identities=33% Similarity=0.527 Sum_probs=210.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCe----
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEY---- 160 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~---- 160 (518)
++|++.+.||.|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 47999999999999999999999999999999986542 22334456788999999995 6999999999987666
Q ss_pred -EEEEEeecCCCchHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-CCcEEEeecccc
Q 010116 161 -LYLIMEYLPGGDMMTLLMRE-----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLC 233 (518)
Q Consensus 161 -lylVmEy~~gG~L~~~l~~~-----~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-~g~vKL~DFGla 233 (518)
+|+||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 888887542 35899999999999999999999999999999999999998 899999999998
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGY 312 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y 312 (518)
..+.... .......+++.|+|||++.+ ..+
T Consensus 159 ~~~~~~~-------------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~ 189 (295)
T cd07837 159 RAFSIPV-------------------------------------------------KSYTHEIVTLWYRAPEVLLGSTHY 189 (295)
T ss_pred eecCCCc-------------------------------------------------cccCCcccccCCCChHHhhCCCCC
Confidence 7542110 00113457899999999875 568
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---------------cCCC---------CCCCChhHHH
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL---------------KFPD---------DSKLSPEAKD 368 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---------------~~p~---------~~~~s~~~~d 368 (518)
+.++|||||||++|+|++|.+||.+.+......++....... .++. ...+++++.+
T Consensus 190 ~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (295)
T cd07837 190 STPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD 269 (295)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHH
Confidence 999999999999999999999999887776665554321100 0110 1247899999
Q ss_pred HHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 369 LICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 369 LI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
||.+||. ||.+|+ ++.+|+.||||+
T Consensus 270 ~i~~~l~~~P~~R~---~~~eil~~~~~~ 295 (295)
T cd07837 270 LLQKMLRYDPAKRI---SAKAALTHPYFD 295 (295)
T ss_pred HHHHHccCChhhcC---CHHHHhcCCCcC
Confidence 9999998 999999 899999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=352.19 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=211.9
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lyl 163 (518)
.++|+.++.||+|+||.||++.+..+++.||+|.+.+.... .....+.+|+.++..+. ||||+++++++.++...|+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 35777888999999999999999999999999998765322 34556788999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHH---h--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 164 IMEYLPGGDMMTLL---M--REDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 164 VmEy~~gG~L~~~l---~--~~~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
||||+. +++.++. . ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++..+.
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999985 4544432 2 246799999999999999999999974 99999999999999999999999999987543
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC---CCCc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK---GYGM 314 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~---~y~~ 314 (518)
... ......||+.|+|||++.+. .++.
T Consensus 160 ~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 189 (288)
T cd06616 160 DSI--------------------------------------------------AKTRDAGCRPYMAPERIDPSARDGYDV 189 (288)
T ss_pred cCC--------------------------------------------------ccccccCccCccCHHHhccccccCCcc
Confidence 110 01134689999999999876 6899
Q ss_pred cccccchhHHHHHHHhCCCCCCCCCh-hhHHHHHhhhcCcccCCC--CCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDP-ITTCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
++|||||||++|+|++|++||...+. .....++... ....++. ...++.++.+||.+||. ||.+|+ ++++|+
T Consensus 190 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~i~ 265 (288)
T cd06616 190 RSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-DPPILSNSEEREFSPSFVNFINLCLIKDESKRP---KYKELL 265 (288)
T ss_pred hhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC-CCCcCCCcCCCccCHHHHHHHHHHccCChhhCc---CHHHHh
Confidence 99999999999999999999976542 1222222221 1112221 23588999999999998 999999 899999
Q ss_pred cCcccccCCccccc
Q 010116 391 AHPWFKDVVWDKLY 404 (518)
Q Consensus 391 ~Hpff~~i~w~~l~ 404 (518)
.||||+...|.+..
T Consensus 266 ~~~~~~~~~~~~~~ 279 (288)
T cd06616 266 EHPFIKDYEERNVD 279 (288)
T ss_pred cChhhhchhhcchh
Confidence 99999987776653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.59 Aligned_cols=256 Identities=28% Similarity=0.484 Sum_probs=207.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||.|+||.||+|.++.+++.||||.+..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999875421 22234467899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++ ++|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 82 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 82 FEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred EecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 99997 4999988664 5789999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
.....++++.|+|||++.+ ..++.++||||||
T Consensus 159 -----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG 191 (291)
T cd07844 159 -----------------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVG 191 (291)
T ss_pred -----------------------------------------------cccccccccccCCcHHhhcCcccCcHHHHHHHH
Confidence 0012357889999999876 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCC-hhhHHHHHhhhcC-----------------cccCCC---------CCCCC--hhHHHHHHHH
Q 010116 323 AIMYEMLVGYPPFYADD-PITTCRKIVHWRN-----------------HLKFPD---------DSKLS--PEAKDLICRL 373 (518)
Q Consensus 323 vilyeml~G~~PF~~~~-~~~~~~~i~~~~~-----------------~l~~p~---------~~~~s--~~~~dLI~~l 373 (518)
|++|+|++|++||.+.. ..+....+..... ...++. ...++ .++.+||.+|
T Consensus 192 ~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 271 (291)
T cd07844 192 CIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKF 271 (291)
T ss_pred HHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHH
Confidence 99999999999997665 2222222211000 000000 01344 8899999999
Q ss_pred hc-cccccCCCCChhhhhcCccc
Q 010116 374 LC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~Hpff 395 (518)
|+ ||.+|+ ++.+++.||||
T Consensus 272 L~~~p~~Rp---s~~e~l~~~~f 291 (291)
T cd07844 272 LQYEPKKRI---SAAEAMKHPYF 291 (291)
T ss_pred hccCccccc---CHHHHhcCCCC
Confidence 98 999999 89999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=344.83 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=214.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC---
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE--- 159 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~--- 159 (518)
..++|++.+.||.|+||.||+|.++.+++.||+|++..... ..+.+.+|..+++.+ +|+||++++++|.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 45889999999999999999999999999999999876532 345688999999998 7999999999997544
Q ss_pred ---eEEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccc
Q 010116 160 ---YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (518)
Q Consensus 160 ---~lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGl 232 (518)
.+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 59999999999999998864 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--- 309 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--- 309 (518)
+....... .......||+.|+|||++..
T Consensus 160 ~~~~~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 190 (275)
T cd06608 160 SAQLDSTL-------------------------------------------------GRRNTFIGTPYWMAPEVIACDEQ 190 (275)
T ss_pred ceecccch-------------------------------------------------hhhcCccccccccCHhHhccccc
Confidence 87543210 00114569999999999864
Q ss_pred --CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCCh
Q 010116 310 --KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA 386 (518)
Q Consensus 310 --~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a 386 (518)
..++.++|+|||||++|+|++|++||..........++... ..........++.++++||.+||. ||.+|+ ++
T Consensus 191 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~ 266 (275)
T cd06608 191 PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN-PPPTLKSPENWSKKFNDFISECLIKNYEQRP---FM 266 (275)
T ss_pred ccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc-CCCCCCchhhcCHHHHHHHHHHhhcChhhCc---CH
Confidence 35788999999999999999999999877666655555442 122233333478899999999998 999999 89
Q ss_pred hhhhcCccc
Q 010116 387 HQIKAHPWF 395 (518)
Q Consensus 387 ~eil~Hpff 395 (518)
.+|++|||+
T Consensus 267 ~~ll~~~~~ 275 (275)
T cd06608 267 EELLEHPFI 275 (275)
T ss_pred HHHhcCCCC
Confidence 999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=364.63 Aligned_cols=261 Identities=30% Similarity=0.495 Sum_probs=210.5
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCe
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEY 160 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~ 160 (518)
++.-..|++++.||+||.++||+|...+. ..||+|++.-. ......+..+++|+.+|.+++ |.+||+||++-..+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 34556799999999999999999986544 55666655322 223445778999999999995 8899999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~-l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+||||||= ..||..+|.+... .+...+++|..|+++|+.++|.+||||-||||.|+|+ -.|.+||+|||+|+.+...
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 99999986 5699999987654 4447999999999999999999999999999999999 6799999999999987543
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC--------
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-------- 311 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-------- 311 (518)
.... ...+.|||+.||+||.+....
T Consensus 513 TTsI-----------------------------------------------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~ 545 (677)
T KOG0596|consen 513 TTSI-----------------------------------------------VKDSQVGTVNYMSPEALTDMSSSRENGKS 545 (677)
T ss_pred ccce-----------------------------------------------eeccccCcccccCHHHHhhccccccCCCc
Confidence 2221 123779999999999997432
Q ss_pred ---CCccccccchhHHHHHHHhCCCCCCCCC-hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCCh
Q 010116 312 ---YGMECDWWSLGAIMYEMLVGYPPFYADD-PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA 386 (518)
Q Consensus 312 ---y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a 386 (518)
.+.++||||||||||+|+.|++||..-. ...-+..|..-...+.||.-+. ..++.++++.||. ||.+|+ ++
T Consensus 546 k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~---si 621 (677)
T KOG0596|consen 546 KIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRW---SI 621 (677)
T ss_pred ceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCC---Cc
Confidence 4688999999999999999999996543 3334445554444567776322 2349999999998 999999 89
Q ss_pred hhhhcCccccc
Q 010116 387 HQIKAHPWFKD 397 (518)
Q Consensus 387 ~eil~Hpff~~ 397 (518)
.++|+|||+..
T Consensus 622 ~eLLqhpFl~~ 632 (677)
T KOG0596|consen 622 PELLQHPFLQI 632 (677)
T ss_pred HHHhcCccccc
Confidence 99999999975
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=350.17 Aligned_cols=255 Identities=31% Similarity=0.514 Sum_probs=211.8
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++++.||.|+||.||+|+++.+|+.||||++..... .......+.+|+++++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 58999999999999999999999999999999865432 22344568889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 167 YLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 167 y~~gG~L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|++ ++|..++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.+|.+||+|||++..+....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence 995 688888855 3578999999999999999999999999999999999999999999999999987543110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC-CCccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGv 323 (518)
.......|++.|+|||++.+.. ++.++|||||||
T Consensus 155 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 189 (284)
T cd07860 155 ---------------------------------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 189 (284)
T ss_pred ---------------------------------------------cccccccccccccCCeEEecCCCCCcHHHHHHHHH
Confidence 0011345789999999987644 688999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcc----------------cCCC---------CCCCChhHHHHHHHHhc-cc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHL----------------KFPD---------DSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l----------------~~p~---------~~~~s~~~~dLI~~lL~-dp 377 (518)
++|+|++|+.||.+.+......++....... .++. ...+++++++||.+||+ ||
T Consensus 190 il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 269 (284)
T cd07860 190 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDP 269 (284)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCc
Confidence 9999999999998877665555544321110 1111 12478999999999998 99
Q ss_pred cccCCCCChhhhhcCccc
Q 010116 378 EHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 378 ~~R~g~~~a~eil~Hpff 395 (518)
.+|+ ++++++.||||
T Consensus 270 ~~Rp---t~~~~l~~~~f 284 (284)
T cd07860 270 NKRI---SAKAALAHPFF 284 (284)
T ss_pred ccCC---CHHHHhcCCCC
Confidence 9999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.20 Aligned_cols=260 Identities=32% Similarity=0.501 Sum_probs=213.6
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||.|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 689999999999999999999999999999999865432 2234456788999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-CCcEEEeecccccccCCCccc
Q 010116 166 EYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-~g~vKL~DFGla~~~~~~~~~ 242 (518)
||++ ++|..++.... .+++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++.......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-- 157 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-- 157 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence 9995 58888876543 3588899999999999999999999999999999999985 5679999999987542110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccch
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSL 321 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSl 321 (518)
......+|++.|+|||++.+ ..++.++|||||
T Consensus 158 -----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 190 (294)
T PLN00009 158 -----------------------------------------------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSV 190 (294)
T ss_pred -----------------------------------------------cccccCceeecccCHHHHhCCCCCCcHHHHHHH
Confidence 00113468899999999876 458999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc-------------------cCCC------CCCCChhHHHHHHHHhc-
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL-------------------KFPD------DSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l-------------------~~p~------~~~~s~~~~dLI~~lL~- 375 (518)
||++|+|++|.+||.+.+......++....... .++. ...+++++++||.+||.
T Consensus 191 G~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 270 (294)
T PLN00009 191 GCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRL 270 (294)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccC
Confidence 999999999999999887766666554321100 0000 13578999999999998
Q ss_pred cccccCCCCChhhhhcCcccccCC
Q 010116 376 DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
||.+|+ ++.+++.||||++++
T Consensus 271 ~P~~Rp---s~~~~l~~~~~~~~~ 291 (294)
T PLN00009 271 DPSKRI---TARAALEHEYFKDLG 291 (294)
T ss_pred ChhhCc---CHHHHhcCchHhHHh
Confidence 999999 899999999999653
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=370.18 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=222.2
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
|.-++.||.|+||.||.|++..+.++||||++.-+.-.....-..+..|+.+|..++|||+|..-++|-.+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55577899999999999999999999999999876655566667899999999999999999999999999999999999
Q ss_pred cCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 168 LPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 168 ~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|- |+-.++|.- +.++.|.++..++.+.+.||.|||+++.||||||..||||+..|.|||+|||.|....
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--------- 177 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--------- 177 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---------
Confidence 95 566666643 4689999999999999999999999999999999999999999999999999876542
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CCCCccccccchhH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMECDWWSLGA 323 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGv 323 (518)
.+.++||||.|||||||+. +.|+-++||||||+
T Consensus 178 --------------------------------------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGI 213 (948)
T KOG0577|consen 178 --------------------------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213 (948)
T ss_pred --------------------------------------------chhcccCCccccchhHheeccccccCCccceeeccc
Confidence 2458999999999999974 67999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
++.||.-.+||..+.+-...+..|... ..+.++. ..+|..++.||..||. -|.+|+ +.++++.|+|...
T Consensus 214 TCIELAERkPPlFnMNAMSALYHIAQN-esPtLqs-~eWS~~F~~Fvd~CLqKipqeRp---tse~ll~H~fv~R 283 (948)
T KOG0577|consen 214 TCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQS-NEWSDYFRNFVDSCLQKIPQERP---TSEELLKHRFVLR 283 (948)
T ss_pred hhhhhhhcCCCccCchHHHHHHHHHhc-CCCCCCC-chhHHHHHHHHHHHHhhCcccCC---cHHHHhhcchhcc
Confidence 999999999999999999988888763 3334443 4689999999999998 899999 8999999999853
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.57 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=216.1
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
....|++++.||+|+||.||+|....+|+.||+|++.............+.+|+.+++.++||||++++++|.+....|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34669999999999999999999999999999999876544444555678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||||++ |++.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.+||+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 999996 567666653 467999999999999999999999999999999999999999999999999998643211
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CCCCCcccccc
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWW 319 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiW 319 (518)
....|++.|+|||++. ...++.++|||
T Consensus 169 --------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~ 198 (307)
T cd06607 169 --------------------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVW 198 (307)
T ss_pred --------------------------------------------------CCccCCccccCceeeeccCCCCCCcccchH
Confidence 1346889999999985 35689999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||||++|||++|.+||.+.+.......+... ....++. ..++.++++||.+||. ||.+|+ ++.+|+.||||..
T Consensus 199 s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 272 (307)
T cd06607 199 SLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLSS-NDWSDYFRNFVDSCLQKIPQDRP---SSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCCCCCc-hhhCHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcc
Confidence 9999999999999999888776665555432 2222222 2478899999999998 999999 8999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.60 Aligned_cols=257 Identities=30% Similarity=0.524 Sum_probs=220.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+.++..++||||+++++++.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4799999999999999999999999999999998765322 34567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||++|++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.+|.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~---- 154 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL---- 154 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC----
Confidence 999999999999888899999999999999999999999 999999999999999999999999999988653210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
.......|+..|+|||++.+..++.++|+||||++
T Consensus 155 ---------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~i 189 (264)
T cd06623 155 ---------------------------------------------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189 (264)
T ss_pred ---------------------------------------------CcccceeecccccCHhhhCCCCCCchhhHHHHHHH
Confidence 00113468899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC---hhhHHHHHhhhcCcccCCCCCC-CChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 325 MYEMLVGYPPFYADD---PITTCRKIVHWRNHLKFPDDSK-LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 325 lyeml~G~~PF~~~~---~~~~~~~i~~~~~~l~~p~~~~-~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
+|+|++|.+||...+ .......+.. .....++ .. ++..+.++|.+||. +|.+|+ ++.+++.||||+.++
T Consensus 190 l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~---~~~~ll~~~~~~~~~ 263 (264)
T cd06623 190 LLECALGKFPFLPPGQPSFFELMQAICD-GPPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHhCCCCCccccccCHHHHHHHHhc-CCCCCCC--cccCCHHHHHHHHHHccCChhhCC---CHHHHHhCHHHHhcc
Confidence 999999999998774 3333444432 1122222 34 78999999999998 999999 899999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=373.72 Aligned_cols=243 Identities=35% Similarity=0.612 Sum_probs=209.4
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ly 162 (518)
..++|++...+|.|+||.|..|.+..+++.+|+|++.+.. ....+|..++... +||||+++.+.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3578999999999999999999999999999999998762 1233466555554 7999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee-CCCCcEEEeecccccccCCCcc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL-DKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl-d~~g~vKL~DFGla~~~~~~~~ 241 (518)
+|||++.||.+.+.+.....+. .++..|++||+.|+.|||++|||||||||+|||+ ++.|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999999987766665 8888999999999999999999999999999999 69999999999999865321
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
..+.|=|..|.|||++...+|+.+||||||
T Consensus 470 --------------------------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSL 499 (612)
T KOG0603|consen 470 --------------------------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSL 499 (612)
T ss_pred --------------------------------------------------hcccchhhcccChhhhccCCCCcchhhHHH
Confidence 114477889999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChh-hHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 322 GAIMYEMLVGYPPFYADDPI-TTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~-~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
|++||+||+|+.||.+.... ++..+| ...+|. ..+|.+|+|||++||+ ||.+|+ ++.+|..||||
T Consensus 500 GvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s--~~vS~~AKdLl~~LL~~dP~~Rl---~~~~i~~h~w~ 566 (612)
T KOG0603|consen 500 GVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS--ECVSDEAKDLLQQLLQVDPALRL---GADEIGAHPWF 566 (612)
T ss_pred HHHHHHHHhCCCccccCCchHHHHHhh----cCCccc--cccCHHHHHHHHHhccCChhhCc---ChhhhccCcch
Confidence 99999999999999876554 333333 233343 4799999999999999 999999 89999999999
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=348.07 Aligned_cols=258 Identities=35% Similarity=0.561 Sum_probs=215.5
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.+++.++|+||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999876432 2334567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++++.+..++.+...+++..+..++.|++.||.|||+.|++||||+|+||+++.+|.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 9999887777776667899999999999999999999999999999999999999999999999999886542210
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccchhHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAI 324 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvi 324 (518)
......+|++.|+|||++.+. .++.++|+|||||+
T Consensus 156 --------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~ 191 (288)
T cd07833 156 --------------------------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191 (288)
T ss_pred --------------------------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHH
Confidence 011245789999999999888 89999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCc-----------------ccCCC-----------CCCCChhHHHHHHHHhc-
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNH-----------------LKFPD-----------DSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~-----------------l~~p~-----------~~~~s~~~~dLI~~lL~- 375 (518)
+|+|++|.+||.+.+.......+...... ..++. ...+++++++||.+||.
T Consensus 192 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 271 (288)
T cd07833 192 MAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRM 271 (288)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhcc
Confidence 99999999999877655444333221000 01110 11358899999999998
Q ss_pred cccccCCCCChhhhhcCccc
Q 010116 376 DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff 395 (518)
+|.+|+ ++.+|++||||
T Consensus 272 ~p~~Rp---s~~~il~~~~f 288 (288)
T cd07833 272 DPKERL---TCDELLQHPYF 288 (288)
T ss_pred Cchhcc---cHHHHhcCCCC
Confidence 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=346.52 Aligned_cols=254 Identities=30% Similarity=0.504 Sum_probs=216.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||.|+||.||+|.++.+++.||+|.+.+... ......+.+|+++++.++||||+++++.+.+...+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478889999999999999999999999999999876532 234566888999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||++|++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.+|.++|+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 999999999999776 789999999999999999999999 99999999999999999999999999998754211
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
......|++.|+|||++.+..++.++|+|||||
T Consensus 155 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ 187 (265)
T cd06605 155 -----------------------------------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGL 187 (265)
T ss_pred -----------------------------------------------HhhcccCChhccCHHHHcCCCCCchhhHHHHHH
Confidence 001257899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC-----ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 324 IMYEMLVGYPPFYAD-----DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 324 ilyeml~G~~PF~~~-----~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
++|+|++|..||... ........+... .....+.. .+++++++||.+||. ||.+|+ ++.+++.||||+.
T Consensus 188 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~~~ 262 (265)
T cd06605 188 SLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPRLPSG-KFSPDFQDFVNLCLIKDPRERP---SYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCCCChh-hcCHHHHHHHHHHcCCCchhCc---CHHHHhhCchhhc
Confidence 999999999999764 223333334332 22233322 278999999999998 999999 8999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=354.04 Aligned_cols=255 Identities=30% Similarity=0.537 Sum_probs=216.5
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|.....||.|+||.||++.+..++..||||++.... ....+.+.+|+.+++.++||||+++++.|...++.|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 4555678999999999999999999999999986542 2334568889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|++|++|.+++. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~------ 172 (292)
T cd06658 100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV------ 172 (292)
T ss_pred CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc------
Confidence 999999999874 4578999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
......+||+.|+|||++.+..++.++|+|||||++|
T Consensus 173 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~ 209 (292)
T cd06658 173 -------------------------------------------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 209 (292)
T ss_pred -------------------------------------------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 0012457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 327 eml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||++|+.||...+.......+... ....++....++..+++||.+||+ ||.+|+ ++++|++||||+..
T Consensus 210 el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~il~~~~~~~~ 278 (292)
T cd06658 210 EMIDGEPPYFNEPPLQAMRRIRDN-LPPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLKLA 278 (292)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhc-CCCccccccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhhcc
Confidence 999999999988776665554432 122333334578999999999998 999999 89999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=362.82 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=213.4
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.+.+..+.+.+++.||+|-||+||+|+.+.+ ..||+|.++...+ ..+.+.+|+.||+.++|++||+|++++..++
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 3445555677789999999999999988643 4799999976543 2356779999999999999999999999988
Q ss_pred eEEEEEeecCCCchHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 160 YLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+|||||||+.|+|.++|.. ...+.......+++||+.|++||+++++|||||.+.|||+++++.+||+|||||+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999986 4689999999999999999999999999999999999999999999999999999543
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
...... .. +.--...|.|||++....|+.++|
T Consensus 355 d~~Y~~-~~-----------------------------------------------~~kfPIkWtAPEa~~~~~FS~kSD 386 (468)
T KOG0197|consen 355 DDEYTA-SE-----------------------------------------------GGKFPIKWTAPEALNYGKFSSKSD 386 (468)
T ss_pred CCceee-cC-----------------------------------------------CCCCCceecCHHHHhhCCcccccc
Confidence 221110 00 001124799999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhh
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI 389 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei 389 (518)
||||||+||||+| |+.|+.+.+..+....+.. ..+.|.+..+|+++-+++..|+. +|++|| +++.+
T Consensus 387 VWSFGVlL~E~fT~G~~py~~msn~ev~~~le~---GyRlp~P~~CP~~vY~lM~~CW~~~P~~RP---tF~~L 454 (468)
T KOG0197|consen 387 VWSFGVLLWELFTYGRVPYPGMSNEEVLELLER---GYRLPRPEGCPDEVYELMKSCWHEDPEDRP---TFETL 454 (468)
T ss_pred eeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc---cCcCCCCCCCCHHHHHHHHHHhhCCcccCC---CHHHH
Confidence 9999999999999 9999999999998888876 34566667899999999999998 999999 66643
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.46 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=209.1
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcE--EEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNI--YAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~--~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
+..++|++.+.||+|+||.||+|+++.++.. +|+|.++.. ........+.+|+.++..+ +||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4568999999999999999999999888765 466665432 2334456788899999999 8999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g 223 (518)
.+|+||||++||+|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999996542 578999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccC
Q 010116 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (518)
Q Consensus 224 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 303 (518)
.+||+|||++....... ......+++.|+|
T Consensus 162 ~~kl~dfg~~~~~~~~~--------------------------------------------------~~~~~~~~~~y~a 191 (303)
T cd05088 162 VAKIADFGLSRGQEVYV--------------------------------------------------KKTMGRLPVRWMA 191 (303)
T ss_pred cEEeCccccCcccchhh--------------------------------------------------hcccCCCcccccC
Confidence 99999999986321000 0011234678999
Q ss_pred hhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccC
Q 010116 304 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381 (518)
Q Consensus 304 PEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 381 (518)
||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.. ....+....+++++.+||.+||. +|.+|+
T Consensus 192 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 268 (303)
T cd05088 192 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERP 268 (303)
T ss_pred HHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc---CCcCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 999988889999999999999999998 9999988877666655533 12222223578999999999998 999999
Q ss_pred CCCChhhhhcC
Q 010116 382 GTGGAHQIKAH 392 (518)
Q Consensus 382 g~~~a~eil~H 392 (518)
++.+++.+
T Consensus 269 ---~~~~il~~ 276 (303)
T cd05088 269 ---SFAQILVS 276 (303)
T ss_pred ---CHHHHHHH
Confidence 89999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.83 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=207.4
Q ss_pred CeeEEeeEeecCceEEEEEEEec--CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--CeEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYLY 162 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~ly 162 (518)
.|++++.||+|+||.||+|.++. +++.||+|++.+...........+.+|+.+++.++||||++++++|.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999875433344456678899999999999999999999988 8899
Q ss_pred EEEeecCCCchHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC----CCcEEEeecccc
Q 010116 163 LIMEYLPGGDMMTLLMRE-----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK----NGHMKLSDFGLC 233 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~-----~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~----~g~vKL~DFGla 233 (518)
+||||++ ++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 4677766421 37899999999999999999999999999999999999999 999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGY 312 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y 312 (518)
..+...... .......+||+.|+|||++.+ ..+
T Consensus 160 ~~~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~ 193 (316)
T cd07842 160 RLFNAPLKP----------------------------------------------LADLDPVVVTIWYRAPELLLGARHY 193 (316)
T ss_pred cccCCCccc----------------------------------------------ccccCCccccccccCHHHHhCCCCC
Confidence 865322100 001124578999999999876 468
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhh---------HHHHHhh------------------------hcCcccCCC-
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPIT---------TCRKIVH------------------------WRNHLKFPD- 358 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~---------~~~~i~~------------------------~~~~l~~p~- 358 (518)
+.++|+|||||++|+|++|++||.+..... ....++. ......++.
T Consensus 194 ~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (316)
T cd07842 194 TKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSN 273 (316)
T ss_pred CcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCc
Confidence 999999999999999999999998654322 1111111 000111110
Q ss_pred --------CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 359 --------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 359 --------~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
....+.++.++|.+||. ||.+|+ ++.||+.||||
T Consensus 274 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~eil~~~~f 316 (316)
T cd07842 274 SLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI---TAEEALEHPYF 316 (316)
T ss_pred cHHHHHHhccCCCHHHHHHHHHHhcCCcccCc---CHHHHhcCCCC
Confidence 01467889999999999 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=339.47 Aligned_cols=253 Identities=34% Similarity=0.601 Sum_probs=216.6
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec--CCeEEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TEYLYLI 164 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~~lylV 164 (518)
+|++++.||.|+||.||+|.+..+|..||+|++..... .....+.+..|+.+++.++||||+++++.+.+ ...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999876543 33445678889999999999999999997753 4578999
Q ss_pred EeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 165 MEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIH-----KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 165 mEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH-----~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
|||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.+|++||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 368999999999999999999999 89999999999999999999999999999886
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
..... .......|++.|+|||++.+..++.+
T Consensus 160 ~~~~~-------------------------------------------------~~~~~~~~~~~~~~pE~~~~~~~~~~ 190 (265)
T cd08217 160 LGHDS-------------------------------------------------SFAKTYVGTPYYMSPEQLNHMSYDEK 190 (265)
T ss_pred ccCCc-------------------------------------------------ccccccccCCCccChhhhcCCCCCch
Confidence 53210 00123568999999999999889999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
+|+||||+++|+|++|..||...+.......+... ....+| ..++.++.+||.+||. +|.+|| ++.+|++|||
T Consensus 191 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---~~~~il~~~~ 264 (265)
T cd08217 191 SDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-KFRRIP--YRYSSELNEVIKSMLNVDPDKRP---STEELLQLPL 264 (265)
T ss_pred hHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-CCCCCc--cccCHHHHHHHHHHccCCcccCC---CHHHHhhCCC
Confidence 99999999999999999999988766665555442 122233 3678999999999998 999999 8999999999
Q ss_pred c
Q 010116 395 F 395 (518)
Q Consensus 395 f 395 (518)
+
T Consensus 265 ~ 265 (265)
T cd08217 265 I 265 (265)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=341.05 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=214.2
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+...+|.+.+.||.|+||.||+|..+.+++.||+|++.+.. .....+.+|+.+++.++||||+++++++..+..+
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 455678999999999999999999999999999999987542 2345678899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999999998653 46899999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
... ......+++.|+|||++.+..++.++|||
T Consensus 158 ~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 189 (263)
T cd05052 158 TYT------------------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVW 189 (263)
T ss_pred eee------------------------------------------------ccCCCCCccccCCHHHhccCCCCchhHHH
Confidence 100 00122356789999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|||++ |.+||.+.+.......+... ...+....+++++.+||.+||. ||.+|| ++.++++
T Consensus 190 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~l~~ 257 (263)
T cd05052 190 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---YRMERPEGCPPKVYELMRACWQWNPSDRP---SFAEIHQ 257 (263)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---CCCCCCCCCCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 99999999998 99999988777766666542 2223334689999999999998 999999 7888765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=340.40 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=212.8
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+..++|+++++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 466789999999999999999999864 567799998865432 356788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999999999653 56888999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.. .......++..|+|||++.+..++.++|||
T Consensus 157 ~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 188 (261)
T cd05072 157 EY------------------------------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVW 188 (261)
T ss_pred ce------------------------------------------------eccCCCccceecCCHHHhccCCCChhhhhh
Confidence 00 001123467789999999988999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|+|++ |..||.+.........+.. ....|....++.++.+||.+||. +|.+|| ++++|..
T Consensus 189 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 256 (261)
T cd05072 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQR---GYRMPRMENCPDELYDIMKTCWKEKAEERP---TFDYLQS 256 (261)
T ss_pred hhHHHHHHHHccCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 99999999998 9999988877776666654 23444445789999999999998 999999 7887764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=357.29 Aligned_cols=263 Identities=28% Similarity=0.462 Sum_probs=214.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee----cCCeE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ----DTEYL 161 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~----~~~~l 161 (518)
++|++.+.||.|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+|+.++||||++++++|. +...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999876432 2334566788999999999999999998886 34579
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||+. |+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999994 68999998778899999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 320 (518)
. ........+||..|+|||++.+ ..++.++||||
T Consensus 163 ~---------------------------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 197 (334)
T cd07855 163 E---------------------------------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWS 197 (334)
T ss_pred C---------------------------------------------CCcccccccccccccChHHhcCCcccccccchHH
Confidence 0 0001124579999999999876 56899999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc------------------cCCC---------CCCCChhHHHHHHHH
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL------------------KFPD---------DSKLSPEAKDLICRL 373 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l------------------~~p~---------~~~~s~~~~dLI~~l 373 (518)
|||++|||++|++||.+.+.......+....+.. .++. ...+++++++||.+|
T Consensus 198 lG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 277 (334)
T cd07855 198 VGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQM 277 (334)
T ss_pred HHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHH
Confidence 9999999999999998876654443332210000 0110 124689999999999
Q ss_pred hc-cccccCCCCChhhhhcCcccccC
Q 010116 374 LC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|+ ||.+|+ ++.+++.||||.+.
T Consensus 278 l~~~P~~Rp---t~~~~l~~~~~~~~ 300 (334)
T cd07855 278 LQFDPEERI---TVEQALQHPFLAQY 300 (334)
T ss_pred ccCChhhCc---CHHHHHhChhhhhc
Confidence 98 999999 89999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=345.08 Aligned_cols=254 Identities=30% Similarity=0.545 Sum_probs=217.6
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|...+.||.|++|.||++.+..+++.+|+|++.... ....+.+.+|+.+++.++||||++++++|...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4555689999999999999999999999999886432 2334567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.+|.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~------ 169 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV------ 169 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC------
Confidence 9999999999876 679999999999999999999999999999999999999999999999999876432110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
.......|++.|+|||++.+..++.++|+|||||++|
T Consensus 170 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ 206 (285)
T cd06648 170 -------------------------------------------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206 (285)
T ss_pred -------------------------------------------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHH
Confidence 0011356899999999999989999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 327 eml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+|++|..||...++.....++... ..........++..+.+||.+||. +|.+|+ ++.+++.||||+.
T Consensus 207 ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~ 274 (285)
T cd06648 207 EMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLAK 274 (285)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHHHcccChhhCc---CHHHHccCccccc
Confidence 999999999988877777666543 122222233478999999999998 999999 8999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.34 Aligned_cols=260 Identities=29% Similarity=0.477 Sum_probs=208.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC-----C
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----E 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~ 159 (518)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... .......+..|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 478999999999999999999999999999999986421 223455677899999999999999999876544 3
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||+. ++|..++ ....+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5899999995 5888777 4467999999999999999999999999999999999999999999999999998864321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 318 (518)
... .......+||+.|+|||++.+ ..++.++||
T Consensus 160 ~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 193 (336)
T cd07849 160 HDH----------------------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKAIDI 193 (336)
T ss_pred ccc----------------------------------------------cCCcCCcCcCCCccChHHhhCCCCCCcHHHH
Confidence 100 001124579999999998765 578999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC--------------------cccC----C---CCCCCChhHHHHHH
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN--------------------HLKF----P---DDSKLSPEAKDLIC 371 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--------------------~l~~----p---~~~~~s~~~~dLI~ 371 (518)
|||||++|+|++|++||.+.+.......+..... .+.. + ..+.+++++.+||.
T Consensus 194 wslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (336)
T cd07849 194 WSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLD 273 (336)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHH
Confidence 9999999999999999987655443332221000 0000 0 01246889999999
Q ss_pred HHhc-cccccCCCCChhhhhcCccccc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+||. ||.+|+ ++.+++.||||+.
T Consensus 274 ~~l~~dP~~Rp---t~~e~l~hp~~~~ 297 (336)
T cd07849 274 KMLTFNPHKRI---TVEEALAHPYLEQ 297 (336)
T ss_pred HHcCCChhhCc---CHHHHhcCccccc
Confidence 9998 999999 8999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.00 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=212.2
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEec-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
..++|.+++.||+|+||.||+|.... ++..||+|+++... .......+.+|+++|+.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34678999999999999999998753 46789999987542 223456789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE--------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH 224 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~--------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~ 224 (518)
..+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999999999999999654 34788999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccCh
Q 010116 225 MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304 (518)
Q Consensus 225 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 304 (518)
+||+|||++......... .......+++.|+||
T Consensus 161 ~kl~d~g~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aP 193 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYY-----------------------------------------------RVGGHTMLPIRWMPP 193 (280)
T ss_pred EEECCcccceecccCcce-----------------------------------------------ecCCCCcccceecCh
Confidence 999999998754211000 001134568899999
Q ss_pred hhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 305 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 305 Evl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
|++.+..++.++|||||||++|||++ |..||...+.......+... .+..+ ...++..+++||.+||+ ||.+|+
T Consensus 194 E~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp- 269 (280)
T cd05049 194 ESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG--RLLQR-PRTCPSEVYDIMLGCWKRDPQQRI- 269 (280)
T ss_pred hhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CcCCC-CCCCCHHHHHHHHHHcCCCcccCC-
Confidence 99999999999999999999999998 99999988877777666642 22222 24688999999999998 999999
Q ss_pred CCChhhhhc
Q 010116 383 TGGAHQIKA 391 (518)
Q Consensus 383 ~~~a~eil~ 391 (518)
++.||+.
T Consensus 270 --~~~eil~ 276 (280)
T cd05049 270 --NIKDIHE 276 (280)
T ss_pred --CHHHHHH
Confidence 8898875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=355.77 Aligned_cols=256 Identities=31% Similarity=0.504 Sum_probs=213.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 159 (518)
.++|++++.||+|+||.||+|.+..+|..||||++.+.. ........+.+|+.+|+.++||||++++++|....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 478999999999999999999999999999999986532 22333456788999999999999999999998664
Q ss_pred -eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 -YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 -~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|+||||+ |++|..++. ...+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 459999999 789988875 46799999999999999999999999999999999999999999999999999875421
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 317 (518)
. .....||+.|+|||++.+ ..++.++|
T Consensus 171 ~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~D 198 (343)
T cd07880 171 E----------------------------------------------------MTGYVVTRWYRAPEVILNWMHYTQTVD 198 (343)
T ss_pred C----------------------------------------------------ccccccCCcccCHHHHhCCCCCCcHHH
Confidence 1 113467899999999976 45899999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc------------------cCC---------CCCCCChhHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL------------------KFP---------DDSKLSPEAKDLI 370 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l------------------~~p---------~~~~~s~~~~dLI 370 (518)
+|||||++|+|++|.+||.+.+......++....... ..| ....+++++.+||
T Consensus 199 i~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 278 (343)
T cd07880 199 IWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVL 278 (343)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHH
Confidence 9999999999999999999877665555544321100 000 0135788999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
.+||+ ||.+|+ ++.+++.||||+..
T Consensus 279 ~~~l~~dP~~R~---t~~~~l~~~~~~~~ 304 (343)
T cd07880 279 EKMLVLDAESRI---TAAEALAHPYFEEF 304 (343)
T ss_pred HHHcCCChhhCC---CHHHHhcCccHhhh
Confidence 99999 999999 89999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=343.94 Aligned_cols=256 Identities=17% Similarity=0.260 Sum_probs=210.9
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
.+..++|++.+.||+|+||.||+|.++ .++..||+|++..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456788999999999999999999864 2456799999865322 223456788999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEE
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRED----------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~----------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vK 226 (518)
+....|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999999986532 356778899999999999999999999999999999999999999
Q ss_pred EeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhh
Q 010116 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (518)
Q Consensus 227 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 306 (518)
|+|||+++.+....... ......+|+.|+|||+
T Consensus 160 l~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~ 192 (277)
T cd05062 160 IGDFGMTRDIYETDYYR-----------------------------------------------KGGKGLLPVRWMSPES 192 (277)
T ss_pred ECCCCCccccCCcceee-----------------------------------------------cCCCCccCHhhcChhH
Confidence 99999988653221000 0012356789999999
Q ss_pred hcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC
Q 010116 307 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG 384 (518)
Q Consensus 307 l~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~ 384 (518)
+.+..++.++|||||||++|||++ |.+||.+.+.......+... ....++ ..+++.+++||.+||. ||.+|+
T Consensus 193 ~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp--- 266 (277)
T cd05062 193 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GLLDKP--DNCPDMLFELMRMCWQYNPKMRP--- 266 (277)
T ss_pred hhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCc---
Confidence 999999999999999999999999 79999888777666665542 222233 4678999999999998 999999
Q ss_pred ChhhhhcC
Q 010116 385 GAHQIKAH 392 (518)
Q Consensus 385 ~a~eil~H 392 (518)
++.|++.+
T Consensus 267 s~~e~l~~ 274 (277)
T cd05062 267 SFLEIISS 274 (277)
T ss_pred CHHHHHHH
Confidence 89988764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=340.76 Aligned_cols=252 Identities=29% Similarity=0.507 Sum_probs=212.3
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||+|+||.||+|+++.+++.||||.+.............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999987655555556677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 166 EYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 166 Ey~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 99999999988853 3568999999999999999999999999999999999999999999999999987653110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.......|++.|+|||++.+..++.++|+|||
T Consensus 161 ------------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 192 (267)
T cd08228 161 ------------------------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred ------------------------------------------------HHHhcCCCCccccChhhhccCCCCchhhHHHH
Confidence 01123568999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCh--hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 322 GAIMYEMLVGYPPFYADDP--ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||++|||++|+.||..... ......+.. ......+. ..++..+++||.+||+ +|.+|| ++.+|++
T Consensus 193 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rp---~~~~vl~ 260 (267)
T cd08228 193 GCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDYPPLPT-EHYSEKLRELVSMCIYPDPDQRP---DIGYVHQ 260 (267)
T ss_pred HHHHHHHhcCCCCCccccccHHHHHHHHhc-CCCCCCCh-hhcCHHHHHHHHHHCCCCcccCc---CHHHHHH
Confidence 9999999999999976543 233333322 11112221 2577899999999998 999999 8999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.84 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=213.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC-----C
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----E 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~ 159 (518)
.++|.+++.||+|+||.||+|++..+++.||||.+.+.. ........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357999999999999999999999999999999987542 2233345677899999999999999999988654 3
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||+. ++|..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||+++.....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999994 789999988889999999999999999999999999999999999999999999999999998764321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 318 (518)
. ......+||..|+|||++.+ ..++.++|+
T Consensus 162 ~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 192 (337)
T cd07858 162 G-------------------------------------------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDV 192 (337)
T ss_pred c-------------------------------------------------ccccccccccCccChHHHhcCCCCCCcccH
Confidence 0 01124568899999999875 568999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc--------------------------ccC-CCCCCCChhHHHHHH
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH--------------------------LKF-PDDSKLSPEAKDLIC 371 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--------------------------l~~-p~~~~~s~~~~dLI~ 371 (518)
|||||++|+|++|++||.+.+.......+...... ..+ .....+++++++||+
T Consensus 193 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 272 (337)
T cd07858 193 WSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLE 272 (337)
T ss_pred HHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHH
Confidence 99999999999999999877654444333221000 000 001357899999999
Q ss_pred HHhc-cccccCCCCChhhhhcCcccccC
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
+||+ ||.+|+ ++.++++||||+.+
T Consensus 273 ~~l~~~P~~Rp---s~~ell~h~~~~~~ 297 (337)
T cd07858 273 KMLVFDPSKRI---TVEEALAHPYLASL 297 (337)
T ss_pred HHhcCChhhcc---CHHHHHcCcchhhh
Confidence 9999 999999 89999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=344.70 Aligned_cols=254 Identities=21% Similarity=0.383 Sum_probs=211.4
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEe----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREK----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
..++|++.+.||+|+||.||+|... .++..||+|.+.... .......+.+|..+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 356789999987532 2334567888999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN 222 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~ 222 (518)
..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 247888999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCcc
Q 010116 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (518)
Q Consensus 223 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 302 (518)
+.+||+|||+++........ ....+..++..|+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~ 193 (283)
T cd05090 161 LHVKISDLGLSREIYSADYY-----------------------------------------------RVQPKSLLPIRWM 193 (283)
T ss_pred CcEEeccccccccccCCcce-----------------------------------------------ecccCCCccceec
Confidence 99999999999865322100 0112345678899
Q ss_pred ChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-ccccc
Q 010116 303 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380 (518)
Q Consensus 303 APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R 380 (518)
|||++.+..++.++|||||||++|||++ |.+||.+.++......+... ..+ +.+..+++.+++||.+||+ ||.+|
T Consensus 194 aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~cl~~~p~~R 270 (283)
T cd05090 194 PPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLL--PCSEDCPPRMYSLMTECWQEGPSRR 270 (283)
T ss_pred ChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcC--CCCCCCCHHHHHHHHHHcccCcccC
Confidence 9999998899999999999999999998 99999887776655555432 222 3334689999999999998 99999
Q ss_pred CCCCChhhhhcC
Q 010116 381 LGTGGAHQIKAH 392 (518)
Q Consensus 381 ~g~~~a~eil~H 392 (518)
| ++.+|+++
T Consensus 271 p---~~~~i~~~ 279 (283)
T cd05090 271 P---RFKDIHTR 279 (283)
T ss_pred c---CHHHHHHH
Confidence 9 78888765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=347.83 Aligned_cols=261 Identities=30% Similarity=0.432 Sum_probs=208.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 159 (518)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4689999999999999999999999999999999865432 2223345678999999999999999999887654
Q ss_pred ---eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 160 ---YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 160 ---~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
..|+||||+. ++|..++... ..+++..++.++.|++.||.|||++|++||||||+|||++.+|.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 4699999995 5888887654 4789999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGM 314 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~ 314 (518)
+....... .......+|++.|+|||++.+. .++.
T Consensus 169 ~~~~~~~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 203 (310)
T cd07865 169 FSLSKNSK---------------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGP 203 (310)
T ss_pred ccCCcccC---------------------------------------------CCCccCcccCccccCcHHhcCCcccCc
Confidence 53221000 0011235688999999998764 4789
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc-----------------ccCCCC-----------CCCChhH
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH-----------------LKFPDD-----------SKLSPEA 366 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-----------------l~~p~~-----------~~~s~~~ 366 (518)
++|+|||||++|||++|++||.+.+.......+...... +.+|.. ...++.+
T Consensus 204 ~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 283 (310)
T cd07865 204 PIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHA 283 (310)
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHH
Confidence 999999999999999999999887765544433321110 111110 1135778
Q ss_pred HHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 367 KDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 367 ~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
++||.+||+ ||.+|+ +++++++||||
T Consensus 284 ~dli~~~l~~~P~~R~---t~~e~l~h~~f 310 (310)
T cd07865 284 LDLIDKLLVLDPAKRI---DADTALNHDFF 310 (310)
T ss_pred HHHHHHHhcCChhhcc---CHHHHhcCCCC
Confidence 999999998 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=344.11 Aligned_cols=254 Identities=32% Similarity=0.526 Sum_probs=212.1
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++++.||.|++|.||+|++..+|+.||||++..... ......+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999976532 2334567789999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 167 YLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 167 y~~gG~L~~~l~~~---~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|++| +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++++|.++|+|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--- 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--- 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence 9975 888887653 468999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
......+||+.|+|||++.+ ..++.++||||||
T Consensus 155 ----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG 188 (284)
T cd07836 155 ----------------------------------------------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG 188 (284)
T ss_pred ----------------------------------------------cccccccccccccChHHhcCCCCCCcHHHHHHHH
Confidence 00113468899999999876 4579999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCc----------------ccCCC---------CCCCChhHHHHHHHHhc-c
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNH----------------LKFPD---------DSKLSPEAKDLICRLLC-D 376 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------------l~~p~---------~~~~s~~~~dLI~~lL~-d 376 (518)
|++|+|++|.+||.+.+..+...++...... ..+|. ...+++.++++|.+||+ |
T Consensus 189 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 268 (284)
T cd07836 189 CIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLN 268 (284)
T ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCC
Confidence 9999999999999988777666655432100 00110 02467899999999998 9
Q ss_pred ccccCCCCChhhhhcCccc
Q 010116 377 VEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 377 p~~R~g~~~a~eil~Hpff 395 (518)
|.+|+ ++.+|+.||||
T Consensus 269 p~~R~---~~~~~l~~~~f 284 (284)
T cd07836 269 PELRI---SAHDALQHPWF 284 (284)
T ss_pred cccCC---CHHHHhcCCCC
Confidence 99999 89999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=351.29 Aligned_cols=253 Identities=32% Similarity=0.572 Sum_probs=214.9
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
|+....||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++..++||||++++++|...+.+|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 4445689999999999999999999999999865432 2345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccc
Q 010116 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247 (518)
Q Consensus 168 ~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 247 (518)
++|++|..++. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..+....
T Consensus 100 ~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~------- 171 (297)
T cd06659 100 LQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------- 171 (297)
T ss_pred CCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-------
Confidence 99999998774 4678999999999999999999999999999999999999999999999999987543110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHH
Q 010116 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327 (518)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilye 327 (518)
......+|++.|+|||++.+..++.++|+|||||++||
T Consensus 172 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 209 (297)
T cd06659 172 ------------------------------------------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209 (297)
T ss_pred ------------------------------------------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 00124579999999999999899999999999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 328 MLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 328 ml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|++|++||...+.......+.... .........+++.+.++|.+||+ +|.+|+ ++.++++||||..
T Consensus 210 l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rp---s~~~ll~~~~~~~ 276 (297)
T cd06659 210 MVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFLERMLTREPQERA---TAQELLDHPFLLQ 276 (297)
T ss_pred HHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHHHHHhcCCcccCc---CHHHHhhChhhcc
Confidence 999999999887766665554321 12222234678999999999998 999999 8999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=345.24 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=205.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|.+++.||+|+||.||+|.++.+|+.||+|++..... ......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999865432 22234567899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||+. ++|...+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--- 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---
Confidence 99995 677766654 4578899999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
......+|++.|+|||++.+ ..++.++||||||
T Consensus 158 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 191 (291)
T cd07870 158 ----------------------------------------------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAG 191 (291)
T ss_pred ----------------------------------------------CCCCCccccccccCCceeecCCCCCcHHHHHHHH
Confidence 00113467899999999876 4589999999999
Q ss_pred HHHHHHHhCCCCCCCCChh-hHHHHHhhhcC---------------------cccCCC-------CCCCChhHHHHHHHH
Q 010116 323 AIMYEMLVGYPPFYADDPI-TTCRKIVHWRN---------------------HLKFPD-------DSKLSPEAKDLICRL 373 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~-~~~~~i~~~~~---------------------~l~~p~-------~~~~s~~~~dLI~~l 373 (518)
|++|+|++|.+||.+.+.. +...++..... ....+. ....++++.+||.+|
T Consensus 192 ~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 271 (291)
T cd07870 192 CIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQM 271 (291)
T ss_pred HHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHH
Confidence 9999999999999765432 22222211000 000000 011357899999999
Q ss_pred hc-cccccCCCCChhhhhcCccc
Q 010116 374 LC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~Hpff 395 (518)
|. ||.+|+ ++.+++.||||
T Consensus 272 l~~dp~~R~---t~~~~l~h~~~ 291 (291)
T cd07870 272 LMMFPKDRI---SAQDALLHPYF 291 (291)
T ss_pred hCcCcccCc---CHHHHhcCCCC
Confidence 98 999999 89999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=343.64 Aligned_cols=251 Identities=30% Similarity=0.512 Sum_probs=205.8
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecC--CeEEEE
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDT--EYLYLI 164 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~--~~lylV 164 (518)
|++++.||+|+||.||+|.+..+++.||+|++++... .... .....|..++..+. |+||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999876432 1122 23456888888885 99999999999988 899999
Q ss_pred EeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++ |+|.+.+.. ...+++..++.++.|++.||.|||+.|++||||||+||+++. |.+||+|||+++.+....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--- 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--- 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence 99996 578887765 467999999999999999999999999999999999999999 999999999987653210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
......||+.|+|||++.. ..++.++||||||
T Consensus 154 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 186 (282)
T cd07831 154 -----------------------------------------------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVG 186 (282)
T ss_pred -----------------------------------------------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHH
Confidence 0113468899999998765 5578999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcC----------------cccCCC---------CCCCChhHHHHHHHHhc-c
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRN----------------HLKFPD---------DSKLSPEAKDLICRLLC-D 376 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~----------------~l~~p~---------~~~~s~~~~dLI~~lL~-d 376 (518)
|++|||++|.+||.+.+.......+..... .+.+|. ...+|.++++||.+||. |
T Consensus 187 v~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 266 (282)
T cd07831 187 CVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYD 266 (282)
T ss_pred HHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccC
Confidence 999999999999998877665555543111 111221 12468999999999998 9
Q ss_pred ccccCCCCChhhhhcCccc
Q 010116 377 VEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 377 p~~R~g~~~a~eil~Hpff 395 (518)
|.+|+ ++.+++.||||
T Consensus 267 P~~R~---~~~~~l~~~~~ 282 (282)
T cd07831 267 PDERI---TAKQALRHPYF 282 (282)
T ss_pred ccccc---CHHHHhhCCCC
Confidence 99999 89999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=345.10 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=211.4
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
..++|.+.+.||.|+||+||++... .++..||+|.+.+.. ......+.+|+.+++.++||+|+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4568999999999999999999853 345679999886542 33456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcE
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRED-------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHM 225 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~-------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~v 225 (518)
..+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999986543 48999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChh
Q 010116 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (518)
Q Consensus 226 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 305 (518)
||+|||+++........ .......|++.|+|||
T Consensus 160 kl~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE 192 (288)
T cd05093 160 KIGDFGMSRDVYSTDYY-----------------------------------------------RVGGHTMLPIRWMPPE 192 (288)
T ss_pred EeccCCccccccCCcee-----------------------------------------------ecCCCCCccccccCHH
Confidence 99999998854321100 0011345688999999
Q ss_pred hhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC
Q 010116 306 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383 (518)
Q Consensus 306 vl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~ 383 (518)
++.+..++.++|+|||||++|+|++ |.+||...+.......+.... .... ...+++++.+||.+||. ||.+||
T Consensus 193 ~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~-~~~~--~~~~~~~l~~li~~~l~~~p~~Rp-- 267 (288)
T cd05093 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQR--PRTCPKEVYDLMLGCWQREPHMRL-- 267 (288)
T ss_pred HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-cCCC--CCCCCHHHHHHHHHHccCChhhCC--
Confidence 9999999999999999999999998 999999888777777776532 1222 23678999999999998 999999
Q ss_pred CChhhhhc
Q 010116 384 GGAHQIKA 391 (518)
Q Consensus 384 ~~a~eil~ 391 (518)
++.+++.
T Consensus 268 -t~~~v~~ 274 (288)
T cd05093 268 -NIKEIHS 274 (288)
T ss_pred -CHHHHHH
Confidence 7888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=348.41 Aligned_cols=257 Identities=31% Similarity=0.524 Sum_probs=218.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||.||++.+..+++.||+|++.... ....+.+.+|+.+++.++||||++++++|.+.+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 468999999999999999999998899999999986432 23346688899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
+||++||+|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~---- 169 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---- 169 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc----
Confidence 999999999999854 468899999999999999999999999999999999999999999999999987543110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
......+|++.|+|||++.+..++.++|+|||||+
T Consensus 170 ---------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~l 204 (293)
T cd06647 170 ---------------------------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204 (293)
T ss_pred ---------------------------------------------cccccccCChhhcCchhhccCCCCchhhHHHHHHH
Confidence 00113468999999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
+|+|++|.+||...+.......+... ....++....++..+++||.+||. +|.+|+ ++.+|+.||||+..
T Consensus 205 l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~h~~~~~~ 275 (293)
T cd06647 205 AIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKIA 275 (293)
T ss_pred HHHHHhCCCCCCCCChhhheeehhcC-CCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhcC
Confidence 99999999999877655443333222 223344444678899999999998 999999 89999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=346.78 Aligned_cols=256 Identities=33% Similarity=0.505 Sum_probs=212.9
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--CeEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYLY 162 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~ly 162 (518)
.++|++.+.||.|+||.||+|.++.+++.||+|.++..... ......+.+|+.++..++||||+++++++.+. ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 36799999999999999999999999999999999765432 33344567899999999999999999999877 8999
Q ss_pred EEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 163 LIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
+||||++ ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 9999996 5999988664 469999999999999999999999999999999999999999999999999988653210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 320 (518)
.......|++.|+|||++.+. .++.++|+||
T Consensus 161 ------------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 192 (293)
T cd07843 161 ------------------------------------------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWS 192 (293)
T ss_pred ------------------------------------------------cccccccccccccCchhhcCCccccchhhHHH
Confidence 001134578999999998764 4689999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc-----------------------------ccCCCCCCCChhHHHHHH
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH-----------------------------LKFPDDSKLSPEAKDLIC 371 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-----------------------------l~~p~~~~~s~~~~dLI~ 371 (518)
|||++|+|++|.+||...+....+.++...... -.++. ..+++.+++||.
T Consensus 193 lG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~ 271 (293)
T cd07843 193 VGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLN 271 (293)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccc-cCCChHHHHHHH
Confidence 999999999999999988777666655431100 01111 115889999999
Q ss_pred HHhc-cccccCCCCChhhhhcCccc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+||+ ||++|+ ++.|++.||||
T Consensus 272 ~~l~~~p~~R~---t~~ell~~~~f 293 (293)
T cd07843 272 RLLTYDPAKRI---SAEDALKHPYF 293 (293)
T ss_pred HHhccCccccC---CHHHHhcCCCC
Confidence 9998 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=342.81 Aligned_cols=256 Identities=31% Similarity=0.533 Sum_probs=215.0
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC---CCceeEEEEEeecCCeEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~~~~lyl 163 (518)
.|++++.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.+. ||||++++++|.+....|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4788899999999999999999999999999987542 2334567888999999996 9999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--- 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence 9999999999999855 589999999999999999999999999999999999999999999999999988653211
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
......+|++.|+|||++.+ ..++.++|+||||
T Consensus 156 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 189 (277)
T cd06917 156 ----------------------------------------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLG 189 (277)
T ss_pred ----------------------------------------------cccccccCCcceeCHHHhccCCccccchhHHHHH
Confidence 00113569999999999875 4579999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
|++|+|++|.+||.+.+.......+... ....++. ..++.++.+||.+||. ||.+|+ ++.+++.||||+...
T Consensus 190 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~---~~~~il~~~~~~~~~ 262 (277)
T cd06917 190 ITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLED-NGYSKLLREFVAACLDEEPKERL---SAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCc-ccCCHHHHHHHHHHcCCCcccCc---CHHHHhhChHhhccc
Confidence 9999999999999887665444333221 1222222 2378899999999998 999999 899999999998643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=342.66 Aligned_cols=256 Identities=32% Similarity=0.497 Sum_probs=211.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--CeEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYLYL 163 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~lyl 163 (518)
++|+.++.||.|++|.||+|.+..+++.||+|.+.+... ......+.+|+++++.++||||++++++|.+. ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999876432 23456688899999999999999999988654 47999
Q ss_pred EEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 164 IMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
||||++||+|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999888743 356899999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
......|+..|+|||.+.+..++.++|+|
T Consensus 159 ---------------------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~ 187 (287)
T cd06621 159 ---------------------------------------------------LAGTFTGTSFYMAPERIQGKPYSITSDVW 187 (287)
T ss_pred ---------------------------------------------------ccccccCCccccCHHHhcCCCCCchhhHH
Confidence 00134578899999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCC-----hhhHHHHHhhhcCcccCCCC----CCCChhHHHHHHHHhc-cccccCCCCChhhh
Q 010116 320 SLGAIMYEMLVGYPPFYADD-----PITTCRKIVHWRNHLKFPDD----SKLSPEAKDLICRLLC-DVEHRLGTGGAHQI 389 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~-----~~~~~~~i~~~~~~l~~p~~----~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei 389 (518)
||||++|+|++|..||.... ..+....+.... ...++.. ..+++++.+||.+||. ||.+|| ++.||
T Consensus 188 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~ei 263 (287)
T cd06621 188 SLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP---TPWDM 263 (287)
T ss_pred HHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-chhhccCCCCCCchHHHHHHHHHHHcCCCcccCC---CHHHH
Confidence 99999999999999998662 233333333311 1122211 2356789999999998 999999 89999
Q ss_pred hcCcccccC
Q 010116 390 KAHPWFKDV 398 (518)
Q Consensus 390 l~Hpff~~i 398 (518)
+.||||+..
T Consensus 264 l~~~~~~~~ 272 (287)
T cd06621 264 LEHPWIKAQ 272 (287)
T ss_pred HhCcccccc
Confidence 999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=338.33 Aligned_cols=255 Identities=31% Similarity=0.512 Sum_probs=209.3
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..+.+.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.+.+.+|+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455656679999999999999999999999999887543 2345678899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-CCcEEEeecccccccCCC
Q 010116 164 IMEYLPGGDMMTLLMRE-DTL--TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~-~~l--~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-~g~vKL~DFGla~~~~~~ 239 (518)
||||++|++|.+++... ..+ ++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999999764 455 88999999999999999999999999999999999986 679999999998754211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC--CCCcccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--GYGMECD 317 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--~y~~~~D 317 (518)
. .......|++.|+|||++.+. .++.++|
T Consensus 163 ~-------------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 193 (268)
T cd06624 163 N-------------------------------------------------PCTETFTGTLQYMAPEVIDKGPRGYGAPAD 193 (268)
T ss_pred C-------------------------------------------------CccccCCCCccccChhhhccccccCCchhh
Confidence 0 001134589999999998764 4899999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChh-hHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPI-TTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+|||||++|+|++|.+||...... .....+........+| ..+++++++||.+||. +|.+|+ ++.+++.||||
T Consensus 194 v~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 268 (268)
T cd06624 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP--ESLSAEAKNFILRCFEPDPDKRA---SAHDLLQDPFL 268 (268)
T ss_pred hHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC--cccCHHHHHHHHHHcCCCchhCC---CHHHHHhCCCC
Confidence 999999999999999999764332 2222221112223344 3578999999999998 999999 89999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=337.48 Aligned_cols=248 Identities=21% Similarity=0.350 Sum_probs=209.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||.||+++.+. +..+|+|.+.+... ....+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4689999999999999999998754 56799998865432 234678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-- 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce--
Confidence 999999999999865 35789999999999999999999999999999999999999999999999999875421100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
.......++..|+|||++.+..++.++|+|||||
T Consensus 156 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~ 189 (256)
T cd05114 156 ----------------------------------------------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189 (256)
T ss_pred ----------------------------------------------eccCCCCCchhhCChhhcccCccchhhhhHHHHH
Confidence 0001234567899999999899999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 324 IMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 324 ilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
++|||++ |++||...+..+....+.... ....| ...+.++.+||.+||+ ||.+|| ++.+|++
T Consensus 190 ~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~c~~~~p~~Rp---s~~~l~~ 253 (256)
T cd05114 190 LMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRP--KLASMTVYEVMYSCWHEKPEGRP---TFAELLR 253 (256)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCC--CCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 9999999 999999888877777776532 22223 3568899999999998 999999 8888874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=344.89 Aligned_cols=256 Identities=22% Similarity=0.366 Sum_probs=213.3
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCC----------------cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSG----------------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~----------------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~ 147 (518)
..++|++++.||+|+||.||+|....++ ..||+|++..... ....+.+.+|+++++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999876544 5689999876532 245677889999999999999
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCc
Q 010116 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-----------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDN 216 (518)
Q Consensus 148 Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~-----------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeN 216 (518)
|+++++++.++..+|+||||+++++|..++.... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997655 68999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccccc
Q 010116 217 LLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (518)
Q Consensus 217 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 296 (518)
|+++.++.++|+|||+++.+...... .......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~ 193 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYY-----------------------------------------------RVQGRAP 193 (296)
T ss_pred eeecCCCceEEccccceeecccCcce-----------------------------------------------eecCcCC
Confidence 99999999999999998764321100 0112446
Q ss_pred CCCCccChhhhcCCCCCccccccchhHHHHHHHh--CCCCCCCCChhhHHHHHhhh----cCcccCCCCCCCChhHHHHH
Q 010116 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYADDPITTCRKIVHW----RNHLKFPDDSKLSPEAKDLI 370 (518)
Q Consensus 297 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~--G~~PF~~~~~~~~~~~i~~~----~~~l~~p~~~~~s~~~~dLI 370 (518)
+|+.|+|||++.+..++.++|||||||++|||++ |..||...+.......+... ......+....++.++.+||
T Consensus 194 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (296)
T cd05051 194 LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELM 273 (296)
T ss_pred CCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHH
Confidence 7889999999998889999999999999999998 78899887766666665543 11222333346789999999
Q ss_pred HHHhc-cccccCCCCChhhhhc
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~ 391 (518)
.+||. ||.+|| ++.+|..
T Consensus 274 ~~cl~~~p~~Rp---t~~el~~ 292 (296)
T cd05051 274 LECWRRDEEDRP---TFREIHL 292 (296)
T ss_pred HHHhccChhcCC---CHHHHHH
Confidence 99998 999999 8998854
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=361.62 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=210.8
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLY 152 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~ 152 (518)
.++.+..++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+.+. |||||+++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 35677788999999999999999999986433 3479999986542 2334567889999999996 99999999
Q ss_pred EEeecCCeEEEEEeecCCCchHHHHhhc----------------------------------------------------
Q 010116 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRE---------------------------------------------------- 180 (518)
Q Consensus 153 ~~f~~~~~lylVmEy~~gG~L~~~l~~~---------------------------------------------------- 180 (518)
+++.+...+|||||||+||+|.++|...
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 9999999999999999999999988542
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCc
Q 010116 181 --------------------------------------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDN 216 (518)
Q Consensus 181 --------------------------------------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeN 216 (518)
..+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 247788889999999999999999999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccccc
Q 010116 217 LLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (518)
Q Consensus 217 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 296 (518)
||++.++.+||+|||+++.+..... .....+..
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~-----------------------------------------------~~~~~~~~ 300 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSN-----------------------------------------------YVSKGSTF 300 (400)
T ss_pred EEEeCCCEEEEEeCCcceecccccc-----------------------------------------------ccccCCcC
Confidence 9999999999999999886431100 00112356
Q ss_pred CCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc
Q 010116 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC 375 (518)
Q Consensus 297 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~ 375 (518)
|++.|+|||++.+..++.++|||||||++|||++ |..||............+... ...+....++.++.+||.+||.
T Consensus 301 ~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~ 378 (400)
T cd05105 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG--YRMAKPDHATQEVYDIMVKCWN 378 (400)
T ss_pred CCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcC--CCCCCCccCCHHHHHHHHHHCc
Confidence 7889999999999999999999999999999997 999998765444443333322 2333335689999999999998
Q ss_pred -cccccCCCCChhhhhc
Q 010116 376 -DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 376 -dp~~R~g~~~a~eil~ 391 (518)
||.+|| ++.+|.+
T Consensus 379 ~dP~~RP---t~~~l~~ 392 (400)
T cd05105 379 SEPEKRP---SFLHLSD 392 (400)
T ss_pred cCHhHCc---CHHHHHH
Confidence 999999 6766654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=364.24 Aligned_cols=246 Identities=26% Similarity=0.366 Sum_probs=214.1
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.|++..+...-+.-||.|+.|.||+++.+ ++.||||+++.- -..++.=|++++||||+.+.+++....
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 35566666666789999999999999765 789999986432 123455688999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|||||||+.|-|..+|+...+++......|..+|+.|++|||.+.|||||||.-||||..+..|||+|||-++.....
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998865311
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
....+++||..|||||||.+.+.+.++|||
T Consensus 266 --------------------------------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIw 295 (904)
T KOG4721|consen 266 --------------------------------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIW 295 (904)
T ss_pred --------------------------------------------------hhhhhhhhhHhhhCHHHhhcCCccccccee
Confidence 112379999999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||+|||||||..||.+-+...++.-+-. +.+.+|-+..++..++=||++||. .|..|+ ++.+|+.|
T Consensus 296 SfGVVLWEmLT~EiPYkdVdssAIIwGVGs--NsL~LpvPstcP~GfklL~Kqcw~sKpRNRP---SFrqil~H 364 (904)
T KOG4721|consen 296 SFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP---SFRQILLH 364 (904)
T ss_pred hhHHHHHHHHhcCCCccccchheeEEeccC--CcccccCcccCchHHHHHHHHHHhcCCCCCc---cHHHHHHH
Confidence 999999999999999988776655544433 456677767899999999999998 999999 89999988
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.07 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=208.9
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEE
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS 154 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 154 (518)
|.+..++|++.+.||.|+||.||+|+.. .+++.||+|++.... .......+..|+.++..+ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 4566678999999999999999999754 345789999986432 223456678899999999 89999999998
Q ss_pred eec-CCeEEEEEeecCCCchHHHHhhc-----------------------------------------------------
Q 010116 155 FQD-TEYLYLIMEYLPGGDMMTLLMRE----------------------------------------------------- 180 (518)
Q Consensus 155 f~~-~~~lylVmEy~~gG~L~~~l~~~----------------------------------------------------- 180 (518)
+.. +..+|+||||++||+|.+++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 764 46799999999999999998542
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccc
Q 010116 181 --------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252 (518)
Q Consensus 181 --------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~ 252 (518)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~---------- 229 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---------- 229 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch----------
Confidence 26788999999999999999999999999999999999999999999999999865321000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-C
Q 010116 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-G 331 (518)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 331 (518)
....+..|++.|+|||++.+..|+.++|||||||++|||++ |
T Consensus 230 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g 272 (337)
T cd05054 230 -------------------------------------VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 272 (337)
T ss_pred -------------------------------------hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcC
Confidence 00113456788999999999999999999999999999998 9
Q ss_pred CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 332 YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 332 ~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
.+||.+....+.....+........| ..+++++.+++.+||+ +|.+|| ++.+|++|
T Consensus 273 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~~p~~RP---s~~ell~~ 329 (337)
T cd05054 273 ASPYPGVQIDEEFCRRLKEGTRMRAP--EYATPEIYSIMLDCWHNNPEDRP---TFSELVEI 329 (337)
T ss_pred CCCCCCCCccHHHHHHHhccCCCCCC--ccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 99998765544444443322222333 3578999999999998 999999 89999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=377.40 Aligned_cols=305 Identities=36% Similarity=0.614 Sum_probs=261.9
Q ss_pred eEeecCceEEEEEEE---ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEEEEeec
Q 010116 93 IIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLIMEYL 168 (518)
Q Consensus 93 ~LG~G~fG~V~l~~~---~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVmEy~ 168 (518)
++|.|+||.|++|+. .+.|..||||++++.....+... +...|+.++..++ ||++|++.+.|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998864 45688999999998876655544 8889999999997 999999999999999999999999
Q ss_pred CCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccc
Q 010116 169 PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248 (518)
Q Consensus 169 ~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 248 (518)
.||+|...+.....+++...++|.++++.|++++|+.||||||+|++||+++.+||++++|||+++..-..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~--------- 150 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE--------- 150 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999865311
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHH
Q 010116 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 328 (518)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyem 328 (518)
...|||..|||||++. ++..++||||+|+++|||
T Consensus 151 --------------------------------------------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~fel 184 (612)
T KOG0603|consen 151 --------------------------------------------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFEL 184 (612)
T ss_pred --------------------------------------------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHH
Confidence 0229999999999998 889999999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCccccc-
Q 010116 329 LVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY- 404 (518)
Q Consensus 329 l~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w~~l~- 404 (518)
++|..||.. ++...|.. ..+.+| ..++..+++++..|+. +|..|+|.+ ++.||++|+||..++|..+.
T Consensus 185 ltg~~pf~~----~~~~~Il~--~~~~~p--~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~ 256 (612)
T KOG0603|consen 185 LTGTLPFGG----DTMKRILK--AELEMP--RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEA 256 (612)
T ss_pred hhCCCCCch----HHHHHHhh--hccCCc--hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhh
Confidence 999999988 56667765 244555 4799999999999998 999999986 89999999999999999885
Q ss_pred -cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCccccc
Q 010116 405 -EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKG 467 (518)
Q Consensus 405 -~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~ 467 (518)
+..|||+|.+..+.|+.+|+.......|......+.+ .+....|.||+|..+..+.+
T Consensus 257 r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~------~s~~~if~g~sfva~~il~~ 314 (612)
T KOG0603|consen 257 RSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSAS------GSDHTIFSGPSFVAPGVLED 314 (612)
T ss_pred cCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCC------ccccchhcCCCccChHHhhc
Confidence 6889999999999999999985444434332222221 12346899999988777665
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=343.41 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=218.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
..|+.++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 357888999999999999999999999999999875432 234577889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|.+++. .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~----- 155 (277)
T cd06640 82 EYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ----- 155 (277)
T ss_pred ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-----
Confidence 9999999999885 4679999999999999999999999999999999999999999999999999987543110
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
.......||..|+|||++.+..++.++|+|||||++
T Consensus 156 --------------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il 191 (277)
T cd06640 156 --------------------------------------------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITA 191 (277)
T ss_pred --------------------------------------------cccccccCcccccCHhHhccCCCccHHHHHHHHHHH
Confidence 001134688999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
|||++|.+||...++......+... ....++ ..++..+.+||.+||. +|.+|+ ++.+++.||||....
T Consensus 192 ~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~ 260 (277)
T cd06640 192 IELAKGEPPNSDMHPMRVLFLIPKN-NPPTLT--GEFSKPFKEFIDACLNKDPSFRP---TAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHCCCCCCCcChHhHhhhhhcC-CCCCCc--hhhhHHHHHHHHHHcccCcccCc---CHHHHHhChHhhhcc
Confidence 9999999999887766555444321 112222 2467899999999998 999999 899999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=336.24 Aligned_cols=253 Identities=32% Similarity=0.571 Sum_probs=215.7
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|.+.+.||+|+||.||++..+.+|..||+|.+...... ....+.+.+|+.+++.++|+||+++++.+.+...+|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 588999999999999999999999999999998765332 2344567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc-EEEeecccccccCCCcccc
Q 010116 167 YLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-MKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 167 y~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~-vKL~DFGla~~~~~~~~~~ 243 (518)
|++|++|.+++.+.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 999999999997643 5899999999999999999999999999999999999998865 6999999987543210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
.......|++.|+|||++.+..++.++|+|||||
T Consensus 157 ----------------------------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08225 157 ----------------------------------------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGC 190 (257)
T ss_pred ----------------------------------------------ccccccCCCccccCHHHHcCCCCCchhhHHHHHH
Confidence 0011346899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
++|+|++|..||...+.......+... .+ .+....++.+++++|.+||. +|.+|+ ++.+|++||||
T Consensus 191 il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~~~~~ 257 (257)
T cd08225 191 VLYELCTLKHPFEGNNLHQLVLKICQG--YF-APISPNFSRDLRSLISQLFKVSPRDRP---SITSILKRPFL 257 (257)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHhcc--cC-CCCCCCCCHHHHHHHHHHhccChhhCc---CHHHHhhCCCC
Confidence 999999999999887776666555432 11 12224578999999999998 999999 89999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=381.88 Aligned_cols=271 Identities=24% Similarity=0.353 Sum_probs=208.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|+++++||+|+||.||+|++..+|+.||||++.+.........+++.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997654333344567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 166 EYLPGGDMMTLLMRE-----------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~-----------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
||++||+|.+++... ..++...+..++.|++.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998641 234556678899999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCc
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 314 (518)
......... .+...+.+. .. ..........+||+.|+|||++.+..++.
T Consensus 162 ~i~~~~~~~---------------~~l~~~~~~--s~--------------~s~~t~~g~~vGT~~YmAPE~l~g~~~S~ 210 (932)
T PRK13184 162 FKKLEEEDL---------------LDIDVDERN--IC--------------YSSMTIPGKIVGTPDYMAPERLLGVPASE 210 (932)
T ss_pred ecccccccc---------------ccccccccc--cc--------------ccccccCCCCCCCCCCCCHHHhcCCCCCc
Confidence 653211000 000000000 00 00001122468999999999999999999
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
++|||||||++|||++|.+||...+.......... ...........+++.+.+++.+||. ||.+|+++ +++++
T Consensus 211 kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss--~eeLl 284 (932)
T PRK13184 211 STDIYALGVILYQMLTLSFPYRRKKGRKISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS--VQELK 284 (932)
T ss_pred HhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCH--HHHHH
Confidence 99999999999999999999987654433222111 1122222234688999999999998 99999853 44443
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=339.54 Aligned_cols=255 Identities=18% Similarity=0.303 Sum_probs=213.6
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
.+..++|++++.||+|+||.||++..+.. +..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 45568999999999999999999988654 4789999986543 2233456888999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEE
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRE----------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~----------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vK 226 (518)
+...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 999999999999999999998643 2467889999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhh
Q 010116 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (518)
Q Consensus 227 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 306 (518)
|+|||+++.+...... .......||+.|+|||+
T Consensus 160 l~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~ 192 (277)
T cd05032 160 IGDFGMTRDIYETDYY-----------------------------------------------RKGGKGLLPVRWMAPES 192 (277)
T ss_pred ECCcccchhhccCccc-----------------------------------------------ccCCCCCccccccCHHH
Confidence 9999998865321100 01113457889999999
Q ss_pred hcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC
Q 010116 307 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG 384 (518)
Q Consensus 307 l~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~ 384 (518)
+.+..++.++|+|||||++|||++ |.+||.+.+..+....+.. .....+|. .++.++.+||.+||+ +|.+|+
T Consensus 193 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp--- 266 (277)
T cd05032 193 LKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGHLDLPE--NCPDKLLELMRMCWQYNPKMRP--- 266 (277)
T ss_pred HhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCCCCCCC--CCCHHHHHHHHHHcCCChhhCC---
Confidence 998899999999999999999998 9999988887777666653 23344443 578999999999999 999999
Q ss_pred Chhhhhc
Q 010116 385 GAHQIKA 391 (518)
Q Consensus 385 ~a~eil~ 391 (518)
++.+|++
T Consensus 267 t~~~l~~ 273 (277)
T cd05032 267 TFLEIVS 273 (277)
T ss_pred CHHHHHH
Confidence 8888875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=348.64 Aligned_cols=254 Identities=20% Similarity=0.321 Sum_probs=209.7
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcE----EEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNI----YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~----~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
+...+|++++.||+|+||.||+|.+..++.. ||+|+++... .......+..|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 3457899999999999999999998776664 8999986432 233456688899999999999999999998765
Q ss_pred CeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
..++|+||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++++||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999999764 568999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
..... .......+|+.|+|||++.+..++.++|
T Consensus 161 ~~~~~-----------------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~D 193 (316)
T cd05108 161 ADEKE-----------------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSD 193 (316)
T ss_pred CCCcc-----------------------------------------------eeccCCccceeecChHHhccCCCCchhh
Confidence 21100 0011234577899999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||||++|||++ |.+||.+...... ..++.. ...+|....++.++.++|.+||. ||.+|+ ++.+|+.+
T Consensus 194 i~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~l~~~ 264 (316)
T cd05108 194 VWSYGVTVWELMTFGSKPYDGIPASEI-SSILEK--GERLPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 264 (316)
T ss_pred hHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhC--CCCCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 9999999999997 9999987765544 344442 23344445688999999999998 999999 89999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=334.66 Aligned_cols=249 Identities=53% Similarity=0.955 Sum_probs=218.8
Q ss_pred EeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010116 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (518)
Q Consensus 94 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L 173 (518)
||.|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||||+++++.++++..+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887666666778899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccccccc
Q 010116 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253 (518)
Q Consensus 174 ~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 253 (518)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------------- 147 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------------- 147 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-------------
Confidence 9999888889999999999999999999999999999999999999999999999999987643210
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCC
Q 010116 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 333 (518)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 333 (518)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 148 ------------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~ 191 (250)
T cd05123 148 ------------------------------------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191 (250)
T ss_pred ------------------------------------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 01124568899999999998889999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 334 PFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 334 PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
||...+.......+.. ..+.+|. .++..+.+||.+||+ ||.+|+....++++++||||
T Consensus 192 p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 192 PFYAEDRKEIYEKILK--DPLRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9988877666666665 3444553 578999999999998 99999932222999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.86 Aligned_cols=261 Identities=32% Similarity=0.532 Sum_probs=224.7
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||++++++|.....+|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999998999999999976532 45667889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~-~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
|+||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+|+++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 999999999999998776 89999999999999999999999999999999999999999999999999976542110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
.......|++.|+|||++.+..++.++|+||||
T Consensus 171 -----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG 203 (286)
T cd06614 171 -----------------------------------------------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLG 203 (286)
T ss_pred -----------------------------------------------hhhccccCCcccCCHhHhcCCCCCCccccHHHH
Confidence 001134588999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
|++|+|++|..||...++......+... ....++....++.++++||.+||. +|.+|+ ++.+|+.||||+...|.
T Consensus 204 vil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~~~~ 279 (286)
T cd06614 204 IMCIEMAEGEPPYLREPPLRALFLITTK-GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLKKACPK 279 (286)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCcchhhCCHHHHHHHHHHhccChhhCc---CHHHHhhChHhhccCch
Confidence 9999999999999887776665555442 222333333478999999999998 999999 89999999999986554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=397.80 Aligned_cols=258 Identities=31% Similarity=0.497 Sum_probs=223.5
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
++.-...||.|.||.||-|.+..||...|||-++-.... ......+.+|..+|..++|||+|+.|++-.+.+.+||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 455567899999999999999999999999988765443 4456678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
||.||+|.+++...+..+|...+.|..|++.||.|||++|||||||||+||+|+.+|-+|++|||.|..+.....
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~----- 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ----- 1389 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh-----
Confidence 999999999999889999999999999999999999999999999999999999999999999999998754310
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CCCCccccccchhH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMECDWWSLGA 323 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGv 323 (518)
+++ + ...+.+|||.|||||++.+ +|.+.+.|||||||
T Consensus 1390 -------------~~~----------------~-----------el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGC 1429 (1509)
T KOG4645|consen 1390 -------------TMP----------------G-----------ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGC 1429 (1509)
T ss_pred -------------cCC----------------H-----------HHHhhcCCchhcCchhhcccccCCCCcchhhhcccc
Confidence 000 1 1226789999999999985 67899999999999
Q ss_pred HHHHHHhCCCCCCCCC-hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 324 IMYEMLVGYPPFYADD-PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 324 ilyeml~G~~PF~~~~-~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
++.||+||+.||..-+ ...+..++-. ...+++|. .+|++.+|||.+||. ||..|. ++.||+.|.|=+
T Consensus 1430 VVlEM~tGkrPW~~~dne~aIMy~V~~-gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw---~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1430 VVLEMATGKRPWAELDNEWAIMYHVAA-GHKPQIPE--RLSSEGRDFLEHCLEQDPKMRW---TASQLLEHAFGK 1498 (1509)
T ss_pred eEEEeecCCCchhhccchhHHHhHHhc-cCCCCCch--hhhHhHHHHHHHHHhcCchhhh---HHHHHHHhhccc
Confidence 9999999999998754 4445555444 45678886 499999999999998 999998 788999998865
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=353.71 Aligned_cols=261 Identities=22% Similarity=0.351 Sum_probs=206.4
Q ss_pred eeEeec--CceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecC
Q 010116 92 TIIGRG--AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 92 ~~LG~G--~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
..||+| +||+||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|++.+.+|+||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 999999999999999999999875432 23445788999999999999999999999999999999999999
Q ss_pred CCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccc
Q 010116 170 GGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247 (518)
Q Consensus 170 gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 247 (518)
+|+|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~---- 158 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA---- 158 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc----
Confidence 99999998764 468999999999999999999999999999999999999999999999998764332110000
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCccccccchhHHH
Q 010116 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIM 325 (518)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil 325 (518)
. .. ........++..|+|||++.+ .+|+.++|||||||++
T Consensus 159 ----------~--~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l 200 (328)
T cd08226 159 ----------K--VV--------------------------YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITA 200 (328)
T ss_pred ----------c--cc--------------------------ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHH
Confidence 0 00 000011245678999999976 4588999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcC-------------------------------------------cccCCCCCCC
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRN-------------------------------------------HLKFPDDSKL 362 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~-------------------------------------------~l~~p~~~~~ 362 (518)
|+|++|.+||.+.........++.... .+..+....+
T Consensus 201 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (328)
T cd08226 201 CELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF 280 (328)
T ss_pred HHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhh
Confidence 999999999987765554443332110 0011112246
Q ss_pred ChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 363 SPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 363 s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
++.+++||++||+ ||.+|+ ++.++++||||+.+
T Consensus 281 ~~~~~~li~~~l~~dP~~Rp---ta~e~l~~~~~~~~ 314 (328)
T cd08226 281 SPAFQNLVELCLQQDPEKRP---SASSLLSHAFFKQV 314 (328)
T ss_pred hHHHHHHHHHHccCCcccCC---CHHHHhhCHHHHHH
Confidence 7889999999998 999999 89999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=339.71 Aligned_cols=254 Identities=30% Similarity=0.473 Sum_probs=216.3
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
-|++++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37788999999999999999999999999999865432 2345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|++||+|..++. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++..+....
T Consensus 83 ~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~------ 155 (277)
T cd06641 83 YLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ------ 155 (277)
T ss_pred eCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch------
Confidence 999999999885 4578999999999999999999999999999999999999999999999999987543110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
.......|+..|+|||.+.+..++.++|+|||||++|
T Consensus 156 -------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~ 192 (277)
T cd06641 156 -------------------------------------------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 192 (277)
T ss_pred -------------------------------------------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHH
Confidence 0011346889999999998888999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 327 eml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
+|++|.+||...........+... ....++ ..++.++.++|.+||. +|.+|+ ++.++++||||...
T Consensus 193 ~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~~~~ 259 (277)
T cd06641 193 ELAKGEPPHSELHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIVRF 259 (277)
T ss_pred HHHcCCCCCCccchHHHHHHHhcC-CCCCCC--cccCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhhh
Confidence 999999999877765555544331 122222 3578999999999998 999999 89999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.52 Aligned_cols=258 Identities=22% Similarity=0.343 Sum_probs=214.5
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 153 (518)
...+..++|++.+.||+|+||.||++..... ...+|+|.+.... .......+.+|+.++..+ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3456678899999999999999999987644 3789999987542 223456688999999999 8999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCce
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMR----------------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~----------------~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNI 217 (518)
++...+.+|+||||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 99999999999999999999999854 24688999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccC
Q 010116 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (518)
Q Consensus 218 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 297 (518)
|++.++.+||+|||+++.+...... .......+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 196 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYY-----------------------------------------------RKTTNGRL 196 (293)
T ss_pred EEcCCCeEEeCccccccccccccce-----------------------------------------------eccCCCCC
Confidence 9999999999999999865422100 00112235
Q ss_pred CCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-
Q 010116 298 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 298 T~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~- 375 (518)
++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+... ..... +..++.++.+||.+||.
T Consensus 197 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~ 273 (293)
T cd05053 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-YRMEK--PQNCTQELYHLMRDCWHE 273 (293)
T ss_pred CccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCC--CCCCCHHHHHHHHHHccc
Confidence 678999999999999999999999999999997 99999988777776665542 22223 34678999999999998
Q ss_pred cccccCCCCChhhhhcC
Q 010116 376 DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 376 dp~~R~g~~~a~eil~H 392 (518)
||.+|+ ++.+++++
T Consensus 274 ~p~~Rp---s~~eil~~ 287 (293)
T cd05053 274 VPSQRP---TFKQLVED 287 (293)
T ss_pred CcccCc---CHHHHHHH
Confidence 999999 89998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.19 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=215.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
..|..++.||+|+||.||++++..++..||+|++.+...........+.+|+.+++.++|||++++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888999999999999999999999999999997654444455667889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||++| +|.+++.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++++||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99975 77777754 56799999999999999999999999999999999999999999999999999764321
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CCCCCccccccch
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWSL 321 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSl 321 (518)
.....|++.|+|||++. ...++.++|||||
T Consensus 178 -----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~sl 210 (317)
T cd06635 178 -----------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 210 (317)
T ss_pred -----------------------------------------------cccccCCccccChhhhhcCCCCCCCccccHHHH
Confidence 01346889999999984 4568999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||++|||++|++||...+.......+.... ........+++.+++||.+||. +|.+|+ ++.+|+.|||+..
T Consensus 211 Gvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~ 282 (317)
T cd06635 211 GITCIELAERKPPLFNMNAMSALYHIAQNE--SPTLQSNEWSDYFRNFVDSCLQKIPQDRP---TSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHhcc--CCCCCCccccHHHHHHHHHHccCCcccCc---CHHHHHhChhhhc
Confidence 999999999999998887766666665522 1222223578899999999998 999999 8999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.14 Aligned_cols=257 Identities=29% Similarity=0.469 Sum_probs=216.3
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|++++.||+|+||.||+|.+..++..||+|++..... ....+.+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 46667889999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|++||+|.+++. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.+|.++|+|||++..+.....
T Consensus 83 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06642 83 YLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred ccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-----
Confidence 999999999885 46789999999999999999999999999999999999999999999999999876432100
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
......|+..|+|||++.+..++.++|+|||||++|
T Consensus 157 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 192 (277)
T cd06642 157 --------------------------------------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAI 192 (277)
T ss_pred --------------------------------------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHH
Confidence 011346889999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 327 eml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
||++|.+||....+......+... ....++ ..++.++.+||.+||. +|.+|+ ++.+|++||||....+.
T Consensus 193 el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~ 262 (277)
T cd06642 193 ELAKGEPPNSDLHPMRVLFLIPKN-SPPTLE--GQYSKPFKEFVEACLNKDPRFRP---TAKELLKHKFITRYTKK 262 (277)
T ss_pred HHHhCCCCCcccchhhHHhhhhcC-CCCCCC--cccCHHHHHHHHHHccCCcccCc---CHHHHHHhHHHHHHhhh
Confidence 999999999876665544433321 111122 3578899999999998 999999 89999999999865543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=333.84 Aligned_cols=252 Identities=31% Similarity=0.525 Sum_probs=212.4
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||.|+||.||+|....+|+.||+|.++..........+.+.+|+.+++.++|++|++++++|.+.+..|+||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999998665555556778899999999999999999999999999999999
Q ss_pred eecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 166 EYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 166 Ey~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
||++||+|..++.. ...+++..+..++.+++.||.|||+.||+||||||+||+++.+|.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 99999999999854 3468999999999999999999999999999999999999999999999999987643210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.......|++.|+|||++.+..++.++|+|||
T Consensus 161 ------------------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 192 (267)
T cd08224 161 ------------------------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred ------------------------------------------------cccceecCCccccCHHHhccCCCCchhcHHHH
Confidence 01124568999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCh--hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 322 GAIMYEMLVGYPPFYADDP--ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||++|+|++|..||..... ......+... .....|. ..++.++.++|.+||. +|.+|+ ++.+|+.
T Consensus 193 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~cl~~~p~~Rp---~~~~il~ 260 (267)
T cd08224 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPPLPA-DHYSEELRDLVSRCINPDPEKRP---DISYVLQ 260 (267)
T ss_pred HHHHHHHHHCCCCcccCCccHHHHHhhhhcC-CCCCCCh-hhcCHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 9999999999999976542 2233333321 1122222 2578899999999998 999999 7887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=338.27 Aligned_cols=252 Identities=30% Similarity=0.516 Sum_probs=211.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||+|+||.||+|+.+.+++.||||.+.+...........+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999988765555556677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 166 EYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 166 Ey~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
||++|++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.+|.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 99999999998863 3568999999999999999999999999999999999999999999999999987543110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
......+|++.|+|||++.+..++.++|+|||
T Consensus 161 ------------------------------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl 192 (267)
T cd08229 161 ------------------------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred ------------------------------------------------cccccccCCcCccCHHHhcCCCccchhhHHHH
Confidence 00124578999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCh--hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 322 GAIMYEMLVGYPPFYADDP--ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|+++|+|++|..||.+... ......+... .....+ ...+++++++||.+||. ||.+|| ++.+|.+
T Consensus 193 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---t~~~i~~ 260 (267)
T cd08229 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPLP-SDHYSEELRQLVNMCINPDPEKRP---DITYVYD 260 (267)
T ss_pred HHHHHHHHhCCCCcccccchHHHHhhhhhcC-CCCCCC-cccccHHHHHHHHHhcCCCcccCC---CHHHHHH
Confidence 9999999999999976543 2333333321 111122 23578999999999998 999999 7887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=341.56 Aligned_cols=254 Identities=32% Similarity=0.527 Sum_probs=211.7
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
|++++.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.+++.++||+|+++++++.+....|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999876432 233445678899999999999999999999999999999999
Q ss_pred cCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 168 LPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 168 ~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
++ ++|..++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.+|.++|+|||++.......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----- 153 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----- 153 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence 94 68999987665 79999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccchhHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAI 324 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvi 324 (518)
......+|++.|+|||++.+. .++.++|+|||||+
T Consensus 154 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 189 (283)
T cd07835 154 --------------------------------------------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI 189 (283)
T ss_pred --------------------------------------------cccCccccccCCCCCceeecCcccCcHHHHHHHHHH
Confidence 001133578999999998764 57999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcc----------------cCCC---------CCCCChhHHHHHHHHhc-ccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHL----------------KFPD---------DSKLSPEAKDLICRLLC-DVE 378 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l----------------~~p~---------~~~~s~~~~dLI~~lL~-dp~ 378 (518)
+|+|++|.+||...+......++....... .++. ...++.++.+||.+||+ ||.
T Consensus 190 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 269 (283)
T cd07835 190 FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPA 269 (283)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChh
Confidence 999999999998887765555544321100 0110 23577899999999999 999
Q ss_pred ccCCCCChhhhhcCccc
Q 010116 379 HRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 379 ~R~g~~~a~eil~Hpff 395 (518)
+|+ ++.+|+.||||
T Consensus 270 ~Rp---t~~~il~~~~~ 283 (283)
T cd07835 270 KRI---SAKAALQHPYF 283 (283)
T ss_pred hCc---CHHHHhcCCCC
Confidence 999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.38 Aligned_cols=253 Identities=29% Similarity=0.471 Sum_probs=210.1
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh---CCCceeEEEEEeecCCe----
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQDTEY---- 160 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~~~~~---- 160 (518)
|++.+.||.|+||.||+|+++.+++.||+|++..... .......+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6889999999999999999998999999999975432 222344566788887766 59999999999998877
Q ss_pred -EEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 161 -LYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 161 -lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
+|+||||++ ++|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++++||+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 5898888664 359999999999999999999999999999999999999999999999999987653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
... .....+|++.|+|||++.+..++.++|
T Consensus 159 ~~~--------------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~D 188 (287)
T cd07838 159 FEM--------------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVD 188 (287)
T ss_pred CCc--------------------------------------------------ccccccccccccChHHhccCCCCCcch
Confidence 210 011345889999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC---cccCCC--------------------CCCCChhHHHHHHHHh
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN---HLKFPD--------------------DSKLSPEAKDLICRLL 374 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---~l~~p~--------------------~~~~s~~~~dLI~~lL 374 (518)
||||||++|+|++|.+||.+.+..+...++..... ...++. ...+++.+.+||.+||
T Consensus 189 i~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 268 (287)
T cd07838 189 MWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKML 268 (287)
T ss_pred hhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHh
Confidence 99999999999999999999887777766654211 001110 0135688899999999
Q ss_pred c-cccccCCCCChhhhhcCccc
Q 010116 375 C-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~Hpff 395 (518)
+ ||.+|+ ++.+++.||||
T Consensus 269 ~~dp~~Rp---~~~~il~~~~~ 287 (287)
T cd07838 269 TFNPHKRI---SAFEALQHPYF 287 (287)
T ss_pred ccCCccCC---CHHHHhcCcCC
Confidence 8 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.18 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=211.4
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEec-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+..|..+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345779999999999999999999987 77899999876432 22334568889999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC---cEEE
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRED-------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKL 227 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~-------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g---~vKL 227 (518)
....|+||||++||+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.+| .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999996643 588999999999999999999999999999999999998765 5999
Q ss_pred eecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhh
Q 010116 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (518)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 307 (518)
+|||+++.+....... ......+++.|+|||++
T Consensus 161 ~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~ 193 (277)
T cd05036 161 ADFGMARDIYRASYYR-----------------------------------------------KGGRAMLPIKWMPPEAF 193 (277)
T ss_pred ccCccccccCCcccee-----------------------------------------------cCCCCCccHhhCCHHHH
Confidence 9999998653211000 00122345689999999
Q ss_pred cCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCC
Q 010116 308 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGG 385 (518)
Q Consensus 308 ~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~ 385 (518)
.+..++.++|||||||++|||++ |..||.+.+.......+... ....+| ..++..+.+||.+||+ ||.+|+ +
T Consensus 194 ~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~cl~~~p~~Rp---s 267 (277)
T cd05036 194 LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPP--KGCPGPVYRIMTDCWQHTPEDRP---N 267 (277)
T ss_pred hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCCcccCc---C
Confidence 99999999999999999999997 99999988776666555432 233333 4688999999999998 999999 8
Q ss_pred hhhhhcC
Q 010116 386 AHQIKAH 392 (518)
Q Consensus 386 a~eil~H 392 (518)
+.+|++|
T Consensus 268 ~~~vl~~ 274 (277)
T cd05036 268 FATILER 274 (277)
T ss_pred HHHHHHH
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=335.81 Aligned_cols=249 Identities=19% Similarity=0.326 Sum_probs=208.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
..+|++.+.||+|+||.||+++++ ++..+|+|++.+... ....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 457899999999999999999876 467899999875432 234577899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 9999999999999653 57899999999999999999999999999999999999999999999999998754211000
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
......++..|+|||++.+..++.++|||||||
T Consensus 157 -----------------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~ 189 (256)
T cd05059 157 -----------------------------------------------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGV 189 (256)
T ss_pred -----------------------------------------------ccCCCCCCccccCHHHhccCCCCchhhHHHHHH
Confidence 000123456899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 324 IMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 324 ilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
++|+|++ |.+||...+.......+.. ....+....+++++.+||.+||+ +|.+|+ ++.++++.
T Consensus 190 il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~~~l~~ 254 (256)
T cd05059 190 LMWEVFSEGKMPYERFSNSEVVESVSA---GYRLYRPKLAPTEVYTIMYSCWHEKPEDRP---AFKKLLSQ 254 (256)
T ss_pred HHHHHhccCCCCCCCCCHHHHHHHHHc---CCcCCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHHH
Confidence 9999999 8999988777766666654 22233334689999999999998 999999 89998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=330.77 Aligned_cols=261 Identities=26% Similarity=0.448 Sum_probs=221.6
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDT 158 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 158 (518)
+.....++.+++..||.|+.|.||+++.+.+|...|||.+.+.. ......++++..+++... ++|+||+.|++|..+
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 34455678888999999999999999999999999999998764 344556777777777666 499999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
..+++.||.| +.-+..+|.+ .++++|..+-.+..-++.||.||.. +||||||+||+|||+|..|+|||||||++..+
T Consensus 164 ~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 164 TDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred chHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 9999999999 4455555544 5789999999999999999999986 69999999999999999999999999998876
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CCCC
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYG 313 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~ 313 (518)
..+. .-+.-.|-+.|||||-|.- ..|+
T Consensus 243 vdSk--------------------------------------------------AhtrsAGC~~YMaPERidp~~~~kYD 272 (391)
T KOG0983|consen 243 VDSK--------------------------------------------------AHTRSAGCAAYMAPERIDPPDKPKYD 272 (391)
T ss_pred eccc--------------------------------------------------ccccccCCccccCccccCCCCCCccc
Confidence 4321 0112468899999999964 5799
Q ss_pred ccccccchhHHHHHHHhCCCCCCCC-ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYAD-DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
-.+||||||+.++||.||..||.+. ...+++.+|++ ..+..+|....+|+.+++|+..||. |+.+|+ .-.++++
T Consensus 273 iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP---~Y~~Ll~ 348 (391)
T KOG0983|consen 273 IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRP---KYNKLLE 348 (391)
T ss_pred hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCc---chHHHhc
Confidence 9999999999999999999999874 56678888888 4556677666799999999999998 999999 7899999
Q ss_pred Cccccc
Q 010116 392 HPWFKD 397 (518)
Q Consensus 392 Hpff~~ 397 (518)
|||++.
T Consensus 349 h~Fi~~ 354 (391)
T KOG0983|consen 349 HPFIKR 354 (391)
T ss_pred Ccceee
Confidence 999984
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=351.40 Aligned_cols=256 Identities=31% Similarity=0.510 Sum_probs=210.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC------
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE------ 159 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~------ 159 (518)
++|.+.+.||+|+||.||+|++..+|+.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 68999999999999999999999999999999987642 22233456788999999999999999999987543
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||+. ++|..++ ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred eEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 4699999995 4776665 347899999999999999999999999999999999999999999999999998753210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 318 (518)
....+||+.|+|||++.+ ..++.++||
T Consensus 171 ----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 198 (342)
T cd07879 171 ----------------------------------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDI 198 (342)
T ss_pred ----------------------------------------------------CCCceeeecccChhhhcCccccCchHHH
Confidence 113468899999999876 468999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC---------------------cccCCC------CCCCChhHHHHHH
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN---------------------HLKFPD------DSKLSPEAKDLIC 371 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------------~l~~p~------~~~~s~~~~dLI~ 371 (518)
|||||++|||++|+.||.+.+.......+..... ...++. .+.+++++++||.
T Consensus 199 ~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (342)
T cd07879 199 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLE 278 (342)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHH
Confidence 9999999999999999998876665555443110 000111 1246788999999
Q ss_pred HHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
+||. ||.+|+ ++.+++.||||.++.+
T Consensus 279 ~~l~~dP~~R~---~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 279 KMLELDVDKRL---TATEALEHPYFDSFRD 305 (342)
T ss_pred HHcCCChhhCc---CHHHHhcCcchhhccc
Confidence 9998 999999 8999999999997654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.02 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=214.2
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
|..++.||+|+||+||+|++..+|..||+|++.............+.+|..+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999999765444445566788899999999999999999999999999999999
Q ss_pred cCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 168 LPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 168 ~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
+. |+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--------
Confidence 96 577777755 46799999999999999999999999999999999999999999999999998753210
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CCCCCccccccchhH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWSLGA 323 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSlGv 323 (518)
....+|++.|+|||++. ...++.++|+|||||
T Consensus 174 ---------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGv 208 (313)
T cd06633 174 ---------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 208 (313)
T ss_pred ---------------------------------------------CCCccccccccChhhccccCCCCCCchhhHHHHHH
Confidence 11356899999999985 356889999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
++|+|++|.+||...+......++.... ....+ ...++..+++||.+||. +|.+|+ ++.+++.||||+..+
T Consensus 209 il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~l~~li~~~l~~~P~~Rp---~~~~~l~~~~~~~~~ 280 (313)
T cd06633 209 TCIELAERKPPLFNMNAMSALYHIAQND-SPTLQ-SNEWTDSFRGFVDYCLQKIPQERP---ASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCC-ccccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCc
Confidence 9999999999999887766666554421 11111 23567889999999998 999999 899999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.72 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=212.9
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEE
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS 154 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 154 (518)
+++..++|.+.+.||+|+||.||++.+. .++..||+|++++.. .....+.+.+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 5567789999999999999999999753 345689999987542 233456788999999999 79999999999
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccc
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGl 232 (518)
+.+.+.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997543 389999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 312 (518)
++.+...... .......+++.|+|||++.+..+
T Consensus 188 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 220 (302)
T cd05055 188 ARDIMNDSNY-----------------------------------------------VVKGNARLPVKWMAPESIFNCVY 220 (302)
T ss_pred cccccCCCce-----------------------------------------------eecCCCCcccccCCHhhhccCCC
Confidence 8765321000 00112346789999999999999
Q ss_pred CccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 313 GMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
+.++|||||||++|||++ |.+||.+........+.... ....+.....++++.+||.+||. +|.+|+ ++.+++
T Consensus 221 ~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ell 295 (302)
T cd05055 221 TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE--GYRMAQPEHAPAEIYDIMKTCWDADPLKRP---TFKQIV 295 (302)
T ss_pred CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc--CCcCCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHH
Confidence 999999999999999998 99999887766555555442 22223334678999999999998 999999 888887
Q ss_pred c
Q 010116 391 A 391 (518)
Q Consensus 391 ~ 391 (518)
.
T Consensus 296 ~ 296 (302)
T cd05055 296 Q 296 (302)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.02 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=203.3
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG 171 (518)
+.||+|+||.||+|+++.+++.||+|.+.+.. .......+.+|..+++.++||||+++++++.+...+|+||||++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999876432 2334567889999999999999999999999999999999999999
Q ss_pred chHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 172 DMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 172 ~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~------- 151 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS------- 151 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-------
Confidence 999999664 468999999999999999999999999999999999999999999999999987543110000
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......++..|+|||.+.+..++.++|||||||++|||++
T Consensus 152 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~ 191 (252)
T cd05084 152 ----------------------------------------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191 (252)
T ss_pred ----------------------------------------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence 0001123467999999999999999999999999999998
Q ss_pred -CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 331 -GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 331 -G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|.+||...........+... ... +....++..+.+||.+||+ ||.+|+ ++.++++
T Consensus 192 ~~~~p~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 248 (252)
T cd05084 192 LGAVPYANLSNQQTREAIEQG-VRL--PCPELCPDAVYRLMERCWEYDPGQRP---SFSTVHQ 248 (252)
T ss_pred CCCCCccccCHHHHHHHHHcC-CCC--CCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999877766555555432 222 3334678999999999998 999999 8888763
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=335.21 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=213.5
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
..++|++.+.||+|+||.||+|..+.+ ...||||+++... .......+.+|..+++.++||||+++++++.+.+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 357899999999999999999988654 4579999986543 23345668889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.+++++|+|||+++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999999664 57899999999999999999999999999999999999999999999999999876311
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.. . .......+++.|+|||.+.+..++.++|||
T Consensus 160 ~~----------------------~-------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~ 192 (266)
T cd05033 160 EA----------------------T-------------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVW 192 (266)
T ss_pred cc----------------------c-------------------------eeccCCCCCccccChhhhccCCCccccchH
Confidence 00 0 001123457789999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||++|+|++ |..||...........+... ...|....+++.+.+||.+||. +|.+|| ++.+|+++
T Consensus 193 slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~ei~~~ 261 (266)
T cd05033 193 SFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG---YRLPPPMDCPSALYQLMLDCWQKDRNERP---TFSQIVST 261 (266)
T ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 99999999998 99999887777666666542 2333344689999999999998 999999 89998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=327.43 Aligned_cols=251 Identities=35% Similarity=0.553 Sum_probs=217.3
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++.+.||+|++|.||++.+..+++.|++|++..... .....+.+|..+++.++|++|++++++|.+....|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 68899999999999999999998999999999976543 345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 167 YLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 167 y~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|++|++|.+++... ..+++..+..++.|++.||.+||.+|++||||+|+||+++.+|.++|+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999999776 6899999999999999999999999999999999999999999999999999876532100
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
.....|+..|+|||++.+..++.++|+||||+++
T Consensus 154 ----------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il 187 (253)
T cd05122 154 ----------------------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA 187 (253)
T ss_pred ----------------------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHH
Confidence 1145688999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
|+|++|..||...+.......+.. .....++....++..+.++|.+||. ||.+|+ ++.+++.|||
T Consensus 188 ~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---t~~~~l~~~~ 253 (253)
T cd05122 188 IELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253 (253)
T ss_pred HHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCC---CHHHHhcCCC
Confidence 999999999988765554444433 2233344434458999999999998 999999 8999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=351.57 Aligned_cols=261 Identities=30% Similarity=0.460 Sum_probs=219.9
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----eE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-----YL 161 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-----~l 161 (518)
+|++.+.||.|+||.||+|++..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999999999999987642 22344567889999999999999999999998875 79
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||++ ++|..++.+...+++..++.++.|++.||.|||+.||+||||||+|||++.+|+++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999996 58999998778999999999999999999999999999999999999999999999999999986532210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 320 (518)
. ........||+.|+|||++.+. .++.++|+||
T Consensus 159 ~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s 192 (330)
T cd07834 159 E----------------------------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWS 192 (330)
T ss_pred c----------------------------------------------cccccccccccCcCCceeeecccCCCcchhHHH
Confidence 0 0011245689999999999887 8999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccC------------------C---------CCCCCChhHHHHHHHH
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKF------------------P---------DDSKLSPEAKDLICRL 373 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~------------------p---------~~~~~s~~~~dLI~~l 373 (518)
|||++|+|++|.+||.+.+..+.+..+........- + ....+++++.+||.+|
T Consensus 193 lG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 272 (330)
T cd07834 193 VGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKM 272 (330)
T ss_pred HHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHH
Confidence 999999999999999998887777766653211100 0 0123688999999999
Q ss_pred hc-cccccCCCCChhhhhcCcccccC
Q 010116 374 LC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|+ ||.+|+ ++++++.||||+++
T Consensus 273 l~~~P~~Rp---t~~~ll~~~~~~~~ 295 (330)
T cd07834 273 LVFDPKKRI---TADEALAHPYLAQL 295 (330)
T ss_pred ccCChhhCC---CHHHHHhCccHHhh
Confidence 98 999999 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=329.35 Aligned_cols=253 Identities=33% Similarity=0.588 Sum_probs=221.1
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++.+.||+|++|.||++.+..+++.||+|.+.+.... ......+.+|++++..++||+++++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 588999999999999999999999999999999876432 3456789999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|++|++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 154 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK----- 154 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-----
Confidence 999999999998888999999999999999999999999999999999999999999999999999986542210
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
......|++.|+|||.+.+..++.++||||||+++|
T Consensus 155 --------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~ 190 (254)
T cd06627 155 --------------------------------------------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVI 190 (254)
T ss_pred --------------------------------------------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHH
Confidence 011346889999999998888999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 327 eml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+|++|.+||...+......++... ....+| ..++..++++|.+||. +|++|+ ++.+++.||||
T Consensus 191 ~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~~l~~~~~ 254 (254)
T cd06627 191 ELLTGNPPYYDLNPMAALFRIVQD-DHPPLP--EGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254 (254)
T ss_pred HHHhCCCCCCCccHHHHHHHHhcc-CCCCCC--CCCCHHHHHHHHHHHhCChhhCc---CHHHHhcCCCC
Confidence 999999999887765555555432 233333 3678999999999998 999999 89999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=337.69 Aligned_cols=253 Identities=19% Similarity=0.298 Sum_probs=208.8
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCc----EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
+..++|++++.||+|+||+||+|++..+|. .||+|++.... .......+.+|+.++..+.||||+++++++.+.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 456899999999999999999999887776 48999886542 233455688899999999999999999998764
Q ss_pred CeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
..+++|||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 578999999999999999764 579999999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
..... .......+++.|+|||++.+..++.++|
T Consensus 161 ~~~~~-----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (279)
T cd05109 161 IDETE-----------------------------------------------YHADGGKVPIKWMALESILHRRFTHQSD 193 (279)
T ss_pred cccce-----------------------------------------------eecCCCccchhhCCHHHhccCCCCchhH
Confidence 21100 0011234567899999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||||++|||++ |.+||...........+... ...+....++.++.++|.+||. ||.+|+ ++.+++.
T Consensus 194 i~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~l~~ 263 (279)
T cd05109 194 VWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG---ERLPQPPICTIDVYMIMVKCWMIDSECRP---RFRELVD 263 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---CcCCCCccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9999999999998 99999877665555444332 2223334688999999999998 999999 8999884
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=338.65 Aligned_cols=255 Identities=32% Similarity=0.534 Sum_probs=213.1
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--CeEEEEE
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYLYLIM 165 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~lylVm 165 (518)
|++++.||.|+||.||+|....+|+.||+|++.... ........+.+|..+++.++|||++++++++.+. ..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 688999999999999999999999999999998764 2334456688899999999999999999999988 8999999
Q ss_pred eecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||++ ++|..++... ..+++..+..++.|++.||+|||+.|++|+||||+|||++.+|.+||+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--- 155 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc---
Confidence 9996 5898888665 6899999999999999999999999999999999999999999999999999886532110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 323 (518)
.......+++.|+|||++.+ ..++.++|||||||
T Consensus 156 ---------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~ 190 (287)
T cd07840 156 ---------------------------------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGC 190 (287)
T ss_pred ---------------------------------------------ccccccccccccCCceeeEccccCChHHHHHHHHH
Confidence 00113457889999998775 46899999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---cCCCC-----------------------CC-CChhHHHHHHHHhc-
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHL---KFPDD-----------------------SK-LSPEAKDLICRLLC- 375 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---~~p~~-----------------------~~-~s~~~~dLI~~lL~- 375 (518)
++|||++|++||...+.......+......+ .++.. .. +++++.++|++||+
T Consensus 191 ~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 270 (287)
T cd07840 191 ILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL 270 (287)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCC
Confidence 9999999999999888777666655421111 00000 11 38899999999998
Q ss_pred cccccCCCCChhhhhcCccc
Q 010116 376 DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff 395 (518)
||.+|+ ++.+++.||||
T Consensus 271 ~P~~Rp---~~~~~l~~~~~ 287 (287)
T cd07840 271 DPKKRI---SADQALQHEYF 287 (287)
T ss_pred ChhhCc---CHHHHhhCcCC
Confidence 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.58 Aligned_cols=253 Identities=24% Similarity=0.407 Sum_probs=211.6
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
+...+|++.++||+|+||.||+|... .++..+|+|.+.... ......+.+|+++++.++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 34568899999999999999999753 356789999886542 3345678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRED---------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN 222 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~---------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~ 222 (518)
....|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999986542 48899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCcc
Q 010116 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (518)
Q Consensus 223 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 302 (518)
+.+||+|||++......... .......+++.|+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~ 191 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY-----------------------------------------------RVGGRTMLPIRWM 191 (280)
T ss_pred CCEEECCCCceeEcCCCcee-----------------------------------------------ecCCCcccccccc
Confidence 99999999998754321000 0011345678999
Q ss_pred ChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-ccccc
Q 010116 303 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380 (518)
Q Consensus 303 APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R 380 (518)
|||++.+..++.++|||||||++|||++ |.+||...........+.... ....| ..+++.+.+||.+||+ ||.+|
T Consensus 192 aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~P~~R 268 (280)
T cd05092 192 PPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERP--RTCPPEVYAIMQGCWQREPQQR 268 (280)
T ss_pred CHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCCC--CCCCHHHHHHHHHHccCChhhC
Confidence 9999999999999999999999999998 999998887777776666532 22333 4688999999999998 99999
Q ss_pred CCCCChhhhhc
Q 010116 381 LGTGGAHQIKA 391 (518)
Q Consensus 381 ~g~~~a~eil~ 391 (518)
+ ++.+|+.
T Consensus 269 p---~~~~l~~ 276 (280)
T cd05092 269 M---VIKDIHS 276 (280)
T ss_pred C---CHHHHHH
Confidence 9 7888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.39 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=211.1
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+..++|++.+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|+.+++.++||||+++++++...+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 456688999999999999999999865 457899999876532 235578899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++.....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999999997644 7899999999999999999999999999999999999999999999999999865311
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.. .......++..|+|||++.+..++.++|+|
T Consensus 157 ~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 188 (261)
T cd05068 157 IY------------------------------------------------EAREGAKFPIKWTAPEAALYNRFSIKSDVW 188 (261)
T ss_pred cc------------------------------------------------cccCCCcCceeccCccccccCCCCchhhHH
Confidence 00 000112334689999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|||++ |.+||.+.+.......+... ...+....++..+.+||.+||. ||.+|| ++.+|..
T Consensus 189 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~l~~ 256 (261)
T cd05068 189 SFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG---YRMPCPPGCPKELYDIMLDCWKEDPDDRP---TFETLQW 256 (261)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHhhcCcccCC---CHHHHHH
Confidence 99999999999 99999988877777666542 2233334678999999999998 999999 7877763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=349.40 Aligned_cols=259 Identities=26% Similarity=0.423 Sum_probs=209.2
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC-------
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------- 158 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------- 158 (518)
.+|++.+.||.|+||.||+|.++.+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 689999999999999999999999999999999866532 4456788999999999999999999776654
Q ss_pred -------CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-CCcEEEeec
Q 010116 159 -------EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDF 230 (518)
Q Consensus 159 -------~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-~g~vKL~DF 230 (518)
..+|+||||++ ++|..++. .+.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 46899999996 58888774 457999999999999999999999999999999999999985 567899999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK- 309 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~- 309 (518)
|++..+...... .......+||+.|+|||++.+
T Consensus 160 g~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~ 193 (342)
T cd07854 160 GLARIVDPHYSH----------------------------------------------KGYLSEGLVTKWYRSPRLLLSP 193 (342)
T ss_pred ccceecCCcccc----------------------------------------------ccccccccccccccCHHHHhCc
Confidence 998765321000 000112368899999998765
Q ss_pred CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC-----------------------cccCC---CCCCCC
Q 010116 310 KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN-----------------------HLKFP---DDSKLS 363 (518)
Q Consensus 310 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-----------------------~l~~p---~~~~~s 363 (518)
..++.++|+|||||++|+|++|..||.+.++......+..... ....| ....++
T Consensus 194 ~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (342)
T cd07854 194 NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVN 273 (342)
T ss_pred cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCC
Confidence 5689999999999999999999999988776655554432100 00000 012478
Q ss_pred hhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 364 PEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 364 ~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
.++++||.+||+ ||.+|+ ++.+++.||||+.+
T Consensus 274 ~~~~~li~~~L~~dP~~R~---t~~ell~h~~~~~~ 306 (342)
T cd07854 274 PEALDFLEQILTFNPMDRL---TAEEALMHPYMSCY 306 (342)
T ss_pred HHHHHHHHHHhCCCchhcc---CHHHHhCCCccccc
Confidence 899999999999 999999 89999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=329.22 Aligned_cols=253 Identities=34% Similarity=0.615 Sum_probs=220.3
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++.+.||.|+||.||++.+..+++.||+|++..... .......+..|+++++.++|||++++++.+.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999999999999999876533 22345668889999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 167 YLPGGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 167 y~~gG~L~~~l~~~----~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
|++|++|.+++... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999763 789999999999999999999999999999999999999999999999999987643210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
......+|++.|+|||.+.+..++.++|+||+|
T Consensus 158 -----------------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG 190 (258)
T cd08215 158 -----------------------------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLG 190 (258)
T ss_pred -----------------------------------------------ceecceeeeecccChhHhccCCCCccccHHHHH
Confidence 011245799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+++|+|++|..||...+.......+... ....+| ..++.++.++|.+||. +|.+|+ ++.+++.||||
T Consensus 191 ~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 258 (258)
T cd08215 191 CVLYELCTLKHPFEGENLLELALKILKG-QYPPIP--SQYSSELRNLVSSLLQKDPEERP---SIAQILQSPFI 258 (258)
T ss_pred HHHHHHHcCCCCCCCCcHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCCCC
Confidence 9999999999999888777666666542 122333 3688999999999998 999999 89999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=343.13 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=212.4
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEec-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCcee
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIV 149 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv 149 (518)
.+++.+..++|.+.+.||+|+||.||+|++.. ++..||+|.+.... .......+..|+.+++.+ +||||+
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34566777899999999999999999998643 23579999987542 223345688899999999 799999
Q ss_pred EEEEEeecCCeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCC
Q 010116 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213 (518)
Q Consensus 150 ~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIK 213 (518)
++++++.+...+|+||||+++|+|.+++... ..++...+..++.|++.||+|||++|++|||||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 167 (307)
T cd05098 88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167 (307)
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 9999999999999999999999999999753 247888999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccc
Q 010116 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293 (518)
Q Consensus 214 PeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (518)
|+|||++.++.+||+|||+++........ ....
T Consensus 168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~-----------------------------------------------~~~~ 200 (307)
T cd05098 168 ARNVLVTEDNVMKIADFGLARDIHHIDYY-----------------------------------------------KKTT 200 (307)
T ss_pred HHheEEcCCCcEEECCCcccccccccchh-----------------------------------------------hccc
Confidence 99999999999999999998754311000 0001
Q ss_pred cccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHH
Q 010116 294 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372 (518)
Q Consensus 294 s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~ 372 (518)
...+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.........+.. .....+| ..++.++++||.+
T Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~ 277 (307)
T cd05098 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-GHRMDKP--SNCTNELYMMMRD 277 (307)
T ss_pred cCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHc-CCCCCCC--CcCCHHHHHHHHH
Confidence 1235578999999999999999999999999999998 8999988776665555543 2223333 4678999999999
Q ss_pred Hhc-cccccCCCCChhhhhcC
Q 010116 373 LLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 373 lL~-dp~~R~g~~~a~eil~H 392 (518)
||. +|.+|+ ++.+|+++
T Consensus 278 ~l~~~p~~Rp---s~~evl~~ 295 (307)
T cd05098 278 CWHAVPSQRP---TFKQLVED 295 (307)
T ss_pred HcccChhhCc---CHHHHHHH
Confidence 998 999999 88888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=352.03 Aligned_cols=255 Identities=29% Similarity=0.496 Sum_probs=214.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY---- 160 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~---- 160 (518)
.++|++.+.||+|+||.||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 578999999999999999999999999999999986542 223344667789999999999999999988876665
Q ss_pred --EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 161 --LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 161 --lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
+|+|+||+ |++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 99999999 7799988854 5799999999999999999999999999999999999999999999999999875421
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 317 (518)
. ....+||+.|+|||++.+ ..++.++|
T Consensus 171 ~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~D 198 (343)
T cd07851 171 E----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVD 198 (343)
T ss_pred c----------------------------------------------------ccCCcccccccCHHHHhCCCCCCchHh
Confidence 1 113468899999999876 46789999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc--------------------------CCC-CCCCChhHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK--------------------------FPD-DSKLSPEAKDLI 370 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~--------------------------~p~-~~~~s~~~~dLI 370 (518)
||||||++|+|++|++||.+.+.......+........ ++. ...+|+++.+||
T Consensus 199 vwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli 278 (343)
T cd07851 199 IWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLL 278 (343)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHH
Confidence 99999999999999999998877766666554211100 000 124689999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCccccc
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
.+||+ ||.+|+ ++.+|+.||||+.
T Consensus 279 ~~~l~~~P~~Rp---t~~ell~h~~~~~ 303 (343)
T cd07851 279 EKMLVLDPDKRI---TAAEALAHPYLAE 303 (343)
T ss_pred HHhCCCChhhCC---CHHHHhcCCCccc
Confidence 99998 999999 8999999999984
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.86 Aligned_cols=268 Identities=31% Similarity=0.493 Sum_probs=211.7
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------- 157 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------- 157 (518)
.++|++++.||.|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++||||+++++.+.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 6899999999999999999999999999999999876432 22223456789999999999999999988743
Q ss_pred -CCeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 158 -TEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 158 -~~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
...+|+||||+. ++|...+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||++..
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 345799999995 477777754 45899999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGM 314 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~ 314 (518)
.......... ... .......+.+||+.|+|||++.+ ..++.
T Consensus 165 ~~~~~~~~~~---------------~~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (311)
T cd07866 165 YDGPPPNPKG---------------GGG-----------------------GGTRKYTNLVVTRWYRPPELLLGERRYTT 206 (311)
T ss_pred ccCCCccccc---------------CCc-----------------------ccccccccceeccCcCChHHhhCCCccCc
Confidence 5322100000 000 00012235678999999999875 45899
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc---------------------CCC-----CCCCChhHHH
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK---------------------FPD-----DSKLSPEAKD 368 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~---------------------~p~-----~~~~s~~~~d 368 (518)
++|||||||++|||++|++||.+.+.......+........ .+. ...+++.+.+
T Consensus 207 ~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (311)
T cd07866 207 AVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLD 286 (311)
T ss_pred hhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHH
Confidence 99999999999999999999998887766666544211100 000 1235578899
Q ss_pred HHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 369 LICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 369 LI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
||.+||. ||.+|+ ++.+++.||||
T Consensus 287 ~i~~~l~~~p~~R~---t~~ell~~~~f 311 (311)
T cd07866 287 LLSKLLSLDPYKRL---TASDALEHPYF 311 (311)
T ss_pred HHHHHcccCcccCc---CHHHHhcCCCC
Confidence 9999998 999999 89999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.97 Aligned_cols=255 Identities=30% Similarity=0.481 Sum_probs=210.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------ 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------ 158 (518)
.++|++++.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.++..++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4889999999999999999999999999999999876421 222345677899999999999999999988643
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..+|+|++++ |++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3578999987 8899887754 4799999999999999999999999999999999999999999999999999875321
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 317 (518)
. .....||+.|+|||++.+ ..++.++|
T Consensus 173 ~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~D 200 (345)
T cd07877 173 E----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVD 200 (345)
T ss_pred c----------------------------------------------------ccccccCCCccCHHHHhCccCCCchhh
Confidence 0 113468999999999876 57899999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc---------------------ccCCC------CCCCChhHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH---------------------LKFPD------DSKLSPEAKDLI 370 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---------------------l~~p~------~~~~s~~~~dLI 370 (518)
||||||++|+|++|++||.+.+.......++..... ...|. ....++++++||
T Consensus 201 vwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 280 (345)
T cd07877 201 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 280 (345)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHH
Confidence 999999999999999999887766555544332110 01111 113578999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCccccc
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
.+||. ||.+|+ ++.+++.||||+.
T Consensus 281 ~~~L~~dp~~R~---t~~e~l~h~~f~~ 305 (345)
T cd07877 281 EKMLVLDSDKRI---TAAQALAHAYFAQ 305 (345)
T ss_pred HHHcCCChhhcC---CHHHHhcChhhhh
Confidence 99998 999999 8999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=331.03 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=212.5
Q ss_pred eeEeecCceEEEEEEEecC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeec
Q 010116 92 TIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL 168 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~ 168 (518)
+.||+|+||.||+|..... +..||+|++....... ..+.+.+|+.++..++|++|+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8999999997654322 4677899999999999999999999999999999999999
Q ss_pred CCCchHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 169 PGGDMMTLLMRE---------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 169 ~gG~L~~~l~~~---------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999865422
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.. ........+++.|+|||++....++.++|+|
T Consensus 159 ~~-----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 191 (262)
T cd00192 159 DY-----------------------------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVW 191 (262)
T ss_pred cc-----------------------------------------------cccccCCCcCccccCHHHhccCCcchhhccH
Confidence 10 0011245688999999999988999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||++|+|++ |..||...+.......+... .....| ..+|+++.++|.+||+ ||.+|+ ++.+++.|
T Consensus 192 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 260 (262)
T cd00192 192 SFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKP--EYCPDELYELMLSCWQLDPEDRP---TFSELVER 260 (262)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCChHHHHHHHHHccCCcccCc---CHHHHHHh
Confidence 99999999999 69999998877777777652 233333 4679999999999998 999999 89999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=334.58 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=207.0
Q ss_pred eeEEeeEeecCceEEEEEEEecC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe----
Q 010116 88 FELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY---- 160 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~---- 160 (518)
|.+.+.||+|+||.||.|....+ +..||+|.++... ........+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987653 4789999987542 223446678999999999999999999988765443
Q ss_pred --EEEEEeecCCCchHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccc
Q 010116 161 --LYLIMEYLPGGDMMTLLMRE------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (518)
Q Consensus 161 --lylVmEy~~gG~L~~~l~~~------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGl 232 (518)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999998432 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 312 (518)
++........ .......++..|+|||++.+..+
T Consensus 160 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05035 160 SKKIYSGDYY-----------------------------------------------RQGRIAKMPVKWIAIESLADRVY 192 (273)
T ss_pred eeeccccccc-----------------------------------------------cccccccCCccccCHhhcccCCC
Confidence 8865321100 00112335678999999998999
Q ss_pred CccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 313 GMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
+.++|||||||++|||++ |.+||.+....+....+... .....| ..+++++.++|.+||. ||.+|+ ++.+++
T Consensus 193 ~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~e~~ 266 (273)
T cd05035 193 TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQP--EDCLDELYDLMYSCWRADPKDRP---TFTKLR 266 (273)
T ss_pred CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cCCCHHHHHHHHHHcCCChhhCc---CHHHHH
Confidence 999999999999999999 99999888877777666543 233333 4689999999999998 999999 888887
Q ss_pred cC
Q 010116 391 AH 392 (518)
Q Consensus 391 ~H 392 (518)
.+
T Consensus 267 ~~ 268 (273)
T cd05035 267 EV 268 (273)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=341.62 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=207.4
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCc--EEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGN--IYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ly 162 (518)
++|++.+.||+|+||.||+|+.+.++. .+|+|.++.. ......+.+.+|+.++.++ +||||+++++++.+...+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999887765 4688877632 2233456688899999999 7999999999999999999
Q ss_pred EEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEE
Q 010116 163 LIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vK 226 (518)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999999653 2488899999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhh
Q 010116 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (518)
Q Consensus 227 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 306 (518)
|+|||++....... ......++..|+|||+
T Consensus 160 l~dfg~~~~~~~~~--------------------------------------------------~~~~~~~~~~y~aPE~ 189 (297)
T cd05089 160 IADFGLSRGEEVYV--------------------------------------------------KKTMGRLPVRWMAIES 189 (297)
T ss_pred ECCcCCCcccccee--------------------------------------------------ccCCCCcCccccCchh
Confidence 99999986321100 0001123557999999
Q ss_pred hcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC
Q 010116 307 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG 384 (518)
Q Consensus 307 l~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~ 384 (518)
+.+..|+.++|||||||++|||++ |.+||.+.+......++... ...+....+++++++||.+||. ||.+|+
T Consensus 190 ~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 263 (297)
T cd05089 190 LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRMEKPRNCDDEVYELMRQCWRDRPYERP--- 263 (297)
T ss_pred hccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCChhhCc---
Confidence 999999999999999999999997 99999988887777766542 2222334689999999999998 999999
Q ss_pred ChhhhhcC
Q 010116 385 GAHQIKAH 392 (518)
Q Consensus 385 ~a~eil~H 392 (518)
++++|++.
T Consensus 264 ~~~~i~~~ 271 (297)
T cd05089 264 PFAQISVQ 271 (297)
T ss_pred CHHHHHHH
Confidence 89998754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.63 Aligned_cols=273 Identities=26% Similarity=0.441 Sum_probs=216.6
Q ss_pred CCeeE-EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchh-----------hHHHHHHHHHHHHHhCCCceeEEEE
Q 010116 86 DDFEL-LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-----------QVEHVRAERNLLAEVASHCIVKLYY 153 (518)
Q Consensus 86 ~~f~i-~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~-----------~~~~~~~E~~il~~l~hp~Iv~l~~ 153 (518)
++|.. .+.||.|+||+||+|+++.+++.||+|++......... ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 47799999999999999999999999998765332210 1124678999999999999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
+|...+.+|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 699999988888999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GY 312 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y 312 (518)
............... ... ..+.......+++.|+|||++.+. .+
T Consensus 167 ~~~~~~~~~~~~~~~--------------~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~ 211 (335)
T PTZ00024 167 RRYGYPPYSDTLSKD--------------ETM---------------------QRREEMTSKVVTLWYRAPELLMGAEKY 211 (335)
T ss_pred eeccccccccccccc--------------ccc---------------------cccccccccccccCCCCChhcccCCCC
Confidence 866432111000000 000 000111235688999999999764 47
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc---CCC---------------------CCCCChhHHH
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK---FPD---------------------DSKLSPEAKD 368 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~---~p~---------------------~~~~s~~~~d 368 (518)
+.++|+|||||++|||++|.+||.+.+.......+........ +|. ....+.++.+
T Consensus 212 ~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (335)
T PTZ00024 212 HFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAID 291 (335)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHH
Confidence 9999999999999999999999999888777666654221110 110 1245788999
Q ss_pred HHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 369 LICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 369 LI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||.+||. ||.+|+ ++++++.||||++
T Consensus 292 li~~~l~~~P~~R~---s~~~~l~~~~~~~ 318 (335)
T PTZ00024 292 LLQSLLKLNPLERI---SAKEALKHEYFKS 318 (335)
T ss_pred HHHHHcCCCchhcc---CHHHHhcCcccCC
Confidence 9999998 999999 8999999999985
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=327.47 Aligned_cols=256 Identities=34% Similarity=0.537 Sum_probs=218.5
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--CeEEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYLYLI 164 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~lylV 164 (518)
+|.+.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.+++.++||+|+++++.+.+. ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588899999999999999999999999999998765432 34567889999999999999999999999988 899999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||++|++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.+|.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988789999999999999999999999999999999999999999999999999998865432100
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
.......|+..|+|||.+.+..++.++|+||||++
T Consensus 158 ---------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~i 192 (260)
T cd06606 158 ---------------------------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCT 192 (260)
T ss_pred ---------------------------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHH
Confidence 00113568899999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCC-hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 325 MYEMLVGYPPFYADD-PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 325 lyeml~G~~PF~~~~-~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+|+|++|..||...+ .......+........+| ..++..+++||.+||. ||.+|+ ++.+++.||||
T Consensus 193 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 260 (260)
T cd06606 193 VIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP--EHLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260 (260)
T ss_pred HHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC--cccCHHHHHHHHHhCcCChhhCC---CHHHHhhCCCC
Confidence 999999999998765 222333333222233334 3568999999999998 999999 89999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=342.67 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=210.9
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
..+..++|++.+.||+|+||.||+|.+..+++.||||.+++... ......+..|..++... .||||+++++++.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 45667899999999999999999999999999999999976532 22334455676666666 5999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 160 YLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+|+||||++ ++|.+++.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++..+.
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999999984 577777655 4679999999999999999999997 699999999999999999999999999987543
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC----CC
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG----YG 313 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y~ 313 (518)
... ......|++.|+|||++.+.. ++
T Consensus 167 ~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 196 (296)
T cd06618 167 DSK--------------------------------------------------AKTRSAGCAAYMAPERIDPPDPNPKYD 196 (296)
T ss_pred CCC--------------------------------------------------cccCCCCCccccCHhhcCCCCCccccc
Confidence 110 001235888999999997553 88
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCCh-hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDP-ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
.++|||||||++|+|++|+.||..... .+....+... ....++....++.++.+||.+||. ||.+|| ++++|+.
T Consensus 197 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~ 272 (296)
T cd06618 197 IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP---KYRELLQ 272 (296)
T ss_pred cchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhc
Confidence 999999999999999999999976433 3344444432 222334333578999999999998 999999 8999999
Q ss_pred Cccccc
Q 010116 392 HPWFKD 397 (518)
Q Consensus 392 Hpff~~ 397 (518)
||||..
T Consensus 273 ~~~~~~ 278 (296)
T cd06618 273 HPFIRR 278 (296)
T ss_pred Chhhhc
Confidence 999983
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=344.70 Aligned_cols=274 Identities=30% Similarity=0.454 Sum_probs=228.6
Q ss_pred hhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechh----hhchhhHHHHHHHHHHHHHhCCCceeEEE
Q 010116 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE----MVKRGQVEHVRAERNLLAEVASHCIVKLY 152 (518)
Q Consensus 77 ~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 152 (518)
.++.+....++|-++..||+|||++||+|.+....++||+|+-.-.. -.+.+..+|..+|.+|-+.++||.||++|
T Consensus 454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence 34567777889999999999999999999999999999999854322 22345678899999999999999999999
Q ss_pred EEee-cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CeEEcCCCCCceeeC---CCCcEE
Q 010116 153 YSFQ-DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--NYIHRDIKPDNLLLD---KNGHMK 226 (518)
Q Consensus 153 ~~f~-~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~--giiHRDIKPeNILld---~~g~vK 226 (518)
++|. |.+.+|-|+|||+|.||..||..+..++|.+|+.|+.||+.||.||... .|||-||||.||||- .-|.||
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 9995 6678999999999999999999999999999999999999999999975 799999999999995 357899
Q ss_pred EeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhh
Q 010116 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (518)
Q Consensus 227 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 306 (518)
|+||||++.++..... ..- .-.++....||.+|++||.
T Consensus 614 ITDFGLSKIMdddSy~------------------~vd------------------------GmeLTSQgAGTYWYLPPEc 651 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYN------------------SVD------------------------GMELTSQGAGTYWYLPPEC 651 (775)
T ss_pred eeecchhhhccCCccC------------------ccc------------------------ceeeecccCceeeecCcce
Confidence 9999999987532110 000 1124556789999999998
Q ss_pred hcC----CCCCccccccchhHHHHHHHhCCCCCCCCChhhH---HHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-ccc
Q 010116 307 LLK----KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITT---CRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVE 378 (518)
Q Consensus 307 l~~----~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~ 378 (518)
+.- ...+.++||||+|||+|.++.|+-||..+-.... ..-|++. ....||..+.+|++|++||++||. .-+
T Consensus 652 FvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKe 730 (775)
T KOG1151|consen 652 FVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKE 730 (775)
T ss_pred eecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc-eeccCCCCCccCHHHHHHHHHHHHhhhh
Confidence 863 2468999999999999999999999976533221 1223332 467899888999999999999999 889
Q ss_pred ccCCCCChhhhhcCcccc
Q 010116 379 HRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 379 ~R~g~~~a~eil~Hpff~ 396 (518)
+|. ++.++..||+|.
T Consensus 731 DR~---DV~qLA~dpyll 745 (775)
T KOG1151|consen 731 DRI---DVQQLACDPYLL 745 (775)
T ss_pred hhh---hHHHHccCcccc
Confidence 999 899999999996
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=332.85 Aligned_cols=245 Identities=25% Similarity=0.378 Sum_probs=203.6
Q ss_pred eEeecCceEEEEEEE--ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 93 IIGRGAFGEVRLCRE--KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 93 ~LG~G~fG~V~l~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
.||+|+||.||+|.. ..+++.||+|+++... ......+.+.+|+.+++.++||||+++++++.+ +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 689999999999965 4578899999986542 233456778899999999999999999998764 567899999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
|+|.+++.....+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~------- 152 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY------- 152 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-------
Confidence 9999999888889999999999999999999999999999999999999999999999999988653221000
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
.......+++.|+|||++.+..++.++|+|||||++|||++
T Consensus 153 ---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 193 (257)
T cd05116 153 ---------------------------------------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193 (257)
T ss_pred ---------------------------------------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence 00112345789999999988889999999999999999998
Q ss_pred -CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 331 -GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 331 -G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|.+||.+.+.......+... .....| ..+++++++||.+||. ||.+|| ++.+|..
T Consensus 194 ~g~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~~~~~p~~Rp---~~~~i~~ 250 (257)
T cd05116 194 YGQKPYKGMKGNEVTQMIESG-ERMECP--QRCPPEMYDLMKLCWTYGVDERP---GFAVVEL 250 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHhccCchhCc---CHHHHHH
Confidence 99999988777776666543 223344 4689999999999998 999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=340.52 Aligned_cols=254 Identities=19% Similarity=0.295 Sum_probs=211.9
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
...+|++++.||.|+||.||+|....+ ++.||||++.... .....+.+..|..++..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 456788899999999999999987643 5789999987542 223346688999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN 222 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~ 222 (518)
..+++++||+++++|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 357888899999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCcc
Q 010116 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (518)
Q Consensus 223 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 302 (518)
+.+||+|||+++....... ........+|+.|+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~y~ 193 (283)
T cd05091 161 LNVKISDLGLFREVYAADY-----------------------------------------------YKLMGNSLLPIRWM 193 (283)
T ss_pred CceEecccccccccccchh-----------------------------------------------eeeccCccCCcccc
Confidence 9999999999886532110 00112345688999
Q ss_pred ChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-ccccc
Q 010116 303 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380 (518)
Q Consensus 303 APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R 380 (518)
|||++.+..++.++|||||||++|||++ |.+||.+.........+.... ....| ..++.++.+||.+||. +|.+|
T Consensus 194 aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~R 270 (283)
T cd05091 194 SPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ-VLPCP--DDCPAWVYTLMLECWNEFPSRR 270 (283)
T ss_pred CHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHhCCCcccC
Confidence 9999998899999999999999999998 899999888877777766532 22233 4688999999999998 99999
Q ss_pred CCCCChhhhhcC
Q 010116 381 LGTGGAHQIKAH 392 (518)
Q Consensus 381 ~g~~~a~eil~H 392 (518)
| ++.+|+..
T Consensus 271 P---~~~~i~~~ 279 (283)
T cd05091 271 P---RFKDIHSR 279 (283)
T ss_pred C---CHHHHHHH
Confidence 9 89998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=333.77 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=207.7
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+..++|+++++||+|+||.||+|++..+ ..||+|++.+... ..+.+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 75 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCc
Confidence 34567899999999999999999988665 4599999876432 23467889999999999999999998754 568
Q ss_pred EEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999999753 46899999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.. .......|+..|+|||++.+..++.++|+|
T Consensus 156 ~~------------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvw 187 (262)
T cd05071 156 EY------------------------------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (262)
T ss_pred cc------------------------------------------------ccccCCcccceecCHhHhccCCCCchhhHH
Confidence 10 001133467889999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|+|++ |.+||.+.........+... ...+....++..+.+||.+||. ||.+|+ ++.++++
T Consensus 188 slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~~~~ 255 (262)
T cd05071 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 255 (262)
T ss_pred HHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC---CCCCCccccCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 99999999999 89999888777776666542 2233334688999999999998 999999 7777664
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.16 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=213.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
...+|++++.||.|+||.||+|.... +..+|+|++.+... .....+..|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34679999999999999999999887 89999999876532 234567889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 164 IMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999753 4689999999999999999999999999999999999999999999999999876431100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
...+..+++.|+|||++.+..++.++|||||
T Consensus 160 -------------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl 190 (261)
T cd05148 160 -------------------------------------------------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSF 190 (261)
T ss_pred -------------------------------------------------cccCCCCceEecCHHHHccCCCCchhhHHHH
Confidence 0112346778999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 322 GAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 322 Gvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||++|+|++ |..||...+.......+.. ....+....+++++.++|.+||+ ||.+|| ++.+|.+
T Consensus 191 G~~l~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~l~~ 256 (261)
T cd05148 191 GILLYEMFTYGQVPYPGMNNHEVYDQITA---GYRMPCPAKCPQEIYKIMLECWAAEPEDRP---SFKALRE 256 (261)
T ss_pred HHHHHHHHcCCCCCCCcCCHHHHHHHHHh---CCcCCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 999999998 8999988887777777664 23334345789999999999998 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=331.24 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=208.9
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+..++|+++++||+|+||.||+|..+ +++.||+|.+.+... ....+.+|+.+++.++||||+++++++. .+.+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 455689999999999999999999864 568899999876532 2356888999999999999999998875 4568
Q ss_pred EEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999999998653 46899999999999999999999999999999999999999999999999998765311
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.. .......++..|+|||++....++.++|+|
T Consensus 156 ~~------------------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~ 187 (260)
T cd05067 156 EY------------------------------------------------TAREGAKFPIKWTAPEAINYGTFTIKSDVW 187 (260)
T ss_pred Cc------------------------------------------------ccccCCcccccccCHHHhccCCcCcccchH
Confidence 00 001133567899999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|||++ |++||.+.+.......+.. ....+....++.++.+||.+||. +|.+|| +++++..
T Consensus 188 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 255 (260)
T cd05067 188 SFGILLTEIVTYGRIPYPGMTNPEVIQNLER---GYRMPRPDNCPEELYELMRLCWKEKPEERP---TFEYLRS 255 (260)
T ss_pred HHHHHHHHHHhCCCCCCCCCChHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 99999999999 9999988877666665543 22334345678999999999998 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=344.69 Aligned_cols=261 Identities=28% Similarity=0.427 Sum_probs=209.9
Q ss_pred CeeEEeeEeecCceEEEEEEEecC--CcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEee----cCC
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKS--GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ----DTE 159 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t--~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~----~~~ 159 (518)
+|++.+.||+|+||.||+|++..+ +..||+|++.... ........+.+|+.+++.+ +||||+++++.+. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 8999999986432 2223345677899999999 5999999998643 235
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|++|||+. ++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999994 799999988889999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 318 (518)
... ........+||+.|+|||++.+ ..++.++||
T Consensus 159 ~~~---------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di 193 (332)
T cd07857 159 PGE---------------------------------------------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDV 193 (332)
T ss_pred ccc---------------------------------------------ccccccCcccCccccCcHHHhCCCCCCcHHHH
Confidence 100 0001124579999999998866 578999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC--------------------------cccCCC-CCCCChhHHHHHH
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN--------------------------HLKFPD-DSKLSPEAKDLIC 371 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--------------------------~l~~p~-~~~~s~~~~dLI~ 371 (518)
|||||++|+|++|.+||.+.+.......++.... ...++. ...++..+.+||.
T Consensus 194 ~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (332)
T cd07857 194 WSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273 (332)
T ss_pred HHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHH
Confidence 9999999999999999988765554444333110 011111 1246789999999
Q ss_pred HHhc-cccccCCCCChhhhhcCccccc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+||. ||.+|+ ++.+++.||||+.
T Consensus 274 ~~l~~~P~~R~---t~~~ll~~~~~~~ 297 (332)
T cd07857 274 KLLAFDPTKRI---SVEEALEHPYLAI 297 (332)
T ss_pred HHccCCcccCC---CHHHHhcChhhhh
Confidence 9998 999999 8999999999973
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=331.85 Aligned_cols=250 Identities=23% Similarity=0.386 Sum_probs=208.1
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+..++|++++.||+|+||.||+|... ++..+|+|.+..... ..+.+.+|+.+++.++||+|+++++.+.. ...
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCc
Confidence 455678999999999999999999765 566799999876432 23468899999999999999999988854 568
Q ss_pred EEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999999999753 46899999999999999999999999999999999999999999999999999764321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.. ....+..|+..|+|||++.+..++.++|+|
T Consensus 156 ~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 187 (260)
T cd05070 156 EY------------------------------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (260)
T ss_pred cc------------------------------------------------ccccCCCCCccccChHHHhcCCCcchhhhH
Confidence 00 001123456789999999988999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|+|++ |.+||.+.+..+....+.. ....+.+...+..+++||.+||+ ||.+|| ++.++.+
T Consensus 188 slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 255 (260)
T cd05070 188 SFGILLTELVTKGRVPYPGMNNREVLEQVER---GYRMPCPQDCPISLHELMLQCWKKDPEERP---TFEYLQS 255 (260)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCCcCCHHHHHHHHHHcccCcccCc---CHHHHHH
Confidence 99999999999 9999988877777766654 22333344688999999999998 999999 7887763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=341.33 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=211.6
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEec-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEE
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLY 152 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 152 (518)
+.+..++|.+.+.||+|+||.||+|++.. ....+|+|+++... .......+..|+.+++.+ +||||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 45666889999999999999999998642 34579999987532 234466788999999999 699999999
Q ss_pred EEeecCCeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCc
Q 010116 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDN 216 (518)
Q Consensus 153 ~~f~~~~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeN 216 (518)
+++.+...+|+||||+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999999999999999999999999653 347888999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccccc
Q 010116 217 LLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (518)
Q Consensus 217 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 296 (518)
||++.++.+||+|||+++........ .......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~ 197 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYY-----------------------------------------------KKTSNGR 197 (314)
T ss_pred EEEcCCCcEEEccccccccccccccc-----------------------------------------------cccccCC
Confidence 99999999999999999865321000 0011223
Q ss_pred CCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc
Q 010116 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC 375 (518)
Q Consensus 297 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~ 375 (518)
+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+... ....+| ..++.++++||.+||.
T Consensus 198 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~ 274 (314)
T cd05099 198 LPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG-HRMDKP--SNCTHELYMLMRECWH 274 (314)
T ss_pred CCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcC
Confidence 5578999999999999999999999999999999 99999888777777666543 222333 4678899999999998
Q ss_pred -cccccCCCCChhhhhc
Q 010116 376 -DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 376 -dp~~R~g~~~a~eil~ 391 (518)
||.+|+ ++.++++
T Consensus 275 ~~p~~Rp---s~~~ll~ 288 (314)
T cd05099 275 AVPTQRP---TFKQLVE 288 (314)
T ss_pred CCcccCc---CHHHHHH
Confidence 999999 7888875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=341.10 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=214.4
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEe-------cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-------KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVK 150 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-------~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~ 150 (518)
.++.+..++|.+.+.||+|+||.||+|+.. .++..||+|++.... .......+.+|+.+++.+ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchh
Confidence 346677889999999999999999999753 234579999886532 233456788999999999 8999999
Q ss_pred EEEEeecCCeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCC
Q 010116 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKP 214 (518)
Q Consensus 151 l~~~f~~~~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKP 214 (518)
+++++.+...+|+||||+++|+|.+++.+. ..++...+..++.|++.||.|||++||+||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999999653 2467788899999999999999999999999999
Q ss_pred CceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccc
Q 010116 215 DNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294 (518)
Q Consensus 215 eNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 294 (518)
+|||++.++.+||+|||+++........ .....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~-----------------------------------------------~~~~~ 198 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYY-----------------------------------------------KKTTN 198 (304)
T ss_pred ceEEEcCCCcEEECCCccceeccccccc-----------------------------------------------ccccC
Confidence 9999999999999999999865321100 01112
Q ss_pred ccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHH
Q 010116 295 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRL 373 (518)
Q Consensus 295 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~l 373 (518)
..+++.|+|||++.+..|+.++|||||||++|+|++ |..||.+.+.......+... .....| ..++.++++||.+|
T Consensus 199 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~c 275 (304)
T cd05101 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDC 275 (304)
T ss_pred CCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHH
Confidence 356788999999999999999999999999999998 89999888777777666542 222233 46889999999999
Q ss_pred hc-cccccCCCCChhhhhcC
Q 010116 374 LC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~H 392 (518)
|. +|.+|+ ++.+|++.
T Consensus 276 l~~~p~~Rp---s~~e~l~~ 292 (304)
T cd05101 276 WHAIPSHRP---TFKQLVED 292 (304)
T ss_pred cccChhhCC---CHHHHHHH
Confidence 98 999999 88888864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.52 Aligned_cols=231 Identities=29% Similarity=0.502 Sum_probs=194.7
Q ss_pred cCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCchHHH
Q 010116 97 GAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176 (518)
Q Consensus 97 G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~ 176 (518)
|+||.||+|+++.+++.||+|++.+... ...|...+....||||+++++++++....|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 22344555566799999999999999999999999999999999
Q ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccC
Q 010116 177 LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256 (518)
Q Consensus 177 l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 256 (518)
+.+...+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||++......
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------------- 138 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------------- 138 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----------------
Confidence 988888999999999999999999999999999999999999999999999999987654211
Q ss_pred CCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCC
Q 010116 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 336 (518)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 336 (518)
..+..++..|+|||++.+..++.++|+||+||++|||++|+.||.
T Consensus 139 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 139 -----------------------------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred -----------------------------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 013456778999999988899999999999999999999999986
Q ss_pred CCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCccc
Q 010116 337 ADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWF 395 (518)
Q Consensus 337 ~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff 395 (518)
..... ......+.+| ..+++.+++||.+||. ||.+|++.+ +++++++||||
T Consensus 184 ~~~~~------~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 184 CHPSG------INTHTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCchh------cccccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 43211 1111223344 3689999999999998 999999642 56999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=341.76 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=212.9
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
..|...+.||.|+||.||+++++.++..+|+|.+.............+.+|+.+++.++|+|++++++++.+....|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777889999999999999999999999999987543334445567788999999999999999999999999999999
Q ss_pred eecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||+. |+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.+|.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence 9996 577777643 457899999999999999999999999999999999999999999999999998753210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CCCCCccccccch
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWSL 321 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSl 321 (518)
...+||+.|+|||++. ...++.++|||||
T Consensus 169 ------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl 200 (308)
T cd06634 169 ------------------------------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (308)
T ss_pred ------------------------------------------------ccccCCccccCHHHHhhcccCCCCcccchHHH
Confidence 1346889999999985 3567889999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||++|+|++|..||...+.......+... .........++..+++||.+||. +|.+|+ ++.+++.|||+..
T Consensus 201 G~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp---~~~~ll~~~~~~~ 272 (308)
T cd06634 201 GITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHHHcCCCCCccccHHHHHHHHhhc--CCCCcCcccccHHHHHHHHHHhhCCcccCC---CHHHHhhCccccc
Confidence 99999999999999887665555554432 11221223678999999999998 999999 8999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=332.81 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=211.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
..+|++.+.||+|+||.||+|.++.++. .+|+|.++... .......+.+|..+++.++||||+++++++.+.+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999875543 79999986542 233456788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 162 YLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+|||++.+++++|+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999765 578999999999999999999999999999999999999999999999999988653210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
.. ........+++.|+|||++.+..++.++|+||
T Consensus 161 ~~----------------------------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s 194 (267)
T cd05066 161 EA----------------------------------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWS 194 (267)
T ss_pred ce----------------------------------------------eeecCCCccceeecCHhHhccCccCchhhhHH
Confidence 00 00011223467899999999999999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 321 LGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 321 lGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||++||+++ |..||...+.......+... ...|....+++.+.+||.+||+ +|.+|| ++.+|++
T Consensus 195 lG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 261 (267)
T cd05066 195 YGIVMWEVMSYGERPYWEMSNQDVIKAIEEG---YRLPAPMDCPAALHQLMLDCWQKDRNERP---KFEQIVS 261 (267)
T ss_pred HHHHHHHHhcCCCCCcccCCHHHHHHHHhCC---CcCCCCCCCCHHHHHHHHHHcccCchhCC---CHHHHHH
Confidence 9999999886 99999887776666666542 3344445688999999999998 999999 7887764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=334.07 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=205.2
Q ss_pred eeEEeeEeecCceEEEEEEEecCCc--EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec------CC
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGN--IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------TE 159 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------~~ 159 (518)
|.+.+.||+|+||.||+|+...++. .+|+|.++... ......+.+..|..+++.++||||+++++.+.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999887775 59999887642 234556788899999999999999999987532 12
Q ss_pred eEEEEEeecCCCchHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 160 YLYLIMEYLPGGDMMTLLMR------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~------~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
..++||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988742 235899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
+........ .......+++.|+|||++.+..++
T Consensus 160 ~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~ 192 (272)
T cd05075 160 KKIYNGDYY-----------------------------------------------RQGRIAKMPVKWIAIESLADRVYT 192 (272)
T ss_pred cccCcccce-----------------------------------------------ecCCcccCCcccCCHHHccCCCcC
Confidence 865321100 000123467889999999999999
Q ss_pred ccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 314 MECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
.++|||||||++|||++ |.+||.+.........+.... .+.+ ...++..++++|.+||+ ||.+|| ++.+|++
T Consensus 193 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~ 266 (272)
T cd05075 193 TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQ--PPDCLDGLYSLMSSCWLLNPKDRP---SFETLRC 266 (272)
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 99999999999999999 899998877776666665532 2233 34688999999999998 999999 8999876
Q ss_pred C
Q 010116 392 H 392 (518)
Q Consensus 392 H 392 (518)
+
T Consensus 267 ~ 267 (272)
T cd05075 267 E 267 (272)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=334.72 Aligned_cols=254 Identities=22% Similarity=0.382 Sum_probs=213.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEec-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
..++|++++.||+|+||.||+|+.+. +.+.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34789999999999999999999764 35679999876542 122456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEee
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRED---------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSD 229 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~---------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~D 229 (518)
...|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+++++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999999997655 699999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC
Q 010116 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (518)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 309 (518)
||+++....... .......+++.|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~y~~PE~~~~ 192 (275)
T cd05046 161 LSLSKDVYNSEY------------------------------------------------YKLRNALIPLRWLAPEAVQE 192 (275)
T ss_pred cccccccCcccc------------------------------------------------cccCCceeEEeecChhhhcc
Confidence 999874321100 00113457788999999998
Q ss_pred CCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 310 KGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 310 ~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
..++.++|||||||++|+|++ |..||...........+... .+.++....++..+.++|.+||+ ||.+|+ ++.
T Consensus 193 ~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp---~~~ 267 (275)
T cd05046 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLELPVPEGCPSRLYKLMTRCWAVNPKDRP---SFS 267 (275)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--CcCCCCCCCCCHHHHHHHHHHcCCCcccCC---CHH
Confidence 889999999999999999998 88999877766666666542 33344445688999999999998 999999 899
Q ss_pred hhhcC
Q 010116 388 QIKAH 392 (518)
Q Consensus 388 eil~H 392 (518)
+++.+
T Consensus 268 ~~l~~ 272 (275)
T cd05046 268 ELVSA 272 (275)
T ss_pred HHHHH
Confidence 98864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=339.66 Aligned_cols=261 Identities=31% Similarity=0.523 Sum_probs=212.8
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC--
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-- 159 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-- 159 (518)
....++|++.+.||.|+||.||+|.++.+|+.||+|+++.... .......+.+|..+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3456889999999999999999999999999999999875432 2233456778999999999999999999987655
Q ss_pred --------eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeec
Q 010116 160 --------YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (518)
Q Consensus 160 --------~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DF 230 (518)
.+|+||||+++ ++..++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 89999999976 677776553 57999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK- 309 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~- 309 (518)
|++........ .......+++.|+|||++.+
T Consensus 161 g~~~~~~~~~~------------------------------------------------~~~~~~~~~~~y~~PE~~~~~ 192 (302)
T cd07864 161 GLARLYNSEES------------------------------------------------RPYTNKVITLWYRPPELLLGE 192 (302)
T ss_pred cccccccCCcc------------------------------------------------cccccceeccCccChHHhcCC
Confidence 99886532100 00112356789999999875
Q ss_pred CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---cCC-----------------------CCCCCC
Q 010116 310 KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL---KFP-----------------------DDSKLS 363 (518)
Q Consensus 310 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---~~p-----------------------~~~~~s 363 (518)
..++.++|||||||++|||++|++||...+.......+....... .+| ....++
T Consensus 193 ~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (302)
T cd07864 193 ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIP 272 (302)
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCC
Confidence 457899999999999999999999999877766665554421110 000 112468
Q ss_pred hhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 364 PEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 364 ~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+.+.+||.+||. ||.+|+ ++.+|+.||||
T Consensus 273 ~~~~~li~~~l~~~P~~Rp---~~~~il~~~~~ 302 (302)
T cd07864 273 TPALDLLDHMLTLDPSKRC---TAEEALNSPWL 302 (302)
T ss_pred HHHHHHHHHHccCChhhCC---CHHHHhcCCCC
Confidence 999999999998 999999 89999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=331.04 Aligned_cols=249 Identities=21% Similarity=0.350 Sum_probs=209.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||.||+++... +..+|+|.+..... ..+.+.+|..++..++||||+++++++.+...+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4689999999999999999997654 45699998875432 235678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence 9999999999999764 4789999999999999999999999999999999999999999999999999875421100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
.......|+..|+|||++.+..++.++|+|||||
T Consensus 156 ----------------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~ 189 (256)
T cd05113 156 ----------------------------------------------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGV 189 (256)
T ss_pred ----------------------------------------------eecCCCccChhhCCHHHHhcCcccchhHHHHHHH
Confidence 0001234667899999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 324 IMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 324 ilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
++|+|++ |..||...+.......+.... ..+.....+..++++|.+||. ||.+|+ ++.+|+.+
T Consensus 190 ~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~ll~~ 254 (256)
T cd05113 190 LMWEVYSLGKMPYERFNNSETVEKVSQGL---RLYRPHLASEKVYAIMYSCWHEKAEERP---TFQQLLSS 254 (256)
T ss_pred HHHHHhcCCCCCcCcCCHHHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHHh
Confidence 9999998 999998877777777776532 222223578999999999998 999999 89998864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=331.60 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=213.0
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
+..++|+..+.||+|+||.||+|+.+.++. .+|+|.+.... .....+.+..|+.+++.++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 456789999999999999999999876665 79999886542 2234566889999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..|+||||+++|+|..++... +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999999764 6789999999999999999999999999999999999999999999999999876532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
..... .......+++.|+|||++.+..++.++||
T Consensus 160 ~~~~~----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv 193 (268)
T cd05063 160 DPEGT----------------------------------------------YTTSGGKIPIRWTAPEAIAYRKFTSASDV 193 (268)
T ss_pred ccccc----------------------------------------------eeccCCCcCceecCHHHhhcCCcChHhHH
Confidence 10000 00011234568999999999899999999
Q ss_pred cchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 319 WSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 319 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||++|||++ |..||...+.......+.. ....|....++.++.+||.+||. +|.+|| ++.+|++
T Consensus 194 ~slG~il~ell~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~i~~ 262 (268)
T cd05063 194 WSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---GFRLPAPMDCPSAVYQLMLQCWQQDRARRP---RFVDIVN 262 (268)
T ss_pred HHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 999999999997 9999988887777777654 23444445678999999999998 999999 7888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=336.94 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=209.1
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
...+|.+.+.||+|+||.||+|+.. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4568999999999999999999854 345679999886543 22345688899999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN 222 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~ 222 (518)
..+++||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 9999999999999999999653 248899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCcc
Q 010116 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (518)
Q Consensus 223 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 302 (518)
+.++|+|||+++........ .......|++.|+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~ 192 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYY-----------------------------------------------RVGGHTMLPIRWM 192 (291)
T ss_pred CcEEECCCCcccccCCCcee-----------------------------------------------ecCCCCCcceeec
Confidence 99999999998754321100 0112346788999
Q ss_pred ChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-ccccc
Q 010116 303 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380 (518)
Q Consensus 303 APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R 380 (518)
|||++.+..++.++|||||||++|||++ |.+||...+.......+.... .... ...++..+.+||.+||. ||.+|
T Consensus 193 aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~li~~~l~~~P~~R 269 (291)
T cd05094 193 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-VLER--PRVCPKEVYDIMLGCWQREPQQR 269 (291)
T ss_pred ChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC-CCCC--CccCCHHHHHHHHHHcccChhhC
Confidence 9999999999999999999999999998 999998888776666554421 1122 23578899999999998 99999
Q ss_pred CCCCChhhhhc
Q 010116 381 LGTGGAHQIKA 391 (518)
Q Consensus 381 ~g~~~a~eil~ 391 (518)
+ ++.+|++
T Consensus 270 p---t~~~v~~ 277 (291)
T cd05094 270 L---NIKEIYK 277 (291)
T ss_pred c---CHHHHHH
Confidence 9 7888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=343.65 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=204.3
Q ss_pred eEeec--CceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 93 IIGRG--AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 93 ~LG~G--~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
+||+| ++|.||+++...+++.||+|++.... ........+..|+.+++.++||||++++++|.+.+.+|++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34444 55667777888899999999997653 2344667899999999999999999999999999999999999999
Q ss_pred CchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccc
Q 010116 171 GDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248 (518)
Q Consensus 171 G~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 248 (518)
|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~---- 159 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR---- 159 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc----
Confidence 9999999753 5689999999999999999999999999999999999999999999999999876532110000
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCccccccchhHHHH
Q 010116 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMY 326 (518)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvily 326 (518)
. .........++..|+|||++.+ .+|+.++|+|||||++|
T Consensus 160 ------------~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~ 201 (314)
T cd08216 160 ------------V--------------------------VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201 (314)
T ss_pred ------------c--------------------------cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHH
Confidence 0 0001124568889999999976 46899999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHhhhcC------------------------------cccCCCCCCCChhHHHHHHHHhc-
Q 010116 327 EMLVGYPPFYADDPITTCRKIVHWRN------------------------------HLKFPDDSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 327 eml~G~~PF~~~~~~~~~~~i~~~~~------------------------------~l~~p~~~~~s~~~~dLI~~lL~- 375 (518)
||++|.+||................. ....+....++.++.+||.+||+
T Consensus 202 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 281 (314)
T cd08216 202 ELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR 281 (314)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhc
Confidence 99999999987654433222111000 00000011345789999999998
Q ss_pred cccccCCCCChhhhhcCcccccC
Q 010116 376 DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||.+|+ ++.++++||||+.+
T Consensus 282 ~P~~Rp---t~~~ll~~p~~~~~ 301 (314)
T cd08216 282 DPESRP---SASQLLNHSFFKQC 301 (314)
T ss_pred CCCcCc---CHHHHhcCchHhhh
Confidence 999999 89999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=339.77 Aligned_cols=251 Identities=31% Similarity=0.546 Sum_probs=212.5
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecC
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
...+||+|+||.||++..+.+|+.||||++.... ......+.+|+.+++.++|+||+++++.|.+.+..|+||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3468999999999999999999999999875432 2334568889999999999999999999999999999999999
Q ss_pred CCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccc
Q 010116 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (518)
Q Consensus 170 gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 249 (518)
|++|.+++. ...+++..++.++.|++.||.|||+.|++||||||+||+++.+|+++|+|||++.......
T Consensus 101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--------- 170 (292)
T cd06657 101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--------- 170 (292)
T ss_pred CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc---------
Confidence 999998774 4578999999999999999999999999999999999999999999999999876542110
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHH
Q 010116 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329 (518)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 329 (518)
......+||+.|+|||++.+..++.++|+||+||++|+|+
T Consensus 171 ----------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~ 210 (292)
T cd06657 171 ----------------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210 (292)
T ss_pred ----------------------------------------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 0011356899999999998888999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 330 VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 330 ~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+|.+||.+.+.......+... ....++....+++.+.++|.+||. ||.+|+ ++.+++.||||..
T Consensus 211 tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~---~~~~ll~~~~~~~ 275 (292)
T cd06657 211 DGEPPYFNEPPLKAMKMIRDN-LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAK 275 (292)
T ss_pred hCCCCCCCCCHHHHHHHHHhh-CCcccCCcccCCHHHHHHHHHHHhCCcccCc---CHHHHhcChHHhc
Confidence 999999987776655544331 122233334678999999999998 999999 8999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=329.02 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=212.2
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
++..++|++.++||+|+||.||+|... +++.||||.+..... ..+.+.+|+.+++.++||||+++++++.+...+
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 456789999999999999999999875 457899999876432 235688899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999999764 47899999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
... ......++..|+|||.+.+..++.++|+|
T Consensus 157 ~~~------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 188 (261)
T cd05034 157 EYT------------------------------------------------AREGAKFPIKWTAPEAANYGRFTIKSDVW 188 (261)
T ss_pred hhh------------------------------------------------hhhccCCCccccCHHHhccCCcCchhHHH
Confidence 000 00122356789999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|+|++ |+.||.+.+......++.. .+..+.+...+.++.++|.+||+ +|.+|+ ++.++..
T Consensus 189 slG~il~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~~ 256 (261)
T cd05034 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVER---GYRMPRPPNCPEELYDLMLQCWDKDPEERP---TFEYLQS 256 (261)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 99999999998 9999988877777776654 22333334578999999999998 999999 7888763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=342.67 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=210.9
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-CCeEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-TEYLY 162 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-~~~ly 162 (518)
..++|++++.||.|+||.||+|.+..+++.||+|++.+.. ........+..|+.+++.++||||++++++|.. ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4578999999999999999999999999999999987543 223345678889999999999999999999876 56899
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
+||||+ +++|..++. ...+++..+..++.|++.||.|||+.||+||||+|+|||++.+|.+||+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 999999 678888774 457899999999999999999999999999999999999999999999999998743210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccch
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSL 321 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSl 321 (518)
..+.+|++.|+|||++.+ ..++.++|||||
T Consensus 162 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 192 (328)
T cd07856 162 -------------------------------------------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192 (328)
T ss_pred -------------------------------------------------cCCCcccccccCceeeeccCCcCcHHHHHHH
Confidence 113468899999999876 678999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcC------------------------cccCCC---CCCCChhHHHHHHHHh
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRN------------------------HLKFPD---DSKLSPEAKDLICRLL 374 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------------------~l~~p~---~~~~s~~~~dLI~~lL 374 (518)
||++|+|++|++||.+.+.......+..... ....|. ...+++++.++|++||
T Consensus 193 G~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 272 (328)
T cd07856 193 GCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272 (328)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHc
Confidence 9999999999999988765443332221100 001111 1246889999999999
Q ss_pred c-cccccCCCCChhhhhcCccccc
Q 010116 375 C-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+ +|.+|+ ++++++.||||..
T Consensus 273 ~~~P~~R~---t~~ell~~~~~~~ 293 (328)
T cd07856 273 VFDPQKRI---SAAEALAHPYLAP 293 (328)
T ss_pred CCChhhCC---CHHHHhcCCcccc
Confidence 8 999999 8999999999973
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=328.38 Aligned_cols=244 Identities=24% Similarity=0.410 Sum_probs=204.7
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEe-ecCCeE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF-QDTEYL 161 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f-~~~~~l 161 (518)
+..++|++.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.+++.++|++|+++++++ .+...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 4457899999999999999999865 47889999986432 345688899999999999999999865 566789
Q ss_pred EEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999997643 4889999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
..+..++..|+|||++.+..++.++|||
T Consensus 156 ----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 183 (256)
T cd05082 156 ----------------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVW 183 (256)
T ss_pred ----------------------------------------------------CCCCccceeecCHHHHccCCCCchhhhH
Confidence 0123456789999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|||++ |.+||...+.......+... ........+++.+++||.+||. +|.+|+ ++.++++
T Consensus 184 slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 251 (256)
T cd05082 184 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPVVYDVMKQCWHLDAATRP---SFLQLRE 251 (256)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 99999999997 99999887776666555432 1222224678999999999998 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=327.72 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=217.2
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+|++.+.||.|+||.||++.++.+++.||+|++.+.... ......+..|..+++.++|+||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999999765432 3345667789999999999999999999999999999999
Q ss_pred ecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 167 YLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 167 y~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
|++|++|..++.+ ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999866 367899999999999999999999999999999999999999999999999998764311
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
......|++.|+|||.+.+..++.++|+||||
T Consensus 157 ------------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG 188 (256)
T cd08530 157 ------------------------------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLG 188 (256)
T ss_pred ------------------------------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHH
Confidence 01134688999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
+++|+|++|+.||...+.......+... .....+ ..++.+++++|.+||. +|.+|+ ++.++++||+.
T Consensus 189 ~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~p~~ 256 (256)
T cd08530 189 CLLYEMATFAPPFEARSMQDLRYKVQRG-KYPPIP--PIYSQDLQNFIRSMLQVKPKLRP---NCDKILASPAV 256 (256)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCc--hhhCHHHHHHHHHHcCCCcccCC---CHHHHhcCCCC
Confidence 9999999999999988876665555432 112222 3678999999999998 999999 89999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.44 Aligned_cols=245 Identities=21% Similarity=0.339 Sum_probs=203.0
Q ss_pred eeEeecCceEEEEEEEecCC---cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeec
Q 010116 92 TIIGRGAFGEVRLCREKKSG---NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL 168 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~ 168 (518)
++||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.++|||||++++++.. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 47999999999999876554 78999998866543 345678889999999999999999998764 4689999999
Q ss_pred CCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccc
Q 010116 169 PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248 (518)
Q Consensus 169 ~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 248 (518)
++|+|.+++.+...+++..+..++.|++.||.|||..|++||||||+|||++.++.+||+|||+++.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~----- 152 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY----- 152 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc-----
Confidence 999999999888889999999999999999999999999999999999999999999999999988653211000
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHH
Q 010116 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 328 (518)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyem 328 (518)
.......++..|+|||.+.+..++.++|+|||||++|+|
T Consensus 153 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~ 191 (257)
T cd05060 153 -----------------------------------------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEA 191 (257)
T ss_pred -----------------------------------------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHH
Confidence 000112356789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 329 LV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 329 l~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
++ |.+||...+..+....+... . ..+....+++.+++||.+||. ||.+|| ++.++++
T Consensus 192 ~~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~~l~~ 250 (257)
T cd05060 192 FSYGAKPYGEMKGAEVIAMLESG-E--RLPRPEECPQEIYSIMLSCWKYRPEDRP---TFSELES 250 (257)
T ss_pred HcCCCCCcccCCHHHHHHHHHcC-C--cCCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 98 99999887776665555442 2 223334688999999999998 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.81 Aligned_cols=258 Identities=27% Similarity=0.378 Sum_probs=221.4
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCc---E-EEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN---I-YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~---~-~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 154 (518)
+.|.+..++-.+.++||+|+||+||+++.+..+. . ||+|..+.+....+.++..+.+|.++|+.++|||||++|++
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3466777888888999999999999999876433 3 89999886555677889999999999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~~-~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
..++..+|||||+|+||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+|||||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999998876 5999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccc-cCCCCccChhhhcCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST-VGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~GT~~Y~APEvl~~~~y 312 (518)
+....- . ..... --...|+|||.+...-|
T Consensus 310 ~~~~~~---~-----------------------------------------------~~~~~~klPirWLAPEtl~~~~~ 339 (474)
T KOG0194|consen 310 RAGSQY---V-----------------------------------------------MKKFLKKLPIRWLAPETLNTGIF 339 (474)
T ss_pred cCCcce---e-----------------------------------------------eccccccCcceecChhhhccCcc
Confidence 753200 0 00001 12358999999999999
Q ss_pred CccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 313 GMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
+.++|||||||++||+++ |..||.+....+...+|+.......+| ...+.+...++.+|+. ||++|+ +..+|.
T Consensus 340 s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~~~~~~~~~c~~~~p~~R~---tm~~i~ 414 (474)
T KOG0194|consen 340 SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPKELAKVMKQCWKKDPEDRP---TMSTIK 414 (474)
T ss_pred ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHHHHHHHHHHhccCChhhcc---CHHHHH
Confidence 999999999999999999 899999999999999996633444444 3678899999999998 999999 677766
Q ss_pred c
Q 010116 391 A 391 (518)
Q Consensus 391 ~ 391 (518)
+
T Consensus 415 ~ 415 (474)
T KOG0194|consen 415 K 415 (474)
T ss_pred H
Confidence 4
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=329.74 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=212.2
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
...+|++.+.||+|+||.||+|..+.+++ .||||++.+.. .......+..|+.+++.++||||+++++++.++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 34679999999999999999999887765 69999987542 34456778999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+|+||||++||+|.+++... +.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999998753 57899999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.... .........++..|+|||++.+..++.++|||
T Consensus 160 ~~~~--------------------------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvw 195 (269)
T cd05065 160 TSDP--------------------------------------------TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVW 195 (269)
T ss_pred cccc--------------------------------------------ccccccCCCcceeecCHhHhccCcccchhhhh
Confidence 1000 00000011235679999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|||++ |.+||...+.......+.. ....|....++..+.++|.+||. +|.+|| ++.+|+.
T Consensus 196 slG~~l~e~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 263 (269)
T cd05065 196 SYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---DYRLPPPMDCPTALHQLMLDCWQKDRNARP---KFGQIVS 263 (269)
T ss_pred hhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---CCcCCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999999886 9999988877766666643 23344445678999999999998 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=346.12 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=206.4
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEE-----ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEE
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCRE-----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS 154 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 154 (518)
+.+..++|++.+.||+|+||+||+|++ ..+++.||||+++... .......+.+|+.+|..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 345668899999999999999999984 3567899999987542 233456788999999999 68999999988
Q ss_pred eec-CCeEEEEEeecCCCchHHHHhhc-----------------------------------------------------
Q 010116 155 FQD-TEYLYLIMEYLPGGDMMTLLMRE----------------------------------------------------- 180 (518)
Q Consensus 155 f~~-~~~lylVmEy~~gG~L~~~l~~~----------------------------------------------------- 180 (518)
+.. ...+|+|||||+||+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 764 45689999999999999998642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 181 --------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 181 --------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
..++...+..++.|++.||.|||++||+||||||+|||++.++++||+|||++.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---- 235 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---- 235 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch----
Confidence 23677888899999999999999999999999999999999999999999998764211000
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
....+..+++.|+|||++.+..|+.++|||||||++|
T Consensus 236 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 272 (343)
T cd05103 236 -------------------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 272 (343)
T ss_pred -------------------------------------------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHH
Confidence 0011234677899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 327 EMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 327 eml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+|++ |..||............+........| ..+++++.++|.+||. ||.+|+ ++.+|++|
T Consensus 273 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl~~~p~~Rp---s~~eil~~ 335 (343)
T cd05103 273 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 335 (343)
T ss_pred HHHHCCCCCCCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 9997 999998765443333333322223333 3578899999999998 999999 89999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=305.67 Aligned_cols=258 Identities=31% Similarity=0.545 Sum_probs=218.6
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|+.+++||+|+||+|++++.+.+++.||+|.++-.+. ..+.-....+|+-+|++++|.|||+|++....+..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46667899999999999999999999999999876542 33445667899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 167 YLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 167 y~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|| ..+|..+... ++-++.+.++.++.|++.||.++|++++.||||||.|+||+.+|.+||+|||+++.+.-..
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv----- 155 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV----- 155 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-----
Confidence 99 5688888755 5789999999999999999999999999999999999999999999999999999764221
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 324 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvi 324 (518)
.| ...-+-|.+|.+|.|+.+ +-|+.+.|+||.|||
T Consensus 156 -----------------rc---------------------------ysaevvtlwyrppdvlfgakly~tsidmwsagci 191 (292)
T KOG0662|consen 156 -----------------RC---------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191 (292)
T ss_pred -----------------Ee---------------------------eeceeeeeeccCcceeeeeehhccchHhhhcchH
Confidence 01 113467999999999998 568999999999999
Q ss_pred HHHHHh-CCCCCCCCChhhHHHHHhh---------hcCcccCCCC----------------CCCChhHHHHHHHHhc-cc
Q 010116 325 MYEMLV-GYPPFYADDPITTCRKIVH---------WRNHLKFPDD----------------SKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 325 lyeml~-G~~PF~~~~~~~~~~~i~~---------~~~~l~~p~~----------------~~~s~~~~dLI~~lL~-dp 377 (518)
+.|+.. |+|.|.+.+......+|.. |..--++|+. ++++...+||+.+||. +|
T Consensus 192 faelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp 271 (292)
T KOG0662|consen 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNP 271 (292)
T ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCc
Confidence 999986 8999999999888888865 2222222221 2356778999999995 99
Q ss_pred cccCCCCChhhhhcCcccccC
Q 010116 378 EHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 378 ~~R~g~~~a~eil~Hpff~~i 398 (518)
.+|+ +|+++++||||.+.
T Consensus 272 ~qri---saeaalqhpyf~d~ 289 (292)
T KOG0662|consen 272 AQRI---SAEAALQHPYFSDF 289 (292)
T ss_pred cccc---CHHHHhcCcccccc
Confidence 9999 89999999999853
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=326.57 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=209.1
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
+..++|++.+.||.|+||.||+|... |+.||+|.+..... ...++.+|..+++.++|+||+++++++.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 45678999999999999999999764 88999999876532 4567889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 163 LIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999997765 79999999999999999999999999999999999999999999999999988642110
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
....++..|+|||++....++.++|+||
T Consensus 157 ----------------------------------------------------~~~~~~~~~~ape~~~~~~~~~~~Di~s 184 (256)
T cd05039 157 ----------------------------------------------------DSGKLPVKWTAPEALREKKFSTKSDVWS 184 (256)
T ss_pred ----------------------------------------------------ccCCCcccccCchhhcCCcCCcHHHHHH
Confidence 0123456799999999888999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 321 LGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 321 lGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||++|+|++ |..||...........+... .....| ..+++++.+||.+||. +|.+|+ ++.++++
T Consensus 185 lG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 251 (256)
T cd05039 185 FGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAP--EGCPPEVYKVMKDCWELDPAKRP---TFKQLRE 251 (256)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCCCc--cCCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 9999999997 99999887766555444331 122233 4678999999999998 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=327.74 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=206.1
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
+..++|++...||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++||+|+++++++.. ...|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 4557899999999999999999987655 4599998765432 23567889999999999999999988854 5689
Q ss_pred EEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 163 LIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999999754 358899999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
. .......++..|+|||++.+..++.++|+||
T Consensus 157 ~------------------------------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s 188 (260)
T cd05069 157 Y------------------------------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188 (260)
T ss_pred c------------------------------------------------cccCCCccchhhCCHHHhccCCcChHHHHHH
Confidence 0 0011234677899999999889999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 321 LGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 321 lGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||++|||++ |.+||.+.........+.. ....+....++..+++||++||. ||.+|| ++++|++
T Consensus 189 lG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 255 (260)
T cd05069 189 FGILLTELVTKGRVPYPGMVNREVLEQVER---GYRMPCPQGCPESLHELMKLCWKKDPDERP---TFEYIQS 255 (260)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCcccCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 9999999999 9999998877777666654 22223334688999999999998 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=344.31 Aligned_cols=264 Identities=30% Similarity=0.474 Sum_probs=213.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecC--CeE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDT--EYL 161 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~--~~l 161 (518)
.++|++.+.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.+ +||||++++++|... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 468999999999999999999999999999999986532 1223345677899999999 999999999998653 468
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||++ ++|..++... .+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++........
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999996 5999888665 889999999999999999999999999999999999999999999999999886532210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 320 (518)
.. ........+||+.|+|||++.+ ..++.++|+||
T Consensus 163 ~~--------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s 198 (337)
T cd07852 163 NP--------------------------------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWS 198 (337)
T ss_pred cc--------------------------------------------cCcchhcccccccccCceeeeccccccccchHHH
Confidence 00 0001124579999999998865 56889999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc-----------------------cc---CC-CCCCCChhHHHHHHHH
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH-----------------------LK---FP-DDSKLSPEAKDLICRL 373 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-----------------------l~---~p-~~~~~s~~~~dLI~~l 373 (518)
|||++|+|++|++||.+........++...... .. +. ....++.++.+||.+|
T Consensus 199 lG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (337)
T cd07852 199 VGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKL 278 (337)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHh
Confidence 999999999999999887766555444332110 00 00 0123688999999999
Q ss_pred hc-cccccCCCCChhhhhcCcccccC
Q 010116 374 LC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|. ||.+|+ ++.+++.||||+.+
T Consensus 279 l~~~P~~Rp---s~~~il~~~~~~~~ 301 (337)
T cd07852 279 LVFNPNKRL---TAEEALEHPYVAQF 301 (337)
T ss_pred ccCCccccc---CHHHHhhChhhhhh
Confidence 98 999999 89999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=336.50 Aligned_cols=256 Identities=20% Similarity=0.351 Sum_probs=206.5
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCC--------------cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCcee
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSG--------------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~--------------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv 149 (518)
..++|++.+.||+|+||.||+|++..++ ..||+|++.... .......+.+|+++++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3468999999999999999999875432 358999987542 233456788999999999999999
Q ss_pred EEEEEeecCCeEEEEEeecCCCchHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCce
Q 010116 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (518)
Q Consensus 150 ~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNI 217 (518)
++++++.....+|+||||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986432 367888999999999999999999999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccC
Q 010116 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (518)
Q Consensus 218 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 297 (518)
|++.++.+||+|||++..+...... .......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 193 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYY-----------------------------------------------RIQGRAVL 193 (295)
T ss_pred EEcCCCcEEecccccccccccCcce-----------------------------------------------eccCcCcC
Confidence 9999999999999998754321000 00113356
Q ss_pred CCCccChhhhcCCCCCccccccchhHHHHHHHh--CCCCCCCCChhhHHHHHhhhc----CcccCCCCCCCChhHHHHHH
Q 010116 298 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYADDPITTCRKIVHWR----NHLKFPDDSKLSPEAKDLIC 371 (518)
Q Consensus 298 T~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~--G~~PF~~~~~~~~~~~i~~~~----~~l~~p~~~~~s~~~~dLI~ 371 (518)
++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.... ..........+++.+++||.
T Consensus 194 ~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 273 (295)
T cd05097 194 PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMM 273 (295)
T ss_pred ceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHH
Confidence 789999999999999999999999999999988 778998777666555443210 11112223357899999999
Q ss_pred HHhc-cccccCCCCChhhhhc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~ 391 (518)
+||. ||.+|| ++.+|++
T Consensus 274 ~~l~~~p~~RP---s~~~i~~ 291 (295)
T cd05097 274 RCWSRDIKDRP---TFNKIHH 291 (295)
T ss_pred HHcCCCchhCc---CHHHHHH
Confidence 9998 999999 8888854
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.51 Aligned_cols=259 Identities=20% Similarity=0.319 Sum_probs=212.7
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecC-------CcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKS-------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVK 150 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t-------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~ 150 (518)
..+.+...+|++++.||+|+||.||+|++... +..||+|++.... .......+.+|+.+++.+ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34566667899999999999999999986432 2368999886432 233456788999999999 8999999
Q ss_pred EEEEeecCCeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCC
Q 010116 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKP 214 (518)
Q Consensus 151 l~~~f~~~~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKP 214 (518)
++++|.+...+|+||||+++|+|.+++.+. ..++...+..++.|++.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 999999999999999999999999999653 2467788888999999999999999999999999
Q ss_pred CceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccc
Q 010116 215 DNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294 (518)
Q Consensus 215 eNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 294 (518)
+|||++.++.+||+|||+++........ .....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~ 195 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYY-----------------------------------------------KKTTN 195 (334)
T ss_pred ceEEEcCCCcEEECCcccceeccccccc-----------------------------------------------ccccC
Confidence 9999999999999999998865321000 00112
Q ss_pred ccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHH
Q 010116 295 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRL 373 (518)
Q Consensus 295 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~l 373 (518)
..++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+.......+... ...+....++.++.+||.+|
T Consensus 196 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~c 272 (334)
T cd05100 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG---HRMDKPANCTHELYMIMREC 272 (334)
T ss_pred CCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHH
Confidence 335678999999999999999999999999999998 89999888777776666542 22222346789999999999
Q ss_pred hc-cccccCCCCChhhhhcC
Q 010116 374 LC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~H 392 (518)
|. +|.+|+ ++.+|+.+
T Consensus 273 l~~~p~~Rp---s~~ell~~ 289 (334)
T cd05100 273 WHAVPSQRP---TFKQLVED 289 (334)
T ss_pred cccChhhCc---CHHHHHHH
Confidence 98 999999 89999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=334.14 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=209.8
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEec-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
+..++|++++.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 345789999999999999999998753 67899999987542 22334568889999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE----------------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~----------------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPe 215 (518)
...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999999999999643 24778888999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccc
Q 010116 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (518)
Q Consensus 216 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 295 (518)
|||++.++.++|+|||++..+...... ......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~ 192 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY-----------------------------------------------KASEND 192 (288)
T ss_pred heEecCCCceEECccccceecccCccc-----------------------------------------------cccCCC
Confidence 999999999999999998754321100 000122
Q ss_pred cCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHh
Q 010116 296 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374 (518)
Q Consensus 296 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL 374 (518)
.+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... .+..| ..++.++.+||.+||
T Consensus 193 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l 269 (288)
T cd05050 193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-VLSCP--DNCPLELYNLMRLCW 269 (288)
T ss_pred ccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHc
Confidence 35678999999999999999999999999999997 889998888777776665422 22223 467899999999999
Q ss_pred c-cccccCCCCChhhhhc
Q 010116 375 C-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~ 391 (518)
+ ||.+|| ++.||++
T Consensus 270 ~~~p~~Rp---t~~el~~ 284 (288)
T cd05050 270 SKLPSDRP---SFASINR 284 (288)
T ss_pred ccCcccCC---CHHHHHH
Confidence 8 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=352.11 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=211.5
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~ 153 (518)
.+.+..++|.+.+.||+|+||.||+|++. .+++.||+|+++... .....+.+.+|+.+|..+. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 35677788999999999999999999864 345689999997542 2333456889999999997 999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhcC----------------------------------------------------
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMRED---------------------------------------------------- 181 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~~---------------------------------------------------- 181 (518)
++.+...+|+|||||+||+|.+++.+..
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999986431
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010116 182 ----------------------------------------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (518)
Q Consensus 182 ----------------------------------------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPe 215 (518)
.++...+..++.|++.||.|||+.||+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 3566778889999999999999999999999999
Q ss_pred ceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccc
Q 010116 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (518)
Q Consensus 216 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 295 (518)
|||++.++.+||+|||+++.+..... .....+.
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~-----------------------------------------------~~~~~~~ 301 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSN-----------------------------------------------YISKGST 301 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccc-----------------------------------------------cccCCCc
Confidence 99999999999999999875421100 0001135
Q ss_pred cCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHh
Q 010116 296 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374 (518)
Q Consensus 296 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL 374 (518)
+||+.|+|||++.+..++.++|||||||++|||++ |..||............+.....+.. +..++.++.+||.+||
T Consensus 302 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl 379 (401)
T cd05107 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK--PAHASDEIYEIMQKCW 379 (401)
T ss_pred CCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHc
Confidence 68899999999999999999999999999999998 89999876655554444442222333 3468899999999999
Q ss_pred c-cccccCCCCChhhhhcC
Q 010116 375 C-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~H 392 (518)
+ +|.+|| ++.+|+..
T Consensus 380 ~~~P~~RP---s~~ell~~ 395 (401)
T cd05107 380 EEKFEIRP---DFSQLVHL 395 (401)
T ss_pred CCChhHCc---CHHHHHHH
Confidence 8 999999 89998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.33 Aligned_cols=255 Identities=21% Similarity=0.382 Sum_probs=206.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEec----------------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCce
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKK----------------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~----------------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~I 148 (518)
.++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4679999999999999999986543 34579999987542 23345678899999999999999
Q ss_pred eEEEEEeecCCeEEEEEeecCCCchHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCce
Q 010116 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-----------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (518)
Q Consensus 149 v~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~-----------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNI 217 (518)
+++++++.+.+.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999986642 366778999999999999999999999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccC
Q 010116 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (518)
Q Consensus 218 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 297 (518)
|++.++.++|+|||+++.+...... .......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 194 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY-----------------------------------------------RIQGRAVL 194 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce-----------------------------------------------eccCcCcC
Confidence 9999999999999998865321100 00112345
Q ss_pred CCCccChhhhcCCCCCccccccchhHHHHHHHh--CCCCCCCCChhhHHHHHhhh----cCcccCCCCCCCChhHHHHHH
Q 010116 298 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYADDPITTCRKIVHW----RNHLKFPDDSKLSPEAKDLIC 371 (518)
Q Consensus 298 T~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~--G~~PF~~~~~~~~~~~i~~~----~~~l~~p~~~~~s~~~~dLI~ 371 (518)
++.|+|||++.+..++.++|+|||||++|||++ |..||...+..........+ .....+|....+++.+.+||.
T Consensus 195 ~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 274 (296)
T cd05095 195 PIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLML 274 (296)
T ss_pred ccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHH
Confidence 778999999988899999999999999999998 78999877665554433221 112233444567899999999
Q ss_pred HHhc-cccccCCCCChhhhhc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~ 391 (518)
+||. ||.+|| ++.+|.+
T Consensus 275 ~cl~~~p~~Rp---~~~~i~~ 292 (296)
T cd05095 275 SCWRRNAKERP---SFQEIHA 292 (296)
T ss_pred HHcCCCcccCC---CHHHHHH
Confidence 9998 999999 7887754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=363.72 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=212.0
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEee-c-
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQ-D- 157 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~-~- 157 (518)
..+...+++|.+.|.+|||+.||+|++...|..||+|++--. .....+.+++|+++|+.|. |+|||.++++.. .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 345566788999999999999999999988899999987543 4566788999999999996 999999999432 1
Q ss_pred -----CCeEEEEEeecCCCchHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCceeeCCCCcEEEe
Q 010116 158 -----TEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLS 228 (518)
Q Consensus 158 -----~~~lylVmEy~~gG~L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~g--iiHRDIKPeNILld~~g~vKL~ 228 (518)
.-.++|.||||.||.|-+++.. ...|+|.++..|+.+++.||.+||.+. |||||||-|||||+.+|+.|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 1247899999999999999964 356999999999999999999999997 9999999999999999999999
Q ss_pred ecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc
Q 010116 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308 (518)
Q Consensus 229 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 308 (518)
|||.|...-... . ...+......+ -...-||.|+|||++.
T Consensus 189 DFGSatt~~~~~----------------------------------~-~~~e~~~ve~e-----I~k~TTp~YRsPEMID 228 (738)
T KOG1989|consen 189 DFGSATTKILSP----------------------------------T-SAQEVNYVEEE-----IEKYTTPQYRSPEMID 228 (738)
T ss_pred cccccccccCCC----------------------------------c-cHHHHHHHHHH-----HHhhCCccccChHHHh
Confidence 999876421110 0 00011100001 1234689999999984
Q ss_pred ---CCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC
Q 010116 309 ---KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG 384 (518)
Q Consensus 309 ---~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~ 384 (518)
+.+.+.++|||+|||+||-|++...||..... ..|++ ..+.||..+.+|..+++||+.||. ||.+||
T Consensus 229 lysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIln--g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP--- 299 (738)
T KOG1989|consen 229 LYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILN--GNYSFPPFPNYSDRLKDLIRTMLQPNPDERP--- 299 (738)
T ss_pred hhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe--ccccCCCCccHHHHHHHHHHHHhccCcccCC---
Confidence 67889999999999999999999999976543 34565 567888888999999999999998 999999
Q ss_pred ChhhhhcC
Q 010116 385 GAHQIKAH 392 (518)
Q Consensus 385 ~a~eil~H 392 (518)
++.+++.+
T Consensus 300 nI~Qv~~~ 307 (738)
T KOG1989|consen 300 NIYQVLEE 307 (738)
T ss_pred CHHHHHHH
Confidence 88888754
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=325.25 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=208.0
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+..++|++.+.||+|+||.||++... .+..+|+|.+.+.. ...+.+.+|+.+++.++|++|+++++.+.+ ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 466789999999999999999999754 45679999887542 234568889999999999999999999988 788
Q ss_pred EEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+||||+++|+|.+++.+. ..++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999999763 46788889999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.. .......++..|+|||++....++.++|+|
T Consensus 156 ~~------------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 187 (260)
T cd05073 156 EY------------------------------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVW 187 (260)
T ss_pred Cc------------------------------------------------ccccCCcccccccCHhHhccCCcCccccch
Confidence 00 000123466789999999988899999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|+|++ |.+||.+.+.......+.. ....+....++.++.++|.+||. +|.+|+ ++.++++
T Consensus 188 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~~ 255 (260)
T cd05073 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYRMPRPENCPEELYNIMMRCWKNRPEERP---TFEYIQS 255 (260)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---CCCCCCcccCCHHHHHHHHHHcccCcccCc---CHHHHHH
Confidence 99999999998 9999998877666665543 23333335688999999999998 999999 7776653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=328.89 Aligned_cols=242 Identities=24% Similarity=0.391 Sum_probs=199.9
Q ss_pred eeEeecCceEEEEEEEecCCcE--EEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeec
Q 010116 92 TIIGRGAFGEVRLCREKKSGNI--YAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYL 168 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~--~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~ 168 (518)
++||+|+||.||+|+.+.++.. +|+|.++.. ........+.+|+.++..+ +||||++++++|.....+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3689999999999999888764 688887642 2234456788999999999 8999999999999999999999999
Q ss_pred CCCchHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccc
Q 010116 169 PGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (518)
Q Consensus 169 ~gG~L~~~l~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGl 232 (518)
++|+|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999996543 478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 312 (518)
+....... ......+++.|+|||++.+..+
T Consensus 159 ~~~~~~~~--------------------------------------------------~~~~~~~~~~y~apE~~~~~~~ 188 (270)
T cd05047 159 SRGQEVYV--------------------------------------------------KKTMGRLPVRWMAIESLNYSVY 188 (270)
T ss_pred ccccchhh--------------------------------------------------hccCCCCccccCChHHHccCCC
Confidence 76321000 0001234668999999999999
Q ss_pred CccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 313 GMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
+.++|+|||||++|||++ |..||.+.+.......+... ...+....++.++.+||.+||. ||.+|+ ++.+|+
T Consensus 189 ~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il 262 (270)
T cd05047 189 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERP---SFAQIL 262 (270)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC---CCCCCCCcCCHHHHHHHHHHcccChhhCC---CHHHHH
Confidence 999999999999999997 99999887776666665431 2222234578999999999998 999999 888887
Q ss_pred c
Q 010116 391 A 391 (518)
Q Consensus 391 ~ 391 (518)
+
T Consensus 263 ~ 263 (270)
T cd05047 263 V 263 (270)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=331.97 Aligned_cols=254 Identities=33% Similarity=0.553 Sum_probs=213.0
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
|++.+.||+|+||.||+|+...+++.||+|++.... ......+.+..|+.+++.++|++|+++++++.+...+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677899999999999999999999999999998754 2233456677899999999999999999999999999999999
Q ss_pred cCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 168 LPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 168 ~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
++ ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.+|.+||+|||+++.......
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----- 153 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR----- 153 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-----
Confidence 97 5899999776 6899999999999999999999999999999999999999999999999999876532100
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccchhHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 325 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil 325 (518)
......+++.|+|||++.+. .++.++|+|||||++
T Consensus 154 --------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l 189 (282)
T cd07829 154 --------------------------------------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIF 189 (282)
T ss_pred --------------------------------------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHH
Confidence 01123567889999999876 889999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcC----------------cccCCC---------CCCCChhHHHHHHHHhc-cccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRN----------------HLKFPD---------DSKLSPEAKDLICRLLC-DVEH 379 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~----------------~l~~p~---------~~~~s~~~~dLI~~lL~-dp~~ 379 (518)
|||++|.+||.+.+......++..... ...++. ...++..+.++|.+||. ||.+
T Consensus 190 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 269 (282)
T cd07829 190 AEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK 269 (282)
T ss_pred HHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCccc
Confidence 999999999998877666555543110 001111 11357899999999998 9999
Q ss_pred cCCCCChhhhhcCccc
Q 010116 380 RLGTGGAHQIKAHPWF 395 (518)
Q Consensus 380 R~g~~~a~eil~Hpff 395 (518)
|+ ++.+++.||||
T Consensus 270 Rp---~~~~~l~~p~~ 282 (282)
T cd07829 270 RI---SAKEALKHPYF 282 (282)
T ss_pred CC---CHHHHhhCcCC
Confidence 99 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=329.64 Aligned_cols=253 Identities=18% Similarity=0.291 Sum_probs=203.6
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcE----EEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNI----YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~----~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
+..++|++++.||+|+||+||+|....++.. +|+|.+... ........+..|..+++.++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 3457899999999999999999999887775 566665322 11223456777888889999999999999875 4
Q ss_pred CeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
...++|+||+++|+|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 568899999999999999976 4678999999999999999999999999999999999999999999999999987543
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.... ........|+..|+|||++.+..|+.++|
T Consensus 161 ~~~~-----------------------------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~D 193 (279)
T cd05111 161 PDDK-----------------------------------------------KYFYSEHKTPIKWMALESILFGRYTHQSD 193 (279)
T ss_pred CCCc-----------------------------------------------ccccCCCCCcccccCHHHhccCCcCchhh
Confidence 1100 00011345778899999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||||++|||++ |..||.+..+......+.. ...+ +....++.++.++|.+|+. ||.+|| ++.|+++
T Consensus 194 v~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rp---s~~el~~ 263 (279)
T cd05111 194 VWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-GERL--AQPQICTIDVYMVMVKCWMIDENVRP---TFKELAN 263 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC--CCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 9999999999998 9999988776555444332 2222 2233567889999999998 999999 8888865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=328.81 Aligned_cols=261 Identities=28% Similarity=0.445 Sum_probs=209.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCC----cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-CCe
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSG----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-TEY 160 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-~~~ 160 (518)
..|++++.||+|+||.||+|..+.++ +.||||+++.... ..+......+|+.++++++|||||.|..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 46899999999999999999665543 3799999875532 12233456789999999999999999999987 889
Q ss_pred EEEEEeecCCCchHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC----CcEEEeecc
Q 010116 161 LYLIMEYLPGGDMMTLLMR-----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN----GHMKLSDFG 231 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~-----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~----g~vKL~DFG 231 (518)
++|++||.+. ||+..+.- ...++...++.++.||+.|+.|||++=|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999964 99988853 2478999999999999999999999999999999999999888 999999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-C
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-K 310 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~ 310 (518)
+++.+...-.+-. .....|-|.+|+|||.|++ .
T Consensus 182 laR~~~~plkpl~----------------------------------------------s~d~VVVTiWYRAPELLLGa~ 215 (438)
T KOG0666|consen 182 LARLFNNPLKPLA----------------------------------------------SLDPVVVTIWYRAPELLLGAR 215 (438)
T ss_pred HHHHhhccccccc----------------------------------------------cCCceEEEEEecChHHhcccc
Confidence 9998754321100 0114678999999999998 6
Q ss_pred CCCccccccchhHHHHHHHhCCCCCCCCCh---------hhHHHHHhh---------hcCcccCCCC-------------
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDP---------ITTCRKIVH---------WRNHLKFPDD------------- 359 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~---------~~~~~~i~~---------~~~~l~~p~~------------- 359 (518)
.|+.++|+|++|||+.|||+-.|.|.+... .....+|++ |..--++|+.
T Consensus 216 hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~ 295 (438)
T KOG0666|consen 216 HYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYD 295 (438)
T ss_pred cccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcC
Confidence 799999999999999999999999976421 233455554 2211222221
Q ss_pred -----------CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 360 -----------SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 360 -----------~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
..-++.+.+|+.+||. ||-+|+ +++++++|+||..
T Consensus 296 n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI---ta~qAleh~yF~~ 342 (438)
T KOG0666|consen 296 NVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI---TAEQALEHPYFTE 342 (438)
T ss_pred cchHHHHHHHhcCCCchHHHHHHHHhccCchhhc---cHHHHhccccccc
Confidence 0126679999999999 999999 8999999999985
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=322.27 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=204.9
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG 171 (518)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+++++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999877 999999998765332 34567889999999999999999999999999999999999999
Q ss_pred chHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 172 DMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 172 ~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
+|.+++... ..+++..+..++.+++.||.|||++|++||||||+|||++.++++||+|||++..........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV------- 150 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-------
Confidence 999999653 578999999999999999999999999999999999999999999999999987543110000
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......++..|+|||++.+..++.++|||||||++|||++
T Consensus 151 ----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t 190 (251)
T cd05041 151 ----------------------------------------SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190 (251)
T ss_pred ----------------------------------------ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence 0001234678999999998899999999999999999999
Q ss_pred -CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 331 -GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 331 -G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|..||...........+.. ....+.+..++.++.+||.+||+ +|.+|+ ++.|+++
T Consensus 191 ~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~ell~ 247 (251)
T cd05041 191 LGDTPYPGMSNQQTRERIES---GYRMPAPQLCPEEIYRLMLQCWAYDPENRP---SFSEIYN 247 (251)
T ss_pred ccCCCCccCCHHHHHHHHhc---CCCCCCCccCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 8999988877666555543 22333334678999999999998 999999 8999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=331.02 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=206.0
Q ss_pred CeeEEeeEeecCceEEEEEEEec-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
+|++.+.||+|+||.||+|.... ....+|+|.+.+... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 335789998865432 23356788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCce
Q 010116 162 YLIMEYLPGGDMMTLLMRE------------------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~------------------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNI 217 (518)
|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998542 2478889999999999999999999999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccC
Q 010116 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (518)
Q Consensus 218 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 297 (518)
|++.++.+||+|||+++........ .......+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 191 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY-----------------------------------------------VKRSKGRI 191 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-----------------------------------------------hcccCCCC
Confidence 9999999999999998754321000 00012346
Q ss_pred CCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-
Q 010116 298 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 298 T~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~- 375 (518)
+..|+|||++.+..++.++|||||||++|||++ |.+||.+..+......+.. ....+....++.++.+||.+||.
T Consensus 192 ~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~cl~~ 268 (290)
T cd05045 192 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT---GYRMERPENCSEEMYNLMLTCWKQ 268 (290)
T ss_pred CccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---CCCCCCCCCCCHHHHHHHHHHccC
Confidence 778999999999999999999999999999998 9999988877665554432 22333345688999999999998
Q ss_pred cccccCCCCChhhhhc
Q 010116 376 DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 376 dp~~R~g~~~a~eil~ 391 (518)
||.+|| ++.+|++
T Consensus 269 ~P~~Rp---~~~~i~~ 281 (290)
T cd05045 269 EPDKRP---TFADISK 281 (290)
T ss_pred CcccCC---CHHHHHH
Confidence 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.04 Aligned_cols=253 Identities=30% Similarity=0.486 Sum_probs=211.7
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
+|.+.+.||+|+||.||++++..++..+++|+++..... .......+..|..+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 488999999999999999999888888888887653321 222344567789999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 165 MEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 165 mEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++. +.+||+|||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 357999999999999999999999999999999999999974 679999999987643210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
.......|++.|+|||.+.+..++.++|+||
T Consensus 160 -------------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s 190 (260)
T cd08222 160 -------------------------------------------------DLATTFTGTPYYMSPEALKHQGYDSKSDIWS 190 (260)
T ss_pred -------------------------------------------------ccccCCCCCcCccCHHHHccCCCCchhhHHH
Confidence 0011346889999999998888999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
||+++|+|++|..||.+.+.......+... ....++ ..++.++.+||.+||. ||.+|+ ++.+|+.||||
T Consensus 191 lG~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 260 (260)
T cd08222 191 LGCILYEMCCLAHAFEGQNFLSVVLRIVEG-PTPSLP--ETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCCc--chhcHHHHHHHHHHhcCChhhCc---CHHHHhhCCCC
Confidence 999999999999999877766666665542 122222 3578999999999998 999999 89999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=322.71 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=211.2
Q ss_pred eeEEeeEeecCceEEEEEEEecCC----cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSG----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
|++++.||.|+||.||+|++..++ ..||+|++..... ......+..|+.++..++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467889999999999999998766 8999999865532 2256788999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 164 IMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~--l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
||||++|++|.+++..... +++..+..++.|++.||.|||+.|++||||||+||+++.+++++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 99999999999999999999999999999999999999999999999999886532200
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.. .....+++.|+|||.+.+..++.++|+|||
T Consensus 159 ~~------------------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 190 (258)
T smart00219 159 YK------------------------------------------------KKGGKLPIRWMAPESLKDGKFTSKSDVWSF 190 (258)
T ss_pred cc------------------------------------------------cccCCCcccccChHHhccCCCCcchhHHHH
Confidence 00 001227889999999988889999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 322 GAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 322 Gvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||++|+|++ |.+||...+.......+.... ....+ ..++.++.++|.+||. ||.+|+ ++.+++.
T Consensus 191 G~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~ 256 (258)
T smart00219 191 GVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKP--ENCPPEIYKLMLQCWAEDPEDRP---TFSELVE 256 (258)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CcCCHHHHHHHHHHCcCChhhCc---CHHHHHh
Confidence 999999998 899998887777777776532 22333 3589999999999999 999999 8999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=330.78 Aligned_cols=252 Identities=35% Similarity=0.549 Sum_probs=208.3
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEEEEe
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVmE 166 (518)
|++.+.||.|+||+||+|+...+++.||||++.+.... .......+|...++.++ ||||+++++++.+....|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999999999999998754321 11223456888999998 9999999999999999999999
Q ss_pred ecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 167 YLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 167 y~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|+ +|+|..++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----
Confidence 99 889999987764 78999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 323 (518)
......||..|+|||++.+ ..++.++|+||||+
T Consensus 154 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~ 187 (283)
T cd07830 154 ----------------------------------------------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGC 187 (283)
T ss_pred ----------------------------------------------CcCCCCCcccccCceeeecCcCcCCccchhhHHH
Confidence 0113468899999998864 56899999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcc-----------------cCCC---------CCCCChhHHHHHHHHhc-c
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHL-----------------KFPD---------DSKLSPEAKDLICRLLC-D 376 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l-----------------~~p~---------~~~~s~~~~dLI~~lL~-d 376 (518)
++|||++|++||...+......++....... .++. ....+.++++||++||+ |
T Consensus 188 ~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 267 (283)
T cd07830 188 IMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWD 267 (283)
T ss_pred HHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccC
Confidence 9999999999998887766665554321110 0000 01236889999999998 9
Q ss_pred ccccCCCCChhhhhcCccc
Q 010116 377 VEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 377 p~~R~g~~~a~eil~Hpff 395 (518)
|.+|+ ++.||+.||||
T Consensus 268 p~~Rp---t~~ei~~~~~~ 283 (283)
T cd07830 268 PKKRP---TASQALQHPYF 283 (283)
T ss_pred cccCC---CHHHHhhCCCC
Confidence 99999 89999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=327.42 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=210.2
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCc----EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
...+|++++.||+|+||.||+|..+.+|. .+|+|++.+... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45789999999999999999999877765 589998876532 3345678889999999999999999999987 7
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 899999999999999999764 5799999999999999999999999999999999999999999999999999986532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
.... .......+++.|+|||.+....++.++|+
T Consensus 162 ~~~~-----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di 194 (279)
T cd05057 162 DEKE-----------------------------------------------YHAEGGKVPIKWMALESILHRIYTHKSDV 194 (279)
T ss_pred cccc-----------------------------------------------eecCCCcccccccCHHHhhcCCcCchhhH
Confidence 1100 00011224678999999988999999999
Q ss_pred cchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 319 WSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 319 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||++||+++ |.+||.+....+....+... .. ++.+...+.++.++|.+||. ||..|| ++.++++
T Consensus 195 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~l~~~p~~Rp---~~~~l~~ 263 (279)
T cd05057 195 WSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ER--LPQPPICTIDVYMVLVKCWMIDAESRP---TFKELIN 263 (279)
T ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CC--CCCCCCCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 999999999998 99999988877766666542 22 33334578999999999998 999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=328.17 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=198.7
Q ss_pred CCe-eEEeeEeecCceEEEEEEE----ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec--C
Q 010116 86 DDF-ELLTIIGRGAFGEVRLCRE----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--T 158 (518)
Q Consensus 86 ~~f-~i~~~LG~G~fG~V~l~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~ 158 (518)
++| ++++.||+|+||+||++.. ..++..||+|+++... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 8999999999999988753 3578899999987542 12234567889999999999999999998765 3
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 468999999999999999865 4699999999999999999999999999999999999999999999999999886532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
.... ........++..|+|||++.+..++.++||
T Consensus 160 ~~~~----------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di 193 (283)
T cd05080 160 GHEY----------------------------------------------YRVREDGDSPVFWYAVECLKENKFSYASDV 193 (283)
T ss_pred cchh----------------------------------------------hccCCCCCCCceeeCHhHhcccCCCccccc
Confidence 1100 000112345678999999998899999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhh--------------HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPIT--------------TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~--------------~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~ 383 (518)
|||||++|||++|..||....... .....+.. ....+....++.++.+||.+||. ||.+||
T Consensus 194 ~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-- 269 (283)
T cd05080 194 WSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER--GMRLPCPKNCPQEVYILMKNCWETEAKFRP-- 269 (283)
T ss_pred HHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc--CCCCCCCCCCCHHHHHHHHHHhccChhhCC--
Confidence 999999999999999986533210 01111111 11222234678999999999998 999999
Q ss_pred CChhhhhc
Q 010116 384 GGAHQIKA 391 (518)
Q Consensus 384 ~~a~eil~ 391 (518)
++.+|+.
T Consensus 270 -s~~~i~~ 276 (283)
T cd05080 270 -TFRSLIP 276 (283)
T ss_pred -CHHHHHH
Confidence 8888874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=324.86 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=199.7
Q ss_pred eEeecCceEEEEEEEe--cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCC
Q 010116 93 IIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 93 ~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
.||+|+||.||+|..+ .++..||+|++.... .....+.+.+|+.+++.++||||++++++++. ..+|+||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999765 455679999986542 23345678899999999999999999998864 578999999999
Q ss_pred CchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccc
Q 010116 171 GDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (518)
Q Consensus 171 G~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 249 (518)
|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~------ 152 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY------ 152 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce------
Confidence 999999875 4679999999999999999999999999999999999999999999999999987543211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHH
Q 010116 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329 (518)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 329 (518)
.......+++.|+|||++.+..++.++|+|||||++|||+
T Consensus 153 ----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05115 153 ----------------------------------------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAF 192 (257)
T ss_pred ----------------------------------------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHh
Confidence 0001123467899999999889999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 330 V-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 330 ~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+ |.+||.+.........+... ....+| ...++++.+||.+||. ||.+|| ++.+|++
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~c~~~~~~~Rp---~~~~i~~ 250 (257)
T cd05115 193 SYGQKPYKKMKGPEVMSFIEQG-KRLDCP--AECPPEMYALMKDCWIYKWEDRP---NFAKVEE 250 (257)
T ss_pred cCCCCCcCcCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 6 99999988777766655543 223333 4678999999999998 999999 6777654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=322.43 Aligned_cols=249 Identities=20% Similarity=0.298 Sum_probs=208.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
..+|++.+.||.|+||.||++.+. ++..+|+|.+.+... ....+.+|+.+++.++||+|+++++++.+....|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 468999999999999999999875 467899999875432 234577899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++||+|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++++||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-- 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc--
Confidence 9999999999999764 5689999999999999999999999999999999999999999999999999875421100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
.......++..|+|||++.+..++.++|+|||||
T Consensus 156 ----------------------------------------------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~ 189 (256)
T cd05112 156 ----------------------------------------------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGV 189 (256)
T ss_pred ----------------------------------------------cccCCCccchhhcCHhHhccCCcChHHHHHHHHH
Confidence 0001234567899999999899999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 324 IMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 324 ilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
++|||++ |.+||...........+... .........+.++.+|+.+||. +|.+|+ ++.+++++
T Consensus 190 ~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp---~~~~~l~~ 254 (256)
T cd05112 190 LMWEVFSEGKTPYENRSNSEVVETINAG---FRLYKPRLASQSVYELMQHCWKERPEDRP---SFSLLLHQ 254 (256)
T ss_pred HHHHHHcCCCCCCCcCCHHHHHHHHhCC---CCCCCCCCCCHHHHHHHHHHcccChhhCC---CHHHHHHh
Confidence 9999998 99999887776666655432 1222223468999999999998 999999 89998763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.18 Aligned_cols=251 Identities=25% Similarity=0.448 Sum_probs=219.5
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh-chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe--EEEEEe
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY--LYLIME 166 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~--lylVmE 166 (518)
.-.+||+|+|-+||+|.+..+|..||--.++-.++. .....+++..|+.+|+.|+|||||++|++|.+..+ +.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346899999999999999999999886555444433 34456899999999999999999999999998766 889999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CeEEcCCCCCceeeCC-CCcEEEeecccccccCCCcccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--NYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~--giiHRDIKPeNILld~-~g~vKL~DFGla~~~~~~~~~~ 243 (518)
++.+|+|..|+.+.+.+....++.|++||+.||.|||++ -|||||||.+||+|+. .|.|||+|+|||+....+
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---- 199 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc----
Confidence 999999999999999999999999999999999999998 5999999999999975 599999999999865322
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
.+.+.+|||.|||||+.. ..|+..+||||||+
T Consensus 200 -----------------------------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGM 231 (632)
T KOG0584|consen 200 -----------------------------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGM 231 (632)
T ss_pred -----------------------------------------------ccceeccCccccChHHHh-hhcchhhhhhhhhH
Confidence 244689999999999986 89999999999999
Q ss_pred HHHHHHhCCCCCC-CCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhhcCccccc
Q 010116 324 IMYEMLVGYPPFY-ADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 324 ilyeml~G~~PF~-~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+|.||+|+..||. ..++.++++++..+..+-.|.. --.|++++||.+||.-...|+ ++.|+|+||||..
T Consensus 232 CmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~fIekCl~~~~~R~---sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 232 CMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREFIEKCLATKSERL---SAKELLKDPFFDE 301 (632)
T ss_pred HHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHHHHHHhcCchhcc---CHHHHhhChhhcc
Confidence 9999999999996 4688899999988665544432 126899999999998789999 8999999999985
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=327.53 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=210.7
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEec----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKK----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD- 157 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~- 157 (518)
+..++|++.+.||+|+||.||.|.+.. ++..||+|++... ........+.+|..+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999876 3588999988643 234456778899999999999999999997654
Q ss_pred CCeEEEEEeecCCCchHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEee
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE--------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSD 229 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~--------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~D 229 (518)
....++++||+++|+|..++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 57889999999999999998653 4589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC
Q 010116 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (518)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 309 (518)
||+++.+....... ......|+..|+|||++.+
T Consensus 161 ~g~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~apE~~~~ 193 (280)
T cd05043 161 NALSRDLFPMDYHC-----------------------------------------------LGDNENRPVKWMALESLVN 193 (280)
T ss_pred CCCcccccCCceEE-----------------------------------------------eCCCCCcchhccCHHHHhc
Confidence 99998653221000 0012245678999999999
Q ss_pred CCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 310 KGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 310 ~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
..++.++|||||||++||+++ |.+||...++......+.. ...++....+++++.++|.+||+ ||++|| ++.
T Consensus 194 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ 267 (280)
T cd05043 194 KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD---GYRLAQPINCPDELFAVMACCWALDPEERP---SFS 267 (280)
T ss_pred CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc---CCCCCCCCcCCHHHHHHHHHHcCCChhhCC---CHH
Confidence 999999999999999999999 9999988877666554443 23333444678999999999998 999999 788
Q ss_pred hhhc
Q 010116 388 QIKA 391 (518)
Q Consensus 388 eil~ 391 (518)
+++.
T Consensus 268 ~~~~ 271 (280)
T cd05043 268 QLVQ 271 (280)
T ss_pred HHHH
Confidence 8874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=329.67 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=203.1
Q ss_pred CeeEEeeEeecCceEEEEEEE----ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--Ce
Q 010116 87 DFELLTIIGRGAFGEVRLCRE----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EY 160 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~ 160 (518)
-|++++.||+|+||.||+|+. +.++..||+|.++... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 478899999999999999974 4578899999986442 233456788999999999999999999998875 67
Q ss_pred EEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999999664 46899999999999999999999999999999999999999999999999998865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
... ........|+..|+|||++.+..++.++|+|
T Consensus 163 ~~~----------------------------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 196 (284)
T cd05079 163 KEY----------------------------------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVW 196 (284)
T ss_pred ccc----------------------------------------------eeecCCCCCCccccCHHHhccCCCCccccch
Confidence 100 0011134577889999999998999999999
Q ss_pred chhHHHHHHHhCCCCCCCCCh--------------hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC
Q 010116 320 SLGAIMYEMLVGYPPFYADDP--------------ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG 384 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~--------------~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~ 384 (518)
||||++|||++|..|+..... .......+. .....+....++..+.+||.+||. ||.+|+
T Consensus 197 slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 271 (284)
T cd05079 197 SFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE--EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT--- 271 (284)
T ss_pred hhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH--cCccCCCCCCCCHHHHHHHHHHccCCcccCc---
Confidence 999999999998877543211 111111121 122334445689999999999998 999999
Q ss_pred ChhhhhcC
Q 010116 385 GAHQIKAH 392 (518)
Q Consensus 385 ~a~eil~H 392 (518)
++.+|+.+
T Consensus 272 t~~~il~~ 279 (284)
T cd05079 272 TFQNLIEG 279 (284)
T ss_pred CHHHHHHH
Confidence 89998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=329.71 Aligned_cols=254 Identities=35% Similarity=0.559 Sum_probs=212.5
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
|++.+.||.|++|.||+|.+..+|+.+|+|.+..... .......+..|..+++.++||+|+++++++.+...+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6778999999999999999999999999999876532 223456778899999999999999999999999999999999
Q ss_pred cCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 168 LPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 168 ~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
+++ +|..++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------ 152 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------ 152 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------
Confidence 965 888888663 689999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccchhHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 325 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil 325 (518)
.......|+..|+|||.+.+. .++.++|+|||||++
T Consensus 153 -------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l 189 (283)
T cd05118 153 -------------------------------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF 189 (283)
T ss_pred -------------------------------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHH
Confidence 001124588899999999876 789999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCc-----------------ccCCC---------CCCCChhHHHHHHHHhc-ccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNH-----------------LKFPD---------DSKLSPEAKDLICRLLC-DVE 378 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~-----------------l~~p~---------~~~~s~~~~dLI~~lL~-dp~ 378 (518)
|+|++|++||.+.+..+...++...... ..++. ...++.++++||.+||. ||.
T Consensus 190 ~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 269 (283)
T cd05118 190 AELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269 (283)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcc
Confidence 9999999999888776665555432110 01111 12367899999999998 999
Q ss_pred ccCCCCChhhhhcCccc
Q 010116 379 HRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 379 ~R~g~~~a~eil~Hpff 395 (518)
+|+ ++.+++.||||
T Consensus 270 ~Rp---~~~~ll~~~~~ 283 (283)
T cd05118 270 KRI---TAEQALAHPYF 283 (283)
T ss_pred cCc---CHHHHhhCCCC
Confidence 999 89999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=323.16 Aligned_cols=246 Identities=20% Similarity=0.323 Sum_probs=206.2
Q ss_pred eeEeecCceEEEEEEEec-CCc--EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeec
Q 010116 92 TIIGRGAFGEVRLCREKK-SGN--IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL 168 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~-t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~ 168 (518)
+.||+|+||.||+|.+.. +++ .||+|++...... ...+.+..|..+++.++||||+++++.+.+ ..+|+||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876443 556788899999999999999999999998 8999999999
Q ss_pred CCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 169 PGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 169 ~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---- 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---- 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc----
Confidence 9999999997654 6899999999999999999999999999999999999999999999999999865321100
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
........|+..|+|||++.+..++.++|+|||||++|
T Consensus 154 ------------------------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~ 191 (257)
T cd05040 154 ------------------------------------------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLW 191 (257)
T ss_pred ------------------------------------------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHH
Confidence 00011345788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 327 EMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 327 eml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||++ |.+||...+..+....+......+ +....++..+.+||.+||+ +|.+|+ ++.+|+.
T Consensus 192 el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 253 (257)
T cd05040 192 EMFTYGEEPWAGLSGSQILKKIDKEGERL--ERPEACPQDIYNVMLQCWAHNPADRP---TFAALRE 253 (257)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCcC--CCCccCCHHHHHHHHHHCCCCcccCC---CHHHHHH
Confidence 9998 999998877777666665422223 3334678999999999998 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=316.81 Aligned_cols=263 Identities=25% Similarity=0.401 Sum_probs=216.5
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC---
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--- 158 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--- 158 (518)
.+..++|++.+.||.|||+.||+++...+++.||+|++.-. ...+++..++|++.-+.++||||++++++...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 35567899999999999999999999999999999988644 345678899999999999999999999876543
Q ss_pred --CeEEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCceeeCCCCcEEEeec
Q 010116 159 --EYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLSDF 230 (518)
Q Consensus 159 --~~lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~g--iiHRDIKPeNILld~~g~vKL~DF 230 (518)
...||+++|...|+|.+.+.. ...++|.++..|+.+++.||++||+.. ++||||||.|||+..+|.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 349999999999999999854 348999999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 310 (518)
|.+....-.. ..+.+..+++.|...+ -|..|+|||.+.-+
T Consensus 174 GS~~~a~i~i--------------------------------~~~~~a~~lQe~a~e~--------Ct~pyRAPELf~vk 213 (302)
T KOG2345|consen 174 GSATQAPIQI--------------------------------EGSRQALRLQEWAEER--------CTIPYRAPELFNVK 213 (302)
T ss_pred cCccccceEe--------------------------------echHHHHHHHHHHHHh--------CCCcccCchheecc
Confidence 9988653110 0123345667776553 57889999998754
Q ss_pred C---CCccccccchhHHHHHHHhCCCCCCCCCh--hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC
Q 010116 311 G---YGMECDWWSLGAIMYEMLVGYPPFYADDP--ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG 384 (518)
Q Consensus 311 ~---y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~ 384 (518)
. .+.++|||||||++|+|+.|..||...-. ....-.+.+ ..+.+|....+|..+..||+.||+ ||.+||
T Consensus 214 ~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n--~q~s~P~~~~yse~l~~lik~mlqvdP~qRP--- 288 (302)
T KOG2345|consen 214 SHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN--AQISIPNSSRYSEALHQLIKSMLQVDPNQRP--- 288 (302)
T ss_pred cCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec--cccccCCCCCccHHHHHHHHHHhcCCcccCC---
Confidence 3 58899999999999999999999943211 011112222 467888888899999999999998 999999
Q ss_pred ChhhhhcC
Q 010116 385 GAHQIKAH 392 (518)
Q Consensus 385 ~a~eil~H 392 (518)
++.+++.+
T Consensus 289 ~i~~ll~~ 296 (302)
T KOG2345|consen 289 TIPELLSK 296 (302)
T ss_pred CHHHHHHH
Confidence 88888764
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=324.79 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=207.9
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
+..++|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN- 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence 3457899999999999999999987654 3569999876542 133456788999999999999999999998764
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 578999999999999999764 4689999999999999999999999999999999999999999999999999876532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
.... ......+++.|+|||++....++.++|+
T Consensus 160 ~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 191 (270)
T cd05056 160 ESYY------------------------------------------------KASKGKLPIKWMAPESINFRRFTSASDV 191 (270)
T ss_pred ccce------------------------------------------------ecCCCCccccccChhhhccCCCCchhhh
Confidence 1000 0012235678999999998999999999
Q ss_pred cchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 319 WSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 319 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||++|||++ |.+||...+..+....+.+. ..+.. ...+++++.+||.+||. +|.+|+ ++.+++.
T Consensus 192 ~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp---t~~~~~~ 260 (270)
T cd05056 192 WMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-ERLPM--PPNCPPTLYSLMTKCWAYDPSKRP---RFTELKA 260 (270)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CcCCC--CCCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 999999999996 99999888776666555442 22333 34689999999999998 999999 7888775
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=324.32 Aligned_cols=247 Identities=22% Similarity=0.278 Sum_probs=195.1
Q ss_pred eeEeecCceEEEEEEEe--cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecC
Q 010116 92 TIIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999764 3567899998865432 2233468889999999999999999999999999999999999
Q ss_pred CCchHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 170 GGDMMTLLMRE-----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 170 gG~L~~~l~~~-----~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||+|.+++... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++++||+|||+++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 99999998643 24567788899999999999999999999999999999999999999999998643211000
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-------CCCcccc
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-------GYGMECD 317 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-------~y~~~~D 317 (518)
......+|++.|+|||++.+. .++.++|
T Consensus 157 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D 191 (269)
T cd05087 157 ---------------------------------------------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191 (269)
T ss_pred ---------------------------------------------ecCCCcCCcccccCHhHhccccccccccCCCccch
Confidence 001134688899999998642 3688999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCC---CCCChhHHHHHHHHhccccccCCCCChhhhhc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDD---SKLSPEAKDLICRLLCDVEHRLGTGGAHQIKA 391 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~---~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~ 391 (518)
+|||||++|||++ |.+||......+.....+.. ....++.+ ..+++.+.++|.+|+.+|.+|| ++++|..
T Consensus 192 iwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp---t~~~l~~ 265 (269)
T cd05087 192 VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-QQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRP---SAEEVHL 265 (269)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc-ccCCCCCCccCCCCChHHHHHHHHHhcCcccCC---CHHHHHH
Confidence 9999999999996 99999877665554443331 22223321 2467889999999988999999 8888763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=323.69 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=194.4
Q ss_pred eeEeecCceEEEEEEEec--CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecC
Q 010116 92 TIIGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996543 34568888765432 22334567889999999999999999999999999999999999
Q ss_pred CCchHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 170 GGDMMTLLMRED-----TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 170 gG~L~~~l~~~~-----~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
+|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 999999996542 3467888999999999999999999999999999999999999999999998643211000
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-------CCCCcccc
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-------KGYGMECD 317 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-------~~y~~~~D 317 (518)
.......+++.|+|||++.. ..++.++|
T Consensus 157 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D 191 (269)
T cd05042 157 ---------------------------------------------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191 (269)
T ss_pred ---------------------------------------------eccCCCCCcccccCHHHHhhccccccccccchhhH
Confidence 00113456788999999753 45788999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCC---CCCCChhHHHHHHHHhccccccCCCCChhhhhc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPD---DSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKA 391 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~---~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~ 391 (518)
||||||++|||++ |.+||..........+++.. ....+|. ...+++...+++..|+.||.+|+ ++++|+.
T Consensus 192 iwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rp---t~~~v~~ 265 (269)
T cd05042 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-QDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRP---TAEEVHE 265 (269)
T ss_pred HHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc-cCccCCCCcccccCCHHHHHHHHHHhcCccccc---CHHHHHH
Confidence 9999999999999 88899887766666655542 2223332 23578889999998888999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.30 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=201.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEE----ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee--cC
Q 010116 85 VDDFELLTIIGRGAFGEVRLCRE----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DT 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~--~~ 158 (518)
..+|++++.||+|+||.||+|.. ..++..||+|++.... ......+.+|+.+++.++||||+++++++. +.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35799999999999999999974 4578899999986542 344567889999999999999999998764 34
Q ss_pred CeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
..+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||++..+.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 5789999999999999999764 568999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
...... .......++..|+|||++.+..++.++|
T Consensus 160 ~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 193 (284)
T cd05081 160 QDKEYY----------------------------------------------KVREPGESPIFWYAPESLTESKFSVASD 193 (284)
T ss_pred CCCcce----------------------------------------------eecCCCCCceEeeCHHHhccCCcChHHH
Confidence 211000 0001123445699999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhh---------------HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccC
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPIT---------------TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~---------------~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 381 (518)
||||||++|||++|..|+....... ....++. ....++....++.++.+||.+||. +|.+|+
T Consensus 194 i~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 271 (284)
T cd05081 194 VWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK--NNGRLPAPPGCPAEIYAIMKECWNNDPSQRP 271 (284)
T ss_pred HHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh--cCCcCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 9999999999999987765432110 0111122 122334445688999999999998 999999
Q ss_pred CCCChhhhhc
Q 010116 382 GTGGAHQIKA 391 (518)
Q Consensus 382 g~~~a~eil~ 391 (518)
++.+|++
T Consensus 272 ---t~~ei~~ 278 (284)
T cd05081 272 ---SFSELAL 278 (284)
T ss_pred ---CHHHHHH
Confidence 8999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.37 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=201.6
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG 171 (518)
++||+|+||.||++... ++..||+|++.... .......+.+|+.+++.++||||+++++++.+....|+||||++||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999854 68899999986542 2223456888999999999999999999999999999999999999
Q ss_pred chHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccc
Q 010116 172 DMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (518)
Q Consensus 172 ~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 250 (518)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-------- 149 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-------- 149 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc--------
Confidence 999998653 56899999999999999999999999999999999999999999999999998754221000
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh
Q 010116 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 330 (518)
......+++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 150 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 150 ----------------------------------------SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred ----------------------------------------cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence 0001234678999999998889999999999999999998
Q ss_pred -CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 331 -GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 331 -G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|..||...........+... ....++ ..++..+.+||.+||. +|.+|+ ++.++++
T Consensus 190 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 246 (250)
T cd05085 190 LGVCPYPGMTNQQAREQVEKG-YRMSCP--QKCPDDVYKVMQRCWDYKPENRP---KFSELQK 246 (250)
T ss_pred CCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 99999888776666555432 222333 3688999999999998 999999 8888865
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.72 Aligned_cols=248 Identities=33% Similarity=0.485 Sum_probs=203.3
Q ss_pred eEEeeEeecCceEEEEEEEe----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 89 ELLTIIGRGAFGEVRLCREK----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 89 ~i~~~LG~G~fG~V~l~~~~----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.+.+.||.|+||.||.|... ..+..|+||+++.. ......+.+.+|.++++.++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999988 45678999999542 2233467889999999999999999999999988889999
Q ss_pred EeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 165 MEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||||++|+|.++|... ..+++.....++.|++.||.|||+++|+|+||+|+|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999876 78999999999999999999999999999999999999999999999999999865211100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
.......+...|+|||++....++.++||||||
T Consensus 160 -----------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG 192 (259)
T PF07714_consen 160 -----------------------------------------------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFG 192 (259)
T ss_dssp -----------------------------------------------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHH
T ss_pred -----------------------------------------------ccccccccccccccccccccccccccccccccc
Confidence 011234567889999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 323 AIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 323 vilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+++|||++ |..||...+......++... ..+.+| ..++..+.++|.+||. ||.+|| ++.+|++
T Consensus 193 ~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~C~~~~p~~RP---s~~~i~~ 257 (259)
T PF07714_consen 193 MLLYEILTLGKFPFSDYDNEEIIEKLKQG-QRLPIP--DNCPKDIYSLIQQCWSHDPEKRP---SFQEILQ 257 (259)
T ss_dssp HHHHHHHTTSSGTTTTSCHHHHHHHHHTT-EETTSB--TTSBHHHHHHHHHHT-SSGGGS-----HHHHHH
T ss_pred ccccccccccccccccccccccccccccc-ccceec--cchhHHHHHHHHHHcCCChhhCc---CHHHHHh
Confidence 99999999 78999888887777777442 233333 4689999999999998 999999 8998864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=331.29 Aligned_cols=258 Identities=25% Similarity=0.429 Sum_probs=210.0
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC--C----ceeEEEEE
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS--H----CIVKLYYS 154 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p----~Iv~l~~~ 154 (518)
+.....+|.+++.+|+|+||+|-.|++..++..||+|+++.-. ...+..+-|+++|..+.+ | .+|.+.++
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3344678999999999999999999999999999999986532 334566779999999942 2 38899999
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-----------
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK----------- 221 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~----------- 221 (518)
|.-.++.|||+|.+ |-+++++|..+ .+++...++.++.|++.++++||+.+++|.||||||||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999999 88999999775 47999999999999999999999999999999999999842
Q ss_pred ---------CCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccc
Q 010116 222 ---------NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLA 292 (518)
Q Consensus 222 ---------~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (518)
+-+|||+|||.|...... -
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~----------------------------------------------------h 266 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEH----------------------------------------------------H 266 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccC----------------------------------------------------c
Confidence 346899999988753211 1
Q ss_pred ccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhh---HHHHHhh----------------hcCc
Q 010116 293 FSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPIT---TCRKIVH----------------WRNH 353 (518)
Q Consensus 293 ~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~----------------~~~~ 353 (518)
.+.|.|..|.||||+++-|++.+|||||+||||+|+.+|...|+..+..+ +...|+. .++.
T Consensus 267 s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~r 346 (415)
T KOG0671|consen 267 STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGR 346 (415)
T ss_pred ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhccc
Confidence 36789999999999999999999999999999999999999999877555 3333332 0011
Q ss_pred ccCCCC-----------------------CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 354 LKFPDD-----------------------SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 354 l~~p~~-----------------------~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
+..|+. ..--.++.|||++||. ||.+|+ ++.|++.||||+..
T Consensus 347 ldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri---Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 347 LDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI---TLREALSHPFFARL 412 (415)
T ss_pred ccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc---cHHHHhcCHHhhcC
Confidence 121110 0012347799999999 999999 99999999999853
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=325.98 Aligned_cols=236 Identities=19% Similarity=0.284 Sum_probs=193.3
Q ss_pred eeEeecCceEEEEEEEecCCcE-------EEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 92 TIIGRGAFGEVRLCREKKSGNI-------YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~-------~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
+.||+|+||.||+|.++.++.. ||+|.+.+.. ....+.+..|..+++.++||||+++++++.+....|+|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 3689999999999988665443 8888875542 33456678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc--------EEEeecccccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH--------MKLSDFGLCKP 235 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~--------vKL~DFGla~~ 235 (518)
|||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999999764 46899999999999999999999999999999999999988775 58889888754
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGM 314 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~ 314 (518)
... .....||+.|+|||++.+ ..++.
T Consensus 158 ~~~-----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ 184 (258)
T cd05078 158 VLP-----------------------------------------------------KEILLERIPWVPPECIENPQNLSL 184 (258)
T ss_pred cCC-----------------------------------------------------chhccccCCccCchhccCCCCCCc
Confidence 311 013468899999999987 45899
Q ss_pred cccccchhHHHHHHHhC-CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 315 ECDWWSLGAIMYEMLVG-YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G-~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
++|||||||++|||++| .+||...++..... +.. ....+|. ..+.++.+||.+||. ||.+|+ ++++|++
T Consensus 185 ~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 255 (258)
T cd05078 185 AADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPA--PKWTELANLINQCMDYEPDFRP---SFRAIIR 255 (258)
T ss_pred hhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCC--CCcHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 99999999999999998 46766655544332 222 2344443 467899999999998 999999 8999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.55 Aligned_cols=254 Identities=18% Similarity=0.286 Sum_probs=206.6
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCc----EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
+..++|++++.||+|+||.||+|.+..+|. .+|+|.+..... ......+.+|..+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345789999999999999999999888776 468888765422 22334578899999999999999999998764
Q ss_pred CeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
..++|+||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 477999999999999998764 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
..... .......++..|+|||++.+..++.++|
T Consensus 161 ~~~~~-----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (303)
T cd05110 161 GDEKE-----------------------------------------------YNADGGKMPIKWMALECIHYRKFTHQSD 193 (303)
T ss_pred Ccccc-----------------------------------------------cccCCCccccccCCHHHhccCCCChHHH
Confidence 21000 0011234678999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||||++|||++ |..||.+........ ++... ..++.....+..+.++|.+|+. +|.+|+ ++.+++..
T Consensus 194 iwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~l~~~ 264 (303)
T cd05110 194 VWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKG--ERLPQPPICTIDVYMVMVKCWMIDADSRP---KFKELAAE 264 (303)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCC--CCCCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999999997 999998776544443 33322 2333334678899999999998 999999 88888774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.83 Aligned_cols=242 Identities=20% Similarity=0.347 Sum_probs=203.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++.+.||+|+||.||++. .+++.||+|++.... ....+.+|+.+++.++||||+++++++..+. +|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEE
Confidence 45789999999999999999875 578899999986432 2356888999999999999999999987654 799
Q ss_pred EEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 164 IMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
||||++||+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.+|.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997643 5899999999999999999999999999999999999999999999999998753211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.....++..|+|||++.+..++.++|+|||
T Consensus 154 --------------------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 183 (254)
T cd05083 154 --------------------------------------------------VDNSKLPVKWTAPEALKHKKFSSKSDVWSY 183 (254)
T ss_pred --------------------------------------------------CCCCCCCceecCHHHhccCCcCchhhHHHH
Confidence 001234568999999998999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 322 GAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 322 Gvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||++|||++ |.+||...+.......+... ...+....+++++.+||.+||. +|.+|| ++.+|+.
T Consensus 184 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 249 (254)
T cd05083 184 GVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYVLMTSCWETEPKKRP---SFHKLRE 249 (254)
T ss_pred HHHHHHHHhCCCCCCccCCHHHHHHHHhCC---CCCCCCCcCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 999999997 99999988776666555432 2222234688999999999998 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.99 Aligned_cols=247 Identities=19% Similarity=0.306 Sum_probs=197.4
Q ss_pred eeEeecCceEEEEEEEec---CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee-cCCeEEEEEee
Q 010116 92 TIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DTEYLYLIMEY 167 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-~~~~lylVmEy 167 (518)
+.||+|+||.||+|.... .+..||+|.+... ......+.+..|..+++.++||||+++++++. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998754 3457999987542 12334567888999999999999999999765 56678999999
Q ss_pred cCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 168 LPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 168 ~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~-- 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV-- 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee--
Confidence 9999999999764 4567788888999999999999999999999999999999999999999999875432110000
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
.......+++.|+|||++.+..++.++|||||||++|
T Consensus 157 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 193 (262)
T cd05058 157 -------------------------------------------HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 193 (262)
T ss_pred -------------------------------------------cccccCcCCccccChhHhccCccchHHHHHHHHHHHH
Confidence 0011234678999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 327 EMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 327 eml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||++ |.+||...+.......+..+ ..+..+ ..+++.+.++|.+||. +|.+|| ++.+|+.
T Consensus 194 el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~il~ 254 (262)
T cd05058 194 ELMTRGAPPYPDVDSFDITVYLLQG-RRLLQP--EYCPDPLYEVMLSCWHPKPEMRP---TFSELVS 254 (262)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CcCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 9999 57778777766666555443 222222 3578999999999998 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.54 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=201.7
Q ss_pred eeEeecCceEEEEEEEecCC------cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 92 TIIGRGAFGEVRLCREKKSG------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
+.||+|+||.||+|+.+... ..||+|.+.+.. .......+.+|..+++.++||||+++++++.+....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999886544 689999886542 1234556788999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-----cEEEeecccc
Q 010116 166 EYLPGGDMMTLLMRE-------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-----HMKLSDFGLC 233 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~-------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-----~vKL~DFGla 233 (518)
||++||+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999642 3478899999999999999999999999999999999999888 8999999998
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
+........ .......++..|+|||++.+..++
T Consensus 159 ~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 191 (269)
T cd05044 159 RDIYKSDYY-----------------------------------------------RKEGEGLLPVRWMAPESLLDGKFT 191 (269)
T ss_pred ccccccccc-----------------------------------------------ccCcccCCCccccCHHHHccCCcc
Confidence 865321100 000123467889999999999999
Q ss_pred ccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 314 MECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
.++|||||||++|||++ |..||...+.......+... ..+.. ...+|..+.+||.+||. +|.+|+ ++.+|+.
T Consensus 192 ~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 265 (269)
T cd05044 192 TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQK--PENCPDKIYQLMTNCWAQDPSERP---TFDRIQE 265 (269)
T ss_pred cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCC--cccchHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 99999999999999998 99999887776666655431 22233 34688999999999998 999999 8888764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=365.55 Aligned_cols=270 Identities=30% Similarity=0.464 Sum_probs=204.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------- 157 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------- 157 (518)
..||+.+..||+||||.||+|+++-+|..||||+|.... .......+.+|+.+|++++|||||+.|.+|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 468999999999999999999999999999999997654 44556678999999999999999999976510
Q ss_pred --------------------------------------------------------------------------------
Q 010116 158 -------------------------------------------------------------------------------- 157 (518)
Q Consensus 158 -------------------------------------------------------------------------------- 157 (518)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEeecCCCchHHHHhhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 010116 158 ------------------------T--------EYLYLIMEYLPGGDMMTLLMREDTL-TENVARFYIAQSVLAIESIHK 204 (518)
Q Consensus 158 ------------------------~--------~~lylVmEy~~gG~L~~~l~~~~~l-~e~~~~~~~~ql~~aL~~LH~ 204 (518)
+ ..+||-||||+...+.+++.++... .-+.++.+++||+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 2489999999887777777655444 478899999999999999999
Q ss_pred CCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHH
Q 010116 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHW 284 (518)
Q Consensus 205 ~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (518)
.|||||||||.||+||++++|||+|||+|+........ .+....+.....++
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~----------------~d~~~~~~~~~~g~------------ 767 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLES----------------IDQDLSFSTNRAGS------------ 767 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhh----------------HhhccCccccccCC------------
Confidence 99999999999999999999999999999863210000 00000000000000
Q ss_pred hhhcccccccccCCCCccChhhhcCCC---CCccccccchhHHHHHHHhCCCCCCCC-ChhhHHHHHhhhcCcccCC---
Q 010116 285 QMNRRKLAFSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYAD-DPITTCRKIVHWRNHLKFP--- 357 (518)
Q Consensus 285 ~~~~~~~~~s~~GT~~Y~APEvl~~~~---y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~l~~p--- 357 (518)
.....++.+||.-|+|||++.+.. |+.++|+||||||+|||+ .||... ....++.++. ...+++|
T Consensus 768 ---~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR--~g~iP~~~~f 839 (1351)
T KOG1035|consen 768 ---NDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLR--KGSIPEPADF 839 (1351)
T ss_pred ---CCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcc--cCCCCCCccc
Confidence 011234789999999999998754 999999999999999999 457543 2223333332 2334444
Q ss_pred CCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 358 DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 358 ~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
.... -+....+|+.||. ||.+|| ||.|+|++.||-
T Consensus 840 ~~~~-~~~e~slI~~Ll~hdP~kRP---tA~eLL~s~llp 875 (1351)
T KOG1035|consen 840 FDPE-HPEEASLIRWLLSHDPSKRP---TATELLNSELLP 875 (1351)
T ss_pred cccc-chHHHHHHHHHhcCCCccCC---CHHHHhhccCCC
Confidence 1112 2556789999998 999999 899999999997
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=320.35 Aligned_cols=237 Identities=21% Similarity=0.245 Sum_probs=191.1
Q ss_pred eeEeecCceEEEEEEEecC------------CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 92 TIIGRGAFGEVRLCREKKS------------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t------------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
+.||+|+||.||++....+ ...+|+|++.... ......+..|..+++.++||||+++++++.+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999975322 2358888876542 233456778899999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc-------EEEeecc
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-------MKLSDFG 231 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~-------vKL~DFG 231 (518)
..|+||||+++|+|..++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|. +||+|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999888653 67999999999999999999999999999999999999987764 8999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-CC
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KK 310 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-~~ 310 (518)
++...... ...+||+.|+|||++. +.
T Consensus 158 ~~~~~~~~-----------------------------------------------------~~~~~~~~y~aPE~~~~~~ 184 (262)
T cd05077 158 IPITVLSR-----------------------------------------------------QECVERIPWIAPECVEDSK 184 (262)
T ss_pred CCccccCc-----------------------------------------------------ccccccccccChhhhcCCC
Confidence 87643210 1346888999999987 46
Q ss_pred CCCccccccchhHHHHHHH-hCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhh
Q 010116 311 GYGMECDWWSLGAIMYEML-VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ 388 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml-~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~e 388 (518)
.++.++|||||||++|||+ .|..||......+.. .... ..... ....++++.+||.+||. ||.+|| ++.+
T Consensus 185 ~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~--~~~~~--~~~~~~~~~~li~~cl~~dp~~Rp---~~~~ 256 (262)
T cd05077 185 NLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYE--GQCML--VTPSCKELADLMTHCMNYDPNQRP---FFRA 256 (262)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHh--cCccC--CCCChHHHHHHHHHHcCCChhhCc---CHHH
Confidence 7899999999999999998 588898776543332 2222 12222 22356889999999998 999999 8999
Q ss_pred hhcC
Q 010116 389 IKAH 392 (518)
Q Consensus 389 il~H 392 (518)
|+.+
T Consensus 257 il~~ 260 (262)
T cd05077 257 IMRD 260 (262)
T ss_pred HHHh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=319.74 Aligned_cols=251 Identities=29% Similarity=0.513 Sum_probs=208.5
Q ss_pred CeeEEeeEeecCceEEEEEEEec-CCcEEEEEEeechhh-------hchhhHHHHHHHHHHHHH-hCCCceeEEEEEeec
Q 010116 87 DFELLTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKSEM-------VKRGQVEHVRAERNLLAE-VASHCIVKLYYSFQD 157 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~-t~~~~AiK~l~k~~~-------~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~f~~ 157 (518)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+..|..++.. ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 788999998864321 223345567778888765 799999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeeccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGl 232 (518)
.+.+|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3579999999999999999999996 7899999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 312 (518)
+....... ......|+..|+|||++.+..+
T Consensus 161 ~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~ 190 (269)
T cd08528 161 AKQKQPES--------------------------------------------------KLTSVVGTILYSCPEIVKNEPY 190 (269)
T ss_pred eeeccccc--------------------------------------------------ccccccCcccCcChhhhcCCCC
Confidence 87543110 1124568999999999998889
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+.++|+|||||++|+|++|.+||...+.......+.... ........+++++.+||.+||. ||.+|| ++.|+.+
T Consensus 191 ~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~e~~~ 265 (269)
T cd08528 191 GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV--YEPLPEGMYSEDVTDVITSCLTPDAEARP---DIIQVSA 265 (269)
T ss_pred chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc--CCcCCcccCCHHHHHHHHHHCCCCCccCC---CHHHHHH
Confidence 999999999999999999999998887776666665422 1111123578999999999998 999999 7888765
Q ss_pred C
Q 010116 392 H 392 (518)
Q Consensus 392 H 392 (518)
+
T Consensus 266 ~ 266 (269)
T cd08528 266 M 266 (269)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=320.98 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=205.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEe----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec--C
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREK----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--T 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~ 158 (518)
..+|++++.||+|+||.||+|+.. .+++.||+|++.+.... .....+.+|+.+++.+.||||+++++++.+ .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357889999999999999999864 35889999999765332 356678999999999999999999999887 6
Q ss_pred CeEEEEEeecCCCchHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~-~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
...|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 68999999999999999997654 69999999999999999999999999999999999999999999999999988654
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
...... .......++..|+|||.+.+..++.++|
T Consensus 161 ~~~~~~----------------------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D 194 (284)
T cd05038 161 EDKDYY----------------------------------------------YVKEPGESPIFWYAPECLRTSKFSSASD 194 (284)
T ss_pred cCCcce----------------------------------------------eccCCCCCcccccCcHHHccCCCCcccc
Confidence 211000 0001123556799999999889999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhh--------------HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPIT--------------TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~--------------~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
+|||||++|||++|..||....... .....+. ....++....++.++.+||.+||. +|.+|+
T Consensus 195 i~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp- 271 (284)
T cd05038 195 VWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK--EGERLPRPPSCPDEVYDLMKLCWEAEPQDRP- 271 (284)
T ss_pred hHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH--cCCcCCCCccCCHHHHHHHHHHhccChhhCC-
Confidence 9999999999999999987643221 1112222 223344445678899999999998 999999
Q ss_pred CCChhhhhc
Q 010116 383 TGGAHQIKA 391 (518)
Q Consensus 383 ~~~a~eil~ 391 (518)
++.+|++
T Consensus 272 --t~~ei~~ 278 (284)
T cd05038 272 --SFADLIL 278 (284)
T ss_pred --CHHHHHH
Confidence 8888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=354.04 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=219.8
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 153 (518)
....+...+-+..+.||+|+||+||+|+.. .....||||.++... .......+++|+++|+.++|||||+|++
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 345567788899999999999999999854 234679999998653 3335678999999999999999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE--------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 219 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~--------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl 219 (518)
++..++.+|||+|||..|||..+|... ..|+..+...++.||+.|++||-++.+|||||...|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 999999999999999999999999532 127788889999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCC
Q 010116 220 DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299 (518)
Q Consensus 220 d~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~ 299 (518)
.++-.|||+||||++.+..++.+....+ ..=..
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~-----------------------------------------------t~lPI 669 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGN-----------------------------------------------TLLPI 669 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCC-----------------------------------------------ceeee
Confidence 9999999999999998766554432211 11235
Q ss_pred CccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cc
Q 010116 300 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 300 ~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp 377 (518)
.||+||.|....|+.++||||+||+|||+++ |..|+++.+..+.+..|.+.+ -+.-| ..++.++.+|+..|+. +|
T Consensus 670 RWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~-lL~~P--e~CP~~vY~LM~~CW~~~P 746 (774)
T KOG1026|consen 670 RWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ-LLSCP--ENCPTEVYSLMLECWNENP 746 (774)
T ss_pred ecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC-cccCC--CCCCHHHHHHHHHHhhcCc
Confidence 8999999999999999999999999999998 999999999999999888753 24444 5899999999999998 99
Q ss_pred cccCCCCChhhhh
Q 010116 378 EHRLGTGGAHQIK 390 (518)
Q Consensus 378 ~~R~g~~~a~eil 390 (518)
.+|| ++.||-
T Consensus 747 ~~RP---sF~eI~ 756 (774)
T KOG1026|consen 747 KRRP---SFKEIH 756 (774)
T ss_pred ccCC---CHHHHH
Confidence 9999 666653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=319.99 Aligned_cols=263 Identities=30% Similarity=0.432 Sum_probs=213.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee--------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-------- 156 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-------- 156 (518)
.+.|+.+.+||+|.||+||+|+.+.+|+.||+|++--. ..+.+.-....+|+.+|..++|+|++.|+..+.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-neKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 45677788999999999999999999999999865321 123344456778999999999999999887663
Q ss_pred cCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
+...+||||.+|. -||..+|... .+++..+++.++.++..||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 3345999999995 5999999765 6899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGM 314 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~ 314 (518)
+..+.... ...-+..|-|.+|++||.+++ ..|+.
T Consensus 174 fs~~~n~~---------------------------------------------kprytnrvvTLwYrppEllLG~r~yg~ 208 (376)
T KOG0669|consen 174 FSTSKNVV---------------------------------------------KPRYTNRVVTLWYRPPELLLGDREYGP 208 (376)
T ss_pred eecccccC---------------------------------------------CCCcccceeeeecCCHHHhhcccccCC
Confidence 75332110 001234678999999999997 67999
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhh---------hcCccc-----------CCCC-----------CCCC
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLK-----------FPDD-----------SKLS 363 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---------~~~~l~-----------~p~~-----------~~~s 363 (518)
+.|+|..||||.||.+|.+-|.+++...++..|.. |...-. .|.. -.-.
T Consensus 209 ~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd 288 (376)
T KOG0669|consen 209 PIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKD 288 (376)
T ss_pred cchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCC
Confidence 99999999999999999999999988887776654 221111 1110 0114
Q ss_pred hhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 364 PEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 364 ~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+++.||+.+||. ||.+|+ .+.++++|.||..
T Consensus 289 ~~a~dLle~ll~~DP~kR~---~ad~alnh~~F~k 320 (376)
T KOG0669|consen 289 DEALDLLEKLLKLDPTKRI---DADQALNHDFFWK 320 (376)
T ss_pred hhHHHHHHHHhccCcccCc---chHhhhchhhhhc
Confidence 689999999999 999999 8999999999964
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=320.93 Aligned_cols=236 Identities=19% Similarity=0.239 Sum_probs=191.6
Q ss_pred eEeecCceEEEEEEEecC------------------------CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCce
Q 010116 93 IIGRGAFGEVRLCREKKS------------------------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148 (518)
Q Consensus 93 ~LG~G~fG~V~l~~~~~t------------------------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~I 148 (518)
.||+|+||.||++....+ ...+|+|++.... ......+.+|..+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999875432 2358899886542 2334567788999999999999
Q ss_pred eEEEEEeecCCeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC----
Q 010116 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---- 223 (518)
Q Consensus 149 v~l~~~f~~~~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g---- 223 (518)
+++++++.+....|+||||++||+|..++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.+|
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 46789999999999999999999999999999999999998654
Q ss_pred ---cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCC
Q 010116 224 ---HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPD 300 (518)
Q Consensus 224 ---~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~ 300 (518)
.+||+|||++...... ....|++.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----------------------------------------------------~~~~~~~~ 185 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----------------------------------------------------EERVERIP 185 (274)
T ss_pred ccceeeecCCccccccccc-----------------------------------------------------cccccCCc
Confidence 4899999987642100 12357888
Q ss_pred ccChhhhcC-CCCCccccccchhHHHHHHH-hCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cc
Q 010116 301 YIAPEVLLK-KGYGMECDWWSLGAIMYEML-VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 301 Y~APEvl~~-~~y~~~~DiWSlGvilyeml-~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp 377 (518)
|+|||++.+ ..++.++|+|||||++|||+ +|.+||....+..... ... ....+|. ..++++.+||.+||+ +|
T Consensus 186 ~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~cl~~~p 260 (274)
T cd05076 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE--KKHRLPE--PSCKELATLISQCLTYEP 260 (274)
T ss_pred ccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH--hccCCCC--CCChHHHHHHHHHcccCh
Confidence 999999876 56899999999999999995 6999998776654432 222 1233443 356789999999998 99
Q ss_pred cccCCCCChhhhhcC
Q 010116 378 EHRLGTGGAHQIKAH 392 (518)
Q Consensus 378 ~~R~g~~~a~eil~H 392 (518)
.+|+ ++.+|+++
T Consensus 261 ~~Rp---s~~~il~~ 272 (274)
T cd05076 261 TQRP---SFRTILRD 272 (274)
T ss_pred hhCc---CHHHHHHh
Confidence 9999 89999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=315.94 Aligned_cols=234 Identities=21% Similarity=0.261 Sum_probs=192.3
Q ss_pred eeEeecCceEEEEEEEecCC----------cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 92 TIIGRGAFGEVRLCREKKSG----------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~----------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
+.||+|+||.||++.+..++ ..+++|++..... ....+.+|..+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998777 3477787654431 15678889999999999999999999988 778
Q ss_pred EEEEeecCCCchHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-------cEEEeecccc
Q 010116 162 YLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-------HMKLSDFGLC 233 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~-~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-------~vKL~DFGla 233 (518)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ ++||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999997765 799999999999999999999999999999999999999988 8999999998
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC--C
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--G 311 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--~ 311 (518)
...... ...+|+..|+|||++.+. .
T Consensus 156 ~~~~~~-----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~ 182 (259)
T cd05037 156 ITVLSR-----------------------------------------------------EERVERIPWIAPECIRNGQAS 182 (259)
T ss_pred cccccc-----------------------------------------------------cccccCCCccChhhhcCCCCC
Confidence 754210 124577889999999876 7
Q ss_pred CCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhh
Q 010116 312 YGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI 389 (518)
Q Consensus 312 y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei 389 (518)
++.++|+|||||++|+|++ |..||...+......... .......+ .+..+.+||.+||. +|.+|+ ++.+|
T Consensus 183 ~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp---t~~~i 254 (259)
T cd05037 183 LTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP----DCAELANLINQCWTYDPTKRP---SFRAI 254 (259)
T ss_pred cchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC----CchHHHHHHHHHhccChhhCC---CHHHH
Confidence 8999999999999999999 688887765433322222 11222222 24789999999998 999999 88888
Q ss_pred hc
Q 010116 390 KA 391 (518)
Q Consensus 390 l~ 391 (518)
++
T Consensus 255 l~ 256 (259)
T cd05037 255 LR 256 (259)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=318.33 Aligned_cols=251 Identities=23% Similarity=0.393 Sum_probs=204.5
Q ss_pred eeEEeeEeecCceEEEEEEEec---CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----
Q 010116 88 FELLTIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 159 (518)
|.+.++||+|+||.||+|..+. +++.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6778899999999999998653 57899999986543 23345667889999999999999999999886532
Q ss_pred -eEEEEEeecCCCchHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccc
Q 010116 160 -YLYLIMEYLPGGDMMTLLMRE------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (518)
Q Consensus 160 -~lylVmEy~~gG~L~~~l~~~------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGl 232 (518)
..++++||+++|+|..++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999998887432 2578999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 312 (518)
++........ .......+++.|++||.+.+..+
T Consensus 160 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05074 160 SKKIYSGDYY-----------------------------------------------RQGCASKLPVKWLALESLADNVY 192 (273)
T ss_pred cccccCCcce-----------------------------------------------ecCCCccCchhhcCHhHHhcCcc
Confidence 8865321100 00112346678999999999999
Q ss_pred CccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 313 GMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
+.++|||||||++|||++ |.+||.+.+.......+..+. .+..+ ..++..+.+|+.+||. +|.+|+ ++.+++
T Consensus 193 ~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---s~~~~~ 266 (273)
T cd05074 193 TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQP--PDCLEDVYELMCQCWSPEPKCRP---SFQHLR 266 (273)
T ss_pred chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHH
Confidence 999999999999999999 999999888777776666532 22222 3578999999999998 999999 888887
Q ss_pred cC
Q 010116 391 AH 392 (518)
Q Consensus 391 ~H 392 (518)
.+
T Consensus 267 ~~ 268 (273)
T cd05074 267 DQ 268 (273)
T ss_pred HH
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=322.11 Aligned_cols=258 Identities=17% Similarity=0.149 Sum_probs=190.8
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecC---CcEEEEEEeechhhhchhhH--------HHHHHHHHHHHHhCCCceeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQV--------EHVRAERNLLAEVASHCIVKL 151 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~--------~~~~~E~~il~~l~hp~Iv~l 151 (518)
+..++|++.++||+|+||.||+|++..+ +..+|+|+............ .....+...+..++|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999998877 67788886432211100000 111122334456689999999
Q ss_pred EEEeecCC----eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEE
Q 010116 152 YYSFQDTE----YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKL 227 (518)
Q Consensus 152 ~~~f~~~~----~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL 227 (518)
++++.... ..|++||++ ..++.+.+.....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 457899988 4567777766666789999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhh
Q 010116 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (518)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 307 (518)
+|||+|+.+........ .........+||+.|+|||++
T Consensus 168 ~DFGla~~~~~~~~~~~------------------------------------------~~~~~~~~~~gt~~y~ape~~ 205 (294)
T PHA02882 168 IDYGIASHFIIHGKHIE------------------------------------------YSKEQKDLHRGTLYYAGLDAH 205 (294)
T ss_pred EEcCCceeeccCCcccc------------------------------------------cccccccccCCCccccCHHHh
Confidence 99999986532110000 000011245799999999999
Q ss_pred cCCCCCccccccchhHHHHHHHhCCCCCCCCChhhH-H--------HHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cc
Q 010116 308 LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITT-C--------RKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 308 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~--------~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp 377 (518)
.+..|+.++|||||||++|||++|.+||.+...... . .++.. ....+ ...++++.+++..|+. +|
T Consensus 206 ~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 206 NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE--GKIKI---KNANKFIYDFIECVTKLSY 280 (294)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh--hhhcc---CCCCHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999987633221 1 11111 11222 2467899999999998 99
Q ss_pred cccCCCCChhhhhc
Q 010116 378 EHRLGTGGAHQIKA 391 (518)
Q Consensus 378 ~~R~g~~~a~eil~ 391 (518)
.+|| +..+|++
T Consensus 281 ~~rp---~~~~l~~ 291 (294)
T PHA02882 281 EEKP---DYDALIK 291 (294)
T ss_pred CCCC---CHHHHHH
Confidence 9999 7888764
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=315.97 Aligned_cols=247 Identities=17% Similarity=0.238 Sum_probs=193.7
Q ss_pred eeEeecCceEEEEEEEecCC--cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecC
Q 010116 92 TIIGRGAFGEVRLCREKKSG--NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~--~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
+.||+|+||.||+++...++ ..+++|.+.... .....+.+.+|..+++.++||||+++++.|.+...+|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 36899999999999764332 345666655432 12345678899999999999999999999999999999999999
Q ss_pred CCchHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 170 GGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 170 gG~L~~~l~~~----~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||+|.+++.+. ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++++||+|||++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 99999999753 3467778889999999999999999999999999999999999999999999764211100
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-------CCCCccccc
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-------KGYGMECDW 318 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-------~~y~~~~Di 318 (518)
.......+|++.|+|||++.. ..++.++||
T Consensus 155 -------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Di 191 (268)
T cd05086 155 -------------------------------------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNV 191 (268)
T ss_pred -------------------------------------------hhcccCCcCcccccCchhcccccCccccCCCCCcchh
Confidence 001124578999999999853 345789999
Q ss_pred cchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCC---CCCCChhHHHHHHHHhccccccCCCCChhhhhc
Q 010116 319 WSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPD---DSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKA 391 (518)
Q Consensus 319 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~---~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil~ 391 (518)
|||||++|||++ |.+||...+..+....+.... ....+. ...+++.+.++|..|+.+|.+|| ++.+|++
T Consensus 192 wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp---~~~~i~~ 264 (268)
T cd05086 192 WALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ-QVKLFKPQLELPYSERWYEVLQFCWLSPEKRA---TAEEVHR 264 (268)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc-ccccCCCccCCCCcHHHHHHHHHHhhCcccCC---CHHHHHH
Confidence 999999999997 577888777766666655422 122111 23478899999999998999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.44 Aligned_cols=263 Identities=30% Similarity=0.501 Sum_probs=227.9
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEee-
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ- 156 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~- 156 (518)
.......+-|+++.+||.|.+|.||+++++.+|+..|+|++.... +.-+.+..|.+||+.. +|||++.+|++|.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344556788999999999999999999999999999999986543 2235577899999877 6999999999985
Q ss_pred ----cCCeEEEEEeecCCCchHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeec
Q 010116 157 ----DTEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (518)
Q Consensus 157 ----~~~~lylVmEy~~gG~L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DF 230 (518)
..+.++||||||.||+.-++++. ...+.|..+..++.+++.||.+||.+.+||||||-.|||++.+|.|||+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 45689999999999999999865 468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK- 309 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~- 309 (518)
|++..++.. +....+.+|||.||||||+..
T Consensus 168 GvSaQldsT-------------------------------------------------~grRnT~iGtP~WMAPEViac~ 198 (953)
T KOG0587|consen 168 GVSAQLDST-------------------------------------------------VGRRNTFIGTPYWMAPEVIACD 198 (953)
T ss_pred eeeeeeecc-------------------------------------------------cccccCcCCCcccccceeeecc
Confidence 999876532 123457899999999999975
Q ss_pred ----CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC
Q 010116 310 ----KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG 384 (518)
Q Consensus 310 ----~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~ 384 (518)
..|+..||+||||++..||--|.||+.+.-+...+.+|-.. .++++..+.++|.++.|||..||. |-++|+
T Consensus 199 e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP--- 274 (953)
T KOG0587|consen 199 ESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKRPKKWSKKFNDFISTCLVKDYEQRP--- 274 (953)
T ss_pred cCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccccchhhHHHHHHHHHHHHHhhccccCc---
Confidence 34889999999999999999999999999998888777652 345555567889999999999997 999999
Q ss_pred ChhhhhcCcccccC
Q 010116 385 GAHQIKAHPWFKDV 398 (518)
Q Consensus 385 ~a~eil~Hpff~~i 398 (518)
...+++.|||...-
T Consensus 275 ~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 275 STEELLKHPFITEQ 288 (953)
T ss_pred chhhhccCCccccc
Confidence 89999999999843
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=348.90 Aligned_cols=264 Identities=21% Similarity=0.331 Sum_probs=185.1
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecC----CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEE-
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKS----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS- 154 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~- 154 (518)
+.....++|++.+.||+|+||.||+|++..+ +..||+|++.... ..+....++ +....+.+++.+...
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e~--l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNER--VRRACPNSCADFVYGF 198 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHHH--HHhhchhhHHHHHHhh
Confidence 4556789999999999999999999999988 9999999876432 111111111 122222222222222
Q ss_pred -----eecCCeEEEEEeecCCCchHHHHhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCeEE
Q 010116 155 -----FQDTEYLYLIMEYLPGGDMMTLLMREDT--------------------LTENVARFYIAQSVLAIESIHKHNYIH 209 (518)
Q Consensus 155 -----f~~~~~lylVmEy~~gG~L~~~l~~~~~--------------------l~e~~~~~~~~ql~~aL~~LH~~giiH 209 (518)
..+...++|||||+++|+|.+++..... ..+..++.++.|++.||.|||++||||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456679999999999999999865321 123456789999999999999999999
Q ss_pred cCCCCCceeeCC-CCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhc
Q 010116 210 RDIKPDNLLLDK-NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNR 288 (518)
Q Consensus 210 RDIKPeNILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (518)
|||||+|||++. ++.+||+|||+|+.+.....
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~----------------------------------------------- 311 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----------------------------------------------- 311 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccc-----------------------------------------------
Confidence 999999999986 68999999999986532110
Q ss_pred ccccccccCCCCccChhhhcCC----------------------CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHH
Q 010116 289 RKLAFSTVGTPDYIAPEVLLKK----------------------GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRK 346 (518)
Q Consensus 289 ~~~~~s~~GT~~Y~APEvl~~~----------------------~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~ 346 (518)
......+||+.|||||++... .|+.++|||||||++|||++|..|+. +....+..
T Consensus 312 -~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~ 388 (566)
T PLN03225 312 -YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNR 388 (566)
T ss_pred -cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHH
Confidence 012256899999999976432 24456799999999999999766643 22222222
Q ss_pred Hhh--------hcCccc--CC--------CCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcccc
Q 010116 347 IVH--------WRNHLK--FP--------DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 347 i~~--------~~~~l~--~p--------~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l 403 (518)
++. |..... .. .....+..+.|||.+||+ ||.+|+ ++.++++||||.+..+..+
T Consensus 389 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~---ta~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 389 QLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI---SAKAALAHPYFDREGLLGL 461 (566)
T ss_pred HHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC---CHHHHhCCcCcCCCCcccc
Confidence 221 111000 00 001123456699999998 999999 8999999999998877644
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=339.94 Aligned_cols=257 Identities=23% Similarity=0.301 Sum_probs=211.1
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
..|.+..+++.+...||+|.||+||++++- -.||||+++-... ...+.+.+++|+.++++-+|.||+-+.+++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 457788889999999999999999999875 3599999987654 445889999999999999999999999999888
Q ss_pred CeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.. .||..+|.|-+|+.+|.- +..|....++.|+.|+++|+.|||.++|||||||..||+|.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 76 899999999999999965 3678999999999999999999999999999999999999999999999999987421
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CCCCc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGM 314 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~ 314 (518)
. |. .........|...|||||+++. .+|+.
T Consensus 540 ~-----------------------------------w~------------g~~q~~qp~gsilwmAPEvIRmqd~nPfS~ 572 (678)
T KOG0193|consen 540 R-----------------------------------WS------------GEQQLEQPHGSLLWMAPEVIRMQDDNPFSF 572 (678)
T ss_pred e-----------------------------------ec------------cccccCCCccchhhhcHHHHhhcccCCCCc
Confidence 0 10 0001123457889999999984 57999
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhc--CcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWR--NHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
.+|||||||++|||++|..||...+..+++..+-.+- ..+..+ ....+.++++|+..|+. ++++|| .+.+|+.
T Consensus 573 qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~-~s~~pk~mk~Ll~~C~~~~~~eRP---~F~~il~ 648 (678)
T KOG0193|consen 573 QSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI-RSNCPKAMKRLLSDCWKFDREERP---LFPQLLS 648 (678)
T ss_pred ccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh-hccCHHHHHHHHHHHHhcCcccCc---cHHHHHH
Confidence 9999999999999999999999666655544443320 011111 23566799999999998 999999 7888774
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=316.92 Aligned_cols=268 Identities=30% Similarity=0.472 Sum_probs=223.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 159 (518)
..+|.-++.+|.|+- .|..|-+.-+++.||+|++... ........+..+|..++..++|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 457888899999998 7888888899999999998765 334445567889999999999999999999997554
Q ss_pred -eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 -YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 -~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|+||||| .++|...+. -.++-..+++++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|...+.
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 479999999 578988876 4577889999999999999999999999999999999999999999999999985431
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
. -..+..+.|..|.|||++.+.+|...+||
T Consensus 171 ~--------------------------------------------------~~mtpyVvtRyyrapevil~~~~ke~vdi 200 (369)
T KOG0665|consen 171 D--------------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDI 200 (369)
T ss_pred c--------------------------------------------------cccCchhheeeccCchheeccCCcccchh
Confidence 1 12335789999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc-----------------------------ccCCCC--------C-
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH-----------------------------LKFPDD--------S- 360 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-----------------------------l~~p~~--------~- 360 (518)
||+|||+.||++|...|.+.+....+.+|+..-++ -.||+. .
T Consensus 201 wSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~ 280 (369)
T KOG0665|consen 201 WSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSK 280 (369)
T ss_pred hhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCc
Confidence 99999999999999999999888888877652111 012221 0
Q ss_pred CCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccccccCCccc
Q 010116 361 KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKP 412 (518)
Q Consensus 361 ~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~~~~~p~~p 412 (518)
.-+..++||+.+||. ||++|. +++++|.||||+ .|-.-.+.++|..|
T Consensus 281 ~~~~~ardll~~MLvi~pe~Ri---sv~daL~HPY~~--vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 281 LDCSLARDLLSKMLVIDPEKRI---SVDDALRHPYIK--VWYDPDEVEAPPPE 328 (369)
T ss_pred cchHHHHHHHHHhhccChhhcc---cHHHHhcCCeee--eecccccccCCCCc
Confidence 124679999999998 999999 999999999999 78666666666655
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.02 Aligned_cols=254 Identities=23% Similarity=0.386 Sum_probs=216.8
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecC-Cc----EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKS-GN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t-~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
+..+.-++++.||+|+||.||.+....- |. .||||.+++. .+...+..+.+|..+|+.++|||||+|++++-+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 4467788999999999999999987643 32 3899998764 456678889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeec
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE-------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~-------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DF 230 (518)
....+|++|||.||||..+|... ..++......++.+|+.|.+||+++++|||||...|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999764 46889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 310 (518)
|||+.+.....+... .+ ..-...|||||.+...
T Consensus 847 GlArDiy~~~yyr~~------------------------------------------~~-----a~lPvkWm~PEsl~d~ 879 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKH------------------------------------------GE-----AMLPVKWMPPESLKDG 879 (1025)
T ss_pred chhHhhhhchheecc------------------------------------------Cc-----cccceecCCHHHHhhc
Confidence 999955433221100 00 0112479999999999
Q ss_pred CCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhh
Q 010116 311 GYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ 388 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~e 388 (518)
.|+.++|||||||+|||+++ |..||.+.+..++..-.+... +++.+..++..+-+++..|+. +|++|+ ++..
T Consensus 880 iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---RL~~P~~CP~~ly~lM~~CW~~~pe~RP---~F~~ 953 (1025)
T KOG1095|consen 880 IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---RLDPPSYCPEKLYQLMLQCWKHDPEDRP---SFRT 953 (1025)
T ss_pred ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---ccCCCCCCChHHHHHHHHHccCChhhCc---cHHH
Confidence 99999999999999999999 999999999988887677643 444446899999999999998 999999 8888
Q ss_pred hhc
Q 010116 389 IKA 391 (518)
Q Consensus 389 il~ 391 (518)
|++
T Consensus 954 i~~ 956 (1025)
T KOG1095|consen 954 IVE 956 (1025)
T ss_pred HHh
Confidence 876
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.84 Aligned_cols=242 Identities=30% Similarity=0.464 Sum_probs=193.9
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC------e
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE------Y 160 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~------~ 160 (518)
-+..-..||+||||.||+++++.||+.||||.+++.. ....++...+|++||++++|||||+++++-++.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 3555678999999999999999999999999998754 2334677889999999999999999998876544 4
Q ss_pred EEEEEeecCCCchHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC--CCCc--EEEeecccc
Q 010116 161 LYLIMEYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--KNGH--MKLSDFGLC 233 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~---~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld--~~g~--vKL~DFGla 233 (518)
-.+|||||+||||+.+|.+. ..|+|.+...++..++.||.|||++|||||||||+||++- .+|. .||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 57999999999999999653 5799999999999999999999999999999999999984 3453 599999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGY 312 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y 312 (518)
+.++.+ ....|++||+.|.|||+... +.|
T Consensus 172 rel~d~--------------------------------------------------s~~~S~vGT~~YLhPel~E~q~~y 201 (732)
T KOG4250|consen 172 RELDDN--------------------------------------------------SLFTSLVGTEEYLHPELYERQKKY 201 (732)
T ss_pred ccCCCC--------------------------------------------------CeeeeecCchhhcChHHHhhccCc
Confidence 987533 13458999999999999985 889
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCC----hhhHHHHHhh-------------------hcCcccCCCCCCCChhHHHH
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADD----PITTCRKIVH-------------------WRNHLKFPDDSKLSPEAKDL 369 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~-------------------~~~~l~~p~~~~~s~~~~dL 369 (518)
+..||.|||||++|++.||..||-... ..++...+.. |...+++ +..+|+.....
T Consensus 202 ~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~ 279 (732)
T KOG4250|consen 202 TATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQ--PNHLSRGLATR 279 (732)
T ss_pred CceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCC--cccccHHHHhh
Confidence 999999999999999999999995422 1223333322 2223333 34666665544
Q ss_pred ----HHHHhc-cccccCC
Q 010116 370 ----ICRLLC-DVEHRLG 382 (518)
Q Consensus 370 ----I~~lL~-dp~~R~g 382 (518)
+..+|. +|.+|-+
T Consensus 280 ~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 280 LTKWLASMLEWNPRKRGH 297 (732)
T ss_pred hhHHHHHHHhhhHHHhCC
Confidence 445555 8999983
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.23 Aligned_cols=201 Identities=27% Similarity=0.377 Sum_probs=173.7
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-eEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-YLY 162 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-~ly 162 (518)
.+++|.--.+||+|+||.||++.... |..||||++....... ...+.+|+.+|..++|||+|+|+++|.+.+ ..+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 45789888999999999999998654 4899999876543211 344999999999999999999999999888 599
Q ss_pred EEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 163 LIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHN---YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~g---iiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
||+|||++|+|.++|.... .+++..-..|+.+++.||+|||... ||||||||.|||||+++..||+|||||+...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999997764 8999999999999999999999854 9999999999999999999999999997543
Q ss_pred C-CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccc-cCCCCccChhhhcCCCCCcc
Q 010116 238 C-STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST-VGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~GT~~Y~APEvl~~~~y~~~ 315 (518)
. .. ...+. .||.+|+|||++..+..+.+
T Consensus 229 ~~~~--------------------------------------------------~~~~~~~gt~gY~~PEy~~~g~lt~K 258 (361)
T KOG1187|consen 229 EGDT--------------------------------------------------SVSTTVMGTFGYLAPEYASTGKLTEK 258 (361)
T ss_pred cccc--------------------------------------------------ceeeecCCCCccCChhhhccCCcCcc
Confidence 1 10 00122 79999999999999889999
Q ss_pred ccccchhHHHHHHHhCCCCCCCC
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYAD 338 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~ 338 (518)
+|||||||+|.||++|+.|....
T Consensus 259 sDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 259 SDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cccccchHHHHHHHhCCcccCCC
Confidence 99999999999999999888643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=352.40 Aligned_cols=267 Identities=40% Similarity=0.711 Sum_probs=222.3
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
-+.+||+.++.|-.|+||.||+++++.+.+.+|| +++|..++-+ +||....+|++|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilR----------nilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILR----------NILTFAGNPFVV------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhh----------ccccccCCccee-------------
Confidence 3457999999999999999999999999999999 4555543322 267777888887
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||-.+++..-+.++.+. +.|++|||+.||+|||+||+|+||+.=||+|++||||++..-.....
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 77788887767777654 88999999999999999999999999999999999999865432211
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
..++...- ..... -.....||||.|+||||+..++|+..+|||++|
T Consensus 200 nl~eg~I~----------------------------k~t~E------f~dKqvcgTPeyiaPeVilrqgygkpvdwwamG 245 (1205)
T KOG0606|consen 200 NLKEGHIE----------------------------KDTHE------FQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 245 (1205)
T ss_pred hhhhcchH----------------------------HHHHH------hhhccccCCccccChhhhhhhccCCCccHHHHH
Confidence 11111000 00000 112256999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCC-CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
+|+||.+.|..||.++.+.+.+.+++. ....+|+ +..++++++|+|.+||. +|..|+|+.++-+|++|+||.++||
T Consensus 246 iIlyeFLVgcvpffGdtpeelfg~vis--d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 246 IILYEFLVGCVPFFGDTPEELFGQVIS--DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred HHHHHHheeeeeccCCCHHHHHhhhhh--hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 999999999999999999999999887 3455555 34678999999999998 9999999999999999999999999
Q ss_pred cccccccCCccccCCCcccCCCCCC
Q 010116 401 DKLYEMEAAFKPEINGELDTQNFMK 425 (518)
Q Consensus 401 ~~l~~~~~p~~p~~~~~~d~~~f~~ 425 (518)
..|...+++|+|.+..+.|+++|+.
T Consensus 324 ~~llRqkaefvpql~~eddtsyfdT 348 (1205)
T KOG0606|consen 324 KSLLRQKAEFVPQLESEDDTSYFDT 348 (1205)
T ss_pred chhhhhhccccccccccccchhhcc
Confidence 9999999999999999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.55 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=190.8
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe----------------cCCcEEEEEEeechhhhc-----------hhhHHHH
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK----------------KSGNIYAMKKLKKSEMVK-----------RGQVEHV 133 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~----------------~t~~~~AiK~l~k~~~~~-----------~~~~~~~ 133 (518)
.++..++|++.++||+|+||.||++... ..++.||||.+....... ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3467889999999999999999998642 345679999986432110 0111223
Q ss_pred HHHHHHHHHhCCCce-----eEEEEEee--------cCCeEEEEEeecCCCchHHHHhhc--------------------
Q 010116 134 RAERNLLAEVASHCI-----VKLYYSFQ--------DTEYLYLIMEYLPGGDMMTLLMRE-------------------- 180 (518)
Q Consensus 134 ~~E~~il~~l~hp~I-----v~l~~~f~--------~~~~lylVmEy~~gG~L~~~l~~~-------------------- 180 (518)
..|..++..+.|+++ ++++++|. ..+..||||||+++|+|.++|...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 456677777776654 55666553 245689999999999999988532
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccC
Q 010116 181 ----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256 (518)
Q Consensus 181 ----~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 256 (518)
..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--------------- 364 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--------------- 364 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc---------------
Confidence 1235667888999999999999999999999999999999999999999999875421100
Q ss_pred CCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC--------------------CC--c
Q 010116 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--------------------YG--M 314 (518)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--------------------y~--~ 314 (518)
.......+||.|+|||++.... |+ .
T Consensus 365 ---------------------------------~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~ 411 (507)
T PLN03224 365 ---------------------------------FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPD 411 (507)
T ss_pred ---------------------------------cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCC
Confidence 0001234589999999986432 22 2
Q ss_pred cccccchhHHHHHHHhCCC-CCCCCChhh----HHHHHh-hh----cCcccCCCCCCCChhHHHHHHHHhc-cc---ccc
Q 010116 315 ECDWWSLGAIMYEMLVGYP-PFYADDPIT----TCRKIV-HW----RNHLKFPDDSKLSPEAKDLICRLLC-DV---EHR 380 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~-PF~~~~~~~----~~~~i~-~~----~~~l~~p~~~~~s~~~~dLI~~lL~-dp---~~R 380 (518)
.+|+||+||++|+|++|.. ||.+..... .+.... .| .....|+....+++.++|||.+||+ +| .+|
T Consensus 412 ~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~R 491 (507)
T PLN03224 412 LFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGR 491 (507)
T ss_pred ccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccC
Confidence 4799999999999999986 775421111 111111 11 1344565556789999999999997 65 578
Q ss_pred CCCCChhhhhcCcccc
Q 010116 381 LGTGGAHQIKAHPWFK 396 (518)
Q Consensus 381 ~g~~~a~eil~Hpff~ 396 (518)
+ ++.|+|+||||.
T Consensus 492 l---Sa~eaL~Hp~f~ 504 (507)
T PLN03224 492 L---SVGQALSHRFFL 504 (507)
T ss_pred C---CHHHHhCCCCcC
Confidence 8 999999999996
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=308.03 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=210.7
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHH-HHHhCCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~f~~~~ 159 (518)
+.+..++.+-+..||.|+||+|++..++.+|+..|||.+..... .....+++.|.+. ++.-+.|+||++|++.-.++
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 55667778888999999999999999999999999999976543 2234456666654 45558999999999999999
Q ss_pred eEEEEEeecCCCchHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 160 YLYLIMEYLPGGDMMTLLM-----REDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~-----~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
.++|.||+| .-+|..+.+ .+..++|..+-.+...++.||+||-. ++||||||||+|||||..|.|||||||+|
T Consensus 137 dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 999999999 445544432 35789999999999999999999986 59999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KG 311 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~ 311 (518)
..+..+.. .+--+|-..|||||-+.. .+
T Consensus 216 GqLv~SiA--------------------------------------------------kT~daGCrpYmAPERi~p~~~g 245 (361)
T KOG1006|consen 216 GQLVDSIA--------------------------------------------------KTVDAGCRPYMAPERIDPSDKG 245 (361)
T ss_pred HhHHHHHH--------------------------------------------------hhhccCCccccChhccCCccCC
Confidence 87643210 112368889999999974 67
Q ss_pred CCccccccchhHHHHHHHhCCCCCCCCC-hhhHHHHHhhhcCcc-cCCC-CCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 312 YGMECDWWSLGAIMYEMLVGYPPFYADD-PITTCRKIVHWRNHL-KFPD-DSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 312 y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~~l-~~p~-~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
|+-.+|+||||++|||+.||..|+..-+ ..+...+++.+..+. .++. ...+|..++.||.-||. |-..|+ ...
T Consensus 246 yDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp---ky~ 322 (361)
T KOG1006|consen 246 YDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP---KYD 322 (361)
T ss_pred cchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCc---chh
Confidence 9999999999999999999999997754 344555555532221 1221 23589999999999997 999999 899
Q ss_pred hhhcCccccc
Q 010116 388 QIKAHPWFKD 397 (518)
Q Consensus 388 eil~Hpff~~ 397 (518)
++++|||++.
T Consensus 323 ~Lk~~~fyr~ 332 (361)
T KOG1006|consen 323 DLKKFPFYRM 332 (361)
T ss_pred hhhcCchhhh
Confidence 9999999984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=293.05 Aligned_cols=253 Identities=30% Similarity=0.505 Sum_probs=208.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCC--e
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTE--Y 160 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~--~ 160 (518)
..++|++++++|+|-|++|+.+....+++.++||+++.-. .+.+.+|+.||..+. ||||++|+++..|.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4689999999999999999999999999999999997542 356889999999997 999999999998764 4
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC-CcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~-g~vKL~DFGla~~~~~~ 239 (518)
..||+||+.+.|...+. .+|+.-.+++|+.|++.||.|+|+.||+|||+||.|++||.. -.++|+|+|||.....+
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 67999999998877665 578999999999999999999999999999999999999964 57999999999977544
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 318 (518)
..++ -.|.+..|--||.+.. ..|+.+-|+
T Consensus 187 ~eYn--------------------------------------------------VRVASRyfKGPELLVdy~~YDYSLD~ 216 (338)
T KOG0668|consen 187 KEYN--------------------------------------------------VRVASRYFKGPELLVDYQMYDYSLDM 216 (338)
T ss_pred ceee--------------------------------------------------eeeehhhcCCchheeechhccccHHH
Confidence 2211 2456778899999987 678999999
Q ss_pred cchhHHHHHHHhCCCCCC-CCChhhHHHHHhhhc-----------Ccc---------------------cCCCCC-CCCh
Q 010116 319 WSLGAIMYEMLVGYPPFY-ADDPITTCRKIVHWR-----------NHL---------------------KFPDDS-KLSP 364 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~-----------~~l---------------------~~p~~~-~~s~ 364 (518)
|||||++..|+..+-||. +.+....+-+|..-- -.+ .-+... -+++
T Consensus 217 WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~p 296 (338)
T KOG0668|consen 217 WSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSP 296 (338)
T ss_pred HHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCCh
Confidence 999999999999998874 445555554443300 000 011111 2479
Q ss_pred hHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 365 EAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 365 ~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
++.|||.+||. |-.+|+ +|.|++.||||..+
T Consensus 297 eaiDlldklLrYDHqeRl---TakEam~HpyF~~~ 328 (338)
T KOG0668|consen 297 EAIDLLDKLLRYDHQERL---TAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHHHHHHHhhcccccc---chHHHhcCchHHHH
Confidence 99999999999 999999 89999999999754
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.38 Aligned_cols=264 Identities=26% Similarity=0.456 Sum_probs=216.3
Q ss_pred HhhhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC------Cce
Q 010116 75 FMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS------HCI 148 (518)
Q Consensus 75 ~~~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h------p~I 148 (518)
|++..-+++.-++|.+....|+|-||+|..|++...|+.||||+|...++.- ..=+.|+.||+.|+. .++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHH
Confidence 4555556677788999999999999999999999999999999998765432 234579999999952 378
Q ss_pred eEEEEEeecCCeEEEEEeecCCCchHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-c
Q 010116 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-H 224 (518)
Q Consensus 149 v~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~---~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-~ 224 (518)
++|+..|....++|||+|-+ ..+|.++|.+.+ .|....++.|+.|++.||..|-.+||+|.||||+|||++..- .
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence 99999999999999999999 679999998753 688899999999999999999999999999999999998764 5
Q ss_pred EEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccCh
Q 010116 225 MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304 (518)
Q Consensus 225 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 304 (518)
+||||||.|....... .+.+.-+.-|.||
T Consensus 576 LKLCDfGSA~~~~ene---------------------------------------------------itPYLVSRFYRaP 604 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE---------------------------------------------------ITPYLVSRFYRAP 604 (752)
T ss_pred eeeccCcccccccccc---------------------------------------------------ccHHHHHHhccCc
Confidence 7999999987653221 0112334579999
Q ss_pred hhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc-------------------cC---------
Q 010116 305 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL-------------------KF--------- 356 (518)
Q Consensus 305 Evl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l-------------------~~--------- 356 (518)
|+|++.+|++..|+||+||+||||.||+..|.+.....+++-.+..++.+ .|
T Consensus 605 EIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT 684 (752)
T KOG0670|consen 605 EIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVT 684 (752)
T ss_pred ceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccc
Confidence 99999999999999999999999999999999998888776655432211 00
Q ss_pred ---------------------------CCC-CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 357 ---------------------------PDD-SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 357 ---------------------------p~~-~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|.+ ..+-.+++||+.+||. ||++|+ ++.++|+||||.+
T Consensus 685 ~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi---t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 685 EREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI---TVNQALKHPFITE 751 (752)
T ss_pred cceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC---CHHHHhcCCcccC
Confidence 000 0112458899999998 999999 8999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=290.87 Aligned_cols=241 Identities=48% Similarity=0.831 Sum_probs=204.7
Q ss_pred CceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCchHHHH
Q 010116 98 AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL 177 (518)
Q Consensus 98 ~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l 177 (518)
+||.||+|....+|+.+|+|++........ ...+.+|+.+++.++|++|+++++.+.+....++||||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999998999999999876543221 567889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCC
Q 010116 178 MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257 (518)
Q Consensus 178 ~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 257 (518)
.....++...+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----------------- 141 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----------------- 141 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------------
Confidence 776669999999999999999999999999999999999999999999999999988654210
Q ss_pred CCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCC
Q 010116 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYA 337 (518)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 337 (518)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus 142 ---------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 142 ---------------------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred ---------------------------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 11245688999999999988899999999999999999999999987
Q ss_pred -CChhhHHHHHhhhcCcccCCCCC-CCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 338 -DDPITTCRKIVHWRNHLKFPDDS-KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 338 -~~~~~~~~~i~~~~~~l~~p~~~-~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
.+.......+.. ......... .++.++.++|.+||. +|.+|+ ++.++++||||
T Consensus 189 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~~~~~~~ 244 (244)
T smart00220 189 DDQLLELFKKIGK--PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 244 (244)
T ss_pred CCcHHHHHHHHhc--cCCCCccccccCCHHHHHHHHHHccCCchhcc---CHHHHhhCCCC
Confidence 444444443332 122222111 288999999999998 999999 89999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.80 Aligned_cols=202 Identities=32% Similarity=0.536 Sum_probs=183.7
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchh-----hHHHHHHHHHHHHHhC---CCceeEEEEEee
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-----QVEHVRAERNLLAEVA---SHCIVKLYYSFQ 156 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~-----~~~~~~~E~~il~~l~---hp~Iv~l~~~f~ 156 (518)
..+|..++.||.|+||.|++|.++.+...|+||.|.|.++.... ..-.+-.|+.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 46899999999999999999999999999999999998765433 3344778999999998 999999999999
Q ss_pred cCCeEEEEEeec-CCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYL-PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~-~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
+++++||+||-- +|-||++++..+..++|.+++.++.|++.|+++||+.||||||||-|||.++.+|-+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999985 5679999999999999999999999999999999999999999999999999999999999998876
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-Cc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GM 314 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~ 314 (518)
..++ ....++||.+|.|||++.+..| +.
T Consensus 720 ~ksg---------------------------------------------------pfd~f~gtv~~aapevl~g~~y~gk 748 (772)
T KOG1152|consen 720 TKSG---------------------------------------------------PFDVFVGTVDYAAPEVLGGEKYLGK 748 (772)
T ss_pred hcCC---------------------------------------------------CcceeeeeccccchhhhCCCccCCC
Confidence 5432 1237899999999999999998 89
Q ss_pred cccccchhHHHHHHHhCCCCCCC
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYA 337 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~ 337 (518)
.-|||+||++||-++....||+.
T Consensus 749 ~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 749 PQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhhhheeeEEEeccCCCcC
Confidence 99999999999999999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=304.16 Aligned_cols=141 Identities=23% Similarity=0.424 Sum_probs=121.0
Q ss_pred HhhhhcCCcCC-CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-----C---
Q 010116 75 FMRLKRHKICV-DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-----S--- 145 (518)
Q Consensus 75 ~~~~~~~~~~~-~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-----h--- 145 (518)
|-++..+.... .+|-+.++||.|-|++||||++..+.+.||||+.+... ...+....|+.+|+.++ |
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred CceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 33444444444 89999999999999999999999999999999987653 34566788999999883 3
Q ss_pred CceeEEEEEeec----CCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCcee
Q 010116 146 HCIVKLYYSFQD----TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLL 218 (518)
Q Consensus 146 p~Iv~l~~~f~~----~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNIL 218 (518)
.+||+|++.|.. ..++|||+|++ |-+|..+|.+. ..++...++.|+.||+.||.|||. +||||.||||+|||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL 220 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL 220 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence 379999999974 56899999999 88999999764 689999999999999999999997 59999999999999
Q ss_pred eC
Q 010116 219 LD 220 (518)
Q Consensus 219 ld 220 (518)
+.
T Consensus 221 l~ 222 (590)
T KOG1290|consen 221 LC 222 (590)
T ss_pred ee
Confidence 94
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=295.03 Aligned_cols=261 Identities=30% Similarity=0.469 Sum_probs=214.2
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----e
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-----Y 160 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-----~ 160 (518)
.|.+--+.||.|+||.||.+.+..+|+.||+|++..- ..+--..+++.+|..+|...+|.|+..+++..+... .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3455568999999999999999999999999988642 223334567889999999999999999998887654 4
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+|.|+| ..||..++.....++.+.++.++.||+.||.|||+.||.||||||.|+|++++..+|||||||++..+..
T Consensus 132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d- 209 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR- 209 (449)
T ss_pred HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-
Confidence 78999999 4699999888889999999999999999999999999999999999999999999999999999864311
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWW 319 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 319 (518)
.+.-.+.-+-|..|.|||++.+ ..|+.++|||
T Consensus 210 -----------------------------------------------~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiW 242 (449)
T KOG0664|consen 210 -----------------------------------------------DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIW 242 (449)
T ss_pred -----------------------------------------------hhhhhHHHHHHHHhccHHHhhcchhhcCcccee
Confidence 1111224567889999999998 5799999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhh---------------------cCcccCCCC---------CCCChhHHHH
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHW---------------------RNHLKFPDD---------SKLSPEAKDL 369 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~---------------------~~~l~~p~~---------~~~s~~~~dL 369 (518)
|+|||+.|||..+..|...++.+...-|... +...+-|.. ..-..++.++
T Consensus 243 SVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~ 322 (449)
T KOG0664|consen 243 SVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDL 322 (449)
T ss_pred hhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHH
Confidence 9999999999999999999998888777552 112222221 1223578889
Q ss_pred HHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 370 ICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 370 I~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
+.++|. ||.+|. +.++.+.|++.....
T Consensus 323 ~~~~l~~d~dkri---s~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 323 LQKLLHFDPDKRI---SVEEALQHRYLEEGR 350 (449)
T ss_pred HHHHhCCCCcccc---cHhhhcccccccccc
Confidence 999998 999999 899999999987543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=275.96 Aligned_cols=229 Identities=29% Similarity=0.507 Sum_probs=187.1
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHH-hCCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE-VASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~f~~~~ 159 (518)
..+..++...+..||+|++|.|-+.++..+|...|+|.+...- ......+..+|.++... ..+|++|.+|+.+.++.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4555677777889999999999999999999999999987542 23334556777777554 57999999999999999
Q ss_pred eEEEEEeecCCCchHHH----HhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 160 YLYLIMEYLPGGDMMTL----LMREDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~----l~~~~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
.+++.||.|. -+|..+ +.+.+.++|..+-.++..++.||.|||++ .+||||+||.||||+.+|+||+||||.|-
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999994 465543 34568999999999999999999999985 99999999999999999999999999988
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccc-ccCCCCccChhhhcC----
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS-TVGTPDYIAPEVLLK---- 309 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~GT~~Y~APEvl~~---- 309 (518)
.+..+. +.+ -.|-..|||||.+..
T Consensus 198 ~L~dSi---------------------------------------------------Akt~daGCkpYmaPEri~~e~n~ 226 (282)
T KOG0984|consen 198 YLVDSI---------------------------------------------------AKTMDAGCKPYMAPERINPELNQ 226 (282)
T ss_pred eehhhh---------------------------------------------------HHHHhcCCCccCChhhcCcccCc
Confidence 764331 112 357788999999863
Q ss_pred CCCCccccccchhHHHHHHHhCCCCCCC-CChhhHHHHHhhhcCcccCCCCCCCChh
Q 010116 310 KGYGMECDWWSLGAIMYEMLVGYPPFYA-DDPITTCRKIVHWRNHLKFPDDSKLSPE 365 (518)
Q Consensus 310 ~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~l~~p~~~~~s~~ 365 (518)
++|+-++||||||+.|+||.+++.||.. .++.+.+.+++.. ..+.+|.. .+|++
T Consensus 227 ~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~Lp~~-~FS~e 281 (282)
T KOG0984|consen 227 KGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQLPAD-TFSPE 281 (282)
T ss_pred ccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCCCccc-ccCCC
Confidence 5899999999999999999999999976 5778888888874 34455553 35554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.56 Aligned_cols=243 Identities=24% Similarity=0.390 Sum_probs=204.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecC--C--cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKS--G--NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t--~--~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
+...+.++||.|-||.||.+....- | --||||.+++... .+..+.+..|..+|+.++|||||+|++++.+. ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 3344567899999999999976432 2 3489999988653 33467899999999999999999999998754 68
Q ss_pred EEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 162 YLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+||||+++-|.|..+|+.+ ..++......|+.||+.||.|||+.++|||||...|||+.+...|||+||||++.+....
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999999765 789999999999999999999999999999999999999999999999999999876443
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
.+. +....-...|||||.+.-..++.++|||.
T Consensus 546 yYk------------------------------------------------aS~~kLPIKWmaPESINfRrFTtASDVWM 577 (974)
T KOG4257|consen 546 YYK------------------------------------------------ASRGKLPIKWMAPESINFRRFTTASDVWM 577 (974)
T ss_pred hhh------------------------------------------------ccccccceeecCccccchhcccchhhHHH
Confidence 221 00111234799999999999999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 321 LGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 321 lGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
|||+|||+|. |..||.+-.....+-.|.++ ..++.| +++++.+-.|+.+|+. ||.+||.
T Consensus 578 FgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-eRlP~P--~nCPp~LYslmskcWayeP~kRPr 638 (974)
T KOG4257|consen 578 FGVCMWEILSLGVKPFQGVKNSDVIGHIENG-ERLPCP--PNCPPALYSLMSKCWAYEPSKRPR 638 (974)
T ss_pred HHHHHHHHHHhcCCccccccccceEEEecCC-CCCCCC--CCCChHHHHHHHHHhccCcccCCc
Confidence 9999999887 99999998777777666654 344444 5899999999999999 9999994
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.54 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=208.7
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
++..+...+.++||+|-||+|.+|.... +..||+|+++... ..+....+..|+.+|.+++|||||.|++++..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 3445667788999999999999998643 6899999998653 233456799999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+|||||..|||..+|+.+ ..+.......++.||+.|++||.+.++|||||.+.|+|+|.++++||+|||+++.+..+
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999999886 34344555669999999999999999999999999999999999999999999977655
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
..+..+ ...|-...|||||.|..+.++.++|+|
T Consensus 691 ~yy~vq-----------------------------------------------gr~vlpiRwmawEsillgkFttaSDvW 723 (807)
T KOG1094|consen 691 DYYRVQ-----------------------------------------------GRAVLPIRWMAWESILLGKFTTASDVW 723 (807)
T ss_pred Cceeee-----------------------------------------------cceeeeeeehhHHHHHhccccchhhhh
Confidence 433221 123456789999999999999999999
Q ss_pred chhHHHHHHHh--CCCCCCCCChhhHHHHHhhhc----CcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV--GYPPFYADDPITTCRKIVHWR----NHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~--G~~PF~~~~~~~~~~~i~~~~----~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+||++|||+++ ...||......+...+.-..- .....+.+.-++..+-.||.+|+. |-.+|| +++++-.
T Consensus 724 afgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP---sFe~lh~ 799 (807)
T KOG1094|consen 724 AFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP---SFEQLHL 799 (807)
T ss_pred hhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC---CHHHHHH
Confidence 99999999765 788997766655544432210 111223345678899999999998 999999 8888743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.59 Aligned_cols=253 Identities=21% Similarity=0.330 Sum_probs=213.3
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEec-CCc--EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKK-SGN--IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~-t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
..++..++++||+|+||.|+.+.++. +|+ .||||+++...... ....+++|..+|..++|||+++||++..+ ..
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 34567778899999999999998864 344 48999997654322 56789999999999999999999999988 67
Q ss_pred EEEEEeecCCCchHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 161 LYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
+.||||++++|+|.+.|.+ .+.|.......|+.||+.|+.||.++++|||||...||||...-.||||||||.+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 8899999999999999976 46899999999999999999999999999999999999999999999999999998764
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
........ -..--...|+|||.|....++.++|+
T Consensus 265 ned~Yvm~----------------------------------------------p~rkvPfAWCaPEsLrh~kFShaSDv 298 (1039)
T KOG0199|consen 265 NEDMYVMA----------------------------------------------PQRKVPFAWCAPESLRHRKFSHASDV 298 (1039)
T ss_pred CCcceEec----------------------------------------------CCCcCcccccCHhHhccccccccchh
Confidence 42211100 00112347999999999999999999
Q ss_pred cchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 319 WSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 319 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|++||++|||++ |.-||.+.....++.+|-. +..+.-| ..+|.++-+++..|+. +|.+|+ ++..|.+
T Consensus 299 WmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~-~erLpRP--k~csedIY~imk~cWah~paDRp---tFsair~ 367 (1039)
T KOG0199|consen 299 WMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA-GERLPRP--KYCSEDIYQIMKNCWAHNPADRP---TFSAIRE 367 (1039)
T ss_pred hhhhhhHHhhhccCCCCCCCCCHHHHHHhccc-cccCCCC--CCChHHHHHHHHHhccCCccccc---cHHHHHH
Confidence 999999999998 8899999999999988873 3444444 5799999999999999 999999 6777653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=318.15 Aligned_cols=267 Identities=28% Similarity=0.383 Sum_probs=203.5
Q ss_pred EeeEeecCceE-EEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEEEeec
Q 010116 91 LTIIGRGAFGE-VRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYL 168 (518)
Q Consensus 91 ~~~LG~G~fG~-V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~ 168 (518)
-+++|.|+-|+ ||++. -.|+.||||.+-.. ....+.+|+.+|++. +|||||+.|+.-++..++||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35789999986 77664 45889999987543 345678999999998 5999999999999999999999999
Q ss_pred CCCchHHHHhhc--C--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CC--cEEEeecccccccCCC
Q 010116 169 PGGDMMTLLMRE--D--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NG--HMKLSDFGLCKPLDCS 239 (518)
Q Consensus 169 ~gG~L~~~l~~~--~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g--~vKL~DFGla~~~~~~ 239 (518)
..+|.+++... . .......+..+.|++.||.+||+.+||||||||.||||+. +| .++|+|||+||++..+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 56999999763 1 1112456788999999999999999999999999999986 44 6799999999998643
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
... -+...+..||-+|+|||++....-+.++||+
T Consensus 665 ~sS----------------------------------------------~~r~s~~sGt~GW~APE~L~~~~~~~avDiF 698 (903)
T KOG1027|consen 665 KSS----------------------------------------------FSRLSGGSGTSGWQAPEQLREDRKTQAVDIF 698 (903)
T ss_pred cch----------------------------------------------hhcccCCCCcccccCHHHHhccccCcccchh
Confidence 210 0123467799999999999998888899999
Q ss_pred chhHHHHHHHhC-CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 320 SLGAIMYEMLVG-YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 320 SlGvilyeml~G-~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||||++|..++| ..||...- +...+|+.....+..-.+ ....+|+|||.+||. ||..|+ +|.+|+.||||=
T Consensus 699 slGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~-~~d~eA~dLI~~ml~~dP~~RP---sa~~VL~HPlFW- 771 (903)
T KOG1027|consen 699 SLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEP-LPDCEAKDLISRMLNPDPQLRP---SATDVLNHPLFW- 771 (903)
T ss_pred hcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeecc-CchHHHHHHHHHhcCCCcccCC---CHHHHhCCCccC-
Confidence 999999999996 89996543 333456654333322111 111299999999999 999999 899999999993
Q ss_pred CCccccccccCCccccCCCcccCCCCC
Q 010116 398 VVWDKLYEMEAAFKPEINGELDTQNFM 424 (518)
Q Consensus 398 i~w~~l~~~~~p~~p~~~~~~d~~~f~ 424 (518)
+|++-. .|.-++++..+..+.+
T Consensus 772 -~~ekrL----~Fl~dvSDRvE~e~r~ 793 (903)
T KOG1027|consen 772 -DSEKRL----SFLRDVSDRVEKENRD 793 (903)
T ss_pred -ChHHHH----HHHHhhhhhhhhhhcc
Confidence 333211 2444555555554444
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.60 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=223.7
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
.++......|.++||.|.||+|+.++.+..|+ .||||.++... ...+...++.|..||-+.+||||++|-++...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 35667788899999999999999999987764 59999997653 45567789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
...+.||.|||++|+|..+|..+ +.|+..++.-+++.|+.|+.||-+.|+|||||...|||++++-.+|++||||++.+
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999999765 68999999999999999999999999999999999999999999999999999976
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccC---CCCccChhhhcCCCCC
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG---TPDYIAPEVLLKKGYG 313 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G---T~~Y~APEvl~~~~y~ 313 (518)
.... ..+++..| ...|.|||.|....++
T Consensus 782 edd~-------------------------------------------------~~~ytt~GGKIPiRWTAPEAIa~RKFT 812 (996)
T KOG0196|consen 782 EDDP-------------------------------------------------EAAYTTLGGKIPIRWTAPEAIAYRKFT 812 (996)
T ss_pred ccCC-------------------------------------------------CccccccCCccceeecChhHhhhcccC
Confidence 4221 01122222 3589999999999999
Q ss_pred ccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 314 MECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
.++||||+|++|||.++ |..||...+..+.+..|.. ...+|.+..++..+..|+..|++ |-..|| .+.+|..
T Consensus 813 sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~---gyRLPpPmDCP~aL~qLMldCWqkdR~~RP---~F~qiV~ 886 (996)
T KOG0196|consen 813 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ---GYRLPPPMDCPAALYQLMLDCWQKDRNRRP---KFAQIVS 886 (996)
T ss_pred chhhccccceEEEEecccCCCcccccchHHHHHHHHh---ccCCCCCCCCcHHHHHHHHHHHHHHhhcCC---CHHHHHH
Confidence 99999999999999665 9999999999999988876 56777777899999999999998 999999 7899887
Q ss_pred C
Q 010116 392 H 392 (518)
Q Consensus 392 H 392 (518)
+
T Consensus 887 ~ 887 (996)
T KOG0196|consen 887 T 887 (996)
T ss_pred H
Confidence 4
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.89 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=214.3
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.|++...|.....+||-|-||.||.+.++.-.-.||||.++.+.+ .++.++.|..+|+.++|||+|+|+++|..+.
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 466667788888999999999999999998888999999987644 4678999999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+|||.|||..|+|.+||... .-++.-...+++.||..|++||..+++|||||...|+|+.++..||++||||++.+.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999999764 346666777788899999999999999999999999999999999999999999764
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
...... +. ..--...|.|||-|.-..++.++|
T Consensus 417 gDTYTA-HA-----------------------------------------------GAKFPIKWTAPEsLAyNtFSiKSD 448 (1157)
T KOG4278|consen 417 GDTYTA-HA-----------------------------------------------GAKFPIKWTAPESLAYNTFSIKSD 448 (1157)
T ss_pred CCceec-cc-----------------------------------------------CccCcccccCcccccccccccchh
Confidence 322110 00 011235799999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
||+|||+|||+.| |-.||.+-+....+.-+.+ .+....+..+++.+-.|++.|+. .|.+|+ ++.||-
T Consensus 449 VWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk---gyRM~~PeGCPpkVYeLMraCW~WsPsDRP---sFaeiH 517 (1157)
T KOG4278|consen 449 VWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK---GYRMDGPEGCPPKVYELMRACWNWSPSDRP---SFAEIH 517 (1157)
T ss_pred hHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc---cccccCCCCCCHHHHHHHHHHhcCCcccCc---cHHHHH
Confidence 9999999999998 8999999988777765543 33444445899999999999999 999999 666653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=336.01 Aligned_cols=238 Identities=21% Similarity=0.266 Sum_probs=186.1
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|....+||+|+||.||+|+.+.++..||+|++..... ....|+.+++.++|||||++++++.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 45667899999999999999999999999999865321 11245788999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH---KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH---~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|++||+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 999999999995 3889999999999999999999 6699999999999999999988876 665432110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
....+||+.|+|||++.+..|+.++|||||||
T Consensus 835 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gv 866 (968)
T PLN00113 835 ------------------------------------------------DTKCFISSAYVAPETRETKDITEKSDIYGFGL 866 (968)
T ss_pred ------------------------------------------------CCCccccccccCcccccCCCCCcccchhhHHH
Confidence 01236899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChh-----hHHHHHhh------hcCcccCCCC----CCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 324 IMYEMLVGYPPFYADDPI-----TTCRKIVH------WRNHLKFPDD----SKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~-----~~~~~i~~------~~~~l~~p~~----~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
++|||++|+.||...... ...+.... +.. ...+.. .....++.+++.+|+. ||.+|| ++.
T Consensus 867 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---t~~ 942 (968)
T PLN00113 867 ILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID-PSIRGDVSVNQNEIVEVMNLALHCTATDPTARP---CAN 942 (968)
T ss_pred HHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC-ccccCCCCccHHHHHHHHHHHHhhCcCCchhCc---CHH
Confidence 999999999999543211 11110000 000 000000 0112356789999998 999999 889
Q ss_pred hhhcC
Q 010116 388 QIKAH 392 (518)
Q Consensus 388 eil~H 392 (518)
||++.
T Consensus 943 evl~~ 947 (968)
T PLN00113 943 DVLKT 947 (968)
T ss_pred HHHHH
Confidence 98763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=310.23 Aligned_cols=261 Identities=28% Similarity=0.477 Sum_probs=225.6
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
-..+||+++..+|.|+||.||+++++.+++..|+|+++-.. ...+.-+..|+-+++.++|||||-+++++.-.+.++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 45689999999999999999999999999999999997542 344566788999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
++||||.||+|.+.-.--++++|.++.+.+++.+.||+|||+.|=+|||||-.|||+++.|.+||+|||.+..+....
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-- 166 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh--
Confidence 999999999999998888999999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CCCCCcccccc
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWW 319 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiW 319 (518)
. ...++.|||.||||||-. ..+|+..||+|
T Consensus 167 --------------------------------------------~---KrksfiGtpywmapEvaaverkggynqlcdiw 199 (829)
T KOG0576|consen 167 --------------------------------------------A---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIW 199 (829)
T ss_pred --------------------------------------------h---hhhcccCCccccchhHHHHHhccccccccccc
Confidence 0 123789999999999874 68899999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhh-hcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVH-WRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~-~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
++|+...|+---.+|-...-+.....-... .-.++...+....++.+.+|++.+|. +|++|+ +++-++.|||...
T Consensus 200 a~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRp---taeklL~h~fvs~ 276 (829)
T KOG0576|consen 200 ALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRP---TAEKLLQHPFVSQ 276 (829)
T ss_pred ccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCC---Chhhheeceeecc
Confidence 999999999999999887777666544433 11233333445789999999999998 999999 8999999999975
Q ss_pred C
Q 010116 398 V 398 (518)
Q Consensus 398 i 398 (518)
-
T Consensus 277 ~ 277 (829)
T KOG0576|consen 277 T 277 (829)
T ss_pred c
Confidence 4
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=284.61 Aligned_cols=289 Identities=22% Similarity=0.401 Sum_probs=207.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEec---CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCe
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 160 (518)
.+.|.++.+||.|+|+.||++.+.. ..+.||+|.+.... ...++.+|.++|..+ .+.||+++.++|...+.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4678899999999999999998876 78899999886543 345689999999998 58899999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-CCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-~g~vKL~DFGla~~~~~~ 239 (518)
+.+||||++..+..+++. .++-.+++.|+..++.||.++|.+|||||||||.|+|.+. .++-.|+|||||...+..
T Consensus 110 v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999999999988888874 4678899999999999999999999999999999999985 578899999999842211
Q ss_pred cccccccc------ccccccccCC----CCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC
Q 010116 240 TLYAIHEH------KTIDDENMAE----PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (518)
Q Consensus 240 ~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 309 (518)
........ ....+..... ..+...++.... ...++..-.+.+|||+|.||||+.+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~---------------~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRC---------------NDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceecc---------------CCCccceecccCCCCCCCchHHHhh
Confidence 10000000 0000000000 000000000000 0012223346789999999999987
Q ss_pred C-CCCccccccchhHHHHHHHhCCCCCCCC-ChhhHHHHHhh-------------------hc-C-------------cc
Q 010116 310 K-GYGMECDWWSLGAIMYEMLVGYPPFYAD-DPITTCRKIVH-------------------WR-N-------------HL 354 (518)
Q Consensus 310 ~-~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~-------------------~~-~-------------~l 354 (518)
- .-+.++|+||.|||+.-++++..||... +.......|+. |. . .+
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 5 4689999999999999999999998543 21111111111 11 0 00
Q ss_pred c----CC----------CCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 355 K----FP----------DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 355 ~----~p----------~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
. .+ .....+..+.||+.+||. ||.+|+ +|+++|+||||...+
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRi---tAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRI---TAEDALKHPFFDEAD 388 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcc---cHHHHhcCcCCcchh
Confidence 0 00 011245689999999998 999999 899999999998543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.21 Aligned_cols=240 Identities=18% Similarity=0.262 Sum_probs=199.4
Q ss_pred EEeeEeecCceEEEEEEEecCCc----EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
..++||+|+||+||++.+-..|+ +||||++..... ......+..|.-+|..++|||+++|++++.... +-||+
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45799999999999998876665 588898866532 334567889999999999999999999998776 88999
Q ss_pred eecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
+|||+|.|.++++.+ +.+-......|+.||+.|+.|||.+++|||||...|||+.+-.|+||+|||+++.+......
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e-- 854 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE-- 854 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc--
Confidence 999999999999764 78999999999999999999999999999999999999999999999999999976532110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
+..+ ...-.+.|||-|.+....|++++||||+||+
T Consensus 855 --------------y~~~-------------------------------~gK~pikwmale~i~~~~~thqSDVWsfGVt 889 (1177)
T KOG1025|consen 855 --------------YSAP-------------------------------GGKVPIKWMALESIRIRKYTHQSDVWSFGVT 889 (1177)
T ss_pred --------------cccc-------------------------------ccccCcHHHHHHHhhccCCCchhhhhhhhhh
Confidence 1110 1112357999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 325 MYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 325 lyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
+||++| |..|+.+....++-. .+..... ++.++.++-++.-++.+||. |+..|++
T Consensus 890 iWElmTFGa~Py~gi~~~eI~d-lle~geR--LsqPpiCtiDVy~~mvkCwmid~~~rp~ 946 (1177)
T KOG1025|consen 890 IWELMTFGAKPYDGIPAEEIPD-LLEKGER--LSQPPICTIDVYMVMVKCWMIDADSRPT 946 (1177)
T ss_pred HHHHHhcCCCccCCCCHHHhhH-HHhcccc--CCCCCCccHHHHHHHHHHhccCcccCcc
Confidence 999998 999998877655544 4443333 45556889999999999998 9999993
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=299.10 Aligned_cols=256 Identities=26% Similarity=0.379 Sum_probs=209.1
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEec---C----CcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKK---S----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKL 151 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~---t----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 151 (518)
.+++..++..+.+.||.|+||.|+++.... . ...||+|.++.... ..+.+.+..|+.+|..+ .||||+.|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 455666667778899999999999997541 1 34699999876543 25677899999999998 59999999
Q ss_pred EEEeecCCeEEEEEeecCCCchHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010116 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (518)
Q Consensus 152 ~~~f~~~~~lylVmEy~~gG~L~~~l~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPe 215 (518)
.+++...+.+++|+||+..|+|..+|.... .++......++.||+.|++||++.++|||||...
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999997654 4888999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccc
Q 010116 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (518)
Q Consensus 216 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 295 (518)
|||+..+..+||+|||||+.......+.. ...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~------------------------------------------------~~~ 479 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRT------------------------------------------------KSS 479 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEe------------------------------------------------cCC
Confidence 99999999999999999996543321110 011
Q ss_pred cCC--CCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCC-hhhHHHHHhhhcCcccCCCCCCCChhHHHHHH
Q 010116 296 VGT--PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADD-PITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371 (518)
Q Consensus 296 ~GT--~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~-~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~ 371 (518)
.|| ..|||||.+....|+.++||||+||+||||++ |..|+.+-. ....+..+..+ ..+..| ..++++.-++++
T Consensus 480 ~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G-~r~~~P--~~c~~eiY~iM~ 556 (609)
T KOG0200|consen 480 AGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEG-NRMEQP--EHCSDEIYDLMK 556 (609)
T ss_pred CCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHH
Confidence 232 25999999999999999999999999999999 899998754 44444444432 344455 478999999999
Q ss_pred HHhc-cccccCCCCChhhhhc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~ 391 (518)
.|+. +|.+|| ++.++..
T Consensus 557 ~CW~~~p~~RP---~F~~~~~ 574 (609)
T KOG0200|consen 557 SCWNADPEDRP---TFSECVE 574 (609)
T ss_pred HHhCCCcccCC---CHHHHHH
Confidence 9998 999999 7777764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=278.34 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=193.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh--CCCceeEEEEEeecCC---
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV--ASHCIVKLYYSFQDTE--- 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~~~f~~~~--- 159 (518)
....+++.+||+|.||.||+|+. +++.||||++... +.+.+.+|++|.+.. .|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 45567788999999999999865 4699999998643 356789999998864 7999999998765444
Q ss_pred -eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCeEEcCCCCCceeeCCCCcEEEee
Q 010116 160 -YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK---------HNYIHRDIKPDNLLLDKNGHMKLSD 229 (518)
Q Consensus 160 -~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~---------~giiHRDIKPeNILld~~g~vKL~D 229 (518)
.++||+||.+.|+|.++|. ...++......++..++.||.|||. -.|+|||||..|||+.+|+...|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~-~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLK-ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHH-hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 7899999999999999995 5689999999999999999999996 2599999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC
Q 010116 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (518)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 309 (518)
||||..+..... ...+...|||..|||||+|.+
T Consensus 360 FGLAl~~~p~~~-----------------------------------------------~~d~~~qVGT~RYMAPEvLEg 392 (534)
T KOG3653|consen 360 FGLALRLEPGKP-----------------------------------------------QGDTHGQVGTRRYMAPEVLEG 392 (534)
T ss_pred cceeEEecCCCC-----------------------------------------------CcchhhhhhhhhhcCHHHHhh
Confidence 999998753210 011335799999999999976
Q ss_pred C-CCC-----ccccccchhHHHHHHHhCCC------------CCC-----CCChhhHHHHHhhhcCcccCCCCCC---CC
Q 010116 310 K-GYG-----MECDWWSLGAIMYEMLVGYP------------PFY-----ADDPITTCRKIVHWRNHLKFPDDSK---LS 363 (518)
Q Consensus 310 ~-~y~-----~~~DiWSlGvilyeml~G~~------------PF~-----~~~~~~~~~~i~~~~~~l~~p~~~~---~s 363 (518)
. .+. ...||||+|.+||||++... ||. ...-.++...++..+..+.+|+... --
T Consensus 393 ainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~ 472 (534)
T KOG3653|consen 393 AINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGM 472 (534)
T ss_pred hcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccH
Confidence 3 222 46899999999999998532 332 1234455666777777778876311 13
Q ss_pred hhHHHHHHHHhc-cccccCCC
Q 010116 364 PEAKDLICRLLC-DVEHRLGT 383 (518)
Q Consensus 364 ~~~~dLI~~lL~-dp~~R~g~ 383 (518)
..+++.|..|+. |++.|+++
T Consensus 473 ~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 473 AVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred HHHHHHHHHHcCCchhhhhhh
Confidence 457888999998 99999954
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=254.34 Aligned_cols=212 Identities=42% Similarity=0.678 Sum_probs=182.3
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
|.+.+.||.|++|.||++....+++.+|+|.+...... .....+.+|...++.++|+|++++++++......|+|+||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 57789999999999999999988999999999765432 2466788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 168 LPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 168 ~~gG~L~~~l~~~~~-l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
+++++|.+++..... +++..+..++.+++.+|.+||++|++|+||+|.||+++.++.++|+|||++........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~----- 153 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA----- 153 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-----
Confidence 999999999987666 89999999999999999999999999999999999999999999999999886532100
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhh-cCCCCCccccccchhHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl-~~~~y~~~~DiWSlGvil 325 (518)
......+|+..|++||++ ....++.++|+||||+++
T Consensus 154 -------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~ 190 (225)
T smart00221 154 -------------------------------------------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVIL 190 (225)
T ss_pred -------------------------------------------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHH
Confidence 001135688899999999 667788899999999999
Q ss_pred HHHHhCCCCCCC-CChh-hHHHHHhh
Q 010116 326 YEMLVGYPPFYA-DDPI-TTCRKIVH 349 (518)
Q Consensus 326 yeml~G~~PF~~-~~~~-~~~~~i~~ 349 (518)
|+|++|++||.+ .++. .....|..
T Consensus 191 ~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 191 YELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred HHHHHCCCCccccchhHHHHHHHHhc
Confidence 999999999987 4444 55555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=244.28 Aligned_cols=211 Identities=45% Similarity=0.714 Sum_probs=186.1
Q ss_pred EeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010116 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (518)
Q Consensus 94 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L 173 (518)
||.|++|.||+|....+++.+++|++....... ....+.+|..+++.+.|++|+++++++......++||||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987653221 356788999999999999999999999999999999999999999
Q ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-CCcEEEeecccccccCCCcccccccccccc
Q 010116 174 MTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (518)
Q Consensus 174 ~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~~~~ 251 (518)
..++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. +++++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence 9999765 57999999999999999999999999999999999999999 89999999999886532210
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccchhHHHHHHHh
Q 010116 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLV 330 (518)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~ 330 (518)
......++..|++||.+... .++.+.|+||||+++|+|
T Consensus 149 ---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-- 187 (215)
T cd00180 149 ---------------------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-- 187 (215)
T ss_pred ---------------------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--
Confidence 01134578899999999887 889999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCc
Q 010116 331 GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHP 393 (518)
Q Consensus 331 G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hp 393 (518)
..+.++|.+||+ ||.+|+ ++.++++|+
T Consensus 188 ---------------------------------~~~~~~l~~~l~~~p~~R~---~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------------------PELKDLIRKMLQKDPEKRP---SAKEILEHL 215 (215)
T ss_pred ---------------------------------HHHHHHHHHHhhCCcccCc---CHHHHhhCC
Confidence 578899999998 999999 899999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=265.91 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=189.7
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHH--hCCCceeEEEEEeecC---
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE--VASHCIVKLYYSFQDT--- 158 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~f~~~--- 158 (518)
...+..+.+.||+|-||+||.++++ |+.||||++...+ .....+|.+|.+. ++|+||..++++=..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3467899999999999999988775 8999999986432 3456678888875 4999999998775433
Q ss_pred -CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEEcCCCCCceeeCCCCcEEEee
Q 010116 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDKNGHMKLSD 229 (518)
Q Consensus 159 -~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~--------giiHRDIKPeNILld~~g~vKL~D 229 (518)
..++||.+|.+.|+|+++|.+ .+++-+....++..+++||++||.. .|.|||||..|||+.++|.+-|+|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 269999999999999999976 7899999999999999999999952 499999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC
Q 010116 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (518)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 309 (518)
+|||-..+... +..++. ....|||..|||||||..
T Consensus 360 LGLAv~h~~~t----------------~~idi~-----------------------------~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 360 LGLAVRHDSDT----------------DTIDIP-----------------------------PNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred ceeeEEecccC----------------CcccCC-----------------------------CCCccceeeccChHHhhh
Confidence 99998754321 111111 125699999999999965
Q ss_pred C----CC--CccccccchhHHHHHHHhC----------CCCCCC----CChhhHHHHHhhh-cCcccCCCCCCCChh---
Q 010116 310 K----GY--GMECDWWSLGAIMYEMLVG----------YPPFYA----DDPITTCRKIVHW-RNHLKFPDDSKLSPE--- 365 (518)
Q Consensus 310 ~----~y--~~~~DiWSlGvilyeml~G----------~~PF~~----~~~~~~~~~i~~~-~~~l~~p~~~~~s~~--- 365 (518)
. .+ -..+||||||.+|||++.. .+||++ +...+..++++-- +-.+.+|....-.+.
T Consensus 395 tin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~ 474 (513)
T KOG2052|consen 395 TINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRV 474 (513)
T ss_pred hcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHH
Confidence 3 22 2468999999999999852 578875 2334445555432 223344442222233
Q ss_pred HHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 366 AKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 366 ~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+-.|++.|+- ||.-|+ +|--|++
T Consensus 475 m~klMkeCW~~Np~aRl---tALriKK 498 (513)
T KOG2052|consen 475 MAKLMKECWYANPAARL---TALRIKK 498 (513)
T ss_pred HHHHHHHhhcCCchhhh---HHHHHHH
Confidence 3456788886 999999 6665554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=251.65 Aligned_cols=239 Identities=23% Similarity=0.363 Sum_probs=186.7
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE-EeecCCeEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY-SFQDTEYLY 162 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~-~f~~~~~ly 162 (518)
.+.|.|.+.||.|-||.+-+|+++.++..+++|.+.+... ....+.+|...--.+ .|.||+.-|+ .|++.+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3679999999999999999999999999999999887643 234566676655555 4789998885 689999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC-C-CCcEEEeecccccccCCCc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-K-NGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld-~-~g~vKL~DFGla~~~~~~~ 240 (518)
++|||+|-|||.+-+.. ..+.|...+.+++|+++||+|+|+.++||||||.+||||- . .-.|||||||+..+.+...
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99999999999988744 5688999999999999999999999999999999999983 3 3479999999987643210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CC--CCcc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KG--YGME 315 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~--y~~~ 315 (518)
. -.--+..|.|||+... +. ....
T Consensus 178 ~----------------------------------------------------~~~~~~~y~~pe~~~~~~ne~~~~~ps 205 (378)
T KOG1345|consen 178 K----------------------------------------------------YLEYVNNYHAPELCDTVVNEKLVVNPS 205 (378)
T ss_pred h----------------------------------------------------hhhhhcccCCcHHHhhccccceEeccc
Confidence 0 1113457999998753 33 3788
Q ss_pred ccccchhHHHHHHHhCCCCCCCCCh-hhHHHHHhhhcC--cccCCC-CCCCChhHHHHHHHHhc-ccccc
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDP-ITTCRKIVHWRN--HLKFPD-DSKLSPEAKDLICRLLC-DVEHR 380 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~--~l~~p~-~~~~s~~~~dLI~~lL~-dp~~R 380 (518)
.|+|.||+|+|.+|+|.+||..... ...+..-+.|.. ....|. ...+|+.+..+.++.|. ++++|
T Consensus 206 ~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 206 TDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred ccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 9999999999999999999974321 222333444432 223443 23579999999999998 88888
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=302.45 Aligned_cols=227 Identities=12% Similarity=0.158 Sum_probs=154.3
Q ss_pred CceeEEEEEe-------ecCCeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCce
Q 010116 146 HCIVKLYYSF-------QDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (518)
Q Consensus 146 p~Iv~l~~~f-------~~~~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNI 217 (518)
+||++++++| .....++++|||+ +++|..+|.. ...+++..++.|+.||+.||.|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4777777777 3345688899988 6799999965 35699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHH-Hhhhccccccccc
Q 010116 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQH-WQMNRRKLAFSTV 296 (518)
Q Consensus 218 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~ 296 (518)
||+..|.+|++|||+|........... .+.+-+....... ... . ....... ............+
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~----ki~DfG~a~~~~~---~~~----~----~~~~~~~~~~~~~~~~~~~~~ 176 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATT----KSREIGSSRREEI---LSE----R----RIEKLEEVKKQPFPMKQILAM 176 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcc----ccccccccccccc---ccc----c----chhhhhccccCCCcccccccC
Confidence 999989999999998865322100000 0000000000000 000 0 0000000 0000000112357
Q ss_pred CCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCC-CCCCChhHHHHHHHHhc
Q 010116 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLC 375 (518)
Q Consensus 297 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~-~~~~s~~~~dLI~~lL~ 375 (518)
||+.|||||++.+..|+.++|||||||+||||++|.+||.... .....+... .+|. ...-.+.+.+++.+||.
T Consensus 177 gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~L~ 250 (793)
T PLN00181 177 EMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR----VLPPQILLNWPKEASFCLWLLH 250 (793)
T ss_pred CCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh----hcChhhhhcCHHHHHHHHHhCC
Confidence 9999999999999999999999999999999999999976432 222222221 1111 11224667899999998
Q ss_pred -cccccCCCCChhhhhcCccccc
Q 010116 376 -DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 376 -dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||.+|+ ++.||++||||..
T Consensus 251 ~~P~~Rp---s~~eil~h~~~~~ 270 (793)
T PLN00181 251 PEPSCRP---SMSELLQSEFINE 270 (793)
T ss_pred CChhhCc---ChHHHhhchhhhh
Confidence 999999 8999999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=286.99 Aligned_cols=324 Identities=32% Similarity=0.524 Sum_probs=269.1
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
..+.++|.+++-+-+|+||.++.+.-..+|...++|+..+..++...+.+..+.+.+++-...+|.++..++.|.-...+
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 35778999999999999999999999999999999999998888888888899999998888999999999998888999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
+|||+|+.||+|...|+.-+..+++-++.++..++++++|||...++|||++|.|+|+..+||.+++|||+......-..
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999999999989999999999999999999999999999999999999999999999999996654432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.. +... ......+.....+ .+..++. ......-...+||+.|.|||.+.+...+..+|||++
T Consensus 960 ~~----------~~sg--~~~~~~~~~~~~~---~~~~~l~---~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 960 TT----------DLSG--PSSSGTPRRLSRS---ERRPQLS---ADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred cC----------Cccc--ccccCcccccccc---ccccccc---cchhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence 00 0000 0000000000000 0011111 111123456789999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCC-CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
|++++|.++|.+||.+..+...+++|.+. ....|. ....++++++++.++|. +|.+|+|..++.+++.||||++++
T Consensus 1022 g~~l~e~l~g~pp~na~tpq~~f~ni~~~--~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAETPQQIFENILNR--DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred hhhhhhhhcCCCCCCCcchhhhhhccccC--CCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 99999999999999999999999999873 444444 23578999999999998 999999988888999999999999
Q ss_pred ccccccccCCccccCCCcccCCCCCC
Q 010116 400 WDKLYEMEAAFKPEINGELDTQNFMK 425 (518)
Q Consensus 400 w~~l~~~~~p~~p~~~~~~d~~~f~~ 425 (518)
|+.|....++|+|...+..|+++|..
T Consensus 1100 ~~~l~~q~~~~~p~~~s~~dtS~~~~ 1125 (1205)
T KOG0606|consen 1100 WENLALQKAEFVPQPESTQDTSYFES 1125 (1205)
T ss_pred ccccccccCccCCCCCCCCccchhhc
Confidence 99999999999999999999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=237.37 Aligned_cols=261 Identities=40% Similarity=0.609 Sum_probs=207.6
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC-ceeEEEEEeecCCeEEEEEe
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~f~~~~~lylVmE 166 (518)
|.+.+.||.|+||.||++.+. ..+|+|.+.+...........+.+|..+++.+.|+ +|++++..+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999887 88999999877654444577789999999999988 79999999988888999999
Q ss_pred ecCCCchHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-cEEEeecccccccCCCccc
Q 010116 167 YLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 167 y~~gG~L~~~l~~~~---~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-~vKL~DFGla~~~~~~~~~ 242 (518)
|+.|+++..++.... .+++..+..++.|++.++.|+|+.|++||||||+|||++..+ .++++|||+++.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997776654 799999999999999999999999999999999999999998 7999999998854321100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CCCCcccccc
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMECDWW 319 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiW 319 (518)
... .......+||+.|+|||++.+ ..++...|+|
T Consensus 159 ~~~-------------------------------------------~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~ 195 (384)
T COG0515 159 SSI-------------------------------------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIW 195 (384)
T ss_pred ccc-------------------------------------------cccccccccccccCCHHHhcCCCCCCCCchHhHH
Confidence 000 001236789999999999988 5789999999
Q ss_pred chhHHHHHHHhCCCCCCCCCh----hhHHHHHhhhcCc-ccCCCCCCC----ChhHHHHHHHHhc-cccccCCCCChhhh
Q 010116 320 SLGAIMYEMLVGYPPFYADDP----ITTCRKIVHWRNH-LKFPDDSKL----SPEAKDLICRLLC-DVEHRLGTGGAHQI 389 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~-l~~p~~~~~----s~~~~dLI~~lL~-dp~~R~g~~~a~ei 389 (518)
|+|++++++++|..||..... ......+...... ...+..... ...+.+++.+++. +|..|. +..+.
T Consensus 196 s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~---~~~~~ 272 (384)
T COG0515 196 SLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL---SSSSD 272 (384)
T ss_pred HHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcC---CHHHH
Confidence 999999999999999887763 3344333332111 111111111 2578999999998 999999 67777
Q ss_pred hcCccccc
Q 010116 390 KAHPWFKD 397 (518)
Q Consensus 390 l~Hpff~~ 397 (518)
..++|...
T Consensus 273 ~~~~~~~~ 280 (384)
T COG0515 273 LSHDLLAH 280 (384)
T ss_pred hhchHhhC
Confidence 77766554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=230.70 Aligned_cols=161 Identities=21% Similarity=0.228 Sum_probs=129.6
Q ss_pred CchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccc
Q 010116 171 GDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (518)
Q Consensus 171 G~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 249 (518)
|+|.+++.. ...+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 789999976 456999999999999999999999999 999999999999999 9998754210
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHH
Q 010116 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329 (518)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 329 (518)
..+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 63 --------------------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 98 (176)
T smart00750 63 --------------------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL 98 (176)
T ss_pred --------------------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHH
Confidence 226899999999999999999999999999999999
Q ss_pred hCCCCCCCCChhh-HHHHHhhhcCcccC---CCCCCCCh--hHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 330 VGYPPFYADDPIT-TCRKIVHWRNHLKF---PDDSKLSP--EAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 330 ~G~~PF~~~~~~~-~~~~i~~~~~~l~~---p~~~~~s~--~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
+|.+||....... ....+......... +....++. ++++||.+||. ||.+|+ ++.+++.|+|+.
T Consensus 99 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp---~~~~ll~~~~~~ 169 (176)
T smart00750 99 DYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRRE---AANHYLAHCRAL 169 (176)
T ss_pred hCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhccccccc---CHHHHHHHHHHH
Confidence 9999997655432 33333321111100 11122344 69999999998 999999 899999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=276.36 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=202.9
Q ss_pred eEEeeEeecCceEEEEEEEecCCcEEEEEEeec---hhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK---SEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 89 ~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k---~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
....++|.|++|.|+.+......+.++.|.... .....+.....+..|.-+-..+.|||++.....+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356789999999999998887777777776542 11112222223555666666779999988777777666666669
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|||++ ||+.+++..+.++..++..++.|++.||.|||..||.||||||+|+|++.+|.+||+|||.+..+......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~--- 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK--- 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch---
Confidence 99999 99999998889999999999999999999999999999999999999999999999999998865432100
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC-ccccccchhHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG-MECDWWSLGAI 324 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvi 324 (518)
.-.....++|+..|+|||++.+..|. ..+||||.|++
T Consensus 477 ------------------------------------------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii 514 (601)
T KOG0590|consen 477 ------------------------------------------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGII 514 (601)
T ss_pred ------------------------------------------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccce
Confidence 00134478999999999999999995 57899999999
Q ss_pred HHHHHhCCCCCCCCChhhHH-HHH--hhhcCcc--cCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 325 MYEMLVGYPPFYADDPITTC-RKI--VHWRNHL--KFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~-~~i--~~~~~~l--~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
+..|.+|+.||......... ... ..+.... ..+....++.+.+.+|.+||. ||.+|. ++++|++.+||+.|
T Consensus 515 ~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~---ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 515 YICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI---TIEQILNDEWIRSI 591 (601)
T ss_pred EEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhee---cHHHHhhChHhhhc
Confidence 99999999999765443221 111 1111111 111123578899999999999 999999 99999999999987
Q ss_pred C
Q 010116 399 V 399 (518)
Q Consensus 399 ~ 399 (518)
.
T Consensus 592 ~ 592 (601)
T KOG0590|consen 592 E 592 (601)
T ss_pred c
Confidence 5
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=246.23 Aligned_cols=146 Identities=17% Similarity=0.179 Sum_probs=117.8
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEec-CCcEEEEEEeechhh--hchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~-t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
....++|++.+.||+|+||+||+|+++. +++.||||++..... ........+.+|+.+|+.++|++|+..++.+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456789999999999999999998876 788889998753211 1223356689999999999999998533332
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCC-CCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI-KPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDI-KPeNILld~~g~vKL~DFGla~~~~ 237 (518)
+..|||||||+|++|.. +... . ...++.|++.||.|||++||||||| ||+|||++.+|.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 45899999999999963 2111 1 1467899999999999999999999 9999999999999999999999764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=234.76 Aligned_cols=258 Identities=20% Similarity=0.270 Sum_probs=208.8
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEecCC-----cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEE
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSG-----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~-----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 152 (518)
++...+...++++...+-+|.||+||.+.++... +.+-+|.++.. .+.-++..+..|--+|..+.|||+..+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 4445556678999999999999999999765432 23445555432 2445677888999999999999999988
Q ss_pred EEe-ecCCeEEEEEeecCCCchHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC
Q 010116 153 YSF-QDTEYLYLIMEYLPGGDMMTLLMR--------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (518)
Q Consensus 153 ~~f-~~~~~lylVmEy~~gG~L~~~l~~--------~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g 223 (518)
++. ++....+.++.++.-|+|..+|.. ...++..+...++.|++.|++|||++||||.||...|.+||+.-
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe
Confidence 866 455677889999999999999962 13577888889999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccC
Q 010116 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (518)
Q Consensus 224 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 303 (518)
.+||+|=.|++.+-+.+......+ ---...||+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDn-----------------------------------------------EnRPvkWMs 466 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDN-----------------------------------------------ENRPVKWMS 466 (563)
T ss_pred eEEeccchhccccCcccccccCCC-----------------------------------------------CCCcccccC
Confidence 999999999997654433221111 112357999
Q ss_pred hhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccC
Q 010116 304 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381 (518)
Q Consensus 304 PEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 381 (518)
||.+.+..|+.++|+|||||+||||++ |+.|+..-+|.++...+..+ ..+.-| .++++++...+.-|+. +|++||
T Consensus 467 lEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-yRlaQP--~NCPDeLf~vMacCWallpeeRP 543 (563)
T KOG1024|consen 467 LEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-YRLAQP--FNCPDELFTVMACCWALLPEERP 543 (563)
T ss_pred HHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-ceecCC--CCCcHHHHHHHHHHHhcCcccCC
Confidence 999999999999999999999999998 99999999999998887764 344444 4799999999999998 999999
Q ss_pred CCCChhhhh
Q 010116 382 GTGGAHQIK 390 (518)
Q Consensus 382 g~~~a~eil 390 (518)
+.+++.
T Consensus 544 ---sf~Qlv 549 (563)
T KOG1024|consen 544 ---SFSQLV 549 (563)
T ss_pred ---CHHHHH
Confidence 777764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-25 Score=228.79 Aligned_cols=252 Identities=24% Similarity=0.282 Sum_probs=186.1
Q ss_pred CeeEEeeEeecCceEEEEEEEecCC-cEEEEEEeechhhhchhhHHHHHHHHHHHHHhC----CCceeEEEEEe-ecCCe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSG-NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA----SHCIVKLYYSF-QDTEY 160 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~-~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~----hp~Iv~l~~~f-~~~~~ 160 (518)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|..+|..+. .+++..++..+ ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988775 6799998765432211 14677888888886 36899999999 58889
Q ss_pred EEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC-----CcEEEeecccc
Q 010116 161 LYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-----GHMKLSDFGLC 233 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~-----g~vKL~DFGla 233 (518)
-|+||+.+ |.+|.++.... +.|+...+..++.|++.+|++||+.|+|||||||+|+++... -.+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 99999988544 689999999999999999999999999999999999999865 35899999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
+........... . ...+.....+.||..|+++.+..+...+
T Consensus 175 r~~~~~~~~~~~-------------~--------------------------~~~r~~~~~~rGT~ry~S~~~H~~~e~~ 215 (322)
T KOG1164|consen 175 RRFKYVGDSGGN-------------L--------------------------RPPRPQKGLFRGTLRYASINVHLGIEQG 215 (322)
T ss_pred ccccccCCCCcc-------------c--------------------------ccCCCCccCCCCccccccHHHhCCCccC
Confidence 843211000000 0 0000111246799999999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCC-CCCCChhHHHHHHHHhc-cccccC
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLC-DVEHRL 381 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~R~ 381 (518)
..-|+||++.++.||+.|..||.+........++........... ....+.+...+...+-. +...+|
T Consensus 216 r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P 285 (322)
T KOG1164|consen 216 RRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKP 285 (322)
T ss_pred CchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCC
Confidence 999999999999999999999977654333333333222222221 11223445555444433 566666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=205.05 Aligned_cols=243 Identities=22% Similarity=0.246 Sum_probs=186.4
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC-CceeEEEEEeecCCeE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDTEYL 161 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~~l 161 (518)
+....|.++++||.|+||.+|++....+|..||||+=.+.. ..-++.-|..+...+.+ +.|..+..++....+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45678999999999999999999999999999999854432 12346678888888865 6788888888899999
Q ss_pred EEEEeecCCCchHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC---cEEEeecccccccC
Q 010116 162 YLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLD 237 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~-~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g---~vKL~DFGla~~~~ 237 (518)
.|||+++ |.+|.+++. ....|+...+.-++-|++.-|+|+|.+++|||||||+|+|..-+- .+.|+||||||.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 899999885 357899999999999999999999999999999999999997554 47899999999875
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.......-+. ..-....||..|.+--...+..-+..-|
T Consensus 166 d~~t~~HIpy------------------------------------------re~r~ltGTaRYASinAh~g~eqSRRDD 203 (341)
T KOG1163|consen 166 DIRTRQHIPY------------------------------------------REDRNLTGTARYASINAHLGIEQSRRDD 203 (341)
T ss_pred cccccccCcc------------------------------------------ccCCccceeeeehhhhhhhhhhhhhhhh
Confidence 3211100000 0112567999999988888888889999
Q ss_pred ccchhHHHHHHHhCCCCCCCCCh---hhHHHHHhhhcCcccCC-CCCCCChhHHHHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDP---ITTCRKIVHWRNHLKFP-DDSKLSPEAKDLICRL 373 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~~~l~~p-~~~~~s~~~~dLI~~l 373 (518)
+=|+|.+|....-|..||.+-.. .+-+.+|...+...... -...++.++.-.+.-|
T Consensus 204 meSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~ 263 (341)
T KOG1163|consen 204 MESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYC 263 (341)
T ss_pred hhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHH
Confidence 99999999999999999987543 34455665533221111 0234556665555443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=208.71 Aligned_cols=143 Identities=20% Similarity=0.216 Sum_probs=113.2
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhh-----------------------HHHHHHHHHHHHHhCCCc
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-----------------------VEHVRAERNLLAEVASHC 147 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~-----------------------~~~~~~E~~il~~l~hp~ 147 (518)
...||+|+||.||+|.+. +|+.||||++++........ ......|..+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 89999999998653211110 123356999999998776
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCeEEcCCCCCceeeCCCCcEE
Q 010116 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI-HKHNYIHRDIKPDNLLLDKNGHMK 226 (518)
Q Consensus 148 Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~L-H~~giiHRDIKPeNILld~~g~vK 226 (518)
+...+..... . .||||||++|+++...+.....+++..+..++.|++.+|.+| |+.|||||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6433322222 2 389999999988776655567899999999999999999999 799999999999999998 58999
Q ss_pred EeecccccccC
Q 010116 227 LSDFGLCKPLD 237 (518)
Q Consensus 227 L~DFGla~~~~ 237 (518)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=206.96 Aligned_cols=141 Identities=16% Similarity=0.213 Sum_probs=116.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHH------HHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH------VRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~------~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
.++|+++++||.|+||.||++.. ++..||+|++............. +.+|+..+.++.||+|..+..++.+.
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999754 46789999997654333333333 57899999999999999998887644
Q ss_pred --------CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeec
Q 010116 159 --------EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (518)
Q Consensus 159 --------~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DF 230 (518)
...||||||++|.+|.++. .+++. ...+++.+|..||+.|++||||||.||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 3589999999999998773 23433 456999999999999999999999999999999 999999
Q ss_pred cccccc
Q 010116 231 GLCKPL 236 (518)
Q Consensus 231 Gla~~~ 236 (518)
|.++..
T Consensus 179 g~~~~~ 184 (232)
T PRK10359 179 SGKRCT 184 (232)
T ss_pred CCcccc
Confidence 987643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=200.63 Aligned_cols=144 Identities=19% Similarity=0.177 Sum_probs=115.1
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchh-----------------------hHHHHHHHHHHHHHhCCCc
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-----------------------QVEHVRAERNLLAEVASHC 147 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~-----------------------~~~~~~~E~~il~~l~hp~ 147 (518)
.+.||+|+||.||+|++. +|+.||||+++........ .......|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999999875321000 0123467899999999998
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEE
Q 010116 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMK 226 (518)
Q Consensus 148 Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vK 226 (518)
|.......... .||||||++|+++.........+++..+..++.|++.+|.+||+ .||+||||||+|||++ +|.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 74443333222 48999999988665443455678899999999999999999999 9999999999999998 89999
Q ss_pred EeecccccccCC
Q 010116 227 LSDFGLCKPLDC 238 (518)
Q Consensus 227 L~DFGla~~~~~ 238 (518)
|+|||+|..+..
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=206.52 Aligned_cols=217 Identities=24% Similarity=0.335 Sum_probs=177.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~ly 162 (518)
.--.|++.++||.|+||+.+++....++++||||.=... ...-.++.|....+.+. .+.|...|++-+...+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 345799999999999999999999999999999964322 12334667877777774 689999999999998999
Q ss_pred EEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-----cEEEeeccccccc
Q 010116 163 LIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-----HMKLSDFGLCKPL 236 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-----~vKL~DFGla~~~ 236 (518)
||||++ |-+|.+++.- ..+|+...+.-++.|++.-++|+|++.+|+|||||+|+||..-| .|.|+|||+||..
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999 8899998854 46899999999999999999999999999999999999997644 4789999999986
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
........-+. ..-.+..||..||+--..++..-+..-
T Consensus 180 rDp~TkqHIPY------------------------------------------rE~KSLsGTARYMSINTHlGrEQSRRD 217 (449)
T KOG1165|consen 180 RDPKTKQHIPY------------------------------------------REHKSLSGTARYMSINTHLGREQSRRD 217 (449)
T ss_pred cCccccccCcc------------------------------------------ccccccccceeeeEeeccccchhhhhh
Confidence 53321110000 012267899999999999999999999
Q ss_pred cccchhHHHHHHHhCCCCCCC---CChhhHHHHHh
Q 010116 317 DWWSLGAIMYEMLVGYPPFYA---DDPITTCRKIV 348 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i~ 348 (518)
|.=|||-++...|-|..||.+ ++..+-+.+|-
T Consensus 218 DLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 218 DLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred hHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 999999999999999999976 34445555553
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-24 Score=210.22 Aligned_cols=274 Identities=26% Similarity=0.365 Sum_probs=185.5
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCc-----------------------------------EEEEEEeechhh
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGN-----------------------------------IYAMKKLKKSEM 124 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~-----------------------------------~~AiK~l~k~~~ 124 (518)
..+++++||+|...||+|.-..||.|+...+|. +.|||.+-.-+.
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 457788999999999999999999887654221 356666543322
Q ss_pred hchh--hHHHHHHHH------HHH--------H--------HhCCCceeEEEEEeec-----------------------
Q 010116 125 VKRG--QVEHVRAER------NLL--------A--------EVASHCIVKLYYSFQD----------------------- 157 (518)
Q Consensus 125 ~~~~--~~~~~~~E~------~il--------~--------~l~hp~Iv~l~~~f~~----------------------- 157 (518)
.+.. ....+-+|. ..+ + ...|||||+++..|.|
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 2110 011111121 001 0 1269999999998864
Q ss_pred ----CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee--CCCC--cEEEee
Q 010116 158 ----TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL--DKNG--HMKLSD 229 (518)
Q Consensus 158 ----~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl--d~~g--~vKL~D 229 (518)
...+|+||--.+ .+|..++-. ...+....+.+++|++.|+.|||++||.|||+|.+|||| |.|+ .+.|+|
T Consensus 311 g~g~~~tlylvMkrY~-~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYR-QTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred ccCCCceEEEehhcch-hhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 245899999884 589999854 456778888999999999999999999999999999998 4454 478999
Q ss_pred cccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC
Q 010116 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (518)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 309 (518)
||.|-.-+.-.....+++.. + ..-|.-.-||||+...
T Consensus 389 FGCcLAd~~hGlqlpy~S~~-----------V--------------------------------d~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 389 FGCCLADDNHGLQLPYESDE-----------V--------------------------------DLGGNAKLMAPEIATA 425 (598)
T ss_pred cceeeecccccccccccccc-----------c--------------------------------cCCCcceecchhhhhc
Confidence 99886433211111111000 0 2236677899999874
Q ss_pred CC-----C-CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 310 KG-----Y-GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 310 ~~-----y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
.+ . -.++|.|+.|.+.||++....||++......-..-.....-...| ..+++.+++|+..+|. ||.+|..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp--~~vpp~~rqlV~~lL~r~pskRvs 503 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP--SRVPPVARQLVFDLLKRDPSKRVS 503 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc--ccCChHHHHHHHHHhcCCccccCC
Confidence 32 1 247999999999999999999999854332211111111122333 4789999999999998 9999997
Q ss_pred CCChhhhhcCcccccCCc
Q 010116 383 TGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 383 ~~~a~eil~Hpff~~i~w 400 (518)
..=|..+++-..|..-+|
T Consensus 504 p~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 504 PNIAANVLNLSLWRMGED 521 (598)
T ss_pred ccHHHhHHHHHHhcCchH
Confidence 655666666555544333
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=195.67 Aligned_cols=202 Identities=19% Similarity=0.248 Sum_probs=146.1
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhh-HHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEEEE
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~-~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVm 165 (518)
+.+...||+|+||+|+++.. .+..++.+.+.-.....+.- ...+.+|+++|+.+. |++|++++++ ...|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999997754 67788877776554432221 224789999999995 4789999876 3479999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCC-CCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI-KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDI-KPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||+.|.+|...+.. . ...++.|++.+|.++|++||||||| ||+|||++.+|+++|+|||+|........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~--- 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR--- 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch---
Confidence 99999998754421 1 1347889999999999999999999 79999999999999999999985432100
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCC--chhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCccccccc
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKS--PHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECDWWS 320 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWS 320 (518)
+.. ..+.+.+.... -...++.|++|+--.- ..--...+|++
T Consensus 148 -----------------------------~~r~L~~rDl~~llk~------~~~y~~~~l~~~~~~~l~~~~~~~~~w~~ 192 (218)
T PRK12274 148 -----------------------------WMRLLAREDLRHLLKH------KRMYCPAALTPVERRVLKRTSWIRELWFA 192 (218)
T ss_pred -----------------------------HHHHHHHHHHHHHHHH------HHhcCCCCCCHHHHhhhccchhHHHHHHH
Confidence 000 00111111111 1237889999986532 22236789999
Q ss_pred hhHHHHHHHhCCCCCCCCCh
Q 010116 321 LGAIMYEMLVGYPPFYADDP 340 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~ 340 (518)
.|+.+|.++||..|+.++..
T Consensus 193 ~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 193 TGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hcchHHHHHhccCCccccCC
Confidence 99999999999999887653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-23 Score=201.84 Aligned_cols=233 Identities=24% Similarity=0.346 Sum_probs=151.6
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC-----------CceeEEEE--
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-----------HCIVKLYY-- 153 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-----------p~Iv~l~~-- 153 (518)
.+.....||.|+||.||.+.+..||+.+|+|+..-.........+.+++|.-....+.+ .+++.+--
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35667899999999999999999999999999865554445566777666544333211 11211110
Q ss_pred ------Eee---cCC-----eEEEEEeecCCCchHHHHh---hcCCC---CHHHHHHH-HHHHHHHHHHHHhCCeEEcCC
Q 010116 154 ------SFQ---DTE-----YLYLIMEYLPGGDMMTLLM---REDTL---TENVARFY-IAQSVLAIESIHKHNYIHRDI 212 (518)
Q Consensus 154 ------~f~---~~~-----~lylVmEy~~gG~L~~~l~---~~~~l---~e~~~~~~-~~ql~~aL~~LH~~giiHRDI 212 (518)
++. +.. +.+++|+-+ -+||..++. ..... ....|+.+ ..|++..+++||+.|+||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 111 347788888 568877753 22222 22344444 489999999999999999999
Q ss_pred CCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccc
Q 010116 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLA 292 (518)
Q Consensus 213 KPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (518)
||+|++++.+|.+.|+||+........ .
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~----------------------------------------------------~ 199 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR----------------------------------------------------Y 199 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE----------------------------------------------------E
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce----------------------------------------------------e
Confidence 999999999999999999987653211 0
Q ss_pred ccccCCCCccChhhhcCC--------CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCCh
Q 010116 293 FSTVGTPDYIAPEVLLKK--------GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSP 364 (518)
Q Consensus 293 ~s~~GT~~Y~APEvl~~~--------~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~ 364 (518)
.....+..|.+||+.... .|+.+.|.|+||+++|.|.+|..||....+..... ..|.....+++
T Consensus 200 ~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~--------~~f~~C~~~Pe 271 (288)
T PF14531_consen 200 RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE--------WDFSRCRDMPE 271 (288)
T ss_dssp EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG--------GGGTTSS---H
T ss_pred eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc--------ccchhcCCcCH
Confidence 012345779999987542 47899999999999999999999998664432211 13334446889
Q ss_pred hHHHHHHHHhc-ccccc
Q 010116 365 EAKDLICRLLC-DVEHR 380 (518)
Q Consensus 365 ~~~dLI~~lL~-dp~~R 380 (518)
..++||+.||. ||.+|
T Consensus 272 ~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 272 PVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCcccC
Confidence 99999999998 99987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=189.44 Aligned_cols=136 Identities=15% Similarity=0.200 Sum_probs=109.1
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-----CCCceeEEEEEeecCC---eEE
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-----ASHCIVKLYYSFQDTE---YLY 162 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~f~~~~---~ly 162 (518)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ +||||+++|++++++. .+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 6666665 699886542 22346689999999999 6799999999999874 544
Q ss_pred -EEEee--cCCCchHHHHhhcCCCCHHHHHHHHHHHHHHH-HHHHhCCeEEcCCCCCceeeCCC----CcEEEeeccccc
Q 010116 163 -LIMEY--LPGGDMMTLLMREDTLTENVARFYIAQSVLAI-ESIHKHNYIHRDIKPDNLLLDKN----GHMKLSDFGLCK 234 (518)
Q Consensus 163 -lVmEy--~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL-~~LH~~giiHRDIKPeNILld~~----g~vKL~DFGla~ 234 (518)
+|||| +++|+|.+++.+ ..+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+-+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 668999999965 457666 35688888888 99999999999999999999743 479999955444
Q ss_pred c
Q 010116 235 P 235 (518)
Q Consensus 235 ~ 235 (518)
.
T Consensus 158 ~ 158 (210)
T PRK10345 158 T 158 (210)
T ss_pred c
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-23 Score=226.14 Aligned_cols=263 Identities=24% Similarity=0.413 Sum_probs=213.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEe-cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREK-KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~-~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~ly 162 (518)
...|.+.+.||+|+|+.|-++... .+...+|+|.+.... .......++..|..+-..+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 567899999999999999998764 344567777765443 33445667777888888887 999999999999999999
Q ss_pred EEEeecCCCchHHHH-hhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCeEEcCCCCCceeeCCCC-cEEEeecccccccCC
Q 010116 163 LIMEYLPGGDMMTLL-MRED-TLTENVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDC 238 (518)
Q Consensus 163 lVmEy~~gG~L~~~l-~~~~-~l~e~~~~~~~~ql~~aL~~LH-~~giiHRDIKPeNILld~~g-~vKL~DFGla~~~~~ 238 (518)
++++|..||+++.-+ .... ..+...+.+|+.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999998 5554 7889999999999999999999 99999999999999999999 999999999987642
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccC-CCCccChhhhcCCCC-Cccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG-TPDYIAPEVLLKKGY-GMEC 316 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G-T~~Y~APEvl~~~~y-~~~~ 316 (518)
.. .........|| ++.|+|||...+..| +...
T Consensus 178 ~~----------------------------------------------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~ 211 (601)
T KOG0590|consen 178 KN----------------------------------------------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSV 211 (601)
T ss_pred cC----------------------------------------------CcceeeecccCCCCCCCCcccccchhhcCCCc
Confidence 10 00112235688 999999999998655 7889
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHH-HHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTC-RKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~-~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
|+||.|+++.-|++|..|+......... ......+..+....+..++..+.+++.++|+ +|..|. +.+++..+||
T Consensus 212 d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~---s~~~~~~d~~ 288 (601)
T KOG0590|consen 212 DVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRL---SIEELKLDNW 288 (601)
T ss_pred ccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcc---cccccccccc
Confidence 9999999999999999999765443321 1111111233344456899999999999997 999999 8999999999
Q ss_pred ccc
Q 010116 395 FKD 397 (518)
Q Consensus 395 f~~ 397 (518)
+..
T Consensus 289 ~~~ 291 (601)
T KOG0590|consen 289 LSS 291 (601)
T ss_pred ccc
Confidence 987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-21 Score=188.50 Aligned_cols=146 Identities=16% Similarity=0.125 Sum_probs=116.8
Q ss_pred CeeEEeeEeecCceEEEEEE-EecCCcEEEEEEeechhhhch---------------------hhHHHHHHHHHHHHHhC
Q 010116 87 DFELLTIIGRGAFGEVRLCR-EKKSGNIYAMKKLKKSEMVKR---------------------GQVEHVRAERNLLAEVA 144 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~-~~~t~~~~AiK~l~k~~~~~~---------------------~~~~~~~~E~~il~~l~ 144 (518)
.|.+.+.||+|+||.||+|. +..+|+.||||++........ .....+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 677899999999875431100 01123578999999997
Q ss_pred CC--ceeEEEEEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEEcCCCCCceeeCC
Q 010116 145 SH--CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN-YIHRDIKPDNLLLDK 221 (518)
Q Consensus 145 hp--~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~g-iiHRDIKPeNILld~ 221 (518)
+. .+.+++.. . ..||||||++|++|...+.....+.+..++.++.|++.+|.+||++| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34455442 2 34899999999888776655566777788899999999999999999 99999999999999
Q ss_pred CCcEEEeecccccccC
Q 010116 222 NGHMKLSDFGLCKPLD 237 (518)
Q Consensus 222 ~g~vKL~DFGla~~~~ 237 (518)
++.++|+|||+|....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8999999999998654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-22 Score=219.68 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=180.9
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechh-hh-chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE-MV-KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~-~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
+|...+.||++-|=+|.+|++.. | .|+||++-+.. .. -+...+++. |+. ....++||++.+.-+-..+...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLE-EIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHH-HHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 68888999999999999887643 4 48999987654 22 223333443 444 6677999999888887888889999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
-+|.. -+|++.|..+.-+..-+.++|+-|++.||.-+|..||+|+|||.|||||++-.-+.|+||.--|+..-..
T Consensus 100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe---- 174 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE---- 174 (1431)
T ss_pred HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCC----
Confidence 99994 5999999888889999999999999999999999999999999999999999999999998766532110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccccc-CCCCccChhhhcCCC-----------C
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV-GTPDYIAPEVLLKKG-----------Y 312 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~-GT~~Y~APEvl~~~~-----------y 312 (518)
|+.+.+ ...+.+. --..|+|||-+...+ .
T Consensus 175 ------------------------DNPadf---------------~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L 215 (1431)
T KOG1240|consen 175 ------------------------DNPADF---------------TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLL 215 (1431)
T ss_pred ------------------------CCcccc---------------eEEEecCCceeeecChHhhhccccccccCCccccc
Confidence 000000 0000111 113699999876422 5
Q ss_pred CccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCc-ccCCC---CCCCChhHHHHHHHHhc-cccccCCCCCh
Q 010116 313 GMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNH-LKFPD---DSKLSPEAKDLICRLLC-DVEHRLGTGGA 386 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~-l~~p~---~~~~s~~~~dLI~~lL~-dp~~R~g~~~a 386 (518)
+++-||||+||++.||++ |.|||.- .+.+.++.. -..|+ ..--+...+.||..|+. ||.+|+ +|
T Consensus 216 ~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~Rl---SA 285 (1431)
T KOG1240|consen 216 TPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRL---SA 285 (1431)
T ss_pred ChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhcc---CH
Confidence 788999999999999998 7999831 111111111 00000 00013578999999998 999999 89
Q ss_pred hhhhcC
Q 010116 387 HQIKAH 392 (518)
Q Consensus 387 ~eil~H 392 (518)
++.|+-
T Consensus 286 edyL~~ 291 (1431)
T KOG1240|consen 286 EDYLQK 291 (1431)
T ss_pred HHHHHh
Confidence 998875
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.2e-21 Score=214.25 Aligned_cols=199 Identities=22% Similarity=0.313 Sum_probs=158.1
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC---CCceeEEEEEeec
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQD 157 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~ 157 (518)
.++....|.|-+.||+|+||+||.|.... |+.||+|+=+......- .--..++.+|+ -+.|..+..++.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf------YI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF------YICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee------eehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34566789999999999999999999877 99999998765543221 11122333333 2455555555555
Q ss_pred CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-------CCcEEEeec
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-------NGHMKLSDF 230 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-------~g~vKL~DF 230 (518)
.+.-+||+||.+.|+|.+++.....+++..+.+++.|++..|+.||..+|||+||||+|+||.. .--++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 5667899999999999999998899999999999999999999999999999999999999953 235899999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 310 (518)
|-+..+..- ++ .......++|-.+-.+|+..|.
T Consensus 846 G~siDm~lf------p~-----------------------------------------~~~F~~~~~td~f~C~EM~~gr 878 (974)
T KOG1166|consen 846 GRSIDMKLF------PD-----------------------------------------GTKFKAVWHTDLFDCIEMREGR 878 (974)
T ss_pred ccceeeeEc------CC-----------------------------------------CcEEeeeeccccchhHHHhcCC
Confidence 987644211 00 0123467899999999999999
Q ss_pred CCCccccccchhHHHHHHHhCCC
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYP 333 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~ 333 (518)
++++.+|.|.|..+++-||.|+.
T Consensus 879 pWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 879 PWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCchhhhhHHHHHHHHHHHHHHH
Confidence 99999999999999999999964
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=179.70 Aligned_cols=137 Identities=23% Similarity=0.302 Sum_probs=113.9
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+.||+|++|.||+|+. .|..+++|+....... .......+.+|..++..+.|++|+....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999976 6778999986533211 11123457889999999999988777777777788999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
|++|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865332 7778899999999999999999999999999999 89999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.9e-20 Score=173.04 Aligned_cols=133 Identities=21% Similarity=0.285 Sum_probs=106.6
Q ss_pred eEeecCceEEEEEEEecCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEee
Q 010116 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 93 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 167 (518)
.||+|+||.||++. .+|..+++|+....... ......++.+|..++..+.|+++.....++.+....++||||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999997 46788999986543211 112246678899999999887654444444556667899999
Q ss_pred cCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 168 ~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
++|++|.+++..... .++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988754321 7889999999999999999999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=171.93 Aligned_cols=139 Identities=21% Similarity=0.193 Sum_probs=109.3
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch-------------------hhHHHHHHHHHHHHHhCCC--
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR-------------------GQVEHVRAERNLLAEVASH-- 146 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~-------------------~~~~~~~~E~~il~~l~hp-- 146 (518)
|.+.+.||.|+||.||+|... +|+.||||++........ ........|..++..+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777899999999999999874 799999999765321000 0112356788889888777
Q ss_pred ceeEEEEEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEE
Q 010116 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (518)
Q Consensus 147 ~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vK 226 (518)
.++..+.. ...|+||||++|++|..+... ..+..++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 44554432 345899999999998765421 34567889999999999999999999999999999999999
Q ss_pred EeecccccccC
Q 010116 227 LSDFGLCKPLD 237 (518)
Q Consensus 227 L~DFGla~~~~ 237 (518)
|+|||+|....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-19 Score=166.80 Aligned_cols=140 Identities=18% Similarity=0.209 Sum_probs=101.9
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHH---------------------HHHHHHHHHHHhCCCc--
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE---------------------HVRAERNLLAEVASHC-- 147 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~---------------------~~~~E~~il~~l~hp~-- 147 (518)
.+.||+|+||+||+|.+. +|+.||||++............ ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999876 8999999998764321111111 1135666666665443
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEE
Q 010116 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMK 226 (518)
Q Consensus 148 Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vK 226 (518)
+.+.++.. ..++||||++||.+........... ..++.++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDLN----RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEecC----CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 44554432 3589999999965432221111111 6788899999999999999 9999999999999999 99999
Q ss_pred EeecccccccC
Q 010116 227 LSDFGLCKPLD 237 (518)
Q Consensus 227 L~DFGla~~~~ 237 (518)
|+|||.+....
T Consensus 155 liDfg~a~~~~ 165 (187)
T cd05119 155 IIDVPQAVEID 165 (187)
T ss_pred EEECccccccc
Confidence 99999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-19 Score=191.99 Aligned_cols=138 Identities=23% Similarity=0.280 Sum_probs=111.5
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechh-----hhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE-----MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
|...+.||+|+||+||++.... ..+++|+..... .......+++.+|..++..++|++|+..+.++.+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 4557899999999999987643 334444332211 111123456889999999999999988877777777889
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||+|+..
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999999885 356789999999999999999999999999999 6889999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-20 Score=173.68 Aligned_cols=238 Identities=20% Similarity=0.278 Sum_probs=189.4
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
+...+..++.+|...-.|+.|.+++. |..++.|+++-.+...+ ....+..|.--|+...||||+.+++.++...++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 45567778899999999999988775 56677788765544332 2244677777888889999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC-CeEEc-CCCCCceeeCCCCcEEEe--eccccccc
Q 010116 163 LIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKH-NYIHR-DIKPDNLLLDKNGHMKLS--DFGLCKPL 236 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~-giiHR-DIKPeNILld~~g~vKL~--DFGla~~~ 236 (518)
+|..|||.|+|+.+|.... .++..++..++..++.|+.|||+. .+|-| -|....++||++-+.+|+ |--++-..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999997653 467788999999999999999997 45554 478889999998877764 22211100
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC---C
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY---G 313 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y---~ 313 (518)
....-.|.||+||.+..++- -
T Consensus 344 --------------------------------------------------------~gr~y~pawmspealqrkped~n~ 367 (448)
T KOG0195|consen 344 --------------------------------------------------------VGRAYSPAWMSPEALQRKPEDLNI 367 (448)
T ss_pred --------------------------------------------------------cccccCcccCCHHHHhcCchhcch
Confidence 01234689999999988764 3
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccC
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 381 (518)
.++|+|||.+++|||.|...||..-++.+.-.+|.-..-...+| +.+|+....|+.-|+. ||.+||
T Consensus 368 raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip--pgis~hm~klm~icmnedpgkrp 434 (448)
T KOG0195|consen 368 RAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP--PGISRHMNKLMNICMNEDPGKRP 434 (448)
T ss_pred hhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC--CCccHHHHHHHHHHhcCCCCcCC
Confidence 58999999999999999999999999988877776533344455 5899999999999998 999999
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.7e-17 Score=159.32 Aligned_cols=138 Identities=20% Similarity=0.299 Sum_probs=105.6
Q ss_pred eeEe-ecCceEEEEEEEecCCcEEEEEEeechhhh----c------hhhHHHHHHHHHHHHHhCCCce--eEEEEEeecC
Q 010116 92 TIIG-RGAFGEVRLCREKKSGNIYAMKKLKKSEMV----K------RGQVEHVRAERNLLAEVASHCI--VKLYYSFQDT 158 (518)
Q Consensus 92 ~~LG-~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~----~------~~~~~~~~~E~~il~~l~hp~I--v~l~~~f~~~ 158 (518)
.+|| .||.|+||.+.. .+..+++|.+....+. . ......+.+|..++..+.|++| +..+......
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 888888888765 3778999988653221 1 1223567889999999988774 6666654332
Q ss_pred -Ce---EEEEEeecCC-CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 159 -EY---LYLIMEYLPG-GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 159 -~~---lylVmEy~~g-G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
.. .++||||++| .+|..++.. ..+++.. +.+++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 2599999998 688888754 4566554 568999999999999999999999999999999999999998
Q ss_pred ccc
Q 010116 234 KPL 236 (518)
Q Consensus 234 ~~~ 236 (518)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-18 Score=178.30 Aligned_cols=182 Identities=27% Similarity=0.383 Sum_probs=136.8
Q ss_pred CCeEEEEEeecCCCchHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~---~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
..++||.|++|.-++|.++|.+.. .-+.-....++.|+..|++| +|.+|||+||.||.+..++.+||.||||..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 346999999999999999997543 45566788889999999999 999999999999999999999999999987
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCc
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 314 (518)
....... ..+ ....-+..+||+.||+||.|.+..|+.
T Consensus 405 s~~~~~~------------------~~~-------------------------~~a~~t~~~gt~~YmsPEQi~g~~y~~ 441 (516)
T KOG1033|consen 405 SQDKDET------------------VAP-------------------------AAASHTQQVGTLLYMSPEQIRGQQYSE 441 (516)
T ss_pred ecccCCc------------------ccc-------------------------hhhhhhhcccccccCCHHHHhhhhhhh
Confidence 6542210 000 011123568999999999999999999
Q ss_pred cccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCC-ChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 315 ECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKL-SPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 315 ~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~-s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
++||||||+|++|+++ =..+|.. ..++.-+. +..+|..... -|+..+|+.+||. .|.+|| ++.+.--
T Consensus 442 kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r----~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP---~~~~~~~ 511 (516)
T KOG1033|consen 442 KVDIYALGLILAELLIQFSTQFER---IATLTDIR----DGIIPPEFLQDYPEEYTLLQQLLSPSPEERP---SAIEVAL 511 (516)
T ss_pred hcchhhHHHHHHHHHHHhccHHHH---HHhhhhhh----cCCCChHHhhcCcHHHHHHHHhcCCCcccCc---hHHHHhh
Confidence 9999999999999997 3344321 22222222 2334421111 2556699999998 999999 7887777
Q ss_pred Cccc
Q 010116 392 HPWF 395 (518)
Q Consensus 392 Hpff 395 (518)
|+|.
T Consensus 512 ~~~~ 515 (516)
T KOG1033|consen 512 HEFL 515 (516)
T ss_pred hhhc
Confidence 7774
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.1e-17 Score=145.03 Aligned_cols=133 Identities=20% Similarity=0.258 Sum_probs=113.5
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC--CceeEEEEEeecCCeEEEEEee
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~~~~lylVmEy 167 (518)
+++.||.|+++.||++... +..+++|+..+... ...+..|..++..+.+ .++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999874 37899999865432 4567889999999976 5899999999888899999999
Q ss_pred cCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH---NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 168 ~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~---giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
++|+.+..+ +......++.+++.+|.+||.. +++|+||+|+|||++..+.++++|||++...
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 999877654 5566677889999999999985 7999999999999999999999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.5e-16 Score=163.71 Aligned_cols=201 Identities=25% Similarity=0.285 Sum_probs=150.8
Q ss_pred HHHhCCCceeEEEEEeecCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe-EEcCCCCCce
Q 010116 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNY-IHRDIKPDNL 217 (518)
Q Consensus 140 l~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~gi-iHRDIKPeNI 217 (518)
|+.+.|.|+.++++...+...+++|.+||..|+|.+.+... -.++.-..-.++++++.||.|||.--| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35678999999999999999999999999999999999763 467777777788999999999998755 9999999999
Q ss_pred eeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccC
Q 010116 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (518)
Q Consensus 218 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 297 (518)
++|....+||+|||+........... ......-
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~-----------------------------------------------~~~~~~~ 113 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPE-----------------------------------------------AHHPIRK 113 (484)
T ss_pred eeeeeEEEEechhhhccccccccccc-----------------------------------------------ccchhHH
Confidence 99999999999999976542100000 0000112
Q ss_pred CCCccChhhhcCCC-------CCccccccchhHHHHHHHhCCCCCCCC----ChhhHHHHHhhhcCcccCCC---CCCCC
Q 010116 298 TPDYIAPEVLLKKG-------YGMECDWWSLGAIMYEMLVGYPPFYAD----DPITTCRKIVHWRNHLKFPD---DSKLS 363 (518)
Q Consensus 298 T~~Y~APEvl~~~~-------y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~i~~~~~~l~~p~---~~~~s 363 (518)
..-|.|||++.... -+.++|+||+|++++|+++..-||... ++.+....+........-|. ...+.
T Consensus 114 ~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~ 193 (484)
T KOG1023|consen 114 ALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELP 193 (484)
T ss_pred HHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcc
Confidence 24689999998632 366799999999999999999999763 22344444444122222222 11455
Q ss_pred hhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 364 PEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 364 ~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
+++..++.+|+. +|..|| ++++|.
T Consensus 194 ~~l~~l~~~cw~e~P~~rP---s~~~i~ 218 (484)
T KOG1023|consen 194 PELLLLVARCWEEIPEKRP---SIEQIR 218 (484)
T ss_pred hHHHHHHHHhcccChhhCc---cHHHHH
Confidence 679999999998 999999 555544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.2e-16 Score=166.93 Aligned_cols=143 Identities=21% Similarity=0.364 Sum_probs=100.2
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh-------------------------------chhhHHHHH
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-------------------------------KRGQVEHVR 134 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-------------------------------~~~~~~~~~ 134 (518)
.+|+. +.||+|++|.||.|+.+.+|+.||||++++.... -.+..+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 56776 7899999999999999988999999999754100 001223345
Q ss_pred HHHHHHHHhCCCceeEEEEEeec-------------CCeEEEEEeecCCCchHHH--HhhcC----CCCHHHHHHHHHHH
Q 010116 135 AERNLLAEVASHCIVKLYYSFQD-------------TEYLYLIMEYLPGGDMMTL--LMRED----TLTENVARFYIAQS 195 (518)
Q Consensus 135 ~E~~il~~l~hp~Iv~l~~~f~~-------------~~~lylVmEy~~gG~L~~~--l~~~~----~l~e~~~~~~~~ql 195 (518)
+|.+++.+. .|+.++...|.+ ...-+|||||+.|+.+.++ +...+ .+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 199 DELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 555555444 122222222222 3345699999999999764 33333 35555566666665
Q ss_pred HHHHHHHHhCCeEEcCCCCCceeeCCCC----cEEEeecccccccCC
Q 010116 196 VLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLDC 238 (518)
Q Consensus 196 ~~aL~~LH~~giiHRDIKPeNILld~~g----~vKL~DFGla~~~~~ 238 (518)
+ ..|++|+|+||.||+++.+| .++++|||++..++.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 59999999999999999988 999999999987753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.3e-16 Score=162.81 Aligned_cols=259 Identities=20% Similarity=0.249 Sum_probs=195.1
Q ss_pred CCeeEEeeEee--cCceEEEEEEE--ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCe
Q 010116 86 DDFELLTIIGR--GAFGEVRLCRE--KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 86 ~~f~i~~~LG~--G~fG~V~l~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 160 (518)
..|.+...+|. |.+|.||.++. ..++..||+|.-+... .....-.+-.+|..-...+ .|++.|+.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCc
Confidence 45778889999 99999999998 8899999999743221 1111112223444444455 48899999999999999
Q ss_pred EEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHH----HHHHHHhCCeEEcCCCCCceeeCCC-CcEEEeeccccc
Q 010116 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVL----AIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCK 234 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~----aL~~LH~~giiHRDIKPeNILld~~-g~vKL~DFGla~ 234 (518)
+|+-+|+| |.+|..+.... ..+++..++.+..+... ||.++|..+++|-|+||+||++..+ ..++++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999999 67888887654 45899999999999999 9999999999999999999999999 889999999999
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCc
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 314 (518)
.+..+........ ....-|...|++||++ +.-++.
T Consensus 272 ~i~~~~~~~~~~~--------------------------------------------~~r~~~~~~Y~~ke~~-~~l~~~ 306 (524)
T KOG0601|consen 272 KISDGNFSSVFKV--------------------------------------------SKRPEGDCIYAAKELL-NGLATF 306 (524)
T ss_pred EccCCccccceee--------------------------------------------eecCCCCceEeChhhh-ccccch
Confidence 8865543221110 0122466789999987 556899
Q ss_pred cccccchhHHHHHHHhCCCCCCCC--ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYAD--DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
..|++|||.++.+-.+|..++... +.+...++.. ....|- ...+.++...+..|+. +|..|+ +++.+++
T Consensus 307 ~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---ip~e~~--~~~s~~l~~~~~~~~d~~~~~~~---~~q~~~~ 378 (524)
T KOG0601|consen 307 ASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---IPLEFC--EGGSSSLRSVTSQMLDEDPRLRL---TAQILTA 378 (524)
T ss_pred HhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---Cchhhh--cCcchhhhhHHHHhcCcchhhhh---HHHHHhc
Confidence 999999999999999988777554 3333333322 122222 2456677778888887 899999 8999999
Q ss_pred CcccccCC
Q 010116 392 HPWFKDVV 399 (518)
Q Consensus 392 Hpff~~i~ 399 (518)
|++.+...
T Consensus 379 l~~i~s~~ 386 (524)
T KOG0601|consen 379 LNVIHSKL 386 (524)
T ss_pred cccccchh
Confidence 99998543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.6e-14 Score=150.65 Aligned_cols=140 Identities=19% Similarity=0.304 Sum_probs=95.6
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhh--c-----------------------------hhhHH------HHH
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--K-----------------------------RGQVE------HVR 134 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~-----------------------------~~~~~------~~~ 134 (518)
+.||.|++|.||+|+.+ +|+.||||+.+..... . ..... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999864 7899999998653100 0 00001 133
Q ss_pred HHHHHHHHh-----CCCce--eEEEEEeecCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 010116 135 AERNLLAEV-----ASHCI--VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVL-AIESIHKH 205 (518)
Q Consensus 135 ~E~~il~~l-----~hp~I--v~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~-aL~~LH~~ 205 (518)
+|...+..+ ++++| .++|..+ ...-+|||||++|++|.++.... ..++ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 344444444 23433 3333322 33468999999999998876432 1222 2234444544 47889999
Q ss_pred CeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 206 giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
|++|+|+||.||+++.+|.++|+|||++..++
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998775
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1e-13 Score=127.65 Aligned_cols=129 Identities=19% Similarity=0.229 Sum_probs=96.6
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc-eeEEEEEeecCCeEEEEEeecC
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
++.|+.|.++.||+++.. +..|++|+...... .......|..+++.+.+.. +.++++... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999998753 78899998754421 1123567888888886544 345555443 23479999999
Q ss_pred CCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCe-----EEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY-----IHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 170 gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~gi-----iHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++|+|||.|...
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 9887643 11123457899999999999885 9999999999998 778999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=5e-14 Score=148.57 Aligned_cols=252 Identities=24% Similarity=0.247 Sum_probs=185.1
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe-cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK-KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDT 158 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~-~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 158 (518)
......+|..+..||.|.|+.|+.+..+ .++..|++|.+.+.......++.. ..|.-+...+ .|.+++..+..|...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccc
Confidence 3445679999999999999999998766 678899999887664443333333 3455555555 588999999988888
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC-CcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~-g~vKL~DFGla~~~~ 237 (518)
...|+-.|||.|+++...+.-...+.+...+....|++.++.++|+..++|+|+||+||++..+ +..++.|||.++.+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 8899999999999887776555678899999999999999999999999999999999999886 788999999987532
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCC-CCc-cChhhhcCCCCCcc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGT-PDY-IAPEVLLKKGYGME 315 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT-~~Y-~APEvl~~~~y~~~ 315 (518)
... ....++ ..| .+|+.+....+..+
T Consensus 419 ~~~----------------------------------------------------~~~~~~~r~~p~~~~~~e~~~~~~~ 446 (524)
T KOG0601|consen 419 FSS----------------------------------------------------GVFHHIDRLYPIAEILLEDYPHLSK 446 (524)
T ss_pred eec----------------------------------------------------ccccccccccccchhhccccccccc
Confidence 110 011222 234 35555667889999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
+|++|||.-++|.++|.+.-...... ..|.. -..|.....+.++..+...++. |+..|+ .+.++..|+=
T Consensus 447 ~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~----~~~p~~~~~~~~~q~~~kv~~~~~~~~~~---l~~~l~~~~~ 516 (524)
T KOG0601|consen 447 ADIFSLGLSVDEAITGSPLSESGVQS---LTIRS----GDTPNLPGLKLQLQVLLKVMINPDRKRRP---SAVELSLHSE 516 (524)
T ss_pred cccccccccccccccCcccCcccccc---eeeec----ccccCCCchHHhhhhhhhhhcCCccccch---hhhhhcccch
Confidence 99999999999999997643332221 11222 1122222345777788888776 777776 6777777655
Q ss_pred c
Q 010116 395 F 395 (518)
Q Consensus 395 f 395 (518)
|
T Consensus 517 ~ 517 (524)
T KOG0601|consen 517 F 517 (524)
T ss_pred h
Confidence 4
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-12 Score=123.25 Aligned_cols=142 Identities=14% Similarity=0.138 Sum_probs=104.1
Q ss_pred EeeEeecCceEEEEEEEec------CCcEEEEEEeechhh--------h-----------chhhHHH----HHHHHHHHH
Q 010116 91 LTIIGRGAFGEVRLCREKK------SGNIYAMKKLKKSEM--------V-----------KRGQVEH----VRAERNLLA 141 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~------t~~~~AiK~l~k~~~--------~-----------~~~~~~~----~~~E~~il~ 141 (518)
...||.|-=+.||.|.... .+..+|||+.+-+.. . +.+.... ..+|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997543 357899998753210 0 0111223 348999999
Q ss_pred HhCC--CceeEEEEEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCeEEcCCCCCcee
Q 010116 142 EVAS--HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI-HKHNYIHRDIKPDNLL 218 (518)
Q Consensus 142 ~l~h--p~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~L-H~~giiHRDIKPeNIL 218 (518)
++.. -++.+++++ ..-+|||||+.|+.+..-..+...+++..+..+..+++.+|..| |+.||||+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8853 456666654 34679999997655543333444566677778889999999999 8999999999999999
Q ss_pred eCCCCcEEEeecccccccC
Q 010116 219 LDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 219 ld~~g~vKL~DFGla~~~~ 237 (518)
++ +|.+.|+|||.|...+
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 96 6789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.5e-12 Score=133.50 Aligned_cols=169 Identities=19% Similarity=0.236 Sum_probs=130.4
Q ss_pred EEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCchHHHHhhcCCC
Q 010116 104 LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTL 183 (518)
Q Consensus 104 l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l 183 (518)
.+..+.++.+|.+.+.+.+.- ...+.+.+-..-|+.++||||++++.++..++.+|||+|-+. -|..++...+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 455677889999998876532 344556777788999999999999999999999999999984 5666775443
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCC
Q 010116 184 TENVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262 (518)
Q Consensus 184 ~e~~~~~~~~ql~~aL~~LH-~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (518)
...+..-+.||+.||.||| ..+++|++|.-+-|+++..|+.||++|-++........
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------------------- 160 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------------------- 160 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---------------------
Confidence 7778888999999999998 57999999999999999999999999999865431100
Q ss_pred CCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhC
Q 010116 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 331 (518)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 331 (518)
.+....---.|..|+.+.... ...|.|-|||+++|++.|
T Consensus 161 ----------------------------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 ----------------------------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ----------------------------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 000111112466776654333 568999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.2e-11 Score=116.76 Aligned_cols=141 Identities=16% Similarity=0.215 Sum_probs=106.4
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC--CceeEEEEEeecC---CeEEEEEe
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDT---EYLYLIME 166 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~~---~~lylVmE 166 (518)
+.||.|.++.||++.... |+.|++|+....... .....+..|..+++.+.+ ..+.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 578999999999997643 688999987654321 123467889999999876 3467777776653 36789999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK------------------------------------------ 204 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~------------------------------------------ 204 (518)
|++|+++...+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765532 456666666777777777777763
Q ss_pred --------------CCeEEcCCCCCceeeCC--CCcEEEeeccccccc
Q 010116 205 --------------HNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPL 236 (518)
Q Consensus 205 --------------~giiHRDIKPeNILld~--~g~vKL~DFGla~~~ 236 (518)
..+||+|+.|.|||++. ++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 34699999999999998 677899999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.7e-11 Score=109.65 Aligned_cols=134 Identities=22% Similarity=0.259 Sum_probs=97.6
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEe-ech----hhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKL-KKS----EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l-~k~----~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
..+++|+=+.|+.+... |..+.+|.= +|. .+..+-..++..+|..+|..+.--.|...+-++.|.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999988553 444666642 221 12222234567889999998865554444445556667789999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
|++|-.|.+++... . -.++..+-.-+.-||..||||+||.++||++..++ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888655 1 34566777777889999999999999999996655 99999999884
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.5e-11 Score=120.91 Aligned_cols=212 Identities=21% Similarity=0.264 Sum_probs=150.4
Q ss_pred HHHHHHhCCCceeEEEEEeecCC-----eEEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 010116 137 RNLLAEVASHCIVKLYYSFQDTE-----YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKH-- 205 (518)
Q Consensus 137 ~~il~~l~hp~Iv~l~~~f~~~~-----~lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~-- 205 (518)
.+-|-.+.|.|||+++.++.+.. ...++.|||..|+|..+|++ ...+.....+.|+-||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34455668999999998887654 47899999999999999965 35788889999999999999999997
Q ss_pred CeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHh
Q 010116 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQ 285 (518)
Q Consensus 206 giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (518)
-|||+++..+-|++..+|-|||. .+.+- .. ...- .
T Consensus 198 piihgnlTc~tifiq~ngLIkig---~~ap~--s~----h~s~------------------------------------~ 232 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG---SVAPD--ST----HPSV------------------------------------N 232 (458)
T ss_pred ccccCCcchhheeecCCceEEec---ccCcc--cc----chhh------------------------------------h
Confidence 69999999999999999988874 21110 00 0000 0
Q ss_pred hhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCC-CCCCChhhHHHHHhhhcCcccCCCCCCCCh
Q 010116 286 MNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP-FYADDPITTCRKIVHWRNHLKFPDDSKLSP 364 (518)
Q Consensus 286 ~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P-F~~~~~~~~~~~i~~~~~~l~~p~~~~~s~ 364 (518)
..+.....-..|-++|.|||.=....-+.++|||++|....||..|..- -.+.+....-..|.+-...+. .+
T Consensus 233 ~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~ 305 (458)
T KOG1266|consen 233 STREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NG 305 (458)
T ss_pred hhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------Cc
Confidence 0000001123467899999976666678899999999999999998754 333332222222222110111 12
Q ss_pred hHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcccc
Q 010116 365 EAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 365 ~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l 403 (518)
--+++|.+||. .|..|+ ++.+++-||-.-+|.-.++
T Consensus 306 lqr~~i~kcl~~eP~~rp---~ar~llfHpllfeVhslkl 342 (458)
T KOG1266|consen 306 LQRGSITKCLEGEPNGRP---DARLLLFHPLLFEVHSLKL 342 (458)
T ss_pred cccCcCcccccCCCCCCc---chhhhhcCceeeecchHHH
Confidence 33689999999 999999 8999999999877765554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.6e-10 Score=102.79 Aligned_cols=144 Identities=24% Similarity=0.290 Sum_probs=105.9
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEee-c----hhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-K----SEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~-k----~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.+..|-+|+=+.|+.+. ..|+.+.||.=. | ..+...-...+..+|..+|.++.--.|.-..-+|.|...-+|+
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 67889999999999775 468888888532 1 1222222345678899999988654444444456677777899
Q ss_pred EeecCC-CchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc---EEEeecccccc
Q 010116 165 MEYLPG-GDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKP 235 (518)
Q Consensus 165 mEy~~g-G~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~---vKL~DFGla~~ 235 (518)
|||++| -++.+++... ..........++..+-..|.-||..+|||+||..+||+|..+|. +.|+||||+..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999977 4777777553 33333344678888999999999999999999999999987763 57999999764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.3e-09 Score=111.53 Aligned_cols=210 Identities=17% Similarity=0.230 Sum_probs=151.3
Q ss_pred ceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee----cCCeEEEEEeecCC-Cch
Q 010116 99 FGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ----DTEYLYLIMEYLPG-GDM 173 (518)
Q Consensus 99 fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~----~~~~lylVmEy~~g-G~L 173 (518)
-.+.|+|....+|..|++|.+.-......+. ...-.++++++.|+|||++..+|. .+..+++|++|.|+ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3578999999999999999995443322222 233467899999999999999997 34579999999986 577
Q ss_pred HHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 174 MTLLMR---------------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 174 ~~~l~~---------------~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
+++-.. +...+|..++.|+.|+..||.++|+.|+.-+-|.|.+||++.+..|+|+-.|....+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 766421 23578999999999999999999999999999999999999888889887776544321
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
.. | |-+.. -.+-|.
T Consensus 446 d~--------------------------------------------------------~-------~~le~---~Qq~D~ 459 (655)
T KOG3741|consen 446 DP--------------------------------------------------------T-------EPLES---QQQNDL 459 (655)
T ss_pred CC--------------------------------------------------------C-------cchhH---HhhhhH
Confidence 10 0 00100 124578
Q ss_pred cchhHHHHHHHhCCCC-CCCCChhhH-HHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 319 WSLGAIMYEMLVGYPP-FYADDPITT-CRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 319 WSlGvilyeml~G~~P-F~~~~~~~~-~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
=.||.+++.|.+|..- +..+...+. ...|. ..+|.+++++|.-+.. ++++ . ++.+++.|
T Consensus 460 ~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~-k---sI~~llp~ 521 (655)
T KOG3741|consen 460 RDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFRE-K---SIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCccc-c---cHHHHHHH
Confidence 8899999999999643 222222222 22222 2578899999988776 6665 3 47777765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1e-10 Score=125.33 Aligned_cols=169 Identities=22% Similarity=0.354 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCC
Q 010116 193 AQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271 (518)
Q Consensus 193 ~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (518)
.+++.|+.|+|.. ++||+.|-|++|.++..|..||+.|+.|........+-..+ .+...
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~--------------yd~~l------ 165 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSE--------------YDPPL------ 165 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCcccccc--------------CCCCC------
Confidence 3445899999975 99999999999999999999999999987654322111100 00000
Q ss_pred CCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHH-hCCCCCCCCChhhHHHHHhhh
Q 010116 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYADDPITTCRKIVHW 350 (518)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml-~G~~PF~~~~~~~~~~~i~~~ 350 (518)
.....-...|.|||++.+...+.++|++||||++|-+. .|+.-|.+......+......
T Consensus 166 --------------------p~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~ 225 (700)
T KOG2137|consen 166 --------------------PLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL 225 (700)
T ss_pred --------------------ChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc
Confidence 01123456899999999988899999999999999999 566666655444443333322
Q ss_pred cCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccc
Q 010116 351 RNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 351 ~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~ 404 (518)
..--.+-....+++++++=|.++|. ++..|+ ++.+++.-|||.+.--..|.
T Consensus 226 ~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp---~~~~l~~~~ff~D~~~~aLr 277 (700)
T KOG2137|consen 226 LNAGAFGYSNNLPSELRESLKKLLNGDSAVRP---TLDLLLSIPFFSDPGLKALR 277 (700)
T ss_pred cccccccccccCcHHHHHHHHHHhcCCcccCc---chhhhhcccccCCchhhhhh
Confidence 1222233335789999999999998 999999 79999999999987655554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.2e-09 Score=102.97 Aligned_cols=127 Identities=15% Similarity=0.122 Sum_probs=90.0
Q ss_pred cCCcEEEEEEeechhh---hch-----hhHHHHHHHHHHHHHhCCC--ceeEEEEEeec-----CCeEEEEEeecCCC-c
Q 010116 109 KSGNIYAMKKLKKSEM---VKR-----GQVEHVRAERNLLAEVASH--CIVKLYYSFQD-----TEYLYLIMEYLPGG-D 172 (518)
Q Consensus 109 ~t~~~~AiK~l~k~~~---~~~-----~~~~~~~~E~~il~~l~hp--~Iv~l~~~f~~-----~~~lylVmEy~~gG-~ 172 (518)
-.|+.|.||....... .+. .-.....+|...+..+..- .++.+.+++.. ...-|||||+++|- +
T Consensus 43 ~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s 122 (268)
T PRK15123 43 LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS 122 (268)
T ss_pred ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence 3577888886643221 010 1112467888888777322 22333334432 23578999999886 7
Q ss_pred hHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-------CCcEEEeecccccc
Q 010116 173 MMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-------NGHMKLSDFGLCKP 235 (518)
Q Consensus 173 L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-------~g~vKL~DFGla~~ 235 (518)
|.+++.. ....++.....++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+..
T Consensus 123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 8888753 345667788899999999999999999999999999999985 46899999998863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1e-08 Score=96.33 Aligned_cols=129 Identities=20% Similarity=0.241 Sum_probs=83.0
Q ss_pred EEEEEEEecCCcEEEEEEeechhhh-----------------------chhhHHHHHHHHHHHHHhCCC--ceeEEEEEe
Q 010116 101 EVRLCREKKSGNIYAMKKLKKSEMV-----------------------KRGQVEHVRAERNLLAEVASH--CIVKLYYSF 155 (518)
Q Consensus 101 ~V~l~~~~~t~~~~AiK~l~k~~~~-----------------------~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~f 155 (518)
.||.|.. ..|..+|+|+.+..... ..-......+|.+.|..+..- ++.+++.+-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888875 46789999987542100 001134578899999999765 466666443
Q ss_pred ecCCeEEEEEeecC--CCchHHHHhhcCCCCHHHHHHHHHHHHHHHHH-HHhCCeEEcCCCCCceeeCCCCcEEEeeccc
Q 010116 156 QDTEYLYLIMEYLP--GGDMMTLLMREDTLTENVARFYIAQSVLAIES-IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (518)
Q Consensus 156 ~~~~~lylVmEy~~--gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~-LH~~giiHRDIKPeNILld~~g~vKL~DFGl 232 (518)
.-+|||||++ |..+..+. .. .++.+....++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~-~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLK-DV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHH-HC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHH-hc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2359999998 54454333 22 22255567777888885555 579999999999999999776 899999999
Q ss_pred ccccC
Q 010116 233 CKPLD 237 (518)
Q Consensus 233 a~~~~ 237 (518)
|....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 87654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2e-10 Score=121.89 Aligned_cols=245 Identities=20% Similarity=0.211 Sum_probs=163.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc-eeEEEEEeecCCeEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYL 163 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~~lyl 163 (518)
...+....-+++|+++++++.+...+.... .+.+... ...+-++++|.+++||| .+.-++.++.+.+..+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 345667778899999999988766554444 5555332 34566889999999999 7777788888999999
Q ss_pred EEeecCCC-chHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 164 IMEYLPGG-DMMTL-LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 164 VmEy~~gG-~L~~~-l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
+|+++.+| +.... ....-.+.+-.....++.-..+|+++|+.-=+||| |||..+ +..|+.||+....+...
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~-- 384 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT-- 384 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc--
Confidence 99999887 22111 11122334444455566777889999998778999 888754 78899999987665321
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
....+..||+.++|||++....|....|.||+
T Consensus 385 ------------------------------------------------~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~ 416 (829)
T KOG0576|consen 385 ------------------------------------------------MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSL 416 (829)
T ss_pred ------------------------------------------------cccccCCCCCCCCCchhhcccccccCCCccCC
Confidence 01236789999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChh-HHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPE-AKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~-~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|+-..+|--|-+|-.+ +......+-.......+......++. -.++...|+. -|..|. ....++.|.+|.+-
T Consensus 417 ~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pk---v~mgacfsKvfngC 490 (829)
T KOG0576|consen 417 AVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPK---VHMGACFSKVFNGC 490 (829)
T ss_pred CcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCc---chhhHHHHHHhccC
Confidence 9988888888887654 11111111110000000000011111 1245666665 666666 66777778888764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.3e-08 Score=93.85 Aligned_cols=128 Identities=22% Similarity=0.232 Sum_probs=92.1
Q ss_pred cCCcEEEEEEeechh----hhchhhHHHHHHHHHHHHHhCCC--ceeEEEEEeecC----CeEEEEEeecCCC-chHHHH
Q 010116 109 KSGNIYAMKKLKKSE----MVKRGQVEHVRAERNLLAEVASH--CIVKLYYSFQDT----EYLYLIMEYLPGG-DMMTLL 177 (518)
Q Consensus 109 ~t~~~~AiK~l~k~~----~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~f~~~----~~lylVmEy~~gG-~L~~~l 177 (518)
..++.|-+|.+.+.- ....-......+|...+..+..- .++..+++.... ...|||+|+++|. +|.+++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence 345666666543221 11112234567787777766422 233444444331 2458999999985 799998
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC---cEEEeeccccccc
Q 010116 178 MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPL 236 (518)
Q Consensus 178 ~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g---~vKL~DFGla~~~ 236 (518)
......+......++.+++..+.-||..||+|+|++|.|||++.++ .+.|+||+-++..
T Consensus 110 ~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 110 QQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 7755578888889999999999999999999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.1e-07 Score=93.79 Aligned_cols=232 Identities=15% Similarity=0.191 Sum_probs=146.8
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeE--------EEEEeecCCe
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVK--------LYYSFQDTEY 160 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~--------l~~~f~~~~~ 160 (518)
..+.||+|+-+.+|-.-.- +. .+.|+..+....- -...+..|... .||-+-. |++. .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh--hc-hhheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 3568999999999955322 22 3447776543211 11223334433 4553222 1111 11223
Q ss_pred EEEEEeecCCCchHHHH-------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 161 LYLIMEYLPGGDMMTLL-------MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l-------~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
+-+.|..++|-.=-..+ +....+..+.+...++.++.|...||..|.+-+|+.++|+|+++++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 77889888775322222 12245667888888999999999999999999999999999999999999864321
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL----- 308 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~----- 308 (518)
....+ .......||.+.|.+||.-.
T Consensus 165 qi~~n--------------------------------------------------g~~~~cpVg~~eftPPElQ~~~sf~ 194 (637)
T COG4248 165 QINAN--------------------------------------------------GTLHLCPVGVSEFTPPELQTLPSFV 194 (637)
T ss_pred eeccC--------------------------------------------------CceEecccCccccCCHHHhcccccc
Confidence 11010 01223568999999999865
Q ss_pred CCCCCccccccchhHHHHHHHhC-CCCCCCC-------ChhhHHHHHhhh------------cCcccCCCCCCCChhHHH
Q 010116 309 KKGYGMECDWWSLGAIMYEMLVG-YPPFYAD-------DPITTCRKIVHW------------RNHLKFPDDSKLSPEAKD 368 (518)
Q Consensus 309 ~~~y~~~~DiWSlGvilyeml~G-~~PF~~~-------~~~~~~~~i~~~------------~~~l~~p~~~~~s~~~~d 368 (518)
+.+-+...|-|.|||++|++|.| +.||.+- ++.++ .|-+. +....-+...-+++++..
T Consensus 195 g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqA 272 (637)
T COG4248 195 GFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQA 272 (637)
T ss_pred ccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHH
Confidence 33456789999999999999997 8999652 22221 22221 011111123457899999
Q ss_pred HHHHHhc---cccccCCC
Q 010116 369 LICRLLC---DVEHRLGT 383 (518)
Q Consensus 369 LI~~lL~---dp~~R~g~ 383 (518)
|..+++. ++.-|+..
T Consensus 273 lF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 273 LFQQAFTESGVATPRPTA 290 (637)
T ss_pred HHHHHhcccCCCCCCCCH
Confidence 9999996 35578743
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.8e-07 Score=85.81 Aligned_cols=141 Identities=21% Similarity=0.345 Sum_probs=91.5
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHH------HHHHHHHHHHhC---CCceeEEEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH------VRAERNLLAEVA---SHCIVKLYY 153 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~------~~~E~~il~~l~---hp~Iv~l~~ 153 (518)
+...+|.+++++-......|.+.. .+|+.|.+|..+............ ..++...+..+. -..++.++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 345789999999888877777654 567899999876432111111111 223333333332 122222222
Q ss_pred -----EeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEe
Q 010116 154 -----SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228 (518)
Q Consensus 154 -----~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~ 228 (518)
.+.-....+|||||++|-.|.++. .++++ +...++.++.-||+.|+.|+|..|.|++++.++ +++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIE----DIDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccch----hcCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 222234567999999998887654 23332 345677889999999999999999999998555 9999
Q ss_pred eccccc
Q 010116 229 DFGLCK 234 (518)
Q Consensus 229 DFGla~ 234 (518)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.1e-07 Score=88.68 Aligned_cols=138 Identities=17% Similarity=0.214 Sum_probs=100.0
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh-----------------ch--hhHHHHHHHHHHHHHhCCC--ce
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----------------KR--GQVEHVRAERNLLAEVASH--CI 148 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----------------~~--~~~~~~~~E~~il~~l~hp--~I 148 (518)
+...||-|-=|.||.|... .|..+|||.=+-.... +. -......+|..+|..+... .|
T Consensus 95 iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 5689999999999999865 6899999964321100 00 0123457788888888655 55
Q ss_pred eEEEEEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEe
Q 010116 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228 (518)
Q Consensus 149 v~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~ 228 (518)
.+.+++ +.-.+||||+.|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+=|||++.||.+.++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence 555443 4456999999986665432 2445555566666666666668999999999999999999999999
Q ss_pred ecccccccC
Q 010116 229 DFGLCKPLD 237 (518)
Q Consensus 229 DFGla~~~~ 237 (518)
||--|....
T Consensus 245 DwPQ~v~~~ 253 (304)
T COG0478 245 DWPQAVPIS 253 (304)
T ss_pred eCcccccCC
Confidence 999877654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.9e-07 Score=96.20 Aligned_cols=144 Identities=17% Similarity=0.244 Sum_probs=90.9
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhh--------------------hc-----------hhhHHHHH------
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--------------------VK-----------RGQVEHVR------ 134 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~--------------------~~-----------~~~~~~~~------ 134 (518)
.-|+.++-|.||.|+.++ |+.||||+.+..-. .. .+..+.+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 568999999999998765 99999999865310 00 00112223
Q ss_pred HHHHHHHHh-----CCCceeEEEEEeecCCeEEEEEeecCCCchHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Q 010116 135 AERNLLAEV-----ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHNYI 208 (518)
Q Consensus 135 ~E~~il~~l-----~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~-~~~~l~e~~~~~~~~ql~~aL~~LH~~gii 208 (518)
+|..-+.++ +.+.|.--.-+++-...-.|+|||++|-.+.+... +...++...+.....++. +..+=..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 333333333 23443222222333344569999999988888742 224455333222222211 2333348999
Q ss_pred EcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 209 HRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
|.|..|.||+++.+|++.+.|||+...++.
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999887754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.5e-06 Score=82.62 Aligned_cols=139 Identities=13% Similarity=0.171 Sum_probs=99.8
Q ss_pred eecCceEEEEEEEecCCcEEEEEEeechh---hhchhhHHHHHHHHHHHHHhCCC--ceeEEEEEeec----CCeEEEEE
Q 010116 95 GRGAFGEVRLCREKKSGNIYAMKKLKKSE---MVKRGQVEHVRAERNLLAEVASH--CIVKLYYSFQD----TEYLYLIM 165 (518)
Q Consensus 95 G~G~fG~V~l~~~~~t~~~~AiK~l~k~~---~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~f~~----~~~lylVm 165 (518)
|+||-+-|+.... .|+.|=+|.-.... +.-......+.+|...|..+..- .+.+..+.-.. .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6788888996643 34567788654110 11023456788999999888532 24444422111 12468999
Q ss_pred eecCC-CchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc--EEEeecccccc
Q 010116 166 EYLPG-GDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH--MKLSDFGLCKP 235 (518)
Q Consensus 166 Ey~~g-G~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~--vKL~DFGla~~ 235 (518)
|-+.| -||.+++... .+.++.....++.+++.+|.-||+.|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 4788777553 35577777889999999999999999999999999999997787 99999997764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.9e-06 Score=83.63 Aligned_cols=133 Identities=20% Similarity=0.172 Sum_probs=85.0
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC--ceeEEEEEeecCCeEEEEEeecC
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
..||.|..+.||++ .|..+++|...... ....+.+|.++++.+..- .+.+.+.+..+.+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 25567888875422 234578899999988643 25677777778888899999999
Q ss_pred CCc-hH--------------HHH-------hhc--C--CCCHHHHHHHHH----------HHHH-HHHHHHh----CCeE
Q 010116 170 GGD-MM--------------TLL-------MRE--D--TLTENVARFYIA----------QSVL-AIESIHK----HNYI 208 (518)
Q Consensus 170 gG~-L~--------------~~l-------~~~--~--~l~e~~~~~~~~----------ql~~-aL~~LH~----~gii 208 (518)
|.+ +. ..+ +.- . .++... ..+.. .+.. ...+|.. ..++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 864 11 111 000 0 111111 11100 1111 1222321 2578
Q ss_pred EcCCCCCceeeCCCCcEEEeecccccc
Q 010116 209 HRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 209 HRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
|+|+.|.||+++.+| +.|+||+.|..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.8e-06 Score=81.59 Aligned_cols=138 Identities=20% Similarity=0.336 Sum_probs=83.4
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC--ceeEEEEEe---ecCCeEEEEE
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLYYSF---QDTEYLYLIM 165 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~f---~~~~~lylVm 165 (518)
++.|+.|..+.||++.... ..|++|+.... .....+..|..+++.+... .+.+++... ......|++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999987654 58999986543 2345677888888887533 355666533 3344689999
Q ss_pred eecCCCchHH----------------HHh---hc----CCCCHHH---HH---HH---------------HHHHHH-HHH
Q 010116 166 EYLPGGDMMT----------------LLM---RE----DTLTENV---AR---FY---------------IAQSVL-AIE 200 (518)
Q Consensus 166 Ey~~gG~L~~----------------~l~---~~----~~l~e~~---~~---~~---------------~~ql~~-aL~ 200 (518)
++++|..+.. .+. .. ..+.... .. .. ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 111 11 0011000 00 00 111222 233
Q ss_pred HHHh-------CCeEEcCCCCCceeeC-CCCcEEEeecccccc
Q 010116 201 SIHK-------HNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKP 235 (518)
Q Consensus 201 ~LH~-------~giiHRDIKPeNILld-~~g~vKL~DFGla~~ 235 (518)
.+++ ..++|+|+.|.|||++ .+|.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3332 4699999999999999 677778999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.8e-06 Score=80.52 Aligned_cols=140 Identities=19% Similarity=0.199 Sum_probs=96.6
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchh-------------------h--HHHHHHHHHHHHHhC--CCc
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-------------------Q--VEHVRAERNLLAEVA--SHC 147 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~-------------------~--~~~~~~E~~il~~l~--hp~ 147 (518)
...|..|--+.||+|.. .++..+|+|+.+.+....+. + .....+|..-|.++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34777888889999865 56889999998654322111 1 122456666666663 334
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCch-HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcE
Q 010116 148 IVKLYYSFQDTEYLYLIMEYLPGGDM-MTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHM 225 (518)
Q Consensus 148 Iv~l~~~f~~~~~lylVmEy~~gG~L-~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~v 225 (518)
+.+-+..+. -.|||||+..... .-.| +.-.+..+++..+..+++..+.-|-. .|+||+||..=|||+. +|.+
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 445554443 3599999944311 1112 22334445788888999999988877 8999999999999998 8999
Q ss_pred EEeecccccccC
Q 010116 226 KLSDFGLCKPLD 237 (518)
Q Consensus 226 KL~DFGla~~~~ 237 (518)
.|+|||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1e-05 Score=79.11 Aligned_cols=134 Identities=16% Similarity=0.110 Sum_probs=82.8
Q ss_pred EeecCc-eEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEEEEeecCCC
Q 010116 94 IGRGAF-GEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (518)
Q Consensus 94 LG~G~f-G~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVmEy~~gG 171 (518)
|-.|.. ..||.+... +..+.+|...... ...+.+|..++..+. +--+.+++++..+.+.-++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 344555 789988543 4678888765432 234667888888874 345667888877777789999999997
Q ss_pred chHHHH----------------hhcCCC-------CHH------HHHHHHH----------------HHHHHHHHH----
Q 010116 172 DMMTLL----------------MREDTL-------TEN------VARFYIA----------------QSVLAIESI---- 202 (518)
Q Consensus 172 ~L~~~l----------------~~~~~l-------~e~------~~~~~~~----------------ql~~aL~~L---- 202 (518)
.+.... .+-..+ ... .....+. .+...+..|
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 665331 000011 100 0000000 011112222
Q ss_pred ---HhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 203 ---HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 203 ---H~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
....++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123589999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.5e-06 Score=94.77 Aligned_cols=200 Identities=21% Similarity=0.243 Sum_probs=144.2
Q ss_pred HHHHHHHHHHHHhCCCceeEEEEEeecCC----eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 010116 131 EHVRAERNLLAEVASHCIVKLYYSFQDTE----YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206 (518)
Q Consensus 131 ~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~g 206 (518)
....-|...+....|+|++.++.+--... .+.+..++|.+-+++..+..-+.++.+.++.|..+++.||.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34455667778889999998887654332 23456688999999999999999999999999999999999999996
Q ss_pred eEEcCCCCC---ceeeCCCCcEEEe--ecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHH
Q 010116 207 YIHRDIKPD---NLLLDKNGHMKLS--DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQL 281 (518)
Q Consensus 207 iiHRDIKPe---NILld~~g~vKL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (518)
..|.-+-.. +-..+..+++.++ ||+.++.+....
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~----------------------------------------- 345 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE----------------------------------------- 345 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcc-----------------------------------------
Confidence 666555444 4455566777777 888877654221
Q ss_pred HHHhhhcccccccccCCCCccChhhhcCCCCCcc--ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCC
Q 010116 282 QHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME--CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD 359 (518)
Q Consensus 282 ~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~--~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~ 359 (518)
...+..-+..|.|||......+..+ .|+|++|.....+..|..+-.-. ..+. .+-.
T Consensus 346 ---------~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~------~~~~------~~l~- 403 (1351)
T KOG1035|consen 346 ---------KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS------AVPV------SLLD- 403 (1351)
T ss_pred ---------cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc------cchh------hhhc-
Confidence 0113344567889998887776655 69999999999999886553111 1111 1111
Q ss_pred CCCC-hhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 360 SKLS-PEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 360 ~~~s-~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
..+ .+..+++.+|+. +.++|+ ++.+++.|||.+-
T Consensus 404 -~~~~~~~~d~~~~~~~~~~~~Rl---~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 404 -VLSTSELLDALPKCLDEDSEERL---SALELLTHPFLRF 439 (1351)
T ss_pred -cccchhhhhhhhhhcchhhhhcc---chhhhhhchhccc
Confidence 112 267788899987 999999 8999999999874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1e-05 Score=87.11 Aligned_cols=142 Identities=20% Similarity=0.283 Sum_probs=89.3
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhh----------------------------chhhHHHHHHHHHHHH--
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV----------------------------KRGQVEHVRAERNLLA-- 141 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~----------------------------~~~~~~~~~~E~~il~-- 141 (518)
+.||.-+.|.|+.|+.+. |+.||||+-+..--. -.+-.+.+..|.+.+.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 468999999999999876 999999997653100 0001122233333332
Q ss_pred --------HhCCCc------eeEEEEEeecCCeEEEEEeecCCCchHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 010116 142 --------EVASHC------IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHN 206 (518)
Q Consensus 142 --------~l~hp~------Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~-~~~~l~e~~~~~~~~ql~~aL~~LH~~g 206 (518)
.+.|-. |.++|..+.. .-.|+||||+|.-+.++-. ....++...+...+.+.. ++-|=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 223333 4555444433 3569999999987766532 233444443333222222 12233578
Q ss_pred eEEcCCCCCceeeCC----CCcEEEeecccccccCC
Q 010116 207 YIHRDIKPDNLLLDK----NGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 207 iiHRDIKPeNILld~----~g~vKL~DFGla~~~~~ 238 (518)
++|.|=.|.|||++. ++.+.|-|||+...+..
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67899999999987754
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.5e-05 Score=89.86 Aligned_cols=147 Identities=20% Similarity=0.332 Sum_probs=92.3
Q ss_pred EEeeEeecCceEEEEEEEecCC--cEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCc--eeEEEEEeecC---CeE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSG--NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHC--IVKLYYSFQDT---EYL 161 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~--~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~--Iv~l~~~f~~~---~~l 161 (518)
-++.|+.|.++.+|++.....+ ..|++|+........ ....+.+|..+|+.+. |++ +.+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3678899999999998764432 467778764432211 1245778999999995 555 47878777764 467
Q ss_pred EEEEeecCCCchHH--------------------HH---hhcC----CC---------CHHHHHHHHHH-----------
Q 010116 162 YLIMEYLPGGDMMT--------------------LL---MRED----TL---------TENVARFYIAQ----------- 194 (518)
Q Consensus 162 ylVmEy~~gG~L~~--------------------~l---~~~~----~l---------~e~~~~~~~~q----------- 194 (518)
|+||||++|..+.+ .| +.-. .+ ....+..|..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999998864321 11 1100 00 11222222111
Q ss_pred ----HHHHHHHHHh-----------CCeEEcCCCCCceeeCCC-Cc-EEEeecccccccCC
Q 010116 195 ----SVLAIESIHK-----------HNYIHRDIKPDNLLLDKN-GH-MKLSDFGLCKPLDC 238 (518)
Q Consensus 195 ----l~~aL~~LH~-----------~giiHRDIKPeNILld~~-g~-vKL~DFGla~~~~~ 238 (518)
+...+.+|.. ..+||+|++|.|||++.+ +. +-|.||++|..-+.
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 2233556632 259999999999999853 34 57999999886543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.4e-05 Score=72.96 Aligned_cols=129 Identities=25% Similarity=0.347 Sum_probs=89.1
Q ss_pred CCCeeEEeeEeecCc-eEEEEEEEecCCcEEEEEEeechhh----------hch--------hhHHHHHHHHHHHHHh--
Q 010116 85 VDDFELLTIIGRGAF-GEVRLCREKKSGNIYAMKKLKKSEM----------VKR--------GQVEHVRAERNLLAEV-- 143 (518)
Q Consensus 85 ~~~f~i~~~LG~G~f-G~V~l~~~~~t~~~~AiK~l~k~~~----------~~~--------~~~~~~~~E~~il~~l-- 143 (518)
..+++.++.||.|+- |.||+++. .|+.||+|+...-.. ... ....-+..|-+...++
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 379999999999999 99998864 588999999322110 000 1223355666655544
Q ss_pred -CCCce--eEEEEEeecC------------------CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 010116 144 -ASHCI--VKLYYSFQDT------------------EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202 (518)
Q Consensus 144 -~hp~I--v~l~~~f~~~------------------~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~L 202 (518)
.+..+ |++++++.-. ....||.||++... .++.. -+.+|..-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHH
Confidence 44455 9999887311 12467888886643 22222 356777888889
Q ss_pred HhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 203 H~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
|+.||+-+|+++.|.. + -||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc---C--CEEEecccC
Confidence 9999999999999987 3 389999854
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00015 Score=68.94 Aligned_cols=131 Identities=18% Similarity=0.243 Sum_probs=91.6
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhh-------------chhhHHHHHHHHHHHHHhC------CCceeEEE
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-------------KRGQVEHVRAERNLLAEVA------SHCIVKLY 152 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-------------~~~~~~~~~~E~~il~~l~------hp~Iv~l~ 152 (518)
..||+|+.-.||. + ......+||++...... ........++|..-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5789999999994 3 33455788998776510 0112344566666655555 77899999
Q ss_pred EEeecCCeEEEEEeecCC------CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC--C-
Q 010116 153 YSFQDTEYLYLIMEYLPG------GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN--G- 223 (518)
Q Consensus 153 ~~f~~~~~lylVmEy~~g------G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~--g- 223 (518)
+..+++.-+-+|+|.+.+ -+|.+++ +.+.+++ .++. .+-.-..||-.++|+.+||+|.||++... |
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998743 2577777 4455666 3333 33344568889999999999999999643 2
Q ss_pred -cEEEeec
Q 010116 224 -HMKLSDF 230 (518)
Q Consensus 224 -~vKL~DF 230 (518)
.+.|+|-
T Consensus 159 ~~lvlIDG 166 (199)
T PF10707_consen 159 FRLVLIDG 166 (199)
T ss_pred eEEEEEeC
Confidence 4777773
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=9.2e-07 Score=101.95 Aligned_cols=201 Identities=15% Similarity=0.105 Sum_probs=142.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHHhCCCceeEEEEEeecC--Ce
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EY 160 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~ 160 (518)
..++++.--+|-|.+++--..+.+. -.+.+|+.+..... .+-..+....|++-+++..|++++.-+.-..+. ..
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~ki--d~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKI--DWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhh--ceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 4567776667777666433222221 23456655433221 222345566778888888999988766555443 34
Q ss_pred EEEEEeecCCCchHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-----CeEEcCCCCCceeeCCCCcEEEeecc
Q 010116 161 LYLIMEYLPGGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKH-----NYIHRDIKPDNLLLDKNGHMKLSDFG 231 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~----~~l~e~~~~~~~~ql~~aL~~LH~~-----giiHRDIKPeNILld~~g~vKL~DFG 231 (518)
.|.+++|+.+|++++.|.+. ..+.+..+-....+.+++..-+|+. -.+|++||+-|.+|..+-.+|+.++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 68999999999999999764 2333333333344448888888864 26899999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~ 311 (518)
+.+..... .......+++|.|++|++...-.
T Consensus 1386 LdKIknp~-------------------------------------------------~sf~Gl~l~sp~~v~qli~N~ik 1416 (2724)
T KOG1826|consen 1386 LDKIKNPV-------------------------------------------------LSFFGLELCSPIYVLQLIKNEIK 1416 (2724)
T ss_pred cccccCch-------------------------------------------------HhhhhhhhCCHHHHHHHHHHHHh
Confidence 98822110 01223578899999999999999
Q ss_pred CCccccccchhHHHHHHHhCCCCCC
Q 010116 312 YGMECDWWSLGAIMYEMLVGYPPFY 336 (518)
Q Consensus 312 y~~~~DiWSlGvilyeml~G~~PF~ 336 (518)
++.++|+|+.|+.+|+.-.|.++|-
T Consensus 1417 ~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1417 FTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999999999999999999883
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=5e-05 Score=69.80 Aligned_cols=129 Identities=16% Similarity=0.236 Sum_probs=89.8
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecC
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
+.+.||+|.+|.||+|.++ |..+|+|+-..+ .....+..|..+|..+..-++..=.+.+-. -++.|||+.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~ 95 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYID 95 (201)
T ss_pred hhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhc
Confidence 4578999999999999764 678999986543 234568889999999987766443333321 235599999
Q ss_pred CCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCC-CCceeeCCCCcEEEeecccccc
Q 010116 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK-PDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 170 gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIK-PeNILld~~g~vKL~DFGla~~ 235 (518)
|-.|.+.-... +.+ -+..++.+---|-..||-|..|. |..++|-.++.+.|+||.-|+.
T Consensus 96 G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98887765321 222 22334444334566799999985 6666666777999999998873
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.92 E-value=6.2e-05 Score=73.35 Aligned_cols=73 Identities=15% Similarity=0.206 Sum_probs=45.7
Q ss_pred eeEeecCce-EEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC---ceeEEEEEeecC---CeEEEE
Q 010116 92 TIIGRGAFG-EVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH---CIVKLYYSFQDT---EYLYLI 164 (518)
Q Consensus 92 ~~LG~G~fG-~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp---~Iv~l~~~f~~~---~~lylV 164 (518)
..|+.|+.. .||.+ +..+.+|..... .....+.+|..+|..+... -+.+.++..... ...|+|
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457767766 59976 234777864432 1234688899999887532 344555444332 245899
Q ss_pred EeecCCCchH
Q 010116 165 MEYLPGGDMM 174 (518)
Q Consensus 165 mEy~~gG~L~ 174 (518)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999996653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=70.99 Aligned_cols=137 Identities=15% Similarity=0.194 Sum_probs=81.6
Q ss_pred EeeEeecCceEEEEEEEec-CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC-CceeEEEEEeecCCeEEEEEeec
Q 010116 91 LTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDTEYLYLIMEYL 168 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~-t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~~lylVmEy~ 168 (518)
++.|..|-...||++.... .++.|++|+...... . .-...+|..++..+.. ..++++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888899999986443 357888997654311 1 1123468888888843 345566555432 3799999
Q ss_pred CCCchHHH--------------Hh---hcC-CC----------C-HHHHHHHHHH----------------------HH-
Q 010116 169 PGGDMMTL--------------LM---RED-TL----------T-ENVARFYIAQ----------------------SV- 196 (518)
Q Consensus 169 ~gG~L~~~--------------l~---~~~-~l----------~-e~~~~~~~~q----------------------l~- 196 (518)
+|-++... |. ... .. . .+.+..|... +.
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98665211 11 100 11 0 1122222211 11
Q ss_pred --HHHH-HHH----hCCeEEcCCCCCceeeCC-CCcEEEeecccccc
Q 010116 197 --LAIE-SIH----KHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKP 235 (518)
Q Consensus 197 --~aL~-~LH----~~giiHRDIKPeNILld~-~g~vKL~DFGla~~ 235 (518)
..|. .+- ..+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111 111 236999999999999998 68899999998874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00093 Score=70.14 Aligned_cols=81 Identities=22% Similarity=0.217 Sum_probs=55.1
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhh-h-c--hhhHHHHHHHHHHHHHhC---CCceeEEEEEeecCCeEE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-V-K--RGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~-~-~--~~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~~~~ly 162 (518)
-.+.||.|.+..||.+.....++.+.||.-....- . . .-..++...|.+.|..+. ..++++++.+ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 35789999999999998764445899997431110 0 0 123456777888888763 3457777766 446678
Q ss_pred EEEeecCCCc
Q 010116 163 LIMEYLPGGD 172 (518)
Q Consensus 163 lVmEy~~gG~ 172 (518)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00063 Score=68.88 Aligned_cols=77 Identities=13% Similarity=0.047 Sum_probs=54.0
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC---CceeEEEEEeec---CCeEEE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS---HCIVKLYYSFQD---TEYLYL 163 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h---p~Iv~l~~~f~~---~~~lyl 163 (518)
-.+.||.|..+.||.... ++..+.+|..+.. .....+..|...|+.+.. ..|.++++++.+ .+.-||
T Consensus 18 ~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYD--SQGNPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEc--CCCCEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 356899999999997743 2234666764321 012467889999988853 367888877754 366899
Q ss_pred EEeecCCCch
Q 010116 164 IMEYLPGGDM 173 (518)
Q Consensus 164 VmEy~~gG~L 173 (518)
|||+++|+.+
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=97.61 E-value=4.7e-05 Score=58.22 Aligned_cols=60 Identities=33% Similarity=0.546 Sum_probs=40.2
Q ss_pred ccCCccccc--cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCCcccccCCCCCCcccCceee
Q 010116 396 KDVVWDKLY--EMEAAFKPEINGELDTQNFMK-FDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYK 460 (518)
Q Consensus 396 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 460 (518)
++|+|+.|. ++.|||+|.+.+..|+++|+. +.......+... . .......+..|.||+|.
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s~~~-~----~~~~~~~~~~F~gfsy~ 63 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLTPVD-S----PASGGSQQEPFRGFSYV 63 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCCCCC-c----cccccccccccCCCccc
Confidence 479999995 689999999999999999987 544433222111 1 01011114689999995
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00087 Score=68.08 Aligned_cols=143 Identities=19% Similarity=0.183 Sum_probs=85.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC--ceeEEEEEe------ec
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLYYSF------QD 157 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~f------~~ 157 (518)
+....++.++.|.-..||++.. .+| .|++|+..... ..+.+..|.+++..+... .+.+.+..- ..
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 3455577888888899998853 334 57788765421 123455677777777422 234444321 23
Q ss_pred CCeEEEEEeecCCCchH-----------HH---Hhhc-CCC----------CHH---HHH----------HHHHHHHHHH
Q 010116 158 TEYLYLIMEYLPGGDMM-----------TL---LMRE-DTL----------TEN---VAR----------FYIAQSVLAI 199 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~-----------~~---l~~~-~~l----------~e~---~~~----------~~~~ql~~aL 199 (518)
.+..|+||+|++|..+. .. ++.. ..+ +.. ... .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 45678999999985431 11 1110 011 000 000 0011233345
Q ss_pred HHHHh-------CCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 200 ESIHK-------HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 200 ~~LH~-------~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
+++.. .++||+|+.+.||+++.++.+.|+||+.|..
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 55542 6899999999999999988778999998864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00035 Score=65.84 Aligned_cols=98 Identities=20% Similarity=0.222 Sum_probs=78.2
Q ss_pred HHHHHHHHhCC-CceeEEEEEeecCCeEEEEEeecCCCchHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCe
Q 010116 135 AERNLLAEVAS-HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL---LMREDTLTENVARFYIAQSVLAIESIHK---HNY 207 (518)
Q Consensus 135 ~E~~il~~l~h-p~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~---l~~~~~l~e~~~~~~~~ql~~aL~~LH~---~gi 207 (518)
.|.-+|+.+.+ ++++++++++-+ ++|.||.+.+++... +..-..-++.....++.+++..+++|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 46777888865 699999999843 479999987766532 2222346788888999999999999997 457
Q ss_pred EEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 208 iHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
.-.|++|+|+-++++|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 77999999999999999999999976643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00062 Score=68.54 Aligned_cols=138 Identities=17% Similarity=0.137 Sum_probs=83.9
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC--ceeEEEEE------eecCCeE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLYYS------FQDTEYL 161 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~------f~~~~~l 161 (518)
-++.|..|....||++.. ++..+++|+.... ....+..|..++..+.+. .+++++.. ....+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 356788888899998753 3457889987531 124466677887777432 24444432 2334567
Q ss_pred EEEEeecCCCchHH-----------HH---hhc-CCCC--------HHHHH------------HHHHHHHHHHHHHHh--
Q 010116 162 YLIMEYLPGGDMMT-----------LL---MRE-DTLT--------ENVAR------------FYIAQSVLAIESIHK-- 204 (518)
Q Consensus 162 ylVmEy~~gG~L~~-----------~l---~~~-~~l~--------e~~~~------------~~~~ql~~aL~~LH~-- 204 (518)
++|++|++|..+.. .| +.. ..+. ..... .....+..++.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999866421 01 100 0000 00000 011122334444443
Q ss_pred -----CCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 205 -----HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 205 -----~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.++||+|+.|.|||++.++.+.|+||+.|..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999887789999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00052 Score=69.37 Aligned_cols=137 Identities=17% Similarity=0.183 Sum_probs=83.2
Q ss_pred EeeEeecCceEEEEEEEec------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC-ceeEEEEEeecCCeEEE
Q 010116 91 LTIIGRGAFGEVRLCREKK------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~f~~~~~lyl 163 (518)
++.|..|-...||++.... +++.|++|+..... .......+|..++..+... ...++++++.+ .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4566777788999887543 25789999865431 1123456788888887533 34566666653 25
Q ss_pred EEeecCCCchHHH--------------H---hhcC-CC--------C--HHHHHHH------------------------
Q 010116 164 IMEYLPGGDMMTL--------------L---MRED-TL--------T--ENVARFY------------------------ 191 (518)
Q Consensus 164 VmEy~~gG~L~~~--------------l---~~~~-~l--------~--e~~~~~~------------------------ 191 (518)
|+||++|..+... | ++.. .. + ......+
T Consensus 75 v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (302)
T cd05156 75 IEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELS 154 (302)
T ss_pred hhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHH
Confidence 8999998765421 1 1100 00 0 0011111
Q ss_pred --HHHHHHHHHHHHh---------CCeEEcCCCCCceeeCCC----CcEEEeecccccc
Q 010116 192 --IAQSVLAIESIHK---------HNYIHRDIKPDNLLLDKN----GHMKLSDFGLCKP 235 (518)
Q Consensus 192 --~~ql~~aL~~LH~---------~giiHRDIKPeNILld~~----g~vKL~DFGla~~ 235 (518)
..++...+.+|-. .+++|+|+.|.|||++.+ +.+.|+||..|..
T Consensus 155 ~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 155 LFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 1122222334431 368999999999999985 8899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00051 Score=67.79 Aligned_cols=133 Identities=17% Similarity=0.214 Sum_probs=78.2
Q ss_pred EeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc-eeEEEEEeecCCeEEEEEeecCCCc
Q 010116 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGD 172 (518)
Q Consensus 94 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~~lylVmEy~~gG~ 172 (518)
+..|-.+.+|++. .+++.|++|....... .-.+ ...+|..+++.+.... ..++++... -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~--~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK--ALGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc--cccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4568888999876 4567888987543311 0001 2467888888885432 344444433 268999999865
Q ss_pred hHH--------------HHhh---cC----CCC-HHHHHHHHHHH---------HHHHHHHHh--------CCeEEcCCC
Q 010116 173 MMT--------------LLMR---ED----TLT-ENVARFYIAQS---------VLAIESIHK--------HNYIHRDIK 213 (518)
Q Consensus 173 L~~--------------~l~~---~~----~l~-e~~~~~~~~ql---------~~aL~~LH~--------~giiHRDIK 213 (518)
+.. .+.+ .. +++ ...+..|..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 431 1111 11 111 12222332222 111222221 258999999
Q ss_pred CCceeeCCCCcEEEeeccccccc
Q 010116 214 PDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 214 PeNILld~~g~vKL~DFGla~~~ 236 (518)
|.|||++.+| +.|+||+.|..-
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcC
Confidence 9999999887 789999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0025 Score=64.88 Aligned_cols=137 Identities=15% Similarity=0.107 Sum_probs=75.3
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC--ceeEEEEE------eecCCeEE
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLYYS------FQDTEYLY 162 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~------f~~~~~ly 162 (518)
++.|+.|....+|.+... +..|++|+.... ..+.+..|..++..+... .+.+.+.+ ....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~------~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFERL------TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEeccC------ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 456778888899988642 336888987511 122344455666655311 13333321 22355678
Q ss_pred EEEeecCCCchH-----------HHH---hhc-CCC--------C--H--HHHHH-----------HHHH-HHHHHHHHH
Q 010116 163 LIMEYLPGGDMM-----------TLL---MRE-DTL--------T--E--NVARF-----------YIAQ-SVLAIESIH 203 (518)
Q Consensus 163 lVmEy~~gG~L~-----------~~l---~~~-~~l--------~--e--~~~~~-----------~~~q-l~~aL~~LH 203 (518)
++++|++|..+. ..| +.. ..+ . . ..+.. .+.+ +...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999986431 111 110 001 0 0 00000 1111 111223332
Q ss_pred -------hCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 204 -------KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 204 -------~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
..|+||+|+.|.|||++.+...-|+||+.|..
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 23899999999999998665558999998864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0097 Score=60.22 Aligned_cols=30 Identities=27% Similarity=0.557 Sum_probs=26.6
Q ss_pred CCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 205 ~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.++||+|+.+.|||++. +.+.|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 58999999999999987 7789999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0057 Score=63.28 Aligned_cols=142 Identities=13% Similarity=0.168 Sum_probs=83.6
Q ss_pred CCeeEEeeEeecCceEEEEEEEec----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc-eeEEEEEeecCCe
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKK----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEY 160 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~~ 160 (518)
+...+ +.|-.|-...+|++.... +++.|.+|+..... ...+.+ .+|..+++.+.... -.++++.|...
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g-- 109 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG-- 109 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc--
Confidence 34444 455558889999986432 34689999876532 222232 56888888885433 34666776443
Q ss_pred EEEEEeecCCCchHHH--------------Hh---hcC------CCCHHHHHHHHHHH-----------------HHHHH
Q 010116 161 LYLIMEYLPGGDMMTL--------------LM---RED------TLTENVARFYIAQS-----------------VLAIE 200 (518)
Q Consensus 161 lylVmEy~~gG~L~~~--------------l~---~~~------~l~e~~~~~~~~ql-----------------~~aL~ 200 (518)
.|.+|++|.+|... +. .-. ....+.+..+..++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 58999987655311 11 100 01122233332211 11121
Q ss_pred HH----H----hCCeEEcCCCCCceeeCC-CCcEEEeeccccccc
Q 010116 201 SI----H----KHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPL 236 (518)
Q Consensus 201 ~L----H----~~giiHRDIKPeNILld~-~g~vKL~DFGla~~~ 236 (518)
.| . ...++|+|+++.|||++. ++.+.|+||..|...
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22 1 236899999999999986 478999999988743
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0085 Score=60.00 Aligned_cols=32 Identities=28% Similarity=0.532 Sum_probs=26.9
Q ss_pred CeEEcCCCCCceeeCCCCcE-EEeecccccccC
Q 010116 206 NYIHRDIKPDNLLLDKNGHM-KLSDFGLCKPLD 237 (518)
Q Consensus 206 giiHRDIKPeNILld~~g~v-KL~DFGla~~~~ 237 (518)
.+||+|+.|.|||++.+|.+ -|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 58999999999999976664 699999987543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0078 Score=62.13 Aligned_cols=83 Identities=19% Similarity=0.167 Sum_probs=51.3
Q ss_pred eEeecCceEEEEEEEecCCcEEEEEEeechhhh----chhhHHHHHHHHHHHHHhC--CC-ceeEEEEEeecCCeEEEEE
Q 010116 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV----KRGQVEHVRAERNLLAEVA--SH-CIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 93 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~----~~~~~~~~~~E~~il~~l~--hp-~Iv~l~~~f~~~~~lylVm 165 (518)
.||-|...-||++.....++-++||.-..-.-. -.-..++..-|...|+... .| .++++|+ | |++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-ccccceehH
Confidence 579999999999987543467999864321110 0223456677888887764 34 4555443 3 445566999
Q ss_pred eecCCC-chHHHH
Q 010116 166 EYLPGG-DMMTLL 177 (518)
Q Consensus 166 Ey~~gG-~L~~~l 177 (518)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 333444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0067 Score=62.10 Aligned_cols=144 Identities=24% Similarity=0.263 Sum_probs=96.0
Q ss_pred eEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchh----------------------hH-HHHHHHHHHHHHhCC
Q 010116 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG----------------------QV-EHVRAERNLLAEVAS 145 (518)
Q Consensus 89 ~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~----------------------~~-~~~~~E~~il~~l~h 145 (518)
++-..|..|-=+-||.|.. .+|..+|||+.+-+-+.-.+ .+ -....|.+-|.+++.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3556788898999999875 46788999998755332111 11 113455666776654
Q ss_pred CceeEEEEEeecCCeEEEEEeecCCCchHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEcCCCCCceeeCCCC
Q 010116 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL-LMREDTLTENVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDKNG 223 (518)
Q Consensus 146 p~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~-l~~~~~l~e~~~~~~~~ql~~aL~~LH-~~giiHRDIKPeNILld~~g 223 (518)
-.|.-.--+.. ..-.|||+|+. ++=+-. ..+.-.++...++.+-.+++.-+.-|- .+++||.||.-=|+|+ .+|
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDG 301 (520)
T ss_pred cCCCCCCceee--ecceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECC
Confidence 33221100000 12359999994 443322 224457888889998888888888774 5799999999999999 789
Q ss_pred cEEEeecccccccC
Q 010116 224 HMKLSDFGLCKPLD 237 (518)
Q Consensus 224 ~vKL~DFGla~~~~ 237 (518)
++.|+|-+-+...+
T Consensus 302 ~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEEccccccCC
Confidence 99999998776543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.00081 Score=67.55 Aligned_cols=138 Identities=16% Similarity=0.169 Sum_probs=92.7
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc------hh-----------hH--HHHHHHHHHHHHhCC-C-
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK------RG-----------QV--EHVRAERNLLAEVAS-H- 146 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~------~~-----------~~--~~~~~E~~il~~l~h-p- 146 (518)
+.+...||-|-=+.||++-+ ..|+.+++|.-......- ++ .. -...+|...|+.+.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 55778999999999999865 458899999643221110 00 01 123567777777642 2
Q ss_pred ceeEEEEEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEE
Q 010116 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (518)
Q Consensus 147 ~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vK 226 (518)
-|.+.+ |-..-|+|||++.|-.|...-.-. .+..+...+..-|--|-.+|+||+|..-=||+++.+++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 233333 334578999999987776543211 1223344555556678889999999999999999999999
Q ss_pred Eeeccccccc
Q 010116 227 LSDFGLCKPL 236 (518)
Q Consensus 227 L~DFGla~~~ 236 (518)
++||--+...
T Consensus 243 vIDFPQmvS~ 252 (465)
T KOG2268|consen 243 VIDFPQMVST 252 (465)
T ss_pred EeechHhhcc
Confidence 9999876543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.025 Score=57.56 Aligned_cols=149 Identities=13% Similarity=0.162 Sum_probs=86.6
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC--CceeEEEEEeecCC--eEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDTE--YLY 162 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~~~--~ly 162 (518)
...++..+-.|.--.+|.... +++.+++. ... ............+|..+|+.+.. .-+...+..+.++. ..|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 344555554444445554433 37888888 321 12223345556778888887754 23445556665555 679
Q ss_pred EEEeecCCCchHHH------------------Hhh---c-----------CCCCHHHHHHHHHHH--------------H
Q 010116 163 LIMEYLPGGDMMTL------------------LMR---E-----------DTLTENVARFYIAQS--------------V 196 (518)
Q Consensus 163 lVmEy~~gG~L~~~------------------l~~---~-----------~~l~e~~~~~~~~ql--------------~ 196 (518)
.||+|+.|..+.+. |.. - +.+.......+..+. .
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 99999988432221 110 0 000111112222222 2
Q ss_pred HHHHHHHhC--------CeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 197 LAIESIHKH--------NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 197 ~aL~~LH~~--------giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.-..+|+.+ .++|+|+.+.||+++.++-+-+.||+++..-+..
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 234455542 5899999999999999988999999999876543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.022 Score=58.64 Aligned_cols=142 Identities=17% Similarity=0.197 Sum_probs=81.5
Q ss_pred CCeeEEeeEeecCceEEEEEEEecC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCce-eEEEEEeecCCeE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDTEYL 161 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~f~~~~~l 161 (518)
++..+..+.| |=...+|++..... +..|.+|+..... ...+ .-.+|..+++.+....+ .++++++.. +
T Consensus 15 ~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~-G-- 86 (330)
T PLN02421 15 SDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFGN-G-- 86 (330)
T ss_pred CceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeCC-c--
Confidence 4555544444 88888998865432 3378899875431 1112 23568888888864433 466666642 2
Q ss_pred EEEEeecCCCchHH--------------HHhh---cC-C----C-CHHHHHHHHHHH----------------------H
Q 010116 162 YLIMEYLPGGDMMT--------------LLMR---ED-T----L-TENVARFYIAQS----------------------V 196 (518)
Q Consensus 162 ylVmEy~~gG~L~~--------------~l~~---~~-~----l-~e~~~~~~~~ql----------------------~ 196 (518)
+|.+|++|-.|.. .|.+ .. + . ....+..|..++ .
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5899998765421 1111 11 0 1 112233333222 1
Q ss_pred HHHHH---HH-hC----CeEEcCCCCCceeeCC-CCcEEEeeccccccc
Q 010116 197 LAIES---IH-KH----NYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPL 236 (518)
Q Consensus 197 ~aL~~---LH-~~----giiHRDIKPeNILld~-~g~vKL~DFGla~~~ 236 (518)
.-+.. +. .. -++|.|+-|.|||++. ++.++|+||..|..-
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11222 22 11 3799999999999975 578999999998743
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.028 Score=59.15 Aligned_cols=77 Identities=17% Similarity=0.168 Sum_probs=51.2
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhh-hch---hhHHHHHHHHHHHHHhC---CCceeEEEEEeecCCeEE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-VKR---GQVEHVRAERNLLAEVA---SHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~-~~~---~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~~~~ly 162 (518)
..+.||.|....||++.. .+..|+||.-..... ... ....+...|...|+.+. ...+.++|.+..+ .-+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 467889999999999876 345688987542111 011 13445556677776664 2477888877763 356
Q ss_pred EEEeecCC
Q 010116 163 LIMEYLPG 170 (518)
Q Consensus 163 lVmEy~~g 170 (518)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.065 Score=54.44 Aligned_cols=30 Identities=13% Similarity=0.184 Sum_probs=28.1
Q ss_pred CeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 206 giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
++||+|+.++|||++.++.+.++||..|..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.071 Score=55.95 Aligned_cols=80 Identities=18% Similarity=0.182 Sum_probs=47.3
Q ss_pred CCeeEEeeEeecCceEEEEEEEecC-CcE-----EEEEEeechhhhchhhHHHHHHHHHHHHHhCCC-ceeEEEEEeecC
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKS-GNI-----YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDT 158 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t-~~~-----~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~f~~~ 158 (518)
++.++ +.|..|-...+|+|..... +.. |.+++.... ....-.-.+|..+++.+... .-.++++.|..
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~- 124 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD- 124 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence 34444 4555588999999975432 223 333332111 11111235688889888644 55677777753
Q ss_pred CeEEEEEeecCCCchH
Q 010116 159 EYLYLIMEYLPGGDMM 174 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~ 174 (518)
++|.||++|-.|.
T Consensus 125 ---g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 ---FTIQEWVEGNTMG 137 (383)
T ss_pred ---EEEEEEeccccCC
Confidence 5999999987653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.12 Score=52.11 Aligned_cols=135 Identities=19% Similarity=0.238 Sum_probs=73.0
Q ss_pred eEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC---CCceeEEEEEeecCCeEEEEE
Q 010116 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 89 ~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~~~~lylVm 165 (518)
+-.+.||.|....+|.+. .+++.|-+|+-... ....+..|..-|+.+. .-.+++.+.+....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345788999999999775 77888999986532 1234677888888773 346778888887777779999
Q ss_pred eecCCCc--------hHHH---Hhh-c--CC-----------------CCHHHHHHHHHH------------------HH
Q 010116 166 EYLPGGD--------MMTL---LMR-E--DT-----------------LTENVARFYIAQ------------------SV 196 (518)
Q Consensus 166 Ey~~gG~--------L~~~---l~~-~--~~-----------------l~e~~~~~~~~q------------------l~ 196 (518)
||++.+. |-.. |++ . +. ....-..||+.+ +-
T Consensus 92 e~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~ 171 (288)
T PF03881_consen 92 EFLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELE 171 (288)
T ss_dssp E--------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHH
T ss_pred EeecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHH
Confidence 9998761 1111 122 1 11 123334444332 00
Q ss_pred HHHHHHHh----C----CeEEcCCCCCceeeCCCCcEEEeecc
Q 010116 197 LAIESIHK----H----NYIHRDIKPDNLLLDKNGHMKLSDFG 231 (518)
Q Consensus 197 ~aL~~LH~----~----giiHRDIKPeNILld~~g~vKL~DFG 231 (518)
..++-+.+ . -.||+||-+.|++.+.+|.+.|.|=.
T Consensus 172 ~l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 172 RLVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 11122222 1 38999999999999999999998865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.051 Score=56.91 Aligned_cols=85 Identities=19% Similarity=0.205 Sum_probs=54.9
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc---hhhHHHHHHHHHHHHHhC--CC-ceeEEEEEeecCCeEEEE
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK---RGQVEHVRAERNLLAEVA--SH-CIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~---~~~~~~~~~E~~il~~l~--hp-~Iv~l~~~f~~~~~lylV 164 (518)
++.||-|.-.-||++.+...++-++||.-..-.-.. .-..++..-|.++|+... .| .++++|++ |++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 788999999999999874445678888642211111 123567778888888764 34 45555443 45566799
Q ss_pred EeecCCC-chHHHH
Q 010116 165 MEYLPGG-DMMTLL 177 (518)
Q Consensus 165 mEy~~gG-~L~~~l 177 (518)
||+++.. .|.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9999643 344444
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.03 Score=57.35 Aligned_cols=73 Identities=25% Similarity=0.469 Sum_probs=54.0
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
...++|++|++- |+.+.-. + .-...++..++.+.+..+.-+... .+-|||+.-+||||+ .|+|-|+||-+|+.
T Consensus 297 e~~y~yl~~kdh-gt~is~i--k--~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII--K--ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceeeee--e--cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 345788899986 6665421 1 223455556667777666666654 789999999999999 99999999999984
|
|
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.0038 Score=44.94 Aligned_cols=46 Identities=28% Similarity=0.372 Sum_probs=23.3
Q ss_pred CCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCC
Q 010116 414 INGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNF 462 (518)
Q Consensus 414 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 462 (518)
|+++.|++||+......++..+.. ..+. .+....+..|.||||+++
T Consensus 2 v~~~~DtsnFD~eFt~~~~~~t~~--~~~~-~~~~~~~~~F~GFTy~~~ 47 (48)
T PF00433_consen 2 VKSETDTSNFDPEFTEEPPVDTPP--SDPS-PLSSSMQENFQGFTYVNP 47 (48)
T ss_dssp -SSTT-GTTSCHHHHTSSSSS--S----HH-HHCTSSGGGGTT-CEETC
T ss_pred CCchhhhhhcCcccccCCCCCCCc--ccCC-cccccccCcCCCCeecCC
Confidence 678999999998333333322211 0011 112344556999999875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.044 Score=58.44 Aligned_cols=78 Identities=17% Similarity=0.174 Sum_probs=55.4
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCC-----------CCCChhHHHHHHHHhc-cccccCC
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-----------SKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~-----------~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
++||||+|.++.|+..|...+......+....|...- ..+.. ..++.-..++..+|+- .|..|+
T Consensus 111 KsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~---~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~- 186 (725)
T KOG1093|consen 111 KSDVWSLGFIILELYLGISLEAELTESEYLEILLKYY---TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP- 186 (725)
T ss_pred chhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhc---cCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc-
Confidence 9999999999999999998887665555555544311 11100 1234556677788886 888898
Q ss_pred CCChhhhhcCcccccC
Q 010116 383 TGGAHQIKAHPWFKDV 398 (518)
Q Consensus 383 ~~~a~eil~Hpff~~i 398 (518)
...+..+|+-|..+
T Consensus 187 --l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 --LPMELSKRCSFTEV 200 (725)
T ss_pred --chhHHhcCccHHHH
Confidence 68888999988776
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.076 Score=50.64 Aligned_cols=31 Identities=35% Similarity=0.693 Sum_probs=22.5
Q ss_pred CCeEEcCCCCCceee-CCCCcEEEeecccccc
Q 010116 205 HNYIHRDIKPDNLLL-DKNGHMKLSDFGLCKP 235 (518)
Q Consensus 205 ~giiHRDIKPeNILl-d~~g~vKL~DFGla~~ 235 (518)
..++|.||.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 368999999999999 8899999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.091 Score=50.47 Aligned_cols=84 Identities=24% Similarity=0.322 Sum_probs=58.2
Q ss_pred HHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEE
Q 010116 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK--HNYIH 209 (518)
Q Consensus 132 ~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~--~giiH 209 (518)
.+..+.++++++ ..|++|..- +.-.+-+|+|+|--.... ..-+ +.--+.+|.-.|+ .+.+|
T Consensus 104 ~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i~------------~~N~-i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 104 LYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKIN------------FSNF-ITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCcccc------------hhHH-HHHhHHHHHHhhccCCCeec
Confidence 356778888876 367777632 344567999999432111 1111 1222456777895 48999
Q ss_pred cCCCCCceeeCCCCcEEEeeccc
Q 010116 210 RDIKPDNLLLDKNGHMKLSDFGL 232 (518)
Q Consensus 210 RDIKPeNILld~~g~vKL~DFGl 232 (518)
+|-.|+||+-|+.|.+||.|-+.
T Consensus 167 GD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 167 GDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999874
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.57 Score=48.02 Aligned_cols=71 Identities=11% Similarity=0.075 Sum_probs=41.4
Q ss_pred cCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC--ceeEEE---E--EeecCCeEEEEEeecC
Q 010116 97 GAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLY---Y--SFQDTEYLYLIMEYLP 169 (518)
Q Consensus 97 G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~---~--~f~~~~~lylVmEy~~ 169 (518)
|.-..||.+.. .+|..|++|+..... .....+..|..++..+... .++... + .+..++..+.|+++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34467898753 346779999875432 1234566777777766321 122211 1 1223567889999998
Q ss_pred CCc
Q 010116 170 GGD 172 (518)
Q Consensus 170 gG~ 172 (518)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.55 Score=55.58 Aligned_cols=31 Identities=32% Similarity=0.503 Sum_probs=26.8
Q ss_pred CCeEEcCCCCCceeeCCCC--cEE-Eeecccccc
Q 010116 205 HNYIHRDIKPDNLLLDKNG--HMK-LSDFGLCKP 235 (518)
Q Consensus 205 ~giiHRDIKPeNILld~~g--~vK-L~DFGla~~ 235 (518)
.++||.|+.+.|||++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999876 565 999998764
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.048 Score=55.19 Aligned_cols=51 Identities=29% Similarity=0.462 Sum_probs=36.2
Q ss_pred HHHHHHHHHHHHHHHHHHH----hCCeEEcCCCCCceeeCCCC------------------cEEEeecccccc
Q 010116 185 ENVARFYIAQSVLAIESIH----KHNYIHRDIKPDNLLLDKNG------------------HMKLSDFGLCKP 235 (518)
Q Consensus 185 e~~~~~~~~ql~~aL~~LH----~~giiHRDIKPeNILld~~g------------------~vKL~DFGla~~ 235 (518)
.+-+++++.|+++-.-.+- ..+++|-||||+|||+-.+. .++|.||.++..
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 3567888889887654443 34799999999999984322 246777777764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 518 | ||||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-79 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-79 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-79 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-77 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-77 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-73 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-73 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-72 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-62 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-62 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-62 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-62 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-62 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-62 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-62 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-62 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-62 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-62 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-62 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-61 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-61 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-61 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-61 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-61 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-61 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-61 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-61 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-61 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-61 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-61 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-61 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-61 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-61 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-61 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-61 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-61 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-61 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-61 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-61 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-61 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-61 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-61 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-61 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-61 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-61 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-61 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-60 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-60 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-60 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-60 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-60 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-60 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-60 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-60 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-60 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-60 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-60 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-60 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-60 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-60 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-60 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-54 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-53 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-53 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-53 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-51 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-51 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-50 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-50 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-50 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-50 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-50 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-49 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-49 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-49 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-49 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-49 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-48 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-47 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-47 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-47 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-47 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-46 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-46 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-46 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-46 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-46 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-46 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-44 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-43 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-43 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-43 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-43 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-43 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-43 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-43 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-43 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-43 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-43 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-43 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-43 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-43 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-42 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-42 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-42 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-42 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-42 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-42 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-42 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-42 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-41 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-41 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-35 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-35 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-34 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-34 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-34 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-34 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-34 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-33 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-33 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-33 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-33 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-32 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-32 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-32 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-32 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-32 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-32 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-32 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-32 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-32 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-32 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-32 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-32 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-31 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-31 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-31 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-31 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-31 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-31 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-31 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-31 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-31 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-31 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-31 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-31 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-31 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-31 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-31 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-31 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-31 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-31 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-31 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-31 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-31 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-31 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-31 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-30 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-30 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-30 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-30 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-30 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-30 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-30 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-30 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-30 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-30 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-30 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-29 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-29 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-29 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-29 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-29 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-29 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-29 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-28 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-28 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-28 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-28 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-28 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-28 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-28 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-28 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-27 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-27 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-27 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-27 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-27 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-27 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-27 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-26 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-26 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-26 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-26 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-26 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-26 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-26 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-26 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-26 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-26 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-26 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-26 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-25 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-25 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-25 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-25 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-25 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-25 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-25 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-25 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-25 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-25 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-25 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-25 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-25 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-25 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-25 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-25 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-25 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-25 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-25 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-25 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-24 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-24 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-24 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-24 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-24 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-24 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-24 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-23 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-22 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-22 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-22 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-22 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-22 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-22 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-22 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-21 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-21 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-21 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-21 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-19 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-16 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-16 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 7e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 4ax8_A | 569 | Medium Resolution Structure Of The Bifunctional Kin | 3e-05 | ||
| 4azs_A | 569 | High Resolution (2.2 A) Crystal Structure Of Wbdd. | 3e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 6e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-05 | ||
| 4azw_A | 471 | Crystal Structure Of Monomeric Wbdd Length = 471 | 9e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-04 |
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AX8|A Chain A, Medium Resolution Structure Of The Bifunctional Kinase- Methyltransferase Wbdd Length = 569 | Back alignment and structure |
|
| >pdb|4AZS|A Chain A, High Resolution (2.2 A) Crystal Structure Of Wbdd. Length = 569 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4AZW|A Chain A, Crystal Structure Of Monomeric Wbdd Length = 471 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 483 bits (1245), Expect = e-169
Identities = 158/417 (37%), Positives = 219/417 (52%), Gaps = 59/417 (14%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM 116
+ + + L+ E +RLK ++ DDFE+L +IGRGAF EV + + K++G +YAM
Sbjct: 32 ELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAM 91
Query: 117 KKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176
K + K +M+KRG+V R ER++L I +L+++FQD YLYL+MEY GGD++TL
Sbjct: 92 KIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTL 151
Query: 177 LMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235
L + + + +ARFY+A+ V+AI+S+H+ Y+HRDIKPDN+LLD+ GH++L+DFG C
Sbjct: 152 LSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295
L + +
Sbjct: 212 LR------------------------------------------------ADGTVRSLVA 223
Query: 296 VGTPDYIAPEVLLKKG-------YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV 348
VGTPDY++PE+L G YG ECDWW+LG YEM G PFYAD T KIV
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283
Query: 349 HWRNHLKFP-DDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYEME 407
H++ HL P D + EA+D I RLLC E RLG GGA + HP+F + WD L +
Sbjct: 284 HYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSV 343
Query: 408 AAFKPEINGELDTQNFMK-FDELDPPASGRTSSGP-SRKMLLTPKDLSFVGYTYKNF 462
F P+ G DT NF D L SG + R+ L FVGY+Y
Sbjct: 344 PPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCM 400
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 474 bits (1221), Expect = e-165
Identities = 154/411 (37%), Positives = 222/411 (54%), Gaps = 60/411 (14%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM 116
+ + N+ L R + +++ ++ +D+E++ +IGRGAFGEV+L R K + +YAM
Sbjct: 40 ALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 117 KKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176
K L K EM+KR ER+++A S +V+L+Y+FQD YLY++MEY+PGGD++ L
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 177 LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
+ D + E ARFY A+ VLA+++IH +IHRD+KPDN+LLDK+GH+KL+DFG C +
Sbjct: 160 MSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218
Query: 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296
+ + V
Sbjct: 219 N------------------------------------------------KEGMVRCDTAV 230
Query: 297 GTPDYIAPEVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN 352
GTPDYI+PEVL +G YG ECDWWS+G +YEMLVG PFYAD + T KI++ +N
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290
Query: 353 HLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLY--EMEAAF 410
L FPDD+ +S EAK+LIC L D E RLG G +IK H +FK+ W + A
Sbjct: 291 SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPV 350
Query: 411 KPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461
P+++ ++DT NF +E L FVG+TY +
Sbjct: 351 VPDLSSDIDTSNFDDLEEDKGE-----EETFPIPKAFVGNQLPFVGFTYYS 396
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 471 bits (1215), Expect = e-164
Identities = 160/416 (38%), Positives = 230/416 (55%), Gaps = 58/416 (13%)
Query: 53 SSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN 112
++ P+ + N+++ LE + ++K+ ++ +DFE+L +IGRGAFGEV + + K +
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK 100
Query: 113 IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD 172
++AMK L K EM+KR + R ER++L S I L+Y+FQD LYL+M+Y GGD
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160
Query: 173 MMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
++TLL + ED L E +ARFY+A+ V+AI+S+H+ +Y+HRDIKPDN+L+D NGH++L+DFG
Sbjct: 161 LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 220
Query: 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291
C L D +SS
Sbjct: 221 SCLKLM----------------------------EDGTVQSS------------------ 234
Query: 292 AFSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRK 346
VGTPDYI+PE+L K YG ECDWWSLG MYEML G PFYA+ + T K
Sbjct: 235 --VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
Query: 347 IVHWRNHLKFPDD-SKLSPEAKDLICRLLCDVEHRLGTGGAHQIKAHPWFKDVVWDKLYE 405
I++ + +FP + +S AKDLI RL+C EHRLG G K HP+F + WD +
Sbjct: 293 IMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRN 352
Query: 406 MEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKN 461
EA + PE++ DT NF D+ + + P + L FVG+TY +
Sbjct: 353 CEAPYIPEVSSPTDTSNFDVDDDCLKNSE---TMPPPTHTAFSGHHLPFVGFTYTS 405
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 376 bits (969), Expect = e-128
Identities = 120/400 (30%), Positives = 192/400 (48%), Gaps = 60/400 (15%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
++ DF L +IG+G+FG+V L R K YA+K L+K ++K+
Sbjct: 21 PSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK 80
Query: 129 QVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV 187
+ +H+ +ERN+L + H +V L++SFQ + LY +++Y+ GG++ L RE E
Sbjct: 81 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 140
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
ARFY A+ A+ +H N ++RD+KP+N+LLD GH+ L+DFGLCK
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK------------- 187
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
EN+ + GTP+Y+APEVL
Sbjct: 188 -----ENIEH-------------------------------NSTTSTFCGTPEYLAPEVL 211
Query: 308 LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAK 367
K+ Y DWW LGA++YEML G PPFY+ + I++ L+ + ++ A+
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPN--ITNSAR 267
Query: 368 DLICRLLC-DVEHRLG-TGGAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF 423
L+ LL D RLG +IK+H +F + WD L ++ F P ++G D ++F
Sbjct: 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHF 327
Query: 424 -MKFDELDPPAS-GRTSSGPSRKMLLTPKDLSFVGYTYKN 461
+F E P + G+ + +F+G++Y
Sbjct: 328 DPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAP 367
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-127
Identities = 101/341 (29%), Positives = 167/341 (48%), Gaps = 55/341 (16%)
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
+ + K +DF+ I+G G+F V L RE + YA+K L+K ++K +V
Sbjct: 16 QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
+V ER++++ + VKLY++FQD E LY + Y G+++ + + + E RFY
Sbjct: 76 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
A+ V A+E +H IHRD+KP+N+LL+++ H++++DFG K L
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------------- 181
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+++ A S VGT Y++PE+L +K
Sbjct: 182 ---------------------------------PESKQARANSFVGTAQYVSPELLTEKS 208
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
D W+LG I+Y+++ G PPF A + +KI+ FP+ P+A+DL+
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEK--FFPKARDLVE 264
Query: 372 RLLC-DVEHRLG---TGGAHQIKAHPWFKDVVWDKLYEMEA 408
+LL D RLG G +KAHP+F+ V W+ L++
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-124
Identities = 124/356 (34%), Positives = 189/356 (53%), Gaps = 62/356 (17%)
Query: 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRG-QVEH 132
KI + FELL ++G+G +G+V R+ +G I+AMK LKK+ +V+ H
Sbjct: 8 NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI 192
+AERN+L EV IV L Y+FQ LYLI+EYL GG++ L RE E+ A FY+
Sbjct: 68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
A+ +A+ +H+ I+RD+KP+N++L+ GH+KL+DFGLCK
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK------------------ 169
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
E++ + + + GT +Y+APE+L++ G+
Sbjct: 170 ESIHDG-------------------------------TVTHTFCGTIEYMAPEILMRSGH 198
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372
DWWSLGA+MY+ML G PPF ++ T KI+ L P L+ EA+DL+ +
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPY--LTQEARDLLKK 254
Query: 373 LLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF 423
LL + RLG G A +++AHP+F+ + W++L ++E FKP + E D F
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-124
Identities = 118/389 (30%), Positives = 190/389 (48%), Gaps = 67/389 (17%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+ K+ ++DF L ++G+G+FG+V L KK+ +A+K LKK ++ VE E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 139 LLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
+L+ H + ++ +FQ E L+ +MEYL GGD+M + + A FY A+ +L
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
++ +H ++RD+K DN+LLDK+GH+K++DFG+CK ENM
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK------------------ENMLG 171
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ GTPDYIAPE+LL + Y D
Sbjct: 172 D-------------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVD 200
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-D 376
WWS G ++YEML+G PF+ D I ++ +P L EAKDL+ +L +
Sbjct: 201 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRW--LEKEAKDLLVKLFVRE 256
Query: 377 VEHRLGTGGAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF-MKFDELDPPA 433
E RLG G I+ HP F+++ W++L E++ F+P++ D NF +F P
Sbjct: 257 PEKRLGVRG--DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 314
Query: 434 SGRTSSGPSRKMLLTPKDLS-FVGYTYKN 461
S + + L+ D + F +++ N
Sbjct: 315 S------FADRALINSMDQNMFRNFSFMN 337
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-124
Identities = 115/405 (28%), Positives = 196/405 (48%), Gaps = 68/405 (16%)
Query: 66 KDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV 125
K+ ++ +++ +D+FE + ++G+G+FG+V L R K++G++YA+K LKK ++
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 126 KRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLT 184
+ VE E+ +L+ +H + +L+ FQ + L+ +ME++ GGD+M + +
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244
E ARFY A+ + A+ +H I+RD+K DN+LLD GH KL+DFG+CK
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---------- 172
Query: 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304
E + + GTPDYIAP
Sbjct: 173 --------EGICN-------------------------------GVTTATFCGTPDYIAP 193
Query: 305 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSP 364
E+L + YG DWW++G ++YEML G+ PF A++ I++ + + +P L
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTW--LHE 249
Query: 365 EAKDLICRLLC-DVEHRLG---TGGAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGEL 418
+A ++ + + RLG GG H I HP+FK++ W +L ++E F+P I
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSRE 309
Query: 419 DTQNF-MKFDELDPPASGRTSSGPSRKMLLTPKDLS-FVGYTYKN 461
D NF F + +P + P + L + F + Y +
Sbjct: 310 DVSNFDPDFIKEEPVLT------PIDEGHLPMINQDEFRNFEYVS 348
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-123
Identities = 125/388 (32%), Positives = 188/388 (48%), Gaps = 61/388 (15%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
K+ ++DF+ L ++G+G FG+V L REK +G YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ L Y+FQ + L +MEY GG++ L RE TE ARFY A+ V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H + ++RDIK +NL+LDK+GH+K++DFGLCK E +++
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK------------------EGISD---- 158
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
+ GTP+Y+APEVL YG DWW L
Sbjct: 159 ---------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
G +MYEM+ G PFY D I+ ++FP LSPEAK L+ LL D + R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRT--LSPEAKSLLAGLLKKDPKQR 247
Query: 381 LGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF-MKFDELDPPAS- 434
LG G A ++ H +F + W + ++ FKP++ E+DT+ F +F +
Sbjct: 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITP 307
Query: 435 -GRTSSGPSRKMLLTPKDLSFVGYTYKN 461
R S ++ + F + Y
Sbjct: 308 PDRYDSLGLLELDQREEQEMFEDFDYIA 335
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-122
Identities = 126/359 (35%), Positives = 184/359 (51%), Gaps = 62/359 (17%)
Query: 73 TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRGQ 129
T ++ K FELL ++G+G+FG+V L ++ + +YAMK LKK+ + R +
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 130 VEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVAR 189
V + ER++L EV IVKL+Y+FQ LYLI+++L GGD+ T L +E TE +
Sbjct: 71 V-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
FY+A+ LA++ +H I+RD+KP+N+LLD+ GH+KL+DFGL K
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------------- 174
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309
E++ K A+S GT +Y+APEV+ +
Sbjct: 175 ---ESIDHE-------------------------------KKAYSFCGTVEYMAPEVVNR 200
Query: 310 KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDL 369
+G+ DWWS G +M+EML G PF D T I+ L P LSPEA+ L
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQF--LSPEAQSL 256
Query: 370 ICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF 423
+ L + +RLG G G +IK H +F + W+KLY E+ FKP DT F
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYF 315
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 362 bits (931), Expect = e-122
Identities = 111/391 (28%), Positives = 184/391 (47%), Gaps = 68/391 (17%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
R ++ + DF L ++G+G+FG+V L K + +YA+K LKK +++ VE E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 139 LLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
+LA + +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ +
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
+ + I+RD+K DN++LD GH+K++DFG+CK EN+ +
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK------------------ENIWD 174
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ GTPDYIAPE++ + YG D
Sbjct: 175 -------------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVD 203
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-D 376
WW+ G ++YEML G PF +D + I+ +++ +P +S EA + L+
Sbjct: 204 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKS--MSKEAVAICKGLMTKH 259
Query: 377 VEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF-MKFDELDP 431
RLG G G IK H +F+ + W+KL E++ +KP+ G + +NF F P
Sbjct: 260 PGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPP 318
Query: 432 PASGRTSSGPSRKMLLTPKD-LSFVGYTYKN 461
+ P + ++ D F G+++ N
Sbjct: 319 VLT------PPDQEVIRNIDQSEFEGFSFVN 343
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-122
Identities = 127/381 (33%), Positives = 195/381 (51%), Gaps = 68/381 (17%)
Query: 59 EEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCRE---KKSGNIYA 115
+ L+ T + K+ +++FELL ++G GA+G+V L R+ +G +YA
Sbjct: 27 DGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 116 MKKLKKSEMVKRG-QVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDM 173
MK LKK+ +V++ EH R ER +L + +V L+Y+FQ L+LI++Y+ GG++
Sbjct: 87 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 146
Query: 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
T L + + TE+ + Y+ + VLA+E +HK I+RDIK +N+LLD NGH+ L+DFGL
Sbjct: 147 FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
K E +A+ + A+
Sbjct: 207 K------------------EFVADETE------------------------------RAY 218
Query: 294 STVGTPDYIAPEVLL--KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTC----RKI 347
GT +Y+AP+++ G+ DWWSLG +MYE+L G PF D + R+I
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278
Query: 348 VHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY 404
+ + +P + +S AKDLI RLL D + RLG G A +IK H +F+ + WD L
Sbjct: 279 LK--SEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLA 334
Query: 405 --EMEAAFKPEINGELDTQNF 423
++ A FKP I ELD NF
Sbjct: 335 AKKVPAPFKPVIRDELDVSNF 355
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 357 bits (918), Expect = e-120
Identities = 86/354 (24%), Positives = 152/354 (42%), Gaps = 69/354 (19%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+ + D FE+L IG+G+FG+V + ++ + +YAMK + K + V+R +V +V E
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
++ + +V L+YSFQD E ++++++ L GGD+ L + E + +I + V+A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
++ + IHRD+KPDN+LLD++GH+ ++DF +
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA------------------------ 163
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK---GYGME 315
+ R + GT Y+APE+ + GY
Sbjct: 164 --------------------------MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 316 CDWWSLGAIMYEMLVGYPPFY---ADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372
DWWSLG YE+L G P++ + + +P S E L+ +
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSA--WSQEMVSLLKK 253
Query: 373 LLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF 423
LL + + R ++ P+ D+ WD ++ + F P N
Sbjct: 254 LLEPNPDQRF--SQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK----GRLNC 301
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-119
Identities = 119/398 (29%), Positives = 189/398 (47%), Gaps = 77/398 (19%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ + DF+LL +IGRG++ +V L R KK+ IYAMK +KK + ++ V+ E+++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 142 EVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
+ ++H +V L+ FQ L+ ++EY+ GGD+M + R+ L E ARFY A+ LA+
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H+ I+RD+K DN+LLD GH+KL+D+G+CK E +
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------------------EGLRP--- 163
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
+ GTP+YIAPE+L + YG DWW+
Sbjct: 164 ----------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 195
Query: 321 LGAIMYEMLVGYPPF---------YADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
LG +M+EM+ G PF + + I+ ++ P LS +A ++
Sbjct: 196 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRS--LSVKAASVLK 251
Query: 372 RLLC-DVEHRLGTG---GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF-M 424
L D + RLG G I+ HP+F++V WD + ++ FKP I+GE NF
Sbjct: 252 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDS 311
Query: 425 KFDELDPPASGRTSSGPSRKMLLTPKDLS-FVGYTYKN 461
+F + P ++ D S F G+ Y N
Sbjct: 312 QFTNEPVQLT------PDDDDIVRKIDQSEFEGFEYIN 343
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-116
Identities = 120/414 (28%), Positives = 193/414 (46%), Gaps = 77/414 (18%)
Query: 66 KDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV 125
++ E T + + DF+LL +IGRG++ +V L R KK+ IYAM+ +KK +
Sbjct: 32 EEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN 91
Query: 126 KRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLT 184
++ V+ E+++ + ++H +V L+ FQ L+ ++EY+ GGD+M + R+ L
Sbjct: 92 DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP 151
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244
E ARFY A+ LA+ +H+ I+RD+K DN+LLD GH+KL+D+G+CK
Sbjct: 152 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---------- 201
Query: 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304
E + + GTP+YIAP
Sbjct: 202 --------EGLRP-------------------------------GDTTSTFCGTPNYIAP 222
Query: 305 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPF---------YADDPITTCRKIVHWRNHLK 355
E+L + YG DWW+LG +M+EM+ G PF + + I+ ++
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIR 280
Query: 356 FPDDSKLSPEAKDLICRLLC-DVEHRLGTG---GAHQIKAHPWFKDVVWDKLY--EMEAA 409
P LS +A ++ L D + RLG G I+ HP+F++V WD + ++
Sbjct: 281 IPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPP 338
Query: 410 FKPEINGELDTQNF-MKFDELDPPASGRTSSGPSRKMLLTPKDLS-FVGYTYKN 461
FKP I+GE NF +F + P ++ D S F G+ Y N
Sbjct: 339 FKPNISGEFGLDNFDSQFTNEPVQLT------PDDDDIVRKIDQSEFEGFEYIN 386
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 347 bits (891), Expect = e-115
Identities = 122/351 (34%), Positives = 180/351 (51%), Gaps = 59/351 (16%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+H++ +++FE L ++G+G FG+V L +EK +G YAMK LKK +V + +V H E
Sbjct: 141 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
+L + L YSFQ + L +MEY GG++ L RE +E+ ARFY A+ V A
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 199 IESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
++ +H + N ++RD+K +NL+LDK+GH+K++DFGLCK E + +
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK------------------EGIKD 302
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ GTP+Y+APEVL YG D
Sbjct: 303 G-------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-D 376
WW LG +MYEM+ G PFY D I+ ++FP L PEAK L+ LL D
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRT--LGPEAKSLLSGLLKKD 387
Query: 377 VEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF 423
+ RLG G A +I H +F +VW +Y ++ FKP++ E DT+ F
Sbjct: 388 PKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYF 438
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 350 bits (899), Expect = e-113
Identities = 113/417 (27%), Positives = 190/417 (45%), Gaps = 68/417 (16%)
Query: 53 SSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN 112
+ + + K R ++ + DF L ++G+G+FG+V L K +
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 113 IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGG 171
+YA+K LKK +++ VE E+ +LA + +L+ FQ + LY +MEY+ GG
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 172 DMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
D+M + + E A FY A+ + + + I+RD+K DN++LD GH+K++DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291
+CK EN+ +
Sbjct: 488 MCK------------------ENIWD-------------------------------GVT 498
Query: 292 AFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWR 351
+ GTPDYIAPE++ + YG DWW+ G ++YEML G PF +D + I+
Sbjct: 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-- 556
Query: 352 NHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EM 406
+++ +P +S EA + L+ RLG G G IK H +F+ + W+KL E+
Sbjct: 557 HNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEI 614
Query: 407 EAAFKPEINGELDTQNF-MKFDELDPPASGRTSSGPSRKMLLTPKDLS-FVGYTYKN 461
+ +KP+ +G + +NF F P + P + ++ D S F G+++ N
Sbjct: 615 QPPYKPKASGR-NAENFDRFFTRHPPVLT------PPDQEVIRNIDQSEFEGFSFVN 664
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 341 bits (876), Expect = e-112
Identities = 110/462 (23%), Positives = 182/462 (39%), Gaps = 85/462 (18%)
Query: 1 MEEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEE 60
++ E+ + + A+ + Q + + V + + D +
Sbjct: 89 WKDIEDYDTADDA---LRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQP 145
Query: 61 QINLIKDLERKE--------------TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR 106
+ + + ++ L+ + D F ++GRG FGEV C+
Sbjct: 146 LLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQ 205
Query: 107 EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166
K +G +YA KKL K + KR + E+ +LA+V S IV L Y+F+ L L+M
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265
Query: 167 YLPGGDMM----TLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN 222
+ GGD+ + E A FY AQ V +E +H+ N I+RD+KP+N+LLD +
Sbjct: 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD 325
Query: 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQ 282
G++++SD GL E A
Sbjct: 326 GNVRISDLGLAV------------------ELKAG------------------------- 342
Query: 283 HWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPIT 342
+ GTP ++APE+LL + Y D+++LG +YEM+ PF A
Sbjct: 343 ------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 396
Query: 343 TC----RKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWF 395
++++ + +PD K SP +KD LL D E RLG ++ HP F
Sbjct: 397 ENKELKQRVLE--QAVTYPD--KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
Query: 396 KDVVWDKLY--EMEAAFKPEINGELDTQNFM--KFDELDPPA 433
+D+ W +L + F P+ F + A
Sbjct: 453 RDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVA 494
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 341 bits (876), Expect = e-111
Identities = 104/420 (24%), Positives = 178/420 (42%), Gaps = 83/420 (19%)
Query: 54 SDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNI 113
S P + ++ I + ++ L+R + + F ++G+G FGEV C+ + +G +
Sbjct: 154 SVAPFADYLDSIY--FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKM 211
Query: 114 YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173
YA KKL+K + KR E+ +L +V S +V L Y+++ + L L++ + GGD+
Sbjct: 212 YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL 271
Query: 174 MTLL--MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
+ M + E A FY A+ +E +H+ ++RD+KP+N+LLD +GH+++SD G
Sbjct: 272 KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLG 331
Query: 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291
L + +
Sbjct: 332 LAV--------------------------------------------------HVPEGQT 341
Query: 292 AFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTC----RKI 347
VGT Y+APEV+ + Y DWW+LG ++YEM+ G PF R +
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401
Query: 348 VHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY 404
++ + + SP+A+ L +LLC D RLG A ++K HP FK + + +L
Sbjct: 402 KE--VPEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLG 457
Query: 405 --EMEAAFKPEINGE--LDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLS-FVGYTY 459
+E FKP+ D + +F + L P D + +
Sbjct: 458 AGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVE-------------LEPTDQDFYQKFAT 504
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-109
Identities = 107/398 (26%), Positives = 169/398 (42%), Gaps = 85/398 (21%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+ ++DF + IIGRG FGEV CR+ +G +YAMK L K + + ER
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 139 LLAEVASHC---IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQS 195
+L+ V++ IV + Y+F + L I++ + GGD+ L + +E RFY A+
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+L +E +H ++RD+KP N+LLD++GH+++SD GL
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--------------------- 340
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGM 314
+K ++VGT Y+APEVL K Y
Sbjct: 341 ------------------------------DFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 315 ECDWWSLGAIMYEMLVGYPPFYAD---DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
DW+SLG +++++L G+ PF D R + ++ PD SPE + L+
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLE 426
Query: 372 RLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEING-----ELDTQ 421
LL DV RLG GA ++K P+F+ + W ++ + P D
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIG 486
Query: 422 NFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTY 459
+ FDE D T LL + +
Sbjct: 487 S---FDEED------TKGIK----LLDSDQELYRNFPL 511
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-101
Identities = 95/325 (29%), Positives = 146/325 (44%), Gaps = 59/325 (18%)
Query: 73 TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH 132
T + + K +DDF++ +G+G FG V L REK++ I A+K L KS++ K G
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI 192
+R E + + + I+++Y F D + +YL++E+ P G++ L + E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
+ A+ H+ IHRDIKP+NLL+ G +K++DFG
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
H RR+ + GT DY+ PE++ K +
Sbjct: 163 ------------------------------HAPSLRRR---TMCGTLDYLPPEMIEGKTH 189
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372
+ D W G + YE LVG PPF + T R+IV LKFP LS +KDLI +
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFP--PFLSDGSKDLISK 245
Query: 373 LLC-DVEHRLGTGGAHQIKAHPWFK 396
LL RL + HPW K
Sbjct: 246 LLRYHPPQRL---PLKGVMEHPWVK 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-101
Identities = 95/326 (29%), Positives = 140/326 (42%), Gaps = 59/326 (18%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
K+ + ++DFE+ +G+G FG V L REK+S I A+K L K+++ K G +R E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
+ + + I++LY F D +YLI+EY P G + L + E YI + A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
+ H IHRDIKP+NLLL G +K++DFG S +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR------RTDL-------- 167
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
C GT DY+ PE++ + + + D
Sbjct: 168 -----C--------------------------------GTLDYLPPEMIEGRMHDEKVDL 190
Query: 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377
WSLG + YE LVG PPF A+ T ++I R FP ++ A+DLI RLL +
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFP--DFVTEGARDLISRLLKHNP 246
Query: 378 EHRLGTGGAHQIKAHPWFKDVVWDKL 403
R ++ HPW
Sbjct: 247 SQRP---MLREVLEHPWITANSSKPS 269
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 9e-83
Identities = 90/315 (28%), Positives = 146/315 (46%), Gaps = 60/315 (19%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
++DF++ ++G+G+F V +G A+K + K M K G V+ V+ E + ++
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIH 203
I++LY F+D+ Y+YL++E G+M L R +EN AR ++ Q + + +H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
H +HRD+ NLLL +N ++K++DFGL +T
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGL------ATQ---------------------- 161
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV-GTPDYIAPEVLLKKGYGMECDWWSLG 322
+ + T+ GTP+YI+PE+ + +G+E D WSLG
Sbjct: 162 --LKMPH----------------EKHY----TLCGTPNYISPEIATRSAHGLESDVWSLG 199
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381
+ Y +L+G PPF D T K+V + P LS EAKDLI +LL + RL
Sbjct: 200 CMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSF--LSIEAKDLIHQLLRRNPADRL 255
Query: 382 GTGGAHQIKAHPWFK 396
+ HP+
Sbjct: 256 SL---SSVLDHPFMS 267
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 3e-82
Identities = 77/334 (23%), Positives = 132/334 (39%), Gaps = 60/334 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DFE + ++G+GAFG+V R YA+KK++ +E ++ + +E LLA +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNH 61
Query: 146 HCIVKLYYSFQDTE-------------YLYLIMEYLPGGDMMTLLMREDTLT-ENVARFY 191
+V+ Y ++ + L++ MEY G + L+ E+ +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
Q + A+ IH IHRD+KP N+ +D++ ++K+ DFGL K + S + + +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+ S +GT Y+A EVL G
Sbjct: 182 GSS-----------------------------------DNLTSAIGTAMYVATEVLDGTG 206
Query: 312 -YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLI 370
Y + D +SLG I +EM+ YP + + +K+ D K +I
Sbjct: 207 HYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKII 264
Query: 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKL 403
L+ D R GA + W D++
Sbjct: 265 RLLIDHDPNKRP---GARTLLNSGWLPVKHQDEV 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 2e-81
Identities = 82/313 (26%), Positives = 138/313 (44%), Gaps = 57/313 (18%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+ +G+G F + + + ++A K + KS ++K Q E + E ++ +A
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+V + F+D +++++++E ++ L R LTE AR+Y+ Q VL + +H+
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+ IHRD+K NL L+++ +K+ DFGL ++ K + C
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVL-------------C 176
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
GTP+YIAPEVL KKG+ E D WS+G I
Sbjct: 177 --------------------------------GTPNYIAPEVLSKKGHSFEVDVWSIGCI 204
Query: 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383
MY +LVG PPF T +I +N P ++P A LI ++L D R
Sbjct: 205 MYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKH--INPVAASLIQKMLQTDPTARP-- 258
Query: 384 GGAHQIKAHPWFK 396
+++ +F
Sbjct: 259 -TINELLNDEFFT 270
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 3e-81
Identities = 68/314 (21%), Positives = 115/314 (36%), Gaps = 64/314 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
F+ L+ +G G++GEV R K+ G +YA+K+ + AE +V
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQ 115
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIH 203
H C V+L ++++ LYL E G + +L E Y+ ++LA+ +H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+H D+KP N+ L G KL DFGL
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV----------------------------- 205
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
++ G P Y+APE+ L+ YG D +SLG
Sbjct: 206 ---------------------ELGTAGAGEVQEGDPRYMAPEL-LQGSYGTAADVFSLGL 243
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382
+ E+ + + +++ +F LS E + ++ +L D + R
Sbjct: 244 TILEVACNMELPHGGEGW---QQLRQGYLPPEFTA--GLSSELRSVLVMMLEPDPKLRA- 297
Query: 383 TGGAHQIKAHPWFK 396
A + A P +
Sbjct: 298 --TAEALLALPVLR 309
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 6e-81
Identities = 72/393 (18%), Positives = 134/393 (34%), Gaps = 102/393 (25%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM 116
P+ +++ + +K ++D+ ++ + +G F ++ LC + YA+
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYAL 59
Query: 117 KKLKKSEMVK--------------RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162
KK +KS + K + + + + E ++ ++ + + + + +Y
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY 119
Query: 163 LIMEYLPGGDMMTLLMREDTL--------TENVARFYIAQSVLAIESIHKHNYI-HRDIK 213
+I EY+ ++ L V + I + + IH I HRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
P N+L+DKNG +KLSDFG + D
Sbjct: 180 PSNILMDKNGRVKLSDFGESE-----------------------------YMVD------ 204
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIMYEMLVG 331
+ K + GT +++ PE + G + D WSLG +Y M
Sbjct: 205 -------------KKIK---GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
Query: 332 YPPFYAD-DPITTCRKIVHWRNHLKFPDDSK-----------------LSPEAKDLICRL 373
PF + I ++++P D LS E D +
Sbjct: 249 VVPFSLKISLVELFNNIR--TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF 306
Query: 374 LC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYE 405
L + R+ + H W D + L E
Sbjct: 307 LRKNPAERI---TSEDALKHEWLADTNIEDLRE 336
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 9e-81
Identities = 82/313 (26%), Positives = 138/313 (44%), Gaps = 57/313 (18%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+ +G+G F + + + ++A K + KS ++K Q E + E ++ +A
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+V + F+D +++++++E ++ L R LTE AR+Y+ Q VL + +H+
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+ IHRD+K NL L+++ +K+ DFGL ++ K + C
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVL-------------C 202
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
GTP+YIAPEVL KKG+ E D WS+G I
Sbjct: 203 --------------------------------GTPNYIAPEVLSKKGHSFEVDVWSIGCI 230
Query: 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383
MY +LVG PPF T +I +N P ++P A LI ++L D R
Sbjct: 231 MYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKH--INPVAASLIQKMLQTDPTARP-- 284
Query: 384 GGAHQIKAHPWFK 396
+++ +F
Sbjct: 285 -TINELLNDEFFT 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-74
Identities = 78/368 (21%), Positives = 142/368 (38%), Gaps = 61/368 (16%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + L IG G+FG+ L + + G Y +K++ S M + + E R E +LA +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKH 82
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIH 203
IV+ SF++ LY++M+Y GGD+ + + E+ + Q LA++ +H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+HRDIK N+ L K+G ++L DFG+ + L+ + A +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA----RAC------------- 185
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
+GTP Y++PE+ K Y + D W+LG
Sbjct: 186 --------------------------------IGTPYYLSPEICENKPYNNKSDIWALGC 213
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382
++YE+ F A KI+ + S + + L+ +L + R
Sbjct: 214 VLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVS--LHYSYDLRSLVSQLFKRNPRDRP- 269
Query: 383 TGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPS 442
+ I + + + + E + ++ + PASG+ S
Sbjct: 270 --SVNSILEKGFIAKRI--EKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVM 325
Query: 443 RKMLLTPK 450
+T
Sbjct: 326 PAQKITKP 333
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-74
Identities = 87/334 (26%), Positives = 139/334 (41%), Gaps = 71/334 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA- 144
+++E I+GRG VR C K + YA+K + + E L EV
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 145 -----SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
H I++L +++ + +L+ + + G++ L + TL+E R + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
I ++HK N +HRD+KP+N+LLD + ++KL+DFG LD E + E
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-------------PGEKLRE- 182
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL------LKKGY 312
GTP Y+APE++ GY
Sbjct: 183 ------------------------------------VCGTPSYLAPEIIECSMNDNHPGY 206
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLI 370
G E D WS G IMY +L G PPF+ + R I+ + +F S KDL+
Sbjct: 207 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--SGNYQFGSPEWDDYSDTVKDLV 264
Query: 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKL 403
R L + R A + AHP+F+ V +++
Sbjct: 265 SRFLVVQPQKRY---TAEEALAHPFFQQYVVEEV 295
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 3e-74
Identities = 83/318 (26%), Positives = 139/318 (43%), Gaps = 62/318 (19%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D++++ +G+GAF VR C K +G +A K + ++ R + + E + ++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 64
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV+L+ S Q+ + YL+ + + GG++ ++ + +E A I Q + +I H +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+HR++KP+NLLL K +KL+DFGL ++ D E
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-------------DSEAW------- 164
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
GTP Y++PEVL K Y D W+ G
Sbjct: 165 ------------------------------HGFAGTPGYLSPEVLKKDPYSKPVDIWACG 194
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEH 379
I+Y +LVGYPPF+ +D +I +P ++PEAK LI +L + +
Sbjct: 195 VILYILLVGYPPFWDEDQHRLYAQIK--AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKK 252
Query: 380 RLGTGGAHQIKAHPWFKD 397
R+ A Q PW +
Sbjct: 253 RI---TADQALKVPWICN 267
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 5e-74
Identities = 67/159 (42%), Positives = 106/159 (66%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
K + DF++L +G G+FG V L R + +G YAMK LKK +V+ QVEH ER +L+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
V I++++ +FQD + +++IM+Y+ GG++ +LL + VA+FY A+ LA+E
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
+H + I+RD+KP+N+LLDKNGH+K++DFG K + T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-54
Identities = 63/144 (43%), Positives = 84/144 (58%), Gaps = 10/144 (6%)
Query: 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKF 356
GTPDYIAPEV+ K Y DWWS G ++YEML GY PFY + + T KI++ L+F
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRF 222
Query: 357 PDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFK 411
P + + KDL+ RL+ D+ RLG G +K HPWFK+VVW+KL +E ++
Sbjct: 223 P--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYE 280
Query: 412 PEI-NGELDTQNFMKFDELDPPAS 434
P I G+ DT F K+ E D
Sbjct: 281 PPIQQGQGDTSQFDKYPEEDINYG 304
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 9e-74
Identities = 76/342 (22%), Positives = 137/342 (40%), Gaps = 71/342 (20%)
Query: 70 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ 129
TE + + + + +L IG G +V + IYA+K + E +
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQ-T 69
Query: 130 VEHVRAERNLLAEVASHC--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV 187
++ R E L ++ H I++LY +Y+Y++ME D+ + L ++ ++
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE 128
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ Y + A+ +IH+H +H D+KP N L+ +G +KL DFG+ +
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ---------- 177
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
PDT + + S VGT +Y+ PE +
Sbjct: 178 ------------------PDTTS-------------------VVKDSQVGTVNYMPPEAI 200
Query: 308 L-----------KKGYGMECDWWSLGAIMYEMLVGYPPFYA-DDPITTCRKIVHWRNHLK 355
K + D WSLG I+Y M G PF + I+ I+ + ++
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260
Query: 356 FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396
FPD + +D++ L D + R+ ++ AHP+ +
Sbjct: 261 FPDI--PEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 297
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 2e-73
Identities = 88/333 (26%), Positives = 146/333 (43%), Gaps = 63/333 (18%)
Query: 71 KETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQV 130
+ +EFM K D++++ +G+GAF VR C K +G +A K + ++ R
Sbjct: 15 RGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DF 72
Query: 131 EHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF 190
+ + E + ++ IV+L+ S Q+ + YL+ + + GG++ ++ + +E A
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
I Q + +I H + +HR++KP+NLLL K +KL+DFGL ++
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---------- 182
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
D E GTP Y++PEVL
Sbjct: 183 ---DSEAW-------------------------------------HGFAGTPGYLSPEVL 202
Query: 308 LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPE 365
K Y D W+ G I+Y +LVGYPPF+ +D +I +P ++PE
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK--AGAYDYPSPEWDTVTPE 260
Query: 366 AKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
AK LI +L + + R+ T A Q PW +
Sbjct: 261 AKSLIDSMLTVNPKKRI-T--ADQALKVPWICN 290
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 4e-73
Identities = 83/318 (26%), Positives = 141/318 (44%), Gaps = 63/318 (19%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + ++ ++G+G+FGEV C+++ + YA+K + K+ + + E LL ++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I+KL+ +D+ Y++ E GG++ +++ +E+ A I Q I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
N +HRD+KP+N+LL +K+ +K+ DFGL + M +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-------------QNTKMKD----- 182
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
+GT YIAPEV L+ Y +CD WS G
Sbjct: 183 --------------------------------RIGTAYYIAPEV-LRGTYDEKCDVWSAG 209
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEH 379
I+Y +L G PPFY + +++ F +S +AKDLI ++L
Sbjct: 210 VILYILLSGTPPFYGKNEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 380 RLGTGGAHQIKAHPWFKD 397
R+ A Q HPW +
Sbjct: 268 RI---TATQCLEHPWIQK 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 7e-73
Identities = 91/326 (27%), Positives = 141/326 (43%), Gaps = 70/326 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMK-----KLKKSEMVKRGQVEHVRAERNLL 140
++ +IGRG VR C + +G+ +A+K + S E R E ++L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 141 AEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+VA H I+ L S++ + +++L+ + + G++ L + L+E R + + A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
+H +N +HRD+KP+N+LLD N ++LSDFG L+ E + E
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-------------PGEKLRE-- 258
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL------LKKGYG 313
GTP Y+APE+L GYG
Sbjct: 259 -----------------------------------LCGTPGYLAPEILKCSMDETHPGYG 283
Query: 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLIC 371
E D W+ G I++ +L G PPF+ I R I+ +F S KDLI
Sbjct: 284 KEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM--EGQYQFSSPEWDDRSSTVKDLIS 341
Query: 372 RLLC-DVEHRLGTGGAHQIKAHPWFK 396
RLL D E RL T A Q HP+F+
Sbjct: 342 RLLQVDPEARL-T--AEQALQHPFFE 364
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 8e-73
Identities = 88/318 (27%), Positives = 140/318 (44%), Gaps = 65/318 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
F + ++G GAF EV L +++ +G ++A+K +KKS + + E +L ++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSSLENEIAVLKKIKH 65
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV L ++ T + YL+M+ + GG++ ++ TE A I Q + A++ +H++
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+HRD+KP+NLL ++N + ++DFGL K + M
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLS--------------KMEQNGIM------- 164
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
+ GTP Y+APEVL +K Y D WS+G
Sbjct: 165 ------------------------------STACGTPGYVAPEVLAQKPYSKAVDCWSIG 194
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEH 379
I Y +L GYPPFY + KI + +F +S AKD IC LL D
Sbjct: 195 VITYILLCGYPPFYEETESKLFEKIK--EGYYEFESPFWDDISESAKDFICHLLEKDPNE 252
Query: 380 RLGTGGAHQIKAHPWFKD 397
R T + +HPW
Sbjct: 253 RY-T--CEKALSHPWIDG 267
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-72
Identities = 84/378 (22%), Positives = 144/378 (38%), Gaps = 99/378 (26%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VK 126
+E + + + L IG+G++G VR+ E ++ I A+K + K+++ +
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 127 RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD-------------- 172
VE ++ E L+ ++ I +LY ++D +Y+ L+ME GG
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 173 --------------------------MMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
+ E + + Q A+ +H
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188
Query: 207 YIHRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
HRDIKP+N L +K+ +KL DFGL
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGL-------------------------------- 216
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL--LKKGYGMECDWWSLG 322
S +++ M + GTP ++APEVL + YG +CD WS G
Sbjct: 217 -------SKEFYKLNNGEYYGMT------TKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEH 379
+++ +L+G PF + T +++ L F + + LSP A+DL+ LL +V+
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVL--NKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 380 RLGTGGAHQIKAHPWFKD 397
R A + HPW
Sbjct: 322 RF---DAMRALQHPWISQ 336
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 4e-72
Identities = 84/322 (26%), Positives = 136/322 (42%), Gaps = 65/322 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEHVRAERNLLAE 142
D +E+ +G G F VR CR+K +G YA K +KK + + E + E N+L E
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+ I+ L+ F++ + LI+E + GG++ L +++LTE+ A ++ Q + + +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 203 HKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
H H D+KP+N++L N +KL DFG+ ++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-------------AGNEFKN- 170
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GTP+++APE++ + G+E D
Sbjct: 171 ------------------------------------IFGTPEFVAPEIVNYEPLGLEADM 194
Query: 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC- 375
WS+G I Y +L G PF + T I + F ++ S S AKD I RLL
Sbjct: 195 WSIGVITYILLSGASPFLGETKQETLTNIS--AVNYDFDEEYFSNTSELAKDFIRRLLVK 252
Query: 376 DVEHRLGTGGAHQIKAHPWFKD 397
D + R+ Q H W K
Sbjct: 253 DPKRRM---TIAQSLEHSWIKA 271
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 6e-72
Identities = 83/332 (25%), Positives = 139/332 (41%), Gaps = 65/332 (19%)
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEH 132
M + + D +++ +G G F V+ CREK +G YA K +KK + + E
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI 192
+ E ++L +V H ++ L+ +++ + LI+E + GG++ L ++++L+E A +I
Sbjct: 62 IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
Q + + +H H D+KP+N++L H+KL DFGL ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----------- 170
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
D GTP+++APE++
Sbjct: 171 --DGVEFKN-------------------------------------IFGTPEFVAPEIVN 191
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEA 366
+ G+E D WS+G I Y +L G PF D T I F ++ S S A
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--SVSYDFDEEFFSHTSELA 249
Query: 367 KDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
KD I +LL + RL + HPW
Sbjct: 250 KDFIRKLLVKETRKRL---TIQEALRHPWITP 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 6e-72
Identities = 81/322 (25%), Positives = 131/322 (40%), Gaps = 69/322 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D F +G GAFG+V L E+ SG +K + K + +E + AE +L +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSL-D 78
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGD----MMTLLMREDTLTENVARFYIAQSVLAIE 200
H I+K++ F+D +Y++ME GG+ +++ R L+E + Q + A+
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 201 SIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
H + +H+D+KP+N+L + +K+ DFGL
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL------------------------- 173
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ E + GT Y+APEV K+ +CD
Sbjct: 174 --------------AELFKSDEHST-----------NAAGTALYMAPEV-FKRDVTFKCD 207
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-SKLSPEAKDLICRLLC- 375
WS G +MY +L G PF +K + + L+P+A DL+ ++L
Sbjct: 208 IWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT--YKEPNYAVECRPLTPQAVDLLKQMLTK 265
Query: 376 DVEHRLGTGGAHQIKAHPWFKD 397
D E R A Q+ H WFK
Sbjct: 266 DPERRP---SAAQVLHHEWFKQ 284
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 7e-72
Identities = 71/177 (40%), Positives = 109/177 (61%)
Query: 64 LIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE 123
L K E ++ ++ +D F+ + +G G+FG V L + K+SGN YAMK L K +
Sbjct: 19 LAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 124 MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTL 183
+VK Q+EH E+ +L V +VKL +SF+D LY++MEY+ GG+M + L R
Sbjct: 79 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 184 TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
+E ARFY AQ VL E +H + I+RD+KP+NLL+D+ G+++++DFG K + T
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-55
Identities = 61/143 (42%), Positives = 82/143 (57%), Gaps = 9/143 (6%)
Query: 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKF 356
GTP+ +APE++L KGY DWW+LG ++YEM GYPPF+AD PI KIV ++F
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRF 257
Query: 357 PDDSKLSPEAKDLICRLLC-DVEHRLGT--GGAHQIKAHPWFKDVVWDKLY--EMEAAFK 411
P S S + KDL+ LL D+ R G G + IK H WF W +Y ++EA F
Sbjct: 258 P--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFI 315
Query: 412 PEINGELDTQNFMKFDELDPPAS 434
P+ G DT NF ++E + S
Sbjct: 316 PKFKGPGDTSNFDDYEEEEIRVS 338
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-71
Identities = 74/325 (22%), Positives = 132/325 (40%), Gaps = 71/325 (21%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +L IG G +V + IYA+K + E + ++ R E L ++ H
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 67
Query: 147 C--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
I++LY +Y+Y++ME D+ + L ++ ++ + Y + A+ +IH+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
H +H D+KP N L+ +G +KL DFG+ +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ--------------------------- 158
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----------KKGYG 313
PDT + + S VGT +Y+ PE + K
Sbjct: 159 -PDTTS-------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 198
Query: 314 MECDWWSLGAIMYEMLVGYPPFYA-DDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372
+ D WSLG I+Y M G PF + I+ I+ + ++FPD + +D++
Sbjct: 199 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKC 256
Query: 373 LLC-DVEHRLGTGGAHQIKAHPWFK 396
L D + R+ ++ AHP+ +
Sbjct: 257 CLKRDPKQRI---SIPELLAHPYVQ 278
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 3e-71
Identities = 83/332 (25%), Positives = 139/332 (41%), Gaps = 65/332 (19%)
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEH 132
M + + D +++ +G G F V+ CREK +G YA K +KK + + E
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI 192
+ E ++L +V I+ L+ +++ + LI+E + GG++ L ++++L+E A +I
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
Q + + +H H D+KP+N++L H+KL DFGL ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----------- 170
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
D GTP+++APE++
Sbjct: 171 --DGVEFKN-------------------------------------IFGTPEFVAPEIVN 191
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEA 366
+ G+E D WS+G I Y +L G PF D T I F ++ S+ S A
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--AVSYDFDEEFFSQTSELA 249
Query: 367 KDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
KD I +LL + RL + HPW
Sbjct: 250 KDFIRKLLVKETRKRL---TIQEALRHPWITP 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-71
Identities = 88/318 (27%), Positives = 136/318 (42%), Gaps = 65/318 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L IGRG++GEV++ +K + A KK+ K + V+ + E ++ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDH 65
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I++LY +F+D +YL+ME GG++ ++ + E+ A + + A+ HK
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
N HRD+KP+N L + +KL DFGL + M
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-------------PGKMMRT----- 167
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
VGTP Y++P+V L+ YG ECD WS G
Sbjct: 168 --------------------------------KVGTPYYVSPQV-LEGLYGPECDEWSAG 194
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEH 379
+MY +L GYPPF A KI FP+ +SP+A+ LI RLL +
Sbjct: 195 VMMYVLLCGYPPFSAPTDSEVMLKIR--EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ 252
Query: 380 RLGTGGAHQIKAHPWFKD 397
R+ + Q H WF+
Sbjct: 253 RI---TSLQALEHEWFEK 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-70
Identities = 81/322 (25%), Positives = 133/322 (41%), Gaps = 65/322 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEHVRAERNLLAE 142
D ++ +G G F V+ CREK +G YA K +KK + E + E ++L E
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+ ++ L+ +++ + LI+E + GG++ L +++LTE A ++ Q + + +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 203 HKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
H H D+KP+N++L +K+ DFGL +D
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-------------FGNEFKN- 176
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GTP+++APE++ + G+E D
Sbjct: 177 ------------------------------------IFGTPEFVAPEIVNYEPLGLEADM 200
Query: 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC- 375
WS+G I Y +L G PF D T + + +F D+ S S AKD I RLL
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVS--AVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 376 DVEHRLGTGGAHQIKAHPWFKD 397
D + R+ HPW K
Sbjct: 259 DPKKRM---TIQDSLQHPWIKP 277
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-70
Identities = 81/327 (24%), Positives = 132/327 (40%), Gaps = 73/327 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ--VEHVRAERNLLAEV 143
D +EL +IG+G F VR C +++G +A+K + ++ E ++ E ++ +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-------EDTLTENVARFYIAQSV 196
IV+L ++ LY++ E++ G D L +E VA Y+ Q +
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGAD---LCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 197 LAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
A+ H +N IHRD+KP +LL + + +KL FG+ L
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE------------SGL 188
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313
VGTP ++APEV+ ++ YG
Sbjct: 189 VAGG-------------------------------------RVGTPHFMAPEVVKREPYG 211
Query: 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLIC 371
D W G I++ +L G PFY I+ + K S +S AKDL+
Sbjct: 212 KPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGII--KGKYKMNPRQWSHISESAKDLVR 268
Query: 372 RLLC-DVEHRLGTGGAHQIKAHPWFKD 397
R+L D R+ T ++ HPW K+
Sbjct: 269 RMLMLDPAERI-T--VYEALNHPWLKE 292
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-70
Identities = 90/341 (26%), Positives = 148/341 (43%), Gaps = 63/341 (18%)
Query: 63 NLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
+++ L F++ D ++ ++G+G+FGEV LC++K +G A+K + K
Sbjct: 4 SMMDHLHATPGMFVQHSTAIF-SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT 182
++ ++ E + E LL ++ I+KLY F+D Y YL+ E GG++ ++
Sbjct: 63 QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 122
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCS 239
+E A I Q + I +HK+ +HRD+KP+NLLL K+ ++++ DFGL +
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-- 180
Query: 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
+ M + +GT
Sbjct: 181 -----------ASKKMKD-------------------------------------KIGTA 192
Query: 300 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD 359
YIAPEV L Y +CD WS G I+Y +L G PPF + +K+ + F
Sbjct: 193 YYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE--KGKYTFELP 249
Query: 360 --SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
K+S AKDLI ++L R+ A H W +
Sbjct: 250 QWKKVSESAKDLIRKMLTYVPSMRI---SARDALDHEWIQT 287
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 3e-70
Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLY 152
+GRG F VR C K +G YA K LKK + + E +L S ++ L+
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIHKHNYIHR 210
+++T + LI+EY GG++ +L + E ++EN I Q + + +H++N +H
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 211 DIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
D+KP N+LL G +K+ DFG+ + + + E
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG-------------HACELRE---------- 192
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
+GTP+Y+APE+L D W++G I Y
Sbjct: 193 ---------------------------IMGTPEYLAPEILNYDPITTATDMWNIGIIAYM 225
Query: 328 MLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEHRLGTG 384
+L PF +D T I + ++ + ++ S +S A D I LL + E R
Sbjct: 226 LLTHTSPFVGEDNQETYLNIS--QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP--- 280
Query: 385 GAHQIKAHPWFKD 397
A +H W +
Sbjct: 281 TAEICLSHSWLQQ 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-69
Identities = 87/328 (26%), Positives = 143/328 (43%), Gaps = 73/328 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA- 144
D++ + +G GA GEV+L E+K+ A+K + K + E A + E+
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN-VETEIEI 68
Query: 145 ----SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+H CI+K+ F D E Y+++E + GG++ ++ L E + Y Q +LA+
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 200 ESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ +H++ IHRD+KP+N+LL +++ +K++DFG K L + M
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-------------ETSLMR 174
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---LKKGYG 313
GTP Y+APEVL GY
Sbjct: 175 T-------------------------------------LCGTPTYLAPEVLVSVGTAGYN 197
Query: 314 MECDWWSLGAIMYEMLVGYPPFYAD-DPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLI 370
D WSLG I++ L GYPPF ++ +I F + +++S +A DL+
Sbjct: 198 RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT--SGKYNFIPEVWAEVSEKALDLV 255
Query: 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+LL D + R + HPW +D
Sbjct: 256 KKLLVVDPKARF---TTEEALRHPWLQD 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-69
Identities = 86/328 (26%), Positives = 143/328 (43%), Gaps = 73/328 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA- 144
D++ + +G GA GEV+L E+K+ A++ + K + E A + E+
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALN-VETEIEI 193
Query: 145 ----SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+H CI+K+ F D E Y+++E + GG++ ++ L E + Y Q +LA+
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 200 ESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ +H++ IHRD+KP+N+LL +++ +K++DFG K L
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG------------------- 293
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---LKKGYG 313
+ T GTP Y+APEVL GY
Sbjct: 294 -----ETSLMRT--------------------------LCGTPTYLAPEVLVSVGTAGYN 322
Query: 314 MECDWWSLGAIMYEMLVGYPPFYADD-PITTCRKIVHWRNHLKFPDD--SKLSPEAKDLI 370
D WSLG I++ L GYPPF ++ +I F + +++S +A DL+
Sbjct: 323 RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT--SGKYNFIPEVWAEVSEKALDLV 380
Query: 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+LL D + R + HPW +D
Sbjct: 381 KKLLVVDPKARF---TTEEALRHPWLQD 405
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-69
Identities = 83/318 (26%), Positives = 138/318 (43%), Gaps = 61/318 (19%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
++++L +G+GAF VR C + +G YA + ++ + + E + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKH 69
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV+L+ S + + YLI + + GG++ ++ + +E A I Q + A+ H+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+HR++KP+NLLL K +KL+DFGL +
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-------------------------- 163
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
+ + F GTP Y++PEVL K YG D W+ G
Sbjct: 164 ------------EGEQQAW-----------FGFAGTPGYLSPEVLRKDPYGKPVDLWACG 200
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEH 379
I+Y +LVGYPPF+ +D ++I FP ++PEAKDLI ++L +
Sbjct: 201 VILYILLVGYPPFWDEDQHRLYQQIK--AGAYDFPSPEWDTVTPEAKDLINKMLTINPSK 258
Query: 380 RLGTGGAHQIKAHPWFKD 397
R+ A + HPW
Sbjct: 259 RI---TAAEALKHPWISH 273
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-69
Identities = 90/337 (26%), Positives = 137/337 (40%), Gaps = 78/337 (23%)
Query: 78 LKRHKICVDDFELLT---IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVR 134
+K ++L +G G+F R C KKS +A+K + K + +
Sbjct: 1 MKDSPF-YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQ 53
Query: 135 AERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA 193
E L H IVKL+ F D + +L+ME L GG++ + ++ +E A + +
Sbjct: 54 KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR 113
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
+ V A+ +H +HRD+KP+NLL + N +K+ DFG + K
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR------------LKPP 161
Query: 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310
D++ + P T Y APE+L +
Sbjct: 162 DNQPLKTP-------------------------------------CFTLHYAAPELLNQN 184
Query: 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTC-------RKIVHWRNHLKFPDD--SK 361
GY CD WSLG I+Y ML G PF + D TC +KI + F +
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK--KGDFSFEGEAWKN 242
Query: 362 LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+S EAKDLI LL D RL ++ + W +D
Sbjct: 243 VSQEAKDLIQGLLTVDPNKRL-K--MSGLRYNEWLQD 276
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 225 bits (574), Expect = 7e-69
Identities = 73/325 (22%), Positives = 131/325 (40%), Gaps = 71/325 (21%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +L IG G +V + IYA+K + E + ++ R E L ++ H
Sbjct: 57 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 114
Query: 147 C--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
I++LY +Y+Y++ME D+ + L ++ ++ + Y + A+ +IH+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
H +H D+KP N L+ +G +KL DFG+ +
Sbjct: 174 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ--------------------------- 205
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----------KKGYG 313
PDT + + S VG +Y+ PE + K
Sbjct: 206 -PDTTS-------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245
Query: 314 MECDWWSLGAIMYEMLVGYPPFYA-DDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372
+ D WSLG I+Y M G PF + I+ I+ + ++FPD + +D++
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI--PEKDLQDVLKC 303
Query: 373 LLC-DVEHRLGTGGAHQIKAHPWFK 396
L D + R+ ++ AHP+ +
Sbjct: 304 CLKRDPKQRI---SIPELLAHPYVQ 325
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 230 bits (587), Expect = 8e-69
Identities = 85/374 (22%), Positives = 152/374 (40%), Gaps = 67/374 (17%)
Query: 33 QMKNIQERKERRWVLERKLASSDVPMEEQIN---LIKDLERKETEFMRLKRHKICVDDFE 89
+ + ++ R + ++ + N + D+ ++ +H +D ++
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160
Query: 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+ +G GAFG V E+ +GN +A K + E VR E ++ + +V
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLV 217
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYI 208
L+ +F+D + +I E++ GG++ + E ++E+ A Y+ Q + +H++NY+
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 209 HRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
H D+KP+N++ ++ +KL DFGL LD
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLD----------------------------- 308
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326
P + ++ T GT ++ APEV K G D WS+G + Y
Sbjct: 309 ----------PKQSVKV-----------TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSY 347
Query: 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEHRLGT 383
+L G PF ++ T R + D S +S + KD I +LL D R+
Sbjct: 348 ILLSGLSPFGGENDDETLRNVK--SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM-- 403
Query: 384 GGAHQIKAHPWFKD 397
HQ HPW
Sbjct: 404 -TIHQALEHPWLTP 416
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 8e-69
Identities = 84/319 (26%), Positives = 141/319 (44%), Gaps = 65/319 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + ++ ++G+G+FGEV C+++ + YA+K + K+ + + E LL ++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-D 79
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
H I+KL+ +D+ Y++ E GG++ +++ +E+ A I Q I +HK
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 205 HNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
HN +HRD+KP+N+LL +K+ +K+ DFGL + M
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-------------QNTKM------ 180
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
+GT YIAPEV L+ Y +CD WS
Sbjct: 181 -------------------------------KDRIGTAYYIAPEV-LRGTYDEKCDVWSA 208
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVE 378
G I+Y +L G PPFY + +++ F +S +AKDLI ++L
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 379 HRLGTGGAHQIKAHPWFKD 397
R+ A Q HPW +
Sbjct: 267 LRI---TATQCLEHPWIQK 282
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-68
Identities = 76/318 (23%), Positives = 123/318 (38%), Gaps = 65/318 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + + +GRG FG V C E S Y K +K K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMM-TLLMREDTLTENVARFYIAQSVLAIESIHK 204
I+ L+ SF+ E L +I E++ G D+ + L E Y+ Q A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 205 HNYIHRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
HN H DI+P+N++ ++ +K+ +FG + L
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK------------------------- 155
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
P + + P+Y APEV D WSLG
Sbjct: 156 --------------PGDNFR-----------LLFTAPEYYAPEVHQHDVVSTATDMWSLG 190
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEH 379
++Y +L G PF A+ I+ F ++ ++S EA D + RLL + +
Sbjct: 191 TLVYVLLSGINPFLAETNQQIIENIM--NAEYTFDEEAFKEISIEAMDFVDRLLVKERKS 248
Query: 380 RLGTGGAHQIKAHPWFKD 397
R+ A + HPW K
Sbjct: 249 RM---TASEALQHPWLKQ 263
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-68
Identities = 84/351 (23%), Positives = 151/351 (43%), Gaps = 64/351 (18%)
Query: 53 SSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN 112
+ + +D+ +K + D +++L +G GAFG V C EK +G
Sbjct: 18 YDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGR 77
Query: 113 IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD 172
++ K + V+ E +++ ++ ++ L+ +F+D + LI+E+L GG+
Sbjct: 78 VFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 173 MMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL--DKNGHMKLSD 229
+ + ED ++E Y+ Q+ ++ +H+H+ +H DIKP+N++ K +K+ D
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194
Query: 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289
FGL L+ P E ++
Sbjct: 195 FGLATKLN---------------------------------------PDEIVK------- 208
Query: 290 KLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH 349
T T ++ APE++ ++ G D W++G + Y +L G PF +D + T + +
Sbjct: 209 ----VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK- 263
Query: 350 WRNHLKFPDD--SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
R +F +D S +SPEAKD I LL + RL H HPW K
Sbjct: 264 -RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKG 310
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 3e-68
Identities = 96/356 (26%), Positives = 149/356 (41%), Gaps = 73/356 (20%)
Query: 58 MEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMK 117
+ + + ++R K KI + + + +G GA+GEV LC+EK + A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKI-GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK 67
Query: 118 KLKKSEMVKRGQVEHVRA----ERNLLAEVA-----SH-CIVKLYYSFQDTEYLYLIMEY 167
+KKS+ K + + + E++ H I+KL+ F+D +Y YL+ E+
Sbjct: 68 VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127
Query: 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGH 224
GG++ ++ E A + Q + I +HKHN +HRDIKP+N+LL + +
Sbjct: 128 YEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187
Query: 225 MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHW 284
+K+ DFGL D +
Sbjct: 188 IKIVDFGLSSFFS-------------KDYKL----------------------------- 205
Query: 285 QMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTC 344
+GT YIAPEV LKK Y +CD WS G IMY +L GYPPF +
Sbjct: 206 --------RDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256
Query: 345 RKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+K+ + F + +S EAK+LI +L D R A + W K
Sbjct: 257 KKVE--KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC---TAEEALNSRWIKK 307
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 4e-68
Identities = 97/347 (27%), Positives = 153/347 (44%), Gaps = 64/347 (18%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM 116
E + DL+ F+ K+ + + ++ + +G GA+GEV LCR+K + A+
Sbjct: 9 SGRENLYFQGDLQATPGMFITSKKGHL-SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67
Query: 117 KKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176
K ++K+ + + E +L + I+KLY F+D YL+ME GG++
Sbjct: 68 KIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE 126
Query: 177 LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLC 233
++ E A I Q + + +HKHN +HRD+KP+NLLL +K+ +K+ DFGL
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
+ + + M
Sbjct: 187 AVFE-------------NQKKM-------------------------------------K 196
Query: 294 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH 353
+GT YIAPEV L+K Y +CD WS+G I++ +L GYPPF RK+ +
Sbjct: 197 ERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE--KGK 253
Query: 354 LKFPDD--SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
F +S AKDLI ++L D + R+ A Q HPW K+
Sbjct: 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI---SAQQALEHPWIKE 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-68
Identities = 86/324 (26%), Positives = 136/324 (41%), Gaps = 68/324 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+D+E+L IG G++G + R K G I K+L M + + + + +E NLL E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 146 HCIVKLYYSFQDTE--YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAI 199
IV+ Y D LY++MEY GGD+ +++ + L E + Q LA+
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 200 ESIHKHNY-----IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
+ H+ + +HRD+KP N+ LD ++KL DFGL + L+ T +A KT
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KTF---- 176
Query: 255 MAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314
VGTP Y++PE + + Y
Sbjct: 177 -----------------------------------------VGTPYYMSPEQMNRMSYNE 195
Query: 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
+ D WSLG ++YE+ PPF A KI + + S E ++I R+L
Sbjct: 196 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RIPYRYSDELNEIITRML 252
Query: 375 C-DVEHRLGTGGAHQIKAHPWFKD 397
HR +I +P +
Sbjct: 253 NLKDYHRP---SVEEILENPLILE 273
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-67
Identities = 87/348 (25%), Positives = 142/348 (40%), Gaps = 84/348 (24%)
Query: 69 ERKETEFMRLKRHKICVDDFELLT-IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR 127
+ +++K++ I +DD+++ + ++G G G+V K++ +A+K L+ +R
Sbjct: 45 QFHVKSGLQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR 103
Query: 128 GQVEHVRAERNLLAEVASH-CIVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMR--- 179
E L + IV++ +++ + L ++ME L GG+ L R
Sbjct: 104 --------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQD 152
Query: 180 --EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCK 234
+ TE A + AI+ +H N HRD+KP+NLL N +KL+DFG
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-- 210
Query: 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294
+ + H L +
Sbjct: 211 -------------------------------------AKETTSHNSLT-----------T 222
Query: 295 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH--WRN 352
TP Y+APEVL + Y CD WSLG IMY +L GYPPFY++ + +
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282
Query: 353 HLKFPDD--SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+FP+ S++S E K LI LL + R+ + HPW
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 327
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-67
Identities = 78/317 (24%), Positives = 131/317 (41%), Gaps = 64/317 (20%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
I+G G FG+V C E +G A K +K M + E V+ E +++ ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKH 205
+++LY +F+ + L+MEY+ GG++ ++ E LTE ++ Q I +H+
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 206 NYIHRDIKPDNLLL-DKNGH-MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+H D+KP+N+L +++ +K+ DFGL + E +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-------------PREKLKV------ 247
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
GTP+++APEV+ D WS+G
Sbjct: 248 -------------------------------NFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVEHR 380
I Y +L G PF D+ T I+ D+ +S EAK+ I +LL + R
Sbjct: 277 IAYMLLSGLSPFLGDNDAETLNNIL--ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWR 334
Query: 381 LGTGGAHQIKAHPWFKD 397
+ A + HPW D
Sbjct: 335 I---SASEALKHPWLSD 348
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-67
Identities = 82/346 (23%), Positives = 141/346 (40%), Gaps = 81/346 (23%)
Query: 63 NLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
++++ L R +F D +E+ IG G++ + C K + +A+K + KS
Sbjct: 8 SIVQQLHRNSIQFT---------DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS 58
Query: 123 EMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED 181
+ E +L H I+ L + D +Y+Y++ E + GG+++ ++R+
Sbjct: 59 K-------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK 111
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL-DKNGH---MKLSDFGLCKPLD 237
+E A + +E +H +HRD+KP N+L D++G+ +++ DFG K L
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297
++ + P
Sbjct: 172 A------------ENGLLMTP-------------------------------------CY 182
Query: 298 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYA---DDPITTCRKIVHWRNHL 354
T +++APEVL ++GY CD WSLG ++Y ML GY PF D P +I
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG--SGKF 240
Query: 355 KFPDD--SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+ +S AKDL+ ++L D RL A + HPW
Sbjct: 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRL---TAALVLRHPWIVH 283
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-66
Identities = 89/331 (26%), Positives = 133/331 (40%), Gaps = 84/331 (25%)
Query: 86 DDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
DD++L ++G G G+V C +++G A+K L S ++ E + + +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQAS 79
Query: 145 SH-CIVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMR-----EDTLTENVARFYIAQ 194
IV + +++ L +IME + GG+ L R + TE A +
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGE---LFSRIQERGDQAFTEREAAEIMRD 136
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
AI+ +H HN HRD+KP+NLL +K+ +KL+DFG K + L
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---------- 186
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+ TP Y+APEVL +
Sbjct: 187 -----------------------------------------QTPCYTPYYVAPEVLGPEK 205
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH--WRNHLKFPDD--SKLSPEAK 367
Y CD WSLG IMY +L G+PPFY++ + FP+ S++S +AK
Sbjct: 206 YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAK 265
Query: 368 DLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
LI LL D RL Q HPW
Sbjct: 266 QLIRLLLKTDPTERL---TITQFMNHPWINQ 293
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-66
Identities = 87/319 (27%), Positives = 140/319 (43%), Gaps = 67/319 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D FE+ + +GRGA V C++K + YA+K LKK+ + VR E +L ++
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSH 107
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I+KL F+ + L++E + GG++ ++ + +E A + Q + A+ +H++
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+HRD+KP+NLL + +K++DFGL K ++ M
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-------------HQVLM------- 207
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
+ GTP Y APE+L YG E D WS+G
Sbjct: 208 ------------------------------KTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237
Query: 323 AIMYEMLVGYPPFYAD-DPITTCRKIVHWRNHLKFPDD--SKLSPEAKDLICRLLC-DVE 378
I Y +L G+ PFY + R+I+ F ++S AKDL+ +L+ D +
Sbjct: 238 IITYILLCGFEPFYDERGDQFMFRRIL--NCEYYFISPWWDEVSLNAKDLVRKLIVLDPK 295
Query: 379 HRLGTGGAHQIKAHPWFKD 397
RL T Q HPW
Sbjct: 296 KRL-T--TFQALQHPWVTG 311
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-66
Identities = 78/335 (23%), Positives = 129/335 (38%), Gaps = 73/335 (21%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G GA V+ C + YA+K ++K R V E +L + H +++L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
F++ + YL+ E + GG +++ + + E A + A++ +H HRD
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 212 IKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDT 268
+KP+N+L ++ +K+ DF L + + + I + P
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLN-----GDCSPISTPELLTP---------- 181
Query: 269 DNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGA 323
G+ +Y+APEV+ Y CD WSLG
Sbjct: 182 ---------------------------CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRN-------------HLKFPDD--SKLSPEAKD 368
I+Y +L GYPPF +FPD + +S AKD
Sbjct: 215 ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKD 274
Query: 369 LICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDK 402
LI +LL D + RL A Q+ HPW + +
Sbjct: 275 LISKLLVRDAKQRL---SAAQVLQHPWVQGCAPEN 306
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-66
Identities = 66/332 (19%), Positives = 109/332 (32%), Gaps = 89/332 (26%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DF+ + +IG G FG+V + + G Y +K++K + E E LA++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63
Query: 146 HCIVKLYYSFQDTE----------------YLYLIMEYLPGGDMMTLL--MREDTLTENV 187
IV + + L++ ME+ G + + R + L + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
A Q ++ IH I+RD+KP N+ L +K+ DFGL
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT------------- 170
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
+ + GT Y++PE +
Sbjct: 171 -------------------------------------SLKNDGKRTRSKGTLRYMSPEQI 193
Query: 308 LKKGYGMECDWWSLGAIMYEML-VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEA 366
+ YG E D ++LG I+ E+L V F T R D +
Sbjct: 194 SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG-------IISD--IFDKKE 244
Query: 367 KDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
K L+ +LL E R +I
Sbjct: 245 KTLLQKLLSKKPEDRP---NTSEILRTLTVWK 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 6e-64
Identities = 71/330 (21%), Positives = 122/330 (36%), Gaps = 65/330 (19%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DFE + +GRG FG V + K YA+K+++ E V E LA++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62
Query: 146 HCIVKLYYSFQD------------TEYLYLIMEYLPGGDMMTLLMREDTLT---ENVARF 190
IV+ + ++ + YLY+ M+ ++ + T+ +V
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
Q A+E +H +HRD+KP N+ + +K+ DFGL +D
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ------- 175
Query: 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310
+ H VGT Y++PE +
Sbjct: 176 ----------------TVLTPMPAYARHT--------------GQVGTKLYMSPEQIHGN 205
Query: 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-SKLSPEAKDL 369
Y + D +SLG I++E+L YP + + T + +LKFP ++ P +
Sbjct: 206 SYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDV----RNLKFPPLFTQKYPCEYVM 259
Query: 370 ICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398
+ +L R A I + F+D+
Sbjct: 260 VQDMLSPSPMERP---EAINIIENAVFEDL 286
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-63
Identities = 72/357 (20%), Positives = 122/357 (34%), Gaps = 98/357 (27%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ L I+G+GA V R KK+G+++A+K ++ V+ E +L
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLK 62
Query: 142 EVASHCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLM---REDTLTENVARFYIAQSV 196
++ IVKL+ ++ T + LIME+ P G + T+L L E+ + V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 197 LAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
+ + ++ +HR+IKP N++ D KL+DFG + L+ DD
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------------DD 169
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL----- 307
E S GT +Y+ P++
Sbjct: 170 EQFV-------------------------------------SLYGTEEYLHPDMYERAVL 192
Query: 308 ---LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH--------------- 349
+K YG D WS+G Y G PF + +++++
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 350 ------WRNHLKFPDDSKLSPEAKD----LICRLLC-DVEHRLGTGGAHQIKAHPWF 395
P LS + ++ +L D E G Q A
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAETSD 306
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-62
Identities = 74/295 (25%), Positives = 118/295 (40%), Gaps = 57/295 (19%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+F + IGRG F EV G A+KK++ +++ E +LL ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL----MREDTLTENVARFYIAQSVLAIES 201
++K Y SF + L +++E GD+ ++ ++ + E Y Q A+E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H +HRDIKP N+ + G +KL D GL + T
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------------------- 190
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
A S VGTP Y++PE + + GY + D WSL
Sbjct: 191 ----------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222
Query: 322 GAIMYEMLVGYPPFYADD--PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
G ++YEM PFY D + C+KI ++ P D S E + L+ +
Sbjct: 223 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPLPSD-HYSEELRQLVNMCI 275
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-62
Identities = 90/347 (25%), Positives = 145/347 (41%), Gaps = 84/347 (24%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+ ++ + L IG+G++G V+L + YAMK L K +++++ R
Sbjct: 6 SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRG 65
Query: 139 LLA-----------------EVA-----SH-CIVKLY--YSFQDTEYLYLIMEYLPGGDM 173
E+A H +VKL + ++LY++ E + G +
Sbjct: 66 TRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV 125
Query: 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
M + L+E+ ARFY + IE +H IHRDIKP NLL+ ++GH+K++DFG+
Sbjct: 126 MEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
N + D L
Sbjct: 185 --------------------NEFKGSD-----------------------------ALLS 195
Query: 294 STVGTPDYIAPEVL--LKKGY-GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW 350
+TVGTP ++APE L +K + G D W++G +Y + G PF + + KI
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK-- 253
Query: 351 RNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396
L+FPD ++ + KDLI R+L + E R+ +IK HPW
Sbjct: 254 SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV---PEIKLHPWVT 297
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-61
Identities = 71/317 (22%), Positives = 125/317 (39%), Gaps = 61/317 (19%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
V+D++L+ +G GA+GEV+L + + A+K + V E+++ E + +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+VK Y ++ YL +EY GG++ + + + E A+ + Q + + +H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
HRDIKP+NLLLD+ ++K+SDFGL + + +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA--------------------TVFRYNNRER- 162
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 323
L GT Y+APE+L ++ + D WS G
Sbjct: 163 --------------------------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 324 IMYEMLVGYPPFYADDPITTC---RKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379
++ ML G P+ D P +C K+ L+ ++L +
Sbjct: 197 VLTAMLAGELPW--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSA 252
Query: 380 RLGTGGAHQIKAHPWFK 396
R+ IK W+
Sbjct: 253 RITI---PDIKKDRWYN 266
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-61
Identities = 83/320 (25%), Positives = 136/320 (42%), Gaps = 59/320 (18%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
++ + + L +G G FG+V++ + +G+ A+K L + ++ V ++ E
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
L I+KLY +++MEY+ GG++ + + + E AR Q + A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
++ H+H +HRD+KP+N+LLD + + K++DFGL NM
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS--------------------NMMS- 162
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD 317
DG F T + G+P+Y APEV+ + Y G E D
Sbjct: 163 ---DGEFLRT--------------------------SCGSPNYAAPEVISGRLYAGPEVD 193
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-D 376
WS G I+Y +L G PF + T +KI P+ L+ L+ +L D
Sbjct: 194 IWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEY--LNRSVATLLMHMLQVD 249
Query: 377 VEHRLGTGGAHQIKAHPWFK 396
R I+ H WFK
Sbjct: 250 PLKRATI---KDIREHEWFK 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 5e-61
Identities = 94/361 (26%), Positives = 138/361 (38%), Gaps = 63/361 (17%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
D ++ + IG G FG RL R+K + + A+K +++ + E+V+ E
Sbjct: 13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREII 68
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
+ IV+ +L +IMEY GG++ + +E+ ARF+ Q +
Sbjct: 69 NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG 128
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHM--KLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ H HRD+K +N LLD + K+ DFG
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY------------------------ 164
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GME 315
S H Q + STVGTP YIAPEVLL++ Y G
Sbjct: 165 ---------------SKSSVLHSQPK-----------STVGTPAYIAPEVLLRQEYDGKI 198
Query: 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW--RNHLKFPDDSKLSPEAKDLICRL 373
D WS G +Y MLVG PF + RK + PDD ++SPE LI R+
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRI 258
Query: 374 LC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPP 432
D R+ +IK H WF + L E Q+ ++
Sbjct: 259 FVADPATRISI---PEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISE 315
Query: 433 A 433
A
Sbjct: 316 A 316
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-60
Identities = 73/329 (22%), Positives = 117/329 (35%), Gaps = 75/329 (22%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH-VRAER 137
K + ++ L ++G+G FG V A+K + ++ ++ + V
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 138 -----NLLAEVASH-CIVKLYYSFQDTEYLYLIMEY-LPGGDMMTLLMREDTLTENVARF 190
+ H +++L F+ E L++E LP D+ + + L E +R
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
+ Q V AI+ H +HRDIK +N+L+D + G KL DFG L
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG------SGALLH------ 191
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309
D + GT Y PE + +
Sbjct: 192 ------------DEPY-TD--------------------------FDGTRVYSPPEWISR 212
Query: 310 KGY-GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD 368
Y + WSLG ++Y+M+ G PF D I L FP + +SP+
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGDIPFERDQEIL--------EAELHFP--AHVSPDCCA 262
Query: 369 LICRLLC-DVEHRLGTGGAHQIKAHPWFK 396
LI R L R +I PW +
Sbjct: 263 LIRRCLAPKPSSRPSL---EEILLDPWMQ 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-60
Identities = 63/322 (19%), Positives = 106/322 (32%), Gaps = 61/322 (18%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ + +G G F V L G+ YA+K++ E R E + E ++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHP 86
Query: 147 CIVKLYYSFQD----TEYLYLIMEYLPGGD----MMTLLMREDTLTENVARFYIAQSVLA 198
I++L +L++ + G + L + + LTE+ + +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
+E+IH Y HRD+KP N+LL G L D G ++ A
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA----------CIHVEGSRQA-- 194
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY---GME 315
LQ W + T Y APE+ + +
Sbjct: 195 --------------------LTLQDW--------AAQRCTISYRAPELFSVQSHCVIDER 226
Query: 316 CDWWSLGAIMYEMLVGYPPFYADD-PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
D WSLG ++Y M+ G P+ + V N L P + S L+ ++
Sbjct: 227 TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--NQLSIPQSPRHSSALWQLLNSMM 284
Query: 375 C-DVEHRLGTGGAHQIKAHPWF 395
D R + +
Sbjct: 285 TVDPHQRP---HIPLLLSQLEA 303
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-60
Identities = 71/317 (22%), Positives = 125/317 (39%), Gaps = 61/317 (19%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
V+D++L+ +G GA+GEV+L + + A+K + V E+++ E + +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+VK Y ++ YL +EY GG++ + + + E A+ + Q + + +H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
HRDIKP+NLLLD+ ++K+SDFGL + + +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA--------------------TVFRYNNRER- 162
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 323
L GT Y+APE+L ++ + D WS G
Sbjct: 163 --------------------------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 324 IMYEMLVGYPPFYADDPITTC---RKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379
++ ML G P+ D P +C K+ L+ ++L +
Sbjct: 197 VLTAMLAGELPW--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSA 252
Query: 380 RLGTGGAHQIKAHPWFK 396
R+ IK W+
Sbjct: 253 RITI---PDIKKDRWYN 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-60
Identities = 73/352 (20%), Positives = 122/352 (34%), Gaps = 98/352 (27%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L I+G+GA V R KK+G+++A+K ++ V+ E +L ++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 146 HCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLM---REDTLTENVARFYIAQSVLAIE 200
IVKL+ ++ T + LIME+ P G + T+L L E+ + V +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 201 SIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ ++ +HR+IKP N++ D KL+DFG + L+ DDE
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------------DDEQFV 173
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL--------L 308
S GT +Y+ P++
Sbjct: 174 -------------------------------------SLYGTEEYLHPDMYERAVLRKDH 196
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH------------------- 349
+K YG D WS+G Y G PF + +++++
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN 256
Query: 350 --WRNHLKFPDDSKLSPEAKDLICRLL-----CDVEHRLGTGGAHQIKAHPW 394
P LS + L+ +L D E G Q A
Sbjct: 257 GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAETS 305
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-60
Identities = 75/369 (20%), Positives = 131/369 (35%), Gaps = 72/369 (19%)
Query: 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMK-----KLKKSEMVKRGQVEHVR 134
+ ++ +G GAFG V +K+ +K K+ + ++ ++ V
Sbjct: 18 CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 135 AERNLLAEVASHCIVKLYYSFQDTEYLYLIME-YLPGGDMMTLLMREDTLTENVARFYIA 193
E +L+ V I+K+ F++ + L+ME + G D+ + R L E +A +
Sbjct: 78 LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
Q V A+ + + IHRDIK +N+++ ++ +KL DFG L+
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---------------- 181
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY- 312
G T GT +Y APEVL+ Y
Sbjct: 182 --------RGKLFYT--------------------------FCGTIEYCAPEVLMGNPYR 207
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372
G E + WSLG +Y ++ PF + + P +S E L+
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPFCELEETVEAA--------IHPP--YLVSKELMSLVSG 257
Query: 373 LLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFK-PEINGELDTQNFMKFDELD 430
LL E R ++ PW V Y E F+ + + + ++
Sbjct: 258 LLQPVPERRTTL---EKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRS 314
Query: 431 PPASGRTSS 439
+
Sbjct: 315 LSDVAQAQE 323
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 1e-58
Identities = 39/340 (11%), Positives = 97/340 (28%), Gaps = 87/340 (25%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--------------- 137
++G+ ++++G + + +E ++ ++ E
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 138 ----------NLLAEVASHCIVKLYYSFQDTEYL--YLIME------YLPGGDMMTLLMR 179
+L+ + ++++ +D L + + G +++
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 180 EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
+L + Q + + S+H + +H ++P +++LD+ G + L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR---- 255
Query: 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
DG + ++ P
Sbjct: 256 ----------------------DGARVVSSVSRGFEPP----------------ELEARR 277
Query: 300 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD 359
I+ + D W+LG ++Y + P D + I F
Sbjct: 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI--------FRSC 329
Query: 360 SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398
+ + L+ L E RL Q P ++ +
Sbjct: 330 KNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQL 366
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-58
Identities = 82/339 (24%), Positives = 130/339 (38%), Gaps = 73/339 (21%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
+ T+ K + +++ ++G G FG V A+K ++K + G
Sbjct: 26 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 85
Query: 129 QVEH---VRAERNLLAEVASHC--IVKLYYSFQDTEYLYLIMEY-LPGGDMMTLLMREDT 182
++ + V E LL +V+S +++L F+ + LI+E P D+ +
Sbjct: 86 ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 145
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDCSTL 241
L E +AR + Q + A+ H +HRDIK +N+L+D N G +KL DFG L
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG------SGAL 199
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
D + D D GT Y
Sbjct: 200 LK------------------DTVYTDFD---------------------------GTRVY 214
Query: 302 IAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDS 360
PE + Y G WSLG ++Y+M+ G PF D+ I R + F
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------RGQVFFR--Q 264
Query: 361 KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398
++S E + LI L R +I+ HPW +DV
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTF---EEIQNHPWMQDV 300
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 197 bits (501), Expect = 6e-58
Identities = 45/389 (11%), Positives = 100/389 (25%), Gaps = 106/389 (27%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA----------- 141
++G+ ++++G + + +E ++ ++ E L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 142 ----------EVASHCIVKLYYSFQDTEYLYLIMEY-----LPGGDMMTLL------MRE 180
++ K + E ++ ++ T
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 181 DTLTENVARFYIA-QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
+ AR + Q + + S+H + +H ++P +++LD+ G + L+ F S
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
+ I P
Sbjct: 265 AVSPIG------------------------------------------------RGFAPP 276
Query: 300 DYIAPEVLL-----KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL 354
+ A +L D W+LG +Y + P D + I
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI------- 329
Query: 355 KFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPE 413
F + + L+ L E RL Q P ++ +L +A P
Sbjct: 330 -FRSCKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYE-----QLRTELSAALPL 380
Query: 414 INGELDTQNFMKFDELDPPASGRTSSGPS 442
+ + P + + +
Sbjct: 381 YQTDGEPTR---EGGAPPSGTSQPDEAGA 406
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-57
Identities = 79/314 (25%), Positives = 134/314 (42%), Gaps = 60/314 (19%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+ ++ LL IG+G F +V+L R +G A+K + K+++ ++ + E ++ +
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN 72
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
IVKL+ + + LYLIMEY GG++ L+ + E AR Q V A++ H+
Sbjct: 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+HRD+K +NLLLD + ++K++DFG
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGF-------------------------------- 160
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 323
S+ + +L + G P Y APE+ K Y G E D WSLG
Sbjct: 161 -------SNEFTVGGKLDAF-----------CGAPPYAAPELFQGKKYDGPEVDVWSLGV 202
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382
I+Y ++ G PF + +++ K+ +S + ++L+ R L + R
Sbjct: 203 ILYTLVSGSLPFDGQNLKELRERVL----RGKYRIPFYMSTDCENLLKRFLVLNPIKRGT 258
Query: 383 TGGAHQIKAHPWFK 396
QI W
Sbjct: 259 L---EQIMKDRWIN 269
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-57
Identities = 85/320 (26%), Positives = 137/320 (42%), Gaps = 59/320 (18%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
++ + + L +G G FG+V++ + + +G+ A+K L + ++ V +R E
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
L I+KLY ++++MEY+ GG++ + + L E +R Q +
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
++ H+H +HRD+KP+N+LLD + + K++DFGL NM
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS--------------------NMMS- 167
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD 317
DG F T + G+P+Y APEV+ + Y G E D
Sbjct: 168 ---DGEFLRT--------------------------SCGSPNYAAPEVISGRLYAGPEVD 198
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-D 376
WS G I+Y +L G PF D T +KI P L+P L+ +L D
Sbjct: 199 IWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQY--LNPSVISLLKHMLQVD 254
Query: 377 VEHRLGTGGAHQIKAHPWFK 396
R I+ H WFK
Sbjct: 255 PMKRATI---KDIREHEWFK 271
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-57
Identities = 94/355 (26%), Positives = 155/355 (43%), Gaps = 62/355 (17%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER 137
+ K + + + +G G+FG+V+L K+ A+K + + + K V E
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 138 NLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
+ L + I+KLY + +++EY GG++ ++ + +TE+ R + Q +
Sbjct: 61 SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
AIE H+H +HRD+KP+NLLLD N ++K++DFGL
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL------------------------- 154
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMEC 316
S+ + L+ ++ G+P+Y APEV+ K Y G E
Sbjct: 155 --------------SNIMTDGNFLK-----------TSCGSPNYAAPEVINGKLYAGPEV 189
Query: 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC- 375
D WS G ++Y MLVG PF + +K+ PD LSP A+ LI R++
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--SCVYVMPDF--LSPGAQSLIRRMIVA 245
Query: 376 DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQ--NFMKFDE 428
D R+ +I+ PWF + D L ME + + ++ M F E
Sbjct: 246 DPMQRITI---QEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSE 297
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-56
Identities = 70/347 (20%), Positives = 112/347 (32%), Gaps = 88/347 (25%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+E+ +G G FG V + +G A+K+ ++ K E E ++ ++
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLN 70
Query: 145 SHCIVKLYYSFQDTEYL------YLIMEYLPGGDMMTLLM---REDTLTENVARFYIAQS 195
+V + L L MEY GGD+ L L E R ++
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
A+ +H++ IHRD+KP+N++L K+ D G K LD
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-------------QG 177
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
E VGT Y+APE+L +K Y
Sbjct: 178 ELCT-------------------------------------EFVGTLQYLAPELLEQKKY 200
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV----------------HWRNHLKF 356
+ D+WS G + +E + G+ PF + V +
Sbjct: 201 TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVL 260
Query: 357 PDDSKLSPEAKDLICRLL-----CDVEHRLGTGGAHQIKAHPWFKDV 398
P + LS + R L R G Q F+ +
Sbjct: 261 PTPNHLSGILAGKLERWLQCMLMWHQRQR---GTDPQNPNVGCFQAL 304
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 8e-56
Identities = 74/379 (19%), Positives = 122/379 (32%), Gaps = 97/379 (25%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ I+G G+ G V G A+K++ + E LL E
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDD 67
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGG--DMM----TLLMREDTLTENVARFYIAQSVLA 198
H +++ Y S +LY+ +E D++ E + Q
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 199 IESIHKHNYIHRDIKPDNLLLD-------------KNGHMKLSDFGLCKPLDCSTLYAIH 245
+ +H IHRD+KP N+L+ +N + +SDFGLCK LD
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305
GT + APE
Sbjct: 188 NLNNP---------------------------------------------SGTSGWRAPE 202
Query: 306 VLL-------KKGYGMECDWWSLGAIMYEMLV-GYPPFYAD-DPITTCRKIVHWRNHLKF 356
+L K+ D +S+G + Y +L G PF + + + + +K
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKC 262
Query: 357 PDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEIN 415
D L EA DLI +++ D R A ++ HP F + F
Sbjct: 263 LHDRSLIAEATDLISQMIDHDPLKRP---TAMKVLRHPLFWP------KSKKLEFL---- 309
Query: 416 GELDTQNFMKFDELDPPAS 434
L + ++ + DPP++
Sbjct: 310 --LKVSDRLEIENRDPPSA 326
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-55
Identities = 68/352 (19%), Positives = 120/352 (34%), Gaps = 75/352 (21%)
Query: 58 MEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMK 117
M +L +D +ET + + + C D ++G GA G + + R A+K
Sbjct: 1 MGSSPSLEQDDGDEETSVVIVGKISFCPKD-----VLGHGAEGTI-VYRGMFDNRDVAVK 54
Query: 118 KLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176
++ E LL E H +++ + + +D ++ Y+ +E +
Sbjct: 55 RILPE------CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYV 108
Query: 177 LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-----MKLSDFG 231
++ + Q+ + +H N +HRD+KP N+L+ +SDFG
Sbjct: 109 EQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291
LCK L + S
Sbjct: 169 LCKKLA----------------------------VGRHSFSRRSGV-------------- 186
Query: 292 AFSTVGTPDYIAPEVL---LKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKI 347
GT +IAPE+L K+ D +S G + Y ++ G PF I
Sbjct: 187 ----PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NI 240
Query: 348 VHWRNHLKFPDDSK-LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+ L K A++LI +++ D + R A + HP+F
Sbjct: 241 LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAKHVLKHPFFWS 289
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-55
Identities = 56/387 (14%), Positives = 109/387 (28%), Gaps = 87/387 (22%)
Query: 51 LASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREK-- 108
L+ P+ N + + K ++ + ++G GAF +V +
Sbjct: 31 LSGLSKPVSSYPN-TFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89
Query: 109 ---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165
K+ + +K K + + L H +K Y + L+
Sbjct: 90 NDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146
Query: 166 EYLPGGDMMTLLMR-----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL- 219
E G ++ + E + + + + + + IE +H IH DIKPDN +L
Sbjct: 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206
Query: 220 ----------DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTD 269
D + + L D G + FP
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMK--------------------------LFPKGT 240
Query: 270 NKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329
+ + T + E+L K + + D++ + A +Y ML
Sbjct: 241 ---------------------IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279
Query: 330 VGYPPFYADDPITTCRKIV---HWRNH---------LKFPDDSKLSPEAKDLICRLLCDV 377
G ++ + + L PD L P L +L
Sbjct: 280 FGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHL-PSLDLLRQKLKKVF 338
Query: 378 EHRLGTGGAHQIKAHPWFKDVVWDKLY 404
+ + + ++ K
Sbjct: 339 QQHYTNKI--RALRNRLIVLLLECKRS 363
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 6e-55
Identities = 69/319 (21%), Positives = 122/319 (38%), Gaps = 61/319 (19%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE-HVRAERNLLAEV 143
+ + + ++G G++G+V+ + ++ A+K LKK ++ + E +V+ E LL +
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 144 ASHCIVKLY--YSFQDTEYLYLIMEYLPGGDM-MTLLMREDTLTENVARFYIAQSVLAIE 200
+++L ++ + +Y++MEY G M + E A Y Q + +E
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H +H+DIKP NLLL G +K+S G+ P
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA--------------------EALHPFA 163
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGY-GMECDW 318
D ++ G+P + PE+ + G + D
Sbjct: 164 ADD---------------------------TCRTSQGSPAFQPPEIANGLDTFSGFKVDI 196
Query: 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377
WS G +Y + G PF D+ I + P D P DL+ +L +
Sbjct: 197 WSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGD--CGPPLSDLLKGMLEYEP 252
Query: 378 EHRLGTGGAHQIKAHPWFK 396
R QI+ H WF+
Sbjct: 253 AKRFSI---RQIRQHSWFR 268
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-53
Identities = 61/319 (19%), Positives = 106/319 (33%), Gaps = 53/319 (16%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+F L IG G FG V C ++ G IYA+K+ KK + +R E A +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQ 69
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL----MREDTLTENVARFYIAQSVLAIE 200
H +V+ + ++ + +++ + EY GG + + E + + Q +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
IH + +H DIKP N+ + + + + S K I D
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF---K-IGDLGHV---- 181
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWW 319
+ SP G ++A EVL + + D +
Sbjct: 182 -----------TRISSPQ---------------VEEGDSRFLANEVLQENYTHLPKADIF 215
Query: 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLC-DV 377
+L + P D R+ + P LS E +L+ ++ D
Sbjct: 216 ALALTVVCAAGAEPLPRNGDQWHEIRQG-------RLPRIPQVLSQEFTELLKVMIHPDP 268
Query: 378 EHRLGTGGAHQIKAHPWFK 396
E R A + H
Sbjct: 269 ERRP---SAMALVKHSVLL 284
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-52
Identities = 72/350 (20%), Positives = 123/350 (35%), Gaps = 58/350 (16%)
Query: 49 RKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREK 108
++ + + + + E ++ V +GRG+FGEV ++K
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 109 KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL 168
++G A+KK++ E A ++S IV LY + ++ ++ + ME L
Sbjct: 81 QTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 169 PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKL 227
GG + L+ + L E+ A +Y+ Q++ +E +H +H D+K DN+LL +G L
Sbjct: 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAAL 192
Query: 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMN 287
DFG L L
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGD-------------------------------------- 214
Query: 288 RRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKI 347
GT ++APEV++ K + D WS +M ML G P+ C KI
Sbjct: 215 ------YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268
Query: 348 VHWRNHLKFPDDSKLSPEAKDLICR-LLCDVEHRLGTGGAHQIKAHPWFK 396
+P I L + HR A +++
Sbjct: 269 AS-EPPPIREIPPSCAPLTAQAIQEGLRKEPVHR---ASAMELRRKVGKA 314
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-47
Identities = 62/324 (19%), Positives = 109/324 (33%), Gaps = 66/324 (20%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH- 146
+ ++ G F V ++ SG YA+K+L +E K + E + +++ H
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHP 86
Query: 147 CIVKLYYSF-------QDTEYLYLIMEYLPGGDMMTLLMR---EDTLTENVARFYIAQSV 196
IV+ + + +L++ L G ++ L + L+ + Q+
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 197 LAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
A++ +H+ IHRD+K +NLLL G +KL DFG +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS----------------- 189
Query: 255 MAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---LKKG 311
P + + + TP Y PE++
Sbjct: 190 --------------------HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP 229
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
G + D W+LG I+Y + PF +IV P LI
Sbjct: 230 IGEKQDIWALGCILYLLCFRQHPFEDGAK----LRIV--NGKYSIPPHDTQYTVFHSLIR 283
Query: 372 RLLC-DVEHRLGTGGAHQIKAHPW 394
+L + E RL ++
Sbjct: 284 AMLQVNPEERL---SIAEVVHQLQ 304
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 4e-47
Identities = 68/373 (18%), Positives = 121/373 (32%), Gaps = 106/373 (28%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----------------------EKKSGNIYAMKKLKKSE 123
DFE + +GRG FG V + EK + A+ KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 124 MVK---------------------------------RGQVEHVRAERNLLAEVASHCIVK 150
+V+ ++ + + ++ V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLT---ENVARFYIAQSVLAIESIHKHNY 207
YLY+ M+ ++ + R +L V Q A+E +H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
+HRD+KP N+ + +K+ DFGL +D D
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMD----------------------------QD 217
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
+ ++ H VGT Y++PE + Y + D +SLG I++E
Sbjct: 218 EEEQTVLTPMPAYATH---------TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
Query: 328 MLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-SKLSPEAKDLICRLLC-DVEHRLGTGG 385
+L Y + + + RN LKFP ++ P+ ++ +L R
Sbjct: 269 LL--YSFSTQMERVRIITDV---RN-LKFPLLFTQKYPQEHMMVQDMLSPSPTERP---E 319
Query: 386 AHQIKAHPWFKDV 398
A I + F+++
Sbjct: 320 ATDIIENAIFENL 332
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-47
Identities = 79/317 (24%), Positives = 128/317 (40%), Gaps = 73/317 (23%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
++G+G +G V R+ + A+K + S + + E L + IV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-----LHEEIALHKHLKHKNIVQ 83
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNY 207
SF + ++ + ME +PGG + LL + E FY Q + ++ +H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 208 IHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
+HRDIK DN+L++ +G +K+SDFG K
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSK-------------------------------- 171
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAI 324
+L + GT Y+APE++ K +GYG D WSLG
Sbjct: 172 -------------RLAGINPCTE----TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCT 214
Query: 325 MYEMLVGYPPFY-ADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC---DVEHR 380
+ EM G PPFY +P K+ ++ H + P+ +S EAK I L C D + R
Sbjct: 215 IIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES--MSAEAKAFI--LKCFEPDPDKR 270
Query: 381 LGTGGAHQIKAHPWFKD 397
A+ + + K
Sbjct: 271 A---CANDLLVDEFLKV 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-45
Identities = 92/350 (26%), Positives = 152/350 (43%), Gaps = 62/350 (17%)
Query: 52 ASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDD----FELLTIIGRGAFGEVRLCRE 107
SS V + + + +F R + D + IG G+ G V L RE
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLARE 66
Query: 108 KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167
K SG A+K + + +R E + E ++ + +V++Y S+ E L+++ME+
Sbjct: 67 KHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKL 227
L GG + T ++ + L E + A+ +H IHRDIK D++LL +G +KL
Sbjct: 124 LQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182
Query: 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMN 287
SDFG C Q+ +
Sbjct: 183 SDFGFCA---------------------------------------------QISK-DVP 196
Query: 288 RRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKI 347
+RK S VGTP ++APEV+ + Y E D WSLG ++ EM+ G PP+++D P+ +++
Sbjct: 197 KRK---SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253
Query: 348 VHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396
K + K+SP +D + R+L D + R A ++ HP+
Sbjct: 254 RD-SPPPKLKNSHKVSPVLRDFLERMLVRDPQER---ATAQELLDHPFLL 299
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 62/313 (19%), Positives = 116/313 (37%), Gaps = 65/313 (20%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
IGRG+F V + ++ A +L+ ++ K + + + E +L + IV+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 153 YSFQDT----EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY- 207
S++ T + + L+ E + G + T L R + V R + Q + ++ +H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 208 -IHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
IHRD+K DN+ + G +K+ D GL
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLAT------------------------------- 180
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
+ R A + +GTP+++APE+ ++ Y D ++ G M
Sbjct: 181 --------------------LKRASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCM 219
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG 384
EM P+ + V D PE K++I + + + R
Sbjct: 220 LEMATSEYPYSECQNAAQIYRRVT-SGVKPASFDKVAIPEVKEIIEGCIRQNKDERY--- 275
Query: 385 GAHQIKAHPWFKD 397
+ H +F++
Sbjct: 276 SIKDLLNHAFFQE 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 86/316 (27%), Positives = 141/316 (44%), Gaps = 66/316 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ IG+GA G V + +G A++++ + K+ E + E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA----QSVLAIES 201
IV S+ + L+++MEYL GG + T ++ E + E IA + + A+E
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEG----QIAAVCRECLQALEF 131
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H + IHRDIK DN+LL +G +KL+DFG C
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--------------------------- 164
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
Q+ + ++R + VGTP ++APEV+ +K YG + D WSL
Sbjct: 165 ------------------QITP-EQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
G + EM+ G PP+ ++P+ I + + KLS +D + R L DVE R
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261
Query: 381 LGTGGAHQIKAHPWFK 396
G A ++ H + K
Sbjct: 262 ---GSAKELLQHQFLK 274
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 69/343 (20%), Positives = 126/343 (36%), Gaps = 71/343 (20%)
Query: 67 DLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSE 123
++ + +R++ ++D E L +G G G+V R +K+G++ A+K+++ E
Sbjct: 6 SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 124 MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTL 183
KR ++ +L IV+ + +F +++ ME + + +
Sbjct: 66 ENKRILMDL----DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121
Query: 184 TENVARFYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
E + + +++ A+ + KH IHRD+KP N+LLD+ G +KL DFG
Sbjct: 122 PERILG-KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG---------- 170
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
I G D K + G Y
Sbjct: 171 -------------------ISGRLVDDKAKD---------------------RSAGCAAY 190
Query: 302 IAPEVL-----LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPI-TTCRKIVHWRNHLK 355
+APE + K Y + D WSLG + E+ G P+ K++
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPL 249
Query: 356 FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
P S + + + L D R +++ H + K
Sbjct: 250 LPGHMGFSGDFQSFVKDCLTKDHRKRP---KYNKLLEHSFIKR 289
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 78/315 (24%), Positives = 131/315 (41%), Gaps = 65/315 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEV 143
+ F L IG+G+FGEV + ++ + A+K L+++E ++E ++ E +L++
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQC 77
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
S + K Y S+ L++IMEYL GG + L + L E + + + ++ +H
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLH 136
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
IHRDIK N+LL ++G +KL+DFG+
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAG----------------------------- 167
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
QL +R + VGTP ++APEV+ + Y + D WSLG
Sbjct: 168 ----------------QLTD-TQIKRN---TFVGTPFWMAPEVIKQSAYDSKADIWSLGI 207
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLC-DVEHRL 381
E+ G PP P+ I +N P + S K+ + L + R
Sbjct: 208 TAIELARGEPPHSELHPMKVLFLIP--KN--NPPTLEGNYSKPLKEFVEACLNKEPSFRP 263
Query: 382 GTGGAHQIKAHPWFK 396
A ++ H +
Sbjct: 264 ---TAKELLKHKFIL 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 82/316 (25%), Positives = 131/316 (41%), Gaps = 64/316 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ F++L +G G++G V K++G I A+K++ ++ + E +++ + S
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+VK Y S+ L+++MEY G D++ L R TLTE+ + ++ +E +
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYL 141
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H IHRDIK N+LL+ GH KL+DFG+
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAG---------------------------- 173
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
QL M +R + +GTP ++APEV+ + GY D WSLG
Sbjct: 174 -----------------QLTD-TMAKRN---TVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381
EM G PP+ P+ I F S D + + L E R
Sbjct: 213 ITAIEMAEGKPPYADIHPMRAIFMIPT-NPPPTFRKPELWSDNFTDFVKQCLVKSPEQR- 270
Query: 382 GTGGAHQIKAHPWFKD 397
A Q+ HP+ +
Sbjct: 271 --ATATQLLQHPFVRS 284
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 72/329 (21%), Positives = 128/329 (38%), Gaps = 69/329 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEV 143
DD+EL +IG GA V+ A+K L+K + ++ + E +++
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQC 70
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMRED-----TLTENVARFYIAQS 195
IV Y SF + L+L+M+ L GG D++ ++ + L E+ + +
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+ +E +HK+ IHRD+K N+LL ++G ++++DFG+
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS---------------------- 168
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGM 314
+ + + RK + VGTP ++APEV+ + +GY
Sbjct: 169 -------AFLATGGDIT------------RNKVRK---TFVGTPCWMAPEVMEQVRGYDF 206
Query: 315 ECDWWSLGAIMYEMLVGYPPFYADDP------ITTCRKIVHWRNHLKFPDDSKLSPEAKD 368
+ D WS G E+ G P++ P K +
Sbjct: 207 KADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK 266
Query: 369 LICRLLC-DVEHRLGTGGAHQIKAHPWFK 396
+I L D E R A ++ H +F+
Sbjct: 267 MISLCLQKDPEKRP---TAAELLRHKFFQ 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 69/335 (20%), Positives = 125/335 (37%), Gaps = 74/335 (22%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRA 135
+ +D + L IGRGA+G V K SG I A+K+++ + K+ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL--- 71
Query: 136 ERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG--DMMTLLM--REDTLTENVARFY 191
++ IV+ Y + ++ ME + + +D + E +
Sbjct: 72 -DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-K 129
Query: 192 IAQSVL-AIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
I + + A+ + IHRDIKP N+LLD++G++KL DFG+ L S
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---------- 179
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-- 307
+ + + G Y+APE +
Sbjct: 180 ------------------------------------IAKTR----DAGCRPYMAPERIDP 199
Query: 308 --LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTC-RKIVHWRN-HLKFPDDSKLS 363
++GY + D WSLG +YE+ G P+ + + ++V L ++ + S
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259
Query: 364 PEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
P + + L D R ++ HP+
Sbjct: 260 PSFINFVNLCLTKDESKRP---KYKELLKHPFILM 291
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-42
Identities = 76/332 (22%), Positives = 132/332 (39%), Gaps = 76/332 (22%)
Query: 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRAER 137
++ DD E + +GRGA+G V R SG I A+K+++ S+ KR ++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL----D 57
Query: 138 NLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTENVARFYIAQ 194
+ V V Y + +++ ME + ++ + T+ E++ IA
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG-KIAV 116
Query: 195 SVL-AIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
S++ A+E +H K + IHRD+KP N+L++ G +K+ DFG+ L
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD------------- 163
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST-VGTPDYIAPEVLL--- 308
+A G Y+APE +
Sbjct: 164 --------------------------------------VAKDIDAGCKPYMAPERINPEL 185
Query: 309 -KKGYGMECDWWSLGAIMYEMLVGYPPFYADD-PITTCRKIVHWRNHLKFPDDSKLSPEA 366
+KGY ++ D WSLG M E+ + P+ + P +++V + P D K S E
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-EPSPQLPAD-KFSAEF 243
Query: 367 KDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
D + L + + R ++ HP+F
Sbjct: 244 VDFTSQCLKKNSKERP---TYPELMQHPFFTL 272
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-41
Identities = 83/339 (24%), Positives = 140/339 (41%), Gaps = 67/339 (19%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
RK E+ ++R + +E++ +G GAFG+V + K++G + A K ++ +
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-- 59
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTE 185
+E E +LA IVKL ++ L++++E+ PGG +M L R LTE
Sbjct: 60 -LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTE 116
Query: 186 NVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
+ Q + A+ +H IHRD+K N+L+ G ++L+DFG+
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS------------ 164
Query: 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305
+ + +R S +GTP ++APE
Sbjct: 165 ---------------------------------AKNLK-TLQKRD---SFIGTPYWMAPE 187
Query: 306 VLL-----KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDS 360
V++ Y + D WSLG + EM PP + +P+ KI + S
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SDPPTLLTPS 246
Query: 361 KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398
K S E +D + L + E R A Q+ HP+ +
Sbjct: 247 KWSVEFRDFLKIALDKNPETR---PSAAQLLEHPFVSSI 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 72/286 (25%), Positives = 115/286 (40%), Gaps = 64/286 (22%)
Query: 65 IKDLERKETEFMRL--------KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM 116
+++LE E + RL K ++ DDFE ++ +G G G V K SG + A
Sbjct: 4 LEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMAR 63
Query: 117 KKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176
K + K + E +L E S IV Y +F + + ME++ GG + +
Sbjct: 64 KLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121
Query: 177 LMREDTLTENVARFYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
L + + E + ++ +V+ + + KH +HRD+KP N+L++ G +KL DFG+
Sbjct: 122 LKKAGRIPEQILG-KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294
L S +A S
Sbjct: 181 QLIDS---------------------------------------------------MANS 189
Query: 295 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDP 340
VGT Y++PE L Y ++ D WS+G + EM VG P D
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 83/330 (25%), Positives = 131/330 (39%), Gaps = 77/330 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
FEL+ ++G G +G+V R K+G + A+K + V + E ++ E N+L + +
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 146 HC-IVKLYYSF------QDTEYLYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSV 196
H I Y +F + L+L+ME+ G + L+ + +TL E + + +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ +H+H IHRDIK N+LL +N +KL DFG+
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 177
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-----G 311
QL + RR + +GTP ++APEV+
Sbjct: 178 -----------------------QLDR-TVGRRN---TFIGTPYWMAPEVIACDENPDAT 210
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFP--DDSKLSPEAKDL 369
Y + D WSLG EM G PP P+ I RN P K S + +
Sbjct: 211 YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--RN--PAPRLKSKKWSKKFQSF 266
Query: 370 ICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398
I L + R Q+ HP+ +D
Sbjct: 267 IESCLVKNHSQRP---ATEQLMKHPFIRDQ 293
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 49/261 (18%), Positives = 92/261 (35%), Gaps = 49/261 (18%)
Query: 86 DDFELLTIIGRGA--FGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
+ELLT+IG+G V L R K +G ++++ E V ++ E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIES 201
IV +F L+++ ++ G L+ D + E + + + A++
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
IH Y+HR +K ++L+ +G + LS
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSN---------------------------- 175
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL--LKKGYGMECDWW 319
+ Q +V +++PEVL +GY + D +
Sbjct: 176 -LSMISHGQR-------------QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221
Query: 320 SLGAIMYEMLVGYPPFYADDP 340
S+G E+ G+ PF
Sbjct: 222 SVGITACELANGHVPFKDMPA 242
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 26/173 (15%)
Query: 74 EFMRLKRHKICVDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH 132
+++K++ I +DD+++ ++G G G+V K++ +A+K L+ +R
Sbjct: 6 SGLQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----- 59
Query: 133 VRAERNLLAEVASH-CIVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMR-----EDT 182
E L + IV++ +++ + L ++ME L GG+ L R +
Sbjct: 60 ---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQA 113
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGL 232
TE A + AI+ +H N HRD+KP+NLL N +KL+DFG
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 33/101 (32%), Positives = 46/101 (45%), Gaps = 9/101 (8%)
Query: 302 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH--WRNHLKFPDD 359
A E + Y CD WSLG IMY +L GYPPFY++ + + +FP+
Sbjct: 166 FAKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 360 --SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
S++S E K LI LL + R+ + HPW
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 262
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 80/376 (21%), Positives = 137/376 (36%), Gaps = 109/376 (28%)
Query: 69 ERKETEFMRLKRHKI---CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV 125
+ E+ + H + DD++L+ +GRG + EV + +K LK
Sbjct: 16 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---- 71
Query: 126 KRGQVEHVRAER--NLLAEVASH-CIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMRE 180
V+ + +R +L + I+ L +D + L+ E++ D L
Sbjct: 72 ----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--- 124
Query: 181 DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCS 239
TLT+ RFY+ + + A++ H +HRD+KP N+++D ++ ++L D+GL
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL------- 177
Query: 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
AE P + N R V +
Sbjct: 178 ----------------AEFYH-----PGQE----------------YNVR------VASR 194
Query: 300 DYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYA-----------------DDPI 341
+ PE+L+ + Y D WSLG ++ M+ PF+ +D
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254
Query: 342 TTCRKI-----------------VHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383
K W + + +SPEA D + +LL D + RL T
Sbjct: 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-T 313
Query: 384 GGAHQIKAHPWFKDVV 399
A + HP+F VV
Sbjct: 314 --AREAMEHPYFYTVV 327
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-31
Identities = 68/295 (23%), Positives = 102/295 (34%), Gaps = 71/295 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ E+ ++GRGAFG V C+ K A+K+++ K E L+ V
Sbjct: 8 KEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESESERK-----AFIVELRQLSRVNH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTE--NVARFYIAQSV-LAIESI 202
IVKLY + + L+MEY GG + +L + L + +
Sbjct: 61 PNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 203 HKHNY---IHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
H IHRD+KP NLLL G +K+ DFG I H T
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--------DIQTHMT--------- 161
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ G+ ++APEV Y +CD
Sbjct: 162 -----------------------------------NNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 319 WSLGAIMYEMLVGYPPF-YADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372
+S G I++E++ PF P VH + L + L+ R
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN--LPKPIESLMTR 239
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 24/195 (12%), Positives = 48/195 (24%), Gaps = 40/195 (20%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+L+ + G V L R+ + +A+K R ++E + A +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 147 CIVKLY--------------------------YSFQDTEYLYLIMEYLPGGDMMTLL--- 177
+ L+M D+ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTL 181
Query: 178 ----MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
+ AQ + ++ +H PDNL + +G + L D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 234 KPLD------CSTLY 242
+ +
Sbjct: 242 WKVGTRGPASSVPVT 256
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 24/113 (21%), Positives = 35/113 (30%), Gaps = 11/113 (9%)
Query: 294 STVGTPDYIAPEVLLKKG--YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKI---- 347
++ Y E L + + W LG +Y + + PF P
Sbjct: 250 ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSL 309
Query: 348 -VHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398
V + L F + L K LI R L D RL + P F +
Sbjct: 310 RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL---LPLEAMETPEFLQL 359
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 69/306 (22%), Positives = 115/306 (37%), Gaps = 55/306 (17%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+EL I+G G EV L R+ + A+K L+ R E A +
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 148 IVKLY----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
IV +Y Y++MEY+ G + ++ E +T A IA + A+ H
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
++ IHRD+KP N+++ +K+ DFG+ + + S ++
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-------NSVTQTAAV------- 179
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
+GT Y++PE D +SLG
Sbjct: 180 --------------------------------IGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFP--DDSKLSPEAKDLICRLLC-DVEHR 380
++YE+L G PPF D P++ + H R P LS + ++ + L + E+R
Sbjct: 208 VLYEVLTGEPPFTGDSPVSVAYQ--HVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
Query: 381 LGTGGA 386
T
Sbjct: 266 YQTAAE 271
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 54/255 (21%), Positives = 104/255 (40%), Gaps = 48/255 (18%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
++++ +G G V L + A+K + K ++ E + ++++
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
IV + ++ + YL+MEY+ G + + L+ + A + Q + I+ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
+HRDIKP N+L+D N +K+ DFG+ K + + ++ +
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIA--------------KALSETSLTQ---------- 168
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
T+ +GT Y +PE + D +S+G ++YE
Sbjct: 169 TN------------------------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYE 204
Query: 328 MLVGYPPFYADDPIT 342
MLVG PPF + ++
Sbjct: 205 MLVGEPPFNGETAVS 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 40/148 (27%), Positives = 67/148 (45%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
F L IG G+FG V R+ ++ + A+KK+ S + + + E L ++
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
++ + +L+MEY G L + + L E ++ + +H H
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
N IHRD+K N+LL + G +KL DFG
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 27/119 (22%), Positives = 46/119 (38%), Gaps = 18/119 (15%)
Query: 285 QMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPI 341
M S VGTP ++APEV+L + Y + D WSLG E+ PP + + +
Sbjct: 203 IMAPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259
Query: 342 TTCRKIVHWRN---HLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396
+ I +N L+ S ++ + L + R + + H +
Sbjct: 260 SALYHIA--QNESPALQ---SGHWSEYFRNFVDSCLQKIPQDR---PTSEVLLKHRFVL 310
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 57/269 (21%), Positives = 104/269 (38%), Gaps = 55/269 (20%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK-SEMVKRGQVEHVRAERNLLA 141
D ++G+G FG+ +++G + MK+L + E +R L
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE----------TQRTFLK 56
Query: 142 EVA-----SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQ 194
EV H ++K + L I EY+ GG + ++ D+ + R A+
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQ-RVSFAK 115
Query: 195 SV-LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
+ + +H N IHRD+ N L+ +N ++ ++DFGL + L
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL------ARL------------ 157
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313
+ + S K P RK ++ VG P ++APE++ + Y
Sbjct: 158 -------MVDEKTQPEGLRSLKKP----------DRKKRYTVVGNPYWMAPEMINGRSYD 200
Query: 314 MECDWWSLGAIMYEMLVGYPPFYADDPIT 342
+ D +S G ++ E++ P T
Sbjct: 201 EKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 46/153 (30%), Positives = 81/153 (52%), Gaps = 11/153 (7%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRA----ERNLL 140
++ +E + IG G++G V CR + +G I A+KK +SE ++ E +L
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRML 56
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAI 199
++ +V L F+ L+L+ EY ++ L + + E++ + Q++ A+
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
HKHN IHRD+KP+N+L+ K+ +KL DFG
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 7e-09
Identities = 29/127 (22%), Positives = 47/127 (37%), Gaps = 32/127 (25%)
Query: 301 YIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV---------HW 350
Y +PE+L+ YG D W++G + E+L G P + + I H
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227
Query: 351 --------RNHLKFPDDS----------KLSPEAKDLICRLL-CDVEHRLGTGGAHQIKA 391
+ +K PD +S A L+ L D RL Q+
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL---TCEQLLH 284
Query: 392 HPWFKDV 398
HP+F+++
Sbjct: 285 HPYFENI 291
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 51/153 (33%), Positives = 85/153 (55%), Gaps = 9/153 (5%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS---EMVKRGQVEHVRAERNLL 140
++ +E L ++G G++G V CR K +G I A+KK +S +MVK+ + R E LL
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM---R-EIKLL 78
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAI 199
++ +V L + + YL+ E++ ++ L + + L V + Y+ Q + I
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H HN IHRDIKP+N+L+ ++G +KL DFG
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 33/145 (22%), Positives = 52/145 (35%), Gaps = 32/145 (22%)
Query: 301 YIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV---------HW 350
Y APE+L+ YG D W++G ++ EM +G P F D I I+ H
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 351 RNHLKFPD------------------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391
K P KLS DL + L D + R ++
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP---FCAELLH 306
Query: 392 HPWFKDVVWDKLYEMEAAFKPEING 416
H +F+ + + + E K + +
Sbjct: 307 HDFFQMDGFAERFSQELQLKVQKDA 331
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 54/252 (21%), Positives = 94/252 (37%), Gaps = 50/252 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVASH 146
+ L ++GRG G+V + I A+K + + ++ E +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
+V ++ + LY+ M + G D+ +L R+ L A + Q A+++ H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
HRD+KP+N+L+ + L DFG+ DE +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIAS--------------ATTDEKLT---------- 190
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326
Q+ +TVGT Y+APE + D ++L ++Y
Sbjct: 191 ------------------QLG------NTVGTLYYMAPERFSESHATYRADIYALTCVLY 226
Query: 327 EMLVGYPPFYAD 338
E L G PP+ D
Sbjct: 227 ECLTGSPPYQGD 238
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 63/286 (22%), Positives = 113/286 (39%), Gaps = 34/286 (11%)
Query: 52 ASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSG 111
S E Q + R D +E+ +IG G++G V +K
Sbjct: 19 TVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEK 78
Query: 112 NIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEVASHCIVKLY-----YSFQDTEYLYLI 164
+ A+KK+ + V ++ R R +L + +VK+ + + LY++
Sbjct: 79 RVVAIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135
Query: 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH 224
+E D L LTE + + ++ ++ +H +HRD+KP N L++++
Sbjct: 136 LEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS 194
Query: 225 MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHW 284
+K+ DFGL + +D ++ N P+ + K+ QL
Sbjct: 195 VKVCDFGLARTVDYP-----------ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243
Query: 285 QMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 329
V T Y APE++L ++ Y D WS+G I E+L
Sbjct: 244 -----------VVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEV 143
+++F+ + IG G +G V R K +G + A+KK++ + G +R E +LL E+
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIR-EISLLKEL 59
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIES 201
IVKL LYL+ E+L D+ + + + + Y+ Q + +
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H H +HRD+KP NLL++ G +KL+DFGL
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 74/376 (19%), Positives = 130/376 (34%), Gaps = 85/376 (22%)
Query: 48 ERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCRE 107
++ D+P E + ++ + + I D + IG G+FG V R
Sbjct: 7 HHPMSDYDIPTTENLYFQGAMDGDDMD--------IPWCDLNIKEKIGAGSFGTV--HRA 56
Query: 108 KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167
+ G+ A+K L + + +V E ++ + IV + L ++ EY
Sbjct: 57 EWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115
Query: 168 LPGGDMMTLLMREDTLTE--NVARFYIAQSV-LAIESIHKHNY--IHRDIKPDNLLLDKN 222
L G + LL + + R +A V + +H N +HR++K NLL+DK
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK 175
Query: 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQ 282
+K+ DFGL + + L + T
Sbjct: 176 YTVKVCDFGLSRLKASTFLSSKSAAGTP-------------------------------- 203
Query: 283 HWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPIT 342
W M APEVL + + D +S G I++E+ P+ +P
Sbjct: 204 EW-M----------------APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
Query: 343 TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC---DVEHRLGTGGAHQIKAHPWFKDVV 399
+ L+ P + L+P+ +I C + R P F ++
Sbjct: 247 VVAAVGFKCKRLEIPRN--LNPQVAAIIEG--CWTNEPWKR------------PSFATIM 290
Query: 400 WDKLYEMEAAFKPEIN 415
D L + + P N
Sbjct: 291 -DLLRPLIKSAVPPPN 305
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH----VRAERNL 139
+E + IG GA+G V R+ SG+ A+K ++ G VR E L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR-EVAL 64
Query: 140 LAE--VASH-CIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVAR 189
L H +V+L + L+ E++ D+ T L L +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ Q + ++ +H + +HRD+KP+N+L+ G +KL+DFGL
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 7e-11
Identities = 26/122 (21%), Positives = 39/122 (31%), Gaps = 27/122 (22%)
Query: 301 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WR 351
Y APEVLL+ Y D WS+G I EM P F + KI W
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 352 NHLKFPDDS--------------KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396
+ P + ++ L+ +L + R+ A + H +
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI---SAFRALQHSYLH 301
Query: 397 DV 398
Sbjct: 302 KD 303
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 49/262 (18%), Positives = 88/262 (33%), Gaps = 71/262 (27%)
Query: 88 FELLTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKS---EMVKRGQVEHVRAERNLLAEV 143
+E+ I G G + L ++ +G +K L S E AER LAEV
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-----AMAERQFLAEV 136
Query: 144 ASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
IV+++ Y++MEY+ G + L A Y+ + + A
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
+ +H ++ D+KP+N++L + +KL D G I+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAV--------------SRINSFGYL-- 237
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GTP + APE+ ++ G + D
Sbjct: 238 -------------------------------------YGTPGFQAPEI-VRTGPTVATDI 259
Query: 319 WSLGAIMYEMLVGYPPFYADDP 340
+++G + + + P
Sbjct: 260 YTVGRTLAALTLDLPTRNGRYV 281
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 49/164 (29%), Positives = 87/164 (53%), Gaps = 15/164 (9%)
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH--- 132
+ +K +E L +G G F V R+K + I A+KK+K + R + +
Sbjct: 3 LDVKSR---AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGIN 56
Query: 133 ---VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVA 188
+R E LL E++ I+ L +F + L+ +++ D+ ++ LT +
Sbjct: 57 RTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHI 114
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ Y+ ++ +E +H+H +HRD+KP+NLLLD+NG +KL+DFGL
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 28/123 (22%), Positives = 44/123 (35%), Gaps = 29/123 (23%)
Query: 301 YIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------W 350
Y APE+L + YG+ D W++G I+ E+L+ P D + +I W
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237
Query: 351 RNHLKFPDD---------------SKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAHPW 394
+ PD S + DLI L + R+ A Q +
Sbjct: 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---TATQALKMKY 294
Query: 395 FKD 397
F +
Sbjct: 295 FSN 297
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 59/265 (22%), Positives = 96/265 (36%), Gaps = 66/265 (24%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLA 141
I + L IIG G FG+V R G+ A+K + Q +E+VR E L A
Sbjct: 4 IDFAELTLEEIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ I+ L L L+ME+ GG + +L + ++ + Q +
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNY 120
Query: 202 IHKHNY---IHRDIKPDNLLLDK--------NGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
+H IHRD+K N+L+ + N +K++DFGL + +T +
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS------- 173
Query: 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310
G ++APEV+
Sbjct: 174 --------------------------------------------AAGAYAWMAPEVIRAS 189
Query: 311 GYGMECDWWSLGAIMYEMLVGYPPF 335
+ D WS G +++E+L G PF
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 46/263 (17%), Positives = 95/263 (36%), Gaps = 59/263 (22%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
I + E+ +IG+G FG+V + G + A++ + + Q++ + E +
Sbjct: 30 IPFEQLEIGELIGKGRFGQV--YHGRWHGEV-AIRLIDIERDNED-QLKAFKREVMAYRQ 85
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIES 201
+V + +L +I G + +++ + L N R + V +
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H +H+D+K N+ D NG + ++DFGL ++ + + +D+ +
Sbjct: 146 LHAKGILHKDLKSKNVFYD-NGKVVITDFGL------FSISGVLQAGRREDKLRIQN--- 195
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---------LKKGY 312
G ++APE++ K +
Sbjct: 196 -----------------------------------GWLCHLAPEIIRQLSPDTEEDKLPF 220
Query: 313 GMECDWWSLGAIMYEMLVGYPPF 335
D ++LG I YE+ PF
Sbjct: 221 SKHSDVFALGTIWYELHAREWPF 243
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEV 143
+ +E L IG G +G V + +++ I A+K+++ + G +R E LL E+
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALR-EICLLKEL 58
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESI 202
IV+L+ + L L+ E+ D+ L + + ++ Q + +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H N +HRD+KP NLL+++NG +KL++FGL
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGL 147
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 9e-09
Identities = 34/126 (26%), Positives = 47/126 (37%), Gaps = 31/126 (24%)
Query: 301 YIAPEVLL-KKGYGMECDWWSLGAIMYEML-VGYPPFYADDPITTCRKIVH--------- 349
Y P+VL K Y D WS G I E+ G P F +D ++I
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 350 WRNHLKFPD----------------DSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAH 392
W + K PD KL+ +DL+ LL C+ R+ A + H
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---SAEEALQH 283
Query: 393 PWFKDV 398
P+F D
Sbjct: 284 PYFSDF 289
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 87/371 (23%), Positives = 141/371 (38%), Gaps = 106/371 (28%)
Query: 71 KETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKR 127
K + F+L +++G GA+G V K +G I A+KK++ K R
Sbjct: 3 KRIVYNISSD-------FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR 55
Query: 128 GQVEHVRAERNLLAEVASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL---MR 179
+R E +L I+ ++ SF++ +Y+I E M T L +
Sbjct: 56 T----LR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVIS 105
Query: 180 EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
L+++ +++I Q++ A++ +H N IHRD+KP NLL++ N +K+ DFGL + +D
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID-- 163
Query: 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
A + T M E V T
Sbjct: 164 ESAADNSEPTGQQSGMVE-------------------------------------FVATR 186
Query: 300 DYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW-------- 350
Y APEV+L Y D WS G I+ E+ + P F D I
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 351 ----------RNHLK-------------FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA 386
R ++K FP ++P+ DL+ R+L D R+ A
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPR---VNPKGIDLLQRMLVFDPAKRI---TA 300
Query: 387 HQIKAHPWFKD 397
+ HP+ +
Sbjct: 301 KEALEHPYLQT 311
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 41/157 (26%), Positives = 78/157 (49%), Gaps = 20/157 (12%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH--------VRAE 136
++ + L +G G + V + K + N+ A+K+++ +EH +R E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIR-E 50
Query: 137 RNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQS 195
+LL ++ IV L+ + L L+ EYL D+ L + + + + ++ Q
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + H+ +HRD+KP NLL+++ G +KL+DFGL
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL 146
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 28/126 (22%), Positives = 42/126 (33%), Gaps = 31/126 (24%)
Query: 301 YIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------W 350
Y P++LL Y + D W +G I YEM G P F I W
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225
Query: 351 RNHLKFPD-----------------DSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAH 392
L + +L + DL+ +LL + +R+ A H
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI---SAEDAMKH 282
Query: 393 PWFKDV 398
P+F +
Sbjct: 283 PFFLSL 288
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 25/162 (15%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH--------VRAE 136
F+ L +G G + V K +G A+K++K ++ +R E
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---------LDSEEGTPSTAIR-E 53
Query: 137 RNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL------MREDTLTENVARF 190
+L+ E+ IV+LY L L+ E++ D+ + L N+ ++
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ Q + + H++ +HRD+KP NLL++K G +KL DFGL
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL 154
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 7e-10
Identities = 32/130 (24%), Positives = 44/130 (33%), Gaps = 35/130 (26%)
Query: 301 YIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------W 350
Y AP+VL+ + Y D WS G I+ EM+ G P F + + I W
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 351 RNHLKFPD---------------------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ 388
+ K P L D + LL + + RL A Q
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL---SAKQ 290
Query: 389 IKAHPWFKDV 398
HPWF +
Sbjct: 291 ALHHPWFAEY 300
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 77/306 (25%), Positives = 129/306 (42%), Gaps = 62/306 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
+EL+ +G+GA+G V ++++G + A+KK+ + + R R +L E+
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILTEL 65
Query: 144 ASH-CIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQ 194
+ H IV L + +D +YL+ +Y M T L +R + L ++ + Q
Sbjct: 66 SGHENIVNLLNVLRADNDRD---VYLVFDY-----METDLHAVIRANILEPVHKQYVVYQ 117
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
+ I+ +H +HRD+KP N+LL+ H+K++DFGL + + +I++
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 255 MAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST--VGTPDYIAPEVLLK-KG 311
D T V T Y APE+LL
Sbjct: 178 ENFDDDQP------------------------------ILTDYVATRWYRAPEILLGSTK 207
Query: 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKL----SPEAK 367
Y D WSLG I+ E+L G P F + +I+ + FP + + SP AK
Sbjct: 208 YTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII---GVIDFPSNEDVESIQSPFAK 264
Query: 368 DLICRL 373
+I L
Sbjct: 265 TMIESL 270
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 27/165 (16%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ +IG G+FG V + SG + A+KK+ + + K R E ++ ++ HC
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NR-ELQIMRKL-DHC 107
Query: 148 -IVKLYYSF------QDTEYLYLIMEYLPGGDMMTL--LMRE-----DTLTENVARFYIA 193
IV+L Y F +D YL L+++Y+P T+ + R TL + Y+
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLD 237
Q ++ IH HRDIKP NLLLD + +KL DFG K L
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 32/124 (25%), Positives = 45/124 (36%), Gaps = 30/124 (24%)
Query: 301 YIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------W 350
Y APE++ Y D WS G ++ E+L+G P F D + +I+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 351 R------NHLKFPD----------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHP 393
R KFP + PEA L RLL RL + AH
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHS 338
Query: 394 WFKD 397
+F +
Sbjct: 339 FFDE 342
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 43/151 (28%), Positives = 79/151 (52%), Gaps = 6/151 (3%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAE 142
++ ++ L +G G +G V ++ G I A+K+++ + G +R E +LL E
Sbjct: 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIR-EISLLKE 75
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIES 201
+ IV L L L+ E++ D+ +L + L ++ + Y+ Q + +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H+H +HRD+KP NLL++ +G +KL+DFGL
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGL 165
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 2e-10
Identities = 33/126 (26%), Positives = 43/126 (34%), Gaps = 31/126 (24%)
Query: 301 YIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------W 350
Y AP+VL+ K Y D WS+G I EM+ G P F KI W
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244
Query: 351 RNHLKFPD-----------------DSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAH 392
+ P E DL+ +L D R+ A H
Sbjct: 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI---SARDAMNH 301
Query: 393 PWFKDV 398
P+FKD+
Sbjct: 302 PYFKDL 307
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 49/257 (19%), Positives = 98/257 (38%), Gaps = 56/257 (21%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
I + IG G+FG V + K G++ A+K L + + Q++ + E +L +
Sbjct: 21 IPDGQITVGQRIGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK 76
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV-LAIES 201
I+ L ++ ++ G + L +T E IA+ ++
Sbjct: 77 TRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H + IHRD+K +N+ L ++ +K+ DFGL +T + + +
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL------ATE----KSRWSGSHQFEQL--- 182
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG---YGMECDW 318
G+ ++APEV+ + Y + D
Sbjct: 183 ----------------------------------SGSILWMAPEVIRMQDSNPYSFQSDV 208
Query: 319 WSLGAIMYEMLVGYPPF 335
++ G ++YE++ G P+
Sbjct: 209 YAFGIVLYELMTGQLPY 225
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 82/355 (23%), Positives = 133/355 (37%), Gaps = 109/355 (30%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
+ L +G GA+G V + ++G A+KKL + + ++ RA R LL +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHM 81
Query: 144 ASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQ 194
++ L + D YL+M + M T L M+ + L E+ +F + Q
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
+ + IH IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---------------DSE 181
Query: 255 MAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYG 313
M V T Y APEV+L Y
Sbjct: 182 MTG-------------------------------------YVVTRWYRAPEVILNWMRYT 204
Query: 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV-----------------HWRNHLK- 355
D WS+G IM EM+ G F D + ++I+ +N++K
Sbjct: 205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264
Query: 356 ------------FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+ SP A +L+ ++L D E R+ A + AHP+F+
Sbjct: 265 LPELEKKDFASILTN---ASPLAVNLLEKMLVLDAEQRV---TAGEALAHPYFES 313
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 76/359 (21%), Positives = 126/359 (35%), Gaps = 106/359 (29%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
++ L IG GA G V + A+KKL + + Q RA R L+ V
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---PFQNQTHAKRAYRELVLMKCV 81
Query: 144 ASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
I+ L S ++ + +Y++ME + ++ ++ E L + + Q +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 138
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
I+ +H IHRD+KP N+++ + +K+ DFGL + M
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------------TSFMMTP 185
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
V T Y APEV+L GY D
Sbjct: 186 -------------------------------------YVVTRYYRAPEVILGMGYKENVD 208
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW----------------RNHLK------ 355
WS+G IM EM+ G F D I K++ R +++
Sbjct: 209 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYA 268
Query: 356 -------FPD---------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
FPD + + +A+DL+ ++L D R+ + HP+
Sbjct: 269 GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI---SVDEALQHPYINV 324
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 77/354 (21%), Positives = 129/354 (36%), Gaps = 103/354 (29%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
+ L+ IG GA+G V + + A+KK+ E Q R R +L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ----RTLREIKILLRF 82
Query: 144 ASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQS 195
I+ + + + + +Y++ + M T L ++ L+ + +++ Q
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQI 137
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+ ++ IH N +HRD+KP NLLL+ +K+ DFGL + D D +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD-------------PDHDH 184
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGM 314
+ T+ V T Y APE++L KGY
Sbjct: 185 TGFL--------TEY-------------------------VATRWYRAPEIMLNSKGYTK 211
Query: 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW-----------------RNHLK-- 355
D WS+G I+ EML P F + I+ RN+L
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 271
Query: 356 -----------FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
FP+ +A DL+ ++L + R+ Q AHP+ +
Sbjct: 272 PHKNKVPWNRLFPN---ADSKALDLLDKMLTFNPHKRI---EVEQALAHPYLEQ 319
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 48/150 (32%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEV 143
++ + L IG G +G V + G +A+KK++ E G +R E ++L E+
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIR-EISILKEL 57
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESI 202
IVKLY + L L+ E+L D+ LL + E L A+ ++ Q + I
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H +HRD+KP NLL+++ G +K++DFGL
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGL 146
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 32/125 (25%), Positives = 44/125 (35%), Gaps = 30/125 (24%)
Query: 301 YIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------W 350
Y AP+VL+ K Y D WS+G I EM+ G P F +I W
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 351 RNHLKFPD----------------DSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAHP 393
N + P L DL+ ++L D R+ A Q H
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAKQALEHA 282
Query: 394 WFKDV 398
+FK+
Sbjct: 283 YFKEN 287
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 81/352 (23%), Positives = 136/352 (38%), Gaps = 104/352 (29%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
+ T +G GA+G V +K+SG A+KKL + + ++ RA R LL +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLKHM 80
Query: 144 ASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
++ L S ++ YL+M ++ D+ ++ + +E ++ + Q +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLK 137
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
++ IH +HRD+KP NL ++++ +K+ DFGL + D M
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA---------------DAEMTG 182
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316
V T Y APEV+L Y
Sbjct: 183 -------------------------------------YVVTRWYRAPEVILSWMHYNQTV 205
Query: 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIV-----------------HWRNHLK---- 355
D WS+G IM EML G F D + +I+ +++++
Sbjct: 206 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ 265
Query: 356 ---------FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
FP SP+A DL+ ++L DV+ RL A Q HP+F+
Sbjct: 266 TPRKDFTQLFPRA---SPQAADLLEKMLELDVDKRL---TAAQALTHPFFEP 311
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 25/163 (15%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH---------VR 134
+D + +T +G G +GEV + + A+K+++ +EH +R
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---------LEHEEEGVPGTAIR 82
Query: 135 AERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQ 194
E +LL E+ I++L L+LI EY D+ + + ++ V + ++ Q
Sbjct: 83 -EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKN-----GHMKLSDFGL 232
+ + H +HRD+KP NLLL + +K+ DFGL
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 33/126 (26%), Positives = 42/126 (33%), Gaps = 31/126 (24%)
Query: 301 YIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------W 350
Y PE+LL + Y D WS+ I EML+ P F D I KI W
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262
Query: 351 RNHLKFPD-----------------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392
PD + L E DL+ +L D R+ A H
Sbjct: 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI---SAKNALEH 319
Query: 393 PWFKDV 398
P+F
Sbjct: 320 PYFSHN 325
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 19/179 (10%)
Query: 64 LIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE 123
+ K + E F V +E L IG+G FGEV R +K+G A+KK+ E
Sbjct: 1 MAKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-ME 53
Query: 124 MVKRG-QVEHVRAERNLLAEVASHCIVKLY--------YSFQDTEYLYLIMEYLPGGDMM 174
K G + +R E +L + +V L + +YL+ ++ D+
Sbjct: 54 NEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLA 111
Query: 175 TLL-MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
LL T + + + + + IH++ +HRD+K N+L+ ++G +KL+DFGL
Sbjct: 112 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 29/127 (22%), Positives = 38/127 (29%), Gaps = 33/127 (25%)
Query: 301 YIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------W 350
Y PE+LL ++ YG D W G IM EM P + I W
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253
Query: 351 RNHLKFPD-------------------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390
N + P A DLI +LL D R+ +
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI---DSDDAL 310
Query: 391 AHPWFKD 397
H +F
Sbjct: 311 NHDFFWS 317
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 63/265 (23%), Positives = 107/265 (40%), Gaps = 43/265 (16%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
D++ + +IGRG++G V L +K + A+KK+ + + ++ R R +L +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNRL 82
Query: 144 ASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
S I++LY + LY+++E D+ L LTE + + +L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
IH+ IHRD+KP N LL+++ +K+ DFGL + ++
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN--------------------- 180
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST--VGTPDYIAPEVLLK-KGYGME 315
+ + E + N+ T V T Y APE++L + Y
Sbjct: 181 --------SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232
Query: 316 CDWWSLGAIMYEMLVGYPPFYADDP 340
D WS G I E+L D
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPT 257
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 76/359 (21%), Positives = 125/359 (34%), Gaps = 106/359 (29%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
++ L IG GA G V + A+KKL + + Q RA R L+ V
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---PFQNQTHAKRAYRELVLMKCV 118
Query: 144 ASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
I+ L + ++ + +YL+ME + ++ ++ E L + + Q +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 175
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
I+ +H IHRD+KP N+++ + +K+ DFGL + M
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------------TSFMMTP 222
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
V T Y APEV+L GY D
Sbjct: 223 -------------------------------------YVVTRYYRAPEVILGMGYKENVD 245
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW----------------RNHLK------ 355
WS+G IM EM+ F D I K++ RN+++
Sbjct: 246 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA 305
Query: 356 -------FPD---------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
FPD + + +A+DL+ ++L D R+ HP+
Sbjct: 306 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 361
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 67/360 (18%), Positives = 115/360 (31%), Gaps = 107/360 (29%)
Query: 86 DDFELLTIIGRGAFGEVRLCREK-KSGNIYAMKKLKKSEMVKRGQV--EHV----RAER- 137
+ + I G++G V C G A+K++ + R R R
Sbjct: 22 SPYTVQRFISSGSYGAV--CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 138 -NLLAEVASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARF 190
LL I+ L + LYL+ E + D+ ++ + ++ ++
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY 138
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
++ +L + +H+ +HRD+ P N+LL N + + DF L +
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT------------- 185
Query: 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK- 309
D N V Y APE++++
Sbjct: 186 ADANKTH-------------------------------------YVTHRWYRAPELVMQF 208
Query: 310 KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW-----------------RN 352
KG+ D WS G +M EM F KIV R+
Sbjct: 209 KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARD 268
Query: 353 HLK--------------FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+L+ P P A DLI ++L + + R+ Q HP+F+
Sbjct: 269 YLRNSLSNVPARAWTAVVPT---ADPVALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 31/169 (18%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKS-GNIYAMKKLKKSEMVKRGQVEH---------V 133
+E + IG GA+G+V R+ K+ G A+K+++ V+ +
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---------VQTGEEGMPLSTI 59
Query: 134 RAERNLLAE--VASH-CIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL--MREDTL 183
R E +L H +V+L+ L L+ E++ D+ T L + E +
Sbjct: 60 R-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 184 TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + Q + ++ +H H +HRD+KP N+L+ +G +KL+DFGL
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 35/144 (24%), Positives = 53/144 (36%), Gaps = 27/144 (18%)
Query: 301 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WR 351
Y APEVLL+ Y D WS+G I EM P F + KI+ W
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244
Query: 352 NHLKFPDDS--------------KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396
+ P + + KDL+ + L + R+ A+ +HP+F+
Sbjct: 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQ 301
Query: 397 DVVWDKLYEMEAAFKPEINGELDT 420
D+ K + EL+T
Sbjct: 302 DLERCKENLDSHLPPSQNTSELNT 325
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 70/361 (19%), Positives = 124/361 (34%), Gaps = 113/361 (31%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKL--KKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L +G G G V + A+KK+ + VK +R E ++ +
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA----LR-EIKIIRRLDH 67
Query: 146 HCIVKLY--------------YSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVA 188
IVK++ S + +Y++ EY M T L + + L E A
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLEEHA 122
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEH 247
R ++ Q + ++ IH N +HRD+KP NL ++ ++ +K+ DFGL + +D
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD---------- 172
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
+ + ++ + T Y +P +L
Sbjct: 173 ---PHYSHKGHL--------SEG-------------------------LVTKWYRSPRLL 196
Query: 308 LK-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH----------------W 350
L Y D W+ G I EML G F + + I+
Sbjct: 197 LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI 256
Query: 351 RNHLK-------------FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396
+++ P +S EA D + ++L RL A + +HP+
Sbjct: 257 PVYIRNDMTEPHKPLTQLLPG---ISREAVDFLEQILTFSPMDRL---TAEEALSHPYMS 310
Query: 397 D 397
Sbjct: 311 I 311
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 28/165 (16%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ +IG G+FG V + +S + A+KK V + + R E ++ V H
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEV-AIKK------VLQDKRFKNR-ELQIMRIV-KHP 92
Query: 148 -IVKLYYSF------QDTEYLYLIMEYLPGGDMMTL--LMR-----EDTLTENVARFYIA 193
+V L F +D +L L++EY+P T+ R + T+ + + Y+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLD 237
Q + ++ IH HRDIKP NLLLD G +KL DFG K L
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 33/124 (26%), Positives = 47/124 (37%), Gaps = 30/124 (24%)
Query: 301 YIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------W 350
Y APE++ Y D WS G +M E++ G P F + I +I+
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 351 R------NHLKFPD----------DSKLSPEAKDLICRLL-CDVEHRLGTGGAHQIKAHP 393
+ KFP + P+A DLI RLL RL A + HP
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL---TAIEALCHP 323
Query: 394 WFKD 397
+F +
Sbjct: 324 FFDE 327
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 60/262 (22%), Positives = 113/262 (43%), Gaps = 67/262 (25%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVA-- 144
+E+L +IG+G+FG+V + K A+K ++ + ++ E +R +L +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDN 157
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQSVLAI 199
+ ++ + +F ++ + E L M L L++++ + + R + + +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGH--MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
+++HK+ IH D+KP+N+LL + G +K+ DFG + +EH+ +
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS----------SCYEHQRV------- 256
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ Q + Y APEV+L YGM D
Sbjct: 257 ------------------YTYIQSRF-----------------YRAPEVILGARYGMPID 281
Query: 318 WWSLGAIMYEMLVGYPPFYADD 339
WSLG I+ E+L GYP +D
Sbjct: 282 MWSLGCILAELLTGYPLLPGED 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK----SEMVKR 127
+EF + + + ++ E IG+G FG V R K ++ A+K L E
Sbjct: 5 GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 128 GQVEHVRAERNLLAEVASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN 186
+ + + E +++ + IVKLY ++ME++P GD+ L+ + +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLM---HNPPRMVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 187 VARFYIAQSV-LAIESIHKHNY--IHRDIKPDNLLLDKNG-----HMKLSDFGLCK 234
+ + + L IE + N +HRD++ N+ L K++DFGL +
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 20/83 (24%), Positives = 34/83 (40%), Gaps = 6/83 (7%)
Query: 294 STVGTPDYIAPEVLLKKG--YGMECDWWSLGAIMYEMLVGYPPF--YADDPITTCRKIVH 349
+G ++APE + + Y + D +S I+Y +L G PF Y+ I I
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 350 WRNHLKFPDDSKLSPEAKDLICR 372
P+D P +++I
Sbjct: 245 EGLRPTIPED--CPPRLRNVIEL 265
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+D F++ + G+G FG V+L +EK +G A+KK+ + + +++ ++ LA +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVLH 77
Query: 145 SHCIVKLYYSFQDTE-------YLYLIMEYLPGGD----MMTLLMREDTLTENVARFYIA 193
IV+L F YL ++MEY+P R+ + + ++
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 194 QSVLAIESIHK--HNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLD 237
Q + +I +H N HRDIKP N+L+++ +G +KL DFG K L
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 30/127 (23%), Positives = 46/127 (36%), Gaps = 33/127 (25%)
Query: 301 YIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPI---------------TTC 344
Y APE++ + Y D WS+G I EM++G P F D+
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 345 RKIVHWRNHLKFP-------------DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390
RK+ + K + EA DL+ LL E R+ ++
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM---KPYEAL 313
Query: 391 AHPWFKD 397
HP+F +
Sbjct: 314 CHPYFDE 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 52/284 (18%), Positives = 94/284 (33%), Gaps = 75/284 (26%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--LL 140
+ +D+ +LL +IGRG +G V + A+K + ++ E+N +
Sbjct: 10 LDLDNLKLLELIGRGRYGAV--YKGSLDERPVAVKVFSFANR------QNFINEKNIYRV 61
Query: 141 AEVASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQS 195
+ I + + L+MEY P G + L + + R +A S
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR--LAHS 119
Query: 196 V----------LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
V L +K HRD+ N+L+ +G +SDFGL
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL------------- 166
Query: 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305
+ + + + VGT Y+APE
Sbjct: 167 ----------------------SMRLTGNRLVRPGEEDNAAISE------VGTIRYMAPE 198
Query: 306 VL-------LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPIT 342
VL + + D ++LG I +E+ + + + +
Sbjct: 199 VLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 4e-20
Identities = 66/369 (17%), Positives = 107/369 (28%), Gaps = 71/369 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-- 145
+ ++ +G G F V L + + AMK +K +E E E LL V +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSD 94
Query: 146 ------HCIVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIA 193
+V+L F+ + ++ ++ E L G ++ +++ L + I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 194 QSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
Q + ++ +H IH DIKP+N+LL N S
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
A ++ P K K W + T Y + EVL+ GY
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT---EDIQTRQYRSLEVLIGSGY 270
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH------------------WRNHL 354
D WS + +E+ G F R H +
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330
Query: 355 KFPDDS----------------------KLSPEAKDLICRLLC-----DVEHRLGTGGAH 387
+F + S E L E R A
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA---TAA 387
Query: 388 QIKAHPWFK 396
+ HPW
Sbjct: 388 ECLRHPWLN 396
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 67/384 (17%), Positives = 129/384 (33%), Gaps = 121/384 (31%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVE-----HVR-AERNLL 140
+ L+ +G G F V L ++ + AMK ++ + + E V A+
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 141 AEVASHCIVKLYYSFQ----DTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQ 194
+ ++ I+KL F + ++ ++ E L G +++ L+ + + + + Q
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 195 SVLAIESIHKH-NYIHRDIKPDNLLLD------KNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+L ++ +H+ IH DIKP+N+L++ +K++D G A
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN----------ACWYD 189
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
+ +++ T +Y +PEVL
Sbjct: 190 EHY------------------------------------------TNSIQTREYRSPEVL 207
Query: 308 LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH------------------ 349
L +G D WS +++E++ G F D+ + + H
Sbjct: 208 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRN 267
Query: 350 -------------WRNH--LKFPDDSKLSPEA-----------KDLICRLLC-DVEHRLG 382
RN LKF + E D + +L D R
Sbjct: 268 GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA- 326
Query: 383 TGGAHQIKAHPWFKDVVWDKLYEM 406
A + HPW KD + + +
Sbjct: 327 D--AGGLVNHPWLKDTLGMEEIRV 348
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 9/163 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ + +G G FG+V L + + A+K LK + + E ++L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILR 88
Query: 142 EVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+ I+K L L+MEY+P G + L ++ + Q +
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGM 147
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+H +YIHRD+ N+LLD + +K+ DFGL K + Y
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 15/158 (9%), Positives = 50/158 (31%), Gaps = 3/158 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ LL G + + A+ + ++ ++ + L+ +
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+ ++ ++ E++ GG + + + + + A + A ++ H+
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST-LYAI 244
P + + +G + L+ + + I
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIRGI 188
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 11/82 (13%), Positives = 22/82 (26%), Gaps = 10/82 (12%)
Query: 296 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV-HWRNHL 354
+ P + + D +GA +Y +LV P +
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 355 KFPDD--SKLSPEAKDLICRLL 374
P D + + + R +
Sbjct: 223 IEPADIDRDIPFQISAVAARSV 244
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 48/288 (16%), Positives = 89/288 (30%), Gaps = 85/288 (29%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS---------EMVKRG 128
+ +LL + RG FG V + A+K E+
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLP 73
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
++H N+L + + L+LI + G + L + + ++ N
Sbjct: 74 GMKH----ENILQFIGA-EKRGTSVDVD----LWLITAFHEKGSLSDFL-KANVVSWN-E 122
Query: 189 RFYIAQSV-----------LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+IA+++ ++ HK HRDIK N+LL N ++DFGL +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297
+ + VG
Sbjct: 183 -----------------------------------------AGKSAGDTHGQ------VG 195
Query: 298 TPDYIAPEVL-----LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDP 340
T Y+APEVL ++ + D +++G +++E+
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 10/164 (6%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ L +G+G FG V +CR + +G + A+KKL+ S + E +L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILK 66
Query: 142 EVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLA 198
+ IVK L LIMEYLP G + L + ++ + Y +Q
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+E + YIHRD+ N+L++ +K+ DFGL K L +
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 51/279 (18%), Positives = 82/279 (29%), Gaps = 72/279 (25%)
Query: 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
+ +++ IG+G +GEV + + + G A+K +E E
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE----ASWFRETEIYQT 85
Query: 141 AEVASHCIVKLY----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+ I+ LYLI +Y G + L + TL +A S
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKS-MLKLAYSS 143
Query: 197 ---------LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ K HRD+K N+L+ KNG ++D GL T
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT------- 196
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
+D VGT Y+ PEVL
Sbjct: 197 NEVDIPPNTR--------------------------------------VGTKRYMPPEVL 218
Query: 308 ------LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDP 340
+ D +S G I++E+ +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 50/181 (27%), Positives = 77/181 (42%), Gaps = 18/181 (9%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEM 124
+R T+F + L +G+G FG V +CR + +G + A+KKL+ S
Sbjct: 32 DRDPTQFEE--------RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 83
Query: 125 VKRGQVEHVRAERNLLAEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMT-LLMRED 181
+ E +L + IVK L LIMEYLP G + L ++
Sbjct: 84 ---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 140
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
+ Y +Q +E + YIHRD+ N+L++ +K+ DFGL K L
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
Query: 242 Y 242
Y
Sbjct: 201 Y 201
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 61/366 (16%), Positives = 113/366 (30%), Gaps = 99/366 (27%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVAS- 145
F ++ +G G FG V LC+ + YA+K ++ + + ++E ++L ++ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADILKKIQND 91
Query: 146 ----HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQSV 196
+ IVK + F +++ LI E L +L ++ + + Y + +
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPLG----PSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
A+ + K + H D+KP+N+LLD K + I
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI------ 201
Query: 257 EPMDID---GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313
ID F +D S + T Y APEV+L G+
Sbjct: 202 --KLIDFGCATF-KSDYHGSI---------------------INTRQYRAPEVILNLGWD 237
Query: 314 MECDWWSLGAIMYEMLVGYPPF-------------------------------------- 335
+ D WS G ++ E+ G F
Sbjct: 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297
Query: 336 ----YADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390
A + + D + +L D R ++
Sbjct: 298 DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELL 354
Query: 391 AHPWFK 396
H + +
Sbjct: 355 KHKFLE 360
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 23/162 (14%), Positives = 56/162 (34%), Gaps = 10/162 (6%)
Query: 78 LKRHK-ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAE 136
+ +H I LT + GE+ + + GN +K LK + R + E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEE 57
Query: 137 RNLLAEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA-RFYIA 193
L + ++ + + LI ++P G + +L + + A
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 194 QSV-LAIESIHKHNY--IHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + +H + ++++D++ ++S +
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 5/82 (6%)
Query: 294 STVGTPDYIAPEVLLKKGYGME---CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW 350
+ P ++APE L KK D WS +++E++ PF + K+
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE 226
Query: 351 RNHLKFPDDSKLSPEAKDLICR 372
P +SP L+
Sbjct: 227 GLRPTIPPG--ISPHVSKLMKI 246
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 76/390 (19%), Positives = 130/390 (33%), Gaps = 113/390 (28%)
Query: 67 DLERKETEFMRLKRHKICVDDFELLTI-IGRGAFGEVRLCREK--KSGNIYAMKKLKKSE 123
D + K +R D FE +GRG +G V + K K YA+K+++ +
Sbjct: 4 DYDFKVKLSSERER---VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG 60
Query: 124 MVKRGQVEHVRAERNLLAEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMTLL---- 177
+ + R E LL E+ ++ L + ++L+ +Y D+ ++
Sbjct: 61 I----SMSACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHR 114
Query: 178 -----MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ L + + + Q + I +H + +HRD+KP N+L+ G + G
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER----GR 170
Query: 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLA 292
K I D A + SP + L
Sbjct: 171 VK---------------IADMGFA---------------RLFNSPLKPLADLDPV----- 195
Query: 293 FSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCR------ 345
V T Y APE+LL + Y D W++G I E+L P F+
Sbjct: 196 ---VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252
Query: 346 ---KIVH---------WRNHLKFPD-------------------------DSKLSPEAKD 368
+I + W + K P+ K +A
Sbjct: 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 312
Query: 369 LICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
L+ +LL D R+ + Q P+F +
Sbjct: 313 LLQKLLTMDPIKRI---TSEQAMQDPYFLE 339
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 56/279 (20%), Positives = 84/279 (30%), Gaps = 72/279 (25%)
Query: 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
+ L IG+G FGEV R K G A+K E + AE
Sbjct: 37 QRTIARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQT 90
Query: 141 AEVASHCIVKLYYSFQDTEY----LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+ I+ + L+L+ +Y G + L R T+T +A S
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEG-MIKLALST 148
Query: 197 ---------LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ + K HRD+K N+L+ KNG ++D GL D
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD-------SAT 201
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
TID VGT Y+APEVL
Sbjct: 202 DTIDIAPNHR--------------------------------------VGTKRYMAPEVL 223
Query: 308 LKKG------YGMECDWWSLGAIMYEMLVGYPPFYADDP 340
D +++G + +E+ +
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 64/260 (24%), Positives = 103/260 (39%), Gaps = 69/260 (26%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAE--VA 144
+E+ ++IG+G+FG+V ++ A+K +K K + + Q+E VR +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-VRLLELMNKHDTEM 114
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQSVLAI 199
+ IV L F +L L+ E L L L+R ++ N+ R + Q A+
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLS----YNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 200 ESIH--KHNYIHRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+ + + IH D+KP+N+LL K +K+ DFG S + + I
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-------S---SCQLGQRI----- 215
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315
+ Q + Y +PEVLL Y +
Sbjct: 216 --------------------YQYIQSRF-----------------YRSPEVLLGMPYDLA 238
Query: 316 CDWWSLGAIMYEMLVGYPPF 335
D WSLG I+ EM G P F
Sbjct: 239 IDMWSLGCILVEMHTGEPLF 258
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 17/181 (9%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEM 124
E T F + + + +G G FG+V LCR G+ A+K LK
Sbjct: 12 EVDPTHFEK--------RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG 63
Query: 125 VKRGQVEHVRAERNLLAEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMT-LLMRED 181
+ ++ E +L + IVK + + LIME+LP G + L ++
Sbjct: 64 GN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
+ Y Q ++ + Y+HRD+ N+L++ +K+ DFGL K ++
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 242 Y 242
Y
Sbjct: 182 Y 182
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 53/274 (19%), Positives = 81/274 (29%), Gaps = 74/274 (27%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D LL +G+G +GEV + G A+K + + + L H
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVML-----RH 61
Query: 147 -CIVKLY----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV----- 196
I+ S + L+LI Y G + L + TL I S+
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVS-CLRIVLSIASGLA 119
Query: 197 ----LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
+ K HRD+K N+L+ KNG ++D GL +D
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS-------QSTNQLDV 172
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL----- 307
N VGT Y+APEVL
Sbjct: 173 GNNPR--------------------------------------VGTKRYMAPEVLDETIQ 194
Query: 308 -LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDP 340
D W+ G +++E+ +
Sbjct: 195 VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 45/186 (24%), Positives = 72/186 (38%), Gaps = 37/186 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKL---------------------------- 119
+ L +G G+FG V + +SG +A+KK+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 120 ---KKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD---- 172
E K Q + ++ + + +YL +IMEY+P
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 173 MMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFG 231
+ + + ++ N+ YI Q A+ IH HRDIKP NLL++ K+ +KL DFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 232 LCKPLD 237
K L
Sbjct: 188 SAKKLI 193
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 27/124 (21%), Positives = 48/124 (38%), Gaps = 30/124 (24%)
Query: 301 YIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------- 349
Y APE++L Y D WS+G + E+++G P F + I +I+
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266
Query: 350 -----WRNHLKFPDDSKLS----------PEAKDLICRLLC-DVEHRLGTGGAHQIKAHP 393
++FP A DL+ ++L + + R+ ++ AHP
Sbjct: 267 IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHP 323
Query: 394 WFKD 397
+F
Sbjct: 324 FFDH 327
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 49/180 (27%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 70 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEMV 125
+ T F + ++ +G+G FG V LCR G+ A+K+L+ S
Sbjct: 15 QDPTIFEE--------RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD 66
Query: 126 KRGQVEHVRAERNLLAEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMT-LLMREDT 182
Q + E +L + S IVK + L L+MEYLP G + L
Sbjct: 67 ---QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR 123
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
L + Y +Q +E + +HRD+ N+L++ H+K++DFGL K L Y
Sbjct: 124 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 65/367 (17%), Positives = 121/367 (32%), Gaps = 103/367 (28%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIY-AMKKLK-KSEMVKRGQVEHVRAERNLLAEVA- 144
+E++ +G G FG+V C + G A+K ++ + + ++E N+L ++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-----INVLKKIKE 75
Query: 145 -----SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQ 194
V + F ++ + E L ++E+ R Q
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELLG----KNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
A+ +H++ H D+KP+N+L + L + +I + D
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI---RVAD--- 185
Query: 255 MAEPMDIDG--CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
G F D ++ ++ V T Y PEV+L+ G+
Sbjct: 186 -------FGSATF-DHEHHTTI---------------------VATRHYRPPEVILELGW 216
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADD-------------PI------------------ 341
CD WS+G I++E G+ F + PI
Sbjct: 217 AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGG 276
Query: 342 ----TTCRKIVHWRNHLK-----FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391
+ + + K DS + DL+ R+L D R+ +
Sbjct: 277 LVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI---TLAEALL 333
Query: 392 HPWFKDV 398
HP+F +
Sbjct: 334 HPFFAGL 340
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 39/179 (21%), Positives = 71/179 (39%), Gaps = 40/179 (22%)
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRA 135
M + + + +++ IG G+FG + + A+K E R+
Sbjct: 1 MSGQNNVVG-VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRS 47
Query: 136 ERNLLAE--------VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV 187
+ L + I +YY Q+ + L+++ L G + ED L
Sbjct: 48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL------EDLLDLCG 100
Query: 188 ARF------YIA-QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK-----LSDFGLCK 234
+F A Q + ++SIH+ + ++RDIKPDN L+ + + DFG+ K
Sbjct: 101 RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 33/164 (20%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE----- 142
F + IG G FGE+RL + + A+K +E +++ L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFY 58
Query: 143 ---VASHCIVKLYYSFQDTEYLYLIMEYLPGG----DMMTLLMREDTLTENVARFYIAQS 195
+ I ++YY +Y +++E L G D+ L R +L + V I Q
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL-KTVLMIAI-QL 114
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMK-----LSDFGLCK 234
+ +E +H N I+RD+KP+N L+ + G+ + DF L K
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 29/161 (18%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER-NLLAEVA-- 144
+ L IG G+FG++ L + +G A+K E V+ + L E
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIY 58
Query: 145 -----SHCIVKLYYSFQDTEYLYLIMEYLPG---GDMMTLLMREDTLTENVARFYIAQSV 196
I + + + +Y ++ME L G D+ R+ +L + V Q +
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL-KTVLLLAD-QMI 115
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMK---LSDFGLCK 234
IE IH N+IHRD+KPDN L+ + DFGL K
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 3/166 (1%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+D L IGRG FGEV R + + A+K +++ E +L + +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSH 171
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESIHK 204
IV+L + +Y++ME + GGD +T L L + + +E +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
IHRD+ N L+ + +K+SDFG+ + A + +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV 277
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 67/365 (18%), Positives = 130/365 (35%), Gaps = 103/365 (28%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGN-IYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVA- 144
+E++ +G GAFG+V C + K+G A+K +K + + E +L +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNT 70
Query: 145 -----SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQ 194
+ V++ F+ ++ ++ E L ++ ++E+ + R Q
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELLG----LSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
++ +H + H D+KP+N+L ++ + + + + + I K +D
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI---KVVD--- 180
Query: 255 MAEPMDIDG--CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
G + D ++ S+ V T Y APEV+L G+
Sbjct: 181 -------FGSATY-DDEHHSTL---------------------VSTRHYRAPEVILALGW 211
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADD-------------PI------TTCRKIVHWRNH 353
CD WS+G I+ E +G+ F D P+ T ++ +
Sbjct: 212 SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDR 271
Query: 354 LKFPDDSKLS---------------------PEAKDLICRLLC-DVEHRLGTGGAHQIKA 391
L + + S DLI ++L D R+ +
Sbjct: 272 LDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI---TLREALK 328
Query: 392 HPWFK 396
HP+F
Sbjct: 329 HPFFD 333
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 54/249 (21%), Positives = 95/249 (38%), Gaps = 54/249 (21%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ D + +G G +GEV KK A+K LK+ M +VE E ++ E
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 272
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIE 200
+ +V+L Y+I E++ G+++ L ++ V + Q A+E
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+ K N+IHR++ N L+ +N +K++DFGL + + D A
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-------------GDTYTAHA-- 377
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
FP W APE L + ++ D W+
Sbjct: 378 -GAKFP-----IKW---------------------------TAPESLAYNKFSIKSDVWA 404
Query: 321 LGAIMYEML 329
G +++E+
Sbjct: 405 FGVLLWEIA 413
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 37/169 (21%), Positives = 71/169 (42%), Gaps = 22/169 (13%)
Query: 86 DDFELLTIIGRGAFGEV---RLCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLA 141
+F+ + ++G GAFG V E + I A+K+L+++ K A + +L
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--------ANKEILD 66
Query: 142 EVA-----SH-CIVKLY-YSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIA 193
E + + +L T + LI + +P G ++ + +D + +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
Q + + +HRD+ N+L+ H+K++DFGL K L
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 29/162 (17%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAE-RNLLAEVA-- 144
F L IG G+FGE+ L ++ A+K E+V+ + LL E
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIY 56
Query: 145 -----SHCIVKLYYSFQDTEYLYLIMEYLPG---GDMMTLLMREDTLTENVARFYIAQSV 196
I + + + +Y L+M+ L G D+ R+ +L + V Q +
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL-KTVLMLAD-QMI 113
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMK---LSDFGLCKP 235
+E +H +++HRDIKPDN L+ + DFGL K
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 3e-17
Identities = 59/283 (20%), Positives = 105/283 (37%), Gaps = 65/283 (22%)
Query: 56 VPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYA 115
+ L + E R + L +G+G FGEV + + + A
Sbjct: 245 TVCPTSKPQTQGLAKDAWEIPR--------ESLRLEVKLGQGCFGEVWMGTWNGTTRV-A 295
Query: 116 MKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT 175
+K LK M E E ++ ++ +V+LY + E +Y++ EY+ G ++
Sbjct: 296 IKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 350
Query: 176 LLMREDTLTENVARF--YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
L E + + AQ + + + NY+HRD++ N+L+ +N K++DFGL
Sbjct: 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
+ ++ + A K FP K W
Sbjct: 411 RLIEDNEYTARQGAK----------------FP-------IK--------W--------- 430
Query: 294 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 335
APE L + ++ D WS G ++ E+ G P+
Sbjct: 431 --------TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 59/283 (20%), Positives = 105/283 (37%), Gaps = 65/283 (22%)
Query: 56 VPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYA 115
+ L + E R + L +G+G FGEV + + + A
Sbjct: 162 TVCPTSKPQTQGLAKDAWEIPR--------ESLRLEVKLGQGCFGEVWMGTWNGTTRV-A 212
Query: 116 MKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT 175
+K LK M E E ++ ++ +V+LY + E +Y++ EY+ G ++
Sbjct: 213 IKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 267
Query: 176 LLMREDTLTENVARF--YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
L E + + AQ + + + NY+HRD++ N+L+ +N K++DFGL
Sbjct: 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
+ ++ + A K FP K W
Sbjct: 328 RLIEDNEYTARQGAK----------------FP-------IK--------W--------- 347
Query: 294 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 335
APE L + ++ D WS G ++ E+ G P+
Sbjct: 348 --------TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
+ ++ L+ +G GA+G V + K+G A+KKL + + + R R LL +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLKHM 85
Query: 144 ASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQ 194
++ L S ++ +YL+ M L ++ LT++ +F I Q
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ ++ IH + IHRD+KP NL ++++ +K+ DFGL +
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 36/134 (26%), Positives = 52/134 (38%), Gaps = 38/134 (28%)
Query: 296 VGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW---- 350
V T Y APE++L Y D WS+G IM E+L G F D I + I+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249
Query: 351 -------------RNHLK-------------FPDDSKLSPEAKDLICRLLC-DVEHRLGT 383
RN+++ F +P A DL+ ++L D + R+
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIG---ANPLAVDLLEKMLVLDSDKRI-- 304
Query: 384 GGAHQIKAHPWFKD 397
A Q AH +F
Sbjct: 305 -TAAQALAHAYFAQ 317
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 10/168 (5%)
Query: 86 DDFELLTIIGRGAFGEV---RLCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLA 141
+F+ + ++G GAFG V E + I A+K+L+++ K + + E ++A
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 72
Query: 142 EVASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLAI 199
V + + +L T + LI + +P G ++ + +D + + Q +
Sbjct: 73 SVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ +HRD+ N+L+ H+K++DFGL K L E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 38/156 (24%), Positives = 64/156 (41%), Gaps = 5/156 (3%)
Query: 86 DDFELLTIIGRGAFGEVR--LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAE 142
D LL +G G+FG VR + A+K LK + + ++ E N +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLAIES 201
+ +++LY T + ++ E P G ++ L + Y Q +
Sbjct: 78 LDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ +IHRD+ NLLL +K+ DFGL + L
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 28/169 (16%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ L IG G FG + L A +K E + G + E VA
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFS---ELKFYQRVAKKD 94
Query: 148 IV---------------KLYYS----FQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
+ Y S F+ Y +++ME L G D+ + + T ++
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV 153
Query: 189 RFYIA-QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK--LSDFGLCK 234
+ + + +E IH++ Y+H DIK NLLL + L+D+GL
Sbjct: 154 -LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 36/173 (20%), Positives = 66/173 (38%), Gaps = 33/173 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNI-----YAMKKLKK--------SEMVKRGQVEHVR 134
+++ IG+G FG + L S ++ +K + +R
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 135 AERNLLAEVASHCIVKLYYS----FQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF 190
+ ++ + K + S Y ++IM+ G D+ + N RF
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL------QKIYEANAKRF 149
Query: 191 ------YIA-QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK--LSDFGLCK 234
++ + + +E IH+H Y+H DIK NLLL+ + L D+GL
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 4/147 (2%)
Query: 93 IIGRGAFGEVR--LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
+G G FG V+ + KK A+K LK + E + E N++ ++ + IV+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVR 82
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
+ + E L+ME G + L + + + + Q + ++ + + N++HR
Sbjct: 83 MI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLD 237
D+ N+LL + K+SDFGL K L
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALR 168
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 31/148 (20%), Positives = 61/148 (41%), Gaps = 6/148 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + IG G FG V L + A+K +++ M E E ++ +++
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHK 204
+V+LY + + L+ E++ G + L + + + +
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
IHRD+ N L+ +N +K+SDFG+
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGM 150
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 32/168 (19%), Positives = 66/168 (39%), Gaps = 10/168 (5%)
Query: 86 DDFELLTIIGRGAFGEVR---LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ L ++G G FG V E +S I +K ++ + + V +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIG 70
Query: 142 EVASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLAI 199
+ IV+L + L L+ +YLP G ++ + L + + Q +
Sbjct: 71 SLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ +H +HR++ N+LL ++++DFG+ L ++
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D + +G G +GEV KK A+K LK+ M +VE E ++ E+
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIH 203
+V+L Y+I E++ G+++ L ++ V + Q A+E +
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
K N+IHRD+ N L+ +N +K++DFGL
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGL 157
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 30/186 (16%)
Query: 56 VPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYA 115
ME + + R + +LL IG+G FG+V L + GN A
Sbjct: 171 KVMEGTVAAQDEFYRSGWALNM--------KELKLLQTIGKGEFGDVMLGDYR--GNKVA 220
Query: 116 MKKLKKSEMVKRGQVEHVRAERNLLAEVA-----SH-CIVKLY-YSFQDTEYLYLIMEYL 168
+K +K + LAE + H +V+L ++ LY++ EY+
Sbjct: 221 VKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 169 PGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226
G ++ L L + + A+E + +N++HRD+ N+L+ ++ K
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 329
Query: 227 LSDFGL 232
+SDFGL
Sbjct: 330 VSDFGL 335
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 2e-15
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 7/165 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEVR--LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNL 139
I + EL IG G FG+V + ++ + A+K K E E
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALT 444
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLA 198
+ + IVKL + +++IME G++ + L +R+ +L Y Q A
Sbjct: 445 MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
+ + ++HRDI N+L+ N +KL DFGL + ++ ST Y
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 18/160 (11%)
Query: 83 ICVDDFELLTIIGRGAFGEVR--LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNL 139
I + IIG G GEV R ++ A+K LK + R+
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--------QRRDF 97
Query: 140 LAEVA-----SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYI 192
L+E + H I++L ++ EY+ G + T L + T +
Sbjct: 98 LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + Y+HRD+ N+L+D N K+SDFGL
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 7/165 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNL 139
I + EL IG G FG+V N A+K K E E
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALT 69
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLA 198
+ + IVKL + +++IME G++ + L +R+ +L Y Q A
Sbjct: 70 MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
+ + ++HRDI N+L+ N +KL DFGL + ++ ST Y
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 30/184 (16%)
Query: 58 MEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMK 117
M + + R + +LL IG+G FG+V L + GN A+K
Sbjct: 1 MGGSVAAQDEFYRSGWALNM--------KELKLLQTIGKGEFGDVMLGDYR--GNKVAVK 50
Query: 118 KLKKSEMVKRGQVEHVRAERNLLAEVA-----SHC-IVKLY-YSFQDTEYLYLIMEYLPG 170
+K + LAE + H +V+L ++ LY++ EY+
Sbjct: 51 CIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99
Query: 171 GDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228
G ++ L L + + A+E + +N++HRD+ N+L+ ++ K+S
Sbjct: 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS 159
Query: 229 DFGL 232
DFGL
Sbjct: 160 DFGL 163
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 5e-15
Identities = 47/154 (30%), Positives = 70/154 (45%), Gaps = 7/154 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEVR--LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNL 139
I +D L I+G G FGEV + K I A+K KK + E +E +
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVI 66
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLA 198
+ + IVKL + E ++IME P G++ L R +++L Y Q A
Sbjct: 67 MKNLDHPHIVKLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + N +HRDI N+L+ +KL DFGL
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 8/163 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
I + +L +G G FGEV + K + A+K +K M VE AE N++
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKT 239
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIE 200
+ +VKL+ E +Y+I E++ G ++ L ++ + + + + AQ +
Sbjct: 240 LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
I + NYIHRD++ N+L+ + K++DFGL + ++ + A
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 7e-15
Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 12/176 (6%)
Query: 66 KDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVR---LCREKKSGNIYAMKKLKKS 122
D E + + + LKR + + D EL G G FG VR KK ++ A+K LK+
Sbjct: 320 SDPEELKDKKLFLKRDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDV-AIKVLKQG 374
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMRED 181
E + E ++ ++ + IV+L E L L+ME GG + L+ + +
Sbjct: 375 TEKA--DTEEMMREAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKRE 431
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ + + Q + ++ + + N++HR++ N+LL + K+SDFGL K L
Sbjct: 432 EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 8e-15
Identities = 35/151 (23%), Positives = 68/151 (45%), Gaps = 12/151 (7%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D L +G G FG V+ + + ++ A+K +K+ M + E ++ ++
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA----IES 201
+V+LY +++I EY+ G ++ L + + + V +ES
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++HRD+ N L++ G +K+SDFGL
Sbjct: 139 ---KQFLHRDLAARNCLVNDQGVVKVSDFGL 166
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 37/148 (25%), Positives = 70/148 (47%), Gaps = 6/148 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
++ LL +G G FG V+L + K ++ A+K +K+ M + E + +++
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV-LAIESIHK 204
+VK Y +Y++ EY+ G ++ L E + V + +
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H +IHRD+ N L+D++ +K+SDFG+
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGM 150
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 6/151 (3%)
Query: 86 DDFELLTIIGRGAFGEVR--LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ + ++G G FGEV + I A+K LK K Q E +++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIMGQ 102
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIES 201
I++L ++ + ++ EY+ G + + L + T + ++
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ Y+HRD+ N+L++ N K+SDFGL
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 21/171 (12%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIY--AMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
+D + +IG G FG+V R KK G A+K++K+ E +L ++
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 82
Query: 144 ASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIE 200
H I+ L + + YLYL +EY P G+++ L R A S L+ +
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 201 SIHK--------------HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ +IHRD+ N+L+ +N K++DFGL + +
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 193
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 38/155 (24%), Positives = 65/155 (41%), Gaps = 7/155 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEV---RLCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERN 138
I +IG G FGEV L + A+K LK K Q E
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAG 98
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVL 197
++ + + H I++L + + +I EY+ G + L ++ + +
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++ + NY+HRD+ N+L++ N K+SDFGL
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 34/205 (16%)
Query: 51 LASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR---- 106
+ ++P++E + + + EF R D +L +GRGAFG+V
Sbjct: 1 MDPDELPLDEHCERLP-YDASKWEFPR--------DRLKLGKPLGRGAFGQVIEADAFGI 51
Query: 107 -EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLY-YSFQDTEYLYL 163
+ + A+K LK+ + + +E +L + H +V L + L +
Sbjct: 52 DKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 109
Query: 164 IMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIESIHK--------------HNY 207
I+E+ G++ T L R + + VA + + L +E +
Sbjct: 110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC 169
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGL 232
IHRD+ N+LL + +K+ DFGL
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGL 194
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 28/173 (16%), Positives = 59/173 (34%), Gaps = 33/173 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNI--------YAMKKLKKSEMVKRGQVEHVRAERNL 139
++L + R G + + +++K K + Q RA + L
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 140 -------LAEVASHCIVKLYYS-FQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
L I +Y +L++ L G + + L +
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSL------QSALDVSPKHVL 156
Query: 192 IAQSVL--------AIESIHKHNYIHRDIKPDNLLLDKNGHMK--LSDFGLCK 234
+SVL A+E +H++ Y+H ++ +N+ +D + L+ +G
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 46/208 (22%), Positives = 85/208 (40%), Gaps = 34/208 (16%)
Query: 49 RKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEV------ 102
R +++D PM ++ + E + EF R D L +G G FG+V
Sbjct: 52 RLSSTADTPMLAGVSEYELPEDPKWEFPR--------DKLTLGKPLGEGCFGQVVMAEAV 103
Query: 103 RLCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEY 160
+ ++K + A+K LK K + + +E ++ + H I+ L +
Sbjct: 104 GIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161
Query: 161 LYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIESIHK-------------- 204
LY+I+EY G++ L R + + + + + + +
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
IHRD+ N+L+ +N MK++DFGL
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGL 249
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 22/167 (13%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLL 140
++ + +G GAFG+V K+ + A+K LK + + E + +E ++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIM 103
Query: 141 AEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+ + H IV L + + +I EY GD++ L R+ + E F IA S +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 200 ESIHK--------------HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ N IHRD+ N+LL K+ DFGL
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 32/171 (18%), Positives = 69/171 (40%), Gaps = 25/171 (14%)
Query: 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY-------AMKKLKKSEMVKRGQVEHV 133
HKI +D +G+G F ++ ++ G+ +K L K+ E
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESF 59
Query: 134 RAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA 193
+++++++ +V Y + L+ E++ G + T L + + + +A
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 194 QSVLA----IESIHKHNYIHRDIKPDNLLLDK--------NGHMKLSDFGL 232
+ + A +E + IH ++ N+LL + +KLSD G+
Sbjct: 120 KQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 34/209 (16%)
Query: 48 ERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEV----- 102
S PM ++ + E + EF R D L +G GAFG+V
Sbjct: 5 HHHHHHSQDPMLAGVSEYELPEDPKWEFPR--------DKLTLGKPLGEGAFGQVVMAEA 56
Query: 103 -RLCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTE 159
+ ++K + A+K LK K + + +E ++ + H I+ L +
Sbjct: 57 VGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 160 YLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHK------------- 204
LY+I+EY G++ L R + + + + + + +
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 174
Query: 205 -HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
IHRD+ N+L+ +N MK++DFGL
Sbjct: 175 SQKCIHRDLAARNVLVTENNVMKIADFGL 203
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 10/163 (6%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY--AMKKLKKSEMVKRGQVEHVRA 135
LKR + + D EL G G FG VR + A+K LK+ E +
Sbjct: 6 LKRDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 59
Query: 136 ERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQ 194
E ++ ++ + IV+L E L L+ME GG + L+ + + + + Q
Sbjct: 60 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ ++ + + N++HRD+ N+LL + K+SDFGL K L
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 32/165 (19%), Positives = 67/165 (40%), Gaps = 7/165 (4%)
Query: 89 ELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+IGRG FG V + A+K L + + +V E ++ + +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 85
Query: 146 HCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIH 203
++ L + +++ Y+ GD+ + E T + Q ++ +
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
++HRD+ N +LD+ +K++DFGL + + Y++H
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ +L+ +G G FGEV + + A+K LK+ M + AE NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIH 203
+V+LY + E +Y+I EY+ G ++ L LT N AQ + I
Sbjct: 68 QRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ NYIHRD++ N+L+ K++DFGL
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGL 155
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 35/184 (19%), Positives = 78/184 (42%), Gaps = 10/184 (5%)
Query: 70 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVK 126
E + + + ++ +IG+G FG V A+K L + ++
Sbjct: 8 LAEVKDVLIPHERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64
Query: 127 RGQVEHVRAERNLLAEVASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLT 184
QVE E L+ + ++ L ++++ Y+ GD++ + + T
Sbjct: 65 --QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244
+ Q +E + + ++HRD+ N +LD++ +K++DFGL + + Y++
Sbjct: 123 VKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182
Query: 245 HEHK 248
+H+
Sbjct: 183 QQHR 186
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 26/171 (15%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLL 140
+ +G GAFG+V K + A+K LK S + + E + +E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 141 AEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVL 197
+ + +H IV L + +I EY GD++ L R+ + + + L
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 198 AIES----------------IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
A++ + N IHRD+ N+LL K+ DFGL
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 51/224 (22%), Positives = 85/224 (37%), Gaps = 40/224 (17%)
Query: 38 QERKERRWVLERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRG 97
Q R E + + + SSD ++ + + EF R + E ++G G
Sbjct: 6 QFRYESQLQMVQVTGSSD-NEYFYVDFREYEYDLKWEF---PRENL-----EFGKVLGSG 56
Query: 98 AFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKL 151
AFG+V K +I A+K LK+ + E + +E ++ ++ SH IV L
Sbjct: 57 AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNL 114
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK------- 204
+ + +YLI EY GD++ L + Y Q L E
Sbjct: 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174
Query: 205 ----------------HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ +HRD+ N+L+ +K+ DFGL
Sbjct: 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 18/163 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAE 142
F L ++G+G FG VR + K+ + A+K LK + +E E + E
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKE 81
Query: 143 VASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+ KL + +I+ ++ GD+ L + EN + V
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLV 140
Query: 197 LAIESIHK-------HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ I N+IHRD+ N +L ++ + ++DFGL
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 26/156 (16%)
Query: 93 IIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA----- 144
+G G FG V + + A+KKL + + ++ E+
Sbjct: 38 KMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEE-----LKQQFDQEIKVMAKC 87
Query: 145 SH-CIVKLY-YSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTEN-VARFYIAQSVLA-- 198
H +V+L +S + L+ Y+P G ++ L + T + R IAQ A
Sbjct: 88 QHENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA-ANG 145
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
I +H++++IHRDIK N+LLD+ K+SDFGL +
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR 181
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 30/149 (20%), Positives = 61/149 (40%), Gaps = 7/149 (4%)
Query: 89 ELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+IGRG FG V + A+K L + + +V E ++ + +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 149
Query: 146 HCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIH 203
++ L + +++ Y+ GD+ + E T + Q ++ +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++HRD+ N +LD+ +K++DFGL
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGL 238
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 36/177 (20%), Positives = 66/177 (37%), Gaps = 17/177 (9%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ L I+G G FG V K+ A+K +K +R E + E + +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKD 92
Query: 143 VASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
+ +++L S Q +I+ ++ GD+ T L L + +
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLK 151
Query: 198 AIESIHK-------HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ I N++HRD+ N +L + + ++DFGL K + Y
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI 208
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 40/206 (19%), Positives = 77/206 (37%), Gaps = 29/206 (14%)
Query: 48 ERKLASSDVPMEEQINLIKDLERKETEFMR-LKRHKICVDDFELLTIIGRGAFGEVRLCR 106
+ Q ++I++ + + +KR I L +G GAFG+V L
Sbjct: 7 SSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDI-----VLKWELGEGAFGKVFLAE 61
Query: 107 ----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161
+ + A+K LK++ R + + E LL + IV+ + + L
Sbjct: 62 CHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 162 YLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESIHK--------------HN 206
++ EY+ GD+ L +A L + + +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGL 232
++HRD+ N L+ + +K+ DFG+
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGM 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 40/171 (23%), Positives = 69/171 (40%), Gaps = 26/171 (15%)
Query: 86 DDFELLTIIGRGAFGEVRLCR-------EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
D L +G GAFG+V L + A+K LK K + + +E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 139 LLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQS 195
++ + H I+ L + LY+I+EY G++ L R L + + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 196 VLAIESIHK--------------HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
L+ + + IHRD+ N+L+ ++ MK++DFGL
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 28/162 (17%), Positives = 69/162 (42%), Gaps = 17/162 (10%)
Query: 86 DDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
+ + +G+G+FG V + + A+K + ++ ++ + E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVL-- 197
E H +V+L + +IME + GD+ + L + N + S +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 198 -------AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ ++ + ++HRD+ N ++ ++ +K+ DFG+
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 42/182 (23%), Positives = 68/182 (37%), Gaps = 41/182 (22%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEH 132
+KR I L +G GAFG+V L + A+K LK +
Sbjct: 12 IKRRDI-----VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-------- 58
Query: 133 VRAERNLLAEVA-----SHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM--REDTLT 184
A ++ E H IVK Y D + L ++ EY+ GD+ L D +
Sbjct: 59 -AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 117
Query: 185 ENVARFYIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDKNGHMKLSDF 230
+ A+ L + + +++HRD+ N L+ N +K+ DF
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 231 GL 232
G+
Sbjct: 178 GM 179
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 86 DDFELLTIIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
++F+ +IG G FG+V L + G A+K+ +G E E L+
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVL----RDGAKVALKRRTPES--SQGIEE-FETEIETLSF 91
Query: 143 VASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN---VARFYIA-QSVL 197
+V L + + E + LI +Y+ G++ L D T + R I +
Sbjct: 92 CRHPHLVSLIGFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ +H IHRD+K N+LLD+N K++DFG+ K
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 47/205 (22%), Positives = 79/205 (38%), Gaps = 39/205 (19%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGN 112
P+ ++ K LE + EF R + L +G G FG+V + ++G
Sbjct: 2 PLSLSVDAFKILEDPKWEFPR--------KNLVLGKTLGEGEFGKVVKATAFHLKGRAGY 53
Query: 113 IY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171
A+K LK++ ++ + +E N+L +V ++KLY + L LI+EY G
Sbjct: 54 TTVAVKMLKENASPS--ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 172 DMMTLLM--REDTLTENVARFYIAQSVLAIESIHK----------------------HNY 207
+ L R+ + S L
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGL 232
+HRD+ N+L+ + MK+SDFGL
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGL 196
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 51/170 (30%), Positives = 73/170 (42%), Gaps = 32/170 (18%)
Query: 86 DDFELLTIIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
D+F I+GRG FG+V RL G + A+K+LK +R Q E E
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRL----ADGTLVAVKRLK----EERTQ----GGELQFQTE 77
Query: 143 V-----ASH-CIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV---ARFYI 192
V A H +++L + TE L L+ Y+ G + + L + R I
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 193 AQSV---LAI--ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
A LA + IHRD+K N+LLD+ + DFGL K +D
Sbjct: 137 ALGSARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 33/176 (18%), Positives = 56/176 (31%), Gaps = 28/176 (15%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEH 132
+ + + +G FG+V A+K LK E
Sbjct: 6 ISLSAV-----RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREE 58
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARF 190
R E L A + +V L + L +I Y GD+ L + +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 191 YIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+S L H+ +H+D+ N+L+ ++K+SD GL
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 39/205 (19%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGN 112
PM +++ L+ + + E+ R+ I E + IG GAFG V R
Sbjct: 26 PMYQRMPLLLNPKLLSLEY---PRNNI-----EYVRDIGEGAFGRVFQARAPGLLPYEPF 77
Query: 113 IY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171
A+K LK+ + E L+AE + IVKL + + L+ EY+ G
Sbjct: 78 TMVAVKMLKEEASAD--MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYG 135
Query: 172 DMMTLLM--REDTLTENVARFYIAQSVLAIESIHK----------------------HNY 207
D+ L T+ ++ ++ +
Sbjct: 136 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 195
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGL 232
+HRD+ N L+ +N +K++DFGL
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGL 220
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 34/162 (20%), Positives = 66/162 (40%), Gaps = 17/162 (10%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLL 140
+ L+ +G GAFGEV + + A+K L + + E ++
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV-LAI 199
++ IV+ + +++ME + GGD+ + L + + + +A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 200 ------ESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGL 232
+ + ++++IHRDI N LL G K+ DFG+
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 33/162 (20%), Positives = 62/162 (38%), Gaps = 17/162 (10%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLL 140
+ L+ +G GAFGEV + + A+K L + + E ++
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
++ IV+ + ++++E + GGD+ + L + + +
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 201 SIHK-------HNYIHRDIKPDNLLLDKNGH---MKLSDFGL 232
I +++IHRDI N LL G K+ DFG+
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 37/191 (19%), Positives = 68/191 (35%), Gaps = 22/191 (11%)
Query: 56 VPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR-----EKKS 110
+P++E + + + EF R D +L +GRGAFG+V + +
Sbjct: 1 LPLDEHCERL-PYDASKWEFPR--------DRLKLGKPLGRGAFGQVIEADAFGIDKTAT 51
Query: 111 GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLY-YSFQDTEYLYLIMEYL 168
A+K LK+ + + +E +L + H +V L + L +I+E+
Sbjct: 52 CRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 109
Query: 169 PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228
G++ T L + Y + + I D+K + + S
Sbjct: 110 KFGNLSTYLRSKRNEFVP----YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS 165
Query: 229 DFGLCKPLDCS 239
F K L
Sbjct: 166 GFVEEKSLSDV 176
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 2e-09
Identities = 34/200 (17%), Positives = 60/200 (30%), Gaps = 48/200 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL-----KKSEMVKRGQVEHVRAERNLL 140
+ + IG G FGEV A+K + + E + E +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 141 AEVA-----------------SHCIVKLYY----------------------SFQDTEYL 161
E++ S V+ Y F + L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLD 220
++++E+ GG + MR + A+ + Q ++ + HRD+ N+LL
Sbjct: 138 FIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 221 KNGHMKLSDFGLCKPLDCST 240
K KL K +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPS 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 9e-05
Identities = 56/439 (12%), Positives = 131/439 (29%), Gaps = 110/439 (25%)
Query: 14 LTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERKET 73
L ++ + + +E ++ + + + W R SS++ + I ++ +
Sbjct: 187 LNLKNCNSPETVLE-----MLQKLLYQIDPNWT-SRSDHSSNIKLR-----IHSIQAELR 235
Query: 74 EFMRLKRHKIC---VDDFELLTIIGRGAFGEVRLC------REKKSGNIYAMKKLKKSEM 124
++ K ++ C + + + AF + C R K+ + + +
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAW--NAF-NLS-CKILLTTRFKQVTDFLSAATTTHISL 291
Query: 125 VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLT 184
++LL + L T L ++ +R+ T
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL--------SIIAESIRDGLAT 343
Query: 185 ---------ENVARFYIAQSVLAIES-IHKHNY----IHR-DIK-PDNLL------LDKN 222
+ + I S+ +E ++ + + P LL + K+
Sbjct: 344 WDNWKHVNCDKLTTI-IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS 402
Query: 223 GHM----KLSDFGLCKPLDCSTLYAIHE---------------HKTIDDE-NMAEPMDID 262
M KL + L + + +I H++I D N+ + D D
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
Query: 263 GCFPDT-DNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW-WS 320
P D H L++ + R F V L D+ +
Sbjct: 463 DLIPPYLDQYFYSHIGH-HLKNIEHPERMTLF----------RMVFL--------DFRFL 503
Query: 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHR 380
I ++ + + + ++ ++ +D K RL+ +
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQLKF---YKPYI-CDNDPKYE--------RLVNAILDF 551
Query: 381 LGTGGAHQIKAHPWFKDVV 399
L + I + + D++
Sbjct: 552 LPKIEENLICSK--YTDLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 75/556 (13%), Positives = 153/556 (27%), Gaps = 155/556 (27%)
Query: 1 MEEAEEEEVLGSKLTMEKV------------AAAKQFIEN----HYRAQMKNIQER---- 40
+ + E + ++ SK + ++F+E +Y+ M I+
Sbjct: 46 LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQP 105
Query: 41 ----------KERRWVLERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFEL 90
++R + + A +V + ++ + L+ K
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR------QALLELRPAKN------- 152
Query: 91 LTIIGRGAFGEVRL----CREKK-----SGNIY--AMKKLKKSEMV-KRGQVEHVRAERN 138
+ I G G+ + C K I+ +K E V + Q + + N
Sbjct: 153 VLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPN 212
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIME--YLPGGDMMTLLMREDTLTENVAR-FYIAQS 195
+ +KL E L+ Y LL+ + F ++
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-----ENCLLVLLNVQNAKAWNAFNLSCK 267
Query: 196 VLA-------IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
+L + + H + ++ L + L L K LDC E
Sbjct: 268 ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL----LLKYLDCRPQDLPREVL 323
Query: 249 TIDDENMAEPMDIDGC------FPDT-DNKSSWKSPHEQLQHWQMNR-RKLAFSTVGTPD 300
T + P + T DN WK + ++ + + +
Sbjct: 324 TTN------PRRLSIIAESIRDGLATWDN---WK----HVNCDKLTTIIESSL------N 364
Query: 301 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDS 360
+ P K M++ L +PP I T + W + + D
Sbjct: 365 VLEPAEYRK---------------MFDRLSVFPP---SAHIPTILLSLIWFD-VIKSDVM 405
Query: 361 KLSPEAKDLICRLLCDVEHRLGTGGAHQI----KAHPWFKDVVWDKLYEMEAAFKPEING 416
+ L L + + + T I K + Y + + ++
Sbjct: 406 VV---VNKLHKYSLVEKQPKESTISIPSIYLELKVKL-------ENEYALHRSI---VDH 452
Query: 417 ELDTQNFMKFDELDPPASG---------RTSSGPSRKMLLTPK---DLSFVG----YTYK 460
+ F D + P + +M L D F+ +
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 461 NFDAVKGLRSL--DLK 474
++A + + LK
Sbjct: 513 AWNASGSILNTLQQLK 528
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 6e-04
Identities = 62/478 (12%), Positives = 132/478 (27%), Gaps = 138/478 (28%)
Query: 48 ERKLASSDVPMEEQINLIKDLERKETE-FMR--LKRHKICVDDFELLTIIGRGAFGEVRL 104
E + D+ + + + + K+ + + L + + +D II
Sbjct: 13 EHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEE--IDH-----IIMSKD------ 59
Query: 105 CREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164
+ ++ K+ EMV++ E +R L + +
Sbjct: 60 -AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS-------PIKTEQRQ------- 104
Query: 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNG 223
P + + D L N + + +V ++ K + N+L+D G
Sbjct: 105 ----PSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID--G 157
Query: 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQH 283
+ G K + + +
Sbjct: 158 -VL----GSGK----TWVAL----DVCLSY------KVQCKMDFK-------------IF 185
Query: 284 WQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITT 343
W L +P+ + E+L K Y ++ +W S
Sbjct: 186 W------LNLKNCNSPETV-LEMLQKLLYQIDPNWTSRSDHSSN-----IKLRIHSIQAE 233
Query: 344 CRKIVHWRNH---LKFPDD--SKLSPEAKDLICRLL-----CDVEHRLGTGGAHQIKAHP 393
R+++ + + L + + + A +L C++L V L I
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI---- 289
Query: 394 WFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLS 453
L P+ L +K+ + P P + P+ LS
Sbjct: 290 --------SLDHHSMTLTPDEVKSL----LLKYLDCRPQDL------PREVLTTNPRRLS 331
Query: 454 FVG------------YTYKNFDAVKGLRSLDLKRSLSAKQPSIG-------SIFSESA 492
+ + + N D + + ++ SL+ +P+ S+F SA
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTI----IESSLNVLEPAEYRKMFDRLSVFPPSA 385
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 31/147 (21%), Positives = 57/147 (38%), Gaps = 17/147 (11%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKK-LKKS----EMVKRGQVEHVRAERNLLAEVASHC 147
+IG+GA E + R+ +K+ +KK + + + E LA V
Sbjct: 343 LIGKGA--EADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFG 400
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
I Y D + ++M Y+ G ++ + + + +HK++
Sbjct: 401 IPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGE--------IVGKLHKNDV 452
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCK 234
IH D+ N + D + + DFGL K
Sbjct: 453 IHNDLTTSNFIFD--KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.87 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.64 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.52 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.49 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.46 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.42 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.13 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.02 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.34 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.75 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-74 Score=577.98 Aligned_cols=279 Identities=37% Similarity=0.678 Sum_probs=253.3
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
+...+||++++.||+|+||+||+|+++.+|+.||||++.+..+......+.+.+|+++|+.++|||||+++++|++++++
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 44568999999999999999999999999999999999988777777888999999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|||||||+||+|.+++.+.+.++|..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~- 186 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES- 186 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT-
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999764211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
....+.+.||||.|||||++.+.+|+.++|||||
T Consensus 187 ----------------------------------------------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 220 (311)
T 4aw0_A 187 ----------------------------------------------KQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 220 (311)
T ss_dssp ----------------------------------------------TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHH
T ss_pred ----------------------------------------------CcccccCcccCcccCCHHHHcCCCCCcHHHHHHH
Confidence 1123457899999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC---ChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG---GAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~---~a~eil~Hpff~~ 397 (518)
||++|||++|++||.+.+..+++.+|++ ..+.+|. .+|++++|||.+||+ ||.+|++.. +..+|++||||++
T Consensus 221 Gvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 221 GCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCc--ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999999999999999999987 4566774 699999999999998 999999431 2234799999999
Q ss_pred CCccccccccCCcc
Q 010116 398 VVWDKLYEMEAAFK 411 (518)
Q Consensus 398 i~w~~l~~~~~p~~ 411 (518)
+||+.|++..||.+
T Consensus 297 idw~~l~~~~pP~l 310 (311)
T 4aw0_A 297 VTWENLHQQTPPKL 310 (311)
T ss_dssp CCCTTGGGSCCCCC
T ss_pred CCHHHhcCCCCCCC
Confidence 99999998887754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-71 Score=605.00 Aligned_cols=290 Identities=33% Similarity=0.620 Sum_probs=257.8
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHH---HhCCCceeEEEEEeec
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA---EVASHCIVKLYYSFQD 157 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~---~l~hp~Iv~l~~~f~~ 157 (518)
..++.+||+++++||+|+||+||+|+++.+|+.||||++.+..+........+.+|+.++. .++|||||+|+++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 4788999999999999999999999999999999999999988777777777777766655 4589999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+++|||||||+||+|.++|.+.+.|+|..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~ 316 (518)
.. .+.+.||||.|||||++.+ .+|+.++
T Consensus 344 ~~---------------------------------------------------~~~t~~GTp~YmAPEvl~~~~~y~~~v 372 (689)
T 3v5w_A 344 KK---------------------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSA 372 (689)
T ss_dssp SC---------------------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHH
T ss_pred CC---------------------------------------------------CCCCccCCcCccCHHHHhCCCCCCcHH
Confidence 21 2347899999999999974 6899999
Q ss_pred cccchhHHHHHHHhCCCCCCCCC---hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC--CChhhhh
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADD---PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT--GGAHQIK 390 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~--~~a~eil 390 (518)
||||||||+|||++|++||.+.+ ...+...+.. ..+.+|. .+|++++|||.+||+ ||.+|+|+ .+++||+
T Consensus 373 DiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp HHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 99999999999999999998643 3344555555 4556664 799999999999998 99999986 3799999
Q ss_pred cCcccccCCccccc--cccCCccccCCCcccCCCCCC
Q 010116 391 AHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNFMK 425 (518)
Q Consensus 391 ~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~ 425 (518)
+||||++|||+.|. ++.|||+|.+.+..++++|+.
T Consensus 449 ~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~ 485 (689)
T 3v5w_A 449 ESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDI 485 (689)
T ss_dssp TSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC-
T ss_pred cCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCC
Confidence 99999999999996 689999999988888877763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-72 Score=562.50 Aligned_cols=279 Identities=43% Similarity=0.765 Sum_probs=243.4
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
..++..++|++++.||+|+||+||+|++. .+++.||||++++...... ....+.+|+.+|+.++|||||+++++|+
T Consensus 18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 18 HEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEE
T ss_pred cccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 34556689999999999999999999984 4688999999987654333 2346788999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+++.+|||||||+||+|.++|.+.+.+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+..
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
... .....+.||||.|||||++.+.+|+.++
T Consensus 177 ~~~-------------------------------------------------~~~~~~~~GT~~YmAPE~~~~~~y~~~~ 207 (304)
T 3ubd_A 177 IDH-------------------------------------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSA 207 (304)
T ss_dssp -----------------------------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHH
T ss_pred cCC-------------------------------------------------CccccccccCcccCCHHHhccCCCCCCC
Confidence 311 1123468999999999999999999999
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCc
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHP 393 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hp 393 (518)
|||||||++|||++|++||.+.+..+++.+|.+ ..+.+|. .+|+++++||.+||+ ||.+|+++. +++||++||
T Consensus 208 DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp 283 (304)
T 3ubd_A 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283 (304)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred cccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence 999999999999999999999999999999987 4556664 699999999999998 999999753 578999999
Q ss_pred ccccCCccccc--cccCCccc
Q 010116 394 WFKDVVWDKLY--EMEAAFKP 412 (518)
Q Consensus 394 ff~~i~w~~l~--~~~~p~~p 412 (518)
||+++||+.|. +++|||+|
T Consensus 284 ~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 284 FFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp GGTTCCHHHHHTTCSCCSSCC
T ss_pred cccCCCHHHHHhCCCCcCcCC
Confidence 99999999995 58899998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-67 Score=556.06 Aligned_cols=342 Identities=44% Similarity=0.819 Sum_probs=283.8
Q ss_pred HHHhhhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEE
Q 010116 73 TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152 (518)
Q Consensus 73 ~~~~~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 152 (518)
....++++..+..++|+++++||+|+||+||+|+++.+|+.||||++.+.........+++.+|+.+|..++|||||+++
T Consensus 48 ~~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp HHHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred hhhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 34456667788899999999999999999999999999999999999987766666777899999999999999999999
Q ss_pred EEeecCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecc
Q 010116 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231 (518)
Q Consensus 153 ~~f~~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFG 231 (518)
++|++.+++|||||||+||+|.+++.+. ..+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||
T Consensus 128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999999999875 489999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL--- 308 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~--- 308 (518)
+|+...... .....+.+||+.|+|||++.
T Consensus 208 la~~~~~~~------------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~ 239 (412)
T 2vd5_A 208 SCLKLRADG------------------------------------------------TVRSLVAVGTPDYLSPEILQAVG 239 (412)
T ss_dssp TCEECCTTS------------------------------------------------CEECSSCCSCGGGCCHHHHHHHH
T ss_pred hheeccCCC------------------------------------------------ccccceeccccCcCCHHHHhhcc
Confidence 998653210 01123578999999999998
Q ss_pred ----CCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCC-CCCCChhHHHHHHHHhccccccCCC
Q 010116 309 ----KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLCDVEHRLGT 383 (518)
Q Consensus 309 ----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~-~~~~s~~~~dLI~~lL~dp~~R~g~ 383 (518)
...|+.++|||||||++|||++|++||.+.+...++.+|+.+...+.+|. ...+|+++++||++||++|.+|+|+
T Consensus 240 ~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr 319 (412)
T 2vd5_A 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGR 319 (412)
T ss_dssp TCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSCGGGCTTT
T ss_pred cCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCChhhcCCC
Confidence 35799999999999999999999999999999999999998765666664 3479999999999999999999988
Q ss_pred CChhhhhcCcccccCCccccccccCCccccCCCcccCCCCCCCCCCCCCCCCC--CCCCCcccccCCCCCCcccCceeeC
Q 010116 384 GGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGR--TSSGPSRKMLLTPKDLSFVGYTYKN 461 (518)
Q Consensus 384 ~~a~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~f~~~~~~~ 461 (518)
.+++||++||||++++|+.+.+..|||+|.+.++.|++||+.+.+........ ..............+..|.||||.+
T Consensus 320 ~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 399 (412)
T 2vd5_A 320 GGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSC 399 (412)
T ss_dssp TTHHHHHTSGGGTTCCSTTSTTSCCSCCCC-----CCSSCC--CCCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSC
T ss_pred CCHHHHhcCCCcCCCCHHHHhhcCCCCCCcCCCcccccccCcccccccccccccCCCcccccCCCccccCCCCCCCcccC
Confidence 89999999999999999999999999999999999999999764432211100 0000000011224567899999987
Q ss_pred C
Q 010116 462 F 462 (518)
Q Consensus 462 ~ 462 (518)
.
T Consensus 400 ~ 400 (412)
T 2vd5_A 400 M 400 (412)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-67 Score=553.47 Aligned_cols=336 Identities=45% Similarity=0.836 Sum_probs=290.0
Q ss_pred HhhhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEE
Q 010116 75 FMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (518)
Q Consensus 75 ~~~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 154 (518)
...+....+..++|+++++||+|+||+||+|+++.+++.||||++.+.........+.+.+|+.+|+.++|||||+++++
T Consensus 58 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 58 INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34455677888999999999999999999999999999999999998776666667778999999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
|++...+|||||||+||+|.+++.. ..+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999999999864 579999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC---
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--- 311 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--- 311 (518)
...... .....+.+||+.|+|||++.+.+
T Consensus 217 ~~~~~~------------------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~ 248 (410)
T 3v8s_A 217 KMNKEG------------------------------------------------MVRCDTAVGTPDYISPEVLKSQGGDG 248 (410)
T ss_dssp ECCTTS------------------------------------------------EEECCSCCSCGGGCCHHHHHTTTTTC
T ss_pred eeccCC------------------------------------------------cccccCCcCCccccCHHHhhccCCCc
Confidence 654221 01233679999999999998766
Q ss_pred -CCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhccccccCCCCChhhhh
Q 010116 312 -YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLCDVEHRLGTGGAHQIK 390 (518)
Q Consensus 312 -y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~R~g~~~a~eil 390 (518)
|+.++|||||||++|||++|++||.+.+...++.+|+.+...+.+|....+|+++++||++||+++.+|+|+.+++||+
T Consensus 249 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp EEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred CCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 8999999999999999999999999999999999999877678888877899999999999999666666666999999
Q ss_pred cCcccccCCcccc--ccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCcc
Q 010116 391 AHPWFKDVVWDKL--YEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDA 464 (518)
Q Consensus 391 ~Hpff~~i~w~~l--~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~ 464 (518)
+||||++++|+.+ .++.|||+|.+.++.|++||+.+++...+...... + .. ....+..|.||||.+...
T Consensus 329 ~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~~~~~~~~--~--~~-~~~~~~~f~~f~~~~~~~ 399 (410)
T 3v8s_A 329 RHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPI--P--KA-FVGNQLPFVGFTYYSNRR 399 (410)
T ss_dssp TSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCCSCCCCCCC--C--SS-CCCTTGGGTTCCEECC--
T ss_pred cCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCCccccccccccCCC--c--hh-hcccccccccceEeCccc
Confidence 9999999999865 47899999999999999999987665433221111 1 11 224577899999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-67 Score=555.12 Aligned_cols=340 Identities=45% Similarity=0.824 Sum_probs=286.6
Q ss_pred hhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 77 ~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
.++...+..++|+++++||+|+||+||+|+++.+++.||||++.+...........+.+|+.++..++|||||+++++|+
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556778899999999999999999999999999999999999877666666677899999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
+.+.+|||||||+||+|.+++.+ .+.+++..+++|++|++.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999999987 57899999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----CC
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KK 310 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~ 310 (518)
..... .......+||+.|+|||++. ..
T Consensus 225 ~~~~~------------------------------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~ 256 (437)
T 4aw2_A 225 LMEDG------------------------------------------------TVQSSVAVGTPDYISPEILQAMEGGKG 256 (437)
T ss_dssp CCTTS------------------------------------------------CEECCSCCSCGGGCCHHHHHHHHTSCC
T ss_pred cccCC------------------------------------------------CcccccccCCcCeeChHHHhhcccCCC
Confidence 53210 01123578999999999997 56
Q ss_pred CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCC-CCCChhHHHHHHHHhccccccCCCCChhhh
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD-SKLSPEAKDLICRLLCDVEHRLGTGGAHQI 389 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~-~~~s~~~~dLI~~lL~dp~~R~g~~~a~ei 389 (518)
.|+.++|||||||++|||++|++||.+.+..+.+.+|+.+...+.+|.. ..+|+++++||++||+.+.+|+++.+++||
T Consensus 257 ~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei 336 (437)
T 4aw2_A 257 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDF 336 (437)
T ss_dssp EECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH
T ss_pred CCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHH
Confidence 7999999999999999999999999999999999999887666777764 468999999999999955566666699999
Q ss_pred hcCcccccCCccccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCccccc
Q 010116 390 KAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVKG 467 (518)
Q Consensus 390 l~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~ 467 (518)
++||||++++|+.+.+++|||+|.+.++.|++||+..+.......... +.........+..|.||||+++....+
T Consensus 337 l~Hpff~~i~w~~l~~~~~p~~P~~~~~~d~~~fd~~~~~~~~~~~~~---~~~~~~~~~~~~~f~~~~~~~~~~~~~ 411 (437)
T 4aw2_A 337 KKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMP---PPTHTAFSGHHLPFVGFTYTSSCVLSD 411 (437)
T ss_dssp HTSGGGTTCCTTTGGGSCCSCCCCCSSTTCCTTSCCC---------------------CCTTGGGTTCCEESSCTTST
T ss_pred hCCCccCCCCHHHHhhCCCCCCCcCCCccchhhcCCcccccccccCCC---CCccccccccCccccCCCcCCchhhcc
Confidence 999999999999999999999999999999999987543322211111 111111345678999999998765533
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-66 Score=518.37 Aligned_cols=255 Identities=32% Similarity=0.593 Sum_probs=217.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999987766666778899999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||| +|+|.+++.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----- 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----- 165 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-----
Confidence 9999 7899999999999999999999999999999999999999999999999999999999999999864311
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-CccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGv 323 (518)
....+.||||.|||||++.+.+| +.++|||||||
T Consensus 166 ---------------------------------------------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGv 200 (275)
T 3hyh_A 166 ---------------------------------------------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 200 (275)
T ss_dssp ------------------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHH
T ss_pred ---------------------------------------------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHH
Confidence 11236799999999999999887 68999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
++|||++|++||.+.+...++.+|... .+.+|. .+|+++++||.+||+ ||.+|+ +++||++||||+.
T Consensus 201 ily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~---s~~eil~hpw~k~ 268 (275)
T 3hyh_A 201 ILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPK--FLSPGAAGLIKRMLIVNPLNRI---SIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCT--TSCHHHHHHHHHHSCSSGGGSC---CHHHHHHCHHHHT
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHccCChhHCc---CHHHHHcCccccc
Confidence 999999999999999998888888873 455664 699999999999998 999999 8999999999973
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-66 Score=532.61 Aligned_cols=256 Identities=30% Similarity=0.532 Sum_probs=230.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35799999999999999999999999999999999865432 345678999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---- 224 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---- 224 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC----
Confidence 999999999998864 679999999999999999999999999999999999999999999999999998764210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
....+.||||.|||||++.+.+|+.++|||||||+
T Consensus 225 ---------------------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvi 259 (346)
T 4fih_A 225 ---------------------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIM 259 (346)
T ss_dssp ---------------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred ---------------------------------------------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHH
Confidence 12347899999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+|||++|++||.+.+..+.+..|... ....++.+..+|++++|||.+||+ ||.+|+ +++||++||||+.
T Consensus 260 lyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 260 VIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAK 329 (346)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGG
T ss_pred HHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhcC
Confidence 99999999999999999988888763 233444455799999999999998 999999 8999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-65 Score=530.53 Aligned_cols=326 Identities=34% Similarity=0.669 Sum_probs=275.3
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
..+..++|+++++||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|..+ +|||||+++++|++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 456789999999999999999999999999999999999988777777788899999999998 7999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+|||||+||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.....+.|||+.|+|||++.+..|+.++|||
T Consensus 178 -------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 208 (353)
T 3txo_A 178 -------------------------------------------------GVTTATFCGTPDYIAPEILQEMLYGPAVDWW 208 (353)
T ss_dssp ---------------------------------------------------------CCGGGCCHHHHHHHHCTTHHHHH
T ss_pred -------------------------------------------------CccccccCCCcCeEChhhcCCCCcCCccCCC
Confidence 0123367999999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC---CChhhhhcCccc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT---GGAHQIKAHPWF 395 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~---~~a~eil~Hpff 395 (518)
||||++|||++|.+||.+.+...++.+|.. ..+.+|. .+++++++||++||+ ||.+|+++ .++++|++||||
T Consensus 209 slG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 209 AMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred cchHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 999999999999999999999999999987 4556664 689999999999998 99999965 355999999999
Q ss_pred ccCCccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCc
Q 010116 396 KDVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFD 463 (518)
Q Consensus 396 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~ 463 (518)
++++|+.+. +++|||+|.+.+..|++||+.......+..+...+... ....+..|.||+|.+.+
T Consensus 285 ~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~----~~~~~~~f~~f~~~~~~ 350 (353)
T 3txo_A 285 KEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHL----PMINQDEFRNFEYVSPE 350 (353)
T ss_dssp TTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCCCTTSG----GGSCGGGGTTCCEECC-
T ss_pred cCCCHHHHhcCcCCCCccCCCCCcccccccCcccccCCCcCCCcccccc----CcccccccCCceeeCcc
Confidence 999999985 68999999999999999998643332222221111111 11234579999998743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-66 Score=530.76 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=226.6
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++|||||+++++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 458999999999999999999999999999999999876543 3456789999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 164 IMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|||||+||+|.++|... ..++|..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 99999999999999654 46799999999999999999999999999999999999999999999999999865311
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
...+.+.|||+.|||||++.+.+|+.++|||||
T Consensus 179 -----------------------------------------------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSl 211 (350)
T 4b9d_A 179 -----------------------------------------------VELARACIGTPYYLSPEICENKPYNNKSDIWAL 211 (350)
T ss_dssp -----------------------------------------------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHH
T ss_pred -----------------------------------------------cccccccCCCccccCHHHHCCCCCCcHHHHHHH
Confidence 112346799999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||++|||++|++||.+.+..+++.+|+.... . +.+..+|+++++||.+||+ ||.+|+ +++||++||||+.
T Consensus 212 GvilyemltG~~PF~~~~~~~~~~~i~~~~~-~--~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 212 GCVLYELCTLKHAFEAGSMKNLVLKIISGSF-P--PVSLHYSYDLRSLVSQLFKRNPRDRP---SVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-C--CCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHT
T ss_pred HHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-C--CCCccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHHhhc
Confidence 9999999999999999999999999987431 1 2235799999999999998 999999 8999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-65 Score=524.28 Aligned_cols=326 Identities=37% Similarity=0.683 Sum_probs=277.6
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
+..++|++++.||+|+||+||+|+++.+|+.||||++.+..........++.+|+.+|+.++||||++++++|++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 56789999999999999999999999999999999999877666777888999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
+||||++||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--- 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT---
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC---
Confidence 99999999999999998899999999999999999999999999999999999999999999999999999853211
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
.....+.+||+.|+|||++.+.+|+.++||||||
T Consensus 159 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 192 (337)
T 1o6l_A 159 ----------------------------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192 (337)
T ss_dssp ----------------------------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHH
T ss_pred ----------------------------------------------CCcccccccChhhCChhhhcCCCCCchhhcccch
Confidence 0112367899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCC
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVV 399 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~ 399 (518)
|++|||++|.+||.+.+....+..|.. ..+.+|. .+|+++++||.+||. ||.+|+|+. ++.||++||||++++
T Consensus 193 ~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 193 VVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred hHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999999998888888876 4566664 689999999999998 999999764 899999999999999
Q ss_pred ccccc--cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCCccccc--CCCCCCcccCceeeC
Q 010116 400 WDKLY--EMEAAFKPEINGELDTQNFMK-FDELDPPASGRTSSGPSRKML--LTPKDLSFVGYTYKN 461 (518)
Q Consensus 400 w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~f~~~~~~~ 461 (518)
|+.+. ++.|||+|.+.++.|+++|+. |.......+..........+. ....+..|.||+|.+
T Consensus 269 ~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 335 (337)
T 1o6l_A 269 WQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335 (337)
T ss_dssp HHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEEC
T ss_pred HHHHHhCCCCCCCCCCCCCcchhhcccchhccCccCcCCCcccccccccccccccccccCCCceecC
Confidence 99985 588999999999999999985 433322211111111100000 112457899999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-65 Score=537.51 Aligned_cols=329 Identities=34% Similarity=0.636 Sum_probs=272.2
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
..+..++|+++++||+|+||+||+|+++.+++.||||++++...........+.+|+.+|..+ +|||||+++++|++..
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 456778999999999999999999999999999999999988766666677889999999887 8999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|||||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
...+.+.|||+.|+|||++.+.+|+.++|||
T Consensus 207 -------------------------------------------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diw 237 (396)
T 4dc2_A 207 -------------------------------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 237 (396)
T ss_dssp -------------------------------------------------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHH
T ss_pred -------------------------------------------------CCccccccCCcccCCchhhcCCCCChHHHHH
Confidence 0123467999999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCC---------ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC---Ch
Q 010116 320 SLGAIMYEMLVGYPPFYAD---------DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG---GA 386 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~---------~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~---~a 386 (518)
||||++|||++|.+||... ........|.. ..+.+|. .+|+++++||++||+ ||.+|+++. ++
T Consensus 238 slGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 313 (396)
T 4dc2_A 238 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGF 313 (396)
T ss_dssp HHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTTTHH
T ss_pred HHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCCCCH
Confidence 9999999999999999643 22334555555 4566664 689999999999998 999999762 57
Q ss_pred hhhhcCcccccCCccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCcc
Q 010116 387 HQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDA 464 (518)
Q Consensus 387 ~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~ 464 (518)
+||++||||++++|+.+. ++.|||+|.+.++.|++||+.....+++..+.... ..+....+..|.||+|.+...
T Consensus 314 ~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~~~~~~~~----~~~~~~~~~~f~~f~~~~~~~ 389 (396)
T 4dc2_A 314 ADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDD----DIVRKIDQSEFEGFEYINPLL 389 (396)
T ss_dssp HHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCCCCCCCCH----HHHTTSCGGGGTTCCEECC--
T ss_pred HHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCCccCCCcc----hhhccccccccCCcEeECccc
Confidence 999999999999999996 58899999999999999999643333332211111 111122346799999998765
Q ss_pred cc
Q 010116 465 VK 466 (518)
Q Consensus 465 ~~ 466 (518)
+.
T Consensus 390 ~~ 391 (396)
T 4dc2_A 390 MS 391 (396)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-65 Score=528.59 Aligned_cols=326 Identities=33% Similarity=0.647 Sum_probs=278.1
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
.++..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+++..|+.+|..+ +||||++++++|++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 456789999999999999999999999999999999999988776677788899999999987 8999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||++||+|.+++.+.+.+++..+++|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.....+.+||+.|+|||++.+.+|+.++|||
T Consensus 175 -------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 205 (353)
T 2i0e_A 175 -------------------------------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 205 (353)
T ss_dssp -------------------------------------------------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHH
T ss_pred -------------------------------------------------CcccccccCCccccChhhhcCCCcCCccccc
Confidence 0113367999999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFK 396 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~ 396 (518)
||||++|||++|.+||.+.+...++.+|+. ..+.+|. .+|+++++||.+||+ ||.+|+++. ++++|++||||+
T Consensus 206 slG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~ 281 (353)
T 2i0e_A 206 AFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281 (353)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred chHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence 999999999999999999999999999987 4556664 689999999999998 999999863 789999999999
Q ss_pred cCCccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCcc
Q 010116 397 DVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDA 464 (518)
Q Consensus 397 ~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~ 464 (518)
+++|+.+. ++.|||+|.+.+. |++||+.+....++..+... ...+....+..|.||+|.+++.
T Consensus 282 ~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~~----~~~~~~~~~~~f~~f~~~~~~~ 346 (353)
T 2i0e_A 282 YIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPD----QEVIRNIDQSEFEGFSFVNSEF 346 (353)
T ss_dssp TCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCCC----HHHHHHSCTTTTCSCCEECTTC
T ss_pred CCCHHHHHhCCCCCCcCCCCCCc-chhhccchhccCCcccCCcc----ccccccccccccCCCeeeCccc
Confidence 99999995 6899999999998 99999875433332221111 0000112356899999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-65 Score=533.89 Aligned_cols=256 Identities=30% Similarity=0.532 Sum_probs=230.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999986543 2345688999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||||+||+|.+++. .+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 227 mEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~---- 301 (423)
T 4fie_A 227 MEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---- 301 (423)
T ss_dssp EECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC----
T ss_pred EeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC----
Confidence 99999999999885 4679999999999999999999999999999999999999999999999999998764210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
....+.|||+.|||||++.+.+|+.++|||||||+
T Consensus 302 ---------------------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvi 336 (423)
T 4fie_A 302 ---------------------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIM 336 (423)
T ss_dssp ---------------------------------------------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred ---------------------------------------------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHH
Confidence 12347899999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+|||++|++||.+.+....+..|... ....++....+|++++|||.+||+ ||.+|+ ++.||++||||+.
T Consensus 337 lyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~ell~Hp~~~~ 406 (423)
T 4fie_A 337 VIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAK 406 (423)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGG
T ss_pred HHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHHhcC
Confidence 99999999999999999988888763 233445556799999999999998 999999 8999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-64 Score=520.56 Aligned_cols=322 Identities=35% Similarity=0.660 Sum_probs=253.1
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
.++..++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|+.+|..+ +||||++++++|++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 456789999999999999999999999999999999999988766667788899999999987 9999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||++||+|.+++.+.+.+++..+++|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999999854211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
. ..+.+.+||+.|+|||++.+.+|+.++|||
T Consensus 172 ~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 202 (345)
T 1xjd_A 172 D-------------------------------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWW 202 (345)
T ss_dssp T-------------------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHH
T ss_pred C-------------------------------------------------CcccCCCCCcccCChhhhcCCCCCChhhhH
Confidence 0 113367999999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh-hhhcCccccc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH-QIKAHPWFKD 397 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~-eil~Hpff~~ 397 (518)
||||++|||++|.+||.+.+....+.+|... ...+|. .+|+++++||.+||+ ||.+|+ ++. +|++||||++
T Consensus 203 slG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dp~~R~---~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 203 SFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPR--WLEKEAKDLLVKLFVREPEKRL---GVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHSCSSGGGSB---TTBSCGGGSGGGTT
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCc--ccCHHHHHHHHHHhcCCHhHcC---CChHHHHcCccccC
Confidence 9999999999999999999999999888873 455664 689999999999998 999999 565 9999999999
Q ss_pred CCccccc--cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCc
Q 010116 398 VVWDKLY--EMEAAFKPEINGELDTQNFMK-FDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFD 463 (518)
Q Consensus 398 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~ 463 (518)
++|+.+. ++.|||+|.+.++.|++||+. |....+..+ .... .......+..|.||+|.+..
T Consensus 276 ~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~-~~~~----~~~~~~~~~~f~~f~~~~~~ 339 (345)
T 1xjd_A 276 INWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLS-FADR----ALINSMDQNMFRNFSFMNPG 339 (345)
T ss_dssp CCHHHHHTTCSCC-------------------------------------------CCTTTTCCC----
T ss_pred CCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccCC-cccc----cccccccccccCCCeeeChh
Confidence 9999995 589999999999999999986 443332211 1111 11111245689999998654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-64 Score=524.51 Aligned_cols=330 Identities=35% Similarity=0.653 Sum_probs=246.6
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHH-HHHhCCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~f~~~~ 159 (518)
..+..++|++++.||+|+||+||+|+++.+++.||||++.+..........++..|+.+ ++.++|||||+++++|++.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 45677899999999999999999999999999999999998877666677778888887 57789999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.....+.+||+.|+|||++.+.+|+.++|||
T Consensus 193 -------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 223 (373)
T 2r5t_A 193 -------------------------------------------------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 223 (373)
T ss_dssp -------------------------------------------------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHH
T ss_pred -------------------------------------------------CCccccccCCccccCHHHhCCCCCCchhhhH
Confidence 0123367999999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC-ChhhhhcCccccc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG-GAHQIKAHPWFKD 397 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~-~a~eil~Hpff~~ 397 (518)
||||++|||++|.+||.+.+...++.+|+.. .+.+|. .+++++++||.+||+ ||.+|+++. ++.+|++||||++
T Consensus 224 slG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 224 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKP--NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCCCCS--SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccCCCC--CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999999999999999999873 455653 689999999999998 999999864 6789999999999
Q ss_pred CCccccc--cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCC-CcccccCCCCCCcccCceeeCCc
Q 010116 398 VVWDKLY--EMEAAFKPEINGELDTQNFMK-FDELDPPASGRTSSG-PSRKMLLTPKDLSFVGYTYKNFD 463 (518)
Q Consensus 398 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~f~~~~~~~~~ 463 (518)
++|+.+. ++.|||+|.+.++.|++||+. |.....+........ ..........+..|.||||.+..
T Consensus 300 ~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 369 (373)
T 2r5t_A 300 INWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPT 369 (373)
T ss_dssp CCHHHHHTTCSCCSCCCSCCC-------------------------------------------------
T ss_pred CCHHHHHhCCCCCCCCCCCCCcchhhhcCcccccccccccccCCccccccccccccccccCCCCcccCch
Confidence 9999995 589999999999999999985 444332211110000 00000012345679999997653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-63 Score=499.04 Aligned_cols=254 Identities=24% Similarity=0.425 Sum_probs=219.2
Q ss_pred CCe-eEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec----CCe
Q 010116 86 DDF-ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----TEY 160 (518)
Q Consensus 86 ~~f-~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~----~~~ 160 (518)
.+| ++.++||+|+||+||+|+++.++..||+|++.+... .....+.+.+|+.+|+.++|||||+++++|++ +..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 355 778899999999999999999999999999987644 33456789999999999999999999999975 467
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCceeeCC-CCcEEEeecccccccC
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLD 237 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~g--iiHRDIKPeNILld~-~g~vKL~DFGla~~~~ 237 (518)
+|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999999999999999999999999999999999998 999999999999985 8999999999997532
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
. ..+.+.||||.|||||++.+ +|+.++|
T Consensus 184 ~---------------------------------------------------~~~~~~~GTp~YmAPE~~~~-~y~~~~D 211 (290)
T 3fpq_A 184 A---------------------------------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVD 211 (290)
T ss_dssp T---------------------------------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHH
T ss_pred C---------------------------------------------------CccCCcccCccccCHHHcCC-CCCcHHH
Confidence 1 12346799999999999865 6999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCCh-hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDP-ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
||||||++|||++|++||.+.+. ......+.....+..++ ..+|+++++||.+||. ||.+|+ +++||++||||
T Consensus 212 iwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~---s~~e~l~Hp~~ 286 (290)
T 3fpq_A 212 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFF 286 (290)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGG
T ss_pred HHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC--ccCCHHHHHHHHHHccCChhHCc---CHHHHhcCccc
Confidence 99999999999999999987554 44555555433333333 3578999999999998 999999 89999999999
Q ss_pred cc
Q 010116 396 KD 397 (518)
Q Consensus 396 ~~ 397 (518)
++
T Consensus 287 ~~ 288 (290)
T 3fpq_A 287 QE 288 (290)
T ss_dssp C-
T ss_pred cC
Confidence 84
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-63 Score=503.53 Aligned_cols=293 Identities=44% Similarity=0.864 Sum_probs=256.0
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
+..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+++.+|+.+|+.++||||++++++|++...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45789999999999999999999999999999999999877666677888999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
+||||++||+|.+++.+...+++..+++|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 9999999999999999889999999999999999999999999999999999999999999999999999986431
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
...+.+||+.|+|||++.+.+|+.++||||||
T Consensus 159 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 190 (318)
T 1fot_A 159 ------------------------------------------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFG 190 (318)
T ss_dssp ------------------------------------------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHH
T ss_pred ------------------------------------------------ccccccCCccccCHhHhcCCCCCcccchhhhH
Confidence 12357899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCC
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVV 399 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~ 399 (518)
|++|||++|.+||.+.+....+.+|+.. .+.+|. .+++++++||.+||+ ||.+|+++. ++++|++||||++++
T Consensus 191 ~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 191 ILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 9999999999999999999999999873 456664 689999999999998 999999764 799999999999999
Q ss_pred ccccc--cccCCccccCC-CcccCCCCCCCCCCCC
Q 010116 400 WDKLY--EMEAAFKPEIN-GELDTQNFMKFDELDP 431 (518)
Q Consensus 400 w~~l~--~~~~p~~p~~~-~~~d~~~f~~~~~~~~ 431 (518)
|+.+. ++.|||+|.+. +..|+++|+.+.+...
T Consensus 267 ~~~~~~~~~~~p~~p~~~~~~~d~~~f~~~~~~~~ 301 (318)
T 1fot_A 267 WEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDI 301 (318)
T ss_dssp HHHHHTTCSCCSCCCCC----------------CC
T ss_pred HHHHHhCCCCCCCCCCcCCCccchhhcCCCCcccc
Confidence 99995 58899999998 5899999998866543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-63 Score=510.83 Aligned_cols=323 Identities=35% Similarity=0.663 Sum_probs=273.1
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCe
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 160 (518)
.+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.++..+ +|||||+++++|++...
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 46678999999999999999999999999999999999988766667788899999999988 89999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~- 163 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 163 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999999853211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
.....+.+||+.|+|||++.+..|+.++||||
T Consensus 164 ------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 195 (345)
T 3a8x_A 164 ------------------------------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 195 (345)
T ss_dssp ------------------------------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred ------------------------------------------------CCcccccCCCccccCccccCCCCCChHHhHHH
Confidence 01123678999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCC---------CChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC---Chh
Q 010116 321 LGAIMYEMLVGYPPFYA---------DDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG---GAH 387 (518)
Q Consensus 321 lGvilyeml~G~~PF~~---------~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~---~a~ 387 (518)
|||++|||++|.+||.. .........+.. ..+.+|. .+|+++++||.+||. ||.+|+++. ++.
T Consensus 196 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 271 (345)
T 3a8x_A 196 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFA 271 (345)
T ss_dssp HHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHH
T ss_pred HHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHH
Confidence 99999999999999975 233344555555 3456664 689999999999998 999999752 468
Q ss_pred hhhcCcccccCCccccc--cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCC
Q 010116 388 QIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNFMK-FDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNF 462 (518)
Q Consensus 388 eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 462 (518)
+|++||||++++|+.+. ++.|||+|.+.++.|+++|+. |........ ... . .......+..|.||+|.++
T Consensus 272 ~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~--~--~~~~~~~~~~f~~f~~~~~ 344 (345)
T 3a8x_A 272 DIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLT-PDD--D--DIVRKIDQSEFEGFEYINP 344 (345)
T ss_dssp HHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSSCC-CCC--H--HHHTTSCGGGGTTCCEECC
T ss_pred HHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCcccCC-Ccc--c--cccccccccccCCCEeeCC
Confidence 99999999999999985 588999999999999999986 433322111 111 0 0111223567999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-64 Score=511.04 Aligned_cols=251 Identities=29% Similarity=0.401 Sum_probs=219.1
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++.++||+|+||+||+|+++.+|+.||||++++.... .+|+.+|+.++|||||+++++|++++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 457899999999999999999999999999999999875432 369999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-cEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-~vKL~DFGla~~~~~~~~~ 242 (518)
|||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999989999999999999999999999999999999999999999998 6999999999976422100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
. ......+.||||.|||||++.+.+|+.++||||||
T Consensus 208 ~--------------------------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlG 243 (336)
T 4g3f_A 208 K--------------------------------------------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243 (336)
T ss_dssp --------------------------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHH
T ss_pred c--------------------------------------------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHH
Confidence 0 00112357899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc-cCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHL-KFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l-~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|++|||++|++||.+.+...++.+|......+ .+| ..+|+++++||.+||+ ||.+|+ ++.||++
T Consensus 244 vilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~---sa~el~~ 309 (336)
T 4g3f_A 244 CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP--PSCAPLTAQAIQEGLRKEPVHRA---SAMELRR 309 (336)
T ss_dssp HHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcC--ccCCHHHHHHHHHHccCCHhHCc---CHHHHHH
Confidence 99999999999999998888888888743322 233 4799999999999998 999999 8999853
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-62 Score=503.73 Aligned_cols=296 Identities=43% Similarity=0.817 Sum_probs=271.0
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
.......++|++++.||+|+||.||+|+++.+|+.||||++.+.........+++.+|+.+|+.++||||++++++|++.
T Consensus 34 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 113 (350)
T 1rdq_E 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp CCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34456778999999999999999999999999999999999988776667788899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..+|+||||++||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999986531
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
. ..+.+||+.|+|||++.+.+|+.++||
T Consensus 194 ~----------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di 221 (350)
T 1rdq_E 194 R----------------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDW 221 (350)
T ss_dssp C----------------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHH
T ss_pred C----------------------------------------------------cccccCCccccCHHHhcCCCCCCcCCE
Confidence 1 125689999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC--CChhhhhcCccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT--GGAHQIKAHPWF 395 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~--~~a~eil~Hpff 395 (518)
|||||++|||++|.+||.+.+....+.+|... .+.+|. .+|+++++||.+||+ ||.+|+++ .++++|++||||
T Consensus 222 wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 99999999999999999999999999999874 456664 689999999999998 99999964 259999999999
Q ss_pred ccCCccccc--cccCCccccCCCcccCCCCCCCCCCC
Q 010116 396 KDVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELD 430 (518)
Q Consensus 396 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~ 430 (518)
++++|..+. ++.|||+|.+.++.|+++|+.|.+.+
T Consensus 298 ~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~~~~~~~ 334 (350)
T 1rdq_E 298 ATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEE 334 (350)
T ss_dssp TTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCCCCCCC
T ss_pred CCCCHHHHhhccCCCCCCCCCCCcccccccccccccc
Confidence 999999986 58999999999999999999776554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-63 Score=552.53 Aligned_cols=328 Identities=33% Similarity=0.639 Sum_probs=284.0
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
..+..++|+++++||+|+||+||+|+++.+++.||||++++.........+.+..|+.+|..+ +||+|++++++|++.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 456789999999999999999999999999999999999987766677788899999999987 7999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+||||||++||+|..++...+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.....+.+||+.|+|||++.+.+|+.++|||
T Consensus 496 -------------------------------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~Dvw 526 (674)
T 3pfq_A 496 -------------------------------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 526 (674)
T ss_dssp -------------------------------------------------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHH
T ss_pred -------------------------------------------------CcccccccCCCcccCHhhhcCCCCCccceEe
Confidence 0123367999999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC--CChhhhhcCcccc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT--GGAHQIKAHPWFK 396 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~--~~a~eil~Hpff~ 396 (518)
||||++|||++|.+||.+.+..+++.+|+. ..+.+|. .+|+++++||++||. ||.+|+++ .+++||++||||+
T Consensus 527 SlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 527 AFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred chHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 999999999999999999999999999987 4566774 699999999999998 99999976 3569999999999
Q ss_pred cCCccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCcccCceeeCCcccc
Q 010116 397 DVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPKDLSFVGYTYKNFDAVK 466 (518)
Q Consensus 397 ~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~ 466 (518)
+++|+.+. ++.|||+|.+.+ .|++||+.+....++..+.... ..+....+..|.||+|.+...+.
T Consensus 603 ~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~~----~~~~~~~~~~f~~f~~~~~~~~~ 669 (674)
T 3pfq_A 603 YIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPDQ----EVIRNIDQSEFEGFSFVNSEFLK 669 (674)
T ss_dssp SCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCCH----HHHTTCCGGGGTTCCEECSSCCC
T ss_pred CCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhccCCCccCCCch----hhhhcccccccCCCcccChhhhc
Confidence 99999995 589999999998 9999999876655443322211 11112335689999999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-62 Score=508.33 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=226.5
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec------CC
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------TE 159 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------~~ 159 (518)
++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||+++++|.+ .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 689999999999999999999999999999999976543 33445678899999999999999999998764 46
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|||||||. |+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 8999999995 789999998899999999999999999999999999999999999999999999999999999865322
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~Di 318 (518)
.. .......+.|||+.|||||++.+. .|+.++||
T Consensus 212 ~~---------------------------------------------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~Di 246 (398)
T 4b99_A 212 PA---------------------------------------------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246 (398)
T ss_dssp -------------------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred cc---------------------------------------------ccccccccceeChHhcCHHHhcCCCCCCChhhe
Confidence 10 011223478999999999999875 56999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc------------------CCC---------CCCCChhHHHHHH
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK------------------FPD---------DSKLSPEAKDLIC 371 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~------------------~p~---------~~~~s~~~~dLI~ 371 (518)
||+|||+|||++|++||.+.+...++..|+.....+. +|. ...+|++++|||.
T Consensus 247 WSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 326 (398)
T 4b99_A 247 WSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLG 326 (398)
T ss_dssp HHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHH
T ss_pred ehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHH
Confidence 9999999999999999999999999988876432211 111 1247899999999
Q ss_pred HHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
+||+ ||.+|+ +|.|+++||||+...
T Consensus 327 ~mL~~dP~~R~---ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 327 RMLRFEPSARI---SAAAALRHPFLAKYH 352 (398)
T ss_dssp HHSCSSTTTSC---CHHHHTTSGGGTTTC
T ss_pred HHCcCChhHCc---CHHHHhcCHhhCcCC
Confidence 9999 999999 899999999999754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-62 Score=489.89 Aligned_cols=268 Identities=26% Similarity=0.424 Sum_probs=204.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC------
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE------ 159 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~------ 159 (518)
+||++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 57999999999999999999999999999999997653 2334567899999999999999999999997543
Q ss_pred ------eEEEEEeecCCCchHHHHhhcCCC---CHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeec
Q 010116 160 ------YLYLIMEYLPGGDMMTLLMREDTL---TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (518)
Q Consensus 160 ------~lylVmEy~~gG~L~~~l~~~~~l---~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DF 230 (518)
++|||||||+||+|.+++.....+ ++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 589999999999999999876544 45678999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 310 (518)
|+|+.+.......... + .........+.||||.|||||++.+.
T Consensus 163 Gla~~~~~~~~~~~~~-----------------------------~--------~~~~~~~~~~~~GT~~YmAPE~~~~~ 205 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVL-----------------------------T--------PMPAYARHTGQVGTKLYMSPEQIHGN 205 (299)
T ss_dssp CCC---------------------------------------------------------------CCCTTSCHHHHTTC
T ss_pred ccceecCCCccccccc-----------------------------c--------ccccccccCCcccCccccCHHHHcCC
Confidence 9999765321100000 0 00011123467999999999999999
Q ss_pred CCCccccccchhHHHHHHHhCCCCCCCCCh-hhHHHHHhhhcCcccCCC-CCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDP-ITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
+|+.++|||||||++|||++ ||.+... ......+.. ..+|. ....++.+++||.+||. ||.+|+ ++.
T Consensus 206 ~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ 275 (299)
T 4g31_A 206 SYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERP---EAI 275 (299)
T ss_dssp CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSC---CHH
T ss_pred CCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCc---CHH
Confidence 99999999999999999996 8865432 122233322 23332 12357889999999998 999999 899
Q ss_pred hhhcCcccccCCccc
Q 010116 388 QIKAHPWFKDVVWDK 402 (518)
Q Consensus 388 eil~Hpff~~i~w~~ 402 (518)
||++||||++++|..
T Consensus 276 eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 276 NIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHTSGGGCCC----
T ss_pred HHhcCHhhCCCCCCC
Confidence 999999999999853
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-60 Score=494.30 Aligned_cols=283 Identities=27% Similarity=0.446 Sum_probs=214.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCe
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 160 (518)
.++|++++.||+|+||+||+|+++ .+++.||||++.+.. ....+.+|+.+|+.+ +|||||+++++|++.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 468999999999999999999986 467899999987642 345678899999998 69999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC-CcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~-g~vKL~DFGla~~~~~~ 239 (518)
+|||||||+||+|.+++ +.+++.+++.|+.||+.||+|||++|||||||||+|||++.+ |++||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999999999998 359999999999999999999999999999999999999877 89999999999876543
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~Di 318 (518)
......-... ........... ......+.....+.|||+.|||||++.+. .|+.++||
T Consensus 172 ~~~~~~~~~~---~~~~~~~~~~~------------------~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di 230 (361)
T 4f9c_A 172 KIELLKFVQS---EAQQERCSQNK------------------CSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM 230 (361)
T ss_dssp SCGGGGGC-----------------------------------------------CCCCGGGCCHHHHTTCSCCCTHHHH
T ss_pred cccccccccc---ccccccccccc------------------ccccccccccccccccCccccCHHHHcCCCCCCCccch
Confidence 2111000000 00000000000 00001122345578999999999999875 58999999
Q ss_pred cchhHHHHHHHhCCCCCCCC-ChhhHHHHHhhhcCc--------------------------------------------
Q 010116 319 WSLGAIMYEMLVGYPPFYAD-DPITTCRKIVHWRNH-------------------------------------------- 353 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~-------------------------------------------- 353 (518)
||+|||+|||++|++||... +..+.+..|....+.
T Consensus 231 WSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~ 310 (361)
T 4f9c_A 231 WSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTS 310 (361)
T ss_dssp HHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----------
T ss_pred hhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccc
Confidence 99999999999999999654 444555544331100
Q ss_pred ------ccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 354 ------LKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 354 ------l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
...+.+..+|++++|||++||+ ||.+|+ +|+|+++||||++++
T Consensus 311 ~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~---ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 311 DIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRI---TAEEALLHPFFKDMS 360 (361)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGTTC-
T ss_pred ccccccccccccccCCHHHHHHHHHHCcCChhHCc---CHHHHhcCcccCCCC
Confidence 0111234689999999999999 999999 899999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=521.82 Aligned_cols=264 Identities=30% Similarity=0.500 Sum_probs=237.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+|+++|++...+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999976532 3356788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC--CcEEEeecccccccCCCcc
Q 010116 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN--GHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 165 mEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~--g~vKL~DFGla~~~~~~~~ 241 (518)
||||+||+|.++|.. .+.+++..++.|++||+.||+|||++|||||||||+|||++.+ |++||+|||+|+.+...
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 999999999999964 4689999999999999999999999999999999999999864 89999999999976422
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
....+.|||+.|||||++.+.+|+.++|||||
T Consensus 311 ------------------------------------------------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSl 342 (573)
T 3uto_A 311 ------------------------------------------------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342 (573)
T ss_dssp ------------------------------------------------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred ------------------------------------------------CceeeeEECccccCHHHhCCCCCCcHHHHHHH
Confidence 12346799999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
||+||||++|.+||.+.+..+++.+|......+..+....+|++++|||.+||+ ||.+|+ ++.|+++||||+..+|
T Consensus 343 Gvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~---t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 343 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcCcCCCCC
Confidence 999999999999999999999999998754333333345799999999999998 999999 8999999999999998
Q ss_pred cccc
Q 010116 401 DKLY 404 (518)
Q Consensus 401 ~~l~ 404 (518)
....
T Consensus 420 ~~~~ 423 (573)
T 3uto_A 420 PGRD 423 (573)
T ss_dssp TTTT
T ss_pred CCch
Confidence 7653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-59 Score=506.41 Aligned_cols=295 Identities=33% Similarity=0.647 Sum_probs=253.4
Q ss_pred hhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 77 ~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
.+.+..+..++|+++++||+|+||.||+|+++.+|+.||||++.+..+........+.+|+.+|+.++|||||+++++|+
T Consensus 175 ~l~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 175 WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp HHHTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 34566788999999999999999999999999999999999999887766777788999999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
+.+.+|+|||||+||+|..++...+ .+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccce
Confidence 9999999999999999999997654 49999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCc
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 314 (518)
.+.... ...+.+||+.|+|||++.+.+|+.
T Consensus 335 ~~~~~~--------------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~ 364 (576)
T 2acx_A 335 HVPEGQ--------------------------------------------------TIKGRVGTVGYMAPEVVKNERYTF 364 (576)
T ss_dssp ECCTTC--------------------------------------------------CEECCCSCGGGCCHHHHTTCEESS
T ss_pred ecccCc--------------------------------------------------cccccCCCccccCHHHHcCCCCCc
Confidence 653210 123568999999999999999999
Q ss_pred cccccchhHHHHHHHhCCCCCCCCC----hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--Chh
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADD----PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAH 387 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~ 387 (518)
++|||||||++|||++|.+||.+.+ ...+...+.. ....+| ..+|+++++||.+||+ ||.+|+|+. +++
T Consensus 365 ~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~ 440 (576)
T 2acx_A 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAR 440 (576)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHH
T ss_pred cchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHH
Confidence 9999999999999999999998764 3344555544 344555 4689999999999998 999999874 799
Q ss_pred hhhcCcccccCCccccc--cccCCccccCCC-----cccCCCCCC
Q 010116 388 QIKAHPWFKDVVWDKLY--EMEAAFKPEING-----ELDTQNFMK 425 (518)
Q Consensus 388 eil~Hpff~~i~w~~l~--~~~~p~~p~~~~-----~~d~~~f~~ 425 (518)
||++||||++++|+.+. .+.|||+|.+.. ..|+.+|..
T Consensus 441 eil~HpfF~~i~w~~l~~~~~~pp~~p~~~~~~~~~~~d~~~f~~ 485 (576)
T 2acx_A 441 EVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFST 485 (576)
T ss_dssp HHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCCCC-----------
T ss_pred HHHhChhhccCCHHHHhcCCCCCCCCCCccccccCCcccHhhccc
Confidence 99999999999999996 578999998753 445555544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-58 Score=499.31 Aligned_cols=284 Identities=35% Similarity=0.635 Sum_probs=252.8
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
....+..++|+++++||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++.
T Consensus 178 ~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK 257 (543)
T ss_dssp HTSCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence 34667889999999999999999999999999999999999988776667788899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~----~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
..+|+||||++||+|..++... ..+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 9999999999999999999763 479999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCc
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 314 (518)
.+.... ....+.+||+.|+|||++.+.+|+.
T Consensus 338 ~~~~~~-------------------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~ 368 (543)
T 3c4z_A 338 ELKAGQ-------------------------------------------------TKTKGYAGTPGFMAPELLLGEEYDF 368 (543)
T ss_dssp ECCTTC-------------------------------------------------CCBCCCCSCTTTSCHHHHTTCCBCT
T ss_pred eccCCC-------------------------------------------------cccccccCCccccChhhhcCCCCCh
Confidence 653210 0123568999999999999999999
Q ss_pred cccccchhHHHHHHHhCCCCCCCCC----hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--Chh
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADD----PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAH 387 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~ 387 (518)
++|||||||++|||++|.+||.+.+ .......+.. ....+| ..+|+++++||.+||+ ||.+|++.. +++
T Consensus 369 ~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ 444 (543)
T 3c4z_A 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCD 444 (543)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSH
T ss_pred HHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCC--cccCHHHHHHHHHhccCCHhHCCCCcccCHH
Confidence 9999999999999999999998763 3456666665 345555 4789999999999998 999999864 689
Q ss_pred hhhcCcccccCCccccc--cccCCccccCC
Q 010116 388 QIKAHPWFKDVVWDKLY--EMEAAFKPEIN 415 (518)
Q Consensus 388 eil~Hpff~~i~w~~l~--~~~~p~~p~~~ 415 (518)
+|++||||++++|..+. .+.|||+|.+.
T Consensus 445 ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~ 474 (543)
T 3c4z_A 445 GLRTHPLFRDISWRQLEAGMLTPPFVPDSR 474 (543)
T ss_dssp HHHTSGGGTTCCHHHHHTTCSCCSCCCCSS
T ss_pred HHHcCccccCCCHHHHHcCCCCCCCCCCcc
Confidence 99999999999999996 57899999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=494.79 Aligned_cols=295 Identities=41% Similarity=0.762 Sum_probs=252.1
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+..........++.+|+.+|+.++||||++++++|.+.+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 45567789999999999999999999999999999999998876656666777889999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|||||||+||+|..++.+...+++..++.++.||+.||+|||+ +|||||||||+||||+.+|++||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999999988999999999999999999999998 9999999999999999999999999999975321
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
.. ....+.+||+.|+|||++.+..|+.++||
T Consensus 302 ~~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 332 (446)
T 4ejn_A 302 DG-------------------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332 (446)
T ss_dssp ------------------------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHH
T ss_pred CC-------------------------------------------------cccccccCCccccCHhhcCCCCCCCccch
Confidence 10 11235789999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWF 395 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff 395 (518)
|||||++|||++|.+||.+.+.......+.. ..+.+|. .+++++++||.+||. ||.+|+++. +++||++||||
T Consensus 333 wslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred hhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 9999999999999999999999888888876 4556664 689999999999998 999999754 79999999999
Q ss_pred ccCCccccc--cccCCccccCCCcccCCCCCCCC
Q 010116 396 KDVVWDKLY--EMEAAFKPEINGELDTQNFMKFD 427 (518)
Q Consensus 396 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~ 427 (518)
++++|+.+. ++.|||+|.+.++.|+++|+...
T Consensus 409 ~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~ 442 (446)
T 4ejn_A 409 AGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEF 442 (446)
T ss_dssp TTCCHHHHHTTCSCCSCCCSCSSTTCCTTC----
T ss_pred cCCCHHHHhhCcCCCCccCCCCCccchhhcchhh
Confidence 999999985 58899999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=480.42 Aligned_cols=281 Identities=31% Similarity=0.645 Sum_probs=248.4
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
...+..++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|+.+|+.++|||||+++++|++..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 35677899999999999999999999999999999999999887777777889999999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||++||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CCCCccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMEC 316 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~ 316 (518)
....+.+||+.|+|||++.+ .+|+.++
T Consensus 169 --------------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 198 (384)
T 4fr4_A 169 --------------------------------------------------TQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198 (384)
T ss_dssp --------------------------------------------------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTH
T ss_pred --------------------------------------------------CceeccCCCccccCCeeeccCCCCCCCccc
Confidence 11236789999999999974 5699999
Q ss_pred cccchhHHHHHHHhCCCCCCCCCh---hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDP---ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
|||||||++|||++|.+||...+. ......+.. ....+| ..+|+++.+||.+||. ||.+|++ ++++|++|
T Consensus 199 DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p--~~~s~~~~~li~~lL~~dP~~R~s--~~~~l~~h 272 (384)
T 4fr4_A 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYP--SAWSQEMVSLLKKLLEPNPDQRFS--QLSDVQNF 272 (384)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHSCSSGGGSCC--SHHHHHTS
T ss_pred eeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCC--CcCCHHHHHHHHHHhcCCHhHhcc--cHHHHHcC
Confidence 999999999999999999985433 333333333 344555 4689999999999998 9999995 39999999
Q ss_pred cccccCCccccc--cccCCccccCCC
Q 010116 393 PWFKDVVWDKLY--EMEAAFKPEING 416 (518)
Q Consensus 393 pff~~i~w~~l~--~~~~p~~p~~~~ 416 (518)
|||++++|+.+. ++.|||+|....
T Consensus 273 p~f~~~~w~~~~~~~~~p~~~p~~~~ 298 (384)
T 4fr4_A 273 PYMNDINWDAVFQKRLIPGFIPNKGR 298 (384)
T ss_dssp GGGTTCCHHHHHTTCSCCCCCCSCCS
T ss_pred hhhhcCCHHHHHhCCCCCCCCCCCCC
Confidence 999999999986 588999998643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-59 Score=470.66 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=223.2
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 155 (518)
..+..++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.+|+.++|||||+++++|
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 3566789999999999999999999875 46889999999764 234457799999999999999999999999
Q ss_pred ecCCeEEEEEeecCCCchHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC
Q 010116 156 QDTEYLYLIMEYLPGGDMMTLLMRE-------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN 222 (518)
Q Consensus 156 ~~~~~lylVmEy~~gG~L~~~l~~~-------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~ 222 (518)
.+.+.+|||||||+||+|.++|.+. ..+++..+..++.|++.||.|||+++||||||||+||||+.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 9999999999999999999999764 369999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCcc
Q 010116 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (518)
Q Consensus 223 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 302 (518)
+++||+|||+|+....... .......+||+.||
T Consensus 165 ~~~Ki~DFGla~~~~~~~~-----------------------------------------------~~~~~~~~gt~~ym 197 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDY-----------------------------------------------YRVGGHTMLPIRWM 197 (299)
T ss_dssp GCEEECCCSCHHHHTGGGC-----------------------------------------------EEETTTEEECGGGC
T ss_pred CcEEECCcccceecCCCCc-----------------------------------------------eeecCceecChhhc
Confidence 9999999999986532210 11223567999999
Q ss_pred ChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-ccccc
Q 010116 303 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380 (518)
Q Consensus 303 APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R 380 (518)
|||++.+..|+.++|||||||++|||+| |++||.+.+..+....|.... .+..| ..+|+++.+||.+||. ||.+|
T Consensus 198 APE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~~~~li~~cl~~dP~~R 274 (299)
T 4asz_A 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRP--RTCPQEVYELMLGCWQREPHMR 274 (299)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGS
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999999999998 999999999988888887742 34444 4789999999999998 99999
Q ss_pred CCCCChhhhhcCccccc
Q 010116 381 LGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 381 ~g~~~a~eil~Hpff~~ 397 (518)
| ++.+| |+|++.
T Consensus 275 P---s~~~i--~~~L~~ 286 (299)
T 4asz_A 275 K---NIKGI--HTLLQN 286 (299)
T ss_dssp C---CHHHH--HHHHHH
T ss_pred c---CHHHH--HHHHHH
Confidence 9 89998 567754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=469.83 Aligned_cols=292 Identities=42% Similarity=0.794 Sum_probs=239.6
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
..+..++|++++.||+|+||.||+|++. .+|+.||||++++..... ......+.+|+.+|+.++||||++++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4567789999999999999999999985 689999999998764332 234566789999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999998753
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
... .....+.+||+.|+|||++.+..|+.++
T Consensus 172 ~~~-------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 202 (327)
T 3a62_A 172 IHD-------------------------------------------------GTVTHTFCGTIEYMAPEILMRSGHNRAV 202 (327)
T ss_dssp --------------------------------------------------------CTTSSCCTTSCHHHHTTSCCCTHH
T ss_pred ccC-------------------------------------------------CccccccCCCcCccCHhhCcCCCCCCcc
Confidence 211 0112356899999999999999999999
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCc
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHP 393 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hp 393 (518)
|||||||++|+|++|.+||.+.+......++... .+.+|. .+++++++||.+||. ||.+|++.. ++.++++||
T Consensus 203 DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 203 DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred cchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 9999999999999999999999988888888873 445553 689999999999998 999999765 899999999
Q ss_pred ccccCCccccc--cccCCccccCCCcccCCCCCC
Q 010116 394 WFKDVVWDKLY--EMEAAFKPEINGELDTQNFMK 425 (518)
Q Consensus 394 ff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~ 425 (518)
||++++|+.+. ...|||+|.+....|.++|+.
T Consensus 279 ~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~~ 312 (327)
T 3a62_A 279 FFRHINWEELLARKVEPPFKPLLQSEEDVSQFDS 312 (327)
T ss_dssp GGSSCCHHHHHTTCSCCSCCCC------------
T ss_pred cccCCCHHHHhhccCCCCCCCCcCChhhhhhcch
Confidence 99999999885 578999999999999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=465.63 Aligned_cols=257 Identities=22% Similarity=0.377 Sum_probs=217.4
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 154 (518)
...+..+||.+.++||+|+||+||+|+.+ .++..||||++++. .....+.+.+|+.+|+.++|||||+++++
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34567789999999999999999999865 46889999999764 23445779999999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMRE---------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 219 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~---------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl 219 (518)
|.+.+.+|||||||+||+|.++|.+. .++++..+..|+.|++.||.|||+++||||||||+||||
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 99999999999999999999999653 368999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCC
Q 010116 220 DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299 (518)
Q Consensus 220 d~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~ 299 (518)
+.++++||+|||+|+.+..... .....+.+||+
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~-----------------------------------------------~~~~~~~~gt~ 224 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDY-----------------------------------------------YRVGGRTMLPI 224 (329)
T ss_dssp ETTTEEEECCCC---------------------------------------------------------------CCCCG
T ss_pred CCCCcEEEcccccceeccCCCc-----------------------------------------------ceecCcccccc
Confidence 9999999999999986532210 01123568999
Q ss_pred CccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cc
Q 010116 300 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 300 ~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp 377 (518)
.|||||++.+..|+.++|||||||+||||+| |++||.+.+..+....|... ..+.+| ..+|+++.+||.+||. ||
T Consensus 225 ~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-~~~~~p--~~~~~~~~~li~~cl~~dP 301 (329)
T 4aoj_A 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELERP--RACPPEVYAIMRGCWQREP 301 (329)
T ss_dssp GGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHCCSST
T ss_pred cccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCc--ccccHHHHHHHHHHcCcCh
Confidence 9999999999999999999999999999999 99999999998888888764 244455 4789999999999998 99
Q ss_pred cccCCCCChhhhhcC
Q 010116 378 EHRLGTGGAHQIKAH 392 (518)
Q Consensus 378 ~~R~g~~~a~eil~H 392 (518)
.+|| ++.||+++
T Consensus 302 ~~RP---s~~ei~~~ 313 (329)
T 4aoj_A 302 QQRH---SIKDVHAR 313 (329)
T ss_dssp TTSC---CHHHHHHH
T ss_pred hHCc---CHHHHHHH
Confidence 9999 89999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=459.70 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=222.0
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 154 (518)
-.++..+++++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|+.++|||||+++++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 34567789999999999999999999853 467899999997542 23345679999999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCcee
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLL 218 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNIL 218 (518)
+.+++.+|||||||+||+|.++|... ..+++..+..++.||+.||+|||+++||||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 99999999999999999999999643 45899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCC
Q 010116 219 LDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGT 298 (518)
Q Consensus 219 ld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT 298 (518)
|++++++||+|||+|+.+.... ......+.+||
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~-----------------------------------------------~~~~~~~~~gt 210 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAAD-----------------------------------------------YYKLLGNSLLP 210 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGG-----------------------------------------------CBCSSSSSCBC
T ss_pred ECCCCCEEECCcccceeccCCC-----------------------------------------------ceeEecccccC
Confidence 9999999999999998653211 01123357899
Q ss_pred CCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-c
Q 010116 299 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-D 376 (518)
Q Consensus 299 ~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-d 376 (518)
+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+..+....|... ..++.| ..+|+++.+||.+||. |
T Consensus 211 ~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~C~~~d 287 (308)
T 4gt4_A 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QVLPCP--DDCPAWVYALMIECWNEF 287 (308)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSS
T ss_pred CcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCc--ccchHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999998 89999999998888888763 233344 4789999999999998 9
Q ss_pred ccccCCCCChhhhhcC
Q 010116 377 VEHRLGTGGAHQIKAH 392 (518)
Q Consensus 377 p~~R~g~~~a~eil~H 392 (518)
|.+|| ++.||+++
T Consensus 288 P~~RP---s~~ei~~~ 300 (308)
T 4gt4_A 288 PSRRP---RFKDIHSR 300 (308)
T ss_dssp GGGSC---CHHHHHHH
T ss_pred hhHCc---CHHHHHHH
Confidence 99999 89999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=458.32 Aligned_cols=258 Identities=21% Similarity=0.264 Sum_probs=211.6
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.|++..++|++.+.||+|+||+||+|+.+ ..||||+++... ......+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 57888999999999999999999999754 359999987543 234456789999999999999999999998754 5
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|||||||+||+|.++|... ..+++..+..++.|++.||+|||++|||||||||+||||+++|++||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 689999999999999999764 6899999999999999999999999999999999999999999999999999986532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CCCCcc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGME 315 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~ 315 (518)
.. ....+.+.+||+.|||||++.+ ..|+.+
T Consensus 185 ~~-----------------------------------------------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k 217 (307)
T 3omv_A 185 WS-----------------------------------------------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217 (307)
T ss_dssp --------------------------------------------------------CCCCTTSCCHHHHHCCSSCCCCHH
T ss_pred CC-----------------------------------------------cceeecccccCCCccCHHHhhccCCCCCCcH
Confidence 10 0012336799999999999974 459999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhc-CcccCC-CCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWR-NHLKFP-DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~l~~p-~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+|||||||+||||++|++||.+.+.......++... .....+ .+..+|+++.+||.+||. ||.+|| ++.||+++
T Consensus 218 sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~~ 294 (307)
T 3omv_A 218 SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERP---LFPQILSS 294 (307)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSC---CHHHHHHH
T ss_pred HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 999999999999999999999877666555555421 111111 134689999999999998 999999 78887643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-57 Score=464.00 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=221.3
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC-CceeEEE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKLY 152 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~ 152 (518)
.+|++..++|++++.||+|+||+||+|++..+ ++.||||++.... .....+.+.+|+.+|..+.| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 35678889999999999999999999998754 3689999997653 23345678999999999976 8999999
Q ss_pred EEeec-CCeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010116 153 YSFQD-TEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (518)
Q Consensus 153 ~~f~~-~~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPe 215 (518)
++|.+ ...+|||||||+||+|.++|... ..+++..+..|+.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 99865 56799999999999999999653 34899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccc
Q 010116 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (518)
Q Consensus 216 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 295 (518)
||||+.+|++||+|||+|+.+..... ...+.+.
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~-----------------------------------------------~~~~~~~ 247 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPD-----------------------------------------------YVRKGDA 247 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTT-----------------------------------------------SEEETTE
T ss_pred ceeeCCCCCEEECcchhhhhcccCCC-----------------------------------------------ceeeccc
Confidence 99999999999999999986542210 0123367
Q ss_pred cCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHh
Q 010116 296 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374 (518)
Q Consensus 296 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL 374 (518)
+||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+....+.+++.....+..| ..+|+++.+||.+||
T Consensus 248 ~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p--~~~~~~~~~li~~c~ 325 (353)
T 4ase_A 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCW 325 (353)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHT
T ss_pred cccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCC--ccCCHHHHHHHHHHc
Confidence 89999999999999999999999999999999998 999999877655555555433445555 468999999999999
Q ss_pred c-cccccCCCCChhhhhcC
Q 010116 375 C-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~H 392 (518)
. ||.+|| ++.||++|
T Consensus 326 ~~dP~~RP---t~~eil~~ 341 (353)
T 4ase_A 326 HGEPSQRP---TFSELVEH 341 (353)
T ss_dssp CSSGGGSC---CHHHHHHH
T ss_pred CcChhHCc---CHHHHHHH
Confidence 8 999999 89999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=455.09 Aligned_cols=268 Identities=30% Similarity=0.501 Sum_probs=237.3
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
..++|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||++++++|.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 34689999999999999999999999999999999987653321 135678999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC----cEEEeeccccccc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPL 236 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g----~vKL~DFGla~~~ 236 (518)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999998888999999999999999999999999999999999999998887 8999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
.... ...+.+||+.|+|||++.+..|+.++
T Consensus 170 ~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 199 (361)
T 2yab_A 170 EDGV--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEA 199 (361)
T ss_dssp CTTC--------------------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred CCCC--------------------------------------------------ccccCCCCccEECchHHcCCCCCccc
Confidence 3210 12256899999999999999999999
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
|||||||++|+|++|.+||.+.+....+..|......+..+.+..+|+++++||.+||+ ||.+|+ ++.|+++||||
T Consensus 200 DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~ 276 (361)
T 2yab_A 200 DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL---TIQEALRHPWI 276 (361)
T ss_dssp HHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSTTT
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCc---CHHHHhcCcCc
Confidence 99999999999999999999999999988887743222211234689999999999998 999999 89999999999
Q ss_pred ccCCccccc
Q 010116 396 KDVVWDKLY 404 (518)
Q Consensus 396 ~~i~w~~l~ 404 (518)
++++|....
T Consensus 277 ~~~~~~~~~ 285 (361)
T 2yab_A 277 TPVDTQQAM 285 (361)
T ss_dssp SCSSHHHHH
T ss_pred CCCchhhhh
Confidence 999997664
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=451.92 Aligned_cols=291 Identities=43% Similarity=0.777 Sum_probs=242.3
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhh-chhhHHHHHHHHHHHHHh-CCCceeEEEEEe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMV-KRGQVEHVRAERNLLAEV-ASHCIVKLYYSF 155 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f 155 (518)
..+..++|++++.||+|+||.||+|++. .+|+.||||++++.... .....+.+.+|+.+|..+ +||||++++++|
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3455689999999999999999999984 58999999999765432 122345577899999999 699999999999
Q ss_pred ecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 156 QDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 156 ~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.+...+|+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+||||+.+|++||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCC
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYG 313 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~ 313 (518)
+.... .......+||+.|+|||++.+ ..++
T Consensus 209 ~~~~~------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 240 (355)
T 1vzo_A 209 FVADE------------------------------------------------TERAYDFCGTIEYMAPDIVRGGDSGHD 240 (355)
T ss_dssp CCGGG------------------------------------------------GGGGCGGGSCCTTCCHHHHTTCC---C
T ss_pred cccCC------------------------------------------------CCcccCcccCcCccChhhhcCCCCCCC
Confidence 53210 012235789999999999986 4588
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCCh----hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--Ch
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDP----ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GA 386 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a 386 (518)
.++|||||||++|||++|..||..... ......+.. ....+| ..+++.+++||.+||. ||.+|+++. ++
T Consensus 241 ~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~s~ 316 (355)
T 1vzo_A 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDA 316 (355)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred chhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCC--cccCHHHHHHHHHHhhhCHHHhcCCCCCCH
Confidence 999999999999999999999976433 233333433 233344 4689999999999998 999999765 89
Q ss_pred hhhhcCcccccCCccccc--cccCCccccCCCcccCCCC
Q 010116 387 HQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF 423 (518)
Q Consensus 387 ~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f 423 (518)
.++++||||.+++|..+. ...+||.|.+.++.|.+||
T Consensus 317 ~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 317 DEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355 (355)
T ss_dssp HHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred HHHHcCcchhcCChhHhhhccCCCCCCCccccccccccC
Confidence 999999999999999986 4779999999999999887
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=440.11 Aligned_cols=260 Identities=29% Similarity=0.519 Sum_probs=233.5
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
....++|++++.||+|+||.||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+...+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 3456899999999999999999999999999999999987643 334567788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999997653210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC-ccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG-MECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiWS 320 (518)
...+.+||+.|+|||++.+..|. .++||||
T Consensus 169 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 199 (328)
T 3fe3_A 169 -------------------------------------------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWS 199 (328)
T ss_dssp -------------------------------------------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHH
T ss_pred -------------------------------------------------ccccccCCcceeCcccccCCCcCCchhhhhh
Confidence 12357899999999999988874 8999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
|||++|+|++|.+||.+.+.......+... ...+|. .+|+++.+||.+||. ||.+|+ +++||++||||+...
T Consensus 200 lG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 200 LGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPF--YMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHCCSSTTTSC---CHHHHTTCTTTTTTC
T ss_pred hHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHCCCChhHCc---CHHHHhcCHhhcCCC
Confidence 999999999999999999998888888773 445553 689999999999999 999999 899999999998643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=444.96 Aligned_cols=279 Identities=29% Similarity=0.545 Sum_probs=233.7
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lyl 163 (518)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... ...+|+.+|..+ +|||||+++++|++...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3679999999999999999999999999999999987532 134678888887 79999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-C---CcEEEeecccccccCCC
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-N---GHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-~---g~vKL~DFGla~~~~~~ 239 (518)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+.. + +++||+|||+|+.....
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999999999998899999999999999999999999999999999999999844 3 35999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
. ....+.+||+.|+|||++.+.+|+.++|||
T Consensus 174 ~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 204 (342)
T 2qr7_A 174 N-------------------------------------------------GLLMTPCYTANFVAPEVLERQGYDAACDIW 204 (342)
T ss_dssp T-------------------------------------------------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHH
T ss_pred C-------------------------------------------------CceeccCCCccccCHHHhcCCCCCCccCee
Confidence 0 112357899999999999998999999999
Q ss_pred chhHHHHHHHhCCCCCCC---CChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 320 SLGAIMYEMLVGYPPFYA---DDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~---~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
||||++|||++|.+||.+ .+.......|......+..+.+..+|+++++||.+||. ||.+|+ ++.++++||||
T Consensus 205 slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~~il~hp~~ 281 (342)
T 2qr7_A 205 SLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL---TAALVLRHPWI 281 (342)
T ss_dssp HHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHH
T ss_pred eHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCCee
Confidence 999999999999999986 34556666776633222222345789999999999998 999999 89999999999
Q ss_pred ccCCccccc--cccCCccccCCCcccCCCCC
Q 010116 396 KDVVWDKLY--EMEAAFKPEINGELDTQNFM 424 (518)
Q Consensus 396 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~ 424 (518)
. +|+.+. ++.+|+.|......+..+|.
T Consensus 282 ~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 310 (342)
T 2qr7_A 282 V--HWDQLPQYQLNRQDAPHLVKGAMAATYS 310 (342)
T ss_dssp H--TGGGSCCSCCCCCCCHHHHHHHHHHHHH
T ss_pred c--CccccccccCCCccchhhhhhHHHHHHh
Confidence 6 688775 46677777654433443443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=431.01 Aligned_cols=266 Identities=30% Similarity=0.496 Sum_probs=233.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||++++++|.+...+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3579999999999999999999999999999999987543221 1356788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC----cEEEeecccccccC
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLD 237 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g----~vKL~DFGla~~~~ 237 (518)
|+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++ ++||+|||+|+...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888999999999999999999999999999999999999999888 89999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
... .....+||+.|+|||++.+..|+.++|
T Consensus 170 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 199 (326)
T 2y0a_A 170 FGN--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEAD 199 (326)
T ss_dssp TTS--------------------------------------------------CCCCCCSCTTTCCHHHHTTCCCCTHHH
T ss_pred CCC--------------------------------------------------ccccccCCcCcCCceeecCCCCCcHHH
Confidence 210 112467999999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
||||||++|+|++|.+||.+.+.......+......+..+....+|+++++||.+||. ||.+|+ ++.++++||||+
T Consensus 200 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~ 276 (326)
T 2y0a_A 200 MWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIK 276 (326)
T ss_dssp HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTS
T ss_pred HHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCC---CHHHHhcCCCcc
Confidence 9999999999999999999998888887777643222211124689999999999998 999999 899999999999
Q ss_pred cCCcccc
Q 010116 397 DVVWDKL 403 (518)
Q Consensus 397 ~i~w~~l 403 (518)
+.+|...
T Consensus 277 ~~~~~~~ 283 (326)
T 2y0a_A 277 PKDTQQA 283 (326)
T ss_dssp CCSHHHH
T ss_pred CCcchhh
Confidence 9887654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=436.91 Aligned_cols=259 Identities=31% Similarity=0.566 Sum_probs=230.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+++.++|||||+++++|.+...+|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3679999999999999999999999999999999987643 334567789999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC---cEEEeecccccccCCCcc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g---~vKL~DFGla~~~~~~~~ 241 (518)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 99999999999998888999999999999999999999999999999999999998654 59999999998653210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.....+||+.|+|||++.+..|+.++|||||
T Consensus 186 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 216 (362)
T 2bdw_A 186 -------------------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216 (362)
T ss_dssp -------------------------------------------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred -------------------------------------------------ccccCCCCccccCHHHHccCCCCchhhHHHH
Confidence 1125689999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||++|+|++|.+||.+.+.......+......+..+.+..+|+++++||.+||. ||.+|+ ++.++++||||.+
T Consensus 217 G~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 217 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSHHHHT
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCcccCC
Confidence 999999999999999999888888888754333333345689999999999998 999999 8999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=448.00 Aligned_cols=259 Identities=32% Similarity=0.589 Sum_probs=231.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|.++.+|+.||+|++.+.... ....+.+.+|+.+|+.++|||||+++++|.+.+.+|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999876432 334567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC---CCCcEEEeecccccccCCCccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---KNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld---~~g~vKL~DFGla~~~~~~~~~ 242 (518)
|||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-- 167 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-- 167 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--
Confidence 9999999999999999999999999999999999999999999999999999998 46889999999997653210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
....+.+||+.|+|||++.+..|+.++||||||
T Consensus 168 -----------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlG 200 (444)
T 3soa_A 168 -----------------------------------------------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG 200 (444)
T ss_dssp -----------------------------------------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred -----------------------------------------------ceeecccCCcccCCHHHhcCCCCCCccccHHHH
Confidence 112356899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|++|+|++|.+||.+.+.......+......+..+.+..+|+++++||.+||. ||.+|+ ++.|+++||||++
T Consensus 201 vilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~e~L~hp~~~~ 273 (444)
T 3soa_A 201 VILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI---TAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSCTTHH
T ss_pred HHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCC---CHHHHhcCccccC
Confidence 99999999999999999999999988755445555556899999999999998 999999 8999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-53 Score=428.18 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=227.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||.||+|+++.+++.||+|++... ......+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 57899999999999999999999999999999998754 23345688999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC--CCcEEEeecccccccCCCcc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~--~g~vKL~DFGla~~~~~~~~ 241 (518)
||||+||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++.+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999999999765 47999999999999999999999999999999999999997 8999999999998654221
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.....+||+.|+|||++.+..|+.++|||||
T Consensus 159 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 189 (321)
T 1tki_A 159 -------------------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp -------------------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred -------------------------------------------------ccccccCChhhcCcHHhcCCCCCchhhHHHH
Confidence 1225689999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||++|+|++|.+||.+.+.......+......+..+....+|+++++||.+||. ||.+|+ ++.|+++||||+.
T Consensus 190 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~ 263 (321)
T 1tki_A 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHS
T ss_pred HHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCc---CHHHHhcChhhcc
Confidence 999999999999999999988888888743222222234689999999999998 999999 8999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=418.08 Aligned_cols=258 Identities=30% Similarity=0.508 Sum_probs=226.9
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++++.||+|+||+||+|++..+|+.||+|++..... ...+.+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 35689999999999999999999999999999999976532 334668899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||||+||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 170 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (297)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred EEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc---
Confidence 9999999999999965 479999999999999999999999999999999999999999999999999988653210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
....+.+||+.|+|||++.+..|+.++|||||||
T Consensus 171 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 204 (297)
T 3fxz_A 171 ----------------------------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204 (297)
T ss_dssp ----------------------------------------------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHH
T ss_pred ----------------------------------------------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHH
Confidence 0122568999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
++|||++|.+||.+.+.......+... ....++.+..+++.+++||.+||. ||.+|+ ++.|+++||||+..
T Consensus 205 il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~h~~~~~~ 276 (297)
T 3fxz_A 205 MAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHHSSCTTTTSCHHHHHHHHHHH-CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhccc
Confidence 999999999999998887777666543 223333345789999999999998 999999 89999999999854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=434.78 Aligned_cols=257 Identities=32% Similarity=0.570 Sum_probs=226.6
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
...++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 44689999999999999999999999999999999998765554555567899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
+||||+ +|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--- 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--- 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC---
Confidence 999999 8899999988899999999999999999999999999999999999999999999999999998764321
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-Cccccccch
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSL 321 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSl 321 (518)
....+.+||+.|+|||++.+..| +.++|||||
T Consensus 162 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (336)
T 3h4j_B 162 -----------------------------------------------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194 (336)
T ss_dssp -----------------------------------------------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred -----------------------------------------------cccccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence 01225689999999999998887 789999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||++|+|++|.+||.+........++.. ....+| ..+|+++++||++||. ||.+|+ +++||++||||+.
T Consensus 195 G~il~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~p--~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 264 (336)
T 3h4j_B 195 GIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVYVMP--DFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFNV 264 (336)
T ss_dssp HHHHHHHHHSSCSSBCSSSTTCBCCCCS--SCCCCC--TTSCHHHHHHHHTTSCSSGGGSC---CHHHHTTCHHHHT
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCCCc--ccCCHHHHHHHHHHcCCChhHCc---CHHHHHhChhhcc
Confidence 9999999999999988766555444432 223334 4689999999999998 999999 8999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=419.77 Aligned_cols=266 Identities=29% Similarity=0.480 Sum_probs=221.6
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
.....++|++++.||+|+||+||+|++. +|+.||+|++.... ........+.+|+.+|+.++|||||+++++|.+...
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 4455789999999999999999999985 58999999997653 233445678899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+|+||||++ |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 999999997 4788877654 56999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 318 (518)
. ......+||+.|+|||++.+ ..|+.++||
T Consensus 173 ~-------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 203 (311)
T 3niz_A 173 V-------------------------------------------------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203 (311)
T ss_dssp C-------------------------------------------------C---CCCCCCTTCCHHHHTTCCSCCTHHHH
T ss_pred c-------------------------------------------------ccccCCcccCCcCCHHHhcCCCCCCchHHh
Confidence 0 01124579999999999987 568999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCC--------------------------CCCCCChhHHHHHHH
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFP--------------------------DDSKLSPEAKDLICR 372 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p--------------------------~~~~~s~~~~dLI~~ 372 (518)
|||||++|+|++|.+||.+.+.......+.......... ....+++++++||.+
T Consensus 204 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 283 (311)
T 3niz_A 204 WSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSN 283 (311)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHH
Confidence 999999999999999999888777777765422111100 012478899999999
Q ss_pred Hhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 373 LLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 373 lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
||+ ||.+|+ ++.|+++||||++++++
T Consensus 284 ~L~~dP~~Rp---t~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 284 MLCFDPNKRI---SARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp HSCSCTTTSC---CHHHHHTSGGGTTSCTT
T ss_pred HcCCChhHCC---CHHHHhcCcccccCCcc
Confidence 999 999999 89999999999998864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=413.22 Aligned_cols=260 Identities=27% Similarity=0.472 Sum_probs=217.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||++++++|.+...+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 3689999999999999999999999999999999976542 334456788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~-~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++| +|..++. ..+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--- 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC---
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc---
Confidence 999976 5555554 46789999999999999999999999999999999999999999999999999998653210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC-CCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlG 322 (518)
......+||+.|+|||++.+.. |+.++||||||
T Consensus 156 ----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 189 (292)
T 3o0g_A 156 ----------------------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189 (292)
T ss_dssp ----------------------------------------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred ----------------------------------------------ccccCCccccCCcChHHHcCCCCcCchHHHHHHH
Confidence 0112467999999999998765 89999999999
Q ss_pred HHHHHHHhCCCC-CCCCChhhHHHHHhhhcCccc---------------CC----------CCCCCChhHHHHHHHHhc-
Q 010116 323 AIMYEMLVGYPP-FYADDPITTCRKIVHWRNHLK---------------FP----------DDSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 323 vilyeml~G~~P-F~~~~~~~~~~~i~~~~~~l~---------------~p----------~~~~~s~~~~dLI~~lL~- 375 (518)
|++|+|++|..| |.+.+.......+........ ++ ....+++++++||.+||.
T Consensus 190 ~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 269 (292)
T 3o0g_A 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269 (292)
T ss_dssp HHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCS
T ss_pred HHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhcc
Confidence 999999987777 556666666666654211110 00 012478999999999998
Q ss_pred cccccCCCCChhhhhcCcccccC
Q 010116 376 DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||.+|+ +++|+++||||+++
T Consensus 270 dP~~R~---t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 270 NPVQRI---SAEEALQHPYFSDF 289 (292)
T ss_dssp SGGGSC---CHHHHHTSGGGTTC
T ss_pred ChhhCC---CHHHHhcCcccccC
Confidence 999999 89999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=431.89 Aligned_cols=263 Identities=30% Similarity=0.544 Sum_probs=224.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch--hhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR--GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~--~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+++.++|||||+++++|.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3579999999999999999999999999999999976543322 23577899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc---EEEeecccccc
Q 010116 163 LIMEYLPGGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKP 235 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~----~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~---vKL~DFGla~~ 235 (518)
+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888543 35899999999999999999999999999999999999987665 99999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
..... ....+.+||+.|+|||++.+..|+.+
T Consensus 183 ~~~~~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 213 (351)
T 3c0i_A 183 LGESG-------------------------------------------------LVAGGRVGTPHFMAPEVVKREPYGKP 213 (351)
T ss_dssp CCTTS-------------------------------------------------CBCCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred ecCCC-------------------------------------------------eeecCCcCCcCccCHHHHcCCCCCch
Confidence 53210 01225689999999999999999999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
+|||||||++|+|++|.+||.+.. ......+......+..+.+..+|+++++||.+||. ||.+|+ ++.++++|||
T Consensus 214 ~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~ 289 (351)
T 3c0i_A 214 VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI---TVYEALNHPW 289 (351)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHH
T ss_pred HhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcChh
Confidence 999999999999999999998754 45566666532222211224689999999999998 999999 8999999999
Q ss_pred cccCCc
Q 010116 395 FKDVVW 400 (518)
Q Consensus 395 f~~i~w 400 (518)
|++.++
T Consensus 290 ~~~~~~ 295 (351)
T 3c0i_A 290 LKERDR 295 (351)
T ss_dssp HHTHHH
T ss_pred hcCCcc
Confidence 987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=444.28 Aligned_cols=261 Identities=30% Similarity=0.556 Sum_probs=236.1
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
...+..++|.+++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+..
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45677899999999999999999999999999999999998876555556778999999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-Cccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~Di 318 (518)
....+.+||+.|+|||++.+..| +.++||
T Consensus 170 --------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 199 (476)
T 2y94_A 170 --------------------------------------------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDI 199 (476)
T ss_dssp --------------------------------------------------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHH
T ss_pred --------------------------------------------------ccccccCCCcCeEChhhccCCCCCCCccee
Confidence 01225689999999999998876 789999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|||||++|+|++|.+||.+.+......++... .+..| ..+++++++||.+||. ||.+|+ ++.+|++||||+.
T Consensus 200 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~Rp---t~~eil~hp~~~~ 272 (476)
T 2y94_A 200 WSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTP--QYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHT
T ss_pred hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcCCC--ccCCHHHHHHHHHHcCCCchhCc---CHHHHHhCHHhhh
Confidence 99999999999999999998888888888763 34444 4689999999999998 999999 8999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=433.36 Aligned_cols=281 Identities=26% Similarity=0.451 Sum_probs=214.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCC--eE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTE--YL 161 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~--~l 161 (518)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|..+. |||||+++++|...+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 478999999999999999999999999999999987542 33445567889999999997 999999999997544 79
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+|||||. |+|..++.. ..+++..++.++.|++.||.|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999996 689988865 6899999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 320 (518)
..... +...... ...+ ........+.+||+.|+|||++.+ ..|+.++||||
T Consensus 165 ~~~~~-----------~~~~~~~----------------~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 216 (388)
T 3oz6_A 165 VTNNI-----------PLSINEN----------------TENF-DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS 216 (388)
T ss_dssp CCCCG-----------GGCCC--------------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred ccccc-----------ccccccc----------------cccc-ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHH
Confidence 00000 0000000 0000 001122346799999999999987 67999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc-------------------------------------------CC
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK-------------------------------------------FP 357 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~-------------------------------------------~p 357 (518)
|||++|||++|.+||.+.+....+..|+....... ..
T Consensus 217 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (388)
T 3oz6_A 217 LGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296 (388)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccc
Confidence 99999999999999999998888877764211100 01
Q ss_pred CCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 358 DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 358 ~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
....+++++.+||.+||+ ||.+|+ +++|+++||||+.+.
T Consensus 297 ~~~~~~~~~~dll~~~L~~dP~~R~---t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 297 PKADCNEEALDLLDKLLQFNPNKRI---SANDALKHPFVSIFH 336 (388)
T ss_dssp TTCCCCHHHHHHHHHHCCSSGGGSC---CHHHHTTSTTTTTTC
T ss_pred ccccCCHHHHHHHHHhhccCcccCC---CHHHHhCCHHHHHhc
Confidence 112678999999999999 999999 899999999987643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=426.01 Aligned_cols=252 Identities=22% Similarity=0.256 Sum_probs=192.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC----eE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----YL 161 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----~l 161 (518)
.+|.+.+.||+|+||+||+|++ +|+.||||++..... .......|+.++..++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999976 689999999975431 1122334555567789999999999997653 68
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~--------giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
|||||||+||+|.++|.+ ..++++.+..++.|++.||.|||++ |||||||||+||||+.+|++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999965 5789999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC---
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--- 310 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--- 310 (518)
+........ ......+.+||+.|||||++.+.
T Consensus 156 ~~~~~~~~~---------------------------------------------~~~~~~~~~GT~~ymAPE~l~~~~~~ 190 (303)
T 3hmm_A 156 VRHDSATDT---------------------------------------------IDIAPNHRVGTKRYMAPEVLDDSINM 190 (303)
T ss_dssp EEEETTTTE---------------------------------------------ESCC-----CCGGGCCHHHHTTCSCT
T ss_pred ccccCCCCc---------------------------------------------eeeecccccccccccCHHHhcccccc
Confidence 865422100 00112356899999999999764
Q ss_pred ---CCCccccccchhHHHHHHHhCCCCCCCCC---------------hhhHHHHHhhhcCcccCCCC---CCCChhHHHH
Q 010116 311 ---GYGMECDWWSLGAIMYEMLVGYPPFYADD---------------PITTCRKIVHWRNHLKFPDD---SKLSPEAKDL 369 (518)
Q Consensus 311 ---~y~~~~DiWSlGvilyeml~G~~PF~~~~---------------~~~~~~~i~~~~~~l~~p~~---~~~s~~~~dL 369 (518)
.|+.++|||||||+||||++|.+||.... .......+......+.+|.. ...++.+.+|
T Consensus 191 ~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~l 270 (303)
T 3hmm_A 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 270 (303)
T ss_dssp TCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHH
T ss_pred cCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHH
Confidence 47889999999999999999988764321 11222233332222333321 1123467899
Q ss_pred HHHHhc-cccccCCCCChhhhhcC
Q 010116 370 ICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 370 I~~lL~-dp~~R~g~~~a~eil~H 392 (518)
|.+||. ||.+|| ++.||+++
T Consensus 271 i~~cl~~dP~~RP---t~~ei~~~ 291 (303)
T 3hmm_A 271 MRECWYANGAARL---TALRIKKT 291 (303)
T ss_dssp HHTTCCSSGGGSC---CHHHHHHH
T ss_pred HHHHcccCHhHCc---CHHHHHHH
Confidence 999998 999999 89998863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=441.73 Aligned_cols=292 Identities=25% Similarity=0.375 Sum_probs=209.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee-----cC
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-----DT 158 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-----~~ 158 (518)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. .......+.+.+|+.+|+.++|||||+++++|. +.
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 347899999999999999999999999999999999764 233445677899999999999999999999994 34
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..+|+||||+ +|+|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 6799999998 689999998888999999999999999999999999999999999999999999999999999987643
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHH--hhhcccccccccCCCCccChhhhc-CCCCCcc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHW--QMNRRKLAFSTVGTPDYIAPEVLL-KKGYGME 315 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~GT~~Y~APEvl~-~~~y~~~ 315 (518)
....... ...... .....+..+ ..+......+.+||+.|+|||++. +..|+.+
T Consensus 209 ~~~~~~~-------------~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 264 (458)
T 3rp9_A 209 PENGNSQ-------------LPISPR-----------EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA 264 (458)
T ss_dssp CTTCCCC-------------CC--------------------------------------CCCTTCCHHHHTTCCCCCTH
T ss_pred ccccccc-------------cccCcc-----------ccccccccccccccccccccCCcccccccChHHhhCCCCCCcH
Confidence 2110000 000000 000000000 001112345689999999999874 5679999
Q ss_pred ccccchhHHHHHHHh-----------CCCCCCCCCh--------------------hhHHHHHhhhcCcc----------
Q 010116 316 CDWWSLGAIMYEMLV-----------GYPPFYADDP--------------------ITTCRKIVHWRNHL---------- 354 (518)
Q Consensus 316 ~DiWSlGvilyeml~-----------G~~PF~~~~~--------------------~~~~~~i~~~~~~l---------- 354 (518)
+||||||||+|||++ |.+||.+.+. ......|....+..
T Consensus 265 ~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 344 (458)
T 3rp9_A 265 IDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344 (458)
T ss_dssp HHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSC
T ss_pred hHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCC
Confidence 999999999999999 7888876542 12222222210000
Q ss_pred --------cCC---------CCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccc
Q 010116 355 --------KFP---------DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 355 --------~~p---------~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~ 404 (518)
.+| ....+++++.|||.+||+ ||.+|+ +++|+++||||+++.|..+.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---t~~e~L~Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRI---TINECLAHPFFKEVRIAEVE 409 (458)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGTTTCCGGGC
T ss_pred HHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccC---CHHHHhcCHhhhhcCCCccC
Confidence 001 013568999999999999 999999 89999999999999998775
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=431.44 Aligned_cols=276 Identities=20% Similarity=0.314 Sum_probs=225.8
Q ss_pred cCCCCeeEEeeEeec--CceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 83 ICVDDFELLTIIGRG--AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G--~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
...++|++++.||+| +||.||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456789999999999 999999999999999999999987543 34556778899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 161 LYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999775 7899999999999999999999999999999999999999999999999999876432
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMEC 316 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~ 316 (518)
....... ........+||+.|+|||++.+ ..|+.++
T Consensus 181 ~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 218 (389)
T 3gni_B 181 HGQRQRV------------------------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 218 (389)
T ss_dssp TTEECSC------------------------------------------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHH
T ss_pred ccccccc------------------------------------------cccccccccccccccCHHHHhccCCCCCcHh
Confidence 1100000 0011224589999999999987 6899999
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc------------------------------------------c
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH------------------------------------------L 354 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~------------------------------------------l 354 (518)
|||||||++|||++|.+||.+.+.......++..... .
T Consensus 219 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (389)
T 3gni_B 219 DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298 (389)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------------------------
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCC
Confidence 9999999999999999999887766665554431100 0
Q ss_pred cCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccc
Q 010116 355 KFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 355 ~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~ 404 (518)
..+....+++++++||.+||. ||.+|+ ++.|+++||||+.+.|....
T Consensus 299 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~ell~hp~f~~~~~~~~~ 346 (389)
T 3gni_B 299 SHPYHRTFSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFKQIKRRASE 346 (389)
T ss_dssp -------CCHHHHHHHHHHTCSCTTTSC---CHHHHTTSGGGGGC---CCS
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCC---CHHHHhcCHHHHHHhhcchh
Confidence 111224578999999999999 999999 89999999999998875543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=430.27 Aligned_cols=260 Identities=29% Similarity=0.529 Sum_probs=228.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999976532 2345688999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC--CCcEEEeecccccccCCCcc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~--~g~vKL~DFGla~~~~~~~~ 241 (518)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++++||+|||+|+......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 9999999999999765 47999999999999999999999999999999999999974 5789999999998653210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.....+||+.|+|||++.+..|+.++|||||
T Consensus 206 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 236 (387)
T 1kob_A 206 -------------------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAI 236 (387)
T ss_dssp -------------------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred -------------------------------------------------ceeeeccCCCccCchhccCCCCCCcccEeeH
Confidence 1224689999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
||++|||++|.+||.+.+.......+......+..+....+|+++++||.+||. ||.+|+ ++.++++||||++..+
T Consensus 237 G~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 237 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSCCT
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhhCccccCCcc
Confidence 999999999999999999888888887643333333345789999999999998 999999 8999999999997544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=447.92 Aligned_cols=267 Identities=33% Similarity=0.604 Sum_probs=238.0
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
+..++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34468999999999999999999999999999999998776555566788999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee---CCCCcEEEeecccccccCCC
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl---d~~g~vKL~DFGla~~~~~~ 239 (518)
+|||||.||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||+ +.++++||+|||+|+.+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999999988999999999999999999999999999999999999999 56789999999999865322
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
. ...+.+||+.|+|||++.+ .|+.++|||
T Consensus 183 ~--------------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Diw 211 (484)
T 3nyv_A 183 K--------------------------------------------------KMKDKIGTAYYIAPEVLHG-TYDEKCDVW 211 (484)
T ss_dssp C--------------------------------------------------SHHHHTTGGGTCCHHHHHT-CCCTHHHHH
T ss_pred c--------------------------------------------------ccccCCCCccccCceeecC-CCCCcceeH
Confidence 1 1124689999999999976 699999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||||++|+|++|.+||.+.+......++......+..|.+..+|+++++||++||. ||.+|+ ++.|+++||||+..
T Consensus 212 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 212 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCc---CHHHHhhChhhccc
Confidence 99999999999999999999999999888765555556556799999999999998 999999 89999999999977
Q ss_pred Ccccc
Q 010116 399 VWDKL 403 (518)
Q Consensus 399 ~w~~l 403 (518)
.++.+
T Consensus 289 ~~~~~ 293 (484)
T 3nyv_A 289 TKEQI 293 (484)
T ss_dssp TC---
T ss_pred ccccc
Confidence 66443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=416.00 Aligned_cols=259 Identities=35% Similarity=0.654 Sum_probs=221.1
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc-----------------------hhhHHHHHHHHHH
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-----------------------RGQVEHVRAERNL 139 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-----------------------~~~~~~~~~E~~i 139 (518)
+..++|++++.||+|+||.||+|++..+|+.||||++.+..... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45689999999999999999999999999999999997754322 1224568899999
Q ss_pred HHHhCCCceeEEEEEeec--CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCce
Q 010116 140 LAEVASHCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (518)
Q Consensus 140 l~~l~hp~Iv~l~~~f~~--~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNI 217 (518)
|+.++||||+++++++.+ ...+|+||||++||+|.+++ ....+++..++.++.|++.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 67899999999999998865 456899999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccC
Q 010116 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (518)
Q Consensus 218 Lld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 297 (518)
|++.+|++||+|||+++...... ......+|
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------~~~~~~~g 199 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD-------------------------------------------------ALLSNTVG 199 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS-------------------------------------------------CEECCCCS
T ss_pred EECCCCCEEEecCCCcccccccc-------------------------------------------------ccccCCcC
Confidence 99999999999999998653211 01224689
Q ss_pred CCCccChhhhcCCC---CCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHh
Q 010116 298 TPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374 (518)
Q Consensus 298 T~~Y~APEvl~~~~---y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL 374 (518)
|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+.. ..+.+|....+++++++||.+||
T Consensus 200 t~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l 277 (298)
T 2zv2_A 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS--QALEFPDQPDIAEDLKDLITRML 277 (298)
T ss_dssp CGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCSSSCCCHHHHHHHHHHT
T ss_pred CccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc--ccCCCCCccccCHHHHHHHHHHh
Confidence 99999999998765 47899999999999999999999999887777777665 34566666689999999999999
Q ss_pred c-cccccCCCCChhhhhcCcccc
Q 010116 375 C-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
. ||.+|+ ++.||++||||+
T Consensus 278 ~~dp~~R~---s~~e~l~hp~~~ 297 (298)
T 2zv2_A 278 DKNPESRI---VVPEIKLHPWVT 297 (298)
T ss_dssp CSCTTTSC---CHHHHTTCHHHH
T ss_pred hcChhhCC---CHHHHhcCcccc
Confidence 8 999999 899999999996
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=409.00 Aligned_cols=260 Identities=35% Similarity=0.587 Sum_probs=232.1
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
..+..++|++++.||+|+||.||+|++..++..||+|++.+...........+.+|+.+++.++||||++++++|.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 45678999999999999999999999999999999999987765555556778999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
.....+||+.|+|||++.+..++.++||||
T Consensus 163 --------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 192 (279)
T 3fdn_A 163 --------------------------------------------------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWS 192 (279)
T ss_dssp -------------------------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHH
T ss_pred --------------------------------------------------cccccCCCCCccCHhHhccCCCCccchhHh
Confidence 112457999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|||++|+|++|.+||...+.......+.. ....+| ..+++++++||.+||. ||.+|+ ++.||++||||++.
T Consensus 193 lG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 193 LGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFP--DFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITAN 264 (279)
T ss_dssp HHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCC--TTSCHHHHHHHHHHCCSSGGGSC---CHHHHHHCHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHh--CCCCCC--CcCCHHHHHHHHHHhccChhhCC---CHHHHhhCccccCC
Confidence 99999999999999999988888877765 334444 3689999999999998 999999 89999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=405.01 Aligned_cols=265 Identities=30% Similarity=0.543 Sum_probs=235.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 35899999999999999999999999999999999976543 33455778899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc---EEEeecccccccCCCc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKPLDCST 240 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~---vKL~DFGla~~~~~~~ 240 (518)
||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999999999999988899999999999999999999999999999999999999987665 9999999997653210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
.....+||+.|+|||++.+..|+.++||||
T Consensus 163 --------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 192 (284)
T 3kk8_A 163 --------------------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 192 (284)
T ss_dssp --------------------------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred --------------------------------------------------cccCCCCCcCCcCchhhcCCCCCcccchHH
Confidence 112467999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
|||++|+|++|.+||.+.+.......+.........+....+++++.+||.+||. ||.+|+ ++.|+++||||++..
T Consensus 193 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 193 CGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCC---CHHHHhcCccccCCh
Confidence 9999999999999999999888888887754444444455789999999999998 999999 899999999999766
Q ss_pred ccc
Q 010116 400 WDK 402 (518)
Q Consensus 400 w~~ 402 (518)
+..
T Consensus 270 ~~~ 272 (284)
T 3kk8_A 270 RVA 272 (284)
T ss_dssp CGG
T ss_pred hHH
Confidence 543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=422.01 Aligned_cols=266 Identities=27% Similarity=0.434 Sum_probs=218.4
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
....++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 4456899999999999999999999999999999999976532 233345677899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC-----CCCcEEEeeccccccc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-----KNGHMKLSDFGLCKPL 236 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld-----~~g~vKL~DFGla~~~ 236 (518)
|+||||++ |+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99999996 59999999888999999999999999999999999999999999999994 5556999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCcc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGME 315 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~ 315 (518)
.... ......+||+.|+|||++.+. .|+.+
T Consensus 188 ~~~~-------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~ 218 (329)
T 3gbz_A 188 GIPI-------------------------------------------------RQFTHEIITLWYRPPEILLGSRHYSTS 218 (329)
T ss_dssp C------------------------------------------------------------CCTTCCHHHHTTCCCCCTH
T ss_pred CCcc-------------------------------------------------cccCCCcCCccccCHHHhcCCCCCCcH
Confidence 3210 011245799999999999874 58999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccC----------------CC----------CCCCChhHHHH
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKF----------------PD----------DSKLSPEAKDL 369 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~----------------p~----------~~~~s~~~~dL 369 (518)
+|||||||++|||++|.+||.+.+......++......... +. ...+++++++|
T Consensus 219 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
T 3gbz_A 219 VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDL 298 (329)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHH
Confidence 99999999999999999999999888888777653211110 00 00168999999
Q ss_pred HHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 370 ICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 370 I~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
|.+||. ||.+|+ ++.|+++||||++++|+
T Consensus 299 i~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 299 LTAMLEMDPVKRI---SAKNALEHPYFSHNDFD 328 (329)
T ss_dssp HHHHTCSSGGGSC---CHHHHHTSGGGSSSCSC
T ss_pred HHHHccCChhhCC---CHHHHhCCcccCCCCCC
Confidence 999999 999999 89999999999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=419.51 Aligned_cols=261 Identities=26% Similarity=0.457 Sum_probs=220.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||+||+|+++.+++.||||++...... ...+.+.+|+.+++.++|||||++++++.+...+|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 57999999999999999999999999999999999755322 2235678999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||||+||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 159 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 159 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC----
Confidence 9999999999999888899999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-CccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGv 323 (518)
........+||+.|+|||++.+..+ +.++|||||||
T Consensus 160 -------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 196 (323)
T 3tki_A 160 -------------------------------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196 (323)
T ss_dssp -------------------------------------------EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHH
T ss_pred -------------------------------------------cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHH
Confidence 0112235689999999999988776 78999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
++|+|++|.+||...+........... .....+....+++++.+||.+||. ||.+|+ ++.||++||||+..
T Consensus 197 il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~ 268 (323)
T 3tki_A 197 VLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHHSSCSCSSSCTTSHHHHHHHT-TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred HHHHHHhCCCCCCCCchHHHHHHHHhc-ccccCCccccCCHHHHHHHHHHccCChhhCc---CHHHHhhChhhccc
Confidence 999999999999876654332222221 122333335689999999999998 999999 89999999999854
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=407.06 Aligned_cols=261 Identities=35% Similarity=0.613 Sum_probs=233.6
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
...+..++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 45567789999999999999999999999999999999998765555555677899999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998754311
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.....+||+.|+|||++.+..++.++|+|
T Consensus 168 ---------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 196 (284)
T 2vgo_A 168 ---------------------------------------------------RRRTMCGTLDYLPPEMIEGKTHDEKVDLW 196 (284)
T ss_dssp ---------------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTTHHHH
T ss_pred ---------------------------------------------------ccccccCCCCcCCHHHhccCCCCcccchh
Confidence 01245799999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||||++|+|++|.+||...+.......+.. ..+.+| ..+++++++||.+||. ||.+|+ ++.+|++||||+..
T Consensus 197 slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 197 CAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFP--PFLSDGSKDLISKLLRYHPPQRL---PLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCC--TTSCHHHHHHHHHHSCSSGGGSC---CHHHHHTCHHHHHH
T ss_pred hHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--cccCCC--CcCCHHHHHHHHHHhhcCHhhCC---CHHHHhhCHHHHhh
Confidence 999999999999999999888887777776 344555 3689999999999998 999999 89999999999853
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=424.98 Aligned_cols=256 Identities=34% Similarity=0.554 Sum_probs=213.4
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
...++|++++.||+|+||+||+|+++.+++.||||++.+.... .+.+.+|+.+++.++|||||+++++|.+...+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3457899999999999999999999999999999999765332 245788999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc--EEEeecccccccCCCc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH--MKLSDFGLCKPLDCST 240 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~--vKL~DFGla~~~~~~~ 240 (518)
+|||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999999999988889999999999999999999999999999999999999988775 999999998743211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc-cccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME-CDWW 319 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~-~DiW 319 (518)
....+.+||+.|+|||++.+..|+.+ +|||
T Consensus 172 -------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 202 (361)
T 3uc3_A 172 -------------------------------------------------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVW 202 (361)
T ss_dssp ----------------------------------------------------------CTTSCHHHHHCSSCCHHHHHHH
T ss_pred -------------------------------------------------CCCCCCcCCCCcCChhhhcCCCCCCCeeeee
Confidence 01125689999999999999888655 8999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhH----HHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITT----CRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~----~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
||||++|+|++|.+||.+.+.... ...+.. ....+|....+|+++++||.+||. ||.+|+ ++.||++|||
T Consensus 203 slG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~ 277 (361)
T 3uc3_A 203 SCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--VKYSIPDDIRISPECCHLISRIFVADPATRI---SIPEIKTHSW 277 (361)
T ss_dssp HHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT--TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSC---CHHHHHTSHH
T ss_pred hhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc--CCCCCCCcCCCCHHHHHHHHHHccCChhHCc---CHHHHHhCcc
Confidence 999999999999999987654333 333433 345666666789999999999998 999999 8999999999
Q ss_pred ccc
Q 010116 395 FKD 397 (518)
Q Consensus 395 f~~ 397 (518)
|..
T Consensus 278 f~~ 280 (361)
T 3uc3_A 278 FLK 280 (361)
T ss_dssp HHT
T ss_pred hhc
Confidence 964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=417.88 Aligned_cols=265 Identities=31% Similarity=0.538 Sum_probs=233.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+++.++||||++++++|.+...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4679999999999999999999999999999999987543221 1356788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC----cEEEeecccccccC
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLD 237 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g----~vKL~DFGla~~~~ 237 (518)
|+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++ ++||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999998888999999999999999999999999999999999999999988 89999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
... .....+||+.|+|||++.+..|+.++|
T Consensus 171 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 200 (321)
T 2a2a_A 171 DGV--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEAD 200 (321)
T ss_dssp TTC--------------------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred ccc--------------------------------------------------cccccCCCCCccCcccccCCCCCCccc
Confidence 210 112457999999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCC--CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
||||||++|+|++|..||.+.+.......+.... ..++. ...+|+.+++||.+||. ||.+|+ ++.|+++|||
T Consensus 201 i~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~hp~ 275 (321)
T 2a2a_A 201 MWSIGVITYILLSGASPFLGDTKQETLANITSVS--YDFDEEFFSHTSELAKDFIRKLLVKETRKRL---TIQEALRHPW 275 (321)
T ss_dssp HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSC---CHHHHHHSTT
T ss_pred cHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc--cccChhhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhcCcc
Confidence 9999999999999999999998888887776632 22221 24689999999999998 999999 8999999999
Q ss_pred cccCCccccc
Q 010116 395 FKDVVWDKLY 404 (518)
Q Consensus 395 f~~i~w~~l~ 404 (518)
|.+++|....
T Consensus 276 ~~~~~~~~~~ 285 (321)
T 2a2a_A 276 ITPVDNQQAM 285 (321)
T ss_dssp TSCSSHHHHH
T ss_pred ccCCCccccc
Confidence 9999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=416.58 Aligned_cols=264 Identities=28% Similarity=0.467 Sum_probs=209.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||.||+|+++.+|+.||+|++.... .......+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999997653 223345678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 165 MEYLPGGDMMTLLMRE------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
|||++ |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5999988653 3599999999999999999999999999999999999999999999999999986532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 317 (518)
.. ......+||+.|+|||++.+ ..|+.++|
T Consensus 161 ~~-------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 191 (317)
T 2pmi_A 161 PV-------------------------------------------------NTFSSEVVTLWYRAPDVLMGSRTYSTSID 191 (317)
T ss_dssp CC-------------------------------------------------CCCCCCCSCCTTCCHHHHTTCCCCCTHHH
T ss_pred Cc-------------------------------------------------ccCCCCcccccccCchHhhCCCCCCcHHH
Confidence 10 01124579999999999987 46899999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc---------C---------------------CCCCCCChhHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK---------F---------------------PDDSKLSPEAK 367 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~---------~---------------------p~~~~~s~~~~ 367 (518)
||||||++|||++|.+||.+.+.......+........ . .....++++++
T Consensus 192 iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 271 (317)
T 2pmi_A 192 IWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLM 271 (317)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHH
Confidence 99999999999999999999988887777755211100 0 01125789999
Q ss_pred HHHHHHhc-cccccCCCCChhhhhcCcccccCCcccc
Q 010116 368 DLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 368 dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l 403 (518)
+||.+||+ ||.+|+ ++.|+++||||++..|...
T Consensus 272 ~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 272 DFLHGLLQLNPDMRL---SAKQALHHPWFAEYYHHAS 305 (317)
T ss_dssp HHHHHHSCSSGGGSC---CHHHHTTSGGGGGGCC---
T ss_pred HHHHHHCCCCcccCC---CHHHHhCChhhhcccchhh
Confidence 99999999 999999 8999999999998776543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=442.23 Aligned_cols=261 Identities=32% Similarity=0.618 Sum_probs=232.5
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 679999999999999999999999999999999987543 2334577889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC---CCCcEEEeecccccccCCCccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---KNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld---~~g~vKL~DFGla~~~~~~~~~ 242 (518)
|||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-- 178 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--
Confidence 9999999999998889999999999999999999999999999999999999995 46689999999998653210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
.....+||+.|+|||++.+ .|+.++||||||
T Consensus 179 ------------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG 209 (486)
T 3mwu_A 179 ------------------------------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAG 209 (486)
T ss_dssp ---------------------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHH
T ss_pred ------------------------------------------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHH
Confidence 1125689999999999976 599999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
|++|+|++|.+||.+.+.......+......+..|.+..+|+++++||.+||. ||.+|+ ++.++++||||+.....
T Consensus 210 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 210 VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSSE 286 (486)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHHHCHHHHHTCCC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCHhhccCccc
Confidence 99999999999999999999999888865555666666799999999999998 999999 89999999999876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=421.07 Aligned_cols=262 Identities=33% Similarity=0.543 Sum_probs=214.4
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
....++|++.+.||+|+||.||+|+++.+++.||||++.+.. ..+.+.+|+.+|+.++||||++++++|.+...+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 344578999999999999999999999999999999997643 235578899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CCcEEEeecccccccCC
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g~vKL~DFGla~~~~~ 238 (518)
|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999999988889999999999999999999999999999999999999976 89999999999886431
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
. ....+.+||+.|+|||++.+..|+.++||
T Consensus 204 ~--------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 233 (349)
T 2w4o_A 204 Q--------------------------------------------------VLMKTVCGTPGYCAPEILRGCAYGPEVDM 233 (349)
T ss_dssp -----------------------------------------------------------CGGGSCHHHHTTCCCCTHHHH
T ss_pred c--------------------------------------------------cccccccCCCCccCHHHhcCCCCCcccch
Confidence 1 01225689999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhh-HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPIT-TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
|||||++|||++|..||....... ....+......+..+....+++++++||.+||+ ||.+|+ ++.++++||||.
T Consensus 234 wslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~ 310 (349)
T 2w4o_A 234 WSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVT 310 (349)
T ss_dssp HHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTT
T ss_pred HHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCc---CHHHHhcCcccC
Confidence 999999999999999998766544 566666543333333345789999999999998 999999 899999999999
Q ss_pred cCCcc
Q 010116 397 DVVWD 401 (518)
Q Consensus 397 ~i~w~ 401 (518)
+..+.
T Consensus 311 ~~~~~ 315 (349)
T 2w4o_A 311 GKAAN 315 (349)
T ss_dssp STTCC
T ss_pred CCccc
Confidence 76543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=408.62 Aligned_cols=259 Identities=29% Similarity=0.460 Sum_probs=216.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|++ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 6799999999976532 2233466788999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||++| +|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 154 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---- 154 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc----
Confidence 99975 999988764 789999999999999999999999999999999999999999999999999998653110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 323 (518)
......+||+.|+|||++.+ ..|+.++|||||||
T Consensus 155 ---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 189 (288)
T 1ob3_A 155 ---------------------------------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189 (288)
T ss_dssp ----------------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred ---------------------------------------------cccccccccccccCchheeCCCCCCcHHHHHHHHH
Confidence 01124579999999999976 46899999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCccc----------------CC---------CCCCCChhHHHHHHHHhc-cc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLK----------------FP---------DDSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~----------------~p---------~~~~~s~~~~dLI~~lL~-dp 377 (518)
++|||++|.+||.+.+.......+........ ++ ....+++++++||.+||. ||
T Consensus 190 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 269 (288)
T 1ob3_A 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269 (288)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSST
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCc
Confidence 99999999999999888777776654211100 00 012478999999999998 99
Q ss_pred cccCCCCChhhhhcCcccccCC
Q 010116 378 EHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 378 ~~R~g~~~a~eil~Hpff~~i~ 399 (518)
.+|+ ++.|+++||||++.+
T Consensus 270 ~~Rp---t~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 270 NQRI---TAKQALEHAYFKENN 288 (288)
T ss_dssp TTSC---CHHHHHTSGGGGC--
T ss_pred ccCC---CHHHHhcCcchhhcC
Confidence 9999 899999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=441.68 Aligned_cols=262 Identities=35% Similarity=0.591 Sum_probs=228.1
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch----------hhHHHHHHHHHHHHHhCCCceeEEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR----------GQVEHVRAERNLLAEVASHCIVKLYY 153 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~----------~~~~~~~~E~~il~~l~hp~Iv~l~~ 153 (518)
..++|++++.||+|+||+||+|+++.+++.||+|++.+...... ...+.+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999999999999999987653321 34567899999999999999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC---cEEEeec
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDF 230 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g---~vKL~DF 230 (518)
+|.+...+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999998889999999999999999999999999999999999999999876 6999999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 310 (518)
|+|+...... .....+||+.|+|||++. .
T Consensus 194 g~a~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~-~ 222 (504)
T 3q5i_A 194 GLSSFFSKDY--------------------------------------------------KLRDRLGTAYYIAPEVLK-K 222 (504)
T ss_dssp TTCEECCTTS--------------------------------------------------CBCCCCSCTTTCCHHHHT-T
T ss_pred CCCEEcCCCC--------------------------------------------------ccccccCCcCCCCHHHhc-c
Confidence 9998653210 122568999999999986 5
Q ss_pred CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhh
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI 389 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei 389 (518)
.|+.++|||||||++|+|++|.+||.+.+.......+......+..+.+..+|+++++||++||+ ||.+|+ ++.|+
T Consensus 223 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~e~ 299 (504)
T 3q5i_A 223 KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC---TAEEA 299 (504)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHH
T ss_pred CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCC---CHHHH
Confidence 69999999999999999999999999999999988888754444444446799999999999998 999999 89999
Q ss_pred hcCcccccCC
Q 010116 390 KAHPWFKDVV 399 (518)
Q Consensus 390 l~Hpff~~i~ 399 (518)
++||||+...
T Consensus 300 l~h~~~~~~~ 309 (504)
T 3q5i_A 300 LNSRWIKKYA 309 (504)
T ss_dssp HTSHHHHHTC
T ss_pred hcCHhhhhch
Confidence 9999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=429.02 Aligned_cols=253 Identities=32% Similarity=0.553 Sum_probs=210.4
Q ss_pred CCCCeeEE-eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHH-HhCCCceeEEEEEeec----
Q 010116 84 CVDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA-EVASHCIVKLYYSFQD---- 157 (518)
Q Consensus 84 ~~~~f~i~-~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~f~~---- 157 (518)
..++|.++ ++||+|+||+||+|+++.+|+.||||++.+. ..+.+|+.++. ..+||||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 45788887 7999999999999999999999999998643 24567888874 4589999999999875
Q ss_pred CCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CCcEEEeeccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGL 232 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g~vKL~DFGl 232 (518)
..++|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++. +|.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 67899999999999999999765 36999999999999999999999999999999999999998 78999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 312 (518)
|+..... ....+.+||+.|+|||++.+..|
T Consensus 211 a~~~~~~--------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 240 (400)
T 1nxk_A 211 AKETTSH--------------------------------------------------NSLTTPCYTPYYVAPEVLGPEKY 240 (400)
T ss_dssp CEECC-------------------------------------------------------------CTTCCGGGSCCCCS
T ss_pred ccccCCC--------------------------------------------------CccccCCCCCCccCHhhcCCCCC
Confidence 9864311 01225689999999999999999
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhh----HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPIT----TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
+.++|||||||++|||++|.+||.+.+... ....+......+..+.+..+|+++++||.+||. ||.+|+ ++.
T Consensus 241 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ 317 (400)
T 1nxk_A 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TIT 317 (400)
T ss_dssp SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHH
T ss_pred CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCc---CHH
Confidence 999999999999999999999998765432 445555533333344445799999999999998 999999 899
Q ss_pred hhhcCccccc
Q 010116 388 QIKAHPWFKD 397 (518)
Q Consensus 388 eil~Hpff~~ 397 (518)
||++||||..
T Consensus 318 eil~hp~~~~ 327 (400)
T 1nxk_A 318 EFMNHPWIMQ 327 (400)
T ss_dssp HHHHSHHHHT
T ss_pred HHhcCccccC
Confidence 9999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=438.28 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=212.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------ 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------ 158 (518)
.++|++++.||+|+||+||+|++..+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 578999999999999999999999999999999998652 3344567788999999999999999999999755
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..+|||||||.| +|...+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 468999999965 5666664 3599999999999999999999999999999999999999999999999999986432
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
. ......+||+.|+|||++.+.+|+.++||
T Consensus 217 ~--------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 246 (464)
T 3ttj_A 217 S--------------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDI 246 (464)
T ss_dssp C--------------------------------------------------CCC----CCCTTCCHHHHTTCCCCTTHHH
T ss_pred C--------------------------------------------------cccCCCcccccccCHHHHcCCCCCHHHHH
Confidence 1 01235789999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc-----------------CCCCCC--------------------
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK-----------------FPDDSK-------------------- 361 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~-----------------~p~~~~-------------------- 361 (518)
|||||++|||++|++||.+.+....+.+|+....... .|....
T Consensus 247 wSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (464)
T 3ttj_A 247 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 326 (464)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccccccc
Confidence 9999999999999999999998888887765321110 000000
Q ss_pred -CChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 362 -LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 362 -~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
.+++++|||.+||. ||.+|+ +++|+++||||+.
T Consensus 327 ~~s~~~~dLl~~mL~~dP~~R~---ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 327 LKASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHHHHHHHHSCSSTTTSC---CHHHHHTSTTTGG
T ss_pred ccCHHHHHHHHHHcCCChhhCC---CHHHHhcChhhhh
Confidence 15679999999999 999999 8999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=412.53 Aligned_cols=265 Identities=29% Similarity=0.479 Sum_probs=230.4
Q ss_pred CCeeEE-eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEE
Q 010116 86 DDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 86 ~~f~i~-~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lyl 163 (518)
+.|.+. +.||+|+||.||+|+++.+|+.||+|++.+.... ......+.+|+.++..+. ||||++++++|.+...+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 457787 8999999999999999999999999999875432 234567889999999995 6999999999999999999
Q ss_pred EEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CCcEEEeecccccccCC
Q 010116 164 IMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g~vKL~DFGla~~~~~ 238 (518)
||||++||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++. +|.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999998553 68999999999999999999999999999999999999998 79999999999986532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
.. .....+||+.|+|||++.+..|+.++||
T Consensus 187 ~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 216 (327)
T 3lm5_A 187 AC--------------------------------------------------ELREIMGTPEYLAPEILNYDPITTATDM 216 (327)
T ss_dssp ---------------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHH
T ss_pred cc--------------------------------------------------ccccccCCcCccCCeeecCCCCCchhhH
Confidence 10 1124679999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|||||++|+|++|.+||.+.+.......+.........+....+++.+++||.+||. ||.+|+ ++++|++||||++
T Consensus 217 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~~ll~h~~~~~ 293 (327)
T 3lm5_A 217 WNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP---TAEICLSHSWLQQ 293 (327)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTCGGGCC
T ss_pred HHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhCCHhhcc
Confidence 999999999999999999999888888887754444444445789999999999998 999999 8999999999999
Q ss_pred CCccccc
Q 010116 398 VVWDKLY 404 (518)
Q Consensus 398 i~w~~l~ 404 (518)
++|+.+.
T Consensus 294 ~~~~~~~ 300 (327)
T 3lm5_A 294 WDFENLF 300 (327)
T ss_dssp CCTTCC-
T ss_pred ccccccc
Confidence 9998875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=428.10 Aligned_cols=288 Identities=27% Similarity=0.395 Sum_probs=218.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC-----C
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----E 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~ 159 (518)
.++|++++.||+|+||.||+|+++.+|+.||||++.+. .........+.+|+.+|+.++|||||++++++.+. .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 57899999999999999999999999999999999764 23344567789999999999999999999999876 5
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||+. |+|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 7999999995 699999988888999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-CCCCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-~~~y~~~~Di 318 (518)
......... . ... .......+......+.+||+.|+|||++. +..|+.++||
T Consensus 183 ~~~~~~~~~-------~------~~~--------------~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~Di 235 (432)
T 3n9x_A 183 KDTNIVNDL-------E------ENE--------------EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235 (432)
T ss_dssp -------------------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred ccccccccc-------c------ccc--------------cccccccchhccccCCCCCccccCHHHHhcCCCCCccccc
Confidence 111000000 0 000 00000001112345789999999999974 5679999999
Q ss_pred cchhHHHHHHHh-----------CCCCCCCCCh-----------------hhHHHHHhhhcCc-----------------
Q 010116 319 WSLGAIMYEMLV-----------GYPPFYADDP-----------------ITTCRKIVHWRNH----------------- 353 (518)
Q Consensus 319 WSlGvilyeml~-----------G~~PF~~~~~-----------------~~~~~~i~~~~~~----------------- 353 (518)
|||||++|||++ |.++|.+.+. ......|+...+.
T Consensus 236 wSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~ 315 (432)
T 3n9x_A 236 WSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315 (432)
T ss_dssp HHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHH
T ss_pred chHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHH
Confidence 999999999998 5555555431 1222222211000
Q ss_pred ---c--cCCC-----CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccc
Q 010116 354 ---L--KFPD-----DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 354 ---l--~~p~-----~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~ 404 (518)
+ ..+. ...+|+++++||.+||. ||.+|+ +++|+++||||+++.|....
T Consensus 316 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---ta~e~L~Hp~f~~~~~~~~e 374 (432)
T 3n9x_A 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDVRKKKLE 374 (432)
T ss_dssp HHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTCGGGTTTCCTTTC
T ss_pred HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCC---CHHHHhcChhhhhccCcccC
Confidence 0 0000 13589999999999999 999999 89999999999999998765
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=440.23 Aligned_cols=260 Identities=35% Similarity=0.608 Sum_probs=225.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||+||+|+++.++..||+|++.+..... .....+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999998764332 23567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CCcEEEeecccccccCCCccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g~vKL~DFGla~~~~~~~~~ 242 (518)
|||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 99999999999988899999999999999999999999999999999999999976 4569999999998653210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
...+.+||+.|+|||++. ..|+.++||||||
T Consensus 194 ------------------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG 224 (494)
T 3lij_A 194 ------------------------------------------------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIG 224 (494)
T ss_dssp ------------------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHH
T ss_pred ------------------------------------------------cccccCCCcCeeCHHHHc-ccCCCchhHHHHH
Confidence 122568999999999986 5699999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
|++|+|++|.+||.+.+.......+......+..|.+..+|+++++||.+||. ||.+|+ ++.++++||||+...+
T Consensus 225 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 225 VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI---SAQQALEHPWIKEMCS 300 (494)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCc---cHHHHhcCcccccCcc
Confidence 99999999999999999999998888755444455556799999999999998 999999 8999999999987533
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=419.66 Aligned_cols=268 Identities=31% Similarity=0.527 Sum_probs=226.6
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
++|++++.||+|+||.||+|++..+++.||+|++.+.... .....+.+.+|+.+|+.++|||||+++++|.+...+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5799999999999999999999999999999999876432 34456789999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 010116 164 IMEYLPGGDMMTLLMR----------------------------------------EDTLTENVARFYIAQSVLAIESIH 203 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~----------------------------------------~~~l~e~~~~~~~~ql~~aL~~LH 203 (518)
|||||+||+|.+++.. ...+++..++.++.|++.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999842 112467889999999999999999
Q ss_pred hCCeEEcCCCCCceeeCCCC--cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHH
Q 010116 204 KHNYIHRDIKPDNLLLDKNG--HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQL 281 (518)
Q Consensus 204 ~~giiHRDIKPeNILld~~g--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (518)
++||+||||||+|||++.++ .+||+|||+|+.+......
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~--------------------------------------- 226 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG--------------------------------------- 226 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc---------------------------------------
Confidence 99999999999999998777 8999999999865321000
Q ss_pred HHHhhhcccccccccCCCCccChhhhcC--CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCC
Q 010116 282 QHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDD 359 (518)
Q Consensus 282 ~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~ 359 (518)
......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+.......+......+..|..
T Consensus 227 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 300 (345)
T 3hko_A 227 ------EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300 (345)
T ss_dssp --------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGG
T ss_pred ------ccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCccc
Confidence 0001225679999999999975 67899999999999999999999999999998888888875444444444
Q ss_pred CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 360 SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 360 ~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
..+++++++||.+||. ||.+|+ ++.++++||||+++.|.
T Consensus 301 ~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 301 NVLSPLARDLLSNLLNRNVDERF---DAMRALQHPWISQFSDK 340 (345)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSC---CHHHHHHSHHHHTTSSC
T ss_pred ccCCHHHHHHHHHHcCCChhHCC---CHHHHhcChhhccChHh
Confidence 4589999999999998 999999 89999999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=402.44 Aligned_cols=268 Identities=31% Similarity=0.557 Sum_probs=230.7
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhh------hchhhHHHHHHHHHHHHHhC-CCceeEEEEEee
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM------VKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQ 156 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~------~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~ 156 (518)
..++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35899999999999999999999999999999999975431 11233466789999999995 999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+...+|+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc------CC
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------KK 310 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~------~~ 310 (518)
.... .....+||+.|+|||++. ..
T Consensus 175 ~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 204 (298)
T 1phk_A 175 DPGE--------------------------------------------------KLREVCGTPSYLAPEIIECSMNDNHP 204 (298)
T ss_dssp CTTC--------------------------------------------------CBCCCCSCGGGCCHHHHHHHHCTTSC
T ss_pred CCCc--------------------------------------------------ccccccCCccccCHHHhccccccccc
Confidence 3210 112457999999999986 45
Q ss_pred CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhh
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI 389 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei 389 (518)
.|+.++|||||||++|+|++|..||.+.+.......+......+..+....+++++.+||.+||. ||.+|+ ++.++
T Consensus 205 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l 281 (298)
T 1phk_A 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEA 281 (298)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHH
T ss_pred cCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCC---CHHHH
Confidence 78999999999999999999999999988888888877744333334445689999999999998 999999 89999
Q ss_pred hcCcccccCCccccc
Q 010116 390 KAHPWFKDVVWDKLY 404 (518)
Q Consensus 390 l~Hpff~~i~w~~l~ 404 (518)
++||||++..|+.+.
T Consensus 282 l~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 282 LAHPFFQQYVVEEVR 296 (298)
T ss_dssp TTSGGGCTTC-----
T ss_pred HhChHhhhccchhhc
Confidence 999999999887764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=408.61 Aligned_cols=263 Identities=26% Similarity=0.408 Sum_probs=215.6
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHHhC---CCceeEEEEEee
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQ 156 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~ 156 (518)
.+..++|++++.||+|+||+||+|++..+|+.||||++...... .......+.+|+.+++.+. ||||++++++|.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34568999999999999999999999999999999999754321 1112234667777777664 999999999998
Q ss_pred cCC-----eEEEEEeecCCCchHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEee
Q 010116 157 DTE-----YLYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSD 229 (518)
Q Consensus 157 ~~~-----~lylVmEy~~gG~L~~~l~~~~~--l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~D 229 (518)
+.. .+|+||||+. |+|.+++..... +++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 765 5899999996 699999977644 99999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC
Q 010116 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (518)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 309 (518)
||+|+..... ......+||+.|+|||++.+
T Consensus 164 fg~a~~~~~~--------------------------------------------------~~~~~~~gt~~y~aPE~~~~ 193 (308)
T 3g33_A 164 FGLARIYSYQ--------------------------------------------------MALTPVVVTLWYRAPEVLLQ 193 (308)
T ss_dssp CSCTTTSTTC--------------------------------------------------CCSGGGGCCCSSCCHHHHHT
T ss_pred CccccccCCC--------------------------------------------------cccCCccccccccCchHHcC
Confidence 9999764321 01225689999999999999
Q ss_pred CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc--------------CCC---------CCCCChhH
Q 010116 310 KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK--------------FPD---------DSKLSPEA 366 (518)
Q Consensus 310 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~--------------~p~---------~~~~s~~~ 366 (518)
..|+.++|||||||++|+|++|.+||.+.+......++........ ++. ...+++++
T Consensus 194 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (308)
T 3g33_A 194 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESG 273 (308)
T ss_dssp SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHH
T ss_pred CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHH
Confidence 9999999999999999999999999999998888888765321111 000 12578999
Q ss_pred HHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 367 KDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 367 ~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
.+||.+||. ||.+|+ ++.|+++||||+..
T Consensus 274 ~~li~~~L~~dP~~R~---t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 274 AQLLLEMLTFNPHKRI---SAFRALQHSYLHKD 303 (308)
T ss_dssp HHHHHHHTCSSTTTSC---CHHHHHTSTTC---
T ss_pred HHHHHHHhcCCCccCC---CHHHHhcCccccCC
Confidence 999999999 999999 89999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=405.31 Aligned_cols=265 Identities=29% Similarity=0.449 Sum_probs=220.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||+||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|.+...+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 4789999999999999999999999999999999876532 233456678999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||++|++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 156 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS---- 156 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc----
Confidence 9999999999999888899999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 323 (518)
......+||+.|+|||++.+ ..|+.++|||||||
T Consensus 157 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 191 (311)
T 4agu_A 157 ---------------------------------------------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGC 191 (311)
T ss_dssp ------------------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHH
T ss_pred ---------------------------------------------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHH
Confidence 01124579999999999986 67899999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcC-----------------cccCCC----------CCCCChhHHHHHHHHhc-
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRN-----------------HLKFPD----------DSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~-----------------~l~~p~----------~~~~s~~~~dLI~~lL~- 375 (518)
++|+|++|.+||.+.+.......+..... ....|. ...+|+++.+||.+||.
T Consensus 192 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 271 (311)
T 4agu_A 192 VFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHM 271 (311)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccC
Confidence 99999999999999887776665543211 111111 13578999999999998
Q ss_pred cccccCCCCChhhhhcCcccccCCccc
Q 010116 376 DVEHRLGTGGAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff~~i~w~~ 402 (518)
||.+|+ +++||++||||+++.|..
T Consensus 272 dP~~Rp---t~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 272 DPTERL---TCEQLLHHPYFENIREIE 295 (311)
T ss_dssp STTTSC---CHHHHHTSGGGTTCC---
T ss_pred ChhhcC---CHHHHhcChHHHhccCHH
Confidence 999999 899999999999887654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=415.95 Aligned_cols=252 Identities=33% Similarity=0.556 Sum_probs=198.4
Q ss_pred CCeeEE---eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeE
Q 010116 86 DDFELL---TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 86 ~~f~i~---~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~l 161 (518)
++|++. +.||+|+||.||+|+++.+|+.||||++.+. ....+.+|+.+++.+. |||||+++++|.+...+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 346665 7899999999999999999999999999754 2356778999999997 99999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC---cEEEeecccccccCC
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLDC 238 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g---~vKL~DFGla~~~~~ 238 (518)
|+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999999889999999999999999999999999999999999999998766 899999999985432
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
.. ....+.+||+.|+|||++.+..|+.++||
T Consensus 162 ~~-------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 192 (325)
T 3kn6_A 162 DN-------------------------------------------------QPLKTPCFTLHYAAPELLNQNGYDESCDL 192 (325)
T ss_dssp -----------------------------------------------------------------------CCCCHHHHH
T ss_pred CC-------------------------------------------------CcccccCCCcCccCHHHhcCCCCCCccch
Confidence 10 01225689999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCCh-------hhHHHHHhhhcCcccCCC--CCCCChhHHHHHHHHhc-cccccCCCCChhh
Q 010116 319 WSLGAIMYEMLVGYPPFYADDP-------ITTCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ 388 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~e 388 (518)
|||||++|+|++|.+||.+.+. .....++... .+.++. +..+|+++++||.+||. ||.+|+ ++.+
T Consensus 193 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e 267 (325)
T 3kn6_A 193 WSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL---KMSG 267 (325)
T ss_dssp HHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCC---CTTT
T ss_pred HHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--CCCCCcccccCCCHHHHHHHHHHCCCChhHCC---CHHH
Confidence 9999999999999999987543 3445555542 233332 23589999999999998 999999 8999
Q ss_pred hhcCccccc
Q 010116 389 IKAHPWFKD 397 (518)
Q Consensus 389 il~Hpff~~ 397 (518)
+++||||++
T Consensus 268 ll~h~w~~~ 276 (325)
T 3kn6_A 268 LRYNEWLQD 276 (325)
T ss_dssp STTCGGGCT
T ss_pred HhcChhhcc
Confidence 999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=423.34 Aligned_cols=260 Identities=30% Similarity=0.541 Sum_probs=221.9
Q ss_pred CeeE--EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 87 DFEL--LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 87 ~f~i--~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.|.+ .+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444 6789999999999999999999999999986532 3456788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee--CCCCcEEEeecccccccCCCcc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl--d~~g~vKL~DFGla~~~~~~~~ 241 (518)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 9999999999988654 579999999999999999999999999999999999999 667899999999998653210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.....+||+.|+|||++.+..|+.++|||||
T Consensus 244 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 274 (373)
T 2x4f_A 244 -------------------------------------------------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274 (373)
T ss_dssp -------------------------------------------------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHH
T ss_pred -------------------------------------------------ccccccCCCcEeChhhccCCCCCcHHhHHHH
Confidence 1124579999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
||++|||++|.+||.+.+......++......+..+....+++++++||.+||+ ||.+|+ ++.|+++||||++..|
T Consensus 275 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 275 GVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKL 351 (373)
T ss_dssp HHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHCHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCC---CHHHHhcCcCcCCCch
Confidence 999999999999999999988888888743333322234689999999999998 999999 8999999999998765
Q ss_pred cc
Q 010116 401 DK 402 (518)
Q Consensus 401 ~~ 402 (518)
..
T Consensus 352 ~~ 353 (373)
T 2x4f_A 352 HS 353 (373)
T ss_dssp HH
T ss_pred hh
Confidence 43
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=411.32 Aligned_cols=268 Identities=29% Similarity=0.528 Sum_probs=215.3
Q ss_pred CCCeeEE-eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEE
Q 010116 85 VDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 85 ~~~f~i~-~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ly 162 (518)
.+.|++. +.||+|+||.||+|++..+++.||||++.+.. ......+.+|+.+|..+ +||||++++++|.+.+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4679996 78999999999999999999999999997653 23456788999999985 7999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc---EEEeecccccccCCC
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKPLDCS 239 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~---vKL~DFGla~~~~~~ 239 (518)
+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999988889999999999999999999999999999999999999998876 999999998865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-----CCCCc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KGYGM 314 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~ 314 (518)
..... .......+.+||+.|+|||++.+ ..|+.
T Consensus 168 ~~~~~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 205 (316)
T 2ac3_A 168 GDCSP------------------------------------------ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK 205 (316)
T ss_dssp --------------------------------------------------------CCSGGGCCHHHHHHTSHHHHHHTT
T ss_pred Ccccc------------------------------------------ccccccccccCCcCccChHHhhcccccccCCCc
Confidence 10000 00011235679999999999975 56899
Q ss_pred cccccchhHHHHHHHhCCCCCCCCCh---------------hhHHHHHhhhcCcccCCC--CCCCChhHHHHHHHHhc-c
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDP---------------ITTCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLLC-D 376 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~---------------~~~~~~i~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-d 376 (518)
++|||||||++|||++|.+||.+... ......+.. ....+|. ...+++++++||.+||. |
T Consensus 206 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~d 283 (316)
T 2ac3_A 206 RCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRD 283 (316)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred ccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCC
Confidence 99999999999999999999987642 234444544 2334442 24689999999999998 9
Q ss_pred ccccCCCCChhhhhcCcccccCCccc
Q 010116 377 VEHRLGTGGAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 377 p~~R~g~~~a~eil~Hpff~~i~w~~ 402 (518)
|.+|+ ++.|+++||||++..|..
T Consensus 284 P~~Rp---s~~e~l~hp~~~~~~~~~ 306 (316)
T 2ac3_A 284 AKQRL---SAAQVLQHPWVQGCAPEN 306 (316)
T ss_dssp TTTSC---CHHHHHHSTTCC------
T ss_pred hhhCC---CHHHHhcChhhcCCCCcc
Confidence 99999 899999999999876654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=399.82 Aligned_cols=253 Identities=34% Similarity=0.610 Sum_probs=225.4
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++.+.||+|+||.||+|+++.++..||+|++.+... ...+.+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999976532 33567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee---CCCCcEEEeecccccccCCCccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl---d~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 999999999999888999999999999999999999999999999999999999 788999999999998653211
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
...+.+||+.|+|||++.+. ++.++||||||
T Consensus 164 ------------------------------------------------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG 194 (277)
T 3f3z_A 164 ------------------------------------------------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAG 194 (277)
T ss_dssp ------------------------------------------------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHH
T ss_pred ------------------------------------------------chhccCCCCCccChHHhccc-CCchhhehhHH
Confidence 11245799999999998654 99999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCC--CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|++|+|++|.+||.+.+.......+... ...+|. ...+++++.+||.+||. ||.+|+ ++.++++||||+.
T Consensus 195 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 195 VMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHHH
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhc
Confidence 9999999999999999888888887763 333332 23689999999999998 999999 8999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=412.16 Aligned_cols=261 Identities=27% Similarity=0.459 Sum_probs=214.7
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||.||+|++..+++.||+|++..... ......+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 3689999999999999999999999999999999875431 11112345789999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++ |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--- 154 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--- 154 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc---
Confidence 99996 5899888765 569999999999999999999999999999999999999999999999999997543110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 322 (518)
......+||+.|+|||++.+ ..|+.++||||||
T Consensus 155 ----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 188 (324)
T 3mtl_A 155 ----------------------------------------------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 188 (324)
T ss_dssp ------------------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred ----------------------------------------------cccccccCcccccChhhhcCCCCCCcHHHHHHHH
Confidence 01124579999999999987 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc-----------------CCC---------CCCCChhHHHHHHHHhc-
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK-----------------FPD---------DSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~-----------------~p~---------~~~~s~~~~dLI~~lL~- 375 (518)
|++|+|++|.+||.+.+.......+........ ++. ...+++++++||.+||.
T Consensus 189 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 268 (324)
T 3mtl_A 189 CIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQF 268 (324)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCc
Confidence 999999999999999988887777765322111 110 12578999999999999
Q ss_pred cccccCCCCChhhhhcCcccccCCc
Q 010116 376 DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
||.+|+ ++.|+++||||.++.+
T Consensus 269 dP~~R~---t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 269 EGRNRI---SAEDAMKHPFFLSLGE 290 (324)
T ss_dssp SGGGSC---CHHHHTTSGGGGGGCS
T ss_pred CcccCC---CHHHHhcChhhhhccc
Confidence 999999 8999999999997654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=418.28 Aligned_cols=259 Identities=30% Similarity=0.473 Sum_probs=216.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 159 (518)
.++|++++.||+|+||.||+|++..+|+.||||++.+.. ......+.+.+|+.+|+.++||||++++++|....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 478999999999999999999999999999999996542 23344567889999999999999999999998763
Q ss_pred -eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 -YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 -~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|+||||+ |++|..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 8999999865 6799999999999999999999999999999999999999999999999999986431
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 317 (518)
. ....+||+.|+|||++.+ ..|+.++|
T Consensus 181 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 208 (367)
T 1cm8_A 181 E----------------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVD 208 (367)
T ss_dssp S----------------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHH
T ss_pred c----------------------------------------------------cCcCcCCCCcCCHHHHhCCCCCChhhh
Confidence 1 124689999999999987 78999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc------------------CC---------CCCCCChhHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK------------------FP---------DDSKLSPEAKDLI 370 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~------------------~p---------~~~~~s~~~~dLI 370 (518)
||||||++|||++|++||.+.+.......|+....... +| ....+++++.+||
T Consensus 209 iwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 288 (367)
T 1cm8_A 209 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 288 (367)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 99999999999999999999988887777765221110 00 0135789999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
.+||+ ||.+|+ ++.|+++||||+.+.+.
T Consensus 289 ~~mL~~dP~~R~---t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 289 EKMLVLDAEQRV---TAGEALAHPYFESLHDT 317 (367)
T ss_dssp HHHSCSSTTTSC---CHHHHHHSGGGTTTC--
T ss_pred HHHccCChhHCC---CHHHHhcChHHHhhcCC
Confidence 99999 999999 89999999999976543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=415.64 Aligned_cols=258 Identities=33% Similarity=0.594 Sum_probs=226.2
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhh-----hchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-----VKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~-----~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
++|++.+.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|..+++.+ +||||++++++|....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 579999999999999999999999999999999876431 1122345678999999999 8999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||++||+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998865421
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC------CCCC
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK------KGYG 313 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------~~y~ 313 (518)
. .....+||+.|+|||++.+ ..|+
T Consensus 254 ~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 283 (365)
T 2y7j_A 254 E--------------------------------------------------KLRELCGTPGYLAPEILKCSMDETHPGYG 283 (365)
T ss_dssp C--------------------------------------------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBC
T ss_pred c--------------------------------------------------ccccCCCCCCccChhhccccccccCcCCC
Confidence 0 1225689999999999963 3689
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
.++|||||||++|+|++|.+||.+.+.......+......+..|.+..+++++.+||.+||. ||.+|+ ++.++++|
T Consensus 284 ~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ell~h 360 (365)
T 2y7j_A 284 KEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL---TAEQALQH 360 (365)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSC---CHHHHHHS
T ss_pred chhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcC
Confidence 99999999999999999999999988888888887754333333345689999999999998 999999 89999999
Q ss_pred cccc
Q 010116 393 PWFK 396 (518)
Q Consensus 393 pff~ 396 (518)
|||+
T Consensus 361 p~f~ 364 (365)
T 2y7j_A 361 PFFE 364 (365)
T ss_dssp GGGC
T ss_pred cccC
Confidence 9996
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=399.46 Aligned_cols=258 Identities=34% Similarity=0.634 Sum_probs=203.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46899999999999999999999999999999999876655555667899999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||++||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--- 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC---
Confidence 9999999999999765 679999999999999999999999999999999999999999999999999988653210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
......+||+.|+|||++.+..++.++|||||||
T Consensus 167 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 200 (278)
T 3cok_A 167 ----------------------------------------------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGC 200 (278)
T ss_dssp -----------------------------------------------------------------------CTHHHHHHH
T ss_pred ----------------------------------------------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHH
Confidence 0112467999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
++|+|++|.+||...+.......+.. .....| ..+++++++||.+||. ||.+|+ ++.++++||||...
T Consensus 201 il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 201 MFYTLLIGRPPFDTDTVKNTLNKVVL--ADYEMP--SFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHHSSCSSCCCSCC-----CCS--SCCCCC--TTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSTTTC--
T ss_pred HHHHHHhCCCCCCChhHHHHHHHHhh--cccCCc--cccCHHHHHHHHHHcccCHhhCC---CHHHHhcCccccCC
Confidence 99999999999988776665555543 223333 4689999999999998 999999 89999999999853
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=397.25 Aligned_cols=260 Identities=31% Similarity=0.517 Sum_probs=232.5
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
...++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34578999999999999999999999999999999998776555666778899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--
Confidence 999999999999999888899999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
......+||+.|+|||++.+..++.++||||||
T Consensus 170 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 202 (294)
T 2rku_A 170 -----------------------------------------------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202 (294)
T ss_dssp -----------------------------------------------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHH
T ss_pred -----------------------------------------------cccccccCCCCcCCcchhccCCCCchhhHHHHH
Confidence 011245799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|++|+|++|..||...........+.. ....+| ..+++++.+||.+||. ||.+|+ ++.++++||||...
T Consensus 203 ~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~~~~~~~ 272 (294)
T 2rku_A 203 CIMYTLLVGKPPFETSCLKETYLRIKK--NEYSIP--KHINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHhh--ccCCCc--cccCHHHHHHHHHHcccChhhCc---CHHHHhhChheecC
Confidence 999999999999999888777776665 334444 3689999999999998 999999 89999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=401.56 Aligned_cols=265 Identities=31% Similarity=0.531 Sum_probs=229.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
++|++++.||+|+||.||+|++..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999987643322 13577899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC----cEEEeecccccccCC
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLDC 238 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g----~vKL~DFGla~~~~~ 238 (518)
+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888999999999999999999999999999999999999999887 899999999886532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
.. .....+||+.|+|||++.+..++.++||
T Consensus 165 ~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 194 (283)
T 3bhy_A 165 GN--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADM 194 (283)
T ss_dssp ---------------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHH
T ss_pred CC--------------------------------------------------cccccCCCcCccCcceecCCCCCcchhh
Confidence 10 1124579999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|||||++|+|++|..||.+.+.......+......+..+....+++.+.+||.+||. ||.+|+ ++.++++||||+.
T Consensus 195 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~ 271 (283)
T 3bhy_A 195 WSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM---TIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSC---CHHHHHHCHHHHH
T ss_pred hhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCc---CHHHHHhCHHHHH
Confidence 999999999999999999988887777776533222211124678999999999998 999999 8999999999998
Q ss_pred CCcccc
Q 010116 398 VVWDKL 403 (518)
Q Consensus 398 i~w~~l 403 (518)
+.|...
T Consensus 272 ~~~~~~ 277 (283)
T 3bhy_A 272 IRRRNV 277 (283)
T ss_dssp HHHCCC
T ss_pred HHHHhh
Confidence 776554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=413.68 Aligned_cols=269 Identities=28% Similarity=0.398 Sum_probs=230.0
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
.+...+..++|++++.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.+|+.++||||++++++|.+
T Consensus 25 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp HTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred hcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 4456777899999999999999999999999999999999997652 33445678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.+|++||+|||++...
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999999999998888999999999999999999999996 9999999999999999999999999998753
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
... .....+||+.|+|||++.+..|+.++
T Consensus 183 ~~~---------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 211 (360)
T 3eqc_A 183 IDS---------------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQS 211 (360)
T ss_dssp HHH---------------------------------------------------C----CCCCTTCCHHHHTTCCCSHHH
T ss_pred ccc---------------------------------------------------cccCCCCCCCeECHHHHcCCCCCchh
Confidence 210 12256899999999999999999999
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHH------------------------------------------HHhhhcCcc
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCR------------------------------------------KIVHWRNHL 354 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~------------------------------------------~i~~~~~~l 354 (518)
|||||||++|+|++|..||...+...... .+... ...
T Consensus 212 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 290 (360)
T 3eqc_A 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE-PPP 290 (360)
T ss_dssp HHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHS-CCC
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhcc-CCC
Confidence 99999999999999999998766544322 12221 111
Q ss_pred cCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccc
Q 010116 355 KFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 355 ~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~ 404 (518)
..+ ...+|+++++||.+||. ||.+|+ ++.|+++||||++.+|+.+.
T Consensus 291 ~~~-~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~~~~~ 337 (360)
T 3eqc_A 291 KLP-SGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEVD 337 (360)
T ss_dssp CCC-TTTSCHHHHHHHHHHHCSSTTTSC---CHHHHHTSHHHHHHHHSCCC
T ss_pred CCC-cccccHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhcchHhhhh
Confidence 222 23578999999999998 999999 89999999999988877663
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=403.95 Aligned_cols=256 Identities=34% Similarity=0.618 Sum_probs=225.5
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 579999999999999999999999999999999986532 22356788999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee---CCCCcEEEeecccccccCCCccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl---d~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--- 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--- 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---
Confidence 999999999999888899999999999999999999999999999999999999 78899999999998753211
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
.....+||+.|+|||++.+..|+.++||||||
T Consensus 163 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 194 (304)
T 2jam_A 163 ------------------------------------------------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIG 194 (304)
T ss_dssp ------------------------------------------------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHH
T ss_pred ------------------------------------------------ccccccCCCCccChHHhccCCCCchhhHHHHH
Confidence 11245799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|++|+|++|.+||.+.+.......+......+..+....+|+++++||.+||. ||.+|+ ++.++++||||.+.
T Consensus 195 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 268 (304)
T 2jam_A 195 VITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY---TCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSC---CHHHHHTSHHHHSS
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCccccCC
Confidence 99999999999999998888888887643333333345789999999999998 999999 89999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=410.12 Aligned_cols=262 Identities=24% Similarity=0.419 Sum_probs=223.1
Q ss_pred HhhhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-----CCcee
Q 010116 75 FMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-----SHCIV 149 (518)
Q Consensus 75 ~~~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-----hp~Iv 149 (518)
....+.+.+..++|+++++||+|+||+||+|++..+++.||||++.+.. ........|..+++.+. |||||
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3445667777899999999999999999999999999999999997532 23455778999999986 99999
Q ss_pred EEEEEeecCCeEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC------
Q 010116 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK------ 221 (518)
Q Consensus 150 ~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~------ 221 (518)
+++++|.+.+.+|+||||+ ||+|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999999 999999997654 5999999999999999999999999999999999999975
Q ss_pred -------------------CCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHH
Q 010116 222 -------------------NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQ 282 (518)
Q Consensus 222 -------------------~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (518)
++.+||+|||+|+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------------------------------------------- 215 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------------------------------------------- 215 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------------------------------------------
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC-------------------------------------------
Confidence 889999999999753211
Q ss_pred HHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc--------
Q 010116 283 HWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL-------- 354 (518)
Q Consensus 283 ~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l-------- 354 (518)
..+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+......+
T Consensus 216 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 286 (360)
T 3llt_A 216 ---------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEA 286 (360)
T ss_dssp ---------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHH
T ss_pred ---------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhh
Confidence 124679999999999999999999999999999999999999999988877776665432111
Q ss_pred ----------------cCCCC------------------CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 355 ----------------KFPDD------------------SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 355 ----------------~~p~~------------------~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
.+|.. ...++.+.+||.+||+ ||.+|+ ++.|+++||||+
T Consensus 287 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---ta~elL~hp~f~ 360 (360)
T 3llt_A 287 TKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELLKHKFLE 360 (360)
T ss_dssp TTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGC
T ss_pred hhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC---CHHHHhcCcccC
Confidence 01110 0124778899999999 999999 899999999995
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=405.09 Aligned_cols=256 Identities=32% Similarity=0.550 Sum_probs=224.3
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|+..+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||++++++|...+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888899999999999999999999999999997543 3345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
|++||+|.+++. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 123 ~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------ 195 (321)
T 2c30_A 123 FLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------ 195 (321)
T ss_dssp CCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS------
T ss_pred cCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc------
Confidence 999999999885 4579999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
....+.+||+.|+|||++.+..|+.++|||||||++|
T Consensus 196 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ 232 (321)
T 2c30_A 196 -------------------------------------------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232 (321)
T ss_dssp -------------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred -------------------------------------------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHH
Confidence 0112568999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 327 EMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 327 eml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
||++|.+||.+.+.......+.... ...+.....+++++++||.+||. ||.+|+ ++.++++||||....
T Consensus 233 el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~ 302 (321)
T 2c30_A 233 EMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSS-CCCCTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGGGCC
T ss_pred HHHhCCCCCCCCCHHHHHHHHhcCC-CCCcCccccCCHHHHHHHHHHccCChhhCc---CHHHHhcChhhccCC
Confidence 9999999999988887777776532 22333334689999999999998 999999 899999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=417.03 Aligned_cols=273 Identities=27% Similarity=0.419 Sum_probs=216.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC----
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE---- 159 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~---- 159 (518)
..++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+++.++||||++++++|.+..
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3579999999999999999999999999999999997643 23345567889999999999999999999998765
Q ss_pred --eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 160 --YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 --~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+|+||||++ |+|.+++. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7899999996 57888875 469999999999999999999999999999999999999999999999999997543
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.. ......+||+.|+|||++.+..|+.++|
T Consensus 179 ~~--------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 208 (371)
T 2xrw_A 179 TS--------------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVD 208 (371)
T ss_dssp -------------------------------------------------------------CTTCCHHHHTTCCCCTTHH
T ss_pred cc--------------------------------------------------cccCCceecCCccCHHHhcCCCCCchHh
Confidence 11 0112468999999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc--------------------c--------------CCCCC---
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL--------------------K--------------FPDDS--- 360 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l--------------------~--------------~p~~~--- 360 (518)
||||||++|+|++|.+||.+.+......+++...... . +|...
T Consensus 209 iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (371)
T 2xrw_A 209 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 288 (371)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccccccc
Confidence 9999999999999999999998887777775421100 0 11000
Q ss_pred -CCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccccccCCcccc
Q 010116 361 -KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPE 413 (518)
Q Consensus 361 -~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~~~~~p~~p~ 413 (518)
..++++++||.+||+ ||.+|+ +++|+++||||+...........+|+.|.
T Consensus 289 ~~~~~~~~~li~~mL~~dP~~R~---t~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 340 (371)
T 2xrw_A 289 KLKASQARDLLSKMLVIDASKRI---SVDEALQHPYINVWYDPSEAEAPPPKIPD 340 (371)
T ss_dssp HHHHHHHHHHHHHHSCSSGGGSC---CHHHHHHSHHHHTTCCHHHHTCCCCCCCT
T ss_pred ccccHHHHHHHHHHCcCChhhCC---CHHHHhCCcchhhhcCccccCCCCCCCCC
Confidence 015689999999999 999999 89999999999853222222344555544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=404.61 Aligned_cols=260 Identities=31% Similarity=0.517 Sum_probs=233.0
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
...++|.+++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34578999999999999999999999999999999998776555666788999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
+||||++|++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-- 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--
Confidence 999999999999999888899999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
......+||+.|+|||++.+..++.++||||||
T Consensus 196 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 228 (335)
T 2owb_A 196 -----------------------------------------------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228 (335)
T ss_dssp -----------------------------------------------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHH
T ss_pred -----------------------------------------------ccccccCCCccccCHHHhccCCCCchhhHHHHH
Confidence 011246799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|++|+|++|..||...........+.. ....+| ..+++++.+||.+||. ||.+|+ ++.+|++||||...
T Consensus 229 ~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~~~~~~~~ 298 (335)
T 2owb_A 229 CIMYTLLVGKPPFETSCLKETYLRIKK--NEYSIP--KHINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTS
T ss_pred HHHHHHHHCcCCCCCCCHHHHHHHHhc--CCCCCC--ccCCHHHHHHHHHHccCChhHCc---CHHHHhcCccccCC
Confidence 999999999999999888777777665 334444 3689999999999998 999999 89999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=395.04 Aligned_cols=261 Identities=30% Similarity=0.537 Sum_probs=223.9
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
...+..++|++++.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34566789999999999999999999999999999999998765555556778899999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-Cccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~Di 318 (518)
. .....+||+.|+|||++.+..+ +.++||
T Consensus 165 ~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 194 (276)
T 2h6d_A 165 E--------------------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDI 194 (276)
T ss_dssp --------------------------------------------------------------CCTGGGTTSCCCHHHHHH
T ss_pred c--------------------------------------------------ceecccCCccccCHHHHcCCCCCCccchH
Confidence 0 1124579999999999988776 689999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|||||++|+|++|..||...+.......+... ...+| ..+++++.+||.+||. ||.+|+ ++.+|++||||+.
T Consensus 195 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~ 267 (276)
T 2h6d_A 195 WSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIP--EYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCc--hhcCHHHHHHHHHHccCChhhCC---CHHHHHhChhhcc
Confidence 99999999999999999988887777777652 33344 3689999999999998 999999 8999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=415.04 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=220.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch-----hhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR-----GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
++|++++.||+|+||.||+|+++.+++.||||++.+...... .....+.+|+.+|+.++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 579999999999999999999999999999999987643222 133456789999999999999999999999999
Q ss_pred EEEEEeecCCC-chHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGG-DMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG-~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+|+||||+.+| +|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999777 99999988889999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-Cccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~Di 318 (518)
....+.+||+.|+|||++.+..+ +.++||
T Consensus 184 --------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 213 (335)
T 3dls_A 184 --------------------------------------------------KLFYTFCGTIEYCAPEVLMGNPYRGPELEM 213 (335)
T ss_dssp --------------------------------------------------CCBCEECSCGGGCCHHHHTTCCBCSHHHHH
T ss_pred --------------------------------------------------CceeccCCCccccChhhhcCCCCCCCcccc
Confidence 11235689999999999998887 889999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|||||++|+|++|..||..... +.. ..... +..+|+++++||.+||. ||.+|+ ++.+|++||||+.
T Consensus 214 wslG~il~el~~g~~pf~~~~~------~~~--~~~~~--~~~~~~~l~~li~~~L~~dP~~Rp---s~~ell~hp~~~~ 280 (335)
T 3dls_A 214 WSLGVTLYTLVFEENPFCELEE------TVE--AAIHP--PYLVSKELMSLVSGLLQPVPERRT---TLEKLVTDPWVTQ 280 (335)
T ss_dssp HHHHHHHHHHHHSSCSCSSGGG------GTT--TCCCC--SSCCCHHHHHHHHHHTCSSGGGSC---CHHHHHHCTTTTC
T ss_pred hhHHHHHHHHHhCCCchhhHHH------HHh--hccCC--CcccCHHHHHHHHHHccCChhhCc---CHHHHhcCccccC
Confidence 9999999999999999976322 111 12222 24689999999999998 999999 8999999999965
Q ss_pred ------CCccccccc
Q 010116 398 ------VVWDKLYEM 406 (518)
Q Consensus 398 ------i~w~~l~~~ 406 (518)
.+|+.+...
T Consensus 281 ~~~~~~~~~~~~~~~ 295 (335)
T 3dls_A 281 PVNLADYTWEEVFRV 295 (335)
T ss_dssp CCCGGGCCHHHHC--
T ss_pred CccccccCHHHHhhh
Confidence 445555443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=411.52 Aligned_cols=266 Identities=25% Similarity=0.384 Sum_probs=222.5
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC---
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE--- 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~--- 159 (518)
...++|++++.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 34578999999999999999999999999999999998765555556678899999999999999999999987654
Q ss_pred -eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 -YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 -~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.+..
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 4599999999999999998888999999999999999999999999999999999999999999999999999986532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
... ........+||+.|+|||++.+..|+.++||
T Consensus 169 ~~~----------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 202 (311)
T 3ork_A 169 SGN----------------------------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202 (311)
T ss_dssp -----------------------------------------------------------CCTTCCHHHHHTCCCCHHHHH
T ss_pred ccc----------------------------------------------ccccccccCcCcccCCHHHhcCCCCCchHhH
Confidence 210 0011235689999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|||||++|+|++|..||.+.+.......+..............+|+++.+||.+||. ||.+|+ ++.+++.|+|++.
T Consensus 203 ~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~---~~~~~l~~~l~~~ 279 (311)
T 3ork_A 203 YSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY---QTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSC---SSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhCh---hhHHHHHHHHHHH
Confidence 999999999999999999998887777766532222211234689999999999998 999999 7899999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=397.36 Aligned_cols=256 Identities=30% Similarity=0.542 Sum_probs=217.9
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|.+.+.||+|+||.||+|+++.++..||+|++.+.. .....+.+.+|+.+|+.++||||++++++|.+...+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 367999999999999999999999999999999998754 233457788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee---CCCCcEEEeecccccccC
Q 010116 165 MEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 165 mEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl---d~~g~vKL~DFGla~~~~ 237 (518)
|||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999999854 3689999999999999999999999999999999999999 556899999999997543
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
... .....+||+.|+|||++. ..++.++|
T Consensus 179 ~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~-~~~~~~~D 207 (285)
T 3is5_A 179 SDE--------------------------------------------------HSTNAAGTALYMAPEVFK-RDVTFKCD 207 (285)
T ss_dssp ----------------------------------------------------------CTTGGGCCHHHHT-TCCCHHHH
T ss_pred Ccc--------------------------------------------------cCcCcccccCcCChHHhc-cCCCcccC
Confidence 210 112467999999999985 57899999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
||||||++|+|++|..||.+.+.......+........ .....+++++.+||.+||. ||.+|+ ++.||++||||+
T Consensus 208 i~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~f~ 283 (285)
T 3is5_A 208 IWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-VECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFK 283 (285)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-C--CCCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGG
T ss_pred eehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-cccCcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHhh
Confidence 99999999999999999999888777766655322222 1223589999999999998 999999 899999999998
Q ss_pred c
Q 010116 397 D 397 (518)
Q Consensus 397 ~ 397 (518)
.
T Consensus 284 ~ 284 (285)
T 3is5_A 284 Q 284 (285)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=427.91 Aligned_cols=263 Identities=32% Similarity=0.589 Sum_probs=214.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc-----hhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-----RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-----~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.++|.+++.||+|+||+||+|+++.+++.||||++.+..... ......+.+|+.+|+.++|||||+++++|...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 478999999999999999999999999999999998764321 12223478899999999999999999998654
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC---cEEEeeccccccc
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPL 236 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g---~vKL~DFGla~~~ 236 (518)
.+|+|||||+||+|.+++.....+++..++.++.|++.||.|||++|||||||||+|||++.++ .+||+|||+|+..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5899999999999999998888999999999999999999999999999999999999997654 5999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CCCC
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYG 313 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~ 313 (518)
... ....+.+||+.|+|||++.+ ..|+
T Consensus 293 ~~~--------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 322 (419)
T 3i6u_A 293 GET--------------------------------------------------SLMRTLCGTPTYLAPEVLVSVGTAGYN 322 (419)
T ss_dssp C-------------------------------------------------------------CTTCCTTTTC----CTTH
T ss_pred CCC--------------------------------------------------ccccccCCCCCccCceeeecCCCCCCC
Confidence 321 01235689999999999864 6789
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHH-HHHhhhcCcccCC--CCCCCChhHHHHHHHHhc-cccccCCCCChhhh
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTC-RKIVHWRNHLKFP--DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI 389 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-~~i~~~~~~l~~p--~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei 389 (518)
.++|||||||++|+|++|.+||......... ..+... ...++ ....+++++++||.+||. ||.+|+ ++.|+
T Consensus 323 ~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~ 397 (419)
T 3i6u_A 323 RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG--KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEA 397 (419)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHH
T ss_pred chhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC--CCCCCchhhcccCHHHHHHHHHHccCChhHCc---CHHHH
Confidence 9999999999999999999999876544333 334332 22222 124689999999999998 999999 89999
Q ss_pred hcCcccccCCcccc
Q 010116 390 KAHPWFKDVVWDKL 403 (518)
Q Consensus 390 l~Hpff~~i~w~~l 403 (518)
++||||++.+|...
T Consensus 398 l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 398 LRHPWLQDEDMKRK 411 (419)
T ss_dssp HHSGGGCCHHHHHH
T ss_pred hCCcccCChhHHHH
Confidence 99999998877653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=410.06 Aligned_cols=268 Identities=27% Similarity=0.376 Sum_probs=221.3
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec------
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------ 157 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------ 157 (518)
..++|++++.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 35789999999999999999999999999999999876543 22334567789999999999999999999987
Q ss_pred --CCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 158 --TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 158 --~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
.+.+|+||||+.| +|...+... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4579999999965 777777554 689999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCC
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYG 313 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~ 313 (518)
.+...... ........+||+.|+|||++.+ ..|+
T Consensus 173 ~~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (351)
T 3mi9_A 173 AFSLAKNS---------------------------------------------QPNRYTNRVVTLWYRPPELLLGERDYG 207 (351)
T ss_dssp ECCCCSSS---------------------------------------------SCCCCCSSCSCGGGCCHHHHTTCCSCC
T ss_pred cccccccc---------------------------------------------cccccCCcccccCccCchhhcCCCCCC
Confidence 65422100 0011235689999999999986 5689
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCC----------------------------CChh
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSK----------------------------LSPE 365 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~----------------------------~s~~ 365 (518)
.++|||||||++|+|++|.+||.+.+.......+......+....... .+++
T Consensus 208 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (351)
T 3mi9_A 208 PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 287 (351)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHH
T ss_pred cHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChH
Confidence 999999999999999999999999988888777765333222111111 2678
Q ss_pred HHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 366 AKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 366 ~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
+++||.+||+ ||.+|+ ++.|+++||||.+..+.
T Consensus 288 ~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 288 ALDLIDKLLVLDPAQRI---DSDDALNHDFFWSDPMP 321 (351)
T ss_dssp HHHHHHHHSCSSGGGSC---CHHHHHTSGGGGSSSCC
T ss_pred HHHHHHHHhcCChhhCC---CHHHHhCCCCcCCCCCc
Confidence 9999999999 999999 89999999999875543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=416.76 Aligned_cols=259 Identities=30% Similarity=0.449 Sum_probs=213.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec------C
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------T 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------~ 158 (518)
..+|+++++||+|+||+||+|++..+++ ||+|++.+.... ..+|+.+|+.++|||||+++++|.. .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 4579999999999999999999887766 888877654321 2369999999999999999999943 3
Q ss_pred CeEEEEEeecCCCchHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC-CCCcEEEeeccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCK 234 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l---~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld-~~g~vKL~DFGla~ 234 (518)
.++|+|||||+++.+..+. .....+++..++.|+.||+.||.|||++||+||||||+|||++ .+|++||+|||+|+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 4589999999765443332 2357899999999999999999999999999999999999999 79999999999998
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCC
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYG 313 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~ 313 (518)
.+.... ...+.+||+.|+|||++.+. .|+
T Consensus 191 ~~~~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ 220 (394)
T 4e7w_A 191 ILIAGE--------------------------------------------------PNVSYICSRYYRAPELIFGATNYT 220 (394)
T ss_dssp ECCTTC--------------------------------------------------CCCSSCSCGGGCCHHHHTTCSSCC
T ss_pred cccCCC--------------------------------------------------CCcccccCcCccCHHHHcCCCCCC
Confidence 653210 11256899999999999775 599
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc---------------ccCCC----------CCCCChhHHH
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH---------------LKFPD----------DSKLSPEAKD 368 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---------------l~~p~----------~~~~s~~~~d 368 (518)
.++|||||||++|||++|.+||.+.+.......|+..... ..+|. ...+++++++
T Consensus 221 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (394)
T 4e7w_A 221 TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAID 300 (394)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHH
Confidence 9999999999999999999999999888877777652111 11221 1247899999
Q ss_pred HHHHHhc-cccccCCCCChhhhhcCcccccCCccccc
Q 010116 369 LICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 369 LI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~ 404 (518)
||.+||. ||.+|+ ++.|+++||||+++.|....
T Consensus 301 li~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 301 LISRLLEYTPSARL---TAIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp HHHHHCCSSGGGSC---CHHHHHTSGGGSTTTSSCCC
T ss_pred HHHHHhCCChhhCC---CHHHHhcChhhhhhcccccc
Confidence 9999999 999999 89999999999998886553
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=403.63 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=206.7
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lyl 163 (518)
.++|+++++||+|+||+||+|+++.+|+.||||++......... ......|...+..+ .|||||+++++|.+.+.+|+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 36799999999999999999999999999999998654332222 23344455555444 99999999999999999999
Q ss_pred EEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||||+ +|+|.+++... ..+++..++.++.|++.||.|||++|||||||||+|||++.+|++||+|||+++......
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-- 211 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-- 211 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--
Confidence 99999 77998888664 569999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
.....+||+.|+|||++.+ .|+.++||||||
T Consensus 212 ------------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG 242 (311)
T 3p1a_A 212 ------------------------------------------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLG 242 (311)
T ss_dssp ---------------------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHH
T ss_pred ------------------------------------------------CCcccCCCccccCHhHhcC-CCCchhhHHHHH
Confidence 1124579999999999876 799999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|++|||++|..||.+... ...+........++ ..+++++.+||.+||. ||.+|+ ++.|+++||||+.
T Consensus 243 ~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~~~~ 310 (311)
T 3p1a_A 243 LTILEVACNMELPHGGEG---WQQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDPKLRA---TAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHH--TTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGSC
T ss_pred HHHHHHHhCCCCCCCccH---HHHHhccCCCcccc--cCCCHHHHHHHHHHcCCChhhCc---CHHHHHhCccccC
Confidence 999999999877765433 23333322122222 3689999999999998 999999 8999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=401.45 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=212.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeec--CCeE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD--TEYL 161 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~--~~~l 161 (518)
.++|++++.||+|+||.||+|++..+++.||||++... ..+.+.+|+.+|+.+. ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 57899999999999999999999999999999998743 2356889999999997 9999999999998 6789
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-cEEEeecccccccCCCc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCST 240 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-~vKL~DFGla~~~~~~~ 240 (518)
|+||||++|++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999999884 489999999999999999999999999999999999999777 89999999998653210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWW 319 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 319 (518)
.....+||+.|+|||++.+ ..|+.++|||
T Consensus 186 --------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 215 (330)
T 3nsz_A 186 --------------------------------------------------EYNVRVASRYFKGPELLVDYQMYDYSLDMW 215 (330)
T ss_dssp --------------------------------------------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHH
T ss_pred --------------------------------------------------ccccccccccccChhhhcCCCcCCchhhHH
Confidence 1124579999999999987 6799999999
Q ss_pred chhHHHHHHHhCCCCCCCC-ChhhHHHHHhhhcC-----------c----------------------ccCCCCCCCChh
Q 010116 320 SLGAIMYEMLVGYPPFYAD-DPITTCRKIVHWRN-----------H----------------------LKFPDDSKLSPE 365 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~-----------~----------------------l~~p~~~~~s~~ 365 (518)
||||++|+|++|..||... +.......+..... . ........++++
T Consensus 216 slG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (330)
T 3nsz_A 216 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 295 (330)
T ss_dssp HHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHH
T ss_pred HHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHH
Confidence 9999999999999999543 33333322221100 0 001111237999
Q ss_pred HHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccc
Q 010116 366 AKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 366 ~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~ 402 (518)
+++||.+||. ||.+|+ +++|+++||||+++.|++
T Consensus 296 ~~~li~~~L~~dP~~Rp---ta~e~l~hp~f~~~~~~~ 330 (330)
T 3nsz_A 296 ALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKDQ 330 (330)
T ss_dssp HHHHHHTTSCSSGGGSC---CHHHHHTSGGGTTCC---
T ss_pred HHHHHHHHhcCCcccCC---CHHHHhcCccHhhhccCC
Confidence 9999999999 999999 899999999999998763
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=407.41 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=223.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
+.|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+|+.++|||||+++++|.+.+.+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999997654444455677899999999999999999999999999999999
Q ss_pred eecCCCchHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 166 EYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 166 Ey~~gG~L~~~l~-~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||+. |+|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9997 67888775 457899999999999999999999999999999999999999999999999999875421
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CCCCCccccccch
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWSL 321 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSl 321 (518)
..+.+||+.|+|||++. +..|+.++|||||
T Consensus 207 -----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 239 (348)
T 1u5q_A 207 -----------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239 (348)
T ss_dssp -----------------------------------------------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHH
T ss_pred -----------------------------------------------CCcccCCcceeCHhhhccccCCCCCcHHHHHHH
Confidence 11457999999999995 5679999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
||++|||++|.+||.+.+.......+..... .......+++.+++||.+||. ||.+|+ ++.+|++||||....
T Consensus 240 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 240 GITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHSCC
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcccChhhCc---CHHHHhhChhhhccC
Confidence 9999999999999999888777777766322 222234689999999999998 999999 899999999997543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=407.80 Aligned_cols=265 Identities=29% Similarity=0.466 Sum_probs=217.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc--hhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK--RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
.++|++++.||+|+||.||+|++..+|+.||||++....... ......+.+|+.+++.++||||++++++|.+...+|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 578999999999999999999999999999999997643221 112245778999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 163 LIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
+||||++| +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.+....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 166 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 166 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc-
Confidence 99999975 888888654 579999999999999999999999999999999999999999999999999998653210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccc
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWS 320 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 320 (518)
......+||+.|+|||++.+ ..|+.++||||
T Consensus 167 ------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 198 (346)
T 1ua2_A 167 ------------------------------------------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 198 (346)
T ss_dssp ------------------------------------------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred ------------------------------------------------ccCCcccccccccCchHhhCCCCCCchhhhHh
Confidence 01124689999999999976 45899999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc---------CCC---------------CCCCChhHHHHHHHHhc-
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK---------FPD---------------DSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~---------~p~---------------~~~~s~~~~dLI~~lL~- 375 (518)
|||++|||++|.+||.+.+....+.++........ .+. ...+++++++||.+||.
T Consensus 199 lG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 278 (346)
T 1ua2_A 199 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF 278 (346)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhcc
Confidence 99999999999999999998888888765321110 000 13467899999999998
Q ss_pred cccccCCCCChhhhhcCcccccCCccc
Q 010116 376 DVEHRLGTGGAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff~~i~w~~ 402 (518)
||.+|+ ++.|+++||||++..|..
T Consensus 279 dP~~Rp---t~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 279 NPCARI---TATQALKMKYFSNRPGPT 302 (346)
T ss_dssp STTTSC---CHHHHHTSGGGTSSSCCC
T ss_pred ChhhCC---CHHHHhcChhhhcCCCCC
Confidence 999999 899999999999766543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=398.70 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=221.4
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
+.+..++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 34556899999999999999999999999999999999976655555567788999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
.......+||+.|+|||++.+..++.++||||
T Consensus 166 ------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 197 (294)
T 4eqm_A 166 ------------------------------------------------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYS 197 (294)
T ss_dssp ---------------------------------------------------------CCSSCCHHHHHTCCCCTTHHHHH
T ss_pred ------------------------------------------------ccccCccccCccccCHhHhcCCCCCchHhHHH
Confidence 00122467999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc-ccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH-LKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
|||++|+|++|.+||.+.+......+.+..... +.......+++.+.++|.+||. ||.+|+ +..+.+.+.|..
T Consensus 198 lG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~---~~~~~l~~~l~~ 272 (294)
T 4eqm_A 198 IGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY---KTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC---SSHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHcc---ccHHHHHHHHHH
Confidence 999999999999999998877766555542111 1111234689999999999998 999999 445555565553
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=412.94 Aligned_cols=256 Identities=30% Similarity=0.493 Sum_probs=213.2
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee------
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ------ 156 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~------ 156 (518)
...++|++++.||+|+||+||+|++..+|+.||||++...... ..+|+.+|+.++|||||+++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4467899999999999999999999999999999998755321 236999999999999999999983
Q ss_pred --------------------------------cCCeEEEEEeecCCCchHHHHh----hcCCCCHHHHHHHHHHHHHHHH
Q 010116 157 --------------------------------DTEYLYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAIE 200 (518)
Q Consensus 157 --------------------------------~~~~lylVmEy~~gG~L~~~l~----~~~~l~e~~~~~~~~ql~~aL~ 200 (518)
+..++|+||||++ |+|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 4456999999997 57766664 3578999999999999999999
Q ss_pred HHHhCCeEEcCCCCCceeeC-CCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchh
Q 010116 201 SIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHE 279 (518)
Q Consensus 201 ~LH~~giiHRDIKPeNILld-~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (518)
|||++||+||||||+|||++ .+|.+||+|||+|+.+....
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------- 196 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------------------------------------- 196 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---------------------------------------
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---------------------------------------
Confidence 99999999999999999998 68999999999998653211
Q ss_pred HHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc-----
Q 010116 280 QLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH----- 353 (518)
Q Consensus 280 ~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----- 353 (518)
...+.+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.......++.....
T Consensus 197 -----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~ 265 (383)
T 3eb0_A 197 -----------PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ 265 (383)
T ss_dssp -----------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred -----------CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 11256799999999999875 5999999999999999999999999999888888777652111
Q ss_pred ----------ccCCC----------CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 354 ----------LKFPD----------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 354 ----------l~~p~----------~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
..+|. ...+|+++++||.+||. ||.+|+ ++.|+++||||+.+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 266 MIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSGGGHHHH
T ss_pred HHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcCHHHHHHH
Confidence 11221 13578999999999999 999999 899999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=420.83 Aligned_cols=262 Identities=19% Similarity=0.200 Sum_probs=204.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh--CCCceeEEEEEe-------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV--ASHCIVKLYYSF------- 155 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~~~f------- 155 (518)
..+|++++.||+|+||.||+|++..+|+.||||++.+.........+.+++|..++..+ +||||++++..|
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34699999999999999999999999999999999987655556677888886666555 599988876443
Q ss_pred ecC-----------------CeEEEEEeecCCCchHHHHhhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCeEEcC
Q 010116 156 QDT-----------------EYLYLIMEYLPGGDMMTLLMRE-DTLTENVA------RFYIAQSVLAIESIHKHNYIHRD 211 (518)
Q Consensus 156 ~~~-----------------~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~------~~~~~ql~~aL~~LH~~giiHRD 211 (518)
... ..+|||||||+ |+|.+++... ..+++... ..++.||+.||.|||++||||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 322 44899999998 8999999764 34444443 45669999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccc
Q 010116 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291 (518)
Q Consensus 212 IKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (518)
|||+||||+.+|++||+|||+|+.....
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~---------------------------------------------------- 247 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR---------------------------------------------------- 247 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE----------------------------------------------------
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC----------------------------------------------------
Confidence 9999999999999999999999865311
Q ss_pred cccccCCCCccChhhhcC--CCCCccccccchhHHHHHHHhCCCCCCCCChhhH--HHH---HhhhcCcccCCCCCCCCh
Q 010116 292 AFSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITT--CRK---IVHWRNHLKFPDDSKLSP 364 (518)
Q Consensus 292 ~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~---i~~~~~~l~~p~~~~~s~ 364 (518)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+..+... +.. .......+.++....+|+
T Consensus 248 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (371)
T 3q60_A 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD 327 (371)
T ss_dssp EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCH
T ss_pred ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCH
Confidence 113467799999999987 7899999999999999999999999987744211 111 111123445565568899
Q ss_pred hHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccc
Q 010116 365 EAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 365 ~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~ 402 (518)
++++||.+||. ||.+|+ ++.++++||||+++.|..
T Consensus 328 ~~~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 328 FVKTLIGRFLNFDRRRRL---LPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp HHHHHHHHHTCSSTTTCC---CHHHHTTSHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCC---CHHHHhcCHHHHHHHHHH
Confidence 99999999998 999999 899999999999987753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=397.34 Aligned_cols=275 Identities=28% Similarity=0.450 Sum_probs=228.8
Q ss_pred HHHhhhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEE
Q 010116 73 TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152 (518)
Q Consensus 73 ~~~~~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 152 (518)
.+|..+.+.....++|++++.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||++++
T Consensus 6 ~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~ 82 (302)
T 2j7t_A 6 REYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLL 82 (302)
T ss_dssp ----CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhcccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeee
Confidence 345555666666789999999999999999999999999999999987542 33456788999999999999999999
Q ss_pred EEeecCCeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecc
Q 010116 153 YSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231 (518)
Q Consensus 153 ~~f~~~~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFG 231 (518)
+++.+.+.+|+||||++||+|..++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp EEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred eeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999999999999999865 4679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL--- 308 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~--- 308 (518)
++...... .......+||+.|+|||++.
T Consensus 163 ~~~~~~~~-------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~ 193 (302)
T 2j7t_A 163 VSAKNLKT-------------------------------------------------LQKRDSFIGTPYWMAPEVVMCET 193 (302)
T ss_dssp HHHHHHHH-------------------------------------------------HHC-----CCGGGCCHHHHHHHH
T ss_pred CCcccccc-------------------------------------------------ccccccccCChhhcCCeeecccc
Confidence 97642100 00112467999999999984
Q ss_pred --CCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCC
Q 010116 309 --KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGG 385 (518)
Q Consensus 309 --~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~ 385 (518)
+..++.++|||||||++|+|++|.+||...+.......+.... ....+....+|.++.+||.+||. ||.+|+ +
T Consensus 194 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s 269 (302)
T 2j7t_A 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD-PPTLLTPSKWSVEFRDFLKIALDKNPETRP---S 269 (302)
T ss_dssp TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCSSGGGSCHHHHHHHHHHSCSCTTTSC---C
T ss_pred CCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC-CcccCCccccCHHHHHHHHHHcccChhhCC---C
Confidence 6778999999999999999999999999988877777766532 22222334689999999999998 999999 8
Q ss_pred hhhhhcCcccccCCcccc
Q 010116 386 AHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 386 a~eil~Hpff~~i~w~~l 403 (518)
+.+|++||||+++.|...
T Consensus 270 ~~~ll~h~~~~~~~~~~~ 287 (302)
T 2j7t_A 270 AAQLLEHPFVSSITSNKA 287 (302)
T ss_dssp HHHHTTSTTTTTCCCCHH
T ss_pred HHHHhcChHHhhhccchh
Confidence 999999999999988753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=416.36 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=213.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec------CC
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------TE 159 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------~~ 159 (518)
.+|++++.||+|+||.||+|+++.+|+.||||++.+... ...+|+.+|+.++|||||+++++|.. ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 469999999999999999999999999999999876431 12369999999999999999998843 33
Q ss_pred eEEEEEeecCCCchHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC-CcEEEeeccccc
Q 010116 160 YLYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCK 234 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~----~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~-g~vKL~DFGla~ 234 (518)
++|+||||+++ +|..++. ....+++..++.++.||+.||.|||++|||||||||+||||+.+ +.+||+|||+|+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 57899999975 6665553 34789999999999999999999999999999999999999965 568999999998
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCC
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYG 313 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~ 313 (518)
.+.... ...+.+||+.|+|||++.+. .|+
T Consensus 206 ~~~~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ 235 (420)
T 1j1b_A 206 QLVRGE--------------------------------------------------PNVSYICSRYYRAPELIFGATDYT 235 (420)
T ss_dssp ECCTTC--------------------------------------------------CCCSCCSCTTSCCHHHHTTCSSCC
T ss_pred hcccCC--------------------------------------------------CceeeeeCCCcCCHHHHcCCCCCC
Confidence 653210 11256899999999999874 799
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC---------------cccCCC----------CCCCChhHHH
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN---------------HLKFPD----------DSKLSPEAKD 368 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------~l~~p~----------~~~~s~~~~d 368 (518)
.++|||||||++|||++|++||.+.+....+.+|+.... .+.+|. ...+++++++
T Consensus 236 ~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 315 (420)
T 1j1b_A 236 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 315 (420)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHH
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHH
Confidence 999999999999999999999999988777777665211 122222 1256899999
Q ss_pred HHHHHhc-cccccCCCCChhhhhcCcccccCCccc
Q 010116 369 LICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 369 LI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~ 402 (518)
||.+||. ||.+|+ ++.|+++||||+++.+..
T Consensus 316 Li~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 316 LCSRLLEYTPTARL---TPLEACAHSFFDELRDPN 347 (420)
T ss_dssp HHHHHSCSSGGGSC---CHHHHHTSGGGGGGGCTT
T ss_pred HHHHhccCChhHCC---CHHHHhCCHhhccccccc
Confidence 9999999 999999 899999999999876544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=413.39 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=205.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------ 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------ 158 (518)
.++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 478999999999999999999999999999999987542 2334456788999999999999999999999764
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..+|+||||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 8899998855 6899999999999999999999999999999999999999999999999999875421
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 317 (518)
. ....+||+.|+|||++.+ ..|+.++|
T Consensus 185 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 212 (367)
T 2fst_X 185 E----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVD 212 (367)
T ss_dssp ----------------------------------------------------------CCCTTCCHHHHTTCCSCCTTHH
T ss_pred c----------------------------------------------------CCCcCcCcCccChHHHcCCcCCCchhh
Confidence 0 124689999999999987 78999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---------------------cCCC------CCCCChhHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL---------------------KFPD------DSKLSPEAKDLI 370 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---------------------~~p~------~~~~s~~~~dLI 370 (518)
||||||++|||++|++||.+.+.......|+...... ..+. ...+++++++||
T Consensus 213 iwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl 292 (367)
T 2fst_X 213 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292 (367)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHH
Confidence 9999999999999999999998887777776521110 0010 124689999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
.+||+ ||.+|+ ++.|+++||||+....
T Consensus 293 ~~mL~~dP~~R~---t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 293 EKMLVLDSDKRI---TAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHSCSSGGGSC---CHHHHHTSGGGTTTCC
T ss_pred HHhCCCCcccCc---CHHHHhcChhhhhccC
Confidence 99999 999999 8999999999997554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=390.51 Aligned_cols=259 Identities=25% Similarity=0.450 Sum_probs=221.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|+++.+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 579999999999999999999999999999999976532 234567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---- 160 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---- 160 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE----
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc----
Confidence 9999999999998878899999999999999999999999999999999999999999999999999886532100
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-CccccccchhHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 324 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvi 324 (518)
.......+||+.|+|||++.+..+ +.++|||||||+
T Consensus 161 -------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 197 (276)
T 2yex_A 161 -------------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197 (276)
T ss_dssp -------------------------------------------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHH
T ss_pred -------------------------------------------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHH
Confidence 011235679999999999988776 789999999999
Q ss_pred HHHHHhCCCCCCCCChhh-HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 325 MYEMLVGYPPFYADDPIT-TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~-~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
+|+|++|..||...+... ....+... ....+....+++++++||.+||. ||.+|+ ++.+|++||||++.
T Consensus 198 l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 268 (276)
T 2yex_A 198 LTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHSSCCCSCSCTTSHHHHHHHTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred HHHHHhCCCCCCCCchHHHHHHHhhhc--ccccCchhhcCHHHHHHHHHHCCCCchhCC---CHHHHhcCccccCh
Confidence 999999999998765432 23333321 22233334689999999999998 999999 89999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=404.08 Aligned_cols=265 Identities=26% Similarity=0.422 Sum_probs=209.9
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC------
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE------ 159 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~------ 159 (518)
++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 57999999999999999999999999999999997643 2345677899999999999999999999985543
Q ss_pred ---------------------------------------------------eEEEEEeecCCCchHHHHhhcC---CCCH
Q 010116 160 ---------------------------------------------------YLYLIMEYLPGGDMMTLLMRED---TLTE 185 (518)
Q Consensus 160 ---------------------------------------------------~lylVmEy~~gG~L~~~l~~~~---~l~e 185 (518)
++|+|||||+||+|.+++.... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 4899999999999999997754 3556
Q ss_pred HHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCC
Q 010116 186 NVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265 (518)
Q Consensus 186 ~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (518)
..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+............ .
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~-------------~----- 225 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL-------------T----- 225 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc-------------c-----
Confidence 6789999999999999999999999999999999999999999999998765321100000 0
Q ss_pred CCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHH
Q 010116 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCR 345 (518)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 345 (518)
...........+||+.|+|||++.+..|+.++|||||||++|||++|..|+... .....
T Consensus 226 -------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~ 284 (332)
T 3qd2_B 226 -------------------PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIIT 284 (332)
T ss_dssp -------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHH
T ss_pred -------------------cccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHH
Confidence 000001223568999999999999999999999999999999999998876321 12222
Q ss_pred HHhhhcCcccCCC-CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 346 KIVHWRNHLKFPD-DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 346 ~i~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
.+.. ..+|. ....++++++||.+||. ||.+|+ ++.|+++||||+++
T Consensus 285 ~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 285 DVRN----LKFPLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENAIFENL 332 (332)
T ss_dssp HHHT----TCCCHHHHHHCHHHHHHHHHHHCSSGGGSC---CHHHHHHSTTCCCC
T ss_pred Hhhc----cCCCcccccCChhHHHHHHHHccCCCCcCC---CHHHHhhchhhhcC
Confidence 2222 22221 12457889999999998 999999 89999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=390.48 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=217.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec----CCe
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----TEY 160 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~----~~~ 160 (518)
...|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|..+|+.++||||++++++|.+ ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3459999999999999999999999999999999986543 34456778999999999999999999998875 567
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCceeeC-CCCcEEEeecccccccC
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~g--iiHRDIKPeNILld-~~g~vKL~DFGla~~~~ 237 (518)
+|+||||++||+|.+++.....+++..++.++.|++.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999999988899999999999999999999999999 99999999999998 78999999999987532
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.. .....+||+.|+|||++. ..++.++|
T Consensus 184 ~~---------------------------------------------------~~~~~~~t~~y~aPE~~~-~~~~~~~D 211 (290)
T 1t4h_A 184 AS---------------------------------------------------FAKAVIGTPEFMAPEMYE-EKYDESVD 211 (290)
T ss_dssp TT---------------------------------------------------SBEESCSSCCCCCGGGGG-TCCCTHHH
T ss_pred cc---------------------------------------------------ccccccCCcCcCCHHHHh-ccCCCcch
Confidence 11 122467999999999886 45999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCCh-hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDP-ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
||||||++|+|++|..||..... ......+........++ ...++++.+||.+||. ||.+|+ ++.+|++||||
T Consensus 212 i~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~h~~f 286 (290)
T 1t4h_A 212 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFF 286 (290)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGG
T ss_pred HHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC--CCCCHHHHHHHHHHccCChhhCC---CHHHHhhCccc
Confidence 99999999999999999987544 34444444332222333 3578999999999998 999999 89999999999
Q ss_pred cc
Q 010116 396 KD 397 (518)
Q Consensus 396 ~~ 397 (518)
++
T Consensus 287 ~~ 288 (290)
T 1t4h_A 287 QE 288 (290)
T ss_dssp C-
T ss_pred cc
Confidence 86
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=399.77 Aligned_cols=275 Identities=27% Similarity=0.438 Sum_probs=222.0
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC----
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT---- 158 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~---- 158 (518)
...++|++++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 34689999999999999999999999999999999996532 233456678999999999999999999987654
Q ss_pred -CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 -~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
..+|+||||+. |+|..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 78999999996 699988865 679999999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~ 316 (518)
......... ..........+||+.|+|||++.+ ..++.++
T Consensus 164 ~~~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 204 (353)
T 2b9h_A 164 ESAADNSEP---------------------------------------TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204 (353)
T ss_dssp -------------------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHH
T ss_pred cccccccCc---------------------------------------cccccchhhccccccccCCeeeccCCCccchh
Confidence 321100000 000011235689999999999875 7799999
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc----------------------CCC------CCCCChhHHH
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK----------------------FPD------DSKLSPEAKD 368 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~----------------------~p~------~~~~s~~~~d 368 (518)
|||||||++|+|++|.+||.+.+.......+........ ++. ...+++++++
T Consensus 205 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
T 2b9h_A 205 DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGID 284 (353)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHH
Confidence 999999999999999999999887666655543211110 111 1368899999
Q ss_pred HHHHHhc-cccccCCCCChhhhhcCcccccCCcccc
Q 010116 369 LICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 369 LI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l 403 (518)
||.+||. ||.+|+ ++.||++||||+.+.|...
T Consensus 285 li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 285 LLQRMLVFDPAKRI---TAKEALEHPYLQTYHDPND 317 (353)
T ss_dssp HHHHHSCSSGGGSC---CHHHHHTSGGGTTTCCTTS
T ss_pred HHHHhcCcCcccCC---CHHHHhcCccccccCCccc
Confidence 9999998 999999 8999999999998776543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=407.53 Aligned_cols=268 Identities=25% Similarity=0.482 Sum_probs=231.5
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhh--------------HHHHHHHHHHHHHhCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ--------------VEHVRAERNLLAEVAS 145 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~--------------~~~~~~E~~il~~l~h 145 (518)
......++|++++.||+|+||.||+|++ +|+.||+|++.......... .+.+.+|+.+++.++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3445668999999999999999999998 89999999998765432221 2778999999999999
Q ss_pred CceeEEEEEeecCCeEEEEEeecCCCchHHH------Hhh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCc
Q 010116 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL------LMR--EDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDN 216 (518)
Q Consensus 146 p~Iv~l~~~f~~~~~lylVmEy~~gG~L~~~------l~~--~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeN 216 (518)
|||+++++++.+.+.+|+||||++||+|.++ +.. ...+++..++.++.|++.||.|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 655 5789999999999999999999999 999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccccc
Q 010116 217 LLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (518)
Q Consensus 217 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 296 (518)
||++.+|++||+|||++...... .....+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~---------------------------------------------------~~~~~~ 211 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK---------------------------------------------------KIKGSR 211 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT---------------------------------------------------EECSSC
T ss_pred EEEcCCCcEEEeccccccccccc---------------------------------------------------cccCCC
Confidence 99999999999999998865321 112457
Q ss_pred CCCCccChhhhcCC-CCCc-cccccchhHHHHHHHhCCCCCCCCCh-hhHHHHHhhhcCcccCCCC--------------
Q 010116 297 GTPDYIAPEVLLKK-GYGM-ECDWWSLGAIMYEMLVGYPPFYADDP-ITTCRKIVHWRNHLKFPDD-------------- 359 (518)
Q Consensus 297 GT~~Y~APEvl~~~-~y~~-~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~l~~p~~-------------- 359 (518)
||+.|+|||++.+. .|+. ++|||||||++|+|++|.+||...+. ......+... .+.+|..
T Consensus 212 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~ 289 (348)
T 2pml_X 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK--NIEYPLDRNHFLYPLTNKKST 289 (348)
T ss_dssp SCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC--CCCCCCSSSSSTTTTCC----
T ss_pred CCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--CcCCccchhhhhccccccccc
Confidence 99999999999887 6776 99999999999999999999998776 6666666553 3444421
Q ss_pred ---CCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcccccc
Q 010116 360 ---SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYE 405 (518)
Q Consensus 360 ---~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~~ 405 (518)
..+++++.+||.+||+ ||.+|+ ++.|+++||||++++|..+.+
T Consensus 290 ~~~~~~~~~l~~li~~~L~~dP~~Rp---s~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 290 CSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp ----CCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSGGGTTCCHHHHHH
T ss_pred cchhhcCHHHHHHHHHHccCChhhCC---CHHHHhcCccccCCCHHHHHH
Confidence 4689999999999999 999999 899999999999999988754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=404.27 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=214.5
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC--CceeEEEEEeecCCe
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDTEY 160 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~~~~ 160 (518)
+..++|++++.||+|+||.||+|.+ .+++.||||++..... .....+.+.+|+.+|..+.| |||+++++++.+...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4567899999999999999999987 4689999999976542 33455778999999999987 899999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+||| +.+|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|+.+....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999999 55899999999989999999999999999999999999999999999999996 7899999999998653211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-----------
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK----------- 309 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~----------- 309 (518)
. .....+.+||+.|+|||++.+
T Consensus 162 ~-----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 194 (343)
T 3dbq_A 162 T-----------------------------------------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 194 (343)
T ss_dssp -------------------------------------------------------CCCCSSCCHHHHHHCC---------
T ss_pred c-----------------------------------------------cccCCCCcCCcCcCCHHHHhhccccccccccc
Confidence 0 001225689999999999975
Q ss_pred CCCCccccccchhHHHHHHHhCCCCCCCCC-hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 310 KGYGMECDWWSLGAIMYEMLVGYPPFYADD-PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 310 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
..|+.++|||||||++|||++|.+||.... .......++.......+| ...++++.+||.+||. ||.+|+ ++.
T Consensus 195 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rp---t~~ 269 (343)
T 3dbq_A 195 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRI---SIP 269 (343)
T ss_dssp --CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSC---CHH
T ss_pred cCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc--ccCCHHHHHHHHHHcCCChhHCC---CHH
Confidence 678999999999999999999999998743 334444555433344444 3568899999999998 999999 899
Q ss_pred hhhcCccccc
Q 010116 388 QIKAHPWFKD 397 (518)
Q Consensus 388 eil~Hpff~~ 397 (518)
|+++||||+.
T Consensus 270 e~l~hp~~~~ 279 (343)
T 3dbq_A 270 ELLAHPYVQI 279 (343)
T ss_dssp HHHTSHHHHS
T ss_pred HHHhCccccc
Confidence 9999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=404.81 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=219.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC-----Ce
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----EY 160 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~~ 160 (518)
++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 68999999999999999999999999999999997542 234456788999999999999999999999765 47
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+||||+. |+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999999996 699998854 579999999999999999999999999999999999999999999999999998654211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWW 319 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 319 (518)
. ........+||+.|+|||++.+ ..|+.++|||
T Consensus 183 ~----------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 216 (364)
T 3qyz_A 183 D----------------------------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 216 (364)
T ss_dssp C----------------------------------------------BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHH
T ss_pred C----------------------------------------------ccccccccccccCCCCCHHhcCCCCCCcchhHH
Confidence 0 0011235689999999998765 5589999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc------------------cCCC---------CCCCChhHHHHHHH
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL------------------KFPD---------DSKLSPEAKDLICR 372 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l------------------~~p~---------~~~~s~~~~dLI~~ 372 (518)
||||++|+|++|.+||.+.+.......++...... .+|. ...+++++.+||.+
T Consensus 217 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 296 (364)
T 3qyz_A 217 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 296 (364)
T ss_dssp HHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHH
Confidence 99999999999999999998888877776421111 0110 13578999999999
Q ss_pred Hhc-cccccCCCCChhhhhcCcccccC
Q 010116 373 LLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 373 lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||. ||.+|+ ++.|+++||||+..
T Consensus 297 ~L~~dP~~R~---t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 297 MLTFNPHKRI---EVEQALAHPYLEQY 320 (364)
T ss_dssp HTCSSTTTSC---CHHHHHTSGGGTTT
T ss_pred HcCCChhhCC---CHHHHhcCcchhhc
Confidence 999 999999 89999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=421.87 Aligned_cols=250 Identities=16% Similarity=0.216 Sum_probs=208.2
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHH---HHHHhCCCceeEEE-------E
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN---LLAEVASHCIVKLY-------Y 153 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~---il~~l~hp~Iv~l~-------~ 153 (518)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+. +|+.++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3578999999999999999999999999999999998765555666788999994 55556899999998 6
Q ss_pred EeecCC-----------------eEEEEEeecCCCchHHHHhhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCeEE
Q 010116 154 SFQDTE-----------------YLYLIMEYLPGGDMMTLLMREDTLTE-------NVARFYIAQSVLAIESIHKHNYIH 209 (518)
Q Consensus 154 ~f~~~~-----------------~lylVmEy~~gG~L~~~l~~~~~l~e-------~~~~~~~~ql~~aL~~LH~~giiH 209 (518)
++.+.+ ..||||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 666553 389999999 7899999987666666 777789999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcc
Q 010116 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289 (518)
Q Consensus 210 RDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (518)
|||||+||||+.+|.+||+|||+|+....
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~--------------------------------------------------- 258 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------------------------------------------------- 258 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC---------------------------------------------------
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC---------------------------------------------------
Confidence 99999999999999999999999985321
Q ss_pred cccccccCCCCccChhhhcCC-----------CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCC
Q 010116 290 KLAFSTVGTPDYIAPEVLLKK-----------GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPD 358 (518)
Q Consensus 290 ~~~~s~~GT~~Y~APEvl~~~-----------~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~ 358 (518)
...+.+| +.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.......+.. .
T Consensus 259 -~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------~ 328 (377)
T 3byv_A 259 -RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR--------S 328 (377)
T ss_dssp -EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS--------S
T ss_pred -cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh--------h
Confidence 1225678 999999999987 899999999999999999999999987765544433322 1
Q ss_pred CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 359 DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 359 ~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
...+++++++||.+||. ||.+|+ ++.++++||||+++
T Consensus 329 ~~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~f~~~ 366 (377)
T 3byv_A 329 CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQL 366 (377)
T ss_dssp CCCCCHHHHHHHHHHTCSSGGGCC---CHHHHHTSHHHHHH
T ss_pred ccCCCHHHHHHHHHHcCCCchhCC---CHHHHhhChHHHHH
Confidence 24689999999999998 999999 89999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=411.93 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=217.0
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC--CCceeEEEEEeecCCe
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA--SHCIVKLYYSFQDTEY 160 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~f~~~~~ 160 (518)
+...+|++++.||+|+||.||+|.+.. ++.||||++.+... .....+.+.+|+.+|..+. |||||++++++.+.+.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 334569999999999999999998765 89999999976543 3445677899999999996 5999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+||||| +.+|+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++ +|.+||+|||+|+.+....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999999 56899999999888999999999999999999999999999999999999995 6899999999998653211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-----------
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK----------- 309 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~----------- 309 (518)
. .....+.+||+.|+|||++.+
T Consensus 209 ~-----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 241 (390)
T 2zmd_A 209 T-----------------------------------------------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241 (390)
T ss_dssp ----------------------------------------------------CCSCCCGGGCCHHHHHCC----------
T ss_pred c-----------------------------------------------cccCCCCCcCCCccChHHhhhccccccccccc
Confidence 0 001235689999999999975
Q ss_pred CCCCccccccchhHHHHHHHhCCCCCCCCC-hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 310 KGYGMECDWWSLGAIMYEMLVGYPPFYADD-PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 310 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
..|+.++|||||||++|||++|.+||.... .......++.....+.+|. ..++++++||.+||. ||.+|+ ++.
T Consensus 242 ~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rp---s~~ 316 (390)
T 2zmd_A 242 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRI---SIP 316 (390)
T ss_dssp --CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSC---CHH
T ss_pred cCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc--cchHHHHHHHHHHcccChhhCC---CHH
Confidence 468999999999999999999999998753 3345555655433444443 568999999999998 999999 899
Q ss_pred hhhcCcccccC
Q 010116 388 QIKAHPWFKDV 398 (518)
Q Consensus 388 eil~Hpff~~i 398 (518)
||++||||+..
T Consensus 317 ell~hp~~~~~ 327 (390)
T 2zmd_A 317 ELLAHPYVQIQ 327 (390)
T ss_dssp HHHTSHHHHSC
T ss_pred HHhhCcCcccc
Confidence 99999999853
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=393.68 Aligned_cols=261 Identities=32% Similarity=0.612 Sum_probs=229.3
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||.||+|++..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 579999999999999999999999999999999976543 2344677889999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC---CcEEEeecccccccCCCccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN---GHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~---g~vKL~DFGla~~~~~~~~~ 242 (518)
||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-- 178 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS--
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC--
Confidence 999999999999888899999999999999999999999999999999999999764 479999999987643210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
.....+||+.|+|||++.+ .++.++||||||
T Consensus 179 ------------------------------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG 209 (287)
T 2wei_A 179 ------------------------------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAG 209 (287)
T ss_dssp ------------------------------------------------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHH
T ss_pred ------------------------------------------------ccccccCcccccChHHhcC-CCCCchhhHhHH
Confidence 0123468999999999876 489999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
|++|+|++|.+||.+.+.......+......+..|....+|+++.+||.+||. ||.+|+ ++.++++||||++..|+
T Consensus 210 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 210 VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHHHCCC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCc---CHHHHhcCHHHhccccC
Confidence 99999999999999998888888777654444445445789999999999998 999999 89999999999987664
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=405.14 Aligned_cols=267 Identities=30% Similarity=0.482 Sum_probs=224.4
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
...++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 456899999999999999999999999999999999876532 2334556789999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
+||||++|++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.+....
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 178 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence 999999999999988778899999999999999999999999999999999999999999999999999997643210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccch
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSL 321 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSl 321 (518)
......+||+.|+|||++.+. .|+.++|||||
T Consensus 179 -----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl 211 (331)
T 4aaa_A 179 -----------------------------------------------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAI 211 (331)
T ss_dssp ----------------------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHH
T ss_pred -----------------------------------------------cccCCCcCCccccCcccccCCCCcchHHHHHHH
Confidence 011245799999999999875 78999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc-----------------ccCCC----------CCCCChhHHHHHHHHh
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNH-----------------LKFPD----------DSKLSPEAKDLICRLL 374 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-----------------l~~p~----------~~~~s~~~~dLI~~lL 374 (518)
||++|+|++|.+||.+.+.......+...... ...|. ...+|+++.+||.+||
T Consensus 212 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 291 (331)
T 4aaa_A 212 GCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCL 291 (331)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHh
Confidence 99999999999999998887776666542111 11111 1257899999999999
Q ss_pred c-cccccCCCCChhhhhcCcccccCCccc
Q 010116 375 C-DVEHRLGTGGAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~Hpff~~i~w~~ 402 (518)
. ||.+|+ ++.||++||||+...|..
T Consensus 292 ~~dP~~Rp---t~~ell~hp~f~~~~~~~ 317 (331)
T 4aaa_A 292 HIDPDKRP---FCAELLHHDFFQMDGFAE 317 (331)
T ss_dssp CSSGGGSC---CGGGGGGSHHHHGGGHHH
T ss_pred ccCcccCC---CHHHHhcCchhccCChhh
Confidence 9 999999 899999999999766543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=403.10 Aligned_cols=261 Identities=32% Similarity=0.613 Sum_probs=216.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
++|++++.||+|+||.||+|+++.+++.||||++.+.... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999999765432 1223345789999999999999999999998765
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc---EEEeecccccccC
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKPLD 237 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~---vKL~DFGla~~~~ 237 (518)
+|+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988889999999999999999999999999999999999999987665 9999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CCCCCc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGM 314 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~ 314 (518)
... .....+||+.|+|||++. ...|+.
T Consensus 169 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 198 (322)
T 2ycf_A 169 ETS--------------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNR 198 (322)
T ss_dssp CCH--------------------------------------------------HHHHHHSCCTTCCHHHHHHTTTTTCTT
T ss_pred ccc--------------------------------------------------ccccccCCcCccCchhhccCCCCCCCc
Confidence 210 112457999999999984 467899
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhh-HHHHHhhhcCcccCCC--CCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPIT-TCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
++|||||||++|+|++|.+||....... ....+... ...++. ...+++++.+||.+||. ||.+|+ ++.+++
T Consensus 199 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~~~l 273 (322)
T 2ycf_A 199 AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG--KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEAL 273 (322)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC--ccccCchhhhhcCHHHHHHHHHHcccCHhhCC---CHHHHh
Confidence 9999999999999999999998765443 33334332 222211 23689999999999998 999999 899999
Q ss_pred cCcccccCCccc
Q 010116 391 AHPWFKDVVWDK 402 (518)
Q Consensus 391 ~Hpff~~i~w~~ 402 (518)
+||||++.+|..
T Consensus 274 ~h~~~~~~~~~~ 285 (322)
T 2ycf_A 274 RHPWLQDEDMKR 285 (322)
T ss_dssp TSGGGCCHHHHH
T ss_pred hCcCcCCHHHHH
Confidence 999999877653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=413.42 Aligned_cols=254 Identities=25% Similarity=0.459 Sum_probs=216.2
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh------CCCceeEEEEEeec
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV------ASHCIVKLYYSFQD 157 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~f~~ 157 (518)
...+|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+ +|+||++++++|..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 3467999999999999999999999999999999997642 2345577888888887 57799999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc--EEEeecccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH--MKLSDFGLC 233 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~--vKL~DFGla 233 (518)
...+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++|||||||||+||||+.+|. +||+|||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999995 69999987653 5999999999999999999999999999999999999999988 999999998
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
..... ...+.+||+.|+|||++.+..|+
T Consensus 250 ~~~~~----------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~ 277 (429)
T 3kvw_A 250 CYEHQ----------------------------------------------------RVYTYIQSRFYRAPEVILGARYG 277 (429)
T ss_dssp EETTC----------------------------------------------------CCCSSCSCGGGCCHHHHHTBCCC
T ss_pred eecCC----------------------------------------------------cccccCCCCCccChHHHhCCCCC
Confidence 75321 12256899999999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc------------------cCC------------------
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL------------------KFP------------------ 357 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l------------------~~p------------------ 357 (518)
.++|||||||++|||++|.+||.+.+.......++...... .+|
T Consensus 278 ~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (429)
T 3kvw_A 278 MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGG 357 (429)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCE
T ss_pred chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccccccccccccccc
Confidence 99999999999999999999999998887777665421100 000
Q ss_pred ----------C---------CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 358 ----------D---------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 358 ----------~---------~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
. ....++++++||.+||+ ||.+|+ ++.|+++||||+.
T Consensus 358 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp---ta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM---TPGQALRHPWLRR 414 (429)
T ss_dssp ECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC---CHHHHHTSTTTC-
T ss_pred ccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC---CHHHHhCChhhcc
Confidence 0 01237889999999999 999999 8999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=390.95 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=205.4
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+..++|++++.||+|+||.||+|++..+|+.||+|++..... .......+..+..+++.++||||+++++++.+.+.+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4567899999999999999999999999999999999976532 222334455556667888999999999999999999
Q ss_pred EEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 162 YLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
|+||||++ |+|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++++||+|||+++..
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 588777643 46899999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhh----cCCCC
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL----LKKGY 312 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl----~~~~y 312 (518)
.... .....+||+.|+|||++ .+..|
T Consensus 161 ~~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~ 190 (290)
T 3fme_A 161 VDDV--------------------------------------------------AKDIDAGCKPYMAPERINPELNQKGY 190 (290)
T ss_dssp -----------------------------------------------------------CCCCCCSCHHHHSCCTTC--C
T ss_pred cccc--------------------------------------------------cccccCCCccccChhhcChhhcCcCC
Confidence 3210 11234799999999996 46679
Q ss_pred CccccccchhHHHHHHHhCCCCCCC-CChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYA-DDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
+.++|||||||++|+|++|..||.. .........+... .....+ ...+|+++.+||.+||. ||.+|+ ++.|++
T Consensus 191 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---t~~e~l 265 (290)
T 3fme_A 191 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSPQLP-ADKFSAEFVDFTSQCLKKNSKERP---TYPELM 265 (290)
T ss_dssp CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CCCCCC-TTTSCHHHHHHHHHHTCSSGGGSC---CHHHHT
T ss_pred CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-CCCCcc-cccCCHHHHHHHHHHhhcChhhCc---CHHHHH
Confidence 9999999999999999999999986 3444444444442 222333 24689999999999998 999999 899999
Q ss_pred cCccccc
Q 010116 391 AHPWFKD 397 (518)
Q Consensus 391 ~Hpff~~ 397 (518)
+||||+.
T Consensus 266 ~hp~f~~ 272 (290)
T 3fme_A 266 QHPFFTL 272 (290)
T ss_dssp TSHHHHH
T ss_pred hCccccc
Confidence 9999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=387.13 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=210.5
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylV 164 (518)
++|++++.||+|+||.||+|++..+++.||+|++.+.... ......+.+|..++..+ +||||++++++|.+.+.+|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 6799999999999999999999999999999999865322 23456677899999998 999999999999999999999
Q ss_pred EeecCCCchHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-----------------
Q 010116 165 MEYLPGGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----------------- 223 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~----~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g----------------- 223 (518)
|||++||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999764 6799999999999999999999999999999999999998544
Q ss_pred --cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCc
Q 010116 224 --HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301 (518)
Q Consensus 224 --~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 301 (518)
.+||+|||++...... ...+||+.|
T Consensus 170 ~~~~kl~Dfg~~~~~~~~-----------------------------------------------------~~~~gt~~y 196 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP-----------------------------------------------------QVEEGDSRF 196 (289)
T ss_dssp CCCEEECCCTTCEETTCS-----------------------------------------------------CCCCCCGGG
T ss_pred ceEEEEcccccccccCCc-----------------------------------------------------cccCCCccc
Confidence 7999999998865321 134699999
Q ss_pred cChhhhcCC-CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccc
Q 010116 302 IAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379 (518)
Q Consensus 302 ~APEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~ 379 (518)
+|||++.+. .++.++|||||||++|+|++|.+||..... ...+... ....+| ..+++++.+||.+||. ||.+
T Consensus 197 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~dp~~ 270 (289)
T 1x8b_A 197 LANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQG-RLPRIP--QVLSQEFTELLKVMIHPDPER 270 (289)
T ss_dssp CCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTT-CCCCCS--SCCCHHHHHHHHHHTCSSGGG
T ss_pred cChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcC-CCCCCC--cccCHHHHHHHHHHhCCCccc
Confidence 999999876 677899999999999999999988865533 3333332 122333 4689999999999998 9999
Q ss_pred cCCCCChhhhhcCcccccC
Q 010116 380 RLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 380 R~g~~~a~eil~Hpff~~i 398 (518)
|+ ++.++++||||.+.
T Consensus 271 Rp---s~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 271 RP---SAMALVKHSVLLSA 286 (289)
T ss_dssp SC---CHHHHHTCTTC---
T ss_pred CC---CHHHHhhChHhhhh
Confidence 99 89999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=413.48 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=198.5
Q ss_pred CCeeE-EeeEeecCceEEEEEEEe--cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEe--ecCCe
Q 010116 86 DDFEL-LTIIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF--QDTEY 160 (518)
Q Consensus 86 ~~f~i-~~~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f--~~~~~ 160 (518)
+.|++ .++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+|+.++|||||+++++| .+...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 45776 458999999999999976 5689999999975432 23577899999999999999999999 45789
Q ss_pred EEEEEeecCCCchHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee----CCCCcEEE
Q 010116 161 LYLIMEYLPGGDMMTLLMRE---------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKL 227 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~---------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl----d~~g~vKL 227 (518)
+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||| +.+|++||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 6888887532 259999999999999999999999999999999999999 77899999
Q ss_pred eecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhh
Q 010116 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (518)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 307 (518)
+|||+|+.+..... ........+||+.|+|||++
T Consensus 174 ~Dfg~a~~~~~~~~----------------------------------------------~~~~~~~~~gt~~y~aPE~~ 207 (405)
T 3rgf_A 174 ADMGFARLFNSPLK----------------------------------------------PLADLDPVVVTFWYRAPELL 207 (405)
T ss_dssp CCTTCCC--------------------------------------------------------------CCCTTCCHHHH
T ss_pred EECCCceecCCCCc----------------------------------------------ccccCCCceecCcccCchhh
Confidence 99999986532100 00112357899999999999
Q ss_pred cCC-CCCccccccchhHHHHHHHhCCCCCCCCChh---------hHHHHHhhhcCcccCC--------------------
Q 010116 308 LKK-GYGMECDWWSLGAIMYEMLVGYPPFYADDPI---------TTCRKIVHWRNHLKFP-------------------- 357 (518)
Q Consensus 308 ~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---------~~~~~i~~~~~~l~~p-------------------- 357 (518)
.+. .|+.++|||||||++|||++|.+||.+.... ..+..|+.........
T Consensus 208 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (405)
T 3rgf_A 208 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRR 287 (405)
T ss_dssp TTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCG
T ss_pred cCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccc
Confidence 874 5999999999999999999999999876542 3444443311111000
Q ss_pred --------------CCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcccc
Q 010116 358 --------------DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 358 --------------~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l 403 (518)
.....++++.+||.+||+ ||.+|+ +++||++||||.+..|...
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~---ta~e~L~hp~f~~~~~~~~ 345 (405)
T 3rgf_A 288 NTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYFLEDPLPTS 345 (405)
T ss_dssp GGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGTSSSCCCS
T ss_pred cCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC---CHHHHhcChhhccCCCCcc
Confidence 001237899999999999 999999 8999999999998766554
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=405.17 Aligned_cols=258 Identities=30% Similarity=0.463 Sum_probs=218.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE---
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL--- 161 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l--- 161 (518)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+++.++||||++++++|.+....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 378999999999999999999999999999999997643 2334457788999999999999999999999887765
Q ss_pred ---EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 162 ---YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 162 ---ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
|+||||+. |+|..++. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999996 68888773 4599999999999999999999999999999999999999999999999999875421
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 317 (518)
. ....+||+.|+|||++.+ ..|+.++|
T Consensus 197 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 224 (371)
T 4exu_A 197 E----------------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVD 224 (371)
T ss_dssp -------------------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHH
T ss_pred C----------------------------------------------------cCCcccCccccCHHHhcCCCCCCcHHh
Confidence 1 124679999999999987 78999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---------------------cCCC------CCCCChhHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL---------------------KFPD------DSKLSPEAKDLI 370 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---------------------~~p~------~~~~s~~~~dLI 370 (518)
||||||++|+|++|.+||.+.+.......++...... ..+. ...+++++++||
T Consensus 225 iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 304 (371)
T 4exu_A 225 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 304 (371)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHH
Confidence 9999999999999999999998888777775421111 0000 125789999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
.+||+ ||.+|+ ++.|+++||||+.+.+.
T Consensus 305 ~~~L~~dP~~Rp---t~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 305 EKMLELDVDKRL---TAAQALTHPFFEPFRDP 333 (371)
T ss_dssp HHHSCSCTTTSC---CHHHHHTSGGGTTTCCG
T ss_pred HHHCCCChhhcC---CHHHHhcCcccccCCCc
Confidence 99999 999999 89999999999976544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=394.20 Aligned_cols=267 Identities=28% Similarity=0.476 Sum_probs=221.7
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeec
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD 157 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~ 157 (518)
.......++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.+++.+ +||||++++++|..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344556789999999999999999999999999999999987542 2345688899999999 79999999999976
Q ss_pred ------CCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEee
Q 010116 158 ------TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSD 229 (518)
Q Consensus 158 ------~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~D 229 (518)
...+|+||||++||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence 56899999999999999999764 5799999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-
Q 010116 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL- 308 (518)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~- 308 (518)
||++....... ......+||+.|+|||++.
T Consensus 173 fg~~~~~~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~ 203 (326)
T 2x7f_A 173 FGVSAQLDRTV-------------------------------------------------GRRNTFIGTPYWMAPEVIAC 203 (326)
T ss_dssp CTTTC--------------------------------------------------------------CCGGGCCHHHHC-
T ss_pred CcCceecCcCc-------------------------------------------------cccccccCCccccChhhhcc
Confidence 99987653110 0112457999999999997
Q ss_pred ----CCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC
Q 010116 309 ----KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383 (518)
Q Consensus 309 ----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~ 383 (518)
+..|+.++|||||||++|+|++|.+||.+.+.......+.... ........+++.+++||.+||. ||.+|+
T Consensus 204 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-- 279 (326)
T 2x7f_A 204 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--APRLKSKKWSKKFQSFIESCLVKNHSQRP-- 279 (326)
T ss_dssp -------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCCCSCSCSCHHHHHHHHHHCCSSGGGSC--
T ss_pred ccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cccCCccccCHHHHHHHHHHhccChhhCC--
Confidence 5678999999999999999999999999888777766665422 2222234689999999999998 999999
Q ss_pred CChhhhhcCcccccCCcccc
Q 010116 384 GGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 384 ~~a~eil~Hpff~~i~w~~l 403 (518)
++.++++||||++..+...
T Consensus 280 -s~~~ll~hp~~~~~~~~~~ 298 (326)
T 2x7f_A 280 -ATEQLMKHPFIRDQPNERQ 298 (326)
T ss_dssp -CHHHHHTSHHHHCCTTHHH
T ss_pred -CHHHHhhChHHhhCccccc
Confidence 8999999999998776543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=408.67 Aligned_cols=264 Identities=23% Similarity=0.378 Sum_probs=214.7
Q ss_pred HHhhhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC--------C
Q 010116 74 EFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA--------S 145 (518)
Q Consensus 74 ~~~~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~--------h 145 (518)
.|..++.+.+..++|++++.||+|+||+||+|++..+++.||||++.+.. ...+.+.+|+.+|+.+. |
T Consensus 25 ~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~ 100 (397)
T 1wak_A 25 GYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNR 100 (397)
T ss_dssp -CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred CceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCc
Confidence 34455556666789999999999999999999999999999999997542 34566888999999985 7
Q ss_pred CceeEEEEEee----cCCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCcee
Q 010116 146 HCIVKLYYSFQ----DTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLL 218 (518)
Q Consensus 146 p~Iv~l~~~f~----~~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNIL 218 (518)
|||++++++|. +...+|+||||+ +|+|.+.+... ..+++..++.++.||+.||.|||++ |||||||||+|||
T Consensus 101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIl 179 (397)
T 1wak_A 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179 (397)
T ss_dssp GGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEE
T ss_pred ceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHee
Confidence 88999999998 667899999999 66777776554 5799999999999999999999998 9999999999999
Q ss_pred eCCCC-------------------------------------------------cEEEeecccccccCCCcccccccccc
Q 010116 219 LDKNG-------------------------------------------------HMKLSDFGLCKPLDCSTLYAIHEHKT 249 (518)
Q Consensus 219 ld~~g-------------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~ 249 (518)
|+.+| .+||+|||+|......
T Consensus 180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---------- 249 (397)
T 1wak_A 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---------- 249 (397)
T ss_dssp ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------
T ss_pred EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------
Confidence 99876 7999999999864311
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHH
Q 010116 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329 (518)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 329 (518)
....+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 250 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (397)
T 1wak_A 250 ------------------------------------------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287 (397)
T ss_dssp ------------------------------------------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHh
Confidence 12457999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh------hhHHHHHhhhcCccc--------------------------------------CCCCCCCChh
Q 010116 330 VGYPPFYADDP------ITTCRKIVHWRNHLK--------------------------------------FPDDSKLSPE 365 (518)
Q Consensus 330 ~G~~PF~~~~~------~~~~~~i~~~~~~l~--------------------------------------~p~~~~~s~~ 365 (518)
+|.+||.+.+. ......+......+. +......+++
T Consensus 288 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (397)
T 1wak_A 288 TGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367 (397)
T ss_dssp HSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHH
T ss_pred hCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHH
Confidence 99999986542 222233322111100 0001123467
Q ss_pred HHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 366 AKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 366 ~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+++||.+||+ ||.+|+ ++.||++||||++
T Consensus 368 ~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~ 397 (397)
T 1wak_A 368 FTDFLLPMLELIPEKRA---TAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHGGGGCSSGGGSC---CHHHHHTSGGGGC
T ss_pred HHHHHHHHhccChhhcC---CHHHHhhCccccC
Confidence 8999999998 999999 8999999999973
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=394.59 Aligned_cols=262 Identities=25% Similarity=0.420 Sum_probs=218.9
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEE-ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC------ceeE
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCRE-KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH------CIVK 150 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~-~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp------~Iv~ 150 (518)
.+.+.+..++|++++.||+|+||.||+|.+ +.+++.||+|++.... ...+.+.+|+.+++.++|+ +|++
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 345566678999999999999999999998 5688999999997542 3456688899999988765 4999
Q ss_pred EEEEeecCCeEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-------
Q 010116 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK------- 221 (518)
Q Consensus 151 l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~------- 221 (518)
++++|.+.+.+|+||||+ +|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 899999997765 6899999999999999999999999999999999999987
Q ss_pred ------------CCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcc
Q 010116 222 ------------NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289 (518)
Q Consensus 222 ------------~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (518)
++.+||+|||+++.....
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------------- 190 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH-------------------------------------------------- 190 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC--------------------------------------------------
T ss_pred CCccccccccccCCCceEeeCcccccCccc--------------------------------------------------
Confidence 678999999998753211
Q ss_pred cccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc--------------
Q 010116 290 KLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK-------------- 355 (518)
Q Consensus 290 ~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~-------------- 355 (518)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+.......+......+.
T Consensus 191 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 268 (339)
T 1z57_A 191 --HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268 (339)
T ss_dssp --CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEE
T ss_pred --cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHh
Confidence 1246799999999999999999999999999999999999999998887665554433111100
Q ss_pred -----C---------------------CCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 356 -----F---------------------PDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 356 -----~---------------------p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
+ ......++++.+||.+||. ||.+|+ ++.||++||||+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~~ 336 (339)
T 1z57_A 269 HDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI---TLREALKHPFFDLLK 336 (339)
T ss_dssp TTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGGG
T ss_pred hccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc---CHHHHhcCHHHHHHh
Confidence 0 0011235678999999998 999999 899999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=389.93 Aligned_cols=261 Identities=26% Similarity=0.469 Sum_probs=220.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHHhCCCceeEEEEEe--ecCCeE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVASHCIVKLYYSF--QDTEYL 161 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~f--~~~~~l 161 (518)
.++|++++.||+|+||.||+|++..+++.||+|++.+..... ......+.+|+.+++.++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999998765432 34567789999999999999999999998 455689
Q ss_pred EEEEeecCCCchHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 162 YLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
|+||||+++| |.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 7777754 467999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC--CCcccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--YGMECD 317 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y~~~~D 317 (518)
.. ........||+.|+|||++.+.. ++.++|
T Consensus 163 ~~-----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 195 (305)
T 2wtk_C 163 AA-----------------------------------------------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVD 195 (305)
T ss_dssp CS-----------------------------------------------SCEECCCCSCGGGCCHHHHTCCSCEESHHHH
T ss_pred cc-----------------------------------------------ccccccCCCCCCCcChhhccCcccCCcchhh
Confidence 00 00122457999999999998754 478999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
||||||++|+|++|..||.+.+.......+... ...+| ..+++++.+||.+||. ||.+|+ ++.++++||||+
T Consensus 196 i~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~ 268 (305)
T 2wtk_C 196 IWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIP--GDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFR 268 (305)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCC--SSSCHHHHHHHHHHTCSSTTTSC---CHHHHHHSHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCC--CccCHHHHHHHHHHccCChhhCC---CHHHHhcCcccc
Confidence 999999999999999999998888877777663 33444 4689999999999998 999999 899999999998
Q ss_pred cCCc
Q 010116 397 DVVW 400 (518)
Q Consensus 397 ~i~w 400 (518)
....
T Consensus 269 ~~~~ 272 (305)
T 2wtk_C 269 KKHP 272 (305)
T ss_dssp SCCC
T ss_pred cCCC
Confidence 7543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=395.79 Aligned_cols=274 Identities=22% Similarity=0.359 Sum_probs=206.0
Q ss_pred hhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEE
Q 010116 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (518)
Q Consensus 77 ~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 153 (518)
.+....+..++|++++.||+|+||.||+|++..++. .||||++..... .....+.+.+|+.+++.++||||+++++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 345567778999999999999999999999887765 899999976532 3345678899999999999999999999
Q ss_pred EeecCCeE------EEEEeecCCCchHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC
Q 010116 154 SFQDTEYL------YLIMEYLPGGDMMTLLMRED------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK 221 (518)
Q Consensus 154 ~f~~~~~l------ylVmEy~~gG~L~~~l~~~~------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~ 221 (518)
++.+.... |+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC
Confidence 99887765 99999999999999996543 6999999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCc
Q 010116 222 NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301 (518)
Q Consensus 222 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 301 (518)
+|.+||+|||+|+........ .......||+.|
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y 205 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYY-----------------------------------------------RQGCASKLPVKW 205 (323)
T ss_dssp TSCEEECCCCC----------------------------------------------------------------CCGGG
T ss_pred CCCEEEeeccccccccccccc-----------------------------------------------cccccccCcccc
Confidence 999999999999865322100 011234578899
Q ss_pred cChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccc
Q 010116 302 IAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379 (518)
Q Consensus 302 ~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~ 379 (518)
+|||++.+..|+.++|||||||++|||++ |.+||.+.+.......+.... .+.. ...+++++.+||.+||. ||.+
T Consensus 206 ~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~dp~~ 282 (323)
T 3qup_A 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQ--PPECMEEVYDLMYQCWSADPKQ 282 (323)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCC--CTTCCHHHHHHHHHTTCSSGGG
T ss_pred cCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCC--CCccCHHHHHHHHHHccCChhh
Confidence 99999999999999999999999999999 999999988888887776532 2333 34789999999999998 9999
Q ss_pred cCCCCC-------hhhhhcCcccccCCccccc
Q 010116 380 RLGTGG-------AHQIKAHPWFKDVVWDKLY 404 (518)
Q Consensus 380 R~g~~~-------a~eil~Hpff~~i~w~~l~ 404 (518)
|+ + +++++.|||+....++.|.
T Consensus 283 Rp---s~~~l~~~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 283 RP---SFTCLRMELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp SC---CHHHHHHHHHHHHHC------------
T ss_pred Cc---CHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence 99 7 8889999999987666554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=390.65 Aligned_cols=264 Identities=29% Similarity=0.477 Sum_probs=222.5
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
...++|++++.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999997642 2356888999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 163 LIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~-~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
+||||++||+|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 9999999999999996 45789999999999999999999999999999999999999999999999999997653210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
......+||+.|+|||++.+..|+.++|||||
T Consensus 180 ------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (314)
T 3com_A 180 ------------------------------------------------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSL 211 (314)
T ss_dssp ------------------------------------------------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHH
T ss_pred ------------------------------------------------cccCccCCCCCccChhhcCCCCCCccccHHHH
Confidence 01124579999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
||++|+|++|..||...+.......+... ....+.....+++++.+||.+||. ||.+|+ ++.++++||||++..+
T Consensus 212 G~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---t~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 212 GITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSC---CHHHHTTSHHHHTCCC
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcC-CCcccCCcccCCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhcCCc
Confidence 99999999999999988776665554432 222333334678999999999998 999999 8999999999998876
Q ss_pred cccc
Q 010116 401 DKLY 404 (518)
Q Consensus 401 ~~l~ 404 (518)
....
T Consensus 288 ~~~~ 291 (314)
T 3com_A 288 VSIL 291 (314)
T ss_dssp GGGG
T ss_pred chHH
Confidence 6553
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=391.27 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=217.0
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
....+..++|++.+.||+|+||+||+|++ +|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34567788999999999999999999975 688999999976543 334567788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDT---LTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~---l~e~~~~~~~~ql~~aL~~LH~~g--iiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
..+|+||||++||+|.+++..... +++..+..++.|++.||.|||++| |+||||||+|||++.+|.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999976543 999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
+...... ....+.+||+.|+|||++.+..++
T Consensus 187 ~~~~~~~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 217 (309)
T 3p86_A 187 RLKASTF-------------------------------------------------LSSKSAAGTPEWMAPEVLRDEPSN 217 (309)
T ss_dssp ----------------------------------------------------------------CCTTSCHHHHTTCCCC
T ss_pred ccccccc-------------------------------------------------cccccCCCCccccChhhhcCCCCC
Confidence 7532110 011256799999999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc-
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA- 391 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~- 391 (518)
.++|||||||++|+|++|..||.+.+.......+........+| ..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 218 ~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~~ 292 (309)
T 3p86_A 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP--RNLNPQVAAIIEGCWTNEPWKRP---SFATIMDL 292 (309)
T ss_dssp TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 99999999999999999999999998888777775544444555 4789999999999998 999999 8999987
Q ss_pred -Ccccc
Q 010116 392 -HPWFK 396 (518)
Q Consensus 392 -Hpff~ 396 (518)
+++++
T Consensus 293 L~~~~~ 298 (309)
T 3p86_A 293 LRPLIK 298 (309)
T ss_dssp HHHHHC
T ss_pred HHHHHH
Confidence 34443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=403.96 Aligned_cols=262 Identities=30% Similarity=0.432 Sum_probs=216.8
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CC-----ceeEEE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SH-----CIVKLY 152 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp-----~Iv~l~ 152 (518)
.......++|++++.||+|+||+||+|++..+++.||||++.+.. .....+..|+.+++.+. |+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 344556789999999999999999999999999999999997542 23456778888988885 44 499999
Q ss_pred EEeecCCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEEcCCCCCceeeC--CCCcEE
Q 010116 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIH--KHNYIHRDIKPDNLLLD--KNGHMK 226 (518)
Q Consensus 153 ~~f~~~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH--~~giiHRDIKPeNILld--~~g~vK 226 (518)
++|.....+|+||||++ |+|.+++... ..+++..++.++.|++.||.||| +.|||||||||+|||++ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999999995 5999999765 56999999999999999999999 57999999999999995 478899
Q ss_pred EeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhh
Q 010116 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (518)
Q Consensus 227 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 306 (518)
|+|||+|+..... ....+||+.|+|||+
T Consensus 202 L~DFG~a~~~~~~----------------------------------------------------~~~~~~t~~y~aPE~ 229 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----------------------------------------------------IYQYIQSRFYRSPEV 229 (382)
T ss_dssp ECCCTTCEETTCC----------------------------------------------------CCSSCSCGGGCCHHH
T ss_pred EEeccCceecccc----------------------------------------------------cccccCCccccChHH
Confidence 9999999865311 124689999999999
Q ss_pred hcCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc----------------CCC------------
Q 010116 307 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK----------------FPD------------ 358 (518)
Q Consensus 307 l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~----------------~p~------------ 358 (518)
+.+..|+.++|||||||++|||++|.+||.+.+.......|+....... +|.
T Consensus 230 ~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
T 2vx3_A 230 LLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGK 309 (382)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTC
T ss_pred HcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccc
Confidence 9999999999999999999999999999999988888877765211100 000
Q ss_pred -------CCC-------------------------CChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 359 -------DSK-------------------------LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 359 -------~~~-------------------------~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
... .++++++||.+||+ ||.+|+ ++.|+++||||++..|
T Consensus 310 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp---ta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 310 REYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI---QPYYALQHSFFKKTAD 381 (382)
T ss_dssp CCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC---CHHHHTTSGGGCC---
T ss_pred cccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC---CHHHHhcCcccccCCC
Confidence 000 01378999999999 999999 9999999999997654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=401.61 Aligned_cols=258 Identities=31% Similarity=0.468 Sum_probs=202.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 159 (518)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.... ......+...+..++||||++++++|.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 47899999999999999999999999999999998664322 234556777888899999999999996533
Q ss_pred --eEEEEEeecCCCchHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH--hCCeEEcCCCCCceeeCC-CCcEEEeec
Q 010116 160 --YLYLIMEYLPGGDMMTLL----MREDTLTENVARFYIAQSVLAIESIH--KHNYIHRDIKPDNLLLDK-NGHMKLSDF 230 (518)
Q Consensus 160 --~lylVmEy~~gG~L~~~l----~~~~~l~e~~~~~~~~ql~~aL~~LH--~~giiHRDIKPeNILld~-~g~vKL~DF 230 (518)
++|+||||++|+ |...+ .....+++..++.++.|++.||.||| ++||+||||||+|||++. +|++||+||
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 389999999865 43333 35678999999999999999999999 999999999999999997 899999999
Q ss_pred ccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC
Q 010116 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (518)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 310 (518)
|+|+...... .....+||+.|+|||++.+.
T Consensus 177 g~a~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~ 206 (360)
T 3e3p_A 177 GSAKKLSPSE--------------------------------------------------PNVAYICSRYYRAPELIFGN 206 (360)
T ss_dssp TTCBCCCTTS--------------------------------------------------CCCSTTSCGGGCCHHHHTTC
T ss_pred CCceecCCCC--------------------------------------------------CcccccCCcceeCHHHHcCC
Confidence 9998653210 11246799999999999765
Q ss_pred C-CCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---------------c------------CC-CCCC
Q 010116 311 G-YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL---------------K------------FP-DDSK 361 (518)
Q Consensus 311 ~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---------------~------------~p-~~~~ 361 (518)
. |+.++|||||||++|+|++|.+||.+.+.......++...... . ++ ....
T Consensus 207 ~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (360)
T 3e3p_A 207 QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLK 286 (360)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCT
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhcc
Confidence 4 8999999999999999999999999998888877776521110 0 00 0122
Q ss_pred CChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 362 LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 362 ~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
.++++++||.+||+ ||.+|+ ++.|+++||||+++.+
T Consensus 287 ~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 287 DAKEAYDLLSALLQYLPEERM---KPYEALCHPYFDELHD 323 (360)
T ss_dssp THHHHHHHHHHHTCSSGGGSC---CHHHHTTSGGGGGGGC
T ss_pred ccHHHHHHHHHHhccCccccC---CHHHHhcCccccccCC
Confidence 57899999999999 999999 8999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=400.87 Aligned_cols=257 Identities=22% Similarity=0.332 Sum_probs=219.9
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe-------cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEE
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK-------KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLY 152 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~-------~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 152 (518)
+.+..++|++++.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+|+.+ +|||||+++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 4566789999999999999999999975 345679999997652 344567789999999999 899999999
Q ss_pred EEeecCCeEEEEEeecCCCchHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCc
Q 010116 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDN 216 (518)
Q Consensus 153 ~~f~~~~~lylVmEy~~gG~L~~~l~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeN 216 (518)
++|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999997643 48899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccccc
Q 010116 217 LLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (518)
Q Consensus 217 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 296 (518)
||++.+|++||+|||+|+.+..... ........
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~-----------------------------------------------~~~~~~~~ 266 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDY-----------------------------------------------YKKTTNGR 266 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCT-----------------------------------------------TCTTTTTT
T ss_pred EEECCCCCEEEccccCCcccCcccc-----------------------------------------------eecccCCC
Confidence 9999999999999999986532110 00112456
Q ss_pred CCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc
Q 010116 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC 375 (518)
Q Consensus 297 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~ 375 (518)
||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+.......+... .....| ..+++++.+||.+||.
T Consensus 267 ~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~ 343 (370)
T 2psq_A 267 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDCWH 343 (370)
T ss_dssp SCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTC
T ss_pred cccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcC
Confidence 8899999999999999999999999999999999 99999998887777666553 223333 4689999999999998
Q ss_pred -cccccCCCCChhhhhcC
Q 010116 376 -DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 376 -dp~~R~g~~~a~eil~H 392 (518)
||.+|+ ++.||+++
T Consensus 344 ~dP~~Rp---t~~ell~~ 358 (370)
T 2psq_A 344 AVPSQRP---TFKQLVED 358 (370)
T ss_dssp SSGGGSC---CHHHHHHH
T ss_pred CChhhCc---CHHHHHHH
Confidence 999999 89998864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=398.18 Aligned_cols=256 Identities=18% Similarity=0.273 Sum_probs=211.6
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcE----EEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNI----YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~----~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
..+..++|++++.||+|+||+||+|++..+++. ||+|++.... .......+.+|..+++.++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 345678999999999999999999999988887 5666554332 1222345678999999999999999999987
Q ss_pred cCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
+ ..+|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 86 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 G-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp B-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred C-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 4 5689999999999999999764 6899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
+..... ........||+.|+|||++.+..|+.+
T Consensus 165 ~~~~~~-----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (325)
T 3kex_A 165 LPPDDK-----------------------------------------------QLLYSEAKTPIKWMALESIHFGKYTHQ 197 (325)
T ss_dssp SCCCTT-----------------------------------------------CCC-----CCTTTSCHHHHHHCCCCHH
T ss_pred cCcccc-----------------------------------------------cccccCCCCcccccChHHhccCCCChh
Confidence 542210 001124568899999999999999999
Q ss_pred ccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 316 CDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 316 ~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+|||||||++|+|++ |..||.+.........+... ..+..| ..+++++.+||.+||. ||.+|+ ++.+|++|
T Consensus 198 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~el~~~ 270 (325)
T 3kex_A 198 SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQP--QICTIDVYMVMVKCWMIDENIRP---TFKELANE 270 (325)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCC--TTBCTTTTHHHHHHTCSCTTTSC---CHHHHHHH
T ss_pred hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCC--CcCcHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999999999999 99999988877766666542 233333 4688999999999998 999999 88888775
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=392.80 Aligned_cols=274 Identities=26% Similarity=0.434 Sum_probs=201.2
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.+.+..++|++++.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 356778999999999999999999999999999999999865432 233566788999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecc
Q 010116 160 YLYLIMEYLPGGDMMTLLMR--------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~--------~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFG 231 (518)
.+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999999864 4569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-C
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-K 310 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~ 310 (518)
++.......... ........+||+.|+|||++.+ .
T Consensus 167 ~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~ 202 (303)
T 2vwi_A 167 VSAFLATGGDIT--------------------------------------------RNKVRKTFVGTPCWMAPEVMEQVR 202 (303)
T ss_dssp HHHHCC-----------------------------------------------------------CCCTTCCHHHHHHHH
T ss_pred chheeccCCCcc--------------------------------------------chhhhcccCCCccccCHHHhcccc
Confidence 998654221000 0011225679999999999976 6
Q ss_pred CCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCC-------CCCCCChhHHHHHHHHhc-cccccCC
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFP-------DDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p-------~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
.++.++|||||||++|+|++|..||................ ....+ ....+++++++||.+||. ||.+|+
T Consensus 203 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp- 280 (303)
T 2vwi_A 203 GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP- 280 (303)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC-
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCc-
Confidence 78999999999999999999999999887766655544321 11111 123578999999999998 999999
Q ss_pred CCChhhhhcCcccccCCcccc
Q 010116 383 TGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 383 ~~~a~eil~Hpff~~i~w~~l 403 (518)
++.+|++||||+...+..+
T Consensus 281 --s~~~ll~h~~~~~~~~~~~ 299 (303)
T 2vwi_A 281 --TAAELLRHKFFQKAKNKEF 299 (303)
T ss_dssp --CHHHHHTSTTC--------
T ss_pred --CHHHHhhChhhhcCCCCcc
Confidence 8999999999998776554
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=390.91 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=219.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEe-cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh---CCCceeEEEEEee----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREK-KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQ---- 156 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~-~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~---- 156 (518)
.++|++++.||+|+||.||+|++. .+|+.||+|++...... ......+.+|+.+++.+ .||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 478999999999999999999995 67899999999764321 11223455677777766 8999999999987
Q ss_pred -cCCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 157 -DTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 157 -~~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
....+|+||||+. |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 6678999999997 6999999764 35999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
+..... ......+||+.|+|||++.+..|+
T Consensus 168 ~~~~~~--------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 197 (326)
T 1blx_A 168 RIYSFQ--------------------------------------------------MALTSVVVTLWYRAPEVLLQSSYA 197 (326)
T ss_dssp CCCCGG--------------------------------------------------GGGCCCCCCCTTCCHHHHTTCCCC
T ss_pred ccccCC--------------------------------------------------CCccccccccceeCHHHHhcCCCC
Confidence 764311 012256799999999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---cCC--------------------CCCCCChhHHHHH
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL---KFP--------------------DDSKLSPEAKDLI 370 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---~~p--------------------~~~~~s~~~~dLI 370 (518)
.++|||||||++|+|++|.+||.+.+.......++...... .++ ....+++++++||
T Consensus 198 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 277 (326)
T 1blx_A 198 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277 (326)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHH
T ss_pred cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHH
Confidence 99999999999999999999999998888877776421100 000 0135789999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
.+||. ||.+|+ ++.++++||||++++|.
T Consensus 278 ~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 278 LKCLTFNPAKRI---SAYSALSHPYFQDLERC 306 (326)
T ss_dssp HHHSCSSTTTSC---CHHHHHTSGGGTTCCCC
T ss_pred HHHcCCCcccCC---CHHHHhcCccccccchh
Confidence 99998 999999 89999999999988764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=396.34 Aligned_cols=258 Identities=30% Similarity=0.456 Sum_probs=217.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY---- 160 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~---- 160 (518)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+++.++||||++++++|.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999997643 233445678899999999999999999999988764
Q ss_pred --EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 161 --LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 161 --lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
+|+||||+. |+|..++. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 499999996 68888774 3599999999999999999999999999999999999999999999999999875421
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 317 (518)
. ....+||+.|+|||++.+ ..++.++|
T Consensus 179 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 206 (353)
T 3coi_A 179 E----------------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVD 206 (353)
T ss_dssp ---------------------------------------------------------CCSBCCSCHHHHSCCSCCCTTHH
T ss_pred C----------------------------------------------------ccccccCcCcCCHHHHhCcCCCCchhh
Confidence 1 114579999999999987 77899999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc--------------------------ccCC-CCCCCChhHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH--------------------------LKFP-DDSKLSPEAKDLI 370 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--------------------------l~~p-~~~~~s~~~~dLI 370 (518)
||||||++|+|++|.+||.+.+.......+...... ..++ ....+++++++||
T Consensus 207 i~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 286 (353)
T 3coi_A 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 286 (353)
T ss_dssp HHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHH
Confidence 999999999999999999998877776666542110 0111 1235789999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
.+||+ ||.+|+ ++.++++||||+.+.+.
T Consensus 287 ~~~L~~dp~~Rp---t~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 287 EKMLELDVDKRL---TAAQALTHPFFEPFRDP 315 (353)
T ss_dssp HHHSCSCTTTSC---CHHHHHTSGGGTTTCCG
T ss_pred HHHcCCCcccCC---CHHHHhcCcchhhccCc
Confidence 99998 999999 89999999999976543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=396.69 Aligned_cols=265 Identities=24% Similarity=0.393 Sum_probs=219.9
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCC-cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc------eeEE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSG-NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC------IVKL 151 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~-~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~------Iv~l 151 (518)
..+....++|++++.||+|+||+||+|++..++ ..||+|++.+.. ...+.+.+|+.+++.+.|++ ++.+
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 345556789999999999999999999998777 689999997542 23456788999999987655 9999
Q ss_pred EEEeecCCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee----------
Q 010116 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---------- 219 (518)
Q Consensus 152 ~~~f~~~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl---------- 219 (518)
+++|.....+|+||||+ +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence 99999999999999999 67777777654 479999999999999999999999999999999999999
Q ss_pred ---------CCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccc
Q 010116 220 ---------DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRK 290 (518)
Q Consensus 220 ---------d~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (518)
+.++.+||+|||+++.....
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------------- 195 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH--------------------------------------------------- 195 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC---------------------------------------------------
T ss_pred ccccccccccCCCcEEEeecCcccccccc---------------------------------------------------
Confidence 66889999999998753211
Q ss_pred ccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc---------------
Q 010116 291 LAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK--------------- 355 (518)
Q Consensus 291 ~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~--------------- 355 (518)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.......+......+.
T Consensus 196 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 274 (355)
T 2eu9_A 196 -HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK 274 (355)
T ss_dssp -CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEET
T ss_pred -ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcc
Confidence 1246799999999999999999999999999999999999999998877665555443211100
Q ss_pred -------------------------CCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcccc
Q 010116 356 -------------------------FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 356 -------------------------~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l 403 (518)
.......++++.+||.+||. ||.+|+ ++.|+++||||++++|+..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 275 GGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI---TLAEALLHPFFAGLTPEER 345 (355)
T ss_dssp TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGCCHHHH
T ss_pred cccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcCCChhhc
Confidence 00111224588999999998 999999 8999999999999988755
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=393.65 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=213.0
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC--
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-- 159 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-- 159 (518)
.+..++|++++.||+|+||+||+|++..+|+.||||++.+.... ...+.+.+|+.+|+.++||||+++++++.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 34567899999999999999999999999999999999865432 33566789999999999999999999998765
Q ss_pred eEEEEEeecCCCchHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee----CCCCcEEEeeccc
Q 010116 160 YLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGL 232 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~---~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl----d~~g~vKL~DFGl 232 (518)
.+|+||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 8899999999999999997653 39999999999999999999999999999999999999 8888999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc----
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---- 308 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---- 308 (518)
|+...... ...+.+||+.|+|||++.
T Consensus 163 a~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~ 192 (319)
T 4euu_A 163 ARELEDDE--------------------------------------------------QFVSLYGTEEYLHPDMYERAVL 192 (319)
T ss_dssp CEECCTTC--------------------------------------------------CBCCCCSCGGGCCHHHHHHHTS
T ss_pred ceecCCCC--------------------------------------------------ceeecccCCCccCHHHhhhccc
Confidence 98653210 112467999999999987
Q ss_pred ----CCCCCccccccchhHHHHHHHhCCCCCCCCC----hhhHHHHHhhhcCcc-----------------cCCCCC---
Q 010116 309 ----KKGYGMECDWWSLGAIMYEMLVGYPPFYADD----PITTCRKIVHWRNHL-----------------KFPDDS--- 360 (518)
Q Consensus 309 ----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~~~~l-----------------~~p~~~--- 360 (518)
+..|+.++|||||||++|||++|.+||.... ......+++...... .+|...
T Consensus 193 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (319)
T 4euu_A 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272 (319)
T ss_dssp CCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSC
T ss_pred cccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccc
Confidence 5789999999999999999999999997533 234444454422100 112111
Q ss_pred -CCChhHHHHHHHHhc-cccccCCCCChhhhhcCc
Q 010116 361 -KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHP 393 (518)
Q Consensus 361 -~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hp 393 (518)
.+++.+.+||.+||. ||.+|+ ++.|+++||
T Consensus 273 ~~~~~~l~~ll~~~L~~dP~~R~---s~~ell~h~ 304 (319)
T 4euu_A 273 RGLQVLLTPVLANILEADQEKCW---GFDQFFAET 304 (319)
T ss_dssp HHHHHHHHHHHHHHSCCCTTTSC---CHHHHHHHH
T ss_pred hhHHHHhHHHHHHhccCChhhhc---cHHHhhhcc
Confidence 235678899999998 999999 899999997
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=404.31 Aligned_cols=264 Identities=18% Similarity=0.260 Sum_probs=222.9
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEE-----EecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~-----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 155 (518)
..+..++|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+++.++|||||+++++|
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45667899999999999999999999 45678899999986532 233455688899999999999999999999
Q ss_pred ecCCeEEEEEeecCCCchHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc---E
Q 010116 156 QDTEYLYLIMEYLPGGDMMTLLMRE-------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---M 225 (518)
Q Consensus 156 ~~~~~lylVmEy~~gG~L~~~l~~~-------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~---v 225 (518)
.+....|+|||||+||+|.+++... ..+++..+..++.|++.||.|||++|||||||||+|||++.+|. +
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999999764 35899999999999999999999999999999999999996664 9
Q ss_pred EEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChh
Q 010116 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (518)
Q Consensus 226 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 305 (518)
||+|||+|+.+.... ........+||+.|+|||
T Consensus 224 kL~DFG~a~~~~~~~-----------------------------------------------~~~~~~~~~~t~~y~aPE 256 (367)
T 3l9p_A 224 KIGDFGMARDIYRAG-----------------------------------------------YYRKGGCAMLPVKWMPPE 256 (367)
T ss_dssp EECCCHHHHHHHHHS-----------------------------------------------SCTTCCGGGSCGGGCCHH
T ss_pred EECCCcccccccccc-----------------------------------------------ccccCCCcCCcccEECHH
Confidence 999999998542110 001122567899999999
Q ss_pred hhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC
Q 010116 306 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383 (518)
Q Consensus 306 vl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~ 383 (518)
++.+..|+.++|||||||++|||++ |.+||.+.+.......+.... .... ...+++++.+||.+||. ||.+|+
T Consensus 257 ~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~~~~l~~li~~~l~~dP~~Rp-- 331 (367)
T 3l9p_A 257 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDP--PKNCPGPVYRIMTQCWQHQPEDRP-- 331 (367)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSC--
T ss_pred HhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CccCCHHHHHHHHHHcCCCHhHCc--
Confidence 9999999999999999999999998 999999998888887776532 2223 34789999999999998 999999
Q ss_pred CChhhhhcCcccccCC
Q 010116 384 GGAHQIKAHPWFKDVV 399 (518)
Q Consensus 384 ~~a~eil~Hpff~~i~ 399 (518)
++.+|++|.++-.-+
T Consensus 332 -s~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 332 -NFAIILERIEYCTQD 346 (367)
T ss_dssp -CHHHHHHHHHHHHHC
T ss_pred -CHHHHHHHHHHHhhC
Confidence 899999998875433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=383.71 Aligned_cols=255 Identities=29% Similarity=0.471 Sum_probs=224.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.+.|++++.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999976542 34567789999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||++||+|.+++. .+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 173 (303)
T ss_dssp EECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB----
T ss_pred EEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc----
Confidence 99999999999985 4689999999999999999999999999999999999999999999999999997653210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
......+||+.|+|||++.+..++.++|||||||+
T Consensus 174 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 208 (303)
T 3a7i_A 174 ---------------------------------------------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 208 (303)
T ss_dssp ---------------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred ---------------------------------------------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHH
Confidence 01124679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+|+|++|.+||...+.......+... ....++ ..+++++.+||.+||. ||.+|+ ++.+|++||||..
T Consensus 209 l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~ 276 (303)
T 3a7i_A 209 AIELARGEPPHSELHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFILR 276 (303)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCC--SSCCHHHHHHHHHHCCSSGGGSC---CHHHHTTCHHHHH
T ss_pred HHHHccCCCCCCCcCHHHHHHHhhcC-CCCCCc--cccCHHHHHHHHHHcCCChhhCc---CHHHHhhChhhhc
Confidence 99999999999988877766665542 222222 4689999999999998 999999 8999999999965
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=397.89 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=218.6
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEE-----EecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~-----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 153 (518)
.+.+..++|++++.||+|+||.||+|+ ...+++.||||++++.. .....+.+.+|+.+|..+ +|||||++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 456778999999999999999999999 45567899999997643 233456789999999999 7899999999
Q ss_pred EeecCC-eEEEEEeecCCCchHHHHhhcCC--------------------------------------------------
Q 010116 154 SFQDTE-YLYLIMEYLPGGDMMTLLMREDT-------------------------------------------------- 182 (518)
Q Consensus 154 ~f~~~~-~lylVmEy~~gG~L~~~l~~~~~-------------------------------------------------- 182 (518)
++.+.+ .+|+|||||+||+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998755 49999999999999999976532
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 183 ----------------LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 183 ----------------l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
+++..+..++.|++.||.|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----- 248 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----- 248 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-----
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-----
Confidence 89999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 326 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 326 (518)
........||+.|+|||++.+..|+.++|||||||++|
T Consensus 249 ------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 286 (359)
T 3vhe_A 249 ------------------------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286 (359)
T ss_dssp ------------------------------------------CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ------------------------------------------chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHH
Confidence 01122467899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 327 EMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 327 eml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||++ |.+||.+..........+........| ..+++++.+||.+||. ||.+|+ ++.+|++|
T Consensus 287 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 349 (359)
T 3vhe_A 287 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 349 (359)
T ss_dssp HHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHhcCCCCCCccchhHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHccCChhhCC---CHHHHHHH
Confidence 9998 999999877655555555533344444 4689999999999998 999999 89999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=392.25 Aligned_cols=266 Identities=20% Similarity=0.254 Sum_probs=215.1
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ly 162 (518)
..++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++.+...+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 35789999999999999999999999999999999875432 23477899999999 9999999999999999999
Q ss_pred EEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc-----EEEeeccccccc
Q 010116 163 LIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-----MKLSDFGLCKPL 236 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~-----vKL~DFGla~~~ 236 (518)
+||||+ ||+|.+++.. ...+++..+..++.|++.||.|||++|||||||||+|||++.+|+ +||+|||+|+.+
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 9999999976 478999999999999999999999999999999999999999988 999999999875
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
......... ......+.+||+.|+|||++.+..|+.++
T Consensus 161 ~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 198 (330)
T 2izr_A 161 IDPETKKHI------------------------------------------PYREHKSLTGTARYMSINTHLGKEQSRRD 198 (330)
T ss_dssp BCTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHH
T ss_pred ecCCCCccc------------------------------------------cccccCCcCCCccccChHHHcCCCCCchh
Confidence 422100000 00112367899999999999999999999
Q ss_pred cccchhHHHHHHHhCCCCCCCCC---hhhHHHHHhhhcCcccCCC-CCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADD---PITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||||++|||++|.+||.+.+ ....+..+........... ...++ ++.+||.+||. ||.+|| ++.+|.+
T Consensus 199 Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP---~~~~l~~ 274 (330)
T 2izr_A 199 DLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKP---DYDYLRK 274 (330)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCC---CHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCC---CHHHHHH
Confidence 99999999999999999998843 3344555544221111110 11234 99999999998 999999 7777765
Q ss_pred ----------CcccccCCcc
Q 010116 392 ----------HPWFKDVVWD 401 (518)
Q Consensus 392 ----------Hpff~~i~w~ 401 (518)
.++...++|.
T Consensus 275 ~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 275 LFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHHHHHTTCCCSCCCTTT
T ss_pred HHHHHHHHcCCCCCCCccCC
Confidence 3344566777
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=388.05 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=215.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee-------
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ------- 156 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~------- 156 (518)
..++|++++.||+|+||.||+|++..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 357899999999999999999999999999999998754 2345677889999999999999999998874
Q ss_pred -------cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC-CCCcEEEe
Q 010116 157 -------DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLS 228 (518)
Q Consensus 157 -------~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld-~~g~vKL~ 228 (518)
+...+|+||||+. |+|.+++. .+.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4578999999997 69999885 46799999999999999999999999999999999999997 56799999
Q ss_pred ecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc
Q 010116 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308 (518)
Q Consensus 229 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 308 (518)
|||+++....... .........||+.|+|||++.
T Consensus 164 Dfg~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~y~aPE~~~ 197 (320)
T 2i6l_A 164 DFGLARIMDPHYS----------------------------------------------HKGHLSEGLVTKWYRSPRLLL 197 (320)
T ss_dssp CCTTCBCC------------------------------------------------------CCCGGGSCCTTCCHHHHH
T ss_pred cCccccccCCCcc----------------------------------------------cccccccccccccccCcHHhc
Confidence 9999986532100 001122457899999999987
Q ss_pred C-CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc--------------------ccCCC------CCC
Q 010116 309 K-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH--------------------LKFPD------DSK 361 (518)
Q Consensus 309 ~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--------------------l~~p~------~~~ 361 (518)
+ ..++.++|||||||++|||++|.+||.+.+.......+...... ...+. ...
T Consensus 198 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (320)
T 2i6l_A 198 SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG 277 (320)
T ss_dssp CTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTT
T ss_pred CcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcch
Confidence 6 77999999999999999999999999998887777776642110 00010 135
Q ss_pred CChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccc
Q 010116 362 LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDK 402 (518)
Q Consensus 362 ~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~ 402 (518)
+++++++||.+||. ||.+|+ ++.++++||||+.++|..
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 278 ISREAVDFLEQILTFSPMDRL---TAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CCHHHHHHHHTTSCSSGGGSC---CHHHHHTSHHHHTTCC--
T ss_pred hhHHHHHHHHHHcCCCccccC---CHHHHhCCcccccccCcc
Confidence 89999999999998 999999 899999999999888754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=381.63 Aligned_cols=257 Identities=33% Similarity=0.572 Sum_probs=221.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee--cCCeEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DTEYLY 162 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~--~~~~ly 162 (518)
.++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++. +...+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 5789999999999999999999999999999999986543 3345677899999999999999999999884 467899
Q ss_pred EEEeecCCCchHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 163 LIMEYLPGGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHN-----YIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~----~~l~e~~~~~~~~ql~~aL~~LH~~g-----iiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
+||||++||+|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+|||++.+|++||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999653 34999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
+...... ......+||+.|+|||++.+..|+
T Consensus 164 ~~~~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 194 (279)
T 2w5a_A 164 RILNHDT-------------------------------------------------SFAKTFVGTPYYMSPEQMNRMSYN 194 (279)
T ss_dssp HHC---C-------------------------------------------------HHHHHHHSCCTTCCHHHHHCC-CC
T ss_pred eeecccc-------------------------------------------------ccccccCCCccccChHHhccCCCC
Confidence 8653210 011245799999999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
.++|||||||++|+|++|.+||...+.......+.... ...+| ..+++++.+||.+||. ||.+|+ ++.+|++|
T Consensus 195 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 268 (279)
T 2w5a_A 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIP--YRYSDELNEIITRMLNLKDYHRP---SVEEILEN 268 (279)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTS
T ss_pred chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-cccCC--cccCHHHHHHHHHHcCCCcccCC---CHHHHHhC
Confidence 99999999999999999999999988877777776632 22333 3689999999999998 999999 89999999
Q ss_pred ccccc
Q 010116 393 PWFKD 397 (518)
Q Consensus 393 pff~~ 397 (518)
+|+.+
T Consensus 269 ~~~~~ 273 (279)
T 2w5a_A 269 PLILE 273 (279)
T ss_dssp TTCCG
T ss_pred hhhhh
Confidence 99975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=396.91 Aligned_cols=260 Identities=24% Similarity=0.393 Sum_probs=211.3
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh--------chhhHHHHHHHHHHHHHhCCCceeEEEEEe
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--------KRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 155 (518)
..++|++++.||+|+||.||+|.+.. |+.||||++.+.... .....+.+.+|+.+|+.++||||++++++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45899999999999999999998754 899999998654221 222347789999999999999999999998
Q ss_pred e-----cCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEee
Q 010116 156 Q-----DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSD 229 (518)
Q Consensus 156 ~-----~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~D 229 (518)
. ....+|+||||+. |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 4 4457999999997 6888887654 4799999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC
Q 010116 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (518)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 309 (518)
||+++..... ......+||+.|+|||++.+
T Consensus 178 fg~~~~~~~~--------------------------------------------------~~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 178 FNLAREDTAD--------------------------------------------------ANKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp TTC-----------------------------------------------------------------CGGGCCHHHHTT
T ss_pred cCcccccccc--------------------------------------------------cccceecccceecCcHHhcC
Confidence 9998743211 01124679999999999987
Q ss_pred -CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCccc----------------------CCC------CC
Q 010116 310 -KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLK----------------------FPD------DS 360 (518)
Q Consensus 310 -~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~----------------------~p~------~~ 360 (518)
..++.++|||||||++|+|++|.+||.+.+.......++....... .+. ..
T Consensus 208 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (362)
T 3pg1_A 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP 287 (362)
T ss_dssp CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHST
T ss_pred CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCC
Confidence 7799999999999999999999999999988887777764221111 110 13
Q ss_pred CCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 361 KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 361 ~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
.+++.+.+||.+||. ||.+|+ ++.|+++||||+.+
T Consensus 288 ~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~ 323 (362)
T 3pg1_A 288 TADPVALDLIAKMLEFNPQRRI---STEQALRHPYFESL 323 (362)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGTTT
T ss_pred CCCHHHHHHHHHHhcCChhhCC---CHHHHHcCchhhhc
Confidence 568899999999998 999999 89999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=389.95 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=220.4
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
...+..++|++.+.||+|+||.||+|++..+++ .||||+++... .....+.+.+|+.+|+.++||||++++++|.
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 356777899999999999999999999986655 49999997542 2344567889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
+...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999999999654 6899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
....... ........||+.|+|||++.+..|+.+
T Consensus 201 ~~~~~~~----------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~ 234 (325)
T 3kul_A 201 LEDDPDA----------------------------------------------AYTTTGGKIPIRWTAPEAIAFRTFSSA 234 (325)
T ss_dssp CC----C----------------------------------------------CEECC---CCGGGSCHHHHHHCEECHH
T ss_pred cccCccc----------------------------------------------eeeccCCCCcccccCHhHhcCCCCCcH
Confidence 5422100 001123457889999999999999999
Q ss_pred ccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 316 CDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 316 ~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+|||||||++|||++ |..||.+.+.......+... ...+....+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 235 ~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~ 306 (325)
T 3kul_A 235 SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG---YRLPAPMGCPHALHQLMLDCWHKDRAQRP---RFSQIVS 306 (325)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---CCCCCCCCcCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999999999999999 99999999888887777653 3344445789999999999998 999999 8998886
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=377.29 Aligned_cols=253 Identities=19% Similarity=0.283 Sum_probs=219.9
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
+.+..++|++++.||+|+||.||+|++. +++.||+|++.+... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 5567789999999999999999999876 577899999976532 23568899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999999654 56999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
. ........||+.|+|||++.+..|+.++|||
T Consensus 160 ~------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 191 (269)
T 4hcu_A 160 Q------------------------------------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191 (269)
T ss_dssp H------------------------------------------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred c------------------------------------------------cccccCcccccccCCHHHhcCCCCCchhhhH
Confidence 1 0112245688899999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||++|+|++ |.+||.+.+.......+... ...+.+..+++++.+||.+||. ||.+|+ ++.++++|
T Consensus 192 slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~ 260 (269)
T 4hcu_A 192 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC---ccCCCCCcCCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 99999999999 99999999888887777653 2223334689999999999998 999999 89999876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=393.67 Aligned_cols=254 Identities=33% Similarity=0.558 Sum_probs=187.3
Q ss_pred cCCCCeeEEe-eEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec----
Q 010116 83 ICVDDFELLT-IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD---- 157 (518)
Q Consensus 83 ~~~~~f~i~~-~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~---- 157 (518)
...++|++++ +||+|+||.||+|+++.+|+.||||++..... ........++.+.||||++++++|..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 4467899965 69999999999999999999999999875421 12223344667799999999999976
Q ss_pred CCeEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CCcEEEeeccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGL 232 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g~vKL~DFGl 232 (518)
...+|+|||||+||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 566999999999999999997653 7999999999999999999999999999999999999986 45699999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 312 (518)
++..... .....+||+.|+|||++.+..|
T Consensus 178 ~~~~~~~---------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~ 206 (336)
T 3fhr_A 178 AKETTQN---------------------------------------------------ALQTPCYTPYYVAPEVLGPEKY 206 (336)
T ss_dssp CEEC-------------------------------------------------------------------------CHH
T ss_pred ceecccc---------------------------------------------------ccccCCCCcCccChhhhCCCCC
Confidence 8754311 1124679999999999999999
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhhHH----HHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTC----RKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~----~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
+.++|||||||++|+|++|.+||.+....... ..+......+..+....+++++++||.+||. ||.+|+ ++.
T Consensus 207 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ 283 (336)
T 3fhr_A 207 DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL---TIT 283 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHH
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc---CHH
Confidence 99999999999999999999999876654432 2222222233334445789999999999998 999999 899
Q ss_pred hhhcCccccc
Q 010116 388 QIKAHPWFKD 397 (518)
Q Consensus 388 eil~Hpff~~ 397 (518)
|+++||||+.
T Consensus 284 ell~hp~~~~ 293 (336)
T 3fhr_A 284 QFMNHPWINQ 293 (336)
T ss_dssp HHHHSHHHHT
T ss_pred HHhcCccccc
Confidence 9999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=386.22 Aligned_cols=266 Identities=20% Similarity=0.340 Sum_probs=215.5
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+..++|++.+.||+|+||+||+|++..+++.||+|++.+. .....+.+.+|+.+|+.++||||+++++++.+...+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 34568999999999999999999999999999999998653 334567789999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 162 YLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999977 5789999999999999999999999999999999999999999999999999998764321
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
..... .............+.+||+.|+|||++.+..|+.++||||
T Consensus 163 ~~~~~-----------------------------------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 207 (310)
T 3s95_A 163 TQPEG-----------------------------------LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFS 207 (310)
T ss_dssp ----------------------------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHH
T ss_pred ccccc-----------------------------------cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHH
Confidence 10000 0000001112334678999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhH-----HHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITT-----CRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPW 394 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~-----~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpf 394 (518)
|||++|||++|..||........ ...... ...| ..+++++.+||.+||. ||.+|+ ++.+|++ |
T Consensus 208 lG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~~l~~--~ 276 (310)
T 3s95_A 208 FGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----RYCP--PNCPPSFFPITVRCCDLDPEKRP---SFVKLEH--W 276 (310)
T ss_dssp HHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----HTCC--TTCCTTHHHHHHHHTCSSGGGSC---CHHHHHH--H
T ss_pred HHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----ccCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH--H
Confidence 99999999999999976433221 111111 1122 4688999999999998 999999 8999886 4
Q ss_pred cc
Q 010116 395 FK 396 (518)
Q Consensus 395 f~ 396 (518)
+.
T Consensus 277 L~ 278 (310)
T 3s95_A 277 LE 278 (310)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=373.02 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=218.3
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
..+..++|++++.||+|+||.||+|+++ ++..||+|++..... ..+.+.+|+.++..++||||+++++++.+...
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 3566789999999999999999999765 567899999976532 23568899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999999999775 45999999999999999999999999999999999999999999999999999865322
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.. .......||+.|+|||++.+..|+.++|||
T Consensus 158 ~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 189 (268)
T 3sxs_A 158 QY------------------------------------------------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189 (268)
T ss_dssp CE------------------------------------------------EECCSCCCCGGGCCHHHHHHSEEETTHHHH
T ss_pred hh------------------------------------------------hcccCCCcCcccCCHHHHhccCCchhhhhH
Confidence 10 011245678899999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||++|+|++ |.+||...+.......+.... ..+.+..+++++.+||.+||. ||.+|+ ++.++++|
T Consensus 190 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (268)
T 3sxs_A 190 AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---RLYRPHLASDTIYQIMYSCWHELPEKRP---TFQQLLSS 258 (268)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---CCCCCTTSCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCccccChHHHHHHHHcCC---CCCCCCcChHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 99999999999 999999888887777766532 222234679999999999998 999999 89999976
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=384.06 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=222.4
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEE
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 152 (518)
...+.+..++|.+.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+|+.++||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 3456677889999999999999999999984 456899999997542 344567789999999999999999999
Q ss_pred EEeecCCeEEEEEeecCCCchHHHHhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCeE
Q 010116 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDT------------------------LTENVARFYIAQSVLAIESIHKHNYI 208 (518)
Q Consensus 153 ~~f~~~~~lylVmEy~~gG~L~~~l~~~~~------------------------l~e~~~~~~~~ql~~aL~~LH~~gii 208 (518)
+++.+.+.+|+||||++||+|.+++..... +++..+..++.|++.||.|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999976533 89999999999999999999999999
Q ss_pred EcCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhc
Q 010116 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNR 288 (518)
Q Consensus 209 HRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (518)
||||||+|||++.+|++||+|||+++........
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------------- 206 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY---------------------------------------------- 206 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE----------------------------------------------
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccc----------------------------------------------
Confidence 9999999999999999999999999865322100
Q ss_pred ccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHH
Q 010116 289 RKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAK 367 (518)
Q Consensus 289 ~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~ 367 (518)
.......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+.......+... ..... ...+++++.
T Consensus 207 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~ 282 (314)
T 2ivs_A 207 -VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG-HRMER--PDNCSEEMY 282 (314)
T ss_dssp -ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCC--CTTCCHHHH
T ss_pred -eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC-CcCCC--CccCCHHHH
Confidence 01123568899999999999999999999999999999999 99999998887777666543 22333 347899999
Q ss_pred HHHHHHhc-cccccCCCCChhhhhcC
Q 010116 368 DLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 368 dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+||.+||. ||.+|+ ++.+|++|
T Consensus 283 ~li~~~l~~dp~~Rp---s~~~l~~~ 305 (314)
T 2ivs_A 283 RLMLQCWKQEPDKRP---VFADISKD 305 (314)
T ss_dssp HHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHccCChhhCc---CHHHHHHH
Confidence 99999998 999999 89999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=388.87 Aligned_cols=260 Identities=21% Similarity=0.317 Sum_probs=218.8
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 153 (518)
.+.+..++|++++.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.+|..+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 45677889999999999999999999973 356789999997543 233456788999999999 8999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEc
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMRED-----------------------TLTENVARFYIAQSVLAIESIHKHNYIHR 210 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~~-----------------------~l~e~~~~~~~~ql~~aL~~LH~~giiHR 210 (518)
++.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 37999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccc
Q 010116 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRK 290 (518)
Q Consensus 211 DIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (518)
||||+|||++.+|++||+|||++........ ..
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-----------------------------------------------~~ 229 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSN-----------------------------------------------YV 229 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTT-----------------------------------------------SE
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCcc-----------------------------------------------ce
Confidence 9999999999999999999999986532110 01
Q ss_pred ccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHH
Q 010116 291 LAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDL 369 (518)
Q Consensus 291 ~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dL 369 (518)
......||+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+.........++... ...+.+..+++++.+|
T Consensus 230 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l 307 (344)
T 1rjb_A 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG--FKMDQPFYATEEIYII 307 (344)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT--CCCCCCTTCCHHHHHH
T ss_pred eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcC--CCCCCCCCCCHHHHHH
Confidence 1224568999999999999999999999999999999998 999999887666666666533 3333345789999999
Q ss_pred HHHHhc-cccccCCCCChhhhhcCc
Q 010116 370 ICRLLC-DVEHRLGTGGAHQIKAHP 393 (518)
Q Consensus 370 I~~lL~-dp~~R~g~~~a~eil~Hp 393 (518)
|.+||. ||.+|| ++.+|++|-
T Consensus 308 i~~~l~~dp~~Rp---s~~~l~~~l 329 (344)
T 1rjb_A 308 MQSCWAFDSRKRP---SFPNLTSFL 329 (344)
T ss_dssp HHHHTCSSGGGSC---CHHHHHHHH
T ss_pred HHHHcCCCchhCc---CHHHHHHHH
Confidence 999998 999999 899999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=394.06 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=208.5
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-----------CCceeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-----------SHCIVK 150 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-----------hp~Iv~ 150 (518)
.+..++|++++.||+|+||+||+|++..+++.||||++.+.. ...+.+.+|+.+++.+. ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 445689999999999999999999999999999999997543 23456778999998876 899999
Q ss_pred EEEEeecCC----eEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeC---
Q 010116 151 LYYSFQDTE----YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLD--- 220 (518)
Q Consensus 151 l~~~f~~~~----~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld--- 220 (518)
++++|.... .+|+||||+ ||+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998654 899999999 99999999763 5699999999999999999999998 999999999999995
Q ss_pred ---CCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccC
Q 010116 221 ---KNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (518)
Q Consensus 221 ---~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 297 (518)
..+.+||+|||+|+..... ....+|
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~----------------------------------------------------~~~~~~ 197 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH----------------------------------------------------YTNSIQ 197 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC----------------------------------------------------CCSCCS
T ss_pred CCcCcceEEEcccccccccCCC----------------------------------------------------CCCCCC
Confidence 4458999999999765311 114579
Q ss_pred CCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCCh------hhHHHHHhhhcCc------------------
Q 010116 298 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDP------ITTCRKIVHWRNH------------------ 353 (518)
Q Consensus 298 T~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~~------------------ 353 (518)
|+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+. ......+......
T Consensus 198 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 277 (373)
T 1q8y_A 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277 (373)
T ss_dssp CGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC
T ss_pred CccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCC
Confidence 9999999999999999999999999999999999999986542 2223333221110
Q ss_pred ----------------------ccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 354 ----------------------LKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 354 ----------------------l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
..++ ..+++++++||.+||+ ||.+|+ ++.||++||||++.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 278 RGLLRNISKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 340 (373)
T ss_dssp --CBSSCCCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTC
T ss_pred cchhcccccccccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccC---CHHHHhhChhhhcc
Confidence 1111 2346789999999999 999999 89999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=376.96 Aligned_cols=256 Identities=20% Similarity=0.339 Sum_probs=219.3
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
...+.+..++|++++.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++..++||||+++++++.+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 3456788899999999999999999999775 677899999976532 23568899999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
...+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999976 568999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
.... ........||+.|+|||++.+..|+.++
T Consensus 171 ~~~~------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 202 (283)
T 3gen_A 171 LDDE------------------------------------------------YTSSVGSKFPVRWSPPEVLMYSKFSSKS 202 (283)
T ss_dssp CCHH------------------------------------------------HHSTTSTTSCGGGCCHHHHHHCCCSHHH
T ss_pred cccc------------------------------------------------cccccCCccCcccCCHHHhccCCCCchh
Confidence 3211 0011245678899999999999999999
Q ss_pred cccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 317 DWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 317 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
|||||||++|+|++ |.+||...+.......+... ...+.+..+++.+.+||.+||. ||.+|+ ++.++++|
T Consensus 203 Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 274 (283)
T 3gen_A 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTIMYSCWHEKADERP---TFKILLSN 274 (283)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc---cCCCCCCcCCHHHHHHHHHHccCChhHCc---CHHHHHHH
Confidence 99999999999998 99999998888888777653 2223334679999999999998 999999 89999876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=385.09 Aligned_cols=270 Identities=16% Similarity=0.247 Sum_probs=228.4
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 153 (518)
..+.+..++|++.+.||+|+||.||+|+++ .+++.||+|++.+.. .......+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 345677789999999999999999999887 467899999997543 2234556889999999999999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE----------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~----------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g 223 (518)
++.+...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999999653 4579999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccC
Q 010116 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (518)
Q Consensus 224 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 303 (518)
++||+|||+++....... .......+||+.|+|
T Consensus 176 ~~kl~Dfg~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~y~a 208 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDY-----------------------------------------------YRKGGKGLLPVRWMS 208 (322)
T ss_dssp CEEECCTTCCCGGGGGGC-----------------------------------------------EEGGGSSEECGGGCC
T ss_pred eEEECcCccccccccccc-----------------------------------------------cccccCCCCCCCccC
Confidence 999999999886532110 011224568999999
Q ss_pred hhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccC
Q 010116 304 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381 (518)
Q Consensus 304 PEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 381 (518)
||++.+..|+.++|||||||++|+|++ |.+||.+.+.......+.... .... ...+++++.+||.+||. ||.+|+
T Consensus 209 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~dp~~Rp 285 (322)
T 1p4o_A 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDK--PDNCPDMLFELMRMCWQYNPKMRP 285 (322)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-cCCC--CCCCCHHHHHHHHHHcCCCcccCc
Confidence 999999999999999999999999999 899999988877777776532 2222 34789999999999998 999999
Q ss_pred CCCChhhhhcC------cccccCCcccc
Q 010116 382 GTGGAHQIKAH------PWFKDVVWDKL 403 (518)
Q Consensus 382 g~~~a~eil~H------pff~~i~w~~l 403 (518)
++.++++| |+|+.++|...
T Consensus 286 ---s~~e~l~~L~~~~~~~~~~~~~~~~ 310 (322)
T 1p4o_A 286 ---SFLEIISSIKEEMEPGFREVSFYYS 310 (322)
T ss_dssp ---CHHHHHHHHGGGSCTTHHHHCSTTS
T ss_pred ---CHHHHHHHHHHhhccCCcccccccc
Confidence 89999987 77777666544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=388.38 Aligned_cols=263 Identities=28% Similarity=0.451 Sum_probs=219.7
Q ss_pred hhhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHHhC--CCceeE
Q 010116 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEVA--SHCIVK 150 (518)
Q Consensus 76 ~~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~--hp~Iv~ 150 (518)
..........++|++++.||+|+||.||+|++..+++.||||++.+...... .....+.+|+.+++.+. ||||++
T Consensus 33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~ 112 (320)
T 3a99_A 33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112 (320)
T ss_dssp -------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence 3444555667899999999999999999999999999999999987643321 11234667999999996 599999
Q ss_pred EEEEeecCCeEEEEEeecCC-CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC-CCCcEEEe
Q 010116 151 LYYSFQDTEYLYLIMEYLPG-GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLS 228 (518)
Q Consensus 151 l~~~f~~~~~lylVmEy~~g-G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld-~~g~vKL~ 228 (518)
++++|.+.+.+|+||||+.+ ++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++ .+|.+||+
T Consensus 113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999999999976 89999998889999999999999999999999999999999999999999 78999999
Q ss_pred ecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc
Q 010116 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308 (518)
Q Consensus 229 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 308 (518)
|||+++..... .....+||+.|+|||++.
T Consensus 193 Dfg~~~~~~~~---------------------------------------------------~~~~~~gt~~y~aPE~~~ 221 (320)
T 3a99_A 193 DFGSGALLKDT---------------------------------------------------VYTDFDGTRVYSPPEWIR 221 (320)
T ss_dssp CCTTCEECCSS---------------------------------------------------CBCCCCSCGGGSCHHHHH
T ss_pred eCccccccccc---------------------------------------------------cccCCCCCccCCChHHhc
Confidence 99998865321 112457999999999998
Q ss_pred CCCC-CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCCh
Q 010116 309 KKGY-GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA 386 (518)
Q Consensus 309 ~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a 386 (518)
+..+ +.++|||||||++|||++|..||...+ .+.. ....++ ..+++++.+||.+||. ||.+|+ ++
T Consensus 222 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~--~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~ 288 (320)
T 3a99_A 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--GQVFFR--QRVSSECQHLIRWCLALRPSDRP---TF 288 (320)
T ss_dssp HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--CCCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred cCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc--cccccc--ccCCHHHHHHHHHHccCChhhCc---CH
Confidence 7776 788999999999999999999996542 2222 223333 4689999999999998 999999 89
Q ss_pred hhhhcCcccccCCccc
Q 010116 387 HQIKAHPWFKDVVWDK 402 (518)
Q Consensus 387 ~eil~Hpff~~i~w~~ 402 (518)
.+|++||||+++.+..
T Consensus 289 ~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 289 EEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp HHHHTSGGGSSCCCHH
T ss_pred HHHhcCHhhcCccCcc
Confidence 9999999999876543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=379.82 Aligned_cols=271 Identities=29% Similarity=0.491 Sum_probs=209.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec--------
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-------- 157 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-------- 157 (518)
++|++++.||+|+||.||+|++..+|+.||||++... ....+.+.+|+.+++.++||||++++++|.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999999654 2345678899999999999999999998864
Q ss_pred -----CCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecc
Q 010116 158 -----TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231 (518)
Q Consensus 158 -----~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFG 231 (518)
...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 46789999999999999999754 468899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK- 310 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~- 310 (518)
++............... ..+ .........+||+.|+|||++.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~---------------~~~--------------------~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQ---------------NLP--------------------GSSDNLTSAIGTAMYVATEVLDGTG 206 (303)
T ss_dssp CCSCTTC------------------------------------------------------------CTTSCHHHHTSCS
T ss_pred chhhcccccchhccccc---------------ccc--------------------ccccccccCCCcccccCcccccCCC
Confidence 99865432100000000 000 001122356899999999999865
Q ss_pred CCCccccccchhHHHHHHHhCCCCCCCC-ChhhHHHHHhhhcCcccCCC--CCCCChhHHHHHHHHhc-cccccCCCCCh
Q 010116 311 GYGMECDWWSLGAIMYEMLVGYPPFYAD-DPITTCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGTGGA 386 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~~~a 386 (518)
.++.++|||||||++|+|++ ||... +.......+... ...+|. ....++.+++||.+||. ||.+|+ ++
T Consensus 207 ~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~ 278 (303)
T 1zy4_A 207 HYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSV--SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GA 278 (303)
T ss_dssp CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHST--TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC---CH
T ss_pred CCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcccc--ccccCccccccchHHHHHHHHHHHhcCcccCc---CH
Confidence 68999999999999999998 55432 333344444332 223332 23567889999999998 999999 89
Q ss_pred hhhhcCcccccCCcccc
Q 010116 387 HQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 387 ~eil~Hpff~~i~w~~l 403 (518)
.++++||||....++..
T Consensus 279 ~~ll~h~~~~~~~~~~~ 295 (303)
T 1zy4_A 279 RTLLNSGWLPVKHQDEV 295 (303)
T ss_dssp HHHHHSSCSCCCCHHHH
T ss_pred HHHhCCCCcCCCChHHH
Confidence 99999999997766543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=372.34 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=207.2
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
.+..++|++.+.||+|+||.||+|++ +|+.||+|++....... ....+.+.+|..+++.++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 35678999999999999999999986 48899999987653322 2345778899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEcCCCCCceeeCC--------CCcEEEee
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN---YIHRDIKPDNLLLDK--------NGHMKLSD 229 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~g---iiHRDIKPeNILld~--------~g~vKL~D 229 (518)
+|+||||++||+|.+++. ...+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999884 568999999999999999999999999 999999999999986 78899999
Q ss_pred cccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC
Q 010116 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (518)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 309 (518)
||+++..... ...+.+||+.|+|||++.+
T Consensus 160 fg~~~~~~~~---------------------------------------------------~~~~~~~~~~y~aPE~~~~ 188 (271)
T 3dtc_A 160 FGLAREWHRT---------------------------------------------------TKMSAAGAYAWMAPEVIRA 188 (271)
T ss_dssp CCC----------------------------------------------------------------CCGGGSCHHHHHH
T ss_pred CCcccccccc---------------------------------------------------cccCCCCccceeCHHHhcc
Confidence 9998754311 0114579999999999999
Q ss_pred CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhh
Q 010116 310 KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ 388 (518)
Q Consensus 310 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~e 388 (518)
..|+.++|||||||++|+|++|..||.+.+.......+... ....+....+++++.+||.+||. ||.+|+ ++.|
T Consensus 189 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~e 263 (271)
T 3dtc_A 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN--KLALPIPSTCPEPFAKLMEDCWNPDPHSRP---SFTN 263 (271)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS--CCCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC--CCCCCCCcccCHHHHHHHHHHhcCCcccCc---CHHH
Confidence 99999999999999999999999999998887777766653 33344445789999999999998 999999 8999
Q ss_pred hhcC
Q 010116 389 IKAH 392 (518)
Q Consensus 389 il~H 392 (518)
+++|
T Consensus 264 ~l~~ 267 (271)
T 3dtc_A 264 ILDQ 267 (271)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=387.45 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=221.6
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 154 (518)
...+..++|++++.||+|+||.||+|++. .+++.||+|++++.. .....+.+.+|+.+++.++||||++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 45677889999999999999999999987 456899999997643 23445678999999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEc
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMRE------------------------DTLTENVARFYIAQSVLAIESIHKHNYIHR 210 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~------------------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHR 210 (518)
+.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999999999999763 579999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccc
Q 010116 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRK 290 (518)
Q Consensus 211 DIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (518)
||||+|||++.+|.+||+|||+++........ .
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~ 231 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-----------------------------------------------K 231 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-----------------------------------------------C
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-----------------------------------------------c
Confidence 99999999999999999999999865321100 0
Q ss_pred ccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHH
Q 010116 291 LAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDL 369 (518)
Q Consensus 291 ~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dL 369 (518)
......||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+.......+.... ...+| ..+++++.+|
T Consensus 232 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~l 308 (343)
T 1luf_A 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNL 308 (343)
T ss_dssp ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHH
T ss_pred ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC-cCCCC--CCCCHHHHHH
Confidence 1124568999999999999999999999999999999999 999999988888777776532 22333 4689999999
Q ss_pred HHHHhc-cccccCCCCChhhhhcC
Q 010116 370 ICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 370 I~~lL~-dp~~R~g~~~a~eil~H 392 (518)
|.+||. ||.+|+ ++.+|+++
T Consensus 309 i~~~l~~~p~~Rp---s~~~~~~~ 329 (343)
T 1luf_A 309 MRLCWSKLPADRP---SFCSIHRI 329 (343)
T ss_dssp HHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHcccCcccCC---CHHHHHHH
Confidence 999998 999999 89998863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=391.33 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=222.4
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecC-------CcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKS-------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVK 150 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t-------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~ 150 (518)
.++.+..++|++++.||+|+||.||+|++..+ +..||+|++.... .......+.+|+.+++.+ +|||||+
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 45677789999999999999999999997643 3579999997652 334567788999999999 9999999
Q ss_pred EEEEeecCCeEEEEEeecCCCchHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCC
Q 010116 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKP 214 (518)
Q Consensus 151 l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKP 214 (518)
++++|.+.+.+|+||||++||+|.+++.... .+++..++.++.|++.||.|||++|||||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999997653 499999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccc
Q 010116 215 DNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294 (518)
Q Consensus 215 eNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 294 (518)
+||||+.+|.+||+|||+|+....... ......
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~-----------------------------------------------~~~~~~ 252 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDY-----------------------------------------------YKKTTN 252 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCT-----------------------------------------------TCCCTT
T ss_pred ceEEEcCCCcEEEcccCcccccccccc-----------------------------------------------cccccC
Confidence 999999999999999999986532110 001124
Q ss_pred ccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHH
Q 010116 295 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRL 373 (518)
Q Consensus 295 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~l 373 (518)
..||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ..... ...+++++.+||.+|
T Consensus 253 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~ 329 (382)
T 3tt0_A 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDK--PSNCTNELYMMMRDC 329 (382)
T ss_dssp CCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCC--CSSCCHHHHHHHHHH
T ss_pred CCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCC--CccCCHHHHHHHHHH
Confidence 568899999999999999999999999999999999 99999998887777766553 22333 357899999999999
Q ss_pred hc-cccccCCCCChhhhhcC
Q 010116 374 LC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~H 392 (518)
|. ||.+|+ ++.+|++|
T Consensus 330 l~~dP~~Rp---s~~ell~~ 346 (382)
T 3tt0_A 330 WHAVPSQRP---TFKQLVED 346 (382)
T ss_dssp TCSSGGGSC---CHHHHHHH
T ss_pred cCCChhhCc---CHHHHHHH
Confidence 98 999999 89999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=396.22 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=219.3
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.+.+..++|++.+.||+|+||.||+|+++.+++.||||+++... .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34566789999999999999999999999999999999987542 2334456788999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999999999765 4699999999999999999999999999999999999999999999999999986432
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
.... .......+|+.|+|||++.+..|+.++||
T Consensus 266 ~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 298 (377)
T 3cbl_A 266 GVYA-----------------------------------------------ASGGLRQVPVKWTAPEALNYGRYSSESDV 298 (377)
T ss_dssp SEEE-----------------------------------------------CCSSCCEEEGGGSCHHHHHHCEEEHHHHH
T ss_pred Ccee-----------------------------------------------ecCCCCCCCcCcCCHhHhccCCCCchhhH
Confidence 1100 00012346788999999999999999999
Q ss_pred cchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 319 WSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 319 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||++|||++ |.+||.+.+.......+... ..+..| ..+++++.+||.+||. ||.+|| ++.+|++
T Consensus 299 wslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~ 367 (377)
T 3cbl_A 299 WSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCP--ELCPDAVFRLMEQCWAYEPGQRP---SFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 999999999998 99999988877766655542 233333 4689999999999998 999999 8888875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=374.78 Aligned_cols=260 Identities=18% Similarity=0.209 Sum_probs=212.7
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
..+..++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|..+++.+ +|++|+++++++.+..
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 34567899999999999999999999999999999999875432 23477899999999 7999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc-----EEEeecccc
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-----MKLSDFGLC 233 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~-----vKL~DFGla 233 (518)
..|+||||+ ||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|. +||+|||+|
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 99999999765 46999999999999999999999999999999999999988876 999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
+........... ........+||+.|+|||++.+..|+
T Consensus 159 ~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (298)
T 1csn_A 159 KFYRDPVTKQHI------------------------------------------PYREKKNLSGTARYMSINTHLGREQS 196 (298)
T ss_dssp EESBCTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred cccccccccccc------------------------------------------cccCccCCCCCcccCCchhhcCCCCC
Confidence 876432110000 00112356899999999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCC---hhhHHHHHhhhcCcccCCC-CCCCChhHHHHHHHHhc-cccccCCCCChhh
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADD---PITTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ 388 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~e 388 (518)
.++|||||||++|||++|..||.+.+ .......+.........+. ...+++++.+||.+||. ||.+|| ++.+
T Consensus 197 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP---~~~~ 273 (298)
T 1csn_A 197 RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP---DYDY 273 (298)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC---CHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCC---CHHH
Confidence 99999999999999999999998743 3344444433221111111 23689999999999998 999999 7887
Q ss_pred hhc
Q 010116 389 IKA 391 (518)
Q Consensus 389 il~ 391 (518)
|++
T Consensus 274 l~~ 276 (298)
T 1csn_A 274 LQG 276 (298)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=379.78 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=220.2
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEE-----ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCRE-----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 153 (518)
.+.+..++|++.+.||+|+||.||+|++ ..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 3556678999999999999999999985 35678999999976532 23456788999999999 9999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMRED------------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~~------------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPe 215 (518)
++.+.+.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 9999999999999999999999997653 4899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccc
Q 010116 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (518)
Q Consensus 216 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 295 (518)
|||++.+|.+||+|||++........ .......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------~~~~~~~ 207 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSN-----------------------------------------------YVVKGNA 207 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTT-----------------------------------------------SEECSSS
T ss_pred eEEEcCCCCEEEcccccccccccccc-----------------------------------------------ceeccCC
Confidence 99999999999999999986542210 0011245
Q ss_pred cCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHh
Q 010116 296 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374 (518)
Q Consensus 296 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL 374 (518)
.||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.........++... ...+....+++++.+||.+||
T Consensus 208 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l 285 (313)
T 1t46_A 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG--FRMLSPEHAPAEMYDIMKTCW 285 (313)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT--CCCCCCTTSCHHHHHHHHHHT
T ss_pred CCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC--CCCCCcccCCHHHHHHHHHHc
Confidence 68899999999999999999999999999999999 999998877666665555532 233333578999999999999
Q ss_pred c-cccccCCCCChhhhhcC
Q 010116 375 C-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~H 392 (518)
. ||.+|+ ++.+|+++
T Consensus 286 ~~dp~~Rp---s~~ell~~ 301 (313)
T 1t46_A 286 DADPLKRP---TFKQIVQL 301 (313)
T ss_dssp CSSGGGSC---CHHHHHHH
T ss_pred CCCchhCc---CHHHHHHH
Confidence 8 999999 89999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=376.83 Aligned_cols=261 Identities=29% Similarity=0.477 Sum_probs=214.5
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
.....++|....+||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||++++++|.+.+.
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3344556666679999999999999999999999999987653 2345678899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-CCcEEEeeccccccc
Q 010116 161 LYLIMEYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPL 236 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~---~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-~g~vKL~DFGla~~~ 236 (518)
+|+||||++||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++. +|.+||+|||+++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99999999999999999764 35679999999999999999999999999999999999987 899999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC--CCCc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--GYGM 314 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--~y~~ 314 (518)
.... ......+||+.|+|||++.+. .++.
T Consensus 174 ~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 204 (295)
T 2clq_A 174 AGIN-------------------------------------------------PCTETFTGTLQYMAPEIIDKGPRGYGK 204 (295)
T ss_dssp CC------------------------------------------------------CCCCCCGGGCCHHHHHHGGGGCSH
T ss_pred CCCC-------------------------------------------------CcccccCCCccccChhhhcCCCCCCCc
Confidence 3210 011245799999999999764 3899
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhh-HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPIT-TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
++|||||||++|+|++|..||....... .............+| ..+++++.+||.+||. ||.+|+ ++.+++.|
T Consensus 205 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~ 279 (295)
T 2clq_A 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP--ESMSAEAKAFILKCFEPDPDKRA---CANDLLVD 279 (295)
T ss_dssp HHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC--TTSCHHHHHHHHHTTCSSTTTSC---CHHHHHTS
T ss_pred HHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc--ccCCHHHHHHHHHHccCChhhCC---CHHHHhcC
Confidence 9999999999999999999997643322 222222222223333 4689999999999998 999999 89999999
Q ss_pred cccccC
Q 010116 393 PWFKDV 398 (518)
Q Consensus 393 pff~~i 398 (518)
|||+..
T Consensus 280 ~~~~~~ 285 (295)
T 2clq_A 280 EFLKVS 285 (295)
T ss_dssp GGGCC-
T ss_pred hhhhhc
Confidence 999854
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=376.23 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=223.1
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
..+.+..++|++.+.||+|+||.||+|.++.++..||+|++... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 46778889999999999999999999999999999999999754 23456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
..+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999764 45999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
..... .......||+.|+|||++.+..++.++
T Consensus 162 ~~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 193 (288)
T 3kfa_A 162 TGDTY------------------------------------------------TAHAGAKFPIKWTAPESLAYNKFSIKS 193 (288)
T ss_dssp CSSSS------------------------------------------------EEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred cCCcc------------------------------------------------ccccCCccccCcCChhhhccCCCCchh
Confidence 42210 011245688999999999999999999
Q ss_pred cccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 317 DWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 317 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||||++|+|++ |.+||.+.+.......+.. ....+....+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 194 Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~~~~ 264 (288)
T 3kfa_A 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---cCCCCCCCCCCHHHHHHHHHHhCCChhhCc---CHHHHHH
Confidence 99999999999999 9999998887777666654 22333345789999999999998 999999 8998875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=375.12 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=208.4
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
...+..++|++.+.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|..+++.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 4566778999999999999999999998654 4579999986542 2344567889999999999999999999985
Q ss_pred cCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
++.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 45789999999999999999765 4799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
...... .......||+.|+|||++.+..|+.+
T Consensus 166 ~~~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (281)
T 1mp8_A 166 MEDSTY------------------------------------------------YKASKGKLPIKWMAPESINFRRFTSA 197 (281)
T ss_dssp -------------------------------------------------------------CCGGGCCHHHHHHCCCSHH
T ss_pred cCcccc------------------------------------------------cccccCCCcccccChhhcccCCCCCc
Confidence 532110 01123457889999999999999999
Q ss_pred ccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 316 CDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 316 ~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+|||||||++|||++ |.+||.+.+.......+.... ...+ ...+++++.+||.+||. ||.+|+ ++.+++++
T Consensus 198 ~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 270 (281)
T 1mp8_A 198 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPM--PPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCC--CCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 999999999999997 999999988888777776532 2333 35789999999999998 999999 89998864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=376.16 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=209.8
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCC-------cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSG-------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~-------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 154 (518)
++..++|++.+.||+|+||.||+|+++.++ ..||+|++.+.. ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999998887 469999987643 3445778899999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc--------E
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH--------M 225 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~~-~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~--------v 225 (518)
+.+.+..|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999999997765 4999999999999999999999999999999999999999987 9
Q ss_pred EEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChh
Q 010116 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (518)
Q Consensus 226 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 305 (518)
||+|||++...... ....||+.|+|||
T Consensus 161 kl~Dfg~~~~~~~~-----------------------------------------------------~~~~~~~~y~aPE 187 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----------------------------------------------------DILQERIPWVPPE 187 (289)
T ss_dssp EECCCCSCTTTSCH-----------------------------------------------------HHHHHTTTTSCHH
T ss_pred eeccCcccccccCc-----------------------------------------------------cccCCcCcccCHH
Confidence 99999998754211 1346899999999
Q ss_pred hhcC-CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC
Q 010116 306 VLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT 383 (518)
Q Consensus 306 vl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~ 383 (518)
++.+ ..++.++|||||||++|||++|..|+...........+.. ....+|. .+++++.+||.+||. ||.+|+
T Consensus 188 ~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~li~~~l~~dp~~Rp-- 261 (289)
T 4fvq_A 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--DRHQLPA--PKAAELANLINNCMDYEPDHRP-- 261 (289)
T ss_dssp HHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--TTCCCCC--CSSCTTHHHHHHHSCSSGGGSC--
T ss_pred HhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh--ccCCCCC--CCCHHHHHHHHHHcCCChhHCc--
Confidence 9988 7799999999999999999995554444433333333333 2333443 568899999999998 999999
Q ss_pred CChhhhhcC
Q 010116 384 GGAHQIKAH 392 (518)
Q Consensus 384 ~~a~eil~H 392 (518)
++.++++|
T Consensus 262 -s~~~ll~~ 269 (289)
T 4fvq_A 262 -SFRAIIRD 269 (289)
T ss_dssp -CHHHHHHH
T ss_pred -CHHHHHHH
Confidence 89999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=378.28 Aligned_cols=257 Identities=23% Similarity=0.307 Sum_probs=208.4
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 36899999999999999999999999999999999987655455556788999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-- 189 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-- 189 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc--
Confidence 999999999999998888999999999999999999999999999999999999999999999999999876432100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
......+||+.|+|||++.+..++.++|||||||
T Consensus 190 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 223 (309)
T 2h34_A 190 ----------------------------------------------TQLGNTVGTLYYMAPERFSESHATYRADIYALTC 223 (309)
T ss_dssp -----------------------------------------------------CCGGGCCGGGTCC----CCCHHHHHHH
T ss_pred ----------------------------------------------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHH
Confidence 0112457999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
++|+|++|..||.+.+.......+.. ...........+|+++.+||.+||. ||.+|++ ++++++.
T Consensus 224 il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~--s~~~l~~ 289 (309)
T 2h34_A 224 VLYECLTGSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYV--TCGDLSA 289 (309)
T ss_dssp HHHHHHHSSCSSCSCHHHHHHHHHHS-CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCS--SHHHHHH
T ss_pred HHHHHHHCCCCCCCchHHHHHHHhcc-CCCCccccCCCCCHHHHHHHHHhccCCHHHHHH--hHHHHHH
Confidence 99999999999988766544333332 1111112234689999999999998 9999995 4666653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=380.35 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=204.3
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
.....++|++++.||+|+||.||+|+++.+|+.||||++...... ......+..+..+++.++||||+++++++.+.+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 445678999999999999999999999999999999999765322 2223344555667888899999999999999999
Q ss_pred EEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 161 LYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
+|+||||+ ++.+..++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.+|++||+|||++.....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999999 6666665544 47899999999999999999999995 999999999999999999999999999875432
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----CCCCC
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYG 313 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~ 313 (518)
.. .....+||+.|+|||++. +..|+
T Consensus 178 ~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 207 (318)
T 2dyl_A 178 DK--------------------------------------------------AKDRSAGCAAYMAPERIDPPDPTKPDYD 207 (318)
T ss_dssp -----------------------------------------------------------CCTTCCHHHHC--------CC
T ss_pred Cc--------------------------------------------------cccccCCCccccChhhcccccccccCCc
Confidence 10 012457999999999995 56789
Q ss_pred ccccccchhHHHHHHHhCCCCCCCC-ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYAD-DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
.++|||||||++|+|++|..||... ........+... ....+|....+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 208 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~ 283 (318)
T 2dyl_A 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP---KYNKLLE 283 (318)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC---CHHHHTT
T ss_pred cccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCCCCCccCCCCHHHHHHHHHHccCChhHCc---CHHHHhh
Confidence 9999999999999999999999873 445555555553 334455555789999999999998 999999 8999999
Q ss_pred CcccccC
Q 010116 392 HPWFKDV 398 (518)
Q Consensus 392 Hpff~~i 398 (518)
||||++.
T Consensus 284 h~~~~~~ 290 (318)
T 2dyl_A 284 HSFIKRY 290 (318)
T ss_dssp SHHHHHH
T ss_pred CHHHHhc
Confidence 9999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=383.98 Aligned_cols=254 Identities=19% Similarity=0.319 Sum_probs=207.8
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEE----EEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~----AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+++.++|||||++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45678999999999999999999998888765 666664332 233456788999999999999999999999876
Q ss_pred CeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
. .++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999976 4689999999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.... ........||+.|+|||++.+..|+.++|
T Consensus 169 ~~~~-----------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3poz_A 169 AEEK-----------------------------------------------EYHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp TTCC------------------------------------------------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred CCcc-----------------------------------------------cccccCCCccccccChHHhccCCCCchhh
Confidence 2210 00112356789999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||||++|||++ |.+||.+.+.......+... ...+....++.++.+||.+||. ||.+|+ ++.+++.|
T Consensus 202 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~ 272 (327)
T 3poz_A 202 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CCCCCCTTBCHHHHHHHHHHTCSCGGGSC---CHHHHHHH
T ss_pred hhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC---CCCCCCccCCHHHHHHHHHHcCCChhhCC---CHHHHHHH
Confidence 9999999999999 99999988777666555442 2333445789999999999998 999999 89999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=371.25 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=212.0
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhh----HHHHHHHHHHHHHhCCCceeEEEEEe
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ----VEHVRAERNLLAEVASHCIVKLYYSF 155 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~----~~~~~~E~~il~~l~hp~Iv~l~~~f 155 (518)
...+..++|++.+.||+|+||.||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 44567789999999999999999999999999999999987654332222 26788999999999999999999999
Q ss_pred ecCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCceeeCCCCc-----EEE
Q 010116 156 QDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGH-----MKL 227 (518)
Q Consensus 156 ~~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~g--iiHRDIKPeNILld~~g~-----vKL 227 (518)
.+.. ++||||++||+|.+++... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 8776 6999999999999888654 57999999999999999999999999 999999999999998887 999
Q ss_pred eecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhh
Q 010116 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (518)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 307 (518)
+|||+++..... ....+||+.|+|||++
T Consensus 171 ~Dfg~~~~~~~~----------------------------------------------------~~~~~g~~~y~aPE~~ 198 (287)
T 4f0f_A 171 ADFGLSQQSVHS----------------------------------------------------VSGLLGNFQWMAPETI 198 (287)
T ss_dssp CCCTTCBCCSSC----------------------------------------------------EECCCCCCTTSCGGGS
T ss_pred CCCCcccccccc----------------------------------------------------ccccCCCccccCchhh
Confidence 999998743211 1246799999999999
Q ss_pred c--CCCCCccccccchhHHHHHHHhCCCCCCCCChhhH--HHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 308 L--KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITT--CRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 308 ~--~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
. ...|+.++|||||||++|+|++|..||...+.... ...+... ....+....+++++.+||.+||. ||.+|+
T Consensus 199 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp- 275 (287)
T 4f0f_A 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--GLRPTIPEDCPPRLRNVIELCWSGDPKKRP- 275 (287)
T ss_dssp SCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS--CCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-
T ss_pred ccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc--CCCCCCCcccCHHHHHHHHHHhcCChhhCc-
Confidence 4 45689999999999999999999999987654433 3333332 22223334789999999999998 999999
Q ss_pred CCChhhhhc
Q 010116 383 TGGAHQIKA 391 (518)
Q Consensus 383 ~~~a~eil~ 391 (518)
++.+|++
T Consensus 276 --s~~~ll~ 282 (287)
T 4f0f_A 276 --HFSYIVK 282 (287)
T ss_dssp --CHHHHHH
T ss_pred --CHHHHHH
Confidence 8999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=385.72 Aligned_cols=268 Identities=25% Similarity=0.442 Sum_probs=198.8
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHH-HHHHhCCCceeEEEEEeec
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN-LLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~f~~ 157 (518)
..+.+..++|++++.||+|+||.||+|.++.+|+.||||++..... ......+..|.. +++.++||||+++++++.+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4567788999999999999999999999999999999999976421 222334444554 6777899999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCceeeCCCCcEEEeecc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMR-----EDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFG 231 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~-----~~~l~e~~~~~~~~ql~~aL~~LH~~-giiHRDIKPeNILld~~g~vKL~DFG 231 (518)
.+.+|+||||++| +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999975 88777753 57899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhh----
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---- 307 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl---- 307 (518)
+++...... .....+||+.|+|||++
T Consensus 172 ~~~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~ 201 (327)
T 3aln_A 172 ISGQLVDSI--------------------------------------------------AKTRDAGCRPYMAPERIDPSA 201 (327)
T ss_dssp SSCC----------------------------------------------------------------------------
T ss_pred Cceeccccc--------------------------------------------------ccccCCCCccccCceeecccc
Confidence 987653210 01134799999999999
Q ss_pred cCCCCCccccccchhHHHHHHHhCCCCCCCCChh-hHHHHHhhhcCcccCCC--CCCCChhHHHHHHHHhc-cccccCCC
Q 010116 308 LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPI-TTCRKIVHWRNHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGT 383 (518)
Q Consensus 308 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~ 383 (518)
.+..|+.++|||||||++|+|++|..||.+.+.. .....+... ....++. ...+++++.+||.+||. ||.+|+
T Consensus 202 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-- 278 (327)
T 3aln_A 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRP-- 278 (327)
T ss_dssp ----CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSC--
T ss_pred CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-CCCCCCCcccccCCHHHHHHHHHHhhCChhhCc--
Confidence 4667999999999999999999999999875432 222222221 1112221 24589999999999998 999999
Q ss_pred CChhhhhcCcccccCCcccc
Q 010116 384 GGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 384 ~~a~eil~Hpff~~i~w~~l 403 (518)
++.+|++||||....+..+
T Consensus 279 -s~~ell~hp~~~~~~~~~~ 297 (327)
T 3aln_A 279 -KYKELLKHPFILMYEERAV 297 (327)
T ss_dssp -CHHHHTTSHHHHHHHHSCC
T ss_pred -CHHHHHhChHHHHhHhhHH
Confidence 8999999999987766544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=378.42 Aligned_cols=264 Identities=27% Similarity=0.449 Sum_probs=215.8
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC--CCceeEEEEEe
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA--SHCIVKLYYSF 155 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~f 155 (518)
++...+..++|++++.||+|+||.||+|++. +++.||+|++..... .....+.+.+|+.++..+. ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3445566778999999999999999999875 589999999976532 3345677899999999997 59999999999
Q ss_pred ecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 156 QDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 156 ~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.+...+|+||| +.+|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++ +|.+||+|||+++.
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 99999999999 56899999999888999999999999999999999999999999999999995 59999999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC------
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK------ 309 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------ 309 (518)
...... .......+||+.|+|||++.+
T Consensus 176 ~~~~~~-----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 208 (313)
T 3cek_A 176 MQPDTT-----------------------------------------------SVVKDSQVGTVNYMPPEAIKDMSSSRE 208 (313)
T ss_dssp -------------------------------------------------------------CCGGGCCHHHHTTCC----
T ss_pred ccCccc-----------------------------------------------cccccCCCCCCCcCCHHHHhhcccccc
Confidence 532110 001124579999999999976
Q ss_pred -----CCCCccccccchhHHHHHHHhCCCCCCCCC-hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 310 -----KGYGMECDWWSLGAIMYEMLVGYPPFYADD-PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 310 -----~~y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
..++.++|||||||++|+|++|..||.... .......+........+| ...++++.+||.+||. ||.+|+
T Consensus 209 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp- 285 (313)
T 3cek_A 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRI- 285 (313)
T ss_dssp ------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSC-
T ss_pred cccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc--ccchHHHHHHHHHHccCCcccCc-
Confidence 478999999999999999999999997753 333444444433333444 3568999999999998 999999
Q ss_pred CCChhhhhcCccccc
Q 010116 383 TGGAHQIKAHPWFKD 397 (518)
Q Consensus 383 ~~~a~eil~Hpff~~ 397 (518)
++.++++||||+.
T Consensus 286 --s~~ell~h~~~~~ 298 (313)
T 3cek_A 286 --SIPELLAHPYVQI 298 (313)
T ss_dssp --CHHHHHTSHHHHC
T ss_pred --CHHHHhcCccccC
Confidence 8999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=368.14 Aligned_cols=250 Identities=18% Similarity=0.240 Sum_probs=216.7
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC-
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT- 158 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~- 158 (518)
...+..++|++++.||+|+||.||+|++. ++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 34567789999999999999999999874 88999999986532 234456789999999999999999999999887
Q ss_pred -CeEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 159 -EYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 159 -~~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~g--iiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
..+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++| |+||||||+|||++.+|.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78999999999999999997765 5899999999999999999999999 999999999999999999999999986
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
.... ....+||+.|+|||++.+..++
T Consensus 161 ~~~~------------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~ 186 (271)
T 3kmu_A 161 FSFQ------------------------------------------------------SPGRMYAPAWVAPEALQKKPED 186 (271)
T ss_dssp CTTS------------------------------------------------------CTTCBSCGGGSCHHHHHSCGGG
T ss_pred eeec------------------------------------------------------ccCccCCccccChhhhccCCCC
Confidence 5421 1145799999999999887655
Q ss_pred c---cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhh
Q 010116 314 M---ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI 389 (518)
Q Consensus 314 ~---~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei 389 (518)
. ++|||||||++|||++|..||.+.+.......+........+| ..+++++.+||.+||. ||.+|+ ++.+|
T Consensus 187 ~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~i 261 (271)
T 3kmu_A 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP--PGISPHVSKLMKICMNEDPAKRP---KFDMI 261 (271)
T ss_dssp SCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHH
Confidence 4 7999999999999999999999988888777776643334444 4789999999999998 999999 89998
Q ss_pred hc
Q 010116 390 KA 391 (518)
Q Consensus 390 l~ 391 (518)
++
T Consensus 262 l~ 263 (271)
T 3kmu_A 262 VP 263 (271)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=380.18 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=220.1
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCc-----EEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGN-----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~-----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 153 (518)
...+..++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+|+.+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 456778999999999999999999999877664 79999997643 233456788999999999 8999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE--------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 219 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~--------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl 219 (518)
++.+.+.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999999999999653 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCC
Q 010116 220 DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299 (518)
Q Consensus 220 d~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~ 299 (518)
+.+|++||+|||+++....... ........||+
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~ 230 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSN-----------------------------------------------YIVKGNARLPV 230 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTT-----------------------------------------------SEECSSCEECG
T ss_pred CCCCeEEECccccccccccccc-----------------------------------------------eeecCCCCCCc
Confidence 9999999999999986532100 00112456889
Q ss_pred CccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cc
Q 010116 300 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 300 ~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp 377 (518)
.|+|||++.+..|+.++|||||||++|||++ |.+||.+.........++..... .+.+..+++++.+||.+||. ||
T Consensus 231 ~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p 308 (333)
T 2i1m_A 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ--MAQPAFAPKNIYSIMQACWALEP 308 (333)
T ss_dssp GGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHhccCh
Confidence 9999999999999999999999999999998 99999987766666666653323 33334689999999999998 99
Q ss_pred cccCCCCChhhhhcC
Q 010116 378 EHRLGTGGAHQIKAH 392 (518)
Q Consensus 378 ~~R~g~~~a~eil~H 392 (518)
.+|| ++.+|+++
T Consensus 309 ~~Rp---s~~~l~~~ 320 (333)
T 2i1m_A 309 THRP---TFQQICSF 320 (333)
T ss_dssp GGSC---CHHHHHHH
T ss_pred hhCc---CHHHHHHH
Confidence 9999 89999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=366.36 Aligned_cols=253 Identities=19% Similarity=0.280 Sum_probs=218.8
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
+.+..++|++++.||+|+||.||+|++. +++.||+|++.+... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4566789999999999999999999886 678899999986532 23568899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999999765 57999999999999999999999999999999999999999999999999998865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
. ........||+.|+|||++.+..++.++|||
T Consensus 158 ~------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 189 (267)
T 3t9t_A 158 Q------------------------------------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189 (267)
T ss_dssp H------------------------------------------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred c------------------------------------------------ccccccccccccccChhhhcCCCccchhchh
Confidence 0 0011245688999999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||++|+|++ |.+||...+.......+... ...+.+..+++++.+||.+||. ||.+|+ ++.+++++
T Consensus 190 slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (267)
T 3t9t_A 190 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred hhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC---CcCCCCccCcHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 99999999999 99999998888877777653 2222234689999999999998 999999 89998874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=378.26 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=216.9
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 153 (518)
.+.+..++|++++.||+|+||.||+|++. .+++.||+|++.+.. .......+.+|+.++..+ +||||+++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 34566789999999999999999999853 567899999997653 233456788999999999 7899999999
Q ss_pred EeecCC-eEEEEEeecCCCchHHHHhhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCc
Q 010116 154 SFQDTE-YLYLIMEYLPGGDMMTLLMREDT----------------LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDN 216 (518)
Q Consensus 154 ~f~~~~-~lylVmEy~~gG~L~~~l~~~~~----------------l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeN 216 (518)
++.+.+ .+|+||||++||+|.+++..... +++..+..++.|++.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987654 59999999999999999976543 8999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccccc
Q 010116 217 LLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (518)
Q Consensus 217 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 296 (518)
||++.+|++||+|||+++....... ........
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------~~~~~~~~ 211 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPD-----------------------------------------------YVRKGDAR 211 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTT-----------------------------------------------SEEETTEE
T ss_pred EEECCCCCEEECCCccccccccCcc-----------------------------------------------ceeccCCC
Confidence 9999999999999999986532110 01122457
Q ss_pred CCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc
Q 010116 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC 375 (518)
Q Consensus 297 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~ 375 (518)
||+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+..........+........| ..+++++.+||.+||.
T Consensus 212 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~ 289 (316)
T 2xir_A 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWH 289 (316)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTC
T ss_pred cceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC--CCCCHHHHHHHHHHcC
Confidence 8999999999999999999999999999999998 999998876555444444433333344 4689999999999998
Q ss_pred -cccccCCCCChhhhhcC
Q 010116 376 -DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 376 -dp~~R~g~~~a~eil~H 392 (518)
||.+|+ ++.+|++|
T Consensus 290 ~dp~~Rp---s~~ell~~ 304 (316)
T 2xir_A 290 GEPSQRP---TFSELVEH 304 (316)
T ss_dssp SSGGGSC---CHHHHHHH
T ss_pred CChhhCc---CHHHHHHH
Confidence 999999 89999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=378.58 Aligned_cols=260 Identities=22% Similarity=0.340 Sum_probs=220.4
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEe-------cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCcee
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREK-------KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIV 149 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-------~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv 149 (518)
...+.+..++|++++.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++.+ +||||+
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 3456677899999999999999999999975 467889999997543 334567788999999999 899999
Q ss_pred EEEEEeecCCeEEEEEeecCCCchHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCC
Q 010116 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213 (518)
Q Consensus 150 ~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIK 213 (518)
++++++.+.+.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+|||||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 99999999999999999999999999997653 38999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccc
Q 010116 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293 (518)
Q Consensus 214 PeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (518)
|+|||++.+|++||+|||+++........ ....
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~-----------------------------------------------~~~~ 217 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYY-----------------------------------------------KKTT 217 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSE-----------------------------------------------ECCS
T ss_pred cceEEEcCCCCEEEccccccccccccccc-----------------------------------------------cccC
Confidence 99999999999999999999865422100 0112
Q ss_pred cccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHH
Q 010116 294 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372 (518)
Q Consensus 294 s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~ 372 (518)
...||+.|+|||++.+..|+.++|||||||++|+|++ |..||.+.+.......+.... ....| ..+++++.+||.+
T Consensus 218 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~ 294 (334)
T 2pvf_A 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTNELYMMMRD 294 (334)
T ss_dssp CCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHH
T ss_pred CCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC-CCCCC--ccCCHHHHHHHHH
Confidence 3468899999999999999999999999999999999 999999988877776666532 22333 4789999999999
Q ss_pred Hhc-cccccCCCCChhhhhcC
Q 010116 373 LLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 373 lL~-dp~~R~g~~~a~eil~H 392 (518)
||. ||.+|+ ++.+|+++
T Consensus 295 ~l~~dp~~Rp---s~~ell~~ 312 (334)
T 2pvf_A 295 CWHAVPSQRP---TFKQLVED 312 (334)
T ss_dssp HTCSSGGGSC---CHHHHHHH
T ss_pred HccCChhhCc---CHHHHHHH
Confidence 998 999999 89999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=375.01 Aligned_cols=257 Identities=24% Similarity=0.408 Sum_probs=207.9
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEE----EecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
..+..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34567899999999999999999998 5678999999998754 2344567889999999999999999999985
Q ss_pred c--CCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 157 D--TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 157 ~--~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
+ ...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4 45699999999999999999775 45999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
+........ ........||+.|+|||++.+..|+
T Consensus 162 ~~~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (295)
T 3ugc_A 162 KVLPQDKEF----------------------------------------------FKVKEPGESPIFWYAPESLTESKFS 195 (295)
T ss_dssp C-----------------------------------------------------------CTTCGGGGCCHHHHHHCCCC
T ss_pred ccccCCcce----------------------------------------------eeeccCCCCccceeCcHHhcCCCCC
Confidence 865322100 0011234588899999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhh---------------HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cc
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPIT---------------TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~---------------~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp 377 (518)
.++|||||||++|||++|..||....... .....+. .....+.+..+++++.+||.+||. ||
T Consensus 196 ~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp 273 (295)
T 3ugc_A 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK--NNGRLPRPDGCPDEIYMIMTECWNNNV 273 (295)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHSCSSG
T ss_pred hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh--ccCcCCCCcCcCHHHHHHHHHHcCCCh
Confidence 99999999999999999999986532110 0111111 223344445789999999999998 99
Q ss_pred cccCCCCChhhhhc
Q 010116 378 EHRLGTGGAHQIKA 391 (518)
Q Consensus 378 ~~R~g~~~a~eil~ 391 (518)
.+|| ++.+|++
T Consensus 274 ~~Rp---s~~el~~ 284 (295)
T 3ugc_A 274 NQRP---SFRDLAL 284 (295)
T ss_dssp GGSC---CHHHHHH
T ss_pred hhCC---CHHHHHH
Confidence 9999 8998875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=379.59 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=214.5
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEE--EEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIY--AMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~--AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
+..++|++.+.||+|+||.||+|+++.+|..+ |+|++.... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 55689999999999999999999999999866 999887532 233456688999999999 8999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~----------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g 223 (518)
.+|+||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 799999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccC
Q 010116 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (518)
Q Consensus 224 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 303 (518)
.+||+|||+++..... .......||+.|+|
T Consensus 180 ~~kL~Dfg~~~~~~~~--------------------------------------------------~~~~~~~~~~~y~a 209 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY--------------------------------------------------VKKTMGRLPVRWMA 209 (327)
T ss_dssp CEEECCTTCEESSCEE--------------------------------------------------CCC----CCTTTCC
T ss_pred eEEEcccCcCcccccc--------------------------------------------------ccccCCCCCccccC
Confidence 9999999998743210 00113457899999
Q ss_pred hhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccC
Q 010116 304 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381 (518)
Q Consensus 304 PEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 381 (518)
||++.+..|+.++|||||||++|||++ |.+||.+.+.......+... ...+....+++++.+||.+||. ||.+|+
T Consensus 210 PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 286 (327)
T 1fvr_A 210 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERP 286 (327)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT---CCCCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred hhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC---CCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999999998 99999998887777766552 2233335789999999999998 999999
Q ss_pred CCCChhhhhcC
Q 010116 382 GTGGAHQIKAH 392 (518)
Q Consensus 382 g~~~a~eil~H 392 (518)
++.++++|
T Consensus 287 ---s~~ell~~ 294 (327)
T 1fvr_A 287 ---SFAQILVS 294 (327)
T ss_dssp ---CHHHHHHH
T ss_pred ---CHHHHHHH
Confidence 89999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=378.97 Aligned_cols=253 Identities=29% Similarity=0.491 Sum_probs=207.2
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHHh----CCCceeEEEEE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEV----ASHCIVKLYYS 154 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l----~hp~Iv~l~~~ 154 (518)
....++|++++.||+|+||.||+|++..+++.||+|++........ .....+.+|+.++..+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3445789999999999999999999999999999999976543221 1223356789999998 89999999999
Q ss_pred eecCCeEEEEEee-cCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC-CCCcEEEeeccc
Q 010116 155 FQDTEYLYLIMEY-LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGL 232 (518)
Q Consensus 155 f~~~~~lylVmEy-~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld-~~g~vKL~DFGl 232 (518)
|.+.+..|+|||| +.|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++ .+|.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999998888999999999999999999999999999999999999999 899999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 312 (518)
+...... .....+||+.|+|||++.+..+
T Consensus 187 ~~~~~~~---------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 215 (312)
T 2iwi_A 187 GALLHDE---------------------------------------------------PYTDFDGTRVYSPPEWISRHQY 215 (312)
T ss_dssp CEECCSS---------------------------------------------------CBCCCCSCTTTSCHHHHHHSCB
T ss_pred hhhcccC---------------------------------------------------cccccCCcccccCceeeecCCC
Confidence 8865321 0124579999999999987776
Q ss_pred -CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 313 -GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 313 -~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
+.++|||||||++|+|++|..||.... .+.. ....++ ..+++++++||.+||. ||.+|+ ++.|++
T Consensus 216 ~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l 282 (312)
T 2iwi_A 216 HALPATVWSLGILLYDMVCGDIPFERDQ------EILE--AELHFP--AHVSPDCCALIRRCLAPKPSSRP---SLEEIL 282 (312)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--TCCCCC--TTSCHHHHHHHHHHTCSSTTTSC---CHHHHH
T ss_pred CCccchHHHHHHHHHHHHHCCCCCCChH------HHhh--hccCCc--ccCCHHHHHHHHHHccCChhhCc---CHHHHh
Confidence 458999999999999999999996532 2333 234454 3689999999999998 999999 899999
Q ss_pred cCcccccC
Q 010116 391 AHPWFKDV 398 (518)
Q Consensus 391 ~Hpff~~i 398 (518)
+||||+..
T Consensus 283 ~~~~~~~~ 290 (312)
T 2iwi_A 283 LDPWMQTP 290 (312)
T ss_dssp HSTTTCC-
T ss_pred cChhhcCc
Confidence 99999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=401.39 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=203.7
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
..+...+|++.++||+|+||+|+. ....+|+.||||++.+... ..+.+|+.+|+.+ +|||||++++++.+..
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 345556799999999999999874 5567899999999976432 1245799999999 7999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CC--cEEEeecccc
Q 010116 160 YLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NG--HMKLSDFGLC 233 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~-~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g--~vKL~DFGla 233 (518)
.+|||||||. |+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++. +| .+||+|||+|
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999995 69999997653 5666778899999999999999999999999999999953 33 5789999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KK 310 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~ 310 (518)
+.+..... ......+.+||+.|+|||++. ..
T Consensus 171 ~~~~~~~~----------------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~ 204 (432)
T 3p23_A 171 KKLAVGRH----------------------------------------------SFSRRSGVPGTEGWIAPEMLSEDCKE 204 (432)
T ss_dssp ECC----------------------------------------------------------CCSCTTSCCGGGTSCC---
T ss_pred eeccCCCc----------------------------------------------ceeeccccCCCcCccChhhhhccccc
Confidence 87542210 001123568999999999998 45
Q ss_pred CCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCccc-CCCCCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 311 GYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLK-FPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 311 ~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~-~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
.++.++|||||||++|||++ |.+||.......... +.. ..... .......+..+++||.+||. ||.+|+ ++.
T Consensus 205 ~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ 279 (432)
T 3p23_A 205 NPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLG-ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAK 279 (432)
T ss_dssp CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTT-CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSC---CHH
T ss_pred CCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-Hhc-cCCccccCccccccHHHHHHHHHHHhCCHhhCC---CHH
Confidence 67889999999999999999 999996654433322 222 11111 11122345678999999998 999999 899
Q ss_pred hhhcCcccccCCcc
Q 010116 388 QIKAHPWFKDVVWD 401 (518)
Q Consensus 388 eil~Hpff~~i~w~ 401 (518)
+|++||||.+++|.
T Consensus 280 evl~hp~f~~~~~~ 293 (432)
T 3p23_A 280 HVLKHPFFWSLEKQ 293 (432)
T ss_dssp HHHTSTTTCCHHHH
T ss_pred HHHhCccccChHHH
Confidence 99999999998883
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=379.35 Aligned_cols=253 Identities=19% Similarity=0.313 Sum_probs=208.9
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEE----EEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM----KKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~Ai----K~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
+..++|++++.||+|+||.||+|++..+++.||+ |.+... ........+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 4568999999999999999999999988887644 444322 1334567788999999999999999999999876
Q ss_pred CeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
. .++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 8899999999999999976 4679999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.... ........||+.|+|||++.+..|+.++|
T Consensus 169 ~~~~-----------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3lzb_A 169 AEEK-----------------------------------------------EYHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp ----------------------------------------------------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred Cccc-----------------------------------------------cccccCCCccccccCHHHHcCCCCChHHH
Confidence 2110 00112346789999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||||++|||++ |.+||.+.+.......+... ...+....+++++.+||.+||. ||.+|+ ++.||++
T Consensus 202 i~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 271 (327)
T 3lzb_A 202 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQPPICTIDVYMIMRKCWMIDADSRP---KFRELII 271 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CCCCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCCccCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 9999999999999 99999988877766655542 2334445789999999999998 999999 8999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=401.28 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=220.9
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.+.+..++|++.+.||+|+||.||+|+++.++..||||+++... ...+.+.+|+.+|+.++|||||++++++.+..
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 45667789999999999999999999999999999999997643 23567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+|||||||+||+|.+++... ..+++..+..++.|++.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999999763 469999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.... .......||+.|+|||++.+..|+.++|
T Consensus 370 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sD 401 (495)
T 1opk_A 370 GDTY------------------------------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSD 401 (495)
T ss_dssp TCCE------------------------------------------------ECCTTCCCCGGGCCHHHHHHCEECHHHH
T ss_pred CCce------------------------------------------------eecCCCcCCcceeCHhHHhcCCCCcHHh
Confidence 2110 0112345788999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||||++|||++ |.+||.+.+.......+.. ....+.+..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 402 vwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~el~~ 471 (495)
T 1opk_A 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHcCcChhHCc---CHHHHHH
Confidence 9999999999999 9999999887777666554 23333345789999999999998 999999 8999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=370.86 Aligned_cols=257 Identities=30% Similarity=0.497 Sum_probs=206.5
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
.....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 34456789999999999999999999999999999999987554455566788999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 161 LYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999999864 467999999999999999999999999999999999999999999999999998754
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
.... ......+||+.|+|||++.+..++.++
T Consensus 187 ~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 217 (310)
T 2wqm_A 187 SSKT-------------------------------------------------TAAHSLVGTPYYMSPERIHENGYNFKS 217 (310)
T ss_dssp -------------------------------------------------------------CCSSCCHHHHTTCCCCHHH
T ss_pred cCCC-------------------------------------------------ccccccCCCeeEeChHHhCCCCCCchh
Confidence 3210 011245799999999999999999999
Q ss_pred cccchhHHHHHHHhCCCCCCCCC--hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADD--PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||||++|+|++|..||.+.. .......+.... ....+ ...+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 218 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~l~~li~~~l~~dp~~Rp---s~~~il~ 290 (310)
T 2wqm_A 218 DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLP-SDHYSEELRQLVNMCINPDPEKRP---DVTYVYD 290 (310)
T ss_dssp HHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-SCCCC-TTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-CCCCc-ccccCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 99999999999999999997653 233444443321 11122 24689999999999998 999999 8999886
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=392.15 Aligned_cols=248 Identities=23% Similarity=0.396 Sum_probs=214.1
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
..+.+..++|++++.||+|+||.||+|... |+.||||+++... ..+.+.+|+.+|+.++|||||++++++.+.
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 456788899999999999999999999764 7899999997643 345688999999999999999999997665
Q ss_pred C-eEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 159 E-YLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 159 ~-~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
. .+|+|||||+||+|.+++...+ .+++..+..++.|++.||.|||++|||||||||+|||++.+|++||+|||+++.
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 4 7999999999999999998754 379999999999999999999999999999999999999999999999999885
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
.... .....+|+.|+|||++.+..|+.+
T Consensus 339 ~~~~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ 366 (450)
T 1k9a_A 339 ASST----------------------------------------------------QDTGKLPVKWTAPEALREKKFSTK 366 (450)
T ss_dssp CC----------------------------------------------------------CCCTTTSCHHHHHSSCCCHH
T ss_pred cccc----------------------------------------------------ccCCCCCcceeCHHHhcCCCCCcH
Confidence 3211 012357899999999999999999
Q ss_pred ccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 316 CDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 316 ~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+|||||||++|||++ |..||.+.+..+....+... ..+.. +..+++++.+||.+||. ||.+|| ++.+|+.
T Consensus 367 sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~--p~~~~~~l~~li~~cl~~dp~~Rp---t~~~l~~ 438 (450)
T 1k9a_A 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA--PDGCPPAVYDVMKNCWHLDAATRP---TFLQLRE 438 (450)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCC--CCcCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999999999998 99999988877777776653 23333 35789999999999998 999999 8888874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=387.62 Aligned_cols=257 Identities=20% Similarity=0.310 Sum_probs=208.8
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
..+..++|++.+.||+|+||.||+|+++ .++..||||+++... .....+.+.+|+.+|+.++|||||++++++.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3566679999999999999999999887 467789999997542 33455678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999999765 47999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
...... ........||+.|+|||++.+..|+.++
T Consensus 198 ~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 231 (373)
T 2qol_A 198 EDDPEA----------------------------------------------AYTTRGGKIPIRWTSPEAIAYRKFTSAS 231 (373)
T ss_dssp --------------------------------------------------------------CTTSCHHHHHHCCCCHHH
T ss_pred ccCCcc----------------------------------------------ceeccCCCcCCCccChhhhccCCcCchh
Confidence 321100 0001123468899999999999999999
Q ss_pred cccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 317 DWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 317 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||||++|||++ |..||...+.......+.. ....+....+++++.+||.+||. ||.+|| ++.+|++
T Consensus 232 Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~~i~~ 302 (373)
T 2qol_A 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRP---KFEQIVS 302 (373)
T ss_dssp HHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT---TEECCCCTTCBHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCccccHHHHHHHHHHhCcChhhCc---CHHHHHH
Confidence 99999999999998 9999999888777776654 23444445789999999999998 999999 8888876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=367.74 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=218.1
Q ss_pred CCcCCCCeeEEe-eEeecCceEEEEEEEe--cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 81 HKICVDDFELLT-IIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 81 ~~~~~~~f~i~~-~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
..+..++|.++. .||+|+||.||+|..+ .++..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 80 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ- 80 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence 445667899988 9999999999999854 568889999997652 3345677899999999999999999999995
Q ss_pred CCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
.+.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 45699999999999999999654 57999999999999999999999999999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
...... ........||+.|+|||++.+..++.++
T Consensus 161 ~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 194 (287)
T 1u59_A 161 GADDSY----------------------------------------------YTARSAGKWPLKWYAPECINFRKFSSRS 194 (287)
T ss_dssp TTCSCE----------------------------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHH
T ss_pred ccCcce----------------------------------------------eeccccccccccccCHHHhccCCCCchh
Confidence 422100 0011234689999999999989999999
Q ss_pred cccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCc
Q 010116 317 DWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHP 393 (518)
Q Consensus 317 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hp 393 (518)
|||||||++|+|++ |.+||.+.+.......+... ....+| ..+++++.+||.+||. ||.+|| ++.++++|.
T Consensus 195 Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~l 267 (287)
T 1u59_A 195 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECP--PECPPELYALMSDCWIYKWEDRP---DFLTVEQRM 267 (287)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHHH
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-CcCCCC--CCcCHHHHHHHHHHcCCChhhCc---CHHHHHHHH
Confidence 99999999999998 99999988887777666653 233344 4789999999999998 999999 899999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=364.97 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=214.4
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
..+..++|++.+.||+|+||.||+|++..+ +..||+|++.+.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 456778999999999999999999987643 4569999997653 23345778999999999999999999999876
Q ss_pred CCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
. ..|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++...
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 5 568999999999999999765 56999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
..... .......||+.|+|||++.+..|+.++
T Consensus 164 ~~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 195 (281)
T 3cc6_A 164 EDEDY------------------------------------------------YKASVTRLPIKWMSPESINFRRFTTAS 195 (281)
T ss_dssp ---------------------------------------------------------CCCCCGGGCCHHHHHHCCCCHHH
T ss_pred ccccc------------------------------------------------cccccCCCCcceeCchhhccCCCCchh
Confidence 32110 011234678999999999999999999
Q ss_pred cccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 317 DWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 317 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
|||||||++|+|++ |..||...+.......+... .. .+....+++.+.+||.+||. ||.+|+ ++.++++|
T Consensus 196 Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~~ 267 (281)
T 3cc6_A 196 DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DR--LPKPDLCPPVLYTLMTRCWDYDPSDRP---RFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-CC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred ccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-CC--CCCCCCCCHHHHHHHHHHccCCchhCc---CHHHHHHH
Confidence 99999999999998 99999988777776666542 22 33334689999999999998 999999 89999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=394.59 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=217.4
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.+.+..++|++.+.||+|+||+||+|+.. ++..||||+++... ...+.+.+|+.+|+.++|||||++++++. .+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 45677889999999999999999999875 46789999997643 23567899999999999999999999987 56
Q ss_pred eEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+|+|||||+||+|.+++... ..+++..+..++.|++.||.|||++|||||||||+|||++.++++||+|||+|+...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 789999999999999999754 378999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.... .......||+.|+|||++....|+.++|
T Consensus 336 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 367 (454)
T 1qcf_A 336 DNEY------------------------------------------------TAREGAKFPIKWTAPEAINFGSFTIKSD 367 (454)
T ss_dssp CHHH------------------------------------------------HTTCSSSSCGGGSCHHHHHHCCCCHHHH
T ss_pred CCce------------------------------------------------eccCCCcccccccCHHHhccCCCCcHHH
Confidence 2100 0112345788999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||||++|||++ |.+||.+.+..+....+... ...|.+..+++++.+||.+||. ||.+|| ++.+|+.
T Consensus 368 vwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~i~~ 437 (454)
T 1qcf_A 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERP---TFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhHCc---CHHHHHH
Confidence 9999999999999 99999998888887777653 3344445789999999999998 999999 8888875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=377.52 Aligned_cols=261 Identities=18% Similarity=0.265 Sum_probs=216.6
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEE-----EecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~-----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
.+..++|++++.||+|+||.||+|+ +..++..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4667899999999999999999998 56678899999996432 2334567889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC---CcEE
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRE-------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN---GHMK 226 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~-------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~---g~vK 226 (518)
+...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999999765 348999999999999999999999999999999999999954 4699
Q ss_pred EeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhh
Q 010116 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (518)
Q Consensus 227 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 306 (518)
|+|||++........ ........||+.|+|||+
T Consensus 184 l~Dfg~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~y~aPE~ 216 (327)
T 2yfx_A 184 IGDFGMARDIYRASY-----------------------------------------------YRKGGCAMLPVKWMPPEA 216 (327)
T ss_dssp ECCCHHHHHHHC-----------------------------------------------------CCGGGSCGGGCCHHH
T ss_pred ECccccccccccccc-----------------------------------------------cccCCCcCCCcceeCHhH
Confidence 999999975432100 001124578999999999
Q ss_pred hcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC
Q 010116 307 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG 384 (518)
Q Consensus 307 l~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~ 384 (518)
+.+..|+.++|||||||++|+|++ |.+||.+.+.......+.... .... ...+++.+.+||.+||. ||.+|+
T Consensus 217 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~dp~~Rp--- 290 (327)
T 2yfx_A 217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDP--PKNCPGPVYRIMTQCWQHQPEDRP--- 290 (327)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSC---
T ss_pred hcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCC--CCCCCHHHHHHHHHHhcCChhhCc---
Confidence 999999999999999999999998 999999888877776666532 2223 34689999999999998 999999
Q ss_pred ChhhhhcCccccc
Q 010116 385 GAHQIKAHPWFKD 397 (518)
Q Consensus 385 ~a~eil~Hpff~~ 397 (518)
++.+|++|.|+-.
T Consensus 291 s~~~ll~~l~~~~ 303 (327)
T 2yfx_A 291 NFAIILERIEYCT 303 (327)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHh
Confidence 8999999988753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=367.97 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=215.2
Q ss_pred cCCcCCCCeeEEe-eEeecCceEEEEEEE--ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 80 RHKICVDDFELLT-IIGRGAFGEVRLCRE--KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 80 ~~~~~~~~f~i~~-~LG~G~fG~V~l~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
...+..++|++.+ .||+|+||.||+|.. ..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 4456678899998 999999999999954 5667899999997653 2333467789999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
..+.+|+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 55678999999999999999988888999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
...... ........||+.|+|||++.+..++.++
T Consensus 168 ~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 201 (291)
T 1xbb_A 168 RADENY----------------------------------------------YKAQTHGKWPVKWYAPECINYYKFSSKS 201 (291)
T ss_dssp CTTCSE----------------------------------------------EEC----CCCGGGCCHHHHHHCEEEHHH
T ss_pred ccCCCc----------------------------------------------ccccccCCCCceeeChHHhccCCCChhh
Confidence 422100 0011234578999999999999999999
Q ss_pred cccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 317 DWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 317 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||||++|+|++ |..||.+.+.......+... ....+| ..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 202 Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 272 (291)
T 1xbb_A 202 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVEL 272 (291)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999999999999 99999998887776666553 233333 4789999999999998 999999 8888875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=368.85 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=209.8
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEE----EecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
..+....|++++.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 34455679999999999999999998 56789999999997653 3345677899999999999999999999998
Q ss_pred cC--CeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 157 DT--EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 157 ~~--~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
+. ..+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 77 679999999999999999954 467999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
......... ........||+.|+|||++.+..++
T Consensus 174 ~~~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~ 207 (302)
T 4e5w_A 174 KAIETDKEY----------------------------------------------YTVKDDRDSPVFWYAPECLMQSKFY 207 (302)
T ss_dssp EECCTTCCE----------------------------------------------EECCCCTTCCGGGCCHHHHHHCEEE
T ss_pred ccccCCCcc----------------------------------------------eeccCCCCCCccccCCeeecCCCCC
Confidence 876432100 0112245789999999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCC--------------ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-ccc
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYAD--------------DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVE 378 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~--------------~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~ 378 (518)
.++|||||||++|+|++|..|+... .........+. .....+.+..+|+++.+||.+||. ||.
T Consensus 208 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~ 285 (302)
T 4e5w_A 208 IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK--EGKRLPCPPNCPDEVYQLMRKCWEFQPS 285 (302)
T ss_dssp HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh--ccCCCCCCCCCCHHHHHHHHHHcCCCCC
Confidence 9999999999999999999986422 11111222222 223334445789999999999998 999
Q ss_pred ccCCCCChhhhhc
Q 010116 379 HRLGTGGAHQIKA 391 (518)
Q Consensus 379 ~R~g~~~a~eil~ 391 (518)
+|+ ++.++++
T Consensus 286 ~Rp---s~~~ll~ 295 (302)
T 4e5w_A 286 NRT---SFQNLIE 295 (302)
T ss_dssp GSC---CHHHHHH
T ss_pred CCC---CHHHHHH
Confidence 999 8988875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=363.21 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=215.3
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.+.+..++|++++.||+|+||.||+|+.. ++..||+|++..... ..+.+.+|+.+|+.++||||+++++++.+ +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 46677889999999999999999999865 567899999976432 34678899999999999999999999875 4
Q ss_pred eEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 5899999999999999996543 79999999999999999999999999999999999999999999999999998654
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.... .......||+.|+|||++.+..++.++|
T Consensus 161 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 192 (279)
T 1qpc_A 161 DNEY------------------------------------------------TAREGAKFPIKWTAPEAINYGTFTIKSD 192 (279)
T ss_dssp SSCE------------------------------------------------ECCTTCCCCTTTSCHHHHHHCEECHHHH
T ss_pred Cccc------------------------------------------------ccccCCCCccCccChhhhccCCCCchhh
Confidence 2210 0112346789999999999899999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||||++|||++ |.+||.+.+.......+... ...+....+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 193 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 262 (279)
T 1qpc_A 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEELYQLMRLCWKERPEDRP---TFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc---cCCCCcccccHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 9999999999999 99999998887777766542 2223335789999999999998 999999 8888875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=379.08 Aligned_cols=254 Identities=21% Similarity=0.238 Sum_probs=201.2
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE- 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~- 159 (518)
..+..++|++++.||+|+||+||+|++. ++.||||++.... ........|+.+|+.++|||||++++++.+..
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 3456789999999999999999999764 8999999997543 22344556888899999999999999998743
Q ss_pred ---eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CeEEcCCCCCceeeCCCCcEE
Q 010116 160 ---YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH----------NYIHRDIKPDNLLLDKNGHMK 226 (518)
Q Consensus 160 ---~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~----------giiHRDIKPeNILld~~g~vK 226 (518)
.+|+|||||+||+|.+++.. ..+++..+..++.|++.||.|||+. |||||||||+|||++.+|++|
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 48999999999999999965 5699999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhh
Q 010116 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (518)
Q Consensus 227 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 306 (518)
|+|||+|+.+..... .......+||+.|+|||+
T Consensus 172 L~DFg~a~~~~~~~~-----------------------------------------------~~~~~~~~gt~~y~aPE~ 204 (322)
T 3soc_A 172 IADFGLALKFEAGKS-----------------------------------------------AGDTHGQVGTRRYMAPEV 204 (322)
T ss_dssp ECCCTTCEEECTTSC-----------------------------------------------CCCCTTCCCCGGGCCHHH
T ss_pred EccCCcccccccccC-----------------------------------------------ccccccCccCccccCHhh
Confidence 999999986542210 001224689999999999
Q ss_pred hcC-----CCCCccccccchhHHHHHHHhCCCCCCCCCh----------------hhHHHHHhhhcCcccCCC---CCCC
Q 010116 307 LLK-----KGYGMECDWWSLGAIMYEMLVGYPPFYADDP----------------ITTCRKIVHWRNHLKFPD---DSKL 362 (518)
Q Consensus 307 l~~-----~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----------------~~~~~~i~~~~~~l~~p~---~~~~ 362 (518)
+.+ ..++.++|||||||++|||++|.+||.+... ......+........++. ....
T Consensus 205 ~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (322)
T 3soc_A 205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284 (322)
T ss_dssp HTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHH
T ss_pred cccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccch
Confidence 987 4567889999999999999999999976432 111222222111111111 0112
Q ss_pred ChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 363 SPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 363 s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
++++.+||.+||. ||.+|+ ++.+|++
T Consensus 285 ~~~l~~li~~cl~~dP~~Rp---s~~ell~ 311 (322)
T 3soc_A 285 MAMLCETIEECWDHDAEARL---SAGCVGE 311 (322)
T ss_dssp HHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 3459999999998 999999 8999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=368.65 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=209.7
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEec-CCc--EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKK-SGN--IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~-t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
.+..++|++++.||+|+||.||+|++.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3456789999999999999999998654 333 6999999876544555677899999999999999999999999876
Q ss_pred CeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
. +|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 88999999999999999764 679999999999999999999999999999999999999999999999999998754
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
..... ........||+.|+|||++.+..++.++|
T Consensus 173 ~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 206 (291)
T 1u46_A 173 QNDDH----------------------------------------------YVMQEHRKVPFAWCAPESLKTRTFSHASD 206 (291)
T ss_dssp C-CCE----------------------------------------------EEC-----CCGGGCCHHHHHHCEEEHHHH
T ss_pred ccccc----------------------------------------------hhhhccCCCCceeeCchhhcCCCCCchhh
Confidence 22100 00112456889999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||||++|+|++ |.+||.+.+.......+.... ..++....+++++.+||.+||. ||.+|+ ++.++++
T Consensus 207 i~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 277 (291)
T 1u46_A 207 TWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG--ERLPRPEDCPQDIYNVMVQCWAHKPEDRP---TFVALRD 277 (291)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC--CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC--CCCCCCcCcCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 9999999999999 999999998888887776633 3344445789999999999998 999999 8999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=373.85 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=214.1
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCC----cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSG----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
..+..++|++.+.||+|+||.||+|+.+.++ ..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4567789999999999999999999987653 359999997542 2334567889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
+...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999999764 6799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
....... ........||+.|+|||++.+..|+.+
T Consensus 197 ~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 230 (333)
T 1mqb_A 197 LEDDPEA----------------------------------------------TYTTSGGKIPIRWTAPEAISYRKFTSA 230 (333)
T ss_dssp ------------------------------------------------------------CCCGGGSCHHHHHSCCCCHH
T ss_pred hcccccc----------------------------------------------ccccCCCCccccccCchhcccCCCCch
Confidence 5321000 001113457889999999999999999
Q ss_pred ccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 316 CDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 316 ~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+|||||||++|||++ |..||.+.+.......+... ...+....+++++.+||.+||. ||.+|+ ++.+|+++
T Consensus 231 ~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 303 (333)
T 1mqb_A 231 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSAIYQLMMQCWQQERARRP---KFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCBHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred hhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC---CcCCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999999999999 99999988887777776653 2334445789999999999998 999999 89998874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=365.35 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=209.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEE-EEeecCCeEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY-YSFQDTEYLYL 163 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~-~~f~~~~~lyl 163 (518)
.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|..+++.+.|++++..+ .++.+....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 47899999999999999999999999999999987654322 2367899999999887655554 45578889999
Q ss_pred EEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee---CCCCcEEEeecccccccCCC
Q 010116 164 IMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl---d~~g~vKL~DFGla~~~~~~ 239 (518)
||||+ ||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999974 4689999999999999999999999999999999999999 78999999999999876432
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
...... ........+||+.|+|||++.+..|+.++|||
T Consensus 162 ~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 199 (296)
T 4hgt_A 162 RTHQHI------------------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLE 199 (296)
T ss_dssp TTCCBC------------------------------------------CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHH
T ss_pred ccCccC------------------------------------------CCCcccccCCCccccchHHhcCCCCCchhHHH
Confidence 110000 00112356899999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChh---hHHHHHhhhcCcccCCC---CCCCChhHHHHHHHHhc-cccccCCCCChhhhhc-
Q 010116 320 SLGAIMYEMLVGYPPFYADDPI---TTCRKIVHWRNHLKFPD---DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA- 391 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~---~~~~~i~~~~~~l~~p~---~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~- 391 (518)
||||++|+|++|.+||.+.+.. .....+... ....|. ...+|+++.+||.+||. ||.+|| ++.+|++
T Consensus 200 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~l~~~ 274 (296)
T 4hgt_A 200 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP---DYSYLRQL 274 (296)
T ss_dssp HHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH--HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC---CHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc--cccchhhhhhccCCHHHHHHHHHHHhcCCCCCC---CHHHHHHH
Confidence 9999999999999999875432 333333331 122221 13678999999999998 999999 7888775
Q ss_pred ---------CcccccCCcccc
Q 010116 392 ---------HPWFKDVVWDKL 403 (518)
Q Consensus 392 ---------Hpff~~i~w~~l 403 (518)
.+|-..++|+.+
T Consensus 275 l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 275 FRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HHHHHHHHTCCTTCCCGGGGC
T ss_pred HHHHHHHhCCCccCccchhhc
Confidence 355555677665
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=384.83 Aligned_cols=262 Identities=18% Similarity=0.202 Sum_probs=202.3
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecC-----CcEEEEEEeechhhhchh--------hHHHHHHHHHHHHHhCCCcee
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRG--------QVEHVRAERNLLAEVASHCIV 149 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~--------~~~~~~~E~~il~~l~hp~Iv 149 (518)
+..++|++++.||+|+||.||+|++..+ ++.||||++......... ....+..|...+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456999999999999999999998765 588999998765311111 112233455566777899999
Q ss_pred EEEEEeecC----CeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC--CC
Q 010116 150 KLYYSFQDT----EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--KN 222 (518)
Q Consensus 150 ~l~~~f~~~----~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld--~~ 222 (518)
++++++.+. .++||||||| ||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 5689999999 99999999775 6899999999999999999999999999999999999999 88
Q ss_pred CcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCcc
Q 010116 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (518)
Q Consensus 223 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 302 (518)
+++||+|||+|+.+........ . ........+||+.|+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~--------------~----------------------------~~~~~~~~~gt~~y~ 228 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKA--------------Y----------------------------AADPKRCHDGTIEFT 228 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCC--------------S----------------------------SCCSSCCCCCCTTTC
T ss_pred CeEEEEECCcceecccCCcccc--------------c----------------------------ccCcccccCCCCCcc
Confidence 9999999999987642210000 0 001123567999999
Q ss_pred ChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhh--hcCcc------cCCCCCCCChhHHHHHHHHh
Q 010116 303 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH--WRNHL------KFPDDSKLSPEAKDLICRLL 374 (518)
Q Consensus 303 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~l------~~p~~~~~s~~~~dLI~~lL 374 (518)
|||++.+..|+.++|||||||++|||++|..||.+............ ....+ .++ ...+++++.+||.+||
T Consensus 229 aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl 307 (364)
T 3op5_A 229 SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVK 307 (364)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHH
T ss_pred CHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHh
Confidence 99999999999999999999999999999999986433222221111 10000 111 1467999999999999
Q ss_pred c-cccccCCCCChhhhhc
Q 010116 375 C-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~ 391 (518)
. ||.+|| ++.+|++
T Consensus 308 ~~~p~~RP---~~~~l~~ 322 (364)
T 3op5_A 308 LLDYTEKP---LYENLRD 322 (364)
T ss_dssp TCCTTCCC---CHHHHHH
T ss_pred cCCCCCCC---CHHHHHH
Confidence 8 999999 7888775
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=374.14 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=212.7
Q ss_pred cCCCCeeEEeeEeecCceEEEEEE----EecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee--
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-- 156 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-- 156 (518)
+..++|++++.||+|+||.||+|+ +..+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 456799999999999999999998 46789999999997652 344567899999999999999999999886
Q ss_pred cCCeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
+...+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 56779999999999999999976 45799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
....... ........||+.|+|||++.+..|+.+
T Consensus 177 ~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 210 (327)
T 3lxl_A 177 LPLDKDY----------------------------------------------YVVREPGQSPIFWYAPESLSDNIFSRQ 210 (327)
T ss_dssp CCTTCSE----------------------------------------------EECSSCCCSCGGGSCHHHHHHCEEEHH
T ss_pred cccCCcc----------------------------------------------ceeeccCCccccccCHHHhccCCCChH
Confidence 5422110 001124568999999999999999999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChh--------------hHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-ccccc
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPI--------------TTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~--------------~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R 380 (518)
+|||||||++|+|++|..||...... ......+. .....+....+++++.+||.+||. ||.+|
T Consensus 211 ~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 288 (327)
T 3lxl_A 211 SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE--EGQRLPAPPACPAEVHELMKLCWAPSPQDR 288 (327)
T ss_dssp HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh--cccCCCCCCcccHHHHHHHHHHcCCChhhC
Confidence 99999999999999999999654332 11112222 223334445789999999999998 99999
Q ss_pred CCCCChhhhhcC
Q 010116 381 LGTGGAHQIKAH 392 (518)
Q Consensus 381 ~g~~~a~eil~H 392 (518)
+ ++.+|++|
T Consensus 289 p---s~~ell~~ 297 (327)
T 3lxl_A 289 P---SFSALGPQ 297 (327)
T ss_dssp C---CHHHHHHH
T ss_pred c---CHHHHHHH
Confidence 9 89998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=387.22 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=195.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylV 164 (518)
+.|.+.++||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|..+ +|||||++++++.+...+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 44556789999999999875 56789999999986542 34567899999887 899999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC-------------Cc
Q 010116 165 MEYLPGGDMMTLLMREDTLT-------ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-------------GH 224 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~-------e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~-------------g~ 224 (518)
||||. |+|.+++....... +..+..++.||+.||.|||++|||||||||+|||++.+ ++
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 69999997654332 33456799999999999999999999999999999754 48
Q ss_pred EEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccCh
Q 010116 225 MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304 (518)
Q Consensus 225 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 304 (518)
+||+|||+|+........ ......+.+||+.|+||
T Consensus 167 ~kL~DFG~a~~~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aP 201 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSS---------------------------------------------FRTNLNNPSGTSGWRAP 201 (434)
T ss_dssp EEECCCTTCEECCC-----------------------------------------------------------CCTTSCH
T ss_pred EEEcccccceecCCCCcc---------------------------------------------ceeeecCCCCCCCccCH
Confidence 999999999876422100 00012256899999999
Q ss_pred hhhcC-------CCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCC-----CCCCChhHHHHHH
Q 010116 305 EVLLK-------KGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPD-----DSKLSPEAKDLIC 371 (518)
Q Consensus 305 Evl~~-------~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~-----~~~~s~~~~dLI~ 371 (518)
|++.+ ..++.++|||||||++|||++ |.+||....... ..++... ..++. ...+++++++||.
T Consensus 202 E~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~--~~~~~~~~~~~~~~~~~~~~li~ 277 (434)
T 2rio_A 202 ELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGI--FSLDEMKCLHDRSLIAEATDLIS 277 (434)
T ss_dssp HHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTC--CCCCCCTTCCCHHHHHHHHHHHH
T ss_pred HHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCC--CCcccccccccccchHHHHHHHH
Confidence 99976 678999999999999999999 999997655433 3344322 22221 1234688999999
Q ss_pred HHhc-cccccCCCCChhhhhcCccccc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+||. ||.+|+ ++.+|++||||.+
T Consensus 278 ~~L~~dP~~Rp---s~~eil~hp~f~~ 301 (434)
T 2rio_A 278 QMIDHDPLKRP---TAMKVLRHPLFWP 301 (434)
T ss_dssp HHTCSSGGGSC---CHHHHHTSGGGSC
T ss_pred HHhhCChhhCC---CHHHHHhCCccCC
Confidence 9998 999999 8999999999964
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=370.09 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=211.1
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEec---CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEE
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 154 (518)
+....+..++|.+.+.||+|+||.||+|+... ++..||+|++..... .....+.+.+|+.+++.++||||++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 44556677899999999999999999998875 556899999875432 33446778899999999999999999999
Q ss_pred eecCC-----eEEEEEeecCCCchHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC
Q 010116 155 FQDTE-----YLYLIMEYLPGGDMMTLLM------REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (518)
Q Consensus 155 f~~~~-----~lylVmEy~~gG~L~~~l~------~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g 223 (518)
+.+.. .+|+||||+++|+|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.+|
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 98765 4599999999999999984 335799999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccC
Q 010116 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (518)
Q Consensus 224 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 303 (518)
++||+|||+++........ .......||+.|+|
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~a 217 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYY-----------------------------------------------RQGRIAKMPVKWIA 217 (313)
T ss_dssp CEEECSCSCC---------------------------------------------------------------CCGGGSC
T ss_pred cEEEeecCcceeccccccc-----------------------------------------------CcccccCCCccccC
Confidence 9999999999865321100 00113457899999
Q ss_pred hhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccC
Q 010116 304 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381 (518)
Q Consensus 304 PEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 381 (518)
||++.+..|+.++|||||||++|+|++ |.+||.+.+.......+.... ...+| ..+++++.+||.+||. ||.+|+
T Consensus 218 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp 294 (313)
T 3brb_A 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQP--EDCLDELYEIMYSCWRTDPLDRP 294 (313)
T ss_dssp HHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCB--TTCCHHHHHHHHHTTCSSGGGSC
T ss_pred chhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCC--ccccHHHHHHHHHHcCCChhhCc
Confidence 999999999999999999999999999 999999988888777776532 23333 4689999999999998 999999
Q ss_pred CCCChhhhhcC
Q 010116 382 GTGGAHQIKAH 392 (518)
Q Consensus 382 g~~~a~eil~H 392 (518)
++.+|+.|
T Consensus 295 ---s~~~l~~~ 302 (313)
T 3brb_A 295 ---TFSVLRLQ 302 (313)
T ss_dssp ---CHHHHHHH
T ss_pred ---CHHHHHHH
Confidence 89999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=363.20 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=209.8
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE-E
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL-Y 162 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l-y 162 (518)
.|++.++||+|+||+||+|++..++. .||+|++.+. ......+.+.+|+.+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46778999999999999999876655 7999998653 2344567789999999999999999999999877665 9
Q ss_pred EEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 163 LIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
+||||+.||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 46789999999999999999999999999999999999999999999999999986542211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.. ........||+.|+|||++.+..|+.++|||||
T Consensus 180 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 214 (298)
T 3pls_A 180 YS---------------------------------------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSF 214 (298)
T ss_dssp GC---------------------------------------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHH
T ss_pred cc---------------------------------------------cccCcCCCCCccccChhhhccCCCChhhchhhH
Confidence 00 001224578999999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 322 GAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 322 Gvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||++|+|++ |.+||...+.......+... ...+....+++++.+||.+||. ||.+|+ ++.++++
T Consensus 215 G~il~~l~~g~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~ 280 (298)
T 3pls_A 215 GVLLWELLTRGAPPYRHIDPFDLTHFLAQG---RRLPQPEYCPDSLYQVMQQCWEADPAVRP---TFRVLVG 280 (298)
T ss_dssp HHHHHHHHHTSCCTTTTSCGGGHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHhhCCCCCCccCCHHHHHHHhhcC---CCCCCCccchHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999999999 55566666666666555542 2333345789999999999998 999999 8998886
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=388.04 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=209.7
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC--
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-- 159 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-- 159 (518)
....++|++.++||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++|||||++++++.+..
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 3456789999999999999999999999999999999986543 233566789999999999999999999998765
Q ss_pred eEEEEEeecCCCchHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee----CCCCcEEEeeccc
Q 010116 160 YLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGL 232 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~---~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl----d~~g~vKL~DFGl 232 (518)
.+|+|||||+||+|.+++.... .+++..++.++.|++.||.|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 7899999999999999997643 39999999999999999999999999999999999999 7888899999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--- 309 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--- 309 (518)
|+...... ...+.+||+.|+|||++.+
T Consensus 163 a~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~ 192 (396)
T 4eut_A 163 ARELEDDE--------------------------------------------------QFVSLYGTEEYLHPDMYERAVL 192 (396)
T ss_dssp CEECCCGG--------------------------------------------------GSSCSSSCCTTCCHHHHHHHCC
T ss_pred ceEccCCC--------------------------------------------------ccccccCCccccCHHHhhcccc
Confidence 98653210 1225679999999999875
Q ss_pred -----CCCCccccccchhHHHHHHHhCCCCCCCC----ChhhHHHHHhhhcCcc-----------------cCCCCC---
Q 010116 310 -----KGYGMECDWWSLGAIMYEMLVGYPPFYAD----DPITTCRKIVHWRNHL-----------------KFPDDS--- 360 (518)
Q Consensus 310 -----~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~i~~~~~~l-----------------~~p~~~--- 360 (518)
..|+.++|||||||++|||++|..||... .......+++...... .+|...
T Consensus 193 ~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 272 (396)
T 4eut_A 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272 (396)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSC
T ss_pred ccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccc
Confidence 57889999999999999999999999642 3334455555422100 112111
Q ss_pred -CCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 361 -KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 361 -~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
.+++.+.+||.+||. ||.+|+ ++.+++++
T Consensus 273 ~~~~~~l~~ll~~~L~~dP~~R~---s~~e~l~~ 303 (396)
T 4eut_A 273 RGLQVLLTPVLANILEADQEKCW---GFDQFFAE 303 (396)
T ss_dssp HHHHHHHHHHHHHHSCCCTTTSC---CHHHHHHH
T ss_pred hHHHhhchHHHHHhhccChhhhc---cHHHHHHH
Confidence 235678899999998 999999 78887653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=380.80 Aligned_cols=261 Identities=19% Similarity=0.202 Sum_probs=202.9
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEec---CCcEEEEEEeechhhh--------chhhHHHHHHHHHHHHHhCCCceeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMV--------KRGQVEHVRAERNLLAEVASHCIVKL 151 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~---t~~~~AiK~l~k~~~~--------~~~~~~~~~~E~~il~~l~hp~Iv~l 151 (518)
+..++|++++.||+|+||.||+|++.. ++..||+|++.+.... .+.....+.+|..++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345789999999999999999999987 7889999998765321 11112335678888999999999999
Q ss_pred EEEeec----CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC--cE
Q 010116 152 YYSFQD----TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG--HM 225 (518)
Q Consensus 152 ~~~f~~----~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g--~v 225 (518)
++++.+ ...+|+||||+ ||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999987 78999999999 999999998888999999999999999999999999999999999999999887 99
Q ss_pred EEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChh
Q 010116 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (518)
Q Consensus 226 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 305 (518)
||+|||+|+.+......... ........+||+.|+|||
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE 230 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQY------------------------------------------QENPRKGHNGTIEFTSLD 230 (345)
T ss_dssp EECCCTTCEESSGGGCCCCC------------------------------------------CCCGGGCSCSCTTTCCHH
T ss_pred EEEeCCCceecccccccccc------------------------------------------hhccccccCCCccccCHH
Confidence 99999999876422100000 001123568999999999
Q ss_pred hhcCCCCCccccccchhHHHHHHHhCCCCCCCC--ChhhHHHHHhhhcCcccCCC-------CCCCChhHHHHHHHHhc-
Q 010116 306 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYAD--DPITTCRKIVHWRNHLKFPD-------DSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 306 vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~l~~p~-------~~~~s~~~~dLI~~lL~- 375 (518)
++.+..|+.++|||||||++|||++|..||.+. +............ ..+|. ...+++++++||.+||.
T Consensus 231 ~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 308 (345)
T 2v62_A 231 AHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL--DELPQSVLKWAPSGSSCCEIAQFLVCAHSL 308 (345)
T ss_dssp HHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHH--HTTTHHHHHHSCTTSCCHHHHHHHHHHHTC
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhc--ccccHHHHhhccccccHHHHHHHHHHHhhc
Confidence 999999999999999999999999999999653 2222222111111 11111 12688999999999998
Q ss_pred cccccCCCCChhhhhc
Q 010116 376 DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 376 dp~~R~g~~~a~eil~ 391 (518)
||.+|+ ++.+|++
T Consensus 309 dp~~Rp---s~~~l~~ 321 (345)
T 2v62_A 309 AYDEKP---NYQALKK 321 (345)
T ss_dssp CTTCCC---CHHHHHH
T ss_pred CcccCC---CHHHHHH
Confidence 999999 8998886
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=380.49 Aligned_cols=247 Identities=18% Similarity=0.265 Sum_probs=200.4
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEE-----EEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC---CCceeEEE
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLC-----REKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVKLY 152 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~-----~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~ 152 (518)
..+..++|.+.+.||+|+||+||+| .+..+++.||||++.+.. ...+..|..++..+. |+||++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 3456688999999999999999999 467789999999987542 345677888888886 89999999
Q ss_pred EEeecCCeEEEEEeecCCCchHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC------
Q 010116 153 YSFQDTEYLYLIMEYLPGGDMMTLLMR-----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK------ 221 (518)
Q Consensus 153 ~~f~~~~~lylVmEy~~gG~L~~~l~~-----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~------ 221 (518)
+++...+..|||||||+||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999999974 467999999999999999999999999999999999999998
Q ss_pred -----CCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccccc
Q 010116 222 -----NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (518)
Q Consensus 222 -----~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 296 (518)
++++||+|||+|+.+.... ......+.+
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~-----------------------------------------------~~~~~~~~~ 246 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFP-----------------------------------------------KGTIFTAKC 246 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSC-----------------------------------------------TTEEECCSS
T ss_pred ccccccCCEEEeeCchhhhhhccC-----------------------------------------------CCceeeeec
Confidence 8999999999997543110 001233578
Q ss_pred CCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-
Q 010116 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 297 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~- 375 (518)
||+.|+|||++.+..|+.++|||||||++|||++|..||....... +.....++. ...++...+++.+||.
T Consensus 247 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~l~~ 318 (365)
T 3e7e_A 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------CKPEGLFRR-LPHLDMWNEFFHVMLNI 318 (365)
T ss_dssp CTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------EEECSCCTT-CSSHHHHHHHHHHHHCC
T ss_pred CCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------eeechhccc-cCcHHHHHHHHHHHcCC
Confidence 9999999999999999999999999999999999999996543311 111111221 1346789999999998
Q ss_pred cccccCCCCChhhhh
Q 010116 376 DVEHRLGTGGAHQIK 390 (518)
Q Consensus 376 dp~~R~g~~~a~eil 390 (518)
+|.+|+. ++.++.
T Consensus 319 ~p~~r~~--~~~~l~ 331 (365)
T 3e7e_A 319 PDCHHLP--SLDLLR 331 (365)
T ss_dssp CCTTCCC--CHHHHH
T ss_pred CCCCcch--HHHHHH
Confidence 9999974 344443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=366.53 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=200.1
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHH--hCCCceeEEEEEeec--
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE--VASHCIVKLYYSFQD-- 157 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~f~~-- 157 (518)
.+..++|++++.||+|+||+||+|++ +|+.||||++.... ......|.+++.. ++||||+++++++.+
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34568999999999999999999976 68999999986542 3445667888877 799999999988643
Q ss_pred --CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCeEEcCCCCCceeeCCCCcEEE
Q 010116 158 --TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH--------KHNYIHRDIKPDNLLLDKNGHMKL 227 (518)
Q Consensus 158 --~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH--------~~giiHRDIKPeNILld~~g~vKL 227 (518)
...+|+||||++||+|.+++. ...+++..+..++.|++.||.||| ++||+||||||+|||++.+|++||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 467999999999999999994 468999999999999999999999 999999999999999999999999
Q ss_pred eecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhh
Q 010116 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (518)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 307 (518)
+|||+|+......... .......+||+.|+|||++
T Consensus 155 ~Dfg~a~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~ 189 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQL---------------------------------------------DVGNNPRVGTKRYMAPEVL 189 (301)
T ss_dssp CCCTTCEEEETTTTEE---------------------------------------------ECCCCCCCCCGGGCCHHHH
T ss_pred eeCCCeeecccccccc---------------------------------------------cccccccccccceeChhhh
Confidence 9999997653221000 0011245899999999999
Q ss_pred cCC------CCCccccccchhHHHHHHHhC----------CCCCCCCCh----hhHHHHHhhh-cCcccCCC---CCCCC
Q 010116 308 LKK------GYGMECDWWSLGAIMYEMLVG----------YPPFYADDP----ITTCRKIVHW-RNHLKFPD---DSKLS 363 (518)
Q Consensus 308 ~~~------~y~~~~DiWSlGvilyeml~G----------~~PF~~~~~----~~~~~~i~~~-~~~l~~p~---~~~~s 363 (518)
.+. .++.++|||||||++|||++| .+||..... ......++.. .....+|. ...++
T Consensus 190 ~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (301)
T 3q4u_A 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTL 269 (301)
T ss_dssp TTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHH
T ss_pred cCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccH
Confidence 876 566899999999999999999 899965322 2223333221 11222221 01245
Q ss_pred hhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 364 PEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 364 ~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+++.+||.+||. ||.+|+ ++.+|++
T Consensus 270 ~~l~~li~~cl~~dP~~Rp---s~~~i~~ 295 (301)
T 3q4u_A 270 TSLAKLMKECWYQNPSARL---TALRIKK 295 (301)
T ss_dssp HHHHHHHHHHCCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCC---CHHHHHH
Confidence 789999999998 999999 8999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=362.68 Aligned_cols=243 Identities=26% Similarity=0.418 Sum_probs=207.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec--------
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-------- 157 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-------- 157 (518)
.+|++++.||+|+||.||+|++..+|+.||+|++.... +.+.+|+.+++.++||||++++++|.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 57999999999999999999999999999999997642 245689999999999999999998864
Q ss_pred --------CCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEE
Q 010116 158 --------TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKL 227 (518)
Q Consensus 158 --------~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL 227 (518)
...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 45689999999999999999654 68999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhh
Q 010116 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (518)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 307 (518)
+|||++....... .....+||+.|+|||++
T Consensus 164 ~Dfg~~~~~~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~ 193 (284)
T 2a19_B 164 GDFGLVTSLKNDG--------------------------------------------------KRTRSKGTLRYMSPEQI 193 (284)
T ss_dssp CCCTTCEESSCCS--------------------------------------------------CCCCCCSCCTTSCHHHH
T ss_pred Ccchhheeccccc--------------------------------------------------cccccCCcccccChhhh
Confidence 9999988653210 01245799999999999
Q ss_pred cCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCCh
Q 010116 308 LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGA 386 (518)
Q Consensus 308 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a 386 (518)
.+..++.++|||||||++|+|++|..||.... .....+.. ..++ ..+++++++||.+||. ||.+|+ ++
T Consensus 194 ~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~----~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~ 262 (284)
T 2a19_B 194 SSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD----GIIS--DIFDKKEKTLLQKLLSKKPEDRP---NT 262 (284)
T ss_dssp HCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT----TCCC--TTSCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred ccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc----cccc--ccCCHHHHHHHHHHccCChhhCc---CH
Confidence 99999999999999999999999999985321 22222222 1223 3588999999999998 999999 89
Q ss_pred hhhhcCcccc
Q 010116 387 HQIKAHPWFK 396 (518)
Q Consensus 387 ~eil~Hpff~ 396 (518)
.|+++|+|.-
T Consensus 263 ~e~l~~l~~~ 272 (284)
T 2a19_B 263 SEILRTLTVW 272 (284)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=392.07 Aligned_cols=246 Identities=17% Similarity=0.209 Sum_probs=194.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHHhC---------CCceeE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----KRGQVEHVRAERNLLAEVA---------SHCIVK 150 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l~---------hp~Iv~ 150 (518)
.++|++++.||+|+||+||+|++ +|+.||||++.+.... .....+.+.+|+.+|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46789999999999999999987 7899999999876421 2334577889999999986 666666
Q ss_pred EEEE-----------------eec-------------CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHH
Q 010116 151 LYYS-----------------FQD-------------TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200 (518)
Q Consensus 151 l~~~-----------------f~~-------------~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~ 200 (518)
+.+. |.+ ...+|||||||+||++.+.+.+ ..+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 6554 333 7899999999999988777744 67899999999999999999
Q ss_pred HHH-hCCeEEcCCCCCceeeCCCC--------------------cEEEeecccccccCCCccccccccccccccccCCCC
Q 010116 201 SIH-KHNYIHRDIKPDNLLLDKNG--------------------HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259 (518)
Q Consensus 201 ~LH-~~giiHRDIKPeNILld~~g--------------------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (518)
||| ++|||||||||+||||+.+| ++||+|||+|+....
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------------------- 234 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------------------- 234 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---------------------
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---------------------
Confidence 999 99999999999999999988 999999999986431
Q ss_pred CCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH-HHHHHhCCCCCCCC
Q 010116 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI-MYEMLVGYPPFYAD 338 (518)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi-lyeml~G~~PF~~~ 338 (518)
...+||+.|+|||++.+.. +.++||||||++ .++++.|..||.+.
T Consensus 235 ---------------------------------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~ 280 (336)
T 2vuw_A 235 ---------------------------------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV 280 (336)
T ss_dssp ---------------------------------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH
T ss_pred ---------------------------------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch
Confidence 1358999999999998776 899999998777 88899999999542
Q ss_pred Ch-hhHHHHHhhhcC---cccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh-cCcccc
Q 010116 339 DP-ITTCRKIVHWRN---HLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK-AHPWFK 396 (518)
Q Consensus 339 ~~-~~~~~~i~~~~~---~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil-~Hpff~ 396 (518)
.. ......+..... ....+....+|+++++||.+||+ | +|.|++ +||||+
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--------sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 281 LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--------SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--------SHHHHHHHCGGGC
T ss_pred hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--------CHHHHHhcCCCcC
Confidence 11 112223332111 10111112478999999999997 5 699999 999995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=375.84 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=211.2
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
......++|++.+.||+|+||.||+|++ .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 3445678999999999999999999985 468999999886542 344677899999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 160 YLYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~----~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999996543 589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
...... .......+||+.|+|||++.+..|+.+
T Consensus 189 ~~~~~~-----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 221 (321)
T 2qkw_B 189 GTELDQ-----------------------------------------------THLSTVVKGTLGYIDPEYFIKGRLTEK 221 (321)
T ss_dssp CSSSSC-----------------------------------------------CCCBCCCEEETTTCCHHHHHHCBCCTH
T ss_pred cccccc-----------------------------------------------cccccccCCCccccCHHHhcCCCCCcc
Confidence 432100 001224579999999999999999999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHh-----hhcCcc------cCC--CCCCCChhHHHHHHHHhc-cccccC
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIV-----HWRNHL------KFP--DDSKLSPEAKDLICRLLC-DVEHRL 381 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-----~~~~~l------~~p--~~~~~s~~~~dLI~~lL~-dp~~R~ 381 (518)
+|||||||++|||++|+.||.+..+......+. .....+ ..+ ....++.++.+||.+||. ||.+||
T Consensus 222 ~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 301 (321)
T 2qkw_B 222 SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301 (321)
T ss_dssp HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCc
Confidence 999999999999999999998765433221110 000000 000 011245678999999998 999999
Q ss_pred CCCChhhhhcCc
Q 010116 382 GTGGAHQIKAHP 393 (518)
Q Consensus 382 g~~~a~eil~Hp 393 (518)
++.++++|.
T Consensus 302 ---s~~ell~~L 310 (321)
T 2qkw_B 302 ---SMGDVLWKL 310 (321)
T ss_dssp ---CHHHHHHHH
T ss_pred ---CHHHHHHHH
Confidence 899999763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=363.48 Aligned_cols=259 Identities=20% Similarity=0.281 Sum_probs=202.0
Q ss_pred hhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 78 ~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
....++..++|++.+.||+|+||.||+|+.. ..||+|+++... ......+.+.+|+.+|+.++||||+++++++ .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 3457788899999999999999999999754 359999987543 2344567789999999999999999999854 5
Q ss_pred CCeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
...+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 6678999999999999999954 467999999999999999999999999999999999999999999999999998754
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc---CCCCC
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYG 313 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~ 313 (518)
..... .......+||+.|+|||++. +..|+
T Consensus 171 ~~~~~-----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (289)
T 3og7_A 171 SRWSG-----------------------------------------------SHQFEQLSGSILWMAPEVIRMQDSNPYS 203 (289)
T ss_dssp ------------------------------------------------------------CCCTTCCHHHHC----CCSC
T ss_pred ccccc-----------------------------------------------cccccccCCCccccCchhhcccCCCCCC
Confidence 31100 00112467999999999997 56789
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC-cccCCC-CCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN-HLKFPD-DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~l~~p~-~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
.++|||||||++|+|++|..||.+.........++.... ...++. ...+++++.+||.+||. ||.+|+ ++.+|+
T Consensus 204 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell 280 (289)
T 3og7_A 204 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP---SFPRIL 280 (289)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCC---CHHHHH
Confidence 999999999999999999999988666555555443221 111111 23678999999999998 999999 899987
Q ss_pred c
Q 010116 391 A 391 (518)
Q Consensus 391 ~ 391 (518)
+
T Consensus 281 ~ 281 (289)
T 3og7_A 281 A 281 (289)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=363.14 Aligned_cols=254 Identities=19% Similarity=0.294 Sum_probs=209.7
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEE-eecCCe
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS-FQDTEY 160 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-f~~~~~ 160 (518)
..+|++.+.||+|+||.||+|++..+ +..||+|++.+.. .....+.+.+|..+++.++||||++++++ +.++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 35799999999999999999987543 3468999987532 34456778899999999999999999998 456678
Q ss_pred EEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999999763 56899999999999999999999999999999999999999999999999999865422
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
.... ........||+.|+|||++.+..++.++|||
T Consensus 182 ~~~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 216 (298)
T 3f66_A 182 EYYS---------------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVW 216 (298)
T ss_dssp GGCB---------------------------------------------C-----CCBCGGGSCHHHHHHCCCCHHHHHH
T ss_pred chhc---------------------------------------------cccccCCCCCccccChHHhcCCCCChHHHHH
Confidence 1100 0012245789999999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|+|++ |.+||.+.+.......+.... .... +..+++++.+||.+||. ||.+|+ ++.++++
T Consensus 217 slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~ 284 (298)
T 3f66_A 217 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQ--PEYCPDPLYEVMLKCWHPKAEMRP---SFSELVS 284 (298)
T ss_dssp HHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-CCCC--CccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999999999 777888777777766666532 2222 34689999999999998 999999 8998886
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=361.83 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=206.3
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-C
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-T 158 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-~ 158 (518)
.+.+..++|++++.||+|+||.||+|++ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+ .
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4567788999999999999999999976 48899999987542 35678899999999999999999998654 4
Q ss_pred CeEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 57999999999999999997654 3899999999999999999999999999999999999999999999999998754
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
... .....||+.|+|||++.+..++.++
T Consensus 168 ~~~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~ 195 (278)
T 1byg_A 168 SST----------------------------------------------------QDTGKLPVKWTAPEALREKKFSTKS 195 (278)
T ss_dssp ------------------------------------------------------------CCTTTSCHHHHHHCCCCHHH
T ss_pred ccc----------------------------------------------------ccCCCccccccCHHHhCCCCCCchh
Confidence 211 0134688999999999999999999
Q ss_pred cccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 317 DWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 317 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||||++|+|++ |.+||...+.......+... ...+....+++++.+||.+||. ||.+|+ ++.++++
T Consensus 196 Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 266 (278)
T 1byg_A 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVYEVMKNCWHLDAAMRP---SFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---CCCCCcccCCHHHHHHHHHHhcCChhhCC---CHHHHHH
Confidence 99999999999998 99999988877777666542 2233335789999999999998 999999 8888875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=371.59 Aligned_cols=262 Identities=22% Similarity=0.348 Sum_probs=209.6
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee----c
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ----D 157 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~----~ 157 (518)
.+..++|++++.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 34567899999999999999999999999999999998654 2345567889999999999999999999987 4
Q ss_pred CCeEEEEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
...+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 4589999999999999999875 467999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC--
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-- 311 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-- 311 (518)
......... ..... .........||+.|+|||++.+..
T Consensus 182 ~~~~~~~~~----------------------------------~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~ 221 (317)
T 2buj_A 182 NQACIHVEG----------------------------------SRQAL------TLQDWAAQRCTISYRAPELFSVQSHC 221 (317)
T ss_dssp EESCEEEES----------------------------------HHHHH------HHHHHHHHHSCGGGCCGGGSSCCSEE
T ss_pred hhccccccc----------------------------------ccccc------cccccccccCCcccCCHhHhccCCCc
Confidence 764311000 00000 000112457899999999998654
Q ss_pred -CCccccccchhHHHHHHHhCCCCCCCCC--hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 312 -YGMECDWWSLGAIMYEMLVGYPPFYADD--PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 312 -y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
++.++|||||||++|+|++|..||.... .......+ . ....+|....+++++.+||.+||. ||.+|+ ++.
T Consensus 222 ~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ 295 (317)
T 2buj_A 222 VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-Q--NQLSIPQSPRHSSALWQLLNSMMTVDPHQRP---HIP 295 (317)
T ss_dssp EECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-H--CC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-h--ccCCCCccccCCHHHHHHHHHHhhcChhhCC---CHH
Confidence 7899999999999999999999995421 11112222 2 244556556789999999999998 999999 899
Q ss_pred hhhcC
Q 010116 388 QIKAH 392 (518)
Q Consensus 388 eil~H 392 (518)
++++|
T Consensus 296 ~ll~~ 300 (317)
T 2buj_A 296 LLLSQ 300 (317)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=387.15 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=212.3
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.+.+..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.+ +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 456777899999999999999999998865 46799999976532 24568899999999999999999999876 6
Q ss_pred eEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+|+|||||+||+|.+++... ..+++..+..++.|++.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 789999999999999999653 569999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.... .......||+.|+|||++.+..|+.++|
T Consensus 332 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sD 363 (452)
T 1fmk_A 332 DNEY------------------------------------------------TARQGAKFPIKWTAPEAALYGRFTIKSD 363 (452)
T ss_dssp -----------------------------------------------------------CCGGGSCHHHHHHCCCCHHHH
T ss_pred CCce------------------------------------------------ecccCCcccccccCHhHHhcCCCCcccc
Confidence 2100 0011345788999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||||++|||++ |.+||.+.+..+....+... ...+.+..+++++.+||.+||. ||.+|| ++.+|+.
T Consensus 364 vwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~~l~~ 433 (452)
T 1fmk_A 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 433 (452)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 9999999999999 99999998888877777542 2334445789999999999998 999999 8998886
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=359.69 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=205.9
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeE-EEEEeecCCeEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK-LYYSFQDTEYLYL 163 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~-l~~~f~~~~~lyl 163 (518)
.++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|..+++.+.|++++. +..++.+...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4789999999999999999999999999999999876432 234788999999999887554 4455577888999
Q ss_pred EEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee---CCCCcEEEeecccccccCCC
Q 010116 164 IMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl---d~~g~vKL~DFGla~~~~~~ 239 (518)
||||+ ||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 9999999974 4689999999999999999999999999999999999999 48899999999999876432
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 319 (518)
...... ........+||+.|+|||++.+..++.++|||
T Consensus 162 ~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 199 (296)
T 3uzp_A 162 RTHQHI------------------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLE 199 (296)
T ss_dssp TTCCBC------------------------------------------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHH
T ss_pred cccccc------------------------------------------ccccccccccccccCChhhhcCCCCCcchhhH
Confidence 110000 00012356899999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCC---hhhHHHHHhhhcCcccCCC---CCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 320 SLGAIMYEMLVGYPPFYADD---PITTCRKIVHWRNHLKFPD---DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~l~~p~---~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||||++|||++|..||.+.+ ....+..+... ....|. ...+|+++.+||.+||. ||.+|+ ++.+|++
T Consensus 200 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 273 (296)
T 3uzp_A 200 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP---DYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH--HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC---CHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc--ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCC---CHHHHHH
Confidence 99999999999999998743 23344444432 122221 13689999999999998 999999 7888775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=373.02 Aligned_cols=264 Identities=21% Similarity=0.276 Sum_probs=208.5
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
....+..++|++.+.||+|+||.||+|+. .+|+.||||++....... ....+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 34456678999999999999999999974 468999999997654222 223578899999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEcCCCCCceeeCCCCcEEEeecc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAIESIHKH---NYIHRDIKPDNLLLDKNGHMKLSDFG 231 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~----~l~e~~~~~~~~ql~~aL~~LH~~---giiHRDIKPeNILld~~g~vKL~DFG 231 (518)
...|+||||++||+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.+|++||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999997643 499999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~ 311 (518)
+|+....... ......+||+.|+|||++.+..
T Consensus 180 ~~~~~~~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~ 211 (326)
T 3uim_A 180 LAKLMDYKDT------------------------------------------------HVTTAVRGTIGHIAPEYLSTGK 211 (326)
T ss_dssp SCEECCSSSS------------------------------------------------CEECCCCSCGGGCCHHHHHHSE
T ss_pred cccccCcccc------------------------------------------------cccccccCCcCccCHHHhccCC
Confidence 9986542210 1122457999999999999999
Q ss_pred CCccccccchhHHHHHHHhCCCCCCC-----CChhhHHHHHhhhcCcccC----------CCCCCCChhHHHHHHHHhc-
Q 010116 312 YGMECDWWSLGAIMYEMLVGYPPFYA-----DDPITTCRKIVHWRNHLKF----------PDDSKLSPEAKDLICRLLC- 375 (518)
Q Consensus 312 y~~~~DiWSlGvilyeml~G~~PF~~-----~~~~~~~~~i~~~~~~l~~----------p~~~~~s~~~~dLI~~lL~- 375 (518)
++.++|||||||++|+|++|.+||.. .........+......... ......++++.+||.+||.
T Consensus 212 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 291 (326)
T 3uim_A 212 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 291 (326)
T ss_dssp ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCS
T ss_pred CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCc
Confidence 99999999999999999999999952 1111111111110000000 0011224679999999998
Q ss_pred cccccCCCCChhhhhcCcccc
Q 010116 376 DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 376 dp~~R~g~~~a~eil~Hpff~ 396 (518)
||.+|| ++.+|++|-.-.
T Consensus 292 dP~~Rp---s~~ell~~L~~~ 309 (326)
T 3uim_A 292 SPMERP---KMSEVVRMLEGD 309 (326)
T ss_dssp CGGGSC---CHHHHHHHHHTS
T ss_pred CCccCC---CHHHHHHHhcCc
Confidence 999999 899999986543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=361.45 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=199.1
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.+..++|++.+.||+|+||.||+|+. +++.||+|++... ...+.+.+|+.+|+.++||||+++++++.+. +
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 74 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLNP--V 74 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--T
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--c
Confidence 35567899999999999999999976 4789999998643 2456788999999999999999999998754 7
Q ss_pred EEEEeecCCCchHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEEcCCCCCceeeCCCCc-EEEeeccccc
Q 010116 162 YLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHK---HNYIHRDIKPDNLLLDKNGH-MKLSDFGLCK 234 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~---~l~e~~~~~~~~ql~~aL~~LH~---~giiHRDIKPeNILld~~g~-vKL~DFGla~ 234 (518)
|+||||++||+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+|||++.+|. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 89999999999999997654 47899999999999999999999 89999999999999999887 7999999987
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCc
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 314 (518)
..... ....+||+.|+|||++.+..|+.
T Consensus 155 ~~~~~----------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~ 182 (307)
T 2eva_A 155 DIQTH----------------------------------------------------MTNNKGSAAWMAPEVFEGSNYSE 182 (307)
T ss_dssp --------------------------------------------------------------CCTTSSCHHHHTCCCCCT
T ss_pred ccccc----------------------------------------------------cccCCCCCceEChhhhCCCCCCc
Confidence 54211 11346999999999999999999
Q ss_pred cccccchhHHHHHHHhCCCCCCCCCh--hhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDP--ITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
++|||||||++|||++|..||..... ......+... ... +....+++.+.+||.+||. ||.+|+ ++.+|++
T Consensus 183 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 256 (307)
T 2eva_A 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-TRP--PLIKNLPKPIESLMTRCWSKDPSQRP---SMEEIVK 256 (307)
T ss_dssp HHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-CCC--CCBTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-CCC--CcccccCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 99999999999999999999976432 2222222221 122 2234689999999999998 999999 8999987
Q ss_pred C
Q 010116 392 H 392 (518)
Q Consensus 392 H 392 (518)
+
T Consensus 257 ~ 257 (307)
T 2eva_A 257 I 257 (307)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=364.08 Aligned_cols=232 Identities=32% Similarity=0.579 Sum_probs=191.5
Q ss_pred CCCCeeEE-eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHH-HHhCCCceeEEEEEeec----
Q 010116 84 CVDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL-AEVASHCIVKLYYSFQD---- 157 (518)
Q Consensus 84 ~~~~f~i~-~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~f~~---- 157 (518)
..++|.++ +.||+|+||.||+|+++.+++.||+|++... ....+|+.++ +..+||||++++++|.+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 35778888 7899999999999999999999999998653 2456788887 56699999999999987
Q ss_pred CCeEEEEEeecCCCchHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CCcEEEeeccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGL 232 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~--~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g~vKL~DFGl 232 (518)
...+|+||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 778999999999999999997754 6999999999999999999999999999999999999998 88999999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 312 (518)
+.... +..|
T Consensus 167 a~~~~-----------------------------------------------------------------------~~~~ 175 (299)
T 3m2w_A 167 AKETT-----------------------------------------------------------------------GEKY 175 (299)
T ss_dssp CEECT-----------------------------------------------------------------------TCGG
T ss_pred ccccc-----------------------------------------------------------------------cccC
Confidence 86431 1347
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhc--CcccCCC--CCCCChhHHHHHHHHhc-cccccCCCCChh
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWR--NHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGTGGAH 387 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ 387 (518)
+.++|||||||++|||++|.+||.+.+.......+.... ....+|. ...+++++++||.+||. ||.+|+ ++.
T Consensus 176 ~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~ 252 (299)
T 3m2w_A 176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TIT 252 (299)
T ss_dssp GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHH
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC---CHH
Confidence 789999999999999999999998766544322221111 1112221 14689999999999998 999999 899
Q ss_pred hhhcCccccc
Q 010116 388 QIKAHPWFKD 397 (518)
Q Consensus 388 eil~Hpff~~ 397 (518)
|+++||||.+
T Consensus 253 e~l~hp~~~~ 262 (299)
T 3m2w_A 253 EFMNHPWIMQ 262 (299)
T ss_dssp HHHTSHHHHT
T ss_pred HHhcChhhcc
Confidence 9999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=367.43 Aligned_cols=263 Identities=22% Similarity=0.358 Sum_probs=193.1
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEe----
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSF---- 155 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f---- 155 (518)
..+...+|++.+.||+|+||.||+|++..+|+.||||++.+.. ......+.+|+.++..+. ||||+++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3445568999999999999999999999999999999986542 334566889999999996 99999999998
Q ss_pred ----ecCCeEEEEEeecCCCchHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCceeeCCCCcEE
Q 010116 156 ----QDTEYLYLIMEYLPGGDMMTLLMR---EDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHMK 226 (518)
Q Consensus 156 ----~~~~~lylVmEy~~gG~L~~~l~~---~~~l~e~~~~~~~~ql~~aL~~LH~~g--iiHRDIKPeNILld~~g~vK 226 (518)
.....+|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+|++|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 44556899999995 799988865 467999999999999999999999999 99999999999999999999
Q ss_pred EeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhh
Q 010116 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (518)
Q Consensus 227 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 306 (518)
|+|||+++............. . ........+.+||+.|+|||+
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~------------------------------~-------~~~~~~~~~~~~t~~y~aPE~ 221 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQ------------------------------R-------RALVEEEITRNTTPMYRTPEI 221 (337)
T ss_dssp BCCCTTCBCCSSCC------------------------------------------------------------------
T ss_pred EecCccceeccccCccccccc------------------------------c-------cccchhhccccCCCCcCChhh
Confidence 999999987643211000000 0 000011225679999999999
Q ss_pred h---cCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 307 L---LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 307 l---~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
+ .+..|+.++|||||||++|+|++|..||......... . .....+.....++.+.+||.+||. ||.+|+
T Consensus 222 ~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp- 294 (337)
T 3ll6_A 222 IDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV----N--GKYSIPPHDTQYTVFHSLIRAMLQVNPEERL- 294 (337)
T ss_dssp --CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSC-
T ss_pred hhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh----c--CcccCCcccccchHHHHHHHHHccCChhhCc-
Confidence 9 5677899999999999999999999999765543322 2 223344445778999999999998 999999
Q ss_pred CCChhhhhcCc
Q 010116 383 TGGAHQIKAHP 393 (518)
Q Consensus 383 ~~~a~eil~Hp 393 (518)
++.|+++|-
T Consensus 295 --s~~e~l~~l 303 (337)
T 3ll6_A 295 --SIAEVVHQL 303 (337)
T ss_dssp --CHHHHHHHH
T ss_pred --CHHHHHHHH
Confidence 899999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=386.85 Aligned_cols=270 Identities=20% Similarity=0.240 Sum_probs=217.8
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC-CceeEEEEEeecCCeEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~~ly 162 (518)
..++|+++++||+|+||.||+|++..+++.||||++...... ..+..|..+++.+.| ++|+.+..++.+....|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 457899999999999999999999999999999988754322 236789999999987 56667777778889999
Q ss_pred EEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceee---CCCCcEEEeecccccccCC
Q 010116 163 LIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILl---d~~g~vKL~DFGla~~~~~ 238 (518)
|||||+ ||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||| +.++++||+|||+|+.+..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 5689999999999999999999999999999999999999 6899999999999987643
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
....... ........+||+.|+|||++.+..|+.++||
T Consensus 159 ~~~~~~~------------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDv 196 (483)
T 3sv0_A 159 TSTHQHI------------------------------------------PYRENKNLTGTARYASVNTHLGIEQSRRDDL 196 (483)
T ss_dssp TTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred Ccccccc------------------------------------------ccccccccCCCccccCHHHhcCCCCChHHHH
Confidence 2110000 0011225789999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCCh---hhHHHHHhhhcCcccCC-CCCCCChhHHHHHHHHhc-cccccCCCCChhhhh---
Q 010116 319 WSLGAIMYEMLVGYPPFYADDP---ITTCRKIVHWRNHLKFP-DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK--- 390 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~~~l~~p-~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil--- 390 (518)
|||||+||||++|..||.+... ...+.++.........+ ....+++++.+||.+||. ||.+|+ ++.+|+
T Consensus 197 wSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RP---s~~el~~~L 273 (483)
T 3sv0_A 197 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYSYLKRLF 273 (483)
T ss_dssp HHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCC---CHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCc---CHHHHHHHH
Confidence 9999999999999999987543 33333333311100000 013578999999999998 999999 666554
Q ss_pred -------cCcccccCCccccc
Q 010116 391 -------AHPWFKDVVWDKLY 404 (518)
Q Consensus 391 -------~Hpff~~i~w~~l~ 404 (518)
.|+|+..+||+.+.
T Consensus 274 ~~l~~~~~~~~~~~~dW~~~~ 294 (483)
T 3sv0_A 274 RDLFIREGFQFDYVFDWTILK 294 (483)
T ss_dssp HHHHHHTTCCCSSCCHHHHHT
T ss_pred HHHHHHcCCCccCCcCchhhc
Confidence 58999999999885
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=398.19 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=209.9
Q ss_pred CCeeEE-eeEeecCceEEEEEEE--ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 86 DDFELL-TIIGRGAFGEVRLCRE--KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 86 ~~f~i~-~~LG~G~fG~V~l~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
..+.+. +.||+|+||+||+|.. +.+++.||||+++... ......+.+.+|+.+|+.++|||||++++++.++ .+|
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~ 445 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWM 445 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEE
Confidence 334443 4899999999999955 4567899999997653 3344567899999999999999999999999754 588
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
+|||||+||+|.+++.....+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+......
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999999876422100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
........||+.|+|||++.+..|+.++||||||
T Consensus 526 ----------------------------------------------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlG 559 (635)
T 4fl3_A 526 ----------------------------------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 559 (635)
T ss_dssp -------------------------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred ----------------------------------------------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHH
Confidence 0011234678999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 323 AIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 323 vilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|++|||++ |..||.+.+.......+... ....+| ..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 560 v~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~~l~~ 624 (635)
T 4fl3_A 560 VLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVEL 624 (635)
T ss_dssp HHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 99999998 99999999888877777653 233444 4789999999999998 999999 7888764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=371.81 Aligned_cols=253 Identities=16% Similarity=0.188 Sum_probs=203.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecC--------CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeE------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKS--------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK------ 150 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t--------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~------ 150 (518)
.++|++++.||+|+||.||+|++..+ ++.||+|++.+. +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47899999999999999999999874 889999998754 24778999999999999887
Q ss_pred ---------EEEEeec-CCeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCcee
Q 010116 151 ---------LYYSFQD-TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLL 218 (518)
Q Consensus 151 ---------l~~~f~~-~~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNIL 218 (518)
+++++.. ...+|+||||+ ||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5566654 78899999999 99999999875 78999999999999999999999999999999999999
Q ss_pred eCCCC--cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccccc
Q 010116 219 LDKNG--HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (518)
Q Consensus 219 ld~~g--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 296 (518)
++.++ .+||+|||+|+.+......... ........+
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~------------------------------------------~~~~~~~~~ 229 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAY------------------------------------------VEGSRSPHE 229 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCC------------------------------------------CTTSSCTTC
T ss_pred EcCCCCceEEEecCcceeeccCCCccccc------------------------------------------ccccccccc
Confidence 99998 9999999999876422100000 000122458
Q ss_pred CCCCccChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCC--hhhHHHHHhhhc-CcccCCC----CCCCChhHHHH
Q 010116 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADD--PITTCRKIVHWR-NHLKFPD----DSKLSPEAKDL 369 (518)
Q Consensus 297 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~-~~l~~p~----~~~~s~~~~dL 369 (518)
||+.|+|||++.+..|+.++|||||||++|||++|..||.+.. .......+.... ....++. +..+++++.+|
T Consensus 230 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 309 (352)
T 2jii_A 230 GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKY 309 (352)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHH
T ss_pred CCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHH
Confidence 9999999999999999999999999999999999999998754 222222222111 1112221 12578999999
Q ss_pred HHHHhc-cccccCCCCChhhhhc
Q 010116 370 ICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 370 I~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|.+||. ||.+|+ ++.+|++
T Consensus 310 i~~~l~~dp~~Rp---s~~~l~~ 329 (352)
T 2jii_A 310 LKVVMALTYEEKP---PYAMLRN 329 (352)
T ss_dssp HHHHHTCCTTCCC---CHHHHHH
T ss_pred HHHHHhCChhhCC---CHHHHHH
Confidence 999998 999999 8888875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=376.72 Aligned_cols=253 Identities=19% Similarity=0.299 Sum_probs=202.8
Q ss_pred CeeEEeeEeecCceEEEEEEEecCC---cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEe-ecCCeEE
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSG---NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF-QDTEYLY 162 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f-~~~~~ly 162 (518)
.|++.+.||+|+||.||+|+...++ ..||+|++... ......+.+.+|..+++.++|||||++++++ ..++..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 5889999999999999999886543 46899998653 2344567889999999999999999999985 4566889
Q ss_pred EEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 163 LIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.+.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999999765 5689999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
.. ........||+.|+|||++.+..|+.++|||||
T Consensus 248 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 282 (373)
T 3c1x_A 248 DS---------------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282 (373)
T ss_dssp -------------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred cc---------------------------------------------ccccCCCCCcccccChHHhcCCCCCcHHHHHHH
Confidence 00 001124568899999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 322 GAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 322 Gvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||++|||++ |.+||.+.+.......+.... .+..| ..+++++.+||.+||. ||.+|+ ++.+|+++
T Consensus 283 G~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p--~~~~~~l~~li~~cl~~dp~~RP---s~~ell~~ 349 (373)
T 3c1x_A 283 GVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 349 (373)
T ss_dssp HHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999999 788898877777766666532 22233 4689999999999998 999999 89998874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=395.49 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=211.0
Q ss_pred CcCCCCeeEEe-eEeecCceEEEEEEEec--CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 82 KICVDDFELLT-IIGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 82 ~~~~~~f~i~~-~LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
.+..+++.+.. .||+|+||.||+|..+. ++..||||++++.. .....+.+.+|+.+|+.++|||||++++++.+
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 34556777777 89999999999998763 56679999997652 33456789999999999999999999999987
Q ss_pred CeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
+.+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 5699999999999999999654 569999999999999999999999999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
..... ........||+.|+|||++.+..|+.++|
T Consensus 488 ~~~~~----------------------------------------------~~~~~~~~~~~~y~APE~~~~~~~~~~sD 521 (613)
T 2ozo_A 488 ADDSY----------------------------------------------YTARSAGKWPLKWYAPECINFRKFSSRSD 521 (613)
T ss_dssp ------------------------------------------------------------CCTTSCHHHHHHCCCCHHHH
T ss_pred CCCce----------------------------------------------eeeccCCCCccceeCHhhhcCCCCCcHHH
Confidence 21100 00011335778999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
||||||++|||++ |..||.+.+..+....+... ..+.+| ..+++++.+||.+||. ||.+|+ ++.+|+
T Consensus 522 vwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~~l~ 590 (613)
T 2ozo_A 522 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECP--PECPPELYALMSDCWIYKWEDRP---DFLTVE 590 (613)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSTTTSC---CHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcCCChhHCc---CHHHHH
Confidence 9999999999998 99999998888887777653 234444 4689999999999998 999999 777764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=364.30 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=206.3
Q ss_pred CCC-eeEEeeEeecCceEEEEEEE----ecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec--
Q 010116 85 VDD-FELLTIIGRGAFGEVRLCRE----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-- 157 (518)
Q Consensus 85 ~~~-f~i~~~LG~G~fG~V~l~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-- 157 (518)
.++ |++++.||+|+||+||+|.. ..+|+.||||++.+.. .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 344 59999999999999988754 4578999999997652 23446678999999999999999999999987
Q ss_pred CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
...+|+||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 46899999999999999999654 59999999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
..... ........||+.|+|||++.+..++.++|
T Consensus 186 ~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 219 (318)
T 3lxp_A 186 EGHEY----------------------------------------------YRVREDGDSPVFWYAPECLKEYKFYYASD 219 (318)
T ss_dssp TTCSE----------------------------------------------EEC---CCCCGGGCCHHHHHHCEEEHHHH
T ss_pred ccccc----------------------------------------------cccccCCCCCceeeChHHhcCCCCCcHHH
Confidence 32100 01122456899999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhh--------------HHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPIT--------------TCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~--------------~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
||||||++|+|++|..||....... .....+. .....+....+++++.+||.+||. ||.+|+
T Consensus 220 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp- 296 (318)
T 3lxp_A 220 VWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE--RGERLPRPDKCPAEVYHLMKNCWETEASFRP- 296 (318)
T ss_dssp HHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-
T ss_pred HHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh--cccCCCCCccccHHHHHHHHHHcCCCcccCc-
Confidence 9999999999999999997542210 1112222 223334445789999999999998 999999
Q ss_pred CCChhhhhc
Q 010116 383 TGGAHQIKA 391 (518)
Q Consensus 383 ~~~a~eil~ 391 (518)
++.+|++
T Consensus 297 --s~~ell~ 303 (318)
T 3lxp_A 297 --TFENLIP 303 (318)
T ss_dssp --CHHHHHH
T ss_pred --CHHHHHH
Confidence 8999885
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=390.09 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=216.7
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
..+.+..++|++.+.||+|+||.||+|++.. +..||||+++.... ..+.+.+|+.+|+.++|||||++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3456777899999999999999999998865 46799999976532 24568899999999999999999999876
Q ss_pred CeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+.+|||||||.||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 6789999999999999999753 56999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
..... .......||+.|+|||++.+..|+.++
T Consensus 414 ~~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~s 445 (535)
T 2h8h_A 414 EDNEY------------------------------------------------TARQGAKFPIKWTAPEAALYGRFTIKS 445 (535)
T ss_dssp CCHHH------------------------------------------------HTTCSTTSCGGGSCHHHHHHCCCCHHH
T ss_pred CCCce------------------------------------------------ecccCCcCcccccCHHHhccCCCCchh
Confidence 32100 011134578899999999999999999
Q ss_pred cccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 317 DWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 317 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||||+||||++ |..||.+....+....+... ...+....+++++.+||.+||. ||.+|+ ++.+|+.
T Consensus 446 DvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~~l~~ 516 (535)
T 2h8h_A 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 516 (535)
T ss_dssp HHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 99999999999999 99999998888777777542 2333345789999999999998 999999 8998886
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=365.01 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=193.5
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHH--HHhCCCceeEEEEEee--
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL--AEVASHCIVKLYYSFQ-- 156 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il--~~l~hp~Iv~l~~~f~-- 156 (518)
..+..++|++++.||+|+||.||+|+. +++.||||++.... ......|..++ ..++||||+++++.+.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 456789999999999999999999965 78999999997542 23344455554 4589999999997543
Q ss_pred ---cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CeEEcCCCCCceeeCCCCc
Q 010116 157 ---DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH---------NYIHRDIKPDNLLLDKNGH 224 (518)
Q Consensus 157 ---~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~---------giiHRDIKPeNILld~~g~ 224 (518)
....+|+|||||+||+|.+++... .+++..+..++.|++.||.|||++ |||||||||+|||++.+|.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 344789999999999999999654 458999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccCh
Q 010116 225 MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304 (518)
Q Consensus 225 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 304 (518)
+||+|||+|+.+......... .......+.+||+.|+||
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~gt~~y~aP 197 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPG-----------------------------------------EEDNAAISEVGTIRYMAP 197 (336)
T ss_dssp EEECCCTTCEECSSSSCC--------------------------------------------------CCTTSCGGGCCH
T ss_pred EEEeeccceeecccccccCcc-----------------------------------------ccccccccCCCccceeCc
Confidence 999999999876432110000 001122356899999999
Q ss_pred hhhcC-------CCCCccccccchhHHHHHHHhCCCCCCCCChhh-----------------HHHH-HhhhcCcccCCCC
Q 010116 305 EVLLK-------KGYGMECDWWSLGAIMYEMLVGYPPFYADDPIT-----------------TCRK-IVHWRNHLKFPDD 359 (518)
Q Consensus 305 Evl~~-------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----------------~~~~-i~~~~~~l~~p~~ 359 (518)
|++.+ ..++.++|||||||++|||++|..||....... .... +........+|..
T Consensus 198 E~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (336)
T 3g2f_A 198 EVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA 277 (336)
T ss_dssp HHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT
T ss_pred hhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc
Confidence 99987 467789999999999999999977765432111 1111 1111112233321
Q ss_pred ----CCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 360 ----SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 360 ----~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
..+++++.+||.+||. ||.+|+ ++.||++
T Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~e~l~ 311 (336)
T 3g2f_A 278 WKENSLAVRSLKETIEDCWDQDAEARL---TAQXAEE 311 (336)
T ss_dssp CCCCSHHHHHHHHHHHHHSCSSGGGSC---CHHHHHH
T ss_pred cccccchHHHHHHHHHHHhcCChhhCc---chHHHHH
Confidence 1234579999999998 999999 8999854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=361.98 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=197.3
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh--CCCceeEEEEEeecC---
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV--ASHCIVKLYYSFQDT--- 158 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~~~f~~~--- 158 (518)
..++|++++.||+|+||.||+|++. |+.||||++.... ......|.+++..+ +||||+++++++.+.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3468999999999999999999764 8999999986542 23345566666654 899999999999877
Q ss_pred -CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEEcCCCCCceeeCCCCcEEEee
Q 010116 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDKNGHMKLSD 229 (518)
Q Consensus 159 -~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~--------giiHRDIKPeNILld~~g~vKL~D 229 (518)
..+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++ |||||||||+|||++.+|++||+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 789999999999999999954 4799999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC
Q 010116 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (518)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 309 (518)
||+|+.+...... ......+.+||+.|+|||++.+
T Consensus 186 fg~a~~~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 186 LGLAVKFISDTNE---------------------------------------------VDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp CTTCEECC------------------------------------------------------CCSSCSCGGGCCHHHHTT
T ss_pred CCCceeecccccc---------------------------------------------ccCCCCCCccCcceeChhhccc
Confidence 9999865422100 0001225689999999999988
Q ss_pred CCCCcc------ccccchhHHHHHHHhC----------CCCCCCCCh----hhHHHHHhhh-cCcccCCC---CCCCChh
Q 010116 310 KGYGME------CDWWSLGAIMYEMLVG----------YPPFYADDP----ITTCRKIVHW-RNHLKFPD---DSKLSPE 365 (518)
Q Consensus 310 ~~y~~~------~DiWSlGvilyeml~G----------~~PF~~~~~----~~~~~~i~~~-~~~l~~p~---~~~~s~~ 365 (518)
..++.. +|||||||++|||++| ..||..... ......++.. .....+|. ...++++
T Consensus 221 ~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (337)
T 3mdy_A 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQ 300 (337)
T ss_dssp CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHH
T ss_pred ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHH
Confidence 777665 9999999999999999 777755321 1222222221 11222221 1235677
Q ss_pred HHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 366 AKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 366 ~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+.+||.+||. ||.+|+ ++.+|++|
T Consensus 301 l~~li~~~l~~dP~~Rp---s~~ell~~ 325 (337)
T 3mdy_A 301 MGKLMTECWAHNPASRL---TALRVKKT 325 (337)
T ss_dssp HHHHHHHHSCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHhhhhChhhCC---CHHHHHHH
Confidence 9999999998 999999 89999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=381.46 Aligned_cols=250 Identities=17% Similarity=0.215 Sum_probs=198.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC-Cc----------ee----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HC----------IV---- 149 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~----------Iv---- 149 (518)
...|.+.+.||+|+||+||+|++..+|+.||||++...........+.+.+|..+++.+.| ++ ++
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4468899999999999999999999999999999885443344446778899999998876 21 11
Q ss_pred -------EEEEEeec-----CCeEEEEEeecCCCchHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEc
Q 010116 150 -------KLYYSFQD-----TEYLYLIMEYLPGGDMMTLLMR-------EDTLTENVARFYIAQSVLAIESIHKHNYIHR 210 (518)
Q Consensus 150 -------~l~~~f~~-----~~~lylVmEy~~gG~L~~~l~~-------~~~l~e~~~~~~~~ql~~aL~~LH~~giiHR 210 (518)
.+...+.. ...+|++|+++ +|+|.+++.. ...+++..+..++.|++.||.|||++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 11111222 22467888876 7899998841 3457788888899999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccc
Q 010116 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRK 290 (518)
Q Consensus 211 DIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (518)
||||+||||+.+|.+||+|||+|+.....
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~--------------------------------------------------- 264 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------------------------------------------------- 264 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE---------------------------------------------------
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc---------------------------------------------------
Confidence 99999999999999999999998864211
Q ss_pred ccccccCCCCccChhhh----------cCCCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCC
Q 010116 291 LAFSTVGTPDYIAPEVL----------LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDS 360 (518)
Q Consensus 291 ~~~s~~GT~~Y~APEvl----------~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~ 360 (518)
..+.+| +.|+|||++ .+..|+.++|||||||++|||++|+.||...+.......+. +...
T Consensus 265 -~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~--------~~~~ 334 (413)
T 3dzo_A 265 -AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF--------RSCK 334 (413)
T ss_dssp -ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG--------SSCC
T ss_pred -cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH--------hhcc
Confidence 235688 999999999 55668999999999999999999999998876655443332 2234
Q ss_pred CCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCC
Q 010116 361 KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 361 ~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~ 399 (518)
.+|+++++||.+||. ||.+|+ ++.++++||||+.+.
T Consensus 335 ~~~~~~~~li~~~l~~dP~~Rp---t~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 335 NIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLR 371 (413)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSC---CHHHHTTSHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHHHHH
Confidence 688999999999998 999999 899999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.28 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=209.2
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEE----EecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
..+..++|++++.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 44566789999999999999999998 4568999999998764 2345667899999999999999999999987
Q ss_pred cCC--eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 157 DTE--YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 157 ~~~--~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
+.+ .+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 654 789999999999999999775 56999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
......... ........||+.|+|||++.+..++
T Consensus 193 ~~~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~ 226 (326)
T 2w1i_A 193 KVLPQDKEY----------------------------------------------YKVKEPGESPIFWYAPESLTESKFS 226 (326)
T ss_dssp EECCSSCSE----------------------------------------------EECSSCCSCCGGGCCHHHHHHCEEE
T ss_pred hhccccccc----------------------------------------------cccccCCCCceeEECchhhcCCCCC
Confidence 875422100 0011234678899999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChh------------hH---HHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cc
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPI------------TT---CRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~------------~~---~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp 377 (518)
.++|||||||++|||++|..||...... .. ....+. .....+....+++++.+||.+||. ||
T Consensus 227 ~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP 304 (326)
T 2w1i_A 227 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK--NNGRLPRPDGCPDEIYMIMTECWNNNV 304 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHSCSSG
T ss_pred chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh--cCCCCCCCCcccHHHHHHHHHHcCCCh
Confidence 9999999999999999999998643110 00 111122 122334445789999999999998 99
Q ss_pred cccCCCCChhhhhc
Q 010116 378 EHRLGTGGAHQIKA 391 (518)
Q Consensus 378 ~~R~g~~~a~eil~ 391 (518)
.+|| ++.+|++
T Consensus 305 ~~Rp---s~~el~~ 315 (326)
T 2w1i_A 305 NQRP---SFRDLAL 315 (326)
T ss_dssp GGSC---CHHHHHH
T ss_pred hhCc---CHHHHHH
Confidence 9999 8988875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=391.80 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=214.6
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
...+..++|++++.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|+.+|+.++|||||++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456668899999999999999999998654 4679999986542 3344567889999999999999999999985
Q ss_pred cCCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
++.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 45689999999999999999765 4799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 315 (518)
...... .......||+.|+|||++.+..|+.+
T Consensus 541 ~~~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~ 572 (656)
T 2j0j_A 541 MEDSTY------------------------------------------------YKASKGKLPIKWMAPESINFRRFTSA 572 (656)
T ss_dssp CCC----------------------------------------------------------CCGGGCCHHHHHHCCCCHH
T ss_pred cCCCcc------------------------------------------------eeccCCCCCcceeCHHHhcCCCCCch
Confidence 532110 01123467899999999999999999
Q ss_pred ccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 316 CDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 316 ~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
+|||||||++|||++ |.+||.+.+.......+... ..+.+| ..+++++.+||.+||. ||.+|| ++.+|++
T Consensus 573 ~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~l~~dP~~RP---s~~el~~ 644 (656)
T 2j0j_A 573 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKA 644 (656)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccccHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999999999997 99999999888888777763 233344 4789999999999998 999999 8999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=363.62 Aligned_cols=261 Identities=19% Similarity=0.251 Sum_probs=212.8
Q ss_pred hhhcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 77 ~~~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
.++.+.+..++|++.+.||+|+||.||+|++.. .||+|++..... .....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 456778889999999999999999999998753 499999876432 2223345678999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~-~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
+...+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++ +|.+||+|||++..
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999999997654 799999999999999999999999999999999999998 78999999999875
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC------
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK------ 309 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------ 309 (518)
....... ..........||+.|+|||++.+
T Consensus 179 ~~~~~~~--------------------------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 214 (319)
T 2y4i_B 179 SGVLQAG--------------------------------------------RREDKLRIQNGWLCHLAPEIIRQLSPDTE 214 (319)
T ss_dssp -----------------------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--
T ss_pred ccccccc--------------------------------------------ccccccccCCCcccccChHHhhhcccccc
Confidence 4311000 00011224579999999999975
Q ss_pred ---CCCCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCC
Q 010116 310 ---KGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGG 385 (518)
Q Consensus 310 ---~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~ 385 (518)
..|+.++|||||||++|||++|..||...........+..... .......+++++.+||.+||. ||.+|+ +
T Consensus 215 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t 289 (319)
T 2y4i_B 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK--PNLSQIGMGKEISDILLFCWAFEQEERP---T 289 (319)
T ss_dssp CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC--CCCCCSSCCTTHHHHHHHHHCSSTTTSC---C
T ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC--CCCCcCCCCHHHHHHHHHHhcCChhhCc---C
Confidence 4589999999999999999999999999888777777665322 222223688999999999998 999999 8
Q ss_pred hhhhhc
Q 010116 386 AHQIKA 391 (518)
Q Consensus 386 a~eil~ 391 (518)
+.+|++
T Consensus 290 ~~~l~~ 295 (319)
T 2y4i_B 290 FTKLMD 295 (319)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999886
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=357.37 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=202.5
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhh-hchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
|...+.||+|+||.||+|+. +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44458999999999999975 688999999876432 233446778999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 167 YLPGGDMMTLLMR---EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 167 y~~gG~L~~~l~~---~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 188 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-- 188 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS--
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc--
Confidence 9999999999864 34699999999999999999999999999999999999999999999999999886532100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
.......+||+.|+|||++.+ .++.++|||||||
T Consensus 189 ---------------------------------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~ 222 (307)
T 2nru_A 189 ---------------------------------------------TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGV 222 (307)
T ss_dssp ---------------------------------------------CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHH
T ss_pred ---------------------------------------------cccccccCCCcCcCChHHhcC-CCCccchhHHHHH
Confidence 001224579999999999865 5899999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhh----cCc------ccCC-CCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHW----RNH------LKFP-DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~----~~~------l~~p-~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
++|+|++|.+||...........+... ... ..++ .....++.+.+||.+||. ||.+|| ++.+|++
T Consensus 223 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~l~~ 299 (307)
T 2nru_A 223 VLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP---DIKKVQQ 299 (307)
T ss_dssp HHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 999999999999876544333222211 000 0011 112345678999999998 999999 8999886
Q ss_pred C
Q 010116 392 H 392 (518)
Q Consensus 392 H 392 (518)
|
T Consensus 300 ~ 300 (307)
T 2nru_A 300 L 300 (307)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=403.20 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=208.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec------C
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------T 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------~ 158 (518)
.++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 478999999999999999999999999999999987642 34456778899999999999999999999866 7
Q ss_pred CeEEEEEeecCCCchHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc---EEEeeccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGL 232 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~---~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~---vKL~DFGl 232 (518)
+..|+|||||+||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.+|. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 78899999999999999997644 6999999999999999999999999999999999999998775 99999999
Q ss_pred ccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC
Q 010116 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (518)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 312 (518)
+....... .....+||+.|+|||++.+..|
T Consensus 171 a~~~~~~~--------------------------------------------------~~~~~~gt~~Y~APE~l~~~~~ 200 (676)
T 3qa8_A 171 AKELDQGE--------------------------------------------------LCTEFVGTLQYLAPELLEQKKY 200 (676)
T ss_dssp CCBTTSCC--------------------------------------------------CCCCCCSCCTTCSSCSSCCSCC
T ss_pred cccccccc--------------------------------------------------ccccccCCcccCChHHhccCCC
Confidence 98653210 1124689999999999999999
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChhhHHHH---------Hhh---hcCcccC------CC--CCCCChhHHHHHHH
Q 010116 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRK---------IVH---WRNHLKF------PD--DSKLSPEAKDLICR 372 (518)
Q Consensus 313 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~---------i~~---~~~~l~~------p~--~~~~s~~~~dLI~~ 372 (518)
+.++|||||||++|+|++|..||.+......... +.. ....+.+ |. ...+++.+.+||.+
T Consensus 201 s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~ 280 (676)
T 3qa8_A 201 TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC 280 (676)
T ss_dssp STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHH
Confidence 9999999999999999999999976533221100 000 0011111 11 11356889999999
Q ss_pred Hhc-cccccCCCCChhhhhcCcccccC
Q 010116 373 LLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 373 lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||. ||.+|+ ++.+++.||||+.+
T Consensus 281 mL~~DP~kRP---Ta~elL~hp~F~~l 304 (676)
T 3qa8_A 281 MLMWHQRQRG---TDPQNPNVGCFQAL 304 (676)
T ss_dssp HSCSSCC------CCTTCCCCTTHHHH
T ss_pred HccCCHhhCc---CHHHHhcCHHHHHH
Confidence 999 999999 89999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=358.55 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=201.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHH--hCCCceeEEEEEeecCC----
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE--VASHCIVKLYYSFQDTE---- 159 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~f~~~~---- 159 (518)
++|++.+.||+|+||.||+|++ +|+.||||++.+.. ...+.+|..++.. ++||||+++++++.+..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 5799999999999999999986 58999999986542 3456788999988 78999999999998876
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCeEEcCCCCCceeeCCCCcEEEeecc
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH--------KHNYIHRDIKPDNLLLDKNGHMKLSDFG 231 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH--------~~giiHRDIKPeNILld~~g~vKL~DFG 231 (518)
.+|+||||++||+|.+++.+ ..+++..+..++.|++.||.||| ++||+||||||+|||++.+|++||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 89999999999999999965 57999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK- 310 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~- 310 (518)
++......... ........+||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~ 227 (342)
T 1b6c_B 193 LAVRHDSATDT---------------------------------------------IDIAPNHRVGTKRYMAPEVLDDSI 227 (342)
T ss_dssp TCEEEETTTTE---------------------------------------------EEECCCSCCCCGGGCCHHHHTSCC
T ss_pred Cceeccccccc---------------------------------------------cccccccCCcCcccCCHhhhcccc
Confidence 99865322100 00012246799999999999875
Q ss_pred -----CCCccccccchhHHHHHHHhC----------CCCCCCCCh-----hhHHHHHhhhcCcccCCC---CCCCChhHH
Q 010116 311 -----GYGMECDWWSLGAIMYEMLVG----------YPPFYADDP-----ITTCRKIVHWRNHLKFPD---DSKLSPEAK 367 (518)
Q Consensus 311 -----~y~~~~DiWSlGvilyeml~G----------~~PF~~~~~-----~~~~~~i~~~~~~l~~p~---~~~~s~~~~ 367 (518)
.++.++|||||||++|||++| ..||..... ......+........+|. ...+++.+.
T Consensus 228 ~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (342)
T 1b6c_B 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 307 (342)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHH
T ss_pred cccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHH
Confidence 344789999999999999999 789976532 223333333222222232 112345789
Q ss_pred HHHHHHhc-cccccCCCCChhhhhcC
Q 010116 368 DLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 368 dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+||.+||. ||.+|+ ++.+|++|
T Consensus 308 ~li~~cl~~dp~~Rp---s~~~i~~~ 330 (342)
T 1b6c_B 308 KIMRECWYANGAARL---TALRIKKT 330 (342)
T ss_dssp HHHHHHCCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHhccChhhCC---CHHHHHHH
Confidence 99999998 999999 89999876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=387.80 Aligned_cols=244 Identities=22% Similarity=0.306 Sum_probs=200.9
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEec-CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~-t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
+.+..++|++++.||+|+||.||+|++.. +|+.||||++.... .......+.+|+.+|+.++|||||+++++|.+.+
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 34556899999999999999999999976 79999999987542 2334567889999999999999999999998765
Q ss_pred e-----EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 160 Y-----LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 160 ~-----lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
. +||||||++||+|.+++.. .+++..+..++.||+.||.|||++|||||||||+|||++.+ ++||+|||+++
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 5 7999999999999988754 79999999999999999999999999999999999999875 99999999998
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCc
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 314 (518)
..... ...+||+.|+|||++.+. ++.
T Consensus 230 ~~~~~-----------------------------------------------------~~~~gt~~y~aPE~~~~~-~~~ 255 (681)
T 2pzi_A 230 RINSF-----------------------------------------------------GYLYGTPGFQAPEIVRTG-PTV 255 (681)
T ss_dssp ETTCC-----------------------------------------------------SCCCCCTTTSCTTHHHHC-SCH
T ss_pred hcccC-----------------------------------------------------CccCCCccccCHHHHcCC-CCC
Confidence 65311 145799999999998764 589
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCc
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHP 393 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hp 393 (518)
++|||||||++|+|++|.+||.+...... ........+++.+.+||.+||. ||.+|+ +..+++.|+
T Consensus 256 ~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~R~---~~~~~l~~~ 322 (681)
T 2pzi_A 256 ATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDSYGRLLRRAIDPDPRQRF---TTAEEMSAQ 322 (681)
T ss_dssp HHHHHHHHHHHHHHHSCCCEETTEECSSC----------CTTCHHHHHCHHHHHHHHHHTCSSGGGSC---SSHHHHHHH
T ss_pred ceehhhhHHHHHHHHhCCCCCcccccccc----------cccccccccCHHHHHHHhhhccCChhhCC---CHHHHHHHH
Confidence 99999999999999999999875321100 0000001246789999999998 999999 778889999
Q ss_pred ccc
Q 010116 394 WFK 396 (518)
Q Consensus 394 ff~ 396 (518)
|+.
T Consensus 323 l~~ 325 (681)
T 2pzi_A 323 LTG 325 (681)
T ss_dssp HHH
T ss_pred HHH
Confidence 885
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=343.43 Aligned_cols=230 Identities=13% Similarity=0.104 Sum_probs=190.9
Q ss_pred hhcCC-cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee
Q 010116 78 LKRHK-ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (518)
Q Consensus 78 ~~~~~-~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 156 (518)
+..+. +..++|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|..++..++||||+++++++.
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 34444 55678999999999999999999999999999999998765544556678899999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+.+.+|+||||++||+|.+++.. + .....+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred ECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999999999999954 3 4566788899999999999999999999999999999999999997443
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
|++ .++.++
T Consensus 175 ----------------------------------------------------------------~~~-------~~~~~~ 183 (286)
T 3uqc_A 175 ----------------------------------------------------------------TMP-------DANPQD 183 (286)
T ss_dssp ----------------------------------------------------------------CCT-------TCCHHH
T ss_pred ----------------------------------------------------------------ccC-------CCCchh
Confidence 333 378899
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHH---HHhhhcCcccCC--CCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCR---KIVHWRNHLKFP--DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~~~~~l~~p--~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
|||||||++|||++|..||.+.+...... ++.. .....+ ....+++++++||.+||. ||.+| ++.|++
T Consensus 184 Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R----s~~el~ 257 (286)
T 3uqc_A 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA--GQPIEPADIDRDIPFQISAVAARSVQGDGGIR----SASTLL 257 (286)
T ss_dssp HHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT--SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC----CHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc--cCCCChhhcccCCCHHHHHHHHHHcccCCccC----CHHHHH
Confidence 99999999999999999998876543221 1111 111111 124689999999999998 99999 388877
Q ss_pred c
Q 010116 391 A 391 (518)
Q Consensus 391 ~ 391 (518)
+
T Consensus 258 ~ 258 (286)
T 3uqc_A 258 N 258 (286)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=334.77 Aligned_cols=190 Identities=16% Similarity=0.182 Sum_probs=140.4
Q ss_pred eEeecCceEEEEEEEecCCcEEEEEEeechhhh-------chhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCCeEEEE
Q 010116 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-------KRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 93 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-------~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++.|++|.+..++....|+.||+|++.+.... .....+.+.+|+++|+++ .|+||++++++|++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 356788888888888889999999999765321 122345689999999999 799999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||||+||+|.++|.+.+.+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~----- 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD----- 392 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-------
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC-----
Confidence 9999999999999988888875 47899999999999999999999999999999999999999999865321
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
.....+.|||+.|||||++.+ .+..++|+||+|++
T Consensus 393 --------------------------------------------~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~ 427 (569)
T 4azs_A 393 --------------------------------------------CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVH 427 (569)
T ss_dssp ---------------------------------------------CCSHHHHHHHHHHHHHHC-----------------
T ss_pred --------------------------------------------CccccCceechhhccHHHhCC-CCCCcccccccccc
Confidence 012346899999999999975 46778999999999
Q ss_pred HHHHHhCCCCC
Q 010116 325 MYEMLVGYPPF 335 (518)
Q Consensus 325 lyeml~G~~PF 335 (518)
+|+|++|..||
T Consensus 428 ~~~l~~~~~~~ 438 (569)
T 4azs_A 428 PFNLPQPWSNW 438 (569)
T ss_dssp -CCCCTTHHHH
T ss_pred hhhhccccchh
Confidence 99998876654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=283.24 Aligned_cols=192 Identities=19% Similarity=0.197 Sum_probs=148.1
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
..+.||+|+||+||+| ...+..+|+|+....... .....+.+.+|+.+|+.++||||+++..++.+.+..|||
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3568999999999999 556889999987543221 222345689999999999999999555555566677999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||||+||+|.+++.. +..++.|++.||.|||++|||||||||+|||++. ++||+|||+|+.........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~- 486 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA- 486 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH-
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc-
Confidence 999999999999965 6689999999999999999999999999999998 99999999999764221000
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC--CCCCccccccchh
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECDWWSLG 322 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlG 322 (518)
.+......+.+||+.|||||++.. .+|+..+|+||.+
T Consensus 487 -----------------------------------------~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~v 525 (540)
T 3en9_A 487 -----------------------------------------VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEII 525 (540)
T ss_dssp -----------------------------------------HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHH
T ss_pred -----------------------------------------cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHH
Confidence 000012236789999999999987 7899999999999
Q ss_pred HHHHHHHhCCCCC
Q 010116 323 AIMYEMLVGYPPF 335 (518)
Q Consensus 323 vilyeml~G~~PF 335 (518)
+-..+.+.++.+|
T Consensus 526 l~~l~~v~~r~rY 538 (540)
T 3en9_A 526 LELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHTCSCC
T ss_pred HHHHHHHHhcccc
Confidence 9999988887766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=241.88 Aligned_cols=132 Identities=14% Similarity=0.147 Sum_probs=107.8
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch---------------hhHHHHHHHHHHHHHhCCCceeEEEEE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---------------GQVEHVRAERNLLAEVASHCIVKLYYS 154 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---------------~~~~~~~~E~~il~~l~hp~Iv~l~~~ 154 (518)
+.+.||+|+||.||+|++ .+|+.||||+++....... .....+.+|..+|+.++| ++++.+
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence 449999999999999999 8899999999975432111 235668899999999984 555555
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
+.. +.+|+|||||+||+|.+ +. ...+..++.|++.||.|||++|||||||||+|||++ +|++||+|||+|+
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 543 45699999999999988 42 134557999999999999999999999999999999 9999999999976
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.9e-23 Score=200.95 Aligned_cols=142 Identities=15% Similarity=0.117 Sum_probs=110.7
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcE--EEEEEeechhhhch---------------------hhHHHHHHHHHHHHHh
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNI--YAMKKLKKSEMVKR---------------------GQVEHVRAERNLLAEV 143 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~--~AiK~l~k~~~~~~---------------------~~~~~~~~E~~il~~l 143 (518)
-|++.+.||+|+||.||+|.+..+|+. ||||+++....... .....+.+|..+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998888999 99999765421100 1123578899999999
Q ss_pred CCCce--eEEEEEeecCCeEEEEEeecCC-C----chHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEcCCCCC
Q 010116 144 ASHCI--VKLYYSFQDTEYLYLIMEYLPG-G----DMMTLLMREDTLTENVARFYIAQSVLAIESIH-KHNYIHRDIKPD 215 (518)
Q Consensus 144 ~hp~I--v~l~~~f~~~~~lylVmEy~~g-G----~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH-~~giiHRDIKPe 215 (518)
.|++| +.++.. ...||||||+.+ | +|.++... .++..+..++.|++.||.||| ++|||||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 87753 444432 346899999942 4 56555422 346678899999999999999 999999999999
Q ss_pred ceeeCCCCcEEEeecccccccC
Q 010116 216 NLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 216 NILld~~g~vKL~DFGla~~~~ 237 (518)
|||++. +++|+|||+|....
T Consensus 201 NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SEEESS--SEEECCCTTCEETT
T ss_pred HEEEcC--cEEEEECcccccCC
Confidence 999988 99999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.3e-20 Score=190.53 Aligned_cols=138 Identities=13% Similarity=0.138 Sum_probs=101.0
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc-----------hhhH--------HHHHHHHHHHHHhCCCce
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-----------RGQV--------EHVRAERNLLAEVASHCI 148 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-----------~~~~--------~~~~~E~~il~~l~hp~I 148 (518)
|++...||.|+||.||+|.+. +|+.||||+++...... .... .....|...|..+.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999874 69999999986432110 0001 112356666777654443
Q ss_pred e--EEEEEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC---
Q 010116 149 V--KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG--- 223 (518)
Q Consensus 149 v--~l~~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g--- 223 (518)
. ..+.. . ..+|||||++|+.|..+. ....++.++.|++.+|.+||++|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 2 22222 1 136999999999886553 2234567889999999999999999999999999999887
Q ss_pred -------cEEEeeccccccc
Q 010116 224 -------HMKLSDFGLCKPL 236 (518)
Q Consensus 224 -------~vKL~DFGla~~~ 236 (518)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 4899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=6.2e-13 Score=129.78 Aligned_cols=140 Identities=12% Similarity=0.060 Sum_probs=112.2
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylV 164 (518)
+.|++...+|.|+.+.||++.. .+..|++|+....... ....+.+|..+|+.+. +..+.++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 5789999999999999998863 4688999998653211 1234788999999985 66788999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK---------------------------------------- 204 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~---------------------------------------- 204 (518)
|||++|.+|...+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876531 223344678899999999998
Q ss_pred -------------------CCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 205 -------------------HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 205 -------------------~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.+++|+|++|.|||++.++.+.|+||+.|..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4599999999999997655567999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=2e-12 Score=125.25 Aligned_cols=136 Identities=13% Similarity=0.122 Sum_probs=101.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc--eeEEEEEeecCCeEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC--IVKLYYSFQDTEYLY 162 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~f~~~~~ly 162 (518)
..+|.+..+.+.|+.+.||++.. .+|..|++|+.... ....+..|..+++.+.+.. +.++++++.+.+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 45677655555677799999853 56778999987543 1234678999999886543 667888888888899
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN------------------------------------ 206 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~g------------------------------------ 206 (518)
+||||++|.+|. .. ... ...++.+++.+|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998884 21 112 2245667777777777643
Q ss_pred ----------------------eEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 207 ----------------------YIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 207 ----------------------iiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
++|+|++|.|||++.++.+.|+|||.|..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998766677999999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.7e-11 Score=123.96 Aligned_cols=142 Identities=17% Similarity=0.239 Sum_probs=107.6
Q ss_pred eEEeeEeecCceEEEEEEEecCCcEEEEEEee--chhhhchhhHHHHHHHHHHHHHhC--CCceeEEEEEeecC---CeE
Q 010116 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK--KSEMVKRGQVEHVRAERNLLAEVA--SHCIVKLYYSFQDT---EYL 161 (518)
Q Consensus 89 ~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~--k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~f~~~---~~l 161 (518)
..++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+|+.+. +..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 35678999999999988643 5678888775 33211 12345778999999997 44688898888776 458
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK------------------------------------- 204 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~------------------------------------- 204 (518)
|+||||++|..+.+.. ...+++.....++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999998875422 2347788888899999999999997
Q ss_pred ---------------------CCeEEcCCCCCceeeCCCCc--EEEeeccccccc
Q 010116 205 ---------------------HNYIHRDIKPDNLLLDKNGH--MKLSDFGLCKPL 236 (518)
Q Consensus 205 ---------------------~giiHRDIKPeNILld~~g~--vKL~DFGla~~~ 236 (518)
.++||+|++|.|||++.++. +.|+||+.|...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999998764 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.9e-11 Score=122.11 Aligned_cols=135 Identities=20% Similarity=0.235 Sum_probs=100.6
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CC--ceeEEEEEeecCC---eEEEE
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SH--CIVKLYYSFQDTE---YLYLI 164 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp--~Iv~l~~~f~~~~---~lylV 164 (518)
++.++.|.+..||++. ..+++|+.... .....+.+|..+|+.+. +. .+.+++....+.. ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3569999999999763 45889986433 23456889999998883 32 2455555544443 34899
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK---------------------------------------- 204 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~---------------------------------------- 204 (518)
|++++|..|..... ..++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988875432 357777788888888888888886
Q ss_pred ------------------CCeEEcCCCCCceeeCC--CCcEEEeecccccccC
Q 010116 205 ------------------HNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPLD 237 (518)
Q Consensus 205 ------------------~giiHRDIKPeNILld~--~g~vKL~DFGla~~~~ 237 (518)
..++|+|++|.|||++. ++.+.|+||+.+...+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 24799999999999998 4567899999987543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=2.1e-07 Score=93.01 Aligned_cols=134 Identities=16% Similarity=0.184 Sum_probs=93.5
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC---ceeEEEEEee-cCCeEEEEEe
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH---CIVKLYYSFQ-DTEYLYLIME 166 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp---~Iv~l~~~f~-~~~~lylVmE 166 (518)
++.++.|....||++ |..+++|+-... .....+.+|..+|+.+.+. .|.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456899999999987 567888985322 2346788999999999753 3556666653 4566889999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH----------------------------------------- 205 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~----------------------------------------- 205 (518)
|++|..+..... ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988765321 2234444444444444444444432
Q ss_pred -------------------CeEEcCCCCCceeeCC---CCcE-EEeeccccccc
Q 010116 206 -------------------NYIHRDIKPDNLLLDK---NGHM-KLSDFGLCKPL 236 (518)
Q Consensus 206 -------------------giiHRDIKPeNILld~---~g~v-KL~DFGla~~~ 236 (518)
.++|+|++|.|||++. +|.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 4699999999999987 4665 89999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=5.4e-07 Score=87.67 Aligned_cols=133 Identities=17% Similarity=0.146 Sum_probs=93.6
Q ss_pred eEeecCce-EEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEEEEeecCC
Q 010116 93 IIGRGAFG-EVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 93 ~LG~G~fG-~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
.+..|..| .||.......+..+.+|+-... ....+.+|..+|+.+. +--|.+++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34455555 6998877777788999986543 3445788999998884 33477888888999999999999999
Q ss_pred CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 010116 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--------------------------------------------- 205 (518)
Q Consensus 171 G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~--------------------------------------------- 205 (518)
.++.+..... ......++.++...|..||+.
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8876654321 111222334444444444421
Q ss_pred -------------CeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 206 -------------NYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 206 -------------giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.++|+|+.|.|||++.++.+-|+||+.|..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 279999999999998877777999998874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=2.8e-07 Score=95.33 Aligned_cols=81 Identities=21% Similarity=0.234 Sum_probs=51.7
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhh-hc---hhhHHHHHHHHHHHHHhCC--C-ceeEEEEEeecCCeEE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-VK---RGQVEHVRAERNLLAEVAS--H-CIVKLYYSFQDTEYLY 162 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~-~~---~~~~~~~~~E~~il~~l~h--p-~Iv~l~~~f~~~~~ly 162 (518)
.++.||.|.++.||++....+++.|++|....... .. ....+++..|..+|+.+.. | .+.+++++ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997666678899998653211 00 0123456779999988743 3 34456544 344467
Q ss_pred EEEeecCCCc
Q 010116 163 LIMEYLPGGD 172 (518)
Q Consensus 163 lVmEy~~gG~ 172 (518)
+||||++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999998743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.31 E-value=5.4e-06 Score=83.02 Aligned_cols=137 Identities=12% Similarity=0.161 Sum_probs=79.5
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC--CCceeEEEE------EeecCCeE
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA--SHCIVKLYY------SFQDTEYL 161 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~------~f~~~~~l 161 (518)
-++.|+.|..+.||++... +..|++|+..... ..+..|..++..+. .-.+++++. +..+.+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 3456677889999988642 3458999886521 23334555555543 112333333 12346778
Q ss_pred EEEEeecCCCchH--------------HHHhhc-CCC--C----------H-H--------H------------------
Q 010116 162 YLIMEYLPGGDMM--------------TLLMRE-DTL--T----------E-N--------V------------------ 187 (518)
Q Consensus 162 ylVmEy~~gG~L~--------------~~l~~~-~~l--~----------e-~--------~------------------ 187 (518)
|+||+|++|..+. ..++.. ..+ + . . .
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986542 111110 111 1 0 0 0
Q ss_pred -----HHHHHHHHHHHHHHHH-------------hCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 188 -----ARFYIAQSVLAIESIH-------------KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 188 -----~~~~~~ql~~aL~~LH-------------~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
...+..++..++.+|+ ..++||+|+.|.|||++.++.+.|+||+.|..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223334566665 25899999999999998889999999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=9.3e-06 Score=82.30 Aligned_cols=87 Identities=9% Similarity=0.065 Sum_probs=57.0
Q ss_pred eeEEeeE-eecCceEEEEEEEe--c----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC---CceeEEEEEeec
Q 010116 88 FELLTII-GRGAFGEVRLCREK--K----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS---HCIVKLYYSFQD 157 (518)
Q Consensus 88 f~i~~~L-G~G~fG~V~l~~~~--~----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h---p~Iv~l~~~f~~ 157 (518)
...++.| +.|..+.||++... . ++..+++|+..............+.+|..+|+.+.. ..+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446788 88999999988653 1 256788998654320000001346678888887742 357778877766
Q ss_pred C---CeEEEEEeecCCCchH
Q 010116 158 T---EYLYLIMEYLPGGDMM 174 (518)
Q Consensus 158 ~---~~lylVmEy~~gG~L~ 174 (518)
. +..|+||||++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 5 3568999999986653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.94 E-value=3.6e-05 Score=80.09 Aligned_cols=33 Identities=12% Similarity=0.225 Sum_probs=28.9
Q ss_pred HhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 203 H~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+...++|+|++|.|||++.++ ++|+||+.|...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 356899999999999998877 999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.87 E-value=0.00013 Score=73.05 Aligned_cols=76 Identities=21% Similarity=0.152 Sum_probs=60.1
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC---CCceeEEEEEeecCCeEEEEEe
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~~~~lylVmE 166 (518)
-++.|+.|....||++.. ++..|++|+.... ....+..|...|+.+. ...+++++.+..+.+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 457889999999998863 5678889986543 2456788988888874 3568888888888889999999
Q ss_pred ecCCCch
Q 010116 167 YLPGGDM 173 (518)
Q Consensus 167 y~~gG~L 173 (518)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.64 E-value=4.7e-05 Score=75.34 Aligned_cols=133 Identities=13% Similarity=0.000 Sum_probs=75.7
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC-ceeEEEEEeecCCeEEEEEeec-
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYL- 168 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~f~~~~~lylVmEy~- 168 (518)
++.|+.|....+|++ ..|++|+....... .....+|..+++.+... ...++++.+.+ .-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecC
Confidence 788999999999988 45888987543110 01124577777766422 22466655433 346899999
Q ss_pred CCCchHHH---------------H---hhcC-CCC-----HHHHHHHHHH--------------HHHHHHHHH----h--
Q 010116 169 PGGDMMTL---------------L---MRED-TLT-----ENVARFYIAQ--------------SVLAIESIH----K-- 204 (518)
Q Consensus 169 ~gG~L~~~---------------l---~~~~-~l~-----e~~~~~~~~q--------------l~~aL~~LH----~-- 204 (518)
+|-.+... | +..+ .++ ...+..+... +...+..|. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66444210 1 1111 011 1122222111 111122221 1
Q ss_pred --CCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 205 --HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 205 --~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
..++|+|+.|.||| ..+|.+.|+||..|...
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 24899999999999 56788999999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00012 Score=72.70 Aligned_cols=142 Identities=12% Similarity=0.052 Sum_probs=80.4
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc--eeEEEEE------eecC
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC--IVKLYYS------FQDT 158 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~------f~~~ 158 (518)
...-++.|+.|....||++... +| .|++|+..... ..+.+..|..++..+.... +.+++.. ....
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 4455678888999999998643 33 68899886521 1123556777777764211 3333321 1224
Q ss_pred CeEEEEEeecCCCchHH--------------HHhhc-CCC--------CHHHHHH---------------HHHHHHHHHH
Q 010116 159 EYLYLIMEYLPGGDMMT--------------LLMRE-DTL--------TENVARF---------------YIAQSVLAIE 200 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~--------------~l~~~-~~l--------~e~~~~~---------------~~~ql~~aL~ 200 (518)
+..++||+|++|..+.. .++.. ..+ ....-.. +...+...+.
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 56799999999864310 11110 011 1000000 0012334455
Q ss_pred HHHh-------CCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 201 SIHK-------HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 201 ~LH~-------~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.++. .++||+|+.|.|||++.++.+.|+||+.|..
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 5552 4799999999999998776568999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00034 Score=69.67 Aligned_cols=136 Identities=10% Similarity=0.158 Sum_probs=78.5
Q ss_pred eeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCC--ceeEEEEE-----eecCCeEEEE
Q 010116 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLYYS-----FQDTEYLYLI 164 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~-----f~~~~~lylV 164 (518)
..|+ |....||++.. .+|+.|++|+...... ....+..|..++..+... .+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88899998753 3466799999863311 234566788888777422 24444433 1234567899
Q ss_pred EeecCCCchH-----------HH---Hhh---c------CCCCHHH----HHHHH---------------HHHHHHHHHH
Q 010116 165 MEYLPGGDMM-----------TL---LMR---E------DTLTENV----ARFYI---------------AQSVLAIESI 202 (518)
Q Consensus 165 mEy~~gG~L~-----------~~---l~~---~------~~l~e~~----~~~~~---------------~ql~~aL~~L 202 (518)
|+|++|..+. .. ++. . ..++... .+.++ ..+-..++.+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885431 01 111 0 0111110 01111 1111122333
Q ss_pred H-------hCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 203 H-------KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 203 H-------~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
. ...+||+|++|.|||++ + .+.|+||+.|..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2 34689999999999998 4 899999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00036 Score=69.82 Aligned_cols=138 Identities=16% Similarity=0.149 Sum_probs=72.7
Q ss_pred EeeEeecCceE-EEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC--CceeEEEEEeecCCeEEEEEee
Q 010116 91 LTIIGRGAFGE-VRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDTEYLYLIMEY 167 (518)
Q Consensus 91 ~~~LG~G~fG~-V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~~~~lylVmEy 167 (518)
++.|+.|+... +|++.. .+|..|++|...... ...+..|..++..+.. -.+.+++.+..+.+ ++|||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 45666665555 666542 236677777644321 0224457777776642 23556666533333 689999
Q ss_pred cCCCchHHHHhhc--------------------------CCCCHHHHH--------HHH------------HHHHHHHHH
Q 010116 168 LPGGDMMTLLMRE--------------------------DTLTENVAR--------FYI------------AQSVLAIES 201 (518)
Q Consensus 168 ~~gG~L~~~l~~~--------------------------~~l~e~~~~--------~~~------------~ql~~aL~~ 201 (518)
+.|..+.+.+... ..++..... .+. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776654433210 112221110 011 011122233
Q ss_pred H------HhCCeEEcCCCCCceeeCCC----CcEEEeecccccccC
Q 010116 202 I------HKHNYIHRDIKPDNLLLDKN----GHMKLSDFGLCKPLD 237 (518)
Q Consensus 202 L------H~~giiHRDIKPeNILld~~----g~vKL~DFGla~~~~ 237 (518)
+ +...+||+|+.|.|||++.+ +.+.|+||+.|....
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 3 23479999999999999875 789999999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00031 Score=72.19 Aligned_cols=141 Identities=16% Similarity=0.208 Sum_probs=85.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEec-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeec
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD 157 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~ 157 (518)
++++ ++.|..|-...+|++.... +++.|.+|+.... ......+.+|..+++.+. +....++++.+.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 3444 3567778889999987642 3578999985331 112345568999988774 3334677777765
Q ss_pred CCeEEEEEeecCCCchHH--------------HHh---hcC-C----C--CHHHHHHHHHHHHH----------------
Q 010116 158 TEYLYLIMEYLPGGDMMT--------------LLM---RED-T----L--TENVARFYIAQSVL---------------- 197 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~--------------~l~---~~~-~----l--~e~~~~~~~~ql~~---------------- 197 (518)
. +||||++|..|.. .|. .-+ . . -...+..|..++-.
T Consensus 126 g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 G----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp E----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred c----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 2 9999999855421 111 110 1 1 13455555544422
Q ss_pred ---HHHHHH----h----CCeEEcCCCCCceeeCCC----CcEEEeecccccc
Q 010116 198 ---AIESIH----K----HNYIHRDIKPDNLLLDKN----GHMKLSDFGLCKP 235 (518)
Q Consensus 198 ---aL~~LH----~----~giiHRDIKPeNILld~~----g~vKL~DFGla~~ 235 (518)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233332 2 269999999999999877 7899999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00031 Score=71.47 Aligned_cols=76 Identities=14% Similarity=0.069 Sum_probs=45.4
Q ss_pred EEeeEeecCceEEEEEEEec--------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc-eeEEEEEeecCCe
Q 010116 90 LLTIIGRGAFGEVRLCREKK--------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEY 160 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~--------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~~ 160 (518)
-++.|+.|....||++.... .+..|++|+...... .......|..+++.+.... +.++++.+. +
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN--G- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET--T-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC--C-
Confidence 35677889899999987643 136788998654311 1112356888888774333 456776652 2
Q ss_pred EEEEEeecCCCch
Q 010116 161 LYLIMEYLPGGDM 173 (518)
Q Consensus 161 lylVmEy~~gG~L 173 (518)
++||||++|..+
T Consensus 110 -~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 -GRIEEWLYGDPL 121 (369)
T ss_dssp -EEEEECCCSEEC
T ss_pred -cEEEEEecCCcC
Confidence 689999988543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00042 Score=72.35 Aligned_cols=74 Identities=24% Similarity=0.301 Sum_probs=50.4
Q ss_pred EEeeEeecCceEEEEEEEec-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeE
Q 010116 90 LLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~l 161 (518)
-++.|+.|....||++.... ++..|.+|+..... ..+.+..|..+++.+. +...+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678889999999997643 25789999874311 1134557888888874 3334677777653
Q ss_pred EEEEeecCCCc
Q 010116 162 YLIMEYLPGGD 172 (518)
Q Consensus 162 ylVmEy~~gG~ 172 (518)
.+||||++|-.
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28999998743
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0029 Score=61.80 Aligned_cols=80 Identities=14% Similarity=-0.019 Sum_probs=55.2
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC---CceeEEEEEeecCCeEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS---HCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h---p~Iv~l~~~f~~~~~ly 162 (518)
....-+..+|.|..+.||+++. .+|+.|.+|+-..... .....+..|...|+.+.. -.+++++.+- . -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ce
Confidence 3456688999999999999874 5788999998654321 112346789999988842 2355555542 2 26
Q ss_pred EEEeecCCCch
Q 010116 163 LIMEYLPGGDM 173 (518)
Q Consensus 163 lVmEy~~gG~L 173 (518)
+||||+.++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0018 Score=65.20 Aligned_cols=32 Identities=19% Similarity=0.223 Sum_probs=28.5
Q ss_pred CCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 205 ~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
.+++|+|+.|.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998889999999987753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0028 Score=59.46 Aligned_cols=120 Identities=18% Similarity=0.157 Sum_probs=79.5
Q ss_pred chHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccc
Q 010116 172 DMMTLLMR-EDTLTENVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (518)
Q Consensus 172 ~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH-~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 249 (518)
+|.++|.. ..+++|++|+-++.|.+.+|.-+- +..-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 78888865 479999999999999999987762 11212333457899999999998763 2111
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHH
Q 010116 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329 (518)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 329 (518)
.....+.|||... .+-+.+.=|+|||+++|..+
T Consensus 98 ----------------------------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 98 ----------------------------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp -------------------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHh
Confidence 0112345777652 34567788999999999988
Q ss_pred hCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc
Q 010116 330 VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC 375 (518)
Q Consensus 330 ~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~ 375 (518)
-=..|= ..+..+|+.+.+||..|..
T Consensus 131 DygL~e---------------------~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 131 DYGLKE---------------------NEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp TTTCCT---------------------TEEECCCHHHHHHHHHHTT
T ss_pred hcCCCc---------------------ccchhhCHHHHHHHHHHHh
Confidence 422221 1123689999999999974
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0094 Score=62.63 Aligned_cols=76 Identities=14% Similarity=0.197 Sum_probs=49.1
Q ss_pred EEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc-eeEEEEEeecCCeEEEEEeec
Q 010116 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYL 168 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~~lylVmEy~ 168 (518)
-++.|+.|-...||++.....+..|++|+..... ...+ ...+|..+|+.+...+ ..++++.|. . .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEee
Confidence 4567888999999999765445788899874421 1111 1257888999886443 467777774 2 2599999
Q ss_pred CCCch
Q 010116 169 PGGDM 173 (518)
Q Consensus 169 ~gG~L 173 (518)
+|-.|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 88443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0085 Score=62.30 Aligned_cols=76 Identities=11% Similarity=0.080 Sum_probs=49.1
Q ss_pred EEeeEeecCceEEEEEEEecC-------CcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeE
Q 010116 90 LLTIIGRGAFGEVRLCREKKS-------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 90 i~~~LG~G~fG~V~l~~~~~t-------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~l 161 (518)
-++.|..|-...+|++..... +..|.+++..... ...+ ...+|..+++.+. +....++++.+..
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~~---- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFY-DSKVELDVFRYLSNINIAPNIIADFPE---- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCC-CHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhc-CHHHHHHHHHHHHhcCCCCCEEEEcCC----
Confidence 356677788999999976521 5789999864321 1111 2346888887774 3345666665532
Q ss_pred EEEEeecCCCch
Q 010116 162 YLIMEYLPGGDM 173 (518)
Q Consensus 162 ylVmEy~~gG~L 173 (518)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.75 E-value=0.31 Score=49.90 Aligned_cols=30 Identities=27% Similarity=0.458 Sum_probs=25.9
Q ss_pred CeEEcCCCCCceee------CCCCcEEEeecccccc
Q 010116 206 NYIHRDIKPDNLLL------DKNGHMKLSDFGLCKP 235 (518)
Q Consensus 206 giiHRDIKPeNILl------d~~g~vKL~DFGla~~ 235 (518)
.++|.|+.+.|||+ +.++.+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567899999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 518 | ||||
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-84 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-84 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-84 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-80 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-79 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-76 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-74 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-74 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-72 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-71 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-71 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-71 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-70 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-70 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-65 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-61 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-61 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-59 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-56 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-55 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-52 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-51 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-48 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-47 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-46 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-39 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-35 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-15 |
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (669), Expect = 2e-84
Identities = 111/380 (29%), Positives = 180/380 (47%), Gaps = 65/380 (17%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
++DF L ++G+G+FG+V L KK+ +A+K LKK ++ VE E+ +L+
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 145 SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
H + ++ +FQ E L+ +MEYL GGD+M + + A FY A+ +L ++ +H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
++RD+K DN+LLDK+GH+K++DFG+CK
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----------------------- 157
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
+ GTPDYIAPE+LL + Y DWWS G
Sbjct: 158 --------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 191
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382
++YEML+G PF+ D I ++ +P L EAKDL+ +L + E RLG
Sbjct: 192 LLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLG 247
Query: 383 TGGAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSG 440
I+ HP F+++ W++L E++ F+P++ D NF K + P
Sbjct: 248 V--RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKP-----RLS 300
Query: 441 PSRKMLLTPKD-LSFVGYTY 459
+ + L+ D F +++
Sbjct: 301 FADRALINSMDQNMFRNFSF 320
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (665), Expect = 4e-84
Identities = 101/337 (29%), Positives = 168/337 (49%), Gaps = 58/337 (17%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
K +DF+ I+G G+F V L RE + YA+K L+K ++K +V +V ER++++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ VKLY++FQD E LY + Y G+++ + + + E RFY A+ V A+E
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H IHRD+KP+N+LL+++ H++++DFG K
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAK--------------------------- 156
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
+++ A S VGT Y++PE+L +K D W+L
Sbjct: 157 --------------------VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
G I+Y+++ G PPF A + +KI+ L++ K P+A+DL+ +LL D R
Sbjct: 197 GCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPEKFFPKARDLVEKLLVLDATKR 252
Query: 381 LG---TGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEI 414
LG G +KAHP+F+ V W+ L++ P++
Sbjct: 253 LGCEEMEGYGPLKAHPFFESVTWENLHQQTP---PKL 286
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (669), Expect = 4e-84
Identities = 123/386 (31%), Positives = 179/386 (46%), Gaps = 61/386 (15%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
K+ ++DF+ L ++G+G FG+V L REK +G YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ L Y+FQ + L +MEY GG++ L RE TE ARFY A+ V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H + ++RDIK +NL+LDK+GH+K++DFGLCK
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---------------- 164
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
GTP+Y+APEVL YG DWW L
Sbjct: 165 ---------------------------------FCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
G +MYEM+ G PFY D I+ ++FP LSPEAK L+ LL D + R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRT--LSPEAKSLLAGLLKKDPKQR 247
Query: 381 LGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGR 436
LG G A ++ H +F + W + ++ FKP++ E+DT+ F
Sbjct: 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITP 307
Query: 437 TSSGPSRKMLLTPK---DLSFVGYTY 459
S +L + F + Y
Sbjct: 308 PDRYDSLGLLELDQREEQEMFEDFDY 333
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 251 bits (643), Expect = 2e-80
Identities = 128/355 (36%), Positives = 188/355 (52%), Gaps = 62/355 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DF++L +G G+FG V L R + +G YAMK LKK +V+ QVEH ER +L+ V
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I++++ +FQD + +++IM+Y+ GG++ +LL + VA+FY A+ LA+E +H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+ I+RD+KP+N+LLDKNGH+K++DF K + D
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDF--------------GFAKYVPDVTY---------- 159
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325
+ GTPDYIAPEV+ K Y DWWS G ++
Sbjct: 160 ----------------------------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 191
Query: 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT- 383
YEML GY PFY + + T KI++ L+FP + + KDL+ RL+ D+ RLG
Sbjct: 192 YEMLAGYTPFYDSNTMKTYEKILNAE--LRFPP--FFNEDVKDLLSRLITRDLSQRLGNL 247
Query: 384 -GGAHQIKAHPWFKDVVWDKLY--EMEAAFKPEI-NGELDTQNFMKFDELDPPAS 434
G +K HPWFK+VVW+KL +E ++P I G+ DT F K+ E D
Sbjct: 248 QNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYG 302
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 8e-79
Identities = 94/316 (29%), Positives = 138/316 (43%), Gaps = 59/316 (18%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ ++DFE+ +G+G FG V L REK+S I A+K L K+++ K G +R E + +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ I++LY F D +YLI+EY P G + L + E YI + A+
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
H IHRDIKP+NLLL G +K++DFG S +
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----------------- 164
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
GT DY+ PE++ + + + D WSL
Sbjct: 165 ----------------------------------CGTLDYLPPEMIEGRMHDEKVDLWSL 190
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
G + YE LVG PPF A+ T ++I R FPD ++ A+DLI RLL + R
Sbjct: 191 GVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDF--VTEGARDLISRLLKHNPSQR 246
Query: 381 LGTGGAHQIKAHPWFK 396
++ HPW
Sbjct: 247 P---MLREVLEHPWIT 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 242 bits (617), Expect = 3e-76
Identities = 130/385 (33%), Positives = 194/385 (50%), Gaps = 65/385 (16%)
Query: 59 EEQINLIKDLERKETEFMR----LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY 114
EQ ++ + L + + +F++ ++ +D F+ + +G G+FG V L + K+SGN Y
Sbjct: 10 SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 115 AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMM 174
AMK L K ++VK Q+EH E+ +L V +VKL +SF+D LY++MEY+ GG+M
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 175 TLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ L R +E ARFY AQ VL E +H + I+RD+KP+NLL+D+ G+++++DFG K
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294
K L
Sbjct: 190 R--------------------------------------VKGRTWTLCGT---------- 201
Query: 295 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL 354
P+ +APE++L KGY DWW+LG ++YEM GYPPF+AD PI KI +
Sbjct: 202 ----PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKV 255
Query: 355 KFPDDSKLSPEAKDLICRLLC-DVEHRLGT--GGAHQIKAHPWFKDVVWDKLY--EMEAA 409
+FP S + KDL+ LL D+ R G G + IK H WF W +Y ++EA
Sbjct: 256 RFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313
Query: 410 FKPEINGELDTQNFMKFDELDPPAS 434
F P+ G DT NF ++E + S
Sbjct: 314 FIPKFKGPGDTSNFDDYEEEEIRVS 338
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 237 bits (605), Expect = 2e-74
Identities = 83/369 (22%), Positives = 149/369 (40%), Gaps = 60/369 (16%)
Query: 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
+H +D +++ +G GAFG V E+ +GN +A K + + E VR E
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQT 76
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLA 198
++ + +V L+ +F+D + +I E++ GG++ + E ++E+ A Y+ Q
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 199 IESIHKHNYIHRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ +H++NY+H D+KP+N++ ++ +KL DFGL
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---------------------- 174
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316
++ ++ T GT ++ APEV K G
Sbjct: 175 ----------------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC- 375
D WS+G + Y +L G PF ++ T R + ++ S +S + KD I +LL
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 266
Query: 376 DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASG 435
D R+ HQ HPW + + + + + E PP
Sbjct: 267 DPNTRM---TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGR 323
Query: 436 RTSSGPSRK 444
++ RK
Sbjct: 324 ISNYSSLRK 332
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 237 bits (605), Expect = 3e-74
Identities = 100/359 (27%), Positives = 154/359 (42%), Gaps = 63/359 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+DF + IIGRG FGEV CR+ +G +YAMK L K + + ER +L+ V++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 146 HC---IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
IV + Y+F + L I++ + GGD+ L + +E RFY A+ +L +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H ++RD+KP N+LLD++GH+++SD GL +A
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----------------- 166
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSL 321
GT Y+APEVL K Y DW+SL
Sbjct: 167 ----------------------------------GTHGYMAPEVLQKGVAYDSSADWFSL 192
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
G +++++L G+ PF +I + SPE + L+ LL DV R
Sbjct: 193 GCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 251
Query: 381 LGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELDTQNF--MKFDELDPPA 433
LG GA ++K P+F+ + W ++ + P F FDE D
Sbjct: 252 LGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKG 310
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 231 bits (590), Expect = 3e-73
Identities = 85/328 (25%), Positives = 137/328 (41%), Gaps = 67/328 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK------RGQVEHVRAERNL 139
+++E I+GRG VR C K + YA+K + + + E E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 140 LAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
L +V+ H I++L +++ + +L+ + + G++ L + TL+E R + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
I ++HK N +HRD+KP+N+LLD + ++KL+DFG LD
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---------------- 166
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------KKGY 312
GTP Y+APE++ GY
Sbjct: 167 ----------------------------------REVCGTPSYLAPEIIECSMNDNHPGY 192
Query: 313 GMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICR 372
G E D WS G IMY +L G PPF+ + R I+ P+ S KDL+ R
Sbjct: 193 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 373 LLC-DVEHRLGTGGAHQIKAHPWFKDVV 399
L + R A + AHP+F+ V
Sbjct: 253 FLVVQPQKRY---TAEEALAHPFFQQYV 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 4e-72
Identities = 70/315 (22%), Positives = 122/315 (38%), Gaps = 55/315 (17%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
V+D++L+ +G GA+GEV+L + + A+K + V E+++ E + +
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKML 60
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
+VK Y ++ YL +EY GG++ + + + E A+ + Q + + +H
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
HRDIKP+NLLLD+ ++K+SDFGL +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN------------------------ 156
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLG 322
NR +L GT Y+APE+L ++ + D WS G
Sbjct: 157 -----------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381
++ ML G P+ K+ L+ ++L + R+
Sbjct: 194 IVLTAMLAGELPWDQPSDSCQEYSDWK-EKKTYLNPWKKIDSAPLALLHKILVENPSARI 252
Query: 382 GTGGAHQIKAHPWFK 396
IK W+
Sbjct: 253 ---TIPDIKKDRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (581), Expect = 1e-71
Identities = 78/333 (23%), Positives = 136/333 (40%), Gaps = 63/333 (18%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +E++ +G GAFG+V + K++ + A K + ++E E ++LA
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK 204
IVKL +F L++++E+ GG + +++ E LTE+ + Q++ A+ +H
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+ IHRD+K N+L +G +KL+DFG+
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--------------------------- 161
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDWW 319
+ S +GTP ++APEV++ + Y + D W
Sbjct: 162 ----------------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199
Query: 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVE 378
SLG + EM PP + +P+ KI S+ S KD + + L +V+
Sbjct: 200 SLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSRWSSNFKDFLKKCLEKNVD 258
Query: 379 HRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFK 411
R Q+ HP+ + E+ A K
Sbjct: 259 ARW---TTSQLLQHPFVTVDSNKPIRELIAEAK 288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 229 bits (586), Expect = 1e-71
Identities = 83/392 (21%), Positives = 161/392 (41%), Gaps = 61/392 (15%)
Query: 58 MEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMK 117
+ + +D+ +K + D +++L +G GAFG V C EK +G ++ K
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60
Query: 118 KLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL 177
+ + + V+ E +++ ++ ++ L+ +F+D + LI+E+L GG++ +
Sbjct: 61 FINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 117
Query: 178 MRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--KNGHMKLSDFGLCK 234
ED ++E Y+ Q+ ++ +H+H+ +H DIKP+N++ + K +K+ DFGL
Sbjct: 118 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177
Query: 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294
L+ +
Sbjct: 178 KLNPDEIV--------------------------------------------------KV 187
Query: 295 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL 354
T T ++ APE++ ++ G D W++G + Y +L G PF +D + T + +
Sbjct: 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 247
Query: 355 KFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPE 413
S +SPEAKD I LL + RL H HPW K + + ++ +
Sbjct: 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGDHSNLTSRIPSSRYNK 304
Query: 414 INGELDTQNFMKFDELDPPASGRTSSGPSRKM 445
I ++ + + + P + RK
Sbjct: 305 IRQKIK-EKYADWPAPQPAIGRIANFSSLRKH 335
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 227 bits (581), Expect = 2e-71
Identities = 91/345 (26%), Positives = 146/345 (42%), Gaps = 62/345 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D ++ ++G GAF EV L +K++ + A+K + K + G+ + E +L ++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV L ++ +LYLIM+ + GG++ ++ + TE A I Q + A++ +H
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+HRD+KP+NLL D++ + +SDFGL K D ++
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-------------------- 166
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
+ GTP Y+APEVL +K Y D WS+G
Sbjct: 167 ------------------------------STACGTPGYVAPEVLAQKPYSKAVDCWSIG 196
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381
I Y +L GYPPFY ++ +I+ P +S AKD I L+ D E R
Sbjct: 197 VIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF 256
Query: 382 GTGGAHQIKAHPWFK-DVVWDKLYEMEAAFKPEINGELDTQNFMK 425
Q HPW D DK + + +I + +
Sbjct: 257 ---TCEQALQHPWIAGDTALDK--NIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 3e-70
Identities = 119/350 (34%), Positives = 184/350 (52%), Gaps = 60/350 (17%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRGQ-VEHVRAER 137
K+ +++FELL ++G GA+G+V L R+ +G +YAMK LKK+ +V++ + EH R ER
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 138 NLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+L + +V L+Y+FQ L+LI++Y+ GG++ T L + + TE+ + Y+ + V
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
LA+E +HK I+RDIK +N+LLD NGH+ L+DFGL
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS----------------------- 176
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL--KKGYGM 314
+ + + + A+ GT +Y+AP+++ G+
Sbjct: 177 -------------------------KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 211
Query: 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
DWWSLG +MYE+L G PF D + +I + P ++S AKDLI RLL
Sbjct: 212 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLL 271
Query: 375 C-DVEHRLGTG--GAHQIKAHPWFKDVVWDKLY--EMEAAFKPEINGELD 419
D + RLG G A +IK H +F+ + WD L ++ A FKP I ELD
Sbjct: 272 MKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 9e-70
Identities = 83/331 (25%), Positives = 138/331 (41%), Gaps = 62/331 (18%)
Query: 72 ETEFMRLKRHKICVDD----FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR 127
+ E + R + V D + IG+GA G V + +G A++++ + K+
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 128 GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV 187
E + E ++ E + IV S+ + L+++MEYL GG + ++ E
Sbjct: 62 ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQ 117
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ + A+E +H + IHRDIK DN+LL +G +KL+DFG C +
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-------- 169
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
+ + VGTP ++APEV+
Sbjct: 170 -----------------------------------------QSKRSTMVGTPYWMAPEVV 188
Query: 308 LKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAK 367
+K YG + D WSLG + EM+ G PP+ ++P+ I + + KLS +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFR 247
Query: 368 DLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
D + R L DVE R A ++ H + K
Sbjct: 248 DFLNRCLDMDVEKRG---SAKELLQHQFLKI 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-68
Identities = 74/359 (20%), Positives = 121/359 (33%), Gaps = 98/359 (27%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE ++ +G G G V K SG + A K + +K + E +L E S
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH-K 204
IV Y +F + + ME++ GG + +L + + E + + + + K
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
H +HRD+KP N+L++ G +KL DFG+ L S
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---------------------- 161
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
S VGT Y++PE L Y ++ D WS+G
Sbjct: 162 -----------------------------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 192
Query: 325 MYEMLVGYPPFYADD--------------------------------------PITTCRK 346
+ EM VG P D P +
Sbjct: 193 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252
Query: 347 IVHWRNHLKFP--DDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDK 402
++ + + P S E +D + + L + R Q+ H + K ++
Sbjct: 253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEE 308
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (553), Expect = 4e-67
Identities = 69/348 (19%), Positives = 121/348 (34%), Gaps = 62/348 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
F L IG G+FG V R+ ++ + A+KK+ S + + + E L ++
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
++ + +L+MEY G L + + L E ++ + +H H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
N IHRD+K N+LL + G +KL DFG + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------------------------- 169
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWSLG 322
S VGTP ++APEV+L + Y + D WSLG
Sbjct: 170 ----------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381
E+ PP + + ++ I +N S ++ + L + R
Sbjct: 202 ITCIELAERKPPLFNMNAMSALYHIA--QNESPALQSGHWSEYFRNFVDSCLQKIPQDRP 259
Query: 382 GTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDEL 429
+ + H + + + ELD + K ++
Sbjct: 260 ---TSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-66
Identities = 84/321 (26%), Positives = 132/321 (41%), Gaps = 68/321 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+D+E+L IG G++G + R K G I K+L M + + + +E NLL E+
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 62
Query: 146 HCIVKLYYSFQDTE--YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAI 199
IV+ Y D LY++MEY GGD+ +++ + L E + Q LA+
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 200 ESIHK-----HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
+ H+ H +HRD+KP N+ LD ++KL DFGL + L+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----------------- 165
Query: 255 MAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314
+ A + VGTP Y++PE + + Y
Sbjct: 166 --------------------------------HDTSFAKAFVGTPYYMSPEQMNRMSYNE 193
Query: 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374
+ D WSLG ++YE+ PPF A KI + + S E ++I R+L
Sbjct: 194 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RIPYRYSDELNEIITRML 250
Query: 375 C-DVEHRLGTGGAHQIKAHPW 394
HR +I +P
Sbjct: 251 NLKDYHRP---SVEEILENPL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 2e-65
Identities = 79/363 (21%), Positives = 132/363 (36%), Gaps = 65/363 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + + +GRG FG V C E S Y K +K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHK 204
I+ L+ SF+ E L +I E++ G D+ + L E Y+ Q A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 205 HNYIHRDIKPDNLLLD--KNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
HN H DI+P+N++ ++ +K+ +FG + L +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR------------------- 161
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322
P+Y APEV D WSLG
Sbjct: 162 -------------------------------LLFTAPEYYAPEVHQHDVVSTATDMWSLG 190
Query: 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381
++Y +L G PF A+ I++ ++S EA D + RLL + + R+
Sbjct: 191 TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM 250
Query: 382 GTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGP 441
A + HPW K K+ + + +K D ++ R S G
Sbjct: 251 ---TASEALQHPWLK----QKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGG 303
Query: 442 SRK 444
+ +
Sbjct: 304 AIR 306
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 4e-65
Identities = 79/328 (24%), Positives = 131/328 (39%), Gaps = 61/328 (18%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEHVRAERNLLAE 142
D ++ +G G F V+ CREK +G YA K +KK + E + E ++L E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+ ++ L+ +++ + LI+E + GG++ L +++LTE A ++ Q + + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 203 HKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
H H D+KP+N++L +K+ DFGL +D +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI------------- 176
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GTP+++APE++ + G+E D
Sbjct: 177 -------------------------------------FGTPEFVAPEIVNYEPLGLEADM 199
Query: 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377
WS+G I Y +L G PF D T + + S S AKD I RLL D
Sbjct: 200 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDP 259
Query: 378 EHRLGTGGAHQIKAHPWFKDVVWDKLYE 405
+ R+ HPW K +
Sbjct: 260 KKRM---TIQDSLQHPWIKPKDTQQALS 284
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 4e-64
Identities = 62/317 (19%), Positives = 116/317 (36%), Gaps = 65/317 (20%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ IGRG+F V + ++ A +L+ ++ K + + + E +L +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69
Query: 148 IVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
IV+ Y S++ T + + L+ E + G + T L R + V R + Q + ++ +H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 204 KHNY--IHRDIKPDNLLL-DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
IHRD+K DN+ + G +K+ D GL
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------------------------- 163
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
+ R A + +GTP+++APE+ ++ Y D ++
Sbjct: 164 -------------------------LKRASFAKAVIGTPEFMAPEM-YEEKYDESVDVYA 197
Query: 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379
G M EM P+ + V D PE K++I + + +
Sbjct: 198 FGMCMLEMATSEYPYSECQNAAQIYRRVT-SGVKPASFDKVAIPEVKEIIEGCIRQNKDE 256
Query: 380 RLGTGGAHQIKAHPWFK 396
R + H +F+
Sbjct: 257 RY---SIKDLLNHAFFQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-61
Identities = 84/338 (24%), Positives = 139/338 (41%), Gaps = 78/338 (23%)
Query: 76 MRLKRHKICVDDFELLT-IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVR 134
+++K++ I +DD+++ + ++G G G+V K++ +A+K L+ +R
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------- 53
Query: 135 AERNLLAEVASH-CIVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMR--EDTLTENV 187
E L + IV++ +++ + L ++ME L GG++ + + + TE
Sbjct: 54 -EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLCKPLDCSTLYAI 244
A + AI+ +H N HRD+KP+NLL N +KL+DFG K
Sbjct: 113 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 170
Query: 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304
+ TP Y+AP
Sbjct: 171 ------------------------------------------------TTPCYTPYYVAP 182
Query: 305 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTC----RKIVHWRNHLKFPDDS 360
EVL + Y CD WSLG IMY +L GYPPFY++ + +I + P+ S
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 361 KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
++S E K LI LL + R+ + HPW
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 199 bits (507), Expect = 7e-61
Identities = 68/303 (22%), Positives = 115/303 (37%), Gaps = 51/303 (16%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +EL I+G G EV L R+ + A+K L+ R E A +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 146 HCIVKLYYSFQDTE----YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
IV +Y + + Y++MEY+ G + ++ E +T A IA + A+
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
H++ IHRD+KP N+++ +K+ DFG+ + +
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI------------------------- 161
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
N + +GT Y++PE D +SL
Sbjct: 162 ---------------------ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
G ++YE+L G PPF D P++ + V LS + ++ + L + E+R
Sbjct: 201 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 260
Query: 381 LGT 383
T
Sbjct: 261 YQT 263
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-59
Identities = 77/326 (23%), Positives = 124/326 (38%), Gaps = 73/326 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH---VRAERNLLAE 142
+++ ++G G FG V A+K ++K + G++ + V E LL +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 143 VASHC--IVKLYYSFQDTEYLYLIMEYL-PGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
V+S +++L F+ + LI+E P D+ + L E +AR + Q + A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 200 ESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
H +HRDIK +N+L+D N G +KL DFG L +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---------------- 167
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD 317
GT Y PE + Y G
Sbjct: 168 -----------------------------------DFDGTRVYSPPEWIRYHRYHGRSAA 192
Query: 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-D 376
WSLG ++Y+M+ G PF D+ I R + F ++S E + LI L
Sbjct: 193 VWSLGILLYDMVCGDIPFEHDEEII--------RGQVFFRQ--RVSSECQHLIRWCLALR 242
Query: 377 VEHRLGTGGAHQIKAHPWFKDVVWDK 402
R +I+ HPW +DV+ +
Sbjct: 243 PSDRP---TFEEIQNHPWMQDVLLPQ 265
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-56
Identities = 82/337 (24%), Positives = 130/337 (38%), Gaps = 80/337 (23%)
Query: 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASH 146
E L +G G F V R+K + I A+KK+K K G E LL E++
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
I+ L +F + L+ +++ + + LT + + Y+ ++ +E +H+H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
+HRD+KP+NLLLD+NG +KL+DFGL K
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK-------------------------------- 148
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 325
S+ SP+ H V T Y APE+L + YG+ D W++G I+
Sbjct: 149 ------SFGSPNRAYTHQ-----------VVTRWYRAPELLFGARMYGVGVDMWAVGCIL 191
Query: 326 YEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPDD---------------SK 361
E+L+ P D + +I W + PD S
Sbjct: 192 AELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 251
Query: 362 LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+ DLI L + R+ A Q +F +
Sbjct: 252 AGDDLLDLIQGLFLFNPCARI---TATQALKMKYFSN 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 9e-55
Identities = 74/351 (21%), Positives = 116/351 (33%), Gaps = 87/351 (24%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
V +E L IG+G FGEV R +K+G A+KK+ K G E +L +
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK 67
Query: 145 SHCIVKLYYSFQDTE--------YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+V L + +YL+ ++ L T + + + +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ IH++ +HRD+K N+L+ ++G +KL+DFGL + + + +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR------ 181
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGME 315
V T Y PE+LL ++ YG
Sbjct: 182 ---------------------------------------VVTLWYRPPELLLGERDYGPP 202
Query: 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPDDSKL---- 362
D W G IM EM P + I W N + KL
Sbjct: 203 IDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVK 262
Query: 363 ---------------SPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
P A DLI +LL D R+ + H +F
Sbjct: 263 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI---DSDDALNHDFFWS 310
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 9e-54
Identities = 82/341 (24%), Positives = 122/341 (35%), Gaps = 81/341 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
++F+ + IG G +G V R K +G + A+KK++ G E +LL E+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHK 204
IVKL LYL+ E+L + T + + + Y+ Q + + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
H +HRD+KP NLL++ G +KL+DFGL +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------------------------ 156
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 323
+ V T Y APE+LL Y D WSLG
Sbjct: 157 -------------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPDD--------------- 359
I EM+ F D I +I W PD
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV 251
Query: 360 -SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398
L + + L+ ++L D R+ A AHP+F+DV
Sbjct: 252 VPPLDEDGRSLLSQMLHYDPNKRI---SAKAALAHPFFQDV 289
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 4e-53
Identities = 53/304 (17%), Positives = 104/304 (34%), Gaps = 63/304 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ IG G+FG V + A+K L + + Q++ + E +L +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRH 63
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHK 204
I+ + + L ++ ++ G + L +T Q+ ++ +H
Sbjct: 64 VNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+ IHRD+K +N+ L ++ +K+ DFGL
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS--------------------------- 155
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECDWWSL 321
+ + G+ ++APEV+ K Y + D ++
Sbjct: 156 --------------------RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 195
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKL----SPEAKDLICRLLC-D 376
G ++YE++ G P+ + +V PD SK+ K L+ L
Sbjct: 196 GIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPKAMKRLMAECLKKK 253
Query: 377 VEHR 380
+ R
Sbjct: 254 RDER 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-53
Identities = 67/326 (20%), Positives = 116/326 (35%), Gaps = 61/326 (18%)
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLC--REKKSGNIYAMKKLKKSEMVKRGQVEHV 133
+ LKR + + D E +G G FG VR R +K A+K LK+ ++ E +
Sbjct: 3 LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEM 56
Query: 134 RAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYI 192
E ++ ++ + IV+L Q L L+ME GG + L+ + + + + +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
Q + ++ + + N++HRD+ N+LL + K+SDFGL K L Y
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY---------- 165
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
+ + APE + + +
Sbjct: 166 ------------------------------------YTARSAGKWPLKWYAPECINFRKF 189
Query: 313 GMECDWWSLGAIMYEML-VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLIC 371
D WS G M+E L G P+ I + ++ P + PE L+
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPE--CPPELYALMS 246
Query: 372 RLLC-DVEHRLGTGGAHQIKAHPWFK 396
E R Q ++
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 8e-53
Identities = 65/320 (20%), Positives = 113/320 (35%), Gaps = 59/320 (18%)
Query: 87 DFELLTI----IGRGAFGEVRLC--REKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
D +LLT+ +G G FG V+ + KK A+K LK E + + AE N++
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVM 62
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
++ + IV++ + E L+ME G + L + + + + Q + ++
Sbjct: 63 QQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+ + N++HRD+ N+LL + K+SDFGL K L
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--------------------- 160
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
N K + APE + + + D WS
Sbjct: 161 -------------------------ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 195
Query: 321 LGAIMYEML-VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVE 378
G +M+E G P+ + + + E DL+ DVE
Sbjct: 196 FGVLMWEAFSYGQKPYRGMKGSEVTAML---EKGERMGCPAGCPREMYDLMNLCWTYDVE 252
Query: 379 HRLGTGGAHQIKAHPWFKDV 398
+R G + ++ V
Sbjct: 253 NRPGFAAVELRLRNYYYDVV 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-52
Identities = 88/402 (21%), Positives = 139/402 (34%), Gaps = 111/402 (27%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ +IG G+FG V + SG + A+KK+ + + K E ++ ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDH 72
Query: 146 HCIVKLYYSF------QDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSV 196
IV+L Y F +D YL L+++Y+P + TL + Y+ Q
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
++ IH HRDIKP NLLLD + +KL DFG K
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--------------------- 171
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGM 314
Q+ R + S + + Y APE++ Y
Sbjct: 172 -----------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYTS 202
Query: 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------------WRNHLKFPD- 358
D WS G ++ E+L+G P F D + +I+ KFP
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 262
Query: 359 ---------DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEA 408
+ PEA L RLL RL + AH +F ++
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDP------- 312
Query: 409 AFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTPK 450
++ DT F + +S+ P +L+ P
Sbjct: 313 --NVKLPNGRDTPALFNFTTQE-----LSSNPPLATILIPPH 347
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 176 bits (448), Expect = 3e-52
Identities = 76/339 (22%), Positives = 119/339 (35%), Gaps = 81/339 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + L IG G +G V + G +A+KK++ + G E ++L E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKH 59
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IVKLY + L L+ E+L L + E L A+ ++ Q + I H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+HRD+KP NLL+++ G +K++DFGL +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV------------------------- 154
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAI 324
+ + T Y AP+VL+ Y D WS+G I
Sbjct: 155 ------------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 325 MYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPDDS--------------- 360
EM+ G P F +I W N + P
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 361 -KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
L DL+ ++L D R+ A Q H +FK+
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRI---TAKQALEHAYFKE 286
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-52
Identities = 80/377 (21%), Positives = 131/377 (34%), Gaps = 86/377 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L+ IG GA+G V + + A+KK+ E + + E +L
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 146 HCIVKLYYSFQDTEY----LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
I+ + + ++ +L G D+ LL + L+ + +++ Q + ++
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
IH N +HRD+KP NLLL+ +K+ DFGL + D
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH--------------------- 163
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWS 320
+ V T Y APE++L GY D WS
Sbjct: 164 -------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 198
Query: 321 LGAIMYEMLVGYPPFYADDPITTCRKIVH------------------WRNHLKFPDDSK- 361
+G I+ EML P F + I+ L P +K
Sbjct: 199 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 258
Query: 362 --------LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKP 412
+A DL+ ++L + R+ Q AHP+ + +D E A
Sbjct: 259 PWNRLFPNADSKALDLLDKMLTFNPHKRI---EVEQALAHPYLEQ-YYDPSDEPIAEAPF 314
Query: 413 EINGELDTQNFMKFDEL 429
+ + ELD K EL
Sbjct: 315 KFDMELDDLPKEKLKEL 331
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-51
Identities = 63/361 (17%), Positives = 123/361 (34%), Gaps = 90/361 (24%)
Query: 59 EEQINLIKDLERKETEFMRLKRHKICVD--------DFELLTIIGRGAFGEVRLCREKKS 110
E Q+ +++ + E+ + + D + E ++G GAFG+V
Sbjct: 2 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61
Query: 111 GNI-----YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLI 164
A+K LK+ + E + +E ++ ++ SH IV L + + +YLI
Sbjct: 62 SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 165 MEYLPGGDMMTLLMRE-----------------------DTLTENVARFYIAQSVLAIES 201
EY GD++ L + + LT + Q +E
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+ + +HRD+ N+L+ +K+ DFGL + + + Y +
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR---------------- 223
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
+ ++APE L + Y ++ D WS
Sbjct: 224 -------------------------------GNARLPVKWMAPESLFEGIYTIKSDVWSY 252
Query: 322 GAIMYEML-VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379
G +++E+ +G P+ K++ +N K + E ++ D
Sbjct: 253 GILLWEIFSLGVNPYPGIPVDANFYKLI--QNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310
Query: 380 R 380
R
Sbjct: 311 R 311
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 176 bits (446), Expect = 2e-51
Identities = 73/376 (19%), Positives = 131/376 (34%), Gaps = 105/376 (27%)
Query: 69 ERKETEFMRLKRHKIC---VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV 125
+ E+ + H + DD++L+ +GRG + EV + +K LK
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--- 71
Query: 126 KRGQVEHVRAERNLLAEVASH-CIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMREDT 182
+ + ++ E +L + I+ L +D + L+ E++ D L
Sbjct: 72 ---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--- 125
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTL 241
LT+ RFY+ + + A++ H +HRD+KP N+++D ++ ++L D+GL +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
Y + V + +
Sbjct: 186 YNVR--------------------------------------------------VASRYF 195
Query: 302 IAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYADD--------------------- 339
PE+L+ + Y D WSLG ++ M+ PF+
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 340 -------------PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGG 385
I W + + +SPEA D + +LL D + RL
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL---T 312
Query: 386 AHQIKAHPWFKDVVWD 401
A + HP+F VV D
Sbjct: 313 AREAMEHPYFYTVVKD 328
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 3e-51
Identities = 73/347 (21%), Positives = 126/347 (36%), Gaps = 86/347 (24%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGN-IYAMKKLKKSEMVKRGQVEHVR--AERNLLA 141
+E + IG GA+G+V R+ K+G A+K+++ + + +R A L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 142 EVASHCIVKLYYSFQDTE-----YLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQS 195
+V+L+ + L L+ E++ L E + + + Q
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+ ++ +H H +HRD+KP N+L+ +G +KL+DFGL +
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR--------------------- 164
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315
+ + S V T Y APEVLL+ Y
Sbjct: 165 -----------------------------IYSFQMALTSVVVTLWYRAPEVLLQSSYATP 195
Query: 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVH---------WRNHLKFPDD------- 359
D WS+G I EM P F + KI+ W + P
Sbjct: 196 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 255
Query: 360 -------SKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398
+ + KDL+ + L + R+ A+ +HP+F+D+
Sbjct: 256 QPIEKFVTDIDELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQDL 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (439), Expect = 9e-51
Identities = 62/341 (18%), Positives = 124/341 (36%), Gaps = 72/341 (21%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ D + +G G +GEV KK A+K LK+ M +VE E ++ E
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIE 200
+ +V+L Y+I E++ G+++ L ++ V + Q A+E
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+ K N+IHRD+ N L+ +N +K++DFGL + + T A
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--------------- 174
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
+ APE L + ++ D W+
Sbjct: 175 ---------------------------------GAKFPIKWTAPESLAYNKFSIKSDVWA 201
Query: 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379
G +++E+ Y ++ +++ ++ P+ + +L+ +
Sbjct: 202 FGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG--CPEKVYELMRACWQWNPSD 259
Query: 380 RLGTGGAHQIKAHPWFKDVVW--DKLYEMEAAFKPEINGEL 418
R P F ++ + +++ E++ E+ EL
Sbjct: 260 R------------PSFAEIHQAFETMFQ-ESSISDEVEKEL 287
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-50
Identities = 55/301 (18%), Positives = 97/301 (32%), Gaps = 55/301 (18%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
D LL +G G+FG VR A+K LK + + ++ E N +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIES 201
+ +++LY + ++ E P G ++ L + Y Q +
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+ +IHRD+ NLLL +K+ DFGL + L + + + +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-------------- 172
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
+ APE L + + D W
Sbjct: 173 --------------------------------HRKVPFAWCAPESLKTRTFSHASDTWMF 200
Query: 322 GAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379
G ++EM G P+ + KI L P+D + +++ + E
Sbjct: 201 GVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED--CPQDIYNVMVQCWAHKPED 258
Query: 380 R 380
R
Sbjct: 259 R 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-49
Identities = 50/298 (16%), Positives = 100/298 (33%), Gaps = 59/298 (19%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D L +G G FG V+ + + A+K +K+ M + + E ++ ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHK 204
+V+LY +++I EY+ G ++ L A+E +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
++HRD+ N L++ G +K+SDFGL + + +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--------------------- 157
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
+ + + PEVL+ + + D W+ G +
Sbjct: 158 ---------------------------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 190
Query: 325 MYEML-VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
M+E+ +G P+ T I L+ S + ++ + R
Sbjct: 191 MWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTIMYSCWHEKADER 245
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (426), Expect = 9e-49
Identities = 56/320 (17%), Positives = 104/320 (32%), Gaps = 55/320 (17%)
Query: 65 IKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK-SE 123
+D EF + +I + ++ +IG G FGEV K G +K
Sbjct: 9 FEDPNEAVREFAK----EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS 64
Query: 124 MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-T 182
Q +E +++ + ++ L + + +I E++ G + + L + D
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
T + ++ + NY+HRD+ N+L++ N K+SDFGL + L+ T
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302
+ +
Sbjct: 185 PTYTSAL--------------------------------------------GGKIPIRWT 200
Query: 303 APEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYADDPITTCRKIVHWRNHLKFPDDSK 361
APE + + + D WS G +M+E++ G P++ I + P
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQDYRLPPPMD 257
Query: 362 LSPEAKDLICRLLC-DVEHR 380
L+ D HR
Sbjct: 258 CPSALHQLMLDCWQKDRNHR 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-48
Identities = 60/317 (18%), Positives = 111/317 (35%), Gaps = 66/317 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L +G+G FGEV + A+K LK M E E ++ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRH 71
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIH 203
+V+LY + E +Y++ EY+ G ++ L E L AQ + +
Sbjct: 72 EKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+ NY+HRD++ N+L+ +N K++DFGL + ++ + A
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------------------ 172
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
+ APE L + ++ D WS G
Sbjct: 173 ------------------------------GAKFPIKWTAPEAALYGRFTIKSDVWSFGI 202
Query: 324 IMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381
++ E+ G P+ ++ + P + DL+C+ + E R
Sbjct: 203 LLTELTTKGRVPYPGMVNREVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERP 259
Query: 382 GTGGAHQIKA--HPWFK 396
++A +F
Sbjct: 260 ---TFEYLQAFLEDYFT 273
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 7e-48
Identities = 80/375 (21%), Positives = 135/375 (36%), Gaps = 93/375 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L +G GA+G V + ++G A+KKL + + E LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRH 76
Query: 146 HCIVKLYYSFQDTE------YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
++ L F E YL+M ++ G + LM+ + L E+ +F + Q + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
IH IHRD+KP NL ++++ +K+ DFGL
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------------------------- 168
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDW 318
+ ++ + V T Y APEV+L Y D
Sbjct: 169 ---------------RQADSEMTGY-----------VVTRWYRAPEVILNWMRYTQTVDI 202
Query: 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVH------------------WRNHLKFPDDS 360
WS+G IM EM+ G F D + ++I+ P+
Sbjct: 203 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 262
Query: 361 K---------LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAF 410
K SP A +L+ ++L D E R+ A + AHP+F+ + + +
Sbjct: 263 KKDFASILTNASPLAVNLLEKMLVLDAEQRV---TAGEALAHPYFESLHDTEDEPQVQKY 319
Query: 411 KPEINGELDTQNFMK 425
+ T + K
Sbjct: 320 DDSFDDVDRTLDEWK 334
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 8e-48
Identities = 56/333 (16%), Positives = 101/333 (30%), Gaps = 57/333 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + L IG G+FG++ L + +G A+K + + E + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQG 61
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
I + + + +Y ++ME L + Q + IE IH
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 205 HNYIHRDIKPDNLLLDKNGHMKL---SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
N+IHRD+KPDN L+ L DFGL K + +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH------------------- 162
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
QH K + GT Y + L D SL
Sbjct: 163 --------------------QHIPYRENK---NLTGTARYASINTHLGIEQSRRDDLESL 199
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNH-LKFPDD---SKLSPEAKDLICRLLC-D 376
G ++ +G P+ T +K + P + E +
Sbjct: 200 GYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR 259
Query: 377 VEHRLGTGGAHQIKAHPWFKD-VVWDKLYEMEA 408
+ + Q+ + + + +D +++
Sbjct: 260 FDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 292
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-47
Identities = 51/303 (16%), Positives = 103/303 (33%), Gaps = 67/303 (22%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ + + +LL IG+G FG+V L + GN A+K +K + AE +++ +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA-----FLAEASVMTQ 56
Query: 143 VASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAI 199
+ +V+L ++ LY++ EY+ G ++ L L + + A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
E + +N++HRD+ N+L+ ++ K D +
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNV--------AKVSDFGLTKEASSTQD---------- 158
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWW 319
+ + APE L +K + + D W
Sbjct: 159 ----------------------------------TGKLPVKWTAPEALREKKFSTKSDVW 184
Query: 320 SLGAIMYEML-VGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DV 377
S G +++E+ G P+ ++ K P +++ D
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGYKMDAPDGCPPAVYEVMKNCWHLDA 241
Query: 378 EHR 380
R
Sbjct: 242 AMR 244
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-47
Identities = 50/298 (16%), Positives = 96/298 (32%), Gaps = 59/298 (19%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + IG G FG V L + + A+K +++ M + E E ++ +++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSH 59
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHK 204
+V+LY + + L+ E++ G + L + L + V + + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
IHRD+ N L+ +N +K+SDFG+ + + +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST------------------- 160
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324
T + +PEV Y + D WS G +
Sbjct: 161 -----------------------------GTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 191
Query: 325 MYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
M+E+ G P+ I + S ++ E R
Sbjct: 192 MWEVFSEGKIPYENRSNSEVVEDI---STGFRLYKPRLASTHVYQIMNHCWKERPEDR 246
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-47
Identities = 73/340 (21%), Positives = 120/340 (35%), Gaps = 81/340 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+E L IG G +G V + +++ I A+K+++ + G E LL E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV+L+ + L L+ E+ L + + ++ Q + + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
N +HRD+KP NLL+++NG +KL++FGL +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV------------------------- 155
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAI 324
+ + V T Y P+VL Y D WS G I
Sbjct: 156 ------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 325 MYEMLVG-YPPFYADDPITTCRKIVH---------WRNHLKFPD---------------- 358
E+ P F +D ++I W + K PD
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 359 DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
KL+ +DL+ LL + R+ A + HP+F D
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRI---SAEEALQHPYFSD 288
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 5e-47
Identities = 61/301 (20%), Positives = 106/301 (35%), Gaps = 59/301 (19%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ + +L+ +G G FGEV + A+K LK+ M + AE NL+ +
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIE 200
+ +V+LY E +Y+I EY+ G ++ L LT N AQ +
Sbjct: 65 LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
I + NYIHRD++ N+L+ K++DFGL + ++ + A
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--------------- 168
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
+ APE + + ++ D WS
Sbjct: 169 ---------------------------------GAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379
G ++ E++ Y + + + PD+ E L+ E
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--CPEELYQLMRLCWKERPED 253
Query: 380 R 380
R
Sbjct: 254 R 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-46
Identities = 57/318 (17%), Positives = 101/318 (31%), Gaps = 72/318 (22%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ +D + +IG G FG+V R KK G + E + E +L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 142 EVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLT 184
++ H I+ L + + YLYL +EY P G+++ L + TL+
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244
+ A ++ + + +IHRD+ N+L+ +N K++DFGL +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---------- 175
Query: 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304
++A
Sbjct: 176 ----------------------------------------GQEVYVKKTMGRLPVRWMAI 195
Query: 305 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLS 363
E L Y D WS G +++E++ G P+ K+ +
Sbjct: 196 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQGYRLEKPLNCD 252
Query: 364 PEAKDLICRLLC-DVEHR 380
E DL+ + R
Sbjct: 253 DEVYDLMRQCWREKPYER 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 160 bits (405), Expect = 7e-46
Identities = 48/297 (16%), Positives = 93/297 (31%), Gaps = 57/297 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH- 146
+++ IG G+FG + + A+K + R +R E +A
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
I +YY Q+ + L+++ L L + + Q + ++SIH+ +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 207 YIHRDIKPDNLLLDK-----NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
++RDIKPDN L+ + + + DFG+ K
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP---------------------- 159
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321
+ + + + + GT Y++ L + D +L
Sbjct: 160 --------------VTKQHIPYREKK------NLSGTARYMSINTHLGREQSRRDDLEAL 199
Query: 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKL----SPEAKDLICRLL 374
G + L G P+ T +K + +L E +
Sbjct: 200 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYAR 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 8e-46
Identities = 59/326 (18%), Positives = 104/326 (31%), Gaps = 83/326 (25%)
Query: 86 DDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
++ E + IG GAFG V R + + A+K LK+ + E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALM 70
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED------------------- 181
AE + IVKL + + L+ EY+ GD+ L
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 182 -----TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
L+ Q + + + ++HRD+ N L+ +N +K++DFGL + +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296
+ Y K +
Sbjct: 191 YSADYY-----------------------------------------------KADGNDA 203
Query: 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLK 355
++ PE + Y E D W+ G +++E+ G P+Y + N L
Sbjct: 204 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-GNILA 262
Query: 356 FPDDSKLSPEAKDLICRLLC-DVEHR 380
P++ E +L+ R
Sbjct: 263 CPEN--CPLELYNLMRLCWSKLPADR 286
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-45
Identities = 82/397 (20%), Positives = 133/397 (33%), Gaps = 111/397 (27%)
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
++ F LKR ++ L IG GA G V + A+KKL + + +
Sbjct: 10 DSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAK 61
Query: 132 HVRAERNLLAEVASHCIVKLYYSF------QDTEYLYLIMEYLPGGDMMTLLMREDTLTE 185
E L+ V I+ L F ++ + +YL+ME + + M D
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---H 118
Query: 186 NVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
+ + Q + I+ +H IHRD+KP N+++ + +K+ DFGL + S + +
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178
Query: 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305
V T Y APE
Sbjct: 179 --------------------------------------------------VVTRYYRAPE 188
Query: 306 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHW--------------- 350
V+L GY D WS+G IM EM+ F D I K++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 351 ----------RNHLKFPD-------------DSKLSPEAKDLICRLLC-DVEHRLGTGGA 386
L FP + + +A+DL+ ++L D R+
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI---SV 305
Query: 387 HQIKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNF 423
HP+ W E+EA + +LD +
Sbjct: 306 DDALQHPYINV--WYDPAEVEAPPPQIYDKQLDEREH 340
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-45
Identities = 47/298 (15%), Positives = 94/298 (31%), Gaps = 52/298 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK--SEMVKRGQVEHVRAERNLLAEV 143
+F+ + ++G GAFG V G + K E + + E ++A V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
+ + +L + + G + + +D + + Q + +
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+HRD+ N+L+ H+K++DFGL K L
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------------------------ 164
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323
+ A ++A E +L + Y + D WS G
Sbjct: 165 -----------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 201
Query: 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
++E++ Y P + I+ L P + + ++ + D + R
Sbjct: 202 TVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI--CTIDVYMIMVKCWMIDADSR 257
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 76/346 (21%), Positives = 129/346 (37%), Gaps = 91/346 (26%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ ++ L+ +G GA+G V + K+G A+KKL + + E LL +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKH 76
Query: 146 HCIVKLYYSFQDTEYL-----YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
++ L F L ++ +L G D+ + ++ LT++ +F I Q + ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
IH + IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------------------- 175
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWW 319
V T Y APE++L Y D W
Sbjct: 176 --------------------------------TGYVATRWYRAPEIMLNWMHYNQTVDIW 203
Query: 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVH---------------------WRNHLKFPD 358
S+G IM E+L G F D I + I+ ++ + P
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263
Query: 359 DS------KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397
+ +P A DL+ ++L D + R+ A Q AH +F
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRI---TAAQALAHAYFAQ 306
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-45
Identities = 64/314 (20%), Positives = 101/314 (32%), Gaps = 59/314 (18%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK-SEMVKRGQVEHVRAERNLLA 141
I + EL IG G FG+V N +K E E +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIE 200
+ IVKL + +++IME G++ + L +L Y Q A+
Sbjct: 64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+ ++HRDI N+L+ N +KL DFGL + ++ ST Y
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY------------------ 164
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
A ++APE + + + D W
Sbjct: 165 ------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWM 194
Query: 321 LGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVE 378
G M+E+L+ G PF +I N + P P L+ + D
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIGRI---ENGERLPMPPNCPPTLYSLMTKCWAYDPS 251
Query: 379 HRLGTGGAHQIKAH 392
R ++KA
Sbjct: 252 RRP---RFTELKAQ 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-44
Identities = 60/334 (17%), Positives = 107/334 (32%), Gaps = 77/334 (23%)
Query: 73 TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKR 127
T+ + + + +G GAFG+V + + A+K LK S +
Sbjct: 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT- 68
Query: 128 GQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR------- 179
+ E + +E +L+ + +H IV L + +I EY GD++ L R
Sbjct: 69 -EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 180 -----------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228
E L + Q + + N IHRD+ N+LL K+
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNR 288
DFGL + + + Y + +
Sbjct: 188 DFGLARDIKNDSNYVVKGN----------------------------------------- 206
Query: 289 RKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYADDPITTCRKI 347
++APE + Y E D WS G ++E+ +G P+ + K+
Sbjct: 207 ------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 348 VHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
+ + + E D++ D R
Sbjct: 261 I--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 8e-43
Identities = 55/301 (18%), Positives = 96/301 (31%), Gaps = 56/301 (18%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+IG G FGEV K S A+K LK Q E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMG 64
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIE 200
+ + H I++L + + +I EY+ G + L +D + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+ NY+HRD+ N+L++ N K+SDFGL + L+
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----------------------- 161
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320
+ APE + + + D WS
Sbjct: 162 -----------------------DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 198
Query: 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEH 379
G +M+E++ Y + K ++ L P D L+ + +
Sbjct: 199 FGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD--CPSAIYQLMMQCWQQERAR 256
Query: 380 R 380
R
Sbjct: 257 R 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-42
Identities = 47/335 (14%), Positives = 109/335 (32%), Gaps = 76/335 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
+ + +G+G+FG V K + A+K + ++ ++ + E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------TLTENVARF 190
E H +V+L + +IME + GD+ + L + +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
+ + ++ + ++HRD+ N ++ ++ +K+ DFG+ + + + Y
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG----- 192
Query: 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310
+ +++PE L
Sbjct: 193 ------------------------------------------GKGLLPVRWMSPESLKDG 210
Query: 311 GYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLI 370
+ D WS G +++E+ Y + V L PD+ +L+
Sbjct: 211 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN--CPDMLFELM 268
Query: 371 CRLLC-DVEHRLGTGGAHQI------KAHPWFKDV 398
+ + R +I + P F++V
Sbjct: 269 RMCWQYNPKMRP---SFLEIISSIKEEMEPGFREV 300
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-42
Identities = 47/295 (15%), Positives = 99/295 (33%), Gaps = 57/295 (19%)
Query: 93 IIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+IGRG FG V L A+K L + G+V E ++ + + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 150 KLY-YSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNY 207
L + +++ Y+ GD+ + E T + Q ++ + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
+HRD+ N +LD+ +K++DFGL + + ++H
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT------------------- 192
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 327
++A E L + + + D WS G +++E
Sbjct: 193 --------------------------GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226
Query: 328 MLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHR 380
++ G PP+ + ++ R + +++ + E R
Sbjct: 227 LMTRGAPPYPDVNTFDITVYLLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-41
Identities = 57/320 (17%), Positives = 103/320 (32%), Gaps = 76/320 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
D L +G GAFG+V L A+K LK + + +E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEME 70
Query: 139 LLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR----------------ED 181
++ + H I+ L + LY+I+EY G++ L E+
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
L+ Q +E + IHRD+ N+L+ ++ MK++DFGL + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
Y + +
Sbjct: 191 YKKTTNGR-----------------------------------------------LPVKW 203
Query: 302 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSK 361
+APE L + Y + D WS G +++E+ Y P+ K++ + + P +
Sbjct: 204 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN-- 261
Query: 362 LSPEAKDLICRLLC-DVEHR 380
+ E ++ R
Sbjct: 262 CTNELYMMMRDCWHAVPSQR 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-39
Identities = 58/332 (17%), Positives = 107/332 (32%), Gaps = 79/332 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
D +L +GRGAFG+V + + A+K LK+ + + +E +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKIL 70
Query: 141 AEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMTLL----------------MREDT 182
+ H V + L +I+E+ G++ T L + +D
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
LT Y Q +E + IHRD+ N+LL + +K+ DFGL + + Y
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302
++
Sbjct: 191 VRKG-----------------------------------------------DARLPLKWM 203
Query: 303 APEVLLKKGYGMECDWWSLGAIMYEMLVGY-PPFYADDPITTCRKIVHWRNHLKFPDDSK 361
APE + + Y ++ D WS G +++E+ P+ + + ++ PD
Sbjct: 204 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY-- 261
Query: 362 LSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392
+PE + + R ++ H
Sbjct: 262 TTPEMYQTMLDCWHGEPSQRP---TFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 133 bits (334), Expect = 3e-35
Identities = 60/401 (14%), Positives = 130/401 (32%), Gaps = 113/401 (28%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL-------L 140
+ L+ +G G F V L ++ + AMK ++ ++ + ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 141 AEVASHCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQS 195
+ ++ I+KL F ++++M + G+ + L+++ + + Q
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 196 VLAIESIH-KHNYIHRDIKPDNLLLDKNGHM-KLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
+L ++ +H + IH DIKP+N+L++ L + + + +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN------ 188
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313
++ T +Y +PEVLL +G
Sbjct: 189 -----------------------------------------SIQTREYRSPEVLLGAPWG 207
Query: 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL------------------- 354
D WS +++E++ G F D+ + + H +
Sbjct: 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRT 267
Query: 355 -------------------------KFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ 388
K+ + E D + +L D R A
Sbjct: 268 FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD---AGG 324
Query: 389 IKAHPWFKDVVWDKLYEMEAAFKPEINGELDTQNFMKFDEL 429
+ HPW KD + + E+ + D + F+E+
Sbjct: 325 LVNHPWLKDTLGME--EIRVPDRELYGSGSDIPGW--FEEV 361
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 6e-34
Identities = 49/284 (17%), Positives = 84/284 (29%), Gaps = 68/284 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
L IG+G FGEV + + G A+K E + AE +
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE----RSWFREAEIYQTVMLRH 56
Query: 146 HCIVKLYYSFQDTE----YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA-------Q 194
I+ + L+L+ +Y G + L R E + + ++
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
+ + + K HRD+K N+L+ KNG ++D GL D +T
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR---- 172
Query: 255 MAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------ 308
VGT Y+APEVL
Sbjct: 173 -----------------------------------------VGTKRYMAPEVLDDSINMK 191
Query: 309 KKGYGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN 352
D +++G + +E+ + + +
Sbjct: 192 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.0 bits (173), Expect = 7e-15
Identities = 20/160 (12%), Positives = 47/160 (29%), Gaps = 28/160 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKS---------------EMVKRGQVEHVRAER 137
++G G V C + +K K + R E
Sbjct: 7 LMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 138 NLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
L ++ + K+Y + ++ME + ++ + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILE 114
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ + +H D+ N+L+ + G + DF +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.16 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.53 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-73 Score=577.19 Aligned_cols=292 Identities=41% Similarity=0.754 Sum_probs=269.6
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
+++.+||++++.||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+|+.++|||||+++++|++.+.+
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 46789999999999999999999999999999999999988777777888999999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|+|||||+||+|..++.+.+.++|..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998653210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
....+.|||+.|||||++.+.+|+.++|||||
T Consensus 160 ------------------------------------------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSl 191 (337)
T d1o6la_ 160 ------------------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp ------------------------------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred ------------------------------------------------cccccceeCHHHhhhhhccCCCCChhhcccch
Confidence 12346899999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccC
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDV 398 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i 398 (518)
||++|||++|++||.+.+...++.++.. ..+.+|. .+|++++|||++||+ ||.+|+++. +++||++||||+++
T Consensus 192 Gvilyeml~G~~pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 192 GVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hhHHHHHHHCCCCCCCcCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 9999999999999999999999988887 4567774 699999999999998 999999753 69999999999999
Q ss_pred Cccccc--cccCCccccCCCcccCCCCCCC
Q 010116 399 VWDKLY--EMEAAFKPEINGELDTQNFMKF 426 (518)
Q Consensus 399 ~w~~l~--~~~~p~~p~~~~~~d~~~f~~~ 426 (518)
+|+.+. ++.|||+|.+..+.|+++|+..
T Consensus 268 ~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~ 297 (337)
T d1o6la_ 268 NWQDVVQKKLLPPFKPQVTSEVDTRYFDDE 297 (337)
T ss_dssp CHHHHHTTCSCCSCCCCCSSTTCCTTSCHH
T ss_pred CHHHHHhCCCCCCCCCCCCChhhhhhcCch
Confidence 999985 5889999999999999999853
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-69 Score=545.32 Aligned_cols=292 Identities=44% Similarity=0.865 Sum_probs=255.2
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
+.+||++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||+++++|++.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 45799999999999999999999999999999999998777667778899999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||||+||+|..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999865311
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
..+.+||+.|||||++.+.+|+.++|||||||
T Consensus 158 ------------------------------------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGv 189 (316)
T d1fota_ 158 ------------------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGI 189 (316)
T ss_dssp ------------------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHH
T ss_pred ------------------------------------------------cccccCcccccCHHHHcCCCCCchhhccccch
Confidence 23578999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCcccccCCc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWFKDVVW 400 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff~~i~w 400 (518)
++|||++|++||.+.+..+.+.+|... ...+| ..+|+++++||.+||. ||.+|++.. ++++|++||||++++|
T Consensus 190 ilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 190 LIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred hHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 999999999999999999999999873 45555 3689999999999998 999998653 8999999999999999
Q ss_pred cccc--cccCCccccC-CCcccCCCCCCCCCCCC
Q 010116 401 DKLY--EMEAAFKPEI-NGELDTQNFMKFDELDP 431 (518)
Q Consensus 401 ~~l~--~~~~p~~p~~-~~~~d~~~f~~~~~~~~ 431 (518)
+.|. ++++||+|.+ ....|+++|+++++++.
T Consensus 266 ~~l~~~~~~~p~~p~~~~~~~d~~~f~~~~~~~~ 299 (316)
T d1fota_ 266 EKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDI 299 (316)
T ss_dssp HHHHTTCSCCSCCCCC----------------CC
T ss_pred HHHHhCCCCcCCCCCcCCCcchhhhcCCCccccc
Confidence 9985 6889999986 45679999998876543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-68 Score=548.65 Aligned_cols=295 Identities=43% Similarity=0.816 Sum_probs=270.0
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 160 (518)
.....++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...
T Consensus 36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 115 (350)
T d1rdqe_ 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence 34556899999999999999999999999999999999988776667778889999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999999999999899999999999999999999999999999999999999999999999999999875321
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
..+.+||+.|||||++.+.+|+.++||||
T Consensus 195 ---------------------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwS 223 (350)
T d1rdqe_ 195 ---------------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWA 223 (350)
T ss_dssp ---------------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHH
T ss_pred ---------------------------------------------------cccccCccccCCHHHHcCCCCCccccccc
Confidence 12578999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCC--CChhhhhcCccccc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGT--GGAHQIKAHPWFKD 397 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~--~~a~eil~Hpff~~ 397 (518)
|||++|||++|++||.+.+....+.+|... .+.+| ..+|+++++||++||+ ||.+|++. .++++|++||||++
T Consensus 224 lGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred hhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCCCC--ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 999999999999999999999999998873 45555 4799999999999998 99999754 38999999999999
Q ss_pred CCccccc--cccCCccccCCCcccCCCCCCCCCCCC
Q 010116 398 VVWDKLY--EMEAAFKPEINGELDTQNFMKFDELDP 431 (518)
Q Consensus 398 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~ 431 (518)
++|+.+. +++|||+|.+.++.|++||+.+.+.+.
T Consensus 300 ~~~~~~~~~~~~~p~~p~~~~~~d~s~~~~~~~~~~ 335 (350)
T d1rdqe_ 300 TDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEI 335 (350)
T ss_dssp CCHHHHHTTCSCCSCCCCCCSTTCCTTSCCCCCCCC
T ss_pred CCHHHHHhcCCCcCccCCCCCcchhhhcCCCCcccc
Confidence 9999986 478999999999999999998765553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-69 Score=544.11 Aligned_cols=314 Identities=35% Similarity=0.677 Sum_probs=250.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHH-HhCCCceeEEEEEeecCCeEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA-EVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|..++. .++|||||+++++|++.+.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 479999999999999999999999999999999999877666677778888888775 6899999999999999999999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
|||||+||+|..++.....+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--- 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--- 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998643210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhH
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 323 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 323 (518)
......+||+.|+|||++.+.+|+.++|||||||
T Consensus 158 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 191 (320)
T d1xjda_ 158 ----------------------------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 191 (320)
T ss_dssp ----------------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred ----------------------------------------------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhH
Confidence 1122568999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChh-hhhcCcccccCCcc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAH-QIKAHPWFKDVVWD 401 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~-eil~Hpff~~i~w~ 401 (518)
++|||++|++||.+.+...+..+|.. ..+.+|. .+|+++++||++||+ ||.+|+ ++. ++++||||++++|+
T Consensus 192 ilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~~L~~dP~~R~---s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 192 LLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPR--WLEKEAKDLLVKLFVREPEKRL---GVRGDIRQHPLFREINWE 264 (320)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSB---TTBSCGGGSGGGTTCCHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHhcccCCCCCc---CHHHHHHhCchhccCCHH
Confidence 99999999999999999999988876 3455664 689999999999998 999999 674 89999999999999
Q ss_pred ccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCCcccccCCC-CCCcccCcee
Q 010116 402 KLY--EMEAAFKPEINGELDTQNFMKFDELDPPASGRTSSGPSRKMLLTP-KDLSFVGYTY 459 (518)
Q Consensus 402 ~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~~~~~ 459 (518)
.+. +++||++|.+.++.|++||+.....+.+...... +.+.+. .+..|.||+|
T Consensus 265 ~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~-----~~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 265 ELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFAD-----RALINSMDQNMFRNFSF 320 (320)
T ss_dssp HHHTTCSCC-------------------------------------------CCTTTTCCC
T ss_pred HHHhcCCCCCCCCCCCCccchhhcChHhhhCCccCCCCc-----ccccCchhhcccCcCcC
Confidence 885 5789999999999999999864333222221111 112333 3456999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-69 Score=535.74 Aligned_cols=277 Identities=36% Similarity=0.694 Sum_probs=249.8
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|++++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 44568999999999999999999999999999999999988776777788899999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~ 241 (518)
|||||||+||+|.+++...+.+++..++.++.|++.||+|||++|||||||||+|||++.+|++||+|||+|+.+....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~- 162 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES- 162 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998764221
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
......+.+||+.|||||++.+..|+.++|||||
T Consensus 163 ----------------------------------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSl 196 (288)
T d1uu3a_ 163 ----------------------------------------------KQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196 (288)
T ss_dssp -----------------------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred ----------------------------------------------cccccccccCCccccCceeeccCCCCcccceehh
Confidence 0112346789999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhh------hhcCcc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ------IKAHPW 394 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~e------il~Hpf 394 (518)
||++|||++|.+||.+.+...++.+|.+. .+.+|. .+|+++++||.+||+ ||.+|+ +++| |++|||
T Consensus 197 Gvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~---t~~e~~~~~~i~~Hpf 269 (288)
T d1uu3a_ 197 GCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPE--KFFPKARDLVEKLLVLDATKRL---GCEEMEGYGPLKAHPF 269 (288)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCT--TCCHHHHHHHHTTSCSSGGGST---TSGGGTCHHHHHTSGG
T ss_pred hHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCc--cCCHHHHHHHHHHccCCHhHCc---CHHHHcCCHHHHcCCc
Confidence 99999999999999999999999999874 456664 699999999999998 999999 5665 799999
Q ss_pred cccCCccccccccCCccc
Q 010116 395 FKDVVWDKLYEMEAAFKP 412 (518)
Q Consensus 395 f~~i~w~~l~~~~~p~~p 412 (518)
|++++|++|.+..||..|
T Consensus 270 f~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 270 FESVTWENLHQQTPPKLT 287 (288)
T ss_dssp GTTCCCTTGGGSCCCCCC
T ss_pred cCCCCHHHhhcCCCCCCC
Confidence 999999999988888765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-65 Score=528.66 Aligned_cols=290 Identities=32% Similarity=0.593 Sum_probs=239.5
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHH---HHHHHHhCCCceeEEEEEeecCC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAE---RNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E---~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
++.++|+++++||+|+||+||+|+++.+|+.||||++.+...........+.+| ..+++.++|||||+++++|.+.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 467899999999999999999999999999999999988766555444555555 45555667999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
.+|||||||+||+|.++|.+...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 318 (518)
...+.+||+.|||||++.+ ..|+.++||
T Consensus 161 ---------------------------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~~Di 189 (364)
T d1omwa3 161 ---------------------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADW 189 (364)
T ss_dssp ---------------------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHH
T ss_pred ---------------------------------------------------cccccccccccchhHHhhcCCCCCcccch
Confidence 1235689999999999975 679999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--ChhhhhcCccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIKAHPWF 395 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil~Hpff 395 (518)
|||||++|||++|++||.+.+...... +.........+.+..+|+++++||.+||. ||.+|+++. +|+||++||||
T Consensus 190 wSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 190 FSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp HHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence 999999999999999998765443322 22211222233334799999999999998 999999652 48999999999
Q ss_pred ccCCccccc--cccCCccccCCCcccCCCCC
Q 010116 396 KDVVWDKLY--EMEAAFKPEINGELDTQNFM 424 (518)
Q Consensus 396 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~ 424 (518)
++++|..+. +++|||+|......+.+.|+
T Consensus 269 ~~i~~~~~~~~~~~~p~~p~~~~~~~~~~~d 299 (364)
T d1omwa3 269 RSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 299 (364)
T ss_dssp TTCCHHHHHTTCSCCSCCCCCC---------
T ss_pred cCCCHHHHhcCCCCcCcCCCCCCCCcCCccc
Confidence 999999885 57899999876655555444
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-65 Score=505.23 Aligned_cols=257 Identities=36% Similarity=0.600 Sum_probs=236.9
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEE
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 162 (518)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 35689999999999999999999999999999999999877766677788999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 99999999999999998899999999999999999999999999999999999999999999999999999864321
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
...+.+||+.|||||++.+.+|+.++||||||
T Consensus 160 ------------------------------------------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlG 191 (263)
T d2j4za1 160 ------------------------------------------------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 191 (263)
T ss_dssp ------------------------------------------------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred ------------------------------------------------cccccCCCCcccCHHHHcCCCCCchhhhhhHh
Confidence 12256899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|++|||++|++||.+.+..+.+.++.. ..+.+|. .+|+++++||.+||+ ||.+|+ +++||++||||.+
T Consensus 192 vilyell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dp~~R~---t~~eil~hp~~~~ 260 (263)
T d2j4za1 192 VLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPD--FVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CHHHHHTCHHHHH
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHHccCCHhHCc---CHHHHHcCcCcCC
Confidence 999999999999999999888888876 3455664 689999999999998 999999 8999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-64 Score=497.62 Aligned_cols=260 Identities=26% Similarity=0.454 Sum_probs=222.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .+..+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 5789999999999999999999999999999999976543 22345688999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||||+||+|.+++.+...+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+....
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~---- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 157 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC----
Confidence 9999999999999888899999999999999999999999999999999999999999999999999998753221
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-CccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGv 323 (518)
......+.+||+.|||||++.+..| +.++|||||||
T Consensus 158 -------------------------------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGv 194 (271)
T d1nvra_ 158 -------------------------------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 194 (271)
T ss_dssp -------------------------------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHH
T ss_pred -------------------------------------------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHH
Confidence 1112346799999999999998886 67899999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
++|||++|++||...+........... .....+....+|+++++||.+||+ ||.+|+ +++||++||||+.
T Consensus 195 ilyeml~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hpwf~~ 265 (271)
T d1nvra_ 195 VLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHSSCSCSSSSTTSHHHHHHHT-TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTC
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhCc
Confidence 999999999999876554433333332 222333345789999999999998 999999 8999999999973
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-63 Score=495.69 Aligned_cols=267 Identities=30% Similarity=0.494 Sum_probs=233.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++|||||+++++|++.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999999999999999987654322 2367789999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC----cEEEeecccccccC
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLD 237 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g----~vKL~DFGla~~~~ 237 (518)
|||||||+||+|.+++...+.+++..++.++.|++.||+|||++|||||||||+|||++.+| ++||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999889999999999999999999999999999999999999999877 59999999998754
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
... ...+.+||+.|+|||++.+..|+.++|
T Consensus 169 ~~~--------------------------------------------------~~~~~~~t~~y~APE~~~~~~~~~~~D 198 (293)
T d1jksa_ 169 FGN--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEAD 198 (293)
T ss_dssp TSC--------------------------------------------------BCSCCCCCGGGCCHHHHTTCCBCTHHH
T ss_pred CCc--------------------------------------------------cccccCCCCcccCHHHHcCCCCCCccc
Confidence 221 123568999999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
||||||++|||++|.+||.+.+..+++.+|......+..+....+|+++++||++||. ||.+|+ +++||++||||+
T Consensus 199 iwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~ 275 (293)
T d1jksa_ 199 MWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIK 275 (293)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTC
T ss_pred chhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccC
Confidence 9999999999999999999999999998888754333222235789999999999999 999999 899999999999
Q ss_pred cCCccccc
Q 010116 397 DVVWDKLY 404 (518)
Q Consensus 397 ~i~w~~l~ 404 (518)
+++|....
T Consensus 276 ~~~~~~~l 283 (293)
T d1jksa_ 276 PKDTQQAL 283 (293)
T ss_dssp C-------
T ss_pred CCChhHhh
Confidence 99998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-63 Score=500.83 Aligned_cols=258 Identities=33% Similarity=0.569 Sum_probs=218.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999998765432 345688999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC---CCCcEEEeecccccccCCCcc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---KNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld---~~g~vKL~DFGla~~~~~~~~ 241 (518)
||||+||+|.+++...+.+++..++.|+.||+.||+|||++|||||||||+|||+. .+|++||+|||+|+.....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-- 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-- 163 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence 99999999999999889999999999999999999999999999999999999995 5799999999999865321
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
....+.+||+.|||||++.+.+|+.++|||||
T Consensus 164 ------------------------------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSl 195 (307)
T d1a06a_ 164 ------------------------------------------------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 195 (307)
T ss_dssp ---------------------------------------------------------CTTSCHHHHTTCCCCTHHHHHHH
T ss_pred ------------------------------------------------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhh
Confidence 11235789999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||++|||++|.+||.+.+...+...|......+..|....+|+++++||.+||. ||.+|+ +++||++||||++
T Consensus 196 Gvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 269 (307)
T d1a06a_ 196 GVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTTS
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhCC
Confidence 999999999999999999999999998865555555566899999999999998 999999 8999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-63 Score=493.93 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=228.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 3579999999999999999999999999999999986543 2346789999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
||||+||+|..++.+ ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~---- 170 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---- 170 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc----
Confidence 999999999988754 579999999999999999999999999999999999999999999999999998754211
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 324 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 324 (518)
....+.+||+.|||||++.+..|+.++|||||||+
T Consensus 171 ---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 205 (293)
T d1yhwa1 171 ---------------------------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205 (293)
T ss_dssp ---------------------------------------------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHH
T ss_pred ---------------------------------------------ccccccccCCCccChhhhcCCCCCchhceehHhHH
Confidence 11235689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 325 MYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 325 lyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
+|+|++|.+||.+.+.......+.... ...++.+..+|+++++||.+||. ||.+|+ ++.||++||||+.
T Consensus 206 lyemltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 206 AIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHHC-SCCCSSGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHTTCGGGGG
T ss_pred HHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCCCcccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCC
Confidence 999999999999998888777776542 33344445799999999999998 999999 8999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.8e-62 Score=500.62 Aligned_cols=263 Identities=30% Similarity=0.506 Sum_probs=234.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999976542 3356788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC--CCcEEEeecccccccCCCcc
Q 010116 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 165 mEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~--~g~vKL~DFGla~~~~~~~~ 241 (518)
||||+||+|.+++.+ .+.+++..++.|+.||+.||+|||++|||||||||+||||+. +|++||+|||+|+.+...
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 999999999999954 468999999999999999999999999999999999999964 689999999999875422
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
....+.+||+.|||||++.+.+|+.++|||||
T Consensus 180 ------------------------------------------------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSl 211 (350)
T d1koaa2 180 ------------------------------------------------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 211 (350)
T ss_dssp ------------------------------------------------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHH
T ss_pred ------------------------------------------------cccceecCcccccCHHHHcCCCCChhHhhhhh
Confidence 11236789999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
||++|||++|.+||.+.+..+++.+|......+..+....+|+++++||.+||+ ||.+|+ +++||++||||+..+|
T Consensus 212 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 212 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSC---CHHHHHHSTTTSCTTC
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCCCC
Confidence 999999999999999999999999998754333333334689999999999999 999999 8999999999998877
Q ss_pred ccc
Q 010116 401 DKL 403 (518)
Q Consensus 401 ~~l 403 (518)
...
T Consensus 289 ~~~ 291 (350)
T d1koaa2 289 PGR 291 (350)
T ss_dssp CSC
T ss_pred CCc
Confidence 554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-63 Score=502.14 Aligned_cols=264 Identities=28% Similarity=0.422 Sum_probs=225.5
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeE
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 161 (518)
++..++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+.+|+.+|+.++|||||+++++|.++.++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 355789999999999999999999999999999999997652 334456789999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 162 ylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
|||||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ +|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 9999999999999999988999999999999999999999997 5999999999999999999999999999986421
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
....+.+||+.|||||++.+..|+.++||||
T Consensus 158 -------------------------------------------------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWS 188 (322)
T d1s9ja_ 158 -------------------------------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188 (322)
T ss_dssp -------------------------------------------------HTC---CCSSCCCCHHHHHCSCCCTTHHHHH
T ss_pred -------------------------------------------------CccccccCCccccCchHHcCCCCCcHHHHHH
Confidence 1223679999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHH------------------------------------------HhhhcCcccCCC
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRK------------------------------------------IVHWRNHLKFPD 358 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~------------------------------------------i~~~~~~l~~p~ 358 (518)
|||++|||++|+.||.+.+....... +.. .....+|.
T Consensus 189 lGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 267 (322)
T d1s9ja_ 189 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN-EPPPKLPS 267 (322)
T ss_dssp HHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHT-SCCCCCCB
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhc-cCCccCcc
Confidence 99999999999999987654322110 000 01111221
Q ss_pred CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcccc
Q 010116 359 DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKL 403 (518)
Q Consensus 359 ~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l 403 (518)
..+|++++|||.+||+ ||.+|+ +|+|+++||||+..+|+.+
T Consensus 268 -~~~s~~~~dli~~~L~~dP~~R~---ta~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 268 -GVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp -TTBCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHHHHHSCC
T ss_pred -ccCCHHHHHHHHHHcCCChhHCc---CHHHHhhCHhhCcCCcccc
Confidence 2468999999999999 999999 9999999999998877654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-62 Score=488.44 Aligned_cols=257 Identities=29% Similarity=0.479 Sum_probs=227.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 357999999999999999999999999999999997652 33456788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||||+||+|..++.+ ...+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 999999999999765 467999999999999999999999999999999999999999999999999999754211
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhc-----CCCCCccccc
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDW 318 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~Di 318 (518)
.....+.+||+.|||||++. +.+|+.++||
T Consensus 164 ---------------------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~Di 198 (288)
T d2jfla1 164 ---------------------------------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV 198 (288)
T ss_dssp ---------------------------------------------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHH
T ss_pred ---------------------------------------------cccccccccccccCCHHHHhhcccCCCCCChhhhH
Confidence 01223678999999999994 4678999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|||||++|||++|.+||.+.+..+.+.++.... ...++.+..+|+++++||.+||. ||.+|+ +++||++||||+.
T Consensus 199 wSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~ell~hp~~~~ 274 (288)
T d2jfla1 199 WSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE-PPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC-CCCCSSGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSGGGCC
T ss_pred HHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCccccCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCC
Confidence 999999999999999999999999988888743 23344445789999999999998 999999 8999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-62 Score=490.35 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=229.1
Q ss_pred CeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 87 ~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999988766566667889999999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
||+||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-------- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--------
Confidence 999999988888888999999999999999999999999999999999999999999999999999985421
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CCCCccccccchhH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMECDWWSLGA 323 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGv 323 (518)
..+.+||+.|||||++.+ ..|+.++|||||||
T Consensus 168 ---------------------------------------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGv 202 (309)
T d1u5ra_ 168 ---------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202 (309)
T ss_dssp ---------------------------------------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHH
T ss_pred ---------------------------------------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHH
Confidence 125689999999999974 46999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
++|||++|.+||.+.+......++.... ...+....+|+++++||.+||+ ||.+|+ +++||++||||..
T Consensus 203 ilyel~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 203 TCIELAERKPPLFNMNAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCCCSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHS
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHHCcCChhHCc---CHHHHHhCHHhcC
Confidence 9999999999999999888888887743 2333345789999999999999 999999 8999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-61 Score=493.97 Aligned_cols=258 Identities=29% Similarity=0.554 Sum_probs=230.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999875432 345678999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeC--CCCcEEEeecccccccCCCcc
Q 010116 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--KNGHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld--~~g~vKL~DFGla~~~~~~~~ 241 (518)
||||+||+|.+++... ..+++.+++.++.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+.+...
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999999999987665 4799999999999999999999999999999999999998 6799999999999876422
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
....+.+||+.|||||++.+..|+.++|||||
T Consensus 183 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 214 (352)
T d1koba_ 183 ------------------------------------------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAI 214 (352)
T ss_dssp ------------------------------------------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred ------------------------------------------------CceeeccCcccccCHHHHcCCCCCCccchHHH
Confidence 12336789999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||++|||++|.+||.+.+....+.+|......+..+....+|+++++||.+||+ ||.+|+ ++.||++||||++.
T Consensus 215 GvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 215 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSC
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCCC
Confidence 999999999999999999999999888743333333345799999999999999 999999 89999999999873
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-61 Score=477.91 Aligned_cols=255 Identities=33% Similarity=0.582 Sum_probs=216.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec--CCeEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TEYLY 162 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~~ly 162 (518)
.+||++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4789999999999999999999999999999999987654 34456778999999999999999999999965 46799
Q ss_pred EEEeecCCCchHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEEcCCCCCceeeCCCCcEEEeecccc
Q 010116 163 LIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHN-----YIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (518)
Q Consensus 163 lVmEy~~gG~L~~~l~~----~~~l~e~~~~~~~~ql~~aL~~LH~~g-----iiHRDIKPeNILld~~g~vKL~DFGla 233 (518)
||||||+||+|.+++.+ ...+++..++.++.|++.||+|||++| ||||||||+||||+.+|++||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 367999999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
+.+.... ....+.+||+.|||||++.+..|+
T Consensus 162 ~~~~~~~-------------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~ 192 (269)
T d2java1 162 RILNHDT-------------------------------------------------SFAKAFVGTPYYMSPEQMNRMSYN 192 (269)
T ss_dssp HHC------------------------------------------------------------CCCSCCCHHHHTTCCCC
T ss_pred eecccCC-------------------------------------------------CccccCCCCcccCCHHHHcCCCCC
Confidence 8754210 122367899999999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
.++|||||||++|||++|.+||.+.+..++..+|.... ...+| ..+|+++++||.+||. ||.+|+ ++.||++|
T Consensus 193 ~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~s~~l~~li~~~L~~dp~~Rp---s~~ell~h 266 (269)
T d2java1 193 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIP--YRYSDELNEIITRMLNLKDYHRP---SVEEILEN 266 (269)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTS
T ss_pred hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCC--cccCHHHHHHHHHHcCCChhHCc---CHHHHHhC
Confidence 99999999999999999999999999988888887742 22333 4789999999999998 999999 89999999
Q ss_pred ccc
Q 010116 393 PWF 395 (518)
Q Consensus 393 pff 395 (518)
||.
T Consensus 267 p~i 269 (269)
T d2java1 267 PLI 269 (269)
T ss_dssp TTC
T ss_pred CcC
Confidence 995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-60 Score=473.99 Aligned_cols=260 Identities=32% Similarity=0.567 Sum_probs=232.9
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhc------hhhHHHHHHHHHHHHHhC-CCceeEEEEEeec
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK------RGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD 157 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~------~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~ 157 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|+.++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 479999999999999999999999999999999998764332 223456889999999997 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
++++|||||||+||+|.++|..++.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999998754
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC------CC
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK------KG 311 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------~~ 311 (518)
... .....+||+.|+|||++.+ ..
T Consensus 162 ~~~--------------------------------------------------~~~~~~gt~~y~~PE~~~~~~~~~~~~ 191 (277)
T d1phka_ 162 PGE--------------------------------------------------KLREVCGTPSYLAPEIIECSMNDNHPG 191 (277)
T ss_dssp TTC--------------------------------------------------CBCCCCSCGGGCCHHHHHHHHCTTSCC
T ss_pred CCC--------------------------------------------------ceeeeeccCCCCCHHHhhccccccCCC
Confidence 211 1125689999999999963 45
Q ss_pred CCccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 312 YGMECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 312 y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
|+.++||||+||++|||++|++||.+.+.......|......+..+....+|+++++||.+||. ||.+|+ +++||+
T Consensus 192 ~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---s~~eil 268 (277)
T d1phka_ 192 YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEAL 268 (277)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHT
T ss_pred CCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHHHH
Confidence 7899999999999999999999999999999998898865555555556899999999999999 999999 899999
Q ss_pred cCccccc
Q 010116 391 AHPWFKD 397 (518)
Q Consensus 391 ~Hpff~~ 397 (518)
+||||+.
T Consensus 269 ~h~~~~~ 275 (277)
T d1phka_ 269 AHPFFQQ 275 (277)
T ss_dssp TSGGGCT
T ss_pred cCHHHHH
Confidence 9999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-61 Score=488.93 Aligned_cols=292 Identities=41% Similarity=0.723 Sum_probs=248.1
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEe---cCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHHhCC-CceeEEEEEe
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVAS-HCIVKLYYSF 155 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f 155 (518)
.++..++|++++.||+|+||+||+|++. .+|+.||||++++..... ....+.+.+|+.+|+.++| |||++++++|
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 3466799999999999999999999874 478999999998764432 2335568899999999977 7999999999
Q ss_pred ecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 156 QDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 156 ~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.+...+|+||||+.||+|..++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC--CCC
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--GYG 313 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--~y~ 313 (518)
+.... .....+.+||+.|+|||++.+. .|+
T Consensus 179 ~~~~~------------------------------------------------~~~~~~~~g~~~~~~pe~~~~~~~~~~ 210 (322)
T d1vzoa_ 179 FVADE------------------------------------------------TERAYDFCGTIEYMAPDIVRGGDSGHD 210 (322)
T ss_dssp CCGGG------------------------------------------------GGGGCGGGSCCTTCCHHHHTTCC---C
T ss_pred hcccc------------------------------------------------cccccccccccccchhHHhhcCCcCCC
Confidence 54221 1122367899999999999764 468
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCC--Chhhhh
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTG--GAHQIK 390 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~--~a~eil 390 (518)
.++|||||||+||||++|.+||.+.+.......+.........+.+..+|+++++||.+||. ||.+|+++. +++||+
T Consensus 211 ~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 211 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 89999999999999999999998877666665555432222333334799999999999999 999999753 699999
Q ss_pred cCcccccCCccccc--cccCCccccCCCcccC
Q 010116 391 AHPWFKDVVWDKLY--EMEAAFKPEINGELDT 420 (518)
Q Consensus 391 ~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~ 420 (518)
+||||++++|+.+. ++++||+|.+.++.|.
T Consensus 291 ~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~~~ 322 (322)
T d1vzoa_ 291 EHLFFQKINWDDLAAKKVPAPFKPVIRDELDV 322 (322)
T ss_dssp TSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC
T ss_pred cCHhhcCCCHHHHHhCCCCcCCCCCCCCCCCC
Confidence 99999999999986 5899999999988773
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-60 Score=470.76 Aligned_cols=251 Identities=24% Similarity=0.425 Sum_probs=217.6
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec----CCeEEE
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----TEYLYL 163 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~----~~~lyl 163 (518)
|++.++||+|+||+||+|+++.+++.||+|++.+... .....+.+.+|+++|+.++|||||+++++|.+ ...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4677899999999999999999999999999987644 33456778999999999999999999999875 467999
Q ss_pred EEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCceeeC-CCCcEEEeecccccccCCCc
Q 010116 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~g--iiHRDIKPeNILld-~~g~vKL~DFGla~~~~~~~ 240 (518)
|||||+||+|.+++.+...+++..++.++.||+.||+|||++| ||||||||+||||+ .+|++||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999999998899999999999999999999999998 99999999999996 5899999999999753211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
.+.+.+|||.|||||++.+ +|+.++||||
T Consensus 169 --------------------------------------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwS 197 (270)
T d1t4ha_ 169 --------------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYA 197 (270)
T ss_dssp --------------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHH
T ss_pred --------------------------------------------------ccCCcccCccccCHHHhCC-CCCCcCchhh
Confidence 1236789999999999865 6999999999
Q ss_pred hhHHHHHHHhCCCCCCCCC-hhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 321 LGAIMYEMLVGYPPFYADD-PITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
|||++|||++|++||.+.. .......+.....+..++ ..+++++++||.+||. ||.+|+ +++||++||||+
T Consensus 198 lGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~---s~~ell~Hp~fk 270 (270)
T d1t4ha_ 198 FGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC
T ss_pred HHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccC--ccCCHHHHHHHHHHccCCHhHCc---CHHHHhCCcccC
Confidence 9999999999999997654 445556665543333333 3579999999999998 999999 899999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-60 Score=480.24 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=228.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+|+.++|||||+++++|++++++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999998653 2234578999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC--CcEEEeecccccccCCCcc
Q 010116 165 MEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN--GHMKLSDFGLCKPLDCSTL 241 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~-~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~--g~vKL~DFGla~~~~~~~~ 241 (518)
||||+||+|.+++...+ .+++.+++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 99999999999997664 79999999999999999999999999999999999999854 48999999999865322
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccch
Q 010116 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSL 321 (518)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 321 (518)
....+.+||+.|+|||++.+..|+.++|||||
T Consensus 158 ------------------------------------------------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSl 189 (321)
T d1tkia_ 158 ------------------------------------------------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp ------------------------------------------------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred ------------------------------------------------CcccccccccccccchhccCCCCCchhhcccH
Confidence 11236789999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 322 GAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 322 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
||++|+|++|.+||.+.+....+.+|.+....+..+....+|+++++||.+||. ||.+|+ ++.|+++||||+.
T Consensus 190 Gvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~ 263 (321)
T d1tkia_ 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhcc
Confidence 999999999999999999999999998853332222234689999999999998 999999 8999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-59 Score=468.54 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=217.6
Q ss_pred eEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhch--hhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEe
Q 010116 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR--GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (518)
Q Consensus 89 ~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~--~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 166 (518)
+.+++||+|+||+||+|+++.+|+.||||++++...... .....+.+|+.+|+.++|||||+++++|.+++++|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 357899999999999999999999999999976543322 123568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccccc
Q 010116 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (518)
Q Consensus 167 y~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~ 246 (518)
||.||++..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~------ 154 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------ 154 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc------
Confidence 99999888887777899999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCccccccchhHHH
Q 010116 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 325 (518)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 325 (518)
....+.+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 155 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil 191 (299)
T d1ua2a_ 155 -------------------------------------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL 191 (299)
T ss_dssp -------------------------------------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHH
T ss_pred -------------------------------------------ccccceecChhhccHHHHccCCCCChhhhhhhcchHH
Confidence 11235689999999999975 5689999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHhhhcCccc------------------CCC------CCCCChhHHHHHHHHhc-ccccc
Q 010116 326 YEMLVGYPPFYADDPITTCRKIVHWRNHLK------------------FPD------DSKLSPEAKDLICRLLC-DVEHR 380 (518)
Q Consensus 326 yeml~G~~PF~~~~~~~~~~~i~~~~~~l~------------------~p~------~~~~s~~~~dLI~~lL~-dp~~R 380 (518)
|||++|.+||.+.+..++..+|........ ++. ...+|++++|||.+||+ ||.+|
T Consensus 192 ~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R 271 (299)
T d1ua2a_ 192 AELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 271 (299)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTS
T ss_pred HHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhC
Confidence 999999999999999888888765311110 000 12568999999999999 99999
Q ss_pred CCCCChhhhhcCcccccC
Q 010116 381 LGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 381 ~g~~~a~eil~Hpff~~i 398 (518)
+ +|+|+++||||++.
T Consensus 272 ~---sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 272 I---TATQALKMKYFSNR 286 (299)
T ss_dssp C---CHHHHHTSGGGTSS
T ss_pred c---CHHHHhCCHhhCCC
Confidence 9 89999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=472.17 Aligned_cols=252 Identities=33% Similarity=0.572 Sum_probs=211.5
Q ss_pred CCCeeEEe-eEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeec----C
Q 010116 85 VDDFELLT-IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD----T 158 (518)
Q Consensus 85 ~~~f~i~~-~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~----~ 158 (518)
.++|+++. +||+|+||+||+|+++.+|+.||||++++. ..+.+|+.++.++ +|||||+++++|++ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 57899985 699999999999999999999999999754 2466789887654 89999999999976 5
Q ss_pred CeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CCcEEEeecccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLC 233 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g~vKL~DFGla 233 (518)
.++|||||||+||+|.++|.+. ..+++.+++.|+.||+.||+|||++|||||||||+|||++. ++++||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6799999999999999999764 47999999999999999999999999999999999999985 568999999999
Q ss_pred cccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCC
Q 010116 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (518)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 313 (518)
+...... ...+.+||+.|||||++.+..|+
T Consensus 162 ~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~y~ 191 (335)
T d2ozaa1 162 KETTSHN--------------------------------------------------SLTTPCYTPYYVAPEVLGPEKYD 191 (335)
T ss_dssp EECCCCC--------------------------------------------------CCCCCSCCCSSCCCCCCCGGGGS
T ss_pred eeccCCC--------------------------------------------------ccccccCCcccCCcHHHcCCCCC
Confidence 8653211 12356899999999999999999
Q ss_pred ccccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhc--CcccCCC--CCCCChhHHHHHHHHhc-cccccCCCCChhh
Q 010116 314 MECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWR--NHLKFPD--DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQ 388 (518)
Q Consensus 314 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~e 388 (518)
.++|||||||++|+|++|++||.+.+.......+.... ....+|. ...+|+++++||++||+ ||.+|+ ++.|
T Consensus 192 ~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e 268 (335)
T d2ozaa1 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITE 268 (335)
T ss_dssp HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC---CHHH
T ss_pred HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHH
Confidence 99999999999999999999998877655544443321 2233443 23589999999999998 999999 8999
Q ss_pred hhcCccccc
Q 010116 389 IKAHPWFKD 397 (518)
Q Consensus 389 il~Hpff~~ 397 (518)
|++||||..
T Consensus 269 il~hp~~~~ 277 (335)
T d2ozaa1 269 FMNHPWIMQ 277 (335)
T ss_dssp HHHSHHHHT
T ss_pred HHcCHHhhC
Confidence 999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-58 Score=456.50 Aligned_cols=251 Identities=29% Similarity=0.492 Sum_probs=217.0
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhh---HHHHHHHHHHHHHhC--CCceeEEEEEeecCC
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEHVRAERNLLAEVA--SHCIVKLYYSFQDTE 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~---~~~~~~E~~il~~l~--hp~Iv~l~~~f~~~~ 159 (518)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+........ ...+.+|+.+|+.++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999999999999999998765433222 233568999999997 899999999999999
Q ss_pred eEEEEEeecCC-CchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCC-CcEEEeecccccccC
Q 010116 160 YLYLIMEYLPG-GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 ~lylVmEy~~g-G~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~-g~vKL~DFGla~~~~ 237 (518)
.+|+||||+.| +++..++.+...+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 6888888888999999999999999999999999999999999999999854 799999999998543
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-Cccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMEC 316 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~ 316 (518)
.. ...+.+||+.|+|||++.+..| +.++
T Consensus 163 ~~---------------------------------------------------~~~~~~GT~~y~aPE~~~~~~~~~~~~ 191 (273)
T d1xwsa_ 163 DT---------------------------------------------------VYTDFDGTRVYSPPEWIRYHRYHGRSA 191 (273)
T ss_dssp SS---------------------------------------------------CBCCCCSCGGGSCHHHHHHSCBCHHHH
T ss_pred cc---------------------------------------------------cccccccCCCcCCHHHHcCCCCCCccc
Confidence 11 1235789999999999987765 6789
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
|||||||++|||++|++||.+.+ .+.. ....++ ..+|+++++||.+||. ||.+|+ +++||++||||
T Consensus 192 DiwSlGvilyell~g~~Pf~~~~------~i~~--~~~~~~--~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~ 258 (273)
T d1xwsa_ 192 AVWSLGILLYDMVCGDIPFEHDE------EIIR--GQVFFR--QRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWM 258 (273)
T ss_dssp HHHHHHHHHHHHHHSSCSCCSHH------HHHH--CCCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGG
T ss_pred ccccceeeehhHhhCCCCCCCch------HHhh--cccCCC--CCCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhh
Confidence 99999999999999999997642 3443 344455 3799999999999998 999999 89999999999
Q ss_pred ccCC
Q 010116 396 KDVV 399 (518)
Q Consensus 396 ~~i~ 399 (518)
+++.
T Consensus 259 ~~~~ 262 (273)
T d1xwsa_ 259 QDVL 262 (273)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 9764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=457.30 Aligned_cols=262 Identities=31% Similarity=0.489 Sum_probs=218.1
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+++|+.++|||||+++++|++...+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 379999999999999999999999999999999997653 2333456788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccc
Q 010116 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (518)
Q Consensus 165 mEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 243 (518)
||||.|+.+..+... ...+++..++.++.|++.||+|||++|||||||||+|||++.++++||+|||+|+......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--- 156 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--- 156 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS---
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc---
Confidence 999965544433333 4679999999999999999999999999999999999999999999999999998653210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCC-Cccccccchh
Q 010116 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDWWSLG 322 (518)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlG 322 (518)
......+||+.|+|||++....| +.++|+||||
T Consensus 157 ----------------------------------------------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlG 190 (298)
T d1gz8a_ 157 ----------------------------------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190 (298)
T ss_dssp ----------------------------------------------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHH
T ss_pred ----------------------------------------------ccceeecccceeeehhhhccccCCCccccccccc
Confidence 11235689999999999888765 8999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc----------------cCCC---------CCCCChhHHHHHHHHhc-c
Q 010116 323 AIMYEMLVGYPPFYADDPITTCRKIVHWRNHL----------------KFPD---------DSKLSPEAKDLICRLLC-D 376 (518)
Q Consensus 323 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~l----------------~~p~---------~~~~s~~~~dLI~~lL~-d 376 (518)
|++|+|++|++||.+.+......++....... .++. ...+|++++|||++||+ |
T Consensus 191 vily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d 270 (298)
T d1gz8a_ 191 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD 270 (298)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSS
T ss_pred hhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCC
Confidence 99999999999999998887777765421110 0110 12578999999999999 9
Q ss_pred ccccCCCCChhhhhcCcccccCC
Q 010116 377 VEHRLGTGGAHQIKAHPWFKDVV 399 (518)
Q Consensus 377 p~~R~g~~~a~eil~Hpff~~i~ 399 (518)
|.+|+ +++||++||||++++
T Consensus 271 P~~R~---t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 271 PNKRI---SAKAALAHPFFQDVT 290 (298)
T ss_dssp TTTSC---CHHHHHTSGGGTTCC
T ss_pred hhHCc---CHHHHhCCHhhccCC
Confidence 99999 899999999998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-57 Score=452.07 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=221.4
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC----e
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----Y 160 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----~ 160 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||++++++.+.. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998876656666778999999999999999999999997654 4
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|||||||+||+|..++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||+++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999989999999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
. ......+.+||+.|||||++.+..|+.++||||
T Consensus 166 ~----------------------------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwS 199 (277)
T d1o6ya_ 166 N----------------------------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 199 (277)
T ss_dssp -----------------------------------------------------------TTCCHHHHTTCCCCHHHHHHH
T ss_pred c----------------------------------------------cccccccccCcccccCHHHHcCCCCCcceeccc
Confidence 0 011234678999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFK 396 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~ 396 (518)
|||++|||++|.+||.+.+..+...+++.............+|+++++||.+||. ||.+|+. ++++ +.|+|.+
T Consensus 200 lGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~--sa~~-l~~~l~r 273 (277)
T d1o6ya_ 200 LGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ--TAAE-MRADLVR 273 (277)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS--SHHH-HHHHHHH
T ss_pred chHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh--HHHH-HHHHHHH
Confidence 9999999999999999999988888888754333333345799999999999998 9999994 3555 4566654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=456.68 Aligned_cols=262 Identities=27% Similarity=0.420 Sum_probs=217.8
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecC-CcEEEEEEeechhhhchhhHHHHHHHHHHHHHh---CCCceeEEEEEee----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKS-GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQ---- 156 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t-~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~---- 156 (518)
.++|++++.||+|+||+||+|++..+ ++.||||++++.... ......+.+|+.+|+.+ +|||||+++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 37899999999999999999999765 678999999765332 22223455778877766 7999999999985
Q ss_pred -cCCeEEEEEeecCCCchHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccc
Q 010116 157 -DTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (518)
Q Consensus 157 -~~~~lylVmEy~~gG~L~~~l~-~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~ 234 (518)
....+|+|||||.||++..... ....+++..++.++.|++.||+|||++|||||||||+|||++.+|++||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3457999999998887765543 34679999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCc
Q 010116 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (518)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 314 (518)
..... ....+.+||+.|+|||++.+.+|+.
T Consensus 165 ~~~~~--------------------------------------------------~~~~~~~gT~~Y~APE~~~~~~y~~ 194 (305)
T d1blxa_ 165 IYSFQ--------------------------------------------------MALTSVVVTLWYRAPEVLLQSSYAT 194 (305)
T ss_dssp CCCGG--------------------------------------------------GGGCCCCCCCTTCCHHHHTTCCCCT
T ss_pred hhccc--------------------------------------------------ccCCCcccChhhcCcchhcCCCCCh
Confidence 54311 1123678999999999999999999
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---cCC--------------------CCCCCChhHHHHHH
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL---KFP--------------------DDSKLSPEAKDLIC 371 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---~~p--------------------~~~~~s~~~~dLI~ 371 (518)
++|||||||++|||++|.+||.+.+...+..+|+...... .++ ....+|++++|||.
T Consensus 195 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 274 (305)
T d1blxa_ 195 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 274 (305)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred hehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHH
Confidence 9999999999999999999999999888888876521110 000 12357899999999
Q ss_pred HHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
+||+ ||.+|+ +|.|+++||||+++++
T Consensus 275 ~mL~~dP~~R~---sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 275 KCLTFNPAKRI---SAYSALSHPYFQDLER 301 (305)
T ss_dssp HHSCSSTTTSC---CHHHHHTSGGGTTCCC
T ss_pred HHCcCChhHCc---CHHHHhcChhhcCchh
Confidence 9999 999999 8999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=455.63 Aligned_cols=259 Identities=21% Similarity=0.321 Sum_probs=220.1
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCc-----EEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGN-----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~-----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 153 (518)
.+++..++|+++++||+|+||+||+|+++.+++ .||+|++.+.. .......+.+|+.+|..+ +|||||++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 356777899999999999999999999876654 69999986543 233445688999999998 8999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEc
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE-----------------------DTLTENVARFYIAQSVLAIESIHKHNYIHR 210 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~-----------------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHR 210 (518)
+|.+.+.+|||||||+||+|.++|... ..+++..++.|+.|++.||+|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 999999999999999999999999654 358999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccc
Q 010116 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRK 290 (518)
Q Consensus 211 DIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (518)
||||+|||++.+|++||+|||+|+...... ...
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~-----------------------------------------------~~~ 221 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDS-----------------------------------------------NYV 221 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT-----------------------------------------------TSE
T ss_pred cCchhccccccCCeEEEeeccccccccCCC-----------------------------------------------cee
Confidence 999999999999999999999998653211 011
Q ss_pred ccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHH
Q 010116 291 LAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDL 369 (518)
Q Consensus 291 ~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dL 369 (518)
...+.+||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+....+.+++.....+.. +..+|+++++|
T Consensus 222 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~--p~~~~~~l~~l 299 (325)
T d1rjba_ 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYII 299 (325)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHH
T ss_pred eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC--CCcCCHHHHHH
Confidence 2235679999999999999999999999999999999997 89999988877777777774433444 45799999999
Q ss_pred HHHHhc-cccccCCCCChhhhhcC
Q 010116 370 ICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 370 I~~lL~-dp~~R~g~~~a~eil~H 392 (518)
|.+||. ||.+|| +++||++|
T Consensus 300 i~~cl~~dP~~RP---t~~ei~~~ 320 (325)
T d1rjba_ 300 MQSCWAFDSRKRP---SFPNLTSF 320 (325)
T ss_dssp HHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHcCCChhHCc---CHHHHHHH
Confidence 999998 999999 89999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-56 Score=446.72 Aligned_cols=259 Identities=28% Similarity=0.443 Sum_probs=219.9
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 164 (518)
.++|+++++||+|+||+||+|+++ +|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 378999999999999999999885 789999999976543 334467788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccccc
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 244 (518)
|||+.|+++..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|.......
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~---- 154 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---- 154 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc----
Confidence 9999888888887778999999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccccchhH
Q 010116 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 323 (518)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGv 323 (518)
......+||+.|+|||++.+. .|+.++|||||||
T Consensus 155 ---------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv 189 (286)
T d1ob3a_ 155 ---------------------------------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189 (286)
T ss_dssp ----------------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred ---------------------------------------------cccceecccchhhhHHHHhCCCCCCcceeehhcCc
Confidence 012245799999999999864 5699999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhhcCccc---------C-------C---------CCCCCChhHHHHHHHHhc-cc
Q 010116 324 IMYEMLVGYPPFYADDPITTCRKIVHWRNHLK---------F-------P---------DDSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 324 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~---------~-------p---------~~~~~s~~~~dLI~~lL~-dp 377 (518)
++|||++|++||.+.+....+.++........ . . ....+|++++|||++||. ||
T Consensus 190 ~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 269 (286)
T d1ob3a_ 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269 (286)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSST
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCCh
Confidence 99999999999999888888777654211110 0 0 013578999999999999 99
Q ss_pred cccCCCCChhhhhcCccccc
Q 010116 378 EHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 378 ~~R~g~~~a~eil~Hpff~~ 397 (518)
.+|+ ++.||++||||++
T Consensus 270 ~~R~---s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 270 NQRI---TAKQALEHAYFKE 286 (286)
T ss_dssp TTSC---CHHHHHTSGGGGC
T ss_pred hHCc---CHHHHhcCcccCc
Confidence 9999 8999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.4e-57 Score=448.36 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=218.9
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
.++++..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 457788899999999999999999999999999999999997653 2356789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+.+|||||||++|+|..++... ..+++..++.++.|++.||+|||++|||||||||+||||+.+|++||+|||+|+..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999999754 67899999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
.... .....+..||+.|+|||++.+..|+.++
T Consensus 166 ~~~~------------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~k~ 197 (287)
T d1opja_ 166 TGDT------------------------------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKS 197 (287)
T ss_dssp CSSS------------------------------------------------SEEETTEEECGGGCCHHHHHHCCCSHHH
T ss_pred CCCC------------------------------------------------ceeeccccccccccChHHHcCCCCCchh
Confidence 3221 0112245689999999999999999999
Q ss_pred cccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 317 DWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 317 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||||++|||++|..||..........+++.....+.+| ..+|+++++||.+||. ||.+|| ++.||++
T Consensus 198 DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~ei~~ 268 (287)
T d1opja_ 198 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP--EGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC--ccchHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 99999999999999766655444444444444433333444 5799999999999998 999999 8999965
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-55 Score=448.50 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=213.2
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeec--CCe
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD--TEY 160 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~--~~~ 160 (518)
..++|+++++||+|+||+||+|+++.+|+.||||++++.. .+.+.+|+.+|+.+. ||||++++++|.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3478999999999999999999999999999999987542 356889999999995 9999999999974 467
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-cEEEeecccccccCCC
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCS 239 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-~vKL~DFGla~~~~~~ 239 (518)
+|+|||||.+|+|..+. ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999997764 5799999999999999999999999999999999999999765 5999999999865422
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~Di 318 (518)
. .....+||+.|+|||++.+. .|+.++|+
T Consensus 184 ~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 213 (328)
T d3bqca1 184 Q--------------------------------------------------EYNVRVASRYFKGPELLVDYQMYDYSLDM 213 (328)
T ss_dssp C--------------------------------------------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHH
T ss_pred C--------------------------------------------------cccccccCccccCcccccCCCCCCcccch
Confidence 1 12256899999999998874 58999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChh-hHHHHHhhhc---------------------------------CcccCCCCCCCCh
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPI-TTCRKIVHWR---------------------------------NHLKFPDDSKLSP 364 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~---------------------------------~~l~~p~~~~~s~ 364 (518)
|||||++|||++|..||...... .....+.... ..+..+....+|+
T Consensus 214 wslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 293 (328)
T d3bqca1 214 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 293 (328)
T ss_dssp HHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCH
T ss_pred hhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCH
Confidence 99999999999999999765432 2222222100 0001111234789
Q ss_pred hHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCcc
Q 010116 365 EAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWD 401 (518)
Q Consensus 365 ~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~ 401 (518)
+++|||++||+ ||.+|+ ||+||++||||++|.|+
T Consensus 294 ~~~dli~~mL~~dP~~R~---ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 294 EALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 328 (328)
T ss_dssp HHHHHHHHHSCSSGGGSC---CHHHHHTSGGGTTSCCC
T ss_pred HHHHHHHHHccCChhHCc---CHHHHhcCcccCCCCCC
Confidence 99999999999 999999 89999999999999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=446.37 Aligned_cols=264 Identities=27% Similarity=0.354 Sum_probs=218.3
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec-------
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------- 157 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------- 157 (518)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||++++++|.+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5789999999999999999999999999999999977643 33445668899999999999999999999865
Q ss_pred -CCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 158 -TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 158 -~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
...+|+|||||.++++..+......+++..++.++.|++.||.|||++|||||||||+|||++.+|.+||+|||+|+.+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 4568999999988877777666789999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCcc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGME 315 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~ 315 (518)
....... .....+.+||+.|+|||++.+. .|+.+
T Consensus 168 ~~~~~~~---------------------------------------------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k 202 (318)
T d3blha1 168 SLAKNSQ---------------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPP 202 (318)
T ss_dssp CC--------------------------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTH
T ss_pred ccccccc---------------------------------------------cccccceecCHHHhhHHHHcCCCCCCcH
Confidence 4321100 0112357899999999999864 78999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcccCCCCC----------------------------CCChhHH
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHLKFPDDS----------------------------KLSPEAK 367 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~----------------------------~~s~~~~ 367 (518)
+|||||||++|||++|++||.+.+.......+......+...... ..+++++
T Consensus 203 ~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (318)
T d3blha1 203 IDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282 (318)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHH
T ss_pred HHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHH
Confidence 999999999999999999999988888877776533221111000 1378899
Q ss_pred HHHHHHhc-cccccCCCCChhhhhcCccccc
Q 010116 368 DLICRLLC-DVEHRLGTGGAHQIKAHPWFKD 397 (518)
Q Consensus 368 dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~ 397 (518)
|||.+||. ||.+|+ +|+|++.||||+.
T Consensus 283 dLl~~mL~~dP~~R~---sa~elL~Hpff~~ 310 (318)
T d3blha1 283 DLIDKLLVLDPAQRI---DSDDALNHDFFWS 310 (318)
T ss_dssp HHHHHHSCSSTTTSC---CHHHHHHSGGGSS
T ss_pred HHHHHHCcCChhHCc---CHHHHHcChhhcc
Confidence 99999999 999999 8999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=450.86 Aligned_cols=253 Identities=31% Similarity=0.497 Sum_probs=212.2
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee------cCC
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ------DTE 159 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~------~~~ 159 (518)
-+|+.+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+.+|+.++|||||+++++|. +..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 3699999999999999999999999999999999765321 236999999999999999999984 445
Q ss_pred eEEEEEeecCCCchHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC-cEEEeecccccc
Q 010116 160 YLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKP 235 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l---~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g-~vKL~DFGla~~ 235 (518)
++|||||||+||.+..+. .....+++..++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 789999999776443332 3456899999999999999999999999999999999999999876 899999999986
Q ss_pred cCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCc
Q 010116 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGM 314 (518)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~ 314 (518)
+... ....+.+||+.|+|||++.+ ..|+.
T Consensus 173 ~~~~--------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (350)
T d1q5ka_ 173 LVRG--------------------------------------------------EPNVSYICSRYYRAPELIFGATDYTS 202 (350)
T ss_dssp CCTT--------------------------------------------------SCCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred ccCC--------------------------------------------------cccccccccccccChHHhhcccCCCc
Confidence 5321 11235789999999999876 57899
Q ss_pred cccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC---------------cccCCC----------CCCCChhHHHH
Q 010116 315 ECDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN---------------HLKFPD----------DSKLSPEAKDL 369 (518)
Q Consensus 315 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------~l~~p~----------~~~~s~~~~dL 369 (518)
++|||||||++|||++|.+||.+.+....+.+|+.... ...++. ...+|++++||
T Consensus 203 ~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 282 (350)
T d1q5ka_ 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282 (350)
T ss_dssp HHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHH
T ss_pred ceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHH
Confidence 99999999999999999999999988887777754211 111111 23578999999
Q ss_pred HHHHhc-cccccCCCCChhhhhcCcccccC
Q 010116 370 ICRLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 370 I~~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
|.+||+ ||.+|+ +|.|+++||||+++
T Consensus 283 l~~mL~~dP~~R~---ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 283 CSRLLEYTPTARL---TPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHSCSSGGGSC---CHHHHHTSGGGGGG
T ss_pred HHHHccCChhHCc---CHHHHhcCHhhccc
Confidence 999999 999999 89999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=437.38 Aligned_cols=258 Identities=23% Similarity=0.358 Sum_probs=219.6
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.+++..++|++++.||+|+||+||+|+.+ +++.||||++++... ..+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 46677889999999999999999999875 578899999976532 34568999999999999999999998765 5
Q ss_pred eEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 679999999999999987543 469999999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.... ....+.+||+.|||||++.+..|+.++|
T Consensus 161 ~~~~------------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~~sD 192 (272)
T d1qpca_ 161 DNEY------------------------------------------------TAREGAKFPIKWTAPEAINYGTFTIKSD 192 (272)
T ss_dssp SSCE------------------------------------------------ECCTTCCCCTTTSCHHHHHHCEECHHHH
T ss_pred CCcc------------------------------------------------ccccccCCcccccChHHHhCCCCCchhh
Confidence 3210 1122467999999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc--Cc
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA--HP 393 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~--Hp 393 (518)
||||||++|||+| |.+||...+..+....+... ..+.. +..+|+++++||.+||. ||.+|| ++.+|++ |+
T Consensus 193 vwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~--p~~~~~~l~~li~~cl~~~P~~Rp---t~~ei~~~L~~ 266 (272)
T d1qpca_ 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVR--PDNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLED 266 (272)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHH
T ss_pred hhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCC--cccChHHHHHHHHHHcCCCHhHCc---CHHHHHHHhhh
Confidence 9999999999999 56666677777777777653 23333 35799999999999998 999999 8999988 88
Q ss_pred cccc
Q 010116 394 WFKD 397 (518)
Q Consensus 394 ff~~ 397 (518)
||..
T Consensus 267 ~fts 270 (272)
T d1qpca_ 267 FFTA 270 (272)
T ss_dssp HHHH
T ss_pred hhhc
Confidence 9864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=449.93 Aligned_cols=258 Identities=30% Similarity=0.469 Sum_probs=214.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 159 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 579999999999999999999999999999999998653 34455678899999999999999999999998765
Q ss_pred -eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 -YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 -~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+||||||| |++|..++ +...+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 66777665 567899999999999999999999999999999999999999999999999999986532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-CCCcccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD 317 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~D 317 (518)
. ..+.+||+.|+|||++.+. .++.++|
T Consensus 174 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 201 (346)
T d1cm8a_ 174 E----------------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVD 201 (346)
T ss_dssp S----------------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHH
T ss_pred c----------------------------------------------------cccccccccccCHHHHcCCCCCCccch
Confidence 1 1256899999999999874 5699999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---------------------cCC------CCCCCChhHHHHH
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL---------------------KFP------DDSKLSPEAKDLI 370 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---------------------~~p------~~~~~s~~~~dLI 370 (518)
||||||++|||++|++||.+.+.......+......+ ... ....+|++++|||
T Consensus 202 iwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 281 (346)
T d1cm8a_ 202 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281 (346)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHH
T ss_pred hhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHH
Confidence 9999999999999999999988777666554421110 000 0135789999999
Q ss_pred HHHhc-cccccCCCCChhhhhcCcccccCCc
Q 010116 371 CRLLC-DVEHRLGTGGAHQIKAHPWFKDVVW 400 (518)
Q Consensus 371 ~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w 400 (518)
++||+ ||.+|+ ++.||++||||+++.+
T Consensus 282 ~~mL~~dP~~R~---ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 282 EKMLVLDAEQRV---TAGEALAHPYFESLHD 309 (346)
T ss_dssp HHHSCSSTTTSC---CHHHHHHSGGGTTTC-
T ss_pred HHHCcCChhHCc---CHHHHhcChhhCcCCC
Confidence 99999 999999 8999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=431.65 Aligned_cols=250 Identities=20% Similarity=0.284 Sum_probs=208.3
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+.+|+.+++.++|||||++++++.+++.+|+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 4579999999999999999999875 567899999976432 23568899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
|||||++|+|.+++... ..++++.+..++.|++.||.|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-- 155 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 155 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC--
Confidence 99999999999998654 678999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
.......+||+.|+|||++.+..|+.++||||||
T Consensus 156 ----------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~G 189 (263)
T d1sm2a_ 156 ----------------------------------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 189 (263)
T ss_dssp -------------------------------------------------------CTTSCCHHHHTTCCCCHHHHHHHHH
T ss_pred ----------------------------------------------ceeecceecCcccCChHHhcCCCCCchhhhcchH
Confidence 0112246799999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 323 AIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 323 vilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
|++|||++ |.+||...+..+....+... ..+..| ..+++++.+||.+||. ||.+|| +++||++|
T Consensus 190 vil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~p~~Rp---s~~~il~~ 255 (263)
T d1sm2a_ 190 VLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKP--RLASTHVYQIMNHCWKERPEDRP---AFSRLLRQ 255 (263)
T ss_dssp HHHHHHHTTSCCTTCSCCHHHHHHHHHHT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHhc-CCCCCc--cccCHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 99999999 57777777777777777663 233333 4689999999999998 999999 89999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-55 Score=440.91 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=210.3
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
.+..++|++.++||+|+||+||+|+++.+|+ .||||++.... .....+.+.+|+.+|+.++|||||++++++.+.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 5667899999999999999999999987765 58889886542 234556789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988764 579999999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
...... ........+||+.|||||++.+..|+.++|
T Consensus 180 ~~~~~~--------------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sD 215 (299)
T d1jpaa_ 180 DDTSDP--------------------------------------------TYTSALGGKIPIRWTAPEAIQYRKFTSASD 215 (299)
T ss_dssp ------------------------------------------------------------CGGGSCHHHHHSCCCCHHHH
T ss_pred CCCCcc--------------------------------------------eeeecccccCCccccCHHHHhcCCCCcccc
Confidence 221000 001122356899999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||||++|||++ |.+||.+.+..+....+... ...|.+..+++++.+||.+||. ||.+|| ++.||+++
T Consensus 216 vwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~ei~~~ 286 (299)
T d1jpaa_ 216 VWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD---YRLPPPMDCPSALHQLMLDCWQKDRNHRP---KFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred cccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 9999999999998 89999999888888777653 3334445799999999999998 999999 88888764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=438.12 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=212.8
Q ss_pred eeEeecCceEEEEEEEec--CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEEeecC
Q 010116 92 TIIGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (518)
Q Consensus 92 ~~LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 169 (518)
++||+|+||+||+|..+. +++.||||+++... ......+.+.+|+.+|+.++|||||++++++.++ .+|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 579999999999998654 56789999997653 3344567799999999999999999999999765 5789999999
Q ss_pred CCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccccccc
Q 010116 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (518)
Q Consensus 170 gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 249 (518)
||+|.+++.+...+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~-------- 162 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-------- 162 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS--------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc--------
Confidence 999999999889999999999999999999999999999999999999999999999999999987642210
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHHHHHH
Q 010116 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 329 (518)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 329 (518)
........+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 163 --------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell 204 (277)
T d1xbba_ 163 --------------------------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204 (277)
T ss_dssp --------------------------------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred --------------------------------------ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence 011122467999999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhh---hcCcccccCC
Q 010116 330 V-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI---KAHPWFKDVV 399 (518)
Q Consensus 330 ~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei---l~Hpff~~i~ 399 (518)
+ |.+||.+.+..+....+... ..+.+| ..+|+++++||.+||. ||.+|| ++.+| ++|+|+.-++
T Consensus 205 t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dp~~RP---s~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 205 SYGQKPYRGMKGSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHHcCCCHhHCc---CHHHHHHHhhCHHhhcCC
Confidence 8 99999998888877777653 334444 4799999999999998 999999 78887 5677775443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=437.54 Aligned_cols=258 Identities=20% Similarity=0.243 Sum_probs=211.8
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
.|++..++|++++.||+|+||+||+|+.+ ..||||+++.... .....+.+.+|+.+|+.++|||||++++++. +.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 46778899999999999999999999743 4599999976543 3445678999999999999999999998764 56
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|||||||+||+|.+++... ..+++..+..++.|++.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 689999999999999999654 6799999999999999999999999999999999999999999999999999986532
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC---CCCCcc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGME 315 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~ 315 (518)
.. ......+.+||+.|||||++.+ ..|+.+
T Consensus 157 ~~-----------------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ 189 (276)
T d1uwha_ 157 WS-----------------------------------------------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189 (276)
T ss_dssp --------------------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHH
T ss_pred cC-----------------------------------------------CcccccccccCcccCCHHHHhcccCCCCCch
Confidence 10 0012235789999999999974 358999
Q ss_pred ccccchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC-cccC-CCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 316 CDWWSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRN-HLKF-PDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 316 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~l~~-p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+|||||||++|||++|+.||.+.+.......++.... .... .....+|+++++||.+||. ||.+|| ++.||++|
T Consensus 190 sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~il~~ 266 (276)
T d1uwha_ 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP---LFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred hhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 9999999999999999999998776665555544221 1111 1134689999999999998 999999 89999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=435.61 Aligned_cols=260 Identities=23% Similarity=0.355 Sum_probs=219.7
Q ss_pred CcCCCCeeEEee-EeecCceEEEEEEEec--CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 82 KICVDDFELLTI-IGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 82 ~~~~~~f~i~~~-LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
-+..++|.+... ||+|+||+||+|.++. ++..||||++++.. .....+.+.+|+.+|+.++|||||++++++.++
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 81 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 81 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 345578889885 9999999999998754 45579999997642 344567789999999999999999999999765
Q ss_pred CeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+|||||||+||+|.+++.. +..+++..+..++.|++.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 82 -~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred -eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 58999999999999999865 4689999999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
..... .......+||+.|||||++.+..|+.++|
T Consensus 161 ~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksD 194 (285)
T d1u59a_ 161 ADDSY----------------------------------------------YTARSAGKWPLKWYAPECINFRKFSSRSD 194 (285)
T ss_dssp TCSCE----------------------------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHH
T ss_pred ccccc----------------------------------------------cccccccccCccccChHHHhCCCCCccch
Confidence 32100 01122467999999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhh---hcC
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQI---KAH 392 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~ei---l~H 392 (518)
||||||++|||++ |.+||.+.+..+....|... ..+.+| ..+|+++.+||.+||. ||.+|| ++.+| ++|
T Consensus 195 VwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~p~~RP---s~~~i~~~L~~ 268 (285)
T d1u59a_ 195 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECP--PECPPELYALMSDCWIYKWEDRP---DFLTVEQRMRA 268 (285)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHHHHH
T ss_pred hhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcCCCHhHCc---CHHHHHHHHHH
Confidence 9999999999998 99999998888887777663 234454 4799999999999998 999999 66666 678
Q ss_pred cccc
Q 010116 393 PWFK 396 (518)
Q Consensus 393 pff~ 396 (518)
+|+.
T Consensus 269 ~~~~ 272 (285)
T d1u59a_ 269 CYYS 272 (285)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=426.96 Aligned_cols=250 Identities=20% Similarity=0.345 Sum_probs=220.4
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEE
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 163 (518)
..++|++++.||+|+||+||+|+.+ +++.||||++++... ..+.+.+|+.+++.++|||||+++++|.+++.+|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 3579999999999999999999974 778999999987643 23568899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCccc
Q 010116 164 IMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~ 242 (518)
||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+|+.+.....
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 155 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 155 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence 9999999999999755 46899999999999999999999999999999999999999999999999999986542210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchh
Q 010116 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLG 322 (518)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 322 (518)
......+||+.|+|||++.+..|+.++||||||
T Consensus 156 -----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G 188 (258)
T d1k2pa_ 156 -----------------------------------------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 188 (258)
T ss_dssp -----------------------------------------------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred -----------------------------------------------eeecccCCCCCcCCcHHhcCCCCCcceeecccc
Confidence 011245799999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 323 AIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 323 vilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
|++|||++ |+.||.+.+..++..+|.... .+..| ..+++++++||.+||. ||.+|| ++++|++|
T Consensus 189 ~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dP~~RP---t~~eil~~ 254 (258)
T d1k2pa_ 189 VLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRP--HLASEKVYTIMYSCWHEKADERP---TFKILLSN 254 (258)
T ss_dssp HHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred hhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCc--ccccHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 99999998 899999999988888887632 33344 5789999999999998 999999 89999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=429.10 Aligned_cols=260 Identities=27% Similarity=0.452 Sum_probs=222.1
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCCeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 165 (518)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.+...+++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 68999999999999999999999999999999997654 34456788999999999999999999999999999999999
Q ss_pred eecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 166 Ey~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
|++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++++||+|||+|+......
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~----- 155 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----- 155 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-----
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-----
Confidence 999999999999888999999999999999999999999999999999999999999999999999998654221
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC-CCccccccchhHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAI 324 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvi 324 (518)
.......+++.|+|||++.+.. ++.++|||||||+
T Consensus 156 --------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~i 191 (292)
T d1unla_ 156 --------------------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191 (292)
T ss_dssp --------------------------------------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred --------------------------------------------ccceeeccccchhhhhHhccCCCCCchhhccccchH
Confidence 0112346788999999998765 6999999999999
Q ss_pred HHHHHhCCCCCC-CCChhhHHHHHhhhcCcc---------cCC----------------CCCCCChhHHHHHHHHhc-cc
Q 010116 325 MYEMLVGYPPFY-ADDPITTCRKIVHWRNHL---------KFP----------------DDSKLSPEAKDLICRLLC-DV 377 (518)
Q Consensus 325 lyeml~G~~PF~-~~~~~~~~~~i~~~~~~l---------~~p----------------~~~~~s~~~~dLI~~lL~-dp 377 (518)
+|||++|+.||. +.+......++....... ..+ ....+|++++|||++||+ ||
T Consensus 192 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP 271 (292)
T d1unla_ 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271 (292)
T ss_dssp HHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCCh
Confidence 999999998864 555556666554321110 000 113568999999999999 99
Q ss_pred cccCCCCChhhhhcCcccccC
Q 010116 378 EHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 378 ~~R~g~~~a~eil~Hpff~~i 398 (518)
.+|+ +|+||++||||+++
T Consensus 272 ~~R~---sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 272 VQRI---SAEEALQHPYFSDF 289 (292)
T ss_dssp GGSC---CHHHHTTSGGGSSC
T ss_pred hHCc---CHHHHhcChhhcCC
Confidence 9999 89999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=429.45 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=210.4
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCC---cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSG---NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
+++..++|++++.||+|+||+||+|++..++ ..||||+++... .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 5677789999999999999999999986543 468888886432 34456778999999999999999999999964
Q ss_pred CCeEEEEEeecCCCchHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~-~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+.+|+|||||+||+|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 678999999999999998765 467999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
.... .......+||+.|+|||++.+..|+.++
T Consensus 159 ~~~~------------------------------------------------~~~~~~~~gt~~y~apE~l~~~~~~~~~ 190 (273)
T d1mp8a_ 159 EDST------------------------------------------------YYKASKGKLPIKWMAPESINFRRFTSAS 190 (273)
T ss_dssp ------------------------------------------------------------CCGGGCCHHHHHHCCCSHHH
T ss_pred cCCc------------------------------------------------ceeccceecCcccchhhHhccCCCCCcc
Confidence 3211 0112346799999999999999999999
Q ss_pred cccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 317 DWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 317 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
|||||||++|||++ |.+||.+.+..+...++.... .+.+ +..+|+++++||.+||. ||.+|| ++.||++|
T Consensus 191 DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~--~~~~~~~~~~li~~cl~~dp~~Rp---s~~ei~~~ 262 (273)
T d1mp8a_ 191 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPM--PPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred ccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCCHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 99999999999998 899999999999888887642 3334 45799999999999998 999999 89999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=441.11 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=212.7
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC-----e
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-----Y 160 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-----~ 160 (518)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|+.++|||||++++++.... +
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997653 3445667899999999999999999999997653 3
Q ss_pred EEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCc
Q 010116 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 161 lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~ 240 (518)
+|+| +|+.||+|.+++.. ..+++..++.++.|++.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 86 ~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 5555 56669999999954 579999999999999999999999999999999999999999999999999998654221
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcC-CCCCcccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWW 319 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 319 (518)
. ........+||+.|+|||++.. ..|+.++|||
T Consensus 164 ~----------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diw 197 (345)
T d1pmea_ 164 D----------------------------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 197 (345)
T ss_dssp C----------------------------------------------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHH
T ss_pred c----------------------------------------------cceeeccccccceechHHHhhcCCCCCchhhhh
Confidence 0 0012235789999999999854 5789999999
Q ss_pred chhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc------------------cCCC---------CCCCChhHHHHHHH
Q 010116 320 SLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL------------------KFPD---------DSKLSPEAKDLICR 372 (518)
Q Consensus 320 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l------------------~~p~---------~~~~s~~~~dLI~~ 372 (518)
|+||++|||++|.+||.+.+.......+....... ..+. ...+|+++++||.+
T Consensus 198 SlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 277 (345)
T d1pmea_ 198 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277 (345)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred ccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHH
Confidence 99999999999999999888766665554311000 0111 23578999999999
Q ss_pred Hhc-cccccCCCCChhhhhcCcccccC
Q 010116 373 LLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 373 lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
||+ ||.+|+ +|.|+++||||+..
T Consensus 278 ~L~~dP~~R~---ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 278 MLTFNPHKRI---EVEQALAHPYLEQY 301 (345)
T ss_dssp HSCSSTTTSC---CHHHHHTSGGGTTT
T ss_pred HccCChhHCc---CHHHHhcCHhhccC
Confidence 999 999999 89999999999843
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=429.20 Aligned_cols=259 Identities=22% Similarity=0.370 Sum_probs=214.8
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 158 (518)
..+.+..++|++.+.||+|+||+||+|+++.+ +.||||++++... ..+.+.+|+.+|+.++|||||++++++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 34677889999999999999999999998755 5699999976532 23568899999999999999999999865
Q ss_pred CeEEEEEeecCCCchHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 159 EYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~--~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
+.+|+|||||++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 457899999999999998865 357999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
..+. .....+.+||+.|+|||++.+..|+.++
T Consensus 164 ~~~~------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ks 195 (285)
T d1fmka3 164 EDNE------------------------------------------------YTARQGAKFPIKWTAPEAALYGRFTIKS 195 (285)
T ss_dssp ------------------------------------------------------------CCGGGSCHHHHHHCCCCHHH
T ss_pred cCCC------------------------------------------------ceeeccccccccccChHHHhCCCCCcHH
Confidence 3221 0112246799999999999999999999
Q ss_pred cccchhHHHHHHHhC-CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc--C
Q 010116 317 DWWSLGAIMYEMLVG-YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA--H 392 (518)
Q Consensus 317 DiWSlGvilyeml~G-~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~--H 392 (518)
|||||||++|||++| .+||.+....+....+... ...|.+..+|+++++||.+||. ||++|| ++++|++ |
T Consensus 196 DI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~~L~ 269 (285)
T d1fmka3 196 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLE 269 (285)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHH
T ss_pred hhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---CCCCCCcccCHHHHHHHHHHcccCHhHCc---CHHHHHHHHh
Confidence 999999999999995 5556666666666666542 2334445799999999999998 999999 8999988 8
Q ss_pred ccccc
Q 010116 393 PWFKD 397 (518)
Q Consensus 393 pff~~ 397 (518)
+||..
T Consensus 270 ~~~~~ 274 (285)
T d1fmka3 270 DYFTS 274 (285)
T ss_dssp TTTSC
T ss_pred hhhcC
Confidence 88875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=444.83 Aligned_cols=269 Identities=27% Similarity=0.398 Sum_probs=212.9
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec------C
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------T 158 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------~ 158 (518)
.++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3789999999999999999999999999999999987643 44556778999999999999999999999963 4
Q ss_pred CeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 159 ~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.++|+|||||.|+ +...+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 7899999999655 54444 35799999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
. ......+||+.|+|||++.+..|+.++||
T Consensus 172 ~--------------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~Di 201 (355)
T d2b1pa1 172 S--------------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDI 201 (355)
T ss_dssp -----------------------------------------------------------CCTTCCHHHHTTCCCCTTHHH
T ss_pred c--------------------------------------------------cccccccccccccChhhhcCCCCCCCccc
Confidence 1 11235689999999999999999999999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCc--------------------cc---------C-----CC----CC
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNH--------------------LK---------F-----PD----DS 360 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--------------------l~---------~-----p~----~~ 360 (518)
||+||++|||++|++||.+.+......+++..... .. + +. ..
T Consensus 202 wSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (355)
T d2b1pa1 202 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281 (355)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred ccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccc
Confidence 99999999999999999998887777666531110 00 0 00 01
Q ss_pred CCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccccccCCc
Q 010116 361 KLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAF 410 (518)
Q Consensus 361 ~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~~~~~p~ 410 (518)
.+|++++|||++||+ ||.+|+ +|+|||+||||+...|.......+|.
T Consensus 282 ~~s~~~~dll~~mL~~dP~~R~---ta~elL~Hpw~~~~~~~~~~~~~~~~ 329 (355)
T d2b1pa1 282 LKASQARDLLSKMLVIDPAKRI---SVDDALQHPYINVWYDPAEVEAPPPQ 329 (355)
T ss_dssp HHHHHHHHHHHHHSCSSTTTSC---CHHHHHTSTTTGGGCCHHHHTCCCC-
T ss_pred cCCHHHHHHHHHHCcCChhHCc---CHHHHhcCcccCCCCCcccccCCCCC
Confidence 236789999999999 999999 99999999999975443333444443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=441.99 Aligned_cols=257 Identities=29% Similarity=0.432 Sum_probs=215.6
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecC-----C
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----E 159 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~ 159 (518)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 378999999999999999999999999999999998653 2334456788999999999999999999999643 3
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~ 239 (518)
..++||+|+.||+|.+++. .+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred ceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 3466677888999999885 45799999999999999999999999999999999999999999999999999875421
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCC-CCccccc
Q 010116 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECDW 318 (518)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~Di 318 (518)
...+.+||+.|+|||++.+.. ++.++||
T Consensus 174 ---------------------------------------------------~~~~~~g~~~y~apE~~~~~~~~~~~~Di 202 (348)
T d2gfsa1 174 ---------------------------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDI 202 (348)
T ss_dssp ---------------------------------------------------GGSSSCHHHHTSCHHHHTTCSCCCTTHHH
T ss_pred ---------------------------------------------------ccccccccccccCchhhcCCccCCcccch
Confidence 122568999999999987755 6899999
Q ss_pred cchhHHHHHHHhCCCCCCCCChhhHHHHHhhhcCcc---------------------cCCC------CCCCChhHHHHHH
Q 010116 319 WSLGAIMYEMLVGYPPFYADDPITTCRKIVHWRNHL---------------------KFPD------DSKLSPEAKDLIC 371 (518)
Q Consensus 319 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~l---------------------~~p~------~~~~s~~~~dLI~ 371 (518)
|||||++|+|++|.+||.+.+.......|....... ..+. ...+|++++|||+
T Consensus 203 wSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 282 (348)
T d2gfsa1 203 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 282 (348)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHH
T ss_pred hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHH
Confidence 999999999999999999998888887776532211 0110 1357999999999
Q ss_pred HHhc-cccccCCCCChhhhhcCcccccC
Q 010116 372 RLLC-DVEHRLGTGGAHQIKAHPWFKDV 398 (518)
Q Consensus 372 ~lL~-dp~~R~g~~~a~eil~Hpff~~i 398 (518)
+||+ ||.+|+ +|.||++||||+.+
T Consensus 283 ~mL~~dP~~R~---ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 283 KMLVLDSDKRI---TAAQALAHAYFAQY 307 (348)
T ss_dssp HHSCSSGGGSC---CHHHHHTSGGGTTT
T ss_pred HHCcCChhhCc---CHHHHhcCHhhCCC
Confidence 9999 999999 89999999999854
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-54 Score=428.94 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=207.3
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEec-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 153 (518)
++.+..++|++++.||+|+||+||+|++.. +++.||||++++.. .....+.+.+|..++.++ +|||||.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 456777899999999999999999999764 45789999987543 233445677788888777 6889999999
Q ss_pred Eeec-CCeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCc
Q 010116 154 SFQD-TEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDN 216 (518)
Q Consensus 154 ~f~~-~~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeN 216 (518)
++.. ...+|+|||||+||+|.++|... ..+++..+..|+.|++.||+|||++|||||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 8765 45799999999999999999643 348999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccccc
Q 010116 217 LLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (518)
Q Consensus 217 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 296 (518)
|||+.+|++||+|||+|+....... .....+.+
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~-----------------------------------------------~~~~~~~~ 197 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPD-----------------------------------------------YVRKGDAR 197 (299)
T ss_dssp EEECGGGCEEECC------CCSCTT-----------------------------------------------SCCTTSCC
T ss_pred eeECCCCcEEEccCcchhhcccccc-----------------------------------------------ccccCcee
Confidence 9999999999999999986532210 01123568
Q ss_pred CCCCccChhhhcCCCCCccccccchhHHHHHHHhC-CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc
Q 010116 297 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC 375 (518)
Q Consensus 297 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G-~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~ 375 (518)
||+.|||||++.+..|+.++|||||||++|||++| .+||.+.+....+..++.....+..| ..+|+++++||.+||+
T Consensus 198 gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~ 275 (299)
T d1ywna1 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWH 275 (299)
T ss_dssp CGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTC
T ss_pred eCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHcC
Confidence 99999999999999999999999999999999986 57888776666666665544444444 4689999999999998
Q ss_pred -cccccCCCCChhhhhcC
Q 010116 376 -DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 376 -dp~~R~g~~~a~eil~H 392 (518)
||.+|+ ++.||++|
T Consensus 276 ~dP~~Rp---t~~eil~~ 290 (299)
T d1ywna1 276 GEPSQRP---TFSELVEH 290 (299)
T ss_dssp SSGGGSC---CHHHHHHH
T ss_pred CChhHCc---CHHHHHHH
Confidence 999999 89999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=430.80 Aligned_cols=254 Identities=20% Similarity=0.307 Sum_probs=210.0
Q ss_pred CCCCeeEEeeEeecCceEEEEEEEecCCc----EEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 84 CVDDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 84 ~~~~f~i~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
..+||+++++||+|+||+||+|++..+|+ .||+|+++... .....+.+.+|+.+|+.++|||||++++++.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 34789999999999999999999988887 47777775432 334567789999999999999999999999875
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
..++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 577889999999999888664 6899999999999999999999999999999999999999999999999999987642
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
... ...+...+||+.|||||++.+..|+.++||
T Consensus 164 ~~~-----------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDv 196 (317)
T d1xkka_ 164 EEK-----------------------------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDV 196 (317)
T ss_dssp TCC-------------------------------------------------------CCTTTSCHHHHHHCCCCHHHHH
T ss_pred ccc-----------------------------------------------cccccccccCccccChHHHhcCCCChhhhh
Confidence 210 011224579999999999999999999999
Q ss_pred cchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCc
Q 010116 319 WSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHP 393 (518)
Q Consensus 319 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hp 393 (518)
|||||++|||+| |.+||.+.+..+....+... ..+..| ..+|+++.+||.+||. ||.+|| ++.||+.|.
T Consensus 197 wS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dP~~RP---s~~eil~~l 267 (317)
T d1xkka_ 197 WSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQP--PICTIDVYMIMVKCWMIDADSRP---KFRELIIEF 267 (317)
T ss_dssp HHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHHH
T ss_pred hhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHhCCCChhhCc---CHHHHHHHH
Confidence 999999999998 89999888877776666543 333344 5789999999999998 999999 899999983
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=420.09 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=208.5
Q ss_pred CcCCCCeeEEeeEeecCceEEEEEEEecCC----cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeec
Q 010116 82 KICVDDFELLTIIGRGAFGEVRLCREKKSG----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (518)
Q Consensus 82 ~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 157 (518)
++..+.|++.++||+|+||+||+|..+.++ ..||||++.... .......+.+|+.+|+.++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 566788999999999999999999987665 479999997543 23345668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccccccc
Q 010116 158 TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~ 236 (518)
.+.+|+|||||.+|++..++... ..+++..+..++.|++.||+|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999999988654 68999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccc
Q 010116 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (518)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 316 (518)
..... .........||+.|||||++.+..|+.++
T Consensus 161 ~~~~~----------------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~s 194 (283)
T d1mqba_ 161 EDDPE----------------------------------------------ATYTTSGGKIPIRWTAPEAISYRKFTSAS 194 (283)
T ss_dssp -----------------------------------------------------------CCCGGGSCHHHHHSCCCCHHH
T ss_pred cCCCc----------------------------------------------cceEeccCCCCccccCHHHHccCCCCCcc
Confidence 42210 00012245799999999999999999999
Q ss_pred cccchhHHHHHHHhC-CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhc
Q 010116 317 DWWSLGAIMYEMLVG-YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 317 DiWSlGvilyeml~G-~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
|||||||++|||++| .+||...+..+....+... ...|.+..+++++++||.+||. ||.+|| ++.||++
T Consensus 195 DI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~eil~ 265 (283)
T d1mqba_ 195 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSAIYQLMMQCWQQERARRP---KFADIVS 265 (283)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCBHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred cccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc---CCCCCchhhHHHHHHHHHHHCcCCHhHCc---CHHHHHH
Confidence 999999999999995 5555556666666655542 2334445789999999999998 999999 8999876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=420.43 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=209.1
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecC-C--cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEeecCC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKS-G--NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t-~--~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 159 (518)
+..+||++++.||+|+||+||+|+...+ + ..||||++++.........+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 3457899999999999999999987543 3 36899999887666666678899999999999999999999999764
Q ss_pred eEEEEEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~ 238 (518)
.+|+|||||++|++.+++... +.+++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 678999999999999887654 6799999999999999999999999999999999999999999999999999997643
Q ss_pred CccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccc
Q 010116 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318 (518)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 318 (518)
... ........+||+.|+|||++.+..|+.++||
T Consensus 164 ~~~----------------------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 197 (273)
T d1u46a_ 164 NDD----------------------------------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDT 197 (273)
T ss_dssp -CC----------------------------------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHH
T ss_pred CCC----------------------------------------------cceecCccccCcccCCHHHHhCCCCCcchhh
Confidence 211 0111224568889999999999999999999
Q ss_pred cchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 319 WSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 319 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
|||||++|||++ |.+||.+.+..+...++.... ..++....+|+++++||.+||. ||.+|| ++.+|+
T Consensus 198 ~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~ei~ 266 (273)
T d1u46a_ 198 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG--ERLPRPEDCPQDIYNVMVQCWAHKPEDRP---TFVALR 266 (273)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC--CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC--CCCCCcccccHHHHHHHHHHcCCChhHCc---CHHHHH
Confidence 999999999998 899999999999988888743 3444446799999999999998 999999 899986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-53 Score=421.86 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=220.5
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEec-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 153 (518)
...++..++|++++.||+|+||+||+|+.+. +++.||||++++.. .....+.+.+|+.+|+.++||||+++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 3456677899999999999999999999763 56789999987543 3344677899999999999999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEE
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMRED------------------------TLTENVARFYIAQSVLAIESIHKHNYIH 209 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~~------------------------~l~e~~~~~~~~ql~~aL~~LH~~giiH 209 (518)
++.+.+.+++||||+++|+|.+++.... .+++..+..++.|++.||+|||++||||
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH 163 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence 9999999999999999999999996432 4889999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcc
Q 010116 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289 (518)
Q Consensus 210 RDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (518)
|||||+|||||.++++||+|||+|+.+.... ..
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~-----------------------------------------------~~ 196 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSAD-----------------------------------------------YY 196 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGG-----------------------------------------------CB
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCc-----------------------------------------------cc
Confidence 9999999999999999999999998653211 11
Q ss_pred cccccccCCCCccChhhhcCCCCCccccccchhHHHHHHHhCC-CCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHH
Q 010116 290 KLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY-PPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKD 368 (518)
Q Consensus 290 ~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~-~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~d 368 (518)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|. +||.+.+..+....+.... .+..| ..+++++.+
T Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-~~~~p--~~~~~~~~~ 273 (301)
T d1lufa_ 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYN 273 (301)
T ss_dssp C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHH
T ss_pred cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHH
Confidence 1233578999999999999999999999999999999999985 7899999888888877642 23333 478999999
Q ss_pred HHHHHhc-cccccCCCCChhhhhc
Q 010116 369 LICRLLC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 369 LI~~lL~-dp~~R~g~~~a~eil~ 391 (518)
||.+||+ ||.+|| ++.||.+
T Consensus 274 li~~cl~~~P~~RP---t~~ev~~ 294 (301)
T d1lufa_ 274 LMRLCWSKLPADRP---SFCSIHR 294 (301)
T ss_dssp HHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHcCCChhHCc---CHHHHHH
Confidence 9999998 999999 8999854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=423.32 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=214.5
Q ss_pred cCCCCeeEEeeEeecCceEEEEEEEecCCcE--EEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEEEeecCC
Q 010116 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNI--YAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (518)
Q Consensus 83 ~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~--~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 159 (518)
+..++|++.++||+|+||+||+|+++.+|.. ||||++.+.. .....+.+.+|+.+|..+ +|||||+++++|.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5568999999999999999999999998875 5667665432 333456789999999998 7999999999999999
Q ss_pred eEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g 223 (518)
.+|+|||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999654 5799999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccC
Q 010116 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (518)
Q Consensus 224 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 303 (518)
.+||+|||+|+..... ......+||+.|+|
T Consensus 165 ~~kl~DfG~a~~~~~~--------------------------------------------------~~~~~~~gt~~y~a 194 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY--------------------------------------------------VKKTMGRLPVRWMA 194 (309)
T ss_dssp CEEECCTTCEESSCEE--------------------------------------------------CCC----CCTTTCC
T ss_pred ceEEcccccccccccc--------------------------------------------------ccccceecCCcccc
Confidence 9999999999854311 01124579999999
Q ss_pred hhhhcCCCCCccccccchhHHHHHHHhCC-CCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccC
Q 010116 304 PEVLLKKGYGMECDWWSLGAIMYEMLVGY-PPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRL 381 (518)
Q Consensus 304 PEvl~~~~y~~~~DiWSlGvilyeml~G~-~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 381 (518)
||++.+..|+.++|||||||++|||++|. +||.+.+..+....+..+ ..+.+ +..+|+++++||.+||. ||++||
T Consensus 195 PE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-~~~~~--~~~~~~~~~~li~~cl~~dP~~RP 271 (309)
T d1fvra_ 195 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEK--PLNCDDEVYDLMRQCWREKPYERP 271 (309)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCCCC--CTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred hHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCCCC--CccCCHHHHHHHHHHcCCChhHCc
Confidence 99999999999999999999999999965 678888888888887764 23333 35789999999999998 999999
Q ss_pred CCCChhhhhcC
Q 010116 382 GTGGAHQIKAH 392 (518)
Q Consensus 382 g~~~a~eil~H 392 (518)
++.||++|
T Consensus 272 ---s~~eil~~ 279 (309)
T d1fvra_ 272 ---SFAQILVS 279 (309)
T ss_dssp ---CHHHHHHH
T ss_pred ---CHHHHHHH
Confidence 89999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=413.53 Aligned_cols=247 Identities=23% Similarity=0.403 Sum_probs=209.2
Q ss_pred CCcCCCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee-cCC
Q 010116 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DTE 159 (518)
Q Consensus 81 ~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-~~~ 159 (518)
|.+..++|++++.||+|+||.||+|+. +|+.||||+++++. ..+.+.+|+.+|+.++|||||++++++. +.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 567889999999999999999999987 47899999997643 3466889999999999999999999885 456
Q ss_pred eEEEEEeecCCCchHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccC
Q 010116 160 YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~--~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~ 237 (518)
.+||||||+++|+|.++|... ..+++..++.++.||+.||.|||+++||||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 789999999999999999654 369999999999999999999999999999999999999999999999999998543
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
.. ....+||+.|+|||++.+..|+.++|
T Consensus 155 ~~----------------------------------------------------~~~~~~~~~y~aPE~l~~~~~t~~sD 182 (262)
T d1byga_ 155 ST----------------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSD 182 (262)
T ss_dssp -----------------------------------------------------------CCTTTSCHHHHHHCCCCHHHH
T ss_pred CC----------------------------------------------------CccccccccCCChHHHhCCCCChHHH
Confidence 11 11456899999999999999999999
Q ss_pred ccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 318 WWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 318 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
||||||++|||++ |.+||...+..+....|.+. ..+.+| ..+++++++||.+||. ||.+|| ++.+|++|
T Consensus 183 IwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~cl~~dP~~Rp---s~~~l~~~ 253 (262)
T d1byga_ 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcccCHhHCc---CHHHHHHH
Confidence 9999999999998 79999998888888887653 234444 4689999999999998 999999 89988764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=418.31 Aligned_cols=258 Identities=22% Similarity=0.335 Sum_probs=216.4
Q ss_pred hcCCcCCCCeeEEeeEeecCceEEEEEEEecCC-------cEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeE
Q 010116 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSG-------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVK 150 (518)
Q Consensus 79 ~~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~t~-------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~ 150 (518)
+++.+..++|++++.||+|+||.||+|+...++ ..||||++++.. .......+.+|..++..+ +|||||+
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 457788899999999999999999999987654 479999997653 334456788898888888 8999999
Q ss_pred EEEEeecCCeEEEEEeecCCCchHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCC
Q 010116 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKP 214 (518)
Q Consensus 151 l~~~f~~~~~lylVmEy~~gG~L~~~l~~~----------------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKP 214 (518)
++++|.++..+|+|||||.||+|.++|... ..+++..+..++.||+.||+|||++|||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 999999999999999999999999999654 3589999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhccccccc
Q 010116 215 DNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294 (518)
Q Consensus 215 eNILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 294 (518)
+|||++.+|.+||+|||+++....... ......
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~-----------------------------------------------~~~~~~ 196 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDY-----------------------------------------------YKKTTN 196 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCT-----------------------------------------------TCCCTT
T ss_pred cceeecCCCCeEeccchhhcccccccc-----------------------------------------------cccccc
Confidence 999999999999999999986542210 011235
Q ss_pred ccCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHH
Q 010116 295 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRL 373 (518)
Q Consensus 295 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~l 373 (518)
.+||+.|+|||++.++.|+.++|||||||++|||++ |.+||.+.+.......+... ..+.+| ..+|+++++||.+|
T Consensus 197 ~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~c 273 (299)
T d1fgka_ 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKP--SNCTNELYMMMRDC 273 (299)
T ss_dssp SCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCC--SSCCHHHHHHHHHH
T ss_pred CCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccchHHHHHHHHHH
Confidence 689999999999999999999999999999999998 79999888887777666553 344444 57999999999999
Q ss_pred hc-cccccCCCCChhhhhc
Q 010116 374 LC-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 374 L~-dp~~R~g~~~a~eil~ 391 (518)
|. ||.+|| ++.||++
T Consensus 274 l~~dP~~Rp---s~~eil~ 289 (299)
T d1fgka_ 274 WHAVPSQRP---TFKQLVE 289 (299)
T ss_dssp TCSSGGGSC---CHHHHHH
T ss_pred ccCCHhHCc---CHHHHHH
Confidence 98 999999 8999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=416.23 Aligned_cols=258 Identities=23% Similarity=0.291 Sum_probs=222.2
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEe-----cCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHh-CCCceeEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 153 (518)
.+++..++|++.+.||+|+||.||+|+.. .+++.||||++++.. .......+.+|..+++.+ +|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 46677899999999999999999999864 466789999997653 234456788999999999 6999999999
Q ss_pred EeecCCeEEEEEeecCCCchHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010116 154 SFQDTEYLYLIMEYLPGGDMMTLLMRED------------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (518)
Q Consensus 154 ~f~~~~~lylVmEy~~gG~L~~~l~~~~------------------~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPe 215 (518)
++.+...+|||||||+||+|.+++.+.. .+++..+..|+.||+.||+|||++|||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999996543 5899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccc
Q 010116 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (518)
Q Consensus 216 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 295 (518)
|||++.++++||+|||+++....... .......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~-----------------------------------------------~~~~~~~ 207 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSN-----------------------------------------------YVVKGNA 207 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTT-----------------------------------------------SEECSSS
T ss_pred cccccccCcccccccchheeccCCCc-----------------------------------------------ceEeeec
Confidence 99999999999999999986542210 0122356
Q ss_pred cCCCCccChhhhcCCCCCccccccchhHHHHHHHh-CCCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHh
Q 010116 296 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLL 374 (518)
Q Consensus 296 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL 374 (518)
+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+....+.+++.....+..| ..+|+++++||.+||
T Consensus 208 ~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl 285 (311)
T d1t46a_ 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCW 285 (311)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHT
T ss_pred ccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHc
Confidence 89999999999999999999999999999999998 777787777777777777754444444 468999999999999
Q ss_pred c-cccccCCCCChhhhhc
Q 010116 375 C-DVEHRLGTGGAHQIKA 391 (518)
Q Consensus 375 ~-dp~~R~g~~~a~eil~ 391 (518)
. ||.+|| ++.+|++
T Consensus 286 ~~dP~~RP---s~~~il~ 300 (311)
T d1t46a_ 286 DADPLKRP---TFKQIVQ 300 (311)
T ss_dssp CSSGGGSC---CHHHHHH
T ss_pred CCChhHCc---CHHHHHH
Confidence 8 999999 8999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=415.84 Aligned_cols=264 Identities=17% Similarity=0.260 Sum_probs=225.9
Q ss_pred cCCcCCCCeeEEeeEeecCceEEEEEEEec-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEE
Q 010116 80 RHKICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (518)
Q Consensus 80 ~~~~~~~~f~i~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 154 (518)
.|.+..++|++++.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.+++.++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 467888999999999999999999998863 35789999997643 33455678999999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCc
Q 010116 155 FQDTEYLYLIMEYLPGGDMMTLLMRE----------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH 224 (518)
Q Consensus 155 f~~~~~lylVmEy~~gG~L~~~l~~~----------~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~ 224 (518)
+..+..+|+|||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||+||||+.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999998542 24788999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccCh
Q 010116 225 MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304 (518)
Q Consensus 225 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 304 (518)
+||+|||+|+.+..... .......+||+.|+||
T Consensus 172 ~Kl~DFGla~~~~~~~~-----------------------------------------------~~~~~~~~~t~~y~aP 204 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY-----------------------------------------------YRKGGKGLLPVRWMSP 204 (308)
T ss_dssp EEECCTTCCCGGGGGGC-----------------------------------------------EEGGGSSEECGGGCCH
T ss_pred EEEeecccceeccCCcc-----------------------------------------------eeeccceecccccCCH
Confidence 99999999986532210 0112345799999999
Q ss_pred hhhcCCCCCccccccchhHHHHHHHhC-CCCCCCCChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCC
Q 010116 305 EVLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYADDPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLG 382 (518)
Q Consensus 305 Evl~~~~y~~~~DiWSlGvilyeml~G-~~PF~~~~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g 382 (518)
|++.+..|+.++|||||||++|||++| .+||.+.+..+....+.... .+..| ..+|+++.+||.+||. ||.+||
T Consensus 205 e~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~P~~RP- 280 (308)
T d1p4oa_ 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRP- 280 (308)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC-
T ss_pred HHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCc--ccchHHHHHHHHHHcCCChhHCc-
Confidence 999999999999999999999999998 58898888888888887642 23333 4789999999999998 999999
Q ss_pred CCChhhhhc------CcccccC
Q 010116 383 TGGAHQIKA------HPWFKDV 398 (518)
Q Consensus 383 ~~~a~eil~------Hpff~~i 398 (518)
++.+|++ +|+|+.+
T Consensus 281 --s~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 281 --SFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp --CHHHHHHHHGGGSCTTHHHH
T ss_pred --CHHHHHHHHHHhcCCCCcCC
Confidence 8999987 6666543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-50 Score=405.98 Aligned_cols=263 Identities=20% Similarity=0.262 Sum_probs=202.9
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc-eeEEEEEeecCCeEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~~lylV 164 (518)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+..|..+++.++|++ |+.+++++.+....|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5699999999999999999999999999999998765321 23678999999998765 56666777888999999
Q ss_pred EeecCCCchHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC---CCcEEEeecccccccCCCc
Q 010116 165 MEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLCKPLDCST 240 (518)
Q Consensus 165 mEy~~gG~L~~~l-~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~---~g~vKL~DFGla~~~~~~~ 240 (518)
|||+ ||+|...+ .....+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+.+....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 55555555 44578999999999999999999999999999999999998764 5579999999999764321
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccc
Q 010116 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWS 320 (518)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 320 (518)
..... ......+.+||+.|||||++.+.+|+.++||||
T Consensus 161 ~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 198 (299)
T d1ckia_ 161 THQHI------------------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLES 198 (299)
T ss_dssp TCCBC------------------------------------------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHH
T ss_pred cccce------------------------------------------eccccCCcCCCccccCHHHHhCCCCCChhhEEe
Confidence 10000 001223678999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChhhHHHHHhhhcC-cccCCC---CCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCccc
Q 010116 321 LGAIMYEMLVGYPPFYADDPITTCRKIVHWRN-HLKFPD---DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWF 395 (518)
Q Consensus 321 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~l~~p~---~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff 395 (518)
|||++|||++|.+||...........+..... .+..|. ...+|+++.+||.+||. ||.+||....+.++++|+|.
T Consensus 199 lG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 199 LGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999987665544433322111 111111 23689999999999998 99999932223466788876
Q ss_pred c
Q 010116 396 K 396 (518)
Q Consensus 396 ~ 396 (518)
+
T Consensus 279 ~ 279 (299)
T d1ckia_ 279 R 279 (299)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=397.42 Aligned_cols=249 Identities=19% Similarity=0.293 Sum_probs=203.5
Q ss_pred EeeEeecCceEEEEEEEecCC---cEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCceeEEEEEee-cCCeEEEEEe
Q 010116 91 LTIIGRGAFGEVRLCREKKSG---NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DTEYLYLIME 166 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-~~~~lylVmE 166 (518)
.++||+|+||+||+|+...++ ..||||++++. ......+.+.+|+++|+.++|||||++++++. .+..+|+|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 678999999999999986543 36999998753 24455678999999999999999999999875 4678999999
Q ss_pred ecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeecccccccCCCcccccc
Q 010116 167 YLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (518)
Q Consensus 167 y~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 245 (518)
||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||||++++++||+|||+++.........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~-- 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS-- 187 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC--
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc--
Confidence 99999999998754 567888899999999999999999999999999999999999999999999998764321100
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCccccccchhHHH
Q 010116 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 325 (518)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 325 (518)
........||+.|+|||++.+..|+.++|||||||++
T Consensus 188 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl 224 (311)
T d1r0pa_ 188 -------------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224 (311)
T ss_dssp -------------------------------------------TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred -------------------------------------------ceecccccccccccChHHHhcCCCCChhHhhhhHHHH
Confidence 0112245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC-ChhhHHHHHhhhcCcccCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcC
Q 010116 326 YEMLVGYPPFYAD-DPITTCRKIVHWRNHLKFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 326 yeml~G~~PF~~~-~~~~~~~~i~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
|||++|..||... +.......+.... .+..| ..+++++.+||.+||. ||.+|| ++.||++|
T Consensus 225 ~El~t~~~p~~~~~~~~~~~~~i~~g~-~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~~ 287 (311)
T d1r0pa_ 225 WELMTRGAPPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 287 (311)
T ss_dssp HHHHTTSCCSCC------CHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCc--ccCcHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 9999977776553 4445555555532 33334 4689999999999998 999999 89999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-48 Score=390.49 Aligned_cols=255 Identities=18% Similarity=0.211 Sum_probs=206.2
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC-CceeEEEEEeecCCeEEE
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~~lyl 163 (518)
-++|++++.||+|+||+||+|++..+|+.||||++.+... ...+.+|.++++.+.| ++|+.+++++.+....|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4689999999999999999999999999999999865432 1236778899999976 899999999999999999
Q ss_pred EEeecCCCchHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCC-----CCcEEEeecccccccC
Q 010116 164 IMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-----NGHMKLSDFGLCKPLD 237 (518)
Q Consensus 164 VmEy~~gG~L~~~l~~~-~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~-----~g~vKL~DFGla~~~~ 237 (518)
||||+ ||+|.+++... ..+++..+..++.|++.||+|||++|||||||||+|||++. ++++||+|||+|+.+.
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999988765 57999999999999999999999999999999999999974 6789999999999764
Q ss_pred CCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCCCCCcccc
Q 010116 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (518)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 317 (518)
........ ......+.+||+.|||||++.+..|+.++|
T Consensus 158 ~~~~~~~~------------------------------------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~D 195 (293)
T d1csna_ 158 DPVTKQHI------------------------------------------PYREKKNLSGTARYMSINTHLGREQSRRDD 195 (293)
T ss_dssp CTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHH
T ss_pred cCccccce------------------------------------------eecccCceEEchhhcCHHHhcCCCCChHHH
Confidence 32110000 001123678999999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCChh---hHHHHHhhhcCcccCCC-CCCCChhHHHHHHHHhc-cccccCCCCChhhhh
Q 010116 318 WWSLGAIMYEMLVGYPPFYADDPI---TTCRKIVHWRNHLKFPD-DSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIK 390 (518)
Q Consensus 318 iWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil 390 (518)
||||||++|||++|.+||.+.... ....++...+.....+. ...+|+++.+||..|+. +|.+|| +.+.+.
T Consensus 196 iwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP---~y~~l~ 270 (293)
T d1csna_ 196 LEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP---DYDYLQ 270 (293)
T ss_dssp HHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC---CHHHHH
T ss_pred HHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCc---CHHHHH
Confidence 999999999999999999865433 33344443222111110 13688999999999998 999999 555544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-47 Score=392.31 Aligned_cols=273 Identities=25% Similarity=0.386 Sum_probs=207.0
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-----------CCceeEEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-----------SHCIVKLYYS 154 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-----------hp~Iv~l~~~ 154 (518)
++|+++++||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+|+.++ |+|||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 469999999999999999999999999999999987542 2345677888888775 5789999988
Q ss_pred ee--cCCeEEEEEeecCCCchHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCceeeCCCCc----
Q 010116 155 FQ--DTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGH---- 224 (518)
Q Consensus 155 f~--~~~~lylVmEy~~gG~L~~~l---~~~~~l~e~~~~~~~~ql~~aL~~LH~-~giiHRDIKPeNILld~~g~---- 224 (518)
+. .....++||+++.++...... .....+++..++.++.|++.||.|||+ +||+||||||+||||+.+|.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 75 456778888887666544333 234689999999999999999999998 89999999999999987764
Q ss_pred --EEEeecccccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCcc
Q 010116 225 --MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (518)
Q Consensus 225 --vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 302 (518)
+||+|||.|..... .....+||+.|+
T Consensus 169 ~~~kl~dfg~s~~~~~----------------------------------------------------~~~~~~gt~~y~ 196 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----------------------------------------------------HYTNSIQTREYR 196 (362)
T ss_dssp EEEEECCCTTCEETTB----------------------------------------------------CCCSCCSCGGGC
T ss_pred ceeeEeeccccccccc----------------------------------------------------cccccccccccc
Confidence 99999999875421 122568999999
Q ss_pred ChhhhcCCCCCccccccchhHHHHHHHhCCCCCCCCChhh------HHHHHhhhcC------------------------
Q 010116 303 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPIT------TCRKIVHWRN------------------------ 352 (518)
Q Consensus 303 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~~------------------------ 352 (518)
|||++.+.+|+.++|+||+||++++|++|++||...+... ....++...+
T Consensus 197 aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~ 276 (362)
T d1q8ya_ 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 276 (362)
T ss_dssp CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBS
T ss_pred ChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhh
Confidence 9999999999999999999999999999999997543211 1111111000
Q ss_pred ---cc-----------cCCCCCCCChhHHHHHHHHhc-cccccCCCCChhhhhcCcccccCCccccccccCCccccCCCc
Q 010116 353 ---HL-----------KFPDDSKLSPEAKDLICRLLC-DVEHRLGTGGAHQIKAHPWFKDVVWDKLYEMEAAFKPEINGE 417 (518)
Q Consensus 353 ---~l-----------~~p~~~~~s~~~~dLI~~lL~-dp~~R~g~~~a~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~ 417 (518)
.. .+......+++++|||.+||+ ||.+|+ +|.|||+||||+++.+. .++..|..|...+.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp---ta~e~L~Hp~f~~~~~~--~~~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 277 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDTLGM--EEIRVPDRELYGSG 351 (362)
T ss_dssp SCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTCTTC--TTCCCTTSCTTCBS
T ss_pred ccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc---CHHHHhcCcccCCCCCc--ccCCCCCcccCCCC
Confidence 00 000011246889999999999 999999 99999999999966532 33445555555443
Q ss_pred cc
Q 010116 418 LD 419 (518)
Q Consensus 418 ~d 419 (518)
.|
T Consensus 352 ~~ 353 (362)
T d1q8ya_ 352 SD 353 (362)
T ss_dssp TT
T ss_pred CC
Confidence 33
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=388.09 Aligned_cols=250 Identities=23% Similarity=0.284 Sum_probs=190.4
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHH--HHHHhCCCceeEEEEEeecCC----
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--LLAEVASHCIVKLYYSFQDTE---- 159 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~--il~~l~hp~Iv~l~~~f~~~~---- 159 (518)
.+|.+.+.||+|+||+||+|+. +|+.||||++.... ......|++ .+..++|||||++++++.+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 5789999999999999999975 68999999986542 223334444 445789999999999987653
Q ss_pred eEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCeEEcCCCCCceeeCCCCcEEEeecc
Q 010116 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK--------HNYIHRDIKPDNLLLDKNGHMKLSDFG 231 (518)
Q Consensus 160 ~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~--------~giiHRDIKPeNILld~~g~vKL~DFG 231 (518)
.+|+|||||++|+|.++|.+ ..++++....++.|++.||.|||+ +|||||||||+||||+.+|++||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 68999999999999999965 478999999999999999999996 599999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCCCCCCCCCCCCCCCCCCCCCchhHHHHHhhhcccccccccCCCCccChhhhcCC-
Q 010116 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK- 310 (518)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~- 310 (518)
+|+......... .......+||+.|||||++.+.
T Consensus 154 l~~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 188 (303)
T d1vjya_ 154 LAVRHDSATDTI---------------------------------------------DIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp TCEEEETTTTEE---------------------------------------------CC----CCSCGGGCCHHHHTTCS
T ss_pred ccccccCCCcce---------------------------------------------eccccceecccCcCChhhccccc
Confidence 998764321000 0112356899999999999764
Q ss_pred -----CCCccccccchhHHHHHHHhCCCCCCCCC--------------hhhHHHHHhh-hcCcccCCCC---CCCChhHH
Q 010116 311 -----GYGMECDWWSLGAIMYEMLVGYPPFYADD--------------PITTCRKIVH-WRNHLKFPDD---SKLSPEAK 367 (518)
Q Consensus 311 -----~y~~~~DiWSlGvilyeml~G~~PF~~~~--------------~~~~~~~i~~-~~~~l~~p~~---~~~s~~~~ 367 (518)
.|+.++|||||||+||||++|.+||.... ........+. ....+.+|.. ......+.
T Consensus 189 ~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~ 268 (303)
T d1vjya_ 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 268 (303)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHH
T ss_pred cccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHH
Confidence 26789999999999999999998874321 1111222221 1111222221 11224588
Q ss_pred HHHHHHhc-cccccCCCCChhhhhcC
Q 010116 368 DLICRLLC-DVEHRLGTGGAHQIKAH 392 (518)
Q Consensus 368 dLI~~lL~-dp~~R~g~~~a~eil~H 392 (518)
+||.+||. ||.+|| ++.||+++
T Consensus 269 ~li~~cl~~dp~~Rp---s~~ei~~~ 291 (303)
T d1vjya_ 269 KIMRECWYANGAARL---TALRIKKT 291 (303)
T ss_dssp HHHHTTCCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHcccCHhHCc---CHHHHHHH
Confidence 99999998 999999 89998763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=7.2e-27 Score=217.13 Aligned_cols=137 Identities=14% Similarity=0.154 Sum_probs=108.4
Q ss_pred eeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhh---------------chhhHHHHHHHHHHHHHhCCCceeEEE
Q 010116 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV---------------KRGQVEHVRAERNLLAEVASHCIVKLY 152 (518)
Q Consensus 88 f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~---------------~~~~~~~~~~E~~il~~l~hp~Iv~l~ 152 (518)
+.+.++||+|+||+||+|++. +|+.||||+++..... ..........|..++..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999874 7899999987643211 011123456788889999999999888
Q ss_pred EEeecCCeEEEEEeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCceeeCCCCcEEEeeccc
Q 010116 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (518)
Q Consensus 153 ~~f~~~~~lylVmEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL~~LH~~giiHRDIKPeNILld~~g~vKL~DFGl 232 (518)
++.. .++||||++++.+. .+++..+..++.|++.||.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6643 27999999886653 35666678899999999999999999999999999999865 489999999
Q ss_pred ccccC
Q 010116 233 CKPLD 237 (518)
Q Consensus 233 a~~~~ 237 (518)
|....
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 87653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=2e-07 Score=87.88 Aligned_cols=140 Identities=12% Similarity=0.078 Sum_probs=92.3
Q ss_pred CCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeecCCeEEEE
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLI 164 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylV 164 (518)
..|++.+..+.|+.+.||++. .+++.+.+|+...... .....+.+|..++..+. +-.+.+++++..+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 467777776666678999764 4567788888754422 22334677888888774 33467888888888999999
Q ss_pred EeecCCCchHHHHhhcCCCCHHHHHHHHHHHHHHH---------------------------------------------
Q 010116 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI--------------------------------------------- 199 (518)
Q Consensus 165 mEy~~gG~L~~~l~~~~~l~e~~~~~~~~ql~~aL--------------------------------------------- 199 (518)
|++++|..+........ ....++.++...|
T Consensus 89 ~~~l~G~~~~~~~~~~~-----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ-----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTCS-----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccccc-----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 99999987754431110 0111111222222
Q ss_pred --------HHHHh------CCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 200 --------ESIHK------HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 200 --------~~LH~------~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
..+.. ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 22222 1379999999999998776667999998874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.16 E-value=2.5e-06 Score=85.77 Aligned_cols=81 Identities=22% Similarity=0.295 Sum_probs=50.3
Q ss_pred EeeEeecCceEEEEEEEecCCcEEEEEEeech-hhhc---hhhHHHHHHHHHHHHHhC-C--CceeEEEEEeecCCeEEE
Q 010116 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS-EMVK---RGQVEHVRAERNLLAEVA-S--HCIVKLYYSFQDTEYLYL 163 (518)
Q Consensus 91 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~-~~~~---~~~~~~~~~E~~il~~l~-h--p~Iv~l~~~f~~~~~lyl 163 (518)
.+.||.|....||++....+++.|++|.-... .... .-...+...|..+|+.+. + ..+++++++ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999988777888999964321 1111 112345667888887763 2 346666654 3344578
Q ss_pred EEeecCCCch
Q 010116 164 IMEYLPGGDM 173 (518)
Q Consensus 164 VmEy~~gG~L 173 (518)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=2.4e-05 Score=72.68 Aligned_cols=135 Identities=13% Similarity=0.118 Sum_probs=82.2
Q ss_pred EeecC-ceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCC--CceeEEEEEeecCCeEEEEEeecCC
Q 010116 94 IGRGA-FGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDTEYLYLIMEYLPG 170 (518)
Q Consensus 94 LG~G~-fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~~~~lylVmEy~~g 170 (518)
+..|. -+.||++.. .++..+.+|.-.... ...+..|..+|+.+.. -.+.+++.+..+.+..|+||++++|
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 34444 468898764 456678888765432 2236678888877643 2367788888888899999999988
Q ss_pred CchHHH--------------HhhcCC-------CCHHH-------HHHHH---------------HHHHHHHHHHHhC--
Q 010116 171 GDMMTL--------------LMREDT-------LTENV-------ARFYI---------------AQSVLAIESIHKH-- 205 (518)
Q Consensus 171 G~L~~~--------------l~~~~~-------l~e~~-------~~~~~---------------~ql~~aL~~LH~~-- 205 (518)
-++... |.+-.. +.... ...+. ......+..+...
T Consensus 91 ~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 170 (255)
T d1nd4a_ 91 QDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP 170 (255)
T ss_dssp EETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred cccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCC
Confidence 655321 111000 00000 00000 0112223334332
Q ss_pred -----CeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 206 -----NYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 206 -----giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.+||+|+.|.|||++.++.+-|+||+.+..
T Consensus 171 ~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 171 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 389999999999998776678999998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.00033 Score=67.85 Aligned_cols=130 Identities=9% Similarity=0.182 Sum_probs=74.9
Q ss_pred ceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc--eeEEE-----EEeecCCeEEEEEeecCCC
Q 010116 99 FGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC--IVKLY-----YSFQDTEYLYLIMEYLPGG 171 (518)
Q Consensus 99 fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~-----~~f~~~~~lylVmEy~~gG 171 (518)
--.||+++. .+|..|++|+..... ...+.+..|..+|..+.... ++... ..+...+..+.|+++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 368998865 568889999976542 22355777888887774221 11111 1234567789999999873
Q ss_pred chH--------------HHHhh----c-----CC-------------------CCHHHHHHHHHHHHHHHHHHHh-----
Q 010116 172 DMM--------------TLLMR----E-----DT-------------------LTENVARFYIAQSVLAIESIHK----- 204 (518)
Q Consensus 172 ~L~--------------~~l~~----~-----~~-------------------l~e~~~~~~~~ql~~aL~~LH~----- 204 (518)
.+. ..+.. . .. ++......+...+-..++.+..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 321 11111 0 01 1111111222222233333322
Q ss_pred --CCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 205 --HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 205 --~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
.++||+|+.|.|||++. | ..++||+-|..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999974 4 45899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.10 E-value=0.00099 Score=66.09 Aligned_cols=78 Identities=22% Similarity=0.327 Sum_probs=52.8
Q ss_pred CCeeEEeeEeecCceEEEEEEEec-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhC-CCceeEEEEEeec
Q 010116 86 DDFELLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD 157 (518)
Q Consensus 86 ~~f~i~~~LG~G~fG~V~l~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~ 157 (518)
+++++ +.|+.|-.-.+|++.... ..+.|.+++.-.. ... ....+|..+++.+. +....+++++|.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETE-SHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 44544 678889999999998653 3456777776432 112 23557888888874 4445688888764
Q ss_pred CCeEEEEEeecCCCch
Q 010116 158 TEYLYLIMEYLPGGDM 173 (518)
Q Consensus 158 ~~~lylVmEy~~gG~L 173 (518)
.+||||++|-.|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 589999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.53 E-value=0.003 Score=60.09 Aligned_cols=144 Identities=14% Similarity=0.066 Sum_probs=76.5
Q ss_pred CCCeeEEeeEeecCceEEEEEEEecCCcEEEEEEeechhhhchhhHHHHHHHHHHHHHhCCCc--eeEEEE------Eee
Q 010116 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC--IVKLYY------SFQ 156 (518)
Q Consensus 85 ~~~f~i~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~------~f~ 156 (518)
.....-++.|..|---+.|++... +| .|++|+..+.. .. +.+..|.++|..+.... +..... ...
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CH---HHHHHHHHHHHhhhhccccccccceecCCCccee
Confidence 345555667778888899988643 34 58999986532 12 23455667777664221 111110 112
Q ss_pred cCCeEEEEEeecCCCchHH--------------HHhh---c------CCCCHH------------------HHHHHHHHH
Q 010116 157 DTEYLYLIMEYLPGGDMMT--------------LLMR---E------DTLTEN------------------VARFYIAQS 195 (518)
Q Consensus 157 ~~~~lylVmEy~~gG~L~~--------------~l~~---~------~~l~e~------------------~~~~~~~ql 195 (518)
-....+.++.++.|..... .+.. . ...... .....+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 2455677777777643211 1100 0 000010 111122222
Q ss_pred HHHHHHHHh----CCeEEcCCCCCceeeCCCCcEEEeecccccc
Q 010116 196 VLAIESIHK----HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (518)
Q Consensus 196 ~~aL~~LH~----~giiHRDIKPeNILld~~g~vKL~DFGla~~ 235 (518)
...+...+. .|+||+|+.++|||++.++..-|.||+.|..
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 333333322 4799999999999999887778999999863
|